Citrus Sinensis ID: 048668

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-----
Protein Sequence
LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM
Secondary Structure (PSIPRED)
cEEcccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHHcccccccEEcccccccccccHHccccccccEEccccccccccccHHHHcccccccEEEccccccEEcccHHHHHHccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEEEccEEEEcccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHHHcccccccEEccccccEEEcccccccccccccHHHHcccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEcccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEcccccccccHHHHHHHHHHHcccccccccEEEEccccccccccEEEEEEcccccccHHccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccHcccEEEEccccccccccHHHccccccEEEEEccccccccccHHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEcccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHcHccccccEEEEEcccccccccccccccccccccHHHcccHcHHHHEEccccccEEcccHHHHHcccccEEEccccEEEEEccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHccccccEEEEccccccccccccccEccccHHHHcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHcHHHHHHHEEEEEccccccccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHHcccccccccccccccEEEEEccEcccccHHccc
Coil and Loop (DISEMBL)
LEGQIPKEIGSLFKLQALALAGnyltgklpdfIGNLSALQVIHIkgnslggkfpttLGLLRNLVQLNVAEnkfygmfprsicnissleyfyltsnrfsgslpfdivvnlpnlkelgigannffglipdslsnasnlelldlsnnqfkgkvsidfSSLKILWRLNLEqnnlgigaandlGFVTFLTNcsslkvlslsdnqfggelphsIANLSSTMIVFLIggnqisgtiplgIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNflqgsipsglgnltklakldlgsnslqgnFIASQNKLIGALPQQLLSITTLSLYLDLSnnllngslpqqvgnlKNLIILDissnqfsgmipvtLSTCvsleyvdissncfhgiippslgflksIKFLDvscnnfsgqfpkfleNLSFLEFLNLSYnhlegevptkgvfsnkskiplqgnvrlcggidelhlpscpsrgsrklKITLLKVLIPVAVSCWILFSCLTIVYARRrrsahnsadtspmekqfpMVSYAELSKatsefsssnmigqgsfgsvykgilgedEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIcsstdfkgvDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLhhhcqppmvhgdlkpsnvlldhdmvahVGDFGLAKFlsshhldtssktpsssigikgtvgyvapgkffm
Flexible Loop (DISEMBL)
LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSahnsadtspmekqFPMVSYAELSKATSefsssnmigqGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITicsstdfkgVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDtssktpsssigikgtvgyvapgkffm
Low Complexity Region (SEG)
LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTlslyldlsnnllngslPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKflenlsfleflnlsYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM
Disordered region (IsUnstruct)
********IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYAR*******************************************FGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS***************IKGTVGYVA******
Disordered Region (DISOPRED)
LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGID********************KVLIPVAVSCWILFSCLTIVY********************PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS***************GIKGTVGYVAPGKFFM
Disordered Region (DISEMBL)
LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRR************EKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH************IGIKGTVGYVAPGKFFM
Disordered Region (DISPRO)
*EGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSA********MEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH********PSSSIGIKGTVGYVAPGKFFM
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	725	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.984	0.706	0.425	1e-161
C0LGT6	1031	LRR receptor-like serine/	no	no	0.966	0.679	0.437	1e-158
Q9SD62	1025	Putative receptor-like pr	no	no	0.986	0.697	0.453	1e-150
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.975	0.721	0.353	1e-101
Q9FL28	1173	LRR receptor-like serine/	no	no	0.971	0.600	0.334	1e-101
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.965	0.559	0.324	2e-96
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.958	0.556	0.338	1e-93
O49318	1124	Probable leucine-rich rep	no	no	0.953	0.614	0.314	3e-90
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.907	0.629	0.322	5e-90
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.942	0.681	0.328	2e-89

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  568 bits (1465), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 318/747 (42%), Positives = 467/747 (62%), Gaps = 33/747 (4%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G +P E+GSL  L  L L GN + GKLP  +GNL+ L+ + +  N+L G+ P+ +  L
Sbjct: 150 LGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQL 209

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
             +  L +  N F G+FP ++ N+SSL+   +  N FSG L  D+ + LPNL    +G N
Sbjct: 210 TQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGN 269

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
            F G IP +LSN S LE L ++ N   G +   F ++  L  L L  N+LG  ++ DL F
Sbjct: 270 YFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEF 328

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +T LTNC+ L+ L +  N+ GG+LP SIANLS+ ++   +GG  ISG+IP  I NL+NL 
Sbjct: 329 LTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQ 388

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG- 299
            L ++ N L G +P  +G+L NL+ L L+ N L G IP+ +GN+T L  LDL +N  +G 
Sbjct: 389 KLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGI 448

Query: 300 ------------NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
                             NKL G +P +++ I  L L LD+S N L GSLPQ +G L+NL
Sbjct: 449 VPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGSLPQDIGALQNL 507

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             L +  N+ SG +P TL  C+++E + +  N F+G IP  L  L  +K +D+S N+ SG
Sbjct: 508 GTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSG 566

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPS 467
             P++  + S LE+LNLS+N+LEG+VP KG+F N + + + GN  LCGGI    L  C S
Sbjct: 567 SIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLS 626

Query: 468 RG-------SRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSP--MEKQ 518
           +        S +LK  ++ V + + +   +  + +T+++ R+R+    + + +P  +E  
Sbjct: 627 QAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVL 686

Query: 519 FPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA 578
              +SY +L  AT+ FSSSNM+G GSFG+VYK +L  ++ +VAVKV+N++++GA +SF+A
Sbjct: 687 HEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMA 746

Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC--- 635
           ECE+L++IRHRNL+K++T CSS DF+G +F+AL++E+M NGSL+ WLH   ++VE     
Sbjct: 747 ECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP--EEVEEIHRP 804

Query: 636 --KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
              L+L++RLNIAIDVAS ++YLH HC  P+ H DLKPSNVLLD D+ AHV DFGLA+ L
Sbjct: 805 SRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLL 864

Query: 694 SSHHLDTSSKTPSSSIGIKGTVGYVAP 720
                + S     SS G++GT+GY AP
Sbjct: 865 LKFD-EESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  558 bits (1439), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 330/755 (43%), Positives = 458/755 (60%), Gaps = 54/755 (7%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
           +P E+GSL KL  L L+ N LTG  P  +GNL++LQ +    N + G+ P  +  L  +V
Sbjct: 161 VPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMV 220

Query: 65  QLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
              +A N F G FP ++ NISSLE   L  N FSG+L  D    LPNL+ L +G N F G
Sbjct: 221 FFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTG 280

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
            IP +L+N S+LE  D+S+N   G + + F  L+ LW L +  N+LG  +++ L F+  +
Sbjct: 281 AIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAV 340

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
            NC+ L+ L +  N+ GGELP SIANLS+T+    +G N ISGTIP  I NLV+L  L++
Sbjct: 341 ANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSL 400

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIAS 304
           E N L G +P   G+L NLQ++ LY N + G IPS  GN+T+L KL L SNS  G    S
Sbjct: 401 ETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQS 460

Query: 305 -------------QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILD 351
                         N+L G +PQ++L I +L+ Y+DLSNN L G  P++VG L+ L+ L 
Sbjct: 461 LGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLG 519

Query: 352 ISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK 411
            S N+ SG +P  +  C+S+E++ +  N F G I P +  L S+K +D S NN SG+ P+
Sbjct: 520 ASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAI-PDISRLVSLKNVDFSNNNLSGRIPR 578

Query: 412 FLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGS- 470
           +L +L  L  LNLS N  EG VPT GVF N + + + GN  +CGG+ E+ L  C  + S 
Sbjct: 579 YLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASP 638

Query: 471 RKLK---------------ITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPM 515
           RK K               I  L ++I VA  CW +          +R+  +N++D +P 
Sbjct: 639 RKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFM----------KRKKKNNASDGNPS 688

Query: 516 EKQ-----FPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK 570
           +          VSY EL  ATS FSS+N+IG G+FG+V+KG+LG +  +VAVKV+NL + 
Sbjct: 689 DSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKH 748

Query: 571 GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH---- 626
           GA +SF+AECE  + IRHRNL+K+IT+CSS D +G DF+ALV+E+M  GSL+ WL     
Sbjct: 749 GATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDL 808

Query: 627 -QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
            + ND      L+  ++LNIAIDVASA+EYLH HC  P+ H D+KPSN+LLD D+ AHV 
Sbjct: 809 ERVNDHSR--SLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVS 866

Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+ L  +  + S     SS G++GT+GY AP
Sbjct: 867 DFGLAQLLYKYDRE-SFLNQFSSAGVRGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  533 bits (1374), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 339/748 (45%), Positives = 470/748 (62%), Gaps = 33/748 (4%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           LE  +P E GSL KL  L+L  N LTGK P  +GNL++LQ++    N + G+ P  +  L
Sbjct: 165 LEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARL 224

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           + ++   +A NKF G+FP  I N+SSL +  +T N FSG+L  D    LPNL+ L +G N
Sbjct: 225 KQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGIN 284

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +F G IP++LSN S+L  LD+ +N   GK+ + F  L+ L  L L  N+LG  ++ DL F
Sbjct: 285 SFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDF 344

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +  LTNCS L+ L++  N+ GG+LP  IANLS+ +    +GGN ISG+IP GI NLV+L 
Sbjct: 345 LGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQ 404

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L +  N L G +P  +GEL  L+ + LY N L G IPS LGN++ L  L L +NS +G+
Sbjct: 405 TLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGS 464

Query: 301 FIAS-------------QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
             +S              NKL G++P +L+ + +L + L++S NLL G L Q +G LK L
Sbjct: 465 IPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKLKFL 523

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
           + LD+S N+ SG IP TL+ C+SLE++ +  N F G IP   G L  ++FLD+S NN SG
Sbjct: 524 LALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSG 582

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC-- 465
             P+++ N S L+ LNLS N+ +G VPT+GVF N S + + GN+ LCGGI  L L  C  
Sbjct: 583 TIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSV 642

Query: 466 --PSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRR----RSAHNSADT--SPMEK 517
             P R S   KI  + V   +A    +    + + + + R    R+ +N  D   SP++ 
Sbjct: 643 ELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKS 702

Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV 577
            +  +SY EL K T  FSSSN+IG G+FG+V+KG LG     VA+KV+NL ++GA +SF+
Sbjct: 703 FYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFI 762

Query: 578 AECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC-- 635
           AECEAL  IRHRNL+K++TICSS+DF+G DF+ALV+E+M NG+L+ WLH   D++E    
Sbjct: 763 AECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIEETGN 820

Query: 636 ---KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF 692
               L L  RLNIAIDVASA+ YLH +C  P+ H D+KPSN+LLD D+ AHV DFGLA+ 
Sbjct: 821 PSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQL 880

Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           L     DT      SS G++GT+GY AP
Sbjct: 881 LLKFDRDT-FHIQFSSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  369 bits (946), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 276/780 (35%), Positives = 405/780 (51%), Gaps = 73/780 (9%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNL-SALQVIHIKGNSLGGKFPTTLGL 59
           L G+I   I +L  L  L L+ N+  GK+P  IG+L   L+ + +  N L G  P  LGL
Sbjct: 78  LGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGL 137

Query: 60  LRNLVQLNVAENKFYGMFPRSI-CN--ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG 116
           L  LV L++  N+  G  P  + CN   SSL+Y  L++N  +G +P +   +L  L+ L 
Sbjct: 138 LNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLL 197

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKV-SIDFSSLKILWRLNLEQNNLGIGAA 175
           + +N   G +P SLSN++NL+ +DL +N   G++ S   S +  L  L L  N+  +   
Sbjct: 198 LWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHF-VSHN 256

Query: 176 NDLGFVTF---LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG 232
           N+     F   L N S L+ L L+ N  GGE+  S+ +LS  ++   +  N+I G+IP  
Sbjct: 257 NNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPE 316

Query: 233 I---------------------RNLVNLIALA---VEVNQLHGTIPDVIGELKNLQLLGL 268
           I                     R L  L  L    +  N L G IP  +G++  L LL +
Sbjct: 317 ISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDV 376

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIA-------------SQNKLIGALPQQ 315
            +N L GSIP   GNL++L +L L  N L G                 S N L G +P +
Sbjct: 377 SRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVE 436

Query: 316 LLS-ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYV 374
           ++S +  L LYL+LS+N L+G +P ++  +  ++ +D+SSN+ SG IP  L +C++LE++
Sbjct: 437 VVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHL 496

Query: 375 DISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP 434
           ++S N F   +P SLG L  +K LDVS N  +G  P   +  S L+ LN S+N L G V 
Sbjct: 497 NLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVS 556

Query: 435 TKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSCWILFSC 494
            KG FS  +     G+  LCG I  +   +C  +  +   + L  +L  +A     +F  
Sbjct: 557 DKGSFSKLTIESFLGDSLLCGSIKGMQ--AC-KKKHKYPSVLLPVLLSLIATPVLCVFGY 613

Query: 495 LTIVYAR--RRRSAHNSADTSPMEKQ------FPMVSYAELSKATSEFSSSNMIGQGSFG 546
             +  +R  +  + +   +    EKQ      +P +SY +L  AT  F++S++IG G FG
Sbjct: 614 PLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFG 673

Query: 547 SVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSTDFKG 605
            VYKG+L  +   VAVKV++ K    F  SF  EC+ L+  RHRNLI+IIT CS      
Sbjct: 674 HVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKP---- 728

Query: 606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV 665
             F ALV   M NGSLE  L+    +     L LIQ +NI  DVA  I YLHH+    +V
Sbjct: 729 -GFNALVLPLMPNGSLERHLYPG--EYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVV 785

Query: 666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG-----IKGTVGYVAP 720
           H DLKPSN+LLD +M A V DFG+++ +     +T S   S S G     + G+VGY+AP
Sbjct: 786 HCDLKPSNILLDDEMTALVTDFGISRLVQGVE-ETVSTDDSVSFGSTDGLLCGSVGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  368 bits (945), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 275/821 (33%), Positives = 410/821 (49%), Gaps = 117/821 (14%)

Query: 1    LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            LEG IP EIG+   L  L L  N LTGK+P  +GNL  LQ + I  N L    P++L  L
Sbjct: 252  LEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRL 311

Query: 61   RNLVQLNVAEN------------------------KFYGMFPRSICNISSLEYFYLTSNR 96
              L  L ++EN                         F G FP+SI N+ +L    +  N 
Sbjct: 312  TQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNN 371

Query: 97   FSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSS 156
             SG LP D+ + L NL+ L    N   G IP S+SN + L+LLDLS+NQ  G++   F  
Sbjct: 372  ISGELPADLGL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGR 430

Query: 157  LKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMI 216
            + + + +++ +N+      +D+       NCS+L+ LS++DN   G L   I  L   + 
Sbjct: 431  MNLTF-ISIGRNHFTGEIPDDI------FNCSNLETLSVADNNLTGTLKPLIGKLQK-LR 482

Query: 217  VFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGS 276
            +  +  N ++G IP  I NL +L  L +  N   G IP  +  L  LQ L +Y N L+G 
Sbjct: 483  ILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGP 542

Query: 277  IPSGLGNLTKLAKLDLGSN-------------------SLQGN----------------- 300
            IP  + ++  L+ LDL +N                   SLQGN                 
Sbjct: 543  IPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLN 602

Query: 301  -FIASQNKLIGALPQQLL-SITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
             F  S N L G +P +LL S+  + LYL+ SNNLL G++P+++G L+ +  +D+S+N FS
Sbjct: 603  TFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFS 662

Query: 359  GMIPVTLSTCVSLEYVD-------------------------ISSNCFHGIIPPSLGFLK 393
            G IP +L  C ++  +D                         +S N F G IP S G + 
Sbjct: 663  GSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMT 722

Query: 394  SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRL 453
             +  LD+S NN +G+ P+ L NLS L+ L L+ N+L+G VP  GVF N +   L GN  L
Sbjct: 723  HLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDL 782

Query: 454  CGGIDELHLPSCPSRGSRKLKITLLKVLI-------PVAVSCWILFSCLTIVYARRRRSA 506
            CG    L   +   + S   K T + ++I        + +   ++ +C      +   S+
Sbjct: 783  CGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSS 842

Query: 507  HNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 566
             +S        +       EL +AT  F+S+N+IG  S  +VYKG L ED  ++AVKV+N
Sbjct: 843  ESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLN 901

Query: 567  LKQKGAF--RSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW 624
            LK+  A   + F  E + L  ++HRNL+KI+       ++    KALV  +M NG+LED 
Sbjct: 902  LKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDT 957

Query: 625  LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
            +H S   +     SL++++++ + +AS I+YLH     P+VH DLKP+N+LLD D VAHV
Sbjct: 958  IHGSAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHV 1013

Query: 685  GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM 725
             DFG A+ L          T +S+   +GT+GY+AP   +M
Sbjct: 1014 SDFGTARILGFRE---DGSTTASTSAFEGTIGYLAPEFAYM 1051

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  353 bits (906), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 259/799 (32%), Positives = 389/799 (48%), Gaps = 99/799 (12%)

Query: 1    LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            L G+IP EI +   L+ L L+ N LTG++PD +  L  L  +++  NSL G   +++  L
Sbjct: 349  LSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNL 408

Query: 61   RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
             NL +  +  N   G  P+ I  +  LE  YL  NRFSG +P +I  N   L+E+    N
Sbjct: 409  TNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIG-NCTRLQEIDWYGN 467

Query: 121  NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
               G IP S+    +L  L L  N+  G +     +   +  ++L  N L     +  GF
Sbjct: 468  RLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGF 527

Query: 181  VTFLTNCSSLKVLSLSDNQFGGELPHSIANL----------------------SSTMIVF 218
            +T      +L++  + +N   G LP S+ NL                      SS+ + F
Sbjct: 528  LT------ALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSF 581

Query: 219  LIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP 278
             +  N   G IPL +    NL  L +  NQ  G IP   G++  L LL + +N L G IP
Sbjct: 582  DVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIP 641

Query: 279  SGLGNLTKLAKLDLGSNSLQG-------------NFIASQNKLIGALPQQLLSITT-LSL 324
              LG   KL  +DL +N L G                 S NK +G+LP ++ S+T  L+L
Sbjct: 642  VELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTL 701

Query: 325  YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGI 384
            +LD   N LNGS+PQ++GNL+ L  L++  NQ SG +P T+     L  + +S N   G 
Sbjct: 702  FLD--GNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGE 759

Query: 385  IPPSLGFLKSIK-FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP--------- 434
            IP  +G L+ ++  LD+S NNF+G+ P  +  L  LE L+LS+N L GEVP         
Sbjct: 760  IPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSL 819

Query: 435  -------------TKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLK-ITLLKV 480
                          K  FS        GN  LCG      L  C   GS+  + ++   V
Sbjct: 820  GYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTV 875

Query: 481  LIPVAVSCWILFSCLTIVYA----------RRRRSAHNSADTSPMEKQFPMVS------- 523
            +I  A+S     + + +V            ++ R  +++  ++    Q P+ S       
Sbjct: 876  VIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSD 935

Query: 524  --YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE 581
              + ++ +AT   +   MIG G  G VYK  L   E I   K++      + +SF  E +
Sbjct: 936  IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVK 995

Query: 582  ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
             L  IRHR+L+K++  CSS   K      L++EYM NGS+ DWLH + +  +   L    
Sbjct: 996  TLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052

Query: 642  RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
            RL IA+ +A  +EYLH+ C PP+VH D+K SNVLLD ++ AH+GDFGLAK L+ ++ DT+
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNY-DTN 1111

Query: 702  SKTPSSSIGIKGTVGYVAP 720
            ++   S+    G+ GY+AP
Sbjct: 1112 TE---SNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  344 bits (883), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 266/786 (33%), Positives = 381/786 (48%), Gaps = 91/786 (11%)

Query: 1    LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            L G IP+ +  L +L  L L  N L G L   I NL+ LQ + +  N+L GK P  +  L
Sbjct: 372  LAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISAL 431

Query: 61   RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
            R L  L + EN+F G  P+ I N +SL+   +  N F G +P  I   L  L  L +  N
Sbjct: 432  RKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQN 490

Query: 121  NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDL-- 178
               G +P SL N   L +LDL++NQ  G +   F  LK L +L L  N+L     + L  
Sbjct: 491  ELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLIS 550

Query: 179  ---------------GFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGN 223
                           G +  L   SS     +++N F  E+P  + N S  +    +G N
Sbjct: 551  LRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGN-SQNLDRLRLGKN 609

Query: 224  QISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN 283
            Q++G IP  +  +  L  L +  N L GTIP  +   K L  + L  NFL G IP  LG 
Sbjct: 610  QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669

Query: 284  LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGN 343
            L++L +L L           S N+ + +LP +L + T L L L L  N LNGS+PQ++GN
Sbjct: 670  LSQLGELKL-----------SSNQFVESLPTELFNCTKL-LVLSLDGNSLNGSIPQEIGN 717

Query: 344  LKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIK-FLDVSC 402
            L  L +L++  NQFSG +P  +     L  + +S N   G IP  +G L+ ++  LD+S 
Sbjct: 718  LGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSY 777

Query: 403  NNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP----------------------TKGVFS 440
            NNF+G  P  +  LS LE L+LS+N L GEVP                       K  FS
Sbjct: 778  NNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFS 837

Query: 441  NKSKIPLQGNVRLCGGIDELHLPSCPSRGS--RKLKITLLKVLIPVAVSCWILFSCLTIV 498
                    GN  LCG      L  C    S  ++  ++   V+I  A+S       + +V
Sbjct: 838  RWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILV 893

Query: 499  YA---RRRR----------SAHNSADTSPMEKQFPM---------VSYAELSKATSEFSS 536
             A   ++R           +A+ S+ +S      P+         + + ++ +AT   S 
Sbjct: 894  IALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSE 953

Query: 537  SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
              MIG G  G VYK  L   E +   K++      + +SF  E + L  IRHR+L+K++ 
Sbjct: 954  EFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013

Query: 597  ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK--LSLIQRLNIAIDVASAIE 654
             CSS   K      L++EYM NGS+ DWLH+    +E  K  L    RL IA+ +A  +E
Sbjct: 1014 YCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVE 1070

Query: 655  YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
            YLHH C PP+VH D+K SNVLLD +M AH+GDFGLAK L + + DT++    S+     +
Sbjct: 1071 YLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL-TENCDTNT---DSNTWFACS 1126

Query: 715  VGYVAP 720
             GY+AP
Sbjct: 1127 YGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  333 bits (854), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 247/786 (31%), Positives = 381/786 (48%), Gaps = 95/786 (12%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           + G++PKEIG L KLQ + L  N  +G +P  IGNL++L+ + + GNSL G  P+ +G +
Sbjct: 241 ISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNM 300

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           ++L +L + +N+  G  P+ +  +S +     + N  SG +P ++   +  L+ L +  N
Sbjct: 301 KSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELS-KISELRLLYLFQN 359

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
              G+IP+ LS   NL  LDLS N   G +   F +L  + +L L  N+L       LG 
Sbjct: 360 KLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGL 419

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
                  S L V+  S+NQ  G++P  I    S +I+  +G N+I G IP G+    +L+
Sbjct: 420 Y------SPLWVVDFSENQLSGKIPPFICQ-QSNLILLNLGSNRIFGNIPPGVLRCKSLL 472

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L V  N+L G  P  + +L NL  + L +N   G +P  +G   KL +L L +N    N
Sbjct: 473 QLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSN 532

Query: 301 -------------FIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
                        F  S N L G +P ++ +   L   LDLS N   GSLP ++G+L  L
Sbjct: 533 LPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQ-RLDLSRNSFIGSLPPELGSLHQL 591

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKF-LDVSCNNFS 406
            IL +S N+FSG IP T+     L  + +  N F G IPP LG L S++  +++S N+FS
Sbjct: 592 EILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFS 651

Query: 407 GQFPKFLENLSFLEFL------------------------NLSYNHLEGEVPTKGVFSNK 442
           G+ P  + NL  L +L                        N SYN+L G++P   +F N 
Sbjct: 652 GEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNM 711

Query: 443 SKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKV--------------------LI 482
           +     GN  LCGG    HL SC    S    I+ LK                     L+
Sbjct: 712 TLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLL 767

Query: 483 PVAVSCWILFSCL--TIVYARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMI 540
            +A+    L + +  T  Y   +      +D   + K+    +  ++ +AT  F  S ++
Sbjct: 768 LIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE--RFTVKDILEATKGFHDSYIV 825

Query: 541 GQGSFGSVYKGILGEDEMIVAVKV------INLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           G+G+ G+VYK ++   + I   K+       N        SF AE   L  IRHRN++++
Sbjct: 826 GRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRL 885

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            + C     +G +   L++EYM  GSL + LH          +    R  IA+  A  + 
Sbjct: 886 YSFCY---HQGSNSNLLLYEYMSRGSLGELLHGGKSH----SMDWPTRFAIALGAAEGLA 938

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           YLHH C+P ++H D+K +N+L+D +  AHVGDFGLAK +        SK+ S+   + G+
Sbjct: 939 YLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM----PLSKSVSA---VAGS 991

Query: 715 VGYVAP 720
            GY+AP
Sbjct: 992 YGYIAP 997

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  332 bits (852), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 238/738 (32%), Positives = 355/738 (48%), Gaps = 80/738 (10%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G+IP EIG++  L  L+L  N LTG +P  +GN+  L V+H+  N L G  P  LG +
Sbjct: 274 LSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEM 333

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
            +++ L ++ENK  G  P S   +++LE+ +L  N+ SG +P  I  N   L  L +  N
Sbjct: 334 ESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGI-ANSTELTVLQLDTN 392

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           NF G +PD++     LE L L +N F+G V       K L R+  + N+     +   G 
Sbjct: 393 NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
                   +L  + LS+N F G+L  +    S  ++ F++  N I+G IP  I N+  L 
Sbjct: 453 Y------PTLNFIDLSNNNFHGQLSANWEQ-SQKLVAFILSNNSITGAIPPEIWNMTQLS 505

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L +  N++ G +P+ I  +  +  L L  N L G IPSG+  LT L  LDL S      
Sbjct: 506 QLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSS------ 559

Query: 301 FIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGM 360
                N+    +P  L ++  L  Y++LS N L+ ++P+ +  L  L +LD+S NQ  G 
Sbjct: 560 -----NRFSSEIPPTLNNLPRL-YYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGE 613

Query: 361 IPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLE 420
           I     +  +LE +D+S N   G IPPS   + ++  +DVS NN                
Sbjct: 614 ISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNN---------------- 657

Query: 421 FLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELH-LPSC---PSRGSRKLKIT 476
                   L+G +P    F N      +GN  LCG ++    L  C    S+ S K +  
Sbjct: 658 --------LQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNL 709

Query: 477 LLKVLIPVAVSCWILFSC--LTIVYARRRRSAHNSADTSPMEKQFPM------VSYAELS 528
           ++ +L+P+  +  IL  C  + I + +R +      D+    +   +      V Y E+ 
Sbjct: 710 IIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEII 769

Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEA 582
           KAT EF    +IG G  G VYK  L     I+AVK +N      +      + F+ E  A
Sbjct: 770 KATGEFDPKYLIGTGGHGKVYKAKL--PNAIMAVKKLNETTDSSISNPSTKQEFLNEIRA 827

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           L  IRHRN++K+   CS    +   F  LV+EYM  GSL   L   ND  E  KL   +R
Sbjct: 828 LTEIRHRNVVKLFGFCS---HRRNTF--LVYEYMERGSLRKVLE--NDD-EAKKLDWGKR 879

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           +N+   VA A+ Y+HH   P +VH D+   N+LL  D  A + DFG AK L     D+S+
Sbjct: 880 INVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKP---DSSN 936

Query: 703 KTPSSSIGIKGTVGYVAP 720
            +      + GT GYVAP
Sbjct: 937 WS-----AVAGTYGYVAP 949

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  330 bits (847), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 245/746 (32%), Positives = 377/746 (50%), Gaps = 63/746 (8%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G +P  + +L +L+ L L GNY +GK+P   G    L+ + + GN L GK P  +G L
Sbjct: 154 LTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNL 213

Query: 61  RNLVQLNVAE-NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
             L +L +   N F    P  I N+S L  F   +   +G +P +I   L  L  L +  
Sbjct: 214 TTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIG-KLQKLDTLFLQV 272

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
           N F G I   L   S+L+ +DLSNN F G++   FS LK L  LNL +N L  GA  +  
Sbjct: 273 NAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKL-YGAIPE-- 329

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
              F+     L+VL L +N F G +P  +   +  +++  +  N+++GT+P  + +   L
Sbjct: 330 ---FIGEMPELEVLQLWENNFTGSIPQKLGE-NGRLVILDLSSNKLTGTLPPNMCSGNRL 385

Query: 240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG 299
           + L    N L G+IPD +G+ ++L  + + +NFL GSIP  L  L KL++++L  N L G
Sbjct: 386 MTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTG 445

Query: 300 NFIAS--------------QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLK 345
               S               N+L G+LP  + +++ +   L L  N  +GS+P ++G L+
Sbjct: 446 ELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLL-LDGNKFSGSIPPEIGRLQ 504

Query: 346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
            L  LD S N FSG I   +S C  L +VD+S N   G IP  L  +K + +L++S N+ 
Sbjct: 505 QLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHL 564

Query: 406 SGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC 465
            G  P  + ++  L  ++ SYN+L G VP+ G FS  +     GN  LCG     +L  C
Sbjct: 565 VGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGP----YLGPC 620

Query: 466 PSRGSRKLKITLLKVLIPVAVS-----CWILFSCLTIVYARRRRSAHNSADTSPMEKQFP 520
             +G+ +  +  L     + +      C ++F+ + I+ AR  R+A  +       K + 
Sbjct: 621 -GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEA-------KAWR 672

Query: 521 MVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS- 575
           + ++  L     +        N+IG+G  G VYKG + + ++ VAVK +     G+    
Sbjct: 673 LTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDL-VAVKRLATMSHGSSHDH 731

Query: 576 -FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV 634
            F AE + L  IRHR++++++  CS+      +   LV+EYM NGSL + LH        
Sbjct: 732 GFNAEIQTLGRIRHRHIVRLLGFCSNH-----ETNLLVYEYMPNGSLGEVLHGKKGG--- 783

Query: 635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
             L    R  IA++ A  + YLHH C P +VH D+K +N+LLD +  AHV DFGLAKFL 
Sbjct: 784 -HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 842

Query: 695 SHHLDTSSKTPSSSIGIKGTVGYVAP 720
                  S T      I G+ GY+AP
Sbjct: 843 ------DSGTSECMSAIAGSYGYIAP 862

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	725
359482058	1040	PREDICTED: probable LRR receptor-like se	0.984	0.686	0.498	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.984	0.375	0.497	0.0
357505893	1003	Receptor kinase-like protein [Medicago t	0.980	0.708	0.470	0.0
255553269	2793	receptor-kinase, putative [Ricinus commu	0.987	0.256	0.478	0.0
357497603	1027	CCP [Medicago truncatula] gi|355494105|g	0.986	0.696	0.485	0.0
449440269	1041	PREDICTED: probable LRR receptor-like se	0.993	0.691	0.478	0.0
224081190	1011	predicted protein [Populus trichocarpa]	0.980	0.703	0.488	0.0
357484501	1006	Kinase-like protein [Medicago truncatula	0.977	0.704	0.496	1e-180
224090977	1034	predicted protein [Populus trichocarpa]	0.986	0.691	0.477	1e-178
356566660	1020	PREDICTED: probable LRR receptor-like se	0.980	0.697	0.472	1e-178

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/744 (49%), Positives = 487/744 (65%), Gaps = 30/744 (4%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G+IP  +GS  K+  + L  N LTG +PD +GNL++++ +    N L G  P  LG L
Sbjct: 165 LIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQL 224

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           + L  + +  N F G+ P S+ N+SSLE F L  N+  GSLP+D+   LPNL+ L IG N
Sbjct: 225 QTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNN 284

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +F G +P SLSNASNL   D++ + F GKVSIDF  +  LW L L  N LG G A+DL F
Sbjct: 285 DFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSF 344

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +  L  C +LKVL LS +QFGG LP+SIANLS+ ++   +  NQ+SGTIP GI NLVNL 
Sbjct: 345 LNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLT 404

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L +  N   G+IP +IG L+ L  + L +N L G IPS LGN+T+L  L L +N L G 
Sbjct: 405 DLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGK 464

Query: 301 FIA-------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
             +             S N L G +P++++ + +L++ L+L+ N L G LP +V  LKNL
Sbjct: 465 IPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNL 524

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             LD+S N+ SG IP  L +C++LE++ +  N F G IPPS   L+ +  LD+S NN SG
Sbjct: 525 GHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSG 584

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC-- 465
           Q P+FL+ LS L  LNLS+N+ EG++PTKGVF+N +   + GN +LCGGI ELHLP+C  
Sbjct: 585 QIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPV 643

Query: 466 --PSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPM-V 522
             P  G  K  + L+  L+   +   ++ S L I   R RR     + TS   K   + V
Sbjct: 644 TKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVI--NRLRRVKREPSQTSASSKDLILNV 701

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           SY  L KAT  FSS+N+IG G FGSVYKGILG+DE +VAVKVI L Q+GA +SF AECEA
Sbjct: 702 SYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEA 761

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH------QSNDQVEVCK 636
           LRNIRHRNL+K++T CSS D++G DFKALV+E+M NGSLE+WLH      + ND + +  
Sbjct: 762 LRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRI-- 819

Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           LSL QRLNIAIDVASA++YLHHHC  P+VH DLKPSN+LLD+DM AHVGDFGLA+F+   
Sbjct: 820 LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFI-PE 878

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
               S  + SSSIG+KGT+GY AP
Sbjct: 879 AAGRSHPSQSSSIGLKGTIGYAAP 902

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  654 bits (1686), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/744 (49%), Positives = 486/744 (65%), Gaps = 30/744 (4%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G+IP  +GS  K+  + L  N LTG +PD +GNL++++ +    N L G  P  LG L
Sbjct: 196 LIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQL 255

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           + L  + +  N F G+ P S+ N+SSLE F L  N+  GSLP+D+   LPNL+ L IG N
Sbjct: 256 QTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNN 315

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +F G +P SLSNASNL   D++ + F GKVSIDF  +  LW L L  N LG G A+DL F
Sbjct: 316 DFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSF 375

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +  L  C +LKVL LS +QFGG LP+SIANLS+ ++   +  NQ+SGTIP GI NLVNL 
Sbjct: 376 LNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLT 435

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L +  N   G+IP +IG L+ L  + L +N L G IPS LGN+T+L  L L +N L G 
Sbjct: 436 DLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGK 495

Query: 301 FIA-------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
             +             S N L G +P++++ + +L++ L+L+ N L G LP +V  LKNL
Sbjct: 496 IPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNL 555

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             LD+S N+ SG IP  L +C++LE++ +  N F G IPPS   L+ +  LD+S NN SG
Sbjct: 556 GHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSG 615

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC-- 465
           Q P+FL+ LS L  LNLS+N+ EG++PTKGVF+N +   + GN +LCGGI ELHLP+C  
Sbjct: 616 QIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPV 674

Query: 466 --PSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPM-V 522
             P  G  K  + L+  L+   +   ++ S L I   R RR     + TS   K   + V
Sbjct: 675 TKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVI--NRLRRVKREPSQTSASSKDLILNV 732

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           SY  L KAT  FSS+N+IG G FGSVYKG LG+DE +VAVKVI L Q+GA +SF AECEA
Sbjct: 733 SYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEA 792

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH------QSNDQVEVCK 636
           LRNIRHRNL+K++T CSS D++G DFKALV+E+M NGSLE+WLH      + ND + +  
Sbjct: 793 LRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRI-- 850

Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           LSL QRLNIAIDVASA++YLHHHC  P+VH DLKPSN+LLD+DM AHVGDFGLA+F+   
Sbjct: 851 LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFI-PE 909

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
               S  + SSSIG+KGT+GY AP
Sbjct: 910 AAGRSHPSQSSSIGLKGTIGYAAP 933

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357505893|ref|XP_003623235.1| Receptor kinase-like protein [Medicago truncatula] gi|355498250|gb|AES79453.1| Receptor kinase-like protein [Medicago truncatula]

 Score =  644 bits (1660), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/733 (47%), Positives = 475/733 (64%), Gaps = 22/733 (3%)

Query: 3   GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
           G IP  +    +L  L+   N  TG +P +IGN S+L ++++  N+L G  P  +G L  
Sbjct: 146 GSIPSNLSQCIELSILSSGHNNFTGTIPTWIGNFSSLSLLNLAVNNLHGTIPNEVGKLSR 205

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L    +  N  YG  P S+ NISSL +   + N   G+LP+D+   LPNL+    G N+F
Sbjct: 206 LTLFALNGNHLYGTIPLSVFNISSLSFLTFSQNNLHGNLPYDVGFTLPNLETFAGGVNDF 265

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
            G IP+SLSNAS LE+LD + N   G +  +   L +L RLN + N LG G   +L F+T
Sbjct: 266 TGTIPESLSNASRLEILDFAENNLIGTLPKNIGRLTLLKRLNFDTNRLGNGEDGELNFLT 325

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
            L NC++L+VL L++NQFGG+LP SI NLS  +    +G N I G+IP+GI NLVNL +L
Sbjct: 326 SLINCTALEVLGLAENQFGGKLPSSIGNLSINLNALDLGENAIYGSIPIGISNLVNLTSL 385

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            +E N L G +PD IG L+ L  L LY N   G IPS +GNLT+L KL +  N+ +G+  
Sbjct: 386 GMEKNNLSGFVPDTIGMLQKLVDLELYSNKFSGVIPSSIGNLTRLTKLLIADNNFEGSIP 445

Query: 303 A-------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLII 349
                         S N L G++P+Q+ ++++LS+YLDLS+N L GSLP ++G L NL  
Sbjct: 446 TSLENCQRLLMLNLSHNMLNGSIPRQVFALSSLSIYLDLSHNSLTGSLPFEIGKLVNLAN 505

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           LD+S N+ SGMIP ++ +CVSLE++ +  N F G IP ++  L+ I+ +D+SCNN SG+ 
Sbjct: 506 LDLSKNKLSGMIPSSIGSCVSLEWLHMQGNFFEGNIPSTIQNLRGIQHIDLSCNNLSGKI 565

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRG 469
           P+FL  +  L  LNLSYN+L+GE+P  G+F N +   + GN++LCGG+ EL+LP+C    
Sbjct: 566 PEFLGEIKGLMHLNLSYNNLDGELPMNGIFKNATSFSINGNIKLCGGVPELNLPACT--- 622

Query: 470 SRKLKITLLKVLIPVAVS-CWILF-SCLTIVYARRRRSAHNSADTSPMEKQFPMVSYAEL 527
            +K K   LKV+IP+A +  ++LF S   I+   +R     S +T+ +E     +SY+E+
Sbjct: 623 IKKEKFHSLKVIIPIASALIFLLFLSGFLIIIVIKRSRKKTSRETTTIEDLELNISYSEI 682

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
            K T  FS+ N+IG GSFGSVYKG L  D   +A+KV+NL+Q+GA +SF+ EC AL+ IR
Sbjct: 683 VKCTGGFSNDNLIGSGSFGSVYKGTLSSDGTTIAIKVLNLEQRGASKSFIDECNALKVIR 742

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           HRNL+KIIT  SS D +G DFKALV+E+M NGSLEDWLH  N +     L+ +QRLNIAI
Sbjct: 743 HRNLLKIITAISSIDHQGKDFKALVYEFMSNGSLEDWLHPINQKK---TLTFVQRLNIAI 799

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           DVA A+EYLHH C+ P+VH D+KPSNVLLD+DMVA VGDFGLA FL     D S K  + 
Sbjct: 800 DVACALEYLHHFCETPIVHCDIKPSNVLLDNDMVARVGDFGLATFLFEESCD-SPKHSTM 858

Query: 708 SIGIKGTVGYVAP 720
           S  +KG+VGY+ P
Sbjct: 859 SASLKGSVGYIPP 871

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255553269|ref|XP_002517677.1| receptor-kinase, putative [Ricinus communis] gi|223543309|gb|EEF44841.1| receptor-kinase, putative [Ricinus communis]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/746 (47%), Positives = 485/746 (65%), Gaps = 30/746 (4%)

Query: 1    LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            L G+IP E+GSL KL+ L+L+ N LTG++P  +GNLS+L +     NSL G  P  +G L
Sbjct: 285  LSGKIPAELGSLLKLEVLSLSMNKLTGEIPASLGNLSSLTIFQATYNSLVGNIPQEMGRL 344

Query: 61   RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
             +L    V  N+  G+ P SI N SS+     T N+ + SLP +I  +LPNL   GIG N
Sbjct: 345  TSLTVFGVGANQLSGIIPPSIFNFSSVTRLLFTQNQLNASLPDNI--HLPNLTFFGIGDN 402

Query: 121  NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
            N FG IP+SL NAS LE++DL  N F G+V I+  SLK LWR+ L  NNLG  +++DL F
Sbjct: 403  NLFGSIPNSLFNASRLEIIDLGWNYFNGQVPINIGSLKNLWRIRLHGNNLGSNSSSDLAF 462

Query: 181  VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
            +T L NC+ L++L    N FGG LP+S+ANLS+ + +F  G NQI G IP G+ NL+NL+
Sbjct: 463  LTSLNNCTKLRILDFGRNNFGGVLPNSVANLSTELSLFYFGRNQIRGIIPAGLENLINLV 522

Query: 241  ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG- 299
             L +  N   G +P   G+ + LQ+L L+ N L G IPS LGNLT L+ L L  N  +G 
Sbjct: 523  GLVMHYNLFTGVVPSYFGKFQKLQVLDLFGNRLSGRIPSSLGNLTGLSMLYLSRNLFEGS 582

Query: 300  -----------NFIA-SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
                       N +A S NKL GA+P ++L +T+LS  LDLS N L G+LP ++G L +L
Sbjct: 583  IPSSIGNLKNLNTLAISHNKLTGAIPHEILGLTSLSQALDLSQNSLTGNLPPEIGKLTSL 642

Query: 348  IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
              L IS N  SG IP ++  C+SLEY+ +  N F G IP SL  LK ++++D+S N  +G
Sbjct: 643  TALFISGNNLSGEIPGSIGNCLSLEYLYMKDNFFQGTIPSSLASLKGLQYVDLSGNILTG 702

Query: 408  QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPS 467
              P+ L+++ +L+ LNLS+N LEGEVPT+GVF N S + L GN +LCGG+ ELHLP CP 
Sbjct: 703  PIPEGLQSMQYLKSLNLSFNDLEGEVPTEGVFRNLSALSLTGNSKLCGGVPELHLPKCPK 762

Query: 468  RGSRKLKITL-LKVLIPVAVSCWILFSCLTIVYARRRRS-----------AHNSADTSPM 515
            +  ++  + L L ++IP A  C +L     + Y++R+               +S+ +  +
Sbjct: 763  KVKKEHSLMLKLAIIIPCAALCVVLILAFLLQYSKRKSDKKSSSSIMNYFKRSSSSSLMI 822

Query: 516  EKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS 575
             +    +SY +L +AT+ F+S N+IG GSFGSVYKG L + E  VAVKV+ L+Q GA +S
Sbjct: 823  NRILLKLSYRDLCRATNGFASENLIGTGSFGSVYKGFLDQVERPVAVKVLKLEQTGASKS 882

Query: 576  FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-SNDQVEV 634
            F+AEC+ L+NIRHRNL+K++T CSS D K  +FKALVFE M NGSLE WLH  +N   + 
Sbjct: 883  FIAECKVLQNIRHRNLVKMLTFCSSIDEKLNEFKALVFELMENGSLESWLHHDTNSDNQS 942

Query: 635  CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
              LS +QRL+IAIDVASA+ YLH  C+ P++H DLKPSNVLLD DMVAHV DFGLA+ LS
Sbjct: 943  RNLSFLQRLDIAIDVASALHYLHDLCKRPIIHCDLKPSNVLLDDDMVAHVCDFGLARLLS 1002

Query: 695  SHHLDTSSKTPSSSIGIKGTVGYVAP 720
            +   + SS++  S+ GIKGT+GY AP
Sbjct: 1003 TS--NASSESQFSTAGIKGTIGYAAP 1026

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357497603|ref|XP_003619090.1| CCP [Medicago truncatula] gi|355494105|gb|AES75308.1| CCP [Medicago truncatula]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/738 (48%), Positives = 483/738 (65%), Gaps = 23/738 (3%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G+IP EIGSL KLQA+++  N+LT  +P FIGNLS L  +++  N+  GK P  +  L
Sbjct: 168 LNGKIPIEIGSLKKLQAISVGNNHLTEGIPSFIGNLSCLTRLNLGENNFSGKIPQEICFL 227

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           ++L  L V+EN   G  P  + NISSL    +T N   GS P ++   LPN++     AN
Sbjct: 228 KHLTILGVSENNLSGKIPSCLYNISSLISLTVTQNHLHGSFPPNMFHTLPNIQIFAFAAN 287

Query: 121 NFFGLIPDSLSNASNLELLDLSNN-QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
            F G IP S++NAS L++LDL NN    G+V     +L+ L  L+LE NNLG  +  DL 
Sbjct: 288 QFSGPIPTSIANASALQILDLGNNMNLVGQVP-SLRNLQDLSFLSLEVNNLGNNSTMDLE 346

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
           F+ +LTNCS L VLS+S N FGG LP+SI NLS+ +    +GGN ISG IP  +  LV L
Sbjct: 347 FLKYLTNCSKLYVLSISYNNFGGHLPNSIGNLSTELPELYMGGNMISGKIPAELGRLVGL 406

Query: 240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG 299
           I L +E N   G IP   G+ + +Q+L L +N L G IP  +GNL++L  L+L  N  QG
Sbjct: 407 ILLTMESNCFEGIIPTNFGKFQKMQVLSLRENKLSGGIPPFIGNLSQLYYLELNHNMFQG 466

Query: 300 NFIAS-------------QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKN 346
           +   S              NKL G +P ++L++ +LS+ L+LS+N L+GSLP++VG LKN
Sbjct: 467 SIPPSIGNCQNLQSLDLSHNKLRGTIPVEVLNLFSLSILLNLSHNSLSGSLPREVGMLKN 526

Query: 347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
           +  LD+S N  SG IP  +  C SLEY+ +  N F+G IP SL FLK +++LD+S N  S
Sbjct: 527 IEALDVSENHLSGDIPREIGECTSLEYIHLQRNSFNGTIPSSLTFLKGLRYLDLSRNQLS 586

Query: 407 GQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCP 466
           G  P  ++N+S LE+LN+S+N LEGEVPT GVF N ++I L GN +LCGGI  LHLP CP
Sbjct: 587 GSIPDGMQNISVLEYLNVSFNMLEGEVPTNGVFGNATQIDLIGNKKLCGGISHLHLPPCP 646

Query: 467 SRG---SRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVS 523
            +G   +++ K  L+ VL+ V VS  ++ S +  +Y  R+R+   S D SP   Q   VS
Sbjct: 647 IKGRKHAKQHKFRLIAVLVSV-VSFILILSFIITIYMMRKRNQKRSFD-SPTIDQLAKVS 704

Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y EL   T  FS+ NMIG GSFGSVYKG +  ++ +VAVKV+NL++KGA +SF+ EC AL
Sbjct: 705 YQELHVGTDGFSNRNMIGSGSFGSVYKGNIVSEDNVVAVKVLNLQKKGAHKSFIVECNAL 764

Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVCKLSLIQR 642
           +NIRHRNL+K++T CSST++KG +FKALVFEYM NGSLE WLH ++ +      L+L  R
Sbjct: 765 KNIRHRNLVKVLTCCSSTNYKGQEFKALVFEYMKNGSLEQWLHPETLNANPPTTLNLGHR 824

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           LNI IDVASA+ YLH  C+  ++H DLKPSNVLLD DMVAHV DFG+A+ +S+  +  +S
Sbjct: 825 LNIIIDVASALHYLHRECEQLILHCDLKPSNVLLDDDMVAHVSDFGIARLVST--ISGTS 882

Query: 703 KTPSSSIGIKGTVGYVAP 720
              +S+IG+KGTVGY  P
Sbjct: 883 NKNTSTIGVKGTVGYAPP 900

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440269|ref|XP_004137907.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/737 (47%), Positives = 476/737 (64%), Gaps = 17/737 (2%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            EGQIP +  +L KL+ L    N LTG++P +IGN +++  +    N+  G  P+ +G L
Sbjct: 158 FEGQIPHQFFTLTKLEGLGFGINNLTGRIPPWIGNFTSILGMSFGYNNFQGNIPSEIGRL 217

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
             L +L V  N   G    SICNI+SL Y  L  N+  G+LP +I   LPNL+ LG G N
Sbjct: 218 SRLKRLVVVSNNLTGPVWPSICNITSLTYLSLADNQLQGTLPPNIGFTLPNLQALGGGVN 277

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           NF G IP SL+N S L++LD   N+  G +  D   LK L  LN   N LG G   DL F
Sbjct: 278 NFHGPIPKSLANISGLQILDFPQNKLVGMLPDDMGRLKYLEHLNFASNRLGRGKVGDLNF 337

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +++L NC+SL++LSLS N FGG LP SI NLS+ M   ++G N +SG+IP GI NL+NL 
Sbjct: 338 ISYLANCTSLRILSLSSNHFGGVLPSSIGNLSTQMRSLVLGQNMLSGSIPTGIGNLINLQ 397

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            LA+EVN L+G+IP  IG+LKNL++L L  N L G +PS + NL+ L KL +  N L+ +
Sbjct: 398 RLAMEVNFLNGSIPPNIGKLKNLEVLYLNYNELSGPVPSSIANLSSLTKLYMSHNKLKES 457

Query: 301 FIA-------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
             A             S N L G +P+++L +++LS+ L L +N   G LP +VG L  L
Sbjct: 458 IPAGLGQCESLLTLELSSNNLSGTIPKEILYLSSLSMSLALDHNSFTGPLPHEVGLLVRL 517

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             LD+S NQ SG IP  L  C+ +E +++  N F G IP SLG LK I+ L++S NN SG
Sbjct: 518 SKLDVSENQLSGDIPTNLENCIRMERLNLGGNQFEGTIPESLGALKGIEELNLSSNNLSG 577

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCP- 466
           + P+FL  L  L++LNLSYN+ EG+VP +GVFSN + I + GN  LCGG+ ELHLP C  
Sbjct: 578 KIPQFLGKLGSLKYLNLSYNNFEGQVPKEGVFSNSTMISVIGNNNLCGGLPELHLPPCKY 637

Query: 467 SRGSRKLKITLLKVLIPVAVSCW---ILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVS 523
            R   + K    +VLIP+A +     IL S + + +  R+     S ++S  ++  P +S
Sbjct: 638 DRTYSRKKFMAPRVLIPIASTVTFLVILVSIIFVCFVLRKSKKDASTNSSSTKEFLPQIS 697

Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y ELSK+T+ FS  N IG GSFGSVYKGIL  D  IVA+KV+NL+ +GA +SFV EC AL
Sbjct: 698 YLELSKSTNGFSKENFIGSGSFGSVYKGILSSDGSIVAIKVLNLQHQGASKSFVDECNAL 757

Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            NIRHRNL+KIIT CSS D +G +FKAL+F +M NG+L+  LH +N Q    +LSLIQRL
Sbjct: 758 SNIRHRNLLKIITSCSSIDVQGNEFKALIFNFMSNGNLDCLLHPTNKQNNQRRLSLIQRL 817

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           NIAID+A  ++YLH+HC+PP+ H DLKPSN+LLD DMVAHVGDFGLA+F+     D +S 
Sbjct: 818 NIAIDIAYGLDYLHNHCEPPIAHCDLKPSNILLDDDMVAHVGDFGLARFMLEGSNDQTSL 877

Query: 704 TPSSSIGIKGTVGYVAP 720
           + + S+ +KG++GY+ P
Sbjct: 878 SQTMSLALKGSIGYIPP 894

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  641 bits (1654), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/743 (48%), Positives = 480/743 (64%), Gaps = 32/743 (4%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G+IP ++GSL KL A  L GN L G +P   GNLS++Q      N L G  P +LG L
Sbjct: 158 LTGKIPAQLGSLSKLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNL 217

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           + L    VAEN   G  P SICNISSL Y  L  N+  GSLP D+ +NLPNL  L I  N
Sbjct: 218 KRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFN 277

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +  G IP +LSNAS + L+DLS N   GK+  D +SL  L +L +  N+LG G  +DL F
Sbjct: 278 HLNGPIPATLSNASKIFLVDLSYNNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDDLSF 336

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +  L N ++L+ L ++DN FGG LP  ++N S+ +     G NQI G+IP  I NL++L 
Sbjct: 337 LYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLD 396

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L++E NQLHG IP  IG+L+NL  L L +N + GSIPS LGN+T L ++    N+LQG 
Sbjct: 397 TLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGT 456

Query: 301 FIAS-------------QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
             AS             QN L G +P+++L I++LS+ L L +N L GSLP +VG L NL
Sbjct: 457 IPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNL 516

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             L +S N+ SG IP +L +C SLE +D+  N F G +P  L  L++++ L +S NN SG
Sbjct: 517 GFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSG 575

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC-- 465
           Q P+FL++   LE L+LSYN  EGEVP +GVF N S+I +QGN +LCGGI +L LP C  
Sbjct: 576 QIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTS 635

Query: 466 --PSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVS 523
             P+R     K+ L+ + IP      +L +   + Y+R+ +    S  +   E  F  ++
Sbjct: 636 NEPARPKSHTKLILI-IAIPCGFLGIVLMTSFLLFYSRKTKDEPASGPS--WESSFQRLT 692

Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y +L +AT  FSSSN++G G+FGSVY+G L  D  +VAVKV+NL +KGA +SF+AEC AL
Sbjct: 693 YQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAAL 752

Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEVCKLSLI 640
            NIRHRNL+K+IT CSS DF+G DFKALV+E+M NGSLE+WLH    S+   E   L L+
Sbjct: 753 INIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDLV 812

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
           QRLNIAIDVASA++YLH+HCQ P+VH DLKPSNVLL  DM A VGDFGLA+FL     + 
Sbjct: 813 QRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLP----EA 868

Query: 701 SSKTP---SSSIGIKGTVGYVAP 720
           S++ P   SSS+G+KGT+GY AP
Sbjct: 869 SNQLPADESSSVGLKGTIGYAAP 891

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484501|ref|XP_003612538.1| Kinase-like protein [Medicago truncatula] gi|355513873|gb|AES95496.1| Kinase-like protein [Medicago truncatula]

 Score =  639 bits (1648), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 365/735 (49%), Positives = 473/735 (64%), Gaps = 26/735 (3%)

Query: 3   GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
           G+IP EIGSL KLQ + + GN LTG  P FIGNLS+L  I +  N+L G+ P  +  L+N
Sbjct: 146 GKIPIEIGSLKKLQLINVWGNNLTGGFPSFIGNLSSLIGIAVTYNNLKGEIPQEICNLKN 205

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           + +L+V EN   GMFP  + NISSL    LT N+F GSLP ++   LPNL    IG N F
Sbjct: 206 IRRLHVGENNLSGMFPSCLYNISSLTQLSLTENKFIGSLPSNLFNTLPNLNMFQIGKNQF 265

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
           FG +P S+ NAS+L+LLDL+ N   G+V      L+ L+ LNLE N  G  +  DL F+ 
Sbjct: 266 FGSMPISIVNASSLQLLDLAQNYLVGQVP-SLEKLQDLYWLNLEDNYFGNNSTIDLEFLK 324

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
           +LTNCS L+V+S+ +N+FGG LP+SI +LS+ +    +GGN ISG IP+ I NLV LI L
Sbjct: 325 YLTNCSKLEVVSICNNKFGGSLPNSIGSLSTQLTELCLGGNLISGKIPVEIGNLVELILL 384

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
           A++ N   G IP   G+ + +Q L L  N L G IP  +GNL++L KLDL  N  QGN  
Sbjct: 385 AIDFNHFEGIIPTSFGKFQKMQYLALSGNKLSGYIPPFIGNLSQLFKLDLYRNMFQGNIP 444

Query: 303 AS-------------QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLII 349
            S              NKL G +P ++  I +LS  L+LS+N L+GSLP++VG LKN+  
Sbjct: 445 PSIENCQKLQYLDLSHNKLSGTIPSEIFHIFSLSNLLNLSHNFLSGSLPREVGLLKNIDW 504

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           LD+S N  SG IP T+  C +LEY+ +  N F+G IP SL  L+ ++ LD+S N  SG  
Sbjct: 505 LDVSENHLSGDIPTTIGDCTALEYLHLQGNSFNGTIPSSLASLEGLQHLDLSRNRLSGSI 564

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRG 469
           P  ++N+S LE+LN+S+N LEGEVP  GVF N +K+ L GN +LCGGI  LHLP CP +G
Sbjct: 565 PDVMQNISVLEYLNVSFNMLEGEVPKNGVFGNVTKVELIGNNKLCGGILLLHLPPCPIKG 624

Query: 470 ---SRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSYAE 526
              ++  K  L+ V++ V     IL   +TI + R+R +   S D SP   Q   VSY +
Sbjct: 625 RKDTKHHKFMLVAVIVSVVFFLLILSFIITIYWVRKRNNKR-SID-SPTIDQLATVSYQD 682

Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI 586
           L   T+ FSS N+IG GSFGSVYKG L  +   VAVKV+NL++KGA +SF+ EC  L+NI
Sbjct: 683 LHHGTNGFSSRNLIGSGSFGSVYKGNLVSENNAVAVKVLNLQKKGAHKSFIVECNVLKNI 742

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK-LSLIQRLNI 645
           RHRNL+KI+T CSS D+K  +FKALVF Y+ NGSLE WLH      E  K L L  RLNI
Sbjct: 743 RHRNLVKILTCCSSIDYKVQEFKALVFYYIKNGSLEQWLHPEFLNEEHPKTLDLGHRLNI 802

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
            IDVAS + YLH  C+  ++H DLKPSNVLLD DMVAHV DFG+AK +S+    TS  T 
Sbjct: 803 IIDVASTLHYLHQECEQLVIHCDLKPSNVLLDDDMVAHVTDFGIAKLVSA----TSGNT- 857

Query: 706 SSSIGIKGTVGYVAP 720
            S+IGIKGTVGY  P
Sbjct: 858 -STIGIKGTVGYAPP 871

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa]

 Score =  630 bits (1625), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 355/744 (47%), Positives = 489/744 (65%), Gaps = 29/744 (3%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L GQIP ++GSL KL+ + L  N L G +PD +GN+S+++ + +  N+  G  P  LG L
Sbjct: 163 LTGQIPYQLGSLQKLERVQLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSIPDALGRL 222

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           + L  L +  N   GM P +I N+SSL  F L  N+  G+LP D+ + LPNL+ L IG N
Sbjct: 223 KTLNFLGLGLNNLSGMIPPTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQVLNIGHN 282

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
            F G +P S+SNASNL  LD+  + F  KV+IDF  L  LW L L  N LG G A+DL F
Sbjct: 283 FFSGPLPVSISNASNLLELDIDTSNFT-KVTIDFGGLPNLWSLALSSNPLGKGEADDLSF 341

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +  LT C +L++L LS++ FGG +P SI NLS+ + +  + GNQ+SG+IP  I NL+NL 
Sbjct: 342 IDSLTKCRNLRLLDLSNSHFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIENLLNLA 401

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG- 299
            L VE N L G+IP V+G LK LQ L L +N L G IPS LGN+T+L +  L  N + G 
Sbjct: 402 ELTVEKNYLSGSIPSVLGNLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQKNQIMGS 461

Query: 300 ------------NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
                       N   SQN L G +P++++ +++L++ L+L+ N L G LP +  NL NL
Sbjct: 462 IPSSFGNLKYLQNLDLSQNLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNL 521

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             LD+S N+  G IP +L +CV+LE + +  N F G IPPS   L+ ++ +D+S NN SG
Sbjct: 522 GYLDVSENKLYGQIPSSLGSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSG 581

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC-- 465
           Q P+FL+ L+ +  LNLS+NH EGEVP +G F N + I L GN RLCGGI +L LP C  
Sbjct: 582 QIPQFLKRLALIS-LNLSFNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKLPRCVV 640

Query: 466 ----PSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPM 521
                 + SR++K+ ++ +L P+ V  +++ S L I   R++    + A +   +++  +
Sbjct: 641 NRSKNGKTSRRVKL-MIAILTPLLVLVFVM-SILVINRLRKKNRQSSLASSLSSKQELLL 698

Query: 522 -VSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAEC 580
            VSY  L KAT+ FSS+N+IG GSFGSVY+GIL  +E +VAVKV+ ++Q+   +SF+AEC
Sbjct: 699 KVSYRNLHKATAGFSSANLIGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAEC 758

Query: 581 EALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH---QSNDQVEVCK- 636
           E L+NIRHRNL+KI+T CSS DF+G DFKALV+E+M NG+LE WLH   ++N   E  K 
Sbjct: 759 EILKNIRHRNLVKILTACSSVDFQGNDFKALVYEFMPNGTLESWLHSFPRTNGINEDLKI 818

Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           LS  QRLNIAIDVA+A+ YLH+ C  P+VH DLKPSNVLLD+DM AHVGDFGLA+F+   
Sbjct: 819 LSFHQRLNIAIDVAAALNYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFI-EE 877

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
            ++ S +  SSS+G+KGTVGY AP
Sbjct: 878 AINPSHRNESSSVGLKGTVGYAAP 901

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566660|ref|XP_003551548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max]

 Score =  630 bits (1625), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 350/740 (47%), Positives = 470/740 (63%), Gaps = 29/740 (3%)

Query: 3   GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
           G IP  +    +L  L+   N  TG +P +IGN S+L ++++  N+L G  P  +G L  
Sbjct: 151 GSIPSNLSHCTELSILSAGHNNYTGTIPAWIGNSSSLSLLNLAVNNLHGNIPNEIGQLSR 210

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L  L +  N   G  P +I NISSL +F ++ N   G++P D+    PNL+    G N+F
Sbjct: 211 LTLLALNGNYLSGTIPGTIFNISSLFFFTVSQNHLHGNIPADVGYTFPNLETFAGGVNSF 270

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
            G IP+SLSNAS LE+LD + N   G +  +   L +L RLN + N LG G A DL F+ 
Sbjct: 271 TGTIPESLSNASRLEILDFAENGLTGTLPKNIGRLPLLKRLNFDDNRLGTGKAGDLNFLA 330

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
            L NC++LKVL LSDN FGGELP +IANLS+ +    +GGN I G++P+GIRNLVNL  L
Sbjct: 331 SLVNCTALKVLGLSDNSFGGELPSTIANLSTQLTSLTLGGNGIHGSVPIGIRNLVNLTFL 390

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            +E N L G +P  IG L+ L  L L  N   G IPS +GNLT+L +L +  N+ +G+  
Sbjct: 391 GLEENNLSGFVPHTIGMLRLLNGLDLNGNNFSGVIPSSIGNLTRLTRLQMEENNFEGSIP 450

Query: 303 A-------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLII 349
           A             S N L G +P+Q+L++++LS+YLDLS+N L G +  +VG L NL  
Sbjct: 451 ANLGKCQSLLMLNLSHNMLNGTIPRQVLTLSSLSIYLDLSHNALTGPVLAEVGKLVNLAQ 510

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           LD+S N+ SGMIP +L +C+ LE++ +  N F G IP ++ +L+ ++ +D+SCNNFSG+ 
Sbjct: 511 LDLSENKLSGMIPSSLGSCIGLEWIHLQGNFFEGNIPSTMRYLRGLQDIDLSCNNFSGKI 570

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCP-SR 468
           P+FL     LE LNLSYN   G++P  G+F N +   + GN +LCGG  EL LP+C   +
Sbjct: 571 PEFLGEFKVLEHLNLSYNDFSGKLPMNGIFKNATSYSVYGNSKLCGGAPELDLPACTIKK 630

Query: 469 GSRKLKITLLKVLIPVAVS---CWILFSCLTIVYARR-RRSAHNSADTSPMEKQFPMVSY 524
            S   K    KV+I V V+     +LF  L I   +R R+ A  S  T  ++ Q   +SY
Sbjct: 631 ASSFRKFHDPKVVISVIVALVFVLLLFCFLAISMVKRARKKASRSTTTKDLDLQ---ISY 687

Query: 525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALR 584
           +E++K T  FS  N++G GSFGSVYKG L  D   VAVKV+NL+Q+GA +SF+ EC+ LR
Sbjct: 688 SEIAKCTGGFSPDNLVGSGSFGSVYKGTLSSDGSSVAVKVLNLEQRGASKSFIDECQVLR 747

Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-SNDQVEVCKLSLIQRL 643
           +IRHRNL+KIIT  SS D +G DFKALVFE+M NGSLEDWLH   N Q +   LS IQRL
Sbjct: 748 SIRHRNLLKIITAISSVDHQGNDFKALVFEFMPNGSLEDWLHPVDNQQKQTKTLSFIQRL 807

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           NIAIDVA A+EYLHH C  P+VH D+KPSNVLLD+DMVAHVGDFGLA FL     + SS 
Sbjct: 808 NIAIDVACALEYLHHFCHTPIVHCDIKPSNVLLDNDMVAHVGDFGLATFL----FEESSG 863

Query: 704 TPSSSIG---IKGTVGYVAP 720
           +P  S     +KG++GY+ P
Sbjct: 864 SPQQSTMSGVLKGSIGYIPP 883

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	725
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.982	0.694	0.428	2.2e-146
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.96	0.679	0.395	1.9e-122
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.965	0.693	0.377	8.5e-120
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.964	0.692	0.366	1.8e-112
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.965	0.678	0.368	1.8e-112
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.964	0.691	0.351	3e-112
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.864	0.771	0.392	1.2e-106
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.951	0.704	0.346	5e-92
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.968	0.598	0.327	3.1e-90
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.624	0.362	0.320	3.9e-85

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1430 (508.4 bits), Expect = 2.2e-146, P = 2.2e-146
 Identities = 316/738 (42%), Positives = 447/738 (60%)

Query:     1 LEGQIPKEIGSLFK-LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGL 59
             L G IP+EIG+  K L  L L  N L+G++P  +GNL++LQ   +  N L G  P++LG 
Sbjct:   163 LRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQ 222

Query:    60 LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
             L +L+ +N+ +N   GM P SI N+SSL  F +  N+  G +P +    L  L+ + +G 
Sbjct:   223 LSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGT 282

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
             N F G IP S++NAS+L ++ +  N F G ++  F  L+ L  L L +N       +D G
Sbjct:   283 NRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWG 342

Query:   180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
             F++ LTNCS L+ L+L +N  GG LP+S +NLS+++    +  N+I+G+IP  I NL+ L
Sbjct:   343 FISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGL 402

Query:   240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG 299
               L +  N   G++P  +G LKNL +L  Y+N L GSIP  +GNLT+L  L LG+N   G
Sbjct:   403 QHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSG 462

Query:   300 ----------NFIA---SQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKN 346
                       N ++   S N L G +P +L +I T                PQ++G+LKN
Sbjct:   463 WIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKN 522

Query:   347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
             L+     SN+ SG IP TL  C  L Y+ + +N   G IP +LG LK ++ LD+S NN S
Sbjct:   523 LVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLS 582

Query:   407 GQFPKXXXXXXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC- 465
             GQ P               +N   GEVPT G F+  S I +QGN +LCGGI +LHLP C 
Sbjct:   583 GQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCC 642

Query:   466 PSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSYA 525
             P   +RK    +L + + +A +  IL S L ++    +R+   +   + M K  P+VSY+
Sbjct:   643 PLLENRK-HFPVLPISVSLAAALAIL-SSLYLLITWHKRTKKGAPSRTSM-KGHPLVSYS 699

Query:   526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN 585
             +L KAT  F+ +N++G GSFGSVYKG L   +  VAVKV+ L+   A +SF AECEALRN
Sbjct:   700 QLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH-VAVKVLKLENPKALKSFTAECEALRN 758

Query:   586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVCKLSLIQRLN 644
             +RHRNL+KI+TICSS D +G DFKA+V+++M NGSLEDW+H ++NDQ +   L+L +R+ 
Sbjct:   759 MRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVT 818

Query:   645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS-- 702
             I +DVA A++YLH H   P+VH D+K SNVLLD DMVAHVGDFGLA+ L    +D +S  
Sbjct:   819 ILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARIL----VDGTSLI 874

Query:   703 KTPSSSIGIKGTVGYVAP 720
             +  +SS+G  GT+GY AP
Sbjct:   875 QQSTSSMGFIGTIGYAAP 892

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
 Identities = 294/743 (39%), Positives = 409/743 (55%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L G+ P  +G+L  LQ L    N + G++P  I  L  +    I  N   G FP  +  L
Sbjct:   189 LTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNL 248

Query:    61 RNLVQLNVAENKFYGMF-PRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              +L+ L++  N F G   P     + +L+  Y+  N F+G++P + + N+ +L++L I +
Sbjct:   249 SSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIP-ETLSNISSLRQLDIPS 307

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN-LEQNNLGIGAANDL 178
             N+  G IP S     NL LL L+NN      S D   L  L   + L+  N+G    N L
Sbjct:   308 NHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGF---NKL 364

Query:   179 G--FVTFLTNCSS-LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
             G     F+ N S+ L  LSL  N   G +PH I NL S   + L G N ++G +P  +  
Sbjct:   365 GGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDL-GENLLTGKLPPSLGE 423

Query:   236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
             L  L  + +  N L G IP  +G +  L  L L  N  +GSIPS LG+ + L  L+LG+N
Sbjct:   424 LSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTN 483

Query:   296 SLQGNFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSN 355
                        KL G++P +L+ + +                 Q +G LK L+ LD+S N
Sbjct:   484 -----------KLNGSIPHELMELPSLVVLNVSFNLLVGPLR-QDIGKLKFLLALDVSYN 531

Query:   356 QFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXXX 415
             + SG IP TL+ C+SLE++ +  N F G IP   G L  ++FLD+S NN SG  P+    
Sbjct:   532 KLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMAN 590

Query:   416 XXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC----PSRGSR 471
                        N+ +G VPT+GVF N S + + GN+ LCGGI  L L  C    P R S 
Sbjct:   591 FSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSS 650

Query:   472 KLKITLLKVLIPVAVSCWILFSCLTIVY-------ARRRRSAHNSADTS--PMEKQFPMV 522
               KI  + V    AV   +L  CL +VY        +  R+ +N  D S  P++  +  +
Sbjct:   651 VRKIITICVS---AVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKI 707

Query:   523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
             SY EL K T  FSSSN+IG G+FG+V+KG LG     VA+KV+NL ++GA +SF+AECEA
Sbjct:   708 SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767

Query:   583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC-----KL 637
             L  IRHRNL+K++TICSS+DF+G DF+ALV+E+M NG+L+ WLH   D++E        L
Sbjct:   768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIEETGNPSRTL 825

Query:   638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
              L  RLNIAIDVASA+ YLH +C  P+ H D+KPSN+LLD D+ AHV DFGLA+ L    
Sbjct:   826 GLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFD 885

Query:   698 LDTSSKTPSSSIGIKGTVGYVAP 720
              DT      SS G++GT+GY AP
Sbjct:   886 RDTFH-IQFSSAGVRGTIGYAAP 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1179 (420.1 bits), Expect = 8.5e-120, P = 8.5e-120
 Identities = 278/737 (37%), Positives = 413/737 (56%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             + G++P  +G+L  L+ LAL+ N L G++P  +  L+ +  + +  N+  G FP  L  L
Sbjct:   174 MRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNL 233

Query:    61 RNLVQLNVAENKFYGMF-PRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              +L  L +  N F G   P     + +L  F +  N F+GS+P  +  N+  L+ LG+  
Sbjct:   234 SSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLS-NISTLERLGMNE 292

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
             NN  G IP +  N  NL+LL L  N      S D   L  L     +   LGIG  N LG
Sbjct:   293 NNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCT-QLETLGIGR-NRLG 349

Query:   180 --FVTFLTNCSS-LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNL 236
                   + N S+ L  L L      G +P+ I NL +   + L   N +SG +P  +  L
Sbjct:   350 GDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLIL-DQNMLSGPLPTSLGKL 408

Query:   237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS 296
             +NL  L++  N+L G IP  IG +  L+ L L  N  +G +P+ LGN + L +L +G N 
Sbjct:   409 LNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNK 468

Query:   297 LQGNFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSNQ 356
             L G       K+     QQLL +                  PQ +G L+NL  L +  N+
Sbjct:   469 LNGTIPLEIMKI-----QQLLRLDMSGNSLIGSL-------PQDIGALQNLGTLSLGDNK 516

Query:   357 FSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXXXX 416
              SG +P TL  C+++E + +  N F+G IP   G L  +K +D+S N+ SG  P+     
Sbjct:   517 LSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASF 575

Query:   417 XXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGS---RKL 473
                      +N+LEG+VP KG+F N + + + GN  LCGGI    L  C S+     +K 
Sbjct:   576 SKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKH 635

Query:   474 KITLLKVLIPVAVSCWILF----SCLTIVYARRRRSAHNSADTSP--MEKQFPMVSYAEL 527
                L KV+I V+V   +L     + +T+++ R+R+    + + +P  +E     +SY +L
Sbjct:   636 SSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDL 695

Query:   528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
               AT+ FSSSNM+G GSFG+VYK +L  ++ +VAVKV+N++++GA +SF+AECE+L++IR
Sbjct:   696 RNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIR 755

Query:   588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK----LSLIQRL 643
             HRNL+K++T CSS DF+G +F+AL++E+M NGSL+ WLH    + E+ +    L+L++RL
Sbjct:   756 HRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE-EIHRPSRTLTLLERL 814

Query:   644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             NIAIDVAS ++YLH HC  P+ H DLKPSNVLLD D+ AHV DFGLA+ L     + S  
Sbjct:   815 NIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFD-EESFF 873

Query:   704 TPSSSIGIKGTVGYVAP 720
                SS G++GT+GY AP
Sbjct:   874 NQLSSAGVRGTIGYAAP 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
 Identities = 270/737 (36%), Positives = 402/737 (54%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L+G+ P  I +L  L  L L  N+L G++PD I  LS +  + +  N+  G FP     L
Sbjct:   174 LKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNL 233

Query:    61 RNLVQLNVAENKFYGMFPRSICNI-SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              +L  L +  N F G       N+  ++    L  N  +G++P  +  N+  L+  GIG 
Sbjct:   234 SSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLA-NISTLEMFGIGK 292

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAA-NDL 178
             N   G I  +     NL  L+L+NN   G  S  F  L  L  L    +  G+  + N L
Sbjct:   293 NRMTGSISPNFGKLENLHYLELANNSL-GSYS--FGDLAFLDALTNCSHLHGLSVSYNRL 349

Query:   179 G--FVTFLTNCSS-LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
             G    T + N S+ L VL+L  N   G +PH I NL     + L+  N ++G +P  + N
Sbjct:   350 GGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSL-LLADNLLTGPLPTSLGN 408

Query:   236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
             LV L  L +  N+  G IP  IG L  L  L L  N  +G +P  LG+ + +  L +G  
Sbjct:   409 LVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIG-- 466

Query:   296 SLQGNFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSN 355
                       NKL G +P++++ I T                P  +G L+NL+ L + +N
Sbjct:   467 ---------YNKLNGTIPKEIMQIPTLVHLNMESNSLSGSL-PNDIGRLQNLVELLLGNN 516

Query:   356 QFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXXX 415
               SG +P TL  C+S+E + +  N F G IP   G L  +K +D+S NN SG   +    
Sbjct:   517 NLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFEN 575

Query:   416 XXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC----PSRGSR 471
                        N+ EG VPT+G+F N + + + GN  LCG I EL L  C    P   +R
Sbjct:   576 FSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETR 635

Query:   472 KLKITLLKVLIPVAV--SCWILFSCLTIVYARRRRSAHNSADTSP--MEKQFPMVSYAEL 527
                + L KV I V+V  +  +L   +++ + ++R++     +++P  +E     +SY +L
Sbjct:   636 HPSL-LKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDL 694

Query:   528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
               AT  FSSSN++G GSFG+V+K +L  +  IVAVKV+N++++GA +SF+AECE+L++IR
Sbjct:   695 RNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIR 754

Query:   588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK----LSLIQRL 643
             HRNL+K++T C+S DF+G +F+AL++E+M NGSL+ WLH    + E+ +    L+L++RL
Sbjct:   755 HRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVE-EIHRPSRTLTLLERL 813

Query:   644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             NIAIDVAS ++YLH HC  P+ H DLKPSN+LLD D+ AHV DFGLA+ L     + S  
Sbjct:   814 NIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQE-SFF 872

Query:   704 TPSSSIGIKGTVGYVAP 720
                SS G++GT+GY AP
Sbjct:   873 NQLSSAGVRGTIGYAAP 889

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
 Identities = 273/740 (36%), Positives = 403/740 (54%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L G  P  +G+L  LQ L  A N + G++PD +  L+ +    I  NS  G FP  L  +
Sbjct:   181 LTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNI 240

Query:    61 RNLVQLNVAENKFYGMFPRSICNI-SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              +L  L++A+N F G        +  +L    L +N+F+G++P   + N+ +L+   I +
Sbjct:   241 SSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIP-KTLANISSLERFDISS 299

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL-NLEQ-NNLGIGAAND 177
             N   G IP S     NL  L + NN      S   S L+ +  + N  Q   L +G  N 
Sbjct:   300 NYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSS---SGLEFIGAVANCTQLEYLDVGY-NR 355

Query:   178 LG--FVTFLTNCSS-LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIR 234
             LG      + N S+ L  L L  N   G +PH I NL S   + L   N +SG +P+   
Sbjct:   356 LGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSL-ETNMLSGELPVSFG 414

Query:   235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
              L+NL  + +  N + G IP   G +  LQ L L  N   G IP  LG    L  LDL  
Sbjct:   415 KLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYL--LDLWM 472

Query:   295 NSLQGNFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISS 354
             ++         N+L G +PQ++L I +                P++VG L+ L+ L  S 
Sbjct:   473 DT---------NRLNGTIPQEILQIPSLAYIDLSNNFLTGHF-PEEVGKLELLVGLGASY 522

Query:   355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXX 414
             N+ SG +P  +  C+S+E++ +  N F G IP  +  L S+K +D S NN SG+ P+   
Sbjct:   523 NKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLA 581

Query:   415 XXXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGS-RKL 473
                         N  EG VPT GVF N + + + GN  +CGG+ E+ L  C  + S RK 
Sbjct:   582 SLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKR 641

Query:   474 K-ITLLKVLIP---VAVSCWILFSCL-TIVYARRRRSAHNSADTSPMEK----QF-PMVS 523
             K +++ K ++    + ++  +L   + ++ +  +R+  +N++D +P +      F   VS
Sbjct:   642 KPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVS 701

Query:   524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
             Y EL  ATS FSS+N+IG G+FG+V+KG+LG +  +VAVKV+NL + GA +SF+AECE  
Sbjct:   702 YEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETF 761

Query:   584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN-DQVEVCKLSLI-- 640
             + IRHRNL+K+IT+CSS D +G DF+ALV+E+M  GSL+ WL   + ++V     SL   
Sbjct:   762 KGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPA 821

Query:   641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
             ++LNIAIDVASA+EYLH HC  P+ H D+KPSN+LLD D+ AHV DFGLA+ L  +  + 
Sbjct:   822 EKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE- 880

Query:   701 SSKTPSSSIGIKGTVGYVAP 720
             S     SS G++GT+GY AP
Sbjct:   881 SFLNQFSSAGVRGTIGYAAP 900

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1091 (389.1 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
 Identities = 260/739 (35%), Positives = 406/739 (54%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L+G++P+ +G+L  L++L    N + G++PD +  LS +  + +  N   G FP  +  L
Sbjct:   174 LKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNL 233

Query:    61 RNLVQLNVAENKFYGMFPRSICNI-SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
               L  L +  + F G       N+  ++    L  N   G++P  +  N+  L++ GI  
Sbjct:   234 SALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLS-NISTLQKFGINK 292

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN--LEQNNLGIGAAND 177
             N   G I  +     +L+ LDLS N   G  S  F  L+ +  L        L +G    
Sbjct:   293 NMMTGGIYPNFGKVPSLQYLDLSENPL-G--SYTFGDLEFIDSLTNCTHLQLLSVGYTRL 349

Query:   178 LGFV-TFLTNCSS-LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
              G + T + N S+ L  L+L  N F G +P  I NL     + L G N ++G +P  +  
Sbjct:   350 GGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQL-GKNMLTGPLPTSLGK 408

Query:   236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
             L+ L  L++  N++ G IP  IG L  L++L L  N  +G +P  LG  + +  L +G  
Sbjct:   409 LLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIG-- 466

Query:   296 SLQGNFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSN 355
                       NKL G +P++++ I T                P  +G+L+NL+ L + +N
Sbjct:   467 ---------YNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSL-PNDIGSLQNLVKLSLENN 516

Query:   356 QFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXXX 415
             +FSG +P TL  C+++E + +  N F G IP   G L  ++ +D+S N+ SG  P+    
Sbjct:   517 KFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFAN 575

Query:   416 XXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC-----P--SR 468
                        N+  G+VP+KG F N + + + GN  LCGGI +L L  C     P  ++
Sbjct:   576 FSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETK 635

Query:   469 GSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAH--NSADTSPMEKQFPMVSYAE 526
              S  LK   + V I +A+   ++ + + + + R+RR     N+   S +E     +SY +
Sbjct:   636 HSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGD 695

Query:   527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI 586
             L  AT+ FSSSNM+G GSFG+V+K +L  +  IVAVKV+N++++GA +SF+AECE+L++ 
Sbjct:   696 LRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDT 755

Query:   587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK-----LSLIQ 641
             RHRNL+K++T C+STDF+G +F+AL++EY+ NGS++ WLH   ++VE  +     L+L++
Sbjct:   756 RHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP--EEVEEIRRPPRTLTLLE 813

Query:   642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
             RLNI IDVAS ++YLH HC  P+ H DLKPSNVLL+ D+ AHV DFGLA+ L     + S
Sbjct:   814 RLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKE-S 872

Query:   702 SKTPSSSIGIKGTVGYVAP 720
                  SS G++GT+GY AP
Sbjct:   873 FLNQLSSAGVRGTIGYAAP 891

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
 Identities = 257/655 (39%), Positives = 363/655 (55%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L G IP  +G L  L  LALA N L+G +P   G L  L  + +  N+L G  P  +  +
Sbjct:   162 LSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAFNNLSGAIPDPIWNI 221

Query:    61 RNLVQLNVAENKFYGMFP-RSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              +L    V  NK  G  P  +  N+ SL+  Y+  N+F G +P  I  N  N+    IG 
Sbjct:   222 SSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASIG-NASNISIFTIGL 280

Query:   120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL-NLEQNNLGIGAANDL 178
             N+F G++P  +    NL+ L+L     + + + D+  +  L    NL++  LG G     
Sbjct:   281 NSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCSNLQEVELG-GCKFGG 339

Query:   179 GFVTFLTNCSSLKV-LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV 237
                  ++N SS  V LS+ DN+  G LP  I NL +   + L   N ++G++P     L 
Sbjct:   340 VLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSL-ANNSLTGSLPSSFSKLK 398

Query:   238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSL 297
             NL  L V+ N+L G++P  IG L  L  + +  N   G+IPS LGNLTKL +++LG N  
Sbjct:   399 NLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHN-- 456

Query:   298 QGNFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSNQF 357
               NFI       G +P ++ SI                  P+++G LKN++     SN+ 
Sbjct:   457 --NFI-------GQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKL 507

Query:   358 SGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXXXXX 417
             SG  P T+  C  L+++ + +N  +G IP +L  LK +  LD+S NN SGQ P       
Sbjct:   508 SGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMP 567

Query:   418 XXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCP--SRGSRKLKI 475
                     +N   GEVPT GVF+N S+I +QGN  +CGGI ELHLP+C   SR  +K +I
Sbjct:   568 LLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQI 627

Query:   476 TLLKVLIPVAVSCWILFSCL-TIVYARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEF 534
              LL V+I + VS   +FS L  ++   +RR     A TS M+   PM++Y +L KAT  F
Sbjct:   628 LLLVVVICL-VSTLAVFSLLYMLLTCHKRRKKEVPATTS-MQGH-PMITYKQLVKATDGF 684

Query:   535 SSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
             SSS+++G GSFGSVYKG      GE   +VAV+V+ L+   A +SF AECE LRN RHRN
Sbjct:   685 SSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRN 744

Query:   591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVCKLSLIQRLN 644
             L+KI+TICSS D +G DFKA+V+++M NGSLEDWLH ++NDQ E   L+L QR++
Sbjct:   745 LVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 917 (327.9 bits), Expect = 5.0e-92, P = 5.0e-92
 Identities = 259/748 (34%), Positives = 380/748 (50%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFI---GNLSALQVIHIKGNSLGGKFPTTL 57
             L G IP+E+G L +L  L L  N L G +P  +   G+ S+LQ I +  NSL G+ P   
Sbjct:   127 LHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNY 186

Query:    58 GL-LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG 116
                L+ L  L +  NK  G  P S+ N ++L++  L SN  SG LP  ++  +P L+ L 
Sbjct:   187 HCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLY 246

Query:   117 IGANNFFG------LIP--DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN 168
             +  N+F        L P   SL+N+S+L+ L+L+ N   G+++   SS++ L  +NL Q 
Sbjct:   247 LSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEIT---SSVRHL-SVNLVQI 302

Query:   169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGT 228
             +L     +       ++N  +L +L+LS N   G +P  +  LS    V+L   N ++G 
Sbjct:   303 HLDQNRIHG-SIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYL-SNNHLTGE 360

Query:   229 IPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLA 288
             IP+ + ++  L  L V  N L G+IPD  G L  L+ L LY N L G++P  LG    L 
Sbjct:   361 IPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLE 420

Query:   289 KLDLGSNSLQGNFIASQNKLIGALPQQLLS-ITTXXXXXXXXXXXXXXXXPQQVGNLKNL 347
              LDL           S N L G +P +++S +                  P ++  +  +
Sbjct:   421 ILDL-----------SHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMV 469

Query:   348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
             + +D+SSN+ SG IP  L +C++LE++++S N F   +P SLG L  +K LDVS N  +G
Sbjct:   470 LSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTG 529

Query:   408 QFPKXXXXXXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPS 467
               P               +N L G V  KG FS  +     G+  LCG I  +   +C  
Sbjct:   530 AIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKK 587

Query:   468 RGSRKLKITLLKVLIP-VAVSCWILFSCLTIVYAR--RRRSAHNSADTSPMEKQ------ 518
             +   K    LL VL+  +A     +F    +  +R  +  + +   +    EKQ      
Sbjct:   588 K--HKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPK 645

Query:   519 FPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFV 577
             +P +SY +L  AT  F++S++IG G FG VYKG+L  +   VAVKV++ K    F  SF 
Sbjct:   646 YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTK-VAVKVLDPKTALEFSGSFK 704

Query:   578 AECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKL 637
              EC+ L+  RHRNLI+IIT CS   F      ALV   M NGSLE  L+      +   L
Sbjct:   705 RECQILKRTRHRNLIRIITTCSKPGFN-----ALVLPLMPNGSLERHLYPGEYSSK--NL 757

Query:   638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
              LIQ +NI  DVA  I YLHH+    +VH DLKPSN+LLD +M A V DFG+++ +    
Sbjct:   758 DLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE 817

Query:   698 LDTSSKTPSSSIG-----IKGTVGYVAP 720
              +T S   S S G     + G+VGY+AP
Sbjct:   818 -ETVSTDDSVSFGSTDGLLCGSVGYIAP 844

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
 Identities = 246/751 (32%), Positives = 379/751 (50%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L G I +EIG L  L+ L L  N  TG+ P  I NL  L V+ +  N++ G+ P  LGLL
Sbjct:   324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLL 383

Query:    61 RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
              NL  L+  +N   G  P SI N + L+   L+ N+ +G +P        NL  + IG N
Sbjct:   384 TNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGF--GRMNLTFISIGRN 441

Query:   121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
             +F G IPD + N SNLE L +++N   G +      L+ L  L +  N+L      ++G 
Sbjct:   442 HFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIG- 500

Query:   181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISGTIPLGIRNLVNL 239
                  N   L +L L  N F G +P  ++NL  T++  L +  N + G IP  + ++  L
Sbjct:   501 -----NLKDLNILYLHSNGFTGRIPREMSNL--TLLQGLRMYSNDLEGPIPEEMFDMKLL 553

Query:   240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN---- 295
               L +  N+  G IP +  +L++L  L L  N   GSIP+ L +L+ L   D+  N    
Sbjct:   554 SVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTG 613

Query:   296 SLQGNFIAS-----------QNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNL 344
             ++ G  +AS            N L G +P++L  +                  P+ +   
Sbjct:   614 TIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSI-PRSLQAC 672

Query:   345 KNLIILDISSNQFSGMIPVTLSTCVSLEY-VDISSNCFHGIIPPSLGFLKSIKFLDVSCN 403
             KN+  LD S N  SG IP  +   + +   +++S N F G IP S G +  +  LD+S N
Sbjct:   673 KNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSN 732

Query:   404 NFSGQFPKXXXXXXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLP 463
             N +G+ P+               N+L+G VP  GVF N +   L GN  LCG    L   
Sbjct:   733 NLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPC 792

Query:   464 SCPSRGSRKLKITLLKVLIPVAVSCWILFSCLTIVYA---RRRRSAHNSADTS-P-MEKQ 518
             +   + S   K T + ++I  + +  +L   L ++     ++ +   NS+++S P ++  
Sbjct:   793 TIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSA 852

Query:   519 FPMVSYA--ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS- 575
               +  +   EL +AT  F+S+N+IG  S  +VYKG L ED  ++AVKV+NLK+  A    
Sbjct:   853 LKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDK 911

Query:   576 -FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV 634
              F  E + L  ++HRNL+KI+       ++    KALV  +M NG+LED +H S   +  
Sbjct:   912 WFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIG- 966

Query:   635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
                SL++++++ + +AS I+YLH     P+VH DLKP+N+LLD D VAHV DFG A+ L 
Sbjct:   967 ---SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILG 1023

Query:   695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM 725
                 +  S T S+S   +GT+GY+AP   +M
Sbjct:  1024 FR--EDGSTTASTS-AFEGTIGYLAPEFAYM 1051

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 3.9e-85, Sum P(2) = 3.9e-85
 Identities = 154/480 (32%), Positives = 216/480 (45%)

Query:     1 LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
             L G IP ++G L ++Q+L L  NYL G +P  +GN S L V     N L G  P  LG L
Sbjct:   179 LTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRL 238

Query:    61 RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
              NL  LN+A N   G  P  +  +S L+Y  L +N+  G +P  +  +L NL+ L + AN
Sbjct:   239 ENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLA-DLGNLQTLDLSAN 297

Query:   121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
             N  G IP+   N S L  L L+NN   G +     S       NLEQ  L +      G 
Sbjct:   298 NLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNT----NLEQ--LVLSGTQLSGE 351

Query:   181 VTF-LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
             +   L+ C SLK L LS+N   G +P ++  L     ++L   N + GT+   I NL NL
Sbjct:   352 IPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYL-HNNTLEGTLSPSISNLTNL 410

Query:   240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG 299
               L +  N L G +P  I  L+ L++L LY+N   G IP  +GN T L  +D+  N  +G
Sbjct:   411 QWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEG 470

Query:   300 NFIAS-------------QNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKN 346
                 S             QN+L+G LP  L +                   P   G LK 
Sbjct:   471 EIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSI-PSSFGFLKG 529

Query:   347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
             L  L + +N   G +P +L +  +L  +++S N  +G I P  G    + F DV+ N F 
Sbjct:   530 LEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF-DVTNNGFE 588

Query:   407 GQFPKXXXXXXXXXXXXXXYNHLEGEVP-TKGVFSNKSKIPLQGNVRLCGGIDELHLPSC 465
              + P                N L G++P T G     S + +  N  L G I  L L  C
Sbjct:   589 DEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNA-LTGTIP-LQLVLC 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00050192 hypothetical protein (1011 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	725
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-81
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-57
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-24
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-08
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	5e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.001
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.001
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.001
COG3173	321	COG3173, COG3173, Predicted aminoglycoside phospho	0.001
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.002
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.002
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.002
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.003
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.003
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	0.004
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.004
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  278 bits (712), Expect = 3e-81
 Identities = 214/697 (30%), Positives = 332/697 (47%), Gaps = 75/697 (10%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G+IP  + +L  L+ L LA N L G++P  +G + +L+ I++  N+L G+ P  +G L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
            +L  L++  N   G  P S+ N+ +L+Y +L  N+ SG +P  I  +L  L  L +  N
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDN 294

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +  G IP+ +    NLE+L L +N F GK+ +  +SL  L  L L  N        +LG 
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG- 353

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
                  ++L VL LS N   GE+P  + +               SG       NL  LI
Sbjct: 354 -----KHNNLTVLDLSTNNLTGEIPEGLCS---------------SG-------NLFKLI 386

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
             +   N L G IP  +G  ++L+ + L  N   G +PS    L  +  LD+ +N+LQG 
Sbjct: 387 LFS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR 443

Query: 301 FIA-------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
             +             ++NK  G LP    S    +L  DLS N  +G++P+++G+L  L
Sbjct: 444 INSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL--DLSRNQFSGAVPRKLGSLSEL 501

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
           + L +S N+ SG IP  LS+C  L  +D+S N   G IP S   +  +  LD+S N  SG
Sbjct: 502 MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561

Query: 408 QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPS 467
           + PK L N+  L  +N+S+NHL G +P+ G F   +   + GN+ LCGG     LP C  
Sbjct: 562 EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC-- 619

Query: 468 RGSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAH---NSADTSPMEKQFPMVSY 524
           +  RK       +   +     +       V+ R R +        +    E QF   S 
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF-FDSK 678

Query: 525 AELSKATSEFSSS----NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAEC 580
              S   ++  SS    N+I +G  G+ YKG   ++ M   VK IN        S +A+ 
Sbjct: 679 VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD- 736

Query: 581 EALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
             +  ++H N++K+I +C S   KG     L+ EY+   +L + L           LS  
Sbjct: 737 --MGKLQHPNIVKLIGLCRSE--KGA---YLIHEYIEGKNLSEVLRN---------LSWE 780

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 677
           +R  IAI +A A+ +LH  C P +V G+L P  +++D
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  209 bits (533), Expect = 6e-57
 Identities = 145/438 (33%), Positives = 222/438 (50%), Gaps = 23/438 (5%)

Query: 14  KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL-GLLRNLVQLNVAENK 72
           ++ ++ L+G  ++GK+   I  L  +Q I++  N L G  P  +     +L  LN++ N 
Sbjct: 70  RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129

Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
           F G  PR   +I +LE   L++N  SG +P DI     +LK L +G N   G IP+SL+N
Sbjct: 130 FTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGS-FSSLKVLDLGGNVLVGKIPNSLTN 186

Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            ++LE L L++NQ  G++  +   +K L  + L  NNL      ++G +T      SL  
Sbjct: 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT------SLNH 240

Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT 252
           L L  N   G +P S+ NL +   +FL   N++SG IP  I +L  LI+L +  N L G 
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLY-QNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGAL 312
           IP+++ +L+NL++L L+ N   G IP  L +L +L  L L S           NK  G +
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS-----------NKFSGEI 348

Query: 313 PQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLE 372
           P+ L     L++ LDLS N L G +P+ + +  NL  L + SN   G IP +L  C SL 
Sbjct: 349 PKNLGKHNNLTV-LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407

Query: 373 YVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGE 432
            V +  N F G +P     L  + FLD+S NN  G+      ++  L+ L+L+ N   G 
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467

Query: 433 VPTKGVFSNKSKIPLQGN 450
           +P          + L  N
Sbjct: 468 LPDSFGSKRLENLDLSRN 485

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  173 bits (440), Expect = 5e-45
 Identities = 127/358 (35%), Positives = 189/358 (52%), Gaps = 25/358 (6%)

Query: 108 NLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLE 166
           N   +  + +   N  G I  ++     ++ ++LSNNQ  G +  D F++   L  LNL 
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            NN         G +       +L+ L LS+N   GE+P+ I + SS  ++ L GGN + 
Sbjct: 127 NNNFTGSIPR--GSI------PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL-GGNVLV 177

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
           G IP  + NL +L  L +  NQL G IP  +G++K+L+ + L  N L G IP  +G LT 
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237

Query: 287 LAKLDLGSNSLQGNFIAS-------------QNKLIGALPQQLLSITTLSLYLDLSNNLL 333
           L  LDL  N+L G   +S             QNKL G +P  + S+  L + LDLS+N L
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDLSDNSL 296

Query: 334 NGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK 393
           +G +P+ V  L+NL IL + SN F+G IPV L++   L+ + + SN F G IP +LG   
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356

Query: 394 SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGN 450
           ++  LD+S NN +G+ P+ L +   L  L L  N LEGE+P   G   +  ++ LQ N
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  138 bits (351), Expect = 2e-37
 Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 23/183 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIITIC 598
           +G+G FG+VY     +    VA+K+I  +   +     + E E L+ + H N++K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
              +        LV EY   GSL+D L ++       KLS  + L I + +   +EYLH 
Sbjct: 61  EDENHLY-----LVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110

Query: 659 HCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
           +    ++H DLKP N+LLD D     + DFGL+K L+S      +        I GT  Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--------IVGTPAY 159

Query: 718 VAP 720
           +AP
Sbjct: 160 MAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  133 bits (336), Expect = 6e-35
 Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 24/182 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+GSFG VY     +   +VA+KVI   K K      + E + L+ ++H N++++  + 
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
               F+  D   LV EY   G L D L +        +LS  +       + SA+EYLH 
Sbjct: 66  ----FEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYLHS 115

Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                +VH DLKP N+LLD D    + DFGLA+ L      T+           GT  Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---------FVGTPEYM 163

Query: 719 AP 720
           AP
Sbjct: 164 AP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (330), Expect = 4e-34
 Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 24/183 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           +G GSFG+VYK        IVAVK++  +       ++   E   LR + H N++++I  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
               D        LV EY   G L D+L +         LS  +   IA+ +   +EYLH
Sbjct: 67  FEDKDHL-----YLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLH 115

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
            +    ++H DLKP N+LLD + V  + DFGLAK L       ++          GT  Y
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--------FVGTPWY 164

Query: 718 VAP 720
           +AP
Sbjct: 165 MAP 167

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  128 bits (324), Expect = 3e-33
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 21/174 (12%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG VYKG L       E  VAVK +     +     F+ E   ++ + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           + +C+    +G     +V EYM  G L D+L +  +     KL+L   L +A+ +A  +E
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGME 116

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL---SSHHLDTSSKTP 705
           YL        VH DL   N L+  ++V  + DFGL++ +     +      K P
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  126 bits (318), Expect = 2e-32
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 19/170 (11%)

Query: 539 MIGQGSFGSVYKGIL----GEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIK 593
            +G+G+FG VYKG L       E+ VAVK +     +     F+ E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 594 IITICSSTD-FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           ++ +C+  +         +V EYM  G L D+L ++  +     LSL   L+ A+ +A  
Sbjct: 66  LLGVCTEEEPLM------IVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARG 115

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           +EYL        +H DL   N L+  ++V  + DFGL++ L         
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (317), Expect = 2e-32
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 20/164 (12%)

Query: 539 MIGQGSFGSVYKGIL----GEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIK 593
            +G+G+FG VYKG L    G+ ++ VAVK +     +     F+ E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 594 IITICSSTD-FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           ++ +C+  +         +V EYM  G L  +L ++       KLSL   L+ A+ +A  
Sbjct: 66  LLGVCTEEEPLY------IVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARG 114

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +EYL        +H DL   N L+  ++V  + DFGL++ L   
Sbjct: 115 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 19/168 (11%)

Query: 538 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIK 593
             +G+G+FG VYKG L         VAVK +     +   + F+ E   ++ + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 594 IITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK---LSLIQRLNIAID 648
           ++ +C+  +  +       LV EYM  G L D+L +S       +   LSL   L+ AI 
Sbjct: 61  LLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +A  +EYL        VH DL   N L+  D+V  + DFGL++ +   
Sbjct: 114 IAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  106 bits (267), Expect = 1e-25
 Identities = 47/190 (24%), Positives = 88/190 (46%), Gaps = 20/190 (10%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRN 590
           E++   ++G+GSFGSVY  +  +   ++AVK + L         +   E   L +++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           +++        +   ++   +  EY+  GSL   L +           +I++      + 
Sbjct: 61  IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKK----FGKLPEPVIRKY--TRQIL 111

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
             + YLH +    +VH D+K +N+L+D D V  + DFG AK L         +T   +  
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG------DIETGEGTGS 162

Query: 711 IKGTVGYVAP 720
           ++GT  ++AP
Sbjct: 163 VRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 59/180 (32%), Positives = 88/180 (48%), Gaps = 19/180 (10%)

Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN 585
            ++    +  ++  IG+G FG V  G     +  VAVK +      A ++F+AE   +  
Sbjct: 2   AINSKELKLGAT--IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAA-QAFLAEASVMTT 56

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           +RH NL++++ +        +    +V EYM  GSL D+L      V    ++L Q+L  
Sbjct: 57  LRHPNLVQLLGVV--LQGNPL---YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGF 107

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A+DV   +EYL    +   VH DL   NVL+  D+VA V DFGLAK  S      S K P
Sbjct: 108 ALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DSGKLP 162

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =   99 bits (250), Expect = 2e-23
 Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 34/194 (17%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
            F     IG+G FG VYK         VA+KVI L+ K      + E + L+  +H N++
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN------IA 646
           K      S   K  D   +V E+   GSL+D L            S  Q L       + 
Sbjct: 61  KYYG---SYLKK--DELWIVMEFCSGGSLKDLLK-----------STNQTLTESQIAYVC 104

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
            ++   +EYLH +    ++H D+K +N+LL  D    + DFGL+  LS       +K  +
Sbjct: 105 KELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS------DTKARN 155

Query: 707 SSIGIKGTVGYVAP 720
           + +   GT  ++AP
Sbjct: 156 TMV---GTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.3 bits (248), Expect = 4e-23
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 30/191 (15%)

Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKI 594
            N IG G+FG VY  +  +   ++AVK I ++       +    E + L  ++H NL+K 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63

Query: 595 ITICSSTDFKGVDF---KALVF-EYMGNGSLEDWL-HQSNDQVEVCKLSLIQRLNIAIDV 649
                   + GV+    K  +F EY   G+LE+ L H       V ++  +Q L      
Sbjct: 64  --------YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL------ 109

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
              + YLH H    +VH D+KP+N+ LDH+ V  +GDFG A  L ++    ++       
Sbjct: 110 -EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN----TTTMGEEVQ 161

Query: 710 GIKGTVGYVAP 720
            + GT  Y+AP
Sbjct: 162 SLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (255), Expect = 3e-22
 Identities = 75/227 (33%), Positives = 109/227 (48%), Gaps = 39/227 (17%)

Query: 210 NLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGEL-KNLQLLGL 268
           N SS ++   + G  ISG I   I  L  +  + +  NQL G IPD I     +L+ L L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDL 328
             N   GSIP G                                     SI  L   LDL
Sbjct: 126 SNNNFTGSIPRG-------------------------------------SIPNLET-LDL 147

Query: 329 SNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS 388
           SNN+L+G +P  +G+  +L +LD+  N   G IP +L+   SLE++ ++SN   G IP  
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE 207

Query: 389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT 435
           LG +KS+K++ +  NN SG+ P  +  L+ L  L+L YN+L G +P+
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Length = 968

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 20/168 (11%)

Query: 537 SNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRN 590
              +G+G FG V             E  VAVK +N   +   RS F  E E LR + H N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++K   +C     + +    L+ EY+ +GSL D+L +  DQ     ++L + L  +  + 
Sbjct: 68  IVKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQ-----INLKRLLLFSSQIC 119

Query: 651 SAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
             ++YL         +H DL   N+L++ + +  + DFGLAK L    
Sbjct: 120 KGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 34/188 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKIITIC 598
           +GQGS G VYK        I A+K I++     FR   + E + LR+     ++K     
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63

Query: 599 SSTDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                 G  +K    ++V EYM  GSL D L +     E   L+ I     A  +   ++
Sbjct: 64  ----CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV-LAYI-----ARQILKGLD 113

Query: 655 YLH--HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           YLH   H    ++H D+KPSN+L++      + DFG++K      L+ +    ++ +   
Sbjct: 114 YLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV--- 161

Query: 713 GTVGYVAP 720
           GTV Y++P
Sbjct: 162 GTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.5 bits (230), Expect = 9e-21
 Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 32/171 (18%)

Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 591
           +G+G+FG V+ G         D+ +VAVK   LK+     A + F  E E L N +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH---------QSNDQVEVCKLSLIQR 642
           +K   +C+  D        +VFEYM +G L  +L          +S D   + +L+L Q 
Sbjct: 71  VKFYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS-PMGELTLSQL 124

Query: 643 LNIAIDVASAIEYL--HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           L IA+ +AS + YL   H      VH DL   N L+ +D+V  +GDFG+++
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 14/175 (8%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            EF+    +G G FG V++G L ++ + VA+K++        + F  E +AL+ +RH++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           I +  +CS       +   ++ E M  GSL  +L     QV    L +   +++A  VA 
Sbjct: 65  ISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAE 115

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-SSHHLDTSSKTP 705
            + YL        +H DL   N+L+  D+V  V DFGLA+ +    +L +  K P
Sbjct: 116 GMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP 167

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 20/163 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G VYK    +   +VA+K I ++ +  G   + + E + L+ +RH N++++  I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 598 CSSTDFKGVDFKALVFEYMG---NGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            +S     +    +VFEYM     G L        D  EV K +  Q       +   ++
Sbjct: 67  VTSKGKGSI---YMVFEYMDHDLTGLL--------DSPEV-KFTESQIKCYMKQLLEGLQ 114

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           YLH +    ++H D+K SN+L+++D V  + DFGLA+  +  +
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 14/162 (8%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFRSFV-AECEALRNIRHRNLIKII 595
             IG+GSFG VY      D  +  +K I+L       R     E + L+ + H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
                  F+      +V EY   G L   + +   + +       Q L+  + +  A++Y
Sbjct: 66  E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGK--PFPEEQILDWFVQLCLALKY 118

Query: 656 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           LH       ++H D+KP N+ L  + +  +GDFG++K LSS 
Sbjct: 119 LHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 29/168 (17%)

Query: 538 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNL 591
            +IG G FG V +G L   G+ E+ VA+K   LK          F+ E   +    H N+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 592 IKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           I++          GV  K+    ++ EYM NGSL+ +L + ND     K ++ Q + +  
Sbjct: 68  IRLE---------GVVTKSRPVMIITEYMENGSLDKFLRE-NDG----KFTVGQLVGMLR 113

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L  
Sbjct: 114 GIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 89.0 bits (219), Expect = 8e-19
 Identities = 64/185 (34%), Positives = 90/185 (48%), Gaps = 19/185 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+GSFG VY   L  D  +VA+KV+  K   +      F+ E + L ++ H   I  + 
Sbjct: 8   LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
                +        LV EY+  GSLED L +   +     LS  + L I   + SA+EYL
Sbjct: 65  DFFQDE----GSLYLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALEYL 117

Query: 657 HHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           H      ++H D+KP N+LLD D  V  + DFGLAK L      +S     S+    GT 
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGTP 172

Query: 716 GYVAP 720
           GY+AP
Sbjct: 173 GYMAP 177

Length = 384

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 36/194 (18%)

Query: 539 MIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAF-----RSFVAECEALRNIRHRN 590
           +IG G FG V +G L   G+ E+ VA+K +    K  +     R F++E   +    H N
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +I +         +GV  K+    ++ E+M NG+L+ +L Q++ Q  V     IQ + + 
Sbjct: 67  IIHL---------EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-----IQLVGML 112

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
             +A+ ++YL    +   VH DL   N+L++ ++V  V DFGL++FL     DTS  T +
Sbjct: 113 RGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYT 166

Query: 707 SSIGIKGTVGYVAP 720
           SS+G K  + + AP
Sbjct: 167 SSLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 26/191 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 590
            +   ++IG+G+FG VYKG+  E    VA+K I+L   ++ A +S + E + L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQRLNIAIDV 649
           ++K I        +  D   ++ EY  NGSL   + +     E +  + + Q       V
Sbjct: 61  IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------V 108

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
              + YLH   +  ++H D+K +N+L   D V  + DFG+A  L+    D +S       
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS------- 158

Query: 710 GIKGTVGYVAP 720
            + GT  ++AP
Sbjct: 159 -VVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 20/185 (10%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRN 590
           ++ +  + +G G +G VY+G+  +  + VAVK   LK+       F+ E   ++ I+H N
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 63

Query: 591 LIKIITICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           L++++ +C+    F       ++ E+M  G+L D+L +  ++ EV  + L+    +A  +
Sbjct: 64  LVQLLGVCTREPPF------YIITEFMTYGNLLDYL-RECNRQEVNAVVLLY---MATQI 113

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
           +SA+EYL        +H DL   N L+  + +  V DFGL++ ++    DT +    +  
Sbjct: 114 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKF 167

Query: 710 GIKGT 714
            IK T
Sbjct: 168 PIKWT 172

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 83.3 bits (207), Expect = 1e-17
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           +G+G++G VYK    +   IVA+K I L  +  G   + + E   L+ ++H N++K++ +
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
             +          LVFEY     L+ +L +    +     +LI+   I   +   + Y H
Sbjct: 67  IHT-----ERKLYLVFEYCDM-DLKKYLDKRPGPLS---PNLIKS--IMYQLLRGLAYCH 115

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            H    ++H DLKP N+L++ D V  + DFGLA+    
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 63/167 (37%), Positives = 85/167 (50%), Gaps = 19/167 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMI-VAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           IG+G FG V   +LG+     VAVK I  K     ++F+AE   +  +RH NL++++ + 
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
              + KG  +  +V EYM  GSL D+L      V    L     L  ++DV  A+EYL  
Sbjct: 69  --VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEA 120

Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           +     VH DL   NVL+  D VA V DFGL K  SS   DT  K P
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DT-GKLP 162

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 18/156 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 597
           +G G FG V+ G        VAVK   LK  G     +F+ E + ++ +RH  L+++  +
Sbjct: 14  LGAGQFGEVWMG-TWNGTTKVAVKT--LKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
           CS  +        +V EYM  GSL D+L       E  KL L Q +++A  +A  + YL 
Sbjct: 70  CSEEEPI-----YIVTEYMSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
                  +H DL   N+L+  ++V  + DFGLA+ +
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 25/158 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           IG+G+FG VYKG+L +    VAVK        +LK+K     F+ E E L+   H N++K
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I +C     + +    +V E +  GSL  +L +  +++ V KL     L +++D A+ +
Sbjct: 57  LIGVC--VQKQPI---YIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGM 106

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           EYL        +H DL   N L+  + V  + DFG+++
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 80.6 bits (200), Expect = 6e-17
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 27/185 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+GSFG V      +   + A+KV+    + ++      + E   L  I H  ++K   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKLSLIQRLNIAIDVASAIEY 655
             +   F+  +   LV EY   G L   L +      E  +         A ++  A+EY
Sbjct: 59  HYA---FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-------YAAEIVLALEY 108

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           LH      +++ DLKP N+LLD D    + DFGLAK LSS    T++          GT 
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--------FCGTP 157

Query: 716 GYVAP 720
            Y+AP
Sbjct: 158 EYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 22/182 (12%)

Query: 532 SEFSSSNMIGQGSFGSVYKGI---LGEDEMI-VAVKVINLKQ-KGAFRSFVAECEALRNI 586
           +E     ++G G+FG+VYKG+    GE   I VA+KV+  +    A +  + E   + ++
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            H ++++++ IC S+         L+ + M  G L D++    D      +     LN  
Sbjct: 67  DHPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWC 115

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL---SSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L      +     K
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 704 TP 705
            P
Sbjct: 173 VP 174

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 20/163 (12%)

Query: 540 IGQGSFGSVYKG-ILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           IG+G FG+V +G   G+    VAVK  N+K     ++F+ E   +  + H+NL++++ + 
Sbjct: 14  IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
                       +V E M  G+L ++L      +    +S+IQ L  ++DVA  +EYL  
Sbjct: 69  LHNGLY------IVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE- 117

Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
                +VH DL   N+L+  D VA V DFGLA+ + S  +D S
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNS 157

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 9/164 (5%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK--QKGAFRSFVAECEALRNIRH 588
                ++G+G FGSV +G L +D+     VAVK + L          F++E   +++  H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 589 RNLIKIITIC-SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            N++K+I +C  ++  + +    ++  +M +G L  +L  S       KL L   L   +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           D+A  +EYL +      +H DL   N +L  DM   V DFGL+K
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 50/187 (26%), Positives = 75/187 (40%), Gaps = 49/187 (26%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIK- 593
           IG+GSFG+V K     D  I+  K I+      K+K      V+E   LR ++H N+++ 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNIVRY 64

Query: 594 ---IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR-------- 642
              II   + T +       +V EY   G L                 LIQ+        
Sbjct: 65  YDRIIDRSNQTLY-------IVMEYCEGGDLA---------------QLIQKCKKERKYI 102

Query: 643 -----LNIAIDVASAIEYLHH--HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                  I   +  A+   H+       ++H DLKP+N+ LD +    +GDFGLAK L  
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Query: 696 HHLDTSS 702
                 +
Sbjct: 163 DSSFAKT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 22/170 (12%)

Query: 540 IGQGSFGSVY----KGILGE-DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V+      +L E D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLH---------QSNDQVEVCKLSLIQRLNI 645
             +C+           +VFEYM +G L  +L             + V   +L+L Q L I
Sbjct: 73  YGVCTEGRPL-----LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           A  +AS + YL        VH DL   N L+   +V  +GDFG+++ + S
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 14/164 (8%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           + +   IG+G+ G VYK         VA+K + L+++      + E   +++ +H N++ 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVD 79

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                 S       +  +V EYM  GSL D + Q+  ++   +++ + R     +V   +
Sbjct: 80  YY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-----EVLQGL 129

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           EYLH      ++H D+K  N+LL  D    + DFG A  L+   
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 24/164 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR------HRNLIK 593
           IG+G++G VYK        IVA+K I L+    F S      ALR I+      H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLR----FESEGIPKTALREIKLLKELNHPNIIK 62

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           ++ +     F+      LVFE+M      D      D+      SLI+  +    +   +
Sbjct: 63  LLDV-----FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIK--SYLYQLLQGL 111

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
            + H H    ++H DLKP N+L++ + V  + DFGLA+   S  
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 18/156 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 597
           +G G FG V++G L  +   VAVK   LK  G    + F+AE + ++ +RH  LI++  +
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVK--TLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
           C+  +        +V E M  GSL ++L          KL   Q +++A  VAS + YL 
Sbjct: 70  CTLEEPI-----YIVTELMKYGSLLEYLQ--GGAGRALKLP--QLIDMAAQVASGMAYLE 120

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
                  +H DL   NVL+  + +  V DFGLA+ +
Sbjct: 121 AQ---NYIHRDLAARNVLVGENNICKVADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 28/192 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRH 588
           SE +    +G G FG V+ G   G+ +  VA+K+I    +GA     F+ E + +  + H
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKID--VAIKMIR---EGAMSEDDFIEEAKVMMKLSH 58

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            NL+++  +C  T  + +    +V EYM NG L ++L +        KL     L++  D
Sbjct: 59  PNLVQLYGVC--TKQRPI---FIVTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSD 108

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V  A+EYL  +     +H DL   N L+  D V  V DFGLA+++    LD      +SS
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQY---TSS 158

Query: 709 IGIKGTVGYVAP 720
            G K  V +  P
Sbjct: 159 QGTKFPVKWAPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 28/188 (14%)

Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQK--GAFRS-FVAE 579
           E+  +   F     +G+G+FG VYKG L    E     +V +  LK+      +  F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCK- 636
            E + +++H N++ ++ +C+    K      ++FEY+ +G L ++L  +  +  V     
Sbjct: 59  AELMSDLQHPNIVCLLGVCT----KEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 637 -------LSLIQRLNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
                  L     L+IAI +A+ +EYL  HH     VH DL   N L+   +   + DFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169

Query: 689 LAKFLSSH 696
           L++ + S 
Sbjct: 170 LSRDIYSA 177

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 57/170 (33%), Positives = 80/170 (47%), Gaps = 30/170 (17%)

Query: 540 IGQGSFGSVYKGIL--------GEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRN 590
           +G+G FG V    L        G  EM VAVK +  +      S +  E   L+ + H N
Sbjct: 12  LGEGHFGKV---SLYCYDPANDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++K    CS    KG+    L+ EY+  GSL D+L +         L+L Q L  A  + 
Sbjct: 68  IVKYKGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQIC 117

Query: 651 SAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
             + YLH  H+     +H DL   NVLLD+D +  +GDFGLAK +   H 
Sbjct: 118 EGMAYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 38/201 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-------KQKGAFRSFVAECEAL-RNIRHRNL 591
           IG+GSF +V      E     A+K+++        K K        E E L R   H  +
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLTRLNGHPGI 64

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           IK+    +  D + + F   V EY  NG L  ++ +         L        A ++  
Sbjct: 65  IKLY--YTFQDEENLYF---VLEYAPNGELLQYIRK------YGSLDEKCTRFYAAEILL 113

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYLH      ++H DLKP N+LLD DM   + DFG AK L  +    S+K  +++I  
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 712 K------------GTVGYVAP 720
           +            GT  YV+P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSP 191

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 22/183 (12%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVI-NLKQKGAFRSFVAECEALRN 585
            +E     ++G G FG+V+KGI + E + I   VA+K I +   +  F+       A+ +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H  +++++ IC     +      LV +    GSL D + Q  D ++  +L     LN 
Sbjct: 66  LDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNW 114

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL---SSHHLDTSS 702
            + +A  + YL  H    MVH +L   N+LL  D +  + DFG+A  L      +  +  
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 703 KTP 705
           KTP
Sbjct: 172 KTP 174

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 20/163 (12%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIK 593
           +GQGSFG VY+G+      GE E  VA+K +N       R  F+ E   ++     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 594 IITICSSTDFKGVDFKALV-FEYMGNGSLEDWLHQSN-DQVEVCKL---SLIQRLNIAID 648
           ++ + S+          LV  E M  G L+ +L     +      L   +L + + +A +
Sbjct: 74  LLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +A  + YL        VH DL   N ++  D+   +GDFG+ +
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 5e-15
 Identities = 50/160 (31%), Positives = 73/160 (45%), Gaps = 27/160 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLI 592
           +G G+FGSVY     E   +VA+K    K K  F S+  EC  LR ++       H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61

Query: 593 KIITICSSTDFKGVDFKALVFEYM-GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           K+  +     F+  D    VFEYM GN      L+Q     +    S     +I   +  
Sbjct: 62  KLKEV-----FRENDELYFVFEYMEGN------LYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            + ++H H      H DLKP N+L+    V  + DFGLA+
Sbjct: 111 GLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 16/158 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G+ G V+K    E    VA+K + L++   G     + E +AL+  +H  ++K++ +
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
                  G     LV EYM    L + L           L   Q  +    +   + Y+H
Sbjct: 68  --FPHGSGF---VLVMEYMP-SDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMH 116

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                 ++H DLKP+N+L+  D V  + DFGLA+  S 
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 27/157 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G+GS+GSVYK I  E   +VA+KV+ +  +   +  + E   L+      ++K      
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62

Query: 600 STDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI--DVASAI 653
              + G  FK     +V EY G GS+       +D +++   +L +    AI       +
Sbjct: 63  ---YYGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           EYLH +     +H D+K  N+LL+ +  A + DFG++
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 18/170 (10%)

Query: 539 MIGQGSFGSVYKGI--LGEDEMI-VAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
            IG+G FG VY+G+    E+E I VAVK        + R  F+ E   +R   H +++K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           I + +       +   +V E    G L  +L  +   +++  L L      +  +++A+ 
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY-----SYQLSTALA 121

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           YL        VH D+   NVL+       +GDFGL+++L       +SK 
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG 168

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 26/194 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 589
           SE +    IG G FG V+ G   E    VA+K I   ++GA     F+ E + +  + H 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
            L+++  +C+           LVFE+M +G L D+L          K S    L + +DV
Sbjct: 60  KLVQLYGVCTERSPI-----CLVFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDV 109

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
              + YL       ++H DL   N L+  + V  V DFG+ +F+    LD      +SS 
Sbjct: 110 CEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQY---TSST 159

Query: 710 GIKGTVGYVAPGKF 723
           G K  V + +P  F
Sbjct: 160 GTKFPVKWSSPEVF 173

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 30/176 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 593
           IG G++G V   +       VA+K I+      +  K   R    E + LR++RH N+I 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENIIG 63

Query: 594 IITIC---SSTDFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKLSLIQRLNIAIDV 649
           ++ I    S  DF  V    +V E M    L   +        +  +  L Q L      
Sbjct: 64  LLDILRPPSPEDFNDV---YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL------ 113

Query: 650 ASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
              ++YLH  +     +H DLKPSN+L++ +    + DFGLA+ +     +    T
Sbjct: 114 -RGLKYLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 75.8 bits (186), Expect = 2e-14
 Identities = 82/256 (32%), Positives = 122/256 (47%), Gaps = 16/256 (6%)

Query: 83  NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS 142
           N+  L    L  NR   ++    ++ L NL  L +  NN   + P      SNL+ LDLS
Sbjct: 91  NLLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLS 148

Query: 143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG 202
           +N+ +  +     +L  L  L+L  N+L     +DL  +  L+N S+L  L LS N+   
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDL-----SDLPKL--LSNLSNLNNLDLSGNKI-S 199

Query: 203 ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKN 262
           +LP  I  LS+   + L   + I   +   + NL NL  L +  N+L   +P+ IG L N
Sbjct: 200 DLPPEIELLSALEELDLSNNSIIE--LLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSN 256

Query: 263 LQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTL 322
           L+ L L  N  Q S  S LG+LT L +LDL  NSL          L+       L +T  
Sbjct: 257 LETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314

Query: 323 SLYLDLSNNLLNGSLP 338
           +L L L++ LLN ++ 
Sbjct: 315 ALELKLNSILLNNNIL 330

Length = 394

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 27/170 (15%)

Query: 538 NMIGQGSFGSVYKGIL------GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNIR 587
           N +G G+FG VY+G        G   + VAVK +   +KGA     + F+ E   + N  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ-VEVCKLSLIQRLNIA 646
           H N++K++ +C        + + ++ E M  G L  +L  +  +      L+L + L+I 
Sbjct: 58  HPNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAK 691
           +DVA    YL    Q   +H DL   N L+     D D V  +GDFGLA+
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 17/164 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG G++G VYK        +VA+KVI L+    F     E   L+  RH N++       
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF---- 66

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
              +   D   +V EY G GSL+D    +   +   +++ + R     +    + YLH  
Sbjct: 67  -GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET 120

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +   +H D+K +N+LL  D    + DFG++  L++    T +K
Sbjct: 121 GK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA----TIAK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 29/170 (17%)

Query: 540 IGQGSFGSVYKGILGE--------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           +G+G+FG V+   L E        D+M+VAVK +      A + F  E E L N++H ++
Sbjct: 13  LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEV--------CKLSLIQ 641
           +K   +C        D   +VFEYM +G L  +L  H  +  + V         +L L Q
Sbjct: 70  VKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            L+IA  +AS + YL        VH DL   N L+  +++  +GDFG+++
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF------RSFVAECEALRNIRHRNLI 592
           ++G+G++G V K        IVA+K    K K +       ++ + E + LR +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAIDVA 650
            +         KG  +  LVFEY+    LE  L  S   +  +  +  + Q L       
Sbjct: 64  NLKEAFRR---KGRLY--LVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQ------ 111

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            AI Y H H    ++H D+KP N+L+    V  + DFG A+ L +
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 72.6 bits (179), Expect = 7e-14
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 39/171 (22%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G++  VYK    E   IVA+K I L      + G   + + E + L+ ++H N+I +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI---DVAS 651
           + +             LVFE+M    LE                +I+  +I +   D+ S
Sbjct: 68  LDVFGHKSNI-----NLVFEFME-TDLE---------------KVIKDKSIVLTPADIKS 106

Query: 652 -------AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                   +EYLH +    ++H DLKP+N+L+  D V  + DFGLA+   S
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 28/196 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALR 584
           S  +   +IG G FG V++GIL   G  E+ VA+K +      KQ+   + F++E   + 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61

Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
              H N+I++  +   T FK      ++ EYM NG+L+ +L   + +      S  Q + 
Sbjct: 62  QFSHHNIIRLEGVV--TKFKPA---MIITEYMENGALDKYLRDHDGE-----FSSYQLVG 111

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           +   +A+ ++YL        VH DL   N+L++ ++   V DFGL++ L     D    T
Sbjct: 112 MLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE----DDPEGT 164

Query: 705 PSSSIGIKGTVGYVAP 720
            ++S G K  + + AP
Sbjct: 165 YTTS-GGKIPIRWTAP 179

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 36/195 (18%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----GAFRSFVAECEALRNIRHR 589
           F    +IG+G+FG V      + + + A+K +N KQK    G+ R+ + E   L+ + H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNI 645
            L+ +     S  F+  +   LV + +  G L   L Q    S +QV         +  I
Sbjct: 61  FLVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV---------KFWI 106

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
             ++  A+EYLH      ++H D+KP N+LLD     H+ DF +A       +   + T 
Sbjct: 107 C-EIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT-----KVTPDTLTT 157

Query: 706 SSSIGIKGTVGYVAP 720
           S+S    GT GY+AP
Sbjct: 158 STS----GTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 23/187 (12%)

Query: 540 IGQGSFGSVY---KGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           I +G++G V+   K   G+   I A+KVI    + +K      + E + L   +   ++K
Sbjct: 1   ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +    S   F+G     LV EY+  G L   L       E      + R+ IA ++  A+
Sbjct: 58  LY--YS---FQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLAL 106

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           EYLH +    ++H DLKP N+L+D +    + DFGL+K          +        I G
Sbjct: 107 EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163

Query: 714 TVGYVAP 720
           T  Y+AP
Sbjct: 164 TPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 8/157 (5%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS----FVAECEALRNIRHRNLIKII 595
           +G+G FGSV +G L +D+ I+ V V  +K     RS    F++E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 596 TIC-SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            +C  + + +G     ++  +M +G L  +L  S        L     +    D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           YL        +H DL   N +L+ +M   V DFGL+K
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 22/185 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKIITIC 598
           IG G+   VY  I   +   VA+K I+L++       +  E +A+    H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK----- 63

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI---DVASAIEY 655
             T F   D   LV  Y+  GSL D +  S           +    IA    +V   +EY
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEY 117

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           LH + Q   +H D+K  N+LL  D    + DFG++  L     D   +T        GT 
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL----ADGGDRTRKVRKTFVGTP 170

Query: 716 GYVAP 720
            ++AP
Sbjct: 171 CWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 56/186 (30%), Positives = 81/186 (43%), Gaps = 36/186 (19%)

Query: 523 SYAEL-SKATSE--FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSF 576
             AEL SK   E  F+    IG GSFG+VY         +VA+K ++   K +   ++  
Sbjct: 3   EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62

Query: 577 VAECEALRNIRHRNLIKIITICSSTDFKGVDFKA----LVFEY-MGNGSLEDWLHQSNDQ 631
           + E   L+ +RH N I         ++KG   +     LV EY +G+ S         D 
Sbjct: 63  IKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYCLGSAS---------DI 104

Query: 632 VEVCKLSLIQRLNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
           +EV K  L Q + IA         + YLH H     +H D+K  N+LL       + DFG
Sbjct: 105 LEVHKKPL-QEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG 160

Query: 689 LAKFLS 694
            A  +S
Sbjct: 161 SASLVS 166

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.0 bits (175), Expect = 2e-13
 Identities = 55/189 (29%), Positives = 77/189 (40%), Gaps = 38/189 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V            A+K      ++ LKQ       + E   L++IRH  L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQSIRHPFLVN 65

Query: 594 IITICSSTDFKGVDFKAL--VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +        F+  D   L  V EY+  G L   L +S       +         A  V  
Sbjct: 66  LYG-----SFQ--DDSNLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVL 112

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYLH      +V+ DLKP N+LLD D    + DFG AK      +   + T      +
Sbjct: 113 ALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYT------L 158

Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 159 CGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 20/164 (12%)

Query: 540 IGQGSFGSV-----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V     Y     +D+++VAVK +      A + F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVC------KLSLIQRLNIAI 647
             +C        D   +VFEYM +G L  +L     D V +       +L+  Q L+IA 
Sbjct: 73  YGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            +A+ + YL        VH DL   N L+  +++  +GDFG+++
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 23/160 (14%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FGSV KG+       E+ VAVK   LKQ       + F+ E   +  + H  +++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I +C            LV E    G L  +L +   ++ V  L       +A  VA  +
Sbjct: 61  LIGVCKGEPL------MLVMELAPLGPLLKYL-KKRREIPVSDL-----KELAHQVAMGM 108

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        VH DL   NVLL +   A + DFG+++ L
Sbjct: 109 AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 23/162 (14%)

Query: 539 MIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHRNL 591
           +IG G FG V  G L   G+ E+ VA+K +      KQ+   R F++E   +    H N+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           I +  +   T  K V    +V EYM NGSL+ +L + + Q  V     IQ + +   +AS
Sbjct: 68  IHLEGVV--TKSKPV---MIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLRGIAS 117

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            ++YL        VH DL   N+L++ ++V  V DFGL++ L
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 26/183 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 597
           +GQG FG V+ G        VA+K +   + G     +F+ E + ++ +RH  L+++  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-VAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            S           +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+ 
Sbjct: 70  VSEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE 119

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
              +   VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + +
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKW 169

Query: 718 VAP 720
            AP
Sbjct: 170 TAP 172

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 34/176 (19%)

Query: 540 IGQGSFGSVYK----GIL-GEDEMIVAVKVINLKQKGAF---RSFVAECEALRNIRHRNL 591
           IGQG+FG V++    G+L  E   +VAVK+  LK++ +      F  E   +    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL-HQSNDQVEV---------------C 635
           +K++ +C+           L+FEYM  G L ++L H+S                      
Sbjct: 71  VKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            LS  ++L IA  VA+ + YL    +   VH DL   N L+  +MV  + DFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 27/165 (16%)

Query: 539 MIGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
            +G+G+FGSV    Y  +      +VAVK +        R F  E E L++++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK- 69

Query: 595 ITICSSTDFKGVDFKA------LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
                   +KGV + A      LV EY+  GSL D+L +  ++++  KL     L  A  
Sbjct: 70  --------YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQ 116

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           +   +EYL        VH DL   N+L++ +    +GDFGL K L
Sbjct: 117 ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 28/187 (14%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIIT 596
           ++G+G+FG V+      D+ +V +K I ++Q  K    +   EC+ L+ + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 597 ICSSTDFKGVDFKAL--VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                +F  ++ KAL  V EY   G+L +++ +  +       SL+    I       + 
Sbjct: 67  -----NF--LEDKALMIVMEYAPGGTLAEYIQKRCN-------SLLDEDTILHFFVQILL 112

Query: 655 YLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            LHH     ++H DLK  N+LLD H MV  +GDFG++K LSS          S +  + G
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---------SKAYTVVG 163

Query: 714 TVGYVAP 720
           T  Y++P
Sbjct: 164 TPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 54/185 (29%), Positives = 79/185 (42%), Gaps = 44/185 (23%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
             F+    IG+GSFG VYK I      +VA+KVI+L+            EA   I   ++
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEI--EDI 46

Query: 592 IKIITICSS------TDFKG---VDFK-ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
            + I   S       T + G      K  ++ EY G GS  D L          K   + 
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----------KPGKLD 96

Query: 642 RLNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
              IA    +V   +EYLH   +   +H D+K +N+LL  +    + DFG++  L+S   
Sbjct: 97  ETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS--- 150

Query: 699 DTSSK 703
            T SK
Sbjct: 151 -TMSK 154

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 20/170 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHR 589
           +EF   N IG+G++G VY+        IVA+K + +  +  G   S + E   L N+RH 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGN--GSLEDWLHQSNDQVEV-CKLSLIQRLNIA 646
           N++++  +      K +D   LV EY      SL D +     + +V C         + 
Sbjct: 67  NIVELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC---------LM 114

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           + +   ++YLH +    ++H DLK SN+LL       + DFGLA+     
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 508 NSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL 567
            S+ +S         S    +K+ SE    N IG G+ G+VYK I      + A+KVI  
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109

Query: 568 KQKGAFRSFVA-ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
             +   R  +  E E LR++ H N++K    C        + + L+ E+M  GSLE    
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--T 162

Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
              D+  +         ++A  + S I YLH      +VH D+KPSN+L++      + D
Sbjct: 163 HIADEQFLA--------DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIAD 211

Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           FG+++ L +  +D      +SS+   GT+ Y++P
Sbjct: 212 FGVSRIL-AQTMDPC----NSSV---GTIAYMSP 237

Length = 353

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 22/168 (13%)

Query: 538 NMIGQGSFGSVYKGILGED--EMIVAVKVIN-LKQKGAFRSFVAECEALRNI-RHRNLIK 593
           ++IG+G+FG V + ++ +D  +M  A+K++     +   R F  E E L  +  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS----------NDQVEVCKLSLIQRL 643
           ++  C +   +G  + A+  EY   G+L D+L +S           +      L+  Q L
Sbjct: 68  LLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             A DVA+ ++YL    +   +H DL   NVL+  ++ + + DFGL++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 9/168 (5%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDE---MIVAVKVI--NLKQKGAFRSFVAECEALRNIRH 588
           F+   M+G+G FGSV +  L  ++     VAVK++  ++        F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 589 RNLIKIITICSSTDFKG-VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            N+IK+I +   +  KG +    ++  +M +G L  +L  S    E   L L   +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           D+AS +EYL        +H DL   N +L+ +M   V DFGL+K + S
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 15/171 (8%)

Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVK--VINLKQKGAFRSFVAECEALRNIR---HRNL 591
              IG+G++G+VYK         VA+K   + L ++G   S + E   L+ +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDW-LHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++++ +C            LVFE++      D  L     +     L      ++   + 
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
             +++LH H    +VH DLKP N+L+  D    + DFGLA+  S     TS
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 19/156 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 597
           +G G FG V+ G        VA+K  +LKQ G+    +F+AE   ++ ++H  L+++  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIK--SLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +           ++ EYM NGSL D+L       E  KL++ + +++A  +A  + ++ 
Sbjct: 70  VTQEPI------YIITEYMENGSLVDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
              +   +H DL+ +N+L+   +   + DFGLA+ +
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 16/169 (9%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK-VINLKQKGAFRSFVA--ECEALRNIRH 588
           S++     IGQG+FG V+K    + + IVA+K V+   +K  F    A  E + L+ ++H
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-PITALREIKILQLLKH 70

Query: 589 RNLIKIITICSSTDFKGVDFKA---LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            N++ +I IC +       +K    LVFE+  +  L   L  SN  V   K +L +   +
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNV---KFTLSEIKKV 124

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
              + + + Y+H +    ++H D+K +N+L+  D +  + DFGLA+  S
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 16/157 (10%)

Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y          VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
             IC+     G+    L+ E++ +GSL+++L ++ +     K++L Q+L  A+ +   ++
Sbjct: 72  KGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMD 123

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           YL        VH DL   NVL++ +    +GDFGL K
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 31/193 (16%)

Query: 539 MIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA---FRSFVAECEALRNI-RHR 589
            +G+G+FG V K          +   VAVK+  LK           V+E E ++ I +H+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK----------LSL 639
           N+I ++ +C+    +G  +  +V EY  +G+L D+L       E             L+ 
Sbjct: 77  NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
              ++ A  VA  +E+L        +H DL   NVL+  D V  + DFGLA+ +  HH+D
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHID 186

Query: 700 TSSKTPSSSIGIK 712
              KT +  + +K
Sbjct: 187 YYRKTTNGRLPVK 199

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 26/183 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 597
           +GQG FG V+ G        VA+K +   + G     +F+ E + ++ +RH  L+ +  +
Sbjct: 14  LGQGCFGEVWMGTW-NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            S           +V E+MG GSL D+L + + +     L L Q +++A  +A  + Y+ 
Sbjct: 70  VSEEPI------YIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIE 119

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
              +   +H DL+ +N+L+  ++V  + DFGLA+ +  +         ++  G K  + +
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPIKW 169

Query: 718 VAP 720
            AP
Sbjct: 170 TAP 172

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 19/167 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVIN-LKQKGAFRSFVAECEALRNI 586
           +E     ++G G+FG+VYKGI + E E +   VA+K++N      A   F+ E   + ++
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            H +L++++ +C S   +      LV + M +G L D++H+  D +    L     LN  
Sbjct: 67  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWC 115

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           + +A  + YL    +  +VH DL   NVL+       + DFGLA+ L
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 30/185 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + +  + H  L+++  +
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
           C+     +       +V EYM NG L ++L +   + +  +L     L +  DV   + Y
Sbjct: 68  CTKQRPIY-------IVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAY 115

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L        +H DL   N L+D      V DFGL++++    LD      +SS+G K  V
Sbjct: 116 LESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEY---TSSVGSKFPV 165

Query: 716 GYVAP 720
            +  P
Sbjct: 166 RWSPP 170

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 46/198 (23%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 598
           IG+G++G VYK    +   +VA+K++++  +        E   LR    H N+       
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIA------ 66

Query: 599 SSTDFKGVDFKA----------LVFEYMGNGSLEDW---LHQSNDQVEVCKLSLIQRLNI 645
               F G   K           LV E  G GS+ D    L +   +++   ++ I R   
Sbjct: 67  ---TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR--- 120

Query: 646 AIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVG--DFGLAKFLSSHHLDTSS 702
             +    + YLH +      +H D+K  N+LL  +  A V   DFG+     S  LD++ 
Sbjct: 121 --ETLRGLAYLHENKV----IHRDIKGQNILLTKN--AEVKLVDFGV-----SAQLDSTL 167

Query: 703 KTPSSSIGIKGTVGYVAP 720
              ++ I   GT  ++AP
Sbjct: 168 GRRNTFI---GTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 7e-12
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 16/151 (10%)

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           L + +    G IP  +S    L+ +++S N   G IPPSLG + S++ LD+S N+F+G  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVPTK--GVFSNKSKIPLQGNVRLCG--GIDEL--HLP 463
           P+ L  L+ L  LNL+ N L G VP    G   +++      N  LCG  G+     HL 
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542

Query: 464 SCPSRGSRKLKITL-----LKVLIPVAVSCW 489
                   K+ I          L+  A+  W
Sbjct: 543 V-----GAKIGIAFGVSVAFLFLVICAMCWW 568

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 7e-12
 Identities = 34/85 (40%), Positives = 53/85 (62%)

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           L L N  L G +P  +  L++L  +++S N   G IP +L +  SLE +D+S N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 386 PPSLGFLKSIKFLDVSCNNFSGQFP 410
           P SLG L S++ L+++ N+ SG+ P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 22/174 (12%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-R 587
           ++    ++IG+G+FG V K  + +D + +   +  +K+   K   R F  E E L  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H N+I ++  C   + +G  +  L  EY  +G+L D+L +S                  L
Sbjct: 67  HPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           S  Q L+ A DVA  ++YL    Q   +H DL   N+L+  + VA + DFGL++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 26/164 (15%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLI 592
           ++G+GS+G V K    E   IVA+K         + +K A R    E   L+ +RH NL+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKLSLIQRLNIAIDVAS 651
            +I +     F+      LVFE++ +  L+D     N       +  L Q L        
Sbjct: 64  NLIEV-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR------- 111

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            IE+ H H    ++H D+KP N+L+    V  + DFG A+ L++
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 26/168 (15%)

Query: 538 NMIGQGSFGSVYKG-ILGED----EMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNL 591
             +G G+FG VY+G   G D    E+ VAVK +         S F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 592 IKIITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQS-NDQVEVCKLSLIQRLNIA 646
           +++I         GV F+ L    + E M  G L+ +L ++         L++   L  A
Sbjct: 72  VRLI---------GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVGDFGLAK 691
            DVA   +YL    +   +H D+   N LL       VA + DFG+A+
Sbjct: 123 RDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 23/161 (14%)

Query: 540 IGQGSFGSVYKGI---LGEDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G GSFG V +G     G   + VAVK + + K       F+ E   + ++ H NLI++ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLS--LIQRL-NIAIDVASA 652
            +  +          +V E    GSL D L +         L   LI  L + A+ +A+ 
Sbjct: 63  GVVLTHPLM------MVTELAPLGSLLDRLRKD-------ALGHFLISTLCDYAVQIANG 109

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           + YL        +H DL   N+LL  D    +GDFGL + L
Sbjct: 110 MRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.4 bits (163), Expect = 1e-11
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 51/177 (28%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR----------HR 589
           +G+G++G V+K I    + +VA+K    K   AFR+     +A R  R          H 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALK----KIFDAFRN---ATDAQRTFREIMFLQELGDHP 67

Query: 590 NLIKIITICSSTDFKGVDFKA-------LVFEYMGNGSLEDWLHQSNDQVEVCK---LSL 639
           N++K++ +           KA       LVFEYM     E  LH       V +   L  
Sbjct: 68  NIVKLLNV----------IKAENDKDIYLVFEYM-----ETDLHA------VIRANILED 106

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           + +  I   +  A++Y+H      ++H DLKPSN+LL+ D    + DFGLA+ LS  
Sbjct: 107 VHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 30/181 (16%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG VYKGI    + +VA+K+I+L++        AE E + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 594 IITICSS---TDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K     ++ EY+G GS  D L      +E   ++ I R    
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 108

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL--DTSSKT 704
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L+   +  +T   T
Sbjct: 109 -EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 705 P 705
           P
Sbjct: 165 P 165

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 26/180 (14%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFR-SFVAECEALRN 585
            +   +F     IG+G++G VYK    +   +VA+K + L  +K  F  + + E + LR 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 586 IRHRNLIKIITICSSTDFKGVDFKA------LVFEYMGN---GSLEDWL-HQSNDQVEVC 635
           + HRN++ +  I +      +DFK       LVFEYM +   G LE  L H S D ++  
Sbjct: 63  LNHRNIVNLKEIVTDKQ-DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-- 119

Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             S +++L         + Y H   +   +H D+K SN+LL++     + DFGLA+  +S
Sbjct: 120 --SFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 41/191 (21%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLIKI---- 594
           +G G+ G V K +      I+AVK I L+   A  +  + E + L       ++      
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 595 -----ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
                I+IC               EYM  GSL+  L +   ++    L       IA+ V
Sbjct: 69  YNNGDISIC--------------MEYMDGGSLDKILKEVQGRIPERILG-----KIAVAV 109

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
              + YLH   +  ++H D+KPSN+L++      + DFG++  L    +++ +KT     
Sbjct: 110 LKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKT----- 158

Query: 710 GIKGTVGYVAP 720
              GT  Y+AP
Sbjct: 159 -FVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 50/191 (26%), Positives = 89/191 (46%), Gaps = 31/191 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKIITI 597
           +G G FG V+ G    +   VAVK +   + G     SF+ E + ++ +RH  L+++  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            S           +V EYM  GSL D+L     +     L L   +++A  VA+ + Y+ 
Sbjct: 70  VSEEPI------YIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
              +   +H DL+ +N+L+   +V  + DFGLA+ +  +         ++  G K  + +
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIKW 169

Query: 718 VAP-----GKF 723
            AP     G+F
Sbjct: 170 TAPEAALYGRF 180

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 46/156 (29%), Positives = 82/156 (52%), Gaps = 19/156 (12%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           ++G+G+FG V+KG L +D+  VAVK    +L Q+   + F++E   L+   H N++K+I 
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +C  T  + +    +V E +  G    +L +  D+     L   Q +  A+D A+ + YL
Sbjct: 60  VC--TQRQPI---YIVMELVPGGDFLSFLRKKKDE-----LKTKQLVKFALDAAAGMAYL 109

Query: 657 H-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
              +C    +H DL   N L+  + V  + DFG+++
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 28/172 (16%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L++        AE E + +I+    I 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 594 IITICSS---TDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K     ++ EY+G GS  D L       E   L   Q   I 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 107

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L+   +
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 32/189 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-RSFVAECEA----LRNIRHRNLIK 593
           ++G GSFGSVY+G+  +D    AVK ++L   G   +  V + E     L  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 594 IITICSSTDFKGVDFKALVF-EYMGNGSLEDWLHQSNDQVE-VCKLSLIQRLNIAIDVAS 651
            +      D         +F E +  GSL   L +     E V +L   Q L        
Sbjct: 67  YLGTEREED------NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------L 113

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            +EYLH       VH D+K +N+L+D + V  + DFG+AK      +   S   S     
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKS----F 161

Query: 712 KGTVGYVAP 720
           KG+  ++AP
Sbjct: 162 KGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 40/153 (26%), Positives = 78/153 (50%), Gaps = 13/153 (8%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+G++ +VYKG       IVA+K I+L  ++G   + + E   ++ ++H N++++  + 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
             T+ K +    LVFEYM +  L+ ++     +     L      +    +   I + H 
Sbjct: 68  H-TENKLM----LVFEYM-DKDLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCHE 118

Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +    ++H DLKP N+L++      + DFGLA+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 5e-11
 Identities = 29/81 (35%), Positives = 48/81 (59%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G IP +I  L  LQ++ L+GN + G +P  +G++++L+V+ +  NS  G  P +LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 61  RNLVQLNVAENKFYGMFPRSI 81
            +L  LN+  N   G  P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 19/169 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMI-VAVKVI-NLKQKGAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+    GE   I VA+K +       A +  + E   + ++
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +      L   LN  
Sbjct: 67  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI--GSQYL---LNWC 115

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 33/204 (16%)

Query: 540 IGQGSFGSVYKG-ILGEDE----MIVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 590
           +G+G FG V     +G D+     +  V V  LK           ++E E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLI 640
           +I ++  C+     G  +  ++ EY   G+L ++L               QV   +LS  
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  HH+D 
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 195

Query: 701 SSKTPSSSIGIKGTVGYVAPGKFF 724
             KT +  + +K    ++AP   F
Sbjct: 196 YKKTTNGRLPVK----WMAPEALF 215

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.8 bits (152), Expect = 8e-11
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 22/168 (13%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNI-RHRNLIK 593
           ++IG+G+FG V K  + +D + +   +  +K+  +    R F  E E L  +  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLIQRL 643
           ++  C     +G  + A+  EY  +G+L D+L +S                  LS  Q L
Sbjct: 61  LLGACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           + A DVA  ++YL    Q   +H DL   N+L+  + VA + DFGL++
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 26/167 (15%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFRSFVAECEALRNI 586
           E+   N I +G++G VY+    +   IVA+K + ++++       + R    E   L  +
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLKL 61

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLN 644
           +H N++ +  +   ++   +D   +V EY+ +   SL + + Q   Q EV K  ++Q L 
Sbjct: 62  QHPNIVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMETMKQPFLQSEV-KCLMLQLL- 116

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                 S + +LH +    ++H DLK SN+LL++  +  + DFGLA+
Sbjct: 117 ------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 32/182 (17%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L++        AE E + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 594 IITICSS---TDFKGVDFKA----LVFEYMGNGSLEDWLHQSN-DQVEVCKLSLIQRLNI 645
           +++ C S   T + G   K     ++ EY+G GS  D L     D+ ++  +        
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM-------- 106

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL--DTSSK 703
             ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L+   +  +T   
Sbjct: 107 LKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 704 TP 705
           TP
Sbjct: 164 TP 165

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 40/173 (23%), Positives = 83/173 (47%), Gaps = 16/173 (9%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMI----VAVK-VINLKQKGAFRSFVAECEALRNIRH 588
            + S+++ +G+FG ++ GIL +++      V VK V +   +      + E   L  + H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK--LSLIQRLNIA 646
           +N++ I+ +C        +   +++ YM  G+L+ +L Q           LS  Q +++A
Sbjct: 68  QNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK--FLSSHH 697
           I +A  + YLH      ++H D+   N ++D ++   + D  L++  F   +H
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 44/219 (20%)

Query: 533 EFSSSNMI-----GQGSFGSVYK----GILGE--DEMI-VAVKVINLKQKGA---FRSFV 577
           EF    ++     G+G FG V +    GI     D+ + VAVK+  LK           +
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLI 65

Query: 578 AECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS-----NDQ 631
           +E E ++ I +H+N+I ++ +C+    +G  +  ++ EY   G+L ++L        +  
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYT 120

Query: 632 VEVCK-----LSLIQRLNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
            ++ K     LS    ++ A  VA  +EYL    C    +H DL   NVL+  D V  + 
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIA 176

Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           DFGLA+    H +D   KT +  + +K    ++AP   F
Sbjct: 177 DFGLAR--GVHDIDYYKKTSNGRLPVK----WMAPEALF 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---RSFVAECEALRNIRHRNLIKIIT 596
           IG G FG V  G +        V V  L+   +      F+ E +  R+++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            C+        +  LV E+   G L+ +L      ++     + +QR+  A ++A  + +
Sbjct: 63  QCTEV----TPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLH 115

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           LH +     +H DL   N LL  D+   +GD+GL+
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 61/186 (32%), Positives = 85/186 (45%), Gaps = 28/186 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFRSFVAECEAL-RNIRHRNLIKI 594
           IG+GSFG V       D    AVKV+     LK+K   +  +AE   L +N++H  L+ +
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+  D    V +Y+  G L  + H    Q E        R   A ++ASA+ 
Sbjct: 62  -----HYSFQTADKLYFVLDYVNGGEL--FFHL---QRERSFPEPRARF-YAAEIASALG 110

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           YLH      +++ DLKP N+LLD      + DFGL K    H     SKT S+     GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-----SKTTST---FCGT 159

Query: 715 VGYVAP 720
             Y+AP
Sbjct: 160 PEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 27/187 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           IG+G F  VYK I   D  +VA+K +    +    A +  + E + L+ + H N+IK + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI---AIDVASAI 653
                 F   +   +V E    G L   +     Q       LI    I    + + SA+
Sbjct: 70  -----SFIENNELNIVLELADAGDLSRMIKHFKKQKR-----LIPERTIWKYFVQLCSAL 119

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           E++H      ++H D+KP+NV +    V  +GD GL +F SS      S          G
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------G 168

Query: 714 TVGYVAP 720
           T  Y++P
Sbjct: 169 TPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 23/169 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFRSFVAECEALRN 585
            +      +G G+FG V+       E   A+K      VI LKQ+    +   E   L+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKE 57

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H  +I++    +  D +   F  ++ EY+  G L  +L  S       + S    L  
Sbjct: 58  VSHPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFY 106

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           A ++  A+EYLH      +V+ DLKP N+LLD +    + DFG AK L 
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 30/165 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVK-VINLKQK-----GAFRSFVAECEALRNIRHRNLIK 593
           +G+G+FG VYK    +   +VA+K ++   +K      A R    E + L+ ++H N++ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 594 IITIC-----SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC--KLSLIQRLNIA 646
           +I +       S   +G  +  +V  YM +  L   L   + ++     K  ++Q L   
Sbjct: 72  LIDMAVERPDKSKRKRGSVY--MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLE-- 126

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                 I YLH   +  ++H D+K +N+L+D+  +  + DFGLA+
Sbjct: 127 -----GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 21/166 (12%)

Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRH 588
           A + + +   +G+GS+ +VYKGI   +  +VA+KVI++K ++G   + + E   L+ ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 589 RNLI---KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            N++    II    +  F        VFEYM +  L  ++ Q    +    + L      
Sbjct: 63  ANIVLLHDIIHTKETLTF--------VFEYM-HTDLAQYMIQHPGGLHPYNVRLFM---- 109

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
              +   + Y+H      ++H DLKP N+L+ +     + DFGLA+
Sbjct: 110 -FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 51/191 (26%), Positives = 95/191 (49%), Gaps = 25/191 (13%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINL---------KQKGAFRSFVAECEALRNIRHR 589
           +IG GSFGSVY G+      ++AVK + L         +++    +   E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N+++ +   SS D    D   +  EY+  GS+   L+      E    +L++  N    +
Sbjct: 67  NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
              + YLH+     ++H D+K +N+L+D+     + DFG++K L ++ L T +     S 
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171

Query: 710 GIKGTVGYVAP 720
            ++G+V ++AP
Sbjct: 172 -LQGSVFWMAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G GS G V+  +  + +  VAVK I L    + +  + E + +R + H N++K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 600 ST---------DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
            +             ++   +V EYM    L + L Q     E  +L + Q L       
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHH 697
             ++Y+H      ++H DLKP+NV ++  D+V  +GDFGLA+ +  H+
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 42/218 (19%)

Query: 533 EFSSSNM-----IGQGSFGSVYKG-ILGEDE------MIVAVKVINLKQKGA---FRSFV 577
           E S + +     +G+G FG V     +G D+      + VAVK+  LK           V
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLV 65

Query: 578 AECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS-----NDQ 631
           +E E ++ I +H+N+I ++  C+    +      LV EY   G+L ++L        +  
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYS 120

Query: 632 VEVCK-----LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
            + CK     L+    ++ A  VA  +EYL        +H DL   NVL+  D V  + D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIAD 177

Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           FGLA+    H++D   KT +  + +K    ++AP   F
Sbjct: 178 FGLAR--DVHNIDYYKKTTNGRLPVK----WMAPEALF 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 6e-10
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 223 NQ-ISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
           NQ + G IP  I  L +L ++ +  N + G IP  +G + +L++L L  N   GSIP  L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 282 GNLTKLAKLDLGSNSLQGNFIASQNKLIGALP 313
           G LT L  L+L  NSL G   A+    +G   
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAA----LGGRL 514

Length = 623

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 25/159 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G VYK        IVA+K I L+   +G   + + E   L+ + H N+++++ +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 598 CSSTDFKGVDFKA-LVFEYMGNGSLEDWL----HQSNDQVEVCKLSLIQRLNIAIDVASA 652
             S      + K  LVFE++ +  L+ ++        D   + K  L Q L         
Sbjct: 67  VHS------ENKLYLVFEFL-DLDLKKYMDSSPLTGLDP-PLIKSYLYQLL-------QG 111

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           I Y H H    ++H DLKP N+L+D +    + DFGLA+
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 7e-10
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 12/100 (12%)

Query: 266 LGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLY 325
           LGL    L+G IP+ +  L  L  ++L  NS++GN           +P  L SIT+L + 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN-----------IPPSLGSITSLEV- 470

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
           LDLS N  NGS+P+ +G L +L IL+++ N  SG +P  L
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 13/162 (8%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR---HRNLIKI 594
           IG G++G+VYK         VA+K + ++  + G   S V E   L+ +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           + +C+++         LVFE++ +  L  +L    D+V    L      ++       ++
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +LH +C   +VH DLKP N+L+       + DFGLA+  S  
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 30/196 (15%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQKGAF--RSFVAECEALRNIR 587
           SE +    +G G FG V+   LG+   ++ VA+K IN   +GA     F+ E + +  + 
Sbjct: 4   SELTFMKELGSGQFGVVH---LGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLS 57

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H  L+++  +C  T  K +    +V E+M NG L ++L Q        KLS    L++  
Sbjct: 58  HPKLVQLYGVC--TQQKPL---YIVTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQ 107

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           DV   +EYL    +   +H DL   N L+    V  V DFG+ +++    LD      +S
Sbjct: 108 DVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEY---TS 157

Query: 708 SIGIKGTVGYVAPGKF 723
           S G K  V +  P  F
Sbjct: 158 SSGAKFPVKWSPPEVF 173

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 26/159 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           IG+G+FG V+ G L  D   VAVK        +LK K     F+ E   L+   H N+++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I +C+    K   +  +V E +  G    +L     + E  +L + + + +  + A+ +
Sbjct: 58  LIGVCTQ---KQPIY--IVMELVQGGDFLTFL-----RTEGPRLKVKELIQMVENAAAGM 107

Query: 654 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           EYL   HC    +H DL   N L+    V  + DFG+++
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 26/192 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAEC--EA--LRNIRH 588
           +F   N IG+GSFG V+K +   D+ + A+K I+L      R    E   EA  L  +  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAIDEARVLAKLDS 58

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             +I+         F       +V EY  NG L   L     +     L   Q     I 
Sbjct: 59  SYIIRYY-----ESFLDKGKLNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQ 109

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +   + +LH      ++H D+K  N+ LD      +GD G+AK LS +     + T    
Sbjct: 110 ILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANT---- 160

Query: 709 IGIKGTVGYVAP 720
             I GT  Y++P
Sbjct: 161 --IVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 60.3 bits (146), Expect = 8e-10
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 18/179 (10%)

Query: 511 DTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK 570
           D   +EK   +VS  +  K  + F     IGQG+ G+VY  I       VA+K +NL+Q+
Sbjct: 1   DEEILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ 57

Query: 571 GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND 630
                 + E   +R  +H N++  +       +   D   +V EY+  GSL        D
Sbjct: 58  PKKELIINEILVMRENKHPNIVNYL-----DSYLVGDELWVVMEYLAGGSL-------TD 105

Query: 631 QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
            V    +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 106 VVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 16/158 (10%)

Query: 538 NMIGQGSFGSVYKGILGEDEMI---VAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIK 593
            +IG+G FG VY G L + +      AVK +N +        F+ E   +++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           ++ IC  ++        +V  YM +G L +++        V  L     +   + VA  +
Sbjct: 61  LLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           EYL        VH DL   N +LD      V DFGLA+
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 43/161 (26%), Positives = 81/161 (50%), Gaps = 17/161 (10%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNL 591
           F     IG+G++G VYK        +VA+K I L  + +G   + + E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 592 IKIITICSSTDFKGVDFKA-LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           +K++ +  +      + K  LVFE++ +  L+ ++  S   +    L LI+  +    + 
Sbjct: 62  VKLLDVIHT------ENKLYLVFEFL-HQDLKKFMDAS--PLSGIPLPLIK--SYLFQLL 110

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 38/154 (24%), Positives = 77/154 (50%), Gaps = 14/154 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+ G    +   VAVK +      + ++F+ E   ++ ++H  L+++  + +
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             +        ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 72  KEEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 120

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            +   +H DL+ +NVL+   ++  + DFGLA+ +
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 31/165 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLIKIIT 596
           IG GSFG+VY         +VAVK ++   K     ++  + E + L+ ++H N I    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI---- 84

Query: 597 ICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
                ++KG   K     LV EY         L  ++D +EV K  L Q + IA     A
Sbjct: 85  -----EYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIAAITHGA 130

Query: 653 IE---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           ++   YLH H    M+H D+K  N+LL       + DFG A   S
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 22/157 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G+V+K    E   IVA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 598 CSSTDFKGVDFK-ALVFEYMGNGSLEDWLHQSNDQVE--VCKLSLIQRLNIAIDVASAIE 654
             S      D K  LVFEY  +  L+ +    N  ++  + K  + Q L         + 
Sbjct: 68  LHS------DKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLK-------GLA 113

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 33/313 (10%)

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
           L+P SLS   +L+LL  S             +L  L  L+L  N L          ++ L
Sbjct: 61  LLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRL-------RSNISEL 112

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
              ++L  L L +N    ++P  I  L S +    +  N+I  ++P  +RNL NL  L +
Sbjct: 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ------ 298
             N L   +P ++  L NL  L L  N +   +P  +  L+ L +LDL +NS+       
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL 228

Query: 299 GNFIASQNKLIGALPQQLLSITTLSL-----YLDLSNNLLNGSLPQQVGNLKNLIILDIS 353
            N   + + L  +  +      ++        LDLSNN ++ S+    G+L NL  LD+S
Sbjct: 229 SNLK-NLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISSL-GSLTNLRELDLS 285

Query: 354 SNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFL 413
            N  S  +P+     + LE   + +                +  + ++ N  S       
Sbjct: 286 GNSLSNALPLIALLLLLLE--LLLNLLLTLKALE-----LKLNSILLNNNILSNGETSSP 338

Query: 414 ENLSFLEFLNLSY 426
           E LS LE LN  +
Sbjct: 339 EALSILESLNNLW 351

Length = 394

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 31/171 (18%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 590
           FS    IG GSFG+VY      +  +VA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            I          ++G   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 77  TI---------QYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 118

Query: 647 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
                A++   YLH H    M+H D+K  N+LL    +  +GDFG A  ++
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 540 IGQGSFGSVYKGI--LGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLIKIIT 596
           +G G+FG V KG+  + + ++ VA+KV+  + + + R   + E E +  + +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +C +          LV E    G L  +L    D++ V  +  +        V+  ++YL
Sbjct: 63  VCEAEAL------MLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-----QVSMGMKYL 111

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                   VH DL   NVLL +   A + DFGL+K L +
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 26/184 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMI-VAVKVI--NLKQKGAFRSFVAECEALRN 585
           +E     ++G G+FG+VYKGI    GE+  I VA+KV+  N   K A +  + E   +  
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 65

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           +    + +++ IC ++  +      LV + M  G L D++ ++ D++    L     LN 
Sbjct: 66  VGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNW 114

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL----SSHHLDTS 701
            + +A  + YL    +  +VH DL   NVL+       + DFGLA+ L    + +H D  
Sbjct: 115 CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-G 170

Query: 702 SKTP 705
            K P
Sbjct: 171 GKVP 174

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 13/153 (8%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR---SFVAECEALRNIRHRNLIKIIT 596
           IG G FG V    +  D  +  V V  LK   + +    F+ + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
            C     + + +  LVFEY   G L+ +L Q        +L L+QR+  A ++A+ + ++
Sbjct: 63  QC----VEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHM 115

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
           H H     +H DL   N  L  D+   VGD+G+
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 21/192 (10%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK---VINLKQKGAFRSFVAECEALRNIRH 588
           + F     IG+G F  VY+     D + VA+K   + +L    A    + E + L+ + H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N+IK         F   +   +V E    G L   +     Q  +     + +    + 
Sbjct: 62  PNVIKY-----YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQ 114

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + SA+E++H      ++H D+KP+NV +    V  +GD GL +F        SSKT +++
Sbjct: 115 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKT-TAA 163

Query: 709 IGIKGTVGYVAP 720
             + GT  Y++P
Sbjct: 164 HSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 32/165 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVK---------VINLKQKGAFRSFVAECEALRNIRHRN 590
           IG+GS+G V+K    E   IVA+K         VI   +K A R    E   L+ ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIALR----EIRMLKQLKHPN 61

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           L+ +I +     F+      LVFEY  + ++   L++           LI++  I     
Sbjct: 62  LVNLIEV-----FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKK--IIWQTL 110

Query: 651 SAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            A+ + H H+C    +H D+KP N+L+       + DFG A+ L+
Sbjct: 111 QAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 22/158 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G VYK         +A+K I L+Q+  G   + + E   L+ ++H N++++  +
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND---QVEVCKLSLIQRLNIAIDVASAIE 654
             S   K +    LVFEY+ +  L+  +  S D      + K  L Q L         I 
Sbjct: 70  VHSE--KRL---YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL-------RGIA 116

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVA-HVGDFGLAK 691
           Y H H    ++H DLKP N+L+D    A  + DFGLA+
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 22/164 (13%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G       GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK----LSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 72  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 127 EIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 40/172 (23%), Positives = 74/172 (43%), Gaps = 22/172 (12%)

Query: 534 FSSSNM-----IGQGSFGSVYKG-----ILGEDEMIVAVKVIN-LKQKGAFRSFVAECEA 582
           F  SN+     +G+G FG V+            E +V VK +   K +     F  E + 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK---LSL 639
            R + H+N+++++ +C     +  +   ++ EY   G L+ +L  +  + E  K   LS 
Sbjct: 62  FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            Q++ +   +A  +++L +      VH DL   N L+       V    L+K
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 60/186 (32%), Positives = 83/186 (44%), Gaps = 26/186 (13%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +IG+GSFG V       +E   AVKV+     LK+K            L+N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+  D    V +Y+  G L   L     Q E C L    R   A ++ASA+ 
Sbjct: 62  -----HFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARF-YAAEIASALG 110

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           YLH      +V+ DLKP N+LLD      + DFGL K    H+  TS+          GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST--------FCGT 159

Query: 715 VGYVAP 720
             Y+AP
Sbjct: 160 PEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 5e-09
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 2/87 (2%)

Query: 197 DNQ-FGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPD 255
           DNQ   G +P+ I+ L     + L  GN I G IP  + ++ +L  L +  N  +G+IP+
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINL-SGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 256 VIGELKNLQLLGLYKNFLQGSIPSGLG 282
            +G+L +L++L L  N L G +P+ LG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 37/164 (22%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+GS+ +VYKG       +VA+K I L+  +GA  + + E   L++++H N++ +  I 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 599 SSTDFKGVDFKALVFEYM-----------GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            +          LVFEY+           G G     L   N      +L L Q L    
Sbjct: 73  HTK-----KTLTLVFEYLDTDLKQYMDDCGGG-----LSMHN-----VRLFLFQLLR--- 114

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                + Y H      ++H DLKP N+L+       + DFGLA+
Sbjct: 115 ----GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 29/177 (16%)

Query: 540 IGQGSFGSVY----KGI---LGEDE-------MIVAVKVINLK-QKGAFRSFVAECEALR 584
           +G+G FG V+    +G+   LGE         ++VAVK++     K A   F+ E + + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK------LS 638
            +++ N+I+++ +C S D        ++ EYM NG L  +L Q   +           +S
Sbjct: 73  RLKNPNIIRLLGVCVSDDPL-----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           +   L +A+ +AS ++YL        VH DL   N L+ +     + DFG+++ L S
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 24/187 (12%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIK 593
           ++GQG+FG VY     +    +AVK +         K    +   E + L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
               C   D     F     EYM  GS++D L       E    ++ ++    I     +
Sbjct: 69  YYG-CLRDDETLSIF----MEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--LEGV 117

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           EYLH +    +VH D+K +N+L D      +GDFG +K L +     +         + G
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VTG 169

Query: 714 TVGYVAP 720
           T  +++P
Sbjct: 170 TPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 18/171 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+GS+GSVYK     D    A+K ++L     K++      V E   L ++ H N+I  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER---EDAVNEIRILASVNHPNII-- 62

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F   +   +V EY   G L   + +   + ++     I R  I I +   ++
Sbjct: 63  ---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQ 117

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
            LH      ++H DLK +N+LL  + +  +GD G++K L  +   T   TP
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 48/188 (25%), Positives = 71/188 (37%), Gaps = 34/188 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G G FG V    +       A+K +  +   + G      +E E L    H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNIAIDVASA 652
             +  D K +     + EY   G L   L                 ++           A
Sbjct: 60  -RTFKDKKYIYM---LMEYCLGGELWTILRDRGLFDEYTARFYIACVV----------LA 105

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
            EYLH+     +++ DLKP N+LLD +    + DFG AK L S       KT +      
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-----GQKTWT----FC 153

Query: 713 GTVGYVAP 720
           GT  YVAP
Sbjct: 154 GTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 9e-09
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 42/215 (19%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRH 588
            +F    +IG+G+FG V+     +   + A+KV+    + ++       AE + L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             ++K+    S   F+  +   LV EYM  G L + L + +   E        R  IA +
Sbjct: 61  PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIA-E 109

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAK----------FLSSH 696
           +  A++ +H   +   +H D+KP N+L+D D   H+   DFGL K          +L+  
Sbjct: 110 LVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 697 HLDTSSKTPSSSIGIK-----------GTVGYVAP 720
           H                          GT  Y+AP
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 37/178 (20%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-------RSFVAECEALR 584
           S +     IG G++G V   I       VA+K    K   AF       R+   E + LR
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILR 59

Query: 585 NIRHRNLIKIITICSSTDFKGVDFKA--LVFEYMGNGSLEDWLHQ---SNDQVEVCKLS- 638
           + +H N+I I  I       G DFK   +V + M +      LH    S+  +    +  
Sbjct: 60  HFKHDNIIAIRDILRP---PGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRY 111

Query: 639 -LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            L Q L         ++Y+H      ++H DLKPSN+L++ D    +GDFG+A+ LSS
Sbjct: 112 FLYQLLR-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 30/178 (16%)

Query: 540 IGQGSFGSVY----KGIL------------GEDEMIVAVKVINLK-QKGAFRSFVAECEA 582
           +G+G FG V+    +G+             G   ++VAVK++     K A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQ---SNDQVEVCKL 637
           +  ++  N+I+++ +C ++D        ++ EYM NG L  +L  H+   + ++ +V  +
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPL-----CMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           S    + +A  +AS ++YL        VH DL   N L+  +    + DFG+++ L S
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 44/155 (28%), Positives = 81/155 (52%), Gaps = 19/155 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+G++ +V+KG     E +VA+K I L+ ++GA  + + E   L+N++H N++ +  I 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV--CKLSLIQRLNIAIDVASAIEYL 656
             T+        LVFEY+ +  L+ +L    + + +   K+ + Q L         + Y 
Sbjct: 73  H-TERC----LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSYC 119

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           H      ++H DLKP N+L++      + DFGLA+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 29/160 (18%)

Query: 539 MIGQGSFGSVYKGIL---GEDEMIVAVKVI----NLKQKGAFRSFVAECEALRNIRHRNL 591
           ++G G FG + +G L    + E+ VA+  +    + KQ+   R F+AE   L    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLAEALTLGQFDHSNI 68

Query: 592 IK---IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
           ++   +IT  ++          +V EYM NG+L+ +L +   Q     L   Q + +   
Sbjct: 69  VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPG 115

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
           +AS ++YL    +   VH  L    VL++ D+V  +  F 
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 19/155 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+G++ +VYKG     + +VA+K I L+ ++GA  + + E   L++++H N++ +  I 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV--CKLSLIQRLNIAIDVASAIEYL 656
            +          LVFEY+ +  L+ +L    + + +   KL L Q L         + Y 
Sbjct: 74  HTEKSL-----TLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYC 120

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           H      ++H DLKP N+L++      + DFGLA+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 25/182 (13%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+ +FG +YKG L     +   +VA+K + ++     +  F  E   +  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWL-----HQ----SNDQVEVCKLSLIQR--L 643
           + +   T  + V    ++FEY+  G L ++L     H     S+D+    K SL     L
Sbjct: 73  LGVV--TQEQPV---CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK-FLSSHHLDTSS 702
           +IAI +A+ +EYL  H     VH DL   N+L+   +   + D GL++   S+ +     
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 703 KT 704
           K+
Sbjct: 185 KS 186

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 24/184 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+G FG V    +     + A K ++   LK++   +  + E + L  +  R       
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +  +  F+  D   LV   M  G L+  ++   +          + +  A  +   +E+L
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG----FPEARAIFYAAQIICGLEHL 111

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
           H   Q  +V+ DLKP NVLLD      + D GLA       ++          G  GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLA-------VELKGGKKIK--GRAGTPG 159

Query: 717 YVAP 720
           Y+AP
Sbjct: 160 YMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 22/174 (12%)

Query: 530 ATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS---FVAECE 581
           A  + + S  +GQGSFG VY+GI       E E  VA+K +N  +  + R    F+ E  
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 61

Query: 582 ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKL 637
            ++     ++++++ + S      V     + E M  G L+ +L     ++E        
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 31/171 (18%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 590
           F+    IG GSFG+VY         +VA+K ++   K +   ++  + E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
                    S ++KG   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 87  ---------SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 128

Query: 647 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
                A++   YLH H    M+H D+K  N+LL       + DFG A   S
Sbjct: 129 AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 20/171 (11%)

Query: 540 IGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR---HRNLIK 593
           IG+G++G V+K   L      VA+K + ++  ++G   S + E   LR++    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ---VEVCKLSLIQRLNIAIDVA 650
           +  +C+ +         LVFE++ +  L  +L +  +     E  K  + Q L       
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR------ 121

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
             +++LH H    +VH DLKP N+L+       + DFGLA+  S     TS
Sbjct: 122 -GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 168

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 52/157 (33%), Positives = 72/157 (45%), Gaps = 18/157 (11%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +IG+GSFG V       D    AVKV+     LK+K            L+N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+  +    V +Y+  G L  + H    Q E C L    R   A +VASAI 
Sbjct: 62  -----HYSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARF-YAAEVASAIG 110

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           YLH      +++ DLKP N+LLD      + DFGL K
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E  ++ A KVI+ K +     ++ E + L +  H N++K++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70

Query: 600 STDFKGVDFKALVFEYMGNGS-------LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
              F   +   ++ E+   G+       LE  L +   +V VCK +L            A
Sbjct: 71  ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTL-----------EA 115

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           + YLH   +  ++H DLK  N+L   D    + DFG++
Sbjct: 116 LNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 21/192 (10%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK---VINLKQKGAFRSFVAECEALRNIRH 588
           + F     IG+G F  VY+     D   VA+K   +  +    A +  V E + L+ + H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N+IK +       F   +   +V E    G L   +     Q  +     + +    + 
Sbjct: 62  PNVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY--FVQ 114

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + SA+E++H      ++H D+KP+NV +    V  +GD GL +F        SSKT +++
Sbjct: 115 LCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKT-TAA 163

Query: 709 IGIKGTVGYVAP 720
             + GT  Y++P
Sbjct: 164 HSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.9 bits (134), Expect = 2e-08
 Identities = 47/155 (30%), Positives = 79/155 (50%), Gaps = 19/155 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+GS+ +VYKG    +  +VA+KVI L+ ++G   + + E   L+ ++H N++ +  I 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
            +      +   LVFEY+ +  L  ++  H      E  KL L Q L         + Y+
Sbjct: 73  HTK-----ETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYI 119

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           H   Q  ++H DLKP N+L+       + DFGLA+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 40/199 (20%)

Query: 540 IGQGSFGSVYKGIL--GEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           IG+G++G VYK     G+D    A+K       +  G  +S   E   LR ++H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWL-----HQSNDQVEV----CKLSLIQRLNI 645
           + +      K V    L+F+Y    +  D       H+   +V +     K  L Q LN 
Sbjct: 68  VEVFLEHADKSV---YLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN- 119

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSSHHLDTS 701
                  + YLH +    ++H DLKP+N+L+        V  +GD GLA+  ++      
Sbjct: 120 ------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-----P 165

Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K  +    +  T+ Y AP
Sbjct: 166 LKPLADLDPVVVTIWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 46/196 (23%), Positives = 94/196 (47%), Gaps = 27/196 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA------FRSFVAECEALRNI 586
           E++   ++G+G++G+VY G+  + ++I AVK + L           +     E + L+++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV--CKLSLIQRLN 644
           +H N+++ +  C   +   +       E++  GS+   L++     E   CK +      
Sbjct: 60  KHVNIVQYLGTCLDDNTISI-----FMEFVPGGSISSILNRFGPLPEPVFCKYTK----- 109

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
               +   + YLH++C   +VH D+K +NV+L  + +  + DFG A+ L+   L  +   
Sbjct: 110 ---QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 705 PSSSIGIKGTVGYVAP 720
              S  + GT  ++AP
Sbjct: 164 MLKS--MHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 21/190 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRN 590
           S +    +IG+G++G+VY+G       +VA+K+INL       S +  E   L  +R   
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
              I     S   KG     ++ EY   GS+   L ++    E   +S+I R     +V 
Sbjct: 61  PPNITKYYGSY-LKGPRL-WIIMEYAEGGSVRT-LMKAGPIAEKY-ISVIIR-----EVL 111

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
            A++Y+H      ++H D+K +N+L+ +     + DFG+A  L+      SSK       
Sbjct: 112 VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----NSSK----RST 160

Query: 711 IKGTVGYVAP 720
             GT  ++AP
Sbjct: 161 FVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 22/159 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS------FVAECEALRNIRHRNLIK 593
           IG G FG V   +LGE    ++   + +K+  A  +      F+ E +  R + H N+++
Sbjct: 3   IGNGWFGKV---LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 594 IITIC-SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVAS 651
            +  C  S  +       LV E+   G L+++L  +   V ++ +  ++QR+  A +VAS
Sbjct: 60  CLGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVAS 111

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            + +LH   Q   +H DL   N  L  D+   +GD+GLA
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 19/160 (11%)

Query: 540 IGQGSFGSVYKGILG--EDEMIVAVKVI-NLKQKGAFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG+    + E  VAVK++ N     A +   + E   ++ + +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L ++    E     L+ +      V+  ++Y
Sbjct: 63  GICEAESW------MLVMELAELGPLNKFLQKNKHVTEKNITELVHQ------VSMGMKY 110

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           L        VH DL   NVLL     A + DFGL+K L +
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 50/169 (29%), Positives = 74/169 (43%), Gaps = 42/169 (24%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLIK 593
           IG+G++G V      E    VA+K I      AF + +       E + LR++ H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA----NAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 594 IITIC---SSTDFKGVDFKALVFEYMGNGSLEDWLHQ--------SNDQVEVCKLSLIQR 642
           I  I        F  V    +V+E M        LHQ        S+D    C+  L Q 
Sbjct: 69  IKDIMPPPHREAFNDV---YIVYELMDTD-----LHQIIRSSQTLSDDH---CQYFLYQL 117

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           L         ++Y+H      ++H DLKPSN+LL+ +    + DFGLA+
Sbjct: 118 LR-------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 44/192 (22%), Positives = 87/192 (45%), Gaps = 30/192 (15%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINL----------KQKGAFRSFVAECEALRNIRH 588
           +IG+G++G VY  +      ++AVK + L          +QK   ++  +E E L+++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N+++ +           ++ ++  EY+  GS+   L       E       ++      
Sbjct: 68  LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------ 116

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YLH      ++H DLK  N+L+D D +  + DFG++K       D        +
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDN--DQN 167

Query: 709 IGIKGTVGYVAP 720
           + ++G+V ++AP
Sbjct: 168 MSMQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 30/188 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+G+FG VY+    +   I A+KV++ K+       VA+ E    I  RN++    +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERNILVRTLLDE 54

Query: 600 STDFKGVDFK-------ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           S    G+ F         LV +YM  G L  W  Q   +    +     +  IA ++  A
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDR----AKFYIA-ELVLA 108

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +E+LH +    +V+ DLKP N+LLD      + DFGL+K   + +  T++          
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--------FC 157

Query: 713 GTVGYVAP 720
           GT  Y+AP
Sbjct: 158 GTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 42/218 (19%)

Query: 533 EFSSSNM-----IGQGSFGSVYKG-ILGEDE------MIVAVKVI--NLKQKGAFRSFVA 578
           EFS   +     +G+G FG V     LG D+      + VAVK++  +  +K      V+
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVS 69

Query: 579 ECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ--------SN 629
           E E ++ I +H+N+I ++  C+     G  +  ++ EY   G+L ++L          S 
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 630 DQVEVC--KLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
           D   V   +++    ++    VA  +EYL    C    +H DL   NVL+  + V  + D
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 180

Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           FGLA+    +++D   KT +  + +K    ++AP   F
Sbjct: 181 FGLAR--DVNNIDYYKKTTNGRLPVK----WMAPEALF 212

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 7e-08
 Identities = 22/58 (37%), Positives = 38/58 (65%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLG 58
           + G IP  +GS+  L+ L L+ N   G +P+ +G L++L+++++ GNSL G+ P  LG
Sbjct: 454 IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 24/166 (14%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRN 590
           +++    IG+G++G VYKG   +   IVA+K I L+  ++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 591 LIKIITICSSTDFKGVDFKA-LVFEYMGNGSLEDWLHQ--SNDQV--EVCKLSLIQRLNI 645
           ++ +  +         + +  L+FE++ +  L+ +L        +  E+ K  L Q L  
Sbjct: 61  IVCLQDVLMQ------ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ- 112

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                  I + H      ++H DLKP N+L+D+  V  + DFGLA+
Sbjct: 113 ------GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 23/65 (35%), Positives = 42/65 (64%)

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           ++LS N + G++P  +G++ +L +LD+S N F+G IP +L    SL  ++++ N   G +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 386 PPSLG 390
           P +LG
Sbjct: 507 PAALG 511

Length = 623

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 18/180 (10%)

Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57

Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +       +   D   +V EY+  GSL D +    
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVV---- 108

Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E C +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 109 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 26/180 (14%)

Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS-FVAE 579
           E++ +T  F     +G+  FG VYKG L     GE    VA+K +  K +G  R  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL-----HQ---SNDQ 631
                 ++H N++ ++ + +          +++F Y  +  L ++L     H    S D 
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPL-----SMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 632 VEVCKLSL--IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
            +  K +L     ++I   +A+ +E+L  H    +VH DL   NVL+   +   + D GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 14/163 (8%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F     IG G++G VYK        + A+KVI L+    F     E   +++ +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
                     +   D   +  E+ G GSL+D  H +        LS  Q   ++ +    
Sbjct: 70  AYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQG 118

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           + YLH   +   +H D+K +N+LL  +    + DFG++  +++
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 40/172 (23%), Positives = 77/172 (44%), Gaps = 34/172 (19%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALRNI 586
            + + + +G G++G V      +    VA+K ++      +  K  +R    E   L+++
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHM 71

Query: 587 RHRNLIKIITI----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEVCKLSL 639
            H N+I ++ +     S  DF+ V    LV   MG   L + +     S+D ++      
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDV---YLVTHLMG-ADLNNIVKCQKLSDDHIQF----- 122

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                +   +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+
Sbjct: 123 -----LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 9/111 (8%)

Query: 128 DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNC 187
           DS      ++ L L N   +G +  D S L+ L  +NL  N++       LG      + 
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG------SI 465

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIP--LGIRNL 236
           +SL+VL LS N F G +P S+  L+S  I+ L  GN +SG +P  LG R L
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNL-NGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 45/155 (29%), Positives = 83/155 (53%), Gaps = 19/155 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+G++ +V+KG     E +VA+K I L+ ++GA  + + E   L++++H N++ +  I 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV--CKLSLIQRLNIAIDVASAIEYL 656
             TD K +    LVFEY+ +  L+ ++    + + +   K+ L Q L         + Y 
Sbjct: 74  H-TD-KSL---TLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR-------GLAYC 120

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           H      ++H DLKP N+L++      + DFGLA+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 25/157 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E  +  A K+I ++ +     F+ E + L   +H N++ +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---- 68

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQ-----SNDQVE-VCKLSLIQRLNIAIDVASAI 653
              F       L+ E+   G+L+  + +     +  Q+  VC+            +  A+
Sbjct: 69  EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCR-----------QMLEAL 116

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            +LH H    ++H DLK  N+LL  D    + DFG++
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)

Query: 511 DTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK 570
           D   +EK   +VS  +  K  + F     IGQG+ G+VY  I       VA+K +NL+Q+
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57

Query: 571 GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND 630
                 + E   +R  ++ N++  +       +   D   +V EY+  GSL D +     
Sbjct: 58  PKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV----- 107

Query: 631 QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
             E C +   Q   +  +   A+++LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 108 -TETC-MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 23/164 (14%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-----QKGAFRSFVAECEALRNIR 587
           +    + +G+G+ GSV K  L    MI A+K I        QK   R    E E  ++ +
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCK 57

Query: 588 HRNLIKIITIC---SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
              ++K        SS+         +  EY   GSL+    +   +       ++ +  
Sbjct: 58  SPYIVKYYGAFLDESSSSIG------IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK-- 109

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
           IA  V   + YLH      ++H D+KPSN+LL       + DFG
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 22/173 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA--ECEALRNIRHRNLIKIITI 597
           +G+G+FG        ED+ +V  K +NL +        A  E   L  ++H N   II  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV---EVCKLSLIQRLNIAIDVASAIE 654
            +           +  EY   G+L D + +   Q+   E+    L Q       + SA+ 
Sbjct: 65  YNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSAVS 115

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH--HLDTSSKTP 705
           Y+H   +  ++H D+K  N+ L    +  +GDFG++K L S     +T   TP
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 24/182 (13%)

Query: 511 DTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINL 567
           D   MEK   +VS  +  K  + +     IGQG+ G+V+  I    G++   VA+K INL
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQE---VAIKQINL 54

Query: 568 KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ 627
           +++      + E   ++ +++ N++  +       F   D   +V EY+  GSL D +  
Sbjct: 55  QKQPKKELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVV-- 107

Query: 628 SNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF 687
                E C +   Q   +  +   A+E+LH +    ++H D+K  NVLL  D    + DF
Sbjct: 108 ----TETC-MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159

Query: 688 GL 689
           G 
Sbjct: 160 GF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 32/189 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT-- 596
           +IG+G FG VY     +   + A+K ++ K     R  + + E L  +  R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54

Query: 597 -----ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
                +C +  F   D    + + M  G L   L Q          S  +    A ++  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIIL 108

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            +E++H+     +V+ DLKP+N+LLD      + D GLA        D S K P +S+  
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156

Query: 712 KGTVGYVAP 720
            GT GY+AP
Sbjct: 157 -GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 28/163 (17%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +IG+GS+G V   I       VA+K IN   +        + E + LR +RH ++++I  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 597 IC---SSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQV--EVCKLSLIQRLNIAID 648
           I    S  +FK +    +VFE M     E  LHQ   +ND +  E  +  L Q L     
Sbjct: 67  IMLPPSRREFKDI---YVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR---- 114

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
              A++Y+H      + H DLKP N+L + D    + DFGLA+
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 32/189 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT-- 596
           +IG+G FG VY     +   + A+K ++ K     R  + + E L  +  R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54

Query: 597 -----ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
                +C S  F   D  + + + M  G L    H S   V     S  +    A ++  
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEAEMRFYAAEIIL 108

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            +E++H+     +V+ DLKP+N+LLD      + D GLA        D S K P +S+  
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156

Query: 712 KGTVGYVAP 720
            GT GY+AP
Sbjct: 157 -GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 40/181 (22%), Positives = 78/181 (43%), Gaps = 30/181 (16%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINL----KQKGAFRSFVAEC----------EAL 583
             +G+G++G V K        IVA+K + +          R  V  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
             I+H N++ ++ +     +   DF  LV + M    L+  +   + ++   +L+  Q  
Sbjct: 75  NEIKHENIMGLVDV-----YVEGDFINLVMDIM-ASDLKKVV---DRKI---RLTESQVK 122

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSS 702
            I + + + +  LH       +H DL P+N+ ++   +  + DFGLA ++    + DT S
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 703 K 703
           K
Sbjct: 180 K 180

Length = 335

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 15/154 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+     +    VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 14  LGAGQFGEVWMATYNKHTK-VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 72  KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 119

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            Q   +H DL+ +N+L+   +V  + DFGLA+ +
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 26/172 (15%)

Query: 533 EFSSSNM-----IGQGSFGSVYK----GILGEDEMI-VAVKVINLKQKGAFR-SFVAECE 581
           EF  +N+     +G G+FG V +    G+   D ++ VAVK++      + R + ++E +
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 582 ALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
            + ++  H N++ ++  C+     G     ++ EY   G L ++L +  +      L+L 
Sbjct: 91  IMSHLGNHENIVNLLGACTIG---GPIL--VITEYCCYGDLLNFLRRKRESF----LTLE 141

Query: 641 QRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             L+ +  VA  + +L   +C    +H DL   NVLL H  +  + DFGLA+
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 14/151 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G++G VYK        + AVK+I L+    F     E   ++  +H N++       
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF---- 72

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
              +   +   +  EY G GSL+D  H +    E  +++ + R     +    + YLH  
Sbjct: 73  -GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-LQIAYVCR-----ETLQGLAYLHSK 125

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            +   +H D+K +N+LL  +    + DFG+A
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 27/189 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA--LRNIRHRNLIKIITI 597
           +G+GS+G V       D     +K +NL+         AE EA  L  ++H N++     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI---QRLNIAIDVASAIE 654
                ++G D   L++  MG     D  H+  +Q    K  L+   Q +   + +A A++
Sbjct: 65  --RESWEGED--GLLYIVMGFCEGGDLYHKLKEQ----KGKLLPENQVVEWFVQIAMALQ 116

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           YLH   +  ++H DLK  NV L    +  VGD G+A+ L +   D +S        + GT
Sbjct: 117 YLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMAST-------LIGT 165

Query: 715 VGYVAPGKF 723
             Y++P  F
Sbjct: 166 PYYMSPELF 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.9 bits (127), Expect = 5e-07
 Identities = 28/82 (34%), Positives = 47/82 (57%), Gaps = 1/82 (1%)

Query: 49  LGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVN 108
           L G  P  +  LR+L  +N++ N   G  P S+ +I+SLE   L+ N F+GS+P + +  
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP-ESLGQ 488

Query: 109 LPNLKELGIGANNFFGLIPDSL 130
           L +L+ L +  N+  G +P +L
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 52/185 (28%), Positives = 77/185 (41%), Gaps = 23/185 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKI-I 595
           +G+G FG V    +     + A K +N   LK++  +   + E   L  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
              + TD        LV   M  G L    H  N   E       +       + S +E+
Sbjct: 61  AFQTKTDL------CLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           LH      +++ DLKP NVLLD+D    + D GLA  L     D  SKT     G  GT 
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL----KDGQSKTK----GYAGTP 161

Query: 716 GYVAP 720
           G++AP
Sbjct: 162 GFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 48/196 (24%), Positives = 85/196 (43%), Gaps = 31/196 (15%)

Query: 533 EFSSSN---MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR 589
           E+  +    ++G+G++G VY       ++ +A+K I  +     +    E      ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS----NDQVEVCKLSLIQRLNI 645
           N+++ +   S   F    FK +  E +  GSL   L        D  +       Q L  
Sbjct: 66  NIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-- 118

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTSSKT 704
                  ++YLH +    +VH D+K  NVL++ +  V  + DFG +K L+  +  T + T
Sbjct: 119 -----EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170

Query: 705 PSSSIGIKGTVGYVAP 720
                   GT+ Y+AP
Sbjct: 171 --------GTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.4 bits (123), Expect = 8e-07
 Identities = 54/199 (27%), Positives = 81/199 (40%), Gaps = 42/199 (21%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK------VINLKQKGAFRSFVAECEALRN 585
           S+F     +G GSFG V            A+K      ++ +KQ    +    E   L  
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILME 74

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS----NDQVEVCKLSLIQ 641
           + H  ++ ++  CS  D   V F   + E++  G L   L ++    ND   V K     
Sbjct: 75  LSHPFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPND---VAKF---- 122

Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
                 ++  A EYLH      +++ DLKP N+LLD+     V DFG AK          
Sbjct: 123 ---YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------- 166

Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K P  +  + GT  Y+AP
Sbjct: 167 -KVPDRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 38/179 (21%)

Query: 540 IGQGSFGSVYKGILGEDE-----MIVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 590
           +G+G FG V K      +       VAVK++   ++ A     R  ++E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN------------------DQV 632
           +IK+   CS           L+ EY   GSL  +L +S                   D  
Sbjct: 65  VIKLYGACSQDGPL-----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 633 EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   L++   ++ A  ++  ++YL    +  +VH DL   NVL+       + DFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 23/182 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E   + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
           +  + G  +  ++ E+   G+++  + + +  +   ++ +I R      +  A++YLH  
Sbjct: 77  AFYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQYLH-- 127

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF-LSSHHLDTSSKTPSSSIGIKGTVGYV 718
               ++H DLK  NVLL  D     GD  LA F +S+ ++ T  +  S      GT  ++
Sbjct: 128 -SMKIIHRDLKAGNVLLTLD-----GDIKLADFGVSAKNVKTLQRRDS----FIGTPYWM 177

Query: 719 AP 720
           AP
Sbjct: 178 AP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 23/168 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           S   +   IG+GS G V           VAVK ++L+++        E   +R+ +H N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVE-VCKLSLIQRLNIAI 647
           +++     S+   G D   +V E++  G+L D +  +    +Q+  VC   L        
Sbjct: 79  VEMY----SSYLVG-DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL-------- 125

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
               A+ +LH      ++H D+K  ++LL  D    + DFG    +S 
Sbjct: 126 ---KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 35/144 (24%), Positives = 70/144 (48%), Gaps = 20/144 (13%)

Query: 540 IGQGSFGSVYKGI---LGED----EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +GQG+F  ++KGI   +G+     +  V +KV++   +    SF      +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
               +C        D   +V EY+  GSL+ +L ++ +      +++  +L +A  +A A
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLL 676
           + +L       + HG++   NVLL
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 32/194 (16%)

Query: 540 IGQGSFGSVYK-GILGEDEMIVAVKVINLKQ----KGA------FRSFVAECEALR-NIR 587
           +G G+FG VYK       + ++A+K IN+      K            V+E   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H N+++         F   D   +V + +    L +  H ++ + +  + +  +  NI +
Sbjct: 68  HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
            +  A+ YLH   +  +VH DL P+N++L  D    + DFGLAK           K P S
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK----------QKQPES 168

Query: 708 SI-GIKGTVGYVAP 720
            +  + GT+ Y  P
Sbjct: 169 KLTSVVGTILYSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 30/171 (17%)

Query: 540 IGQGSFGSVY----KGILGEDEMI------------VAVKVINL-KQKGAFRSFVAECEA 582
           +G+G FG V+     G+    E              VAVKV+       A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLI 640
           L  +   N+ +++ +C+           ++ EYM NG L  +L  H +      C    +
Sbjct: 73  LSRLSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 641 QR---LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
                L +A  +AS + YL        VH DL   N L+  +    + DFG
Sbjct: 128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 28/182 (15%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 589
             + + + IG+G++G V         + VA+K I+    Q    R+ + E + LR  +H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHE 63

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSLIQR 642
           N+I I+ I     F+  +   +V E M     E  L++       SND     +  L Q 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDH---IQYFLYQI 115

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L         ++Y+H      ++H DLKPSN+LL+ +    + DFGLA+     H  T  
Sbjct: 116 LR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 703 KT 704
            T
Sbjct: 166 LT 167

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 116 GIGANN--FFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG 173
           G+G +N    G IP+ +S   +L+ ++LS N  +G +     S+  L  L+L  N+    
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI 208
               LG +T      SL++L+L+ N   G +P ++
Sbjct: 482 IPESLGQLT------SLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 23/159 (14%)

Query: 539 MIGQGSFGSVYKGILGEDE---MIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLI 592
           ++G+G+FG V   IL  ++      A+K++    +  K      V E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            +        F+  D    V EY   G L  + H S ++V     +  +      ++ SA
Sbjct: 59  AL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEIVSA 107

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 17/188 (9%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F   +++G+G FG V          I A+KV+      A +  V+  E  R+I   +  
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNS 60

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
             I       F+  D   LV EY   G L   L++  DQ +     + Q       +A  
Sbjct: 61  PWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYLAEL 111

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +  +H   Q   VH D+KP NVL+D       G   LA F S+  L T++K  +S + + 
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLID-----RTGHIKLADFGSAARL-TANKMVNSKLPV- 164

Query: 713 GTVGYVAP 720
           GT  Y+AP
Sbjct: 165 GTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.5 bits (118), Expect = 6e-06
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 589
           EF     I +G+FG VY G    +  + AVKV+   ++  K       AE +AL   +  
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
            ++ +     S      +   LV EY+  G ++  LH      E   +  I       +V
Sbjct: 65  FIVHLYYSLQS-----ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS------EV 113

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           A A++YLH H    ++H DLKP N+L+ ++    + DFGL+K
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 18/189 (9%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLI 592
           F    ++G G++G VYKG   +   + A+KV+++           E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 593 KIITICSSTDFKGVDFKA-LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
                    +  G+D +  LV E+ G GS+ D +   N +    K   I    I  ++  
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREILR 122

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            + +LH H    ++H D+K  NVLL  +    + DFG+     S  LD +    ++ I  
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNTFI-- 172

Query: 712 KGTVGYVAP 720
            GT  ++AP
Sbjct: 173 -GTPYWMAP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHR 589
           ++F    ++G+G++G V K    E + IVA+K     ++      + + E + LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----DQVEVCKLSLIQRLNI 645
           N++++        F+      LVFEY+    LE      N    ++V      LI+    
Sbjct: 61  NIVEL-----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK---- 111

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
                 AI + H +    +VH D+KP N+L+ H+ V  + DFG A+ LS
Sbjct: 112 ------AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 45/206 (21%)

Query: 521 MVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAEC 580
           M+    L   T  +     IG+G++G VYK    +D  + AVK+++            E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEI 65

Query: 581 EALRNI-----RHRNLIKIITICSSTDFKGVDFKA---------LVFEYMGNGSLEDWLH 626
           EA  NI      H N++K         F G+ +KA         LV E    GS+     
Sbjct: 66  EAEYNILQSLPNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSV----- 111

Query: 627 QSNDQVEVCKLSLI--QRLN---IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 681
                 E+ K  LI  QRL+   I+  +  A+  L H     ++H D+K +N+LL  +  
Sbjct: 112 -----TELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166

Query: 682 AHVGDFGLAKFLSSHHL--DTSSKTP 705
             + DFG++  L+S  L  +TS  TP
Sbjct: 167 VKLVDFGVSAQLTSTRLRRNTSVGTP 192

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 22/159 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLIK 593
           +G G++GSV      +  + VAVK    K    F+S +       E   L++++H N+I 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 594 IITICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           ++ + + +   +  +   LV   MG           N+ V+  KL+      +   +   
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 8e-06
 Identities = 21/60 (35%), Positives = 27/60 (45%)

Query: 111 NLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
           NLK L +  N    +   +     NL++LDLS N         FS L  L  L+L  NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 28/72 (38%), Positives = 40/72 (55%), Gaps = 1/72 (1%)

Query: 99  GSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLK 158
           G +P DI   L +L+ + +  N+  G IP SL + ++LE+LDLS N F G +      L 
Sbjct: 432 GFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 159 ILWRLNLEQNNL 170
            L  LNL  N+L
Sbjct: 491 SLRILNLNGNSL 502

Length = 623

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 33/164 (20%)

Query: 539 MIGQGSFGSV-----------YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
           ++G+G+FG V           Y   + + E+I+A        K      + E   L+N R
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--------KDEVAHTLTESRVLKNTR 53

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H  L  +        F+  D    V EY+  G L  + H S ++V     S  +      
Sbjct: 54  HPFLTSL-----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGA 102

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++ SA++YLH      +V+ DLK  N++LD D    + DFGL K
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 22/203 (10%)

Query: 522 VSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE 581
           +  + L      F    ++G G++G VYKG   +   + A+KV+++ +         E  
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEIN 64

Query: 582 ALRNI-RHRNLIKIITICSSTDFKGVDFKA-LVFEYMGNGSLEDWLHQS--NDQVEVCKL 637
            L+    HRN+             G D +  LV E+ G GS+ D +  +  N   E   +
Sbjct: 65  MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-I 123

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + I R     ++   + +LH H    ++H D+K  NVLL  +    + DFG+     S  
Sbjct: 124 AYICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQ 170

Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
           LD +    ++ I   GT  ++AP
Sbjct: 171 LDRTVGRRNTFI---GTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 43/164 (26%), Positives = 64/164 (39%), Gaps = 34/164 (20%)

Query: 540 IGQGSFGSVY---KGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           I +G+FGSVY   K   G+   I  +K  ++  K    +  AE    R I          
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYV 59

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL---------NIAI 647
                 F+  D+  LV EY+  G                  SLI+ L             
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIA 104

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +V   +E LH   Q  ++H D+KP N+L+D      + DFGL++
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
           ++G+GSFG V    L E   + AVKV+    + Q       + E   L   R+   +  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN--DQVEVCKLSLIQRLNIAIDVASAI 653
             C    F+  D    V E++  G L   + +S   D+              A ++ SA+
Sbjct: 62  YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--------AAEITSAL 109

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            +LH      +++ DLK  NVLLDH+    + DFG+ K    +   TS+          G
Sbjct: 110 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--------FCG 158

Query: 714 TVGYVAP 720
           T  Y+AP
Sbjct: 159 TPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 22/150 (14%)

Query: 558 MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM 616
           ++VAVK++     K A   F+ E + L  ++  N+I+++ +C   D        ++ EYM
Sbjct: 47  LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYM 101

Query: 617 GNGSLEDWL--HQSNDQVE-----------VCKLSLIQRLNIAIDVASAIEYLHHHCQPP 663
            NG L  +L  H  +D+ E           +  +S    L++A+ +AS ++YL       
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158

Query: 664 MVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            VH DL   N L+  ++   + DFG+++ L
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 19/189 (10%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F    +IG+G+FG V    +   E I A+K++N K +   R+  A     RN+      
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGDC 60

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVAS 651
           + IT      F+  ++  LV +Y   G L   L +  D++ E      I  + +AI    
Sbjct: 61  QWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH--- 116

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           +I  LH+      VH D+KP NVLLD +     G   LA F S   ++    T  SS+ +
Sbjct: 117 SIHQLHY------VHRDIKPDNVLLDMN-----GHIRLADFGSCLKMNQDG-TVQSSVAV 164

Query: 712 KGTVGYVAP 720
            GT  Y++P
Sbjct: 165 -GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 71/263 (26%), Positives = 100/263 (38%), Gaps = 18/263 (6%)

Query: 203 ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH---GTIPDVIGE 259
            L  S  + ++   V        +           NL ++AV    L+    T+  +   
Sbjct: 6   NLLKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSS 65

Query: 260 LKNLQLLGLYKNFLQGS--IPSGLGNLTKLAKLDLGSNSLQGN--FIASQNKLIGA--LP 313
           L  L  L L       S      L NL  L  LDL  N L+ N   +     L       
Sbjct: 66  LSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDN 125

Query: 314 QQLLSITTLSLYLDLSNNLLN------GSLPQQVGNLKNLIILDISSNQFSGMIPVTLST 367
             +  I  L   L  +   L+       SLP  + NL NL  LD+S N  S  +P  LS 
Sbjct: 126 NNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN 184

Query: 368 CVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
             +L  +D+S N     +PP +  L +++ LD+S NN   +    L NL  L  L LS N
Sbjct: 185 LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSGLELSNN 242

Query: 428 HLEGEVPTKGVFSNKSKIPLQGN 450
            LE    + G  SN   + L  N
Sbjct: 243 KLEDLPESIGNLSNLETLDLSNN 265

Length = 394

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 25/183 (13%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEA--LRNIRHRNLIK 593
           ++G+G+FG VY     +    +AVK +      Q+ +      ECE   L+N+RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                   + K +   ++  EYM  GS++D L       E    ++ +R    I     +
Sbjct: 69  YYGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQI--LQGV 119

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            YLH +    +VH D+K +N+L D      +GDFG +K + +  +        S  GIK 
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM--------SGTGIKS 168

Query: 714 TVG 716
             G
Sbjct: 169 VTG 171

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 36/202 (17%)

Query: 513 SPMEKQFPMVSYAELS-KATSEFSSSNMIGQGSFG---SVYKGILGEDEMIVAVKVI--- 565
           S  + QF  V  A+ +      +     IG G+ G   + +  +LG   + VAVK +   
Sbjct: 1   SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRP 57

Query: 566 ---NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN 618
                  K A+R  V     L+ + H+N+I ++ + +      +F+ V    LV E M +
Sbjct: 58  FQNQTHAKRAYRELVL----LKCVNHKNIISLLNVFTPQKSLEEFQDV---YLVMELM-D 109

Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
            +L   +H   D   +  L L Q L         I++LH      ++H DLKPSN+++  
Sbjct: 110 ANLCQVIHMELDHERMSYL-LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKS 158

Query: 679 DMVAHVGDFGLAKFLSSHHLDT 700
           D    + DFGLA+   ++ + T
Sbjct: 159 DCTLKILDFGLARTACTNFMMT 180

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 21/161 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 594
           IG+GSFG +Y      D     +K I+L     K+K A +    E   L  ++H N   I
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           +T  +S    G  F  +V EY   G   D + + N Q  V   S  Q L+  + ++  ++
Sbjct: 62  VTFFASFQENGRLF--IVMEYCDGG---DLMKRINRQRGVL-FSEDQILSWFVQISLGLK 115

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLS 694
           ++H      ++H D+K  N+ L  + MVA +GDFG+A+ L+
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 32/164 (19%)

Query: 539 MIGQGSFGSV-----------YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
           ++G+G+FG V           Y   + + E+IVA        K      + E   L+N R
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--------KDEVAHTLTENRVLQNSR 53

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H  L  +        F+  D    V EY   G L  + H S ++V     S  +      
Sbjct: 54  HPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGA 102

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 17/173 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-----RHRNLIKI 594
           IG+G++G V+K +  ++    AVK+++            E EA  NI      H N++K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
             +    D K  D   LV E    GS+ D +     + E      ++   IA  +  A+ 
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-----RMEEPIIAYILHEALM 135

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS--HHLDTSSKTP 705
            L H      +H D+K +N+LL  +    + DFG++  L+S     +TS  TP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 53/143 (37%), Positives = 73/143 (51%), Gaps = 7/143 (4%)

Query: 4   QIPKEIGSL-FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
            IP  IG L   L+ L L+ N +   LP  + NL  L+ + +  N L    P  L  L N
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN 187

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L  L+++ NK     P  I  +S+LE   L++N     L    + NL NL  L + +NN 
Sbjct: 188 LNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSIIELL--SSLSNLKNLSGLEL-SNNK 243

Query: 123 FGLIPDSLSNASNLELLDLSNNQ 145
              +P+S+ N SNLE LDLSNNQ
Sbjct: 244 LEDLPESIGNLSNLETLDLSNNQ 266

Length = 394

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 22/159 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLIK 593
           +G G++GSV           VAVK    K    F+S +       E   L++++H N+I 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78

Query: 594 IITICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           ++ + + +T  +  +   LV   MG           N+ V+  KLS      +   +   
Sbjct: 79  LLDVFTPATSIENFNEVYLVTNLMGA--------DLNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++Y+H      ++H DLKPSNV ++ D    + DFGLA+
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 24/160 (15%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE-------ALRNIRHRNL 591
           ++G+GSFG V    L   + + AVKV  LK+    +    EC        AL   +H  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
            ++ + C    F+  D    V EY+  G L   + +S       +    +    A ++  
Sbjct: 59  TQLHS-C----FQTKDRLFFVMEYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVL 107

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            +++LH      +++ DLK  NVLLD +    + DFG+ K
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 29/188 (15%)

Query: 539 MIGQGSFGSVY--KGILGEDE-MIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLI 592
           ++GQGSFG V+  + I G D   + A+KV+    LK +   R+ + E + L  + H  ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           K+        F+      L+ +++  G L   L +     EV       +  +A ++A A
Sbjct: 62  KL-----HYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLA-ELALA 110

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++LH      +++ DLKP N+LLD +    + DFGL+K      +D   K  S      
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS----FC 159

Query: 713 GTVGYVAP 720
           GTV Y+AP
Sbjct: 160 GTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 15/150 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
              +   D   +V E++  G+L D +  +    E       Q   + + V  A+  LH  
Sbjct: 84  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
               ++H D+K  ++LL HD    + DFG 
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 18/157 (11%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEAL-RNIRHRNLIKI 594
           +IG+GSFG V       D    AVKV+  K    +   +  +AE   L +N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+  +    V +++  G L  + H    Q E        R   A ++ASA+ 
Sbjct: 62  -----HYSFQTTEKLYFVLDFVNGGEL--FFHL---QRERSFPEPRARFYAA-EIASALG 110

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           YLH      +V+ DLKP N+LLD      + DFGL K
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 11/76 (14%)

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           IA+ +  A+EYLH   +  ++H D+KPSNVL++ +    + DFG    +S + +D+ +KT
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKT 161

Query: 705 PSSSIGIKGTVGYVAP 720
             +     G   Y+AP
Sbjct: 162 IDA-----GCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 22/187 (11%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---FVAECEA--LRNIRHRNLIK 593
           ++GQG+FG VY     +    +AVK +    +    S      ECE   L+N+ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                     + +   ++  E+M  GS++D L       E       ++      +   +
Sbjct: 69  YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGV 119

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            YLH +    +VH D+K +N+L D      +GDFG     +S  L T   + +    + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGTGMKSVTG 171

Query: 714 TVGYVAP 720
           T  +++P
Sbjct: 172 TPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 55/196 (28%), Positives = 76/196 (38%), Gaps = 28/196 (14%)

Query: 26  TGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL-GLLRN--LVQLNVAENKFYGMFPRSIC 82
              L   +     LQ + +  N+LG      L  LLR+  L +L +  N       R + 
Sbjct: 70  LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129

Query: 83  -----NISSLEYFYLTSNRFSGSLPFDIVVNLP---NLKELGIGANNF----FGLIPDSL 130
                   +LE   L  NR  G+    +   L    +LKEL +  N         + + L
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189

Query: 131 SNASNLELLDLSNNQFK----GKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF--- 183
               NLE+LDL+NN         ++   +SLK L  LNL  NNL      D G       
Sbjct: 190 KANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT-----DAGAAALASA 244

Query: 184 -LTNCSSLKVLSLSDN 198
            L+   SL  LSLS N
Sbjct: 245 LLSPNISLLTLSLSCN 260

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 32/164 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G++G+V   +       VA+K +       L  K A+R    E   L++++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 594 IITICSST----DFKGVDFKALVFEYMGN--GSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           ++ + +       F   DF  LV  +MG   G L      S D+++     +++ L    
Sbjct: 79  LLDVFTPDLSLDRFH--DF-YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL---- 131

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                 +Y+H      ++H DLKP N+ ++ D    + DFGLA+
Sbjct: 132 ------KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 23/166 (13%)

Query: 532 SEFSSSNMIGQGSFGSVY---KGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRN 585
            +F     +GQG +G V+   K   GE   IVA+K +    L +    R  + E + L  
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTT 57

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            +   L+K++       F+  ++  L  EY+  G     L+          LS       
Sbjct: 58  TKSEWLVKLLY-----AFQDDEYLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFY 106

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++  A++ LH   +   +H DLKP N L+D      + DFGL+K
Sbjct: 107 MAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 23/159 (14%)

Query: 539 MIGQGSFGSVYKGILGEDEM---IVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLI 592
           ++G+G+FG V   IL  ++      A+K++    +  K      + E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            +        F+  D    V EY   G L  + H S ++V     S  +      ++ SA
Sbjct: 59  AL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSA 107

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           + YLH      +V+ DLK  N++LD D    + DFGL K
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 29/174 (16%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEALR 584
           T+ +     +G G+FG V           VA+K I       +  K  +R    E + L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64

Query: 585 NIRHRNLIKI--ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++RH N+I +  I I    D         V E +G   L   L     + +  +  L Q 
Sbjct: 65  HLRHENIISLSDIFISPLEDI------YFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQI 117

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           L         ++Y+H      +VH DLKPSN+L++ +    + DFGLA+     
Sbjct: 118 LR-------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 24/191 (12%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL--RNIRHRN 590
           +F+   ++G+GSFG V        + + A+K+  LK+    +    EC  +  R +  ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
               +T   S  F+ VD    V EY+  G L   + Q      V K    Q +  A +++
Sbjct: 59  KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD-TSSKTPSSSI 709
             + +LH   +  +++ DLK  NV+LD +    + DFG+ K    H +D  +++T     
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT----- 160

Query: 710 GIKGTVGYVAP 720
              GT  Y+AP
Sbjct: 161 -FCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 35/165 (21%)

Query: 540 IGQGSFGSV---YKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRN 590
           IG G+ G V   Y  + G++   VA+K ++         K A+R  V     ++ + H+N
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYRELVL----MKLVNHKN 76

Query: 591 LIKIITIC----SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +I ++ +     S  +F+ V    LV E M + +L   +    D   +  L L Q L   
Sbjct: 77  IIGLLNVFTPQKSLEEFQDV---YLVMELM-DANLCQVIQMDLDHERMSYL-LYQML--- 128

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                 I++LH      ++H DLKPSN+++  D    + DFGLA+
Sbjct: 129 ----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 44.7 bits (105), Expect = 8e-05
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 17/162 (10%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---FVAECEA--LRNIRHRNLIK 593
           ++GQG+FG VY     +    +A K +    +    S      ECE   L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                     +      +  EYM  GS++D L       E       ++      +   +
Sbjct: 69  YYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGM 119

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            YLH +    +VH D+K +N+L D      +GDFG +K L +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.3 bits (107), Expect = 8e-05
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 27/167 (16%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALRNIR 587
           ++S   +G G++GSV   I       VA+K ++      +  K A+R    E   L++++
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQ 72

Query: 588 HRNLIKIITI-CSSTDFKGVDFKALVFEYMGNGSLED--WLHQSNDQVEVCKLSLIQRLN 644
           H N+I ++ +  S+          LV  YM    L+       S D+V+     ++  L 
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQMLCGL- 130

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                    +Y+H      ++H DLKP N+ ++ D    + DFGLA+
Sbjct: 131 ---------KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.9 bits (106), Expect = 8e-05
 Identities = 46/182 (25%), Positives = 79/182 (43%), Gaps = 33/182 (18%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLKQKGAFRSFVAECEALRNIRHR 589
           E+    +IG G FG VY+     D  I      K+ NL+ +    + V E     NI   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDI 68

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGS------------LEDWLHQSND---QVEV 634
           + I +     + D  G+       +Y G GS            LE  +  + +   +++ 
Sbjct: 69  DKIALWKNIHNIDHLGIP------KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC 122

Query: 635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
               LI+  NI  D+ + +EY+H H    + HGD+KP N+++D +   ++ D+G+A    
Sbjct: 123 KNKKLIK--NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177

Query: 695 SH 696
            H
Sbjct: 178 IH 179

Length = 294

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.7 bits (105), Expect = 9e-05
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 27/193 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 589
           +F    +IG+G+FG V    L   + + A+K++N   + ++     F  E + L N  + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN- 60

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAI 647
              + IT      F+  +   LV +Y   G L   L +  D++  ++ +  L + + IAI
Sbjct: 61  ---QWITTLHYA-FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAI 115

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           D   ++  LH+      VH D+KP N+L+D +    + DFG    L          T  S
Sbjct: 116 D---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKL------MEDGTVQS 160

Query: 708 SIGIKGTVGYVAP 720
           S+ + GT  Y++P
Sbjct: 161 SVAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 27/193 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 589
           +F    +IG+G+FG V    +     + A+K++N   + ++     F  E + L N   R
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAI 647
            +  +        F+  +   LV +Y   G L   L +  D++  ++ +  L + + +AI
Sbjct: 62  WITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-LAI 115

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           D    + Y         VH D+KP NVLL  D   H+    LA F S   L     T  S
Sbjct: 116 DSVHQLGY---------VHRDIKPDNVLL--DKNGHI---RLADFGSCLRLLADG-TVQS 160

Query: 708 SIGIKGTVGYVAP 720
           ++ + GT  Y++P
Sbjct: 161 NVAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 35/152 (23%), Positives = 73/152 (48%), Gaps = 25/152 (16%)

Query: 540 IGQGSFGSVYKGILG------------EDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
           +G+G+   +Y GIL             E E+ V +KV++   +    +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H++++ +  +C   D + +    +V E++  G L+ ++H+ +D      L+   +  +A 
Sbjct: 63  HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAK 112

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 679
            +ASA+ YL       +VHG++   N+LL  +
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 20/158 (12%)

Query: 539 MIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK---- 593
           ++G+GSFG V    L G DE + A+KV  LK+    +    +C  +   R   L      
Sbjct: 2   VLGKGSFGKVMLAELKGTDE-VYAIKV--LKKDVILQDDDVDC-TMTEKRILALAAKHPF 57

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +     F+  D    V EY+  G L   + +S       K    +    A +V  A+
Sbjct: 58  LTALHCC--FQTKDRLFFVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLAL 109

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            +LH H    +++ DLK  N+LLD +    + DFG+ K
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 31/187 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G+G++GSVYK +     + +A+K I L+  +  F   + E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYIV-- 62

Query: 599 SSTDFKGVDF-KALVF---EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              DF G  F +  V+   EYM  GSL D L+      E     +++R  I   V   ++
Sbjct: 63  ---DFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS-SKTPSSSIGIKG 713
           +L       ++H D+KP+NVL++ +    + DFG+     S +L  S +KT   +IG + 
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKT---NIGCQ- 165

Query: 714 TVGYVAP 720
              Y+AP
Sbjct: 166 --SYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 38/206 (18%)

Query: 539 MIGQGSFGSVYKGILGEDEMI---VAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLI 592
           +IG+G  G VY   L  D +    VA+K I  +L +    +  F+ E +   ++ H  ++
Sbjct: 9   LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 593 KIITICSSTD--------FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + +ICS  D         +G   K+L+       SL   L +        K S+   L+
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE--------KTSVGAFLS 117

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH---LDTS 701
           I   + + IEY+H      ++H DLKP N+LL       + D+G A F        LD  
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 702 SKTPSSSIG-------IKGTVGYVAP 720
               +           I GT  Y+AP
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 27/77 (35%), Positives = 35/77 (45%), Gaps = 16/77 (20%)

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A ++   +E LH   +   V+ DLKP N+LLD      + D GLA            K P
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-----------VKIP 153

Query: 706 SSSI--GIKGTVGYVAP 720
                 G  GTVGY+AP
Sbjct: 154 EGESIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 26/170 (15%)

Query: 560 VAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF 613
           VA+K++         Q+  FR   A C  L    H N++ ++    +           VF
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALLDSGEAPP----GLLFAVF 58

Query: 614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 673
           EY+   +L + L  + D      L   +   + + V  A+   H+     +VH DLKP N
Sbjct: 59  EYVPGRTLREVL--AADGA----LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQN 109

Query: 674 VLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           +++        A V DFG+   L     D    T + +  + GT  Y AP
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 26/200 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--R 589
            +F +  +I  G++G+VY     E     A+K IN KQ    R+ + +    R+I     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL-HQSNDQVEVCKLSLIQRLNIAID 648
           N   +   CS   F+      +V EY+  G     L +     V+      + R+  A  
Sbjct: 60  NPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLKNIGALPVD------MARMYFAET 110

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF--------LSSHHLDT 700
           V  A+EYLH++    +VH DLKP N+L+       + DFGL+K         L   H++ 
Sbjct: 111 VL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 701 SSKTPSSSIGIKGTVGYVAP 720
            ++       + GT  Y+AP
Sbjct: 167 DTREFLDK-QVCGTPEYIAP 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 51/200 (25%)

Query: 539 MIGQGSFGSVY--KGILGED-EMIVAVKVINLKQKGAFRSF--VAECEALRNI----RHR 589
           ++G+G +G V+  + + G D   I A+KV  LK+    R+    A  +A RNI    +H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI-D 648
            ++ +I     T  K      L+ EY+  G L  ++H             ++R  I + D
Sbjct: 61  FIVDLI-YAFQTGGK----LYLILEYLSGGEL--FMH-------------LEREGIFMED 100

Query: 649 VAS--------AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
            A         A+E+LH      +++ DLKP N+LLD      + DFGL K   S H  T
Sbjct: 101 TACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGT 155

Query: 701 SSKTPSSSIGIKGTVGYVAP 720
            + T        GT+ Y+AP
Sbjct: 156 VTHT------FCGTIEYMAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 29/149 (19%)

Query: 540 IGQGSFGSVYKGILGED----------EMIVAVKVINLKQKG-AFRSFVAECEALRNIRH 588
           +GQG+F ++YKG+L             E+ V +KV  L        +F      +  + H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV--LGSDHRDSLAFFETASLMSQLSH 60

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV-CKLSLIQRLNIAI 647
           ++L+K+  +C        D   +V EY+  G L+ +LH+  + V +  KL + ++L    
Sbjct: 61  KHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL---- 110

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
             ASA+ YL       +VHG++   N+L+
Sbjct: 111 --ASALHYLEDK---KLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 38/147 (25%), Positives = 55/147 (37%), Gaps = 21/147 (14%)

Query: 560 VAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMG 617
           VAVK INL    K   +    E    R ++H N++  +T      F       +V   M 
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-----FIVDSELYVVSPLMA 82

Query: 618 NGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLL 676
            GS ED L       E      I    I  DV +A++Y+H        +H  +K S++LL
Sbjct: 83  YGSCEDLL--KTHFPEGLPELAIA--FILKDVLNALDYIHSKGF----IHRSVKASHILL 134

Query: 677 DHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             D         L+    S  +    K
Sbjct: 135 SGDGKVV-----LSGLRYSVSMIKHGK 156

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLI-KIIT 596
           IG+G++G VYK        +VA+K   L+  ++G   + + E   L+ +     I +++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKL--SLIQRLNIAIDVASAIE 654
           +    +  G     LVFEY+ +  L+ ++  SN +     L    I+     +    A  
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVA-- 124

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLS 694
           + H H    ++H DLKP N+L+D    +  + D GL +  S
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 45/187 (24%), Positives = 86/187 (45%), Gaps = 38/187 (20%)

Query: 534 FSSSNM-----IGQGSFGSVYKGILGEDEMIVAVK-----VINLKQKGAFRSFVAECEAL 583
           F++ ++     IG+G+FG+V K +      I+AVK     V   +QK      + + + +
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK----RLLMDLDVV 56

Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSL 639
             +R  +   I+       F G  F+     +  E M + SL+ +     + ++     +
Sbjct: 57  --MRSSDCPYIVK------FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSV---I 104

Query: 640 IQRL--NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
            + +   IA+    A+ YL    +  ++H D+KPSN+LLD +    + DFG    +S   
Sbjct: 105 PEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG----ISGQL 158

Query: 698 LDTSSKT 704
           +D+ +KT
Sbjct: 159 VDSIAKT 165

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 15/155 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V           VAVK+++L+++        E   +R+ +H+N++++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY---- 84

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
            +   G +   L+ E++  G+L D + Q+       +L+  Q   +   V  A+ YLH  
Sbjct: 85  KSYLVGEELWVLM-EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ 136

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
               ++H D+K  ++LL  D    + DFG    +S
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 15/155 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V           VAVK ++L+++        E   +R+  H N++ +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY---- 85

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
           ++   G D   +V E++  G+L D +  +    E       Q   + + V  A+ YLH+ 
Sbjct: 86  NSYLVG-DELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
               ++H D+K  ++LL  D    + DFG    +S
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 12/75 (16%)

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A ++   +E LH   Q  +V+ DLKP N+LLD      + D GLA  +       + K  
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIK-- 159

Query: 706 SSSIGIKGTVGYVAP 720
               G  GTVGY+AP
Sbjct: 160 ----GRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 26/164 (15%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNL 591
           IG+GSFG   K IL    ED     +K IN+     K++   R    E   L N++H N 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN- 60

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
             I+    S +  G  +  +V +Y   G   D   + N Q  V      Q L+  + +  
Sbjct: 61  --IVQYQESFEENGNLY--IVMDYCEGG---DLYKKINAQRGVL-FPEDQILDWFVQICL 112

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           A++++H      ++H D+K  N+ L  D    +GDFG+A+ L+S
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 6e-04
 Identities = 19/60 (31%), Positives = 32/60 (53%)

Query: 346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
           NL  LD+S+N+ + +         +L+ +D+S N    I P +   L S++ LD+S NN 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 29/195 (14%)

Query: 534 FSSSNMIGQGSFGSVY--KGILGEDE-MIVAVKVI---NLKQKGAFRSFV-AECEALRNI 586
           F    ++G G++G V+  + + G D   + A+KV+    + QK         E + L +I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           R    +  +     TD K      L+ +Y+  G L   L Q     E       Q + I 
Sbjct: 62  RQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIY 110

Query: 647 I-DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
             ++  A+E+LH   +  +++ D+K  N+LLD +    + DFGL+K     H D   +  
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAY 164

Query: 706 SSSIGIKGTVGYVAP 720
           S      GT+ Y+AP
Sbjct: 165 S----FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 7e-04
 Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 9/84 (10%)

Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           L L Q   +A  + SAI+Y+  H +  ++H D+K  NVL++      +GDFG A F    
Sbjct: 257 LGLAQVTAVARQLLSAIDYI--HGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARG- 312

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
               S  TP    GI GTV   AP
Sbjct: 313 ----SWSTP-FHYGIAGTVDTNAP 331

Length = 461

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 7e-04
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 28/170 (16%)

Query: 540 IGQGSFGSVYKGIL--GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI 597
           +G+G++G VYK     G+DE   A+K I  +  G   S   E   LR ++H N+I +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLH--------QSNDQVEVCKLSLIQRLNIAIDV 649
             S   + V    L+F+Y    +  D  H        ++N +      S+++ L     +
Sbjct: 67  FLSHSDRKV---WLLFDY----AEHDLWHIIKFHRASKANKKPMQLPRSMVKSL--LYQI 117

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSS 695
              I YLH +    ++H DLKP+N+L+           + D G A+  +S
Sbjct: 118 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 1/61 (1%)

Query: 86  SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ 145
           +L+   L++NR +  +P      LPNLK L +  NN   + P++ S   +L  LDLS N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 146 F 146
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 59/265 (22%), Positives = 94/265 (35%), Gaps = 68/265 (25%)

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
            LT    L+ L LSDN  G +    + +L  +                L    L N    
Sbjct: 76  GLTKGCGLQELDLSDNALGPDGCGVLESLLRSS--------------SLQELKLNN---- 117

Query: 243 AVEVNQLHGTIPDVIGE-LKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF 301
               N L      ++ + LK+L                       L KL LG N L+G  
Sbjct: 118 ----NGLGDRGLRLLAKGLKDLPP--------------------ALEKLVLGRNRLEG-- 151

Query: 302 IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG----SLPQQVGNLKNLIILDISSNQF 357
            AS   L  AL     +   L   L+L+NN +      +L + +    NL +LD+++N  
Sbjct: 152 -ASCEALAKALR----ANRDLKE-LNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205

Query: 358 ----SGMIPVTLSTCVSLEYVDISSN-----CFHGIIPPSLGFLKSIKFLDVSCNNF--- 405
               +  +  TL++  SLE +++  N         +    L    S+  L +SCN+    
Sbjct: 206 TDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDD 265

Query: 406 -SGQFPKFLENLSFLEFLNLSYNHL 429
            +    + L     L  L+L  N  
Sbjct: 266 GAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 11/76 (14%)

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           + + +  A+ YL       ++H D+KPSN+LLD      + DFG++  L    +D+ +KT
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSKAKT 172

Query: 705 PSSSIGIKGTVGYVAP 720
            S      G   Y+AP
Sbjct: 173 RS-----AGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.2 bits (99), Expect = 0.001
 Identities = 22/65 (33%), Positives = 34/65 (52%), Gaps = 6/65 (9%)

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           +HH     M+H D+K +N+LL  + +  +GDFG +K  ++   D   +T        GT 
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FCGTP 209

Query: 716 GYVAP 720
            YVAP
Sbjct: 210 YYVAP 214

Length = 496

>gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only]

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 22/81 (27%), Positives = 34/81 (41%), Gaps = 14/81 (17%)

Query: 618 NGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA-IEYLHHHC-----QPPMVHGDLKP 671
              L  W    +D+    K  L  R    I +A   I++L  +       P +VHGD +P
Sbjct: 156 GRQLARW----DDEYRRAKKELGGR----IPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207

Query: 672 SNVLLDHDMVAHVGDFGLAKF 692
            N+++D      V D+ LA  
Sbjct: 208 GNLIIDPGRPTGVLDWELATL 228

Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)

Query: 540 IGQGSFGSVY--KGILGEDE-MIVAVKVIN-----LKQKGAFRSFVAECEALRNIRHRNL 591
           +G G++G V+  + + G D   + A+KV+       K K A  +   E + L  +R    
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLEAVRRCPF 66

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN--DQVEVCKLSLIQRLNIAIDV 649
           +  +     TD K      L+ +Y+  G L   L+Q     + EV       R+ IA ++
Sbjct: 67  LVTLHYAFQTDTK----LHLILDYVNGGELFTHLYQREHFTESEV-------RVYIA-EI 114

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
             A+++LH   Q  +++ D+K  N+LLD +    + DFGL+K   +   + +        
Sbjct: 115 VLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS------ 165

Query: 710 GIKGTVGYVAP 720
              GT+ Y+AP
Sbjct: 166 -FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 33/132 (25%), Positives = 58/132 (43%), Gaps = 24/132 (18%)

Query: 564 VINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV---DFKALVFEYMGNGS 620
           VI   Q+G       E   LR I H ++I++    +   F  +    +K  ++ Y+    
Sbjct: 121 VIKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA--- 174

Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                  +   + +C +  I+R      V  AI+YLH +    ++H D+K  N+ ++H  
Sbjct: 175 -------AKRNIAICDILAIER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPG 219

Query: 681 VAHVGDFGLAKF 692
              +GDFG A F
Sbjct: 220 DVCLGDFGAACF 231

Length = 391

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 0.001
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 17/170 (10%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI---RH 588
            +F S  +IG+G+FG V      +   I A+K +  K +   +  VA   A R+I     
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEAD 59

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
              + +    S   F+  ++  L+ EY+  G +   L + +   E        R  IA +
Sbjct: 60  NPWV-VKLYYS---FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIA-E 109

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
              AI+ +H       +H D+KP N+LLD      + DFGL   L   H 
Sbjct: 110 TILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 22/56 (39%), Positives = 29/56 (51%), Gaps = 2/56 (3%)

Query: 325 YLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
            LDLSNN L   +P      L NL +LD+S N  + + P   S   SL  +D+S N
Sbjct: 4   SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 20/60 (33%), Positives = 33/60 (55%)

Query: 370 SLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHL 429
           +L+ +D+S+N    I   +   L ++K LD+S NN +   P+    L  L  L+LS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 37/200 (18%)

Query: 533 EFSSSNMIGQGSFGSVY--KGILGEDE-MIVAVKVIN----LKQKGAFRSFVAECEALRN 585
            F    ++G G++G V+  + + G D   + A+KV+     +++         E   L +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQ 641
           +R    +  +     T+ K      L+ +Y+  G +   L+Q    S D+V         
Sbjct: 61  VRQSPFLVTLHYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDEVRF------- 109

Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK-FLSSHHLDT 700
               + ++  A+E+LH   +  +V+ D+K  N+LLD +    + DFGL+K FLS     T
Sbjct: 110 ---YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163

Query: 701 SSKTPSSSIGIKGTVGYVAP 720
            S          GT+ Y+AP
Sbjct: 164 YS--------FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 18/192 (9%)

Query: 508 NSADTSPMEKQFPMVSYAELSKATSE-FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 566
           ++ +    E +  M+   +++++ ++ +   N+IG GSFG VY+ I  +    VA+K   
Sbjct: 42  HNNNAGEDEDEEKMID-NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--K 98

Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKI----ITICSSTDFKGVDFKALVFEYMGNGSLE 622
           + Q   +++   E   ++N+ H N+I +     T C   + K + F  +V E++   ++ 
Sbjct: 99  VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNI-FLNVVMEFIPQ-TVH 154

Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMV 681
            ++           L L++    +  +  A+ Y+H      + H DLKP N+L+D +   
Sbjct: 155 KYMKHYARNNHALPLFLVKLY--SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHT 209

Query: 682 AHVGDFGLAKFL 693
             + DFG AK L
Sbjct: 210 LKLCDFGSAKNL 221

Length = 440

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 40.7 bits (96), Expect = 0.002
 Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 39/172 (22%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLI 592
           IG+G+F  V K    +     A+K      K  F+S + +   LR I+       H N++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKS-LEQVNNLREIQALRRLSPHPNIL 61

Query: 593 KIITICSSTDFKGVDFK----ALVFEYMGNGSLEDWL---HQSNDQVEVCKLSLIQRLNI 645
           ++I +         D K    ALVFE M + +L + +    +   +  V K  + Q L  
Sbjct: 62  RLIEVL-------FDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRV-KSYMYQLL-- 110

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
                 +++++H +    + H D+KP N+L+  D++  + DFG  + + S  
Sbjct: 111 -----KSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKP 153

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 36/198 (18%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F   + +G G+ G V K       +I+A K+I+L+ K A R+ +        IR    +
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--------IRE---L 54

Query: 593 KIITICSS---TDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           +++  C+S     F G  +     ++  E+M  GSL+  L ++    E     ++ +++I
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSI 110

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A  V   + YL    Q  ++H D+KPSN+L++      + DFG    +S   +D+ + + 
Sbjct: 111 A--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANS- 161

Query: 706 SSSIGIKGTVGYVAPGKF 723
                  GT  Y++P + 
Sbjct: 162 -----FVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 19/161 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+G  G V+   L     + A+KV++ K   ++   +  + E E L  + H     + T
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           + +S  F+   +  LV +Y   G L   L     Q   C    + R   A +V  A+EYL
Sbjct: 66  LYAS--FQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAA-EVLLALEYL 119

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSS 695
           H      +V+ DLKP N+LL      H+   DF L+K    
Sbjct: 120 H--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDV 155

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 40/168 (23%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI------RHRNLIK 593
           IG G+FG V+      D   VA+K    K    F++ V+     R +      +H N++ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALK----KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 594 IITICSSTDFKGVDFKALVFE--YMGNGSLEDWLHQ--------SNDQVEVCKLSLIQRL 643
            + I        +D     FE  Y+    ++  LH+        S+D V   K+ L Q L
Sbjct: 64  ALDILQPPH---IDP----FEEIYVVTELMQSDLHKIIVSPQPLSSDHV---KVFLYQIL 113

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                    ++YLH      ++H D+KP N+L++ + V  + DFGLA+
Sbjct: 114 R-------GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 18/154 (11%)

Query: 547 SVYKGILGEDEMIV-AVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI----ITICSST 601
           S+YKGI    E+I+   K  +   K        E + LR I   N++KI    I I    
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD- 93

Query: 602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQ 661
               +   +L+ EY   G L + L +  D      LS   +L++AID    +  L+ +  
Sbjct: 94  ----LPRLSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKYTN 143

Query: 662 PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            P  + +L   + L+  +    +   GL K LSS
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSS 175

Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 32/189 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN------IRHRNLI 592
           M+G+GSFG V+   L       A+K   LK+         EC  +          H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC-KLSLIQRLNIAIDVAS 651
            +   C+   F+  +    V EY+  G L    H     ++ C K  L +    A ++  
Sbjct: 60  HLY--CT---FQTKENLFFVMEYLNGGDL--MFH-----IQSCHKFDLPRATFYAAEIIC 107

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            +++LH      +V+ DLK  N+LLD D    + DFG+ K     ++   +KT +     
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCT----F 156

Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 157 CGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 39.6 bits (93), Expect = 0.004
 Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 16/101 (15%)

Query: 617 GNGSLEDW-LHQSNDQVEVCKLS-LIQRLNIAIDVASAIEYLHHH---CQPPMVHGDLKP 671
                 +W + +    + +  +     R  +   +   +  L  H       ++HGDL P
Sbjct: 147 NALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHP 206

Query: 672 SNVLLDHD-MVAHVGDFG----------LAKFLSSHHLDTS 701
            NVL D D  V+   DF           LA  L++ + D +
Sbjct: 207 DNVLFDDDTDVSGFIDFDDAGYGWFIYDLAIALNAWNGDEA 247

Length = 331

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.004
 Identities = 30/143 (20%), Positives = 60/143 (41%), Gaps = 22/143 (15%)

Query: 552 ILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI--KIITICSSTDFKGVDFK 609
           +LG  +    +K+   ++KGA R    E   L+ +  + L   K++      +  G  + 
Sbjct: 16  LLGTKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLASG---ESDGWSY- 69

Query: 610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL 669
            L+ E++   +L++   +  +              IA  +A  +  LH      + HGDL
Sbjct: 70  -LLMEWIEGETLDEVSEEEKED-------------IAEQLAELLAKLHQLPLLVLCHGDL 115

Query: 670 KPSNVLLDHDMVAHVGDFGLAKF 692
            P N+L+D   +  + D+  A +
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 36/198 (18%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F   + +G G+ G V+K       +I+A K+I+L+ K A R+ +        IR    +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--------IRE---L 54

Query: 593 KIITICSS---TDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           +++  C+S     F G  +     ++  E+M  GSL+  L ++    E     ++ +++I
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSI 110

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A  V   + YL    +  ++H D+KPSN+L++      + DFG    +S   +D+ + + 
Sbjct: 111 A--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANS- 161

Query: 706 SSSIGIKGTVGYVAPGKF 723
                  GT  Y++P + 
Sbjct: 162 -----FVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 47/193 (24%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-RSFVAECEALRNIRHRNLIKI-- 594
            ++G G+ G+VYK        I+AVKVI L       +  ++E E L       +I    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 595 -------ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
                  I+IC+              E+M  GSL D   +  + V       + R  IA+
Sbjct: 67  AFFVENRISICT--------------EFMDGGSL-DVYRKIPEHV-------LGR--IAV 102

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
            V   + YL       ++H D+KPSN+L++      + DFG    +S+  +++ +KT   
Sbjct: 103 AVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFG----VSTQLVNSIAKT--- 152

Query: 708 SIGIKGTVGYVAP 720
                GT  Y+AP
Sbjct: 153 ---YVGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	725
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.98
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
KOG0586	596	consensus Serine/threonine protein kinase [General	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
KOG0584	632	consensus Serine/threonine protein kinase [General	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
PHA03212	391	serine/threonine kinase US3; Provisional	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.94
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.94
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
PTZ00036	440	glycogen synthase kinase; Provisional	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.93
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.93
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
PHA03211	461	serine/threonine kinase US3; Provisional	99.93
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.93
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.93
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.92
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.92
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.92
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.92
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.92
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.92
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.92
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.92
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.92
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.92
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.92
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.92
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.92
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.92
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
PHA03207	392	serine/threonine kinase US3; Provisional	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
PTZ00284	467	protein kinase; Provisional	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.92
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.92
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.92
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.92
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.92
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.92
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.92
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.92
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.91
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.91
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.91
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.91
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.91
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.91
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.91
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.91
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.91
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.91
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.91
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.91
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.91
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.91
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.91
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.91
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.91
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.91
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.91
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.91
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.91
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.91
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.91
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.91
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.91
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.91
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.91
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.91
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.91
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.91
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.91
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.91
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.9
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.9
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.9
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.9
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.9
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.9
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.9
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.9
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.9
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.9
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.9
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.9
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.9
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
PHA03210	501	serine/threonine kinase US3; Provisional	99.9
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.9
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.9
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.9
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.9
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.9
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.9
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.9
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.9
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.89
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.89
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.89
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.89
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.89
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.89
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.89
PHA02882	294	putative serine/threonine kinase; Provisional	99.89
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.89
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.89
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.89
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.89
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.89
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.89
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.89
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.89
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.89
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.88
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.88
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.88
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.88
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.88
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.88
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.88
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.88
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.87
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.87
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.87
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.84
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.83
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
smart00090	237	RIO RIO-like kinase.	99.78
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.77
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
PLN00181	793	protein SPA1-RELATED; Provisional	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
PLN03150	623	hypothetical protein; Provisional	99.51
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.43
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.38
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.37
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.37
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.35
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.34
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.33
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.31
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.29
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.28
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.28
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.28
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.26
PLN03150	623	hypothetical protein; Provisional	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.19
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.17
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.17
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.08
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.07
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.88
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.88
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.83
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.81
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.78
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.73
KOG1243	690	consensus Protein kinase [General function predict	98.69
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
PRK09902	216	hypothetical protein; Provisional	98.63
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.59
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.48
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.45
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.4
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.4
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.35
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.33

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.4e-83  Score=763.67  Aligned_cols=680  Identities=31%  Similarity=0.498  Sum_probs=502.4

Q ss_pred             cccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccc
Q 048668            2 EGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSI   81 (725)
Q Consensus         2 ~~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~   81 (725)
                      +|.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+..|..|+.+++|++|+|++|++++..|..|
T Consensus       153 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l  232 (968)
T PLN00113        153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI  232 (968)
T ss_pred             cccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhH
Confidence            35566666667777777777776666666667777777777777777766666667777777777777777666666667


Q ss_pred             cccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccC
Q 048668           82 CNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW  161 (725)
Q Consensus        82 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~  161 (725)
                      +++++|++|++++|.+++.+|.. +.++++|+.|+|++|++++..|..+.++++|++|+|++|.+++..+..|..+++|+
T Consensus       233 ~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  311 (968)
T PLN00113        233 GGLTSLNHLDLVYNNLTGPIPSS-LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE  311 (968)
T ss_pred             hcCCCCCEEECcCceeccccChh-HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCc
Confidence            77777777777777766555543 45667777777777777666666667777777777777777666666666777777


Q ss_pred             eeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCce
Q 048668          162 RLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA  241 (725)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~  241 (725)
                      +|++++|.+....+      ..+.++++|++|++++|.+++.+|..+..+. .|+.|++++|.+.+.+|..+..+.+|+.
T Consensus       312 ~L~l~~n~~~~~~~------~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~  384 (968)
T PLN00113        312 ILHLFSNNFTGKIP------VALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFK  384 (968)
T ss_pred             EEECCCCccCCcCC------hhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCE
Confidence            77777776654322      4466777888888888888777777777776 7788888888888777877777778888


Q ss_pred             EEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccc-------------cccccc
Q 048668          242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI-------------ASQNKL  308 (725)
Q Consensus       242 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------------~~~~~~  308 (725)
                      |++++|.+.+..|..+..+++|+.|++++|.+.+..|..|..++.|+.|++++|.+++...             ...|.+
T Consensus       385 L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~  464 (968)
T PLN00113        385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF  464 (968)
T ss_pred             EECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee
Confidence            8888888877788888888888888888888888888888888888888888888775322             234555


Q ss_pred             cccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCcc
Q 048668          309 IGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS  388 (725)
Q Consensus       309 ~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  388 (725)
                      .+.+|..+ ....+ +.|++++|++++..|..|..+++|+.|+|++|++.+.+|..+..+++|++|+|++|.+++.+|..
T Consensus       465 ~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  542 (968)
T PLN00113        465 FGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS  542 (968)
T ss_pred             eeecCccc-ccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChh
Confidence            66666544 33444 88999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCCCCCCCCCCCCC
Q 048668          389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSR  468 (725)
Q Consensus       389 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~~  468 (725)
                      |+.+++|+.|||++|++++.+|..+..+++|+.|++++|++++.+|..+.+..+....+.||+.+|++.+....+.|...
T Consensus       543 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~  622 (968)
T PLN00113        543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV  622 (968)
T ss_pred             HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc
Confidence            99999999999999999999999999999999999999999999999888888888889999999997654444566432


Q ss_pred             CCccceeeeeeeehhhhHHHHHHHHHHHHHhhhhccccC-CCCCCCccccCCCcc-----CHHHHHHHhcCCCCCccccc
Q 048668          469 GSRKLKITLLKVLIPVAVSCWILFSCLTIVYARRRRSAH-NSADTSPMEKQFPMV-----SYAELSKATSEFSSSNMIGQ  542 (725)
Q Consensus       469 ~~~~~~~~~~~~~i~v~~~~~i~~~~~~~~~~~rr~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ig~  542 (725)
                      ..  .......+++.+++.++++++++.+++.++|+... +.............+     ..-........|...+.||+
T Consensus       623 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~  700 (968)
T PLN00113        623 RK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISR  700 (968)
T ss_pred             cc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEcc
Confidence            11  11111112222222222222222222223222111 111100000000000     00112223346777889999


Q ss_pred             ccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHH
Q 048668          543 GSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLE  622 (725)
Q Consensus       543 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  622 (725)
                      |+||.||+|++..++..||||+++.....    ...|++++++++|||||+++|+|....     ..|+||||+++|+|.
T Consensus       701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~  771 (968)
T PLN00113        701 GKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLS  771 (968)
T ss_pred             CCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHH
Confidence            99999999999889999999998643321    135688999999999999999987654     689999999999999


Q ss_pred             HHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCC
Q 048668          623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS  702 (725)
Q Consensus       623 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  702 (725)
                      ++++         .++|.++.+|+.|+++|++|+|+.+.++|+|||+||+||+++.++.+++. ||.+......      
T Consensus       772 ~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------  835 (968)
T PLN00113        772 EVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------  835 (968)
T ss_pred             HHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------
Confidence            9995         36888999999999999999997767799999999999999999888876 6655432111      


Q ss_pred             CCCcccccccCCccccCCCccc
Q 048668          703 KTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       703 ~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                            ....||++|||||++.
T Consensus       836 ------~~~~~t~~y~aPE~~~  851 (968)
T PLN00113        836 ------TKCFISSAYVAPETRE  851 (968)
T ss_pred             ------CCccccccccCccccc
Confidence                  1135899999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.1e-51  Score=490.33  Aligned_cols=443  Identities=34%  Similarity=0.531  Sum_probs=290.9

Q ss_pred             cccCCcccc-CcccCcEEecCCCccCc----------------------cCCccccCCCCCcEEEccCCcCCccCCCCCC
Q 048668            2 EGQIPKEIG-SLFKLQALALAGNYLTG----------------------KLPDFIGNLSALQVIHIKGNSLGGKFPTTLG   58 (725)
Q Consensus         2 ~~~ip~~~~-~l~~l~~L~l~~n~l~~----------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~   58 (725)
                      +|.+|..+. .+++|++|+|++|++++                      .+|..|+++++|++|+|++|.+.+..|..|+
T Consensus       106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  185 (968)
T PLN00113        106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT  185 (968)
T ss_pred             CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence            355665554 55555555555555554                      4444455555555555555555545555555


Q ss_pred             CCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccce
Q 048668           59 LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLEL  138 (725)
Q Consensus        59 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  138 (725)
                      ++++|++|+|++|.+.+..|..++++++|++|+|++|++++.+|.. +.++++|++|+|++|++++..|..|+++++|++
T Consensus       186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  264 (968)
T PLN00113        186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY  264 (968)
T ss_pred             hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChh-HhcCCCCCEEECcCceeccccChhHhCCCCCCE
Confidence            5555555555555555445555555555555555555555444433 244555555555555555555555555555555


Q ss_pred             ecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeE
Q 048668          139 LDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVF  218 (725)
Q Consensus       139 L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L  218 (725)
                      |+|++|++++..+..+..+++|++|++++|.+....      +..+.++++|++|++++|.+.+..|..+..++ +|+.|
T Consensus       265 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~------p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L  337 (968)
T PLN00113        265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI------PELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVL  337 (968)
T ss_pred             EECcCCeeeccCchhHhhccCcCEEECcCCeeccCC------ChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEE
Confidence            555555555544555555555555555555554222      13345556666666666666666666666555 56666


Q ss_pred             EecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCC
Q 048668          219 LIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       219 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      ++++|.+.+.+|..+..+.+|+.|++++|++.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|+++
T Consensus       338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~  417 (968)
T PLN00113        338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS  417 (968)
T ss_pred             ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee
Confidence            66666666666666666666666666666666666666666666666666666666666666667777777777777666


Q ss_pred             Cccc-------------cccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCcccc
Q 048668          299 GNFI-------------ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL  365 (725)
Q Consensus       299 ~~~~-------------~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  365 (725)
                      +..+             .+.|.+.+.+|..+..+..+ +.|++++|.+.+.+|..+ ..++|+.|++++|++++..|..+
T Consensus       418 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~  495 (968)
T PLN00113        418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKL  495 (968)
T ss_pred             eECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhh
Confidence            4221             13445555555555555555 677777777776666654 34788888888999988999999


Q ss_pred             ccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC-CccCCCCC
Q 048668          366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSK  444 (725)
Q Consensus       366 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~  444 (725)
                      ..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..|..+++|+.|||++|++++.+|.. ..+..++.
T Consensus       496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            99999999999999999999999999999999999999999999999999999999999999999988865 45678889


Q ss_pred             cCccCCcccc
Q 048668          445 IPLQGNVRLC  454 (725)
Q Consensus       445 ~~~~~n~~~c  454 (725)
                      +++++|...+
T Consensus       576 l~ls~N~l~~  585 (968)
T PLN00113        576 VNISHNHLHG  585 (968)
T ss_pred             EeccCCccee
Confidence            9999997655

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-47  Score=383.46  Aligned_cols=433  Identities=22%  Similarity=0.210  Sum_probs=370.1

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCC--CCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNL--SALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSI   81 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~   81 (725)
                      .+|+....  +-..||++++.+.......+..+  +.-+.||+++|+|..+.+..|.++++|+.++|.+|.++ .+|..-
T Consensus        45 ~cpa~c~c--~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~  121 (873)
T KOG4194|consen   45 ECPATCPC--NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG  121 (873)
T ss_pred             cCCCcCCC--CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc
Confidence            56777766  67789999999985444444433  34556999999999899999999999999999999998 677766


Q ss_pred             cccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccC
Q 048668           82 CNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW  161 (725)
Q Consensus        82 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~  161 (725)
                      ....+|+.|+|.+|.|+ ++..+.+..++.|+.|||+.|.|+.+.-..|..-.++++|+|++|+|+.+..+.|.++.+|.
T Consensus       122 ~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~  200 (873)
T KOG4194|consen  122 HESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLL  200 (873)
T ss_pred             ccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchhe
Confidence            66667999999999998 88888888999999999999999988888888888999999999999999999999999999


Q ss_pred             eeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCce
Q 048668          162 RLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA  241 (725)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~  241 (725)
                      .|.|+.|.++.++.      ..|.++++|+.|+|..|+|.-.--..|.+++ .++.|.+.+|.|+......|..+.++++
T Consensus       201 tlkLsrNrittLp~------r~Fk~L~~L~~LdLnrN~irive~ltFqgL~-Sl~nlklqrN~I~kL~DG~Fy~l~kme~  273 (873)
T KOG4194|consen  201 TLKLSRNRITTLPQ------RSFKRLPKLESLDLNRNRIRIVEGLTFQGLP-SLQNLKLQRNDISKLDDGAFYGLEKMEH  273 (873)
T ss_pred             eeecccCcccccCH------HHhhhcchhhhhhccccceeeehhhhhcCch-hhhhhhhhhcCcccccCcceeeecccce
Confidence            99999999998887      4577899999999999999843355677777 8999999999999888899999999999


Q ss_pred             EEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccccccc
Q 048668          242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITT  321 (725)
Q Consensus       242 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~  321 (725)
                      |+|+.|++...-.+++.+++.|+.|+|++|.|..+.++...-.++|++|+|++|+|+            .++++.+...+
T Consensus       274 l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~------------~l~~~sf~~L~  341 (873)
T KOG4194|consen  274 LNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT------------RLDEGSFRVLS  341 (873)
T ss_pred             eecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc------------cCChhHHHHHH
Confidence            999999999888999999999999999999999999999999999999999999988            88888888888


Q ss_pred             ccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCc---cccccccCCcEEEccCCccccccCccccCCCCCCEE
Q 048668          322 LSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP---VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL  398 (725)
Q Consensus       322 ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  398 (725)
                      .++.|.|++|+++..-...|.++++|++|||++|.|+..+.   ..|.++++|+.|+|.+|+|..+.-.+|.++..|+.|
T Consensus       342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L  421 (873)
T KOG4194|consen  342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL  421 (873)
T ss_pred             HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence            88999999999997777889999999999999999987665   467889999999999999998888899999999999


Q ss_pred             eCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccC-CccccCCCCCC
Q 048668          399 DVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQG-NVRLCGGIDEL  460 (725)
Q Consensus       399 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~-n~~~c~~~~~~  460 (725)
                      ||.+|.|..+.|.+|..+ .|++|-+..-.+-|++.-.+..+++....++. -...|+-|+..
T Consensus       422 dL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~L  483 (873)
T KOG4194|consen  422 DLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPL  483 (873)
T ss_pred             cCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcccccceeeeccCCccc
Confidence            999999999999999998 89999998888877776554334443333322 12456655443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=366.06  Aligned_cols=407  Identities=22%  Similarity=0.194  Sum_probs=354.1

Q ss_pred             cCCccccCCCCCcEEEccCCcCCccCCCCCCCC--CCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhh
Q 048668           28 KLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL--RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDI  105 (725)
Q Consensus        28 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  105 (725)
                      ..|....+  +-..||.++++|..+.-..+.+.  ..=++||+|+|+++.+.+..|.++++|+.++|.+|.++ .+|...
T Consensus        45 ~cpa~c~c--~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~  121 (873)
T KOG4194|consen   45 ECPATCPC--NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG  121 (873)
T ss_pred             cCCCcCCC--CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc
Confidence            34444443  34569999999975433333222  34556999999999999999999999999999999999 999643


Q ss_pred             hcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccC
Q 048668          106 VVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT  185 (725)
Q Consensus       106 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  185 (725)
                       ....+|+.|+|.+|.|+++..+.++.++.|++||||.|.|+.++...|..-.++++|+|++|.|+.+..      ..|.
T Consensus       122 -~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~------~~F~  194 (873)
T KOG4194|consen  122 -HESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLET------GHFD  194 (873)
T ss_pred             -ccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccc------cccc
Confidence             345569999999999999999999999999999999999999999999999999999999999999887      5677


Q ss_pred             CCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccE
Q 048668          186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQL  265 (725)
Q Consensus       186 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  265 (725)
                      ++.+|.+|.|+.|+|+...+..|.+++ +|+.|+|..|+|.-.--..|.++++|+.|.|..|.|.....++|.++.++++
T Consensus       195 ~lnsL~tlkLsrNrittLp~r~Fk~L~-~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~  273 (873)
T KOG4194|consen  195 SLNSLLTLKLSRNRITTLPQRSFKRLP-KLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEH  273 (873)
T ss_pred             ccchheeeecccCcccccCHHHhhhcc-hhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccce
Confidence            889999999999999966666677788 9999999999998555678999999999999999999999999999999999


Q ss_pred             EeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCC
Q 048668          266 LGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLK  345 (725)
Q Consensus       266 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~  345 (725)
                      |+|..|+++..-..++.++++|+.|+|++|.|+            .+..+.++...-+.+|+|++|+|+...+..|..+.
T Consensus       274 l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~------------rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~  341 (873)
T KOG4194|consen  274 LNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ------------RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS  341 (873)
T ss_pred             eecccchhhhhhcccccccchhhhhccchhhhh------------eeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence            999999999888889999999999999999988            66666777777779999999999999999999999


Q ss_pred             CCCeEEccCccccccCccccccccCCcEEEccCCccccccCc---cccCCCCCCEEeCCCCcccccCcccccCCCCCCeE
Q 048668          346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPP---SLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFL  422 (725)
Q Consensus       346 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  422 (725)
                      .|++|+|++|+++..-..+|..+++|+.|||++|.|+..+..   .|.+|++|+.|+|.+|+|..+.-.+|.++.+|+.|
T Consensus       342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L  421 (873)
T KOG4194|consen  342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL  421 (873)
T ss_pred             HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence            999999999999988899999999999999999999977654   57889999999999999998888899999999999


Q ss_pred             EcccccCeeecCCCCccCCCCCcCccCCccccCCC
Q 048668          423 NLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       423 ~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                      ||.+|.+...-|..---..+.++.+..-..+|+..
T Consensus       422 dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq  456 (873)
T KOG4194|consen  422 DLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ  456 (873)
T ss_pred             cCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence            99999999887765212255666665555677754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=9.1e-44  Score=346.61  Aligned_cols=416  Identities=29%  Similarity=0.449  Sum_probs=319.5

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +.|++++.+..++.|+.++|++. ++|+.+..+..|..|+.+.|.+. ..|+.++.+-.|+.|+..+|+++ ..|..+.+
T Consensus        82 ~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~  158 (565)
T KOG0472|consen   82 QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN  158 (565)
T ss_pred             hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHH
Confidence            56777777777777777777776 67777777777777777777776 56666677777777777777776 56667777


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCee
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL  163 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L  163 (725)
                      +.+|..|++.+|+++ .+|.+... |+.|++|+..+|.++.+ |..++++.+|+.|||.+|+|..++  .|.++..|++|
T Consensus       159 ~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~tl-P~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~El  233 (565)
T KOG0472|consen  159 LSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLETL-PPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKEL  233 (565)
T ss_pred             HHHHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhhcC-ChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHH
Confidence            777777777777777 66665543 78888888888887744 566788888888888888887655  68888888888


Q ss_pred             ecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEE
Q 048668          164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA  243 (725)
Q Consensus       164 ~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~  243 (725)
                      +++.|.|..+++      +...+++++.+|||.+|+++ +.|+.++-+. ++.+|++++|.|+ ..|..++++ .|+.|.
T Consensus       234 h~g~N~i~~lpa------e~~~~L~~l~vLDLRdNklk-e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~  303 (565)
T KOG0472|consen  234 HVGENQIEMLPA------EHLKHLNSLLVLDLRDNKLK-EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLA  303 (565)
T ss_pred             HhcccHHHhhHH------HHhcccccceeeeccccccc-cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehh
Confidence            888888877665      44557888888888888888 7888888777 7888888888888 567778888 888888


Q ss_pred             ecccccCCCCChhhcC-----------------------------------------CCCccEEeccCcccccCCCCCCc
Q 048668          244 VEVNQLHGTIPDVIGE-----------------------------------------LKNLQLLGLYKNFLQGSIPSGLG  282 (725)
Q Consensus       244 L~~N~l~~~~~~~~~~-----------------------------------------l~~L~~L~L~~N~l~~~~~~~~~  282 (725)
                      +.+|.+..+..+.+.+                                         +.+.+.|++++-+++ .+|+...
T Consensus       304 leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVf  382 (565)
T KOG0472|consen  304 LEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVF  382 (565)
T ss_pred             hcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHH
Confidence            8888776432222211                                         123344555555544 3333322


Q ss_pred             CCCC---CCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccc
Q 048668          283 NLTK---LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSG  359 (725)
Q Consensus       283 ~l~~---L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  359 (725)
                      ...+   ...+++++|++.            ++|.++..+..+...+++++|.+. -+|..+..+++|..|+|++|.+. 
T Consensus       383 ea~~~~~Vt~VnfskNqL~------------elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-  448 (565)
T KOG0472|consen  383 EAAKSEIVTSVNFSKNQLC------------ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-  448 (565)
T ss_pred             HHhhhcceEEEecccchHh------------hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-
Confidence            2222   455566666554            788888888777777888888887 67888999999999999999987 


Q ss_pred             cCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCcc
Q 048668          360 MIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVF  439 (725)
Q Consensus       360 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  439 (725)
                      .+|..++.+..|+.||+|.|++. ..|.....+..|+.+-.++|++....|..+.++.+|..|||.+|.+...||..+..
T Consensus       449 ~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lgnm  527 (565)
T KOG0472|consen  449 DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNM  527 (565)
T ss_pred             hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccc
Confidence            78889999999999999999998 78888888888999999999999888888999999999999999999999999999


Q ss_pred             CCCCCcCccCCccc
Q 048668          440 SNKSKIPLQGNVRL  453 (725)
Q Consensus       440 ~~~~~~~~~~n~~~  453 (725)
                      .+++.+.++|||..
T Consensus       528 tnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  528 TNLRHLELDGNPFR  541 (565)
T ss_pred             cceeEEEecCCccC
Confidence            99999999999764

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=318.80  Aligned_cols=172  Identities=31%  Similarity=0.564  Sum_probs=153.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ...+|...+.||+|+||+||+|+++.++..||||.+.++  .....+-...|+.+|+.++|||||++++++...+     
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-----   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-----   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----
Confidence            456888889999999999999999999999999999876  3445677889999999999999999999977665     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC------Cc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD------MV  681 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~------~~  681 (725)
                      +.|+|||||.||||.+|++.++      .+++..+..++.|++.|+++||++   +||||||||+|||++..      -.
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence            8999999999999999999876      689999999999999999999999   99999999999999875      46


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+|||+||.+....         ...+.||+|.|||||+++
T Consensus       154 LKIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             EEecccchhhhCCchh---------HHHHhhCCccccCHHHHH
Confidence            8999999999886442         233589999999999974

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-36  Score=310.18  Aligned_cols=189  Identities=45%  Similarity=0.745  Sum_probs=162.3

Q ss_pred             CCCccCHHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeE
Q 048668          518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITI  597 (725)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  597 (725)
                      ....+++.++..++++|...+.||+|+||.||+|... ++..||||++........++|.+|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4556889999999999999999999999999999987 448999998865443214669999999999999999999999


Q ss_pred             eecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       598 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                      |.+.+    +..++|+|||++|+|.++++.....    .++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|
T Consensus       140 C~e~~----~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  140 CLEGG----EHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             EecCC----ceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            98765    1489999999999999999976532    689999999999999999999999989999999999999999


Q ss_pred             CCCceEEccccccccccc-CCCCCCCCCCcccccc-cCCccccCCCccc
Q 048668          678 HDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSSIGI-KGTVGYVAPGKFF  724 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~-~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~  724 (725)
                      .++++||+|||+|+.... ..   .      .... .||.+|+|||++.
T Consensus       212 ~~~~aKlsDFGLa~~~~~~~~---~------~~~~~~gt~gY~~PEy~~  251 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEGDT---S------VSTTVMGTFGYLAPEYAS  251 (361)
T ss_pred             CCCCEEccCccCcccCCcccc---c------eeeecCCCCccCChhhhc
Confidence            999999999999975532 11   0      0112 6999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-36  Score=294.19  Aligned_cols=172  Identities=30%  Similarity=0.434  Sum_probs=147.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-------chHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-------GAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      ..+.|...+.+|+|+||.|-+|..+.+|+.||||++.....       .......+|+++|++++|||||++++++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34567888999999999999999999999999999975421       11234579999999999999999999976655


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---  679 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~---  679 (725)
                           ..|+||||++||+|.+++-...      .+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   
T Consensus       250 -----s~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  250 -----SSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             -----ceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence                 7899999999999999998776      467777789999999999999999   99999999999999766   


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ..+||+|||+|+.....         ..+.+.||||.|.|||++-
T Consensus       316 ~llKItDFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~  351 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLA  351 (475)
T ss_pred             eEEEecccchhhccccc---------eehhhhcCCccccChhhee
Confidence            78999999999986432         3344689999999999863

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.2e-38  Score=325.85  Aligned_cols=373  Identities=25%  Similarity=0.361  Sum_probs=326.4

Q ss_pred             cCcccCcEEecCCCccCc-cCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668           10 GSLFKLQALALAGNYLTG-KLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +-++-++-.|+++|.++| ..|.....|++++-|.|.+.+|. .+|+.++.+.+|++|.+++|++. .+-..+..|+.|+
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            345567889999999994 68999999999999999999997 89999999999999999999997 5667899999999


Q ss_pred             eeeccCCCCCC-CCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCC
Q 048668           89 YFYLTSNRFSG-SLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ  167 (725)
Q Consensus        89 ~L~L~~N~l~~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~  167 (725)
                      .+++.+|.+.. -+|.++| .|..|++|+|++|+++ ..|..+....++-.|+||+|+|..|+...|-+++.|-+||||+
T Consensus        82 sv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~  159 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN  159 (1255)
T ss_pred             HHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence            99999999863 4788887 7999999999999998 4588899999999999999999999999999999999999999


Q ss_pred             ccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEeccc
Q 048668          168 NNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN  247 (725)
Q Consensus       168 N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N  247 (725)
                      |.+..++++       .+.+..|++|+|++|.+..      +++.                   .+..|++|+.|.+++.
T Consensus       160 NrLe~LPPQ-------~RRL~~LqtL~Ls~NPL~h------fQLr-------------------QLPsmtsL~vLhms~T  207 (1255)
T KOG0444|consen  160 NRLEMLPPQ-------IRRLSMLQTLKLSNNPLNH------FQLR-------------------QLPSMTSLSVLHMSNT  207 (1255)
T ss_pred             chhhhcCHH-------HHHHhhhhhhhcCCChhhH------HHHh-------------------cCccchhhhhhhcccc
Confidence            999887763       6778889999999997752      1121                   2335778889999887


Q ss_pred             ccC-CCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccccccccccee
Q 048668          248 QLH-GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYL  326 (725)
Q Consensus       248 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L  326 (725)
                      +-+ .-+|..+.++.+|..+|||.|.+. .+|+.+.++++|+.|+|++|.|+            ++......+..+ +.|
T Consensus       208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it------------eL~~~~~~W~~l-EtL  273 (1255)
T KOG0444|consen  208 QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT------------ELNMTEGEWENL-ETL  273 (1255)
T ss_pred             cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee------------eeeccHHHHhhh-hhh
Confidence            764 347888999999999999999998 89999999999999999999888            555566666666 889


Q ss_pred             cccCCccCCCcchhhhcCCCCCeEEccCcccc-ccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcc
Q 048668          327 DLSNNLLNGSLPQQVGNLKNLIILDISSNQFS-GMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF  405 (725)
Q Consensus       327 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  405 (725)
                      ++|+|+++ .+|+.+..++.|+.|++.+|+++ .-+|..++.+.+|+++..++|.+. ..|..+..|..|+.|.|++|++
T Consensus       274 NlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL  351 (1255)
T KOG0444|consen  274 NLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL  351 (1255)
T ss_pred             ccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence            99999999 78999999999999999999986 357888999999999999999998 8999999999999999999999


Q ss_pred             cccCcccccCCCCCCeEEcccccCeeecCC
Q 048668          406 SGQFPKFLENLSFLEFLNLSYNHLEGEVPT  435 (725)
Q Consensus       406 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  435 (725)
                      - .+|+++.-|+.|+.|||+.|+=---||.
T Consensus       352 i-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  352 I-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             e-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            7 7999999999999999999976545554

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=8e-40  Score=319.10  Aligned_cols=397  Identities=29%  Similarity=0.407  Sum_probs=341.6

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      .++|++++++.++..|+++.|.+. ..|+.++.+-.|..|+..+|++. ..|+.+.++.+|..|++.+|+++...|.-+.
T Consensus       104 s~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~  181 (565)
T KOG0472|consen  104 SELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA  181 (565)
T ss_pred             hhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH
Confidence            468999999999999999999998 88999999999999999999998 8889999999999999999999965555554


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCe
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWR  162 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~  162 (725)
                       ++.|+.||+.+|-++ .+|.++ .+|.+|..|+|.+|+|..+ | .|.++..|.+|+++.|+|.-++.....++.++..
T Consensus       182 -m~~L~~ld~~~N~L~-tlP~~l-g~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~v  256 (565)
T KOG0472|consen  182 -MKRLKHLDCNSNLLE-TLPPEL-GGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLV  256 (565)
T ss_pred             -HHHHHhcccchhhhh-cCChhh-cchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHHHhccccccee
Confidence             999999999999998 999886 7899999999999999866 4 7999999999999999999888888889999999


Q ss_pred             eecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceecc-------------
Q 048668          163 LNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTI-------------  229 (725)
Q Consensus       163 L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~-------------  229 (725)
                      |||+.|+++.++.       .++-+.+|++||+|+|.|+ .+|..++++  .++.|-+.||.+...-             
T Consensus       257 LDLRdNklke~Pd-------e~clLrsL~rLDlSNN~is-~Lp~sLgnl--hL~~L~leGNPlrTiRr~ii~~gT~~vLK  326 (565)
T KOG0472|consen  257 LDLRDNKLKEVPD-------EICLLRSLERLDLSNNDIS-SLPYSLGNL--HLKFLALEGNPLRTIRREIISKGTQEVLK  326 (565)
T ss_pred             eeccccccccCch-------HHHHhhhhhhhcccCCccc-cCCcccccc--eeeehhhcCCchHHHHHHHHcccHHHHHH
Confidence            9999999997654       4678899999999999999 788889988  7889999999876310             


Q ss_pred             -------------------------C---cccccccCCceEEecccccCCCCChhhcCCC--CccEEeccCcccccCCCC
Q 048668          230 -------------------------P---LGIRNLVNLIALAVEVNQLHGTIPDVIGELK--NLQLLGLYKNFLQGSIPS  279 (725)
Q Consensus       230 -------------------------~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~  279 (725)
                                               +   .....+.+.+.|+++.-+++.++.+.|....  -.+..+++.|++. .+|.
T Consensus       327 yLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk  405 (565)
T KOG0472|consen  327 YLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPK  405 (565)
T ss_pred             HHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhh
Confidence                                     0   0112345678899999999976666665544  2789999999998 6787


Q ss_pred             CCcCCCCCC-EEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCcccc
Q 048668          280 GLGNLTKLA-KLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS  358 (725)
Q Consensus       280 ~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  358 (725)
                      .+..+..+. .+.+++|.++            .+|..+.++..+ ..|+|++|.+. .+|..++.+..|+.||+|.|++.
T Consensus       406 ~L~~lkelvT~l~lsnn~is------------fv~~~l~~l~kL-t~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr  471 (565)
T KOG0472|consen  406 RLVELKELVTDLVLSNNKIS------------FVPLELSQLQKL-TFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR  471 (565)
T ss_pred             hhHHHHHHHHHHHhhcCccc------------cchHHHHhhhcc-eeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence            777666554 4566777555            677777787777 88999999998 68899999999999999999998


Q ss_pred             ccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecC
Q 048668          359 GMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       359 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  434 (725)
                       ..|..+..+..++.+-.++|++..+.|..+.+|.+|..|||.+|.+. .+|..++++++|++|++++|+|. .|+
T Consensus       472 -~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr  544 (565)
T KOG0472|consen  472 -MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPR  544 (565)
T ss_pred             -cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCH
Confidence             88888877777888888889999777777999999999999999998 78889999999999999999998 444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=288.43  Aligned_cols=172  Identities=30%  Similarity=0.442  Sum_probs=152.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..++||+|+||+||.++.+++++.+|+|+++++.   ..+.+....|..+|.+++||+||+++..     |++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            568999999999999999999999999999999997653   3456788999999999999999999876     66667


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|+||+.||+|...|++.+      .+++..+.-++.+|+.||.|||+.   +|||||+||+|||+|.+|.++|+||
T Consensus        99 kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence            9999999999999999998766      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....        ...+.++|||+.|||||+++
T Consensus       170 gL~k~~~~~--------~~~t~tfcGT~eYmAPEil~  198 (357)
T KOG0598|consen  170 GLCKEDLKD--------GDATRTFCGTPEYMAPEILL  198 (357)
T ss_pred             ccchhcccC--------CCccccccCCccccChHHHh
Confidence            999864332        12233489999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=285.82  Aligned_cols=169  Identities=27%  Similarity=0.426  Sum_probs=148.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +.+..+.||+|..|+||+|+++.+++.+|+|++... +....+++.+|++++++++||+||++||+|....    ...++
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceEEe
Confidence            445568899999999999999999999999999654 3445689999999999999999999999987654    14899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++|+|.++++..+      .++|....+|+.+|++||.|||+ +   +||||||||+|||+...|.|||||||.+
T Consensus       156 ~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             ehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccccc
Confidence            999999999999998764      58999999999999999999996 5   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+...          ...+++||..|||||.+.
T Consensus       227 ~~lvnS----------~a~tfvGT~~YMsPERi~  250 (364)
T KOG0581|consen  227 GILVNS----------IANTFVGTSAYMSPERIS  250 (364)
T ss_pred             HHhhhh----------hcccccccccccChhhhc
Confidence            876433          122478999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-36  Score=280.89  Aligned_cols=180  Identities=27%  Similarity=0.421  Sum_probs=151.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..+|++.++||+|+||.||++.+..+|+.||.|.++..  +....+....|+.+|++++|||||+++++-...   ....
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cchh
Confidence            34678889999999999999999999999999999744  344567889999999999999999999843222   2234


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCceEEcc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      .++|||||++|||.+.++..+..  ...+++..+|+++.|++.||.++|+. .++  |+||||||.||+++.+|.||++|
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence            89999999999999999865432  33689999999999999999999995 235  99999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++++...        ...+.+.+|||+||+||.+.
T Consensus       172 fGL~r~l~s~--------~tfA~S~VGTPyYMSPE~i~  201 (375)
T KOG0591|consen  172 FGLGRFLSSK--------TTFAHSLVGTPYYMSPERIH  201 (375)
T ss_pred             chhHhHhcch--------hHHHHhhcCCCcccCHHHHh
Confidence            9999987543        22344589999999999874

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=8.1e-37  Score=312.59  Aligned_cols=370  Identities=24%  Similarity=0.347  Sum_probs=284.2

Q ss_pred             CCCCcEEEccCCcCC-ccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccE
Q 048668           36 LSALQVIHIKGNSLG-GKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKE  114 (725)
Q Consensus        36 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~  114 (725)
                      ++-.+-.|+++|.++ +..|.....+++++.|-|...++. .+|..++.+.+|+.|.+++|++. ++..+ +..++.|+.
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGE-Ls~Lp~LRs   82 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGE-LSDLPRLRS   82 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhh-hccchhhHH
Confidence            444555677777776 455666666777777777666665 56666777777777777777665 44433 256666666


Q ss_pred             EEccCceee-eeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEE
Q 048668          115 LGIGANNFF-GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL  193 (725)
Q Consensus       115 L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L  193 (725)
                      +.+.+|++. +-+|..+..+..|+.||||+|+++..+ ..+...+++-.|+||+|+|..++.      ..|.+++.|-+|
T Consensus        83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP-~~LE~AKn~iVLNLS~N~IetIPn------~lfinLtDLLfL  155 (1255)
T KOG0444|consen   83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVP-TNLEYAKNSIVLNLSYNNIETIPN------SLFINLTDLLFL  155 (1255)
T ss_pred             HhhhccccccCCCCchhcccccceeeecchhhhhhcc-hhhhhhcCcEEEEcccCccccCCc------hHHHhhHhHhhh
Confidence            666666664 223444556666666677777666443 345555566666666666655544      345556666666


Q ss_pred             ECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCccc
Q 048668          194 SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFL  273 (725)
Q Consensus       194 ~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  273 (725)
                      |||+|++.                          ..|+.++.+..|++|.|++|.+....-..+..++.|++|.+++.+=
T Consensus       156 DLS~NrLe--------------------------~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR  209 (1255)
T KOG0444|consen  156 DLSNNRLE--------------------------MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR  209 (1255)
T ss_pred             ccccchhh--------------------------hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence            66666655                          5566677888999999999998765555667788899999998753


Q ss_pred             c-cCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEc
Q 048668          274 Q-GSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDI  352 (725)
Q Consensus       274 ~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  352 (725)
                      + ..+|..+..+.+|..+|++.|.+.            .+|+.+..+.++ +.|+||+|.|+ .+....+.+.+|++|+|
T Consensus       210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp------------~vPecly~l~~L-rrLNLS~N~it-eL~~~~~~W~~lEtLNl  275 (1255)
T KOG0444|consen  210 TLDNIPTSLDDLHNLRDVDLSENNLP------------IVPECLYKLRNL-RRLNLSGNKIT-ELNMTEGEWENLETLNL  275 (1255)
T ss_pred             hhhcCCCchhhhhhhhhccccccCCC------------cchHHHhhhhhh-heeccCcCcee-eeeccHHHHhhhhhhcc
Confidence            3 468889999999999999999887            899999999998 88999999999 45566778889999999


Q ss_pred             cCccccccCccccccccCCcEEEccCCcccc-ccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCee
Q 048668          353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHG-IIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEG  431 (725)
Q Consensus       353 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  431 (725)
                      |+|+++ ..|.+++.+++|+.|++.+|+++- =+|+.++.+..|+.+..++|.+. ..|+.+..+.+|++|.|+.|++-.
T Consensus       276 SrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT  353 (1255)
T KOG0444|consen  276 SRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT  353 (1255)
T ss_pred             ccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceee
Confidence            999999 999999999999999999999762 37889999999999999999998 899999999999999999999998


Q ss_pred             ecCCCCccCCCCCcCccCCccccCCC
Q 048668          432 EVPTKGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       432 ~~p~~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                      .|.....++.+..+++..||.+.-.|
T Consensus       354 LPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  354 LPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             chhhhhhcCCcceeeccCCcCccCCC
Confidence            88877888999999999998876544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=272.77  Aligned_cols=170  Identities=25%  Similarity=0.372  Sum_probs=143.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.|+....+|+|+||+||+|+++.||+.||||++....  +...+-.++||++|++++|||+|.++++|....     ..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-----kl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-----KL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-----ee
Confidence            45777889999999999999999999999999986442  223455789999999999999999999966554     89


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++|+|||+. ++.+-++....     .++...+.++++|++.|+.|+|++   ++|||||||||||++.+|.+|+||||+
T Consensus        77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence            999999976 55555555432     689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccc-CCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSS-HHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.+.. +..++.         .+.|.+|.|||.+.
T Consensus       148 AR~L~~pgd~YTD---------YVATRWYRaPELLv  174 (396)
T KOG0593|consen  148 ARTLSAPGDNYTD---------YVATRWYRAPELLV  174 (396)
T ss_pred             hHhhcCCcchhhh---------hhhhhhccChhhhc
Confidence            998863 322222         57899999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-34  Score=293.07  Aligned_cols=171  Identities=26%  Similarity=0.429  Sum_probs=152.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..|...+.||+|+|+.||.+++..+|..||+|++.++   +....+...+||++.++++|||||+++++|.     +.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-----Ds~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-----DSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-----cCCc
Confidence            5799999999999999999999889999999999764   3445678899999999999999999999954     4459


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      +|+|.|+|+.++|.++++++.      .++|.++..+.+||+.||.|||++   +|+|||||..|++++++.++||+|||
T Consensus        93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            999999999999999998654      699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|..+....        +...+.||||.|+|||++.
T Consensus       164 LAt~le~~~--------Erk~TlCGTPNYIAPEVl~  191 (592)
T KOG0575|consen  164 LATQLEYDG--------ERKKTLCGTPNYIAPEVLN  191 (592)
T ss_pred             eeeeecCcc--------cccceecCCCcccChhHhc
Confidence            999875431        2334589999999999975

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-34  Score=285.68  Aligned_cols=174  Identities=30%  Similarity=0.441  Sum_probs=150.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.|+..+.||+|.||.||+|++..+|+.||+|+++.+.  .+......+||.+|++++||||+++.+......   ....
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~si  193 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGSI  193 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---CceE
Confidence            35677789999999999999999999999999998764  455677789999999999999999999977652   2368


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|+|||+. ||.-++....     ..+++.++..++.|++.||+|||+.   +|+|||||.+|||||.+|.+||+|||+
T Consensus       194 YlVFeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             EEEEecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence            999999976 9988887543     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.......       -+..+-|.+|.|||+++
T Consensus       265 Ar~y~~~~~~~-------~T~rVvTLWYRpPELLL  292 (560)
T KOG0600|consen  265 ARFYTPSGSAP-------YTSRVVTLWYRPPELLL  292 (560)
T ss_pred             eeeccCCCCcc-------cccceEEeeccChHHhc
Confidence            99886543221       22367899999999875

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=321.86  Aligned_cols=410  Identities=29%  Similarity=0.348  Sum_probs=299.5

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      .|++|+|++|.+. ..|..+..+.+|+.|.+++|-|. ..|.+..++.+|++|+|.+|++. ..|..+..+.+|++|++|
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS  122 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence            3677777777765 66666777777777777777776 55666667777777777777665 566677777777777777


Q ss_pred             CCCCCCCCChhhhcCCCC-------------------ccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCc
Q 048668           94 SNRFSGSLPFDIVVNLPN-------------------LKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDF  154 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~-------------------L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f  154 (725)
                      .|++. .+|.-+ ..+..                   ++.++|..|.+.+.++.....+..  .|||.+|.+.   .-+.
T Consensus       123 ~N~f~-~~Pl~i-~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dl  195 (1081)
T KOG0618|consen  123 FNHFG-PIPLVI-EVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDL  195 (1081)
T ss_pred             hhccC-CCchhH-HhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhh
Confidence            77765 555433 12233                   555566666665555555555544  5777777776   2345


Q ss_pred             ccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccc
Q 048668          155 SSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIR  234 (725)
Q Consensus       155 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~  234 (725)
                      ..+.+|+.|..+.|++....          ..-++|+.|+.++|.++...+   ...+.++.+++++.|+++ .+|.+++
T Consensus       196 s~~~~l~~l~c~rn~ls~l~----------~~g~~l~~L~a~~n~l~~~~~---~p~p~nl~~~dis~n~l~-~lp~wi~  261 (1081)
T KOG0618|consen  196 SNLANLEVLHCERNQLSELE----------ISGPSLTALYADHNPLTTLDV---HPVPLNLQYLDISHNNLS-NLPEWIG  261 (1081)
T ss_pred             hhccchhhhhhhhcccceEE----------ecCcchheeeeccCcceeecc---ccccccceeeecchhhhh-cchHHHH
Confidence            66677777777777776433          244778888888888773322   234457888888888888 4558888


Q ss_pred             cccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccc------------
Q 048668          235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI------------  302 (725)
Q Consensus       235 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------------  302 (725)
                      .+.+|+.+...+|++. ..|..+...++|+.|...+|.+. -+|....++.+|++|||..|.|.....            
T Consensus       262 ~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~  339 (1081)
T KOG0618|consen  262 ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNT  339 (1081)
T ss_pred             hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHH
Confidence            8888888888888885 56777777888888888888887 567777778888889888888774210            


Q ss_pred             --cccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCc
Q 048668          303 --ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNC  380 (725)
Q Consensus       303 --~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  380 (725)
                        .+.+ .....|..-......++.|++.+|.++...-+.+.+++.|+.|+|++|++...+...+.++..|+.|+||+|+
T Consensus       340 ln~s~n-~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNk  418 (1081)
T KOG0618|consen  340 LNVSSN-KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNK  418 (1081)
T ss_pred             Hhhhhc-cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccch
Confidence              0011 1113332222233344779999999998888889999999999999999986666788999999999999999


Q ss_pred             cccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeec-CCCCccCCCCCcCccCCccc
Q 048668          381 FHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEV-PTKGVFSNKSKIPLQGNVRL  453 (725)
Q Consensus       381 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~~~~~~~~~~~n~~~  453 (725)
                      |+ .+|..+..++.|+.|...+|++. ..| .+..++.|+.+|+|.|+|+... |....++.++.++++||.|+
T Consensus       419 L~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  419 LT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99 67899999999999999999998 677 8899999999999999997554 44445689999999999873

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.3e-33  Score=260.51  Aligned_cols=171  Identities=30%  Similarity=0.453  Sum_probs=149.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .+|...+.+|+|.||.||+|++..+|+.||||+++...  .+......+||+.|+.++|+||+.+++++.+.+     ..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence            46777899999999999999999999999999998653  333467889999999999999999999976655     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      .+|+|||+. ||+..+++...     .++..++..++.++++|++|||++   .|+|||+||.|+|++.+|.+||+|||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence            899999976 99999987653     688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.+.......        .+.+-|.+|.|||++|
T Consensus       148 Ar~f~~p~~~~--------~~~V~TRWYRAPELLf  174 (318)
T KOG0659|consen  148 ARFFGSPNRIQ--------THQVVTRWYRAPELLF  174 (318)
T ss_pred             hhccCCCCccc--------ccceeeeeccChHHhc
Confidence            99886543221        1236899999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=264.49  Aligned_cols=169  Identities=28%  Similarity=0.402  Sum_probs=150.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.+|.|+||+|..++.+.+|..+|+|++.+.+-   ...+...+|..+|+.+.||+++++++.|.+..     
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-----  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-----  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----
Confidence            3468888999999999999999999999999999976532   23456789999999999999999998865544     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||.|..++++.+      .+++..+..+|.||+.|++|||+.   +|++||+||||||+|.+|.+||.||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            8999999999999999999876      689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+...+.           +.+.||||.|+|||++.
T Consensus       189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~  214 (355)
T KOG0616|consen  189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQ  214 (355)
T ss_pred             cceEEecCc-----------EEEecCCccccChHHhh
Confidence            999976432           34589999999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=284.13  Aligned_cols=171  Identities=35%  Similarity=0.552  Sum_probs=141.9

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccc--hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ....+.+|+|+||+||+|.++.+ ..||||++......  ..++|.+|+.+|++++|||||+++|+|.....    ..++
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~i  117 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCI  117 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEE
Confidence            34456699999999999999633 23999999755322  25689999999999999999999999977641    4789


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEecCCCCCCeeecCCC-ceEEccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP-MVHGDLKPSNVLLDHDM-VAHVGDFGL  689 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivHrdlkp~Nill~~~~-~~kl~Dfgl  689 (725)
                      |||||++|+|.++++...    ...+++..+++|+.|||+|+.|||++   + ||||||||+|||++.++ ++||+|||+
T Consensus       118 VtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            999999999999998741    12699999999999999999999999   6 99999999999999998 999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++......        .......||+.|||||++-
T Consensus       191 sr~~~~~~--------~~~~~~~GT~~wMAPEv~~  217 (362)
T KOG0192|consen  191 SREKVISK--------TSMTSVAGTYRWMAPEVLR  217 (362)
T ss_pred             ceeecccc--------ccccCCCCCccccChhhhc
Confidence            98754321        1111256999999999873

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.98  E-value=9.4e-33  Score=264.18  Aligned_cols=176  Identities=25%  Similarity=0.408  Sum_probs=151.5

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ...++|+..+.|++|+||.||+|+++.+++.||+|+++++.  .+..-.-.+||.+|.+++|||||.+-++....+   .
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~  149 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---M  149 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---c
Confidence            34567888899999999999999999999999999998764  333445689999999999999999999877655   3


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      +..|+|||||+. ||...++....     .+...++..++.|+++|++|||++   .|+|||+||+|+|+.+.|.+||+|
T Consensus       150 d~iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaD  220 (419)
T KOG0663|consen  150 DKIYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIAD  220 (419)
T ss_pred             ceeeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecc
Confidence            468999999976 99999987753     688999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+||.+.....        ..+..+-|.+|.|||+++
T Consensus       221 FGLAR~ygsp~k--------~~T~lVVTLWYRaPELLL  250 (419)
T KOG0663|consen  221 FGLAREYGSPLK--------PYTPLVVTLWYRAPELLL  250 (419)
T ss_pred             cchhhhhcCCcc--------cCcceEEEeeecCHHHhc
Confidence            999998865422        122367899999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=278.70  Aligned_cols=182  Identities=28%  Similarity=0.439  Sum_probs=154.3

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDF  603 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  603 (725)
                      .+...+|..++.||+|+|++|++|+.+.++++||||++.++   ++...+...+|-++|.++ .||.|++++..|     
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence            34556899999999999999999999999999999999754   234456677899999999 799999999774     


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      ++....|+|+||+++|+|.++|++.+      .+++.....++.+|+.||+|||++   |||||||||||||+|.||++|
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence            44458999999999999999999886      689999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCC---CC--CCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTS---SK--TPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~---~~--~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.|||.|+.+.+......   ..  +.....+++||..|.+||++
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL  259 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL  259 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHh
Confidence            999999999865433211   11  11112568999999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=271.27  Aligned_cols=172  Identities=32%  Similarity=0.473  Sum_probs=142.6

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHc--CCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..+..++||+|+||.||+|+.  +++.||||++....   .+.|..|-++.+.  ++|+||++++++-...+-. ...+|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cccee
Confidence            345567899999999999998  56899999997553   3567777777665  5799999999885544322 34689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEecCCCCCCeeecCCCceEE
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH------CQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                      ||+||.+.|+|.+||+.+       ..+|....+|+..+++||+|||+.      ++|+|+|||||++|||+..|+++.|
T Consensus       285 LVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            999999999999999876       489999999999999999999974      4689999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+|..+....      ......+.+||.+|||||++
T Consensus       358 aDFGLAl~~~p~~------~~~d~~~qVGT~RYMAPEvL  390 (534)
T KOG3653|consen  358 ADFGLALRLEPGK------PQGDTHGQVGTRRYMAPEVL  390 (534)
T ss_pred             eccceeEEecCCC------CCcchhhhhhhhhhcCHHHH
Confidence            9999999886432      22233457899999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.3e-33  Score=269.60  Aligned_cols=168  Identities=26%  Similarity=0.438  Sum_probs=150.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +|++.+.+|+|.||+|-+|+....|+.||||.|+++   ++++.-.+.+||++|..++||||+++|++     |+..+..
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdKI  128 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDKI  128 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCceE
Confidence            577788999999999999999889999999999765   35566778999999999999999999998     4555689


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      .+||||..+|+|+||+.+++      .+++.++..+++||..|+.|+|.+   +++|||+|.+|||+|.++++||+|||+
T Consensus       129 vivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             EEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccch
Confidence            99999999999999999876      699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +-.+.+..         .-.++||+|-|++||++
T Consensus       200 SNly~~~k---------fLqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  200 SNLYADKK---------FLQTFCGSPLYASPEIV  224 (668)
T ss_pred             hhhhcccc---------HHHHhcCCcccCCcccc
Confidence            98775442         23358999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=3.5e-32  Score=276.38  Aligned_cols=169  Identities=34%  Similarity=0.503  Sum_probs=148.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|-+.+.||+|+||.||||+.+.+.+.||+|.+.+..+  .+.+.+.+|++++++++|||||.++++|     ++..+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            467788899999999999999999999999999976543  3467789999999999999999999884     455599


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|+||+.| +|..++.+..      .++|..+..|+.+++.||.|||+.   +|+|||+||.|||++..|.+|+||||+
T Consensus        77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence            999999977 9999998765      699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.+..+..-        -....|||.|||||++
T Consensus       147 Ar~m~~~t~v--------ltsikGtPlYmAPElv  172 (808)
T KOG0597|consen  147 ARAMSTNTSV--------LTSIKGTPLYMAPELV  172 (808)
T ss_pred             hhhcccCcee--------eeeccCcccccCHHHH
Confidence            9987654211        1235799999999975

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=274.77  Aligned_cols=173  Identities=29%  Similarity=0.420  Sum_probs=148.1

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchH-HHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF-RSFVAECEALRNIR-HRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|...+.+|.|.||.||+|+...++..||||.++.+-.... -.-+||+.-|++++ ||||+++.+++.+.+    .
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence            45678889999999999999999999999999999875532211 22368999999999 999999999876543    2


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||| ..+|++.++++..     .+++..+..|+.||++||+|+|.+   |+.|||+||||||+.....+||+||
T Consensus        84 ~L~fVfE~M-d~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   84 ILYFVFEFM-DCNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eEeeeHHhh-hhhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence            789999999 5699999998743     799999999999999999999999   9999999999999998889999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+||.+.....++.         .+-|.+|+|||+++
T Consensus       155 GLARev~SkpPYTe---------YVSTRWYRAPEvLL  182 (538)
T KOG0661|consen  155 GLAREVRSKPPYTE---------YVSTRWYRAPEVLL  182 (538)
T ss_pred             ccccccccCCCcch---------hhhcccccchHHhh
Confidence            99998755433322         57899999999976

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=277.33  Aligned_cols=174  Identities=27%  Similarity=0.404  Sum_probs=149.6

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc----cc-chHHHHHHHHHHHHcCC-CCcccceeeEeecCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK----QK-GAFRSFVAECEALRNIR-HRNLIKIITICSSTD  602 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  602 (725)
                      ...+.|...+.||+|+||+|+.|++..++..||+|++..+    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999999999999999987653    11 23456678999999999 999999999976655


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-Cc
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MV  681 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~  681 (725)
                           ..|+||||+.||+|.+++....      .+.+..+.+++.|++.|++|||++   +|+||||||+||++|.+ ++
T Consensus        94 -----~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   94 -----KIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             -----eEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence                 7999999999999999999854      588899999999999999999999   99999999999999999 99


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+|||++......        .....+.|||+.|+|||++.
T Consensus       160 ~Kl~DFG~s~~~~~~--------~~~l~t~cGsp~Y~aPEvl~  194 (370)
T KOG0583|consen  160 LKLSDFGLSAISPGE--------DGLLKTFCGSPAYAAPEVLS  194 (370)
T ss_pred             EEEeccccccccCCC--------CCcccCCCCCcccCCHHHhC
Confidence            999999999876311        11122478999999999974

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=2.7e-31  Score=270.42  Aligned_cols=150  Identities=25%  Similarity=0.402  Sum_probs=137.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..++||+|+||.||.|+-+.||..+|+|++++.   .....+....|-.+|...++|.||++|..     |++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence            567899999999999999999999999999999999865   34566788899999999999999999987     5556


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ++.||||||++|||+...|....      .+++..+..++.+.+.|++-+|..   |+|||||||+|+|||..|++|++|
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence            69999999999999999998776      699999999999999999999999   999999999999999999999999


Q ss_pred             ccccccc
Q 048668          687 FGLAKFL  693 (725)
Q Consensus       687 fgla~~~  693 (725)
                      ||++.-+
T Consensus       285 FGLs~gl  291 (550)
T KOG0605|consen  285 FGLSTGL  291 (550)
T ss_pred             ccccchh
Confidence            9999643

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=263.09  Aligned_cols=178  Identities=31%  Similarity=0.490  Sum_probs=149.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..+|...+.||+|+||.||.+.+..+|...|||.+...+....+.+.+|+.+|.+++|||||+++|......  . ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence            346778899999999999999998889999999997664333677899999999999999999999744333  1 2688


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Dfgl  689 (725)
                      +.|||+++|+|.+++...+.     .+++..+.++.+||++||+|||++   +||||||||+|||++. ++.+||+|||+
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999999987653     489999999999999999999999   9999999999999999 79999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+......     ..........||+.|||||++.
T Consensus       165 a~~~~~~~-----~~~~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  165 AKKLESKG-----TKSDSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             cccccccc-----ccccccccccCCccccCchhhc
Confidence            98765311     0111222367999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=274.27  Aligned_cols=170  Identities=26%  Similarity=0.413  Sum_probs=151.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ..|+.-..||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+     ..|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEE
Confidence            45777789999999999999999999999999999887777778899999999999999999998876554     8999


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||||+||+|.|.+...       .++|.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++.
T Consensus       348 VMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999999998754       489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+.....        ...+.+|||+|||||++-
T Consensus       418 qi~~~~~--------KR~TmVGTPYWMAPEVvt  442 (550)
T KOG0578|consen  418 QISEEQS--------KRSTMVGTPYWMAPEVVT  442 (550)
T ss_pred             ccccccC--------ccccccCCCCccchhhhh
Confidence            8755432        233478999999999863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=261.18  Aligned_cols=179  Identities=24%  Similarity=0.356  Sum_probs=155.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..++|+..++||.|..++||+|+...++..||||++..++- .....+.+|++.|+.++||||++++..|....     .
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----E   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----e
Confidence            45689999999999999999999999999999999987643 34688999999999999999999999877665     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||.||.+|++.++++.....    .++|..+..|.+++++||.|||.+   |.||||||+.|||++.+|.|||+|||
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence            99999999999999999976543    689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+..+.+...    +......+++||+.|||||+.+
T Consensus       172 vsa~l~~~G~----R~~~rf~tfvgtp~wmAPEvl~  203 (516)
T KOG0582|consen  172 VSASLFDSGD----RQVTRFNTFVGTPCWMAPEVLM  203 (516)
T ss_pred             eeeeecccCc----eeeEeeccccCcccccChHHhh
Confidence            8877655431    1112225678999999999954

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.9e-31  Score=260.24  Aligned_cols=174  Identities=29%  Similarity=0.453  Sum_probs=142.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      -.|+..+++|+|+||.||+|+...+++.||||++-.+.+..    -+|+++|++++|||||++..+|......+..+..+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35677899999999999999999999999999986554321    37999999999999999998887665333346678


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CceEEcccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLA  690 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~~kl~Dfgla  690 (725)
                      |||||+. +|+++++.....  ...++...+.-++.|+.+|++|||+.   +|+||||||.|+|+|.+ |.+||||||.|
T Consensus       100 VleymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            9999976 999999853111  12577788888999999999999998   99999999999999977 89999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+..+..         ..+...|.+|+|||.++
T Consensus       174 K~L~~~ep---------niSYicSRyYRaPELif  198 (364)
T KOG0658|consen  174 KVLVKGEP---------NISYICSRYYRAPELIF  198 (364)
T ss_pred             eeeccCCC---------ceeEEEeccccCHHHHc
Confidence            98865422         22356799999999986

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-33  Score=271.77  Aligned_cols=404  Identities=21%  Similarity=0.291  Sum_probs=284.3

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccC-CcccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE-NKFYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~   82 (725)
                      +||.+++.  ..++++|..|+|+.+.|.+|+.+++|++||||+|+|+.+-|++|.++++|.+|-+.+ |+|+.+..++|.
T Consensus        60 eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            68888888  788999999999976667899999999999999999999999999999988888766 889988888999


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccc------------ccC
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK------------GKV  150 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~------------~~~  150 (725)
                      +|.+|+.|.+.-|++. .++.++|..|++|..|.+..|.+..+....|..+..++++.+..|++.            ...
T Consensus       138 gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~  216 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN  216 (498)
T ss_pred             hHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence            9999999999999998 888899999999999999999998777778999999999999998832            223


Q ss_pred             ccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCCh-hhhhccccceeEEecCccceecc
Q 048668          151 SIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPH-SIANLSSTMIVFLIGGNQISGTI  229 (725)
Q Consensus       151 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~l~~L~l~~n~i~~~~  229 (725)
                      +..++..+......+.++++..+.+..     +...+..+..=-.+.+..-++.|. .|..++ +|+.+++++|+|++.-
T Consensus       217 ~ietsgarc~~p~rl~~~Ri~q~~a~k-----f~c~~esl~s~~~~~d~~d~~cP~~cf~~L~-~L~~lnlsnN~i~~i~  290 (498)
T KOG4237|consen  217 PIETSGARCVSPYRLYYKRINQEDARK-----FLCSLESLPSRLSSEDFPDSICPAKCFKKLP-NLRKLNLSNNKITRIE  290 (498)
T ss_pred             hhhcccceecchHHHHHHHhcccchhh-----hhhhHHhHHHhhccccCcCCcChHHHHhhcc-cceEeccCCCccchhh
Confidence            344555555666666666665544431     122222222111222223334453 455666 8888888888888888


Q ss_pred             CcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCC--------cc
Q 048668          230 PLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG--------NF  301 (725)
Q Consensus       230 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--------~~  301 (725)
                      +.+|.++..+++|.|..|+|..+...+|.++..|++|+|.+|+|+...|.+|..+.+|.+|.|-.|.+-=        .|
T Consensus       291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W  370 (498)
T KOG4237|consen  291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW  370 (498)
T ss_pred             hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH
Confidence            8899999999999999999988888899999999999999999999999999999999999998886541        11


Q ss_pred             ccccccccccccccccccccccceecccCCccCC---Ccchhhh---------cCCCCC-eEEccCccccccCccccccc
Q 048668          302 IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG---SLPQQVG---------NLKNLI-ILDISSNQFSGMIPVTLSTC  368 (725)
Q Consensus       302 ~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~---~~~~~~~---------~l~~L~-~L~Ls~N~l~~~~~~~~~~l  368 (725)
                      ... +...|..|-+   .+..++.+.++.+.+..   ..|+..+         ..+-+. ...-|++.++ .+|..+.  
T Consensus       371 lr~-~~~~~~~~Cq---~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--  443 (498)
T KOG4237|consen  371 LRK-KSVVGNPRCQ---SPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--  443 (498)
T ss_pred             Hhh-CCCCCCCCCC---CCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--
Confidence            111 1122222211   11111233444433220   0111111         111222 1223333333 4443332  


Q ss_pred             cCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccc
Q 048668          369 VSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN  427 (725)
Q Consensus       369 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  427 (725)
                      ..-.+|++.+|.++ .+|..  .+++| .+|+|+|+++..-...|.++.+|.+|-|++|
T Consensus       444 ~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  444 VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            24567888888888 45555  56677 8888888888777777888888888888776

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9e-31  Score=261.67  Aligned_cols=181  Identities=26%  Similarity=0.383  Sum_probs=146.7

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------------chHHHHHHHHHHHHcCCCCcccc
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------------GAFRSFVAECEALRNIRHRNLIK  593 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~  593 (725)
                      .+..++|+..+.||+|.||+|-+|++..+++.||||++.+...              ...+...+||.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            4456789999999999999999999999999999999964321              11357889999999999999999


Q ss_pred             eeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 048668          594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN  673 (725)
Q Consensus       594 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N  673 (725)
                      ++++..+..   .+..|+|+|||..|.+...-....      .+++.+++++++++..||+|||.+   +||||||||+|
T Consensus       173 LiEvLDDP~---s~~~YlVley~s~G~v~w~p~d~~------els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN  240 (576)
T KOG0585|consen  173 LIEVLDDPE---SDKLYLVLEYCSKGEVKWCPPDKP------ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN  240 (576)
T ss_pred             EEEeecCcc---cCceEEEEEeccCCccccCCCCcc------cccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence            999876554   347899999999888765332211      288999999999999999999999   99999999999


Q ss_pred             eeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          674 VLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       674 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|++.+|+|||+|||.+......... .  ........+|||.|||||..
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~-~--~d~~L~~tvGTPAF~APE~c  287 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDE-G--SDDQLSRTVGTPAFFAPELC  287 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCcc-c--cHHHHhhcCCCccccchHhh
Confidence            99999999999999999866433111 1  11112235799999999975

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=2.8e-30  Score=252.88  Aligned_cols=180  Identities=24%  Similarity=0.422  Sum_probs=148.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCc-ccceeeEeecCC-CCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN-LIKIITICSSTD-FKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~  606 (725)
                      ...|+..+.||+|+||+||+|+.+.+|+.||+|+++...  ++......+|+.++++++|+| |+.+++++.... +...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345666778999999999999999999999999998764  345667789999999999999 999999976654 2333


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++|+||++ -+|.++++......  ..++...+..+++|+++||+|||++   +|+||||||+||+++.+|.+||+|
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence            46889999995 49999998765321  2467788999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+...-...        .-+..++|.+|.|||+++
T Consensus       164 FGlAra~~ip~~--------~yt~evvTlWYRaPEvLl  193 (323)
T KOG0594|consen  164 FGLARAFSIPMR--------TYTPEVVTLWYRAPEVLL  193 (323)
T ss_pred             cchHHHhcCCcc--------cccccEEEeeccCHHHhc
Confidence            999986542211        122357999999999865

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-31  Score=269.78  Aligned_cols=180  Identities=30%  Similarity=0.534  Sum_probs=150.9

Q ss_pred             CHHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeec
Q 048668          523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSS  600 (725)
Q Consensus       523 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  600 (725)
                      +.++++...+++.....||+|+||+||+|+|-++   ||||++..+..  ...+.|..|+.++++-+|.||+-+.|||..
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3356666667778889999999999999999643   99999987643  356889999999999999999999999887


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM  680 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~  680 (725)
                      +.      ..||+-+|+|-+|+.+++..+.     .+...+...||.||++|+.|||.+   +|||||||..||++.+++
T Consensus       460 p~------~AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  460 PP------LAIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             Cc------eeeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCC
Confidence            65      3899999999999999987653     688889999999999999999999   999999999999999999


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcccC
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM  725 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  725 (725)
                      .|||+|||+|..-..........      ...|..-|||||++.|
T Consensus       526 kVkIgDFGLatvk~~w~g~~q~~------qp~gsilwmAPEvIRm  564 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSGEQQLE------QPHGSLLWMAPEVIRM  564 (678)
T ss_pred             cEEEecccceeeeeeeccccccC------CCccchhhhcHHHHhh
Confidence            99999999996543322111111      1347888999999876

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-31  Score=269.00  Aligned_cols=166  Identities=30%  Similarity=0.437  Sum_probs=145.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      -|...+.||.|+||.||-|++..+...||||.+....+   ..++++++|+..|++++|||++.+-|||....     ..
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hH
Confidence            35667889999999999999999999999999976543   34678999999999999999999999987665     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||| -|+..|.+.-+..     ++.+..+..|+.+.+.||+|||++   +.||||||+.|||+++.|.||++|||.
T Consensus       102 WLVMEYC-lGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence            9999999 4588888875542     688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |....+.            .+++|||+|||||+++
T Consensus       173 Asi~~PA------------nsFvGTPywMAPEVIL  195 (948)
T KOG0577|consen  173 ASIMAPA------------NSFVGTPYWMAPEVIL  195 (948)
T ss_pred             hhhcCch------------hcccCCccccchhHhe
Confidence            9765432            2478999999999986

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.96  E-value=1e-32  Score=295.97  Aligned_cols=410  Identities=26%  Similarity=0.301  Sum_probs=320.1

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      -||..+..-..++.|+++.|-+-...-+++...-+|++||+++|++. ..|..+..+.+|+.|+++.|.|+ ..|....+
T Consensus        12 ~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~   89 (1081)
T KOG0618|consen   12 LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN   89 (1081)
T ss_pred             ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh
Confidence            47777777667999999999877333345555666999999999997 89999999999999999999998 67889999


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCc-cccccCcc----------
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN-QFKGKVSI----------  152 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N-~i~~~~~~----------  152 (725)
                      +.+|++|+|.+|++. .+|.++ ..+.+|+.|+++.|++. ..|..+..++.++.+++++| ++...+-.          
T Consensus        90 ~~~l~~lnL~~n~l~-~lP~~~-~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n  166 (1081)
T KOG0618|consen   90 MRNLQYLNLKNNRLQ-SLPASI-SELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLN  166 (1081)
T ss_pred             hhcchhheeccchhh-cCchhH-HhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhh
Confidence            999999999999998 899775 78999999999999997 55777788888888888888 22211110          


Q ss_pred             -----CcccccccC-eeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccce
Q 048668          153 -----DFSSLKILW-RLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS  226 (725)
Q Consensus       153 -----~f~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~  226 (725)
                           .......++ .|+|++|.+..+.         +.++++|+.|....|+++...     -...+++.|+.+.|.+.
T Consensus       167 ~l~~~~~~~i~~l~~~ldLr~N~~~~~d---------ls~~~~l~~l~c~rn~ls~l~-----~~g~~l~~L~a~~n~l~  232 (1081)
T KOG0618|consen  167 VLGGSFLIDIYNLTHQLDLRYNEMEVLD---------LSNLANLEVLHCERNQLSELE-----ISGPSLTALYADHNPLT  232 (1081)
T ss_pred             hcccchhcchhhhheeeecccchhhhhh---------hhhccchhhhhhhhcccceEE-----ecCcchheeeeccCcce
Confidence                 001112233 3777777776322         456778888888888776321     11126778888888887


Q ss_pred             eccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccc
Q 048668          227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQN  306 (725)
Q Consensus       227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  306 (725)
                      ...+..  .-.+|++++++.|++++.+ +|+..+.+|+.++..+|++. .+|..+..+++|+.|++..|.++        
T Consensus       233 ~~~~~p--~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~--------  300 (1081)
T KOG0618|consen  233 TLDVHP--VPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE--------  300 (1081)
T ss_pred             eecccc--ccccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh--------
Confidence            433322  2357899999999999654 99999999999999999996 78888888999999999999877        


Q ss_pred             cccccccccccccccccceecccCCccCCCcchhhh-------------------------cCCCCCeEEccCccccccC
Q 048668          307 KLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG-------------------------NLKNLIILDISSNQFSGMI  361 (725)
Q Consensus       307 ~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~-------------------------~l~~L~~L~Ls~N~l~~~~  361 (725)
                          .+|+.......+ +.|+|..|+|...++..+.                         .++.|+.|++.+|.++...
T Consensus       301 ----yip~~le~~~sL-~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c  375 (1081)
T KOG0618|consen  301 ----YIPPFLEGLKSL-RTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSC  375 (1081)
T ss_pred             ----hCCCccccccee-eeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccc
Confidence                666666555555 7777777777643332221                         2345688889999998887


Q ss_pred             ccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCC
Q 048668          362 PVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN  441 (725)
Q Consensus       362 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  441 (725)
                      -+.+.+.+.|+.|+|++|+|...+...+.++..|+.|+||+|+++ .+|..+..++.|++|...+|++...| ....++.
T Consensus       376 ~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~q  453 (1081)
T KOG0618|consen  376 FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQ  453 (1081)
T ss_pred             hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCc
Confidence            788888999999999999999777777889999999999999998 68899999999999999999998766 6677888


Q ss_pred             CCCcCccCCc
Q 048668          442 KSKIPLQGNV  451 (725)
Q Consensus       442 ~~~~~~~~n~  451 (725)
                      ++.++++.|.
T Consensus       454 L~~lDlS~N~  463 (1081)
T KOG0618|consen  454 LKVLDLSCNN  463 (1081)
T ss_pred             ceEEecccch
Confidence            8889988874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=270.00  Aligned_cols=172  Identities=26%  Similarity=0.392  Sum_probs=148.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|...+++|+|+||+|++|..+.+++.+|||+++++   ...+.+..+.|.+|++... ||.+++++.+     |++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence            456899999999999999999999999999999999865   3456788889999988876 9999999987     666


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      .++.|.||||+.|||+..+.+..       .+++..+..++..|+.||+|||++   +|||||||.+|||+|.+|.+||+
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence            67999999999999955554432       589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+++...-        .+..+.++||||.|||||++.
T Consensus       511 DFGlcKe~m~--------~g~~TsTfCGTpey~aPEil~  541 (694)
T KOG0694|consen  511 DFGLCKEGMG--------QGDRTSTFCGTPEFLAPEVLT  541 (694)
T ss_pred             ccccccccCC--------CCCccccccCChhhcChhhhc
Confidence            9999985421        123445699999999999863

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1e-30  Score=239.46  Aligned_cols=172  Identities=25%  Similarity=0.390  Sum_probs=150.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +.++|++++.+|+|.||.||.|+.+.++-.||+|++.+.+   .+..+++.+|+++-+.++||||+++|+++.+..    
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~----   95 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK----   95 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence            3467899999999999999999999999999999997653   344578899999999999999999999976655    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+++||.+.|+++..+++...    ..+++.....++.|+|.|+.|+|..   +|+||||||+|+|++..+..||+|
T Consensus        96 -riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   96 -RIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             -eeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence             89999999999999999986543    2588888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.+.....          ....+.|||.-|.|||+.
T Consensus       168 fGwsV~~p~----------~kR~tlcgt~dyl~pEmv  194 (281)
T KOG0580|consen  168 FGWSVHAPS----------NKRKTLCGTLDYLPPEMV  194 (281)
T ss_pred             CCceeecCC----------CCceeeecccccCCHhhc
Confidence            999864321          123357999999999975

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.7e-30  Score=268.15  Aligned_cols=171  Identities=24%  Similarity=0.363  Sum_probs=150.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+-|+.++.+|+|+-|.|..|++..||+.+|||++..+.   ......+.+||.+|+-+.||||+++|++|....     
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-----   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-----   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-----
Confidence            346788899999999999999999999999999997652   223457889999999999999999999976655     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ++|+|.||++||.|.+++-.++      ++++.++.+++.||+.|+.|||..   +|+|||+||+|+|+|..+++||+||
T Consensus        86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence            8999999999999999998876      689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|..-.++.         .-.+.||+|+|+|||+++
T Consensus       157 GMAsLe~~gk---------lLeTSCGSPHYA~PEIV~  184 (786)
T KOG0588|consen  157 GMASLEVPGK---------LLETSCGSPHYAAPEIVS  184 (786)
T ss_pred             ceeecccCCc---------cccccCCCcccCCchhhc
Confidence            9997643332         223469999999999985

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=251.26  Aligned_cols=179  Identities=26%  Similarity=0.370  Sum_probs=153.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEee--ccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ....|...+.||+|+||.|+.|.++.+|+.||||++.  .+.....++..+|+++++.++|+||+.+.+.+..+..+...
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3445666789999999999999999999999999997  44555668889999999999999999999998875555566


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|+|+| +-||.+.++...      .+++..+..+++|+++||+|+|+.   +|+|||+||.|++++.++.+||+||
T Consensus       100 DvYiV~elM-etDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence            789999999 559999998764      488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....      ......+..+.|.+|.|||+.+
T Consensus       170 GLAR~~~~~------~~~~~mTeYVaTRWYRAPElll  200 (359)
T KOG0660|consen  170 GLARYLDKF------FEDGFMTEYVATRWYRAPELLL  200 (359)
T ss_pred             cceeecccc------CcccchhcceeeeeecCHHHHh
Confidence            999987543      1112234578999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-30  Score=261.85  Aligned_cols=173  Identities=31%  Similarity=0.537  Sum_probs=143.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ...++..+.||+|.||.||.|++. ....||+|.++... ...++|.+|+++|++++|++||+++|+|....     ..|
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piy  277 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIY  277 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceE
Confidence            334556688999999999999996 34479999997542 33478999999999999999999999998765     689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ||||||+.|+|.+||+....    ..+...+.+.++.|||+|++||+++   ++|||||.++|||++++..+||+|||+|
T Consensus       278 IVtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             EEEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence            99999999999999997332    2678889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |...+..+....       +..-...|.|||.+.
T Consensus       351 r~~~d~~Y~~~~-------~~kfPIkWtAPEa~~  377 (468)
T KOG0197|consen  351 RLIGDDEYTASE-------GGKFPIKWTAPEALN  377 (468)
T ss_pred             cccCCCceeecC-------CCCCCceecCHHHHh
Confidence            965544332211       122456799999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=250.18  Aligned_cols=174  Identities=29%  Similarity=0.448  Sum_probs=141.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHc--CCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +.+..+.||+|.||.||+|+|+  |+.||||++...++   +.+.+|.++.+.  ++|+||+.+++.-.... .+..+.|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLw  285 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLW  285 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEE
Confidence            3455688999999999999996  67799999975544   456677777765  59999999998744333 3345789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeecCCCceEEc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      +|+||.+.|+|+|||...       .++....++++..+|.||+|||..     .+|.|.|||||+.|||+..++.+.|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            999999999999999874       588889999999999999999974     47899999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+|-.......    .-.......+||.+|||||++
T Consensus       359 DLGLAv~h~~~t~----~idi~~N~rVGTKRYMAPEvL  392 (513)
T KOG2052|consen  359 DLGLAVRHDSDTD----TIDIPPNPRVGTKRYMAPEVL  392 (513)
T ss_pred             eceeeEEecccCC----cccCCCCCccceeeccChHHh
Confidence            9999976543311    112223347899999999985

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-31  Score=243.07  Aligned_cols=172  Identities=26%  Similarity=0.431  Sum_probs=146.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..+.|+..+.||+|.|+.||++.++.+|+.+|+|++...  .....+++.+|+++.+.++||||+++.+.+...     .
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----S   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----c
Confidence            345778889999999999999999999999999999754  234678899999999999999999999875544     4


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHV  684 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl  684 (725)
                      +.|+|+|+|.|++|..-|-++.      ..++..+-..+.||++||.|+|.+   +|||||+||+|+++..   ..-+|+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             eeEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence            8899999999999976554432      578888999999999999999999   9999999999999963   346999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|..+.++         ..+.+++|||+|||||+.-
T Consensus       155 ~~FGvAi~l~~g---------~~~~G~~GtP~fmaPEvvr  185 (355)
T KOG0033|consen  155 ADFGLAIEVNDG---------EAWHGFAGTPGYLSPEVLK  185 (355)
T ss_pred             cccceEEEeCCc---------cccccccCCCcccCHHHhh
Confidence            999999887532         3345688999999999864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=257.54  Aligned_cols=171  Identities=27%  Similarity=0.426  Sum_probs=150.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..|+..+.||+|+||.||+|.+..+++.||+|++..+. +.+.+.+.+|+.++.+++++||.++|+.|..+.     ..|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence            35777799999999999999999999999999998764 455688899999999999999999999987766     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ++||||.||++.+.++...      .+.+..+..|+++++.|+.|+|++   +.+|||||+.||++..+|.+|++|||+|
T Consensus        88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence            9999999999999998654      347777888999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ..+....        ....+++|||.|||||++.
T Consensus       159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~  184 (467)
T KOG0201|consen  159 GQLTNTV--------KRRKTFVGTPFWMAPEVIK  184 (467)
T ss_pred             eeeechh--------hccccccccccccchhhhc
Confidence            8764332        2224588999999999975

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.96  E-value=6.8e-30  Score=237.59  Aligned_cols=171  Identities=31%  Similarity=0.468  Sum_probs=147.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cc---hHHHHHHHHHHHHcCC-CCcccceeeEeec
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KG---AFRSFVAECEALRNIR-HRNLIKIITICSS  600 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  600 (725)
                      .-..|...+.+|.|..++|.+|.++.+|..+|+|++....     +.   ..++-.+|+.+|+++. ||+|+++.++|..
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456778899999999999999999999999999997432     11   1345678999999984 9999999999665


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM  680 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~  680 (725)
                      ..     ..++|+|.|+.|.|.||+...-      .+++....+|++|+..|+.|+|..   +|||||+||+|||+|++.
T Consensus        95 ~s-----F~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~  160 (411)
T KOG0599|consen   95 DA-----FVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNM  160 (411)
T ss_pred             cc-----hhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecccc
Confidence            55     7899999999999999998654      689999999999999999999999   999999999999999999


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++||+|||+|+.+.++.         .-...||||+|.|||.+
T Consensus       161 ~i~isDFGFa~~l~~Ge---------kLrelCGTPgYLAPEti  194 (411)
T KOG0599|consen  161 NIKISDFGFACQLEPGE---------KLRELCGTPGYLAPETI  194 (411)
T ss_pred             ceEEeccceeeccCCch---------hHHHhcCCCcccChhhe
Confidence            99999999999875542         22347999999999986

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-31  Score=246.52  Aligned_cols=167  Identities=26%  Similarity=0.428  Sum_probs=147.7

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      |.+...+|+|+||.||+|.++.+|..||||.+..+  .+.+++.+|+.++++++.|++|++||.|....     ..|+||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEeeh
Confidence            55667899999999999999999999999998755  45688999999999999999999999876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      |||..|+..++++.+..     .+++.++..+.+..++||+|||..   .-+|||||+.|||+..+|.+|++|||.|-.+
T Consensus       108 EYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             hhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999987653     699999999999999999999998   8899999999999999999999999999776


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+-        .....++.|||.|||||++
T Consensus       180 TDT--------MAKRNTVIGTPFWMAPEVI  201 (502)
T KOG0574|consen  180 TDT--------MAKRNTVIGTPFWMAPEVI  201 (502)
T ss_pred             hhh--------HHhhCccccCcccccHHHH
Confidence            543        2333457899999999986

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=1.6e-28  Score=261.71  Aligned_cols=149  Identities=24%  Similarity=0.354  Sum_probs=132.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||+||+|++..+++.||+|+++...   ......+.+|++++.+++||+|+++++++....     .
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----N   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----e
Confidence            36888999999999999999999899999999997542   233456788999999999999999999876544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++||+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            899999999999999997654      588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccc
Q 048668          689 LAKFLS  694 (725)
Q Consensus       689 la~~~~  694 (725)
                      +|+.+.
T Consensus       147 la~~~~  152 (363)
T cd05628         147 LCTGLK  152 (363)
T ss_pred             Cccccc
Confidence            997653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-28  Score=262.48  Aligned_cols=149  Identities=25%  Similarity=0.376  Sum_probs=133.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++....     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----Y   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----e
Confidence            36888999999999999999999999999999997532   233456789999999999999999999876554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            999999999999999997654      588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccc
Q 048668          689 LAKFLS  694 (725)
Q Consensus       689 la~~~~  694 (725)
                      +++.+.
T Consensus       147 ~~~~~~  152 (364)
T cd05599         147 LCTGLK  152 (364)
T ss_pred             cceecc
Confidence            997653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=6.3e-29  Score=267.50  Aligned_cols=178  Identities=30%  Similarity=0.528  Sum_probs=148.2

Q ss_pred             CCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +....+.||+|+||+||+|+..     ++...||||.++..... ..++|.+|+++++.++|||||+++|+|..++    
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~----  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD----  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC----
Confidence            3445688999999999999863     34568999999876554 6789999999999999999999999999877    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccc--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVE--------VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH  678 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~  678 (725)
                       .+|+|+|||..|||.+||..+.+...        +..++..+.+.||.|||.|++||-++   .+|||||..+|+||.+
T Consensus       563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence             89999999999999999986543322        22488899999999999999999999   9999999999999999


Q ss_pred             CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       679 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +..|||+|||++|.+-...++....      ...-..+|||||-||
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~------~t~lPIRWMppEsIl  678 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRG------NTLLPIRWMPPESIL  678 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccC------CceeeeecCCHHHhh
Confidence            9999999999998765444333211      122467899999876

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=3e-28  Score=255.19  Aligned_cols=165  Identities=28%  Similarity=0.340  Sum_probs=140.5

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +.||+|+||.||+|++..+++.||+|+++...   .....++.+|++++++++||||+++++++....     ..|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEe
Confidence            46899999999999999999999999997542   234467889999999999999999999876554     8899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999997654      578999999999999999999999   99999999999999999999999999997532


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ...        ......+||+.|||||++.
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~  168 (323)
T cd05571         147 SDG--------ATMKTFCGTPEYLAPEVLE  168 (323)
T ss_pred             cCC--------CcccceecCccccChhhhc
Confidence            211        1112357999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-30  Score=262.73  Aligned_cols=171  Identities=25%  Similarity=0.417  Sum_probs=149.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      .|.+...+|.|+||+||+|+.+.++...|.|+|..+.....+.|+-||+||+.++||+||++++.|....     ..|+.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence            4556677999999999999999898888999999888888899999999999999999999998876554     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      .|||+||....++-+-..     .+.+.++..+++|++.||.|||++   +|||||+|+.|||+.-+|.++++|||.+..
T Consensus       108 iEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             EeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence            999999999888766543     689999999999999999999999   999999999999999999999999998764


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ....-++.|||+|||||+.|
T Consensus       180 n~~t--------~qkRDsFIGTPYWMAPEVvm  203 (1187)
T KOG0579|consen  180 NKST--------RQKRDSFIGTPYWMAPEVVM  203 (1187)
T ss_pred             chhH--------HhhhccccCCcccccchhee
Confidence            3221        12223478999999999976

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=2.7e-28  Score=261.53  Aligned_cols=147  Identities=23%  Similarity=0.354  Sum_probs=131.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .|+..+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++...+     ..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----NL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----EE
Confidence            5788899999999999999999999999999997542   234567889999999999999999999976554     89


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            99999999999999997654      578889999999999999999998   999999999999999999999999999


Q ss_pred             cccc
Q 048668          690 AKFL  693 (725)
Q Consensus       690 a~~~  693 (725)
                      ++.+
T Consensus       148 ~~~~  151 (381)
T cd05626         148 CTGF  151 (381)
T ss_pred             Cccc
Confidence            8643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=4.3e-29  Score=255.55  Aligned_cols=174  Identities=26%  Similarity=0.440  Sum_probs=152.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|...+++|+|+||.++.++++.+++.||+|.+....  ....+...+|+.++++++|||||.+.+.|...+    ..
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~   78 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QL   78 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ce
Confidence            457888999999999999999999999999999998664  334457889999999999999999999876554    34


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .+|||+||+||++.+.+.+...    .-+++..+..|+.|++.|+.|||+.   +|+|||||+.||++..++.|||+|||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence            8999999999999999987652    2689999999999999999999988   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.+.+...        ...+.+||+.||.||++
T Consensus       152 laK~l~~~~~--------~a~tvvGTp~YmcPEil  178 (426)
T KOG0589|consen  152 LAKILNPEDS--------LASTVVGTPYYMCPEIL  178 (426)
T ss_pred             hhhhcCCchh--------hhheecCCCcccCHHHh
Confidence            9998865431        22347899999999985

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.6e-28  Score=254.60  Aligned_cols=173  Identities=27%  Similarity=0.423  Sum_probs=151.5

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .....|.+.+.||+|.|++|..|++..++..||||.+++..-  ...+.+.+|+++|..++|||||+++.+.....    
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~----  128 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA----  128 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc----
Confidence            345678999999999999999999999999999999986542  23456889999999999999999999966554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+.+|.+++|+.++.      ...+..+..++.|+.+|++|||++   .|||||||++||+++.+.++||+|
T Consensus       129 -~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  129 -TLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             -eeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeec
Confidence             8999999999999999999876      355678888999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||++.++.....         ..++||++.|+|||+++
T Consensus       199 fgfS~~~~~~~~---------lqt~cgsppyAaPEl~~  227 (596)
T KOG0586|consen  199 FGFSTFFDYGLM---------LQTFCGSPPYAAPELFN  227 (596)
T ss_pred             cccceeeccccc---------ccccCCCCCccChHhhc
Confidence            999988764322         22479999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=2.2e-28  Score=256.85  Aligned_cols=169  Identities=24%  Similarity=0.373  Sum_probs=146.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-----   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----
Confidence            357888999999999999999999999999999997542   233467889999999999999999999876554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence            7899999999999999997654      578888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.....           ....+||+.|||||++.
T Consensus       163 g~~~~~~~~-----------~~~~~gt~~y~aPE~~~  188 (329)
T PTZ00263        163 GFAKKVPDR-----------TFTLCGTPEYLAPEVIQ  188 (329)
T ss_pred             cCceEcCCC-----------cceecCChhhcCHHHHc
Confidence            999865322           11256999999999863

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=2.4e-28  Score=259.98  Aligned_cols=172  Identities=20%  Similarity=0.334  Sum_probs=145.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+++++.++||||+++++++....    
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~----  116 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK----  116 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----
Confidence            346789999999999999999999999999999999643   2223456789999999999999999999876544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++|+|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       117 -~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         117 -YLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             -EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEe
Confidence             899999999999999999643       378888999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.......       ....+.+||+.|||||++
T Consensus       186 FG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         186 FGTCMKMDETGM-------VRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             cccceecccCCc-------eecccCCCCcccCCHHHH
Confidence            999986543211       011235799999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-29  Score=268.71  Aligned_cols=186  Identities=24%  Similarity=0.321  Sum_probs=150.6

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceee-EeecCCCCC-ccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIIT-ICSSTDFKG-VDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~~~~~-~~~~  609 (725)
                      ++++.+.|.+|||+.||.|++...|..||+|++-..++...+...+||++|++|+ |+|||.+++ ......-.. ..++
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            4567789999999999999998887999999998777778889999999999998 999999999 333332222 3467


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      +|.||||+||.|-|++..+...    .+++.++++|+.++++|+++||.. +|+|||||||.||||++.++..||||||.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            8999999999999999876533    599999999999999999999987 78899999999999999999999999998


Q ss_pred             ccccccCC-CCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHH-LDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.-..... ........+..+....|+.|+|||++
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI  227 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI  227 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence            86432211 00011111223345589999999986

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.1e-28  Score=259.99  Aligned_cols=148  Identities=24%  Similarity=0.355  Sum_probs=131.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++....     +
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----Y   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----e
Confidence            36888999999999999999999999999999986532   233467889999999999999999999876554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997653      578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 048668          689 LAKFL  693 (725)
Q Consensus       689 la~~~  693 (725)
                      +|+.+
T Consensus       147 la~~~  151 (377)
T cd05629         147 LSTGF  151 (377)
T ss_pred             ccccc
Confidence            99743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-28  Score=252.57  Aligned_cols=167  Identities=29%  Similarity=0.432  Sum_probs=144.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++...     +.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----Ce
Confidence            36888999999999999999999899999999997542   22345688999999999999999999875544     47


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            899999999999999997654      578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++.....           ....+||+.|+|||++
T Consensus       147 ~~~~~~~~-----------~~~~~gt~~y~aPE~~  170 (291)
T cd05612         147 FAKKLRDR-----------TWTLCGTPEYLAPEVI  170 (291)
T ss_pred             cchhccCC-----------cccccCChhhcCHHHH
Confidence            99865321           1124699999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=259.27  Aligned_cols=176  Identities=30%  Similarity=0.458  Sum_probs=145.4

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~  610 (725)
                      .|...+.+|+|+||.||+|+++.+|+.||||.++... ....+...+|++++++++|||||++++.-.... ........
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            4556688999999999999999999999999997542 344567889999999999999999998732221 11134568


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CC--ceEEcc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DM--VAHVGD  686 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~--~~--~~kl~D  686 (725)
                      +|||||.||||+..+.+-..   .+++++.+.+.+..+++.||.|||++   +||||||||.||++..  +|  -.||+|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence            99999999999999986432   45799999999999999999999999   9999999999999853  34  479999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.||.+.++.         ...+.+||+.|.|||++
T Consensus       168 fG~Arel~d~s---------~~~S~vGT~~YLhPel~  195 (732)
T KOG4250|consen  168 FGAARELDDNS---------LFTSLVGTEEYLHPELY  195 (732)
T ss_pred             ccccccCCCCC---------eeeeecCchhhcChHHH
Confidence            99999876653         23347899999999986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=233.25  Aligned_cols=181  Identities=24%  Similarity=0.397  Sum_probs=149.6

Q ss_pred             CHHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecC
Q 048668          523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSST  601 (725)
Q Consensus       523 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  601 (725)
                      .+++..+-++     +.+|+|+|+.|..|+...+|.+||||++.+.......+..+|++++.+++ |+||+++++|+.+ 
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-  147 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-  147 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence            3566665554     57999999999999999999999999998775556678899999999997 9999999999544 


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-  680 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-  680 (725)
                          ....|+|||-|.||.|.++|+++.      .+.+.++.++..+|+.||.|||.+   ||.|||+||+|||..... 
T Consensus       148 ----d~~FYLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~  214 (463)
T KOG0607|consen  148 ----DTRFYLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNK  214 (463)
T ss_pred             ----cceEEEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCC
Confidence                458999999999999999998775      689999999999999999999999   999999999999997654 


Q ss_pred             --ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 --VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 --~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                        -+|||||.++.-+.....-....++ .-.+.+|+..|||||+.
T Consensus       215 vsPvKiCDfDLgSg~k~~~~~spastP-~L~tPvGSAEfMAPEVV  258 (463)
T KOG0607|consen  215 VSPVKICDFDLGSGIKLNNDCSPASTP-ELLTPVGSAEFMAPEVV  258 (463)
T ss_pred             cCceeeeccccccccccCCCCCCCCCc-cccCcccchhhcchhHH
Confidence              4899999988655433222222222 23357899999999985

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=6.9e-28  Score=252.35  Aligned_cols=165  Identities=28%  Similarity=0.357  Sum_probs=139.9

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +.||+|+||.||+|++..+++.||+|++...   .......+.+|++++++++||||+++++++....     ..|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEe
Confidence            4689999999999999999999999999754   2334567788999999999999999999876544     7899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999999887554      578999999999999999999999   99999999999999999999999999987532


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ...        ......+||+.|||||++.
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~  168 (323)
T cd05595         147 SDG--------ATMKTFCGTPEYLAPEVLE  168 (323)
T ss_pred             CCC--------CccccccCCcCcCCccccc
Confidence            211        1112356999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=5e-28  Score=259.85  Aligned_cols=146  Identities=22%  Similarity=0.340  Sum_probs=130.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     ..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----EE
Confidence            5888899999999999999999999999999997542   234467889999999999999999999976554     89


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|||||++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence            99999999999999997653      478888999999999999999998   999999999999999999999999999


Q ss_pred             ccc
Q 048668          690 AKF  692 (725)
Q Consensus       690 a~~  692 (725)
                      |+.
T Consensus       148 a~~  150 (382)
T cd05625         148 CTG  150 (382)
T ss_pred             Ccc
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=8.3e-28  Score=252.19  Aligned_cols=165  Identities=27%  Similarity=0.362  Sum_probs=140.3

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +.||+|+||.||+|++..+++.||+|++...   .......+.+|+++++.++||||+++++++...+     ..|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEe
Confidence            4689999999999999999999999999754   2334567889999999999999999998866544     8899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999999987554      588999999999999999999999   99999999999999999999999999987532


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ...        ......+||+.|||||++.
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~  168 (328)
T cd05593         147 TDA--------ATMKTFCGTPEYLAPEVLE  168 (328)
T ss_pred             Ccc--------cccccccCCcCccChhhhc
Confidence            211        1112357999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.5e-28  Score=254.61  Aligned_cols=168  Identities=25%  Similarity=0.394  Sum_probs=146.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++....     .
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----Y   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----E
Confidence            36888999999999999999999899999999997542   234567889999999999999999999876554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            899999999999999997654      578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.....           ....+||+.|+|||++.
T Consensus       147 ~a~~~~~~-----------~~~~~gt~~y~aPE~~~  171 (333)
T cd05600         147 LSKGIVTY-----------ANSVVGSPDYMAPEVLR  171 (333)
T ss_pred             CCcccccc-----------cCCcccCccccChhHhc
Confidence            99765321           11256999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=4.1e-28  Score=255.20  Aligned_cols=169  Identities=25%  Similarity=0.403  Sum_probs=144.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc-eEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE-MIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|+++.++ ..||+|++....   ....+.+.+|+++++.++||||+++++++....    
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----  104 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES----  104 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----
Confidence            347888999999999999999876554 689999986432   234567889999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       105 -~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        105 -YLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             -EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence             7899999999999999997654      588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+.....           ....+||+.|||||++.
T Consensus       175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~  201 (340)
T PTZ00426        175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILL  201 (340)
T ss_pred             CCCCeecCCC-----------cceecCChhhcCHHHHh
Confidence            9999865321           11257999999999863

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=5.7e-28  Score=258.93  Aligned_cols=147  Identities=24%  Similarity=0.324  Sum_probs=130.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ......+.+|++++++++||||+++++.+...+     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----N   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----E
Confidence            36889999999999999999999999999999996432   233466889999999999999999999876544     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999997654      578888899999999999999998   99999999999999999999999999


Q ss_pred             cccc
Q 048668          689 LAKF  692 (725)
Q Consensus       689 la~~  692 (725)
                      +|..
T Consensus       147 ~a~~  150 (376)
T cd05598         147 LCTG  150 (376)
T ss_pred             CCcc
Confidence            9853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.6e-28  Score=250.96  Aligned_cols=163  Identities=26%  Similarity=0.375  Sum_probs=139.1

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||.||+|++..+++.||+|++...   .......+.+|++++++++||||+++++++....     ..|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence            69999999999999999999999999753   2334567889999999999999999998876544     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            9999999997654      578999999999999999999998   9999999999999999999999999999754222


Q ss_pred             CCCCCCCCCcccccccCCccccCCCccc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ..        .....+||+.|||||++.
T Consensus       147 ~~--------~~~~~~gt~~y~aPE~~~  166 (312)
T cd05585         147 DD--------KTNTFCGTPEYLAPELLL  166 (312)
T ss_pred             CC--------ccccccCCcccCCHHHHc
Confidence            11        112357999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=5.3e-28  Score=238.62  Aligned_cols=150  Identities=27%  Similarity=0.362  Sum_probs=132.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|.-|+||.|+.+.++..+|+|++.+..   .....+...|-+||+.++||.++.+|+.+     ++.++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccce
Confidence            35667789999999999999999999999999997542   33456778899999999999999999884     44458


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||+||+|....+++...    .+++..+..++.+|+-||+|||-.   |||+|||||||||+.++|.+.++||.
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence            99999999999999998877643    699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 048668          689 LAKFL  693 (725)
Q Consensus       689 la~~~  693 (725)
                      ++...
T Consensus       225 LS~~~  229 (459)
T KOG0610|consen  225 LSLRC  229 (459)
T ss_pred             ccccC
Confidence            87643

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=6.3e-28  Score=251.52  Aligned_cols=171  Identities=30%  Similarity=0.392  Sum_probs=148.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  605 (725)
                      ....|+..+.||+|.||.||+|+.+.+|+.+|+|++.+...   ...+.+.+|+++|+++. |||||++++++....   
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~---  109 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD---  109 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC---
Confidence            34578888999999999999999999999999999976543   23468899999999998 999999999966554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC----Cc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD----MV  681 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~----~~  681 (725)
                        ..++|||+|.||+|.+.+...       .+++..+..++.|++.|++|||+.   +|+|||+||+|+|+...    +.
T Consensus       110 --~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  110 --SVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             --eEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence              899999999999999999765       288999999999999999999998   99999999999999643    47


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|++|||+|......         ......+||++|+|||+..
T Consensus       178 ik~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~  211 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLG  211 (382)
T ss_pred             EEEeeCCCceEccCC---------ceEeeecCCccccCchhhc
Confidence            999999999887541         2233478999999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=1.1e-27  Score=246.45  Aligned_cols=170  Identities=25%  Similarity=0.357  Sum_probs=143.2

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      |+..+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|++++++++|++|+++++++...+     ..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----ALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eEE
Confidence            677789999999999999999899999999987542   223356789999999999999999998876544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        77 lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999988865432    1588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......         .....||+.|||||++.
T Consensus       150 ~~~~~~~~---------~~~~~g~~~y~aPE~~~  174 (285)
T cd05631         150 VQIPEGET---------VRGRVGTVGYMAPEVIN  174 (285)
T ss_pred             EEcCCCCe---------ecCCCCCCCccCHhhhc
Confidence            76532211         11246999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=1.6e-27  Score=250.08  Aligned_cols=164  Identities=27%  Similarity=0.348  Sum_probs=138.8

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +.||+|+||.||+|++..+++.||+|++...   ......++.+|+++++.++||||+++++++....     ..|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEe
Confidence            4689999999999999999999999999753   2234467788999999999999999998866554     7899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      |+++|+|.+++....      .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999887554      58899999999999999999997 6   8999999999999999999999999998754


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....        .....+||+.|||||++
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~  168 (325)
T cd05594         147 IKDGA--------TMKTFCGTPEYLAPEVL  168 (325)
T ss_pred             CCCCc--------ccccccCCcccCCHHHH
Confidence            22111        11225699999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=8.7e-28  Score=255.93  Aligned_cols=176  Identities=20%  Similarity=0.324  Sum_probs=148.1

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      +.....++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++....
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445678999999999999999999999999999999996432   233456789999999999999999999876544


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                           ..|+||||+++|+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       117 -----~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         117 -----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             -----EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCE
Confidence                 789999999999999998653       378888899999999999999999   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|||+|+........       .....+||+.|||||++
T Consensus       182 kL~DfG~a~~~~~~~~~-------~~~~~~gt~~y~aPE~l  215 (371)
T cd05622         182 KLADFGTCMKMNKEGMV-------RCDTAVGTPDYISPEVL  215 (371)
T ss_pred             EEEeCCceeEcCcCCcc-------cccCcccCccccCHHHH
Confidence            99999999876432111       11235799999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=251.41  Aligned_cols=173  Identities=26%  Similarity=0.331  Sum_probs=145.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.++..++|+||+++++++....     .
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----N   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----e
Confidence            3688899999999999999999999999999999742   2234466889999999999999999999876554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++.+...     .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            8999999999999999975432     578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+........       .....+||+.|||||++.
T Consensus       148 ~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~  176 (331)
T cd05597         148 SCLRLLADGTV-------QSNVAVGTPDYISPEILQ  176 (331)
T ss_pred             ceeecCCCCCc-------cccceeccccccCHHHHh
Confidence            99765432111       111246999999999863

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=7.8e-29  Score=251.87  Aligned_cols=156  Identities=28%  Similarity=0.523  Sum_probs=136.9

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      .+.+|+|+.|.||+|+.  .++.||||+++.-+       ..+|+-|++++||||+.+.|+|....     .+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc-----eeEEeeecc
Confidence            46899999999999998  46789999885332       36788999999999999999998776     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      +.|-|+..|+...      .+.....+.|..+||.|+.|||.+   .|||||||+-||||..+..|||+|||-++...+.
T Consensus       195 a~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  195 AQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             ccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            9999999999776      577788899999999999999999   9999999999999999999999999999876443


Q ss_pred             CCCCCCCCCcccccccCCccccCCCccc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .         +...++||..|||||++-
T Consensus       266 S---------TkMSFaGTVaWMAPEvIr  284 (904)
T KOG4721|consen  266 S---------TKMSFAGTVAWMAPEVIR  284 (904)
T ss_pred             h---------hhhhhhhhHhhhCHHHhh
Confidence            1         233489999999999973

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=1.2e-27  Score=255.00  Aligned_cols=172  Identities=20%  Similarity=0.340  Sum_probs=145.1

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++....    
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~----  116 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK----  116 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            3457889999999999999999999999999999996432   233456789999999999999999998866544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||++||+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       117 -~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         117 -YLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             -EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence             789999999999999998653       377888899999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++........       .....+||+.|||||++
T Consensus       186 fG~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~  215 (370)
T cd05596         186 FGTCMKMDANGMV-------RCDTAVGTPDYISPEVL  215 (370)
T ss_pred             ccceeeccCCCcc-------cCCCCCCCcCeECHHHh
Confidence            9999765332110       11235699999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=244.57  Aligned_cols=173  Identities=25%  Similarity=0.360  Sum_probs=149.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+.|..-++||+|+||.||-|+.+.||+.||+|.+.++   .+......+.|-++++++..+.||.+-.+     |++.+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence            34677889999999999999999999999999988644   23344567899999999999999988665     55666


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||..|.||||.-+|...+.    ..+++..+..++.+|+.||++||..   +||+||+||+|||+|+.|+++|+|.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence            99999999999999999887764    2699999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|..+.+...         ..+.+||.+|||||++.
T Consensus       332 GLAvei~~g~~---------~~~rvGT~GYMAPEvl~  359 (591)
T KOG0986|consen  332 GLAVEIPEGKP---------IRGRVGTVGYMAPEVLQ  359 (591)
T ss_pred             ceEEecCCCCc---------cccccCcccccCHHHHc
Confidence            99988765422         22358999999999874

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=1.4e-27  Score=254.19  Aligned_cols=149  Identities=26%  Similarity=0.362  Sum_probs=132.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++...   ......+.+|++++.+++||+|+++++++....     .
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----N   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence            36888899999999999999999999999999997432   234567888999999999999999999865544     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++||+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997654      588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccc
Q 048668          689 LAKFLS  694 (725)
Q Consensus       689 la~~~~  694 (725)
                      +|+.+.
T Consensus       147 ~~~~~~  152 (360)
T cd05627         147 LCTGLK  152 (360)
T ss_pred             CCcccc
Confidence            987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-28  Score=252.43  Aligned_cols=177  Identities=27%  Similarity=0.476  Sum_probs=143.6

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCc----eEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEee
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICS  599 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  599 (725)
                      |+..-++-...+.||+|+||.||+|+.+..+    ..||||....+   ......+|++|+++|++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3333444455689999999999999876432    23899988742   2445688999999999999999999999987


Q ss_pred             cCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       600 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                      ...     ..++|||+|.||+|.+|+++...     .++..+...++.+.|.||+|||++   +++||||.++|+|++.+
T Consensus       232 ~~~-----Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~  298 (474)
T KOG0194|consen  232 LEE-----PLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK  298 (474)
T ss_pred             CCC-----ccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC
Confidence            766     78999999999999999998753     489999999999999999999999   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+||+|||+++.........        ....-...|+|||.+-
T Consensus       299 ~~vKISDFGLs~~~~~~~~~~--------~~~klPirWLAPEtl~  335 (474)
T KOG0194|consen  299 GVVKISDFGLSRAGSQYVMKK--------FLKKLPIRWLAPETLN  335 (474)
T ss_pred             CeEEeCccccccCCcceeecc--------ccccCcceecChhhhc
Confidence            999999999987643111100        0112456899999763

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-28  Score=212.70  Aligned_cols=170  Identities=26%  Similarity=0.457  Sum_probs=144.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|...+.||+|.||+||+|+.+.+++.||+|.++.+  +++......+||-+++.++|.|||++++.....     ....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence            466678999999999999999999999999999865  345567889999999999999999999885433     4788


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|+|||. .+|..|......     .++...+..++.|+++|+.|+|++   ++.|||+||.|.++..+|+.|++|||+|
T Consensus        78 lvfe~cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   78 LVFEFCD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             EeHHHhh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence            9999995 599999876654     467788889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +-+.-.-        ..-...+-|.+|.+|.+++
T Consensus       149 rafgipv--------rcysaevvtlwyrppdvlf  174 (292)
T KOG0662|consen  149 RAFGIPV--------RCYSAEVVTLWYRPPDVLF  174 (292)
T ss_pred             hhcCCce--------EeeeceeeeeeccCcceee
Confidence            8664321        1112246799999999875

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=2.1e-27  Score=244.84  Aligned_cols=171  Identities=26%  Similarity=0.464  Sum_probs=143.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++....     ..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eEE
Confidence            56888999999999999999999999999999997543 233456789999999999999999999865543     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++ +|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999975 99999875432     478889999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        ......||+.|+|||++.
T Consensus       151 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~  176 (288)
T cd07871         151 RAKSVPTK--------TYSNEVVTLWYRPPDVLL  176 (288)
T ss_pred             eeccCCCc--------cccCceecccccChHHhc
Confidence            75432111        111246899999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=1.1e-27  Score=252.97  Aligned_cols=181  Identities=22%  Similarity=0.391  Sum_probs=142.4

Q ss_pred             hcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  603 (725)
                      .++|++.+.||+|+||.||+|++     ..+++.||||++.... ....+.+.+|+++++++ +||||++++++|.... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN-   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence            45788899999999999999975     2345789999987442 23456789999999999 8999999999876433 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCcc---------------------------------------------------
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQV---------------------------------------------------  632 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------------  632 (725)
                         ...++||||+++|+|.+++.......                                                   
T Consensus        85 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          85 ---GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             ---CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence               35789999999999999997532100                                                   


Q ss_pred             -----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcc
Q 048668          633 -----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS  707 (725)
Q Consensus       633 -----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  707 (725)
                           ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+.........      .
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------R  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchh------c
Confidence                 012477888899999999999999998   99999999999999999999999999998653321111      1


Q ss_pred             cccccCCccccCCCccc
Q 048668          708 SIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       708 ~~~~~gt~~y~aPE~~~  724 (725)
                      .....+++.|||||++.
T Consensus       233 ~~~~~~~~~y~aPE~~~  249 (338)
T cd05102         233 KGSARLPLKWMAPESIF  249 (338)
T ss_pred             ccCCCCCccccCcHHhh
Confidence            11234678999999763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=233.78  Aligned_cols=171  Identities=28%  Similarity=0.371  Sum_probs=148.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+++|+|.||+|..|+.+.+++.||+|++++.   .+.+...-..|-++|+..+||.+..+-..     |++.+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence            46788899999999999999999999999999999754   34455667889999999999998876543     67778


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+.||.|.-++.+.+      .+++.....+...|+.||.|||++   +||+||+|.+|.++|++|.+||.||
T Consensus       242 rlCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence            9999999999999998887654      588888899999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.-..        .+..+.++||||.|.|||++
T Consensus       313 GLCKE~I~--------~g~t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  313 GLCKEEIK--------YGDTTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             ccchhccc--------ccceeccccCChhhcCchhh
Confidence            99985322        23345569999999999986

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=2.1e-27  Score=249.65  Aligned_cols=172  Identities=26%  Similarity=0.346  Sum_probs=145.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++...   .......+.+|+.++..++|++|+++++++...+     .
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----Y   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence            4688899999999999999999999999999999643   2233456788999999999999999999876544     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++||+|.+++.....     .+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            8999999999999999976432     578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.+......       .....+||+.|||||++
T Consensus       148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~  175 (331)
T cd05624         148 SCLKMNQDGTV-------QSSVAVGTPDYISPEIL  175 (331)
T ss_pred             ceeeccCCCce-------eeccccCCcccCCHHHH
Confidence            99765432111       11124699999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=3.3e-28  Score=252.42  Aligned_cols=169  Identities=24%  Similarity=0.478  Sum_probs=145.1

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeecc----ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK----QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +...+||+|+|-+||+|.+..+|..||.-.++..    .....++|..|+++|+.++||||+++|.+|.+..-   ....
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            3457899999999999999999999997665533    34456899999999999999999999999887652   3567


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Dfgl  689 (725)
                      +|+|.+..|+|.+|.++.+      .+....+..|++||++||.|||++ .|+|||||||.+||+|.. .|.|||+|+|+
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence            8999999999999999876      477788999999999999999998 789999999999999985 48999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |......+.          ..+.|||.|||||+|
T Consensus       193 Atl~r~s~a----------ksvIGTPEFMAPEmY  216 (632)
T KOG0584|consen  193 ATLLRKSHA----------KSVIGTPEFMAPEMY  216 (632)
T ss_pred             HHHhhcccc----------ceeccCccccChHHH
Confidence            988754322          126799999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=241.06  Aligned_cols=165  Identities=28%  Similarity=0.456  Sum_probs=136.8

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      .+++|+|.||+||-|+++.+|+.||||+|.+..  .....+..+|+.||+++.||.||.+...     |++.+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            478999999999999999999999999997542  2233678899999999999999998876     455569999999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CceEEccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAK  691 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~---~~~kl~Dfgla~  691 (725)
                      -+. ||..+.|-...    ...+++.....++.||+.||.|||.+   +|+|.|+||+|||+...   ..+||||||+||
T Consensus       644 Kl~-GDMLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  644 KLH-GDMLEMILSSE----KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             hhc-chHHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence            994 56655554322    12689999999999999999999999   99999999999999643   479999999999


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+..-.         .+++|||.|.|||++
T Consensus       716 iIgEksFR---------rsVVGTPAYLaPEVL  738 (888)
T KOG4236|consen  716 IIGEKSFR---------RSVVGTPAYLAPEVL  738 (888)
T ss_pred             ecchhhhh---------hhhcCCccccCHHHH
Confidence            98765322         237899999999986

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=2.6e-27  Score=249.27  Aligned_cols=173  Identities=26%  Similarity=0.321  Sum_probs=146.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+++++.++||||+++++++....     .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----N   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----e
Confidence            36888999999999999999999999999999997542   234467889999999999999999998866543     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            8999999999999999986532     588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+......       ......||+.|+|||++.
T Consensus       148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         148 SAARLTANKMV-------NSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             CCeECCCCCce-------eeecccCCccccCHHHhc
Confidence            99876432111       112246999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=4e-27  Score=244.72  Aligned_cols=172  Identities=26%  Similarity=0.433  Sum_probs=143.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eE
Confidence            357899999999999999999999899999999997543 223356788999999999999999999876544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++ +++.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999995 688888875432     478888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.......        ......||+.|||||++.
T Consensus       150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~  176 (303)
T cd07869         150 ARAKSVPSH--------TYSNEVVTLWYRPPDVLL  176 (303)
T ss_pred             ceeccCCCc--------cCCCCcccCCCCChHHHc
Confidence            875432111        111246899999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=3.9e-27  Score=245.90  Aligned_cols=165  Identities=24%  Similarity=0.375  Sum_probs=137.1

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+..|.+++... +||||+++++++....     ..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999999999999997542   23345566777777754 7999999999865544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||++||+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            9999999999987654      588899999999999999999998   9999999999999999999999999999754


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|||||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05592         147 MNGE--------GKASTFCGTPDYIAPEILK  169 (316)
T ss_pred             CCCC--------CccccccCCccccCHHHHc
Confidence            3221        1112357999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=3.1e-27  Score=249.79  Aligned_cols=176  Identities=26%  Similarity=0.345  Sum_probs=145.5

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|++..++..||||++...  ......++.+|++++++++||||+++++++...........|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999999999999999998643  223345788999999999999999999988765544445689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++ ++|.+++....      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 69999987554      588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........     .......+||+.|+|||++
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~  178 (338)
T cd07859         151 RVAFNDTPT-----AIFWTDYVATRWYRAPELC  178 (338)
T ss_pred             cccccccCc-----cccccCCCCCCCcCCHHHH
Confidence            764322111     0111235699999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.95  E-value=4.1e-27  Score=247.20  Aligned_cols=165  Identities=24%  Similarity=0.319  Sum_probs=139.4

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.+++++ +||||+++++++....     ..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEE
Confidence            46899999999999999999999999997542   23345688999999998 6999999999876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999999999887553      589999999999999999999999   9999999999999999999999999998743


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|+|||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (329)
T cd05588         147 IRPG--------DTTSTFCGTPNYIAPEILR  169 (329)
T ss_pred             ccCC--------CccccccCCccccCHHHHc
Confidence            2111        1112357999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.95  E-value=3.9e-27  Score=247.03  Aligned_cols=170  Identities=24%  Similarity=0.328  Sum_probs=141.8

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCC-cccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHR-NLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~  608 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|++...   .....+.+..|+++++.++|+ +|+++++++...+     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----R   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----E
Confidence            478889999999999999999989999999999753   233456788999999999865 5778887765443     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            899999999999999997654      578899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++......        ......+||+.|+|||++.
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~  174 (324)
T cd05587         147 MCKENIFGG--------KTTRTFCGTPDYIAPEIIA  174 (324)
T ss_pred             cceecCCCC--------CceeeecCCccccChhhhc
Confidence            987432111        1112357999999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=3.8e-27  Score=246.45  Aligned_cols=165  Identities=28%  Similarity=0.391  Sum_probs=138.9

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|+++.+++.||+|++...   .....+.+..|++++... +||||+++++++....     ..|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEE
Confidence            4689999999999999999999999999753   233456778899999877 6999999999876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999999999987654      588999999999999999999998   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|||||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (320)
T cd05590         147 IFNG--------KTTSTFCGTPDYIAPEILQ  169 (320)
T ss_pred             CcCC--------CcccccccCccccCHHHHc
Confidence            2211        1112356999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-27  Score=251.41  Aligned_cols=179  Identities=23%  Similarity=0.365  Sum_probs=148.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||||++....   ......+.+|+++++.++||||+++++++....     .
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----H   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----e
Confidence            36888999999999999999999899999999997542   234567889999999999999999998865544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            899999999999999998653      588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCC---------------------CCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDT---------------------SSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~---------------------~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++.........                     ............||+.|+|||++.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR  203 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence            998764432000                     000011122356999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=5.5e-27  Score=246.12  Aligned_cols=165  Identities=25%  Similarity=0.341  Sum_probs=138.7

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.++.++ +||||+++++++....     ..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEE
Confidence            4699999999999999999999999999754   223345677899988877 7999999999876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999999999887543      588999999999999999999999   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|+|||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (329)
T cd05618         147 LRPG--------DTTSTFCGTPNYIAPEILR  169 (329)
T ss_pred             cCCC--------CccccccCCccccCHHHHc
Confidence            2211        1112357999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=4.7e-27  Score=246.05  Aligned_cols=164  Identities=27%  Similarity=0.386  Sum_probs=138.3

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++..+++.||+|++...   .....+.+..|.+++..+ +||||+++++++....     ..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEE
Confidence            4699999999999999989999999999754   233446678899999876 7999999999876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654      578899999999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....        .....+||+.|||||++
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~  168 (321)
T cd05591         147 ILNGV--------TTTTFCGTPDYIAPEIL  168 (321)
T ss_pred             ccCCc--------cccccccCccccCHHHH
Confidence            32211        11235699999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=7.2e-27  Score=244.78  Aligned_cols=165  Identities=25%  Similarity=0.361  Sum_probs=137.4

Q ss_pred             cccccccceEEEEEEEC---CCceEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          538 NMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +.||+|+||.||+|+..   .+++.||+|+++...    ......+.+|++++++++||||+++++++....     ..|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eEE
Confidence            57999999999999863   468899999997432    223456789999999999999999999876544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          77 LILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             EEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            9999999999999997654      477888889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        .....+||+.|+|||++.
T Consensus       148 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~  173 (323)
T cd05584         148 KESIHEGT--------VTHTFCGTIEYMAPEILM  173 (323)
T ss_pred             eecccCCC--------cccccCCCccccChhhcc
Confidence            75422211        112256999999999863

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=6.9e-27  Score=245.03  Aligned_cols=165  Identities=32%  Similarity=0.428  Sum_probs=135.8

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+++.||+|++....   ....+++..|.. +++.++||||+++++++...+     ..|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEE
Confidence            46899999999999999999999999997542   223345555555 567899999999998876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999999999987644      578899999999999999999999   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|||||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (323)
T cd05575         147 IEHS--------KTTSTFCGTPEYLAPEVLR  169 (323)
T ss_pred             ccCC--------CccccccCChhhcChhhhc
Confidence            2211        1112356999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=5.7e-27  Score=245.79  Aligned_cols=168  Identities=26%  Similarity=0.394  Sum_probs=138.9

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHH---HcCCCCcccceeeEeecCCCCCcc
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEAL---RNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      |++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|++++   +.++||||+++++++....     
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-----   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-----   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence            567789999999999999999999999999997542   23345666776655   5667999999999876554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|..++...       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence            889999999999999888643       488999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++......        ......+||+.|||||++.
T Consensus       146 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~  174 (324)
T cd05589         146 GLCKEGMGFG--------DRTSTFCGTPEFLAPEVLT  174 (324)
T ss_pred             cCCccCCCCC--------CcccccccCccccCHhHhc
Confidence            9987532211        1112357999999999863

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=5.3e-27  Score=246.78  Aligned_cols=173  Identities=25%  Similarity=0.334  Sum_probs=144.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||++++..+++.||+|++....   ......+.+|+.++..++|++|+++++++....     .
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----N   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----E
Confidence            36888999999999999999999999999999996432   223456888999999999999999999876544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++.+...     .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            8999999999999999976432     578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.......       ......+||+.|||||++.
T Consensus       148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             hheecccCCc-------ceecccccCccccCHHHHh
Confidence            9975532211       1111246999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=6.3e-27  Score=245.34  Aligned_cols=170  Identities=23%  Similarity=0.316  Sum_probs=141.9

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  608 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+..|.+++..+. |++|+++++++...+     .
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----R   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----E
Confidence            4778899999999999999999999999999997542   233456778888888875 889999998865544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            899999999999999987654      578899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++......        ......+||+.|||||++.
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~  174 (323)
T cd05616         147 MCKENMWDG--------VTTKTFCGTPDYIAPEIIA  174 (323)
T ss_pred             CceecCCCC--------CccccCCCChhhcCHHHhc
Confidence            997542211        1112357999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=5.9e-27  Score=245.34  Aligned_cols=170  Identities=24%  Similarity=0.332  Sum_probs=141.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  608 (725)
                      +|+..+.||+|+||.||+|+++.+++.||+|++....   ....+.+..|+++++.+. |++|+++++++...     +.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CE
Confidence            3677899999999999999999999999999997542   234466788999999886 56777888876544     37


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            899999999999999987654      588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++......        ......+||+.|||||++.
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~  174 (323)
T cd05615         147 MCKEHMVDG--------VTTRTFCGTPDYIAPEIIA  174 (323)
T ss_pred             cccccCCCC--------ccccCccCCccccCHHHHc
Confidence            987542211        1112356999999999863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=8.3e-27  Score=244.28  Aligned_cols=165  Identities=32%  Similarity=0.400  Sum_probs=135.4

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++..+++.||+|++....   .....++.+|.. +++.++||||+++++++....     ..|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999999999999997432   223345556654 678899999999998876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9999999999887543      578888999999999999999998   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|+|||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (321)
T cd05603         147 VEPE--------ETTSTFCGTPEYLAPEVLR  169 (321)
T ss_pred             CCCC--------CccccccCCcccCCHHHhc
Confidence            2211        1112357999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=8.1e-27  Score=244.73  Aligned_cols=165  Identities=30%  Similarity=0.401  Sum_probs=136.1

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+|+.||+|++....   .....++..|.. +++.++||||+++++++...+     ..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEE
Confidence            46899999999999999999999999997542   223345566655 467799999999998876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9999999999887544      588999999999999999999998   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|||||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (325)
T cd05604         147 IAQS--------DTTTTFCGTPEYLAPEVIR  169 (325)
T ss_pred             CCCC--------CCcccccCChhhCCHHHHc
Confidence            2211        1112357999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=1.1e-26  Score=244.34  Aligned_cols=171  Identities=23%  Similarity=0.347  Sum_probs=146.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..++..||+|++.... ....+++.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EE
Confidence            357899999999999999999999999999999997653 233567999999999999999999999976554     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++|+|.+++....      .+++..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            99999999999999997654      5788999999999999999999852  699999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++......          .....||+.|+|||++.
T Consensus       151 ~~~~~~~~----------~~~~~g~~~y~aPE~~~  175 (331)
T cd06649         151 SGQLIDSM----------ANSFVGTRSYMSPERLQ  175 (331)
T ss_pred             cccccccc----------cccCCCCcCcCCHhHhc
Confidence            97653221          11246999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.94  E-value=7.6e-27  Score=242.81  Aligned_cols=179  Identities=24%  Similarity=0.408  Sum_probs=142.3

Q ss_pred             cCCCCCcccccccceEEEEEEECC----------------CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE----------------DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKI  594 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  594 (725)
                      ++|...+.||+|+||.||+|++..                ++..||+|++.... .....+|.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468888999999999999998632                34579999987543 2335678999999999999999999


Q ss_pred             eeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCcc-------------ccccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 048668          595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQ  661 (725)
Q Consensus       595 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  661 (725)
                      ++++....     ..++||||+++|+|.+++.......             ....+++..+.+++.|++.||+|||+.  
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  157 (304)
T cd05096          85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--  157 (304)
T ss_pred             EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence            99986554     6899999999999999986532110             112467888999999999999999999  


Q ss_pred             CCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          662 PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       662 ~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                       +|+||||||+||+++.++.+||+|||+++........      .......++..|||||++.
T Consensus       158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~  213 (304)
T cd05096         158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------RIQGRAVLPIRWMAWECIL  213 (304)
T ss_pred             -CccccCcchhheEEcCCccEEECCCccceecccCcee------EecCcCCCCccccCHHHHh
Confidence             9999999999999999999999999999865332111      0111234688999999753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=7.8e-27  Score=245.81  Aligned_cols=170  Identities=24%  Similarity=0.331  Sum_probs=141.6

Q ss_pred             CCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc----cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFK  604 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  604 (725)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++....    ....+.+.+|++++++++ ||+|+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence            4778899999999999999863   478899999997431    233456789999999995 999999998865443  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|+||||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        79 ---~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl  146 (332)
T cd05614          79 ---KLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL  146 (332)
T ss_pred             ---EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence               7899999999999999997654      588999999999999999999998   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++.......       ......+||+.|||||++
T Consensus       147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~  178 (332)
T cd05614         147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEII  178 (332)
T ss_pred             eeCcCCccccccCC-------CccccccCCccccCHHHh
Confidence            99999976533211       111235799999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=9e-27  Score=243.14  Aligned_cols=165  Identities=23%  Similarity=0.356  Sum_probs=137.6

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|+++.+++.||+|+++...   ....+.+..|.+++... +||+|+++++++....     ..|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEE
Confidence            46999999999999999999999999997542   23445677888888764 8999999999876544     889999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999999999987643      578899999999999999999999   9999999999999999999999999998743


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|+|||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05620         147 VFGD--------NRASTFCGTPDYIAPEILQ  169 (316)
T ss_pred             ccCC--------CceeccCCCcCccCHHHHc
Confidence            2111        1112357999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.94  E-value=5.7e-28  Score=228.98  Aligned_cols=180  Identities=26%  Similarity=0.375  Sum_probs=146.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc----eEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      ...|+....||+|.||.||+|....+.    +.+|+|.++..+  .+......+|+.+++.++|||++.+..++...+  
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d--  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD--  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC--
Confidence            346888999999999999999664332    378999987542  344567789999999999999999998876533  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC----C
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD----M  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~----~  680 (725)
                        ...|+++||.+. ||.++|+-++... ...++...+..|..||+.|+.|||++   =|+|||+||.||++..+    |
T Consensus       101 --~~v~l~fdYAEh-DL~~II~fHr~~~-~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG  173 (438)
T KOG0666|consen  101 --KKVWLLFDYAEH-DLWHIIKFHRASK-AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG  173 (438)
T ss_pred             --ceEEEEehhhhh-hHHHHHHHhccch-hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence              478999999977 9999998765433 35799999999999999999999999   79999999999999887    8


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .|||+|||+||.+...-....     ..-.++-|.+|.|||+++
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~-----s~d~VVVTiWYRAPELLL  212 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLA-----SLDPVVVTIWYRAPELLL  212 (438)
T ss_pred             eeEeecccHHHHhhccccccc-----cCCceEEEEEecChHHhc
Confidence            999999999998865432221     112367899999999875

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=7.1e-27  Score=257.07  Aligned_cols=176  Identities=22%  Similarity=0.292  Sum_probs=146.3

Q ss_pred             CCCCCcccccccceEEEEEEECCC-ceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGED-EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+++++.++||||+++++++...+     ..|+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEE
Confidence            488899999999999999998766 7889999876555555567788999999999999999999976654     8999


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++|+|.++++....  ....+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus       143 v~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            9999999999998865321  112578899999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+.....      .......+||++|||||++.
T Consensus       218 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~  244 (478)
T PTZ00267        218 QYSDSVS------LDVASSFCGTPYYLAPELWE  244 (478)
T ss_pred             ecCCccc------cccccccCCCccccCHhHhC
Confidence            7643211      11122357999999999863

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=8.7e-27  Score=249.30  Aligned_cols=165  Identities=25%  Similarity=0.358  Sum_probs=140.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|+..+.||+|+||.||+|++..+++.||+|...      ...+.+|++++++++||||+++++++....     ..++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeEE
Confidence            57999999999999999999999999999999753      235678999999999999999999876544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||++. ++|.+++....      .+++..++.++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||+|+
T Consensus       161 v~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             EEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence            999995 69999887653      578899999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......       ......+||+.|+|||++.
T Consensus       231 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~  256 (391)
T PHA03212        231 FPVDINA-------NKYYGWAGTIATNAPELLA  256 (391)
T ss_pred             ccccccc-------cccccccCccCCCChhhhc
Confidence            5432211       1112357999999999863

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=7.2e-27  Score=248.00  Aligned_cols=166  Identities=31%  Similarity=0.468  Sum_probs=138.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++|+||+++++++....     ..|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eEE
Confidence            345667899999999999999998999999999965432 33467899999999999999999999875544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+..          ..++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999986532          345677889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+.....        .....+||..|+|||++
T Consensus       216 ~~~~~~~~--------~~~~~~gt~~y~aPE~~  240 (353)
T PLN00034        216 RILAQTMD--------PCNSSVGTIAYMSPERI  240 (353)
T ss_pred             eecccccc--------cccccccCccccCcccc
Confidence            87543211        11124699999999986

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=1.2e-26  Score=242.15  Aligned_cols=165  Identities=25%  Similarity=0.398  Sum_probs=137.6

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+++.||||+++...   ....+.+..|..++... +||||+++++++...+     ..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEE
Confidence            46899999999999999899999999997542   23445677788888764 8999999999876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999999999997643      578889999999999999999998   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|||||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (316)
T cd05619         147 MLGD--------AKTCTFCGTPDYIAPEILL  169 (316)
T ss_pred             CCCC--------CceeeecCCccccCHHHHc
Confidence            2211        1112356999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=1.2e-26  Score=243.43  Aligned_cols=165  Identities=32%  Similarity=0.423  Sum_probs=134.7

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHH-HHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++...+     ..|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEE
Confidence            46999999999999999899999999997532   222334445544 567889999999999876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            9999999999997644      477888889999999999999999   9999999999999999999999999999754


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .....        .....+||+.|||||++.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~  169 (325)
T cd05602         147 IEHNG--------TTSTFCGTPEYLAPEVLH  169 (325)
T ss_pred             ccCCC--------CcccccCCccccCHHHHc
Confidence            32211        112357999999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=1.7e-26  Score=242.73  Aligned_cols=171  Identities=23%  Similarity=0.363  Sum_probs=146.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..++..||+|++.... ......+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----EE
Confidence            357899999999999999999999999999999987543 234467899999999999999999999987654     88


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.+++....      .+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999997644      4788889999999999999999742  799999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++.+....          .....||..|+|||++.
T Consensus       151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~  175 (333)
T cd06650         151 SGQLIDSM----------ANSFVGTRSYMSPERLQ  175 (333)
T ss_pred             chhhhhhc----------cccCCCCccccCHHHhc
Confidence            97653221          11246899999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=1.2e-26  Score=243.30  Aligned_cols=165  Identities=25%  Similarity=0.339  Sum_probs=139.2

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++....     ..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEE
Confidence            46999999999999999999999999997542   23446688999999988 5999999999876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999999999887543      589999999999999999999999   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ....        ......+||+.|||||++.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~  169 (327)
T cd05617         147 LGPG--------DTTSTFCGTPNYIAPEILR  169 (327)
T ss_pred             cCCC--------CceecccCCcccCCHHHHC
Confidence            2211        1112357999999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=237.85  Aligned_cols=170  Identities=25%  Similarity=0.365  Sum_probs=143.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .|+..+.||+|+||.||++.+..+++.||+|++....   ......+.+|++++++++||||+++++++...+     ..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eE
Confidence            3778899999999999999998899999999996532   222356788999999999999999998865543     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999998865431    2588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.......         ....+||+.|||||++
T Consensus       149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~  173 (285)
T cd05605         149 AVEIPEGET---------IRGRVGTVGYMAPEVV  173 (285)
T ss_pred             ceecCCCCc---------cccccCCCCccCcHHh
Confidence            976533211         1124699999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1.4e-26  Score=242.27  Aligned_cols=164  Identities=26%  Similarity=0.355  Sum_probs=137.9

Q ss_pred             cccccccceEEEEEEE---CCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          538 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +.||+|+||.||++++   ..+++.||+|++....  ......+.+|++++++++||||+++++++....     ..|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEE
Confidence            5799999999999876   3578999999997542  223456778999999999999999999876544     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      |||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            99999999999997543      588999999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....        ......+||+.|||||++
T Consensus       148 ~~~~~--------~~~~~~~g~~~y~aPE~~  170 (318)
T cd05582         148 SIDHE--------KKAYSFCGTVEYMAPEVV  170 (318)
T ss_pred             cCCCC--------CceecccCChhhcCHHHH
Confidence            43221        111235799999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=1.3e-26  Score=239.12  Aligned_cols=172  Identities=26%  Similarity=0.380  Sum_probs=142.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....  ....+.+.+|++++++++||||+++++++....     ..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EE
Confidence            36888999999999999999999999999999997542  233467889999999999999999998875543     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++++.+..+.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence            99999999877665543222      588899999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+........       ......||+.|+|||++.
T Consensus       147 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~  174 (287)
T cd07848         147 ARNLSEGSNA-------NYTEYVATRWYRSPELLL  174 (287)
T ss_pred             cccccccccc-------cccccccccccCCcHHHc
Confidence            9875332111       111256999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.94  E-value=2.5e-26  Score=237.35  Aligned_cols=174  Identities=25%  Similarity=0.448  Sum_probs=140.8

Q ss_pred             CCCCCcccccccceEEEEEEECC-CceEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~  606 (725)
                      +|+..+.||+|+||+||+|++.. +++.||+|+++...  ......+.+|+++++.+   +||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68889999999999999999854 56889999987542  22334566788777766   69999999999865444444


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||++ ++|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence            57899999996 699999875432    1578999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+......         ......||+.|+|||++
T Consensus       154 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~  181 (290)
T cd07862         154 FGLARIYSFQM---------ALTSVVVTLWYRAPEVL  181 (290)
T ss_pred             ccceEeccCCc---------ccccccccccccChHHH
Confidence            99997653321         11225699999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=219.69  Aligned_cols=192  Identities=21%  Similarity=0.262  Sum_probs=158.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|++.+.+|+|+|+.||.++.-.+++.||+|++......+.+..++|++..++++|||+++++++.....-++....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45689999999999999999999988999999999988776777889999999999999999999998876665566779


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |++++|...|+|.+.+.....+  ...+++.+++.|+.+|++||+++|+. .|+++||||||.||++.+++.+++.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999999876432  33689999999999999999999998 55799999999999999999999999999


Q ss_pred             ccccccCCCCC-CCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDT-SSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +....-.-... ....-+.+.....|..|.|||.|-
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~  211 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN  211 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence            87643211000 000111222345789999999873

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-27  Score=241.15  Aligned_cols=173  Identities=25%  Similarity=0.423  Sum_probs=144.3

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      ..+.+.||+|.||.|..|... .+..||||.++.... ...++|.+|+++|.+++||||+.++|+|...+     ..++|
T Consensus       540 L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----PicmI  613 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCMI  613 (807)
T ss_pred             eehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHHH
Confidence            345688999999999999875 468999999987643 44589999999999999999999999998876     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +|||++|+|.+|+.++...    ........+|+.||+.|++||.+.   ++||||+.++|+|+|.++++||+|||++|-
T Consensus       614 ~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence            9999999999999987532    234455678999999999999998   999999999999999999999999999996


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcccC
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFFM  725 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  725 (725)
                      +-...++...      ...+-..+|||||.+++
T Consensus       687 lysg~yy~vq------gr~vlpiRwmawEsill  713 (807)
T KOG1094|consen  687 LYSGDYYRVQ------GRAVLPIRWMAWESILL  713 (807)
T ss_pred             cccCCceeee------cceeeeeeehhHHHHHh
Confidence            6444332211      11356789999998764

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=2e-26  Score=236.53  Aligned_cols=167  Identities=26%  Similarity=0.386  Sum_probs=138.3

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||+||+|.+..+++.||+|++....   ....+.+..|++++++++||||+++.+++....     ..|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence            699999999999999999999999996432   223456788999999999999999998865543     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++|+|.+++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            99999988754321  112588999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCCCCCCCCcccccccCCccccCCCccc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ...        .....||+.|+|||++.
T Consensus       151 ~~~--------~~~~~g~~~y~aPE~~~  170 (280)
T cd05608         151 QSK--------TKGYAGTPGFMAPELLQ  170 (280)
T ss_pred             Ccc--------ccccCCCcCccCHHHhc
Confidence            111        11246999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=2e-26  Score=259.56  Aligned_cols=185  Identities=25%  Similarity=0.330  Sum_probs=146.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ....++|.+|++++++++||||+++++++...+     .
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----P   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----E
Confidence            57889999999999999999999899999999997532   223467899999999999999999999976554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCc-----cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQ-----VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      .|+||||++||+|.+++......     ......++..+++++.||++||+|+|+.   +|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            89999999999999998742111     0112456778899999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCC----------CCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTS----------SKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+|+..........          ..........+||+.|||||++.
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~  204 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL  204 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence            999999987622110000          00001112357999999999863

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-26  Score=242.40  Aligned_cols=163  Identities=28%  Similarity=0.361  Sum_probs=134.8

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC---CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI---RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      ||+|+||+||+|++..+++.||||++....   ......+..|..++.+.   +||+|+++++++....     ..|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence            699999999999999999999999996432   22334556677777765   6999999998876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999999999987654      588999999999999999999999   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .....        .....+||+.|||||++.
T Consensus       147 ~~~~~--------~~~~~~gt~~y~aPE~~~  169 (330)
T cd05586         147 LTDNK--------TTNTFCGTTEYLAPEVLL  169 (330)
T ss_pred             CCCCC--------CccCccCCccccCHHHHc
Confidence            22211        112357999999999863

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=2.4e-26  Score=240.31  Aligned_cols=165  Identities=25%  Similarity=0.370  Sum_probs=139.0

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|++..+++.||||++....   ......+.+|+++++.+ +||||+++++++....     ..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence            46999999999999999899999999997542   33456678899999888 6999999999876544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999999999987654      589999999999999999999998   9999999999999999999999999998753


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .....        .....+||+.|||||++.
T Consensus       147 ~~~~~--------~~~~~~g~~~y~aPE~~~  169 (318)
T cd05570         147 ILGGV--------TTSTFCGTPDYIAPEILS  169 (318)
T ss_pred             CcCCC--------cccceecCccccCHHHhc
Confidence            22111        112256999999999863

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=2.7e-26  Score=245.00  Aligned_cols=180  Identities=24%  Similarity=0.417  Sum_probs=142.8

Q ss_pred             hcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||.||+|++     ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|.... 
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence            34688899999999999999974     3456789999986443 33456788999999999 7999999999976654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCc----------------------------------------------------
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQ----------------------------------------------------  631 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  631 (725)
                          ..++|||||++|+|.++++.....                                                    
T Consensus       113 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         113 ----PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ----cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence                789999999999999999753210                                                    


Q ss_pred             -----------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          632 -----------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       632 -----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                                       .+...+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                             0012478888999999999999999998   99999999999999999999999999998654


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ......      ......++..|||||++.
T Consensus       266 ~~~~~~------~~~~~~~~~~y~aPE~~~  289 (375)
T cd05104         266 NDSNYV------VKGNARLPVKWMAPESIF  289 (375)
T ss_pred             Cccccc------ccCCCCCCcceeChhHhc
Confidence            322111      011133567899999763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.94  E-value=6e-26  Score=231.43  Aligned_cols=170  Identities=26%  Similarity=0.403  Sum_probs=146.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++....     ..|+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEEE
Confidence            47899999999999999999998899999999997655455567889999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.++++...      .+++..+..++.|++.|++|+|+.   +|+|||+||+||+++.++.+||+|||+++
T Consensus        84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             EEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence            999999999999987543      578999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......|++.|+|||++
T Consensus       155 ~~~~~~~--------~~~~~~~~~~y~~PE~~  178 (267)
T cd06646         155 KITATIA--------KRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             eeccccc--------ccCccccCccccCHhHc
Confidence            6533211        11124689999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.3e-27  Score=234.52  Aligned_cols=171  Identities=22%  Similarity=0.323  Sum_probs=148.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +-|...+.||+|.|++|-.|++--+|..||||++.+.+  .-...++.+|++-|+-++|||||++|++..     +....
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceE
Confidence            45777789999999999999999999999999997653  234467889999999999999999999843     44489


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-~~~~~kl~Dfg  688 (725)
                      |+|+|.=++|+|++||.++..     .+.+....+++.||+.|+.|+|..   .+||||+||+||.+- +-|-||+.|||
T Consensus        93 yLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence            999999999999999988764     689999999999999999999988   899999999999765 56899999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++-.+.++.         .-.+.||+..|.|||+++
T Consensus       165 FSNkf~PG~---------kL~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  165 FSNKFQPGK---------KLTTSCGSLAYSAPEILL  191 (864)
T ss_pred             ccccCCCcc---------hhhcccchhhccCchhhh
Confidence            997765542         233479999999999975

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.94  E-value=1.4e-26  Score=242.90  Aligned_cols=167  Identities=29%  Similarity=0.400  Sum_probs=143.4

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-C-----CcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-H-----RNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~  606 (725)
                      +|++.+.||+|+||+|.+|.+..|++.||||+++-+ +...++...|+.+|..++ |     -|+|++++++....    
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~----  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN----  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----
Confidence            788999999999999999999999999999999744 334566778999999997 3     39999999977665    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--CceEE
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--MVAHV  684 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~--~~~kl  684 (725)
                       +.|||+|.+ .-+|+++++.....    .++...+..|+.||+.||.+||+.   +|||.||||||||+.+.  ..+||
T Consensus       262 -HlciVfELL-~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  262 -HLCIVFELL-STNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             -ceeeeehhh-hhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence             999999999 55999999987643    689999999999999999999998   99999999999999765  37999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||.|.+.....           .+.+-+..|.|||+++
T Consensus       333 IDFGSSc~~~q~v-----------ytYiQSRfYRAPEVIL  361 (586)
T KOG0667|consen  333 IDFGSSCFESQRV-----------YTYIQSRFYRAPEVIL  361 (586)
T ss_pred             EecccccccCCcc-----------eeeeeccccccchhhc
Confidence            9999998754321           1356788999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=259.98  Aligned_cols=177  Identities=25%  Similarity=0.350  Sum_probs=152.4

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      ++.-..++|.+.++||+|+||.|..++++.+++.||+|++.+.   +......|..|-.+|..-+.+=|++++..     
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----  143 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----  143 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----
Confidence            3444567899999999999999999999999999999999763   34556778899999999999999999866     


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      |++..+.|+|||||+||||-..+.+..      .+|+..+..++..|+-||.-+|+.   |+|||||||+|||+|..|++
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcE
Confidence            666679999999999999999998765      589999999999999999999998   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++|||.+-.+.....-       .....+|||.|++||++
T Consensus       215 kLADFGsClkm~~dG~V-------~s~~aVGTPDYISPEvL  248 (1317)
T KOG0612|consen  215 KLADFGSCLKMDADGTV-------RSSVAVGTPDYISPEVL  248 (1317)
T ss_pred             eeccchhHHhcCCCCcE-------EeccccCCCCccCHHHH
Confidence            99999988776533211       11236799999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.94  E-value=5.5e-27  Score=247.26  Aligned_cols=171  Identities=29%  Similarity=0.523  Sum_probs=143.8

Q ss_pred             CCCcccccccceEEEEEEECCCc---eEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDE---MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .+.++||.|.||.||+|+.+..+   ..||||.++... +...++|+.|+.||.+++||||+++.|+.....     ...
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-----PvM  706 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-----PVM  706 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----eeE
Confidence            45689999999999999987555   479999997653 445678999999999999999999999976654     788


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ||+|||++|+|..||+.+..     .+++.+...+.++|+.|++||-+.   ++|||||.++|||++.+-.+|++|||++
T Consensus       707 IiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999998764     588889999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.+.+...     +..++.+-.-..+|.|||-+
T Consensus       779 Rvledd~~-----~~ytt~GGKIPiRWTAPEAI  806 (996)
T KOG0196|consen  779 RVLEDDPE-----AAYTTLGGKIPIRWTAPEAI  806 (996)
T ss_pred             eecccCCC-----ccccccCCccceeecChhHh
Confidence            98865531     11111122235689999976

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.1e-26  Score=253.30  Aligned_cols=185  Identities=25%  Similarity=0.316  Sum_probs=149.3

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC---
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF---  603 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  603 (725)
                      ...++|++.+.||+|+||+||+|++..+++.||||++....  ......+.+|+..+..++|+||+++++.+.....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34568999999999999999999999899999999997543  3345678899999999999999998876543321   


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      ......++||||+++|+|.++++.....  ...+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+|
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence            1112468999999999999999754321  22588999999999999999999998   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+++.+......      ......+||+.|||||++.
T Consensus       184 L~DFGls~~~~~~~~~------~~~~~~~Gt~~Y~aPE~~~  218 (496)
T PTZ00283        184 LGDFGFSKMYAATVSD------DVGRTFCGTPYYVAPEIWR  218 (496)
T ss_pred             EEecccCeeccccccc------cccccccCCcceeCHHHhC
Confidence            9999999876432111      1112357999999999863

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=2.2e-26  Score=245.46  Aligned_cols=181  Identities=23%  Similarity=0.393  Sum_probs=142.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCC-----ceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ..++|+..+.||+|+||.||+|++...     +..||+|++.... ....+.+.+|+++++.+ +||||++++++|....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            345788999999999999999986433     3579999997543 23346788999999999 7999999999876554


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCc---------------------------------------------------
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQ---------------------------------------------------  631 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------  631 (725)
                           ..++||||+++|+|.+++......                                                   
T Consensus       116 -----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         116 -----PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             -----CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence                 789999999999999998643210                                                   


Q ss_pred             -------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCC
Q 048668          632 -------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL  698 (725)
Q Consensus       632 -------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  698 (725)
                                   .....+++..+++++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                         0112477888999999999999999998   999999999999999999999999999986543211


Q ss_pred             CCCCCCCcccccccCCccccCCCccc
Q 048668          699 DTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       699 ~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .      ....+..+++.|||||++.
T Consensus       268 ~------~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         268 Y------VVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             e------eeccCCCCccceeCHHHhc
Confidence            1      0111233567899999763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-26  Score=245.52  Aligned_cols=184  Identities=24%  Similarity=0.364  Sum_probs=158.0

Q ss_pred             HHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCC
Q 048668          524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTD  602 (725)
Q Consensus       524 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  602 (725)
                      ++.+...++-|++.++||+|.+|+||+++.+.+++.+|+|+...... ..++++.|.++++... |||++.++|++.-.+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444556678899999999999999999999999999999976643 3367788999999874 999999999998776


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      .-..+.+|+|||||.||+..|.++....    ..+.|..+..|++.++.|+.+||.+   .++|||+|-.|||++.++.|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence            6667899999999999999999987652    2689999999999999999999999   89999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++|||++..+...        .....+.+|||.|||||++
T Consensus       163 KLvDFGvSaQldsT--------~grRnT~iGtP~WMAPEVi  195 (953)
T KOG0587|consen  163 KLVDFGVSAQLDST--------VGRRNTFIGTPYWMAPEVI  195 (953)
T ss_pred             EEeeeeeeeeeecc--------cccccCcCCCcccccceee
Confidence            99999999876432        2233357899999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=5.5e-26  Score=231.47  Aligned_cols=173  Identities=25%  Similarity=0.424  Sum_probs=141.7

Q ss_pred             hcCCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..+|++.+.||+|+||.||+|++.   ..+..||+|.++... ....+.|.+|+.++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   79 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----   79 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC----
Confidence            346888899999999999999864   456789999987543 233467899999999999999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++||||+++|+|.+++.....     .+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          80 -TMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             -CcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence             78999999999999999976432     578999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.+.........       ......++..|+|||++
T Consensus       151 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~  180 (266)
T cd05064         151 FRRLQEDKSEAIY-------TTMSGKSPVLWAAPEAI  180 (266)
T ss_pred             Ccccccccccchh-------cccCCCCceeecCHHHH
Confidence            9987653221110       11123467789999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.9e-27  Score=262.28  Aligned_cols=179  Identities=28%  Similarity=0.464  Sum_probs=152.3

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ...+-+|+....||.|.||.||.|....+|...|+|-+....  ......+.+|..++..++|||+|++||+-.+.+   
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--- 1307 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--- 1307 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH---
Confidence            344567888899999999999999999999999999887542  334567789999999999999999999977765   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..+|.||||++|+|.+.++..+      ..++.....+..|++.|++|||++   |||||||||+||+++.+|.+|.+
T Consensus      1308 --kv~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1308 --KVYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             --HHHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence              7899999999999999998654      356666777889999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||.|..+..+....    +..-...+||+.|||||+|.
T Consensus      1377 DFGsa~ki~~~~~~~----~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTM----PGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred             cccceeEecCchhcC----CHHHHhhcCCchhcCchhhc
Confidence            999999887652221    23334578999999999985

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=5.9e-26  Score=242.85  Aligned_cols=175  Identities=23%  Similarity=0.302  Sum_probs=144.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|++..+++.||||++...  .....+++.+|+++++.++||||+++++++...........|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999889999999998643  223446788999999999999999999998765433334689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++ ++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999996 58888886543      588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......       .......+|+.|+|||++.
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~  177 (372)
T cd07853         151 RVEEPDES-------KHMTQEVVTQYYRAPEILM  177 (372)
T ss_pred             eecccCcc-------ccCCCCCcCCCcCCHHHHc
Confidence            86532211       1111246899999999763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.93  E-value=4.3e-26  Score=247.88  Aligned_cols=175  Identities=26%  Similarity=0.390  Sum_probs=139.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC---cc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG---VD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---~~  607 (725)
                      ..+|+..+.||+|+||.||+|++..+++.||||++....    ....+|+.++++++||||+++++++....+..   ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999999899999999885432    23357999999999999999998875443222   23


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEcc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGD  686 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~D  686 (725)
                      ..++||||+++ ++.+++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++ .+||+|
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence            56799999975 78777754221  112588999999999999999999999   999999999999999664 799999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+.+....         .....+||+.|||||++.
T Consensus       215 FGla~~~~~~~---------~~~~~~~t~~y~aPE~~~  243 (440)
T PTZ00036        215 FGSAKNLLAGQ---------RSVSYICSRFYRAPELML  243 (440)
T ss_pred             cccchhccCCC---------CcccCCCCcCccCHHHhc
Confidence            99998654321         111256899999999863

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=5.6e-26  Score=231.65  Aligned_cols=170  Identities=26%  Similarity=0.402  Sum_probs=146.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++....     ..|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEEE
Confidence            46777889999999999999999899999999997665555567889999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++....      .+++.++..++.|++.|++|+|+.   +++||||||+||+++.++.+||+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence            999999999999987554      588999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......|++.|+|||++
T Consensus       155 ~~~~~~~--------~~~~~~~~~~y~aPE~~  178 (267)
T cd06645         155 QITATIA--------KRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             EccCccc--------ccccccCcccccChhhh
Confidence            6533211        11124699999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=7.4e-26  Score=235.90  Aligned_cols=170  Identities=25%  Similarity=0.448  Sum_probs=142.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|...+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++....     ..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEE
Confidence            56888999999999999999999899999999997543 233456789999999999999999999976554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++ ++.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence            99999975 89888865432     478888999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......        ......+|+.|+|||++
T Consensus       152 ~~~~~~~~--------~~~~~~~~~~y~aPE~~  176 (309)
T cd07872         152 RAKSVPTK--------TYSNEVVTLWYRPPDVL  176 (309)
T ss_pred             eecCCCcc--------ccccccccccccCCHHH
Confidence            75432211        11124589999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.93  E-value=7.4e-26  Score=236.62  Aligned_cols=173  Identities=26%  Similarity=0.465  Sum_probs=141.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|++..++.    .||+|+++... ....+++.+|+.+++.++||||++++|+|...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            468899999999999999999865554    48999986442 23456788999999999999999999998643     


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++|+||+++|+|.+++.....     .+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence             35799999999999999986542     478888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++.+.......      ......++..|||||++.
T Consensus       153 fG~a~~~~~~~~~~------~~~~~~~~~~y~apE~~~  184 (316)
T cd05108         153 FGLAKLLGADEKEY------HAEGGKVPIKWMALESIL  184 (316)
T ss_pred             ccccccccCCCcce------eccCCccceeecChHHhc
Confidence            99998764321110      111123567899999763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.93  E-value=1e-25  Score=230.81  Aligned_cols=164  Identities=26%  Similarity=0.360  Sum_probs=136.7

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||.||+++.+.+|+.||+|++....   ....+.+..|++++++++||||+++++++....     +.|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-----HLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-----eEEEEEecC
Confidence            699999999999999899999999996432   223345667999999999999999998865543     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      +||+|.+++.....    ..+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999998865432    2578889999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCCCCCCCCcccccccCCccccCCCccc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ..         .....||+.|+|||++.
T Consensus       149 ~~---------~~~~~~~~~y~aPE~~~  167 (277)
T cd05607         149 KT---------ITQRAGTNGYMAPEILK  167 (277)
T ss_pred             ce---------eeccCCCCCccCHHHHc
Confidence            11         11245899999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-27  Score=230.37  Aligned_cols=180  Identities=26%  Similarity=0.432  Sum_probs=151.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-------cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-------KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      +|-....+|+|+|+.||+|.+...++.||||+-...+       +...+...+|.++-+.++||.||++|+|+....   
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt---  540 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT---  540 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc---
Confidence            4556688999999999999998889999999875421       223456789999999999999999999987554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCce
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVA  682 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~  682 (725)
                       +..|-|+|||+|.+|.-|++.+.      .+++.++..|+.||+.||.||.+. .|+|||-|+||.|||+..   -|.+
T Consensus       541 -dsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  541 -DSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             -ccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence             46789999999999999999876      689999999999999999999987 789999999999999965   4789


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||.|||+++++.+..+..... ..-+...+||.+|.+||.|.
T Consensus       613 KITDFGLSKIMdddSy~~vdG-meLTSQgAGTYWYLPPEcFv  653 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDG-MELTSQGAGTYWYLPPECFV  653 (775)
T ss_pred             EeeecchhhhccCCccCcccc-eeeecccCceeeecCcceee
Confidence            999999999998766553322 22344568999999999985

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.93  E-value=9.9e-26  Score=232.60  Aligned_cols=175  Identities=26%  Similarity=0.433  Sum_probs=142.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +|+..+.||+|+||.||+|+++.+++.||+|.++...  ......+.+|+++++++   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999999999999999987542  22234566777777665   699999999988655444445


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||++ +++.+++.....    ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            7899999997 489998875432    1488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.......         .....||+.|+|||++.
T Consensus       153 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~  180 (288)
T cd07863         153 GLARIYSCQMA---------LTPVVVTLWYRAPEVLL  180 (288)
T ss_pred             CccccccCccc---------CCCccccccccCchHhh
Confidence            99986543211         11245899999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=238.98  Aligned_cols=167  Identities=25%  Similarity=0.400  Sum_probs=143.5

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccC
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMG  617 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~  617 (725)
                      -++|+|.||+||.|++..++..+|||.+..+.....+-...||.+-++++|.|||+++|.+....     +.-|.||-++
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFMEqVP  655 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFMEQVP  655 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEeecCC
Confidence            47999999999999999999999999998776666677889999999999999999999976655     7789999999


Q ss_pred             CCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCceEEcccccccccccC
Q 048668          618 NGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       618 ~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-~~~~~kl~Dfgla~~~~~~  696 (725)
                      ||+|.+.++..-+   +.+-.+..+-.+.+||++||.|||++   .|||||||-+|||+. -.|.+||+|||-++.+..-
T Consensus       656 GGSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi  729 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI  729 (1226)
T ss_pred             CCcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence            9999999986543   12236788888999999999999999   999999999999997 4799999999999876432


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                              ...+.++.||..|||||++
T Consensus       730 --------nP~TETFTGTLQYMAPEvI  748 (1226)
T KOG4279|consen  730 --------NPCTETFTGTLQYMAPEVI  748 (1226)
T ss_pred             --------CccccccccchhhhChHhh
Confidence                    1223457899999999986

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.93  E-value=7e-26  Score=242.40  Aligned_cols=182  Identities=25%  Similarity=0.408  Sum_probs=144.0

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEeecC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSST  601 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  601 (725)
                      ...++|++.+.||+|+||.||+|++..     ++..||||+++... ....+.+.+|+++++++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            345688899999999999999998743     23579999997543 233567899999999996 99999999998655


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCcc-------------------------------------------------
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-------------------------------------------------  632 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------  632 (725)
                      .     ..|+|||||++|+|.+++.......                                                 
T Consensus       114 ~-----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         114 G-----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             C-----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            4     7899999999999999987532100                                                 


Q ss_pred             -----------------------------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          633 -----------------------------------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       633 -----------------------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                                                               ....+++..+..++.|++.|++|||+.   +|+||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence                                                     012477888899999999999999998   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+++.++.+||+|||+++.........      ......+++.|||||++.
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  312 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYV------SKGSTFLPVKWMAPESIF  312 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceecccccccc------ccCCcCCCcceEChhhhc
Confidence            99999999999999999998654321111      111235788999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-26  Score=256.71  Aligned_cols=177  Identities=28%  Similarity=0.482  Sum_probs=144.6

Q ss_pred             CCCCcccccccceEEEEEEECCC-c----eEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          534 FSSSNMIGQGSFGSVYKGILGED-E----MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+..+.||+|+||.||.|...+- +    ..||||.++.. +.+...+|.+|+.+|++++|||||+++|+|....     
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-----  768 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-----  768 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-----
Confidence            34567899999999999987532 2    34899988754 4567789999999999999999999999998754     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCcc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ..+|++|||+||||..||++.+... ....++..+.+.++.|||+|+.||+++   ++|||||..+|+|++....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            7899999999999999999763221 133578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+.+.+..++.....      ..-...|||||.++
T Consensus       846 FGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~  877 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGE------AMLPVKWMPPESLK  877 (1025)
T ss_pred             cchhHhhhhchheeccCc------cccceecCCHHHHh
Confidence            999996554444332211      12346899999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-28  Score=238.62  Aligned_cols=321  Identities=18%  Similarity=0.154  Sum_probs=214.3

Q ss_pred             eeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCC-
Q 048668           89 YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ-  167 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~-  167 (725)
                      ..+.++-.++ .+|.+.   .+....++|..|+|+.+++.+|+.+++|+.||||+|.|+.|.+++|.++++|..|-+-+ 
T Consensus        50 ~VdCr~~GL~-eVP~~L---P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~  125 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANL---PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN  125 (498)
T ss_pred             eEEccCCCcc-cCcccC---CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence            4566666676 777653   45677788888888888888888888888888888888888888887777765554444 


Q ss_pred             ccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEeccc
Q 048668          168 NNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN  247 (725)
Q Consensus       168 N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N  247 (725)
                      |+|+.++.      ..|.++.+                         ++.|.+..|++.......|+.+++|..|.+..|
T Consensus       126 NkI~~l~k------~~F~gL~s-------------------------lqrLllNan~i~Cir~~al~dL~~l~lLslyDn  174 (498)
T KOG4237|consen  126 NKITDLPK------GAFGGLSS-------------------------LQRLLLNANHINCIRQDALRDLPSLSLLSLYDN  174 (498)
T ss_pred             Cchhhhhh------hHhhhHHH-------------------------HHHHhcChhhhcchhHHHHHHhhhcchhcccch
Confidence            55554443      22333333                         344444444444455556666667777777777


Q ss_pred             ccCCCCChhhcCCCCccEEeccCccccc------------CCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccc
Q 048668          248 QLHGTIPDVIGELKNLQLLGLYKNFLQG------------SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQ  315 (725)
Q Consensus       248 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~  315 (725)
                      .+..+....|.++..++++.+..|.+..            ..|..++...-..-..+.++++.            .++..
T Consensus       175 ~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~------------q~~a~  242 (498)
T KOG4237|consen  175 KIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRIN------------QEDAR  242 (498)
T ss_pred             hhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhc------------ccchh
Confidence            7775555577777777777777766321            11222222222222222222222            33332


Q ss_pred             ccccc--cccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCC
Q 048668          316 LLSIT--TLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK  393 (725)
Q Consensus       316 ~~~~~--~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  393 (725)
                      -|...  .+...+....+....-+...|.++++|++|+|++|+|+++-+.+|.+...+++|+|..|+|..+....|.++.
T Consensus       243 kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls  322 (498)
T KOG4237|consen  243 KFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLS  322 (498)
T ss_pred             hhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccc
Confidence            22111  1111222233333323345699999999999999999999999999999999999999999988888999999


Q ss_pred             CCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCC
Q 048668          394 SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       394 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                      .|+.|+|.+|+|+..-|.+|..+.+|.+|+|-.|+|.|.+--.+.-.+++.-...||+ .|+.|
T Consensus       323 ~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~-~Cq~p  385 (498)
T KOG4237|consen  323 GLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP-RCQSP  385 (498)
T ss_pred             cceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC-CCCCC
Confidence            9999999999999999999999999999999999999888755443444443345554 46544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.93  E-value=1.2e-25  Score=231.18  Aligned_cols=170  Identities=25%  Similarity=0.380  Sum_probs=142.7

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      |+..+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++++++|++|+++++.+...+     ..|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----ALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EEE
Confidence            667789999999999999999999999999987542   222356778999999999999999999876544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.++|+|||++
T Consensus        77 lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            99999999999999865432    2588999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ........         .....||..|||||++.
T Consensus       150 ~~~~~~~~---------~~~~~g~~~y~aPE~~~  174 (285)
T cd05630         150 VHVPEGQT---------IKGRVGTVGYMAPEVVK  174 (285)
T ss_pred             eecCCCcc---------ccCCCCCccccChHHHc
Confidence            76432211         11246999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=217.60  Aligned_cols=172  Identities=26%  Similarity=0.358  Sum_probs=143.8

Q ss_pred             HhcCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+++|++. ++||-|-.|+|-.|.++.+|+.+|+|++...     ....+|++.--.. .|||||.++++|... +++..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            45667654 6899999999999999999999999998533     3345788876665 499999999997654 67778


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHV  684 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl  684 (725)
                      ...+|||.|+||+|.+.+++++..    .++|.++..|+.||+.|++|||+.   +|.||||||+|+|...   +..+|+
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            889999999999999999987743    699999999999999999999999   9999999999999974   457999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+|+.....         ....+.|-||+|.|||+.
T Consensus       206 tDfGFAK~t~~~---------~~L~TPc~TPyYvaPevl  235 (400)
T KOG0604|consen  206 TDFGFAKETQEP---------GDLMTPCFTPYYVAPEVL  235 (400)
T ss_pred             cccccccccCCC---------ccccCCcccccccCHHHh
Confidence            999999875432         122236789999999985

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=1.6e-25  Score=230.38  Aligned_cols=169  Identities=25%  Similarity=0.359  Sum_probs=142.2

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ....+.+.+|++++++++|++|+++++++...+     ..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----ALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EEE
Confidence            666788999999999999999899999999986542   223356788999999999999999998876554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999998865432    1589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......         .....|++.|+|||++
T Consensus       150 ~~~~~~~~---------~~~~~g~~~~~aPE~~  173 (285)
T cd05632         150 VKIPEGES---------IRGRVGTVGYMAPEVL  173 (285)
T ss_pred             eecCCCCc---------ccCCCCCcCccChHHh
Confidence            76432211         1124699999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1e-25  Score=243.69  Aligned_cols=168  Identities=27%  Similarity=0.357  Sum_probs=141.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ...|.+.+.||+|+||.||+|++..+++.||||...      ...+.+|++++++++||||+++++++....     ..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEE
Confidence            447889999999999999999999999999999642      234568999999999999999999876654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|||++. ++|.+++.....     .+++.+++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus       237 lv~e~~~-~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999994 699998865432     589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +........      ......+||+.|||||++.
T Consensus       308 ~~~~~~~~~------~~~~~~~GT~~Y~APE~~~  335 (461)
T PHA03211        308 CFARGSWST------PFHYGIAGTVDTNAPEVLA  335 (461)
T ss_pred             eeccccccc------ccccccCCCcCCcCHHHHc
Confidence            865432111      1112357999999999864

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.93  E-value=1.5e-25  Score=238.63  Aligned_cols=175  Identities=23%  Similarity=0.321  Sum_probs=142.7

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKG  605 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  605 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||+|++...  ......++.+|+.+++.++||||+++++++.... +..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3457899999999999999999999989999999998643  2334567889999999999999999999875443 122


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....|+||||+++ ++.+.+..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence            3357999999965 67766642        367888899999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.......         .....||+.|+|||++.
T Consensus       166 Dfg~a~~~~~~~~---------~~~~~~t~~y~aPE~~~  195 (359)
T cd07876         166 DFGLARTACTNFM---------MTPYVVTRYYRAPEVIL  195 (359)
T ss_pred             cCCCccccccCcc---------CCCCcccCCCCCchhcc
Confidence            9999975432211         11246899999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.7e-25  Score=236.77  Aligned_cols=174  Identities=25%  Similarity=0.344  Sum_probs=144.1

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KG  605 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~  605 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            45678999999999999999999998899999999986432  2234567899999999999999999988653321 22


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....|++||++ +++|.++++..       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence            23578999998 78999887643       488999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+++.....           ....+||+.|+|||++.
T Consensus       161 Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~  188 (343)
T cd07878         161 DFGLARQADDE-----------MTGYVATRWYRAPEIML  188 (343)
T ss_pred             CCccceecCCC-----------cCCccccccccCchHhc
Confidence            99999865321           11246999999999863

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=2.5e-26  Score=253.80  Aligned_cols=188  Identities=24%  Similarity=0.382  Sum_probs=146.1

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC---
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF---  603 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  603 (725)
                      .+-..+|+..+.+|+|+||.||+++.+-+|+.||||+|.... ......+.+|+..+++++|||||+++..|.....   
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            445668888999999999999999999999999999998663 3345678899999999999999999966531110   


Q ss_pred             --------------------------------------------------------------------------------
Q 048668          604 --------------------------------------------------------------------------------  603 (725)
Q Consensus       604 --------------------------------------------------------------------------------  603 (725)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --C-----------------------------CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHH
Q 048668          604 --K-----------------------------GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA  652 (725)
Q Consensus       604 --~-----------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~  652 (725)
                        +                             .....||=||||+.-.+++++++....     -.....++++++|++|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHH
Confidence              0                             002468889999998888888765421     1356789999999999


Q ss_pred             HHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc------cC----CCCCCCCCCcccccccCCccccCCCc
Q 048668          653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS------SH----HLDTSSKTPSSSIGIKGTVGYVAPGK  722 (725)
Q Consensus       653 l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~------~~----~~~~~~~~~~~~~~~~gt~~y~aPE~  722 (725)
                      |+|+|+.   +||||||||.||++|.++.|||+|||+|+...      +.    ............++.+||.-|+|||+
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999   99999999999999999999999999998721      00    00011111123446789999999998


Q ss_pred             c
Q 048668          723 F  723 (725)
Q Consensus       723 ~  723 (725)
                      +
T Consensus       787 l  787 (1351)
T KOG1035|consen  787 L  787 (1351)
T ss_pred             h
Confidence            6

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=2.2e-25  Score=228.80  Aligned_cols=165  Identities=24%  Similarity=0.303  Sum_probs=137.5

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccch---HHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      ...||+|++|.||+|++  +|+.||||+++......   .+.|.+|++++++++||||++++|++.... +.....++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEE
Confidence            36799999999999998  68899999997543322   467889999999999999999999986521 2224678999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++....+++.|++.|++|+|+..  +++||||||+||+++.++.+||+|||+++..
T Consensus       102 Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        102 EYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            9999999999998654      5788899999999999999999732  7889999999999999999999999999865


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ....           ....||..|+|||++
T Consensus       174 ~~~~-----------~~~~~~~~y~aPE~~  192 (283)
T PHA02988        174 SSPP-----------FKNVNFMVYFSYKML  192 (283)
T ss_pred             cccc-----------ccccCcccccCHHHh
Confidence            3221           124589999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.93  E-value=2.8e-25  Score=231.22  Aligned_cols=169  Identities=24%  Similarity=0.363  Sum_probs=144.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..++..||+|.+.... ....+++.+|++++++++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEE
Confidence            36888999999999999999999999999999987543 233467889999999999999999999976554     889


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.++++...      .+++..+..++.|++.||+|||+.+  +++||||||+||+++.++.+||+|||++
T Consensus        76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence            9999999999999997653      5788999999999999999999732  8999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......          ....+|++.|+|||++
T Consensus       148 ~~~~~~~----------~~~~~~~~~~~aPE~~  170 (308)
T cd06615         148 GQLIDSM----------ANSFVGTRSYMSPERL  170 (308)
T ss_pred             ccccccc----------cccCCCCcCccChhHh
Confidence            7553221          1125689999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=3.2e-25  Score=228.32  Aligned_cols=176  Identities=28%  Similarity=0.443  Sum_probs=142.9

Q ss_pred             cCCCCCcccccccceEEEEEEE----CCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+|+..+.||+|+||.||+|+.    ..++..||+|.+........+.+.+|++++++++||||+++++++...+   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence            4688889999999999999974    4568899999987665555678899999999999999999999875432   23


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence            57899999999999999975432     478999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++..........     ......++..|+|||++
T Consensus       153 g~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~  183 (284)
T cd05081         153 GLTKVLPQDKEYYK-----VREPGESPIFWYAPESL  183 (284)
T ss_pred             cccccccCCCccee-----ecCCCCCceEeeCHHHh
Confidence            99987643211100     00012245569999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-25  Score=229.64  Aligned_cols=171  Identities=24%  Similarity=0.393  Sum_probs=147.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|++.+.||+|+||.||+|.+..++..||+|++........+.|.+|++++++++||||+++++++....     ..|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEEE
Confidence            46888899999999999999998889999999998665556678999999999999999999999876544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++.....     .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          80 LIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             EeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence            9999999999999876432     588999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......||+.|+|||++
T Consensus       152 ~~~~~~~--------~~~~~~~~~~y~~PE~~  175 (280)
T cd06611         152 KNKSTLQ--------KRDTFIGTPYWMAPEVV  175 (280)
T ss_pred             hhccccc--------ccceeecchhhcCHHHH
Confidence            6432211        11224689999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.3e-25  Score=253.92  Aligned_cols=182  Identities=23%  Similarity=0.393  Sum_probs=146.7

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ....+|++.+.||+|+||.||+|++..++..||+|++....  ......|..|+.++++++|||||++++++....   .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---N   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---C
Confidence            34568999999999999999999999999999999987542  234567899999999999999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEecCCCCCCeeecCC---
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQ----PPMVHGDLKPSNVLLDHD---  679 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~----~~ivHrdlkp~Nill~~~---  679 (725)
                      ...|+||||+++|+|.+++......  ...+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+   
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            4689999999999999999753211  1258999999999999999999998521    259999999999999642   


Q ss_pred             --------------CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 --------------MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 --------------~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                                    +.+||+|||+++.+.....         ....+||+.|||||++.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             cccccccccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHh
Confidence                          3589999999986533211         11256999999999863

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=4e-25  Score=223.24  Aligned_cols=167  Identities=25%  Similarity=0.432  Sum_probs=137.1

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      +.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++....     ..|+||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence            36899999999999998899999999886432 233467899999999999999999999976554     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++.....
T Consensus        76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999975432     478999999999999999999998   9999999999999999999999999998764322


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....      .....++..|+|||++
T Consensus       148 ~~~~~------~~~~~~~~~y~aPE~~  168 (252)
T cd05084         148 VYAST------GGMKQIPVKWTAPEAL  168 (252)
T ss_pred             ccccc------CCCCCCceeecCchhh
Confidence            11100      0112245679999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=4.2e-25  Score=227.14  Aligned_cols=169  Identities=24%  Similarity=0.390  Sum_probs=144.2

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      |++.+.||+|+||.||+|++..++..+|+|.+........+.+.+|+++++.++||||+++++++....     ..|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEEE
Confidence            567788999999999999999899999999997655555678899999999999999999999876554     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||++++++.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++..
T Consensus        82 e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          82 EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999998865321     588999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....        ......||+.|+|||++
T Consensus       154 ~~~~~--------~~~~~~~~~~y~aPE~~  175 (282)
T cd06643         154 TRTIQ--------RRDSFIGTPYWMAPEVV  175 (282)
T ss_pred             ccccc--------ccccccccccccCHhhc
Confidence            32211        11124689999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=2e-25  Score=230.14  Aligned_cols=186  Identities=23%  Similarity=0.322  Sum_probs=151.5

Q ss_pred             HHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       524 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ++.+....++|+..+.||+|+||.||+|++..+++.||+|++.... ....++.+|+.+++++ +||||+++++++....
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455567788999999999999999999999899999999886432 2335678899999999 6999999999886554


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      ....+..++||||+++++|.+++......  ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence            44455789999999999999988643211  12578889999999999999999998   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++|||+++.+.....        ......|++.|+|||++
T Consensus       164 kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             EEccCCceeecccCCC--------ccccccCCCcccChhhh
Confidence            9999999986543211        11124699999999975

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.93  E-value=4.1e-25  Score=231.28  Aligned_cols=174  Identities=24%  Similarity=0.313  Sum_probs=135.4

Q ss_pred             CcccccccceEEEEEEEC--CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          537 SNMIGQGSFGSVYKGILG--EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      .+.||+|+||.||+|++.  .+++.||+|.+....  ....+.+|++++++++||||+++++++....   ....|+|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence            468999999999999965  467889999986432  2345779999999999999999999875432   236899999


Q ss_pred             ccCCCCHHHHhcccCCc---cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCceEEccc
Q 048668          615 YMGNGSLEDWLHQSNDQ---VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDF  687 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill----~~~~~~kl~Df  687 (725)
                      |++ +++.+++......   .....+++..+..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            995 5898887643211   1123588999999999999999999999   99999999999999    45678999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+........     ........||+.|||||++.
T Consensus       157 G~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~  188 (317)
T cd07868         157 GFARLFNSPLKP-----LADLDPVVVTFWYRAPELLL  188 (317)
T ss_pred             CceeccCCCCcc-----ccccCCccccccccCCHHHc
Confidence            999876432111     11112356899999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.4e-25  Score=229.98  Aligned_cols=172  Identities=19%  Similarity=0.157  Sum_probs=130.8

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECC-CceEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCcccceeeEeecC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      ......|+..+.||+|+||+||+|+++. +++.||||++...     .....+.|.+|++++++++|+|++..+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3456689999999999999999999875 6777899987532     122346789999999999999998533221   


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeecCCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL-KPSNVLLDHDM  680 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl-kp~Nill~~~~  680 (725)
                           +..|+||||++|++|... ..         ..   ...++.|+++||+|+|+.   +|+|||| ||+||+++.++
T Consensus        91 -----~~~~LVmE~~~G~~L~~~-~~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLHLA-RP---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             -----CCcEEEEEccCCCCHHHh-Cc---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence                 246899999999999732 11         11   135788999999999998   9999999 99999999999


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+||+|||+|+.+..............-.+..+++.|+|||.+
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            9999999999987543221111111112356799999999975

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=2.7e-25  Score=227.25  Aligned_cols=179  Identities=25%  Similarity=0.378  Sum_probs=147.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCC-cc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKG-VD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~-~~  607 (725)
                      +.+.|+..+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++++ +||||+++++++....... ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            45678888999999999999999998999999999875432 346788999999998 6999999999987543222 24


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+|||+||+||+++.++.+||+||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            68999999999999999986432    2578999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.......        ......|++.|+|||++.
T Consensus       156 g~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         156 GVSAQLDRTVG--------RRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             CCceecccccc--------cCCcccccccccCHhHhc
Confidence            99976532211        112356999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.93  E-value=2.1e-25  Score=237.23  Aligned_cols=175  Identities=22%  Similarity=0.300  Sum_probs=143.2

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKG  605 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  605 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.... +..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45678999999999999999999998899999999986432  233467889999999999999999999875432 223


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....|+||||+++ ++.+++..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence            3457999999965 67777642        367888899999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.......         .....||+.|+|||++.
T Consensus       162 Dfg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~  191 (355)
T cd07874         162 DFGLARTAGTSFM---------MTPYVVTRYYRAPEVIL  191 (355)
T ss_pred             eCcccccCCCccc---------cCCccccCCccCHHHHc
Confidence            9999976533211         11246899999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=3.4e-25  Score=235.21  Aligned_cols=166  Identities=23%  Similarity=0.355  Sum_probs=139.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ...+|++.+.||+|+||.||+|++..+++.||+|+....      ....|+.++++++||||+++++++....     ..
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----IT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-----ee
Confidence            345799999999999999999999989999999975322      2346999999999999999999977654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+. +++.+++.....     .+++..+..|+.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             EEEEEccC-CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence            99999994 689998875432     588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++.....         ....+..||+.|+|||++.
T Consensus       204 a~~~~~~---------~~~~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        204 AQFPVVA---------PAFLGLAGTVETNAPEVLA  229 (357)
T ss_pred             ccccccC---------cccccccccccccCCeecC
Confidence            9753221         1112356999999999864

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=4.7e-25  Score=223.35  Aligned_cols=171  Identities=30%  Similarity=0.495  Sum_probs=140.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||.||+|+++ ++..+|+|.+.... ...+.+.+|++++++++||||+++++++....     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEE
Confidence            46888899999999999999886 45679999886432 23467889999999999999999999876544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++|+|.++++....     .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+|++|||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence            9999999999999975432     478899999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ........       ......++..|+|||++.
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~  174 (256)
T cd05114         149 YVLDDEYT-------SSSGAKFPVKWSPPEVFN  174 (256)
T ss_pred             ccCCCcee-------ccCCCCCchhhCChhhcc
Confidence            65332111       111234667899999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=5.3e-25  Score=227.55  Aligned_cols=171  Identities=25%  Similarity=0.358  Sum_probs=146.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....     ..|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEE
Confidence            56888899999999999999999899999999997665556678899999999999999999999876544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||++++++..++.+...     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999988765432     578999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......|++.|+|||++
T Consensus       159 ~~~~~~~--------~~~~~~~~~~y~aPE~~  182 (292)
T cd06644         159 KNVKTLQ--------RRDSFIGTPYWMAPEVV  182 (292)
T ss_pred             ecccccc--------ccceecCCccccCceee
Confidence            5422211        11124588999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.93  E-value=5.5e-25  Score=224.07  Aligned_cols=176  Identities=23%  Similarity=0.363  Sum_probs=144.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+....     ....+.+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence            47888999999999999999999899999999986432     123457889999999999999999999865432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++++|.+++....      .+++..+.+++.|++.||+|+|+.   +|+|+||||+||+++.++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            36789999999999999997543      467888899999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||.++.........     .......|+..|+|||++.
T Consensus       150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         150 FGASKRLQTICLSG-----TGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             Cccccccccccccc-----cccccCCCCccccChhhhc
Confidence            99998653221110     1112245899999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.93  E-value=4.1e-25  Score=228.61  Aligned_cols=169  Identities=25%  Similarity=0.396  Sum_probs=145.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+........+.+.+|+++++.++||||+++++++....     ..|+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEE
Confidence            47888899999999999999998899999999998765555678899999999999999999999876544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++...       .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        95 v~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             eecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            99999999999998643       368889999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........        .....|++.|+|||.+
T Consensus       165 ~~~~~~~~--------~~~~~~~~~y~aPE~~  188 (296)
T cd06654         165 QITPEQSK--------RSTMVGTPYWMAPEVV  188 (296)
T ss_pred             hccccccc--------cCcccCCccccCHHHH
Confidence            65332111        1124689999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=2.2e-25  Score=226.30  Aligned_cols=168  Identities=33%  Similarity=0.541  Sum_probs=142.1

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccch--HHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |+..+.||+|+||+||+|++..+++.||+|++.......  .....+|+.++++++||||+++++++....     ..++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccc
Confidence            566789999999999999999999999999998664322  223456999999999999999999987644     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++....      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||.+.
T Consensus        76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            999999999999998333      589999999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......        .......+|..|+|||++
T Consensus       147 ~~~~~~--------~~~~~~~~~~~y~aPE~~  170 (260)
T PF00069_consen  147 KLSENN--------ENFNPFVGTPEYMAPEVL  170 (260)
T ss_dssp             ESTSTT--------SEBSSSSSSGGGSCHHHH
T ss_pred             cccccc--------cccccccccccccccccc
Confidence            641111        111235689999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.92  E-value=5.8e-25  Score=225.53  Aligned_cols=172  Identities=28%  Similarity=0.455  Sum_probs=139.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|+..+.||+|+||+||+|++..++.    .||+|.+.... .....++..|+..+++++||||+++++++...     
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-----   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-----   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence            467888999999999999999876665    47777775332 23346788899999999999999999986432     


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++|+||+++|+|.+++.....     .+++..+..++.||+.|++|+|+.   +++||||||+||+++.++.+||+|
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence             46789999999999999976432     578999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++...+.....      ......|+..|+|||++
T Consensus       153 fg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~  183 (279)
T cd05111         153 FGVADLLYPDDKKY------FYSEHKTPIKWMALESI  183 (279)
T ss_pred             CccceeccCCCccc------ccCCCCCcccccCHHHh
Confidence            99998654321111      11124577899999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.92  E-value=4.8e-25  Score=224.91  Aligned_cols=176  Identities=24%  Similarity=0.355  Sum_probs=144.5

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|++++++++|+||+++++++....     .
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~   79 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-----F   79 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-----E
Confidence            34555666678999999999999998899999999987665555678999999999999999999999976554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDF  687 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Df  687 (725)
                      .++||||+++++|.+++......   ...++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence            89999999999999999764310   1127788889999999999999998   9999999999999986 679999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.+.........        .....|++.|+|||++
T Consensus       154 g~~~~~~~~~~~--------~~~~~~~~~~~aPE~~  181 (268)
T cd06624         154 GTSKRLAGINPC--------TETFTGTLQYMAPEVI  181 (268)
T ss_pred             hhheecccCCCc--------cccCCCCccccChhhh
Confidence            998765322110        1123589999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.92  E-value=3.3e-25  Score=227.28  Aligned_cols=180  Identities=25%  Similarity=0.438  Sum_probs=142.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      ..++|+..+.||+|+||.||+|++.     .++..||+|++.... .....++.+|+.+++.++||||+++++++.... 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            4567899999999999999999864     245789999886432 223457889999999999999999999876544 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccc----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                          ..++||||+++|+|.+++.......+    ....++..+..++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        83 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          83 ----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             ----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence                78999999999999999975432111    12457788899999999999999998   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+|++|||+++..........      .....+++.|||||++
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~  193 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRK------GGKGLLPVRWMSPESL  193 (277)
T ss_pred             CCEEECCCCCccccCCcceeec------CCCCccCHhhcChhHh
Confidence            9999999999976533211110      0113467889999985

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.92  E-value=6.3e-25  Score=224.57  Aligned_cols=180  Identities=27%  Similarity=0.446  Sum_probs=140.9

Q ss_pred             CCCcccccccceEEEEEEECCCce--EEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCccee
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEM--IVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVDFK  609 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~  609 (725)
                      .+.+.||+|+||.||+|++..++.  .||+|.++..  .....+.+.+|++++++++||||+++++++..... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999876664  6899988654  23445788999999999999999999998754321 122357


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++|+|.+++...........+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999999885432211223588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+.......      ......+++.|+|||+.
T Consensus       159 ~~~~~~~~~~~------~~~~~~~~~~~~~pe~~  186 (272)
T cd05075         159 SKKIYNGDYYR------QGRIAKMPVKWIAIESL  186 (272)
T ss_pred             ccccCccccee------cCCcccCCcccCCHHHc
Confidence            98764332110      01113467789999985

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=5.1e-25  Score=228.01  Aligned_cols=169  Identities=25%  Similarity=0.396  Sum_probs=146.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++....     ..|+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEEE
Confidence            57888999999999999999998899999999997665555677889999999999999999999976554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++.+.       .+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        94 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          94 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             eecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence            99999999999998643       478889999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........        .....|++.|+|||.+
T Consensus       164 ~~~~~~~~--------~~~~~~~~~y~aPE~~  187 (297)
T cd06656         164 QITPEQSK--------RSTMVGTPYWMAPEVV  187 (297)
T ss_pred             EccCCccC--------cCcccCCccccCHHHH
Confidence            65332111        1124589999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.92  E-value=5.6e-25  Score=222.78  Aligned_cols=172  Identities=28%  Similarity=0.388  Sum_probs=146.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|.+...  .....+.+.+|++++++++||||+++++++....     ..|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEE
Confidence            477788999999999999999989999999998754  2334577899999999999999999999876554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+|++|||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999986421    2588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+......        .....|++.|+|||++.
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~  174 (256)
T cd08529         149 KLLSDNTNF--------ANTIVGTPYYLSPELCE  174 (256)
T ss_pred             eeccCccch--------hhccccCccccCHHHhc
Confidence            866433111        11246899999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.92  E-value=7.7e-25  Score=224.70  Aligned_cols=164  Identities=27%  Similarity=0.372  Sum_probs=140.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|++.... ....+++.+|++++++++||||+++++++....     ..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEEE
Confidence            5778899999999999999998899999999987542 233467889999999999999999999977654     7889


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||++++++..+.          .+++..+..++.|++.|++|+|+.   +|+|+||||+||+++.++.+||+|||++.
T Consensus        77 v~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          77 CTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             EEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            99999999997652          367888899999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ......          ....+||..|+|||++.
T Consensus       144 ~~~~~~----------~~~~~~~~~y~aPE~~~  166 (279)
T cd06619         144 QLVNSI----------AKTYVGTNAYMAPERIS  166 (279)
T ss_pred             eccccc----------ccCCCCChhhcCceeec
Confidence            653221          11246999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=5.9e-25  Score=226.93  Aligned_cols=167  Identities=30%  Similarity=0.405  Sum_probs=145.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     .
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----N   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----e
Confidence            36888899999999999999999899999999986432   233467889999999999999999999876554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.+||+|||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            899999999999999997653      588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++.....           .....|++.|+|||.+
T Consensus       147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~  170 (290)
T cd05580         147 FAKRVKGR-----------TYTLCGTPEYLAPEII  170 (290)
T ss_pred             CccccCCC-----------CCCCCCCccccChhhh
Confidence            99865332           1124689999999976

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.92  E-value=3.3e-25  Score=233.22  Aligned_cols=180  Identities=23%  Similarity=0.398  Sum_probs=142.1

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      ++|++.+.||+|+||.||+|++.     .+++.||+|+++... ....+.+.+|+++++++ +||||++++++|...+  
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~--   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG--   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC--
Confidence            47888999999999999999753     345789999987432 23346788999999999 7999999999876543  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCc-----------------------------------------------------
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQ-----------------------------------------------------  631 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  631 (725)
                        ...++||||+++|+|.+++......                                                     
T Consensus        85 --~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          85 --GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             --CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence              3678999999999999998643210                                                     


Q ss_pred             --cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccc
Q 048668          632 --VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI  709 (725)
Q Consensus       632 --~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~  709 (725)
                        .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+.+.......      ...
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~~  233 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKG  233 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hcc
Confidence              0012578999999999999999999998   99999999999999999999999999998764322111      111


Q ss_pred             cccCCccccCCCccc
Q 048668          710 GIKGTVGYVAPGKFF  724 (725)
Q Consensus       710 ~~~gt~~y~aPE~~~  724 (725)
                      ...++..|||||++.
T Consensus       234 ~~~~~~~y~aPE~~~  248 (337)
T cd05054         234 DARLPLKWMAPESIF  248 (337)
T ss_pred             CCCCCccccCcHHhc
Confidence            234678899999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=5.8e-25  Score=223.60  Aligned_cols=172  Identities=26%  Similarity=0.550  Sum_probs=143.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|+..+.||+|+||.||+|.++.+++.||+|++... .....++.+|++++++++||||+++++++....     ..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcEE
Confidence            4577888999999999999999888999999998643 234567899999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++.....    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999999975432    2578899999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .........       .....++..|+|||++
T Consensus       153 ~~~~~~~~~-------~~~~~~~~~y~aPE~~  177 (263)
T cd05052         153 LMTGDTYTA-------HAGAKFPIKWTAPESL  177 (263)
T ss_pred             ccccceeec-------cCCCCCccccCCHHHh
Confidence            764321110       0112356789999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=8.3e-25  Score=222.49  Aligned_cols=173  Identities=24%  Similarity=0.412  Sum_probs=144.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-----chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.+.....     ...+.+.+|++++++++||||+++++++....    
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE----   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence            468889999999999999999988999999999864321     12357889999999999999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        78 -~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          78 -TLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             -eEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence             8899999999999999987654      478888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++..........     ......|+..|+|||++
T Consensus       148 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~  179 (263)
T cd06625         148 FGASKRLQTICSSGT-----GMKSVTGTPYWMSPEVI  179 (263)
T ss_pred             cccceeccccccccc-----cccCCCcCccccCccee
Confidence            999976543211110     00124588999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.92  E-value=5e-25  Score=232.81  Aligned_cols=180  Identities=23%  Similarity=0.386  Sum_probs=141.2

Q ss_pred             cCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      ++|+..+.||+|+||+||+|++     ..+++.||||+++... ....+.+.+|++++.++ +||||+++++++....  
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG--   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence            4788999999999999999985     2467899999997543 23356788999999999 5899999999876443  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCcc----------------------------------------------------
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQV----------------------------------------------------  632 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------------------------------------------  632 (725)
                        ...++||||+++|+|.+++.......                                                    
T Consensus        85 --~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          85 --GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             --CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence              36789999999999999987532100                                                    


Q ss_pred             ---------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCCC
Q 048668          633 ---------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK  703 (725)
Q Consensus       633 ---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  703 (725)
                               ....+++..+.+++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+++.........   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---  236 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---  236 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchh---
Confidence                     012367888899999999999999998   99999999999999999999999999998653321111   


Q ss_pred             CCcccccccCCccccCCCccc
Q 048668          704 TPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       704 ~~~~~~~~~gt~~y~aPE~~~  724 (725)
                         ......++..|+|||++.
T Consensus       237 ---~~~~~~~~~~y~aPE~~~  254 (343)
T cd05103         237 ---RKGDARLPLKWMAPETIF  254 (343)
T ss_pred             ---hcCCCCCCcceECcHHhc
Confidence               111133677899999763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.92  E-value=4.4e-25  Score=225.09  Aligned_cols=175  Identities=26%  Similarity=0.428  Sum_probs=145.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....   .....++.+|++++++++||||+++++++....     .
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence            57889999999999999999998899999999886432   233457889999999999999999999876543     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++|+|.+++......  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            89999999999999988643211  12478899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++.......        ......|++.|+|||.+.
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~  179 (267)
T cd08228         152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             cceeccchhH--------HHhcCCCCccccChhhhc
Confidence            9987643211        111245889999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.92  E-value=4e-25  Score=236.40  Aligned_cols=184  Identities=24%  Similarity=0.397  Sum_probs=144.8

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEee
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICS  599 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  599 (725)
                      +....++|...+.||+|+||.||+|+++     .+++.||+|+++... ....+.+.+|++++.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344557888899999999999999864     345689999997543 233457889999999998 999999999986


Q ss_pred             cCCCCCcceeeEEEeccCCCCHHHHhcccCCc------------------------------------------------
Q 048668          600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ------------------------------------------------  631 (725)
Q Consensus       600 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------  631 (725)
                      ...     ..++||||+++|+|.++++.....                                                
T Consensus       112 ~~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         112 KGG-----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             cCC-----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            654     789999999999999999754210                                                


Q ss_pred             --------------------------------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 048668          632 --------------------------------------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHG  667 (725)
Q Consensus       632 --------------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHr  667 (725)
                                                                  .....+++..++.++.|++.||+|||+.   +|+||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHr  263 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHR  263 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcc
Confidence                                                        0012467788899999999999999998   99999


Q ss_pred             CCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          668 DLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       668 dlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||||+||+++.++.+|++|||+++.+.......      ......|++.|||||++.
T Consensus       264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYI------SKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             cCCcceEEEeCCCEEEEEecCcceecccccccc------cCCCcCCCCceeChHHhc
Confidence            999999999999999999999998653321110      111235788999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=230.63  Aligned_cols=168  Identities=29%  Similarity=0.534  Sum_probs=143.2

Q ss_pred             CCCcccccccceEEEEEEECC----CceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          535 SSSNMIGQGSFGSVYKGILGE----DEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +..+.||+|.||.||+|....    ...-||||.-+.+ .....+.|+.|+.+|++++||||++++|+|...      ..
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~  465 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM  465 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence            345789999999999998742    2346899988764 344568899999999999999999999999765      48


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|||.++-|.|..|++....     .++......++.||+.||+|||+.   ++|||||..+|||+....-||++|||+
T Consensus       466 WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             eEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence            999999999999999997764     588888899999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|.+.+..++..+.       ..-...|||||-+
T Consensus       538 SR~~ed~~yYkaS~-------~kLPIKWmaPESI  564 (974)
T KOG4257|consen  538 SRYLEDDAYYKASR-------GKLPIKWMAPESI  564 (974)
T ss_pred             hhhccccchhhccc-------cccceeecCcccc
Confidence            99998776554331       2345679999976

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.92  E-value=6.4e-25  Score=225.91  Aligned_cols=178  Identities=27%  Similarity=0.501  Sum_probs=143.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCc-----eEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDE-----MIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++|+..+.||+|+||.||+|.+...+     ..||+|.+..... ....+|.+|++++++++||||+++++++....   
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ---   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence            46888899999999999999875444     6899999864432 33467899999999999999999999876544   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccc----------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVE----------VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  675 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil  675 (725)
                        ..|++|||+++|+|.+++.......+          ...+++..++.++.|++.|++|||+.   +++||||||+||+
T Consensus        82 --~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          82 --PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence              68999999999999999976432111          13578889999999999999999999   9999999999999


Q ss_pred             ecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          676 LDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       676 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.++.+||+|||+++........      .......+++.|||||++
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  198 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAI  198 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccc------cccCCCcccccccCHHHh
Confidence            999999999999999765332111      111123578899999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.92  E-value=4e-25  Score=235.80  Aligned_cols=173  Identities=22%  Similarity=0.294  Sum_probs=142.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... +...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999989999999998643  2334467889999999999999999998865432 2233


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...|+||||+++ ++.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence            467999999965 78777742        367888899999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+......         ......||+.|+|||++
T Consensus       170 fG~a~~~~~~~---------~~~~~~~t~~y~aPE~~  197 (364)
T cd07875         170 FGLARTAGTSF---------MMTPYVVTRYYRAPEVI  197 (364)
T ss_pred             CCCccccCCCC---------cccCCcccCCcCCHHHH
Confidence            99997653221         11124689999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=6.3e-25  Score=228.05  Aligned_cols=171  Identities=25%  Similarity=0.447  Sum_probs=142.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|+++.+++.||+|.++... ......+.+|++++++++||||+++++++....     ..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eE
Confidence            357888999999999999999999899999999997543 233456789999999999999999999976544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||++ ++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  150 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL  150 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence            99999997 599998876432     478889999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.......        ......+++.|+|||++
T Consensus       151 ~~~~~~~~~--------~~~~~~~~~~y~~PE~~  176 (301)
T cd07873         151 ARAKSIPTK--------TYSNEVVTLWYRPPDIL  176 (301)
T ss_pred             hhccCCCCC--------cccccceeecccCcHHH
Confidence            975432211        11123578999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.92  E-value=6.1e-25  Score=225.70  Aligned_cols=178  Identities=30%  Similarity=0.514  Sum_probs=144.1

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++|...+.||+|+||.||+|++.     .+++.||||++...... ..+.+.+|++++++++||||+++++++....   
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD---   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC---
Confidence            46778899999999999999874     34578999998755433 4578999999999999999999999976654   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCC--------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSND--------QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                        ..++||||+++++|.+++.....        ......+++..+..++.|++.|++|+|+.   +++||||||+||+++
T Consensus        82 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~  156 (280)
T cd05049          82 --PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG  156 (280)
T ss_pred             --CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc
Confidence              78999999999999999976532        11123578899999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .++.+||+|||+++.........      ......+++.|+|||++
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~  196 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYR------VGGHTMLPIRWMPPESI  196 (280)
T ss_pred             CCCeEEECCcccceecccCccee------cCCCCcccceecChhhh
Confidence            99999999999997653221110      01123467899999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.92  E-value=8.6e-26  Score=230.72  Aligned_cols=171  Identities=26%  Similarity=0.400  Sum_probs=144.2

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------chHHHHHHHHHHHHcCC---CCcccceeeE
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFRSFVAECEALRNIR---HRNLIKIITI  597 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~  597 (725)
                      +...+|+..+.+|+|+||+|+.|.++....+|+||.|.+.+-        ...-..--||+||+.++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            445578899999999999999999999999999999864321        11123446999999998   9999999999


Q ss_pred             eecCCCCCcceeeEEEecc-CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          598 CSSTDFKGVDFKALVFEYM-GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       598 ~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      +     ++.+++|++||-. +|-+|.++|..+.      .++|.++..|++||+.|+++||++   +|||||||-+|+.+
T Consensus       638 F-----Eddd~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv  703 (772)
T KOG1152|consen  638 F-----EDDDYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV  703 (772)
T ss_pred             e-----ecCCeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence            5     4455899999976 4569999998765      589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+|-+|++|||.|.+...+.-+          .++||..|+|||++
T Consensus       704 d~~g~~klidfgsaa~~ksgpfd----------~f~gtv~~aapevl  740 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKSGPFD----------VFVGTVDYAAPEVL  740 (772)
T ss_pred             ecCCeEEEeeccchhhhcCCCcc----------eeeeeccccchhhh
Confidence            99999999999999876543211          37899999999985

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.92  E-value=5.6e-25  Score=224.54  Aligned_cols=170  Identities=25%  Similarity=0.339  Sum_probs=133.2

Q ss_pred             ccccccceEEEEEEEC--CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEec
Q 048668          539 MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      .||+|+||.||+|...  .....+|+|.+.... ......|.+|+++++.++||||+++++++....     ..|+||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEEe
Confidence            5899999999999653  234578888775432 233467889999999999999999999876554     78999999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS  695 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~  695 (725)
                      +++|+|.+++....... ....++.....++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          77 CPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             CCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccccc
Confidence            99999999997654211 11356778889999999999999999   999999999999999999999999999875432


Q ss_pred             CCCCCCCCCCcccccccCCccccCCCcc
Q 048668          696 HHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       696 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....      ......+++.|+|||++
T Consensus       153 ~~~~~------~~~~~~~~~~y~aPE~~  174 (269)
T cd05042         153 EDYYI------TKDCHAVPLRWLAPELV  174 (269)
T ss_pred             chhee------ccCCCCCcccccCHHHH
Confidence            21110      01123467889999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.4e-26  Score=224.35  Aligned_cols=173  Identities=24%  Similarity=0.343  Sum_probs=146.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  605 (725)
                      ...+|....+||+|+||+|-.|..+.+.+.||||+++++   +..+.+--+.|-++|+--. -|.++++..+     |++
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQT  421 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQT  421 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhh
Confidence            345788899999999999999999999999999999754   2334455567888888775 6788888876     677


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      .+..|.||||+.||+|.-.+++.+      .+.+..+..+|.+||-||-|||++   +|++||+|.+||++|.+|.+||+
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence            789999999999999999998776      577788899999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+++.-.-        ...++.++||||.|+|||++.
T Consensus       493 DFGmcKEni~--------~~~TTkTFCGTPdYiAPEIi~  523 (683)
T KOG0696|consen  493 DFGMCKENIF--------DGVTTKTFCGTPDYIAPEIIA  523 (683)
T ss_pred             eccccccccc--------CCcceeeecCCCcccccceEE
Confidence            9999975322        223445689999999999874

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.92  E-value=1e-24  Score=223.09  Aligned_cols=181  Identities=28%  Similarity=0.470  Sum_probs=142.7

Q ss_pred             CCCCcccccccceEEEEEEECC---CceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcc
Q 048668          534 FSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVD  607 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  607 (725)
                      |...+.||+|+||.||+|.+..   ++..||+|+++...  ......+.+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5667899999999999998754   34789999987543  2335678999999999999999999998765442 2333


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++|+|.+++...........+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            5789999999999999986543222223588999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++..........      .....++..|+|||++
T Consensus       158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~  187 (273)
T cd05035         158 GLSKKIYSGDYYRQ------GRIAKMPVKWIAIESL  187 (273)
T ss_pred             cceeeccccccccc------cccccCCccccCHhhc
Confidence            99987643321111      1112356789999975

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.9e-27  Score=217.68  Aligned_cols=181  Identities=25%  Similarity=0.412  Sum_probs=147.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC---
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG---  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  605 (725)
                      .+.|+....||+|.||.||+|+.+.+++.||+|++-.+  +++......+|+++|..++|+|++.+++.|......+   
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            34566678899999999999999999999999987543  3455567789999999999999999999987644222   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....|+||++|+. ||.-.+.....     .++..++.+++.++..||.|+|+.   .|+|||+||+|+||+.+|.+||+
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence            2347999999976 89988876532     688999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.+.........    .-+..+-|.+|.+||.++
T Consensus       167 DFGlar~fs~~~n~~kp----rytnrvvTLwYrppEllL  201 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKP----RYTNRVVTLWYRPPELLL  201 (376)
T ss_pred             ccccccceecccccCCC----CcccceeeeecCCHHHhh
Confidence            99999876543221111    112356799999999875

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=9.2e-25  Score=221.04  Aligned_cols=171  Identities=22%  Similarity=0.345  Sum_probs=144.5

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +|+..+.||+|+||.||++++..+++.||+|.++... ....+.+.+|++++++++||||+++++++....     ..|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEE
Confidence            4778899999999999999999999999999986532 334567889999999999999999999876554     8899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++|++.+++.....    ..+++..++.++.|++.|+.|+|++   +|+|+||||+||+++.++.++++|||.++
T Consensus        76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence            9999999999999875432    1478899999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......|++.|+|||++
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~~aPE~~  172 (255)
T cd08219         149 LLTSPGA--------YACTYVGTPYYVPPEIW  172 (255)
T ss_pred             eeccccc--------ccccccCCccccCHHHH
Confidence            6533211        11124689999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.92  E-value=8.2e-25  Score=225.64  Aligned_cols=179  Identities=27%  Similarity=0.483  Sum_probs=144.2

Q ss_pred             cCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|.+.+.||+|+||.||++..     ..++..||+|.+........+.+.+|++++++++||||+++++++....    
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence            4678889999999999999985     2345679999987655455678999999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCc-------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQ-------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                       ..++||||+++++|.+++......       .....+++..++.++.|++.||+|+|+.   +++||||||+||+++.+
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          81 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             -ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence             789999999999999999754310       1122489999999999999999999998   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+|++|||+++........      .......++..|+|||++.
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~  195 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIM  195 (288)
T ss_pred             CcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhc
Confidence            99999999999865332110      0111234678899999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.92  E-value=9.3e-25  Score=222.51  Aligned_cols=173  Identities=28%  Similarity=0.484  Sum_probs=142.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||.||+|++..+   ...||||.++... .....+|.+|+.++++++||||+++++++....     
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-----   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-----
Confidence            4688899999999999999998643   4579999987543 334567899999999999999999999876544     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++++|.+++.....     .+++..+++++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence            68999999999999999976432     578999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++........      .......++..|+|||.+
T Consensus       151 g~~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~  180 (266)
T cd05033         151 GLSRRLEDSEAT------YTTKGGKIPIRWTAPEAI  180 (266)
T ss_pred             chhhcccccccc------eeccCCCCCccccChhhh
Confidence            999876421110      011123457789999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.92  E-value=3.4e-25  Score=225.05  Aligned_cols=173  Identities=29%  Similarity=0.508  Sum_probs=146.1

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ...+|+..+.||+|+||.||+|++.. +..||+|++.........++.+|+++++.++||||+++++++....     ..
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----PV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----Ce
Confidence            34578889999999999999999986 8899999997665545678899999999999999999999876554     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++|+|.+++.....    ..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence            999999999999999986432    2578999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.........        .....++..|+|||++
T Consensus       151 ~~~~~~~~~~--------~~~~~~~~~~~~PE~~  176 (261)
T cd05148         151 ARLIKEDVYL--------SSDKKIPYKWTAPEAA  176 (261)
T ss_pred             hhhcCCcccc--------ccCCCCceEecCHHHH
Confidence            9765432111        0123467889999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.92  E-value=9.4e-25  Score=224.13  Aligned_cols=174  Identities=27%  Similarity=0.462  Sum_probs=141.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCce----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ..+|+..+.||+|+||+||+|++..++.    .||+|++.... ....+.+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3578888999999999999999866665    48999986543 33456788999999999999999999987643    


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..+++|||+++|+|.+++.....     .+++..++.++.|++.||+|+|+.   +|+||||||+||+++.++.+||+
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence              46799999999999999976432     588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+++.........      ......+++.|||||+..
T Consensus       152 dfG~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~  184 (279)
T cd05109         152 DFGLARLLDIDETEY------HADGGKVPIKWMALESIL  184 (279)
T ss_pred             CCCceeeccccccee------ecCCCccchhhCCHHHhc
Confidence            999998764321110      011123577899999763

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.4e-24  Score=220.71  Aligned_cols=172  Identities=28%  Similarity=0.425  Sum_probs=148.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||.||+|++..+++.+|+|++........+.+.+|++++++++||||+++++++....     ..|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEE
Confidence            57888899999999999999998889999999998765556678999999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      +|||+++++|.+++.....     .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||.+.
T Consensus        78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999876521     588999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......        ......|+..|+|||++.
T Consensus       150 ~~~~~~~--------~~~~~~~~~~y~~Pe~~~  174 (262)
T cd06613         150 QLTATIA--------KRKSFIGTPYWMAPEVAA  174 (262)
T ss_pred             hhhhhhh--------ccccccCCccccCchhhc
Confidence            6543210        111246899999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.92  E-value=1e-24  Score=222.60  Aligned_cols=171  Identities=24%  Similarity=0.390  Sum_probs=135.3

Q ss_pred             cccccccceEEEEEEEC--CCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          538 NMIGQGSFGSVYKGILG--EDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +.||+|+||.||+|++.  .++..+|+|.++.... .....+.+|+.++++++||||+++++++....     ..++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence            36899999999999864  3456799998875432 23457889999999999999999999876544     6799999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |+++|+|.+++...... .....++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+|++|||.++...
T Consensus        76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999754321 112456777888999999999999998   99999999999999999999999999987543


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....      .......|+..|+|||++
T Consensus       152 ~~~~~------~~~~~~~~~~~y~aPE~~  174 (269)
T cd05087         152 KEDYY------VTPDQLWVPLRWIAPELV  174 (269)
T ss_pred             Cccee------ecCCCcCCcccccCHhHh
Confidence            22111      111124578899999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.92  E-value=8.3e-25  Score=225.05  Aligned_cols=178  Identities=24%  Similarity=0.429  Sum_probs=142.0

Q ss_pred             cCCCCCcccccccceEEEEEEE----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|+..+.||+|+||+||+|++    ..++..||+|.+.... ......+.+|++++++++||||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ----   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence            4677889999999999999985    3456789999987433 233467889999999999999999999876554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCc-----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQ-----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  675 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil  675 (725)
                       ..|+||||+++++|.+++......           .....+++.++..++.|++.|++|+|++   +|+||||||+||+
T Consensus        81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence             789999999999999998643210           0122478889999999999999999998   9999999999999


Q ss_pred             ecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          676 LDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       676 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.++.+|++|||+++.........      ......++..|+|||++
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~  198 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYR------VQPKSLLPIRWMPPEAI  198 (283)
T ss_pred             EcCCCcEEeccccccccccCCccee------cccCCCccceecChHHh
Confidence            9999999999999998764322111      11123467889999976

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=1.2e-24  Score=224.13  Aligned_cols=172  Identities=26%  Similarity=0.402  Sum_probs=142.6

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|++..++..||+|++....  ....+.+.+|+.++++++||||+++++++....     ..|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEE
Confidence            4778899999999999999998899999999987542  233467889999999999999999999976544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++ +++.+++.....   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence            9999997 689998865432   12588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        ......+++.|+|||++.
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~  174 (285)
T cd07861         149 RAFGIPVR--------VYTHEVVTLWYRAPEVLL  174 (285)
T ss_pred             eecCCCcc--------cccCCcccccccChHHhc
Confidence            75432210        111235789999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.2e-24  Score=220.41  Aligned_cols=171  Identities=32%  Similarity=0.511  Sum_probs=139.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|+..+.||+|+||.||+|+++ ++..+|+|++.... .....+.+|++++++++||||+++++++....     ..|+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEE
Confidence            35788899999999999999986 56689999986432 23457889999999999999999999875443     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++.....     .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence            9999999999999976432     578999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ...+.....       .....++..|+|||++.
T Consensus       149 ~~~~~~~~~-------~~~~~~~~~y~~Pe~~~  174 (256)
T cd05059         149 YVLDDQYTS-------SQGTKFPVKWAPPEVFD  174 (256)
T ss_pred             ecccccccc-------cCCCCCCccccCHHHhc
Confidence            654321111       01122456899999763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=1e-24  Score=248.29  Aligned_cols=171  Identities=29%  Similarity=0.417  Sum_probs=145.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++...   ......+.+|+++++.++||||+++++++....     
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-----   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----
Confidence            457889999999999999999999899999999997542   223467889999999999999999998876544     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      +.|+||||+++++|.+++....      .+++..++.|+.||+.||+|||.+   +|+||||||+|||++.++.+||+||
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence            7899999999999999997643      478888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.......        ......||+.|+|||..
T Consensus       149 Gls~~~~~~~~--------~~~~~~~t~~~~~pe~~  176 (669)
T cd05610         149 GLSKVTLNREL--------NMMDILTTPSMAKPKND  176 (669)
T ss_pred             CCCccccCCcc--------cccccccCccccCcccc
Confidence            99987543211        11235689999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=1.3e-24  Score=224.72  Aligned_cols=169  Identities=25%  Similarity=0.416  Sum_probs=145.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ..|+..+.||.|+||.||+|++..+++.||+|.+........+.+.+|+++++.++||||+++++++....     ..|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEE
Confidence            35888899999999999999998899999999997665555678899999999999999999999876544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++...       .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            99999999999998643       478999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........        .....|++.|+|||.+
T Consensus       164 ~~~~~~~~--------~~~~~~~~~y~aPE~~  187 (296)
T cd06655         164 QITPEQSK--------RSTMVGTPYWMAPEVV  187 (296)
T ss_pred             hccccccc--------CCCcCCCccccCcchh
Confidence            65432111        1124689999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.92  E-value=1e-24  Score=220.76  Aligned_cols=170  Identities=27%  Similarity=0.488  Sum_probs=140.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||.||.|++. .+..||+|.+.... ....+|.+|++++++++||||+++++++....     ..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEE
Confidence            46788899999999999999876 34569999886433 23467899999999999999999999976544     6799


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++|+|.+++.....     .+++..++.++.||+.|++|||+.   +++|+||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence            9999999999999976432     478999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........       ......++..|+|||++
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~~pe~~  173 (256)
T cd05113         149 YVLDDEYT-------SSVGSKFPVRWSPPEVL  173 (256)
T ss_pred             ecCCCcee-------ecCCCccChhhCCHHHH
Confidence            65432111       11122366789999975

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=1e-24  Score=224.82  Aligned_cols=171  Identities=23%  Similarity=0.367  Sum_probs=143.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|.+... ......++.+|++++++++||||+++++++....     ..|+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEEE
Confidence            678889999999999999999989999999998754 2333567899999999999999999999866544     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.++++....   ...+++..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~  151 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSG  151 (286)
T ss_pred             EEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence            9999999999999876421   125899999999999999999999632  89999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+.....          ....|++.|+|||++
T Consensus       152 ~~~~~~~----------~~~~~~~~y~aPE~~  173 (286)
T cd06622         152 NLVASLA----------KTNIGCQSYMAPERI  173 (286)
T ss_pred             cccCCcc----------ccCCCccCccCcchh
Confidence            6532211          123588899999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.1e-24  Score=225.38  Aligned_cols=179  Identities=25%  Similarity=0.413  Sum_probs=141.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCC--------------ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGED--------------EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIIT  596 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  596 (725)
                      .+|++.+.||+|+||.||+|++..+              ...||+|.++... ......|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4788899999999999999987532              2358999987542 233467899999999999999999999


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCc------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK  670 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk  670 (725)
                      ++....     ..++||||+++++|.+++......      .....+++..++.++.|++.|++|||+.   +++|||||
T Consensus        85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            976544     789999999999999999653210      0112368889999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          671 PSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       671 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+||+++.++.+|++|||+++........      .......++..|+|||++.
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~  204 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESIL  204 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhc
Confidence            99999999999999999999765332110      1111234678899999753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=1.3e-24  Score=220.62  Aligned_cols=161  Identities=24%  Similarity=0.458  Sum_probs=132.7

Q ss_pred             cccccccceEEEEEEECC------------CceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          538 NMIGQGSFGSVYKGILGE------------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      +.||+|+||.||+|+...            ....||+|.+..........|.+|+.++++++||||+++++++....   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~---   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV---   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            368999999999998532            22358899886655555567889999999999999999999976554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc----
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV----  681 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~----  681 (725)
                        ..++||||+++|+|..++.....     .+++..++.++.||++|++|||+.   +|+||||||+||+++.++.    
T Consensus        78 --~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          78 --ENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             --CCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence              67899999999999999875432     578999999999999999999998   9999999999999987664    


Q ss_pred             ---eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 ---AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ---~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                         +|++|||++......            ....|+..|||||++
T Consensus       148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~  180 (262)
T cd05077         148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECV  180 (262)
T ss_pred             CceeEeCCCCCCccccCc------------ccccccccccChhhh
Confidence               899999998654221            114588899999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=1.3e-24  Score=221.67  Aligned_cols=175  Identities=29%  Similarity=0.490  Sum_probs=141.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+|++.+.||+|+||.||+|++..+   +..||+|.++... ....+.+.+|+.++++++||||+++++++....     
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-----   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----
Confidence            4678889999999999999987533   3479999886542 233467899999999999999999999976543     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++++|.+++.....     .+++.+++.++.|++.|++|+|+.   +++||||||+||+++.++.+|++||
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence            78999999999999999976532     478899999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.+.......     .......++..|+|||++.
T Consensus       151 g~~~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~  182 (267)
T cd05066         151 GLSRVLEDDPEAA-----YTTRGGKIPIRWTAPEAIA  182 (267)
T ss_pred             Cccccccccccee-----eecCCCccceeecCHhHhc
Confidence            9998764321110     0111123467899999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=7e-25  Score=235.79  Aligned_cols=168  Identities=26%  Similarity=0.354  Sum_probs=138.8

Q ss_pred             hcCCCCCcccccccceEEEEEEEC--CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG--EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..+|.+.+.||+|+||.||+|...  .+++.||+|.+...     +...+|++++++++||||+++++++....     .
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----T  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----E
Confidence            357999999999999999999764  35678999987533     23468999999999999999999876544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+. +++.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            899999995 68999985433      589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+........      .......||+.|+|||++.
T Consensus       231 ~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~  260 (392)
T PHA03207        231 AACKLDAHPDT------PQCYGWSGTLETNSPELLA  260 (392)
T ss_pred             cccccCccccc------ccccccccccCccCHhHhc
Confidence            99765433211      1122357999999999863

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=9.5e-25  Score=223.19  Aligned_cols=160  Identities=23%  Similarity=0.388  Sum_probs=130.6

Q ss_pred             ccccccceEEEEEEECC------------------------CceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccce
Q 048668          539 MIGQGSFGSVYKGILGE------------------------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI  594 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  594 (725)
                      .||+|+||.||+|+...                        ....||+|++........++|.+|++++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997532                        124588998865544445678899999999999999999


Q ss_pred             eeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCe
Q 048668          595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV  674 (725)
Q Consensus       595 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Ni  674 (725)
                      +++|....     ..++||||+++|+|.+++.....     .+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI  148 (274)
T ss_pred             EEEEEeCC-----ceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence            99987655     78999999999999999875432     578899999999999999999998   999999999999


Q ss_pred             eecCCC-------ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          675 LLDHDM-------VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       675 ll~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++..+       .+|++|||.+......            ....++..|+|||++
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~  192 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECV  192 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccc------------cccccCCcccCchhh
Confidence            998653       3899999988643211            013478889999976

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.92  E-value=1.3e-24  Score=221.79  Aligned_cols=173  Identities=21%  Similarity=0.387  Sum_probs=143.9

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.....      ...+++.+|++++++++||||+++++++....    
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   76 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS----   76 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence            47788999999999999999988999999999975321      13467899999999999999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVG  685 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~  685 (725)
                       ..++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++ .+||+
T Consensus        77 -~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          77 -HFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             -eEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence             7899999999999999997643      578899999999999999999999   999999999999998776 69999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||.+..+.......    ........||..|+|||++
T Consensus       147 dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~  180 (268)
T cd06630         147 DFGAAARLAAKGTGA----GEFQGQLLGTIAFMAPEVL  180 (268)
T ss_pred             ccccccccccccccC----CccccccccccceeCHhHh
Confidence            999998764431111    1111234689999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=9e-25  Score=225.75  Aligned_cols=186  Identities=24%  Similarity=0.299  Sum_probs=151.5

Q ss_pred             HHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       524 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      .+++..+.++|+..+.||+|+||.||+|....+++.||+|++.... ....++.+|+.+++++ +|||++++++++...+
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3455556788999999999999999999998899999999986432 2345678899999999 7999999999987654


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      ....+..|+||||+++|+|.++++.....  ...+++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            33345689999999999999988643211  12578999999999999999999998   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|||+++........        .....|+..|+|||++
T Consensus       168 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~  200 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVI  200 (291)
T ss_pred             EEeecccchhccccccc--------ccCccCCccccChhhh
Confidence            99999999865432111        1124589999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PTZ00284 protein kinase; Provisional

Probab=99.92  E-value=7.4e-25  Score=241.11  Aligned_cols=172  Identities=23%  Similarity=0.346  Sum_probs=136.6

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC------CcccceeeEeec
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH------RNLIKIITICSS  600 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~  600 (725)
                      +....++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+..|++++++++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345678999999999999999999999899999999996432 223455667777777654      458888888754


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCC
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~  679 (725)
                      ..    .+.|+|||++ +++|.+++.+..      .+++..+..|+.||+.||+|||+ .   +||||||||+|||++.+
T Consensus       203 ~~----~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        203 ET----GHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETS  268 (467)
T ss_pred             CC----ceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecC
Confidence            32    4689999998 779999987654      58899999999999999999997 5   89999999999999876


Q ss_pred             C----------------ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 M----------------VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~----------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +                .+||+|||.+.....           .....+||+.|||||++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----------~~~~~~gt~~Y~APE~~~  318 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----------SRTAIVSTRHYRSPEVVL  318 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCcc-----------ccccccCCccccCcHHhh
Confidence            5                499999998753211           112357999999999874

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=2.1e-24  Score=218.61  Aligned_cols=171  Identities=25%  Similarity=0.369  Sum_probs=146.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||.++...+++.||+|.+....  ....+++.+|++++++++|+||+++++++....     ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEE
Confidence            4788899999999999999999999999999987543  344567889999999999999999999976554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+||+|||.+
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999976531    2578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......        ......|++.|+|||++
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~ape~~  173 (256)
T cd08221         149 KILGSEYS--------MAETVVGTPYYMSPELC  173 (256)
T ss_pred             EEcccccc--------cccccCCCccccCHhhc
Confidence            86643321        11224689999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.92  E-value=2e-24  Score=218.84  Aligned_cols=173  Identities=25%  Similarity=0.398  Sum_probs=144.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|++|.||++++..+++.||+|++....  ....+.+.+|++++++++|||++++++.+...+    ...|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEE
Confidence            4788899999999999999998889999999997543  234567889999999999999999988754322    3578


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.|++|+|+.   +|+||||||+||+++.++.++|+|||++
T Consensus        77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence            99999999999999976432    1578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        ......|++.|+|||++.
T Consensus       150 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~  175 (257)
T cd08223         150 RVLENQCD--------MASTLIGTPYYMSPELFS  175 (257)
T ss_pred             EEecccCC--------ccccccCCcCccChhHhc
Confidence            86633211        111246899999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-26  Score=239.06  Aligned_cols=172  Identities=27%  Similarity=0.437  Sum_probs=152.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+....+|.|.||.||||++..+++..|+|+++......+.-..+|+-+++.++|||||.++|.|...+     ..|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence            457888999999999999999999999999999999876666777789999999999999999999876655     889


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ++||||.||+|++..+-..      .+++.++..+++..++|++|+|+.   +-+|||||-.||++++.|.+|++|||.+
T Consensus        89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence            9999999999999887655      689999999999999999999999   8899999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ..+..--        .....+.||++|||||+..
T Consensus       160 aqitati--------~KrksfiGtpywmapEvaa  185 (829)
T KOG0576|consen  160 AQITATI--------AKRKSFIGTPYWMAPEVAA  185 (829)
T ss_pred             hhhhhhh--------hhhhcccCCccccchhHHH
Confidence            7664321        2233478999999999864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=1.3e-24  Score=220.77  Aligned_cols=172  Identities=24%  Similarity=0.513  Sum_probs=141.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++|+||+++++++....     ..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----CcE
Confidence            357888999999999999999975 567799998864332 3568899999999999999999998865543     689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.++++....    ...++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999975432    2578889999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......++..|+|||++
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~  176 (261)
T cd05072         151 RVIEDNEYT-------AREGAKFPIKWTAPEAI  176 (261)
T ss_pred             eecCCCcee-------ccCCCccceecCCHHHh
Confidence            875432111       01123467789999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.5e-24  Score=218.63  Aligned_cols=173  Identities=29%  Similarity=0.505  Sum_probs=142.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|.+. +++.||+|.++... ...+++.+|++++++++||||+++++++....     ..|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Cee
Confidence            356888899999999999999975 45789999986543 23467899999999999999999999876544     689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||++
T Consensus        78 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeecccCCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence            99999999999999976431    2578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +........       ...+..++..|+|||++.
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~  177 (261)
T cd05068         151 RVIKEDIYE-------AREGAKFPIKWTAPEAAL  177 (261)
T ss_pred             EEccCCccc-------ccCCCcCceeccCccccc
Confidence            876532111       011122456899999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=2.1e-24  Score=219.98  Aligned_cols=175  Identities=26%  Similarity=0.486  Sum_probs=143.8

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc---------hHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---------AFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      .|.....||+|+||.||+|.+..+++.||+|.+......         ..+.+.+|++++++++||||+++++++.... 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence            367788999999999999999888999999988643221         2256889999999999999999999876554 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..++||||+++++|.+++....      .+++..+..++.|++.|++|+|+.   +++||||+|+||+++.++.+|
T Consensus        80 ----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          80 ----HLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             ----ccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence                7899999999999999997654      578888999999999999999998   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||.++...........  ........|+..|+|||++
T Consensus       147 l~dfg~~~~~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~  184 (267)
T cd06628         147 ISDFGISKKLEANSLSTKT--NGARPSLQGSVFWMAPEVV  184 (267)
T ss_pred             ecccCCCcccccccccCCc--cccccccCCCcCccChhHh
Confidence            9999999877533211111  1111224589999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.92  E-value=2.6e-24  Score=219.17  Aligned_cols=176  Identities=23%  Similarity=0.377  Sum_probs=144.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|.+..++..||+|++....     ....+.+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence            36888999999999999999998899999999986432     123456889999999999999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            36789999999999999997543      478888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++.........     .......|+..|+|||++.
T Consensus       150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~  182 (266)
T cd06651         150 FGASKRLQTICMSG-----TGIRSVTGTPYWMSPEVIS  182 (266)
T ss_pred             CCCccccccccccC-----CccccCCccccccCHHHhC
Confidence            99997653321110     0111245899999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.92  E-value=1.3e-24  Score=224.11  Aligned_cols=180  Identities=25%  Similarity=0.429  Sum_probs=141.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      ..++|++.+.||+|+||.||+|.++     ..+..||+|.+..... .....+.+|+.++++++||||+++++++.... 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            4568899999999999999999764     2356899998864432 23356789999999999999999999876554 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccc----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                          ..|+||||+++|+|.+++........    ....++..+..++.|++.|++|||++   +|+||||||+||+++.+
T Consensus        83 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          83 ----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             ----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence                68999999999999999975432111    12346677889999999999999998   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+|++|||+++.........      ......++..|+|||.+
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~  193 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESL  193 (288)
T ss_pred             CcEEECcCCcccccccccccc------ccCCCcccccccCHHHh
Confidence            999999999998653321111      01113467789999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.92  E-value=7.6e-25  Score=221.93  Aligned_cols=170  Identities=36%  Similarity=0.596  Sum_probs=136.0

Q ss_pred             CCcccccccceEEEEEEEC----CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          536 SSNMIGQGSFGSVYKGILG----EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..+.||+|.||.||+|.+.    ..+..|+||.+.... ....+.|.+|++.+++++||||++++|++....     ..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----ccc
Confidence            3578999999999999986    456789999996543 234688999999999999999999999998444     589


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++.....    ..+++..++.|+.||+.||+|||+.   +++|+||+++||+++.++.+||+|||++
T Consensus        78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             cccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            99999999999999998621    2589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........      .......+...|+|||.+
T Consensus       151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~  177 (259)
T PF07714_consen  151 RPISEKSKY------KNDSSQQLPLRYLAPEVL  177 (259)
T ss_dssp             EETTTSSSE------EESTTSESGGGGS-HHHH
T ss_pred             ccccccccc------cccccccccccccccccc
Confidence            876221110      111123477899999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=2.1e-24  Score=223.02  Aligned_cols=173  Identities=27%  Similarity=0.438  Sum_probs=141.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      +.++|...+.||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++|+||+++++++....     .
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----T   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----e
Confidence            3467899999999999999999998899999999997543 233346789999999999999999999876543     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ +++.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence            899999995 688877754332     467888889999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++.......        ......+++.|+|||++.
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~  176 (291)
T cd07870         149 LARAKSIPSQ--------TYSSEVVTLWYRPPDVLL  176 (291)
T ss_pred             cccccCCCCC--------CCCCccccccccCCceee
Confidence            9975432211        111245789999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=2e-24  Score=222.28  Aligned_cols=175  Identities=27%  Similarity=0.454  Sum_probs=142.4

Q ss_pred             CCCCCcccccccceEEEEEEE----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .|+..+.||+|+||.||+|++    +.++..||+|.++... ....+.+.+|++++++++||||+++++++....   ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CC
Confidence            467889999999999999984    3568899999987543 333467899999999999999999999876542   23


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||++|++|.+++.....     .+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+||
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence            67899999999999999965431     478999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.+.......     .......|+..|+|||++
T Consensus       154 g~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~  184 (284)
T cd05079         154 GLTKAIETDKEYY-----TVKDDLDSPVFWYAPECL  184 (284)
T ss_pred             ccccccccCccce-----eecCCCCCCccccCHHHh
Confidence            9998764332110     011124577889999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.92  E-value=1.4e-24  Score=229.10  Aligned_cols=177  Identities=26%  Similarity=0.375  Sum_probs=147.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|++.+.||+|+||.||+|++..+++.||+|++... ......++.+|++++++++||||+++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999999999999999998643 23344678899999999999999999998877666566678


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++ +++.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            99999996 4888887643       488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++..........     ......||+.|||||++
T Consensus       153 ~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~  181 (336)
T cd07849         153 ARIADPEHDHTG-----FLTEYVATRWYRAPEIM  181 (336)
T ss_pred             eeeccccccccC-----CcCCcCcCCCccChHHh
Confidence            986543221111     11235689999999975

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=1.9e-24  Score=223.35  Aligned_cols=171  Identities=26%  Similarity=0.451  Sum_probs=141.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|+++.+++.||+|.+..... .....+.+|++++++++||||+++++++....     ..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eEE
Confidence            578889999999999999999988899999999875432 22345778999999999999999999976544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++ +|.+++.....     .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~-~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence            99999975 99999876532     578899999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        ......++..|+|||++.
T Consensus       151 ~~~~~~~~--------~~~~~~~~~~~~aPE~~~  176 (291)
T cd07844         151 RAKSVPSK--------TYSNEVVTLWYRPPDVLL  176 (291)
T ss_pred             cccCCCCc--------cccccccccccCCcHHhh
Confidence            75422110        011134788999999763

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=2.5e-24  Score=218.00  Aligned_cols=166  Identities=26%  Similarity=0.466  Sum_probs=133.5

Q ss_pred             ccccccceEEEEEEEC--CCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEec
Q 048668          539 MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      .||+|+||.||+|+++  .++..||+|++..... ...+.+.+|++++++++||||+++++++..      +..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999775  4556799999865432 334678999999999999999999998642      257899999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS  695 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~  695 (725)
                      +++|+|.+++.....     .+++..+++++.|++.|++|+|++   +++||||||+||+++.++.+|++|||+++....
T Consensus        76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999975432     588999999999999999999998   999999999999999999999999999976533


Q ss_pred             CCCCCCCCCCcccccccCCccccCCCcc
Q 048668          696 HHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       696 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......     ......++..|+|||++
T Consensus       148 ~~~~~~-----~~~~~~~~~~y~aPE~~  170 (257)
T cd05115         148 DDSYYK-----ARSAGKWPLKWYAPECI  170 (257)
T ss_pred             Ccccee-----ccCCCCCCcccCCHHHH
Confidence            211100     01112346789999975

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.92  E-value=2.3e-24  Score=225.74  Aligned_cols=174  Identities=25%  Similarity=0.327  Sum_probs=134.8

Q ss_pred             CcccccccceEEEEEEECC--CceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          537 SNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      ...||+|+||.||+|+...  ++..||+|.+....  ....+.+|++++++++||||+++++++....   ....|+|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEe
Confidence            3579999999999999653  56789999886432  2346789999999999999999999875432   246799999


Q ss_pred             ccCCCCHHHHhcccCC---ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCceEEccc
Q 048668          615 YMGNGSLEDWLHQSND---QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDF  687 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill----~~~~~~kl~Df  687 (725)
                      |++ +++.+++.....   ......+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            986 588888753321   11123578899999999999999999998   99999999999999    45679999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.........     .......||+.|+|||++.
T Consensus       157 G~a~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~  188 (317)
T cd07867         157 GFARLFNSPLKPL-----ADLDPVVVTFWYRAPELLL  188 (317)
T ss_pred             cceeccCCCcccc-----cccCcceecccccCcHHhc
Confidence            9998764332111     1112356899999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=2.2e-24  Score=224.27  Aligned_cols=180  Identities=24%  Similarity=0.440  Sum_probs=142.7

Q ss_pred             hcCCCCCcccccccceEEEEEEEC-------CCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSST  601 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  601 (725)
                      ..+|.+.+.||+|+||.||+|++.       .++..||+|.+.... ....+++.+|+++++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            457888899999999999999752       234579999886432 33456789999999999 799999999997655


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCcc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQV----------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      .     ..|+||||+++|+|.+++.......          ....+++..+..++.|++.|++|||++   +|+||||||
T Consensus        94 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          94 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            4     7899999999999999997643210          112578888999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+++.++.+||+|||.|+.........      ......+++.|+|||++.
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  212 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYK------KTTNGRLPVKWMAPEALF  212 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccc------cccCCCCCceeeCchhhc
Confidence            99999999999999999998764321111      111234678899999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.92  E-value=2.3e-24  Score=223.37  Aligned_cols=179  Identities=24%  Similarity=0.393  Sum_probs=143.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc----------------eEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE----------------MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIK  593 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  593 (725)
                      .++|+..+.||+|+||.||+|++...+                ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357889999999999999999875433                568999987543 234567889999999999999999


Q ss_pred             eeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCcc-----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 048668          594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD  668 (725)
Q Consensus       594 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd  668 (725)
                      +++++....     ..++||||+++++|.+++.......     ....+++..++.++.|++.||+|||+.   +|+|||
T Consensus        84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            999976553     7899999999999999997654110     112578999999999999999999998   999999


Q ss_pred             CCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          669 LKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       669 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+||+++.++.+|++|||+++........      .......+++.|||||++
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  204 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY------RVQGRAPLPIRWMAWESV  204 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcce------eecCcCCCCceecCHHHh
Confidence            9999999999999999999999765332111      111124578899999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.7e-24  Score=222.05  Aligned_cols=179  Identities=23%  Similarity=0.423  Sum_probs=143.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+.... ......+.+|+++++.++||||+++++++....  
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ--   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence            3578888999999999999998764     34789999986443 233457889999999999999999999976553  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCcc----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQV----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~  680 (725)
                         ..++||||+++|+|.+++.......    ....+++..++.++.|++.|++|+|+.   +|+||||||+||+++.++
T Consensus        83 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          83 ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             ---CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence               7899999999999999997543221    112468889999999999999999998   999999999999999999


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+||+|||+++.+.......      ......+|..|+|||++
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~  193 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESL  193 (277)
T ss_pred             CEEECCcccchhhccCcccc------cCCCCCccccccCHHHH
Confidence            99999999998654322111      11123478899999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=2.2e-24  Score=226.64  Aligned_cols=176  Identities=18%  Similarity=0.194  Sum_probs=139.7

Q ss_pred             CCcccccc--cceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          536 SSNMIGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       536 ~~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ..++||+|  +|++||+++++.+++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEE
Confidence            35789999  68899999999999999999997542  223456778999999999999999999987654     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++|+|.+++......    .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999999999754321    478999999999999999999998   99999999999999999999999998765


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ........... .........++..|||||++.
T Consensus       150 ~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~  181 (327)
T cd08227         150 SMINHGQRLRV-VHDFPKYSVKVLPWLSPEVLQ  181 (327)
T ss_pred             ccccccccccc-cccccccccceecccChHHhh
Confidence            43221111000 000111235788899999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.92  E-value=1.4e-24  Score=221.42  Aligned_cols=174  Identities=25%  Similarity=0.423  Sum_probs=145.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||||.+....   .....++.+|+++++.++||||+++++++....     .
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence            46888899999999999999998899999999886432   233467889999999999999999999876554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++++|.+++.....  ....+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.++++|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            8999999999999999874321  112578999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++........        ......|+..|+|||++
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~~~ape~~  178 (267)
T cd08229         152 LGRFFSSKTT--------AAHSLVGTPYYMSPERI  178 (267)
T ss_pred             hhhccccCCc--------ccccccCCcCccCHHHh
Confidence            9876543211        11124689999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2.8e-24  Score=221.54  Aligned_cols=171  Identities=27%  Similarity=0.409  Sum_probs=145.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  ......+.+|+.++++++||||+++++++....     ..|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeE
Confidence            4778899999999999999998899999999997653  334567899999999999999999999876544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+ +++|.+++.....     .+++.++..++.||+.||+|+|+.   +++|+||||+||+++.++.++++|||.+
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            999999 9999999875432     589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......       .......|+.+|+|||++.
T Consensus       147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07832         147 RLFSEEEP-------RLYSHQVATRWYRAPELLY  173 (286)
T ss_pred             ccccCCCC-------CccccccCcccccCceeee
Confidence            86643211       0111246899999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PLN03210 Resistant to P

Probab=99.92  E-value=1.1e-23  Score=253.30  Aligned_cols=338  Identities=21%  Similarity=0.226  Sum_probs=203.2

Q ss_pred             CCccccCCCCCcEEEccCCc------CCccCCCCCCCC-CCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCC
Q 048668           29 LPDFIGNLSALQVIHIKGNS------LGGKFPTTLGLL-RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSL  101 (725)
Q Consensus        29 ~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  101 (725)
                      .+.+|..|.+|+.|.+..+.      +....|+.|..+ .+|+.|++.+|.++ ..|..| ...+|+.|+|++|++. .+
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L  626 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL  626 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence            34567788888888876553      233456666665 45888888888776 456556 4677888888888887 66


Q ss_pred             ChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCc-cCCccCCCCccc
Q 048668          102 PFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN-NLGIGAANDLGF  180 (725)
Q Consensus       102 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N-~l~~~~~~~~~~  180 (725)
                      +.++ ..+++|+.|+|++|.....+| .+..+++|++|+|++|......+..+..+++|+.|++++| .+..++.     
T Consensus       627 ~~~~-~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-----  699 (1153)
T PLN03210        627 WDGV-HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-----  699 (1153)
T ss_pred             cccc-ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC-----
Confidence            6554 567888888887765444445 3677788888888877654445566777888888888875 3433322     


Q ss_pred             ccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEeccccc-------CCCC
Q 048668          181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQL-------HGTI  253 (725)
Q Consensus       181 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l-------~~~~  253 (725)
                        . .++++|++|++++|.....+|..    ..+++.|++++|.+. .+|..+ .+++|+.|.+..+..       ....
T Consensus       700 --~-i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~  770 (1153)
T PLN03210        700 --G-INLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLT  770 (1153)
T ss_pred             --c-CCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccc
Confidence              1 25778888888887654444432    336677777777765 455444 466777777765332       1122


Q ss_pred             ChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCcc
Q 048668          254 PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLL  333 (725)
Q Consensus       254 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l  333 (725)
                      +..+...++|+.|+|++|...+.+|..+.++++|+.|++++|.           ..+.+|... .+..+ ++|++++|..
T Consensus       771 ~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~-----------~L~~LP~~~-~L~sL-~~L~Ls~c~~  837 (1153)
T PLN03210        771 PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI-----------NLETLPTGI-NLESL-ESLDLSGCSR  837 (1153)
T ss_pred             hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC-----------CcCeeCCCC-Ccccc-CEEECCCCCc
Confidence            2223334567777777776666677777777777777777662           122444433 22222 5555555433


Q ss_pred             CCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCC-ccccccCccccCCCCCCEEeCCCC
Q 048668          334 NGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN-CFHGIIPPSLGFLKSIKFLDVSCN  403 (725)
Q Consensus       334 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N  403 (725)
                      ...+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++| .+. .+|..+..+++|+.|++++|
T Consensus       838 L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        838 LRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             ccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            2223321   234555555555555 44555555555555555552 233 34444455555555555554

syringae 6; Provisional

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.6e-24  Score=225.14  Aligned_cols=150  Identities=28%  Similarity=0.379  Sum_probs=132.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|.+.....   ...+.+.+|++++++++||||+++++++....     ..
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----YL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----EE
Confidence            68888999999999999999998899999999975532   24567889999999999999999999875544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++++|.+++.....    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence            999999999999999875432    2588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccc
Q 048668          690 AKFLS  694 (725)
Q Consensus       690 a~~~~  694 (725)
                      +....
T Consensus       150 ~~~~~  154 (316)
T cd05574         150 SKQSD  154 (316)
T ss_pred             hhccc
Confidence            87653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.92  E-value=2.1e-24  Score=222.99  Aligned_cols=178  Identities=29%  Similarity=0.486  Sum_probs=143.3

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|...+.||+|+||.||+|++.     .++..||+|.+........+.+.+|++++++++||||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD----   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence            35777899999999999999853     345678999886554445567899999999999999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                       ..++||||+++++|.+++......          .....+++..++.++.|++.|++|||++   +|+||||||+||++
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence             789999999999999999764321          0112478999999999999999999999   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++.+||+|||+++........      .......|+..|+|||++
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~  197 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESI  197 (291)
T ss_pred             ccCCcEEECCCCcccccCCCcee------ecCCCCCcceeecChHHh
Confidence            99999999999999765332111      111124578899999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.92  E-value=1.7e-24  Score=224.88  Aligned_cols=175  Identities=29%  Similarity=0.473  Sum_probs=138.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceE--EEEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMI--VAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|++.+.||+|+||.||+|+++.++..  +|+|.+... .....+++.+|++++.++ +||||+++++++....     
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~-----   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-----
Confidence            4788889999999999999998777654  466666432 233456788999999999 8999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCcc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQV----------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                      ..|+||||+++|+|.++++......          ....+++.+++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence            7899999999999999997543211          112578999999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .++.+||+|||+++......         ......++..|+|||++
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~  195 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESL  195 (303)
T ss_pred             CCCcEEeCccccCcccchhh---------hcccCCCcccccCHHHH
Confidence            99999999999986421110         00112356789999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=2.5e-24  Score=223.34  Aligned_cols=169  Identities=28%  Similarity=0.432  Sum_probs=142.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc-----hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +|+..+.||+|+||.||+|.+..+++.||||.+......     ....+..|++++++++|+||+++++++....     
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-----   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence            377788999999999999999888999999999754322     2356778999999999999999999976543     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+ +|+|.+++....     ..+++..+..++.||++||+|||++   +|+|+||||+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            789999999 899999997643     1588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++........        .....+++.|+|||++
T Consensus       147 g~~~~~~~~~~~--------~~~~~~~~~y~aPE~~  174 (298)
T cd07841         147 GLARSFGSPNRK--------MTHQVVTRWYRAPELL  174 (298)
T ss_pred             eeeeeccCCCcc--------ccccccceeeeCHHHH
Confidence            999876432111        1113478899999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.92  E-value=3.4e-24  Score=222.95  Aligned_cols=178  Identities=24%  Similarity=0.346  Sum_probs=144.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+++++.++||||+++++.+....     +.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-----HL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-----EE
Confidence            6888899999999999999999999999999987543   233457889999999999999999999876544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||++|++|.+++....      .+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+|++|||+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence            99999999999999997653      578899999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCC-------CCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDT-------SSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~-------~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++.........       ............|+..|+|||++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL  189 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhcc
Confidence            87422110000       000001112246889999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.92  E-value=1.1e-24  Score=224.93  Aligned_cols=165  Identities=25%  Similarity=0.382  Sum_probs=140.4

Q ss_pred             CCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEec
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      ....||+|+||.||++.+..++..||||.+........+.+.+|+.++++++||||+++++.+...+     ..|+||||
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv~e~  100 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVVMEF  100 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEEEeC
Confidence            3467999999999999998889999999987655555677899999999999999999999876544     78999999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS  695 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~  695 (725)
                      +++++|.+++...       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         101 LEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            9999999988543       478889999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCCCCCCCCcccccccCCccccCCCcc
Q 048668          696 HHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       696 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ...        ......|+..|+|||++
T Consensus       171 ~~~--------~~~~~~~~~~y~aPE~~  190 (292)
T cd06658         171 EVP--------KRKSLVGTPYWMAPEVI  190 (292)
T ss_pred             ccc--------cCceeecCccccCHHHH
Confidence            211        11124689999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.3e-24  Score=218.15  Aligned_cols=176  Identities=23%  Similarity=0.389  Sum_probs=144.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+....     ....+.+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence            46888999999999999999999899999999886431     233467889999999999999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            35789999999999999987543      478888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++........     ........|+..|+|||++.
T Consensus       150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~  182 (264)
T cd06653         150 FGASKRIQTICMS-----GTGIKSVTGTPYWMSPEVIS  182 (264)
T ss_pred             ccccccccccccc-----CccccccCCcccccCHhhhc
Confidence            9999865321110     11112346899999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.6e-25  Score=227.92  Aligned_cols=147  Identities=24%  Similarity=0.345  Sum_probs=130.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      +-|...+.||-|+||+|.+++-.+|...||+|.+++.+   .........|-.||+..+.+-||++|..     |++.+.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            35677889999999999999988899999999998654   2334567789999999999999999876     556669


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      +|+||||++|||+...|.+.+      -++|..+..++.++..|+++.|..   |+|||||||+|||||.+|.+|+.|||
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            999999999999999998776      578888888999999999999998   99999999999999999999999999


Q ss_pred             cccc
Q 048668          689 LAKF  692 (725)
Q Consensus       689 la~~  692 (725)
                      ++.-
T Consensus       775 LCTG  778 (1034)
T KOG0608|consen  775 LCTG  778 (1034)
T ss_pred             cccc
Confidence            9853

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.92  E-value=1.1e-24  Score=225.33  Aligned_cols=166  Identities=25%  Similarity=0.366  Sum_probs=141.0

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++....     ..|+|||
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~e   98 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLME   98 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEEe
Confidence            33457999999999999998889999999997655555577889999999999999999999876544     7899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |+++++|.+++...       .+++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~  168 (297)
T cd06659          99 FLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  168 (297)
T ss_pred             cCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence            99999999987542       478899999999999999999998   99999999999999999999999999987553


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ....        ......|++.|+|||++
T Consensus       169 ~~~~--------~~~~~~~~~~y~aPE~~  189 (297)
T cd06659         169 KDVP--------KRKSLVGTPYWMAPEVI  189 (297)
T ss_pred             cccc--------cccceecCccccCHHHH
Confidence            3211        11125689999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.92  E-value=2.8e-24  Score=221.47  Aligned_cols=170  Identities=26%  Similarity=0.384  Sum_probs=142.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||.||+|+++.+++.||+|++....  ....+.+.+|++++++++||||+++++++....     ..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EE
Confidence            36888899999999999999999899999999986442  223456789999999999999999999876544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||++++.+..+.....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence            99999999988888765433      478999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.........        .....++..|+|||++
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~  172 (286)
T cd07847         147 ARILTGPGDD--------YTDYVATRWYRAPELL  172 (286)
T ss_pred             ceecCCCccc--------ccCcccccccCCHHHH
Confidence            9876432111        1123578899999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=3.6e-24  Score=238.60  Aligned_cols=154  Identities=28%  Similarity=0.279  Sum_probs=94.4

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      .-..|+|++|.++ .+|+.+.  ++|+.|++++|+|+ .+|..   +++|++|+|++|+|+. +|..   .++|+.|+++
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls  270 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF  270 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence            4567778888777 5676665  36778888888877 34432   4677777777777774 3432   3467777777


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      +|.|+ .+|.    .+++|+.|+|++|+|+.+ |.   .+++|+.|+|++|+|++++. .   ...|+.|++++|.++.+
T Consensus       271 ~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~L  337 (788)
T PRK15387        271 SNPLT-HLPA----LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTSL  337 (788)
T ss_pred             CCchh-hhhh----chhhcCEEECcCCccccc-cc---cccccceeECCCCccccCCC-C---cccccccccccCccccc
Confidence            77776 5654    135677777777777654 22   23567777777777776543 1   12455566666666543


Q ss_pred             CCCCcccccccCCCCCCCEEECccCccc
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      +.          -..+|++|+|++|+|+
T Consensus       338 P~----------lp~~Lq~LdLS~N~Ls  355 (788)
T PRK15387        338 PT----------LPSGLQELSVSDNQLA  355 (788)
T ss_pred             cc----------cccccceEecCCCccC
Confidence            21          0134555666655555

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=2.5e-24  Score=219.76  Aligned_cols=177  Identities=29%  Similarity=0.519  Sum_probs=141.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce---EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||.||+|++..+++   .||||++... .....++|..|++++++++||||+++++++....     
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-----   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----
Confidence            457788999999999999999876554   6999998654 2334578999999999999999999999875543     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++|+|.+++.....     .+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence            78999999999999999976432     478899999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++...........   .......++..|+|||++.
T Consensus       151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~  184 (269)
T cd05065         151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIA  184 (269)
T ss_pred             ccccccccCcccccc---ccccCCCcceeecCHhHhc
Confidence            999866432211100   0001111356799999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=2.5e-24  Score=218.43  Aligned_cols=160  Identities=27%  Similarity=0.493  Sum_probs=134.0

Q ss_pred             cccccccceEEEEEEECCCc----------eEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          538 NMIGQGSFGSVYKGILGEDE----------MIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +.||+|+||.||+|.+..++          ..||+|.+...... ...|.+|++++++++||||+++++++.. .     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D-----   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence            46899999999999997665          35788877544333 5788999999999999999999998765 3     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-------
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-------  680 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-------  680 (725)
                      ..++||||+++|+|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++       
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence            56899999999999999986542     578889999999999999999998   999999999999999887       


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+|++|||+++.....            ....++..|+|||++.
T Consensus       146 ~~kl~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~  177 (259)
T cd05037         146 FIKLSDPGIPITVLSR------------EERVERIPWIAPECIR  177 (259)
T ss_pred             eEEeCCCCcccccccc------------cccccCCCccChhhhc
Confidence            7999999999765321            0134777899999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=3.2e-24  Score=218.64  Aligned_cols=174  Identities=27%  Similarity=0.443  Sum_probs=145.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++...   ....+++.+|++++++++|++|+++++++....     .
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----E   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----e
Confidence            57888999999999999999999899999999886432   233567899999999999999999999876544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++|+|.+++......  ...+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            89999999999999998653211  22578999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++........        .....|++.|+|||++
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~~~y~apE~~  178 (267)
T cd08224         152 LGRFFSSKTTA--------AHSLVGTPYYMSPERI  178 (267)
T ss_pred             eeeeccCCCcc--------cceecCCccccCHHHh
Confidence            98765432111        1124589999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=3.3e-24  Score=220.10  Aligned_cols=172  Identities=27%  Similarity=0.477  Sum_probs=141.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce----EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|...... .....++.+|++++++++||||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            467888999999999999999865554    68999886543 2345678899999999999999999999865      


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++|+|.+++.....     .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d  152 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD  152 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence            267899999999999999976542     478999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.++.........      ......++..|+|||.+
T Consensus       153 fg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~  183 (279)
T cd05057         153 FGLAKLLDVDEKEY------HAEGGKVPIKWMALESI  183 (279)
T ss_pred             CcccccccCcccce------ecCCCcccccccCHHHh
Confidence            99998764321110      00112246789999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.91  E-value=3.3e-24  Score=217.82  Aligned_cols=171  Identities=29%  Similarity=0.510  Sum_probs=139.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|++.+.||+|+||.||+|++..+ ..||+|+++.... ..+++.+|++++++++||||+++++++..      +..|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence            35688999999999999999998655 4699999875332 34678999999999999999999987532      2578


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++.....    ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence            99999999999999975432    2478899999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+......       ......++..|+|||+.
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~  175 (262)
T cd05071         150 RLIEDNEYT-------ARQGAKFPIKWTAPEAA  175 (262)
T ss_pred             eeccccccc-------cccCCcccceecCHhHh
Confidence            766432111       01123467889999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.91  E-value=3.1e-24  Score=222.64  Aligned_cols=175  Identities=25%  Similarity=0.435  Sum_probs=142.2

Q ss_pred             cCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      ++|...+.||+|+||.||+|.+     ..++..||+|+++... ....+.+.+|+++++++ +||||+++++++....  
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG--  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC--
Confidence            4688899999999999999975     3356689999987543 23346789999999999 7999999999876554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|+||||+++|+|.++++....    ..+++.++..++.|++.|++|+|+.   +|+|+||||+||+++.++.+|+
T Consensus       113 ---~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         113 ---PILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             ---ceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence               68999999999999999975432    1379999999999999999999998   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+++........      .......++..|+|||++.
T Consensus       183 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~  216 (302)
T cd05055         183 CDFGLARDIMNDSNY------VVKGNARLPVKWMAPESIF  216 (302)
T ss_pred             CCCcccccccCCCce------eecCCCCcccccCCHhhhc
Confidence            999999865432110      0111234678899999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.91  E-value=1.4e-24  Score=223.48  Aligned_cols=169  Identities=25%  Similarity=0.449  Sum_probs=140.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|++..+|+.||+|+++...  ......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence            4777889999999999999999999999999997542  22335678899999999999999999986544     3789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|+||++ +++.+++.....     .+++..++.++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence            9999996 588888765432     589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......        ......+++.|+|||++
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~y~aPE~~  171 (284)
T cd07839         147 RAFGIPVR--------CYSAEVVTLWYRPPDVL  171 (284)
T ss_pred             hccCCCCC--------CcCCCccccCCcChHHH
Confidence            76532211        11123578999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.91  E-value=3.1e-24  Score=218.95  Aligned_cols=175  Identities=27%  Similarity=0.496  Sum_probs=141.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCce---EEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|++..++.   .||+|.+.... ....+.+.+|++++++++||||+++++++...+    
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   79 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK----   79 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC----
Confidence            3467888999999999999999865543   79999986542 334567899999999999999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++++|.+++.....     .+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+|++|
T Consensus        80 -~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  150 (268)
T cd05063          80 -PAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD  150 (268)
T ss_pred             -CcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence             78999999999999999976432     578999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.........     ........+..|+|||++
T Consensus       151 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~  182 (268)
T cd05063         151 FGLSRVLEDDPEGT-----YTTSGGKIPIRWTAPEAI  182 (268)
T ss_pred             Cccceecccccccc-----eeccCCCcCceecCHHHh
Confidence            99997654321110     001112245679999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=1e-24  Score=221.13  Aligned_cols=162  Identities=24%  Similarity=0.410  Sum_probs=134.1

Q ss_pred             cccccccceEEEEEEECCCce-------EEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          538 NMIGQGSFGSVYKGILGEDEM-------IVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +.||+|+||.||+|.++..+.       .||+|.+........+++.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence            468999999999998865443       48888876554445578889999999999999999999977554     678


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc--------e
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--------A  682 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~--------~  682 (725)
                      +||||+++|+|.++++....     .+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.        +
T Consensus        76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence            99999999999999986542     478889999999999999999998   9999999999999987765        6


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |++|||.+......            ....++..|+|||++.
T Consensus       148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~  177 (258)
T cd05078         148 KLSDPGISITVLPK------------EILLERIPWVPPECIE  177 (258)
T ss_pred             EecccccccccCCc------------hhccccCCccCchhcc
Confidence            99999988654221            1245888999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.91  E-value=3.1e-24  Score=221.54  Aligned_cols=177  Identities=24%  Similarity=0.388  Sum_probs=139.6

Q ss_pred             CCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +|+..+.||+|+||.||+|+...     ....||+|.+.... ....+++.+|++++++++||||+++++++...+    
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG----   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence            46778999999999999998742     23578888886443 233567899999999999999999999876554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCc------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQ------------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD  668 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd  668 (725)
                       ..++||||+++|+|.+++......                  .....+++..++.++.|++.|++|||+.   +|+|||
T Consensus        77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence             689999999999999998753211                  0112478899999999999999999998   999999


Q ss_pred             CCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          669 LKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       669 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+||++++++.+||+|||+++.........      ......++..|+|||++
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~apE~~  201 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV------KRSKGRIPVKWMAIESL  201 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchh------cccCCCCCccccCHHHH
Confidence            99999999999999999999997653321111      11123467789999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=4.4e-24  Score=216.46  Aligned_cols=169  Identities=27%  Similarity=0.437  Sum_probs=143.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +|+..+.||+|+||+||+|....++..||+|.+....     +...+.+.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-----   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence            3677889999999999999998889999999987543     224567899999999999999999999876544     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++++|.+++....      .+++..+..++.|++.|++|+|+.   +|+|+||+|+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            7899999999999999997543      478889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |.+.......         ......|+..|+|||.+.
T Consensus       147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~  174 (258)
T cd06632         147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIA  174 (258)
T ss_pred             ccceeccccc---------cccccCCCcceeCHHHhc
Confidence            9987653321         111245899999999753

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.91  E-value=2e-24  Score=222.24  Aligned_cols=178  Identities=21%  Similarity=0.357  Sum_probs=140.8

Q ss_pred             CCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +|...+.||+|+||.||+|++..     .++.||+|++...... ..+.+.+|+.++++++||||+++++++....    
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ----   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC----
Confidence            46667889999999999998743     3578999999754332 3467889999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                       ..++++||+++++|.+++......          .....+++..+..++.|++.||+|+|+.   +|+||||||+||++
T Consensus        82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~  157 (283)
T cd05091          82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV  157 (283)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence             688999999999999998632110          0112478888999999999999999998   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++++.+||+|||+++.........      ......+++.|+|||++.
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  199 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYK------LMGNSLLPIRWMSPEAIM  199 (283)
T ss_pred             cCCCceEecccccccccccchhee------eccCccCCccccCHHHHh
Confidence            999999999999988654321111      111234678999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.91  E-value=5.2e-24  Score=217.18  Aligned_cols=169  Identities=24%  Similarity=0.374  Sum_probs=132.3

Q ss_pred             ccccccceEEEEEEECCC--ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEec
Q 048668          539 MIGQGSFGSVYKGILGED--EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      .||+|+||.||+|+...+  ...+++|.+.... ....+.|.+|+.+++.++||||++++++|....     ..|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEec
Confidence            589999999999975422  3346677665432 234578999999999999999999999976544     78999999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS  695 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~  695 (725)
                      +++|+|.+++.+....  ....++..+..++.||+.||+|+|+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        77 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          77 CELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             CCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence            9999999999764321  11456777889999999999999998   999999999999999999999999999864322


Q ss_pred             CCCCCCCCCCcccccccCCccccCCCcc
Q 048668          696 HHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       696 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ...      .......+|+..|+|||++
T Consensus       152 ~~~------~~~~~~~~~~~~y~aPE~~  173 (268)
T cd05086         152 EDY------IETEDDKCVPLRWLAPELV  173 (268)
T ss_pred             chh------hhcccCCcCcccccCchhc
Confidence            111      0111134688999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.91  E-value=2.4e-24  Score=222.79  Aligned_cols=180  Identities=26%  Similarity=0.431  Sum_probs=142.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCC-----ceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ..++|+..+.||+|+||.||+|.+...     ...||+|.+.... .....++.+|+++++++ +||||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            345788889999999999999987533     3789999987542 23346788999999999 7999999999876544


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPS  672 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~  672 (725)
                           ..++||||+++|+|.++++.....          .....+++..++.++.|++.|++|||+.   +|+||||||+
T Consensus        90 -----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          90 -----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             -----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence                 689999999999999999753210          1122588999999999999999999998   9999999999


Q ss_pred             CeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          673 NVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       673 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.++.+|++|||.++.+........      .....++..|+|||++
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~  206 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEAL  206 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceec------cCCCCCCccccCHHHh
Confidence            99999999999999999987643221111      1112356789999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=4.1e-24  Score=218.58  Aligned_cols=171  Identities=23%  Similarity=0.466  Sum_probs=141.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc----------chHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----------GAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      +|...+.||+|+||.||+|....+++.||+|.++....          ...+.+.+|++++++++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46778899999999999999988899999998864211          11346788999999999999999999876544


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                           ..++||||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++||||+|+||+++.++.+
T Consensus        82 -----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          82 -----YLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             -----ceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence                 7899999999999999997653      578889999999999999999998   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++|||+++.......      ........|+..|+|||++
T Consensus       148 ~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~  182 (272)
T cd06629         148 KISDFGISKKSDDIYD------NDQNMSMQGSVFWMAPEVI  182 (272)
T ss_pred             EEeecccccccccccc------ccccccccCCccccCHHHh
Confidence            9999999976432111      0111224589999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.91  E-value=3.3e-24  Score=220.53  Aligned_cols=185  Identities=24%  Similarity=0.349  Sum_probs=149.8

Q ss_pred             HHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       524 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ..+...+.+.|+..+.+|+|+||.||+|++..+++.||+|++..... ...++..|+.+++++ +||||+++++++....
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            34444566789999999999999999999998999999999865432 345688899999998 6999999999876432


Q ss_pred             C-CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc
Q 048668          603 F-KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       603 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~  681 (725)
                      . ...+..|+||||+++|+|.+++.....    ..+++..++.++.|++.|++|||+.   +|+|||+||+||+++.++.
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence            1 123478999999999999999976432    1478888999999999999999998   9999999999999999999


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+|||+++.......        ......|++.|+|||++.
T Consensus       160 ~~l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             EEEeeCcchhhhhcccc--------CCCcccccccccCHhhcC
Confidence            99999999876532111        111256899999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.91  E-value=3.4e-24  Score=219.73  Aligned_cols=180  Identities=24%  Similarity=0.408  Sum_probs=142.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|+..+.||+|+||.||+|.+..     ++..||+|.+.... ......|.+|+.++++++|+||+++++++....  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence            3568888999999999999999976     67889999886443 233457899999999999999999999876544  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCcc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~---  680 (725)
                         ..++||||+++++|.++++...... ....+++..+.+++.||+.|++|||+.   +++||||||+||+++.++   
T Consensus        83 ---~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          83 ---PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             ---CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence               6789999999999999997654211 122588999999999999999999999   999999999999998764   


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+|++|||+++.+........      .....++..|||||++.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~  194 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRK------GGRAMLPIKWMPPEAFL  194 (277)
T ss_pred             ceEeccCccccccCCccceec------CCCCCccHhhCCHHHHh
Confidence            599999999987632211100      01123467899999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=5.4e-24  Score=216.73  Aligned_cols=174  Identities=24%  Similarity=0.460  Sum_probs=142.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +|+..+.||+|+||.||+|... +++.||+|.+.....      ...+.+.+|++++++++|+||+++++++....    
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence            4778899999999999999875 788999999875421      22356889999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++||||+++++|.+++.+..      .+++..+..++.|++.|++|+|+.   +|+|+||||+||+++.++.+||+|
T Consensus        76 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          76 -TISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             -eEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence             7899999999999999997643      478889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.++..........  .........|+..|+|||++
T Consensus       146 fg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~  180 (265)
T cd06631         146 FGCARRLAWVGLHGT--HSNMLKSMHGTPYWMAPEVI  180 (265)
T ss_pred             chhhHhhhhcccccc--ccccccccCCCccccChhhh
Confidence            999976532111100  01111234689999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.91  E-value=4e-25  Score=197.98  Aligned_cols=172  Identities=22%  Similarity=0.313  Sum_probs=138.5

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +......||+|+||.|-+-++..+|...|+|.++.. ..+..++...|+.+..+. ..|++|++||.+....     ..|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-----dvw  121 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-----DVW  121 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-----cEE
Confidence            344457799999999999999999999999999755 234556788899987776 5999999999765443     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +.||.|+- +|..+-++.-..  ....+|...-+|+..|..||.|||++.  .++|||+||+|||++.+|++|+||||++
T Consensus       122 IcME~M~t-Sldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            99999954 787766543211  126899999999999999999999974  8999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      -.+.+....         +..+|-..|||||.+
T Consensus       197 G~L~dSiAk---------t~daGCkpYmaPEri  220 (282)
T KOG0984|consen  197 GYLVDSIAK---------TMDAGCKPYMAPERI  220 (282)
T ss_pred             eeehhhhHH---------HHhcCCCccCChhhc
Confidence            876543211         114588899999976

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.91  E-value=3.5e-24  Score=221.62  Aligned_cols=174  Identities=24%  Similarity=0.381  Sum_probs=144.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|++++++++||||+++++++....   ...
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence            3578888999999999999999998999999999975432  22346778999999999999999999876542   247


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ ++|.+++.....     .+++..++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~~lv~e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          81 IYMVMEYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             EEEEehhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            899999997 499999876442     589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++........        .....+++.|+|||++.
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         152 LAREYGSPLKP--------YTQLVVTLWYRAPELLL  179 (293)
T ss_pred             ceeeccCCccc--------cccccccccccCchhhc
Confidence            99866433111        11235788999999763

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=4.2e-24  Score=220.71  Aligned_cols=170  Identities=26%  Similarity=0.402  Sum_probs=145.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||+++++++....     ..|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEEE
Confidence            57888999999999999999988889999999987655555577899999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |+||+++++|.+++.+.       .+++..+..++.|++.|+.|||+.   +++|||+||+||+++.++.+||+|||++.
T Consensus        94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          94 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             EEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence            99999999999998753       367888999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......        ......|++.|+|||.+.
T Consensus       164 ~~~~~~~--------~~~~~~~~~~y~~PE~~~  188 (293)
T cd06647         164 QITPEQS--------KRSTMVGTPYWMAPEVVT  188 (293)
T ss_pred             ccccccc--------ccccccCChhhcCchhhc
Confidence            5533211        111246899999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=3.1e-24  Score=220.85  Aligned_cols=170  Identities=21%  Similarity=0.330  Sum_probs=144.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++.... ....+++.+|+++++.++||||+++++++....     ..|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EEE
Confidence            46778899999999999999999899999999987543 334578899999999999999999999977654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++....      .+++..+..++.+++.|+.|||+.+  +++||||||+||+++.++.++|+|||++
T Consensus        80 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             EEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            9999999999999987643      5789999999999999999999732  8999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......          ....+|+..|+|||++.
T Consensus       152 ~~~~~~~----------~~~~~~~~~~~aPE~~~  175 (284)
T cd06620         152 GELINSI----------ADTFVGTSTYMSPERIQ  175 (284)
T ss_pred             cchhhhc----------cCccccCcccCCHHHHc
Confidence            6542211          01246899999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.91  E-value=2.1e-24  Score=221.24  Aligned_cols=168  Identities=28%  Similarity=0.442  Sum_probs=141.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++....     ..|+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-----KLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-----ceEE
Confidence            3556678999999999999998889999999987543 334567889999999999999999999875543     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++...       .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.+|++|||+++
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence            99999999999998643       478889999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......|+..|+|||++
T Consensus       150 ~~~~~~~--------~~~~~~~~~~y~aPE~~  173 (277)
T cd06642         150 QLTDTQI--------KRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             cccCcch--------hhhcccCcccccCHHHh
Confidence            6543211        11124588999999976

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=6e-24  Score=215.87  Aligned_cols=172  Identities=32%  Similarity=0.563  Sum_probs=141.8

Q ss_pred             cccccccceEEEEEEECCC---ceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|.+...   +..||+|++...... ..+.+.+|++.++.++|+||+++++++...     ...++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEE
Confidence            4689999999999999755   889999999765433 367889999999999999999999987653     3789999


Q ss_pred             eccCCCCHHHHhcccCCc---cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQ---VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ||+++++|.+++......   .....+++..++.++.|++.|++|||++   +++||||||+||+++.++.+|++|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999875210   0012689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........      .......+++.|+|||++
T Consensus       153 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~  179 (262)
T cd00192         153 RDVYDDDYY------RKKTGGKLPIRWMAPESL  179 (262)
T ss_pred             ccccccccc------ccccCCCcCccccCHHHh
Confidence            876543210      111224588999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.91  E-value=5.2e-24  Score=215.64  Aligned_cols=169  Identities=28%  Similarity=0.449  Sum_probs=145.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|.+.....  .+++.+|++++++++||||+++++++....     ..|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEE
Confidence            578889999999999999999988889999999875432  578999999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ++||+++++|.+++.....     .+++..+..++.|++.|+.|||+.   +++|||++|+||+++.++.+||+|||++.
T Consensus        76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999975432     589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........        .....|+..|+|||++
T Consensus       148 ~~~~~~~~--------~~~~~~~~~y~~PE~~  171 (256)
T cd06612         148 QLTDTMAK--------RNTVIGTPFWMAPEVI  171 (256)
T ss_pred             hcccCccc--------cccccCCccccCHHHH
Confidence            76432111        1124588999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.91  E-value=5.3e-24  Score=220.57  Aligned_cols=176  Identities=26%  Similarity=0.457  Sum_probs=139.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce--EEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|++.+.||+|+||.||+|+...++.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++....     
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-----   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence            468889999999999999999876654  4688887632 233456789999999999 6999999999876544     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCcc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQV----------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                      ..|+||||+++|+|.++++......          ....+++..+..++.|++.|++|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            6899999999999999997543111          112478899999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++.+||+|||++.......         .......+..|+|||++.
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~  191 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV---------KKTMGRLPVRWMAIESLN  191 (297)
T ss_pred             CCCeEEECCcCCCcccccee---------ccCCCCcCccccCchhhc
Confidence            99999999999986432110         001122456799999763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.9e-24  Score=214.78  Aligned_cols=168  Identities=36%  Similarity=0.534  Sum_probs=141.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|...  ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...     +..+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeE
Confidence            347888899999999999999874  78899999975533 457899999999999999999999987653     3789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+||+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence            99999999999999976542    1578999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......           ...++..|+|||++.
T Consensus       150 ~~~~~~~~-----------~~~~~~~~~ape~~~  172 (256)
T cd05039         150 KEASQGQD-----------SGKLPVKWTAPEALR  172 (256)
T ss_pred             cccccccc-----------cCCCcccccCchhhc
Confidence            86532210           123566899999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.2e-26  Score=227.75  Aligned_cols=170  Identities=24%  Similarity=0.334  Sum_probs=146.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++++....+|-|+||.|-.++.......+|+|++++..   ....+....|-.+|.+++.|.||++|..|..     ..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-----~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-----SKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-----chh
Confidence            34556678999999999999886555568999887542   3345678899999999999999999987544     458


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+.||-|-||.++..+++++      .+++.....++..+++|++|||++   +||+||+||+|.++|.+|-+|+.|||
T Consensus       495 vYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence            999999999999999999876      578888889999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+..+         ..+.++||||.|.|||+++
T Consensus       566 FAKki~~g---------~KTwTFcGTpEYVAPEIIL  592 (732)
T KOG0614|consen  566 FAKKIGSG---------RKTWTFCGTPEYVAPEIIL  592 (732)
T ss_pred             hHHHhccC---------CceeeecCCcccccchhhh
Confidence            99987543         4456799999999999986

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=5.3e-24  Score=215.62  Aligned_cols=167  Identities=35%  Similarity=0.481  Sum_probs=138.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..+|+..+.||+|+||.||+|...  +..||+|.++...  ..+.+.+|+.++++++|++++++++++....    +..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceE
Confidence            347888899999999999999874  6789999886432  3467889999999999999999999764432    3679


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++..++.++.|++.|++|+|++   +|+||||||+||+++.++.+|++|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence            99999999999999976542    1478899999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +......           ....++..|+|||++
T Consensus       150 ~~~~~~~-----------~~~~~~~~y~aPE~~  171 (256)
T cd05082         150 KEASSTQ-----------DTGKLPVKWTAPEAL  171 (256)
T ss_pred             eeccccC-----------CCCccceeecCHHHH
Confidence            7543211           012356789999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.91  E-value=6.2e-24  Score=215.21  Aligned_cols=165  Identities=27%  Similarity=0.430  Sum_probs=134.4

Q ss_pred             ccccccceEEEEEEE--CCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          539 MIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      .||+|+||.||+|.+  ..++..||+|+++...  ....+++.+|+.++++++||||+++++++...      ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CcEEEEe
Confidence            589999999999975  4567899999986443  23356789999999999999999999986432      4689999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |+++|+|.+++....      .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            999999999997543      578999999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......     .......++..|||||++
T Consensus       147 ~~~~~~-----~~~~~~~~~~~y~aPE~~  170 (257)
T cd05116         147 ADENYY-----KAKTHGKWPVKWYAPECM  170 (257)
T ss_pred             CCCCee-----eecCCCCCCccccCHhHh
Confidence            332110     011112356789999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.91  E-value=9.3e-25  Score=203.69  Aligned_cols=167  Identities=21%  Similarity=0.328  Sum_probs=137.0

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeEE
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +....+|.|+.|+|++++++.+|...|||.+.... ..+.++++..++++.+.. .|+||+.+|||....     ..++.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~Ic  169 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVFIC  169 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHHHH
Confidence            34567999999999999999999999999997653 445677888888877765 899999999987654     67899


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      ||.|.. .+...++....     +++|...-++...+.+||.||.+++  +|+|||+||+|||+|+.|++|+||||++-.
T Consensus       170 MelMs~-C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  170 MELMST-CAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHH-HHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccce
Confidence            999843 45555554332     6888888899999999999999875  999999999999999999999999999987


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+....+.         .+|-+.|||||.+
T Consensus       242 lvdSkAhtr---------sAGC~~YMaPERi  263 (391)
T KOG0983|consen  242 LVDSKAHTR---------SAGCAAYMAPERI  263 (391)
T ss_pred             eeccccccc---------ccCCccccCcccc
Confidence            765433222         3699999999975

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.91  E-value=4e-24  Score=225.34  Aligned_cols=179  Identities=26%  Similarity=0.450  Sum_probs=141.3

Q ss_pred             cCCCCCcccccccceEEEEEEECC-------CceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      .+|++.+.||+|+||.||+|++..       .+..||+|.+.... ....+++.+|+++++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999998632       23478999887442 23456889999999999 7999999999976554


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPS  672 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~  672 (725)
                           ..++||||+++|+|.+++......          .....+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus        92 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          92 -----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             -----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence                 689999999999999999764321          1122478888999999999999999998   9999999999


Q ss_pred             CeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          673 NVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       673 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++.++.+||+|||+++.........      ......++..|||||++.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  209 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYK------KTTNGRLPVKWMAPEALF  209 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccc------cccCCCcCceEcCHHHhc
Confidence            9999999999999999998654321111      011123567899999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=2.3e-24  Score=218.53  Aligned_cols=168  Identities=30%  Similarity=0.465  Sum_probs=144.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++...     +..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeE
Confidence            4778899999999999999998889999999997542   23457889999999999999999999886544     489


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++++|.+++....      .+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||.
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999997653      588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........         .....|+..|+|||++
T Consensus       147 ~~~~~~~~~---------~~~~~~~~~y~~PE~~  171 (258)
T cd05578         147 ATKVTPDTL---------TTSTSGTPGYMAPEVL  171 (258)
T ss_pred             ccccCCCcc---------ccccCCChhhcCHHHH
Confidence            876543211         1124588899999975

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=3.8e-24  Score=222.78  Aligned_cols=178  Identities=25%  Similarity=0.420  Sum_probs=141.3

Q ss_pred             cCCCCCcccccccceEEEEEEECC-------CceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ++|.+.+.||+|+||.||+|++..       +...||+|.+.... .....++.+|+++++++ +||||+++++++....
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            578899999999999999998643       23579999997542 33456788999999999 7999999999986554


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCcc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQV----------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPS  672 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~  672 (725)
                           ..|+||||+++|+|.+++.......          ....+++.++++++.|++.||+|+|+.   +++||||||+
T Consensus        98 -----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  169 (307)
T cd05098          98 -----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  169 (307)
T ss_pred             -----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence                 7899999999999999997653210          112478899999999999999999998   9999999999


Q ss_pred             CeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          673 NVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       673 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.++.+||+|||.|+.........      ......+++.|||||++
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~  214 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEAL  214 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhh------ccccCCCccceeChHHh
Confidence            9999999999999999997653221110      01112355789999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.2e-24  Score=217.47  Aligned_cols=169  Identities=30%  Similarity=0.414  Sum_probs=145.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||.|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++....     ..|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEE
Confidence            36788899999999999999999899999999997553 344567889999999999999999999876554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|+||+++++|.+++...       .+++..+..++.|++.|+.|+|+.   +++||||+|+||+++.++.++++|||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            999999999999998753       478999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......        ......|++.|+|||++
T Consensus       146 ~~~~~~~~--------~~~~~~~~~~y~~PE~~  170 (274)
T cd06609         146 GQLTSTMS--------KRNTFVGTPFWMAPEVI  170 (274)
T ss_pred             eeeccccc--------ccccccCCccccChhhh
Confidence            87643311        11124689999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.91  E-value=4.9e-24  Score=220.80  Aligned_cols=178  Identities=24%  Similarity=0.422  Sum_probs=141.1

Q ss_pred             cCCCCCcccccccceEEEEEEECC----------------CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE----------------DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKI  594 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  594 (725)
                      ++|++.+.||+|+||.||+|++..                ++..||+|++.... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468889999999999999986432                34578999987543 3345688999999999999999999


Q ss_pred             eeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCcc-----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 048668          595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL  669 (725)
Q Consensus       595 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl  669 (725)
                      ++++....     ..++||||+++|+|.+++.......     ....+++..+..++.|++.|++|+|+.   +++||||
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            99976654     6899999999999999997643211     112477888999999999999999999   9999999


Q ss_pred             CCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          670 KPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       670 kp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+||+++.++.+|++|||+++.+.......      ......+++.|+|||+.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~  204 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESI  204 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHH
Confidence            9999999999999999999998653321110      01112356789999964

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4e-24  Score=218.97  Aligned_cols=180  Identities=25%  Similarity=0.353  Sum_probs=148.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCC-CCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDF-KGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~~  607 (725)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++..... ..+++.+|+++++++ +|+||+++++++..... ...+
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            46789999999999999999999988899999999875533 346789999999999 69999999999876542 2344


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++++|.+++......  ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence            689999999999999998753210  12578999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.+.........        .....|++.|+|||++
T Consensus       158 ~~~~~~~~~~~~--------~~~~~~~~~y~aPE~~  185 (275)
T cd06608         158 GVSAQLDSTLGR--------RNTFIGTPYWMAPEVI  185 (275)
T ss_pred             ccceecccchhh--------hcCccccccccCHhHh
Confidence            998765332111        1124589999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.91  E-value=6.3e-24  Score=218.05  Aligned_cols=179  Identities=27%  Similarity=0.470  Sum_probs=143.1

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|...     .++..||+|.+..........+.+|++++++++|+||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR----   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence            35677899999999999999742     356789999887655555678999999999999999999999876554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCcc---------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQV---------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                       ..++||||+++|+|.+++.......         ....+++..++.++.|++.|++|||+.   +++||||||+||+++
T Consensus        81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          81 -PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             -ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence             6799999999999999997653210         112478899999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++.+||+|||+++........      .......+++.|+|||++.
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~  197 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESIL  197 (280)
T ss_pred             CCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhc
Confidence            9999999999999765322110      0011234678899999753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.91  E-value=2.6e-24  Score=221.72  Aligned_cols=171  Identities=27%  Similarity=0.421  Sum_probs=142.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+++++.++||||+++++++...     ...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeE
Confidence            36888899999999999999998889999999886432  22345788999999999999999999987544     378


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++++.+.++.....      .+++..+..++.|++.|++|||+.   +|+|||++|+||+++.++.+|++|||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence            99999999999988765432      478999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++.......        ......|+..|+|||++.
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~  173 (286)
T cd07846         147 ARTLAAPGE--------VYTDYVATRWYRAPELLV  173 (286)
T ss_pred             eeeccCCcc--------ccCcccceeeccCcHHhc
Confidence            976533211        111245889999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=5.6e-24  Score=218.87  Aligned_cols=171  Identities=30%  Similarity=0.424  Sum_probs=138.6

Q ss_pred             CCCcccccccceEEEEEEE----CCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          535 SSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +..+.||+|+||+||++..    ..++..||+|.+..... .....|.+|++++++++||||+++++++....   ....
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---GKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---CceE
Confidence            7789999999999988653    34678899999875432 24567889999999999999999999876432   2357


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++|+|.+++...       .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccc
Confidence            8999999999999999653       489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+........     ......++..|+|||++
T Consensus       154 ~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~  182 (283)
T cd05080         154 AKAVPEGHEYYR-----VREDGDSPVFWYAVECL  182 (283)
T ss_pred             ccccCCcchhhc-----cCCCCCCCceeeCHhHh
Confidence            987643211100     01112467789999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.91  E-value=5.1e-24  Score=219.21  Aligned_cols=173  Identities=23%  Similarity=0.336  Sum_probs=138.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHH-HHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEA-LRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||.||+|++..+|+.||+|+++.... ....++..|+.+ ++..+||||+++++++....     ..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence            368888999999999999999999999999999875432 233456667665 56668999999999976554     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++ |+|.+++......  ...+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999996 6898888653221  135899999999999999999999853  899999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+.....         .....|+..|+|||++
T Consensus       151 ~~~~~~~~~---------~~~~~~~~~y~aPE~~  175 (283)
T cd06617         151 SGYLVDSVA---------KTIDAGCKPYMAPERI  175 (283)
T ss_pred             ccccccccc---------cccccCCccccChhhc
Confidence            986533211         1124588999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.91  E-value=5.2e-24  Score=221.27  Aligned_cols=172  Identities=29%  Similarity=0.496  Sum_probs=139.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce----EEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|+..+.||+|+||.||+|++..++.    .||+|.+..... ....++.+|+.++++++||||++++++|...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            467888999999999999999876665    578888864432 2344788999999999999999999987543     


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++|+||+++|+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~D  152 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITD  152 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcc
Confidence             35789999999999999876532     478889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++........      .......++..|+|||++
T Consensus       153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~  183 (303)
T cd05110         153 FGLARLLEGDEKE------YNADGGKMPIKWMALECI  183 (303)
T ss_pred             ccccccccCcccc------cccCCCccccccCCHHHh
Confidence            9999866432111      011123467889999975

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.91  E-value=1e-23  Score=214.55  Aligned_cols=174  Identities=29%  Similarity=0.496  Sum_probs=146.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+.....  ...+.+.+|++++++++|+||+++++++...+     ..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEE
Confidence            47788999999999999999988899999999976543  25678999999999999999999999865443     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|+||+++++|.+++....      .+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.+||+|||.+
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999997643      478888999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ...........    .......++..|+|||++.
T Consensus       147 ~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~  176 (264)
T cd06626         147 VKLKNNTTTMG----EEVQSLAGTPAYMAPEVIT  176 (264)
T ss_pred             cccCCCCCccc----ccccCCcCCcCccChhhcc
Confidence            87644322111    0011246889999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=4.2e-24  Score=238.11  Aligned_cols=264  Identities=26%  Similarity=0.270  Sum_probs=137.7

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      .-..|++++|+|+ .+|..+.  .+|+.|++++|+|+. +|.   .+++|++|+|++|+|+ .+|.    ..++|+.|+|
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~----lp~sL~~L~L  269 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV----LPPGLLELSI  269 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccC----cccccceeec
Confidence            4567788888877 5566554  367777777777773 443   2456777777777776 6663    2356666777


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECcc
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      ++|.++.+. ..   ..+|+.|+|++|+|+.++.    .+++|+.|+|++|+++.++.          ...+|+.|++++
T Consensus       270 s~N~L~~Lp-~l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~----------lp~~L~~L~Ls~  331 (788)
T PRK15387        270 FSNPLTHLP-AL---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA----------LPSELCKLWAYN  331 (788)
T ss_pred             cCCchhhhh-hc---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC----------Cccccccccccc
Confidence            777666442 22   2456666666666665432    12445555555555543321          012344444444


Q ss_pred             CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCC
Q 048668          198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI  277 (725)
Q Consensus       198 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  277 (725)
                      |++++                          +|..   ..+|+.|+|++|+|+++ |..   ..+|+.|++++|.|.. +
T Consensus       332 N~L~~--------------------------LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-L  377 (788)
T PRK15387        332 NQLTS--------------------------LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-L  377 (788)
T ss_pred             Ccccc--------------------------cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-C
Confidence            44431                          2210   12445555555555532 211   1234445555555542 3


Q ss_pred             CCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccc
Q 048668          278 PSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF  357 (725)
Q Consensus       278 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  357 (725)
                      |..   ..+|+.|++++|                                    .+++ +|..   .++|+.|++++|+|
T Consensus       378 P~l---~~~L~~LdLs~N------------------------------------~Lt~-LP~l---~s~L~~LdLS~N~L  414 (788)
T PRK15387        378 PAL---PSGLKELIVSGN------------------------------------RLTS-LPVL---PSELKELMVSGNRL  414 (788)
T ss_pred             ccc---ccccceEEecCC------------------------------------cccC-CCCc---ccCCCEEEccCCcC
Confidence            321   123444444444                                    4432 2211   13456666666666


Q ss_pred             cccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccc
Q 048668          358 SGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFL  413 (725)
Q Consensus       358 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  413 (725)
                      ++ +|..+   .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..+
T Consensus       415 ss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        415 TS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            53 33322   24556666666666 456666666666666666666666555544

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.91  E-value=7.9e-24  Score=215.15  Aligned_cols=170  Identities=27%  Similarity=0.511  Sum_probs=134.1

Q ss_pred             cccccccceEEEEEEECC---CceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGE---DEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++..   ....||+|.+... .....+.+.+|+.+++.++||||+++++++...+    ...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence            468999999999998642   3467999988533 2334578889999999999999999999775433    3578999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+.+|+|.+++.....     ..++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+||+|||+++.+
T Consensus        77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999975432     356777889999999999999998   9999999999999999999999999999765


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......    ........++..|+|||++
T Consensus       149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~  174 (262)
T cd05058         149 YDKEYYS----VHNHTGAKLPVKWMALESL  174 (262)
T ss_pred             cCCccee----ecccccCcCCccccChhHh
Confidence            3321110    0111123467889999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.91  E-value=7e-24  Score=217.43  Aligned_cols=161  Identities=27%  Similarity=0.356  Sum_probs=130.5

Q ss_pred             ccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHH---cCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALR---NIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      .||+|+||.||+|.+..+++.||+|.+....   ......+.+|..+++   ..+||+|+.+++++...+     ..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEE
Confidence            4899999999999998899999999986542   112233445544443   347999999998876544     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      |||+++|+|.+++....      .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+|++|||++..
T Consensus        76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            99999999999987654      589999999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....          .....||+.|+|||++
T Consensus       147 ~~~~~----------~~~~~~~~~y~aPE~~  167 (279)
T cd05633         147 FSKKK----------PHASVGTHGYMAPEVL  167 (279)
T ss_pred             ccccC----------ccCcCCCcCccCHHHh
Confidence            43221          0124599999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=7.5e-24  Score=215.03  Aligned_cols=171  Identities=27%  Similarity=0.519  Sum_probs=139.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+++.+|++++++++||+++++++++..      ...|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence            346888899999999999999876 566799999875433 34678999999999999999999987632      2478


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.++++....    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence            99999999999999976432    2578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......++..|+|||++
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~  175 (260)
T cd05070         150 RLIEDNEYT-------ARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             eeccCcccc-------cccCCCCCccccChHHH
Confidence            765432111       01112356789999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.91  E-value=4.9e-24  Score=222.64  Aligned_cols=179  Identities=26%  Similarity=0.453  Sum_probs=140.9

Q ss_pred             hcCCCCCcccccccceEEEEEEEC-------CCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSST  601 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  601 (725)
                      .++|.+.+.||+|+||.||+|++.       .....||+|++.... ......+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888899999999999999763       234579999987442 23356788999999999 599999999987654


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      .     ..|+||||+++|+|.+++......          .....+++..+.+++.|++.|++|+|++   +|+||||||
T Consensus        91 ~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          91 G-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             C-----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence            4     689999999999999999764311          0112578899999999999999999998   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+++.++.+||+|||+++..........      .....++..|||||++
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~  208 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEAL  208 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccc------cccCCCCccccCHHHH
Confidence            999999999999999999986643211110      0112345689999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.4e-25  Score=224.90  Aligned_cols=179  Identities=25%  Similarity=0.531  Sum_probs=150.6

Q ss_pred             HHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       525 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      ++|+-...+....+++|-|.||.||.|.|+...-.||||.++.+ ....++|++|+.+|+.++|||+|+++|+|....  
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--
Confidence            44444555667788999999999999999999999999999644 345789999999999999999999999998876  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|||+|||..|+|.+|+++....    .++....+.++.||..|++||..+   ++|||||..+|.|+.++..|||
T Consensus       337 ---PFYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  337 ---PFYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             ---CeEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence               789999999999999999976532    466667789999999999999998   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++++....+...       .+..-...|.|||-+
T Consensus       407 ADFGLsRlMtgDTYTAH-------AGAKFPIKWTAPEsL  438 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAH-------AGAKFPIKWTAPESL  438 (1157)
T ss_pred             eccchhhhhcCCceecc-------cCccCcccccCcccc
Confidence            99999999865422111       122345679999965

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.91  E-value=1e-23  Score=212.66  Aligned_cols=165  Identities=27%  Similarity=0.478  Sum_probs=135.0

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      +.||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||+++++++....     ..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECC
Confidence            36899999999999875 678899999865432 23357889999999999999999999976554     689999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++.....     .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++......
T Consensus        75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999875432     478899999999999999999998   9999999999999999999999999998754322


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ....       .....++..|+|||++
T Consensus       147 ~~~~-------~~~~~~~~~y~aPE~~  166 (250)
T cd05085         147 IYSS-------SGLKQIPIKWTAPEAL  166 (250)
T ss_pred             cccc-------CCCCCCcccccCHHHh
Confidence            1110       0112356789999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.91  E-value=8.1e-24  Score=216.93  Aligned_cols=169  Identities=27%  Similarity=0.443  Sum_probs=143.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..|+..+.||+|+||.||+|.+..++..||+|++.... ......+.+|++++++++||||+++++++....     ..|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEE
Confidence            35777789999999999999998889999999987543 344567889999999999999999999976654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++...       .+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++
T Consensus        79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence            999999999999998643       478888999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .........        .....++..|+|||++
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~y~apE~~  173 (277)
T cd06640         149 GQLTDTQIK--------RNTFVGTPFWMAPEVI  173 (277)
T ss_pred             eeccCCccc--------cccccCcccccCHhHh
Confidence            765432111        1124588999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=7.6e-24  Score=218.05  Aligned_cols=172  Identities=25%  Similarity=0.431  Sum_probs=143.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +|+..+.||+|++|.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++...+     ..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence            4788899999999999999999899999999997653 233467788999999999999999999976654     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++ ++.+++.....   ...+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+|++|||+++
T Consensus        76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            9999975 89998875432   12589999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......        ......+++.|+|||++.
T Consensus       149 ~~~~~~~--------~~~~~~~~~~y~~PE~~~  173 (284)
T cd07836         149 AFGIPVN--------TFSNEVVTLWYRAPDVLL  173 (284)
T ss_pred             hhcCCcc--------ccccccccccccChHHhc
Confidence            6533211        011235789999999763

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.91  E-value=6.2e-24  Score=219.14  Aligned_cols=179  Identities=28%  Similarity=0.478  Sum_probs=142.4

Q ss_pred             hcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|+..+.||+|+||.||+|++.     .++..||+|++..... ...+++.+|++++++++||||+++++++....  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~--   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK--   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence            357888999999999999999874     3678899999865432 33467889999999999999999999876554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCc----------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQ----------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD  668 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd  668 (725)
                         ..++||||+++|+|.+++......                .....+++..++.++.|++.||+|+|+.   +++|||
T Consensus        82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          82 ---PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             ---ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence               689999999999999999753211                1112478889999999999999999998   999999


Q ss_pred             CCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          669 LKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       669 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+||+++.++.+|++|||.++.+.......      ......++..|+|||++
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~  204 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK------ASENDAIPIRWMPPESI  204 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcccc------ccCCCccChhhcCHHHH
Confidence            99999999999999999999987653221100      01112356789999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=8.4e-24  Score=215.99  Aligned_cols=171  Identities=25%  Similarity=0.444  Sum_probs=139.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .+|...+.||+|+||.||+|.+...   ...||||...... ....+.+.+|++++++++||||+++++++...      
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------
Confidence            4577889999999999999987533   4568999887553 33456899999999999999999999987542      


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|.+++.....     .+++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+|++||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence            46899999999999999976432     478999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++..........       ....++..|+|||.+
T Consensus       152 g~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~  180 (270)
T cd05056         152 GLSRYLEDESYYKA-------SKGKLPIKWMAPESI  180 (270)
T ss_pred             ceeeecccccceec-------CCCCccccccChhhh
Confidence            99986643311111       112356789999975

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.91  E-value=9.8e-24  Score=214.67  Aligned_cols=170  Identities=29%  Similarity=0.445  Sum_probs=146.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++.+.+++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEE
Confidence            368888999999999999999998999999999976543 34578999999999999999999999976554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      +||||+++++|.+++....      .+++..++.++.|+++|++|+|+ .   +++||||+|+||+++.++.++++|||.
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence            9999999999999997653      58999999999999999999999 8   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +..........        ....++..|+|||.+
T Consensus       147 ~~~~~~~~~~~--------~~~~~~~~y~~pE~~  172 (264)
T cd06623         147 SKVLENTLDQC--------NTFVGTVTYMSPERI  172 (264)
T ss_pred             ceecccCCCcc--------cceeecccccCHhhh
Confidence            98664322111        124588999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.1e-23  Score=213.30  Aligned_cols=166  Identities=26%  Similarity=0.433  Sum_probs=135.1

Q ss_pred             cccccccceEEEEEEECCCc---eEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDE---MIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++..++   ..||+|.+..... ...+++.+|++++++++||||+++++++..      +..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence            46999999999999875444   7899999875543 245678999999999999999999998642      2568999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++..
T Consensus        75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence            9999999999998654      578999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......     .......++..|+|||.+
T Consensus       146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~  170 (257)
T cd05060         146 GAGSDYY-----RATTAGRWPLKWYAPECI  170 (257)
T ss_pred             ecCCccc-----ccccCccccccccCHHHh
Confidence            4332111     011112245689999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.91  E-value=9.6e-24  Score=218.59  Aligned_cols=179  Identities=22%  Similarity=0.347  Sum_probs=143.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++...  ......+.+|+++++++. ||||+++++++......+...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999999899999999986542  223467889999999995 699999999887655333345


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDF  687 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Df  687 (725)
                      .|+||||+++ ++.+++...... ....+++..++.++.||+.||+|||+.   +|+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence            7999999985 899988754321 122579999999999999999999998   9999999999999998 889999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.+......        .....+++.|+|||++
T Consensus       156 g~~~~~~~~~~~--------~~~~~~~~~~~aPE~~  183 (295)
T cd07837         156 GLGRAFSIPVKS--------YTHEIVTLWYRAPEVL  183 (295)
T ss_pred             ccceecCCCccc--------cCCcccccCCCChHHh
Confidence            999765322110        1113578899999976

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=8.7e-24  Score=216.75  Aligned_cols=168  Identities=24%  Similarity=0.395  Sum_probs=143.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCC---CCcccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR---HRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .|+..+.||+|+||.||+|.+..+++.||+|++.... .....++.+|++++++++   |||++++++++....     .
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----R   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----E
Confidence            4777889999999999999998899999999987542 334567889999999997   999999999876544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++++|.+++...       .+++..++.++.|++.|+.|+|+.   +|+|+||+|+||+++.++.++++|||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            89999999999999998643       478899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+........        ......|+..|+|||++
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~  173 (277)
T cd06917         147 VAALLNQNSS--------KRSTFVGTPYWMAPEVI  173 (277)
T ss_pred             ceeecCCCcc--------ccccccCCcceeCHHHh
Confidence            9987644321        11124689999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=1.2e-23  Score=212.97  Aligned_cols=170  Identities=28%  Similarity=0.479  Sum_probs=142.8

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++.+...     +..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence            4778899999999999999998899999999997542  23456889999999999999999999886544     3789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~~kl~Dfgl  689 (725)
                      +||||+++++|.+++.....    ..+++..+..++.|++.|++|+|++   +++|+||||+||+++.+ +.+|++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999976432    2578999999999999999999998   99999999999999865 4689999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.......         .....|+..|+|||.+
T Consensus       149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~  173 (256)
T cd08220         149 SKILSSKSK---------AYTVVGTPCYISPELC  173 (256)
T ss_pred             ceecCCCcc---------ccccccCCcccCchhc
Confidence            986643211         1124589999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.91  E-value=8.9e-24  Score=216.42  Aligned_cols=177  Identities=21%  Similarity=0.376  Sum_probs=142.6

Q ss_pred             cCCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++|+..+.||+|+||.||+|+.+.     +.+.||+|........ ..+.+.+|++++++++||||+++++++....   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE---   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence            468888999999999999999753     3467999988654433 4567899999999999999999999876544   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCcc---ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQV---EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                        ..|+||||+++|+|.+++.......   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        82 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          82 --PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             --cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence              6899999999999999997654211   112478999999999999999999998   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++|||+++.......       .......++..|+|||.+
T Consensus       157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             EEcccccccccCcccc-------cccCCceeEEeecChhhh
Confidence            9999999875432111       111123577889999975

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.91  E-value=1.1e-23  Score=214.50  Aligned_cols=176  Identities=27%  Similarity=0.388  Sum_probs=144.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.+|+|+||.||+|.+..++..||+|++....  ....+++..|++++++++||||+++++++....   ....|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence            4778899999999999999999899999999987542  234567889999999999999999998765432   23678


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHH-----hcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-----~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ++|||+++++|.+++.....  +...+++..++.++.|++.|++|+|     +.   +++|+||||+||+++.++.+|++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence            99999999999999976421  1225889999999999999999999     66   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+++........        .....|++.|+|||++.
T Consensus       153 d~g~~~~~~~~~~~--------~~~~~~~~~~~~pE~~~  183 (265)
T cd08217         153 DFGLAKILGHDSSF--------AKTYVGTPYYMSPEQLN  183 (265)
T ss_pred             cccccccccCCccc--------ccccccCCCccChhhhc
Confidence            99999876433210        11246899999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=9.3e-24  Score=213.83  Aligned_cols=171  Identities=24%  Similarity=0.351  Sum_probs=143.8

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+++...+++.||+|.+....  ....+++.+|++++++++||||+++++++...     +..|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEE
Confidence            4778899999999999999998899999999987532  33456789999999999999999999986544     4889


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+
T Consensus        76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999999999875432    1478899999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .........        .....|++.|+|||+.
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~~pe~~  173 (256)
T cd08218         149 RVLNSTVEL--------ARTCIGTPYYLSPEIC  173 (256)
T ss_pred             eecCcchhh--------hhhccCCccccCHHHh
Confidence            765332111        1124588999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.91  E-value=8.8e-24  Score=217.59  Aligned_cols=170  Identities=26%  Similarity=0.435  Sum_probs=141.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|++..+++.||||.+....  ......+.+|++++++++||||+++++++...     +..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence            4778899999999999999998899999999987543  22345788999999999999999999986544     3789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+. ++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence            9999995 689998875432    2588999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......        ......+++.|+|||++
T Consensus       148 ~~~~~~~~--------~~~~~~~~~~y~aPE~~  172 (284)
T cd07860         148 RAFGVPVR--------TYTHEVVTLWYRAPEIL  172 (284)
T ss_pred             hhcccCcc--------ccccccccccccCCeEE
Confidence            76532211        01123578899999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.91  E-value=1.3e-23  Score=216.90  Aligned_cols=170  Identities=22%  Similarity=0.348  Sum_probs=140.5

Q ss_pred             CCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      +|+..+.||+|+||.||+|++.   .+|+.||+|++....    ....+++.+|+++++++ +|++|+++++++....  
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence            4778899999999999999874   478899999986432    22346778999999999 5999999998865443  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|+||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          79 ---KLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             ---eEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence               7899999999999999997653      478888999999999999999998   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++........       ......|+..|+|||++
T Consensus       147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~  178 (290)
T cd05613         147 TDFGLSKEFHEDEVE-------RAYSFCGTIEYMAPDIV  178 (290)
T ss_pred             eeCccceeccccccc-------ccccccCCcccCChhhc
Confidence            999999865432111       11124689999999976

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.91  E-value=1.1e-23  Score=220.40  Aligned_cols=178  Identities=23%  Similarity=0.369  Sum_probs=142.9

Q ss_pred             CCCCCcccccccceEEEEEEECC--CceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGE--DEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .|+..+.||+|+||.||+|++..  +++.||+|.+....   ....+.+.+|++++++++||||+++++++....   .+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence            37778899999999999999987  78999999997632   334467789999999999999999999987552   23


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC----CCceE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH----DMVAH  683 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~----~~~~k  683 (725)
                      ..|+||||+++ ++.+++....... ...+++..++.++.|++.|++|||+.   +|+||||||+||+++.    ++.+|
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            78999999965 7877775433211 12578999999999999999999998   9999999999999999    89999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||+++........     ........+|+.|+|||++
T Consensus       153 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~  187 (316)
T cd07842         153 IGDLGLARLFNAPLKP-----LADLDPVVVTIWYRAPELL  187 (316)
T ss_pred             ECCCccccccCCCccc-----ccccCCccccccccCHHHH
Confidence            9999999876443211     1111235689999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.91  E-value=1.4e-23  Score=218.90  Aligned_cols=175  Identities=29%  Similarity=0.405  Sum_probs=143.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|+++...  ......+.+|++++++++|+||+++++++....   .+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence            3567999999999999999999999899999999997543  222345678999999999999999999876432   23


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||++ ++|.+++....     ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            5799999996 48988887543     2588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |.++........        .....+++.|+|||++.
T Consensus       153 g~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         153 GLARTYGLPAKP--------MTPKVVTLWYRAPELLL  181 (309)
T ss_pred             ceeeecCCccCC--------CCcccccccccChhhhc
Confidence            999876432111        11134688899999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.91  E-value=8.3e-24  Score=218.25  Aligned_cols=171  Identities=26%  Similarity=0.379  Sum_probs=143.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|.+..+++.||+|+++..  .....+.+.+|++++++++|+||+++++++...+     ..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EEE
Confidence            688889999999999999999989999999998653  2334567899999999999999999999976544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++++.+..+.....      .+++..+..++.||+.|++|||+.   +++|||++|+||+++.++.+||+|||++
T Consensus        77 iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          77 LVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             EEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence            9999999877766654432      478999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ........       .......|+..|+|||++.
T Consensus       148 ~~~~~~~~-------~~~~~~~~~~~~~~PE~~~  174 (288)
T cd07833         148 RALRARPA-------SPLTDYVATRWYRAPELLV  174 (288)
T ss_pred             cccCCCcc-------ccccCcccccCCcCCchhc
Confidence            87644321       0111246889999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.91  E-value=1.5e-23  Score=214.03  Aligned_cols=169  Identities=30%  Similarity=0.485  Sum_probs=133.9

Q ss_pred             cccccccceEEEEEEECCCce--EEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|++.+++.  .+|+|.+... .....+.+.+|++++.++ +||||+++++++....     ..|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEE
Confidence            368999999999999877765  4688877633 233456788999999999 7999999999976554     689999


Q ss_pred             eccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          614 EYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      ||+++|+|.+++......          .....+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            999999999999754311          1112478899999999999999999998   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++|||+++......         .......+..|+|||++
T Consensus       153 l~dfgl~~~~~~~~---------~~~~~~~~~~y~apE~~  183 (270)
T cd05047         153 IADFGLSRGQEVYV---------KKTMGRLPVRWMAIESL  183 (270)
T ss_pred             ECCCCCccccchhh---------hccCCCCccccCChHHH
Confidence            99999986321110         00112346789999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.91  E-value=1.6e-23  Score=218.63  Aligned_cols=181  Identities=27%  Similarity=0.428  Sum_probs=145.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC---
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK---  604 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  604 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++....  ......+.+|++++++++||||+++++++......   
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457899999999999999999999899999999986542  22334567899999999999999999988654321   


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                      .....++||||++ +++.+++.....     .+++.+++.++.|++.|++|||++   +++|+||||+||+++.++.+||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  160 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL  160 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence            2235699999996 588888865432     578999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||++..+.......    ........++..|+|||++
T Consensus       161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         161 ADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             CcCCCcccccCCcccC----CCCccCcccCccccCcHHh
Confidence            9999998764332111    1111234688999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.91  E-value=1.1e-23  Score=213.92  Aligned_cols=171  Identities=24%  Similarity=0.517  Sum_probs=140.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|... +++.||+|.+.... ...+++.+|++++++++||||+++++++..      +..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence            357888999999999999999875 67789999987443 234688999999999999999999987532      2579


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....    ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence            99999999999999875432    2578899999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......++..|+|||++
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~~pe~~  175 (260)
T cd05067         150 RLIEDNEYT-------AREGAKFPIKWTAPEAI  175 (260)
T ss_pred             eecCCCCcc-------cccCCcccccccCHHHh
Confidence            765422111       11123467889999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.91  E-value=6.8e-24  Score=223.58  Aligned_cols=178  Identities=26%  Similarity=0.364  Sum_probs=145.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....  ......+.+|+.++++++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            367888999999999999999999999999999987542  234567788999999999999999998765443 23347


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ |+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence            899999995 69999987543      488999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++........    .........|+..|+|||++
T Consensus       153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             cceeecccCcC----CCcccccccccccccChHHh
Confidence            99765432211    11111235689999999975

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.90  E-value=1.4e-23  Score=212.68  Aligned_cols=168  Identities=26%  Similarity=0.419  Sum_probs=138.2

Q ss_pred             cccccccceEEEEEEECC-Cc--eEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGE-DE--MIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|.+.. .+  ..||+|.+..... ...+++.+|++++++++||||+++++++..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999854 23  3699999976654 456789999999999999999999998654      3689999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|+|.+++.....    ..+++..++.++.|++.||+|+|+.   +++||||||+||+++.++.+||+|||+++.+
T Consensus        75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence            99999999999986542    2578999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........     ......++..|+|||++
T Consensus       148 ~~~~~~~~-----~~~~~~~~~~y~~pE~~  172 (257)
T cd05040         148 PQNEDHYV-----MEEHLKVPFAWCAPESL  172 (257)
T ss_pred             ccccccee-----cccCCCCCceecCHHHh
Confidence            44211100     01124578899999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=1.5e-23  Score=214.91  Aligned_cols=168  Identities=29%  Similarity=0.451  Sum_probs=142.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      -|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++....     ..|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEEE
Confidence            4667789999999999999998889999999986443 233467889999999999999999999976554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++...       .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||+++
T Consensus        80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence            99999999999998643       478899999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+.....        ......|+..|+|||++
T Consensus       150 ~~~~~~~--------~~~~~~~~~~y~~PE~~  173 (277)
T cd06641         150 QLTDTQI--------KRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             ecccchh--------hhccccCCccccChhhh
Confidence            6543211        11124588999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.90  E-value=1.8e-23  Score=211.99  Aligned_cols=171  Identities=30%  Similarity=0.584  Sum_probs=142.5

Q ss_pred             CCCCcccccccceEEEEEEECCCc----eEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      +++.+.||+|+||.||+|++...+    ..||+|++...... ..+.+..|++.+++++|+||+++++++....     .
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----P   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----e
Confidence            356788999999999999997665    88999999755432 5678899999999999999999999876553     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .+++|||+++++|.+++......    .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            89999999999999999765421    289999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++...........       ...+++.|+|||.+
T Consensus       149 ~~~~~~~~~~~~~~-------~~~~~~~y~~Pe~~  176 (258)
T smart00219      149 LSRDLYDDDYYKKK-------GGKLPIRWMAPESL  176 (258)
T ss_pred             Cceecccccccccc-------cCCCcccccChHHh
Confidence            99876543211110       12378899999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.90  E-value=1.8e-23  Score=212.14  Aligned_cols=170  Identities=27%  Similarity=0.519  Sum_probs=138.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|...+.||+|+||.||+|.+..+ ..||+|.+.... ...+.+.+|++++++++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEE
Confidence            4578889999999999999988644 469999886433 234678899999999999999999987632      25789


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++|+|.++++....    ..+++..+..++.|++.||+|+|+.   +++||||||+||++++++.+||+|||.++
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            9999999999999976432    2478899999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........       ......++..|+|||+.
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~y~~Pe~~  175 (260)
T cd05069         151 LIEDNEYT-------ARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             EccCCccc-------ccCCCccchhhCCHHHh
Confidence            66432111       01113467789999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.90  E-value=1.5e-23  Score=214.83  Aligned_cols=163  Identities=26%  Similarity=0.381  Sum_probs=137.1

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||+||+|.+..+++.||+|++....   ....+.+..|++++++++||||+++++++...+     ..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence            689999999999998899999999987532   223456788999999999999999998865543     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++.....    ..+++..+..++.|++.|+.|+|+.   +++||||+|+||+++.++.+|++|||.++.....
T Consensus        76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999976542    2588999999999999999999998   9999999999999999999999999998765331


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ..         .....|+..|+|||++
T Consensus       149 ~~---------~~~~~~~~~y~~PE~~  166 (277)
T cd05577         149 KK---------IKGRAGTPGYMAPEVL  166 (277)
T ss_pred             Cc---------cccccCCCCcCCHHHh
Confidence            11         1124588899999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=2.2e-23  Score=214.61  Aligned_cols=176  Identities=26%  Similarity=0.417  Sum_probs=142.7

Q ss_pred             cCCCCCcccccccceEEEEEEEC----CCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG----EDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||.||+|++.    .+++.||||++...... ..+.|.+|++++++++||||+++++++....   .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~---~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG---G   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC---C
Confidence            35777889999999999999864    34789999999765443 4578999999999999999999999875422   3


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            468999999999999999976542     488999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||.+...........     ......++..|+|||.+
T Consensus       153 fg~~~~~~~~~~~~~-----~~~~~~~~~~~~~Pe~~  184 (284)
T cd05038         153 FGLAKVLPEDKDYYY-----VKEPGESPIFWYAPECL  184 (284)
T ss_pred             cccccccccCCccee-----ccCCCCCcccccCcHHH
Confidence            999987653211100     01112356679999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=2.3e-23  Score=213.54  Aligned_cols=162  Identities=25%  Similarity=0.333  Sum_probs=130.6

Q ss_pred             ccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHH---HHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECE---ALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      .||+|+||.||+|++..+++.||+|++.....   .....+..|..   .++...||+|+++++++...+     ..|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEE
Confidence            48999999999999988899999999875421   11122334443   444557999999998866544     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      |||++||+|.+++....      .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            99999999999886543      589999999999999999999998   999999999999999999999999999875


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .....          .....|+..|+|||++.
T Consensus       147 ~~~~~----------~~~~~~~~~y~aPE~~~  168 (278)
T cd05606         147 FSKKK----------PHASVGTHGYMAPEVLQ  168 (278)
T ss_pred             cCccC----------CcCcCCCcCCcCcHHhc
Confidence            43221          11246999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN03210 Resistant to P

Probab=99.90  E-value=6.4e-23  Score=246.68  Aligned_cols=344  Identities=20%  Similarity=0.232  Sum_probs=173.3

Q ss_pred             cCCCCCCCCCCCCEEEccCCc------ccccCcccccccC-CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeee
Q 048668           52 KFPTTLGLLRNLVQLNVAENK------FYGMFPRSICNIS-SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG  124 (725)
Q Consensus        52 ~~~~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~  124 (725)
                      +.+.+|.++++|+.|.+..+.      +...+|..|..++ +|+.|++++|.++ .+|..+  .+.+|+.|+|.+|++..
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLEK  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCccccc
Confidence            345667788888888886553      2334566666664 4888888888876 777654  46778888888887774


Q ss_pred             eCCCcccccCccceecCCCcc-ccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCccccc
Q 048668          125 LIPDSLSNASNLELLDLSNNQ-FKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       125 ~~~~~~~~l~~L~~L~Ls~N~-i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                      + +..+..+++|+.|+|++|. +..++  .+..+++|++|+|++|....      .++..+.++++|+.|++++|..-+.
T Consensus       626 L-~~~~~~l~~Lk~L~Ls~~~~l~~ip--~ls~l~~Le~L~L~~c~~L~------~lp~si~~L~~L~~L~L~~c~~L~~  696 (1153)
T PLN03210        626 L-WDGVHSLTGLRNIDLRGSKNLKEIP--DLSMATNLETLKLSDCSSLV------ELPSSIQYLNKLEDLDMSRCENLEI  696 (1153)
T ss_pred             c-ccccccCCCCCEEECCCCCCcCcCC--ccccCCcccEEEecCCCCcc------ccchhhhccCCCCEEeCCCCCCcCc
Confidence            3 5566777788888887764 33332  36667777777777654321      1223456667777777776543334


Q ss_pred             CChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcC
Q 048668          204 LPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN  283 (725)
Q Consensus       204 ~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  283 (725)
                      +|..+ ++. .|+.|.+++|...+.+|..   ..+|++|++++|.+.                         .+|..+ .
T Consensus       697 Lp~~i-~l~-sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-------------------------~lP~~~-~  745 (1153)
T PLN03210        697 LPTGI-NLK-SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-------------------------EFPSNL-R  745 (1153)
T ss_pred             cCCcC-CCC-CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-------------------------cccccc-c
Confidence            44433 222 4455555544333333321   234444445544443                         233322 2


Q ss_pred             CCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCcc
Q 048668          284 LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPV  363 (725)
Q Consensus       284 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  363 (725)
                      +++|++|++.++.....+    +. ...++...+.....++.|++++|...+.+|..++.+++|+.|++++|...+.+|.
T Consensus       746 l~~L~~L~l~~~~~~~l~----~~-~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~  820 (1153)
T PLN03210        746 LENLDELILCEMKSEKLW----ER-VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT  820 (1153)
T ss_pred             ccccccccccccchhhcc----cc-ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence            344444444432211000    00 0001111111112224455555544444555555555555555555432223343


Q ss_pred             ccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEccc-ccCeeecCCCCccCCC
Q 048668          364 TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSY-NHLEGEVPTKGVFSNK  442 (725)
Q Consensus       364 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~~~~  442 (725)
                      .+ .+++|+.|+|++|..-..+|..   .++|+.|+|++|.++ .+|..+..+++|+.|+|++ |++++.++....+..+
T Consensus       821 ~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L  895 (1153)
T PLN03210        821 GI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL  895 (1153)
T ss_pred             CC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCC
Confidence            33 3455555555554432222221   234555555555554 3455555555555555554 3444433333333344


Q ss_pred             CCcCcc
Q 048668          443 SKIPLQ  448 (725)
Q Consensus       443 ~~~~~~  448 (725)
                      ..+.+.
T Consensus       896 ~~L~l~  901 (1153)
T PLN03210        896 ETVDFS  901 (1153)
T ss_pred             CeeecC
Confidence            443433

syringae 6; Provisional

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.90  E-value=2.2e-23  Score=214.46  Aligned_cols=168  Identities=24%  Similarity=0.366  Sum_probs=142.5

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      .|...+.||+|++|.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++...+     ..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEE
Confidence            3455679999999999999998889999999987655455567889999999999999999999876544     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +||+++++|.+++...       .+++..+..++.|++.|++|+|++   +|+||||+|+||+++.++.+|++|||.+..
T Consensus        95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            9999999999998762       478889999999999999999999   999999999999999999999999998875


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......        ......|++.|+|||+.
T Consensus       165 ~~~~~~--------~~~~~~~~~~y~aPE~~  187 (285)
T cd06648         165 VSKEVP--------RRKSLVGTPYWMAPEVI  187 (285)
T ss_pred             hccCCc--------ccccccCCccccCHHHh
Confidence            432211        11124589999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=1.9e-23  Score=212.29  Aligned_cols=161  Identities=28%  Similarity=0.387  Sum_probs=138.2

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     ..|+||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence            689999999999998889999999997542   234467899999999999999999999876544     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++....      .+++..+..++.|++.|++|+|+.   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999997654      478889999999999999999998   9999999999999999999999999999866432


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .         ......|++.|+|||++
T Consensus       147 ~---------~~~~~~~~~~~~~PE~~  164 (262)
T cd05572         147 Q---------KTWTFCGTPEYVAPEII  164 (262)
T ss_pred             c---------ccccccCCcCccChhHh
Confidence            1         11124689999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.4e-23  Score=213.30  Aligned_cols=173  Identities=28%  Similarity=0.531  Sum_probs=142.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+++.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ce
Confidence            3467889999999999999999976 55779999987543 23467899999999999999999999865543     68


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++++|.+++.....    ..+++..+..++.|++.|++|+|+.   +++|+||||+||+++.++.+|++|||.
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             EEEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence            999999999999999976432    2578999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++........       ......++..|+|||.+
T Consensus       150 ~~~~~~~~~~-------~~~~~~~~~~y~~PE~~  176 (261)
T cd05034         150 ARLIEDDEYT-------AREGAKFPIKWTAPEAA  176 (261)
T ss_pred             ceeccchhhh-------hhhccCCCccccCHHHh
Confidence            9866432111       00112356789999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=9.8e-24  Score=222.58  Aligned_cols=176  Identities=26%  Similarity=0.352  Sum_probs=145.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..+|...+.||+|+||.||+|++..+++.||||.+...  ......++.+|+.+++.++||||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35788899999999999999999999999999998643  2233456788999999999999999999876544333346


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+. ++|.+++....      .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            899999995 68999887543      588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++......        .......|+..|+|||++.
T Consensus       154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~  181 (337)
T cd07858         154 LARTTSEKG--------DFMTEYVVTRWYRAPELLL  181 (337)
T ss_pred             cccccCCCc--------ccccccccccCccChHHHh
Confidence            997653321        1111245889999999763

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.90  E-value=2.4e-23  Score=212.19  Aligned_cols=178  Identities=27%  Similarity=0.367  Sum_probs=147.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|....++..||+|++.... ....+.+.+|++.++.++|+||+++++.+....     ..|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEE
Confidence            36888999999999999999998889999999987543 224578899999999999999999999876544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....   ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++|||++
T Consensus        76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            99999999999999976432   12578999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ..+........    .......|+..|+|||++.
T Consensus       150 ~~~~~~~~~~~----~~~~~~~~~~~y~~Pe~~~  179 (267)
T cd06610         150 ASLADGGDRTR----KVRKTFVGTPCWMAPEVME  179 (267)
T ss_pred             HHhccCccccc----cccccccCChhhcChHHHc
Confidence            87654322110    1112346899999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-25  Score=208.64  Aligned_cols=173  Identities=21%  Similarity=0.304  Sum_probs=142.0

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +-.+.||-|+||+||.+.+..+|+.||.|++..-  .-...+++.+|++++.-++|.|++..+++......+.....|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999999999999999988522  22345788999999999999999999988665555555678999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +|.|. .||..++-.-.      .++...+.-+.+||++||+|||+.   +|.||||||.|.|+..++..||||||+|+.
T Consensus       136 TELmQ-SDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHH-hhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            99994 48888875433      578888888999999999999999   999999999999999999999999999985


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      -...       .....+..+-|.+|.|||++|
T Consensus       206 ee~d-------~~~hMTqEVVTQYYRAPEiLM  230 (449)
T KOG0664|consen  206 WDQR-------DRLNMTHEVVTQYYRAPELLM  230 (449)
T ss_pred             cchh-------hhhhhHHHHHHHHhccHHHhh
Confidence            4322       112233467899999999986

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.90  E-value=1.9e-23  Score=214.66  Aligned_cols=180  Identities=23%  Similarity=0.385  Sum_probs=143.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECC----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGE----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      .++|+..+.||+|+||.||+|.+..    ++..||+|++.... ....+.+.+|++++++++||||+++++++....   
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG---   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---
Confidence            4578888999999999999999864    36789999886432 234567889999999999999999999876542   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCc--cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQ--VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                       ...++++||+++|+|.+++......  .....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus        82 -~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          82 -EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             -CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence             3678999999999999999764321  1113588999999999999999999998   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||+++.+........      .....++..|+|||++
T Consensus       158 l~d~g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~  191 (280)
T cd05043         158 ITDNALSRDLFPMDYHCL------GDNENRPVKWMALESL  191 (280)
T ss_pred             ECCCCCcccccCCceEEe------CCCCCcchhccCHHHH
Confidence            999999986533211100      0112467789999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.4e-23  Score=210.20  Aligned_cols=166  Identities=30%  Similarity=0.498  Sum_probs=136.8

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      +.||+|+||.||+|.+.. ++.||+|++...... ....+.+|++++++++||||+++++++....     ..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence            468999999999999876 899999998754333 4568899999999999999999999876554     789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++.....     .+++..+..++.+++.|++|+|++   +++||||||+||+++.++.+||+|||.++.....
T Consensus        75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999999975432     478889999999999999999999   9999999999999999999999999999765422


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....      .....++..|+|||++
T Consensus       147 ~~~~~------~~~~~~~~~y~~PE~~  167 (251)
T cd05041         147 IYTVS------DGLKQIPIKWTAPEAL  167 (251)
T ss_pred             cceec------cccCcceeccCChHhh
Confidence            11100      0112346779999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.90  E-value=2.7e-23  Score=212.63  Aligned_cols=181  Identities=29%  Similarity=0.465  Sum_probs=140.2

Q ss_pred             CCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC-cc
Q 048668          534 FSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG-VD  607 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~  607 (725)
                      |.+.+.||+|+||.||+|.++   .+++.||||++..+.  ....+++.+|++++++++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999864   357899999986542  234567889999999999999999999876543221 12


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++++||+++|+|.+++...........+++..++.++.|++.|++|+|+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3578999999999999875432221223578889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.........      ......+++.|+|||.+
T Consensus       158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~  187 (273)
T cd05074         158 GLSKKIYSGDYYR------QGCASKLPVKWLALESL  187 (273)
T ss_pred             cccccccCCccee------cCCCccCchhhcCHhHH
Confidence            9998654321111      11123467789999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.90  E-value=1.3e-23  Score=213.91  Aligned_cols=170  Identities=26%  Similarity=0.375  Sum_probs=138.5

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++||||+++++.+...     ...|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence            6899999999999998899999999865432   3456788999999999999999999876544     3789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++....      .+++..+..++.|++.||+|+|+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999997644      578999999999999999999998   9999999999999999999999999998764332


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ................++..|+|||+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~  173 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVI  173 (265)
T ss_pred             cccccccccccccCcccCccccCHHHh
Confidence            111000001111234688999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.90  E-value=2.5e-23  Score=216.57  Aligned_cols=167  Identities=29%  Similarity=0.419  Sum_probs=140.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..|+..+.||+|+||.||+|++..+++.||+|++.....   ...+++.+|+++++.++||||++++++|....     .
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence            457888999999999999999988899999999864322   23457889999999999999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ |++.+++.....     .+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            899999996 578777754332     578999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++.....            ....|++.|+|||++.
T Consensus       161 ~~~~~~~~------------~~~~~~~~y~aPE~~~  184 (307)
T cd06607         161 SASLVSPA------------NSFVGTPYWMAPEVIL  184 (307)
T ss_pred             cceecCCC------------CCccCCccccCceeee
Confidence            98754321            1245888999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.90  E-value=1.6e-23  Score=216.05  Aligned_cols=164  Identities=25%  Similarity=0.391  Sum_probs=139.8

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ...||+|+||.||+|....++..||||++..........+.+|+.++++++|+||+++++++...+     ..++||||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecC
Confidence            367999999999999998899999999987555445567899999999999999999999876554     889999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++...       .+++..+..++.|++.|++|+|+.   +++||||+|+||+++.++.++|+|||++......
T Consensus       100 ~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657         100 EGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             CCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            999999987543       468888999999999999999999   9999999999999999999999999998765332


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ..        ......|++.|+|||++
T Consensus       170 ~~--------~~~~~~~~~~y~~pE~~  188 (292)
T cd06657         170 VP--------RRKSLVGTPYWMAPELI  188 (292)
T ss_pred             cc--------cccccccCccccCHHHh
Confidence            11        11124689999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.90  E-value=9.9e-24  Score=214.83  Aligned_cols=169  Identities=25%  Similarity=0.395  Sum_probs=144.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +|+..+.||+|+||.||+|.++.+++.||+|++.... ....+++.+|++++++++||||+++++++....     ..++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEEE
Confidence            5777889999999999999999899999999987653 334567899999999999999999999876554     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      |+||+++++|.+++....     ..+++..+..++.|++.|++|+|+ .   +++||||||+||+++.++.+||+|||.+
T Consensus        77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             EEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999998653     158889999999999999999999 7   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .........          ...|+..|+|||++.
T Consensus       149 ~~~~~~~~~----------~~~~~~~y~~PE~~~  172 (265)
T cd06605         149 GQLVNSLAK----------TFVGTSSYMAPERIQ  172 (265)
T ss_pred             hhhHHHHhh----------cccCChhccCHHHHc
Confidence            765322110          145889999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.1e-23  Score=209.64  Aligned_cols=169  Identities=31%  Similarity=0.517  Sum_probs=145.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|++|.||+|++..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++....     ..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Confidence            47788999999999999999988899999999976543  35578899999999999999999999876543     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence            9999999999999997653      589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .........        .....|+..|+|||..
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~y~~pe~~  171 (254)
T cd06627         147 TKLNDVSKD--------DASVVGTPYWMAPEVI  171 (254)
T ss_pred             eecCCCccc--------ccccccchhhcCHhhh
Confidence            876443211        1124589999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=1.8e-23  Score=211.37  Aligned_cols=164  Identities=32%  Similarity=0.519  Sum_probs=136.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|++.+.||+|+||.||+|..  +++.||+|.++...  ..+.+.+|+.++++++||||+++++++...      ..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEE
Confidence            4688899999999999999975  67789999986432  346788999999999999999999987532      3689


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++.....    ..+++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+||+|||+++
T Consensus        76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence            9999999999999976532    2578899999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......           ....+..|+|||++
T Consensus       149 ~~~~~~~-----------~~~~~~~y~~pe~~  169 (254)
T cd05083         149 VGSMGVD-----------NSKLPVKWTAPEAL  169 (254)
T ss_pred             eccccCC-----------CCCCCceecCHHHh
Confidence            5422100           12245689999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.90  E-value=2.2e-23  Score=221.43  Aligned_cols=174  Identities=22%  Similarity=0.297  Sum_probs=142.6

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++...  ......++.+|++++++++||||+++++++.... +...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            456899999999999999999999999999999998643  2233456788999999999999999999875432 2333


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...|+||||++ +++.+++..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            46799999995 588888753        267788899999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++.......         .....||+.|+|||++.
T Consensus       162 fg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~  190 (353)
T cd07850         162 FGLARTAGTSFM---------MTPYVVTRYYRAPEVIL  190 (353)
T ss_pred             CccceeCCCCCC---------CCCCcccccccCHHHHh
Confidence            999986533211         11245899999999763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.90  E-value=3.3e-25  Score=205.99  Aligned_cols=169  Identities=24%  Similarity=0.334  Sum_probs=134.5

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEEEe
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      ...||.|+||+|++-.++.+|+..|||+|+... +.+.+++..|.+...+- +.||||++||.+..+.     ..|+.||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeeeHH
Confidence            357999999999999999999999999998653 35667888898876665 5999999999976554     6899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      .|+ -++..+.+... ......++|...-.|..-.+.||.||-+..  .|||||+||+|||+|..|.+|+||||++-.+.
T Consensus       144 LMd-~SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHh-hhHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            994 46655443211 111235888888889999999999998764  89999999999999999999999999997764


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.-..         +..+|-..|||||-+
T Consensus       220 ~SiAk---------T~daGCrpYmAPERi  239 (361)
T KOG1006|consen  220 DSIAK---------TVDAGCRPYMAPERI  239 (361)
T ss_pred             HHHHh---------hhccCCccccChhcc
Confidence            43211         124688999999975

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.90  E-value=3e-23  Score=213.47  Aligned_cols=170  Identities=28%  Similarity=0.435  Sum_probs=141.5

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |+..+.||+|++|.||+|.+..+|..||+|++....  ....+.+.+|++++++++|||++++++++...     +..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence            567789999999999999998899999999997553  23346788999999999999999999997654     37899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||++ ++|.+++.....    ..+++..++.++.|+++||+|||+.   +++||||+|+||+++.++.+||+|||+++
T Consensus        76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999995 699999876542    2588999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......        ......+++.|+|||++.
T Consensus       148 ~~~~~~~--------~~~~~~~~~~~~aPE~~~  172 (283)
T cd07835         148 AFGVPVR--------TYTHEVVTLWYRAPEILL  172 (283)
T ss_pred             ccCCCcc--------ccCccccccCCCCCceee
Confidence            5532211        011234788999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=3e-23  Score=214.75  Aligned_cols=171  Identities=27%  Similarity=0.421  Sum_probs=139.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|++|.||+|++..+++.||+|.+....  ....+.+.+|++++++++||||+++++++....     ..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eE
Confidence            46888999999999999999998899999999986542  233467889999999999999999999976544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Dfg  688 (725)
                      |+||||++ +++.+++.....    ...++..+..++.||+.||+|||+.   +++||||+|+||+++. ++.+||+|||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            99999995 588888765432    1357888889999999999999998   9999999999999985 5679999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++.......        ......|++.|+|||++
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~  175 (294)
T PLN00009        149 LARAFGIPVR--------TFTHEVVTLWYRAPEIL  175 (294)
T ss_pred             cccccCCCcc--------ccccCceeecccCHHHH
Confidence            9976532210        01123578999999975

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=3.2e-23  Score=215.44  Aligned_cols=178  Identities=27%  Similarity=0.403  Sum_probs=144.6

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC-----
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD-----  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  602 (725)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|+++...  ......+.+|++++++++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568999999999999999999999889999999997543  233456788999999999999999999876543     


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      +.+....++||||+++ ++.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence            1223378999999976 78777765421     588999999999999999999999   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|||.++........       ......++..|+|||++
T Consensus       156 kl~dfg~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~  189 (302)
T cd07864         156 KLADFGLARLYNSEESR-------PYTNKVITLWYRPPELL  189 (302)
T ss_pred             EeCcccccccccCCccc-------ccccceeccCccChHHh
Confidence            99999999866433211       11123468889999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=2.7e-23  Score=214.18  Aligned_cols=173  Identities=25%  Similarity=0.344  Sum_probs=143.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +|+..+.||.|++|.||+|.+..+++.||+|.+..... ....++.+|++++++++||||+++++++....   .+..|+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEEE
Confidence            57788999999999999999988999999999875432 34567899999999999999999999875432   236799


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++......  ...+++..+..++.|++.||+|+|+.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        79 v~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            99999999999987643211  12578889999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......          ....++..|+|||.+
T Consensus       154 ~~~~~~~----------~~~~~~~~y~~pE~~  175 (287)
T cd06621         154 ELVNSLA----------GTFTGTSFYMAPERI  175 (287)
T ss_pred             ccccccc----------ccccCCccccCHHHh
Confidence            5532211          013578899999975

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.3e-23  Score=224.83  Aligned_cols=185  Identities=19%  Similarity=0.268  Sum_probs=135.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC----------------CCceEEEEEEeeccccchHHH--------------HHHH
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG----------------EDEMIVAVKVINLKQKGAFRS--------------FVAE  579 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  579 (725)
                      ..++|+..++||+|+||.||+|.+.                ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                245679999987543332223              3457


Q ss_pred             HHHHHcCCCCcc-----cceeeEeecCCC---CCcceeeEEEeccCCCCHHHHhcccCCc------------------cc
Q 048668          580 CEALRNIRHRNL-----IKIITICSSTDF---KGVDFKALVFEYMGNGSLEDWLHQSNDQ------------------VE  633 (725)
Q Consensus       580 ~~~l~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~  633 (725)
                      +.++.+++|.++     ++++++|.....   ...+..|+||||+++|+|.++++.....                  ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788776554     677777654321   1124679999999999999999753210                  00


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccC
Q 048668          634 VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG  713 (725)
Q Consensus       634 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~g  713 (725)
                      ....++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+|+........       ......+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-------~~~~g~~  372 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-------NPLYGML  372 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-------CccccCC
Confidence            11346778889999999999999998   9999999999999999999999999999765332110       0111235


Q ss_pred             CccccCCCccc
Q 048668          714 TVGYVAPGKFF  724 (725)
Q Consensus       714 t~~y~aPE~~~  724 (725)
                      |+.|+|||++.
T Consensus       373 tp~Y~aPE~l~  383 (507)
T PLN03224        373 DPRYSPPEELV  383 (507)
T ss_pred             CcceeChhhhc
Confidence            89999999875

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1e-23  Score=232.82  Aligned_cols=178  Identities=22%  Similarity=0.271  Sum_probs=133.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCc-eEEEEEEe--------------ec---cccchHHHHHHHHHHHHcCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDE-MIVAVKVI--------------NL---KQKGAFRSFVAECEALRNIRHRNL  591 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni  591 (725)
                      ..++|++.+.||+|+||+||+|..+... ..+++|.+              ..   .......++.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4568999999999999999999765322 22222211              10   111234568899999999999999


Q ss_pred             cceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       592 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      +++++++...+     ..|+|+|++. +++.+++........ .......+..|+.|++.||+|||++   +|+||||||
T Consensus       226 v~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP  295 (501)
T PHA03210        226 LKIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL  295 (501)
T ss_pred             CcEeEEEEECC-----eeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            99999976654     7899999994 588888764321111 1234566788999999999999999   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||++.++.+||+|||+|+.+.....       ....+.+||+.|+|||++.
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~  341 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILA  341 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhc
Confidence            999999999999999999987643211       1112357999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.90  E-value=3.8e-23  Score=209.37  Aligned_cols=170  Identities=31%  Similarity=0.545  Sum_probs=139.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|+..+.||+|+||.||+|.+. .+..+|+|.+.... ....+|.+|++++++++||+|+++++++....     ..++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceEE
Confidence            46788899999999999999885 46789999886432 23457889999999999999999999875544     6899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++++|.+++.....     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence            9999999999999975432     478889999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........       ......++.+|+|||++
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~~~aPe~~  173 (256)
T cd05112         149 FVLDDQYT-------SSTGTKFPVKWSSPEVF  173 (256)
T ss_pred             ecccCccc-------ccCCCccchhhcCHhHh
Confidence            65332111       01112356789999975

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.90  E-value=3e-23  Score=210.57  Aligned_cols=171  Identities=23%  Similarity=0.499  Sum_probs=139.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .+.|+..+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|++++++++|+||+++++++..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            457888999999999999999865 45679999886432 234678899999999999999999988654      2578


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++.....    ...++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+|++|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence            99999999999999976432    2578888999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......++..|+|||++
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~  175 (260)
T cd05073         150 RVIEDNEYT-------AREGAKFPIKWTAPEAI  175 (260)
T ss_pred             eeccCCCcc-------cccCCcccccccCHhHh
Confidence            765432111       11123467789999976

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.90  E-value=1.8e-23  Score=213.42  Aligned_cols=172  Identities=28%  Similarity=0.463  Sum_probs=136.3

Q ss_pred             cccccccceEEEEEEECCCc------eEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          538 NMIGQGSFGSVYKGILGEDE------MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +.||+|+||.||+|++....      +.||+|.+.... ......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence            36899999999999875433      679999886442 234568899999999999999999999876544     689


Q ss_pred             EEEeccCCCCHHHHhcccCCcc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-----ceEE
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-----VAHV  684 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-----~~kl  684 (725)
                      +||||+++++|.+++....... ....+++.+++.++.|++.|++|+|+.   +++|+||||+||+++.++     .+|+
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997543211 122478899999999999999999998   999999999999999877     8999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++..........      .....++..|+|||++
T Consensus       153 ~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~  185 (269)
T cd05044         153 GDFGLARDIYKSDYYRK------EGEGLLPVRWMAPESL  185 (269)
T ss_pred             CCccccccccccccccc------CcccCCCccccCHHHH
Confidence            99999976543211111      1123467889999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.90  E-value=2.8e-23  Score=219.21  Aligned_cols=177  Identities=27%  Similarity=0.406  Sum_probs=143.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+++++++ +||||+++++++...+   .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---D   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---C
Confidence            346788889999999999999999888999999988542  223345677899999999 9999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...|+||||++ ++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            35799999997 5999988653       367888899999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.........   .........||+.|+|||++
T Consensus       151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~  184 (337)
T cd07852         151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEIL  184 (337)
T ss_pred             ccchhccccccccc---cCcchhcccccccccCceee
Confidence            99998764432110   01112235689999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.90  E-value=6.2e-23  Score=208.93  Aligned_cols=168  Identities=26%  Similarity=0.375  Sum_probs=136.0

Q ss_pred             HHHHHHhcCCCCCccc--ccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecC
Q 048668          525 AELSKATSEFSSSNMI--GQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSST  601 (725)
Q Consensus       525 ~~~~~~~~~~~~~~~i--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  601 (725)
                      .+.....++|++.+.+  |+|+||.||+++.+.++..+|+|++........     |+.....+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            4444555677777776  999999999999999999999999865432211     22222222 699999999997665


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-  680 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-  680 (725)
                      +     ..|+||||+++|+|.+++....      .+++..+..++.|+++|++|+|+.   +++||||||+||+++.++ 
T Consensus        82 ~-----~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  147 (267)
T PHA03390         82 K-----GHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKD  147 (267)
T ss_pred             C-----eeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCC
Confidence            4     7899999999999999997653      589999999999999999999999   999999999999999998 


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .++|+|||+++.....            ....|+..|+|||++
T Consensus       148 ~~~l~dfg~~~~~~~~------------~~~~~~~~y~aPE~~  178 (267)
T PHA03390        148 RIYLCDYGLCKIIGTP------------SCYDGTLDYFSPEKI  178 (267)
T ss_pred             eEEEecCccceecCCC------------ccCCCCCcccChhhh
Confidence            9999999998765321            113589999999986

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.90  E-value=5.5e-23  Score=214.95  Aligned_cols=164  Identities=29%  Similarity=0.424  Sum_probs=138.6

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      |+..+.||+|+||.||+|++..++..||+|++....   .....++.+|++++++++|||++++++++....     ..|
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eEE
Confidence            666788999999999999998899999999987442   223457889999999999999999999976654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++ |++.+++.....     .+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||++
T Consensus       102 lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635         102 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             EEEeCCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCc
Confidence            9999996 488887764332     588999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......            ....|++.|+|||++
T Consensus       173 ~~~~~~------------~~~~~~~~y~aPE~~  193 (317)
T cd06635         173 SIASPA------------NSFVGTPYWMAPEVI  193 (317)
T ss_pred             cccCCc------------ccccCCccccChhhh
Confidence            654221            124589999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=2.3e-23  Score=213.93  Aligned_cols=178  Identities=30%  Similarity=0.463  Sum_probs=146.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|...+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|++++++++ ||||+++++++...     +
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence            36888899999999999999999899999999986532   233467889999999998 99999999886544     3


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++++|.+++....      .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++||
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence            7899999999999999997654      589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCC------------CCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSS------------KTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++............            ..........|+..|+|||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  194 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL  194 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHh
Confidence            999876443221000            001122235689999999975

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=3e-23  Score=210.24  Aligned_cols=171  Identities=24%  Similarity=0.388  Sum_probs=142.4

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|++++++++|+||+++++++....     ..|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEE
Confidence            4777889999999999999999899999999997542  234467889999999999999999999875544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Dfgl  689 (725)
                      +|+||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++ .+|++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999999976432    1478999999999999999999998   999999999999999886 579999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........        ......|++.|+|||++
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~~ape~~  174 (257)
T cd08225         149 ARQLNDSME--------LAYTCVGTPYYLSPEIC  174 (257)
T ss_pred             chhccCCcc--------cccccCCCccccCHHHH
Confidence            876543211        01124589999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.90  E-value=4.9e-23  Score=216.88  Aligned_cols=176  Identities=24%  Similarity=0.309  Sum_probs=141.2

Q ss_pred             CCCCCcccccccceEEEEEEECCC--ceEEEEEEeecc--ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGED--EMIVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +|+..+.||+|+||.||+|++..+  +..||+|++...  .....+.+.+|+++++++ +||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            467788999999999999999877  889999998643  222346788999999999 4999999998754331 2234


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+++||++ ++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            6789999985 69999986543      588999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.+.......    ........||+.|+|||++
T Consensus       150 g~a~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         150 GLARGFSENPGEN----AGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             CCceecccccccc----cccccCcccCccccCcHHH
Confidence            9998764332111    1111235699999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.90  E-value=4.3e-23  Score=218.04  Aligned_cols=173  Identities=23%  Similarity=0.336  Sum_probs=142.3

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KG  605 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~  605 (725)
                      ...++|+..+.||+|+||.||+|.+..++..||||++....  ....+.+.+|++++++++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34668999999999999999999999899999999985432  2234568899999999999999999998754321 11


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....++||||+ +++|.+++...       .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+|++
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence            23468999999 77999888642       478999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+++.....           .....+++.|+|||++
T Consensus       161 dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~  187 (343)
T cd07880         161 DFGLARQTDSE-----------MTGYVVTRWYRAPEVI  187 (343)
T ss_pred             ecccccccccC-----------ccccccCCcccCHHHH
Confidence            99999754321           1124578999999975

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=5.6e-23  Score=211.80  Aligned_cols=172  Identities=27%  Similarity=0.416  Sum_probs=146.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..+.|+..+.+|+|+||.||+|.+..++..||+|++..... ..+.+.+|++++++++|+||+++++++....     ..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----EL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----EE
Confidence            44567888899999999999999988899999999976544 4577889999999999999999999877654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|+||+++++|.+++....     ..+++..+..++.|++.|++|+|+.   +|+|+|++|+||+++.++.+||+|||.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence            99999999999999998654     1588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........        ......|+..|+|||++
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~~y~~PE~~  188 (286)
T cd06614         163 AAQLTKEKS--------KRNSVVGTPYWMAPEVI  188 (286)
T ss_pred             hhhhccchh--------hhccccCCcccCCHhHh
Confidence            875533211        11124588899999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.90  E-value=6.3e-23  Score=210.99  Aligned_cols=169  Identities=22%  Similarity=0.324  Sum_probs=137.4

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |+..+.||+|+||.||+|++..+++.||+|++.... ........+|+.+++++. ||||+++++++....   .+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            566788999999999999998899999999986542 222334567999999985 999999999986542   136899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||++ |++.+++.....     .+++..+..++.|++.||+|||+.   +++||||||+||+++. +.+||+|||+++
T Consensus        78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            999996 588888875432     588999999999999999999999   9999999999999999 999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ........         ....++..|+|||++.
T Consensus       148 ~~~~~~~~---------~~~~~~~~y~aPE~~~  171 (282)
T cd07831         148 GIYSKPPY---------TEYISTRWYRAPECLL  171 (282)
T ss_pred             ccccCCCc---------CCCCCCcccCChhHhh
Confidence            65332111         1135889999999753

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1e-23  Score=215.05  Aligned_cols=173  Identities=23%  Similarity=0.313  Sum_probs=140.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  606 (725)
                      ....|++.+.||+||.++||++... +...||+|++...  +......|.+|+..|.+++ |.+||++++|....+    
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~----  433 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG----  433 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc----
Confidence            3457899999999999999999875 4556777777543  3455678999999999997 999999999966544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       +.|+||||= ..||.++|+++..     ..+...+..++.|++.|+.++|.+   ||||.||||.|+|+.. |.+||+|
T Consensus       434 -~lYmvmE~G-d~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLID  502 (677)
T KOG0596|consen  434 -YLYMVMECG-DIDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLID  502 (677)
T ss_pred             -eEEEEeecc-cccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeee
Confidence             899999964 6799999998764     344457788999999999999999   9999999999999865 5999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|..+..+...      ......+||+.|||||-++
T Consensus       503 FGIA~aI~~DTTs------I~kdsQvGT~NYMsPEAl~  534 (677)
T KOG0596|consen  503 FGIANAIQPDTTS------IVKDSQVGTVNYMSPEALT  534 (677)
T ss_pred             echhcccCccccc------eeeccccCcccccCHHHHh
Confidence            9999887654221      1222468999999999764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.89  E-value=6.4e-23  Score=211.49  Aligned_cols=171  Identities=27%  Similarity=0.447  Sum_probs=142.5

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++|||++++++++....   .+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            567789999999999999999889999999998653  334567889999999999999999999986551   247899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++ ++.+++....     ..+++..++.++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.+.
T Consensus        78 v~e~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             Eeccccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999975 8998887543     1588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......       .......++..|+|||.+
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~  173 (287)
T cd07840         149 PYTKRNS-------ADYTNRVITLWYRPPELL  173 (287)
T ss_pred             eccCCCc-------ccccccccccccCCceee
Confidence            6644321       011123578899999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.89  E-value=3.8e-23  Score=218.51  Aligned_cols=176  Identities=27%  Similarity=0.403  Sum_probs=142.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC--------
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF--------  603 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  603 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.....        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            578899999999999999999999999999999976655566788899999999999999999987654321        


Q ss_pred             -CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCc
Q 048668          604 -KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMV  681 (725)
Q Consensus       604 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~  681 (725)
                       ......|+||||++ ++|.+++...       .+++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~  153 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence             11235789999997 5998888643       478899999999999999999998   9999999999999985 567


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|++|||.++..........     ......|+..|+|||++
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~  190 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKG-----YLSEGLVTKWYRSPRLL  190 (342)
T ss_pred             EEECCcccceecCCcccccc-----ccccccccccccCHHHH
Confidence            89999999976533211110     01123588899999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.89  E-value=4.2e-23  Score=217.38  Aligned_cols=177  Identities=24%  Similarity=0.320  Sum_probs=146.5

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+++++.++||||+++++++......+....|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998889999999987543  33456789999999999999999999987665433344789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++ ++|.+++....      .+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+
T Consensus        81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999997 58999887543      588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .........     ........+|+.|+|||++.
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~  179 (330)
T cd07834         151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLL  179 (330)
T ss_pred             Eeecccccc-----cccccccccccCcCCceeee
Confidence            876443211     01112245899999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.89  E-value=8.6e-23  Score=215.40  Aligned_cols=177  Identities=21%  Similarity=0.383  Sum_probs=139.5

Q ss_pred             cCCC-CCcccccccceEEEEEEECCCceEEEEEEeeccccch--------------HHHHHHHHHHHHcCCCCcccceee
Q 048668          532 SEFS-SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--------------FRSFVAECEALRNIRHRNLIKIIT  596 (725)
Q Consensus       532 ~~~~-~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  596 (725)
                      ++|. ..+.||+|+||+||+|++..+++.||||++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3577999999999999998899999999986432211              125779999999999999999999


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ++...+     ..++||||++ |+|.+++....      .+++.....++.|++.|++|||+.   +|+||||||+||++
T Consensus        88 ~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill  152 (335)
T PTZ00024         88 VYVEGD-----FINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI  152 (335)
T ss_pred             EEecCC-----cEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence            976554     7899999996 69999987543      578899999999999999999998   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCC-----C-CCCcccccccCCccccCCCcc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTS-----S-KTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~-----~-~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++.+|++|||.++..........     . ..........+++.|+|||++
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  205 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL  205 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhc
Confidence            9999999999999976542111000     0 001111224578899999976

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.89  E-value=6.4e-23  Score=215.19  Aligned_cols=171  Identities=26%  Similarity=0.327  Sum_probs=142.3

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      +....++|+..+.||+|+||.||+|++..+++.||+|++...  .....+.+.+|++++++++||||+++++++....  
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--   82 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL--   82 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC--
Confidence            344677899999999999999999999999999999988543  2233467889999999999999999999875432  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                        ...|+||||+ +++|.++++..       .+++..+..++.|+++|++|||+.   +|+||||+|+||+++.++.+||
T Consensus        83 --~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          83 --EDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             --CcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence              3678999998 56999888643       367788889999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||.++.....           .....+++.|+|||++
T Consensus       150 ~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~  177 (328)
T cd07856         150 CDFGLARIQDPQ-----------MTGYVSTRYYRAPEIM  177 (328)
T ss_pred             CccccccccCCC-----------cCCCcccccccCceee
Confidence            999998754221           1124578899999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.89  E-value=6.4e-23  Score=214.14  Aligned_cols=184  Identities=23%  Similarity=0.370  Sum_probs=144.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC---CC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF---KG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  605 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....  ......+.+|++++++++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999999899999999986542  2223467789999999999999999987654331   12


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....|+||||+++ ++.+.+.....     .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence            3357999999965 78777765332     589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCC---CCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSK---TPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+++............   .........|++.|+|||++
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL  198 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHh
Confidence            999998654332111100   11112235689999999975

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.89  E-value=1.2e-22  Score=205.07  Aligned_cols=169  Identities=31%  Similarity=0.455  Sum_probs=146.2

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +|+..+.||+|++|.||+|.+..+++.||+|++........+.+.+|++++++++||+++++++++....     ..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEE
Confidence            4777889999999999999998889999999997665445678999999999999999999999876554     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +||+++++|.+++....     ..+++..+..++.|++.|++|+|+.   +++||||+|+||+++.++.+||+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            99999999999987653     1589999999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......         .....|+..|+|||++
T Consensus       148 ~~~~~~---------~~~~~~~~~~~~PE~~  169 (253)
T cd05122         148 LSDTKA---------RNTMVGTPYWMAPEVI  169 (253)
T ss_pred             cccccc---------ccceecCCcccCHHHH
Confidence            643311         1124689999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.89  E-value=1.1e-22  Score=206.08  Aligned_cols=173  Identities=28%  Similarity=0.447  Sum_probs=145.9

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||+|.+..++..||+|++.....  ...+.+.+|++++++++|||++++++.+...     +..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            47788899999999999999988899999999976532  4556788999999999999999999987654     3789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|+||+++++|.+++.....  ....+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence            99999999999999986531  112689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        .......|++.|+|||..
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~  175 (258)
T cd08215         151 KVLSSTV--------DLAKTVVGTPYYLSPELC  175 (258)
T ss_pred             eecccCc--------ceecceeeeecccChhHh
Confidence            7654321        011124689999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.89  E-value=8.3e-23  Score=211.09  Aligned_cols=181  Identities=22%  Similarity=0.328  Sum_probs=131.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccccchH-----------HHHHHHHHHHHcCCCCcccceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKGAF-----------RSFVAECEALRNIRHRNLIKIIT  596 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  596 (725)
                      .++|.+.+.||+|+||+||+|++..+   +..+|+|+.........           .....+...+..++|++|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35799999999999999999998776   66777776543322110           12234445566778999999998


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ++.... ......++++|++. .++.+.+....      ..++..+..++.|++.|++|+|+.   +|+||||||+||++
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLV-ENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             eeeEec-CCceEEEEEEehhc-cCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            765433 22235578888874 46777665432      356778899999999999999998   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++.+||+|||+|+.+......... .........||+.|||||++
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~-~~~~~~~~~gt~~y~ape~~  205 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEY-SKEQKDLHRGTLYYAGLDAH  205 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCccccc-ccccccccCCCccccCHHHh
Confidence            99999999999999876432211110 01111224699999999975

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1e-22  Score=215.39  Aligned_cols=177  Identities=23%  Similarity=0.352  Sum_probs=145.6

Q ss_pred             HHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       525 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      +.+....++|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            455667789999999999999999999998899999999986432  223456889999999999999999999875432


Q ss_pred             -CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc
Q 048668          603 -FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       603 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~  681 (725)
                       +......|++++++ +++|.+++...       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence             22234578888887 78999887643       478899999999999999999999   9999999999999999999


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||+++.....           .....||+.|+|||++
T Consensus       159 ~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~  189 (345)
T cd07877         159 LKILDFGLARHTDDE-----------MTGYVATRWYRAPEIM  189 (345)
T ss_pred             EEEeccccccccccc-----------ccccccCCCccCHHHH
Confidence            999999998754221           1124589999999975

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.2e-22  Score=206.21  Aligned_cols=160  Identities=26%  Similarity=0.366  Sum_probs=131.9

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHH-HcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEAL-RNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|.+..+++.||+|+++...   ......+..|..++ ...+|||++++++++...+     ..|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEE
Confidence            56899999999999998899999999986432   12223445555544 4558999999999976544     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++++|.+++....      .+++..+..++.|++.||.|+|+.   +++||||+|+||+++.++.+||+|||+++..
T Consensus        77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999999999997654      578899999999999999999998   9999999999999999999999999998754


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ...            ....|++.|+|||.+
T Consensus       148 ~~~------------~~~~~~~~y~~pe~~  165 (260)
T cd05611         148 LEN------------KKFVGTPDYLAPETI  165 (260)
T ss_pred             ccc------------ccCCCCcCccChhhh
Confidence            221            124588999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=201.45  Aligned_cols=171  Identities=23%  Similarity=0.340  Sum_probs=143.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|...++||+|+|++|..++++.+.+.||+|++++.   +..+..-...|-.+..+. +||.+|.+..+     |++.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence            45788999999999999999999999999999999754   222223344666777766 59999999877     5555


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++|.||++||+|.-.+++.+      ++|+..+..+...|+-||.|||+.   ||++||+|.+|+|+|..|.+|+.|
T Consensus       324 srlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence            68999999999999988877665      699999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+++.-..        .+..+.++||||.|+|||++
T Consensus       395 ygmcke~l~--------~gd~tstfcgtpnyiapeil  423 (593)
T KOG0695|consen  395 YGMCKEGLG--------PGDTTSTFCGTPNYIAPEIL  423 (593)
T ss_pred             cchhhcCCC--------CCcccccccCCCcccchhhh
Confidence            999985322        22334568999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.89  E-value=1.2e-22  Score=207.29  Aligned_cols=173  Identities=25%  Similarity=0.453  Sum_probs=140.0

Q ss_pred             CCCCCcccccccceEEEEEEECC-CceEEEEEEeeccc----------cchHHHHHHHHHHHHc-CCCCcccceeeEeec
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ----------KGAFRSFVAECEALRN-IRHRNLIKIITICSS  600 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  600 (725)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999976 67899999885321          2234567789998875 789999999998765


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCC
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~  679 (725)
                      ..     ..++||||+++++|.+++......  ...+++..++.++.|++.|+.|||+ .   +++|+||||+||+++.+
T Consensus        81 ~~-----~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~  150 (269)
T cd08528          81 ND-----RLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED  150 (269)
T ss_pred             CC-----eEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence            54     789999999999999988542211  1258889999999999999999996 4   89999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+||+|||.+.......         ......|+..|+|||++.
T Consensus       151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~  186 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVK  186 (269)
T ss_pred             CcEEEecccceeeccccc---------ccccccCcccCcChhhhc
Confidence            999999999997654321         112246899999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.89  E-value=2.4e-22  Score=209.63  Aligned_cols=164  Identities=30%  Similarity=0.429  Sum_probs=138.0

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      |...+.||+|+||+||+|++..+++.||+|++.....   ...+.+.+|++++++++|||++++++++....     ..|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence            5556789999999999999988999999999875422   23457889999999999999999999976654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+. |++.+++.....     .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++
T Consensus        98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence            9999995 588888765432     578999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......            ....|+..|+|||++
T Consensus       169 ~~~~~~------------~~~~~~~~y~aPE~~  189 (313)
T cd06633         169 SKSSPA------------NSFVGTPYWMAPEVI  189 (313)
T ss_pred             cccCCC------------CCccccccccChhhc
Confidence            642111            124689999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.89  E-value=1.8e-22  Score=204.56  Aligned_cols=173  Identities=27%  Similarity=0.461  Sum_probs=146.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|...+.||+|++|.||+|.+..+++.|++|++.....  ...+.+.+|++++++++||||+++++++....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            46778899999999999999998999999999976542  34678899999999999999999999876552   13789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++....      .+++..++.++.|++.|++|||+.   +++|+|++|+||+++.++.+||+|||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999999997654      588999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .........      .......++..|+|||.+
T Consensus       149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606         149 KRLGDIETG------EGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             Eeccccccc------ccccCCCCCccccCHhhh
Confidence            876543211      001124588999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.89  E-value=6e-23  Score=211.81  Aligned_cols=174  Identities=22%  Similarity=0.298  Sum_probs=136.4

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||++++..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++....     ..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cEE
Confidence            4556678999999999999999999999999987543 234567889999999996 999999999876543     678


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ++|||++. ++.++....... ....+++..+..++.|++.|++|+|+..  +|+||||||+||+++.++.+||+|||+|
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchh
Confidence            99999854 655543211000 0125889999999999999999999742  8999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +........         ....|++.|+|||++.
T Consensus       156 ~~~~~~~~~---------~~~~~~~~y~aPE~~~  180 (288)
T cd06616         156 GQLVDSIAK---------TRDAGCRPYMAPERID  180 (288)
T ss_pred             HHhccCCcc---------ccccCccCccCHHHhc
Confidence            765432111         1235899999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.89  E-value=1.1e-22  Score=209.27  Aligned_cols=168  Identities=29%  Similarity=0.406  Sum_probs=139.5

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |++.+.||+|+||.||+|+...+++.||||++..... .......+|+..+++++ ||||+++++++...     +..|+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence            5677899999999999999988899999999865422 22234567999999999 99999999987653     47899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+ +|++.+++.....    ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||.++
T Consensus        76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence            99999 8899999876541    2578999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........         ....|+..|+|||++
T Consensus       148 ~~~~~~~~---------~~~~~~~~~~aPE~~  170 (283)
T cd07830         148 EIRSRPPY---------TDYVSTRWYRAPEIL  170 (283)
T ss_pred             eccCCCCc---------CCCCCcccccCceee
Confidence            65332111         124588999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.89  E-value=1.2e-22  Score=213.62  Aligned_cols=174  Identities=18%  Similarity=0.256  Sum_probs=136.4

Q ss_pred             cccccc--cceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      ..||+|  +||+||+|++..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++....     ..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEE
Confidence            356666  89999999999999999999987543  223467889999999999999999999976654     789999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+++|++.+++......    .+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+|++||+.+...
T Consensus        79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            999999999998865421    478999999999999999999998   9999999999999999999999999865433


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .......... ........++..|||||++.
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  181 (328)
T cd08226         152 VRNGQKAKVV-YDFPQFSTSVLPWLSPELLR  181 (328)
T ss_pred             hccCcccccc-ccccccccCccCccChhhhc
Confidence            2211110000 00011123567899999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.89  E-value=1.6e-22  Score=211.50  Aligned_cols=167  Identities=22%  Similarity=0.243  Sum_probs=132.3

Q ss_pred             cceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCH
Q 048668          544 SFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSL  621 (725)
Q Consensus       544 ~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L  621 (725)
                      ++|.||.++...+++.||||++...  .....+.+.+|++++++++||||+++++++....     ..+++|||+++|++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEeccCCCCH
Confidence            4455666666668999999999754  2344578999999999999999999999876544     78999999999999


Q ss_pred             HHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCC
Q 048668          622 EDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS  701 (725)
Q Consensus       622 ~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  701 (725)
                      .+++......    .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.+..+........
T Consensus        87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999865322    578899999999999999999999   999999999999999999999999999876543221110


Q ss_pred             CCCCcccccccCCccccCCCcc
Q 048668          702 SKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       702 ~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      . .........++..|+|||++
T Consensus       160 ~-~~~~~~~~~~~~~y~aPE~~  180 (314)
T cd08216         160 V-VHDFPKSSVKNLPWLSPEVL  180 (314)
T ss_pred             c-cccccccccccccccCHHHh
Confidence            0 01111234588899999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=1.1e-22  Score=209.85  Aligned_cols=170  Identities=22%  Similarity=0.332  Sum_probs=139.3

Q ss_pred             CCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      +|+..+.||+|+||.||+|++.   .+++.||||+++...    ....+.+.+|++++.++ +||+|+++++.+...   
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~---   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD---   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence            4677889999999999999863   467889999986432    22345788999999999 599999999876544   


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                        ...|+||||+++|+|.+++....      .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+++
T Consensus        78 --~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          78 --TKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             --CEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence              37899999999999999987543      478889999999999999999998   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++........       ......|+..|+|||.+
T Consensus       147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~  178 (288)
T cd05583         147 TDFGLSKEFLAEEEE-------RAYSFCGTIEYMAPEVI  178 (288)
T ss_pred             EECcccccccccccc-------ccccccCCccccCHHHh
Confidence            999998765433111       11124689999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=1.5e-22  Score=205.03  Aligned_cols=172  Identities=26%  Similarity=0.389  Sum_probs=144.1

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +|+..+.||+|+||.||++++..+++.+|+|++....  .....++.+|++++++++||||+++++++...     ...|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            4778889999999999999998899999999987542  23456788999999999999999999886554     4789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++......  ...+++..++.++.|++.|++|+|+.   +++|+||+|+||+++.++.+|++|||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence            999999999999998763211  12578999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......          ....|++.|+|||.+.
T Consensus       151 ~~~~~~~~----------~~~~~~~~~~~Pe~~~  174 (256)
T cd08530         151 KVLKKNMA----------KTQIGTPHYMAPEVWK  174 (256)
T ss_pred             hhhccCCc----------ccccCCccccCHHHHC
Confidence            87643311          1135888999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.88  E-value=2e-22  Score=209.84  Aligned_cols=165  Identities=29%  Similarity=0.445  Sum_probs=138.8

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .|+..+.||+|+||.||+|++..++..||+|.+...   .....+++.+|+++++.++|+|++++++++....     ..
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----ee
Confidence            366678899999999999999888999999998643   2233467889999999999999999999977654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+. |++.+++.....     .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||+
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence            99999996 588887754332     478899999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +......            ....|++.|+|||++
T Consensus       162 ~~~~~~~------------~~~~~~~~y~aPE~~  183 (308)
T cd06634         162 ASIMAPA------------NXFVGTPYWMAPEVI  183 (308)
T ss_pred             ceeecCc------------ccccCCccccCHHHH
Confidence            8764321            124588999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.88  E-value=1.4e-22  Score=224.82  Aligned_cols=181  Identities=21%  Similarity=0.225  Sum_probs=123.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCC----ceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGED----EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FK  604 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~  604 (725)
                      ..++|+..+.||+|+||.||+|++..+    +..||+|++.....  .+.+..|  .++...+.+++.++..+.... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            456899999999999999999999888    89999998753321  1222211  122222333333222211111 12


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCcc--------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQV--------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK  670 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk  670 (725)
                      .....++||||+++++|.+++.......              ......+..+..++.|++.||+|+|+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            3357899999999999999987542100              000112344567999999999999998   99999999


Q ss_pred             CCCeeecC-CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          671 PSNVLLDH-DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       671 p~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||++. ++.+||+|||+|+.+......       .....+||+.|||||++.
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-------~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-------IPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-------CCcccccCCCccChHHhh
Confidence            99999986 579999999999865432111       112357999999999764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=7.8e-23  Score=216.88  Aligned_cols=171  Identities=29%  Similarity=0.483  Sum_probs=139.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCc----eEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +....++||+|+||+||+|.+-..|    .+||+|++... ......++..|+-+|++++|||+++++|+|....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            3455689999999999999985444    47899988654 3445688999999999999999999999997654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                       ..||++||++|.|.+|++.++.     .+-....+.|..|||+|+.|||++   ++|||||..+|||+.....+||.||
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence             6799999999999999998765     466678899999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+........-..      ....-.+.|||=|.+
T Consensus       843 gla~ll~~d~~ey~~------~~gK~pikwmale~i  872 (1177)
T KOG1025|consen  843 GLAKLLAPDEKEYSA------PGGKVPIKWMALESI  872 (1177)
T ss_pred             chhhccCcccccccc------cccccCcHHHHHHHh
Confidence            999987543221111      112234567776654

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.88  E-value=3.8e-22  Score=205.73  Aligned_cols=174  Identities=26%  Similarity=0.432  Sum_probs=140.0

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCcccceeeEeecCCCCCcce
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      |+..+.||+|+||.||+|+++.+++.||+|++....  ......+.+|+++++++   +||||+++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999998889999999997542  22234566788777666   5999999999987765333335


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .+++|||+. +++.+++.....    ..+++..++.++.|++.||+|||+.   +++|+|++|+||+++.++.+||+|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            899999996 489998876432    1589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+..+.....         .....++..|+|||++.
T Consensus       153 ~~~~~~~~~~---------~~~~~~~~~~~~PE~~~  179 (287)
T cd07838         153 LARIYSFEMA---------LTSVVVTLWYRAPEVLL  179 (287)
T ss_pred             cceeccCCcc---------cccccccccccChHHhc
Confidence            9977533211         01134788999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.88  E-value=2.6e-22  Score=212.08  Aligned_cols=171  Identities=25%  Similarity=0.359  Sum_probs=139.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  607 (725)
                      ..+|...+.||+|+||.||+|++..+++.||+|++....  ......+.+|++++++++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888999999999999999998899999999986432  2234568899999999999999999998764431 1223


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+. .++.++...        .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence            5689999996 477776521        478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.....           .....||+.|+|||++.
T Consensus       162 g~~~~~~~~-----------~~~~~~~~~y~aPE~~~  187 (342)
T cd07879         162 GLARHADAE-----------MTGYVVTRWYRAPEVIL  187 (342)
T ss_pred             CCCcCCCCC-----------CCCceeeecccChhhhc
Confidence            998754221           11245889999999863

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.88  E-value=3.4e-22  Score=207.02  Aligned_cols=172  Identities=21%  Similarity=0.329  Sum_probs=138.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... .....++.+|++++.+.. ||||+++++++....     .
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----D   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----e
Confidence            356888899999999999999998889999999997543 233456777888777775 999999999976654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ +++.++......     .+++..+..++.|++.|++|||+..  +|+||||+|+||+++.++.+||+|||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence            899999985 477777655332     5889999999999999999999731  89999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++..+......         ....|+..|+|||++.
T Consensus       161 ~~~~~~~~~~~---------~~~~~~~~y~aPE~~~  187 (296)
T cd06618         161 ISGRLVDSKAK---------TRSAGCAAYMAPERID  187 (296)
T ss_pred             cchhccCCCcc---------cCCCCCccccCHhhcC
Confidence            98765332111         1134788999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=2.4e-22  Score=206.59  Aligned_cols=168  Identities=29%  Similarity=0.454  Sum_probs=141.0

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |+..+.||+|+||.||+|+...+++.||+|++....  ....+.+.+|++++++++|+||+++++++...     +..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            556788999999999999999889999999997653  33456788999999999999999999986654     37899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||++ ++|.+++....     ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.+||+|||.++
T Consensus        76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence            999997 59999998653     1588999999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........        .....++..|+|||++
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~~aPE~~  170 (282)
T cd07829         147 AFGIPLRT--------YTHEVVTLWYRAPEIL  170 (282)
T ss_pred             ccCCCccc--------cCccccCcCcCChHHh
Confidence            65432110        1113467889999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.88  E-value=4.6e-22  Score=200.61  Aligned_cols=162  Identities=32%  Similarity=0.431  Sum_probs=137.4

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      ||+|+||.||+|.+..+++.||+|++....   ......+..|++++++++||||+++++.+...     +..++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence            689999999999998889999999987542   22456788999999999999999999876544     4789999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccC
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH  696 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~  696 (725)
                      ++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999997654      478999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CCCCCCCCCcccccccCCccccCCCcc
Q 048668          697 HLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       697 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ..        ......|+..|+|||.+
T Consensus       147 ~~--------~~~~~~~~~~~~~Pe~~  165 (250)
T cd05123         147 GS--------RTNTFCGTPEYLAPEVL  165 (250)
T ss_pred             CC--------cccCCcCCccccChHHh
Confidence            10        11124588999999975

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=8.9e-23  Score=212.83  Aligned_cols=171  Identities=26%  Similarity=0.406  Sum_probs=140.5

Q ss_pred             CCCcccccccceEEEEEEECC---CceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          535 SSSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ...+.||+|.||+|++|.|..   +...||||+++.+... ....|.+|+.+|.+++|||++++||+....      ...
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hhh
Confidence            345789999999999999863   3346899999876544 678999999999999999999999987653      467


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|||.++.|+|.+.|++...    ..+.......++.|||.|+.||.++   +.||||+..+|+++...-.|||+|||+.
T Consensus       187 MV~ELaplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             HHhhhcccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence            99999999999999987332    2577888899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +-+..+......     .....-...|.|||.+
T Consensus       260 RaLg~ned~Yvm-----~p~rkvPfAWCaPEsL  287 (1039)
T KOG0199|consen  260 RALGENEDMYVM-----APQRKVPFAWCAPESL  287 (1039)
T ss_pred             eccCCCCcceEe-----cCCCcCcccccCHhHh
Confidence            987654322111     1123356679999975

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.88  E-value=3.7e-22  Score=205.30  Aligned_cols=168  Identities=28%  Similarity=0.424  Sum_probs=140.9

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      |+..+.||+|++|.||+|.+..+++.+|+|.+.....  .....+.+|++++++++|+||+++++++...     +..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence            5667889999999999999988999999999875432  3456788999999999999999999986654     37899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      ||||+++ ++.+++.....     .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||.+.
T Consensus        76 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEeccCC-CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999975 89888876432     588999999999999999999998   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......++..|+|||.+
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~~~PE~~  170 (283)
T cd05118         147 SFGSPVR--------PYTHYVVTRWYRAPELL  170 (283)
T ss_pred             ecCCCcc--------cccCccCcccccCcHHH
Confidence            7644320        01113588899999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.87  E-value=6.3e-22  Score=197.71  Aligned_cols=151  Identities=19%  Similarity=0.137  Sum_probs=125.8

Q ss_pred             ccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHH
Q 048668          543 GSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLE  622 (725)
Q Consensus       543 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  622 (725)
                      |.||.||+|++..+++.||+|.+....     .+.+|...+....||||+++++++....     ..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence            889999999999999999999996542     2334555566667999999999866543     789999999999999


Q ss_pred             HHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCC
Q 048668          623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS  702 (725)
Q Consensus       623 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  702 (725)
                      +++....      .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.++++|||.+.......     
T Consensus        74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----  139 (237)
T cd05576          74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----  139 (237)
T ss_pred             HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence            9987643      488999999999999999999998   99999999999999999999999999886543211     


Q ss_pred             CCCcccccccCCccccCCCcc
Q 048668          703 KTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       703 ~~~~~~~~~~gt~~y~aPE~~  723 (725)
                            ....++..|+|||++
T Consensus       140 ------~~~~~~~~y~aPE~~  154 (237)
T cd05576         140 ------DGEAVENMYCAPEVG  154 (237)
T ss_pred             ------ccCCcCccccCCccc
Confidence                  113467789999975

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.87  E-value=3.4e-22  Score=211.32  Aligned_cols=172  Identities=23%  Similarity=0.348  Sum_probs=142.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++...  .....+.+.+|+.++++++||||+++++++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            456788999999999999999999989999999998643  22234567889999999999999999987654432 222


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++|+||+ +++|.+++...       .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence            3589999999 67999998752       488999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||++......           .....++..|+|||.+
T Consensus       162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~  187 (343)
T cd07851         162 FGLARHTDDE-----------MTGYVATRWYRAPEIM  187 (343)
T ss_pred             cccccccccc-----------ccCCcccccccCHHHH
Confidence            9999765322           1124588899999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-22  Score=197.10  Aligned_cols=169  Identities=27%  Similarity=0.400  Sum_probs=138.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC--C----cccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--R----NLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~  604 (725)
                      ..+|.+...+|+|.||+|-.|.++.++..||+|+++--.+ ..+..+-|+++++++.+  |    -+|++.+|     |+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            6789999999999999999999999999999999963322 23556789999999942  2    35667666     44


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC------
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH------  678 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~------  678 (725)
                      ..++.++|+|.+ |-++++++.+....    +++..++..++.|++++++|||+.   +++|-|+|||||++..      
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence            445899999988 77999999876532    689999999999999999999999   9999999999999842      


Q ss_pred             --------------CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          679 --------------DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       679 --------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                                    +..+|++|||.|++....+           ...+-|..|.|||+++
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViL  282 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVIL  282 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchhee
Confidence                          2358999999998754432           1257899999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.87  E-value=6.4e-22  Score=200.84  Aligned_cols=172  Identities=23%  Similarity=0.325  Sum_probs=136.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      +|.+.+.||+|+||.||++++...+..+++|+++..     ......++.+|+.++++++||||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-----   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence            477889999999999999999877666766666431     1223446778999999999999999999865443     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++++|.+++......  ...+++..++.++.|++.|++|||+.   +++|+|+||+||+++. +.+|++||
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence            689999999999999988753211  12589999999999999999999998   9999999999999975 56999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.++........        .....|++.|+|||.+
T Consensus       150 g~~~~~~~~~~~--------~~~~~~~~~~~~pe~~  177 (260)
T cd08222         150 GVSRLLMGSCDL--------ATTFTGTPYYMSPEAL  177 (260)
T ss_pred             CceeecCCCccc--------ccCCCCCcCccCHHHH
Confidence            999776432111        1124588999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=5.2e-22  Score=223.11  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=127.9

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +.++|+++++.++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|++|+|++|+++. +|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECc
Confidence            4566777777666 4555443  46667777777776 3344333  366667777666663 344332  356666666


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      +|.++ .+|..+.   .+|+.|+|++|+|+.+ |..+.  ++|++|+|++|+|+.++.. +.                  
T Consensus       250 ~N~L~-~LP~~l~---s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~LP~~-lp------------------  303 (754)
T PRK15370        250 INRIT-ELPERLP---SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRTLPAH-LP------------------  303 (754)
T ss_pred             CCccC-cCChhHh---CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccccCccc-ch------------------
Confidence            66666 6665432   3566666666666543 33332  3566666666665544321 11                  


Q ss_pred             CCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCC
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI  253 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  253 (725)
                                    ++|+.|++++|+++ .+|..+                           .++|+.|++++|.++++ 
T Consensus       304 --------------~sL~~L~Ls~N~Lt-~LP~~l---------------------------~~sL~~L~Ls~N~Lt~L-  340 (754)
T PRK15370        304 --------------SGITHLNVQSNSLT-ALPETL---------------------------PPGLKTLEAGENALTSL-  340 (754)
T ss_pred             --------------hhHHHHHhcCCccc-cCCccc---------------------------cccceeccccCCccccC-
Confidence                          23444444444444 122110                           02344444444444432 


Q ss_pred             ChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCcc
Q 048668          254 PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLL  333 (725)
Q Consensus       254 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l  333 (725)
                      |..+.  ++|+.|++++|+|. .+|..+.  ++|+.|++++|+|+            .+|..+..   .+++|++++|++
T Consensus       341 P~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt------------~LP~~l~~---sL~~LdLs~N~L  400 (754)
T PRK15370        341 PASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT------------NLPENLPA---ALQIMQASRNNL  400 (754)
T ss_pred             Chhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC------------CCCHhHHH---HHHHHhhccCCc
Confidence            22221  35555555555555 2343332  45666666666555            34443321   235667777776


Q ss_pred             CCCcchh----hhcCCCCCeEEccCcccc
Q 048668          334 NGSLPQQ----VGNLKNLIILDISSNQFS  358 (725)
Q Consensus       334 ~~~~~~~----~~~l~~L~~L~Ls~N~l~  358 (725)
                      + .+|..    +..++++..|++.+|.++
T Consensus       401 ~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        401 V-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             c-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            6 33333    333467777777777776

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.86  E-value=1.2e-22  Score=184.77  Aligned_cols=167  Identities=22%  Similarity=0.423  Sum_probs=139.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..++|++.+.+|+|.|+.||.|....+.+.++||++++-+   .+.+.+|+.+|+.+. ||||+++++...++..   ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---kt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cC
Confidence            3567888999999999999999988888999999997543   356789999999997 9999999998766542   24


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDF  687 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Df  687 (725)
                      ..+|+||+.+-+..+...         .++...+..++.++++||.|||+.   ||+|||+||.|+++|... ..+++|+
T Consensus       110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence            679999999988877654         467778889999999999999999   999999999999999765 6999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|.++.++..+..         .+.+.+|--||++
T Consensus       178 GLAEFYHp~~eYnV---------RVASRyfKGPELL  204 (338)
T KOG0668|consen  178 GLAEFYHPGKEYNV---------RVASRYFKGPELL  204 (338)
T ss_pred             chHhhcCCCceeee---------eeehhhcCCchhe
Confidence            99998866533221         3567788889975

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.2e-21  Score=186.53  Aligned_cols=139  Identities=18%  Similarity=0.149  Sum_probs=107.7

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccc--h-------H-----------------HHHHHHHHHHHcCCCCc
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--A-------F-----------------RSFVAECEALRNIRHRN  590 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n  590 (725)
                      ...||+|+||.||+|.+. +|+.||||+++.....  .       .                 ....+|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 8999999999754211  0       0                 12235999999998887


Q ss_pred             ccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCC
Q 048668          591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDL  669 (725)
Q Consensus       591 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~ivHrdl  669 (725)
                      +.....+..       ...++||||++|+++........      .+++.....++.|++.+|+|+ |+.   +|+||||
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            744332211       12479999999887765432222      578889999999999999999 677   9999999


Q ss_pred             CCCCeeecCCCceEEccccccccc
Q 048668          670 KPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       670 kp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      ||+||+++ ++.++++|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=183.21  Aligned_cols=167  Identities=22%  Similarity=0.338  Sum_probs=135.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .+.|.+.+.+|+|.||.+-.|++++++..+|+|.+.... ...++|.+|...--.+. |.||+.-|+.    .|++.+..
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~v----aFqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEV----AFQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHH----HhhcCceE
Confidence            346888899999999999999999999999999986442 34578999988777775 9999988765    36667788


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCCceEEccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVGDF  687 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~--~~~~~kl~Df  687 (725)
                      .+++||++.|+|.+-+...       .+-|....+++.|+++|+.|+|++   ++||||||.+|||+-  +..++|+|||
T Consensus        98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence            8999999999999877653       477888899999999999999999   999999999999984  3358999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |..+....--           ....-+..|.|||+.
T Consensus       168 G~t~k~g~tV-----------~~~~~~~~y~~pe~~  192 (378)
T KOG1345|consen  168 GLTRKVGTTV-----------KYLEYVNNYHAPELC  192 (378)
T ss_pred             ccccccCcee-----------hhhhhhcccCCcHHH
Confidence            9987543210           012245568888864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-21  Score=209.17  Aligned_cols=167  Identities=32%  Similarity=0.448  Sum_probs=128.2

Q ss_pred             CCcccccccce-EEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeEEE
Q 048668          536 SSNMIGQGSFG-SVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       536 ~~~~ig~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      ..+++|.|+-| .||+|..  .|+.||||++-..   ......+||..++.-+ |||||++|+.-.+     ..+.||..
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-----~qF~YIal  582 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQD-----RQFLYIAL  582 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccC-----CceEEEEe
Confidence            34678899876 5799998  6889999988533   3345569999999986 9999999876433     34899999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---C--CceEEcccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---D--MVAHVGDFG  688 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~--~~~kl~Dfg  688 (725)
                      |.| ..+|.++++......+  .......+.+..|+++||++||+.   +||||||||.||||+.   +  .+++|+|||
T Consensus       583 ELC-~~sL~dlie~~~~d~~--~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVE--MQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             hHh-hhhHHHHHhccccchh--hcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccc
Confidence            999 5699999987521111  112144567889999999999998   9999999999999976   3  479999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++.+..+.....     ...+..||-+|+|||++
T Consensus       657 lsKkl~~~~sS~~-----r~s~~sGt~GW~APE~L  686 (903)
T KOG1027|consen  657 LSKKLAGGKSSFS-----RLSGGSGTSGWQAPEQL  686 (903)
T ss_pred             cccccCCCcchhh-----cccCCCCcccccCHHHH
Confidence            9998865533221     13346799999999986

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.3e-21  Score=217.96  Aligned_cols=120  Identities=28%  Similarity=0.402  Sum_probs=64.1

Q ss_pred             CCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccc
Q 048668          238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL  317 (725)
Q Consensus       238 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~  317 (725)
                      +|+.|++++|++..+ |..+  .++|++|++++|.+++ +|..+.  ++|+.|++++|+|+            .+|..+.
T Consensus       305 sL~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~------------~LP~~lp  366 (754)
T PRK15370        305 GITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT------------VLPETLP  366 (754)
T ss_pred             hHHHHHhcCCccccC-Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC------------cCChhhc
Confidence            566777777777754 3222  2467777777777764 454443  56777777777655            3333221


Q ss_pred             ccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCcccc----ccccCCcEEEccCCccc
Q 048668          318 SITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL----STCVSLEYVDISSNCFH  382 (725)
Q Consensus       318 ~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~  382 (725)
                         ..++.|++++|.++. +|..+.  .+|+.|++++|+|+ .+|..+    ..++.+..|+|.+|.++
T Consensus       367 ---~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        367 ---PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             ---CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence               122556666666653 333332  24555666666655 233222    22345555555555554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.2e-20  Score=180.59  Aligned_cols=139  Identities=23%  Similarity=0.240  Sum_probs=109.9

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccc---------------------h-----HHHHHHHHHHHHcCCCCc
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---------------------A-----FRSFVAECEALRNIRHRN  590 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~n  590 (725)
                      ...||+|+||.||+|++. +|+.||||+++.....                     .     ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 8999999999754210                     0     122457899999999998


Q ss_pred             ccceeeEeecCCCCCcceeeEEEeccCCCCHHHH-hcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecC
Q 048668          591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW-LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGD  668 (725)
Q Consensus       591 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrd  668 (725)
                      +.....+...       ..|+||||++|+++... +...       .++......++.|++.++.++|+ .   +|+|||
T Consensus        81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD  143 (190)
T cd05145          81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDV-------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD  143 (190)
T ss_pred             CCCceEEEec-------CCEEEEEEecCCCchhhhhhhc-------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            7544433221       24799999998855433 3321       46778889999999999999999 8   999999


Q ss_pred             CCCCCeeecCCCceEEcccccccccc
Q 048668          669 LKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       669 lkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      |||+||+++ ++.++|+|||+|+...
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecC
Confidence            999999999 8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.84  E-value=3e-20  Score=183.94  Aligned_cols=170  Identities=32%  Similarity=0.514  Sum_probs=143.8

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      |...+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++....     ..+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEE
Confidence            45678899999999999999888899999999865444 5678899999999999999999999876553     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +||+++++|.+++.....     .+++..+..++.+++.++.|+|..   +++|+|++|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            999999999999986541     178889999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......       .......++..|+|||.+
T Consensus       148 ~~~~~~-------~~~~~~~~~~~~~~pe~~  171 (225)
T smart00221      148 IHRDLA-------ALLKTVKGTPFYLAPEVL  171 (225)
T ss_pred             ecCccc-------ccccceeccCCcCCHhHh
Confidence            643310       011124588899999975

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=2.8e-20  Score=208.60  Aligned_cols=180  Identities=26%  Similarity=0.486  Sum_probs=141.6

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC---C----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCC-CCcccceeeEeec
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG---E----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLIKIITICSS  600 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~---~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  600 (725)
                      ..++....+.+|+|.||.|++|...   .    ....||||..+... ..+.+.+..|+++|+.+. ||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344455669999999999999742   1    14679999987542 345678999999999996 9999999999987


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccC--Ccccc--------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSN--DQVEV--------CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK  670 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk  670 (725)
                      ..     ..++|+||++.|+|.+|++..+  .....        ..++..+.+.++.|||.|++||++.   ++||||+.
T Consensus       374 ~~-----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA  445 (609)
T KOG0200|consen  374 DG-----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA  445 (609)
T ss_pred             CC-----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence            43     7899999999999999998776  00111        1388899999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccC--CccccCCCccc
Q 048668          671 PSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG--TVGYVAPGKFF  724 (725)
Q Consensus       671 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~  724 (725)
                      .+|||+..+..+||+|||+|+.......+...       .-.|  ...|||||.+.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-------~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTK-------SSAGTLPVKWMAPESLF  494 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEec-------CCCCccceeecCHHHhc
Confidence            99999999999999999999865443322211       0112  34599999763

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=6.4e-20  Score=176.29  Aligned_cols=172  Identities=23%  Similarity=0.363  Sum_probs=140.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .-+|.+++.||+|+||+.+.|+.--++++||||.-..+++  .-++..|.+..+.+. .+.|.+.|.|...+-     +-
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-----~N   99 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-----YN   99 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccc-----hh
Confidence            3479999999999999999999988999999998765533  245667888888875 789998887754443     66


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-----ceEE
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-----VAHV  684 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-----~~kl  684 (725)
                      .+|||.+ |.+|+|..+-...     .++...+..+|.|++.-++|+|++   ..|.|||||+|+||...+     .+.|
T Consensus       100 iLVidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEE
Confidence            7999988 8899998876553     689999999999999999999999   999999999999997654     5899


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccC
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA  719 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  719 (725)
                      +|||+|+.+.+......... .......||.+||+
T Consensus       171 iDFGmAK~YrDp~TkqHIPY-rE~KSLsGTARYMS  204 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPY-REHKSLSGTARYMS  204 (449)
T ss_pred             EeccchhhhcCccccccCcc-ccccccccceeeeE
Confidence            99999999987655444332 22334679999997

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.82  E-value=2e-20  Score=186.15  Aligned_cols=145  Identities=31%  Similarity=0.412  Sum_probs=124.8

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECC---CceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDF  603 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  603 (725)
                      ......|...+.||+|.|+.||+|.+..   .++.||+|.+....  ...++..|++.|..+. +.||+++.+++...  
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn--  107 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN--  107 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC--
Confidence            3345568889999999999999998876   77899999986543  3457889999999996 99999999985444  


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-Cce
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVA  682 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~~  682 (725)
                         +...+|+||++..+..++..         .++...+..+++.+..||+++|.+   |||||||||.|++.+.. +.-
T Consensus       108 ---d~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg  172 (418)
T KOG1167|consen  108 ---DQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG  172 (418)
T ss_pred             ---CeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence               48999999999999998876         356778889999999999999999   99999999999999854 678


Q ss_pred             EEccccccc
Q 048668          683 HVGDFGLAK  691 (725)
Q Consensus       683 kl~Dfgla~  691 (725)
                      .|.|||+|.
T Consensus       173 ~LvDFgLA~  181 (418)
T KOG1167|consen  173 VLVDFGLAQ  181 (418)
T ss_pred             eEEechhHH
Confidence            999999998

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.4e-19  Score=173.54  Aligned_cols=142  Identities=17%  Similarity=0.301  Sum_probs=109.9

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-----CCCcccceeeEeecCCCCCcce
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-----RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ....+.||+|+||.||.  +..++.. +||++........+.+.+|+++++++     +||||++++|++....  +.+.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            34567899999999995  6666655 69998765555567899999999999     6799999999976542  2224


Q ss_pred             -eeEEEec--cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEecCCCCCCeeecCC----C
Q 048668          609 -KALVFEY--MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI-EYLHHHCQPPMVHGDLKPSNVLLDHD----M  680 (725)
Q Consensus       609 -~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~ivHrdlkp~Nill~~~----~  680 (725)
                       ..+||||  +++|+|.+++++.       .+++.  ..++.|++.++ +|||++   +|+||||||+||+++..    +
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence             3479999  5579999999653       24444  35677888787 999999   99999999999999743    3


Q ss_pred             ceEEcc-cccccc
Q 048668          681 VAHVGD-FGLAKF  692 (725)
Q Consensus       681 ~~kl~D-fgla~~  692 (725)
                      .++|+| ||.+..
T Consensus       147 ~~~LiDg~G~~~~  159 (210)
T PRK10345        147 IPVVCDNIGESTF  159 (210)
T ss_pred             cEEEEECCCCcce
Confidence            799999 555444

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=181.70  Aligned_cols=157  Identities=34%  Similarity=0.500  Sum_probs=134.8

Q ss_pred             cceEEEEEEECCCceEEEEEEeeccccch-HHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHH
Q 048668          544 SFGSVYKGILGEDEMIVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLE  622 (725)
Q Consensus       544 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  622 (725)
                      +||.||+|++..+++.||+|++....... .+.+.+|++.+++++|+||+++++++....     ..++||||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence            58999999998889999999997654433 678999999999999999999999876553     789999999999999


Q ss_pred             HHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCC
Q 048668          623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS  702 (725)
Q Consensus       623 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  702 (725)
                      +++....      .+++..++.++.+++.++.|+|..   +++|+||+|+||+++.++.++++|||.+.......     
T Consensus        76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----  141 (244)
T smart00220       76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----  141 (244)
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence            9987643      378889999999999999999998   99999999999999999999999999998764321     


Q ss_pred             CCCcccccccCCccccCCCcc
Q 048668          703 KTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       703 ~~~~~~~~~~gt~~y~aPE~~  723 (725)
                          ......|+..|+|||++
T Consensus       142 ----~~~~~~~~~~~~~pE~~  158 (244)
T smart00220      142 ----LLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ----ccccccCCcCCCCHHHH
Confidence                11124588999999975

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=3.1e-19  Score=174.52  Aligned_cols=163  Identities=34%  Similarity=0.577  Sum_probs=137.5

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCC
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGN  618 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  618 (725)
                      ||+|.+|.||+++...+++.+++|++...... ..+.+.+|++.++.++|++|+++++++....     ..+++|||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-----HLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----eEEEEEecCCC
Confidence            68999999999999877999999999755432 3467899999999999999999999876543     78999999999


Q ss_pred             CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEcccccccccccCC
Q 048668          619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFGLAKFLSSHH  697 (725)
Q Consensus       619 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Dfgla~~~~~~~  697 (725)
                      ++|.+++....     ...++..+..++.+++++++|+|+.   +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            99999997652     1478899999999999999999999   9999999999999999 8999999999997654331


Q ss_pred             CCCCCCCCcccccccCCccccCCCcc
Q 048668          698 LDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       698 ~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .        ......+...|++||.+
T Consensus       148 ~--------~~~~~~~~~~~~~pe~~  165 (215)
T cd00180         148 S--------LLKTIVGTPAYMAPEVL  165 (215)
T ss_pred             c--------hhhcccCCCCccChhHh
Confidence            1        01123478889999975

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.81  E-value=1.3e-20  Score=180.56  Aligned_cols=171  Identities=22%  Similarity=0.282  Sum_probs=137.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  608 (725)
                      .+|...+.+|.|.- .|..|.+.-.++.||+|.....  .....++..+|...+..++|+||++++.++....+ +....
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46667788898888 7778888888999999988533  23345677899999999999999999998765432 22335


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||| .++|.+.+...        ++-..+..|..|++.|++|+|+.   +|+||||||+||++..++.+||.|||
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME--------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            79999999 55999888732        45567788999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.-....         ..+-.+.|.+|.|||+++
T Consensus       164 ~ar~e~~~~---------~mtpyVvtRyyrapevil  190 (369)
T KOG0665|consen  164 LARTEDTDF---------MMTPYVVTRYYRAPEVIL  190 (369)
T ss_pred             hhcccCccc---------ccCchhheeeccCchhee
Confidence            998643321         112257899999999975

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=2.1e-19  Score=165.23  Aligned_cols=173  Identities=27%  Similarity=0.385  Sum_probs=136.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC-CcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH-RNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..+.|...+.||+|+||.+|.|....+|..||||+-.....  ..+...|..+.+.++| ..|+.+..|..+..     +
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-----y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKD-----Y   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccc-----c
Confidence            45679999999999999999999999999999998754432  2456788999999874 56777666654444     6


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~  685 (725)
                      -.+|||.. |.+|++...-...     .++..+++-++-|++.-++|+|.+   ++|||||||+|+|..-   ...+.++
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence            67999988 8899998865432     577788899999999999999999   9999999999999863   3468999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccC
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA  719 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  719 (725)
                      |||+|+.+.+........ ........||.+|++
T Consensus       157 DFGLaKky~d~~t~~HIp-yre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIP-YREDRNLTGTARYAS  189 (341)
T ss_pred             eccchhhhccccccccCc-cccCCccceeeeehh
Confidence            999999887654433322 123344679999976

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=5.4e-20  Score=192.58  Aligned_cols=164  Identities=26%  Similarity=0.300  Sum_probs=133.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..+.|.....+|.|+|+.|-.|.+..+++..|+|++.....    +-.+|+.++... +||||+++.+.+....     +
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~-----~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK-----E  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCc-----e
Confidence            35567777889999999999999999999999999975522    223567666665 5999999999876554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-cCCCceEEccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-DHDMVAHVGDF  687 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill-~~~~~~kl~Df  687 (725)
                      .|+|||++.|+-+.+.+....       ....++..|+.+++.|+.|||++   ||||||+||+|||+ +..+.++|+||
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence            999999999998888876543       22267778999999999999998   99999999999999 58899999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |.++.....           -.+.|-|..|.|||+.
T Consensus       461 G~a~~~~~~-----------~~tp~~t~~y~APEvl  485 (612)
T KOG0603|consen  461 GFWSELERS-----------CDTPALTLQYVAPEVL  485 (612)
T ss_pred             chhhhCchh-----------hcccchhhcccChhhh
Confidence            999876433           1123578899999985

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=1e-18  Score=172.10  Aligned_cols=145  Identities=19%  Similarity=0.177  Sum_probs=112.7

Q ss_pred             cCCCCCcccccccceEEEEEE-ECCCceEEEEEEeeccccc------------------------hHHHHHHHHHHHHcC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKG------------------------AFRSFVAECEALRNI  586 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  586 (725)
                      ..|++.+.||+|+||.||+|. +..+|+.||+|+++.....                        ....+.+|+++++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999998 6668999999999753210                        012356899999999


Q ss_pred             CCC--cccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-
Q 048668          587 RHR--NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP-  663 (725)
Q Consensus       587 ~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-  663 (725)
                      .+.  .+++++++   .      ..++||||++|+++..+.....      .........++.|++.+++|+|+.   + 
T Consensus       108 ~~~~i~~p~~~~~---~------~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~  169 (237)
T smart00090      108 YEAGVPVPKPIAW---R------RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GE  169 (237)
T ss_pred             HhcCCCCCeeeEe---c------CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence            763  33444432   1      3479999999988876643222      345556788999999999999999   8 


Q ss_pred             cEecCCCCCCeeecCCCceEEccccccccccc
Q 048668          664 MVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS  695 (725)
Q Consensus       664 ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~  695 (725)
                      |+|||+||+||+++ ++.++++|||.|.....
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            99999999999999 88999999999986543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.77  E-value=3.8e-19  Score=180.17  Aligned_cols=172  Identities=22%  Similarity=0.341  Sum_probs=139.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC------CCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR------HRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~  603 (725)
                      -.+.|.+....|+|-|+.|.+|.+..-|..||||+|+-. +...+.=++|+++|++++      --|+++++..|.+.  
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--  506 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--  506 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--
Confidence            345788888899999999999999888899999999743 223344578999999995      33788888765544  


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ce
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VA  682 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~  682 (725)
                         +++|+|+|-+ ..+|.+.+++.+..   ..+....+..++.|+.-||..|-..   +|+|.||||.|||+.+.. .+
T Consensus       507 ---nHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  507 ---NHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             ---ceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence               4999999987 56999999987653   3678888999999999999999987   999999999999998764 68


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||||||.|....++...     +     +.-+..|.|||+++
T Consensus       577 KLCDfGSA~~~~eneit-----P-----YLVSRFYRaPEIiL  608 (752)
T KOG0670|consen  577 KLCDFGSASFASENEIT-----P-----YLVSRFYRAPEIIL  608 (752)
T ss_pred             eeccCcccccccccccc-----H-----HHHHHhccCcceee
Confidence            99999999877655321     1     23566799999985

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=4.8e-18  Score=177.02  Aligned_cols=178  Identities=23%  Similarity=0.305  Sum_probs=135.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCc-eEEEEEEeeccccchHHHHHHHHHHHHcCCC----CcccceeeEeecCCCCCcc
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDE-MIVAVKVINLKQKGAFRSFVAECEALRNIRH----RNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~  607 (725)
                      .|.+.+.||+|+||.||.|.+..++ ..+|+|+...........+..|+.++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987664 6788998865433322367789999998873    58888888753    2234


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-----Cce
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-----MVA  682 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-----~~~  682 (725)
                      +.|+||+.+ |.+|.++.....    ...++...+.+|+.|++.+|+++|+.   |++||||||+|+.+...     ..+
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence            789999988 889999876554    12689999999999999999999999   99999999999999865     369


Q ss_pred             EEccccccc--ccccCCCCCCCCCCcccccccCCccccCCCc
Q 048668          683 HVGDFGLAK--FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGK  722 (725)
Q Consensus       683 kl~Dfgla~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  722 (725)
                      .+.|||+|+  .+.................+.||..|+++..
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~  208 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV  208 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHH
Confidence            999999998  3322211100111111234669999999864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=2.9e-20  Score=194.79  Aligned_cols=258  Identities=23%  Similarity=0.302  Sum_probs=158.5

Q ss_pred             EEecCCCccC-ccCCccccCCCCCcEEEccCCcCCcc----CCCCCCCCCCCCEEEccCCcccc------cCcccccccC
Q 048668           17 ALALAGNYLT-GKLPDFIGNLSALQVIHIKGNSLGGK----FPTTLGLLRNLVQLNVAENKFYG------MFPRSICNIS   85 (725)
Q Consensus        17 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~   85 (725)
                      .|+|.+++++ ......|..+.+|++|++++|.++..    ++..+...++|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4777788777 34556677778888888888888532    44456667778888888887752      2345667777


Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCC---ccEEEccCceeee----eCCCccccc-CccceecCCCccccccC----ccC
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPN---LKELGIGANNFFG----LIPDSLSNA-SNLELLDLSNNQFKGKV----SID  153 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~---L~~L~L~~N~i~~----~~~~~~~~l-~~L~~L~Ls~N~i~~~~----~~~  153 (725)
                      +|+.|++++|.+.+..+ ..+..+.+   |++|++++|+++.    .....+..+ ++|++|+|++|.+++..    ...
T Consensus        82 ~L~~L~l~~~~~~~~~~-~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116          82 GLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             ceeEEEccCCCCChhHH-HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            88888888888863333 33333443   8888888888762    222344555 77888888888877322    223


Q ss_pred             cccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCccc
Q 048668          154 FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI  233 (725)
Q Consensus       154 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~  233 (725)
                      |..+++|++|++++|.++.....  .+...+...++|++|++++|.+++.....                     +...+
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~~~~~---------------------l~~~~  217 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIR--ALAEGLKANCNLEVLDLNNNGLTDEGASA---------------------LAETL  217 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHH--HHHHHHHhCCCCCEEeccCCccChHHHHH---------------------HHHHh
Confidence            45556777777777777632110  11123344567777777777766322221                     12233


Q ss_pred             ccccCCceEEecccccCCCCChhhc-----CCCCccEEeccCccccc----CCCCCCcCCCCCCEEeCCCCcCC
Q 048668          234 RNLVNLIALAVEVNQLHGTIPDVIG-----ELKNLQLLGLYKNFLQG----SIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       234 ~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      ..+++|++|++++|.+++.....+.     ..+.|+.|++++|.++.    .+...+..+++|+++++++|.++
T Consensus       218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~  291 (319)
T cd00116         218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG  291 (319)
T ss_pred             cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence            4556677777777776643222222     13567777777777651    22333445567777777777666

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=5.2e-18  Score=162.71  Aligned_cols=143  Identities=18%  Similarity=0.169  Sum_probs=114.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchH---HH------HHHHHHHHHcCCCCcccceeeEeecC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---RS------FVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      .++|...+++|+|+||.||.+..  ++..+|+|+++.......   ..      +.+|++.+.++.||+|..+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            56899999999999999999755  466799999975432222   22      68999999999999999998886543


Q ss_pred             CCC---CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC
Q 048668          602 DFK---GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH  678 (725)
Q Consensus       602 ~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~  678 (725)
                      ...   .....++||||++|.+|.++..          .++    ....+++.++..+|+.   +++|||+||+||+++.
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            311   1235789999999999988732          222    2356999999999999   9999999999999999


Q ss_pred             CCceEEccccccccc
Q 048668          679 DMVAHVGDFGLAKFL  693 (725)
Q Consensus       679 ~~~~kl~Dfgla~~~  693 (725)
                      ++ ++++|||..+..
T Consensus       171 ~g-i~liDfg~~~~~  184 (232)
T PRK10359        171 NG-LRIIDLSGKRCT  184 (232)
T ss_pred             CC-EEEEECCCcccc
Confidence            98 999999988655

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=7.5e-20  Score=191.67  Aligned_cols=93  Identities=22%  Similarity=0.187  Sum_probs=44.5

Q ss_pred             EEEccCceee-eeCCCcccccCccceecCCCccccccC----ccCcccccccCeeecCCccCCccCCCCcccccccCCCC
Q 048668          114 ELGIGANNFF-GLIPDSLSNASNLELLDLSNNQFKGKV----SIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCS  188 (725)
Q Consensus       114 ~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~  188 (725)
                      .|+|..+.++ ......|..+.+|+.|++++|.++...    +..+...+.+++|+++++.+...+..-......+.+++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            3566666665 222344556666777777777764321    11233344466666666555421110001112344455


Q ss_pred             CCCEEECccCcccccCCh
Q 048668          189 SLKVLSLSDNQFGGELPH  206 (725)
Q Consensus       189 ~L~~L~L~~N~l~~~~p~  206 (725)
                      +|+.|++++|.+.+..+.
T Consensus        82 ~L~~L~l~~~~~~~~~~~   99 (319)
T cd00116          82 GLQELDLSDNALGPDGCG   99 (319)
T ss_pred             ceeEEEccCCCCChhHHH
Confidence            555555555555533333

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=4.1e-18  Score=171.94  Aligned_cols=139  Identities=26%  Similarity=0.434  Sum_probs=119.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-----C---CcccceeeEeecCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----H---RNLIKIITICSSTDF  603 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~~  603 (725)
                      .+|-+.++||-|.|++||.|.+..+.+.||+|+++... ...+..+.||++|++++     |   ..||+++++|.....
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57888899999999999999999999999999986442 23466789999999984     3   379999999988775


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                      .+. ++++|+|++ |.+|..+|+...-.    .++...+.+|++||+.||.|||..|  +|||-||||+|||+..+
T Consensus       157 NG~-HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQ-HVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCc-EEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence            554 899999999 77999999876533    6899999999999999999999987  99999999999999644

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=2.1e-20  Score=162.82  Aligned_cols=179  Identities=29%  Similarity=0.489  Sum_probs=137.9

Q ss_pred             cccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccc
Q 048668          233 IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGAL  312 (725)
Q Consensus       233 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  312 (725)
                      +.++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|. ..|..++.+++|++|+++-|++.              
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~--------------   92 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN--------------   92 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh--------------
Confidence            345667777778888877 44555777777888888888777 56777777777777777666443              


Q ss_pred             cccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCcccc-ccCccccccccCCcEEEccCCccccccCccccC
Q 048668          313 PQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS-GMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGF  391 (725)
Q Consensus       313 p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  391 (725)
                                             ..|..|+.+|.|+.|||++|++. ...|..|-.+..|+-|+|+.|.+. .+|+.++.
T Consensus        93 -----------------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~  148 (264)
T KOG0617|consen   93 -----------------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGK  148 (264)
T ss_pred             -----------------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhh
Confidence                                   56777888888888888888885 467888888888999999999988 88889999


Q ss_pred             CCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccC---CCCCcCccCCcc
Q 048668          392 LKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFS---NKSKIPLQGNVR  452 (725)
Q Consensus       392 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~---~~~~~~~~~n~~  452 (725)
                      +++|+.|.+.+|.+- ..|..++.+..|++|.+.+|+++-.+|..+.+.   .-+....+.|||
T Consensus       149 lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  149 LTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             hcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCC
Confidence            999999999999987 688999999999999999999998888765432   223344566666

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.8e-17  Score=155.23  Aligned_cols=133  Identities=20%  Similarity=0.164  Sum_probs=104.8

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeecccc----chHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----GAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .....+++|+||+||.+..  .+.+++.+.+.....    .....|.+|+++|+++. |++|++++++         +..
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            3457899999999997765  566777776654322    11235789999999996 5889999885         146


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC-CCCCeeecCCCceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL-KPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl-kp~Nill~~~~~~kl~Dfg  688 (725)
                      |++|||++|.+|.+....             ....++.|++.+++++|++   ||+|||| ||+||+++.++.++|+|||
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            899999999999764321             0134678999999999999   9999999 7999999999999999999


Q ss_pred             cccccc
Q 048668          689 LAKFLS  694 (725)
Q Consensus       689 la~~~~  694 (725)
                      +|....
T Consensus       138 ~A~~~~  143 (218)
T PRK12274        138 LAVRGN  143 (218)
T ss_pred             CceecC
Confidence            998543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.7e-19  Score=157.22  Aligned_cols=149  Identities=34%  Similarity=0.534  Sum_probs=125.5

Q ss_pred             ccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccc
Q 048668          228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK  307 (725)
Q Consensus       228 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  307 (725)
                      .+|+.+..+.+|+.|++.+|+|. ..|..++.+++|+.|+++-|++. ..|..|+.+|.|+.|||.+|.+.         
T Consensus        47 ~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~---------  115 (264)
T KOG0617|consen   47 VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLN---------  115 (264)
T ss_pred             ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccc---------
Confidence            56777788889999999999998 56778999999999999999998 89999999999999999999776         


Q ss_pred             ccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCc
Q 048668          308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPP  387 (725)
Q Consensus       308 ~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  387 (725)
                       ...+|..+|-+.++ +.|+|++|.+. .+|..++.+++|+.|.+..|.+- ..|.+++.+..|++|++++|+++ .+|+
T Consensus       116 -e~~lpgnff~m~tl-ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlpp  190 (264)
T KOG0617|consen  116 -ENSLPGNFFYMTTL-RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPP  190 (264)
T ss_pred             -cccCCcchhHHHHH-HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecCh
Confidence             23677788887777 78888999887 67788888889999988888887 77888888888888888888887 6676


Q ss_pred             cccCC
Q 048668          388 SLGFL  392 (725)
Q Consensus       388 ~~~~l  392 (725)
                      .++++
T Consensus       191 el~~l  195 (264)
T KOG0617|consen  191 ELANL  195 (264)
T ss_pred             hhhhh
Confidence            66543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.5e-17  Score=160.23  Aligned_cols=135  Identities=21%  Similarity=0.317  Sum_probs=110.6

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.||+|++|.||+|++  .+..|++|+......        ....++.+|++++..+.|++|+....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999987  567799997653321        11246789999999999998876666654332     57


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||++|++|.+++....         + .+..++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence            89999999999999986432         2 6788999999999999999   999999999999999 78999999999


Q ss_pred             cccc
Q 048668          690 AKFL  693 (725)
Q Consensus       690 a~~~  693 (725)
                      ++..
T Consensus       141 a~~~  144 (211)
T PRK14879        141 AEFS  144 (211)
T ss_pred             ccCC
Confidence            8764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=5.1e-17  Score=180.94  Aligned_cols=138  Identities=25%  Similarity=0.326  Sum_probs=109.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--c------cchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--Q------KGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      ...|...+.||+|+||.||+|.+...  .+++|+...+  .      ....+++.+|++++++++|++++....++....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34456678999999999999988533  3444433211  1      112356889999999999999988776655433


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                           ..++||||++|++|.+++.              ....++.+++.++.|+|+.   +++|||+||+||++ .++.+
T Consensus       410 -----~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        410 -----EKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             -----CCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence                 5689999999999999875              2357889999999999998   99999999999999 57799


Q ss_pred             EEccccccccc
Q 048668          683 HVGDFGLAKFL  693 (725)
Q Consensus       683 kl~Dfgla~~~  693 (725)
                      +|+|||+|+..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=5.6e-17  Score=156.72  Aligned_cols=142  Identities=25%  Similarity=0.216  Sum_probs=109.6

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc----------------------hHHHHHHHHHHHH
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG----------------------AFRSFVAECEALR  584 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  584 (725)
                      +......|...+.||+|+||.||+|... +|+.||||+++.....                      ....+.+|+.++.
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3333334777899999999999999875 7999999997643210                      0123578899999


Q ss_pred             cCCCCc--ccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 048668          585 NIRHRN--LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQP  662 (725)
Q Consensus       585 ~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~  662 (725)
                      ++.|++  ++..++.         ...++||||++|+++.+....            .....++.+++.++.++|+.   
T Consensus        89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~---  144 (198)
T cd05144          89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH---  144 (198)
T ss_pred             HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---
Confidence            998874  4444432         245899999999998765321            12456888999999999998   


Q ss_pred             CcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          663 PMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       663 ~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      +|+||||||+||+++.++.++|+|||.|...
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.71  E-value=4.4e-17  Score=159.97  Aligned_cols=183  Identities=20%  Similarity=0.333  Sum_probs=141.7

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCc-----eEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDE-----MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      .....+++....+-+|.||.||+|.|++..     +.|-+|.++.. ++-....+..|.-.+..+.|||+.++.+++...
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            334456777788999999999999886433     34556666433 233456789999999999999999999998764


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCcc--ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                      .    +..++++.++.-|+|..|+...+...  ....++..+...++.|++.|++|||++   +|||.||..+|.++|+.
T Consensus       360 ~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  360 Y----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             c----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            3    46789999999999999998443221  123577788899999999999999999   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      -++|++|=.++|.+-+..+.--...      ......|||||-+
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDn------EnRPvkWMslEal  470 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDN------ENRPVKWMSLEAL  470 (563)
T ss_pred             eeEEeccchhccccCcccccccCCC------CCCcccccCHHHH
Confidence            9999999999997755443322221      2256789999964

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=8.6e-17  Score=155.87  Aligned_cols=131  Identities=24%  Similarity=0.350  Sum_probs=103.9

Q ss_pred             ccccccceEEEEEEECCCceEEEEEEeeccc--c------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--K------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .||+|+||.||+|.+  ++..|++|+.....  .      ...+++.+|++++..+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            489999999999986  56789999864321  1      11356788999999999886554443333222     468


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++|++|.+++....      .       .++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.+
T Consensus        74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            9999999999999875421      0       7889999999999999   999999999999999 889999999998


Q ss_pred             ccc
Q 048668          691 KFL  693 (725)
Q Consensus       691 ~~~  693 (725)
                      +..
T Consensus       137 ~~~  139 (199)
T TIGR03724       137 KYS  139 (199)
T ss_pred             cCC
Confidence            764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.67  E-value=6.3e-16  Score=163.07  Aligned_cols=175  Identities=35%  Similarity=0.537  Sum_probs=139.4

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccc---hHHHHHHHHHHHHcCCCC-cccceeeEeecCCCCCccee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFRSFVAECEALRNIRHR-NLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~  609 (725)
                      |...+.+|.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+++....     ..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence            566788999999999999986   67899999765332   367899999999999988 7999999874333     47


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Dfg  688 (725)
                      +++++|+.++++.+++......   ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999999999777654311   2578889999999999999999999   899999999999999998 79999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++............  .......||..|+|||++.
T Consensus       148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~  181 (384)
T COG0515         148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLL  181 (384)
T ss_pred             cceecCCCCcccccc--ccccccccccccCCHHHhc
Confidence            998554332111000  1123467999999999763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.7e-15  Score=145.12  Aligned_cols=136  Identities=24%  Similarity=0.296  Sum_probs=97.4

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccc--hHHH----------------------HHHHHHHHHcCCCCc--
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRS----------------------FVAECEALRNIRHRN--  590 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--  590 (725)
                      .+.||+|+||+||+|++. +++.||||+++.....  ....                      ...|.+.+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 7899999998753211  1111                      135666666665432  


Q ss_pred             ccceeeEeecCCCCCcceeeEEEeccCCCCHHHH-hcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecC
Q 048668          591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW-LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGD  668 (725)
Q Consensus       591 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrd  668 (725)
                      +.+.+++         ...++||||++++.+... +....       .. .....++.+++.++.++|. .   +|+|||
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            4444432         135899999998543221 11110       11 4567899999999999998 7   999999


Q ss_pred             CCCCCeeecCCCceEEcccccccccc
Q 048668          669 LKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       669 lkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      +||+||+++ ++.++++|||.|....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CChhhEEEE-CCcEEEEECccccccc
Confidence            999999999 8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=2.2e-15  Score=139.08  Aligned_cols=135  Identities=21%  Similarity=0.258  Sum_probs=110.0

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC--CcccceeeEeecCCCCCcceeeEEEe
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      .+.+|+|.++.||++...+  ..+++|.......  ...+.+|+..++.++|  ..+++++++....     +..+++||
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e   73 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLME   73 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEE
Confidence            4679999999999999853  6799998865433  4678899999999986  5888888775433     36899999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      |++++.+..+             +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++..
T Consensus        74 ~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          74 WIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9988777543             33455678899999999999864457999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=8.4e-15  Score=144.71  Aligned_cols=140  Identities=17%  Similarity=0.125  Sum_probs=106.0

Q ss_pred             Ccccc-cccceEEEEEEECCCceEEEEEEeeccc-------------cchHHHHHHHHHHHHcCCCCcc--cceeeEeec
Q 048668          537 SNMIG-QGSFGSVYKGILGEDEMIVAVKVINLKQ-------------KGAFRSFVAECEALRNIRHRNL--IKIITICSS  600 (725)
Q Consensus       537 ~~~ig-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~  600 (725)
                      ...+| .|+.|+||.+...  +..+|+|.+....             .....++.+|++++.++.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35687 7899999998874  6678999885311             1123567899999999998875  667766433


Q ss_pred             CCCCCcceeeEEEeccCC-CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          601 TDFKGVDFKALVFEYMGN-GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                      .. ......++||||++| .+|.+++...       .+++.    .+.+++.++.++|+.   ||+||||||+|||++.+
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD  178 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence            22 111234699999997 6999988643       23433    356899999999999   99999999999999999


Q ss_pred             CceEEccccccccc
Q 048668          680 MVAHVGDFGLAKFL  693 (725)
Q Consensus       680 ~~~kl~Dfgla~~~  693 (725)
                      +.++|+|||.++..
T Consensus       179 ~~v~LIDfg~~~~~  192 (239)
T PRK01723        179 GKFWLIDFDRGELR  192 (239)
T ss_pred             CCEEEEECCCcccC
Confidence            99999999998764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.56  E-value=2.5e-15  Score=175.96  Aligned_cols=130  Identities=14%  Similarity=0.218  Sum_probs=87.2

Q ss_pred             CCC-CcccceeeEeecCCCCC--cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 048668          586 IRH-RNLIKIITICSSTDFKG--VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQP  662 (725)
Q Consensus       586 l~h-~niv~l~~~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~  662 (725)
                      +.| +||.++++++.......  ....+.+|||+ +++|.+++....     ..+++.+++.++.||++||+|||++   
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---   99 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ---   99 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence            345 57777777763322111  12466788987 669999997532     1589999999999999999999998   


Q ss_pred             CcEecCCCCCCeeecC-------------------CCceEEcccccccccccCCCC--------CCCCCCcccccccCCc
Q 048668          663 PMVHGDLKPSNVLLDH-------------------DMVAHVGDFGLAKFLSSHHLD--------TSSKTPSSSIGIKGTV  715 (725)
Q Consensus       663 ~ivHrdlkp~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~~--------~~~~~~~~~~~~~gt~  715 (725)
                      +|+||||||+|||++.                   ++.+|++|||+++........        .....+......+||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            9999999999999964                   345666666666542110000        0000011112246899


Q ss_pred             cccCCCccc
Q 048668          716 GYVAPGKFF  724 (725)
Q Consensus       716 ~y~aPE~~~  724 (725)
                      +|||||++.
T Consensus       180 ~Y~APE~~~  188 (793)
T PLN00181        180 WYTSPEEDN  188 (793)
T ss_pred             ceEChhhhc
Confidence            999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=4e-15  Score=164.75  Aligned_cols=169  Identities=22%  Similarity=0.300  Sum_probs=126.4

Q ss_pred             CCcccccccceEEEEEEECCCceEEEEEEeec---cccc--h-HHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINL---KQKG--A-FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~--~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ....+|.|++|.|+.+......+..+.|..+.   ....  . ...+..|+.+-..+.|||++..+..+....     ..
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----GI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----cc
Confidence            45789999999888887765655555554432   1111  1 122566777888899999877665543332     23


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      +-+||||++ ||..++....      .+...++-.++.|++.|++|+|+.   ||.|||+|++|+++..+|.+||+|||.
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~  466 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA  466 (601)
T ss_pred             hhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence            344999999 9999998753      366778889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.........    ......+.+|+..|+|||++
T Consensus       467 ~~vf~~~~e~----~~~~~~g~~gS~pY~apE~~  496 (601)
T KOG0590|consen  467 ASVFRYPWEK----NIHESSGIVGSDPYLAPEVL  496 (601)
T ss_pred             ceeeccCcch----hhhhhcCcccCCcCcCcccc
Confidence            9766443221    11234467899999999986

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=4.5e-14  Score=158.95  Aligned_cols=112  Identities=34%  Similarity=0.555  Sum_probs=99.2

Q ss_pred             CCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcc
Q 048668          346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS  425 (725)
Q Consensus       346 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  425 (725)
                      .++.|+|++|.+.|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCeeecCCCC--ccCCCCCcCccCCccccCCC
Q 048668          426 YNHLEGEVPTKG--VFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       426 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~  457 (725)
                      +|+++|.+|..-  ....+..+.+.+|+.+|+.+
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999998651  22344567889999999865

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=6e-14  Score=158.21  Aligned_cols=169  Identities=22%  Similarity=0.285  Sum_probs=117.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC---CCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~  606 (725)
                      ....|.+.+.+|+|+||.||+|.... |+.||+|+-+....=   +|.-=.+++.+++   -+-|..+..++...     
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~-----  766 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ-----  766 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC-----
Confidence            34567788999999999999999986 999999987644210   0111122333333   12233333332222     


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-------C
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-------D  679 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-------~  679 (725)
                      +.-++|+||.+.|+|.+++...+      .++|..++.++.|++..++.||..   +|||+||||+|.++..       .
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             CcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcc
Confidence            24679999999999999998443      689999999999999999999999   9999999999999953       2


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGK  722 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  722 (725)
                      ..++|+|||-|-.+.--      .........++|-.+-.+|+
T Consensus       838 ~~l~lIDfG~siDm~lf------p~~~~F~~~~~td~f~C~EM  874 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLF------PDGTKFKAVWHTDLFDCIEM  874 (974)
T ss_pred             cceEEEecccceeeeEc------CCCcEEeeeeccccchhHHH
Confidence            35899999998654321      11123334556666555554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.46  E-value=1.6e-15  Score=156.26  Aligned_cols=174  Identities=32%  Similarity=0.477  Sum_probs=123.5

Q ss_pred             CceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccc
Q 048668          239 LIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLS  318 (725)
Q Consensus       239 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~  318 (725)
                      -...+|+.|++. .+|..++.+..|+.+.|..|.+. .+|..+.++..|..|||+.|+++            .+|..++.
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS------------~lp~~lC~  142 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS------------HLPDGLCD  142 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh------------cCChhhhc
Confidence            345667777776 45666666666777777777776 56667777777777777777666            56666665


Q ss_pred             cccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEE
Q 048668          319 ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL  398 (725)
Q Consensus       319 ~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  398 (725)
                      +.-  +.|-+++|+++ .+|..++.++.|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|..+..|+ |..|
T Consensus       143 lpL--kvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~l  216 (722)
T KOG0532|consen  143 LPL--KVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRL  216 (722)
T ss_pred             Ccc--eeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeee
Confidence            442  45677777777 56667777777788888888877 66777777778888888888877 4566666554 7778


Q ss_pred             eCCCCcccccCcccccCCCCCCeEEcccccCeeec
Q 048668          399 DVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEV  433 (725)
Q Consensus       399 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  433 (725)
                      |+|+|+++ .+|-.|..|+.|++|-|.+|+|...+
T Consensus       217 DfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  217 DFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             ecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            88888877 67777888888888888888876443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=3.3e-13  Score=145.16  Aligned_cols=142  Identities=20%  Similarity=0.240  Sum_probs=99.6

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchH----------------------------------------HHH
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF----------------------------------------RSF  576 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  576 (725)
                      .+.||.|++|.||+|+.+ +|+.||||+.+..-....                                        -.|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999986 789999999864311000                                        024


Q ss_pred             HHHHHHHHcCC----CCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHH-
Q 048668          577 VAECEALRNIR----HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS-  651 (725)
Q Consensus       577 ~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~-  651 (725)
                      .+|++.+.++.    |..-+.+..+|....    ...++||||++|+++.++......     ..   ...+++.+++. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARS  268 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHH
Confidence            56666666653    332333333332211    246899999999999887653211     11   23456666665 


Q ss_pred             HHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       652 ~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      .+..+|..   |++|+|+||.||+++.++.++++|||++..+.
T Consensus       269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            46788888   99999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.44  E-value=1.4e-14  Score=152.32  Aligned_cols=159  Identities=24%  Similarity=0.277  Sum_probs=128.1

Q ss_pred             ccccccceEEEEEEE---CCCceEEEEEEeecccc--chHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeEE
Q 048668          539 MIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      ++|+|.||.|+.++-   ...+..+|+|+.++...  ........|-.++..++ ||.+|++...     |++....+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            379999999996642   34677899998875421  11224567788888887 9999999876     4444588999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      ++|..||++...+....      .+.+.....+...++-|++++|..   +|+|||+|++||+++.+|.+|+.|||+++.
T Consensus        76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence            99999999999887665      466777777888999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ..+...            .|||..|||||++
T Consensus       147 ~v~~~~------------~cgt~eymApEI~  165 (612)
T KOG0603|consen  147 AVKEKI------------ACGTYEYRAPEII  165 (612)
T ss_pred             hHhhhh------------cccchhhhhhHhh
Confidence            644311            2799999999986

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.43  E-value=4.4e-13  Score=145.42  Aligned_cols=148  Identities=17%  Similarity=0.195  Sum_probs=96.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc---------------------------------h-HH--
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---------------------------------A-FR--  574 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------------~-~~--  574 (725)
                      ..+|+. +.+|+|++|+||+|+.+.+|+.||||++++.-..                                 + .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 7899999999999999877999999999743100                                 0 01  


Q ss_pred             ----HHHHHHHHHHcCC----CCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHh--cccCCccccccCCHHHHHH
Q 048668          575 ----SFVAECEALRNIR----HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLN  644 (725)
Q Consensus       575 ----~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~  644 (725)
                          +|.+|+..+.++.    +...+.+-.++.+-    ....++||||++|+.+.++-  ...+.  ....+.+..+..
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~--d~~~la~~~v~~  271 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGT--DMKLLAERGVEV  271 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCC--CHHHHHHHHHHH
Confidence                2445555555553    33333333333221    12467999999999998752  22211  011222333333


Q ss_pred             HHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----ceEEccccccccccc
Q 048668          645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----VAHVGDFGLAKFLSS  695 (725)
Q Consensus       645 i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~----~~kl~Dfgla~~~~~  695 (725)
                      ++.|+       +..   |++|+|+||.||+++.++    +++++|||++..+.+
T Consensus       272 ~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            34443       345   999999999999999988    999999999876643

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.38  E-value=5e-14  Score=145.29  Aligned_cols=195  Identities=32%  Similarity=0.478  Sum_probs=146.5

Q ss_pred             CCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccE
Q 048668          186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQL  265 (725)
Q Consensus       186 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  265 (725)
                      .+.--...||+.|++. .+|..+..+- .|+.+.+..|.+. .+|.+++++..|++|+|+.|+++ ..|..++.++ |++
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv  147 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFV-SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV  147 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHH-HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence            3444566778888887 7777777776 6777777778877 77888888888888888888888 4566677776 888


Q ss_pred             EeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCC
Q 048668          266 LGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLK  345 (725)
Q Consensus       266 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~  345 (725)
                      |.+++|+++ .+|..++.++.|..||.+.|.++            .+|.++..+.++ +.|.+..|++. .+|..+..| 
T Consensus       148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~------------slpsql~~l~sl-r~l~vrRn~l~-~lp~El~~L-  211 (722)
T KOG0532|consen  148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ------------SLPSQLGYLTSL-RDLNVRRNHLE-DLPEELCSL-  211 (722)
T ss_pred             EEEecCccc-cCCcccccchhHHHhhhhhhhhh------------hchHHhhhHHHH-HHHHHhhhhhh-hCCHHHhCC-
Confidence            888888887 67777888888888888888777            778888877777 67788888877 566666655 


Q ss_pred             CCCeEEccCccccccCccccccccCCcEEEccCCccccccCcccc---CCCCCCEEeCCCC
Q 048668          346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLG---FLKSIKFLDVSCN  403 (725)
Q Consensus       346 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N  403 (725)
                      .|..||+|.|+++ .+|-.|..|..|++|-|.+|.|. .+|..+.   ...-.++|+..-+
T Consensus       212 pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  212 PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            4788888888887 78888888888888888888887 3444442   2233455555555

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=4.5e-13  Score=132.49  Aligned_cols=125  Identities=26%  Similarity=0.325  Sum_probs=86.9

Q ss_pred             CCCcccceeeEeecCC----------------------CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHH
Q 048668          587 RHRNLIKIITICSSTD----------------------FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN  644 (725)
Q Consensus       587 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~  644 (725)
                      +|||||++.++|.+.-                      .......|+||..++ .+|.+|+....       .+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-------~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-------RSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-------CchHHHHH
Confidence            5999999998865321                      011235689999885 49999998664       45556677


Q ss_pred             HHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCC--ceEEcccccccccccCCCCCCCCCCcccccccCCccccCC
Q 048668          645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDM--VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP  720 (725)
Q Consensus       645 i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~--~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  720 (725)
                      +..|+++|+.|||.+   +|.|||+|++|||+.  +|+  ...|+|||.+--...+.......  .-....-|...-|||
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~--S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYE--SDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccc--cccccCCCcceecch
Confidence            889999999999999   999999999999984  443  57899999874322211111111  111123477789999


Q ss_pred             Cccc
Q 048668          721 GKFF  724 (725)
Q Consensus       721 E~~~  724 (725)
                      |++-
T Consensus       421 Ei~t  424 (598)
T KOG4158|consen  421 EIAT  424 (598)
T ss_pred             hhhh
Confidence            9863

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.37  E-value=5.3e-13  Score=143.91  Aligned_cols=259  Identities=29%  Similarity=0.318  Sum_probs=164.1

Q ss_pred             EEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCC-CCCEEEccCCcccccCcccccccCCCceeeccCC
Q 048668           17 ALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLR-NLVQLNVAENKFYGMFPRSICNISSLEYFYLTSN   95 (725)
Q Consensus        17 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N   95 (725)
                      .|+++.|.+. .....+..++.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            5777777775 34445556678888888888887 5555556664 8888888888887 45566888888888888888


Q ss_pred             CCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCC
Q 048668           96 RFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAA  175 (725)
Q Consensus        96 ~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~  175 (725)
                      +++ .+|... ..+++|+.|++++|+++.+. .....+..|++|++++|++.. ....+..+.++..+.+++|++...  
T Consensus       174 ~l~-~l~~~~-~~~~~L~~L~ls~N~i~~l~-~~~~~~~~L~~l~~~~N~~~~-~~~~~~~~~~l~~l~l~~n~~~~~--  247 (394)
T COG4886         174 DLS-DLPKLL-SNLSNLNNLDLSGNKISDLP-PEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDL--  247 (394)
T ss_pred             hhh-hhhhhh-hhhhhhhheeccCCccccCc-hhhhhhhhhhhhhhcCCccee-cchhhhhcccccccccCCceeeec--
Confidence            887 777543 26788888888888888553 333445668888888885432 234567777788888888887643  


Q ss_pred             CCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCCh
Q 048668          176 NDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPD  255 (725)
Q Consensus       176 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  255 (725)
                           +..+.+++++++|++++|+++. ++. +..+. .++.+++++|.+....|...........+..  +.+. ..+.
T Consensus       248 -----~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~-~l~~L~~s~n~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~  316 (394)
T COG4886         248 -----PESIGNLSNLETLDLSNNQISS-ISS-LGSLT-NLRELDLSGNSLSNALPLIALLLLLLELLLN--LLLT-LKAL  316 (394)
T ss_pred             -----cchhccccccceeccccccccc-ccc-ccccC-ccCEEeccCccccccchhhhccchhHHhhhh--hhhh-cccc
Confidence                 2446677888888888888873 333 55555 7888888888888666654433222111111  2222 1122


Q ss_pred             hhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCc
Q 048668          256 VIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS  296 (725)
Q Consensus       256 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  296 (725)
                      .+.....+....+..+... ..+..+.....+..++...+.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  356 (394)
T COG4886         317 ELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNA  356 (394)
T ss_pred             ccccccccccccccccccc-ccchhhcccccccCceecccc
Confidence            2222233334444444443 344444455555555555553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.35  E-value=5.6e-13  Score=122.75  Aligned_cols=122  Identities=27%  Similarity=0.413  Sum_probs=39.9

Q ss_pred             CCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCC-CCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCC
Q 048668           21 AGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLG-LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSG   99 (725)
Q Consensus        21 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~   99 (725)
                      ..+.|+ ..+. +.+...+++|+|++|+|+.+  +.++ .+.+|+.|+||+|.|+.+.  .+..+++|++|++++|+|+ 
T Consensus         5 t~~~i~-~~~~-~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-   77 (175)
T PF14580_consen    5 TANMIE-QIAQ-YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-   77 (175)
T ss_dssp             -----------------------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS----
T ss_pred             cccccc-cccc-cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-
Confidence            344444 3333 33444678888888888743  3455 4778888888888887432  4777888888888888887 


Q ss_pred             CCChhhhcCCCCccEEEccCceeeeeCC-CcccccCccceecCCCcccccc
Q 048668          100 SLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGK  149 (725)
Q Consensus       100 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~  149 (725)
                      .++..+...+++|++|+|++|+|..+.. ..++.+++|++|+|.+|+++..
T Consensus        78 ~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen   78 SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred             ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence            6665444467888888888888865432 4567788888888888888743

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.34  E-value=1.6e-12  Score=140.22  Aligned_cols=202  Identities=33%  Similarity=0.398  Sum_probs=157.5

Q ss_pred             cEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccC-CCceeeccCCCCCCCCChhhhcCCCCccEEEcc
Q 048668           40 QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNIS-SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG  118 (725)
Q Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  118 (725)
                      ..|+++.|++. ..+.....++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|.. ...+++|+.|+++
T Consensus        96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~-~~~l~~L~~L~l~  171 (394)
T COG4886          96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP-LRNLPNLKNLDLS  171 (394)
T ss_pred             ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhh-hhccccccccccC
Confidence            36899999985 34444555688999999999998 5555666664 8999999999998 77633 3689999999999


Q ss_pred             CceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc-CCccCCCCcccccccCCCCCCCEEECcc
Q 048668          119 ANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN-LGIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       119 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      .|+++.+. ...+.+++|+.|++++|+++.++.. ......|.+|.+++|. +...        ..+.++.++..+.+.+
T Consensus       172 ~N~l~~l~-~~~~~~~~L~~L~ls~N~i~~l~~~-~~~~~~L~~l~~~~N~~~~~~--------~~~~~~~~l~~l~l~~  241 (394)
T COG4886         172 FNDLSDLP-KLLSNLSNLNNLDLSGNKISDLPPE-IELLSALEELDLSNNSIIELL--------SSLSNLKNLSGLELSN  241 (394)
T ss_pred             Cchhhhhh-hhhhhhhhhhheeccCCccccCchh-hhhhhhhhhhhhcCCcceecc--------hhhhhcccccccccCC
Confidence            99998664 3344788999999999999977653 2445569999999995 3322        4467888999999999


Q ss_pred             CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcC
Q 048668          198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGE  259 (725)
Q Consensus       198 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  259 (725)
                      |++. ..+..+..++ .++.|++++|+++...+  +..+.+++.|++++|.+....+.....
T Consensus       242 n~~~-~~~~~~~~l~-~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         242 NKLE-DLPESIGNLS-NLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             ceee-eccchhcccc-ccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence            9987 4467777777 69999999999985444  888999999999999998776665544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.33  E-value=7.8e-13  Score=121.79  Aligned_cols=129  Identities=23%  Similarity=0.337  Sum_probs=53.7

Q ss_pred             ccCcccCcEEecCCCccCccCCcccc-CCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCC
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIG-NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSL   87 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   87 (725)
                      +.+...+++|+|++|.|+ .+. .++ .+.+|+.|+|++|+|+.+  +.+..+++|++|+|++|+|+.+.+.....+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence            445567999999999998 443 455 688999999999999854  358889999999999999996544333579999


Q ss_pred             ceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC---CcccccCccceecC
Q 048668           88 EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP---DSLSNASNLELLDL  141 (725)
Q Consensus        88 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L  141 (725)
                      +.|+|++|+|...-.-..+..+++|++|+|.+|.++....   ..+..+|+|+.||-
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            9999999999832233556789999999999999985421   13678888888774

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.31  E-value=6.7e-13  Score=146.91  Aligned_cols=141  Identities=23%  Similarity=0.260  Sum_probs=110.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHH---HHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFR---SFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++...+.+|++.|=+|.+|+++ .|. |+||++-..+ .-..+   +..+|++ ...++|||++++..+     ..+...
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence            6677789999999999999987 454 8899986554 22333   3344555 556689999987654     223346


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|-+|.. .+|+|.+..+.      -+...+.+.|+.|++.|+.-+|..   +|+|+|||.||||++.-.=+.|+||.
T Consensus        96 AylvRqyvk-hnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   96 AYLVRQYVK-HNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HHHHHHHHh-hhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence            788888884 49999998664      466777788999999999999999   99999999999999988889999997


Q ss_pred             ccc
Q 048668          689 LAK  691 (725)
Q Consensus       689 la~  691 (725)
                      .-|
T Consensus       166 sFK  168 (1431)
T KOG1240|consen  166 SFK  168 (1431)
T ss_pred             ccC
Confidence            554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.29  E-value=3.9e-13  Score=145.02  Aligned_cols=244  Identities=26%  Similarity=0.301  Sum_probs=129.1

Q ss_pred             cCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           34 GNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        34 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      ..+..++.+.+..|.+.. .-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|+|+ .+..  +..++.|+
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~-~i~~--l~~l~~L~  143 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKIT-KLEG--LSTLTLLK  143 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccc-cccc--hhhccchh
Confidence            344556666666666652 23335556667777777777763 2223666667777777777776 3332  23455577


Q ss_pred             EEEccCceeeeeCCCcccccCccceecCCCccccccCc-cCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCE
Q 048668          114 ELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVS-IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV  192 (725)
Q Consensus       114 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~  192 (725)
                      .|++++|.|+.+  ..+..+++|+.+++++|+++.+.. . ...+.+++.+++++|.+..+..        +..+..+..
T Consensus       144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~--------~~~~~~l~~  212 (414)
T KOG0531|consen  144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG--------LDLLKKLVL  212 (414)
T ss_pred             hheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc--------hHHHHHHHH
Confidence            777777777644  345556777777777777776654 2 4566667777777777765433        233344445


Q ss_pred             EECccCcccccCChhhhhccc-cceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCc
Q 048668          193 LSLSDNQFGGELPHSIANLSS-TMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKN  271 (725)
Q Consensus       193 L~L~~N~l~~~~p~~~~~l~~-~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  271 (725)
                      +++..|.++..-+-.  .... .++.+++.+|.+. ..+..+..+..+..|++..|++....  .+...+.+..+++..|
T Consensus       213 ~~l~~n~i~~~~~l~--~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~  287 (414)
T KOG0531|consen  213 LSLLDNKISKLEGLN--ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDN  287 (414)
T ss_pred             hhcccccceeccCcc--cchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHHHhccCcc
Confidence            566666665211110  0000 1344444444444 22234445556666666666665331  1333444555555555


Q ss_pred             ccccC---CCCC-CcCCCCCCEEeCCCCcCC
Q 048668          272 FLQGS---IPSG-LGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       272 ~l~~~---~~~~-~~~l~~L~~L~L~~N~l~  298 (725)
                      .+...   .... ....+.++.+.+.+|.++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
T KOG0531|consen  288 KLALSEAISQEYITSAAPTLVTLTLELNPIR  318 (414)
T ss_pred             hhcchhhhhccccccccccccccccccCccc
Confidence            54411   1111 333445555555555433

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.29  E-value=3.9e-13  Score=134.80  Aligned_cols=216  Identities=23%  Similarity=0.205  Sum_probs=138.2

Q ss_pred             cCCCCCcEEEccCCcCCccCC--CCCCCCCCCCEEEccCCcccccCc--ccccccCCCceeeccCCCCCCCCChhhhcCC
Q 048668           34 GNLSALQVIHIKGNSLGGKFP--TTLGLLRNLVQLNVAENKFYGMFP--RSICNISSLEYFYLTSNRFSGSLPFDIVVNL  109 (725)
Q Consensus        34 ~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l  109 (725)
                      +++++|+...|.++... ..+  +....+++++.||||+|-++...+  .-...|++|+.|+||.|++........-..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            35677888888888776 333  356677888888888887764332  3456778888888888887633333333357


Q ss_pred             CCccEEEccCceeeeeC-CCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCC
Q 048668          110 PNLKELGIGANNFFGLI-PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCS  188 (725)
Q Consensus       110 ~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~  188 (725)
                      +.|+.|.|+.|.++.-. ......+|+|+.|+|+.|....+......-++.|++|+|++|++-..+..     .....++
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~-----~~~~~l~  271 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQG-----YKVGTLP  271 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccc-----ccccccc
Confidence            78888888888887321 22356678888888888865455566666777888888888887654421     3456778


Q ss_pred             CCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCC-ChhhcCCCCccEEe
Q 048668          189 SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI-PDVIGELKNLQLLG  267 (725)
Q Consensus       189 ~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~  267 (725)
                      .|+.|+++.+.+...            ...+.       ..-.-...+++|+.|+++.|+|.... -..+..+++|+.|.
T Consensus       272 ~L~~Lnls~tgi~si------------~~~d~-------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~  332 (505)
T KOG3207|consen  272 GLNQLNLSSTGIASI------------AEPDV-------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR  332 (505)
T ss_pred             chhhhhccccCcchh------------cCCCc-------cchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence            888888888877632            11100       00011234566777777777775331 22345566777777


Q ss_pred             ccCcccc
Q 048668          268 LYKNFLQ  274 (725)
Q Consensus       268 L~~N~l~  274 (725)
                      ...|.+.
T Consensus       333 ~~~n~ln  339 (505)
T KOG3207|consen  333 ITLNYLN  339 (505)
T ss_pred             ccccccc
Confidence            7777766

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.4e-11  Score=116.05  Aligned_cols=130  Identities=18%  Similarity=0.148  Sum_probs=95.3

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcc-cceeeEeecCCCCCcceeeEEEecc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      +.++.|.++.||+++..  +..|++|+...... ....+.+|+++++.+.+.++ ++++.+..  .     ..++||||+
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-----~~~lv~e~i   73 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--E-----TGVLITEFI   73 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--C-----CCeEEEEec
Confidence            56889999999999874  67899998754422 22346789999999875554 45554421  1     347999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC--QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +|.++.+. .         ..    ...++.+++++++.||...  ...++|+|++|.||+++ ++.++++|||.|..
T Consensus        74 ~G~~l~~~-~---------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          74 EGSELLTE-D---------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCccccc-c---------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99877643 0         01    1235678999999999882  12359999999999999 66899999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.28  E-value=9.7e-13  Score=123.57  Aligned_cols=164  Identities=23%  Similarity=0.408  Sum_probs=124.9

Q ss_pred             CCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      ...+|.+...|+.|+|++.++  .+++|++...+  ....+.|..|.-.++-+.||||+.++|.|..+.     ...++.
T Consensus       194 l~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~is  266 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIIS  266 (448)
T ss_pred             hhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEee
Confidence            345688889999999999644  46678776543  233478899999999999999999999998775     778999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      .||+.|+|+..+++....    .++..++.+++.++++|++|||+. .|-|.---+.+..+++|++.+++|+ .+-+++-
T Consensus       267 q~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs  340 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS  340 (448)
T ss_pred             eeccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee
Confidence            999999999999987642    567889999999999999999997 4445455689999999999888775 1212211


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      -..            .+..-.|.||+||-+.
T Consensus       341 fqe------------~gr~y~pawmspealq  359 (448)
T KOG0195|consen  341 FQE------------VGRAYSPAWMSPEALQ  359 (448)
T ss_pred             eec------------cccccCcccCCHHHHh
Confidence            000            0123467899999653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.28  E-value=6.3e-13  Score=126.64  Aligned_cols=174  Identities=23%  Similarity=0.250  Sum_probs=97.0

Q ss_pred             cCcEEecCC--------CccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc---Cccc--
Q 048668           14 KLQALALAG--------NYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM---FPRS--   80 (725)
Q Consensus        14 ~l~~L~l~~--------n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~--   80 (725)
                      +|..|.++.        |-+...+|..+.-+.+|+.+.+|++.-.. +-+.-..-+.|+++...+..++..   .|.+  
T Consensus       183 ~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~  261 (490)
T KOG1259|consen  183 QLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQDVPSLLPETIL  261 (490)
T ss_pred             heeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccccccccchhhh
Confidence            455665554        33444556667777888888888887652 223333346677777766655421   1111  


Q ss_pred             ------------------ccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCC
Q 048668           81 ------------------ICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS  142 (725)
Q Consensus        81 ------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  142 (725)
                                        +..-..|++||||+|.|+ .+...+ .-+|.++.|++++|.|+.+  +.++.+++|+.||||
T Consensus       262 ~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESv-KL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS  337 (490)
T KOG1259|consen  262 ADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESV-KLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLS  337 (490)
T ss_pred             cCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhh-hhccceeEEeccccceeee--hhhhhcccceEeecc
Confidence                              001124666666666665 555443 4556666666666666644  235666666666666


Q ss_pred             CccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       143 ~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      +|.++.+.. .=..+.+.++|.|+.|.|..++.        +..+-+|..||+++|+|.
T Consensus       338 ~N~Ls~~~G-wh~KLGNIKtL~La~N~iE~LSG--------L~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  338 GNLLAECVG-WHLKLGNIKTLKLAQNKIETLSG--------LRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             cchhHhhhh-hHhhhcCEeeeehhhhhHhhhhh--------hHhhhhheeccccccchh
Confidence            666664432 22345556666666666554432        445555566666666554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=3.8e-11  Score=112.98  Aligned_cols=136  Identities=20%  Similarity=0.209  Sum_probs=98.4

Q ss_pred             cccccccceEEEEEEECC------CceEEEEEEeeccc------------c----------chHHHH----HHHHHHHHc
Q 048668          538 NMIGQGSFGSVYKGILGE------DEMIVAVKVINLKQ------------K----------GAFRSF----VAECEALRN  585 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~~  585 (725)
                      ..||.|.-+.||.|....      .+..+|||+.+...            .          ...+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998643      35789999885310            0          011223    389999999


Q ss_pred             CCC--CcccceeeEeecCCCCCcceeeEEEeccCCCCHHH-HhcccCCccccccCCHHHHHHHHHHHHHHHHHH-HhcCC
Q 048668          586 IRH--RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED-WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQ  661 (725)
Q Consensus       586 l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~  661 (725)
                      +..  -++++.+++         ...++||||+++..+.. .+++.       .++..+...+..+++.++.++ |..  
T Consensus        83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~--  144 (197)
T cd05146          83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC--  144 (197)
T ss_pred             HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            863  466677754         14579999997654421 22221       244455667789999999999 777  


Q ss_pred             CCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          662 PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       662 ~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                       +|||+|+++.||+++ ++.+.++|||.|...
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             999999999999997 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.28  E-value=8.1e-12  Score=123.93  Aligned_cols=173  Identities=23%  Similarity=0.323  Sum_probs=106.5

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCC----------CcccceeeEeec
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRH----------RNLIKIITICSS  600 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~  600 (725)
                      ....+.||.|+++.||.+++.++++.+|+|+.....   ....+++.+|.-....+.+          -.++--++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999999999999999986543   2345667776655544322          122222222211


Q ss_pred             CC---C------CCcc---eeeEEEeccCCCCHHHHhcc---cCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          601 TD---F------KGVD---FKALVFEYMGNGSLEDWLHQ---SNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       601 ~~---~------~~~~---~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                      ..   +      ....   ..+++|+-+ .+||.+++..   ....  ........+..+..|+++.++++|+.   |++
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV  167 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GLV  167 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence            10   0      0000   235677777 5588888653   2211  11234455667779999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+||||+|++++.+|.++++||+......+....           ...+..|.|||..
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~  214 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELE  214 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhh
Confidence            9999999999999999999999977654332110           1245778899853

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.26  E-value=8.8e-13  Score=132.29  Aligned_cols=190  Identities=23%  Similarity=0.251  Sum_probs=92.8

Q ss_pred             CcccCcEEecCCCccCccCC--ccccCCCCCcEEEccCCcCCccCC--CCCCCCCCCCEEEccCCcccccCcc-cccccC
Q 048668           11 SLFKLQALALAGNYLTGKLP--DFIGNLSALQVIHIKGNSLGGKFP--TTLGLLRNLVQLNVAENKFYGMFPR-SICNIS   85 (725)
Q Consensus        11 ~l~~l~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~   85 (725)
                      +++.|++..|.++... ..+  .....+++++.||||+|-+....|  ....++++|+.|+||.|++...... .-..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            3455566666665554 222  244555666666666665542211  2234455666666666655422111 112345


Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCc-cCcccccccCeee
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVS-IDFSSLKILWRLN  164 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~  164 (725)
                      +|+.|.|+.|.++..--.......|+|+.|+|..|....+......-+..|++|||++|++..... .....++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            566666666665511111223455666666666664332333344445556666666666544331 1234455555566


Q ss_pred             cCCccCCccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          165 LEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       165 L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      ++.+.+..+...+.+..+-....++|++|+++.|+|.
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            6666555554433332233344555555555555554

>PLN03150 hypothetical protein; Provisional

Probab=99.22  E-value=1.7e-11  Score=138.23  Aligned_cols=112  Identities=34%  Similarity=0.506  Sum_probs=104.1

Q ss_pred             cceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCC
Q 048668          323 SLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC  402 (725)
Q Consensus       323 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  402 (725)
                      +..|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            36799999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCcccccCC-CCCCeEEcccccCeeecC
Q 048668          403 NNFSGQFPKFLENL-SFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       403 N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p  434 (725)
                      |+++|.+|..+..+ .++..+++++|+..|..|
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC
Confidence            99999999998764 467899999998766554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=1.4e-12  Score=124.35  Aligned_cols=133  Identities=23%  Similarity=0.261  Sum_probs=71.8

Q ss_pred             cCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           34 GNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        34 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      ..+.-|+.||||+|.|+ .+-++..-++.++.|++|+|.|..+..  ++.+++|+.||||+|.++ .+... -..+-|++
T Consensus       281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gw-h~KLGNIK  355 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGW-HLKLGNIK  355 (490)
T ss_pred             chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhh-HhhhcCEe
Confidence            33444555666666555 444445555556666666666553222  555556666666666555 33211 12455666


Q ss_pred             EEEccCceeeeeCCCcccccCccceecCCCccccccCc-cCcccccccCeeecCCccCCcc
Q 048668          114 ELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVS-IDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus       114 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      .|.|+.|.|..+  ..+..+-+|..||+++|+|..... ..+++++.|+.+.|.+|.+..+
T Consensus       356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            666666666533  345555666666666666654322 3455666666666666666543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.19  E-value=8.4e-12  Score=138.25  Aligned_cols=143  Identities=30%  Similarity=0.459  Sum_probs=97.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..+|..++.|..|+||.||.++++.+.+.+|+|+ .++.-           +++     ||..+-+           ..+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----------ilR-----nilt~a~-----------npf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----------ILR-----NILTFAG-----------NPF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----------hhh-----ccccccC-----------Ccc
Confidence            4578899999999999999999999999999943 32210           111     1332211           223


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|      ||-...++..+      .++.        +.+.+++|+|+.   +|+|||+||+|.+|..-|.+|+.|||++
T Consensus       134 vv------gDc~tllk~~g------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIG------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ee------chhhhhcccCC------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence            33      45555554433      2332        227899999998   9999999999999999999999999999


Q ss_pred             cccccC--------CCCCCCCCCcccccccCCccccCCCcccC
Q 048668          691 KFLSSH--------HLDTSSKTPSSSIGIKGTVGYVAPGKFFM  725 (725)
Q Consensus       691 ~~~~~~--------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  725 (725)
                      +.....        +..... ..-...+.||||.|+|||++++
T Consensus       191 k~GLms~atnl~eg~I~k~t-~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDT-HEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hhhhhhccchhhhcchHHHH-HHhhhccccCCccccChhhhhh
Confidence            864211        111100 0112345799999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.17  E-value=4.9e-12  Score=130.82  Aligned_cols=179  Identities=23%  Similarity=0.305  Sum_probs=115.4

Q ss_pred             CCCcccccccceEEEEEEECCC---ceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceee-----E--eecCCCC
Q 048668          535 SSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIIT-----I--CSSTDFK  604 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-----~--~~~~~~~  604 (725)
                      .+.+..+..+++.++..+-...   ..+++.+..+.++........+++-.+.-..|.+..-+.+     +  +......
T Consensus       247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~  326 (516)
T KOG1033|consen  247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVG  326 (516)
T ss_pred             cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccc
Confidence            3344555566666554443222   3344444443333222334445555555555544443333     1  1111111


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                      ...+.|+.|++|...+|.+|+......   ...++.....++.|++.|++|   +   +.+|||+||.||++..+..+||
T Consensus       327 ~~~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  327 KKVYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             cccchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhh
Confidence            123689999999999999999755421   246778889999999999999   5   8999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .|||+........  +........+..+||..||+||++-
T Consensus       398 gDFgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~  435 (516)
T KOG1033|consen  398 GDFGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIR  435 (516)
T ss_pred             hhhhheeecccCC--cccchhhhhhhcccccccCCHHHHh
Confidence            9999987654432  1112223344578999999999873

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.17  E-value=1e-12  Score=128.46  Aligned_cols=209  Identities=22%  Similarity=0.219  Sum_probs=121.5

Q ss_pred             cccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCC
Q 048668          182 TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELK  261 (725)
Q Consensus       182 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  261 (725)
                      +++...++|++||||+|.+.-..+..+..+.                     ..++.|++|.|.+|.+...-...++.  
T Consensus        86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll---------------------~s~~~L~eL~L~N~Glg~~ag~~l~~--  142 (382)
T KOG1909|consen   86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELL---------------------SSCTDLEELYLNNCGLGPEAGGRLGR--  142 (382)
T ss_pred             HHHhcCCceeEeeccccccCccchHHHHHHH---------------------HhccCHHHHhhhcCCCChhHHHHHHH--
Confidence            4466777899999999988755555555443                     34677888888888876333233222  


Q ss_pred             CccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCC----Cc
Q 048668          262 NLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG----SL  337 (725)
Q Consensus       262 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~----~~  337 (725)
                      .|..|.  .|+..       ..-+.|+.++.+.|++..        .....-...++....+..+.++.|.|..    ..
T Consensus       143 al~~l~--~~kk~-------~~~~~Lrv~i~~rNrlen--------~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al  205 (382)
T KOG1909|consen  143 ALFELA--VNKKA-------ASKPKLRVFICGRNRLEN--------GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTAL  205 (382)
T ss_pred             HHHHHH--HHhcc-------CCCcceEEEEeecccccc--------ccHHHHHHHHHhccccceEEEecccccCchhHHH
Confidence            222222  22211       223466666666666551        1111111222222223455555555531    12


Q ss_pred             chhhhcCCCCCeEEccCcccccc----CccccccccCCcEEEccCCccccccCccc-----cCCCCCCEEeCCCCcccc-
Q 048668          338 PQQVGNLKNLIILDISSNQFSGM----IPVTLSTCVSLEYVDISSNCFHGIIPPSL-----GFLKSIKFLDVSCNNFSG-  407 (725)
Q Consensus       338 ~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~-  407 (725)
                      ...|..+++|+.|||.+|-++..    ...+++.+++|+.|++++|.++..-..+|     ...++|+.|.|.+|.++. 
T Consensus       206 ~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~d  285 (382)
T KOG1909|consen  206 AEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRD  285 (382)
T ss_pred             HHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHH
Confidence            34567778888888888887632    23556677788888888887764433333     235778888888888763 


Q ss_pred             ---cCcccccCCCCCCeEEcccccCe
Q 048668          408 ---QFPKFLENLSFLEFLNLSYNHLE  430 (725)
Q Consensus       408 ---~~p~~~~~l~~L~~L~l~~N~l~  430 (725)
                         .+-......+.|.+|+|++|.+.
T Consensus       286 a~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  286 AALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHHHHhcchhhHHhcCCccccc
Confidence               22333445677788888888773

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.15  E-value=4.6e-12  Score=136.69  Aligned_cols=152  Identities=27%  Similarity=0.251  Sum_probs=121.1

Q ss_pred             CCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEE
Q 048668           36 LSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL  115 (725)
Q Consensus        36 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  115 (725)
                      .+.++.++..++.+....-. ...+..++.+++..|.|.. +-..+..+.+|+.|++.+|+|. .+... ...+++|++|
T Consensus        48 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~-l~~~~~L~~L  123 (414)
T KOG0531|consen   48 PSDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENL-LSSLVNLQVL  123 (414)
T ss_pred             cchhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccc-hhhhhcchhe
Confidence            45667777777776533222 2567888888999999973 4556888999999999999998 55542 3579999999


Q ss_pred             EccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEEC
Q 048668          116 GIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSL  195 (725)
Q Consensus       116 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L  195 (725)
                      +|++|+|+.+.  .+..++.|+.|++++|.|+.+.  .|..+.+|+.+++++|.+..+...     . ...+.+++.+++
T Consensus       124 ~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~~--~~~~l~~L~~l~l~~n~i~~ie~~-----~-~~~~~~l~~l~l  193 (414)
T KOG0531|consen  124 DLSFNKITKLE--GLSTLTLLKELNLSGNLISDIS--GLESLKSLKLLDLSYNRIVDIEND-----E-LSELISLEELDL  193 (414)
T ss_pred             ecccccccccc--chhhccchhhheeccCcchhcc--CCccchhhhcccCCcchhhhhhhh-----h-hhhccchHHHhc
Confidence            99999999774  4777888999999999999764  466699999999999999876541     1 256789999999


Q ss_pred             ccCccc
Q 048668          196 SDNQFG  201 (725)
Q Consensus       196 ~~N~l~  201 (725)
                      .+|.+.
T Consensus       194 ~~n~i~  199 (414)
T KOG0531|consen  194 GGNSIR  199 (414)
T ss_pred             cCCchh
Confidence            999987

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=2.2e-12  Score=126.11  Aligned_cols=254  Identities=21%  Similarity=0.261  Sum_probs=154.5

Q ss_pred             ccCcccCcEEecCCCccCcc----CCccccCCCCCcEEEccCC---cCCccCCCC-------CCCCCCCCEEEccCCccc
Q 048668            9 IGSLFKLQALALAGNYLTGK----LPDFIGNLSALQVIHIKGN---SLGGKFPTT-------LGLLRNLVQLNVAENKFY   74 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n---~l~~~~~~~-------~~~l~~L~~L~Ls~N~l~   74 (725)
                      +-.+..++.++||+|.|...    +-+.+.+.++|+.-++|+-   ++...+|++       +...++|++||||.|.+.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            44566778888888877632    3345667777777777763   333333433       344557777788777775


Q ss_pred             ccCccc----ccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccC
Q 048668           75 GMFPRS----ICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKV  150 (725)
Q Consensus        75 ~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~  150 (725)
                      ...+..    ++++..|++|+|.+|.+. ......+.  ..|+.|.  .|       ....+-+.|+.+..++|++..-+
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~--~al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~g  173 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLG--RALFELA--VN-------KKAASKPKLRVFICGRNRLENGG  173 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHH--HHHHHHH--HH-------hccCCCcceEEEEeecccccccc
Confidence            333333    445667777777777764 33222211  0111111  11       11233456777777777776443


Q ss_pred             c----cCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccce
Q 048668          151 S----IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS  226 (725)
Q Consensus       151 ~----~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~  226 (725)
                      .    ..|...+.|+.+.+..|.|..-..  ......+..+++|++|||.+|.++......+                  
T Consensus       174 a~~~A~~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~L------------------  233 (382)
T KOG1909|consen  174 ATALAEAFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVAL------------------  233 (382)
T ss_pred             HHHHHHHHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHHH------------------
Confidence            3    245556677777777777753322  1122457788999999999998884322222                  


Q ss_pred             eccCcccccccCCceEEecccccCCCCChhh-----cCCCCccEEeccCcccccC----CCCCCcCCCCCCEEeCCCCcC
Q 048668          227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVI-----GELKNLQLLGLYKNFLQGS----IPSGLGNLTKLAKLDLGSNSL  297 (725)
Q Consensus       227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  297 (725)
                         ...+..+++|++|+++++.+......+|     ...+.|++|.|.+|.|+..    +...+...+.|..|+|++|++
T Consensus       234 ---akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  234 ---AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ---HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence               2334556778888888888865433322     3357899999999988732    222344578899999999987

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=1e-11  Score=137.79  Aligned_cols=176  Identities=27%  Similarity=0.352  Sum_probs=133.8

Q ss_pred             hcCCCCCcccccccceEEEEEEEC-CCceEEEEEEeeccc--cchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG-EDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  606 (725)
                      ...|...+.||+|+|+.|-.+... .....+|+|.+....  .....+...|..+=..+. |+|++++++......    
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~----   94 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR----   94 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc----
Confidence            345777788999999999887763 344567777776543  233445556777777777 999999998866554    


Q ss_pred             ceeeEEEeccCCCCHHHHh-cccCCccccccCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEecCCCCCCeeecCCC-ceE
Q 048668          607 DFKALVFEYMGNGSLEDWL-HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDM-VAH  683 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~ivHrdlkp~Nill~~~~-~~k  683 (725)
                       ..++++||..|+++.+.+ +....     ..+......+..|+..++.|+| +.   ++.|||+||+|.+++..+ ..|
T Consensus        95 -~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~  165 (601)
T KOG0590|consen   95 -SYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK  165 (601)
T ss_pred             -ccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence             789999999999999888 43221     3455666788999999999999 77   999999999999999999 999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccC-CccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKG-TVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~  724 (725)
                      ++|||+|..+....     .........+| ++.|+|||...
T Consensus       166 ~~df~~At~~~~~~-----g~~~~~~~~~g~s~~y~a~E~~~  202 (601)
T KOG0590|consen  166 IADFGLATAYRNKN-----GAERSLKDRCGSSPPYGAPEHLS  202 (601)
T ss_pred             CCCchhhccccccC-----CcceeeecccCCCCCCCCccccc
Confidence            99999998765411     11122233578 99999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=4.8e-10  Score=101.25  Aligned_cols=130  Identities=27%  Similarity=0.341  Sum_probs=95.7

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccc--------cchHHHHHHHHHHHHcCCCCcc--cceeeEeecCCCCCcc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNL--IKIITICSSTDFKGVD  607 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~  607 (725)
                      ..+++|+-+.+|.+.+.  |.++++|.=..+.        +-..++-.+|++++++++--.|  +.++++  ++.     
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~-----   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD-----   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC-----
Confidence            46789999999999773  4446666432221        1123466789999999875444  344443  222     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ...++|||++|..|.+++...             ...++..|-.-+.-||..   +|+|+|+.++||++..+. +.++||
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            457999999999999988753             145667788888899999   999999999999998775 999999


Q ss_pred             cccccc
Q 048668          688 GLAKFL  693 (725)
Q Consensus       688 gla~~~  693 (725)
                      |++.+-
T Consensus       136 GLg~~s  141 (204)
T COG3642         136 GLGEFS  141 (204)
T ss_pred             Cccccc
Confidence            999753

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.08  E-value=8.3e-11  Score=89.12  Aligned_cols=60  Identities=25%  Similarity=0.465  Sum_probs=33.1

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCC
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRF   97 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l   97 (725)
                      +|++|++++|+|+.+.+++|.++++|++|++++|+|+.+.+.+|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555555555555555555555555555555555555555555555555543

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.07  E-value=8.2e-11  Score=89.14  Aligned_cols=59  Identities=44%  Similarity=0.691  Sum_probs=28.0

Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcc
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ  145 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~  145 (725)
                      +|++|++++|+|+ .+|.++|.++++|++|++++|+|+.+.+++|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            3444444444444 4444444444444444444444444444444444444444444444

...

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=1.4e-09  Score=97.57  Aligned_cols=143  Identities=23%  Similarity=0.270  Sum_probs=101.6

Q ss_pred             CCcccccccceEEEEEEECCCceEEEEEEeeccc--------cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ....+-||+-+.|+++.+  .|+.+.||.-..+.        +-..++..+|++.+.++.--.|.-..-++.+..     
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence            567889999999999998  56667777543221        112456789999999987444432222222221     


Q ss_pred             eeeEEEeccCC-CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---ceE
Q 048668          608 FKALVFEYMGN-GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---VAH  683 (725)
Q Consensus       608 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~---~~k  683 (725)
                      .-.++|||++| -++.+++......    .........++.+|-+.+.-||..   +|+|+||..+||++..++   .+.
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence            34699999977 4788888765422    122223367889999999999999   999999999999997765   358


Q ss_pred             Ecccccccc
Q 048668          684 VGDFGLAKF  692 (725)
Q Consensus       684 l~Dfgla~~  692 (725)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.06  E-value=2.6e-10  Score=107.92  Aligned_cols=77  Identities=22%  Similarity=0.267  Sum_probs=65.0

Q ss_pred             CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCC
Q 048668          619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL  698 (725)
Q Consensus       619 g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~  698 (725)
                      |+|.++++....     .+++.+++.|+.||+.||+|||++   +      ||+||+++.++.+|+  ||.++...... 
T Consensus         1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence            689999976432     589999999999999999999998   5      999999999999999  99998653310 


Q ss_pred             CCCCCCCcccccccCCccccCCCccc
Q 048668          699 DTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       699 ~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                                  ..||+.|||||++.
T Consensus        64 ------------~~g~~~y~aPE~~~   77 (176)
T smart00750       64 ------------SRVDPYFMAPEVIQ   77 (176)
T ss_pred             ------------CCCcccccChHHhc
Confidence                        24899999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=1.3e-09  Score=107.56  Aligned_cols=145  Identities=23%  Similarity=0.282  Sum_probs=107.3

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCC--CcccceeeEeecCCCCCcceeeEEEe
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRH--RNLIKIITICSSTDFKGVDFKALVFE  614 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e  614 (725)
                      +.++.|..+.||++... +|+.+++|+...... ....++.+|+++++.+.+  ..+++++.+.....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999875 357899999865432 134578899999999975  34677777654322  1124589999


Q ss_pred             ccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 048668          615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC----------------------------------  660 (725)
Q Consensus       615 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----------------------------------  660 (725)
                      |++|+++.+.+.. .      .+++.+...++.++++++.++|+..                                  
T Consensus        81 ~i~G~~l~~~~~~-~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          81 RVDGRVLRDRLLR-P------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EeCCEecCCCCCC-C------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            9999888775431 1      3566667777888888888888521                                  


Q ss_pred             -------------------CCCcEecCCCCCCeeecC--CCceEEcccccccc
Q 048668          661 -------------------QPPMVHGDLKPSNVLLDH--DMVAHVGDFGLAKF  692 (725)
Q Consensus       661 -------------------~~~ivHrdlkp~Nill~~--~~~~kl~Dfgla~~  692 (725)
                                         ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               235799999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=2e-08  Score=100.25  Aligned_cols=146  Identities=14%  Similarity=0.057  Sum_probs=100.6

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccccc-----------hHHHHHHHHHHHHcCCCCcc--cceeeEeecCCCC
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----------AFRSFVAECEALRNIRHRNL--IKIITICSSTDFK  604 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~  604 (725)
                      +.+-+.....|+++..  .|+.|.||........           ....+.+|++.+.++...+|  ++.+++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4455444555777766  5678999976432211           11247899999988854443  3445554322111


Q ss_pred             CcceeeEEEeccCCC-CHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----
Q 048668          605 GVDFKALVFEYMGNG-SLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-----  678 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-----  678 (725)
                      .....++|||++++. +|.+++.....    ...+......++.+++..+.-||..   ||+|+|+++.|||++.     
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence            123468999999886 89999864221    1345566778999999999999999   9999999999999985     


Q ss_pred             --CCceEEcccccccc
Q 048668          679 --DMVAHVGDFGLAKF  692 (725)
Q Consensus       679 --~~~~kl~Dfgla~~  692 (725)
                        ++.+.++||+-++.
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46799999998854

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.88  E-value=1.1e-09  Score=126.18  Aligned_cols=105  Identities=28%  Similarity=0.415  Sum_probs=60.9

Q ss_pred             cCcEEecCCCc--cCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           14 KLQALALAGNY--LTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        14 ~l~~L~l~~n~--l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      .|++|-+..|.  +.......|..++.|++|||++|.=-+.+|..++.+-+|++|+|++..|+ .+|..+++|..|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            46666666664  44233344666666666666665444466666666666666666666665 5666666666666666


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCc
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGAN  120 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N  120 (725)
                      +..+.-...+ .++...|++|++|.+..-
T Consensus       625 l~~~~~l~~~-~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  625 LEVTGRLESI-PGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccccccccc-cchhhhcccccEEEeecc
Confidence            6666543222 344455666666666443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.88  E-value=2e-09  Score=114.07  Aligned_cols=122  Identities=32%  Similarity=0.507  Sum_probs=97.5

Q ss_pred             HHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 048668          583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQP  662 (725)
Q Consensus       583 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~  662 (725)
                      |+.+.|.|+.+++|.+..+.     ..++|.+||.-|+|.|.+.....     .+++.-...++++++.|++|+|+-   
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s---   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNS---   67 (484)
T ss_pred             CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcC---
Confidence            35788999999999998774     78899999999999999987432     688888899999999999999987   


Q ss_pred             Cc-EecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          663 PM-VHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       663 ~i-vHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +| .|+.+++.|.++|..+.+|++|||+.....+. ....     ......-..-|.|||.+
T Consensus        68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~-~~~~-----~~~~~~~~~lw~aPell  123 (484)
T KOG1023|consen   68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET-AEPE-----AHHPIRKALLWTAPELL  123 (484)
T ss_pred             cceeeeeeccccceeeeeEEEEechhhhccccccc-cccc-----ccchhHHHHhccCHHHh
Confidence            55 99999999999999999999999998766430 0000     00111234568999975

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.88  E-value=9.2e-10  Score=126.76  Aligned_cols=131  Identities=24%  Similarity=0.284  Sum_probs=77.2

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCc--CCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCC
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNS--LGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSL   87 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   87 (725)
                      .+....+++.+-+|.+. .++....+ +.|++|-+.+|.  +..+.++.|..++.|++|||++|.=-+.+|..+++|-+|
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            33455666666666665 44444433 256666666665  443444456666777777777664334666666666667


Q ss_pred             ceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCc
Q 048668           88 EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN  144 (725)
Q Consensus        88 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N  144 (725)
                      ++|+|++..++ .+|.++ .++..|.+|++..+.-...+|+....+++|++|.+-.-
T Consensus       598 ryL~L~~t~I~-~LP~~l-~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGL-GNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             hcccccCCCcc-ccchHH-HHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            77777766666 666553 45666666666655554444555555666666655443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=1.7e-08  Score=94.82  Aligned_cols=125  Identities=26%  Similarity=0.282  Sum_probs=81.0

Q ss_pred             EEEEEEECCCceEEEEEEeeccc--------------c-------c-----hHHHHHHHHHHHHcCCCC--cccceeeEe
Q 048668          547 SVYKGILGEDEMIVAVKVINLKQ--------------K-------G-----AFRSFVAECEALRNIRHR--NLIKIITIC  598 (725)
Q Consensus       547 ~V~~~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~h~--niv~l~~~~  598 (725)
                      .||.|... +|..||+|+.+...              .       .     ......+|++.|.++..-  ++++.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999875 67899999885310              0       0     113457899999999855  567777551


Q ss_pred             ecCCCCCcceeeEEEeccC--CCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEecCCCCCCee
Q 048668          599 SSTDFKGVDFKALVFEYMG--NGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVL  675 (725)
Q Consensus       599 ~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~ivHrdlkp~Nil  675 (725)
                               ..++||||++  |..+.......        ++......++.+++..+..+ |..   +|+|+|+.+.||+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl  139 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL  139 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred             ---------CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence                     3479999998  54454433221        11223456677888866664 677   9999999999999


Q ss_pred             ecCCCceEEccccccccc
Q 048668          676 LDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       676 l~~~~~~kl~Dfgla~~~  693 (725)
                      ++.+ .+.|+|||.|...
T Consensus       140 v~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             EETT-CEEE--GTTEEET
T ss_pred             eecc-eEEEEecCcceec
Confidence            9988 9999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.83  E-value=2.7e-09  Score=113.01  Aligned_cols=174  Identities=27%  Similarity=0.299  Sum_probs=131.0

Q ss_pred             CCCCCccccc--ccceEEEEEEE--CCCceEEEEEEeec--cccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCC
Q 048668          533 EFSSSNMIGQ--GSFGSVYKGIL--GEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKG  605 (725)
Q Consensus       533 ~~~~~~~ig~--G~~g~V~~~~~--~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  605 (725)
                      .|...+.+|.  |.+|.||.+..  +.++..+|+|.-+.  .......+=.+|+..-++++ |++.++.+..+.     +
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-----~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-----G  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-----c
Confidence            4566778999  99999999998  88899999998432  22222233356777777776 999998666544     4


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEecCCCCCCeeecCC-C
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS----AIEYLHHHCQPPMVHGDLKPSNVLLDHD-M  680 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~ivHrdlkp~Nill~~~-~  680 (725)
                      .+..|+=+|++ +.++.++.+....     .++....+.+..+..+    |+.++|+.   +++|-|+||+||+...+ .
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence            45888999988 5788888775432     3777888888888888    99999999   99999999999999999 8


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ..+..|||+...+.+........   ......|...|++||..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~---~~~r~~~~~~Y~~ke~~  300 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFK---VSKRPEGDCIYAAKELL  300 (524)
T ss_pred             eeecCCcceeEEccCCcccccee---eeecCCCCceEeChhhh
Confidence            89999999998876654221111   11222477889999974

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=5.8e-10  Score=108.31  Aligned_cols=103  Identities=24%  Similarity=0.479  Sum_probs=88.2

Q ss_pred             HHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc
Q 048668          580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH  659 (725)
Q Consensus       580 ~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  659 (725)
                      ...+-++.|.|+|+++.||.+..++......++.|||+.|++.++|++....  ...+......+|+.||..||.|||+.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            4456667799999999999888776677788999999999999999875432  23577778889999999999999996


Q ss_pred             CCCCcEecCCCCCCeeecCCCceEEc
Q 048668          660 CQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       660 ~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                       .|+|+|+++..+.|++..+|-+||.
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEec
Confidence             7899999999999999999998875

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.79  E-value=2.9e-10  Score=120.91  Aligned_cols=126  Identities=27%  Similarity=0.277  Sum_probs=100.7

Q ss_pred             ceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCC
Q 048668          324 LYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCN  403 (725)
Q Consensus       324 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  403 (725)
                      ...+.++|.++ .+...+.-++.|+.|||++|+++...  .+..++.|+.|||++|+++.+.--...++. |+.|.|+||
T Consensus       167 ~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN  242 (1096)
T KOG1859|consen  167 ATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNN  242 (1096)
T ss_pred             hhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeeccc
Confidence            45788899998 66788888999999999999998544  788899999999999999854444445566 999999999


Q ss_pred             cccccCcccccCCCCCCeEEcccccCeeecCC--CCccCCCCCcCccCCccccC
Q 048668          404 NFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT--KGVFSNKSKIPLQGNVRLCG  455 (725)
Q Consensus       404 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~~~~~~~~~~~n~~~c~  455 (725)
                      .++...  .+.+|++|+.|||++|.|++--.-  .+.+..+..++++|||.-|.
T Consensus       243 ~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  243 ALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             HHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            997433  567899999999999988754322  24567788899999986664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.78  E-value=3.8e-08  Score=94.57  Aligned_cols=136  Identities=26%  Similarity=0.241  Sum_probs=97.8

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----------------cc-----hHHHHHHHHHHHHcCCCC--
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----------------KG-----AFRSFVAECEALRNIRHR--  589 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~E~~~l~~l~h~--  589 (725)
                      ..++..||.|.-+.||.|.+. .|.++|||.=+...                 ..     ......+|.++|.++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345678999999999999986 78899999654210                 00     123467899999999754  


Q ss_pred             cccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 048668          590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL  669 (725)
Q Consensus       590 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl  669 (725)
                      .|++.+++         +..++||||++|-.|...-           +.....-.++..|++-+.-.-..   ||||+|+
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDl  228 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDL  228 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence            66766654         3678999999987665432           11222334445555555555555   9999999


Q ss_pred             CCCCeeecCCCceEEccccccccc
Q 048668          670 KPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       670 kp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      .+=||+++++|.+.++||--+...
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             chheEEEecCCCEEEEeCcccccC
Confidence            999999999999999999876543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.73  E-value=7.6e-08  Score=99.71  Aligned_cols=148  Identities=15%  Similarity=0.161  Sum_probs=116.2

Q ss_pred             ceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCC-CCHHH
Q 048668          545 FGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGN-GSLED  623 (725)
Q Consensus       545 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~  623 (725)
                      -.+.|+|....+|..|++|+++..+.........-++.++++.|+|||++.+++....|.+ ...++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D-~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGD-LSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCc-ceEEEEEecCCCCchHHH
Confidence            3578999998899999999995443333323345578899999999999999887555443 367899999986 57877


Q ss_pred             HhcccCCc---------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          624 WLHQSNDQ---------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       624 ~l~~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                      +.-.....         ......++...|.++.|+..||.++|+.   |..-+-+.|.+|+++.+.+++|+.-|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            65432221         1234578899999999999999999999   99999999999999999999999998877665


Q ss_pred             cC
Q 048668          695 SH  696 (725)
Q Consensus       695 ~~  696 (725)
                      ..
T Consensus       445 ~d  446 (655)
T KOG3741|consen  445 ED  446 (655)
T ss_pred             CC
Confidence            44

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.69  E-value=7.7e-08  Score=103.08  Aligned_cols=126  Identities=19%  Similarity=0.236  Sum_probs=101.2

Q ss_pred             EEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccC
Q 048668          550 KGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN  629 (725)
Q Consensus       550 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  629 (725)
                      .|..+.++.+|.|...+...........+-++.++.++||+|++++..+...     +..|+|+|.+.  .|..++++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~--Pl~~~lk~l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVR--PLETVLKELG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeeccc--cHHHHHHHhH
Confidence            4566678889999988765553345567788999999999999999875443     48899999884  6777776543


Q ss_pred             CccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       630 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                               .....--+.||+.||.|||+.|  +++|+++.-..|+++..|..||++|-.+...
T Consensus       103 ---------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  103 ---------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             ---------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence                     3445556789999999999775  8999999999999999999999999877543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=4e-10  Score=119.90  Aligned_cols=128  Identities=27%  Similarity=0.282  Sum_probs=68.1

Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeec
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNL  165 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L  165 (725)
                      .|...+.+.|++. .+... +.-++.|+.|+|++|+++...  .+..++.|.+|||++|++..++.-...+.. |..|.+
T Consensus       165 ~L~~a~fsyN~L~-~mD~S-Lqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDES-LQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHH-HHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeee
Confidence            3555566666664 33322 244556666666666665442  556666666666666666655544444443 666666


Q ss_pred             CCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccce
Q 048668          166 EQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS  226 (725)
Q Consensus       166 ~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~  226 (725)
                      ++|.++.+..        +.++.+|+.||+++|-|.+.-.-.+--..+.|+.|+|.+|.+.
T Consensus       240 rnN~l~tL~g--------ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALTTLRG--------IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHHhhhh--------HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            6666654433        4456666666666665553222111111124555555555554

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=5.3e-07  Score=85.04  Aligned_cols=144  Identities=18%  Similarity=0.116  Sum_probs=103.7

Q ss_pred             ccccccceEEEEEEECCCceEEEEEEeecc---c---cchHHHHHHHHHHHHcCCCC--cccceeeEeecCCCCCcceee
Q 048668          539 MIGQGSFGSVYKGILGEDEMIVAVKVINLK---Q---KGAFRSFVAECEALRNIRHR--NLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~  610 (725)
                      --|+|+.+.|++....  |+.+=+|.-.-.   .   +.....|.+|+..+.++...  .+++.. ++...........+
T Consensus        25 N~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~  101 (216)
T PRK09902         25 NYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL  101 (216)
T ss_pred             CcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence            3467899999998764  345778876411   0   22446899999999998632  245555 33222222233568


Q ss_pred             EEEeccCC-CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc--eEEccc
Q 048668          611 LVFEYMGN-GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--AHVGDF  687 (725)
Q Consensus       611 lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~--~kl~Df  687 (725)
                      ||+|-++| .+|.+++.+...    ...+......+..+|+.+++-||+.   ++.|+|+-+.||+++.++.  ++++||
T Consensus       102 LVTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEh
Confidence            99998754 589999865431    1356677788999999999999999   9999999999999987666  999999


Q ss_pred             ccccc
Q 048668          688 GLAKF  692 (725)
Q Consensus       688 gla~~  692 (725)
                      --++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            87654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.59  E-value=3.8e-08  Score=104.46  Aligned_cols=150  Identities=24%  Similarity=0.247  Sum_probs=115.8

Q ss_pred             HHhcCCCCCcccccccceEEEEEEEC-CCceEEEEEEeeccccchH--HHHHHHHHHHHcCC-CCcccceeeEeecCCCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILG-EDEMIVAVKVINLKQKGAF--RSFVAECEALRNIR-HRNLIKIITICSSTDFK  604 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  604 (725)
                      ....+|.....||.|.|+.|+.+..+ .++..||+|.....-....  ..-..|+.+...+. |.+++.++..|..-   
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---  338 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---  338 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence            34557888899999999999988765 6788899997754322221  22346777777765 88888876554433   


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CceE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAH  683 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~~k  683 (725)
                        ...|+=-|||++++....+.-.      ..+.+..++++..|++.++.++|+.   .++|+|+||+||++..+ +..+
T Consensus       339 --r~~~ip~e~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  339 --RQGYIPLEFCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             --ccccCchhhhcCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence              2667889999999987776322      2577888899999999999999988   99999999999999986 7889


Q ss_pred             Ecccccccc
Q 048668          684 VGDFGLAKF  692 (725)
Q Consensus       684 l~Dfgla~~  692 (725)
                      +.|||.+..
T Consensus       408 ~~~~~~~t~  416 (524)
T KOG0601|consen  408 LGDFGCWTR  416 (524)
T ss_pred             ccccccccc
Confidence            999998863

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=5.6e-07  Score=87.11  Aligned_cols=110  Identities=26%  Similarity=0.280  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHHcCCCC--cccceeeEeecCCCCCcceeeEEEeccCCC-CHHHHhcccCCccccccCCHHHHHHHHHHHH
Q 048668          574 RSFVAECEALRNIRHR--NLIKIITICSSTDFKGVDFKALVFEYMGNG-SLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA  650 (725)
Q Consensus       574 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~  650 (725)
                      .++.+|.+.+.++...  .+++.+++...... .....++|+|++++. +|.+++....      ..+......++.+++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA  128 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence            4677888888887533  34566666544321 123568999999884 8999987643      244556778999999


Q ss_pred             HHHHHHHhcCCCCcEecCCCCCCeeecCCC---ceEEccccccccc
Q 048668          651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---VAHVGDFGLAKFL  693 (725)
Q Consensus       651 ~~l~~lH~~~~~~ivHrdlkp~Nill~~~~---~~kl~Dfgla~~~  693 (725)
                      ..++-||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999   999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.48  E-value=6.2e-09  Score=88.34  Aligned_cols=128  Identities=23%  Similarity=0.285  Sum_probs=69.3

Q ss_pred             CcEEecCCCccCccCCcc---ccCCCCCcEEEccCCcCCccCCCCCCC-CCCCCEEEccCCcccccCcccccccCCCcee
Q 048668           15 LQALALAGNYLTGKLPDF---IGNLSALQVIHIKGNSLGGKFPTTLGL-LRNLVQLNVAENKFYGMFPRSICNISSLEYF   90 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L   90 (725)
                      +-.++|+.|++- .++++   +....+|+..+|++|.++ ..|..|.. .+.+++|+|++|+|+ .+|..+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            445666666654 44443   334455555566666665 44554543 346666666666665 455556666666666


Q ss_pred             eccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccc
Q 048668           91 YLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus        91 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      +++.|.+. ..|.-++. +.++-.|+..+|.+..+.-+.| .-+..-..++.++.+.+
T Consensus       106 Nl~~N~l~-~~p~vi~~-L~~l~~Lds~~na~~eid~dl~-~s~~~al~~lgnepl~~  160 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAP-LIKLDMLDSPENARAEIDVDLF-YSSLPALIKLGNEPLGD  160 (177)
T ss_pred             ccccCccc-cchHHHHH-HHhHHHhcCCCCccccCcHHHh-ccccHHHHHhcCCcccc
Confidence            66666665 55544433 6666666666666654433322 22223333445555543

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.45  E-value=2.1e-08  Score=96.31  Aligned_cols=196  Identities=17%  Similarity=0.188  Sum_probs=95.3

Q ss_pred             CCCCCEEEccCCcccc--cCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC-CcccccCcc
Q 048668           60 LRNLVQLNVAENKFYG--MFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNASNL  136 (725)
Q Consensus        60 l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L  136 (725)
                      .+.++.|||.+|+|+.  .+-.-+.+||.|++|+|+.|.++..|.... ..+.+|++|-|.+-.+..... ..+..+|.+
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp-~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v  148 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP-LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV  148 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc-ccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence            3455555555555541  122234455556666666665543222111 234455666665555543222 233555666


Q ss_pred             ceecCCCccccc--cCccCccccc-ccCee---------ecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccC
Q 048668          137 ELLDLSNNQFKG--KVSIDFSSLK-ILWRL---------NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL  204 (725)
Q Consensus       137 ~~L~Ls~N~i~~--~~~~~f~~l~-~L~~L---------~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  204 (725)
                      ++|.+|.|.+.-  +..+...... .+++|         .++-|++.             .-.|++..+-+..|.+.+.-
T Consensus       149 telHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~-------------r~Fpnv~sv~v~e~PlK~~s  215 (418)
T KOG2982|consen  149 TELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLS-------------RIFPNVNSVFVCEGPLKTES  215 (418)
T ss_pred             hhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHH-------------hhcccchheeeecCcccchh
Confidence            666666663331  2222222221 22333         33333332             12356666666666555211


Q ss_pred             ChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC-CChhhcCCCCccEEeccCcccccCCC----C
Q 048668          205 PHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT-IPDVIGELKNLQLLGLYKNFLQGSIP----S  279 (725)
Q Consensus       205 p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~----~  279 (725)
                                              ....+..++.+-.|+|+.|+|... --+++.++++|..|.+++|.+...+.    .
T Consensus       216 ------------------------~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err  271 (418)
T KOG2982|consen  216 ------------------------SEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERR  271 (418)
T ss_pred             ------------------------hcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcce
Confidence                                    112233444555667777777543 23456777777777777777653221    1


Q ss_pred             --CCcCCCCCCEEeCC
Q 048668          280 --GLGNLTKLAKLDLG  293 (725)
Q Consensus       280 --~~~~l~~L~~L~L~  293 (725)
                        .++.+++++.|+=+
T Consensus       272 ~llIaRL~~v~vLNGs  287 (418)
T KOG2982|consen  272 FLLIARLTKVQVLNGS  287 (418)
T ss_pred             EEEEeeccceEEecCc
Confidence              13456667666543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.40  E-value=1e-08  Score=87.04  Aligned_cols=110  Identities=16%  Similarity=0.233  Sum_probs=65.5

Q ss_pred             CcEEEccCCcCCccCCCCCC---CCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEE
Q 048668           39 LQVIHIKGNSLGGKFPTTLG---LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL  115 (725)
Q Consensus        39 L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  115 (725)
                      +..|||++|+|. -++++.+   ....|+..+|++|.++...+..-...+.++.|+|++|.|+ .+|.+ +..|+.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE-~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEE-LAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHH-HhhhHHhhhc
Confidence            555677777765 3344333   3344555577777776333333334456777777777776 66666 4566677777


Q ss_pred             EccCceeeeeCCCcccccCccceecCCCccccccCcc
Q 048668          116 GIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSI  152 (725)
Q Consensus       116 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~  152 (725)
                      +++.|.+... |..+..+.++-.||..+|.+..++.+
T Consensus       106 Nl~~N~l~~~-p~vi~~L~~l~~Lds~~na~~eid~d  141 (177)
T KOG4579|consen  106 NLRFNPLNAE-PRVIAPLIKLDMLDSPENARAEIDVD  141 (177)
T ss_pred             ccccCccccc-hHHHHHHHhHHHhcCCCCccccCcHH
Confidence            7777766633 44555566666666666666655544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.40  E-value=3.2e-06  Score=80.03  Aligned_cols=142  Identities=18%  Similarity=0.196  Sum_probs=90.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHH---------HHHHHHHHHcCC---CCcccceeeEe
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEALRNIR---HRNLIKIITIC  598 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~  598 (725)
                      ..+|...+++-......|.+-..  +|+.+++|..+.......+.         ..+++..+.+++   --....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45666667777666666666554  56788899876543222222         234444444443   22333333333


Q ss_pred             ecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC
Q 048668          599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH  678 (725)
Q Consensus       599 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~  678 (725)
                      ....+.-....++||||++|..+.++..          +++    .++..+.+++.-+|..   |+.|+|..|.|++++.
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence            2222322335568999999988876532          222    2445677889999999   9999999999999986


Q ss_pred             CCceEEcccccccc
Q 048668          679 DMVAHVGDFGLAKF  692 (725)
Q Consensus       679 ~~~~kl~Dfgla~~  692 (725)
                      + .++++||+..+.
T Consensus       171 ~-~i~iID~~~k~~  183 (229)
T PF06176_consen  171 N-GIRIIDTQGKRM  183 (229)
T ss_pred             C-cEEEEECccccc
Confidence            5 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=2.2e-06  Score=93.01  Aligned_cols=140  Identities=20%  Similarity=0.258  Sum_probs=90.6

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecccc----------------------c----h----HH----------HHH
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK----------------------G----A----FR----------SFV  577 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~----~----~~----------~~~  577 (725)
                      +.|+.++-|+||+|+.. +|+.||||+.++.-.                      .    .    .+          .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999997 599999998853210                      0    0    01          234


Q ss_pred             HHHHHHHcCC-----CCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHH
Q 048668          578 AECEALRNIR-----HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA  652 (725)
Q Consensus       578 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~  652 (725)
                      +|+..+.+++     .+++ ++-.+|.+-    .....++|||++|-.+.++......     ..+.   ..++..++++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~~-----g~d~---k~ia~~~~~~  276 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKSA-----GIDR---KELAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceeehhc----cCCcEEEEEeeCCEecccHHHHHhc-----CCCH---HHHHHHHHHH
Confidence            5666666652     3332 233333221    1256799999999888887432211     2332   2233333332


Q ss_pred             -HHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          653 -IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       653 -l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                       +..+-..   |+.|.|..|.||+++.+|++.+.|||+...+.
T Consensus       277 f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         277 FLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence             2223234   89999999999999999999999999987654

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.33  E-value=6.4e-07  Score=81.67  Aligned_cols=123  Identities=23%  Similarity=0.264  Sum_probs=62.5

Q ss_pred             CcEEecCCCccCccCCcccc-CCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIG-NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      =++++|.+.++. .+.. ++ -+.+...+||++|.+.  --+.|.++++|.+|.|++|.|+.+.|.--..+++|..|.|.
T Consensus        21 e~e~~LR~lkip-~ien-lg~~~d~~d~iDLtdNdl~--~l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Lt   96 (233)
T KOG1644|consen   21 ERELDLRGLKIP-VIEN-LGATLDQFDAIDLTDNDLR--KLDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILT   96 (233)
T ss_pred             cccccccccccc-chhh-ccccccccceecccccchh--hcccCCCccccceEEecCCcceeeccchhhhccccceEEec
Confidence            355566665554 1211 11 1234556666666664  22446666666666666666666666555555566666666


Q ss_pred             CCCCCCCCC-hhhhcCCCCccEEEccCceeeeeCC---CcccccCccceecCC
Q 048668           94 SNRFSGSLP-FDIVVNLPNLKELGIGANNFFGLIP---DSLSNASNLELLDLS  142 (725)
Q Consensus        94 ~N~l~~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~Ls  142 (725)
                      +|+|. .+. -+-+..+|+|++|.+-+|.++....   ..+..+++|+.||.+
T Consensus        97 nNsi~-~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~  148 (233)
T KOG1644|consen   97 NNSIQ-ELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQ  148 (233)
T ss_pred             Ccchh-hhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehh
Confidence            66654 221 1223345555555555555542211   123445555555543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	725
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-37
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		9e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-36
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-27
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-11
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		2e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-10
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		4e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-10
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		9e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-06
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		3e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		9e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		2e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		9e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-04
1xwd_C	252	Crystal Structure Of Human Follicle Stimulating Hor		2e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-04
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		2e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		3e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-04
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		3e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-04
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		4e-04
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		4e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-04
4ay9_X	350	Structure Of Follicle-Stimulating Hormone In Comple		6e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		7e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 136/392 (34%), Positives = 196/392 (50%), Gaps = 28/392 (7%)
Query: 14  KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKF 73
           +L+ LA++GN ++G +   +     L+ + +  N+     P  LG    L  L+++ NK 
Sbjct: 176 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 232
Query: 74  YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNA 133
            G F R+I   + L+   ++SN+F G +P    + L +L+ L +  N F G IPD LS A
Sbjct: 233 SGDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 134 SN-LELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            + L  LDLS N F G V   F S  +L  L L  NN     + +L   T L     LKV
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF----SGELPMDTLLK-MRGLKV 344
Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTI-PLGIRNLVN-LIALAVEVNQLH 250
           L LS N+F GELP S+ NLS++++   +  N  SG I P   +N  N L  L ++ N   
Sbjct: 345 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 404
Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG----------- 299
           G IP  +     L  L L  N+L G+IPS LG+L+KL  L L  N L+G           
Sbjct: 405 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 464
Query: 300 --NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSNQF 357
               I   N L G +P  L S  T                P+ +G L+NL IL +S+N F
Sbjct: 465 LETLILDFNDLTGEIPSGL-SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 523
Query: 358 SGMIPVTLSTCVSLEYVDISSNCFHGIIPPSL 389
           SG IP  L  C SL ++D+++N F+G IP ++
Sbjct: 524 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 555

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  152 bits (383), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 150/531 (28%), Positives = 223/531 (41%), Gaps = 83/531 (15%)
Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL-GL 59
           L G   + I +  +L+ L ++ N   G +P     L +LQ + +  N   G+ P  L G 
Sbjct: 232 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              L  L+++ N FYG  P    + S LE   L+SN FSG LP D ++ +  LK L +  
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 349
Query: 120 NNFFGLIPDSLSN-ASNLELLDLSNNQFKGKVSIDF--SSLKILWRLNLEQNNLGIGAAN 176
           N F G +P+SL+N +++L  LDLS+N F G +  +   +    L  L L+ N        
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN-------- 401
Query: 177 DLGFV----TFLTNCSSLKVLSLSDNQFGGELPHSIANLSS------------------- 213
             GF       L+NCS L  L LS N   G +P S+ +LS                    
Sbjct: 402 --GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 459
Query: 214 ----TMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLY 269
               T+   ++  N ++G IP G+ N  NL  +++  N+L G IP  IG L+NL +L L 
Sbjct: 460 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 519
Query: 270 KNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---------------NFIASQN-------- 306
            N   G+IP+ LG+   L  LDL +N   G               NFIA +         
Sbjct: 520 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 579
Query: 307 ------------KLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISS 354
                       +  G   +QL  ++T                P    N  +++ LD+S 
Sbjct: 580 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT-FDNNGSMMFLDMSY 638
Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXX 414
           N  SG IP  + +   L  +++  N   G IP  +G L+ +  LD+S N   G+ P+   
Sbjct: 639 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 698
Query: 415 XXXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC 465
                       N+L G +P  G F          N  LCG      LP C
Sbjct: 699 ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPRC 745

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  154 bits (389), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 136/392 (34%), Positives = 196/392 (50%), Gaps = 28/392 (7%)
Query: 14  KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKF 73
           +L+ LA++GN ++G +   +     L+ + +  N+     P  LG    L  L+++ NK 
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 74  YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNA 133
            G F R+I   + L+   ++SN+F G +P    + L +L+ L +  N F G IPD LS A
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 134 SN-LELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            + L  LDLS N F G V   F S  +L  L L  NN     + +L   T L     LKV
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF----SGELPMDTLLK-MRGLKV 347
Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTI-PLGIRNLVN-LIALAVEVNQLH 250
           L LS N+F GELP S+ NLS++++   +  N  SG I P   +N  N L  L ++ N   
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG----------- 299
           G IP  +     L  L L  N+L G+IPS LG+L+KL  L L  N L+G           
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 300 --NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSNQF 357
               I   N L G +P  L S  T                P+ +G L+NL IL +S+N F
Sbjct: 468 LETLILDFNDLTGEIPSGL-SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526
Query: 358 SGMIPVTLSTCVSLEYVDISSNCFHGIIPPSL 389
           SG IP  L  C SL ++D+++N F+G IP ++
Sbjct: 527 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 150/531 (28%), Positives = 223/531 (41%), Gaps = 83/531 (15%)
Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL-GL 59
           L G   + I +  +L+ L ++ N   G +P     L +LQ + +  N   G+ P  L G 
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
              L  L+++ N FYG  P    + S LE   L+SN FSG LP D ++ +  LK L +  
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 120 NNFFGLIPDSLSN-ASNLELLDLSNNQFKGKVSIDF--SSLKILWRLNLEQNNLGIGAAN 176
           N F G +P+SL+N +++L  LDLS+N F G +  +   +    L  L L+ N        
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN-------- 404
Query: 177 DLGFV----TFLTNCSSLKVLSLSDNQFGGELPHSIANLSS------------------- 213
             GF       L+NCS L  L LS N   G +P S+ +LS                    
Sbjct: 405 --GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 214 ----TMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLY 269
               T+   ++  N ++G IP G+ N  NL  +++  N+L G IP  IG L+NL +L L 
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 270 KNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---------------NFIASQN-------- 306
            N   G+IP+ LG+   L  LDL +N   G               NFIA +         
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582
Query: 307 ------------KLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISS 354
                       +  G   +QL  ++T                P    N  +++ LD+S 
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT-FDNNGSMMFLDMSY 641
Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXX 414
           N  SG IP  + +   L  +++  N   G IP  +G L+ +  LD+S N   G+ P+   
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701
Query: 415 XXXXXXXXXXXYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC 465
                       N+L G +P  G F          N  LCG      LP C
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPRC 748

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  119 bits (299), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV 577
           Q    S  EL  A+  FS+ N++G+G FG VYKG L +  ++   ++   + +G    F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 578 AECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKL 637
            E E +    HRNL+++   C +   +      LV+ YM NGS+   L +  +      L
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQ--PPL 136
Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
              +R  IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +    
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---- 192
Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
                K       ++GT+G++AP
Sbjct: 193 ---DYKDXHVXXAVRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  116 bits (290), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV 577
           Q    S  EL  A+  F + N++G+G FG VYKG L +  ++   ++   + +G    F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 578 AECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKL 637
            E E +    HRNL+++   C +   +      LV+ YM NGS+   L +  +      L
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQ--PPL 128
Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
              +R  IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +    
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---- 184
Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
                K       ++G +G++AP
Sbjct: 185 ---DYKDXHVXXAVRGXIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 520 PMVSY----AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS 575
           P  SY     +L +AT+ F    +IG G FG VYKG+L  D   VA+K    +       
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEE 81
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC 635
           F  E E L   RH +L+ +I  C        +   L+++YM NG+L+  L+ S+  +   
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSD--LPTM 134
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK---F 692
            +S  QRL I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K    
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF 723
           L   HL            +KGT+GY+ P  F
Sbjct: 192 LDQTHLXXV---------VKGTLGYIDPEYF 213

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 520 PMVSY----AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS 575
           P  SY     +L +AT+ F    +IG G FG VYKG+L  D   VA+K    +       
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEE 81
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC 635
           F  E E L   RH +L+ +I  C        +   L+++YM NG+L+  L+ S+  +   
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSD--LPTM 134
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK---F 692
            +S  QRL I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K    
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF 723
           L   HL            +KGT+GY+ P  F
Sbjct: 192 LGQTHLXXV---------VKGTLGYIDPEYF 213

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKII 595
            +IG+G +G+VYKG L  DE  VAVKV +   +   ++F+ E    R   + H N+ + I
Sbjct: 19  ELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFI 73
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                    G     LV EY  NGSL  +L   ++D V  C+L        A  V   + 
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL--------AHSVTRGLA 125
Query: 655 YLH------HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           YLH       H +P + H DL   NVL+ +D    + DFGL+  L+ + L    +  +++
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 709 IGIKGTVGYVAP 720
           I   GT+ Y+AP
Sbjct: 186 ISEVGTIRYMAP 197

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 95/185 (51%), Gaps = 25/185 (13%)
Query: 540 IGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLIKII- 595
           IG GSFG+V++    G D   VAVK++  +   A R   F+ E   ++ +RH N++  + 
Sbjct: 45  IGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +    +       ++V EY+  GSL   LH+S  + +   L   +RL++A DVA  + Y
Sbjct: 102 AVTQPPNL------SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNY 152
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           LH+   PP+VH DLK  N+L+D      V DFGL++  +S  L +            GT 
Sbjct: 153 LHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--------GTP 203
Query: 716 GYVAP 720
            ++AP
Sbjct: 204 EWMAP 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 96/185 (51%), Gaps = 25/185 (13%)
Query: 540 IGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLIKII- 595
           IG GSFG+V++    G D   VAVK++  +   A R   F+ E   ++ +RH N++  + 
Sbjct: 45  IGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +    +       ++V EY+  GSL   LH+S  + +   L   +RL++A DVA  + Y
Sbjct: 102 AVTQPPNL------SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDVAKGMNY 152
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           LH+   PP+VH +LK  N+L+D      V DFGL++  +S  L + S          GT 
Sbjct: 153 LHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--------GTP 203
Query: 716 GYVAP 720
            ++AP
Sbjct: 204 EWMAP 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAE 579
           P  +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 60
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSL 639
              ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ 
Sbjct: 61  AAVMKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVNA 111
Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
           +  L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 112 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------ 162
Query: 700 TSSKTPSSSIGIKGTVGYVAP 720
            +  T ++  G K  + + AP
Sbjct: 163 -TGDTXTAHAGAKFPIKWTAP 182

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 163
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 164 DTYTAHAGAKFPIKWTAP 181

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 107/233 (45%), Gaps = 18/233 (7%)
Query: 5   IPKEIGSLFKLQALALAG-NYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           IP  + +L  L  L + G N L G +P  I  L+ L  ++I   ++ G  P  L  ++ L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
           V L+ + N   G  P SI ++ +L       NR SG++P            + I  N   
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
           G IP + +N  NL  +DLS N  +G  S+ F S K   +++L +N+L    A DLG V  
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL----AFDLGKVGL 242
Query: 184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL----IGGNQISGTIPLG 232
             N   L  L L +N+  G LP  +     T + FL    +  N + G IP G
Sbjct: 243 SKN---LNGLDLRNNRIYGTLPQGL-----TQLKFLHSLNVSFNNLCGEIPQG 287

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 102/268 (38%), Gaps = 42/268 (15%)
Query: 198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVI 257
           N   G +P +IA L+    +++   N +SG IP  +  +  L+ L    N L GT+P  I
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 258 GELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL 317
             L NL  +    N + G+IP   G+ +KL            +   S+N+L G +P    
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFT----------SMTISRNRLTGKIPPTFA 195
Query: 318 SITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDIS 377
           ++                          NL  +D+S N   G   V   +  + + + ++
Sbjct: 196 NL--------------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 378 SNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKXXXXXXXXXXXXXXYNHLEGEVPTKG 437
            N     +   +G  K++  LD+  N   G  P+              +N+L GE+P  G
Sbjct: 230 KNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 438 VFSNKSKIPLQGNVRLCGGIDELHLPSC 465
                       N  LCG      LP+C
Sbjct: 289 NLQRFDVSAYANNKCLCGS----PLPAC 312

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 163
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 164 DTYTAHAGAKFPIKWTAP 181

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++ +  + +G G FG VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           ++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  L +A  ++S
Sbjct: 70  VQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISS 120
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYL    +   +H DL   N L+  + +  V DFGL++ +       +  T ++  G 
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGDTXTAHAGA 170
Query: 712 KGTVGYVAP 720
           K  + + AP
Sbjct: 171 KFPIKWTAP 179

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   +
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 63
Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
           + I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  L
Sbjct: 64  KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLL 114
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       +  
Sbjct: 115 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGD 164
Query: 704 TPSSSIGIKGTVGYVAP 720
           T ++  G K  + + AP
Sbjct: 165 TYTAHAGAKFPIKWTAP 181

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAE 579
           P  +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 63
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSL 639
              ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ 
Sbjct: 64  AAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNA 114
Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
           +  L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +      
Sbjct: 115 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------ 165
Query: 700 TSSKTPSSSIGIKGTVGYVAP 720
            +  T ++  G K  + + AP
Sbjct: 166 -TGDTYTAHAGAKFPIKWTAP 185

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           ++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  L +A  ++S
Sbjct: 70  VQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISS 120
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYL    +   +H DL   N L+  + +  V DFGL++ +       +  T ++  G 
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGDTXTAHAGA 170
Query: 712 KGTVGYVAP 720
           K  + + AP
Sbjct: 171 KFPIKWTAP 179

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 163
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 164 DTYTAHAGAKFPIKWTAP 181

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   +
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 68
Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
           + I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  L
Sbjct: 69  KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLL 119
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       +  
Sbjct: 120 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGD 169
Query: 704 TPSSSIGIKGTVGYVAP 720
           T ++  G K  + + AP
Sbjct: 170 TYTAHAGAKFPIKWTAP 186

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 168
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 169 DTYTAHAGAKFPIKWTAP 186

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 516 EKQFPMVSYAELSKATSEFSSS------NMIGQGSFGSVYKGILGEDEMIVAVK----VI 565
           + +F   S+ EL   T+ F         N +G+G FG VYKG +  +   VAVK    ++
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 566 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL 625
           ++  +   + F  E + +   +H NL++++   S  D    D   LV+ YM NGSL D L
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DL-CLVYVYMPNGSLLDRL 121
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVAH 683
              +       LS   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A 
Sbjct: 122 SCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAK 173
Query: 684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIK--GTVGYVAP 720
           + DFGLA+         S K   + +  +  GT  Y+AP
Sbjct: 174 ISDFGLAR--------ASEKFAQTVMXXRIVGTTAYMAP 204

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 516 EKQFPMVSYAELSKATSEFSSS------NMIGQGSFGSVYKGILGEDEMIVAVK----VI 565
           + +F   S+ EL   T+ F         N +G+G FG VYKG +  +   VAVK    ++
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 566 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL 625
           ++  +   + F  E + +   +H NL++++   S  D    D   LV+ YM NGSL D L
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DL-CLVYVYMPNGSLLDRL 121
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVAH 683
              +       LS   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A 
Sbjct: 122 SCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAK 173
Query: 684 VGDFGLAKFLSSHHLDTSSKTPSSSIG--IKGTVGYVAP 720
           + DFGLA+         S K   + +   I GT  Y+AP
Sbjct: 174 ISDFGLAR--------ASEKFAQTVMXSRIVGTTAYMAP 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y E+    SE   S  IG GSFG+VYKG    D  +  +KV++   +  F++F  E   L
Sbjct: 30  YWEIE--ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVL 86
Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
           R  RH N++  +   +  +       A+V ++    SL   LH     V+  K  + Q +
Sbjct: 87  RKTRHVNILLFMGYMTKDNL------AIVTQWCEGSSLYKHLH-----VQETKFQMFQLI 135
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           +IA   A  ++YLH      ++H D+K +N+ L   +   +GDFGLA   S        +
Sbjct: 136 DIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 704 TPSSSIGIKGTVGYVAP 720
            P+      G+V ++AP
Sbjct: 193 QPT------GSVLWMAP 203

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 168
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 169 DTXTAHAGAKFPIKWTAP 186

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 113
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 163
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 164 DTYTAHAGAKFPIKWTAP 181

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 168
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 169 DTYTAHAGAKFPIKWTAP 186

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 64  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 114
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 164
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 165 DTYTAPAGAKFPIKWTAP 182

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 63  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 113
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 163
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 164 DTYTAHAGAKFPIKWTAP 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 37/219 (16%)
Query: 516 EKQFPMVSYAELSKATSEFSSS------NMIGQGSFGSVYKGILGEDEMIVAVK----VI 565
           + +F   S+ EL   T+ F         N +G+G FG VYKG +  +   VAVK    ++
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 60
Query: 566 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL 625
           ++  +   + F  E + +   +H NL++++   S  D    D   LV+ YM NGSL D L
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DL-CLVYVYMPNGSLLDRL 115
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVAH 683
              +       LS   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A 
Sbjct: 116 SCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAK 167
Query: 684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIK--GTVGYVAP 720
           + DFGLA+         S K     +  +  GT  Y+AP
Sbjct: 168 ISDFGLAR--------ASEKFAQXVMXXRIVGTTAYMAP 198

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 75
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 76  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 126
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 127 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 176
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 177 DTYTAHAGAKFPIKWTAP 194

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 165
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 166 DTYTAPAGAKFPIKWTAP 183

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 165
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 166 DTYTAHAGAKFPIKWTAP 183

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 168
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 169 DTYTAHAGAKFPIKWTAP 186

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 65  MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ +       + 
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TG 165
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 166 DTYTAHAGAKFPIKWTAP 183

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 96/190 (50%), Gaps = 22/190 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++ +  + +G G +G VY G+  +  + VAVK +  +       F+ E   ++ I+H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 592 IKIITICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++++ +C+    F       +V EYM  G+L D+L + N +    +++ +  L +A  ++
Sbjct: 91  VQLLGVCTLEPPF------YIVTEYMPYGNLLDYLRECNRE----EVTAVVLLYMATQIS 140
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
           SA+EYL    +   +H DL   N L+  + V  V DFGL++ +       +  T ++  G
Sbjct: 141 SAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-------TGDTYTAHAG 190
Query: 711 IKGTVGYVAP 720
            K  + + AP
Sbjct: 191 AKFPIKWTAP 200

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 160
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 161 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           ++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  L +A  ++S
Sbjct: 70  VQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISS 120
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYL    +   +H DL   N L+  + +  V DFGL++ +       +  T ++  G 
Sbjct: 121 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGDTFTAHAGA 170
Query: 712 KGTVGYVAP 720
           K  + + AP
Sbjct: 171 KFPIKWTAP 179

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 83  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 134
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 135 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 85  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 136
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 137 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 82  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 133
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 134 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 76  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 127
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 128 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 43/218 (19%)
Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVI----N 566
           ++ + ++A  EF+            +IG G FG V  G L   G+ E+ VA+K +     
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 74
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA----LVFEYMGNGSLE 622
            KQ+   R F++E   +    H N+I +         +GV  K+    ++ E+M NGSL+
Sbjct: 75  EKQR---RDFLSEASIMGQFDHPNVIHL---------EGVVTKSTPVMIITEFMENGSLD 122
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
            +L Q++ Q      ++IQ + +   +A+ ++YL        VH DL   N+L++ ++V 
Sbjct: 123 SFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVC 174
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            V DFGL++FL     DTS  T +S++G K  + + AP
Sbjct: 175 KVSDFGLSRFLED---DTSDPTYTSALGGKIPIRWTAP 209

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 77  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 129 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 84  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 135
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 136 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL 583
           Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 270
Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
           + I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    ++S +  L
Sbjct: 271 KEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLL 321
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +A  ++SA+EYL    +   +H +L   N L+  + +  V DFGL++ +       +  
Sbjct: 322 YMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-------TGD 371
Query: 704 TPSSSIGIKGTVGYVAP 720
           T ++  G K  + + AP
Sbjct: 372 TYTAHAGAKFPIKWTAP 388

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++++  KL     L     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L    ++++  KL     L     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEY 132
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 30/193 (15%)
Query: 537 SNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAF-----RSFVAECEALRNIRH 588
             +IG G FG V +G L   G+ E  VA+K +    KG +     R F++E   +    H
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEH 76
Query: 589 RNLIKIITICSSTDFKGVDFKALVF-EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            N+I++  + +++         ++  E+M NG+L+ +L  ++ Q      ++IQ + +  
Sbjct: 77  PNIIRLEGVVTNS------MPVMILTEFMENGALDSFLRLNDGQ-----FTVIQLVGMLR 125
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
            +AS + YL        VH DL   N+L++ ++V  V DFGL++FL     ++S  T +S
Sbjct: 126 GIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEE---NSSDPTETS 179
Query: 708 SIGIKGTVGYVAP 720
           S+G K  + + AP
Sbjct: 180 SLGGKIPIRWTAP 192

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
           +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 308
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++ I+H NL++++ +C+    +   F  ++ E+M  G+L D+L + N Q    +++ +  
Sbjct: 309 MKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 359
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L +A  ++SA+EYL    +   +H +L   N L+  + +  V DFGL++ +       + 
Sbjct: 360 LYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-------TG 409
Query: 703 KTPSSSIGIKGTVGYVAP 720
            T ++  G K  + + AP
Sbjct: 410 DTYTAHAGAKFPIKWTAP 427

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 528 SKATSEFSSSNM-----IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVA 578
           S+  ++F   ++     +G+G+FGSV    Y  +      +VAVK +    +   R F  
Sbjct: 2   SRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLS 638
           E E L++++H N++K   +C S   + +    L+ EY+  GSL D+L +  ++++  KL 
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL- 117
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
               L     +   +EYL        +H +L   N+L++++    +GDFGL K L     
Sbjct: 118 ----LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170
Query: 699 DTSSKTPSSS 708
               K P  S
Sbjct: 171 YYKVKEPGES 180

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            ++         A+V ++    SL   LH S  + E+ KL     ++IA   A  ++YLH
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D    +GDFGLA    ++  SH  +           + G
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ----------LSG 184
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 185 SILWMAP 191

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 30/193 (15%)
Query: 537 SNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAF-----RSFVAECEALRNIRH 588
             +IG G FG V +G L   G+ E  VA+K +    KG +     R F++E   +    H
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEH 74
Query: 589 RNLIKIITICSSTDFKGVDFKALVF-EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            N+I++  + +++         ++  E+M NG+L+ +L  ++ Q      ++IQ + +  
Sbjct: 75  PNIIRLEGVVTNS------MPVMILTEFMENGALDSFLRLNDGQ-----FTVIQLVGMLR 123
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
            +AS + YL        VH DL   N+L++ ++V  V DFGL++FL     ++S  T +S
Sbjct: 124 GIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEE---NSSDPTYTS 177
Query: 708 SIGIKGTVGYVAP 720
           S+G K  + + AP
Sbjct: 178 SLGGKIPIRWTAP 190

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 538 NMIGQGSFGSVYKGILGEDE---MIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLI 592
            ++G+G FGSV +G L +++   + VAVK + L    +     F++E   +++  H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +++ +C     +G+    ++  +M  G L  +L  S  +     + L   L   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS---HHLDTSSKTPSSSI 709
           +EYL +      +H DL   N +L  DM   V DFGL+K + S   +     +K P   I
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 710 GIKGTVGYVAPGK 722
            I+     V   K
Sbjct: 217 AIESLADRVYTSK 229

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH S  + E+ KL     ++IA   A  ++YLH
Sbjct: 89  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D    +GDFGLA    ++  SH  +           + G
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ----------LSG 184
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 185 SILWMAP 191

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH S  + E+ KL     ++IA   A  ++YLH
Sbjct: 77  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 125
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D    +GDFGLA    ++  SH  +           + G
Sbjct: 126 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ----------LSG 172
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 173 SILWMAP 179

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 33/194 (17%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRN 590
           + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++  +   ++         A+V ++    SL   LH    + E+ KL     ++IA   A
Sbjct: 66  ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTA 114
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPS 706
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S    
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS---- 167
Query: 707 SSIGIKGTVGYVAP 720
                 G++ ++AP
Sbjct: 168 ------GSILWMAP 175

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV    Y  +      +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ E++  GSL ++L +  ++++  KL     L     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           L        +H DL   N+L++++    +GDFGL K L         K P  S
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 33/194 (17%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRN 590
           + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++  +   +          A+V ++    SL   LH    + E+ KL     ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTA 114
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPS 706
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S    
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS---- 167
Query: 707 SSIGIKGTVGYVAP 720
                 G++ ++AP
Sbjct: 168 ------GSILWMAP 175

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 33/194 (17%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRN 590
           + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++  +   +          A+V ++    SL   LH    + E+ KL     ++IA   A
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTA 119
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPS 706
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S    
Sbjct: 120 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS---- 172
Query: 707 SSIGIKGTVGYVAP 720
                 G++ ++AP
Sbjct: 173 ------GSILWMAP 180

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 34/195 (17%)
Query: 537 SNMIGQGSFGSVYKGIL---GEDEMIVAVKVI----NLKQKGAFRSFVAECEALRNIRHR 589
             +IG G FG V  G L   G+ E+ VA+K +      KQ+   R F++E   +    H 
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHP 68
Query: 590 NLIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           N+I +         +GV  K+    ++ E+M NGSL+ +L Q++ Q      ++IQ + +
Sbjct: 69  NVIHL---------EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-----FTVIQLVGM 114
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
              +A+ ++YL        VH  L   N+L++ ++V  V DFGL++FL     DTS  T 
Sbjct: 115 LRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTY 168
Query: 706 SSSIGIKGTVGYVAP 720
           +S++G K  + + AP
Sbjct: 169 TSALGGKIPIRWTAP 183

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 33/194 (17%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRN 590
           + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++  +   +          A+V ++    SL   LH    + E+ KL     ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTA 114
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPS 706
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S    
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---- 167
Query: 707 SSIGIKGTVGYVAP 720
                 G++ ++AP
Sbjct: 168 ------GSILWMAP 175

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH    + E+ KL     ++IA   A  ++YLH
Sbjct: 93  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 141
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S          G
Sbjct: 142 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----------G 188
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 189 SILWMAP 195

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 33/194 (17%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRN 590
           + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++  +   +          A+V ++    SL   LH    + E+ KL     ++IA   A
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTA 119
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPS 706
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S    
Sbjct: 120 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS---- 172
Query: 707 SSIGIKGTVGYVAP 720
                 G++ ++AP
Sbjct: 173 ------GSILWMAP 180

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH    + E+ KL     ++IA   A  ++YLH
Sbjct: 75  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 123
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S          G
Sbjct: 124 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 170
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 171 SILWMAP 177

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH    + E+ KL     ++IA   A  ++YLH
Sbjct: 100 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 148
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S          G
Sbjct: 149 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 195
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 196 SILWMAP 202

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH    + E+ KL     ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 149
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S          G
Sbjct: 150 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----------G 196
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 197 SILWMAP 203

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 33/187 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITI 597
           IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +          A+V ++    SL   LH    + E+ KL     ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 149
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPSSSIGIKG 713
                 ++H DLK +N+ L  D+   +GDFGLA    ++  SH  +  S          G
Sbjct: 150 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----------G 196
Query: 714 TVGYVAP 720
           ++ ++AP
Sbjct: 197 SILWMAP 203

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 28/180 (15%)
Query: 538 NMIGQGSFGSVYKGILGEDEMI---VAVKVINLKQKGAFRSFVA----ECEALRNIRHRN 590
           + +G G+FG V    +GE ++    VAVK++N +QK      V     E + L+  RH +
Sbjct: 17  DTLGVGTFGKVK---IGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 591 LIKIITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           +IK+  + S+ TDF       +V EY+  G L D++ +     E+    L Q+      +
Sbjct: 73  IIKLYQVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------I 120
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSS 708
            SA++Y H H    +VH DLKP NVLLD  M A + DFGL+  +S    L TS  +P+ +
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+G FG V  G    ++  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 20  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             + KG  +  +V EYM  GSL D+L      V    L     L  ++DV  A+EYL  +
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 127
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                VH DL   NVL+  D VA V DFGL K  SS
Sbjct: 128 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 160

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+G FG V  G    ++  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 29  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             + KG  +  +V EYM  GSL D+L      V    L     L  ++DV  A+EYL  +
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 136
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                VH DL   NVL+  D VA V DFGL K  SS
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 16  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 74  EEPI------XIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 123
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 124 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-------TARQGAKFPIKWTA 173
Query: 720 P 720
           P
Sbjct: 174 P 174

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 19  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 77  EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 126
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 127 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 176
Query: 720 P 720
           P
Sbjct: 177 P 177

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+G FG V  G    ++  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 201 IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             + KG  +  +V EYM  GSL D+L      V    L     L  ++DV  A+EYL  +
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 308
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                VH DL   NVL+  D VA V DFGL K  SS
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+G FG V  G    ++  VAVK I  K     ++F+AE   +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             + KG  +  +V EYM  GSL D+L      V    L     L  ++DV  A+EYL  +
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 121
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                VH DL   NVL+  D VA V DFGL K  SS
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ IRH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 275 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 333 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 382
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 432
Query: 720 P 720
           P
Sbjct: 433 P 433

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 349
Query: 720 P 720
           P
Sbjct: 350 P 350

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 518 QFPMVSYAELSKATSEFSSS------NMIGQGSFGSVYKGILGEDEMIVAVK----VINL 567
           +F   S+ EL   T+ F         N  G+G FG VYKG +  +   VAVK    ++++
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDI 59
Query: 568 KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ 627
             +   + F  E +     +H NL++++   S  D    D   LV+ Y  NGSL D L  
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGD----DL-CLVYVYXPNGSLLDRLSC 114
Query: 628 SNDQVEVCKLSLIQRLNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
            +       LS   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A + 
Sbjct: 115 LDG---TPPLSWHXRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKIS 166
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIG---IKGTVGYVAP 720
           DFGLA+         +S+  +  +    I GT  Y AP
Sbjct: 167 DFGLAR---------ASEKFAQXVXXSRIVGTTAYXAP 195

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 349
Query: 720 P 720
           P
Sbjct: 350 P 350

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/166 (34%), Positives = 87/166 (52%), Gaps = 27/166 (16%)
Query: 538 NMIGQGSFGSVYKGILGEDEMI---VAVKVINLKQKGAFRSFVA----ECEALRNIRHRN 590
           + +G G+FG V    +GE ++    VAVK++N +QK      V     E + L+  RH +
Sbjct: 17  DTLGVGTFGKVK---IGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 591 LIKIITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           +IK+  + S+ TDF       +V EY+  G L D++ +     E+    L Q+      +
Sbjct: 73  IIKLYQVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ------I 120
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            SA++Y H H    +VH DLKP NVLLD  M A + DFGL+  +S 
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 17  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 75  EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 124
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 125 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 174
Query: 720 P 720
           P
Sbjct: 175 P 175

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q ++++  +AS + Y+   
Sbjct: 81  EEPI------YIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYVERM 130
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 131 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEW-------TARQGAKFPIKWTA 180
Query: 720 P 720
           P
Sbjct: 181 P 181

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 15  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 73  EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 122
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 123 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 172
Query: 720 P 720
           P
Sbjct: 173 P 173

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 23/191 (12%)
Query: 535 SSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 589
           +   +IG G FG VYKG+L    G+ E+ VA+K +        R  F+ E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N+I++  + S   +K +    ++ EYM NG+L+ +L + + +      S++Q + +   +
Sbjct: 107 NIIRLEGVISK--YKPM---MIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGI 156
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
           A+ ++YL +      VH DL   N+L++ ++V  V DFGL++ L     D    T ++S 
Sbjct: 157 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTS- 208
Query: 710 GIKGTVGYVAP 720
           G K  + + AP
Sbjct: 209 GGKIPIRWTAP 219

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 250 EEPI------YIVGEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 349
Query: 720 P 720
           P
Sbjct: 350 P 350

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q ++++  +AS + Y+   
Sbjct: 81  EEPI------YIVTEYMNKGSLLDFLKGETGKY----LRLPQLVDMSAQIASGMAYVERM 130
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 131 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 180
Query: 720 P 720
           P
Sbjct: 181 P 181

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVCEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 25/176 (14%)
Query: 540 IGQGSFGSV---YKGILGEDEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIK 593
           +G+GSFG V   Y    G+    VA+K+IN K   K   +  +  E   LR +RH ++IK
Sbjct: 21  LGEGSFGKVKLAYHTTTGQK---VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  S D        +V EY GN  L D++ Q +   E       Q+      + SA+
Sbjct: 78  LYDVIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAV 125
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSS 708
           EY H H    +VH DLKP N+LLD  +   + DFGL+  ++  + L TS  +P+ +
Sbjct: 126 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 178

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 25/176 (14%)
Query: 540 IGQGSFGSV---YKGILGEDEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIK 593
           +G+GSFG V   Y    G+    VA+K+IN K   K   +  +  E   LR +RH ++IK
Sbjct: 22  LGEGSFGKVKLAYHTTTGQK---VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  S D        +V EY GN  L D++ Q +   E       Q+      + SA+
Sbjct: 79  LYDVIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAV 126
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSS 708
           EY H H    +VH DLKP N+LLD  +   + DFGL+  ++  + L TS  +P+ +
Sbjct: 127 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 179

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 25/176 (14%)
Query: 540 IGQGSFGSV---YKGILGEDEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIK 593
           +G+GSFG V   Y    G+    VA+K+IN K   K   +  +  E   LR +RH ++IK
Sbjct: 12  LGEGSFGKVKLAYHTTTGQK---VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  S D        +V EY GN  L D++ Q +   E       Q+      + SA+
Sbjct: 69  LYDVIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAV 116
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSS 708
           EY H H    +VH DLKP N+LLD  +   + DFGL+  ++  + L TS  +P+ +
Sbjct: 117 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 169

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 25/176 (14%)
Query: 540 IGQGSFGSV---YKGILGEDEMIVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLIK 593
           +G+GSFG V   Y    G+    VA+K+IN K   K   +  +  E   LR +RH ++IK
Sbjct: 16  LGEGSFGKVKLAYHTTTGQK---VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  S D        +V EY GN  L D++ Q +   E       Q+      + SA+
Sbjct: 73  LYDVIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAV 120
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSS 708
           EY H H    +VH DLKP N+LLD  +   + DFGL+  ++  + L TS  +P+ +
Sbjct: 121 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 173

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 36/203 (17%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-------FRSFVAECEA 582
           A +E      IG+G FG V+KG L +D+ +VA+K + L            F+ F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           + N+ H N++K+  +  +          +V E++  G L    H+  D+    K S+  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDL---YHRLLDKAHPIKWSV--K 124
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLSSHH 697
           L + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DFG         
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--------- 174
Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
             TS ++  S  G+ G   ++AP
Sbjct: 175 --TSQQSVHSVSGLLGNFQWMAP 195

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  G L D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVMEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 29/174 (16%)
Query: 540 IGQGSFGSVYKGILGE--------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           +G+G+FG V+   L E        D+M+VAVK +      A + F  E E L N++H ++
Sbjct: 23  LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC----------KLSLIQ 641
           +K   +C        D   +VFEYM +G L  +L        +           +L L Q
Sbjct: 80  VKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            L+IA  +AS + YL        VH DL   N L+  +++  +GDFG+++ + S
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 36/203 (17%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-------FRSFVAECEA 582
           A +E      IG+G FG V+KG L +D+ +VA+K + L            F+ F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           + N+ H N++K+  +  +          +V E++  G   D  H+  D+    K S+  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSV--K 124
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLSSHH 697
           L + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DFGL        
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-------- 175
Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
              S ++  S  G+ G   ++AP
Sbjct: 176 ---SQQSVHSVSGLLGNFQWMAP 195

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL  +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  G L D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGLA+ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 720 P 720
           P
Sbjct: 184 P 184

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +GQG FG V+ G        VA+K +         +F+ E + ++ +RH  L+++  + S
Sbjct: 193 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 251 EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 300
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                VH DL+ +N+L+  ++V  V DFGL + +  +         ++  G K  + + A
Sbjct: 301 N---YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY-------TARQGAKFPIKWTA 350
Query: 720 P 720
           P
Sbjct: 351 P 351

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 540 IGQGSFGSV-----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V     Y     +D+++VAVK +      A + F  E E L N++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLH-QSNDQVEVC------KLSLIQRLNIAI 647
             +C        D   +VFEYM +G L  +L     D V +       +L+  Q L+IA 
Sbjct: 81  YGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            +A+ + YL        VH DL   N L+  +++  +GDFG+++ + S
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 180

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 28/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRH 588
           SE +    IG G FG V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 59
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L+++  +C            LVFE+M +G L D+L           L     L + +D
Sbjct: 60  PKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 109
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+    LD      +SS
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQY---TSS 159
Query: 709 IGIKGTVGYVAPGKF 723
            G K  V + +P  F
Sbjct: 160 TGTKFPVKWASPEVF 174

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 28/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRH 588
           SE +    IG G FG V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L+++  +C            LVFE+M +G L D+L           L     L + +D
Sbjct: 62  PKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+    LD      +SS
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQY---TSS 161
Query: 709 IGIKGTVGYVAPGKF 723
            G K  V + +P  F
Sbjct: 162 TGTKFPVKWASPEVF 176

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 28/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRH 588
           SE +    IG G FG V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L+++  +C            LVFE+M +G L D+L           L     L + +D
Sbjct: 65  PKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+    LD      +SS
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQY---TSS 164
Query: 709 IGIKGTVGYVAPGKF 723
            G K  V + +P  F
Sbjct: 165 TGTKFPVKWASPEVF 179

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 116/418 (27%), Positives = 172/418 (41%), Gaps = 77/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 9   INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 68
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 69  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 123
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q N G    N +  +  L N
Sbjct: 124 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLNFG----NQVTDLKPLAN 170
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 171 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 224
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 225 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 278
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 279 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 311
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +  S+N    +   SL  L +I +L    N  S   P
Sbjct: 312 YFNNISDISPV--SSLTKLQRLFFSNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 365

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGLA+ L  
Sbjct: 188 VSDFGLARVLED 199

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLI 592
            ++IG+G+FG V K  + +D + +   +  +K+   K   R F  E E L  +  H N+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLIQR 642
            ++  C   + +G  +  L  EY  +G+L D+L +S                  LS  Q 
Sbjct: 80  NLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L+ A DVA  ++YL    Q   +H DL   N+L+  + VA + DFGL++    +   T  
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 191
Query: 703 KTPSSSIGIK 712
           + P   + I+
Sbjct: 192 RLPVRWMAIE 201

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLI 592
            ++IG+G+FG V K  + +D + +   +  +K+   K   R F  E E L  +  H N+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLIQR 642
            ++  C   + +G  +  L  EY  +G+L D+L +S                  LS  Q 
Sbjct: 90  NLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L+ A DVA  ++YL    Q   +H DL   N+L+  + VA + DFGL++    +   T  
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 703 KTPSSSIGIK 712
           + P   + I+
Sbjct: 202 RLPVRWMAIE 211

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 36/203 (17%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-------FRSFVAECEA 582
           A +E      IG+G FG V+KG L +D+ +VA+K + L            F+ F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           + N+ H N++K+  +  +          +V E++  G   D  H+  D+    K S+  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSV--K 124
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLSSHH 697
           L + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DF L        
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL-------- 175
Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
              S ++  S  G+ G   ++AP
Sbjct: 176 ---SQQSVHSVSGLLGNFQWMAP 195

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 21/174 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII- 595
           +G+GSFG V      + +  VA+K I+   LK+         E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            I + TD        +V EY G G L D++ +     E       Q+      +  AIEY
Sbjct: 77  VITTPTDI------VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQ------IICAIEY 123
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS-HHLDTSSKTPSSS 708
            H H    +VH DLKP N+LLD ++   + DFGL+  ++  + L TS  +P+ +
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 22  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 81
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 82  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 133
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 134 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 185
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 186 VSDFGLSRVLED 197

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 16/174 (9%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y          VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
             IC+     G+    L+ E++ +GSL+++L ++ +     K++L Q+L  A+ +   ++
Sbjct: 89  KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMD 140
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           YL        VH DL   NVL++ +    +GDFGL K + +     + K    S
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 28/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRH 588
           SE +    IG G FG V+ G  L +D+  VA+K I   ++G+     F+ E E +  + H
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---KEGSMSEDDFIEEAEVMMKLSH 81
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L+++  +C            LVFE+M +G L D+L           L     L + +D
Sbjct: 82  PKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 131
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+    LD      +SS
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQY---TSS 181
Query: 709 IGIKGTVGYVAPGKF 723
            G K  V + +P  F
Sbjct: 182 TGTKFPVKWASPEVF 196

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 16/174 (9%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y          VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
             IC+     G+    L+ E++ +GSL+++L ++ +     K++L Q+L  A+ +   ++
Sbjct: 77  KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMD 128
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           YL        VH DL   NVL++ +    +GDFGL K + +     + K    S
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV-AECEALRNIRHRN 590
           ++F     +G+G FG V++     D+   A+K I L  +   R  V  E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 591 LIKIIT--ICSSTDFKGVDFKALVFEYMG-----NGSLEDWLHQSNDQVEVCKLSLIQR- 642
           +++     +  +T  K       V+ Y+        +L+DW++        C +   +R 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR------CTIEERERS 118
Query: 643 --LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
             L+I + +A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +     + 
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 701 SSKTP----SSSIGIKGTVGYVAPGK 722
           +  TP    +   G  GT  Y++P +
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQ 201

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 512 TSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVINL 567
           T+P + Q  ++   EL +         ++G G+FG+VYKGI + E E +   VA+K++N 
Sbjct: 25  TAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE 77
Query: 568 KQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
                A   F+ E   + ++ H +L++++ +C S   +      LV + M +G L +++H
Sbjct: 78  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH 131
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
           +  D +    L     LN  + +A  + YL       +VH DL   NVL+       + D
Sbjct: 132 EHKDNIGSQLL-----LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITD 183
Query: 687 FGLAKFLS 694
           FGLA+ L 
Sbjct: 184 FGLARLLE 191

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 37/214 (17%)
Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL--- 567
           +Y + ++A  EF+            +IG G FG V  G L   G+ E+ VA+K + +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 568 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
            KQ+   R F+ E   +    H N+I +  + + +  K V    +V EYM NGSL+ +L 
Sbjct: 64  EKQR---RDFLGEASIMGQFDHPNIIHLEGVVTKS--KPV---MIVTEYMENGSLDTFLK 115
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
           +++ Q      ++IQ + +   +++ ++YL        VH DL   N+L++ ++V  V D
Sbjct: 116 KNDGQ-----FTVIQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 167
Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           FGL++      L+   +   ++ G K  + + AP
Sbjct: 168 FGLSRV-----LEDDPEAAYTTRGGKIPIRWTAP 196

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y         +VAVK +        RS +  E + LR + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              C      G     LV EY+  GSL D+L + +       + L Q L  A  +   + 
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 148
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           YLH       +H DL   NVLLD+D +  +GDFGLAK +   H
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 28/173 (16%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V+       +  +D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---------SNDQVEVCKLSLIQRLNI 645
             +C+    +G     +VFEYM +G L  +L             + V    L L Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 646 AIDVASAIEY---LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           A  VA+ + Y   LH       VH DL   N L+   +V  +GDFG+++ + S
Sbjct: 164 ASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V EYM NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL + L  
Sbjct: 188 VSDFGLGRVLED 199

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 512 TSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVINL 567
           T+P + Q  ++   EL +         ++G G+FG+VYKGI + E E +   VA+K++N 
Sbjct: 2   TAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE 54
Query: 568 KQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
                A   F+ E   + ++ H +L++++ +C S   +      LV + M +G L +++H
Sbjct: 55  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH 108
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
           +  D +    L     LN  + +A  + YL       +VH DL   NVL+       + D
Sbjct: 109 EHKDNIGSQLL-----LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITD 160
Query: 687 FGLAKFLS 694
           FGLA+ L 
Sbjct: 161 FGLARLLE 168

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 115/418 (27%), Positives = 171/418 (40%), Gaps = 77/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 9   INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 68
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 69  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 123
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q N G    N +  +  L N
Sbjct: 124 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLNFG----NQVTDLKPLAN 170
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 171 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 224
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 225 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 278
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 279 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 311
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +   +N    +   SL  L +I +L    N  S   P
Sbjct: 312 YFNNISDISPV--SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 365

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 28/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRH 588
           SE +    IG G FG V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L+++  +C            LVFE+M +G L D+L           L     L + +D
Sbjct: 62  PKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YL    +  ++H DL   N L+  + V  V DFG+ +F+    LD      +SS
Sbjct: 112 VCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQY---TSS 161
Query: 709 IGIKGTVGYVAPGKF 723
            G K  V + +P  F
Sbjct: 162 TGTKFPVKWASPEVF 176

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLI 592
            ++IG+G+FG V K  + +D + +   +  +K+   K   R F  E E L  +  H N+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLIQR 642
            ++  C   + +G  +  L  EY  +G+L D+L +S                  LS  Q 
Sbjct: 87  NLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L+ A DVA  ++YL    Q   +H +L   N+L+  + VA + DFGL++    +   T  
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 198
Query: 703 KTPSSSIGIK 712
           + P   + I+
Sbjct: 199 RLPVRWMAIE 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 87/170 (51%), Gaps = 23/170 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALR 584
           +  S   ++G G FG V  G L    + E+ VA+K + +    KQ+   R F+ E   + 
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMG 89
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
              H N+I++  + + +  K V    +V EYM NGSL+ +L + + Q      ++IQ + 
Sbjct: 90  QFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVG 139
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L 
Sbjct: 140 MLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE 186

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 87/170 (51%), Gaps = 23/170 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALR 584
           +  S   ++G G FG V  G L    + E+ VA+K + +    KQ+   R F+ E   + 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMG 72
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
              H N+I++  + + +  K V    +V EYM NGSL+ +L + + Q      ++IQ + 
Sbjct: 73  QFDHPNIIRLEGVVTKS--KPV---MIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVG 122
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L 
Sbjct: 123 MLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE 169

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 115/418 (27%), Positives = 170/418 (40%), Gaps = 76/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 9   INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 68
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 69  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 123
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q +       DL     L N
Sbjct: 124 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLSFSSNQVTDLKP---LAN 171
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 172 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 225
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 226 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 279
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 280 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 312
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +  S+N    +   SL  L +I +L    N  S   P
Sbjct: 313 YFNNISDISPV--SSLTKLQRLFFSNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 366

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 28/173 (16%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V+       +  +D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---------SNDQVEVCKLSLIQRLNI 645
             +C+    +G     +VFEYM +G L  +L             + V    L L Q L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 646 AIDVASAIEY---LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           A  VA+ + Y   LH       VH DL   N L+   +V  +GDFG+++ + S
Sbjct: 135 ASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 181

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 28/173 (16%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V+       +  +D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---------SNDQVEVCKLSLIQRLNI 645
             +C+    +G     +VFEYM +G L  +L             + V    L L Q L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 646 AIDVASAIEY---LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           A  VA+ + Y   LH       VH DL   N L+   +V  +GDFG+++ + S
Sbjct: 141 ASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 187

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 115/418 (27%), Positives = 169/418 (40%), Gaps = 76/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 9   INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 68
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 69  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 123
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q N       DL     L N
Sbjct: 124 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLNFSSNQVTDLKP---LAN 171
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 172 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 225
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 226 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 279
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 280 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 312
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +   +N    +   SL  L +I +L    N  S   P
Sbjct: 313 YFNNISDISPV--SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 366

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 28/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRH 588
           SE +    IG G FG V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L+++  +C            LV E+M +G L D+L           L     L + +D
Sbjct: 63  PKLVQLYGVCLEQAPI-----CLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 112
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+    LD      +SS
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQY---TSS 162
Query: 709 IGIKGTVGYVAPGKF 723
            G K  V + +P  F
Sbjct: 163 TGTKFPVKWASPEVF 177

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 33/169 (19%)
Query: 538 NMIGQGSFGSVYKGILGEDEMI---VAVKVINLKQK-------GAFRSFVAECEALRNIR 587
           + +G G+FG V    +G+ E+    VAVK++N +QK       G  R    E + L+  R
Sbjct: 22  DTLGVGTFGKVK---VGKHELTGHKVAVKILN-RQKIRSLDVVGKIRR---EIQNLKLFR 74
Query: 588 HRNLIKIITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           H ++IK+  + S+ +D        +V EY+  G L D++ ++    E     L Q+    
Sbjct: 75  HPHIIKLYQVISTPSDI------FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ---- 124
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             + S ++Y H H    +VH DLKP NVLLD  M A + DFGL+  +S 
Sbjct: 125 --ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 29  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 86  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 135
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 136 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 185
Query: 719 AP 720
           AP
Sbjct: 186 AP 187

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 84  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 133
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 134 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 183
Query: 719 AP 720
           AP
Sbjct: 184 AP 185

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 30  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 87  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 136
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 137 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 186
Query: 719 AP 720
           AP
Sbjct: 187 AP 188

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 26  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 83  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 132
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 133 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWT 182
Query: 719 AP 720
           AP
Sbjct: 183 AP 184

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 84  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 133
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 134 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWT 183
Query: 719 AP 720
           AP
Sbjct: 184 AP 185

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 31  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 88  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 137
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 138 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWT 187
Query: 719 AP 720
           AP
Sbjct: 188 AP 189

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 43/217 (19%)
Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL--- 567
           ++ + ++A  EF+            +IG G FG V  G L   G+ E+ VA+K +     
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT 70
Query: 568 -KQKGAFRSFVAECEALRNIRHRNLIK---IITICSSTDFKGVDFKALVFEYMGNGSLED 623
            KQ+   R F++E   +    H N+I    ++T C            ++ EYM NGSL+ 
Sbjct: 71  DKQR---RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDA 119
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L +++      + ++IQ + +   + S ++YL        VH DL   N+L++ ++V  
Sbjct: 120 FLRKNDG-----RFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCK 171
Query: 684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           V DFG+++      L+   +   ++ G K  + + AP
Sbjct: 172 VSDFGMSRV-----LEDDPEAAYTTRGGKIPIRWTAP 203

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 23  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 80  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 129
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 130 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 179
Query: 719 AP 720
           AP
Sbjct: 180 AP 181

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 177
Query: 719 AP 720
           AP
Sbjct: 178 AP 179

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 114/418 (27%), Positives = 172/418 (41%), Gaps = 77/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 13  INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 72
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 73  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 127
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q + G    N +  +  L N
Sbjct: 128 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLSFG----NQVTDLKPLAN 174
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 175 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 228
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 229 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 282
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 283 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 315
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +  ++N    +   SL  L +I +L    N  S   P
Sbjct: 316 YFNNISDISPV--SSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP 369

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWT 177
Query: 719 AP 720
           AP
Sbjct: 178 AP 179

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y         +VAVK +        RS +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              C     K +    LV EY+  GSL D+L + +       + L Q L  A  +   + 
Sbjct: 82  KGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           YLH       +H +L   NVLLD+D +  +GDFGLAK +   H
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 22  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 79  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 128
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 129 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 178
Query: 719 AP 720
           AP
Sbjct: 179 AP 180

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G FG V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +  +        LV +Y  +GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 92  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLH 143
Query: 658 HHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                   +P + H DLK  N+L+  +    + D GLA    S   DT    P+  +G K
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 202
Query: 713 GTVGYVAP 720
               Y+AP
Sbjct: 203 ---RYMAP 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 588
           +  S+F    ++GQG+FG V K     D    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 589 RNLIKIITIC-SSTDF----KGVDFKALVF---EYMGNGSLEDWLHQSNDQVEVCKLSLI 640
           + +++         +F      V  K+ +F   EY  NG+L D +H  N   +  +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK--------- 691
            R      +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK         
Sbjct: 122 FR-----QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 692 FLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
            L S +L  SS   +S+I   GT  YVA
Sbjct: 174 KLDSQNLPGSSDNLTSAI---GTAMYVA 198

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX-------TAREGAKFPIKWT 177
Query: 719 AP 720
           AP
Sbjct: 178 AP 179

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y         +VAVK +        RS +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              C     K +    LV EY+  GSL D+L + +       + L Q L  A  +   + 
Sbjct: 82  KGCCEDQGEKSLQ---LVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           YLH       +H +L   NVLLD+D +  +GDFGLAK +   H
Sbjct: 132 YLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G FG V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +  +        LV +Y  +GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLH 156
Query: 658 HHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                   +P + H DLK  N+L+  +    + D GLA    S   DT    P+  +G K
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 215
Query: 713 GTVGYVAP 720
               Y+AP
Sbjct: 216 ---RYMAP 220

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+ G    +   VA+K +         SF+ E + ++ ++H  L+++  + S
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-VAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      +V EYM  GSL D+L     +     L L   +++A  VA+ + Y+   
Sbjct: 75  EEPI------YIVTEYMNKGSLLDFLKDGEGRA----LKLPNLVDMAAQVAAGMAYIERM 124
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                +H DL+ +N+L+ + ++  + DFGLA+ +  +         ++  G K  + + A
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEX-------TARQGAKFPIKWTA 174
Query: 720 P 720
           P
Sbjct: 175 P 175

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 16  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 73  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 122
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 123 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWT 172
Query: 719 AP 720
           AP
Sbjct: 173 AP 174

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 81
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 82  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 90/193 (46%), Gaps = 26/193 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEAL-RNIR 587
           S+F    +IG+GSFG V       +E+  AVKV+  K   +K   +  ++E   L +N++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H  L+ +        F+  D    V +Y+  G L   L     Q E C L    R   A 
Sbjct: 98  HPFLVGL-----HFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARF-YAA 146
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ASA+ YLH      +V+ DLKP N+LLD      + DFGL K    H+  TS+     
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST----- 198
Query: 708 SIGIKGTVGYVAP 720
                GT  Y+AP
Sbjct: 199 ---FCGTPEYLAP 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 79
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 80  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH DL   N ++ HD    +GDFG+ +
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V E M NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEXMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G FG V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +  +        LV +Y  +GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 72  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 123
Query: 658 HHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                   +P + H DLK  N+L+  +    + D GLA    S   DT    P+  +G K
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 182
Query: 713 GTVGYVAP 720
               Y+AP
Sbjct: 183 ---RYMAP 187

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 22/189 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVINLKQ-KGAFRSFVAECEALRNI 586
           +E     ++G G FG+V+KG+ + E E I   V +KVI  K  + +F++      A+ ++
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            H ++++++ +C  +  +      LV +Y+  GSL D + Q    +    L     LN  
Sbjct: 73  DHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWG 121
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL---SSHHLDTSSK 703
           + +A  + YL  H    MVH +L   NVLL       V DFG+A  L       L + +K
Sbjct: 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 704 TPSSSIGIK 712
           TP   + ++
Sbjct: 179 TPIKWMALE 187

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G FG V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +  +        LV +Y  +GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 69  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLH 120
Query: 658 HHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                   +P + H DLK  N+L+  +    + D GLA    S   DT    P+  +G K
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 179
Query: 713 GTVGYVAP 720
               Y+AP
Sbjct: 180 ---RYMAP 184

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y         +VAVK +        RS +  E E LR + H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              C     K V    LV EY+  GSL D+L +         + L Q L  A  +   + 
Sbjct: 77  KGCCEDQGEKSVQ---LVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGMA 126
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           YLH       +H  L   NVLLD+D +  +GDFGLAK +   H
Sbjct: 127 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 166

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 34/194 (17%)
Query: 537 SNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHR 589
             +IG G FG V  G L   G+ E+ VA+K +      KQ+   R F++E   +    H 
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDFLSEASIMGQFDHP 69
Query: 590 NLIK---IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           N+I    ++T C            ++ EYM NGSL+ +L +++      + ++IQ + + 
Sbjct: 70  NIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG-----RFTVIQLVGML 116
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
             + S ++YL        VH DL   N+L++ ++V  V DFG+++      L+   +   
Sbjct: 117 RGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAY 168
Query: 707 SSIGIKGTVGYVAP 720
           ++ G K  + + AP
Sbjct: 169 TTRGGKIPIRWTAP 182

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 540 IGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
           +G+G FG V    Y         +VAVK +        RS +  E E LR + H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              C     K V    LV EY+  GSL D+L +         + L Q L  A  +   + 
Sbjct: 76  KGCCEDQGEKSVQ---LVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGMA 125
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           YLH       +H  L   NVLLD+D +  +GDFGLAK +   H
Sbjct: 126 YLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 165

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 34/194 (17%)
Query: 537 SNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALRNIRHR 589
             +IG G FG V  G L   G+ E+ VA+K +      KQ+   R F++E   +    H 
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDFLSEASIMGQFDHP 75
Query: 590 NLIK---IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           N+I    ++T C            ++ EYM NGSL+ +L +++      + ++IQ + + 
Sbjct: 76  NIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG-----RFTVIQLVGML 122
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
             + S ++YL        VH DL   N+L++ ++V  V DFG+++      L+   +   
Sbjct: 123 RGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRV-----LEDDPEAAY 174
Query: 707 SSIGIKGTVGYVAP 720
           ++ G K  + + AP
Sbjct: 175 TTRGGKIPIRWTAP 188

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G FG V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +  +        LV +Y  +GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 67  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLH 118
Query: 658 HHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                   +P + H DLK  N+L+  +    + D GLA    S   DT    P+  +G K
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 177
Query: 713 GTVGYVAP 720
               Y+AP
Sbjct: 178 ---RYMAP 182

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 91/189 (48%), Gaps = 22/189 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI---VAVKVINLKQ-KGAFRSFVAECEALRNI 586
           +E     ++G G FG+V+KG+ + E E I   V +KVI  K  + +F++      A+ ++
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            H ++++++ +C  +  +      LV +Y+  GSL D + Q    +    L     LN  
Sbjct: 91  DHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWG 139
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH---LDTSSK 703
           + +A  + YL  H    MVH +L   NVLL       V DFG+A  L       L + +K
Sbjct: 140 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 196
Query: 704 TPSSSIGIK 712
           TP   + ++
Sbjct: 197 TPIKWMALE 205

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 90/188 (47%), Gaps = 24/188 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G FG V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N++  I  
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            +  +        LV +Y  +GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLH 117
Query: 658 HHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                   +P + H DLK  N+L+  +    + D GLA    S   DT    P+  +G K
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 176
Query: 713 GTVGYVAP 720
               Y+AP
Sbjct: 177 ---RYMAP 181

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 114/418 (27%), Positives = 171/418 (40%), Gaps = 77/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 14  INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 73
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 128
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q + G    N +  +  L N
Sbjct: 129 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLSFG----NQVTDLKPLAN 175
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 176 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 229
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 230 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 283
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 284 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 316
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +   +N    +   SL  L +I +L    N  S   P
Sbjct: 317 YFNNISDISPV--SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR 587
           ATS +     IG G++G+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 588 ---HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ---VEVCKLSLIQ 641
              H N+++++ +C+++         LVFE++ +  L  +L ++       E  K  + Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            L         +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 121 FLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR 587
           ATS +     IG G++G+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 588 ---HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ---VEVCKLSLIQ 641
              H N+++++ +C+++         LVFE++ +  L  +L ++       E  K  + Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            L         +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 121 FLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 19/173 (10%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR 587
           ATS +     IG G++G+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 588 ---HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ---VEVCKLSLIQ 641
              H N+++++ +C+++         LVFE++ +  L  +L ++       E  K  + Q
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            L         +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 121 FLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 25/192 (13%)
Query: 513 SPMEKQFPMVSYAELSKA--TSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL 567
            P   + P  +  E +K    +  S   ++G G FG V  G L    + E+ VA+K + +
Sbjct: 24  DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 568 ----KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLED 623
               KQ+   R F+ E   +    H N+I++  + + +  K V    +V E M NGSL+ 
Sbjct: 84  GYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTKS--KPV---MIVTEXMENGSLDS 135
Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 683
           +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  
Sbjct: 136 FLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---AVHRDLAARNILINSNLVCK 187
Query: 684 VGDFGLAKFLSS 695
           V DFGL++ L  
Sbjct: 188 VSDFGLSRVLED 199

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 30/185 (16%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
           C+     F       ++ EYM NG L ++L +   + +  +L     L +  DV  A+EY
Sbjct: 88  CTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEY 135
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L        +H DL   N L++   V  V DFGL++++    LD      +SS+G K  V
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEE---TSSVGSKFPV 185
Query: 716 GYVAP 720
            +  P
Sbjct: 186 RWSPP 190

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 16/184 (8%)
Query: 513 SPMEKQFPMVSYAELSKATSE-FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG 571
           +P  +Q   +    L+K   E F     +G+GS+GSVYK I  E   IVA+K + +  + 
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ES 66
Query: 572 AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ 631
             +  + E   ++     +++K       + FK  D   +V EY G GS+ D +   N  
Sbjct: 67  DLQEIIKEISIMQQCDSPHVVKYY----GSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKT 121
Query: 632 VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   +++ I +  +       +EYLH   +   +H D+K  N+LL+ +  A + DFG+A 
Sbjct: 122 LTEDEIATILQSTL-----KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 692 FLSS 695
            L+ 
Sbjct: 174 QLTD 177

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFRSFVAEC 580
           ++      +   + +G+G F +VYK        IVA+K I L  +     G  R+ + E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 581 EALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
           + L+ + H N+I ++       F      +LVF++M    LE  +    D   V   S I
Sbjct: 64  KLLQELSHPNIIGLLDA-----FGHKSNISLVFDFM-ETDLEVII---KDNSLVLTPSHI 114
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           +   +       +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK   S
Sbjct: 115 KAYMLM--TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 114/418 (27%), Positives = 169/418 (40%), Gaps = 76/418 (18%)
Query: 9   IGSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           I  +F   ALA     + GK  + D +      QV  ++ + LG K    +  L NL Q+
Sbjct: 9   INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQI 68
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           N + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + 
Sbjct: 69  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL---ANLTNLTGLTLFNNQITDID 123
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L N +NL  L+LS+N        D S+L  L  L  +Q +       DL     L N
Sbjct: 124 P--LKNLTNLNRLELSSNTIS-----DISALSGLTSL--QQLSFSSNQVTDLKP---LAN 171
Query: 187 CSSLKVLSLSDNQFGG-ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            ++L+ L +S N+     +   + NL S     +   NQIS   PLGI  L NL  L++ 
Sbjct: 172 LTTLERLDISSNKVSDISVLAKLTNLES----LIATNNQISDITPLGI--LTNLDELSLN 225
Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG---- 299
            NQL   GT+      L NL  L L  N +    P  L  LTKL +L LG+N +      
Sbjct: 226 GNQLKDIGTL----ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 279
Query: 300 -------NFIASQNKLIGALPQQLLSITTXXXXXXXXXXXXXXXXPQQVGNLKNLIILDI 352
                  N   ++N+L    P                           + NLKNL  L +
Sbjct: 280 AGLTALTNLELNENQLEDISP---------------------------ISNLKNLTYLTL 312
Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
             N  S + PV  S+   L+ +   +N    +   SL  L +I +L    N  S   P
Sbjct: 313 YFNNISDISPV--SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 366

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVIN---LKQKGAFRSFVAECEALR 584
           +  +    ++G+GSFG V   IL +D++     AVKVI+   +KQK    S + E + L+
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N++K+        F+   +  LV E    G L D +      +   + S +    
Sbjct: 88  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 136
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL     S H + S
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEAS 188
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 189 KKMKDKI----GTAYYIAP 203

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 12/190 (6%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDE---MIVAVKVI--NLKQKGAFRSFVAECEALRNI 586
            +F+   M+G+G FGSV +  L +++   + VAVK++  ++        F+ E   ++  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 587 RHRNLIKIITICSSTDFKG-VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            H ++ K++ +   +  KG +    ++  +M +G L  +L  S        L L   +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS---HHLDTSS 702
            +D+A  +EYL        +H DL   N +L  DM   V DFGL++ + S   +    +S
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 703 KTPSSSIGIK 712
           K P   + ++
Sbjct: 200 KLPVKWLALE 209

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 23/170 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINL----KQKGAFRSFVAECEALR 584
           +  S   ++G G FG V  G L    + E+ VA+K + +    KQ+   R F+ E   + 
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMG 72
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
              H N+I++  + + +  K V    +V E M NGSL+ +L + + Q      ++IQ + 
Sbjct: 73  QFDHPNIIRLEGVVTKS--KPV---MIVTEXMENGSLDSFLRKHDAQ-----FTVIQLVG 122
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L 
Sbjct: 123 MLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE 169

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 30/185 (16%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
           C+     F       ++ EYM NG L ++L +   + +  +L     L +  DV  A+EY
Sbjct: 88  CTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEY 135
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L        +H DL   N L++   V  V DFGL++++    LD      +SS+G K  V
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY---TSSVGSKFPV 185
Query: 716 GYVAP 720
            +  P
Sbjct: 186 RWSPP 190

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G FG V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 17  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 74  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 123
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H +L+ +N+L+   +   + DFGLA+ +  +         ++  G K  + + 
Sbjct: 124 RN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY-------TAREGAKFPIKWT 173
Query: 719 AP 720
           AP
Sbjct: 174 AP 175

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL--- 567
           +Y E  +A   F+            +IG G  G V  G L   G+ ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 568 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
            +Q+   R F++E   +    H N+I++  + +           +V EYM NGSL+ +L 
Sbjct: 91  ERQR---RDFLSEASIMGQFDHPNIIRLEGVVTRGRLA-----MIVTEYMENGSLDTFLR 142
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
             + Q      +++Q + +   V + + YL        VH DL   NVL+D ++V  V D
Sbjct: 143 THDGQ-----FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           FGL++ L     D +  T    I I+ T 
Sbjct: 195 FGLSRVLEDDP-DAAXTTTGGKIPIRWTA 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 28/187 (14%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G   + +  VAVK+I   ++G+     F  E + +  + H  L+K   +
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 598 CSSTDFKGVDFK-ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           CS       ++   +V EY+ NG L ++L      +E  +L     L +  DV   + +L
Sbjct: 72  CSK------EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFL 120
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
             H     +H DL   N L+D D+   V DFG+ +++    LD       SS+G K  V 
Sbjct: 121 ESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQY---VSSVGTKFPVK 170
Query: 717 YVAPGKF 723
           + AP  F
Sbjct: 171 WSAPEVF 177

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 30/185 (16%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
           C+     F       ++ EYM NG L ++L +   + +  +L     L +  DV  A+EY
Sbjct: 73  CTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEY 120
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L        +H DL   N L++   V  V DFGL++++    LD      +SS+G K  V
Sbjct: 121 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY---TSSVGSKFPV 170
Query: 716 GYVAP 720
            +  P
Sbjct: 171 RWSPP 175

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 30/185 (16%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
           C+     F       ++ EYM NG L ++L +   + +  +L     L +  DV  A+EY
Sbjct: 79  CTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L        +H DL   N L++   V  V DFGL++++    LD      +SS+G K  V
Sbjct: 127 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY---TSSVGSKFPV 176
Query: 716 GYVAP 720
            +  P
Sbjct: 177 RWSPP 181

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVIN---LKQKGAFRSFVAECEALR 584
           +  +    ++G+GSFG V   IL +D++     AVKVI+   +KQK    S + E + L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N++K+        F+   +  LV E    G L D +      +   + S +    
Sbjct: 82  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 130
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL     S H + S
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEAS 182
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 183 KKMKDKI----GTAYYIAP 197

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 89/183 (48%), Gaps = 26/183 (14%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
           C+    + +    ++ EYM NG L ++L +   + +  +L     L +  DV  A+EYL 
Sbjct: 68  CTKQ--RPI---FIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 117
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
                  +H DL   N L++   V  V DFGL++++    LD      +SS+G K  V +
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY---TSSVGSKFPVRW 167
Query: 718 VAP 720
             P
Sbjct: 168 SPP 170

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 94  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 144
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 708 SIGIK 712
            + ++
Sbjct: 202 WMALE 206

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 114 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 164
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 165 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 221
Query: 708 SIGIK 712
            + ++
Sbjct: 222 WMALE 226

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 154 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 204
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 89/183 (48%), Gaps = 26/183 (14%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
           C+    + +    ++ EYM NG L ++L +   + +  +L     L +  DV  A+EYL 
Sbjct: 72  CTKQ--RPI---FIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 121
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
                  +H DL   N L++   V  V DFGL++++    LD      +SS+G K  V +
Sbjct: 122 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY---TSSVGSKFPVRW 171
Query: 718 VAP 720
             P
Sbjct: 172 SPP 174

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVIN---LKQKGAFRSFVAECEALR 584
           +  +    ++G+GSFG V   IL +D++     AVKVI+   +KQK    S + E + L+
Sbjct: 48  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N++K+        F+   +  LV E    G L D +      +   + S +    
Sbjct: 105 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 153
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL     S H + S
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEAS 205
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 206 KKMKDKI----GTAYYIAP 220

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 87  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 137
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 138 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 708 SIGIK 712
            + ++
Sbjct: 195 WMALE 199

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 83
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 84  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH +L   N ++ HD    +GDFG+ +
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 113 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 163
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 164 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 220
Query: 708 SIGIK 712
            + ++
Sbjct: 221 WMALE 225

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 540 IGQGSFGSVYKG-----ILGEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +GQGSFG VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQRLNIAI 647
           ++++ + S    KG     +V E M +G L+ +L     + E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++A  + YL+       VH +L   N ++ HD    +GDFG+ +
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL--- 567
           +Y E  +A   F+            +IG G  G V  G L   G+ ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 568 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
            +Q+   R F++E   +    H N+I++  + +           +V EYM NGSL+ +L 
Sbjct: 91  ERQR---RDFLSEASIMGQFDHPNIIRLEGVVTRGRLA-----MIVTEYMENGSLDTFLR 142
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
             + Q      +++Q + +   V + + YL        VH DL   NVL+D ++V  V D
Sbjct: 143 THDGQ-----FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           FGL++ L     D +  T    I I+ T 
Sbjct: 195 FGLSRVLEDDP-DAAYTTTGGKIPIRWTA 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVIN---LKQKGAFRSFVAECEALR 584
           +  +    ++G+GSFG V   IL +D++     AVKVI+   +KQK    S + E + L+
Sbjct: 49  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N++K+        F+   +  LV E    G L D +      +   + S +    
Sbjct: 106 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 154
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL     S H + S
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEAS 206
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 207 KKMKDKI----GTAYYIAP 221

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 100 SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 150
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 151 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 708 SIGIK 712
            + ++
Sbjct: 203 WMALE 207

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 92  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 142
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 143 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 199
Query: 708 SIGIK 712
            + ++
Sbjct: 200 WMALE 204

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 90  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 140
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 708 SIGIK 712
            + ++
Sbjct: 198 WMALE 202

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 96  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 93  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 143
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 144 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 94  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 144
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 201
Query: 708 SIGIK 712
            + ++
Sbjct: 202 WMALE 206

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 95  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 708 SIGIK 712
            + ++
Sbjct: 203 WMALE 207

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 93  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 143
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL-----SSHHLDTSSKTPSS 707
           ++YL        VH DL   N +LD      V DFGLA+ +      S H  T +K P  
Sbjct: 144 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 200
Query: 708 SIGIK 712
            + ++
Sbjct: 201 WMALE 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 24/160 (15%)
Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNL 591
             IG+G+FG V+ G L  D  +VAVK        +LK K     F+ E   L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +++I +C+           +V E +  G    +L     ++ V  L     L +  D A+
Sbjct: 175 VRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAA 224
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            +EYL   C    +H DL   N L+    V  + DFG+++
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 24/160 (15%)
Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNL 591
             IG+G+FG V+ G L  D  +VAVK        +LK K     F+ E   L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +++I +C+           +V E +  G    +L     ++ V  L     L +  D A+
Sbjct: 175 VRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAA 224
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            +EYL   C    +H DL   N L+    V  + DFG+++
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 33/204 (16%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ-VEVC---------KLSLI 640
           +I ++  C+     G  +  ++ EY   G+L ++L       +E C         +LS  
Sbjct: 96  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  HH+D 
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 205
Query: 701 SSKTPSSSIGIKGTVGYVAPGKFF 724
             KT +  + +K    ++AP   F
Sbjct: 206 YKKTTNGRLPVK----WMAPEALF 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 588
           +  S+F    ++GQG+FG V K     D    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 589 RNLIKIITIC-SSTDF----KGVDFKALVF---EYMGNGSLEDWLHQSNDQVEVCKLSLI 640
           + +++         +F      V  K+ +F   EY  N +L D +H  N   +  +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK--------- 691
            R      +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK         
Sbjct: 122 FR-----QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 692 FLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
            L S +L  SS   +S+I   GT  YVA
Sbjct: 174 KLDSQNLPGSSDNLTSAI---GTAMYVA 198

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 33/204 (16%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ-VEVC---------KLSLI 640
           +I ++  C+     G  +  ++ EY   G+L ++L       +E C         +LS  
Sbjct: 81  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  HH+D 
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 190
Query: 701 SSKTPSSSIGIKGTVGYVAPGKFF 724
             KT +  + +K    ++AP   F
Sbjct: 191 YKKTTNGRLPVK----WMAPEALF 210

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L +++   +  AVK +N +   G    F+ E   +++  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++   +    +V  YM +G L +++        V  L     +   + VA  
Sbjct: 96  SLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +++L        VH DL   N +LD      V DFGLA+ +     D+      + + +K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 22/178 (12%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-----SFVAECEA 582
           S ATS +     IG G++G+VYK         VA+K + +   G        S V E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 583 LRNIR---HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ---VEVCK 636
           LR +    H N+++++ +C+++         LVFE++ +  L  +L ++       E  K
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
             + Q L         +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 124 DLMRQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 588
           +  S+F    ++GQG+FG V K     D    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNH 61
Query: 589 RNLIKIITIC-SSTDF----KGVDFKALVF---EYMGNGSLEDWLHQSNDQVEVCKLSLI 640
           + +++         +F      V  K+ +F   EY  N +L D +H  N   +  +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK--------- 691
            R      +  A+ Y+H      ++H +LKP N+ +D      +GDFGLAK         
Sbjct: 122 FR-----QILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 692 FLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
            L S +L  SS   +S+I   GT  YVA
Sbjct: 174 KLDSQNLPGSSDNLTSAI---GTAXYVA 198

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALR 584
            K   +F    ++G+GSF +V            A+K++  +   ++        E + + 
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
            + H   +K+        F   D + L F   Y  NG L  ++ +     E C      R
Sbjct: 66  RLDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TR 113
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
              A ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       S
Sbjct: 114 FYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ES 164
Query: 703 KTPSSSIGIKGTVGYVAP 720
           K   ++  + GT  YV+P
Sbjct: 165 KQARANXFV-GTAQYVSP 181

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
            K   +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R
Sbjct: 4   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 57
Query: 588 HRNLIKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            R+++  +         F   D + L F   Y  NG L  ++ +     E C      R 
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 112
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             A ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK
Sbjct: 113 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESK 163
Query: 704 TPSSSIGIKGTVGYVAP 720
              ++  + GT  YV+P
Sbjct: 164 QARANXFV-GTAQYVSP 179

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
            K   +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R
Sbjct: 3   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 56
Query: 588 HRNLIKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            R+++  +         F   D + L F   Y  NG L  ++ +     E C      R 
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 111
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             A ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK
Sbjct: 112 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESK 162
Query: 704 TPSSSIGIKGTVGYVAP 720
              ++  + GT  YV+P
Sbjct: 163 QARANXFV-GTAQYVSP 178

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
            K   +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R
Sbjct: 5   KKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTR 58
Query: 588 HRNLIKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            R+++  +         F   D + L F   Y  NG L  ++ +     E C      R 
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRF 113
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             A ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK
Sbjct: 114 YTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESK 164
Query: 704 TPSSSIGIKGTVGYVAP 720
              ++  + GT  YV+P
Sbjct: 165 QARANXFV-GTAQYVSP 180

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINL--- 567
           +Y + ++A  +F+            +IG G FG V  G L   G+ ++ VA+K + +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 568 -KQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
            KQ+   R F+ E   +    H N++ +  +   T  K V    +V E+M NG+L+ +L 
Sbjct: 85  EKQR---RDFLCEASIMGQFDHPNVVHLEGVV--TRGKPV---MIVIEFMENGALDAFLR 136
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
           + + Q      ++IQ + +   +A+ + YL        VH DL   N+L++ ++V  V D
Sbjct: 137 KHDGQ-----FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSD 188
Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           FGL++      ++   +   ++ G K  V + AP
Sbjct: 189 FGLSRV-----IEDDPEAVYTTTGGKIPVRWTAP 217

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 26/179 (14%)
Query: 522 VSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAE 579
           VS A  + +   +     +G+G++G VYK I       VA+K I L  +++G   + + E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKLS 638
              L+ ++HRN+I++ ++             L+FEY  N  L+ ++ ++ D  + V K  
Sbjct: 84  VSLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF 137
Query: 639 LIQRLNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAK 691
           L Q +N        + + H   C    +H DLKP N+LL         V  +GDFGLA+
Sbjct: 138 LYQLIN-------GVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 21/187 (11%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+GSF +VYKG+  E  + VA   +  ++  K   + F  E E L+ ++H N+++    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
             ST  KG     LV E   +G+L+ +L     + +V K+ +++  +    +   +++LH
Sbjct: 94  WEST-VKGKKCIVLVTELXTSGTLKTYLK----RFKVXKIKVLR--SWCRQILKGLQFLH 146
Query: 658 HHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
               PP++H DLK  N+ +        +GD GLA            K  S +  + GT  
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----------KRASFAKAVIGTPE 195
Query: 717 YVAPGKF 723
           + AP  +
Sbjct: 196 FXAPEXY 202

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 37/194 (19%)
Query: 541 GQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSS 600
            +G FG V+K  L  D   VAVK+  L+ K +++S   E  +   ++H NL++ I    +
Sbjct: 24  ARGRFGCVWKAQLMND--FVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFI----A 76
Query: 601 TDFKGVDFKA---LVFEYMGNGSLEDWLHQSN--DQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +G + +    L+  +   GSL D+L + N     E+C        ++A  ++  + Y
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYL-KGNIITWNELC--------HVAETMSRGLSY 127
Query: 656 LHHHC--------QPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTPS 706
           LH           +P + H D K  NVLL  D+ A + DFGLA +F          K P 
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRF-------EPGKPPG 180
Query: 707 SSIGIKGTVGYVAP 720
            + G  GT  Y+AP
Sbjct: 181 DTHGQVGTRRYMAP 194

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G  G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQAGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
           +           ++ EYM NGSL D+L   +      KL++ + L++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYV 718
                 +H DL+ +N+L+   +   + DFGLA+ +            ++  G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEX-------TAREGAKFPIKWT 177
Query: 719 AP 720
           AP
Sbjct: 178 AP 179

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 28/176 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L++                   +  I 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-----------EDEIEDIQQEIT 77
Query: 594 IITICSS---TDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K     ++ EY+G GS  D L       E   L   Q   I 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 130
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L+   +  ++
Sbjct: 131 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 183

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 18/176 (10%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VC 635
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             SL + + +A ++A  + YL+ +     VH DL   N  +  D    +GDFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 84/171 (49%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V ++ L++     A +  + E   + ++
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 109 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 157
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 158 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 205

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L++       +           +  I 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 72
Query: 594 IITICSS---TDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K     ++ EY+G GS  D L       E   L   Q   I 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 125
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A
Sbjct: 126 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 166

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L++       +           +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 594 IITICSS---TDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K     ++ EY+G GS       + D +E   L   Q   I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 110
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L+   +  ++
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 163

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 30/185 (16%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLIKIITI 597
           +G G FG V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L+++  +
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
           C+     F       ++ EYM NG L ++L +   + +  +L     L +  DV  A+EY
Sbjct: 73  CTKQRPIF-------IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEY 120
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L        +H DL   N L++   V  V DFGL++++    LD      +SS G K  V
Sbjct: 121 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEY---TSSRGSKFPV 170
Query: 716 GYVAP 720
            +  P
Sbjct: 171 RWSPP 175

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 28/164 (17%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L++       +           +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 594 IITICSS---TDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K     ++ EY+G GS       + D +E   L   Q   I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIATIL 110
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVIN---LKQKGAFRSFVAECEALR 584
           +  +    ++G+GSFG V   IL +D++     AVKVI+   +KQK    S + E + L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N+ K+        F+   +  LV E    G L D +      +   + S +    
Sbjct: 82  QLDHPNIXKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 130
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S I Y H +    +VH DLKP N+LL+    D    + DFGL     S H + S
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEAS 182
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 183 KKXKDKI----GTAYYIAP 197

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 26/192 (13%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           E     ++G+G+FG V K      +  VA+K   ++ +   ++F+ E   L  + H N++
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVELRQLSRVNHPNIV 65
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           K+   C       ++   LV EY   GSL + LH +     +   +    ++  +  +  
Sbjct: 66  KLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQG 115
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLL-DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           + YLH      ++H DLKP N+LL     V  + DFG A  + +H  +            
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----------- 164
Query: 712 KGTVGYVAPGKF 723
           KG+  ++AP  F
Sbjct: 165 KGSAAWMAPEVF 176

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 26/192 (13%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           E     ++G+G+FG V K      +  VA+K I  + +   ++F+ E   L  + H N++
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           K+   C       ++   LV EY   GSL + LH +     +   +    ++  +  +  
Sbjct: 65  KLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQG 114
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLL-DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           + YLH      ++H DLKP N+LL     V  + DFG A  + +H  +            
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----------- 163
Query: 712 KGTVGYVAPGKF 723
           KG+  ++AP  F
Sbjct: 164 KGSAAWMAPEVF 175

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 127
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-----SNDQVEV 634
              ++     ++++++ + S      V     + E M  G L+ +L       +N+ V +
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPAMANNPV-L 132
Query: 635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
              SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 29  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 82
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 136
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 188
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 189 NXFV-GTAQYVSP 200

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 191
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 192 NXFV-GTAQYVSP 203

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYL-----LNWC 124
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+ G    +   VAVK +      + ++F+ E   ++ ++H  L+++  + +
Sbjct: 21  LGAGQFGEVWMGYYN-NSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             +   +     + EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 79  REEPIYI-----ITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                +H DL+ +NVL+   ++  + DFGLA+ +  +         ++  G K  + + A
Sbjct: 130 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 179
Query: 720 P 720
           P
Sbjct: 180 P 180

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 124
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 26/188 (13%)
Query: 541 GQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSS 600
            +G FG V+K  L  +   VAVK+  ++ K ++++   E  +L  ++H N+++ I     
Sbjct: 33  ARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKR 89
Query: 601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC 660
                VD   L+  +   GSL D+L  +        +S  +  +IA  +A  + YLH   
Sbjct: 90  GTSVDVDL-WLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDI 141
Query: 661 -------QPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTPSSSIGIK 712
                  +P + H D+K  NVLL +++ A + DFGLA KF        + K+   + G  
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-------EAGKSAGDTHGQV 194
Query: 713 GTVGYVAP 720
           GT  Y+AP
Sbjct: 195 GTRRYMAP 202

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 28/164 (17%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+  + IG+GSFG VYKGI    + +VA+K+I+L++       + +            I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE-----------IT 69
Query: 594 IITICSS---TDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +++ C S   T + G   K+    ++ EY+G GS  D L      +E   ++ I R    
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A
Sbjct: 124 -EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 35  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 88
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 142
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 143 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 194
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 195 NXFV-GTAQYVSP 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 189
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 190 NXFV-GTAQYVSP 201

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 191
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 192 NXFV-GTAQYVSP 203

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 96  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ---- 146
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 147 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 201 HHIDXXKKTTNGRLPVK----WMAPEALF 225

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 33  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 86
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 140
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 192
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 193 NXFV-GTAQYVSP 204

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAE 579
           E   A  + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 580 CEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-----SNDQVEV 634
              ++     ++++++ + S      V     + E M  G L+ +L       +N+ V +
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPAMANNPV-L 122
Query: 635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
              SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 191
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 192 NXFV-GTAQYVSP 203

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 14  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 67
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 121
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 122 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 173
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 174 NXFV-GTAQYVSP 185

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 189
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 190 NXFV-GTAQYVSP 201

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 189
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 190 NAFV-GTAQYVSP 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 191
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 192 NXFV-GTAQYVSP 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRH 588
           ++S+F     +G G++ +VYKG+     + VA+K + L  ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN--DQVEVCKLSLIQRLNIA 646
            N++++  +  + +        LVFE+M N  L+ ++      +     +L+L++     
Sbjct: 63  ENIVRLYDVIHTENKL-----TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +     + + H +    ++H DLKP N+L++      +GDFGLA+
Sbjct: 117 L--LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRH 588
            +F    ++G+GSF +V            A+K++  +   ++        E + +  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 589 RNLIKIITICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
              +K+   C   D K      L F   Y  NG L  ++ +     E C      R   A
Sbjct: 97  PFFVKLY-FCFQDDEK------LYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA 144
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
            ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   
Sbjct: 145 -EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQAR 195
Query: 707 SSIGIKGTVGYVAP 720
           ++  + GT  YV+P
Sbjct: 196 ANXFV-GTAQYVSP 208

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 139
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 191
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 192 NXFV-GTAQYVSP 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 80/199 (40%), Gaps = 31/199 (15%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F    +IG G FG V+K     D     +K +    + A R    E +AL  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 593 KIITICSSTDFK---------GVDFKALV--FEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
                    D+              K L    E+   G+LE W+ +   +    KL  + 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVL 123
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
            L +   +   ++Y+H      +++ DLKPSN+ L       +GDFGL          TS
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV---------TS 171
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K        KGT+ Y++P
Sbjct: 172 LKNDGKRXRSKGTLRYMSP 190

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ---- 187
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 188 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 241
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 242 HHIDYYKKTTNGRLPVK----WMAPEALF 266

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGED-EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
           S+     ++G+G FG   K    E  E++V  ++I   ++   R+F+ E + +R + H N
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ-RTFLKEVKVMRCLEHPN 68
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++K I +      K ++F   + EY+  G+L   +   + Q         QR++ A D+A
Sbjct: 69  VLKFIGVLYKD--KRLNF---ITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIA 118
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           S + YLH      ++H DL   N L+  +    V DFGLA+ +
Sbjct: 119 SGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM 158

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 44/212 (20%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F    +IG G FG V+K     D     ++ +    + A R    E +AL  + H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 593 KIITICSSTDF---------KGVDFKA---------------LVFEYMGNGSLEDWLHQS 628
                    D+         +  D+                 +  E+   G+LE W+ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 629 NDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
             +    KL  +  L +   +   ++Y+H      ++H DLKPSN+ L       +GDFG
Sbjct: 129 RGE----KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           L          TS K        KGT+ Y++P
Sbjct: 182 LV---------TSLKNDGKRTRSKGTLRYMSP 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 29  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 82
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 136
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 188
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 189 NSFV-GTAQYVSP 200

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 100 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 148
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 149 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 196

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 516 EKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS 575
           E + P   +A   +   ++   ++IG+G    V + +        AVK++ +  +     
Sbjct: 80  EDELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 576 FVAEC-EALRNIRH--RNLI---KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
            + E  EA R   H  R +     IIT+  S  ++   F  LVF+ M  G L D+L    
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDS--YESSSFMFLVFDLMRKGELFDYL---- 191
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E   LS  +  +I   +  A+ +LH +    +VH DLKP N+LLD +M   + DFG 
Sbjct: 192 --TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF 246
Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
                S HL+   K       + GT GY+AP
Sbjct: 247 -----SCHLEPGEKLRE----LCGTPGYLAP 268

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 33  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 86
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 140
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 192
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 193 NSFV-GTAQYVSP 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL-----LNWC 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 96  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ---- 146
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 147 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 201 HHIDYYKKTTNGRLPVK----WMAPEALF 225

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 72  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 120
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 121 VQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 168

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 96  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ---- 146
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 147 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 201 HHIDYYKKTTNGRLPVK----WMAPEALF 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+     +    VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 23  LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 81  KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 128
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
            Q   +H DL+ +N+L+   +V  + DFGLA+ +  +         ++  G K  + + A
Sbjct: 129 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 180
Query: 720 P 720
           P
Sbjct: 181 P 181

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 85  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 133
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 181

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 88  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ---- 138
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 139 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 192
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 193 HHIDYYKKTTNGRLPVK----WMAPEALF 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 81  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 129
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 130 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 85  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ---- 135
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 136 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 189
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 190 HHIDYYKKTTNGRLPVK----WMAPEALF 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LDT   +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 540 IGQGSFGSVY-KGILGEDE----MIVAVKVINLKQKGAFRSF---VAECEALRNI-RHRN 590
           +G+G+FG V     +G D+     +  V V  LK     +     ++E E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL---------------HQSNDQVEVC 635
           +I ++  C+     G  +  ++ EY   G+L ++L               H   +Q    
Sbjct: 89  IINLLGACTQD---GPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ---- 139
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            LS    ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 140 -LSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 193
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           HH+D   KT +  + +K    ++AP   F
Sbjct: 194 HHIDYYKKTTNGRLPVK----WMAPEALF 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LDT   +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+ G    +   VAVK +      + ++F+ E   ++ ++H  L+++  + +
Sbjct: 20  LGAGQFGEVWMGYYN-NSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             +   +     + E+M  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 78  KEEPIYI-----ITEFMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
                +H DL+ +NVL+   ++  + DFGLA+ +  +         ++  G K  + + A
Sbjct: 129 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 178
Query: 720 P 720
           P
Sbjct: 179 P 179

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +V   +L  +        I + +K   R  + E +     R R++
Sbjct: 32  EDFKFGKILGEGSFSTV---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 85
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-----TRFYTA- 139
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 191
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 192 NSFV-GTAQYVSP 203

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 34/181 (18%)
Query: 540 IGQGSFGSVYK----GILG-EDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIK 593
           IG+G+FG V++    G+L  E   +VAVK++  +     ++ F  E   +    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLS--------------- 638
           ++ +C+           L+FEYM  G L ++L   +    VC LS               
Sbjct: 115 LLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHT-VCSLSHSDLSTRARVSSPGP 168
Query: 639 ----LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
                 ++L IA  VA+ + YL        VH DL   N L+  +MV  + DFGL++ + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 695 S 695
           S
Sbjct: 226 S 226

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+     +    VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 196 LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 254 KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
            Q   +H DL+ +N+L+   +V  + DFGLA+ +  +         ++  G K  + + A
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 353
Query: 720 P 720
           P
Sbjct: 354 P 354

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 69  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 117
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 31/171 (18%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 590
           FS    IG GSFG+VY      +  +VA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            I+         ++G   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 157
Query: 647 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
                A++   YLH H    M+H D+K  N+LL    +  +GDFG A  ++
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 30/173 (17%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F+    IG+GSFG V+KGI    + +VA+K+I+L+                    +  I 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-----------EAEDEIEDIQQEIT 73
Query: 594 IITICSS---TDFKGVDFKA----LVFEYMGNGSLEDWLHQSN-DQVEVCKLSLIQRLNI 645
           +++ C S   T + G   K     ++ EY+G GS  D L     D+ ++          +
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA--------TM 125
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
             ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L+   +
Sbjct: 126 LKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFRSFVAECEAL 583
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 584 RNIR---HRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLS 638
           R++    H N++++  +C+ +         LVFE++     +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           + Q L         +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 126 MFQLLR-------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 25/193 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            +F    ++G+GSF +    +L  +        I + +K   R  + E +     R R++
Sbjct: 30  EDFKFGKILGEGSFSTT---VLARELATSREYAIKILEK---RHIIKENKVPYVTRERDV 83
Query: 592 IKIIT--ICSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           +  +         F   D + L F   Y  NG L  ++ +     E C      R   A 
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA- 137
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK   +
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-----ESKQARA 189
Query: 708 SIGIKGTVGYVAP 720
           +  + GT  YV+P
Sbjct: 190 NXFV-GTAQYVSP 201

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFRSFVAECEAL 583
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 584 RNIR---HRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLS 638
           R++    H N++++  +C+ +         LVFE++     +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           + Q L         +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 126 MFQLLR-------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 28/200 (14%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 589
           +S+F   +++G+G++G V          IVA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSLIQR 642
           N+I I  I     F+  +   ++ E M        LH+       S+D ++     + Q 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYF---IYQT 121
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L        A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D S 
Sbjct: 122 LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 703 KTPSSS--IGIKGTVGYVAP 720
            T   S  +    T  Y AP
Sbjct: 172 PTGQQSGMVEFVATRWYRAP 191

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++FS   +IG+G FG VY     +   + A+K ++ K     R  + + E L  +  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 241
Query: 592 IKIIT-------ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           + +++       +C S  F   D  + + + M  G L    H S   V     S      
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRF 295
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
            A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D S K 
Sbjct: 296 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 345
Query: 705 PSSSIGIKGTVGYVAP 720
           P +S+   GT GY+AP
Sbjct: 346 PHASV---GTHGYMAP 358

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++FS   +IG+G FG VY     +   + A+K ++ K     R  + + E L  +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 242
Query: 592 IKIIT-------ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           + +++       +C S  F   D  + + + M  G L    H S   V     S      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRF 296
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
            A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D S K 
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 346
Query: 705 PSSSIGIKGTVGYVAP 720
           P +S+   GT GY+AP
Sbjct: 347 PHASV---GTHGYMAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++FS   +IG+G FG VY     +   + A+K ++ K     R  + + E L  +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 242
Query: 592 IKIIT-------ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           + +++       +C S  F   D  + + + M  G L    H S   V     S      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRF 296
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
            A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D S K 
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 346
Query: 705 PSSSIGIKGTVGYVAP 720
           P +S+   GT GY+AP
Sbjct: 347 PHASV---GTHGYMAP 359

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFRSFVAECEAL 583
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 584 RNIR---HRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLS 638
           R++    H N++++  +C+ +         LVFE++     +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           + Q L         +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 126 MFQLLR-------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 84/157 (53%), Gaps = 19/157 (12%)
Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIIT 596
           + +G+G++ +VYKG     + +VA+K I L+ ++GA  + + E   L++++H N++ +  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV--CKLSLIQRLNIAIDVASAIE 654
           I  +   K +    LVFEY+ +  L+ +L    + + +   KL L Q L         + 
Sbjct: 68  IIHTE--KSL---TLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLR-------GLA 114
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           Y H   +  ++H DLKP N+L++      + DFGLA+
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 15  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 73  EVIETEKTL-----YLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ------IVSAVQY 121
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LDT   +P
Sbjct: 122 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 169

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAV++I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LDT   +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           ++FS   +IG+G FG VY     +   + A+K ++ K     R  + + E L  +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIM 242
Query: 592 IKIIT-------ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           + +++       +C S  F   D  + + + M  G L    H S   V     S      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRF 296
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
            A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D S K 
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKK 346
Query: 705 PSSSIGIKGTVGYVAP 720
           P +S+   GT GY+AP
Sbjct: 347 PHASV---GTHGYMAP 359

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 18/168 (10%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALAY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           L        VH D+   NVL+  +    +GDFGL++++       +SK
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 33/172 (19%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 590
           FS    IG GSFG+VY      +  +VA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 591 LIKIITICSSTDFKGVDFKA----LVFEY-MGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            I+         ++G   +     LV EY +G+ S         D +EV K  L Q + I
Sbjct: 77  TIQ---------YRGCYLREHTAWLVMEYCLGSAS---------DLLEVHKKPL-QEVEI 117
Query: 646 AIDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
           A     A++   YLH H    M+H D+K  N+LL    +  +GDFG A  ++
Sbjct: 118 AAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFG AK L +   +  ++
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFG AK L +   +  ++
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 26/174 (14%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRSFVAECEA 582
           ++  ++ +  ++G+GS+G V K    +   IVA+K         + +K A R    E + 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW-LHQSNDQVEVCKLSLIQ 641
           L+ +RH NL+ ++ +C     K      LVFE++ +  L+D  L  +    +V +  L Q
Sbjct: 78  LKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            +N        I + H H    ++H D+KP N+L+    V  + DFG A+ L++
Sbjct: 133 IIN-------GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 127
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFG AK L +   +  ++
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G +           E+ KLS       A
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYK---------ELQKLSKFDEQRTA 116
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 168
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 169 T-----TLCGTLDYLPP 180

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 589
           +S+F   +++G+G++G V          IVA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSLIQR 642
           N+I I  I     F+  +   ++ E M        LH+       S+D ++     + Q 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYF---IYQT 121
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L        A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D S 
Sbjct: 122 LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 703 KTPSSSIGIKGTVGYVA 719
            T   S    G   YVA
Sbjct: 172 PTGQQS----GMTEYVA 184

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VA+K+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 20  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          L+ EY   G + D+L       E    S  ++      + SA++Y
Sbjct: 78  EVIETEKTL-----YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IVSAVQY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F     LDT   +P
Sbjct: 127 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSP 174

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++  G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +   +  ++
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 20/196 (10%)
Query: 516 EKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKG 571
           E  + M S  +             IG+G FG V++GI    E   M VA+K   N     
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 572 AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ 631
               F+ E   +R   H +++K+I + +           ++ E    G L  +L     Q
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFL-----Q 482
Query: 632 VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           V    L L   +  A  +++A+ YL        VH D+   NVL+  +    +GDFGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 692 FL--SSHHLDTSSKTP 705
           ++  S+++  +  K P
Sbjct: 540 YMEDSTYYKASKGKLP 555

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 35/188 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E  ++ A KVI+ K +     ++ E + L +  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 600 STDFKGVDFKALVFEYMGNGS-------LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
              F   +   ++ E+   G+       LE  L +S  QV VCK +L            A
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTL-----------DA 147
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           + YLH +    ++H DLK  N+L   D    + DFG++          +++T        
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA--------KNTRTIQRRDSFI 196
Query: 713 GTVGYVAP 720
           GT  ++AP
Sbjct: 197 GTPYWMAP 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSCHAPSSRR 164
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 165 T-----TLSGTLDYLPP 176

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 527 LSKATSE------FSSSNMIGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSF 576
           ++ AT E      +     IG+G+F  V   + +L   E  VAVK+I+  Q    + +  
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGRE--VAVKIIDKTQLNPTSLQKL 61
Query: 577 VAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK 636
             E   ++ + H N++K+  +  +          LV EY   G + D+L       E   
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEA 116
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSS 695
            +  ++      + SA++Y H   Q  +VH DLK  N+LLD DM   + DFG + +F   
Sbjct: 117 RAKFRQ------IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG 167
Query: 696 HHLDTSSKTP 705
           + LDT   +P
Sbjct: 168 NKLDTFCGSP 177

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 31/162 (19%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR----------HR 589
           +G+G++G V+K I      +VAVK I       F +F    +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N++ ++ +  + + + V    LVF+YM     E  LH     +    L  + +  +   +
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYM-----ETDLHAV---IRANILEPVHKQYVVYQL 118
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
              I+YLH      ++H D+KPSN+LL+ +    V DFGL++
Sbjct: 119 IKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +       +   D   +V EY+  GSL D +    
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVV---- 108
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E C +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 109 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              ++      S+        + GT  ++AP
Sbjct: 163 CAQITPEQSKRST--------MVGTPYWMAP 185

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 57/249 (22%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV-AECEALRNI 586
           S+  ++F     +G+G FG V++     D+   A+K I L  +   R  V  E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 587 RHRNLIKIITIC-------------------SSTDF-----KGVDFKALVFEYMGNGSLE 622
            H  +++                         STD+       +D  ++    M   S +
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 623 DWLHQSND---------QVEVCK-----------LSLIQR-----LNIAIDVASAIEYLH 657
           + + Q            Q+++C+            SL  R     L+I I +A A+E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP----SSSIGIKG 713
                 ++H DLKPSN+    D V  VGDFGL   +     + +  TP    ++  G  G
Sbjct: 182 SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVG 238
Query: 714 TVGYVAPGK 722
           T  Y++P +
Sbjct: 239 TKLYMSPEQ 247

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFG AK L +   +  ++
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 189
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 190 T-----TLCGTLDYLPP 201

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           + +A  + YL       +VH DL   NVL+       + DFG AK L +   +  ++
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFG AK L +  
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 178

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 27/158 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E  ++ A KVI+ K +     ++ E + L +  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 600 STDFKGVDFKALVFEYMGNGS-------LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
              F   +   ++ E+   G+       LE  L +S  QV VCK +L            A
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTL-----------DA 147
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           + YLH +    ++H DLK  N+L   D    + DFG++
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   M VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALAY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+       +GDFGL++++  S+++  +  K P
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLP 175

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 27/158 (17%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E  ++ A KVI+ K +     ++ E + L +  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 600 STDFKGVDFKALVFEYMGNGS-------LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
              F   +   ++ E+   G+       LE  L +S  QV VCK +L            A
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTL-----------DA 147
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           + YLH +    ++H DLK  N+L   D    + DFG++
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK---VINLKQKGAFRSFVAECEALRNIRH 588
           + F     IG+G F  VY+     D + VA+K   + +L    A    + E + L+ + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N+IK         F   +   +V E    G L   +     Q  +     + +    + 
Sbjct: 92  PNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY--FVQ 144
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + SA+E++H      ++H D+KP+NV +    V  +GD GL +F        SSKT +++
Sbjct: 145 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKT-TAA 193
Query: 709 IGIKGTVGYVAPGK 722
             + GT  Y++P +
Sbjct: 194 HSLVGTPYYMSPER 207

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 106 GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 154
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 163
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 164 T-----DLCGTLDYLPP 175

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +       +   D   +V EY+  GSL D +    
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVV---- 108
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E C +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 109 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              ++      S         + GT  ++AP
Sbjct: 163 CAQITPEQSKRSE--------MVGTPYWMAP 185

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 163
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 164 T-----ELCGTLDYLPP 175

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++  G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 163
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 164 T-----TLCGTLDYLPP 175

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 164
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 165 T-----DLCGTLDYLPP 176

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGI-LGEDEMI-VAVKVINLKQK---GAFRSFVAECEALRNI 586
           +EF    ++  G+FG+VYKG+ + E E + + V +  L++     A +  + E   + ++
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +    L     LN  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + +A  + YL       +VH DL   NVL+       + DFGLAK L +  
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +       +   D   +V EY+  GSL D +    
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVV---- 108
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E C +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 109 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              ++           S    + GT  ++AP
Sbjct: 163 CAQITPEQ--------SKRSXMVGTPYWMAP 185

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G FG V+     +    VAVK +      +  +F+AE   ++ ++H  L+K+  + +
Sbjct: 190 LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 248 KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 295
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            Q   +H DL+ +N+L+   +V  + DFGLA+
Sbjct: 296 -QRNYIHRDLRAANILVSASLVCKIADFGLAR 326

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD     P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP 176

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 128
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 129 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 180
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 181 T-----TLCGTLDYLPP 192

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 166
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 167 T-----TLCGTLDYLPP 178

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 163
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 164 T-----DLCGTLDYLPP 175

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 20/196 (10%)
Query: 516 EKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKG 571
           E  + M S  +             IG+G FG V++GI    E   M VA+K   N     
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 572 AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ 631
               F+ E   +R   H +++K+I + +           ++ E    G L  +L     Q
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFL-----Q 482
Query: 632 VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           V    L L   +  A  +++A+ YL        VH D+   NVL+       +GDFGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 692 FL--SSHHLDTSSKTP 705
           ++  S+++  +  K P
Sbjct: 540 YMEDSTYYKASKGKLP 555

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 168
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 169 T-----DLCGTLDYLPP 180

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 83  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 131
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 168
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 169 T-----TLCGTLDYLPP 180

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 647 ---IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIANFGWSVHAPSSRR 166
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 167 T-----TLCGTLDYLPP 178

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G +           E+ KLS       A
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYK---------ELQKLSKFDEQRTA 116
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 168
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 169 X-----XLXGTLDYLPP 180

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 28/200 (14%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR 589
           +S+F   +++G+G++G V          IVA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSLIQR 642
           N+I I  I     F+  +   ++ E M        LH+       S+D ++     + Q 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYF---IYQT 121
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           L        A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D S 
Sbjct: 122 LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 703 KTPSSS--IGIKGTVGYVAP 720
            T   S       T  Y AP
Sbjct: 172 PTGQQSGMTEXVATRWYRAP 191

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 2   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +       +   D   +V EY+  GSL D +    
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVV---- 109
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E C +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 110 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 163
Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              ++           S    + GT  ++AP
Sbjct: 164 CAQITPEQ--------SKRSXMVGTPYWMAP 186

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K V +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 117 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 168
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 169 T-----TLCGTLDYLPP 180

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 113
Query: 647 ---IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 114 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIANFGWSVHAPSSRR 165
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 166 T-----TLCGTLDYLPP 177

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 80  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 115
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 116 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 167
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 168 T-----TLCGTLDYLPP 179

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL       + DFG +    S   DT   
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT--- 166
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 167 -------LCGTLDYLPP 176

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 81  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 129
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 163
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 164 T-----XLCGTLDYLPP 175

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 30/191 (15%)
Query: 538 NMIGQGSFGSVYKGILGEDEMI---VAVKVINL---KQKGAFRSFVAECEALRNIRHRNL 591
           + +G G   +VY   L ED ++   VA+K I +   +++   + F  E      + H+N+
Sbjct: 17  DKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           + +I +    D        LV EY+   +L +++           LS+   +N    +  
Sbjct: 74  VSMIDVDEEDDCY-----YLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILD 122
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            I++ H      +VH D+KP N+L+D +    + DFG+AK LS   L  ++        +
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-------V 172
Query: 712 KGTVGYVAPGK 722
            GTV Y +P +
Sbjct: 173 LGTVQYFSPEQ 183

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 110
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 111 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 162
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 163 T-----TLCGTLDYLPP 174

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 20/172 (11%)
Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G FG V++GI    E   + VA+K   N         F+ E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 75  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 123
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL--SSHHLDTSSKTP 705
           L        VH D+   NVL+  +    +GDFGL++++  S+++  +  K P
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 108
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 109 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 160
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 161 T-----TLCGTLDYLPP 172

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 166
Query: 704 TPSSSIGIKGTVGYVAP 720
           T      + GT+ Y+ P
Sbjct: 167 T-----TLCGTLDYLPP 178

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRH 588
            +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI- 647
            N++++        F       L+ EY   G++           E+ KLS       A  
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSRFDEQRTATY 117
Query: 648 --DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
             ++A+A+ Y H      ++H D+KP N+LL  +    + DFG +    S   DT     
Sbjct: 118 ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT----- 169
Query: 706 SSSIGIKGTVGYVAP 720
                + GT+ Y+ P
Sbjct: 170 -----LCGTLDYLPP 179

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEAL 583
           + +   +F   N++G+GSF  VY+       + VA+K+I+ K   + G  +    E +  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
             ++H +++++        F+  ++  LV E   NG +  +L     +  V   S  +  
Sbjct: 66  CQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEAR 115
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           +    + + + YLH H    ++H DL  SN+LL  +M   + DFGLA  L   H      
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH------ 166
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT  Y++P
Sbjct: 167 --EKHYTLCGTPNYISP 181

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAV++I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSP 176

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 31/185 (16%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITI 597
           IG+G +G V+ G    ++  VAVKV    ++    S+  E E  + +  RH N++  I  
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI-- 97
Query: 598 CSSTDFKGVDFKA---LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
             + D KG        L+ +Y  NGSL D+L  +        L     L +A    S + 
Sbjct: 98  --AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLC 148
Query: 655 YLHHHC-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLS-SHHLDTSSKTPSS 707
           +LH        +P + H DLK  N+L+  +    + D GLA KF+S ++ +D     P++
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNT 205
Query: 708 SIGIK 712
            +G K
Sbjct: 206 RVGTK 210

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++ +  L+D++  S   +    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFL-HQDLKDFMDAS--ALTGIPLPLIK--SYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 33/197 (16%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---------RSFVAECEALR 584
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 585 NIR-HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            +  H N+I++        ++   F  LVF+ M  G L D+L    ++V + +    + +
Sbjct: 79  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIM 130
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
              ++V  A+  L+      +VH DLKP N+LLD DM   + DFG      S  LD   K
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF-----SCQLDPGEK 179
Query: 704 TPSSSIGIKGTVGYVAP 720
             S    + GT  Y+AP
Sbjct: 180 LRS----VCGTPSYLAP 192

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 33/195 (16%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRH 588
            +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI- 647
            N++++        F       L+ EY   G++           E+ KLS       A  
Sbjct: 72  PNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSRFDEQRTATY 117
Query: 648 --DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
             ++A+A+ Y H      ++H D+KP N+LL  +    + DFG      S H  +S +T 
Sbjct: 118 ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGW-----SVHAPSSRRT- 168
Query: 706 SSSIGIKGTVGYVAP 720
                + GT+ Y+ P
Sbjct: 169 ----TLCGTLDYLPP 179

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 589
            ++     +G+G++G VYK    +   IVA+K I L  + +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND--QVEVCKLSLIQRLNIAI 647
           N++ +I +  S          LVFE+M    L+  L ++    Q    K+ L Q L    
Sbjct: 80  NIVSLIDVIHSERCL-----TLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR--- 130
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                + + H H    ++H DLKP N+L++ D    + DFGLA+
Sbjct: 131 ----GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 33/202 (16%)
Query: 525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECE 581
           A+   A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 582 ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
              ++RH N++++        F       L+ EY   G++           E+ KLS   
Sbjct: 61  IQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFD 106
Query: 642 RLNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
               A    ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H 
Sbjct: 107 EQRTATYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHA 158
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
            +S +       + GT+ Y+ P
Sbjct: 159 PSSRRA-----ALCGTLDYLPP 175

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q  AF++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 538 NMIGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 594 IITICSSTDFKGVDFKA------LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
                    ++GV +        LV EY+ +G L D+L +   +++  +L L      + 
Sbjct: 73  ---------YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SS 118
Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 119 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++ +  L+D++  S   +    L LI+  +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFL-SMDLKDFMDAS--ALTGIPLPLIK--SYLFQ 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VA+K+I+  Q    + +    E   ++ + H N++K+ 
Sbjct: 23  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          L+ EY   G + D+L       E    S  ++      + SA++Y
Sbjct: 81  EVIETEKTL-----YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IVSAVQY 129
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD DM   + DFG + +F     LD     P
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP 177

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHR 589
            ++     +G+G++G VYK    +   IVA+K I L  + +G   + + E   L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND--QVEVCKLSLIQRLNIAI 647
           N++ +I +  S          LVFE+M    L+  L ++    Q    K+ L Q L    
Sbjct: 80  NIVSLIDVIHSERCL-----TLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR--- 130
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                + + H H    ++H DLKP N+L++ D    + DFGLA+
Sbjct: 131 ----GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q  AF++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++ +  L+D++  S   +    L LI+  +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFL-SMDLKDFMDAS--ALTGIPLPLIK--SYLFQ 113
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 540 IGQGSFGSVYKGILGE---DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 166
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 167 A-----ALCGTLDYLPP 178

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRN 590
            ++    +IG G+   V        +  VA+K INL++ + +    + E +A+    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI--- 647
           ++   T      F   D   LV + +  GS+ D +     + E  K  ++    IA    
Sbjct: 70  IVSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILR 123
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           +V   +EYLH + Q   +H D+K  N+LL  D    + DFG++ FL++    T +K   +
Sbjct: 124 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 708 SIGIKGTVGYVAP 720
            +   GT  ++AP
Sbjct: 181 FV---GTPCWMAP 190

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 189
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 190 D-----DLCGTLDYLPP 201

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 525 AELSKAT---SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVA 578
           AE+ K      +F     +G+G FG+VY     +++ I+A+KV+    L+++G       
Sbjct: 5   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLS 638
           E E   ++RH N++++       D K +    L+ E+   G L   L +     E    +
Sbjct: 65  EIEIQSHLRHPNILRMYNYFH--DRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSAT 119
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            ++ L      A A+ Y H   +  ++H D+KP N+L+ +     + DFG +
Sbjct: 120 FMEEL------ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 20/192 (10%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLI 592
           +     +G G FG V + I  +    VA+K    +     R  +  E + ++ + H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 593 KIITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
               +          D   L  EY   G L  +L+Q  +    C L       +  D++S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISS 132
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           A+ YLH +    ++H DLKP N++L      ++  + D G AK L    L T        
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE------- 182
Query: 709 IGIKGTVGYVAP 720
               GT+ Y+AP
Sbjct: 183 --FVGTLQYLAP 192

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 83/189 (43%), Gaps = 32/189 (16%)
Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
           M+G+GSFG V K      +   AVKVIN    K K    + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLF 87
Query: 596 TICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            I   S+ F       +V E    G L D +      ++  + S      I   V S I 
Sbjct: 88  EILEDSSSF------YIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGIT 135
Query: 655 YLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           Y+H H    +VH DLKP N+LL   + D    + DFGL+         T  +  +     
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKDR 183
Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 184 IGTAYYIAP 192

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 20/192 (10%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLI 592
           +     +G G FG V + I  +    VA+K    +     R  +  E + ++ + H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 593 KIITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
               +          D   L  EY   G L  +L+Q  +    C L       +  D++S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISS 133
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           A+ YLH +    ++H DLKP N++L      ++  + D G AK L    L T        
Sbjct: 134 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE------- 183
Query: 709 IGIKGTVGYVAP 720
               GT+ Y+AP
Sbjct: 184 --FVGTLQYLAP 193

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 26/189 (13%)
Query: 540 IGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIIT 596
           +G+G +G V++G   GE+   VAVK+ + + +   +S+  E E    +  RH N++  I 
Sbjct: 45  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 98
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
              ++         L+  Y   GSL D+L       ++  L  +  L I + +AS + +L
Sbjct: 99  SDMTSRHSSTQL-WLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHL 150
Query: 657 H-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           H        +P + H DLK  N+L+  +    + D GLA      H  ++++    +   
Sbjct: 151 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPR 206
Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 207 VGTKRYMAP 215

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 21/176 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           S +     +G G  G V+  +  + +  VA+K I L    + +  + E + +R + H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 592 IKIITICSS-----TDFKG----VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           +K+  I        TD  G    ++   +V EYM    L + L Q     E  +L + Q 
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQL 129
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHH 697
           L         ++Y+H      ++H DLKP+N+ ++  D+V  +GDFGLA+ +  H+
Sbjct: 130 LR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---------RSFVAECEALR 584
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 585 NIR-HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            +  H N+I++        ++   F  LVF+ M  G L D+L    ++V + +    + +
Sbjct: 66  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIM 117
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
              ++V  A+  L+      +VH DLKP N+LLD DM   + DFG      S  LD   K
Sbjct: 118 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF-----SCQLDPGEK 166
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT  Y+AP
Sbjct: 167 LRE----VCGTPSYLAP 179

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q  AF++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEI 68
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 123 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 173 MRT---------LCGTPTYLAP 185

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 538 NMIGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 594 IITICSSTDFKGVDFKA------LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
                    ++GV +        LV EY+ +G L D+L +   +++  +L L      + 
Sbjct: 77  ---------YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SS 122
Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 123 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 538 NMIGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 594 IITICSSTDFKGVDFKA------LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
                    ++GV +        LV EY+ +G L D+L +   +++  +L L      + 
Sbjct: 89  ---------YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SS 134
Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 135 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 29/167 (17%)
Query: 538 NMIGQGSFGSV----YKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           + +G+G+FGSV    Y  +      +VAVK +        R F  E + L+ +    ++K
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 594 IITICSSTDFKGVDFKA------LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
                    ++GV +        LV EY+ +G L D+L +   +++  +L L      + 
Sbjct: 76  ---------YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SS 121
Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 122 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRN 590
            ++    +IG G+   V        +  VA+K INL++ + +    + E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI--- 647
           ++   T      F   D   LV + +  GS+ D +     + E  K  ++    IA    
Sbjct: 75  IVSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILR 128
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           +V   +EYLH + Q   +H D+K  N+LL  D    + DFG++ FL++    T +K   +
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 708 SIGIKGTVGYVAP 720
            +   GT  ++AP
Sbjct: 186 FV---GTPCWMAP 195

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 22/165 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHR 589
            ++     IG+G++G+V+K    E   IVA+K + L    +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 590 NLIKIITICSSTDFKGVDFK-ALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIA 646
           N++++  +  S      D K  LVFE+  +  L+ +    N  +  E+ K  L Q L   
Sbjct: 62  NIVRLHDVLHS------DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL--- 111
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                 + + H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 ----KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E 
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEI 67
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 68  LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 122 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 171
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 172 MRT---------LCGTPTYLAP 184

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEI 68
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 123 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 173 MRT---------LCGTPTYLAP 185

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 166
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 167 D-----DLCGTLDYLPP 178

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 16/183 (8%)
Query: 536 SSNMIGQGSFGSVYKGIL---GEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
           S  +IG+G FG VY G      ++ +  A+K ++ + +     +F+ E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           + +I I    +        ++  YM +G L  ++        V  L     ++  + VA 
Sbjct: 85  LALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVAR 135
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            +EYL    +   VH DL   N +LD      V DFGLA+ +      +  +   + + +
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 712 KGT 714
           K T
Sbjct: 193 KWT 195

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 525 AELSKAT---SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVA 578
           AE+ K      +F     +G+G FG+VY     +++ I+A+KV+    L+++G       
Sbjct: 4   AEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLS 638
           E E   ++RH N++++       D K +    L+ E+   G L   L +     E    +
Sbjct: 64  EIEIQSHLRHPNILRMYNYFH--DRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSAT 118
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            ++ L      A A+ Y H   +  ++H D+KP N+L+ +     + DFG +
Sbjct: 119 FMEEL------ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E 
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEI 74
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 75  LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 129 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 179 MRT---------LCGTPTYLAP 191

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K  + F     IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 2   SDEEILEKLRIIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +       +   D   +V EY+  GSL D +    
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVV---- 109
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
              E C +   Q   +  +   A+E+LH +    ++H ++K  N+LL  D    + DFG 
Sbjct: 110 --TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGF 163
Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              ++      S+        + GT  ++AP
Sbjct: 164 CAQITPEQSKRST--------MVGTPYWMAP 186

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 99  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEI 68
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 123 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 173 MRT---------LCGTPTYLAP 185

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 113 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 164 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 515 MEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGA 572
           M KQ+  V         S++     IGQG+FG V+K    +    VA+K + ++  ++G 
Sbjct: 1   MAKQYDSVE-CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59
Query: 573 FRSFVAECEALRNIRHRNLIKIITICSST-----DFKGVDFKALVFEYMGN---GSLEDW 624
             + + E + L+ ++H N++ +I IC +        KG  +  LVF++  +   G L + 
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLLSNV 117
Query: 625 LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
           L          K +L +   +   + + + Y+H +    ++H D+K +NVL+  D V  +
Sbjct: 118 L---------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165
Query: 685 GDFGLAKFLS 694
            DFGLA+  S
Sbjct: 166 ADFGLARAFS 175

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 505 SAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEM---IVA 561
           +  N   +S  +KQ      AE  K   EF  +  +G G+F  V   +L E++    + A
Sbjct: 3   ARENGESSSSWKKQ------AEDIKKIFEFKET--LGTGAFSEV---VLAEEKATGKLFA 51
Query: 562 VKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGS 620
           VK I  K  KG   S   E   LR I+H N++ +  I     ++  +   LV + +  G 
Sbjct: 52  VKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDI-----YESPNHLYLVMQLVSGGE 106
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---D 677
           L D + +     E    +LI++      V  A+ YLH   +  +VH DLKP N+L    D
Sbjct: 107 LFDRIVEKGFYTEKDASTLIRQ------VLDAVYYLH---RMGIVHRDLKPENLLYYSQD 157
Query: 678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            +    + DFGL+K      ++      S++    GT GYVAP
Sbjct: 158 EESKIMISDFGLSK------MEGKGDVMSTAC---GTPGYVAP 191

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 113 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 164 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 70
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 71  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 119
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 120 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 172
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 173 V---GTVNYMPP 181

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 26/189 (13%)
Query: 540 IGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIIT 596
           +G+G +G V++G   GE+   VAVK+ + + +   +S+  E E    +  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
              ++         L+  Y   GSL D+L       ++  L  +  L I + +AS + +L
Sbjct: 70  SDMTSRHSSTQL-WLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 657 H-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           H        +P + H DLK  N+L+  +    + D GLA      H  ++++    +   
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPR 177
Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 178 VGTKRYMAP 186

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 26/189 (13%)
Query: 540 IGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIIT 596
           +G+G +G V++G   GE+   VAVK+ + + +   +S+  E E    +  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
              ++         L+  Y   GSL D+L       ++  L  +  L I + +AS + +L
Sbjct: 70  SDMTSRHSSTQL-WLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 657 H-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           H        +P + H DLK  N+L+  +    + D GLA      H  ++++    +   
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----HSQSTNQLDVGNNPR 177
Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 178 VGTKRYMAP 186

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 112 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 163
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 164 X-----XLCGTLDYLPP 175

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 139 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 190 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 113
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 114 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 165
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 166 X-----XLCGTLDYLPP 177

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 21/186 (11%)
Query: 517 KQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFR 574
           KQ+  V         S++     IGQG+FG V+K    +    VA+K + ++  ++G   
Sbjct: 4   KQYDSVE-CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 62
Query: 575 SFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA---LVFEYMGN---GSLEDWLHQS 628
           + + E + L+ ++H N++ +I IC +        KA   LVF++  +   G L + L   
Sbjct: 63  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL--- 119
Query: 629 NDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
                  K +L +   +   + + + Y+H +    ++H D+K +NVL+  D V  + DFG
Sbjct: 120 ------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 170
Query: 689 LAKFLS 694
           LA+  S
Sbjct: 171 LARAFS 176

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 83/189 (43%), Gaps = 32/189 (16%)
Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
           M+G+GSFG V K      +   AVKVIN    K K    + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLF 87
Query: 596 TICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            I   S+ F       +V E    G L D +      ++  + S      I   V S I 
Sbjct: 88  EILEDSSSF------YIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGIT 135
Query: 655 YLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           Y+H H    +VH DLKP N+LL   + D    + DFGL+         T  +  +     
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKDR 183
Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 184 IGTAYYIAP 192

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---------RSFVAECEALR 584
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 585 NIR-HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
            +  H N+I++        ++   F  LVF+ M  G L D+L    ++V + +    + +
Sbjct: 79  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIM 130
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
              ++V  A+  L+      +VH DLKP N+LLD DM   + DFG      S  LD   K
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF-----SCQLDPGEK 179
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT  Y+AP
Sbjct: 180 LRE----VCGTPSYLAP 192

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 66
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 67  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 115
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 116 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 168
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 169 V---GTVNYMPP 177

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 116 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 166
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 167 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 78
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 131
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 132 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 83/189 (43%), Gaps = 32/189 (16%)
Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
           M+G+GSFG V K      +   AVKVIN    K K    + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLF 87
Query: 596 TICS-STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            I   S+ F       +V E    G L D +      ++  + S      I   V S I 
Sbjct: 88  EILEDSSSF------YIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGIT 135
Query: 655 YLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           Y+H H    +VH DLKP N+LL   + D    + DFGL+         T  +  +     
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKDR 183
Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 184 IGTAYYIAP 192

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 115 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 166 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 130
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 33/202 (16%)
Query: 525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECE 581
           A+   A  +F     +G+G FG+VY       + I+A+KV+    L++ G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 582 ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
              ++RH N++++        F       L+ EY   G++           E+ KLS   
Sbjct: 61  IQSHLRHPNILRLYGY-----FHDSTRVYLILEYAPLGTV---------YRELQKLSKFD 106
Query: 642 RLNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
               A    ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H 
Sbjct: 107 EQRTATYITELANALSYCH---SKKVIHRDIKPENLLL-----GSAGELKIADFGWSVHA 158
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
            +S +       + GT+ Y+ P
Sbjct: 159 PSSRRA-----ALCGTLDYLPP 175

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 99  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 105 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 156 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 81
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 134
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 142
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 143 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI 586
           A  +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           RH N++++        F       L+ EY   G++           E+ KLS       A
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 647 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
               ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  S H  +S +
Sbjct: 115 TYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRR 166
Query: 704 TPSSSIGIKGTVGYVAP 720
                  + GT+ Y+ P
Sbjct: 167 X-----XLCGTLDYLPP 178

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 37/209 (17%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRS 575
           P    AE  +   +F   +++G G+F  V   IL ED   + +VA+K I  K  +G   S
Sbjct: 8   PRWKQAEDIRDIYDFR--DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGS 62
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC 635
              E   L  I+H N++ +  I  S          L+ + +  G L D + +     E  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHL-----YLIMQLVSGGELFDRIVEKGFYTERD 117
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL---LDHDMVAHVGDFGLAKF 692
              LI        V  A++YLH      +VH DLKP N+L   LD D    + DFGL+K 
Sbjct: 118 ASRLI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 693 LSSHHLDTSSKTPSSSIGIK-GTVGYVAP 720
                     + P S +    GT GYVAP
Sbjct: 169 ----------EDPGSVLSTACGTPGYVAP 187

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 96
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 149
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 150 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 18/166 (10%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA--ECEALRNIRHR 589
            ++     IG+GS+G V+K    +   IVA+K     +       +A  E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           NL+ ++ +     F+      LVFEY  +  L    H+ +         L++  +I    
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVK--SITWQT 111
Query: 650 ASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
             A+ + H H+C    +H D+KP N+L+    V  + DFG A+ L+
Sbjct: 112 LQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLT 153

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 90  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 140
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 141 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 90
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 143
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 144 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 85
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 138
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 139 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 86
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 87  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 135
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 188
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 189 V---GTVNYMPP 197

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 540 IGQGSFGSVYKGI--LGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G G+FGSV +G+  + + ++ VA+KV+    +K      + E + +  + +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +C +          LV E  G G L  +L    +++ V  ++      +   V+  ++YL
Sbjct: 78  VCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 126
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
               +   VH DL   NVLL +   A + DFGL+K L +   D S  T  S+   K  + 
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSA--GKWPLK 178
Query: 717 YVAP 720
           + AP
Sbjct: 179 WYAP 182

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 82
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 135
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 136 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 69  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 118
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 113 CI---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 164 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 98  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 98  CI---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+++I+ K+K A  S            E E 
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 207
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 208 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 262 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 312 MRT---------LCGTPTYLAP 324

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 167
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 168 ---SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 125 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 176 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 156
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 212
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 213 ---SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------- 142
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
           +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 143 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 167
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 168 ---SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 67
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 68  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKN 116
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 169
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 170 V---GTVNYMPP 178

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 115
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 171
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 172 ---SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 113
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 169
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 170 ---SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 69  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 118
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K   + Q   F++   E + +R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 105
Query: 594 I-ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     SS + K   +  LV +Y+         H S  +    V   KL + Q       
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 161
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 162 ---SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 39/202 (19%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS---------FVAECEA 582
            E+  S  +G G+ G V      +    VA+++I+ K+K A  S            E E 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 193
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQ 641
           L+ + H  +IKI     + D+       +V E M  G L D +  +    E  CKL   Q
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHL 698
            L        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L
Sbjct: 248 ML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             +         + GT  Y+AP
Sbjct: 298 MRT---------LCGTPTYLAP 310

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 89/191 (46%), Gaps = 37/191 (19%)
Query: 538 NMIGQGSFGSVY---KGILGEDEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLI 592
            ++G G+F  V+   + + G+   + A+K I  K+  AFR  S   E   L+ I+H N++
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGK---LFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            +  I  ST         LV + +  G L D + +     E     +IQ+      V SA
Sbjct: 70  TLEDIYEST-----THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSA 118
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
           ++YLH +    +VH DLKP N+L    + +    + DFGL+K   +  + T+  TP    
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP---- 171
Query: 710 GIKGTVGYVAP 720
                 GYVAP
Sbjct: 172 ------GYVAP 176

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 540 IGQGSFGSVYKGILG-----EDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G+FG VY+G +         + VAVK +  +  +     F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 594 IITICSSTDFKGVDFKAL----VFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAID 648
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  L++A D
Sbjct: 99  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 35/205 (17%)
Query: 540 IGQGSFGSVYKG-ILGEDE------MIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 590
           +G+G+FG V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLI 640
           +I ++  C+     G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 641 QRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +++D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NNID 211
Query: 700 TSSKTPSSSIGIKGTVGYVAPGKFF 724
              KT +  + +K    ++AP   F
Sbjct: 212 XXKKTTNGRLPVK----WMAPEALF 232

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 66  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 115
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 113
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 113
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 35/205 (17%)
Query: 540 IGQGSFGSVYKG-ILGEDE------MIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 590
           +G+G+FG V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLI 640
           +I ++  C+     G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 641 QRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +++D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NNID 211
Query: 700 TSSKTPSSSIGIKGTVGYVAPGKFF 724
              KT +  + +K    ++AP   F
Sbjct: 212 XXKKTTNGRLPVK----WMAPEALF 232

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 113
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLSMD-----LKKFMDASALTGIPLPLIKSYLFQ 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 24/173 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFR-SFVAECEALRNIRHR 589
           S++     IGQG+FG V+K    +    VA+K + ++ +K  F  + + E + L+ ++H 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 590 NLIKIITICSST-----DFKGVDFKALVFEYMGN---GSLEDWLHQSNDQVEVCKLSLIQ 641
           N++ +I IC +        KG  +  LVF++  +   G L + L          K +L +
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLLSNVL---------VKFTLSE 126
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
              +   + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+  S
Sbjct: 127 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++ +  L+ ++  S   +    L LI+  +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFL-HQDLKTFMDAS--ALTGIPLPLIK--SYLFQ 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 110
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 112
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLSMD-----LKKFMDASALTGIPLPLIKSYLFQ 112
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 112
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 112
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 110
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 110
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 8/140 (5%)
Query: 546 GSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG 605
           G ++KG    ++++V V  +        R F  EC  LR   H N++ ++  C S     
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---P 80
Query: 606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV 665
                L+  +M  GSL + LH+  + V    +   Q +  A+D+A  + +L H  +P + 
Sbjct: 81  APHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFALDMARGMAFL-HTLEPLIP 135
Query: 666 HGDLKPSNVLLDHDMVAHVG 685
              L   +V++D DM A + 
Sbjct: 136 RHALNSRSVMIDEDMTARIS 155

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 110
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 66  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 115
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 112
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 22/165 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHR 589
            ++     IG+G++G+V+K    E   IVA+K + L    +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 590 NLIKIITICSSTDFKGVDFK-ALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIA 646
           N++++  +  S      D K  LVFE+  +  L+ +    N  +  E+ K  L Q L   
Sbjct: 62  NIVRLHDVLHS------DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL--- 111
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                 + + H      ++H DLKP N+L++ +    + +FGLA+
Sbjct: 112 ----KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 25/188 (13%)
Query: 517 KQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFR 574
           KQ+  V         S++     IGQG+FG V+K    +    VA+K + ++  ++G   
Sbjct: 4   KQYDSVE-CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 62
Query: 575 SFVAECEALRNIRHRNLIKIITICSST-----DFKGVDFKALVFEYMGN---GSLEDWLH 626
           + + E + L+ ++H N++ +I IC +        KG  +  LVF++  +   G L + L 
Sbjct: 63  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY--LVFDFCEHDLAGLLSNVL- 119
Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
                    K +L +   +   + + + Y+H +    ++H D+K +NVL+  D V  + D
Sbjct: 120 --------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 168
Query: 687 FGLAKFLS 694
           FGLA+  S
Sbjct: 169 FGLARAFS 176

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 114
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 115 SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 163
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 216
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 217 V---GTVNYMPP 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 507 HNSADTSPMEKQFPMVSYAELSKA-----------TSEFSSSNMIGQGSFGSVYKGILGE 555
           ++  + SP+ ++  ++ Y E +K              +F    +IG+G+FG V    L  
Sbjct: 38  YDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN 97
Query: 556 DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY 615
            + + A+K++N K +   R+  A     R++      K IT      F+  +   LV +Y
Sbjct: 98  ADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDSKWITTLHYA-FQDDNNLYLVMDY 155
Query: 616 MGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 673
              G L   L +  D++  E+ +  L + + IAID    + Y         VH D+KP N
Sbjct: 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMV-IAIDSVHQLHY---------VHRDIKPDN 205
Query: 674 VLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           +L+D +    + DFG    L          T  SS+ + GT  Y++P
Sbjct: 206 ILMDMNGHIRLADFGSCLKL------MEDGTVQSSVAV-GTPDYISP 245

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 25/189 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIK---- 593
           IG GS+G   K     D  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           II   ++T +       +V EY   G L   + +   + +      +  L +   +  A+
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLAL 124
Query: 654 EYLHHHCQ--PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           +  H        ++H DLKP+NV LD      +GDFGLA+ L+  H  + +KT       
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKT------F 176
Query: 712 KGTVGYVAP 720
            GT  Y++P
Sbjct: 177 VGTPYYMSP 185

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEHVDQD-----LKKFMDASALTGIPLPLIKSYLFQ 114
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 114
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 115 SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 163
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 216
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 217 V---GTVNYMPP 225

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 100 HKNIINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDI--N 208
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 209 NIDYYKKTTNGRLPVK----WMAPEALF 232

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 26/194 (13%)
Query: 514 PMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLK 568
           P+  Q       E+S +   F     +G+  FG VYKG L     GE    VA+K +  K
Sbjct: 10  PLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK 67
Query: 569 QKGAFRS-FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL-- 625
            +G  R  F  E      ++H N++ ++ + +          +++F Y  +G L ++L  
Sbjct: 68  AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLVM 122
Query: 626 --------HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 677
                      +D+     L     +++   +A+ +EYL  H    +VH DL   NVL+ 
Sbjct: 123 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179
Query: 678 HDMVAHVGDFGLAK 691
             +   + D GL +
Sbjct: 180 DKLNVKISDLGLFR 193

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 27/192 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRH 588
            +F     +G+G FG+VY     +   IVA+KV+    ++++G       E E   ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++++        F       L+ EY   G L   L +S      C     +   I  +
Sbjct: 83  PNILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKS------CTFDEQRTATIMEE 131
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +A A+ Y H      ++H D+KP N+LL       + DFG     S H      KT    
Sbjct: 132 LADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKT---- 180
Query: 709 IGIKGTVGYVAP 720
             + GT+ Y+ P
Sbjct: 181 --MCGTLDYLPP 190

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 35/195 (17%)
Query: 534 FSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHR 589
           +   +++G G+F  V   IL ED   + +VA+K I  +  +G   S   E   L  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N++ +  I     ++      L+ + +  G L D + +     E     LI        V
Sbjct: 77  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI------FQV 125
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
             A++YLH      +VH DLKP N+L   LD D    + DFGL+K           + P 
Sbjct: 126 LDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPG 172
Query: 707 SSIGIK-GTVGYVAP 720
           S +    GT GYVAP
Sbjct: 173 SVLSTACGTPGYVAP 187

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 100 HKNIITLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 208
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 209 NIDYYKKTTNGRLPVK----WMAPEALF 232

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA----ECEALRNIR 587
           +E +   +IG G FG VY+     DE  VAVK             +     E +    ++
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H N+I +  +C     K  +   LV E+   G L   L       ++        +N A+
Sbjct: 65  HPNIIALRGVC----LKEPNL-CLVMEFARGGPLNRVLSGKRIPPDIL-------VNWAV 112
Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--------VAHVGDFGLAKFLSSHHLD 699
            +A  + YLH     P++H DLK SN+L+   +        +  + DFGLA+    H   
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHR-- 168
Query: 700 TSSKTPSSSIGIKGTVGYVAP 720
                 ++ +   G   ++AP
Sbjct: 169 ------TTKMSAAGAYAWMAP 183

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 25/189 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIK---- 593
           IG GS+G   K     D  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           II   ++T +       +V EY   G L   + +   + +      +  L +   +  A+
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLAL 124
Query: 654 EYLHHHCQ--PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           +  H        ++H DLKP+NV LD      +GDFGLA+ L+    DT     S +   
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---DT-----SFAKAF 176
Query: 712 KGTVGYVAP 720
            GT  Y++P
Sbjct: 177 VGTPYYMSP 185

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 100 HKNIINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 208
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 209 NIDYYKKTTNGRLPVK----WMAPEALF 232

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 37/209 (17%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRS 575
           P    AE  +   +F   +++G G+F  V   IL ED   + +VA+K I  +  +G   S
Sbjct: 8   PRWKQAEDIRDIYDFR--DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC 635
              E   L  I+H N++ +  I  S          L+ + +  G L D + +     E  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHL-----YLIMQLVSGGELFDRIVEKGFYTERD 117
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL---LDHDMVAHVGDFGLAKF 692
              LI        V  A++YLH      +VH DLKP N+L   LD D    + DFGL+K 
Sbjct: 118 ASRLI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 693 LSSHHLDTSSKTPSSSIGIK-GTVGYVAP 720
                     + P S +    GT GYVAP
Sbjct: 169 ----------EDPGSVLSTACGTPGYVAP 187

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 100 HKNIIHLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +++ 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN- 209
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
            +D   KT +  + +K    ++AP   F
Sbjct: 210 -IDYYKKTTNGRLPVK----WMAPEALF 232

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 35/205 (17%)
Query: 540 IGQGSFGSVYKG-ILGEDE------MIVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 590
           +G+G FG V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKLSLI 640
           +I ++  C+     G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 641 QRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +++D
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NNID 257
Query: 700 TSSKTPSSSIGIKGTVGYVAPGKFF 724
              KT +  + +K    ++AP   F
Sbjct: 258 YYKKTTNGRLPVK----WMAPEALF 278

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 9   IGSLFKLQALALAGNYLTGKLPDF--IGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           + +L K  +L L  N+    L D   + N + L  + +  + +    P  +  L +L  L
Sbjct: 128 LANLTKXYSLNLGANH---NLSDLSPLSNXTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           ++  N+   + P  + +++SL YF    N+ +   P   V N   L  L IG N    L 
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP---VANXTRLNSLKIGNNKITDLS 237
Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
           P  L+N S L  L++  NQ       D +++K L +L      L +G+ N +  ++ L N
Sbjct: 238 P--LANLSQLTWLEIGTNQIS-----DINAVKDLTKLKX----LNVGS-NQISDISVLNN 285
Query: 187 CSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG 232
            S L  L L++NQ G E    I  L++   +FL   N I+   PL 
Sbjct: 286 LSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFL-SQNHITDIRPLA 330

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 37/209 (17%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRS 575
           P    AE  +   +F   +++G G+F  V   IL ED   + +VA+K I  +  +G   S
Sbjct: 8   PRWKQAEDIRDIYDFR--DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGS 62
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC 635
              E   L  I+H N++ +  I  S          L+ + +  G L D + +     E  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHL-----YLIMQLVSGGELFDRIVEKGFYTERD 117
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL---LDHDMVAHVGDFGLAKF 692
              LI        V  A++YLH      +VH DLKP N+L   LD D    + DFGL+K 
Sbjct: 118 ASRLI------FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 693 LSSHHLDTSSKTPSSSIGIK-GTVGYVAP 720
                     + P S +    GT GYVAP
Sbjct: 169 ----------EDPGSVLSTACGTPGYVAP 187

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 21/171 (12%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G+F  V   + IL   E  VAVK+I+  Q    + +    E    + + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIETEKTL-----YLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ------IVSAVQY 128
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA-KFLSSHHLDTSSKTP 705
            H   Q  +VH DLK  N+LLD D    + DFG + +F   + LD     P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAP 176

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 25/189 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLIK---- 593
           IG GS+G   K     D  I+  K ++     +   +  V+E   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           II   ++T +       +V EY   G L   + +   + +      +  L +   +  A+
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLAL 124
Query: 654 EYLHHHCQ--PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           +  H        ++H DLKP+NV LD      +GDFGLA+ L +H  D + +        
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKE-------F 176
Query: 712 KGTVGYVAP 720
            GT  Y++P
Sbjct: 177 VGTPYYMSP 185

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVIN----LKQKGAFRSFVAECEA 582
           A  +   + ++G+G FG VY+G+      +++ VAVK       L  K     F++E   
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVI 78
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++N+ H +++K+I I         +   ++ E    G L  +L ++ + ++V  L L   
Sbjct: 79  MKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-- 130
Query: 643 LNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
              ++ +  A+ YL   +C    VH D+   N+L+       +GDFGL++++       +
Sbjct: 131 ---SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 702 SKT 704
           S T
Sbjct: 184 SVT 186

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 32  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 89  HKNIINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 197
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 198 NIDYYKKTTNGRLPVK----WMAPEALF 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 110/257 (42%), Gaps = 31/257 (12%)
Query: 466 PSRGSRKLKI-TLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSY 524
           P R    L + TLL VL+ +   C          ++  RR  +  A+     K F  +  
Sbjct: 34  PWRNESALSVETLLDVLVCLYTEC---------SHSALRRDKY-VAEFLEWAKPFTQLV- 82
Query: 525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALR 584
            E+     +F    +IG+G+FG V    +   E I A+K++N K +   R+  A     R
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETACFREER 141
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRL 643
           ++      + IT      F+  +   LV +Y   G L   L +  D++ E      I  +
Sbjct: 142 DVLVNGDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 200
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +AID   +I  LH+      VH D+KP NVLLD +    + DFG    ++         
Sbjct: 201 VLAID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMN------DDG 245
Query: 704 TPSSSIGIKGTVGYVAP 720
           T  SS+ + GT  Y++P
Sbjct: 246 TVQSSVAV-GTPDYISP 261

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 110/257 (42%), Gaps = 31/257 (12%)
Query: 466 PSRGSRKLKI-TLLKVLIPVAVSCWILFSCLTIVYARRRRSAHNSADTSPMEKQFPMVSY 524
           P R    L + TLL VL+ +   C          ++  RR  +  A+     K F  +  
Sbjct: 18  PWRNESALSVETLLDVLVCLYTEC---------SHSALRRDKY-VAEFLEWAKPFTQLV- 66
Query: 525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALR 584
            E+     +F    +IG+G+FG V    +   E I A+K++N K +   R+  A     R
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN-KWEMLKRAETACFREER 125
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRL 643
           ++      + IT      F+  +   LV +Y   G L   L +  D++ E      I  +
Sbjct: 126 DVLVNGDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 184
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +AID   +I  LH+      VH D+KP NVLLD +    + DFG    ++         
Sbjct: 185 VLAID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMN------DDG 229
Query: 704 TPSSSIGIKGTVGYVAP 720
           T  SS+ + GT  Y++P
Sbjct: 230 TVQSSVAV-GTPDYISP 245

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++ +  L+ ++  S   +    L LI+  +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEHV-HQDLKTFMDAS--ALTGIPLPLIK--SYLFQ 110
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVI----NLKQKGAFRSFVAECEA 582
           A  +   + ++G+G FG VY+G+      +++ VAVK       L  K     F++E   
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVI 66
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++N+ H +++K+I I         +   ++ E    G L  +L ++ + ++V  L L   
Sbjct: 67  MKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-- 118
Query: 643 LNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
              ++ +  A+ YL   +C    VH D+   N+L+       +GDFGL++++       +
Sbjct: 119 ---SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 702 SKT 704
           S T
Sbjct: 172 SVT 174

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 30  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 87  HKNIINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDI--N 195
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 196 NIDYYKKTTNGRLPVK----WMAPEALF 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS------FVAECEALR 584
           +  +     +G G++G V   +L +D++  A + I + +K +  +       + E   L+
Sbjct: 20  SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N++K+        F+      LV E    G L D +      +   K S +    
Sbjct: 77  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEI------ILRQKFSEVDAAV 125
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S   YLH H    +VH DLKP N+LL+    D +  + DFGL     S H +  
Sbjct: 126 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGL-----SAHFEVG 177
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 178 GKMKERL----GTAYYIAP 192

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 25/178 (14%)
Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMI-VAVKVI--NLKQKGAFRSFVAECEALRN 585
           +E     ++G G+FG+VYKGI    GE+  I VA+KV+  N   K A +  + E   +  
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 75
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           +    + +++ IC ++  +      LV + M  G L D + ++  ++    L     LN 
Sbjct: 76  VGSPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL-----LNW 124
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL----SSHHLD 699
            + +A  + YL       +VH DL   NVL+       + DFGLA+ L    + +H D
Sbjct: 125 CMQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 179

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 35  LGEGCFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 92  HKNIINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 200
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 201 NIDYYKKTTNGRLPVK----WMAPEALF 224

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 49/216 (22%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---------------------- 569
           ++++  + IG+GS+G V       D    A+KV++ K+                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 570 ----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL 625
               +G       E   L+ + H N++K++ +    D    D   +VFE +  G +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPVM--- 126
Query: 626 HQSNDQVEVCK-LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
                +V   K LS  Q      D+   IEYLH+     ++H D+KPSN+L+  D    +
Sbjct: 127 -----EVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKI 178
Query: 685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            DFG+     S+    S    S+++   GT  ++AP
Sbjct: 179 ADFGV-----SNEFKGSDALLSNTV---GTPAFMAP 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 30/191 (15%)
Query: 540 IGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIIT 596
           +G+G +G V++G+  GE    VAVK+ + + +   +S+  E E    +  RH N++  I 
Sbjct: 16  VGKGRYGEVWRGLWHGES---VAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA 69
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
              ++         L+  Y  +GSL D+L +   +  +        L +A+  A  + +L
Sbjct: 70  SDMTSRNSSTQL-WLITHYHEHGSLYDFLQRQTLEPHLA-------LRLAVSAACGLAHL 121
Query: 657 H-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS--SHHLDTSSKTPSSSI 709
           H        +P + H D K  NVL+  ++   + D GLA   S  S +LD  +       
Sbjct: 122 HVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV--- 178
Query: 710 GIKGTVGYVAP 720
              GT  Y+AP
Sbjct: 179 ---GTKRYMAP 186

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 540 IGQGSFGSVYKGI--LGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G G+FGSV +G+  + + ++ VA+KV+    +K      + E + +  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +C +          LV E  G G L  +L    +++ V  ++      +   V+  ++YL
Sbjct: 404 VCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 452
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
               +   VH +L   NVLL +   A + DFGL+K L +   D S  T  S+   K  + 
Sbjct: 453 E---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSA--GKWPLK 504
Query: 717 YVAP 720
           + AP
Sbjct: 505 WYAP 508

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVIN----LKQKGAFRSFVAECEA 582
           A  +   + ++G+G FG VY+G+      +++ VAVK       L  K     F++E   
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK---EKFMSEAVI 62
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           ++N+ H +++K+I I         +   ++ E    G L  +L ++ + ++V  L L   
Sbjct: 63  MKNLDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-- 114
Query: 643 LNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
              ++ +  A+ YL   +C    VH D+   N+L+       +GDFGL++++       +
Sbjct: 115 ---SLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 167
Query: 702 SKT 704
           S T
Sbjct: 168 SVT 170

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    LV   MG     L    H SND +  C   L Q       +
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI--CYF-LYQ-------I 153
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 201

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 24/168 (14%)
Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIK 593
           +G+  FG VYKG L     GE    VA+K +  K +G  R  F  E      ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWL----------HQSNDQVEVCKLSLIQRL 643
           ++ + +          +++F Y  +G L ++L             +D+     L     +
Sbjct: 77  LLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++   +A+ +EYL  H    +VH DL   NVL+   +   + D GL +
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 43/221 (19%)
Query: 514 PMEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN--- 566
           PM ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++   
Sbjct: 2   PMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 61
Query: 567 ---LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNG 619
              +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG  
Sbjct: 62  QSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGAD 114
Query: 620 SLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD 679
                    N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D
Sbjct: 115 L--------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 163
Query: 680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
               + DFGLA+            T     G   T  Y AP
Sbjct: 164 CELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 193

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK--LSLIQRLNIAIDVASAIEY 655
             +          LVFE++               ++VC+  L  +   +  + + + I Y
Sbjct: 69  IHTKKRL-----VLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK--LSLIQRLNIAIDVASAIEY 655
             +          LVFE++               ++VC+  L  +   +  + + + I Y
Sbjct: 69  IHTKKRL-----VLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK--LSLIQRLNIAIDVASAIEY 655
             +          LVFE++               ++VC+  L  +   +  + + + I Y
Sbjct: 69  IHTKKRL-----VLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+  I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 534 FSSSNMIGQGSFGSVYKG---ILGEDEMIVAVKVINL--KQKGAFRSFVAECEALRNIRH 588
           F     IG+G++G VYK    + GE   +VA+  I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K++ +  + +        LVFE++        L +  D   +  + L    +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQ 110
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 114
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 115 SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 163
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     DT+S    S 
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQ 216
Query: 709 IGIKGTVGYVAP 720
           +   G V Y+ P
Sbjct: 217 V---GAVNYMPP 225

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI- 586
           S+ T+EF     IG G FGSV+K +   D  I A+K    + K      V E  ALR + 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 587 ------RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 59  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 113
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 114 K--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI- 586
           S+ T+EF     IG G FGSV+K +   D  I A+K    + K      V E  ALR + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 587 ------RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 118 K--DLLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI- 586
           S+ T+EF     IG G FGSV+K +   D  I A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 587 ------RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 116 K--DLLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 35/199 (17%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS------FVAECEALR 584
           +  +     +G G++G V   +L +D++  A + I + +K +  +       + E   L+
Sbjct: 3   SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 59
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H N++K+        F+      LV E    G L D +      +   K S +    
Sbjct: 60  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEI------ILRQKFSEVDAAV 108
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTS 701
           I   V S   YLH H    +VH DLKP N+LL+    D +  + DFGL     S H +  
Sbjct: 109 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGL-----SAHFEVG 160
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 161 GKMKERL----GTAYYIAP 175

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI- 586
           S+ T+EF     IG G FGSV+K +   D  I A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 587 ------RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 116 K--DLLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 3/163 (1%)
Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           K    L KL+ L L  N L          L  L+ + +  N L          L NL +L
Sbjct: 55  KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL 114
Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
            +  N+   + PR   +++ L Y  L  N    SLP  +   L +LKEL +  NN    +
Sbjct: 115 RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL-YNNQLKRV 172
Query: 127 PD-SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN 168
           P+ +    + L+ L L NNQ K      F SL+ L  L L++N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLIKI 594
            +++G+G+   V   I        AVK+I  KQ G  RS V  E E L   + HRN+++ 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE- 75
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+  D   LVFE M  GS+   +H+     E+    ++Q      DVASA++
Sbjct: 76  ----LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALD 125
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVG--DFGLAKFLSSHHLDTSSKTPSSSIGI 711
           +LH+     + H DLKP N+L +H + V+ V   DFGL   +  +  D S  +    +  
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNG-DCSPISTPELLTP 181
Query: 712 KGTVGYVAP 720
            G+  Y+AP
Sbjct: 182 CGSAEYMAP 190

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++ EY   G+L ++L              ++V   ++
Sbjct: 100 HKNIINLLGACTQD---GPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 208
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D    T +  + +K    ++AP   F
Sbjct: 209 NIDYYKNTTNGRLPVK----WMAPEALF 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIIT 596
           IG+GSFG V      + + + A+K +N +   ++   R+   E + ++ + H  L+ +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS-NDQVEVCKLSLIQRLNIAIDVASAIEY 655
                 F+  +   +V + +  G L   L Q+ + + E  KL + +       +  A++Y
Sbjct: 83  -----SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVMALDY 130
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L +     ++H D+KP N+LLD     H+ DF +A  L      T+         + GT 
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---------MAGTK 178
Query: 716 GYVAPGKF 723
            Y+AP  F
Sbjct: 179 PYMAPEMF 186

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++  Y   G+L ++L              ++V   ++
Sbjct: 100 HKNIINLLGACTQD---GPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 208
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 209 NIDYYKKTTNGRLPVK----WMAPEALF 232

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 21/166 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           +++  +IG GSFG V++  L E + +   KV+   Q   F++   E + +R ++H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN--RELQIMRIVKHPNVVD 96
Query: 594 IIT-ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----VEVCKLSLIQRLNIAID 648
           +     S+ D K   F  LV EY+         H +  +    + + KL + Q L     
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR---- 152
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFL 693
              ++ Y+H      + H D+KP N+LLD    V  + DFG AK L
Sbjct: 153 ---SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 59/105 (56%), Gaps = 8/105 (7%)
Query: 200 FGGELPHSIANLSS-TMIVFLI-GGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPD- 255
            GG   H I+ L   T + +LI  GNQ+  ++P G+   L NL  L +  NQL  ++PD 
Sbjct: 70  LGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDG 127
Query: 256 VIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQG 299
           V  +L NL  L LY N LQ S+P G+   LT L +LDL +N LQ 
Sbjct: 128 VFDKLTNLTYLYLYHNQLQ-SLPKGVFDKLTNLTRLDLDNNQLQS 171

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 62  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 110
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 8   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 65  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 113
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 114 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 21/184 (11%)
Query: 509 SADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINL 567
           SA + P +     +   E      +     +IG+G FG VY G   GE    VA+++I++
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE----VAIRLIDI 65
Query: 568 KQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL 625
           ++  +   ++F  E  A R  RH N++  +  C S         A++       +L   +
Sbjct: 66  ERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVV 120
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
             +   ++V K        IA ++   + YLH      ++H DLK  NV  D+  V  + 
Sbjct: 121 RDAKIVLDVNKTR-----QIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVV-IT 171
Query: 686 DFGL 689
           DFGL
Sbjct: 172 DFGL 175

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 62  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 110
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 62  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 110
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 62  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 110
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 73/144 (50%), Gaps = 20/144 (13%)
Query: 540 IGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +GQG+F  ++KG+  E        E  V +KV++   +    SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
               +C        D   LV E++  GSL+ +L ++ +    C ++++ +L +A  +A+A
Sbjct: 76  LNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKN----C-INILWKLEVAKQLAAA 125
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLL 676
           + +L  +    ++HG++   N+LL
Sbjct: 126 MHFLEENT---LIHGNVCAKNILL 146

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 40/198 (20%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN- 590
            +F     +G GSFG V+      +    A+KV  LK++   R        L+ + H N 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVR--------LKQVEHTND 55
Query: 591 ---LIKIIT----ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKLSLIQR 642
              ++ I+T    I     F+      ++ +Y+  G L   L +S      V K      
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF----- 110
Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
              A +V  A+EYLH      +++ DLKP N+LLD +    + DFG AK++         
Sbjct: 111 --YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV--------- 156
Query: 703 KTPSSSIGIKGTVGYVAP 720
             P  +  + GT  Y+AP
Sbjct: 157 --PDVTYXLCGTPDYIAP 172

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 35/205 (17%)
Query: 525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEA 582
           A  ++ T ++     +G+G+F  V + +        A K+IN K+  A   +    E   
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSL-EDWL---HQSNDQVEVCKLS 638
            R ++H N++++    S   F       LVF+ +  G L ED +   + S      C   
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIHQ 138
Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSS 695
           +++ +N          ++H H    +VH DLKP N+LL          + DFGLA  +  
Sbjct: 139 ILESVN----------HIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAP 720
                      +  G  GT GY++P
Sbjct: 186 EQ--------QAWFGFAGTPGYLSP 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           +EF    ++G+G+FG V   IL +++      A+K++  +    K      + E   L+N
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V     S  +    
Sbjct: 65  SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 113
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 114 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 540 IGQGSFGSVYKGILGE----------DEMIVAVKVI-NLKQKGAFRSFVAECEALRNI-R 587
           +G+G+FG V   ++ E          + + VAVK++ +   +      V+E E ++ I +
Sbjct: 43  LGEGAFGQV---VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----------DQVEVCKL 637
           H+N+I ++  C+     G  +  ++  Y   G+L ++L              ++V   ++
Sbjct: 100 HKNIINLLGACTQD---GPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 638 SLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           +    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ +  +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--N 208
Query: 697 HLDTSSKTPSSSIGIKGTVGYVAPGKFF 724
           ++D   KT +  + +K    ++AP   F
Sbjct: 209 NIDYYKKTTNGRLPVK----WMAPEALF 232

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 74/144 (51%), Gaps = 20/144 (13%)
Query: 540 IGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +GQG+F  ++KG+  E        E  V +KV++   +    SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
               +C    F G D   LV E++  GSL+ +L ++ +    C ++++ +L +A  +A A
Sbjct: 76  LNYGVC----FCG-DENILVQEFVKFGSLDTYLKKNKN----C-INILWKLEVAKQLAWA 125
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLL 676
           + +L  +    ++HG++   N+LL
Sbjct: 126 MHFLEENT---LIHGNVCAKNILL 146

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           +EF    ++G+G+FG V   IL +++      A+K++  +    K      + E   L+N
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V     S  +    
Sbjct: 66  SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 114
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 115 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           +EF    ++G+G+FG V   IL +++      A+K++  +    K      + E   L+N
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V     S  +    
Sbjct: 67  SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 115
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 116 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 85/185 (45%), Gaps = 15/185 (8%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA----ECEAL 583
           +K   ++   +++G+GS+G V + +  E     AVK++  K+     +  A    E + L
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 584 RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
           R +RH+N+I+++ +  + + + +    +V EY   G     + +  D V   +  + Q  
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCG-----MQEMLDSVPEKRFPVCQAH 112
Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
                +   +EYLH      +VH D+KP N+LL       +   G+A+ L     D + +
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 704 TPSSS 708
           T   S
Sbjct: 170 TSQGS 174

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 62  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 110
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVY--KGILGED-EMIVAVKVIN---LKQKGAFRSFVAECEALRN 585
           S+F    ++GQGSFG V+  K I G D   + A+KV+    LK +   R+ + E + L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 83
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H  ++K+        F+      L+ +++  G L   L +     EV       +  +
Sbjct: 84  VNHPFIVKL-----HYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 133
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K      +D   K  
Sbjct: 134 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAY 185
Query: 706 SSSIGIKGTVGYVAP 720
           S      GTV Y+AP
Sbjct: 186 SFC----GTVEYMAP 196

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVY--KGILGED-EMIVAVKVIN---LKQKGAFRSFVAECEALRN 585
           S+F    ++GQGSFG V+  K I G D   + A+KV+    LK +   R+ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H  ++K+        F+      L+ +++  G L   L +     EV       +  +
Sbjct: 83  VNHPFIVKL-----HYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 132
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K      +D   K  
Sbjct: 133 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAY 184
Query: 706 SSSIGIKGTVGYVAP 720
           S      GTV Y+AP
Sbjct: 185 SFC----GTVEYMAP 195

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 43/222 (19%)
Query: 513 SPMEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-- 566
           S M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++  
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 78
Query: 567 ----LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN 618
               +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG 
Sbjct: 79  FQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA 131
Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
                     N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ 
Sbjct: 132 --------DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 180
Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           D    + DFGLA+            T     G   T  Y AP
Sbjct: 181 DCELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 211

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 29/192 (15%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRH 588
           +S    IG G    V++ +L E + I A+K +NL++       ++R+ +A    L+  +H
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 86
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            +  KII +    D++  D    +    GN  L  WL +         +   +R +   +
Sbjct: 87  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKN 135
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +  A+  +H H    +VH DLKP+N L+   M+  + DFG+A  +     D       S 
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DXXXVVKDSQ 188
Query: 709 IGIKGTVGYVAP 720
           +   GTV Y+ P
Sbjct: 189 V---GTVNYMPP 197

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           ++F    ++G+G+FG V   IL  ++      A+K++  +    K      V E   L+N
Sbjct: 10  NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 67  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 115
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 116 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 43/222 (19%)
Query: 513 SPMEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-- 566
           S M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++  
Sbjct: 18  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 77
Query: 567 ----LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN 618
               +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG 
Sbjct: 78  FQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA 130
Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
                     N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ 
Sbjct: 131 --------DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 179
Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           D    + DFGLA+            T     G   T  Y AP
Sbjct: 180 DCELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           +EF    ++G+G+FG V   IL +++      A+K++  +    K      + E   L+N
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V     S  +    
Sbjct: 205 SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 253
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 254 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMI---VAVKVINLK---QKGAFRSFVAECEALRN 585
           +EF    ++G+G+FG V   IL +++      A+K++  +    K      + E   L+N
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            RH  L  +        F+  D    V EY   G L  + H S ++V     S  +    
Sbjct: 208 SRHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFY 256
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 257 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDX 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLIKI 594
           IG+GSFG        ED     +K IN+     K++   R  VA    L N++H N+++ 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA---VLANMKHPNIVQY 88
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+      +V +Y   G   D   + N Q  V      Q L+  + +  A++
Sbjct: 89  -----RESFEENGSLYIVMDYCEGG---DLFKRINAQKGVL-FQEDQILDWFVQICLALK 139
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           ++H      ++H D+K  N+ L  D    +GDFG+A+ L+S
Sbjct: 140 HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGXVATRWYRAP 191

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 532 SEFSSSNMIGQGSFGSVY--KGILGED-EMIVAVKVIN---LKQKGAFRSFVAECEALRN 585
           S+F    ++GQGSFG V+  K I G D   + A+KV+    LK +   R+ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H  ++K+        F+      L+ +++  G L   L +     EV       +  +
Sbjct: 83  VNHPFIVKL-----HYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 132
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K      +D   K  
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAY 184
Query: 706 SSSIGIKGTVGYVAP 720
           S      GTV Y+AP
Sbjct: 185 SFC----GTVEYMAP 195

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 72  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 124
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 125 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDX 173
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 174 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 202

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 39/215 (18%)
Query: 527 LSKATSEFSSSNMI-----GQGSFGSVYKGI---LGEDEMIVAVKVINLKQKGA---FRS 575
           L     EF   N++     G+G FG V K     L        V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN------ 629
            ++E   L+ + H ++IK+   CS           L+ EY   GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 630 ------------DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 677
                       D  +   L++   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                 + DFGL++    +  D+  K     I +K
Sbjct: 185 EGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVK 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/193 (22%), Positives = 88/193 (45%), Gaps = 18/193 (9%)
Query: 501 RRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIV 560
           ++R+  H+S  T+ M +  P   +    +    +   ++IG GS+G V +     ++ +V
Sbjct: 28  QQRKQHHSSKPTASMPR--PHSDW----QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 561 AVKVI--NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGN 618
           A+K I    +     +  + E   L  + H +++K++ I    D +  D   +V E + +
Sbjct: 82  AIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IAD 140
Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
              +          E+   +L+  L + +      +Y+H      ++H DLKP+N L++ 
Sbjct: 141 SDFKKLFRTPVYLTELHIKTLLYNLLVGV------KYVH---SAGILHRDLKPANCLVNQ 191
Query: 679 DMVAHVGDFGLAK 691
           D    V DFGLA+
Sbjct: 192 DCSVKVCDFGLAR 204

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLI 592
           F    ++G G++G VYKG   +   + A+KV+++           E   L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 593 KIITICSSTDFKGVDFK-ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
                    +  G+D +  LV E+ G GS+ D +   N +    K   I    I  ++  
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWI--AYICREILR 140
Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            + +LH H    ++H D+K  NVLL  +    + DFG+     S  LD +    ++ I  
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNTFI-- 190
Query: 712 KGTVGYVAP 720
            GT  ++AP
Sbjct: 191 -GTPYWMAP 198

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 39/215 (18%)
Query: 527 LSKATSEFSSSNMI-----GQGSFGSVYKGI---LGEDEMIVAVKVINLKQKGA---FRS 575
           L     EF   N++     G+G FG V K     L        V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN------ 629
            ++E   L+ + H ++IK+   CS           L+ EY   GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 630 ------------DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 677
                       D  +   L++   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVA 184
Query: 678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                 + DFGL++    +  D+  K     I +K
Sbjct: 185 EGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVK 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 6   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 66  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 118
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 119 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 167
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 168 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 196

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 133
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHT 181

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 63  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 115
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 116 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 164
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 165 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 193

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 137
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 7   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 67  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 119
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 120 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 168
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 169 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 197

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 24  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 83
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 84  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 136
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 137 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 185
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 186 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 214

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ 72
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 73  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 125
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 126 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 174
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 175 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 203

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 39/215 (18%)
Query: 527 LSKATSEFSSSNMI-----GQGSFGSVYKGI---LGEDEMIVAVKVINLKQKGA---FRS 575
           L     EF   N++     G+G FG V K     L        V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 576 FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN------ 629
            ++E   L+ + H ++IK+   CS           L+ EY   GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 630 ------------DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 677
                       D  +   L++   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
                 + DFGL++    +  D+  K     I +K
Sbjct: 185 EGRKMKISDFGLSR--DVYEEDSYVKRSQGRIPVK 217

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 133
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 73  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 125
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 126 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 174
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 175 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 203

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 73  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 125
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 126 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 174
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 175 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 203

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 72  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 124
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 125 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 173
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 174 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 202

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 133
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 135
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI--CYF-LYQ-------I 137
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 7   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 67  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 119
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 120 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDS 168
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 169 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 197

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 137
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVA 578
           P +   ++      +++ + IG+G++G V       +++ VA+K I+  + +   +  + 
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCK 636
           E + L   RH N+I I  I  +   + +    +V + M      L    H SND +  C 
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CY 148
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
             L Q       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 149 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 197
Query: 697 HLDT 700
           H  T
Sbjct: 198 HDHT 201

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 63  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 115
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 116 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDS 164
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 165 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 193

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 133
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           K+ P     EL+K   E    + + + +G G++GSV      +  + +AVK ++      
Sbjct: 32  KERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSI 91
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICS-STDFKGVDFKALVFEYMGNGSLEDWL 625
           +  K  +R    E   L++++H N+I ++ + + +T  +  +   LV   MG        
Sbjct: 92  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADL----- 142
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 143 ---NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 196
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 197 DFGLAR-----------HTDDEMTGYVATRWYRAP 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVA 578
           P +   ++      +++ + IG+G++G V       +++ VA+K I+  + +   +  + 
Sbjct: 19  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 78
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCK 636
           E + L   RH N+I I  I  +   + +    +V + M      L    H SND +  C 
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CY 136
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
             L Q       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 137 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 185
Query: 697 HLDT 700
           H  T
Sbjct: 186 HDHT 189

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVA 578
           P +   ++      +++ + IG+G++G V       +++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCK 636
           E + L   RH N+I I  I  +   + +    +V + M      L    H SND +  C 
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CY 128
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
             L Q       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 129 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 697 HLDT 700
           H  T
Sbjct: 178 HDHT 181

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 17/144 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLIKI 594
            +++G+G+   V   I        AVK+I  KQ G  RS V  E E L   + HRN+++ 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE- 75
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F+  D   LVFE M  GS+   +H+     E+    ++Q      DVASA++
Sbjct: 76  ----LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALD 125
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDH 678
           +LH+     + H DLKP N+L +H
Sbjct: 126 FLHNK---GIAHRDLKPENILCEH 146

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 131
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 132 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 138
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 139 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 139
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 140 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 187

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 130
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 131 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 178

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 137
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVA 578
           P +   ++      +++ + IG+G++G V       +++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCK 636
           E + L   RH N+I I  I  +   + +    +V + M      L    H SND +  C 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CY 132
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
             L Q       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 133 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 697 HLDT 700
           H  T
Sbjct: 182 HDHT 185

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVA 578
           P +   ++      +++ + IG+G++G V       +++ VA+K I+  + +   +  + 
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 75
Query: 579 ECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCK 636
           E + L   RH N+I I  I  +   + +    +V + M      L    H SND +  C 
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CY 133
Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
             L Q       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 134 F-LYQ-------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 697 HLDT 700
           H  T
Sbjct: 183 HDHT 186

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 131
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 132 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 513 SPMEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-- 566
           S M ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++  
Sbjct: 18  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP 77
Query: 567 ----LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN 618
               +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG 
Sbjct: 78  FQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA 130
Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
                     N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ 
Sbjct: 131 --------DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 179
Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           D    + DFGLA+            T     G   T  Y AP
Sbjct: 180 DCELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 210

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 135
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 29/184 (15%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYL 656
              +   D   +V E++  G+L D +  +    +Q+    L+++Q L++           
Sbjct: 84  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVL---------- 132
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
             H Q  ++H D+K  ++LL HD    + DFG            S + P     + GT  
Sbjct: 133 --HAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCA-------QVSKEVPRRKXLV-GTPY 181
Query: 717 YVAP 720
           ++AP
Sbjct: 182 WMAP 185

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 29/184 (15%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 92
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYL 656
              +   D   +V E++  G+L D +  +    +Q+    L+++Q L++          L
Sbjct: 93  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV----------L 141
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
           H      ++H D+K  ++LL HD    + DFG            S + P     + GT  
Sbjct: 142 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA-------QVSKEVPRRKXLV-GTPY 190
Query: 717 YVAP 720
           ++AP
Sbjct: 191 WMAP 194

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 513 SPMEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-- 566
           S M ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++  
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP 78
Query: 567 ----LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN 618
               +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG 
Sbjct: 79  FQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA 131
Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
                     N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ 
Sbjct: 132 --------DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 180
Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           D    + DFGLA+            T     G   T  Y AP
Sbjct: 181 DCELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 211

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + IG G++GSV      +  + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 118
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 119 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXEL 169
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 170 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 196

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 34/190 (17%)
Query: 526 ELSKATSEFSSSNMIGQGSFGSVYK----GILGEDEMI-VAVKVINLKQKGAFR-SFVAE 579
           E  +   EF    ++G G+FG V      GI      I VAVK++  K   + R + ++E
Sbjct: 41  EFPRENLEFG--KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 580 CEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-----SNDQVE 633
            + +  +  H N++ ++  C+     G  +  L+FEY   G L ++L       S D++E
Sbjct: 99  LKMMTQLGSHENIVNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 634 V---CKLSLIQRLNI---------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV 681
                +L   + LN+         A  VA  +E+L        VH DL   NVL+ H  V
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 210
Query: 682 AHVGDFGLAK 691
             + DFGLA+
Sbjct: 211 VKICDFGLAR 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 29/184 (15%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 94
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYL 656
              +   D   +V E++  G+L D +  +    +Q+    L+++Q L++          L
Sbjct: 95  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV----------L 143
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
           H      ++H D+K  ++LL HD    + DFG            S + P     + GT  
Sbjct: 144 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA-------QVSKEVPRRKXLV-GTPY 192
Query: 717 YVAP 720
           ++AP
Sbjct: 193 WMAP 196

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 29/184 (15%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 87
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYL 656
              +   D   +V E++  G+L D +  +    +Q+    L+++Q L++           
Sbjct: 88  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVL---------- 136
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
             H Q  ++H D+K  ++LL HD    + DFG            S + P     + GT  
Sbjct: 137 --HAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCA-------QVSKEVPRRKXLV-GTPY 185
Query: 717 YVAP 720
           ++AP
Sbjct: 186 WMAP 189

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 43/199 (21%)
Query: 540 IGQGSFGSVY--KGILGEDEMIVAVKVINLKQ--KGAF-----------RSFVAECEALR 584
           +G G++G V   K   G  E   A+KVI   Q  KG +                E   L+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEK--AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           ++ H N+IK+  +     F+   +  LV E+   G L + +      +   K       N
Sbjct: 102 SLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI------INRHKFDECDAAN 150
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSSHHLDTS 701
           I   + S I YLH H    +VH D+KP N+LL++    +   + DFGL+ F S  +    
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---- 203
Query: 702 SKTPSSSIGIKGTVGYVAP 720
            K         GT  Y+AP
Sbjct: 204 -KLRDRL----GTAYYIAP 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 36/187 (19%)
Query: 526 ELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI------NLKQKGAFRS 575
           E++K   E    +     +G G++G+V   + G     VA+K +       L  K A+R 
Sbjct: 15  EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR- 73
Query: 576 FVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN--GSLEDWLHQSN 629
              E   L+++RH N+I ++ + +      DF   DF  LV  +MG   G L        
Sbjct: 74  ---ELRLLKHMRHENVIGLLDVFTPDETLDDF--TDF-YLVMPFMGTDLGKLMKHEKLGE 127
Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
           D+++     +++           + Y+H      ++H DLKP N+ ++ D    + DFGL
Sbjct: 128 DRIQFLVYQMLK----------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 690 AKFLSSH 696
           A+   S 
Sbjct: 175 ARQADSE 181

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 24/190 (12%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 590
           F    ++G+GSFG V    + E   + AVKV+    + Q       + E   L   R+  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
            +  +  C    F+  D    V E++  G L   + +S       +    +    A ++ 
Sbjct: 85  FLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEII 134
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
           SA+ +LH      +++ DLK  NVLLDH+    + DFG+ K    + + T++        
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-------- 183
Query: 711 IKGTVGYVAP 720
             GT  Y+AP
Sbjct: 184 FCGTPDYIAP 193

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 521 MVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFV 577
           +V   E+     +F    +IG+G+F  V    + +   + A+K++N   + ++G    F 
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 578 AECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVC 635
            E + L N   R + ++        F+  ++  LV EY   G L   L +  +++  E+ 
Sbjct: 110 EERDVLVNGDRRWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG 688
           +  L + + +AID    + Y         VH D+KP N+LLD      + DFG
Sbjct: 165 RFYLAE-IVMAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFG 207

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +F     IG GSFG +Y G   +    VA+K+ N+K K      + E +  R      ++
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYR------IL 59
Query: 593 KIITICSSTDFKGV--DFKALVFEYMGNGSLEDWLHQSNDQVEVC--KLSLIQRLNIAID 648
           +  T   +  + GV  D+  LV + +G  SLED  +        C  KLSL   L +A  
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFN-------FCSRKLSLKTVLMLADQ 111
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA---HVGDFGLAKFLSSHHLDTSS 702
           + + +E++H       +H D+KP N L+     A   ++ DFGLAK     + DTS+
Sbjct: 112 MINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----KYRDTST 161

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 135
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHT 183

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 513 SPMEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-- 566
           S M ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++  
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP 78
Query: 567 ----LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGN 618
               +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG 
Sbjct: 79  FQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA 131
Query: 619 GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
                     N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ 
Sbjct: 132 --------DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 180
Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           D    + DFGLA+            T     G   T  Y AP
Sbjct: 181 DCELKILDFGLAR-----------HTDDEMXGXVATRWYRAP 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 22/216 (10%)
Query: 505 SAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKV 564
           SAH    ++P+ K+ P V      +    +     +G+G F   Y+    + + + A KV
Sbjct: 18  SAHVDPKSAPL-KEIPDVLVD--PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 565 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW 624
           +   +    +    E  +     H++L     +     F+  DF  +V E     SL + 
Sbjct: 75  V--PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE- 131
Query: 625 LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
           LH+    V   +     R  I       ++YLH++    ++H DLK  N+ L+ DM   +
Sbjct: 132 LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKI 183
Query: 685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           GDFGLA  +     D   K       + GT  Y+AP
Sbjct: 184 GDFGLATKIE---FDGERKK-----DLCGTPNYIAP 211

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + D+GLA+            T     G   T  Y AP
Sbjct: 163 ELKILDYGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 22/216 (10%)
Query: 505 SAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKV 564
           SAH    ++P+ K+ P V      +    +     +G+G F   Y+    + + + A KV
Sbjct: 18  SAHVDPKSAPL-KEIPDVLVD--PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 565 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW 624
           +   +    +    E  +     H++L     +     F+  DF  +V E     SL + 
Sbjct: 75  V--PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE- 131
Query: 625 LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
           LH+    V   +     R  I       ++YLH++    ++H DLK  N+ L+ DM   +
Sbjct: 132 LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKI 183
Query: 685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           GDFGLA  +     D   K       + GT  Y+AP
Sbjct: 184 GDFGLATKIE---FDGERKK-----TLCGTPNYIAP 211

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYL 656
             D   V     V E++  G+L D +  +    +Q+    L+++Q L++          L
Sbjct: 142 VGDELWV-----VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV----------L 186
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           H      ++H D+K  ++LL HD    + DFG    +S  
Sbjct: 187 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N++++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 214
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYL 656
              +   D   +V E++  G+L D +  +    +Q+    L+++Q L++          L
Sbjct: 215 -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV----------L 263
Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           H      ++H D+K  ++LL HD    + DFG    +S  
Sbjct: 264 HAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 23/192 (11%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           S+++GQG+  +V++G   +   + A+KV  N+         + E E L+ + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            I   T  +    K L+ E+   GSL   L + ++      L   + L +  DV   + +
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNH 127
Query: 656 LHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           L  +    +VH ++KP N++     D   V  + DFG A+ L               + +
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---------DEQFVSL 175
Query: 712 KGTVGYVAPGKF 723
            GT  Y+ P  +
Sbjct: 176 YGTEEYLHPDMY 187

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINLKQKG--- 571
           Q P     E  +   +F  +  +G G+FG V +     LG+++ ++ V V  LK      
Sbjct: 26  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 572 AFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN- 629
              + ++E + + ++ +H N++ ++  C+      V     + EY   G L ++L +   
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKAE 138
Query: 630 ---DQVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              D+ +   L L   L+ +  VA  + +L   +C    +H D+   NVLL +  VA +G
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 194
Query: 686 DFGLAK 691
           DFGLA+
Sbjct: 195 DFGLAR 200

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMAGFVATRWYRAP 191

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 591
            +++ + IG+G++G V       +++ VA++ I+  + +   +  + E + L   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNG--SLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I I  I  +   + +    +V + M      L    H SND +  C   L Q       +
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--CYF-LYQ-------I 137
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H  T
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 22/216 (10%)
Query: 505 SAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKV 564
           SAH    ++P+ K+ P V      +    +     +G+G F   Y+    + + + A KV
Sbjct: 18  SAHVDPKSAPL-KEIPDVLVD--PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 565 INLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDW 624
           +   +    +    E  +     H++L     +     F+  DF  +V E     SL + 
Sbjct: 75  V--PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE- 131
Query: 625 LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
           LH+    V   +     R  I       ++YLH++    ++H DLK  N+ L+ DM   +
Sbjct: 132 LHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKI 183
Query: 685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           GDFGLA  +     D   K       + GT  Y+AP
Sbjct: 184 GDFGLATKIE---FDGERKK-----XLCGTPNYIAP 211

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMAGFVATRWYRAP 191

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + DFGLA+            T     G   T  Y AP
Sbjct: 163 ELKILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           S+++GQG+  +V++G   +   + A+KV  N+         + E E L+ + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            I   T  +    K L+ E+   GSL   L + ++      L   + L +  DV   + +
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNH 127
Query: 656 LHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSS 695
           L  +    +VH ++KP N++     D   V  + DFG A+ L  
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 118
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 119 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXEL 169
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 170 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 196

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 25/189 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G+FG V+        +   +K IN  + +       AE E L+++ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
               F+      +V E    G L + +  +  + +      +  L     + +A+ Y H 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL--MKQMMNALAYFHS 142
Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAH----VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
                +VH DLKP N+L   D   H    + DFGLA+           K+   S    GT
Sbjct: 143 QH---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELF---------KSDEHSTNAAGT 189
Query: 715 VGYVAPGKF 723
             Y+AP  F
Sbjct: 190 ALYMAPEVF 198

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 82/192 (42%), Gaps = 35/192 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 IITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +  +  + TD        L+ E +  G L D+L Q     E    S I++      +   
Sbjct: 80  LHDVYENRTDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDG 127
Query: 653 IEYLHHHCQPPMVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLSSHHLDTSSKTPSSS 708
           + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN-- 177
Query: 709 IGIKGTVGYVAP 720
             I GT  +VAP
Sbjct: 178 --IFGTPEFVAP 187

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 82/192 (42%), Gaps = 35/192 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 IITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +  +  + TD        L+ E +  G L D+L Q     E    S I++      +   
Sbjct: 80  LHDVYENRTDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDG 127
Query: 653 IEYLHHHCQPPMVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLSSHHLDTSSKTPSSS 708
           + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN-- 177
Query: 709 IGIKGTVGYVAP 720
             I GT  +VAP
Sbjct: 178 --IFGTPEFVAP 187

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINLKQKG--- 571
           Q P     E  +   +F  +  +G G+FG V +     LG+++ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 572 AFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN- 629
              + ++E + + ++ +H N++ ++  C+      V     + EY   G L ++L +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKAE 146
Query: 630 ---DQVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              D+ +   L L   L+ +  VA  + +L   +C    +H D+   NVLL +  VA +G
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 202
Query: 686 DFGLAK 691
           DFGLA+
Sbjct: 203 DFGLAR 208

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 82/192 (42%), Gaps = 35/192 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 IITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +  +  + TD        L+ E +  G L D+L Q     E    S I++      +   
Sbjct: 80  LHDVYENRTDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDG 127
Query: 653 IEYLHHHCQPPMVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLSSHHLDTSSKTPSSS 708
           + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN-- 177
Query: 709 IGIKGTVGYVAP 720
             I GT  +VAP
Sbjct: 178 --IFGTPEFVAP 187

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 82/192 (42%), Gaps = 35/192 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 IITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +  +  + TD        L+ E +  G L D+L Q     E    S I++      +   
Sbjct: 80  LHDVYENRTDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDG 127
Query: 653 IEYLHHHCQPPMVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLSSHHLDTSSKTPSSS 708
           + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN-- 177
Query: 709 IGIKGTVGYVAP 720
             I GT  +VAP
Sbjct: 178 --IFGTPEFVAP 187

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 21/190 (11%)
Query: 536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLIK 593
           +S ++G+G++  V   +  ++    AVK+I  KQ G  RS V  E E L   + ++N+++
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIE-KQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I       F+      LVFE +  GS+   + +          +  +   +  DVA+A+
Sbjct: 76  LIEF-----FEDDTRFYLVFEKLQGGSILAHIQKQK------HFNEREASRVVRDVAAAL 124
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVG--DFGLAKFLSSHHLDTSSKTPSSSIG 710
           ++LH      + H DLKP N+L +  + V+ V   DF L   +  ++  T   TP  +  
Sbjct: 125 DFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 711 IKGTVGYVAP 720
             G+  Y+AP
Sbjct: 182 C-GSAEYMAP 190

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 33/195 (16%)
Query: 534 FSSSNMIGQGSFGS-VYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALR-NIRHRNL 591
           F   +++G G+ G+ VY+G+   D   VAVK I L +  +F     E + LR +  H N+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRI-LPECFSFAD--REVQLLRESDEHPNV 80
Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN-DQVEVCKLSLIQRLNIAIDVA 650
           I+    C+  D +   F+ +  E +   +L++++ Q +   + +  ++L+Q+        
Sbjct: 81  IRYF--CTEKDRQ---FQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQ------TT 128
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLD----HDMV-AHVGDFGLAKFLSSHHLDTSSKTP 705
           S + +LH      +VH DLKP N+L+     H  + A + DFGL K L+         + 
Sbjct: 129 SGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-----VGRHSF 180
Query: 706 SSSIGIKGTVGYVAP 720
           S   G+ GT G++AP
Sbjct: 181 SRRSGVPGTEGWIAP 195

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLG--GKFPTTLGLLRNLVQLNVAENK 72
           L+ L L+ N +     +F+G L  L+ +  + ++L    +F   L L RNL+ L+++   
Sbjct: 80  LKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTH 137
Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
               F      +SSLE   +  N F  +   DI   L NL  L +       L P + ++
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            S+L++L++S+N F    +  +  L  L  L+   N++      +L         SSL  
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP-----SSLAF 252
Query: 193 LSLSDNQFGGELPH 206
           L+L+ N F     H
Sbjct: 253 LNLTQNDFACTCEH 266

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 85
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 86  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 136
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 137 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 187
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 188 KILDFGLAR-----------HTDDEMXGYVATRWYRAP 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRN 585
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 85  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 136
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSSHHLDTSS 702
              +  +I Y H +    +VH +LKP N+LL          + DFGLA            
Sbjct: 137 ---ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 181
Query: 703 KTPSSSIGIKGTVGYVAP 720
               +  G  GT GY++P
Sbjct: 182 NDSEAWHGFAGTPGYLSP 199

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 32/199 (16%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA---------ECE 581
           + ++S+ + +G G+FG V+  +  E    V VK I  K+K     ++          E  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIA 81
Query: 582 ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
            L  + H N+IK++ I     F+   F  LV E  G+G         + +++    S I 
Sbjct: 82  ILSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
           R      + SA+ YL       ++H D+K  N+++  D    + DFG A +L    L  +
Sbjct: 137 R-----QLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 702 SKTPSSSIGIKGTVGYVAP 720
                      GT+ Y AP
Sbjct: 189 ---------FCGTIEYCAP 198

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 120
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 121 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 172 KILDFGLAR-----------HTADEMTGYVATRWYRAP 198

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 82/192 (42%), Gaps = 35/192 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 594 IITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +  +  + TD        L+ E +  G L D+L Q     E    S I++      +   
Sbjct: 80  LHDVYENRTDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDG 127
Query: 653 IEYLHHHCQPPMVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLSSHHLDTSSKTPSSS 708
           + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN-- 177
Query: 709 IGIKGTVGYVAP 720
             I GT  +VAP
Sbjct: 178 --IFGTPEFVAP 187

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 68
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 69  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 119
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 120 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 170
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 171 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 197

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 67
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 68  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 118
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 119 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 169
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 170 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 196

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 64
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 65  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 115
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 116 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 166
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 167 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 193

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 61
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 62  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 112
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 113 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 163
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 164 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 190

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 120
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 121 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 172 KILDFGLAR-----------HTADEMTGYVATRWYRAP 198

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 120
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 121 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 172 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 198

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 69
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 70  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 120
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 121 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 172 KILDFGLAR-----------HTADEMTGYVATRWYRAP 198

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 113
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 114 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 164
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 165 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      +  
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 63
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 64  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA------- 109
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 110 -DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 165
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 166 DFGLAR-----------HTDDEMTGYVATRWYRAP 189

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      +  
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 63  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL----- 110
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 111 ---NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 164
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 165 DFGLAR-----------HTDDEMTGYVATRWYRAP 188

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRN 585
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 113
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSSHHLDTSS 702
              +  +I Y H +    +VH +LKP N+LL          + DFGLA            
Sbjct: 114 ---ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 158
Query: 703 KTPSSSIGIKGTVGYVAP 720
               +  G  GT GY++P
Sbjct: 159 NDSEAWHGFAGTPGYLSP 176

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      +  
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 63  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL----- 110
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 111 ---NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 164
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 165 DFGLAR-----------HTDDEMTGYVATRWYRAP 188

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 35/188 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E   + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 600 STDFKGVDFK-ALVFEYMGNGSLEDWLHQ-----SNDQVEVCKLSLIQRLNIAIDVASAI 653
                  D K  ++ E+   G+++  + +     +  Q++V    +++ LN         
Sbjct: 79  H------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN--------- 123
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF-LSSHHLDTSSKTPSSSIGIK 712
            +LH      ++H DLK  NVL+  +     GD  LA F +S+ +L T  K  S      
Sbjct: 124 -FLHSKR---IIHRDLKAGNVLMTLE-----GDIRLADFGVSAKNLKTLQKRDS----FI 170
Query: 713 GTVGYVAP 720
           GT  ++AP
Sbjct: 171 GTPYWMAP 178

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      +  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL----- 109
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 110 ---NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 163
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 164 DFGLAR-----------HTDDEMTGYVATRWYRAP 187

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +    VAVK ++      +  
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA------- 107
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 108 -DLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 163
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 164 DFGLAR-----------HTDDEMTGYVATRWYRAP 187

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 35/188 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E   + A KVI  K +     ++ E E L    H  ++K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 600 STDFKGVDFK-ALVFEYMGNGSLEDWLHQ-----SNDQVEVCKLSLIQRLNIAIDVASAI 653
                  D K  ++ E+   G+++  + +     +  Q++V    +++ LN         
Sbjct: 87  H------DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN--------- 131
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF-LSSHHLDTSSKTPSSSIGIK 712
            +LH      ++H DLK  NVL+  +     GD  LA F +S+ +L T  K  S      
Sbjct: 132 -FLHSKR---IIHRDLKAGNVLMTLE-----GDIRLADFGVSAKNLKTLQKRDS----FI 178
Query: 713 GTVGYVAP 720
           GT  ++AP
Sbjct: 179 GTPYWMAP 186

>pdb|1XWD|C Chain C, Crystal Structure Of Human Follicle Stimulating Hormone Complexed With Its Receptor Length = 252

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 24/205 (11%)
Query: 59  LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI- 117
           L RN ++L     K   +   +      LE   ++ N     +  D+  NLP L E+ I 
Sbjct: 28  LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE-QNNLGIGAAN 176
            ANN   + P++  N  NL+ L +SN   K     D   +  L ++ L+ Q+N+ I    
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIKHLP--DVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 177 DLGFVTF----------------LTNC----SSLKVLSLSDNQFGGELPHSIANLSSTMI 216
              FV                  + NC    + L  L+LSDN    ELP+ + + +S  +
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 217 VFLIGGNQISGTIPLGIRNLVNLIA 241
           +  I   +I      G+ NL  L A
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRA 230

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 27/195 (13%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRH 588
           T E+     IG+G+F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++++    S   F       LVF+ +  G L + +       E      IQ++  A+ 
Sbjct: 63  SNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV- 116
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSSHHLDTSSKTP 705
                  LH H Q  +VH DLKP N+LL          + DFGLA  +            
Sbjct: 117 -------LHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG--------DQ 160
Query: 706 SSSIGIKGTVGYVAP 720
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRN 585
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 113
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSSHHLDTSS 702
              +  +I Y H +    +VH +LKP N+LL          + DFGLA            
Sbjct: 114 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 158
Query: 703 KTPSSSIGIKGTVGYVAP 720
               +  G  GT GY++P
Sbjct: 159 NDSEAWHGFAGTPGYLSP 176

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL--RNIRHR 589
           ++F+   ++G+GSFG V        E + A+K+  LK+    +    EC  +  R +   
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALL 76
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           +    +T   S  F+ VD    V EY+  G L   + Q      V K    Q +  A ++
Sbjct: 77  DKPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEI 129
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
           +  + +LH      +++ DLK  NV+LD +    + DFG+ K    H +D       ++ 
Sbjct: 130 SIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDG-----VTTR 178
Query: 710 GIKGTVGYVAP 720
              GT  Y+AP
Sbjct: 179 EFCGTPDYIAP 189

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 35/178 (19%)
Query: 532 SEFSSSNMIGQGSFG---SVYKGILGEDEMIVAVKVINLKQKGAF------RSFVAECEA 582
            E+     IG G++G   S  + + G+    VA+K I      AF      +  + E + 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQ---VAIKKI----PNAFDVVTNAKRTLRELKI 106
Query: 583 LRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKL 637
           L++ +H N+I I  I   T    +FK V    +V + M    L   +H S    +E  + 
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSV---YVVLDLM-ESDLHQIIHSSQPLTLEHVRY 162
Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            L Q L         ++Y+H      ++H DLKPSN+L++ +    +GDFG+A+ L +
Sbjct: 163 FLYQLLR-------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRN 585
           +K +  +     +G+G+F  V + +     +  A K+IN K+  A  F+    E    R 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 61  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 112
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVGDFGLAKFLSSHHLDTSS 702
              +  +I Y H +    +VH +LKP N+LL          + DFGLA            
Sbjct: 113 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 157
Query: 703 KTPSSSIGIKGTVGYVAP 720
               +  G  GT GY++P
Sbjct: 158 NDSEAWHGFAGTPGYLSP 175

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 27/190 (14%)
Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINLKQKG--- 571
           Q P     E  +   +F  +  +G G+FG V +     LG+++ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 572 AFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND 630
              + ++E + + ++ +H N++ ++  C+      V     + EY   G L ++L + + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKSR 146
Query: 631 QVEV--------CKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMV 681
            +E           LS    L+ +  VA  + +L   +C    +H D+   NVLL +  V
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 202
Query: 682 AHVGDFGLAK 691
           A +GDFGLA+
Sbjct: 203 AKIGDFGLAR 212

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/104 (41%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 200 FGGELPHSIANLSS-TMIVFLI-GGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPD- 255
            GG   H I+ L   T + +LI  GNQ+  ++P G+   L NL  L +  NQL  ++PD 
Sbjct: 70  LGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDG 127
Query: 256 VIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQ 298
           V  +L NL  L L  N LQ S+P G+   LT L +LDL  N LQ
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 35/178 (19%)
Query: 532 SEFSSSNMIGQGSFG---SVYKGILGEDEMIVAVKVINLKQKGAF------RSFVAECEA 582
            E+     IG G++G   S  + + G+    VA+K I      AF      +  + E + 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQ---VAIKKI----PNAFDVVTNAKRTLRELKI 107
Query: 583 LRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKL 637
           L++ +H N+I I  I   T    +FK V    +V + M    L   +H S    +E  + 
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSV---YVVLDLM-ESDLHQIIHSSQPLTLEHVRY 163
Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            L Q L         ++Y+H      ++H DLKPSN+L++ +    +GDFG+A+ L +
Sbjct: 164 FLYQLLR-------GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 211

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 84/196 (42%), Gaps = 18/196 (9%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFR-SFVAECEALR 584
           S  +  +    ++G G    V+      D   VAVKV+  +L +  +F   F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H  ++ +     +    G     +V EY+   +L D +H          ++  + + 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIE 120
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           +  D   A+ + H +    ++H D+KP+N+++       V DFG+A+ ++      S  +
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD-----SGNS 172
Query: 705 PSSSIGIKGTVGYVAP 720
            + +  + GT  Y++P
Sbjct: 173 VTQTAAVIGTAQYLSP 188

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLG--GKFPTTLGLLRNLVQLNVAENK 72
           L+ L L+ N +     +F+G L  L+ +  + ++L    +F   L L RNL+ L+++   
Sbjct: 375 LKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTH 432
Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
               F      +SSLE   +  N F  +   DI   L NL  L +       L P + ++
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            S+L++L++S+N F    +  +  L  L  L+   N++      +L         SSL  
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP-----SSLAF 547
Query: 193 LSLSDNQFGGELPH 206
           L+L+ N F     H
Sbjct: 548 LNLTQNDFACTCEH 561

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 12/168 (7%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           ++    IG+G++G V        +  VA+K I+  + +   +  + E + L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            I  I  ++  + +    +V + M     +    Q      +C   L Q       +   
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYF-LYQ-------ILRG 156
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
           ++Y+H      ++H DLKPSN+L++      + DFGLA+     H  T
Sbjct: 157 LKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHT 201

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/196 (20%), Positives = 83/196 (42%), Gaps = 18/196 (9%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFR-SFVAECEALR 584
           S  +  +    ++G G    V+      D   VAVKV+  +L +  +F   F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H  ++ +     +    G     +V EY+   +L D +H          ++  + + 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIE 120
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           +  D   A+ + H +    ++H D+KP+N+L+       V DFG+A+ ++      S  +
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIAD-----SGNS 172
Query: 705 PSSSIGIKGTVGYVAP 720
              +  + GT  Y++P
Sbjct: 173 VXQTAAVIGTAQYLSP 188

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 84/196 (42%), Gaps = 18/196 (9%)
Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI--NLKQKGAFR-SFVAECEALR 584
           S  +  +    ++G G    V+      D   VAVKV+  +L +  +F   F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
            + H  ++ +     +    G     +V EY+   +L D +H          ++  + + 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGP-LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIE 120
Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           +  D   A+ + H +    ++H D+KP+N+++       V DFG+A+ ++      S  +
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD-----SGNS 172
Query: 705 PSSSIGIKGTVGYVAP 720
            + +  + GT  Y++P
Sbjct: 173 VTQTAAVIGTAQYLSP 188

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 9/194 (4%)
Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLG--GKFPTTLGLLRNLVQLNVAENK 72
           L+ L L+ N +     +F+G L  L+ +  + ++L    +F   L L RNL+ L+++   
Sbjct: 399 LKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSL-RNLIYLDISHTH 456
Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
               F      +SSLE   +  N F  +   DI   L NL  L +       L P + ++
Sbjct: 457 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 516
Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            S+L++L++S+N F    +  +  L  L  L+   N++      +L         SSL  
Sbjct: 517 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP-----SSLAF 571
Query: 193 LSLSDNQFGGELPH 206
           L+L+ N F     H
Sbjct: 572 LNLTQNDFACTCEH 585

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 11/72 (15%)
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + S +E+LH   Q  +++ DLKP NVLLD D    + D GLA  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 709 IGIKGTVGYVAP 720
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/139 (24%), Positives = 59/139 (42%), Gaps = 8/139 (5%)
Query: 546 GSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG 605
           G ++KG    ++++V V  +        R F  EC  LR   H N++ ++  C S     
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---P 80
Query: 606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV 665
                L+  +   GSL + LH+  + V    +   Q +  A+D A    +L H  +P + 
Sbjct: 81  APHPTLITHWXPYGSLYNVLHEGTNFV----VDQSQAVKFALDXARGXAFL-HTLEPLIP 135
Query: 666 HGDLKPSNVLLDHDMVAHV 684
              L   +V +D D  A +
Sbjct: 136 RHALNSRSVXIDEDXTARI 154

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 11/72 (15%)
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + S +E+LH   Q  +++ DLKP NVLLD D    + D GLA  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 709 IGIKGTVGYVAP 720
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 11/72 (15%)
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + S +E+LH   Q  +++ DLKP NVLLD D    + D GLA  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 709 IGIKGTVGYVAP 720
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 11/72 (15%)
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           + S +E+LH   Q  +++ DLKP NVLLD D    + D GLA  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 709 IGIKGTVGYVAP 720
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 594 IITICSS-TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +  +  + TD        L+ E +  G L D+L Q     E    S I++      +   
Sbjct: 80  LHDVYENRTDV------VLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDG 127
Query: 653 IEYLHHHCQPPMVHGDLKPSNV-LLDHDM-VAHVG--DFGLAKFLSSHHLDTSSKTPSSS 708
           + YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN-- 177
Query: 709 IGIKGTVGYVAP 720
             I GT  +VAP
Sbjct: 178 --IFGTPEFVAP 187

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 79  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-----KWPV 178
Query: 716 GYVAP 720
            + AP
Sbjct: 179 KWYAP 183

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 28/190 (14%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           F   + +G+G+   VY+      +   A+KV  LK+    +    E   L  + H N+IK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  I     F+     +LV E +  G L D +      VE    S     +    +  A+
Sbjct: 113 LKEI-----FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAV 161
Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
            YLH +    +VH DLKP N+L      D    + DFGL+K +    L  +         
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--------- 209
Query: 711 IKGTVGYVAP 720
           + GT GY AP
Sbjct: 210 VCGTPGYCAP 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +    VAVK ++      
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 68
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 69  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 119
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 120 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 170
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 171 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 197

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL---GIGAANDLGFVTFLTNCSSL 190
           ++ E LDL +          F  L  L  LNL+ N L     G  +DL         + L
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL---------TEL 85
Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQL 249
             L L++NQ    LP  + +  + +    +GGNQ+  ++P G+   L  L  L +  NQL
Sbjct: 86  GTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSG 280
                    +L NLQ L L  N LQ S+P G
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL---GIGAANDLGFVTFLTNCSSL 190
           ++ E LDL +          F  L  L  LNL+ N L     G  +DL         + L
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL---------TEL 85
Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQL 249
             L L++NQ    LP  + +  + +    +GGNQ+  ++P G+   L  L  L +  NQL
Sbjct: 86  GTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSG 280
                    +L NLQ L L  N LQ S+P G
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +    VAVK ++      +  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL----- 109
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 110 ---NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 163
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 164 DFGLAR-----------HTDDEMTGYVATRWYRAP 187

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 27/188 (14%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G+G++G V K        I+AVK I        R+ V   E  R +   ++      C 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 600 ST-DFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
            T  F G  F+     +  E M + SL+ +  Q  D+ +     ++ +  IA+ +  A+E
Sbjct: 111 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 167
Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           +LH      ++H D+KPSNVL++      + DFG++ +L    +D+ +KT  +     G 
Sbjct: 168 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDSVAKTIDA-----GC 216
Query: 715 VGYVAPGK 722
             Y+AP +
Sbjct: 217 KPYMAPER 224

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + D GLA+            T     G   T  Y AP
Sbjct: 163 ELKILDRGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 43/215 (20%)
Query: 520 PMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQ 569
           P     EL+K   E    + + + +G G++GSV      +    VAVK ++      +  
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLEDWL 625
           K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG        
Sbjct: 62  KRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGA------- 107
Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + 
Sbjct: 108 -DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 163
Query: 686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           DFGLA+            T     G   T  Y AP
Sbjct: 164 DFGLAR-----------HTDDEMAGFVATRWYRAP 187

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + D GLA+            T     G   T  Y AP
Sbjct: 163 ELKILDAGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 78/192 (40%), Gaps = 19/192 (9%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH 588
           +    +     +G+G F   Y+    + + + A KV+   +    +    E  +     H
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV--PKSMLLKPHQKEKMSTEIAIH 80
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
           ++L     +     F+  DF  +V E     SL + LH+    V   +     R  I   
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI--- 136
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
               ++YLH++    ++H DLK  N+ L+ DM   +GDFGLA  +     D   K     
Sbjct: 137 --QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE---FDGERKK---- 184
Query: 709 IGIKGTVGYVAP 720
             + GT  Y+AP
Sbjct: 185 -DLCGTPNYIAP 195

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              +  FGLA+            T     G   T  Y AP
Sbjct: 163 ELKILGFGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 29/191 (15%)
Query: 518 QFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINLKQKG--- 571
           Q P     E  +   +F  +  +G G+FG V +     LG+++ ++ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 572 AFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND 630
              + ++E + + ++ +H N++ ++  C+      V     + EY   G L ++L + + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKSR 146
Query: 631 QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPM----------VHGDLKPSNVLLDHDM 680
            +E           IA   AS  + LH   Q             +H D+   NVLL +  
Sbjct: 147 VLETDPA-----FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201
Query: 681 VAHVGDFGLAK 691
           VA +GDFGLA+
Sbjct: 202 VAKIGDFGLAR 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 34/195 (17%)
Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS-----FVAECEALRNIRH 588
           +     +G G++G V   +L  D++    + I + +K +  +      + E   L+ + H
Sbjct: 39  YQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K+        F+      LV E    G L D +      +   K + +    I   
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQ 144
Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           V S + YLH H    +VH DLKP N+LL   + D +  + DFGL+    +       K  
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ------KKM 195
Query: 706 SSSIGIKGTVGYVAP 720
              +   GT  Y+AP
Sbjct: 196 KERL---GTAYYIAP 207

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 73  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 120
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 121 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 172
Query: 716 GYVAP 720
            + AP
Sbjct: 173 KWYAP 177

>pdb|4AY9|X Chain X, Structure Of Follicle-Stimulating Hormone In Complex With The Entire Ectodomain Of Its Receptor Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 59  LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI- 117
           L RN ++L     K   +   +      LE   ++ N     +  D+  NLP L E+ I 
Sbjct: 28  LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE-QNNLGIGAAN 176
            ANN   + P++  N  NL+ L +SN   K     D   +  L ++ L+ Q+N+ I    
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIKHLP--DVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 177 DLGFV--TFLT------------------NCSSLKVLSLSDNQFGGELPHSIANLSSTMI 216
              FV  +F +                  N + L  L+LSDN    ELP+ + + +S  +
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 217 VFLIGGNQISGTIPLGIRNLVNLIA 241
           +  I   +I      G+ NL  L A
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRA 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 75  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 122
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 123 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 174
Query: 716 GYVAP 720
            + AP
Sbjct: 175 KWYAP 179

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLIKI 594
            ++IG+GS+G VY       E  VA+K +N   +     +  + E   L  ++   +I++
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNIAIDVA 650
             +    D    D   +V E + +  L+         + + ++    +L+   N      
Sbjct: 91  YDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN------ 143
Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
               ++H   +  ++H DLKP+N LL+ D    V DFGLA+ ++S
Sbjct: 144 ----FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 21/191 (10%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHR 589
             ++     +G+G++G V   +    E  VAVK++++K+      +   E    + + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N++K          +  + + L  EY   G L D +       E        +L      
Sbjct: 65  NVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 113
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
            + + YLH      + H D+KP N+LLD      + DFGLA     ++ +          
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 165
Query: 710 GIKGTVGYVAP 720
            + GT+ YVAP
Sbjct: 166 -MXGTLPYVAP 175

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 22/168 (13%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKG--ILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI 586
           +  + +     IG GSFG +Y G  I   +E+ + ++ +  K          E +  + +
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMM 61
Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +    I  I  C +      D+  +V E +G  SLED  +  +      K SL   L +A
Sbjct: 62  QGGVGIPTIRWCGAEG----DYNVMVMELLGP-SLEDLFNFCSR-----KFSLKTVLLLA 111
Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAK 691
             + S IEY+H       +H D+KP N L+       + ++ DFGLAK
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 79  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 126
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 178
Query: 716 GYVAP 720
            + AP
Sbjct: 179 KWYAP 183

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + +   +G G++GSV      +    VAVK ++      
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI 72
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 73  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 123
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 124 ------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 174
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGLA+            T     G   T  Y AP
Sbjct: 175 KILDFGLAR-----------HTDDEMTGYVATRWYRAP 201

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 28/220 (12%)
Query: 505 SAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKV 564
           S H S    P E + P   Y +    T E      +G G+FG+V KG     +++  V V
Sbjct: 2   SLHESPYADPEEIR-PKEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQMKKVVKTVAV 57
Query: 565 INLKQKG---AFR-SFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGS 620
             LK +    A +   +AE   ++ + +  ++++I IC +  +       LV E    G 
Sbjct: 58  KILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGP 111
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
           L  +L Q+    +   + L+ +      V+  ++YL    +   VH DL   NVLL    
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLE---ESNFVHRDLAARNVLLVTQH 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            A + DFGL+K L +      ++T       K  V + AP
Sbjct: 163 YAKISDFGLSKALRADENYYKAQTHG-----KWPVKWYAP 197

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 529 KATSEFSSSNMIGQGSFGSVYKGI---LGEDEMIVAVKVINLKQKGAFRSFVAECEALRN 585
           +  + +     IG GSFG +Y G     GE+   VA+K+  +K K        E +  + 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEE---VAIKLECVKTKHP--QLHIESKIYKM 58
Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           ++    I  I  C +      D+  +V E +G  SLED  +  +      K SL   L +
Sbjct: 59  MQGGVGIPTIRWCGAEG----DYNVMVMELLGP-SLEDLFNFCSR-----KFSLKTVLLL 108
Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAK 691
           A  + S IEY+H       +H D+KP N L+       + ++ DFGLAK
Sbjct: 109 ADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 21/191 (10%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHR 589
             ++     +G+G++G V   +    E  VAVK++++K+      +   E    + + H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N++K          +  + + L  EY   G L D +       E        +L      
Sbjct: 66  NVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 114
Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
            + + YLH      + H D+KP N+LLD      + DFGLA     ++ +          
Sbjct: 115 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 166
Query: 710 GIKGTVGYVAP 720
            + GT+ YVAP
Sbjct: 167 -MXGTLPYVAP 176

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 85  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 132
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 133 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 184
Query: 716 GYVAP 720
            + AP
Sbjct: 185 KWYAP 189

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRH 588
           T E+     +G+G+F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSL-EDWL---HQSNDQVEVCKLSLIQRLN 644
            N++++    S   F       LVF+ +  G L ED +   + S      C   +++ +N
Sbjct: 63  PNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 645 IAIDVASAIEYLHHHCQ-PPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDT 700
                         HC    +VH DLKP N+LL          + DFGLA  +       
Sbjct: 118 --------------HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ--- 160
Query: 701 SSKTPSSSIGIKGTVGYVAP 720
                 +  G  GT GY++P
Sbjct: 161 -----QAWFGFAGTPGYLSP 175

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 515 MEKQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---- 566
           M ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++    
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 567 --LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGS 620
             +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG   
Sbjct: 61  SIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL 113
Query: 621 LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM 680
                   N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D 
Sbjct: 114 --------NNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 162
Query: 681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              + D GLA+            T     G   T  Y AP
Sbjct: 163 ELKILDGGLAR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 95  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 142
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 194
Query: 716 GYVAP 720
            + AP
Sbjct: 195 KWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 95  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 142
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           L    +   VH DL   NVLL     A + DFGL+K L +      ++T       K  V
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 194
Query: 716 GYVAP 720
            + AP
Sbjct: 195 KWYAP 199

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 80/200 (40%), Gaps = 37/200 (18%)
Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRH 588
           T E+     +G+G+F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSL-EDWL---HQSNDQVEVCKLSLIQRLN 644
            N++++    S   F       LVF+ +  G L ED +   + S      C   +++ +N
Sbjct: 63  PNIVRLHDSISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN 117
Query: 645 IAIDVASAIEYLHHHCQ-PPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDT 700
                         HC    +VH DLKP N+LL          + DFGLA  +       
Sbjct: 118 --------------HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ--- 160
Query: 701 SSKTPSSSIGIKGTVGYVAP 720
                 +  G  GT GY++P
Sbjct: 161 -----QAWFGFAGTPGYLSP 175

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 23/181 (12%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS G V           VAVK ++L+++        E   +R+  H N++ +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY---- 108
Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
           S+   G D   +V E++  G+L        D V   +++  Q   + + V  A+ YLH+ 
Sbjct: 109 SSYLVG-DELWVVMEFLEGGAL-------TDIVTHTRMNEEQIATVCLSVLRALSYLHNQ 160
Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
               ++H D+K  ++LL  D    + DFG            S + P     + GT  ++A
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCA-------QVSKEVPKRKXLV-GTPYWMA 209
Query: 720 P 720
           P
Sbjct: 210 P 210

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 43/218 (19%)
Query: 517 KQFPMVSYAELSKATSE----FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------ 566
           ++ P     EL+K   E    + + + +G G++GSV      +  + VAVK ++      
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 62
Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSST----DFKGVDFKALVFEYMGNGSLE 622
           +  K  +R    E   L++++H N+I ++ + +      +F  V    LV   MG     
Sbjct: 63  IHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMGADL-- 113
Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
                 N+ V+  KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D   
Sbjct: 114 ------NNIVKSQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSEL 164
Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFGL +            T     G   T  Y AP
Sbjct: 165 KILDFGLCR-----------HTDDEMTGYVATRWYRAP 191

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 22/159 (13%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFRSFVAECEALRNIRHRNLIKIIT 596
           +G G++GSV           VAVK ++   +    A R++  E   L++++H N+I ++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLLD 86
Query: 597 I----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +     S  DF  V    LV   MG           N+ V+   LS      +   +   
Sbjct: 87  VFTPATSIEDFSEV---YLVTTLMGADL--------NNIVKCQALSDEHVQFLVYQLLRG 135
Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           ++Y+H      ++H DLKPSNV ++ D    + DFGLA+
Sbjct: 136 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLIKII 595
           +G G+FG+V KG     +++  V V  LK +    A +   +AE   ++ + +  ++++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            IC +  +       LV E    G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 437 GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 484
Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           L    +   VH DL   NVLL     A + DFGL+K L +
Sbjct: 485 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	725
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-128
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-106
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-105
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-104
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-60
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-89
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-57
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-46
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-37
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-67
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-62
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-56
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-44
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-40
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-04
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-66
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-65
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-33
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-64
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-62
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-61
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-53
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-52
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-50
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-37
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-55
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-52
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-43
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-05
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-56
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-49
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-08
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-50
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-49
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-42
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-42
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-31
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-37
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-33
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-21
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-26
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-21
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-29
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-09
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-29
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-25
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-24
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-10
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-18
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-25
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-21
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-05
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-04
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-15
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-11
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-04
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	6e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	4e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	7e-04
4fev_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  397 bits (1022), Expect = e-128
 Identities = 139/488 (28%), Positives = 223/488 (45%), Gaps = 29/488 (5%)

Query: 1   LEGQIPKEI-GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPT-TLG 58
             G+IP  + G+   L  L L+GN+  G +P F G+ S L+ + +  N+  G+ P  TL 
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340

Query: 59  LLRNLVQLNVAENKFYGMFPRSICNIS-SLEYFYLTSNRFSGSLPFDIVVN-LPNLKELG 116
            +R L  L+++ N+F G  P S+ N+S SL    L+SN FSG +  ++  N    L+EL 
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN 176
           +  N F G IP +LSN S L  L LS N   G +     SL  L  L L  N L      
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE----- 455

Query: 177 DLGFV-TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
             G +   L    +L+ L L  N   GE+P  ++N ++ +    +  N+++G IP  I  
Sbjct: 456 --GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-LNWISLSNNRLTGEIPKWIGR 512

Query: 236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
           L NL  L +  N   G IP  +G+ ++L  L L  N   G+IP+ +   +     +  + 
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572

Query: 296 SLQGNFIA-----------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL 344
                              +  +  G   +QL  ++T +   ++++ +  G       N 
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN-PCNITSRVYGGHTSPTFDNN 631

Query: 345 KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN 404
            +++ LD+S N  SG IP  + +   L  +++  N   G IP  +G L+ +  LD+S N 
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691

Query: 405 FSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPS 464
             G+ P+ +  L+ L  ++LS N+L G +P  G F          N  LCG      LP 
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPR 747

Query: 465 CPSRGSRK 472
           C    +  
Sbjct: 748 CDPSNADG 755

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  340 bits (875), Expect = e-106
 Identities = 123/446 (27%), Positives = 203/446 (45%), Gaps = 37/446 (8%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDF--IGNLSALQVIHIKGNSLGGKFPTTLG 58
           + G +         L +L L+ N L+G +     +G+ S L+ +++  N+L      + G
Sbjct: 89  INGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147

Query: 59  L-LRNLVQLNVAENKFYGMFPRSIC---NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKE 114
           L L +L  L+++ N   G              L++  ++ N+ SG +         NL+ 
Sbjct: 148 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEF 204

Query: 115 LGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL--GI 172
           L + +NNF   IP  L + S L+ LD+S N+  G  S   S+   L  LN+  N     I
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263

Query: 173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG 232
                           SL+ LSL++N+F GE+P  ++    T+    + GN   G +P  
Sbjct: 264 PPL----------PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313

Query: 233 IRNLVNLIALAVEVNQLHGTIP-DVIGELKNLQLLGLYKNFLQGSIPSGLGNLT-KLAKL 290
             +   L +LA+  N   G +P D + +++ L++L L  N   G +P  L NL+  L  L
Sbjct: 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373

Query: 291 DLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQQVGNLKNLII 349
           DL SN+  G            +   L      +L  L L NN   G +P  + N   L+ 
Sbjct: 374 DLSSNNFSGP-----------ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           L +S N  SG IP +L +   L  + +  N   G IP  L ++K+++ L +  N+ +G+ 
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVPT 435
           P  L N + L +++LS N L GE+P 
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  338 bits (869), Expect = e-105
 Identities = 140/490 (28%), Positives = 216/490 (44%), Gaps = 53/490 (10%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           + G +   +     L+ L ++ N  +  +P F+G+ SALQ + I GN L G F   +   
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTC 246

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
             L  LN++ N+F G  P       SL+Y  L  N+F+G +P  +      L  L +  N
Sbjct: 247 TELKLLNISSNQFVGPIPPLPL--KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +F+G +P    + S LE L LS+N F G++ +D                           
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMD--------------------------- 337

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIP--LGIRNLVN 238
              L     LKVL LS N+F GELP S+ NLS++++   +  N  SG I   L       
Sbjct: 338 --TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 239 LIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ 298
           L  L ++ N   G IP  +     L  L L  N+L G+IPS LG+L+KL  L L  N L+
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455

Query: 299 GNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
           G            +PQ+L+ + TL   L L  N L G +P  + N  NL  + +S+N+ +
Sbjct: 456 GE-----------IPQELMYVKTLE-TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503

Query: 359 GMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSF 418
           G IP  +    +L  + +S+N F G IP  LG  +S+ +LD++ N F+G  P  +   S 
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563

Query: 419 LEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITL 477
                ++ N + G+          K +    GN+    GI    L    +R    +   +
Sbjct: 564 K----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619

Query: 478 LKVLIPVAVS 487
                     
Sbjct: 620 YGGHTSPTFD 629

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  334 bits (860), Expect = e-104
 Identities = 117/445 (26%), Positives = 195/445 (43%), Gaps = 38/445 (8%)

Query: 15  LQALALAGNYLT---GKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAEN 71
           + ++ L+   L      +   + +L+ L+ + +  + + G          +L  L+++ N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110

Query: 72  KFYGMFP--RSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDS 129
              G      S+ + S L++  ++SN           + L +L+ L + AN+  G     
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170

Query: 130 L---SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
                    L+ L +S N+  G   +D S    L  L++  NN           + FL +
Sbjct: 171 WVLSDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDVSSNNFS-------TGIPFLGD 221

Query: 187 CSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEV 246
           CS+L+ L +S N+  G+   +I+  +  + +  I  NQ  G IP     L +L  L++  
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTE-LKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 278

Query: 247 NQLHGTIPDVI-GELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF---- 301
           N+  G IPD + G    L  L L  N   G++P   G+ + L  L L SN+  G      
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338

Query: 302 ----------IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGN--LKNLII 349
                       S N+  G LP+ L +++   L LDLS+N  +G +   +       L  
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           L + +N F+G IP TLS C  L  + +S N   G IP SLG L  ++ L +  N   G+ 
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVP 434
           P+ L  +  LE L L +N L GE+P
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIP 483

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  216 bits (553), Expect = 2e-60
 Identities = 87/327 (26%), Positives = 139/327 (42%), Gaps = 36/327 (11%)

Query: 132 NASNLELLDLSNNQFK---GKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCS 188
               +  +DLS+         VS    SL  L  L L  +++        G V+     +
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-------GSVSGFKCSA 100

Query: 189 SLKVLSLSDNQFGGELP--HSIANLSSTMIVFLIGGNQISGTIPL-GIRNLVNLIALAVE 245
           SL  L LS N   G +    S+ + S    + +   N +     + G   L +L  L + 
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNV-SSNTLDFPGKVSGGLKLNSLEVLDLS 159

Query: 246 VNQLHGTIPDVI---GELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG--- 299
            N + G              L+ L +  N + G +   +     L  LD+ SN+      
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217

Query: 300 ---------NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIIL 350
                    +   S NKL G   + + + T L   L++S+N   G +P     LK+L  L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELK-LLNISSNQFVGPIPP--LPLKSLQYL 274

Query: 351 DISSNQFSGMIPVTLST-CVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
            ++ N+F+G IP  LS  C +L  +D+S N F+G +PP  G    ++ L +S NNFSG+ 
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334

Query: 410 PK-FLENLSFLEFLNLSYNHLEGEVPT 435
           P   L  +  L+ L+LS+N   GE+P 
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPE 361

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  281 bits (721), Expect = 3e-89
 Identities = 79/284 (27%), Positives = 122/284 (42%), Gaps = 19/284 (6%)

Query: 184 LTNCSSLKVLSLSDNQFGGE--LPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA 241
            T    +  L LS         +P S+ANL     +++ G N + G IP  I  L  L  
Sbjct: 46  DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105

Query: 242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF 301
           L +    + G IPD + ++K L  L    N L G++P  + +L  L  +           
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF--------- 156

Query: 302 IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMI 361
               N++ GA+P    S + L   + +S N L G +P    NL NL  +D+S N   G  
Sbjct: 157 --DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213

Query: 362 PVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEF 421
            V   +  + + + ++ N     +   +G  K++  LD+  N   G  P+ L  L FL  
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 422 LNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC 465
           LN+S+N+L GE+P  G            N  LCG      LP+C
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS----PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  195 bits (497), Expect = 8e-57
 Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 39/299 (13%)

Query: 2   EGQIPKEIGSLFKLQALALAGNYLTG--KLPDFIGNLSALQVIHI-KGNSLGGKFPTTLG 58
            G +       +++  L L+G  L     +P  + NL  L  ++I   N+L G  P  + 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 59  LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG 118
            L  L  L +      G  P  +  I +L     + N  SG+LP  I  +LPNL  +   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFD 157

Query: 119 ANNFFGLIPDSLSNASNL-ELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAND 177
            N   G IPDS  + S L   + +S N+  GK+   F++L                    
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-------------------- 197

Query: 178 LGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV 237
                      +L  + LS N   G+      +  +T  + L   N ++  +   +    
Sbjct: 198 -----------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHL-AKNSLAFDLG-KVGLSK 244

Query: 238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS 296
           NL  L +  N+++GT+P  + +LK L  L +  N L G IP G GNL +       +N 
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  165 bits (421), Expect = 4e-46
 Identities = 60/234 (25%), Positives = 93/234 (39%), Gaps = 14/234 (5%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L G IP  I  L +L  L +    ++G +PDF+  +  L  +    N+L G  P ++  L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSL-EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
            NLV +    N+  G  P S  + S L     ++ NR +G +P     NL NL  + +  
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF-ANL-NLAFVDLSR 206

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
           N   G       +  N + + L+ N     +       K L  L+L  N +        G
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY-------G 258

Query: 180 FV-TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG 232
            +   LT    L  L++S N   GE+P    NL    +        + G  PL 
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG-SPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  140 bits (355), Expect = 4e-37
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 19/182 (10%)

Query: 271 NFLQGSIPSGLGNLTKLAKLDLGSNSLQGN----------------FIASQNKLIGALPQ 314
               G +        ++  LDL   +L                   +I   N L+G +P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 315 QLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYV 374
            +  +T L  YL +++  ++G++P  +  +K L+ LD S N  SG +P ++S+  +L  +
Sbjct: 96  AIAKLTQLH-YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 375 DISSNCFHGIIPPSLGFLKS-IKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEV 433
               N   G IP S G        + +S N  +G+ P    NL+ L F++LS N LEG+ 
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDA 213

Query: 434 PT 435
             
Sbjct: 214 SV 215

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 33/113 (29%), Positives = 48/113 (42%), Gaps = 3/113 (2%)

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSG--MIPVTLSTCVSLEYVDISS-NCFH 382
            D  N    G L         +  LD+S         IP +L+    L ++ I   N   
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 383 GIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT 435
           G IPP++  L  + +L ++  N SG  P FL  +  L  L+ SYN L G +P 
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  245 bits (628), Expect = 5e-72
 Identities = 67/460 (14%), Positives = 138/460 (30%), Gaps = 50/460 (10%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            +  I K      K   +    N +T  +   +  L+ L+  ++  +    +        
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
            N         + Y        N+  L    + +      LP  +   LP ++ + +  N
Sbjct: 230 ENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACN 283

Query: 121 NFFGL--------IPDSLSNASNLELLDLSNNQFK-GKVSIDFSSLKILWRLNLEQNNLG 171
                                  ++++ +  N  K   V      +K L  L    N L 
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL- 342

Query: 172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIP- 230
                  G +    +   L  L+L+ NQ    +P +    +  +       N++   IP 
Sbjct: 343 ------EGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPN 394

Query: 231 -LGIRNLVNLIALAVEVNQLHG-------TIPDVIGELKNLQLLGLYKNFLQGSIPSGLG 282
               +++  + A+    N++          +     +  N+  + L  N +         
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454

Query: 283 NLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQ-QV 341
             + L+ ++L  N L           +    +   +   L+  +DL  N L       + 
Sbjct: 455 TGSPLSSINLMGNMLTEI----PKNSLKDENENFKNTYLLT-SIDLRFNKLTKLSDDFRA 509

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDI------SSNCFHGIIPPSLGFLKSI 395
             L  L+ +D+S N FS   P       +L+   I        N      P  +    S+
Sbjct: 510 TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568

Query: 396 KFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT 435
             L +  N+      K   N+     L++  N       +
Sbjct: 569 TQLQIGSNDIRKVNEKITPNI---SVLDIKDNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  232 bits (594), Expect = 3e-67
 Identities = 69/460 (15%), Positives = 149/460 (32%), Gaps = 59/460 (12%)

Query: 3   GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG----KFPTTLG 58
            Q    + S  ++  L+L G   +G++PD IG L+ L+V+ +  +          P  + 
Sbjct: 71  AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130

Query: 59  LLRNLVQLNVAENKFYGMFPRSI--CNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG 116
              +  Q       +   F       + S L    + S+    S+            ++G
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS-RITLKDTQIG 189

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN 176
             +NN    +  ++   + L    + N+ F        +  +     N E          
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA-----ENICEAWENENSEYAQQYKTEDL 243

Query: 177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQI--------SGT 228
                    N   L  + + +     +LP  +  L   M +  +  N+            
Sbjct: 244 KWD------NLKDLTDVEVYNCPNLTKLPTFLKALPE-MQLINVACNRGISGEQLKDDWQ 296

Query: 229 IPLGIRNLVNLIALAVEVNQL-HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKL 287
                     +  + +  N L    +   + ++K L +L    N L+G +P+  G+  KL
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKL 355

Query: 288 AKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQ--QVGNLK 345
           A L+L  N +              +P      T     L  ++N L   +P      ++ 
Sbjct: 356 ASLNLAYNQITE------------IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402

Query: 346 NLIILDISSNQFSGM-------IPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL 398
            +  +D S N+   +       +  T    +++  +++S+N               +  +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 399 DVSCNNFSG-------QFPKFLENLSFLEFLNLSYNHLEG 431
           ++  N  +           +  +N   L  ++L +N L  
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  225 bits (576), Expect = 9e-65
 Identities = 63/448 (14%), Positives = 132/448 (29%), Gaps = 66/448 (14%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIH--IKGNSLGGKFPTTLGLLRN 62
            PK I +    +       +      D+        +I   I  +        +  +   
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
             Q+    N       +++  ++ L  FY+ ++ F      +        +         
Sbjct: 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA------WENENSEYAQQ 237

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL--GIGAANDLGF 180
           +        N  +L  +++ N     K+     +L  +  +N+  N    G    +D   
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +        ++++ +  N                           +  +   ++ +  L 
Sbjct: 298 LADAPVGEKIQIIYIGYNNL------------------------KTFPVETSLQKMKKLG 333

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
            L    NQL G +P   G    L  L L  N +     +  G   ++  L    N L+  
Sbjct: 334 MLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY- 391

Query: 301 FIASQNKLIGALPQQLLSITTLS--LYLDLSNNLLNG-------SLPQQVGNLKNLIILD 351
                      +P  +    ++S    +D S N +          L        N+  ++
Sbjct: 392 -----------IPN-IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439

Query: 352 ISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGI-------IPPSLGFLKSIKFLDVSCNN 404
           +S+NQ S       ST   L  +++  N    I          +      +  +D+  N 
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499

Query: 405 FSGQFPKF-LENLSFLEFLNLSYNHLEG 431
            +     F    L +L  ++LSYN    
Sbjct: 500 LTKLSDDFRATTLPYLVGIDLSYNSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  219 bits (561), Expect = 1e-62
 Identities = 67/453 (14%), Positives = 124/453 (27%), Gaps = 88/453 (19%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSL--------GGK 52
                  +  +L  L  + +       KLP F+  L  +Q+I++  N            +
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 53  FPTTLGLLRNLVQLNVAENKF-YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPN 111
                 +   +  + +  N         S+  +  L       N+  G LP     +   
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP--AFGSEIK 354

Query: 112 LKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG 171
           L  L +  N    +  +       +E L  ++N+ K                        
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY----------------------- 391

Query: 172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPL 231
                 +  +    + S +  +  S N+ G     +                     +  
Sbjct: 392 ------IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP------------------LDP 427

Query: 232 GIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG-------SIPSGLGNL 284
                +N+ ++ +  NQ+     ++      L  + L  N L                N 
Sbjct: 428 TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487

Query: 285 TKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQQVGN 343
             L  +DL  N L              L     + T   L  +DLS N  +   P Q  N
Sbjct: 488 YLLTSIDLRFNKLTK------------LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534

Query: 344 LKNLIILDI------SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKF 397
              L    I        N+     P  ++ C SL  + I SN    +         +I  
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNE---KITPNISV 591

Query: 398 LDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
           LD+  N        ++          L Y+  +
Sbjct: 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  201 bits (512), Expect = 9e-56
 Identities = 52/387 (13%), Positives = 114/387 (29%), Gaps = 39/387 (10%)

Query: 47  NSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV 106
           +  G +   +L     +  L++      G  P +I  ++ LE   L S+    +      
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 107 VNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE 166
             +                    +      +  DL  +                    + 
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD-------------------CIN 167

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            +                        +    N     +  ++  L+  +  F +G +   
Sbjct: 168 SDPQQKSIKKSSR------ITLKDTQIGQLSNNITF-VSKAVMRLTK-LRQFYMGNSPFV 219

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
                      N      E  Q + T       LK+L  + +Y       +P+ L  L +
Sbjct: 220 AENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKN 346
           +  +++  N          +    A       I  + +     NNL    +   +  +K 
Sbjct: 275 MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG---YNNLKTFPVETSLQKMKK 331

Query: 347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
           L +L+   NQ  G +P    + + L  ++++ N    I     GF + ++ L  + N   
Sbjct: 332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390

Query: 407 GQFPKFLE--NLSFLEFLNLSYNHLEG 431
              P   +  ++S +  ++ SYN +  
Sbjct: 391 Y-IPNIFDAKSVSVMSAIDFSYNEIGS 416

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  169 bits (429), Expect = 1e-44
 Identities = 60/351 (17%), Positives = 110/351 (31%), Gaps = 35/351 (9%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYL-TGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGL 59
            + Q   +     K+Q + +  N L T  +   +  +  L ++    N L GK P   G 
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGS 351

Query: 60  LRNLVQLNVAENKFYGMFPRSIC-NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG 118
              L  LN+A N+     P + C     +E      N+           ++  +  +   
Sbjct: 352 EIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFS 410

Query: 119 ANNF-------FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL- 170
            N         F  +  +     N+  ++LSNNQ        FS+   L  +NL  N L 
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470

Query: 171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISGTI 229
            I   +         N   L  + L  N+    L       +   +V + +  N  S   
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-F 528

Query: 230 PLGIRNLVNLIALAVEV------NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN 283
           P    N   L    +        N+     P+ I    +L  L +  N ++  +   +  
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI-- 585

Query: 284 LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN 334
              ++ LD+             N  I      +       +Y+   +   +
Sbjct: 586 TPNISVLDI-----------KDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  154 bits (392), Expect = 8e-40
 Identities = 42/316 (13%), Positives = 90/316 (28%), Gaps = 52/316 (16%)

Query: 129 SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCS 188
           SL++   +  L L      G+V      L  L  L L  +   +     L     ++   
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN--ERLFGPKGISANM 133

Query: 189 SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ 248
           S +        +                                  +  +LI   +  + 
Sbjct: 134 SDEQKQKMRMHYQKTFVDYDPRE-----------------------DFSDLIKDCINSDP 170

Query: 249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKL 308
              +I            +G   N +   +   +  LTKL +  +G++             
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVA--------- 220

Query: 309 IGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTC 368
                    +I       +        +   +  NLK+L  +++ +      +P  L   
Sbjct: 221 --------ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272

Query: 369 VSLEYVDISSNCFHGI--------IPPSLGFLKSIKFLDVSCNNF-SGQFPKFLENLSFL 419
             ++ ++++ N                     + I+ + +  NN  +      L+ +  L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332

Query: 420 EFLNLSYNHLEGEVPT 435
             L   YN LEG++P 
Sbjct: 333 GMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  133 bits (337), Expect = 9e-33
 Identities = 35/235 (14%), Positives = 76/235 (32%), Gaps = 26/235 (11%)

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG----SIPSGLGNLTKLAKL 290
           +   +  L++E     G +PD IG+L  L++L L  +  +       P G+       + 
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138

Query: 291 DLGSNSLQGNFIA---------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNG 335
                  Q  F+                + +    ++ +    IT     +   +N +  
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK-SSRITLKDTQIGQLSNNI-T 196

Query: 336 SLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSI 395
            + + V  L  L    + ++ F            + EY        +         LK +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDL 251

Query: 396 KFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGN 450
             ++V       + P FL+ L  ++ +N++ N        K  +   +  P+   
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 16/103 (15%), Positives = 31/103 (30%), Gaps = 1/103 (0%)

Query: 377 SSNCFHGIIPP-SLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT 435
                 G  P  SL     +  L +     SG+ P  +  L+ LE L L  +  +     
Sbjct: 64  KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123

Query: 436 KGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLL 478
            G     + +  +   ++     +  +   P      L    +
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  237 bits (607), Expect = 1e-68
 Identities = 77/448 (17%), Positives = 153/448 (34%), Gaps = 31/448 (6%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           +    P+    L  L+ L L  N L+          + L  +H+  NS+           
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDI-VVNLPNLKELGIGA 119
           +NL+ L+++ N        +   + +L+   L++N+       ++ +    +LK+L + +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFS---SLKILWRLNLEQNNLGIGAAN 176
           N      P        L  L L+N Q    ++       +   +  L+L  + L   +  
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNL 236
                      ++L +L LS N        S A L      FL   N I       +  L
Sbjct: 241 TFLG----LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL-EYNNIQHLFSHSLHGL 295

Query: 237 V---------NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKL 287
                     +    ++ +  L          LK L+ L +  N + G   +    L  L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355

Query: 288 AKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQQVGNLKN 346
             L L ++      +           +  +S+    L  L+L+ N ++         L +
Sbjct: 356 KYLSLSNSFTSLRTLT---------NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406

Query: 347 LIILDISSNQFSGMIPV-TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
           L +LD+  N+    +         ++  + +S N +  +   S   + S++ L +     
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466

Query: 406 SG--QFPKFLENLSFLEFLNLSYNHLEG 431
                 P   + L  L  L+LS N++  
Sbjct: 467 KNVDSSPSPFQPLRNLTILDLSNNNIAN 494

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  231 bits (590), Expect = 3e-66
 Identities = 92/440 (20%), Positives = 160/440 (36%), Gaps = 25/440 (5%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           Q+P ++ +   +  L L  N L           S L  + +  N++    P     L  L
Sbjct: 18  QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             LN+  N+   +  ++    ++L   +L SN     +  +  V   NL  L +  N   
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLS 134

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKI--LWRLNLEQNNLGIGAANDLGFV 181
                +     NL+ L LSNN+ +   S +        L +L L  N +   +       
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH-- 192

Query: 182 TFLTNCSSLKVLSLSDNQFGGELPHSI-ANLSSTMIVFL-IGGNQISGTIPLGIRNL--V 237
                   L  L L++ Q G  L   +   L++T I  L +  +Q+S T       L   
Sbjct: 193 ----AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248

Query: 238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSL 297
           NL  L +  N L+    D    L  L+   L  N +Q      L  L  +  L+L  +  
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 298 QGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
           + +   S   L          +  L  +L++ +N + G        L NL  L +S++  
Sbjct: 309 KQSI--SLASLPKIDDFSFQWLKCLE-HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365

Query: 358 SGMIPVTLSTCV-----SLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP-K 411
           S    +T  T V      L  ++++ N    I   +  +L  ++ LD+  N    +   +
Sbjct: 366 SL-RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424

Query: 412 FLENLSFLEFLNLSYNHLEG 431
               L  +  + LSYN    
Sbjct: 425 EWRGLENIFEIYLSYNKYLQ 444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  227 bits (582), Expect = 4e-65
 Identities = 95/467 (20%), Positives = 174/467 (37%), Gaps = 42/467 (8%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIG---NLSALQVIHIKGNSLGGKFPTTL 57
           ++   P    ++ +L  L L    L   L + +      ++++ + +  + L     TT 
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242

Query: 58  GLLR--NLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL 115
             L+  NL  L+++ N    +   S   +  LEYF+L  N         +   L N++ L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH-GLFNVRYL 301

Query: 116 ---------GIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE 166
                     I   +   +   S      LE L++ +N   G  S  F+ L  L  L+L 
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            +   +    +  FV+     S L +L+L+ N+       + + L    ++ L G N+I 
Sbjct: 362 NSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL-GLNEIG 418

Query: 227 GTIPLG-IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG--SIPSGLGN 283
             +     R L N+  + +  N+      +    + +LQ L L +  L+   S PS    
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

Query: 284 LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN--------G 335
           L  L  LDL +N++              +   +L        LDL +N L         G
Sbjct: 479 LRNLTILDLSNNNIAN------------INDDMLEGLEKLEILDLQHNNLARLWKHANPG 526

Query: 336 SLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSI 395
                +  L +L IL++ SN F  +          L+ +D+  N  + +         S+
Sbjct: 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586

Query: 396 KFLDVSCNNFSGQFPK-FLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
           K L++  N  +    K F      L  L++ +N  +    +   F N
Sbjct: 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  161 bits (409), Expect = 8e-42
 Identities = 72/373 (19%), Positives = 127/373 (34%), Gaps = 31/373 (8%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGL- 59
           L          L  L+ L +  N + G   +    L  L+ + +  +    +  T     
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376

Query: 60  ---LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG 116
                 L  LN+ +NK   +   +   +  LE   L  N     L       L N+ E+ 
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY 436

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID--FSSLKILWRLNLEQNNLGIGA 174
           +  N +  L  +S +   +L+ L L     K   S    F  L+ L  L+L  NN+    
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496

Query: 175 ANDLGFVTFLTNCSSLKVLSLSDNQ--------FGGELPHSIANLSSTMIVFLIGGNQIS 226
            +       L     L++L L  N           G   + +  LS  + +  +  N   
Sbjct: 497 DD------MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH-LHILNLESNGFD 549

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLG-NLT 285
                  ++L  L  + + +N L+     V     +L+ L L KN +        G    
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609

Query: 286 KLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLK 345
            L +LD+  N        S    +  + +   +I       +LS++ L  + P   G   
Sbjct: 610 NLTELDMRFNPFDCT-CESIAWFVNWINETHTNI------PELSSHYLCNTPPHYHG--F 660

Query: 346 NLIILDISSNQFS 358
            + + D SS + S
Sbjct: 661 PVRLFDTSSCKDS 673

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  160 bits (408), Expect = 1e-41
 Identities = 63/314 (20%), Positives = 107/314 (34%), Gaps = 31/314 (9%)

Query: 135 NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLS 194
           + E+ D S+ +      +       +  LNL  N L    A +          S L  L 
Sbjct: 5   SHEVADCSHLKLT---QVPDDLPTNITVLNLTHNQLRRLPAANFT------RYSQLTSLD 55

Query: 195 LSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP 254
           +  N      P     L   + V  +  N++S           NL  L +  N +     
Sbjct: 56  VGFNTISKLEPELCQKLPM-LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 255 DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQ 314
           +   + KNL  L L  N L  +       L  L +L L +N +Q             L  
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA------------LKS 162

Query: 315 QLLSITTLS--LYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCV--- 369
           + L I   S    L+LS+N +    P     +  L  L +++ Q    +   L   +   
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222

Query: 370 SLEYVDISSNCFHGIIPPSLGFLK--SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
           S+  + +S++        +   LK  ++  LD+S NN +         L  LE+  L YN
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282

Query: 428 HLEGEVPTKGVFSN 441
           +++           
Sbjct: 283 NIQHLFS--HSLHG 294

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  135 bits (343), Expect = 2e-33
 Identities = 56/266 (21%), Positives = 97/266 (36%), Gaps = 25/266 (9%)

Query: 189 SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ 248
           S +V   S  +   ++P    +L + + V  +  NQ+             L +L V  N 
Sbjct: 5   SHEVADCSHLKLT-QVPD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKL 308
           +    P++  +L  L++L L  N L           T L +L L SNS+Q      +N  
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK----IKNNP 116

Query: 309 IGALPQQLLSITTLSL-YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLST 367
                         +L  LDLS+N L+ +       L+NL  L +S+N+   +    L  
Sbjct: 117 FVKQK---------NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167

Query: 368 C--VSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFL---ENLSFLEFL 422
               SL+ +++SSN      P     +  +  L ++         + L      + +  L
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227

Query: 423 NLSYNHLEGEVPTKGVFSNKSKIPLQ 448
           +LS + L         F       L 
Sbjct: 228 SLSNSQLSTTSN--TTFLGLKWTNLT 251

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  224 bits (572), Expect = 2e-64
 Identities = 89/476 (18%), Positives = 168/476 (35%), Gaps = 36/476 (7%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSL-GGKFPTTLGL 59
           ++         L  LQ L      L       IG+L  L+ +++  N +   K P     
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYF----YLTSNRFSGSLPFDIVVNLPNLKEL 115
           L NL  L+++ NK   ++   +  +  +        L+ N  +   P         L +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLHKL 205

Query: 116 GIGANNFFG-LIPDSLSNASNLELLDLSNNQFKGKVSI---DFSSLKILWRLNLEQNNLG 171
            +  N     ++   +   + LE+  L   +F+ + ++   D S+L+ L  L +E+  L 
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPL 231
                    +      +++   SL           S         + L    +      L
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLEL-VNCKFGQFPTL 322

Query: 232 GIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQ--GSIPSGLGNLTKLAK 289
            +++L  L           G       +L +L+ L L +N L   G         T L  
Sbjct: 323 KLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 290 LDLGSNSLQG---NFIA---------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSL 337
           LDL  N +     NF+            + L       +       +YLD+S+     + 
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 338 PQQVGNLKNLIILDISSNQFSGMI-PVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIK 396
                 L +L +L ++ N F     P   +   +L ++D+S      + P +   L S++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT--KGVFSNKSKIPLQGN 450
            L++S NNF        + L+ L+ L+ S NH+        +   S+ + + L  N
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  217 bits (556), Expect = 4e-62
 Identities = 99/480 (20%), Positives = 158/480 (32%), Gaps = 60/480 (12%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           ++        SL  L  L L GN +          LS+LQ +     +L       +G L
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 61  RNLVQLNVAENKF-YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG- 118
           + L +LNVA N       P    N+++LE+  L+SN+       D+   L  +  L +  
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLNLSL 182

Query: 119 --ANNFFGLIPDSLSNASNLELLDLSNNQFKGKVS------------------------- 151
             + N    I         L  L L NN     V                          
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 152 ---IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI 208
               D S+L+ L  L +E+  L          +      +++   SL           S 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS- 301

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
                   + L    +      L +++L  L           G       +L +L+ L L
Sbjct: 302 -YNFGWQHLEL-VNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDL 354

Query: 269 YKNFLQ--GSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYL 326
            +N L   G         T L  LDL  N +              +    L +  L  +L
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT------------MSSNFLGLEQLE-HL 401

Query: 327 DLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           D  ++ L       V  +L+NLI LDIS            +   SLE + ++ N F    
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461

Query: 386 PP-SLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSK 444
            P     L+++ FLD+S        P    +LS L+ LN+S+N+          +   + 
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNS 519

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  215 bits (550), Expect = 2e-61
 Identities = 91/458 (19%), Positives = 154/458 (33%), Gaps = 43/458 (9%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           +IP  +      + L L+ N L         +   LQV+ +    +          L +L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             L +  N    +   +   +SSL+         +    F I  +L  LKEL +  N   
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI-GHLKTLKELNVAHNLIQ 137

Query: 124 GL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLK----ILWRLNLEQNNLGIGAANDL 178
              +P+  SN +NLE LDLS+N+ +     D   L     +   L+L  N +        
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN------- 190

Query: 179 GFVTFLTNCSSLKVLSLSDNQFGGELP-HSIANLSSTMIVFLIGG-----NQISGTIPLG 232
                      L  L+L +N     +    I  L+   +  L+ G       +       
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 233 IRNLVNLIALAVEVNQL---HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAK 289
           +  L NL      +  L      I D+   L N+    L    ++               
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308

Query: 290 LDLGSNSLQG----------NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN--GSL 337
           L+L +                   + NK   A     + + +L  +LDLS N L+  G  
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLE-FLDLSRNGLSFKGCC 365

Query: 338 PQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS-LGFLKSIK 396
            Q      +L  LD+S N     +         LE++D   +    +   S    L+++ 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP 434
           +LD+S  +    F      LS LE L ++ N  +    
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  191 bits (488), Expect = 9e-53
 Identities = 91/475 (19%), Positives = 154/475 (32%), Gaps = 72/475 (15%)

Query: 3   GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQV----IHIKGNSLGGKFPTTLG 58
            ++P+   +L  L+ L L+ N +       +  L  + +    + +  N +    P    
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198

Query: 59  LLRNLVQLNVAENKFYGMFPRSIC-NISSLEYFYLTSNRFSGS--LPFDIVVNLPNLKEL 115
            +  L +L +  N       ++    ++ LE   L    F     L       L  L  L
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 116 GIGANN------FFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN 169
            I          +   I D  +  +N+    L +   +     DFS       L L    
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315

Query: 170 LGIGAANDLGFVTFLT-------------NCSSLKVLSLSDNQ--FGGELPHSIANLSST 214
            G      L  +  LT             +  SL+ L LS N   F G    S    +S 
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS- 374

Query: 215 MIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP-DVIGELKNLQLLGLYKNFL 273
           +    +  N +  T+      L  L  L  + + L       V   L+NL  L +     
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 274 QGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLL 333
           + +       L+ L  L +  NS Q NF+         +  +L ++T L    DLS   L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-------IFTELRNLTFL----DLSQCQL 482

Query: 334 NGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLG-FL 392
               P    +L +L +L++S N F  +         SL+ +D S N         L  F 
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 393 KSIKFLDVSCNNFSG--------------------------QFPKFLENLSFLEF 421
            S+ FL+++ N+F+                             P   + +  L  
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  154 bits (390), Expect = 1e-39
 Identities = 73/374 (19%), Positives = 124/374 (33%), Gaps = 34/374 (9%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYL---TGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL 57
           LE      +  L  L        YL      + D    L+ +    +   ++        
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--F 300

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
                   L +   KF       + ++  L     TSN+   +      V+LP+L+ L +
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSE---VDLPSLEFLDL 354

Query: 118 GAN--NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAA 175
             N  +F G    S    ++L+ LDLS N     +S +F  L+ L  L+ + +NL     
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL----- 408

Query: 176 NDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-R 234
             +   +   +  +L  L +S              LSS + V  + GN         I  
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDIFT 467

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
            L NL  L +   QL    P     L +LQ+L +  N            L  L  LD   
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527

Query: 295 NSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQ--VGNLKNLIILDI 352
           N +  +             Q+L    +   +L+L+ N    +   Q  +  +K+   L +
Sbjct: 528 NHIMTSK-----------KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576

Query: 353 SSNQFSGMIPVTLS 366
              +     P    
Sbjct: 577 EVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  127 bits (322), Expect = 6e-31
 Identities = 51/269 (18%), Positives = 98/269 (36%), Gaps = 37/269 (13%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPT-TLGL 59
            +G   +       L+ L L+ N +   +      L  L+ +  + ++L           
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
           LRNL+ L+++       F      +SSLE   +  N F  +   DI   L NL  L +  
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
                L P + ++ S+L++L++S+N F     +D    K                     
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFS---LDTFPYK--------------------- 515

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG--IRNLV 237
                   +SL+VL  S N         + +  S++    +  N  + T      ++ + 
Sbjct: 516 ------CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569

Query: 238 NLIALAVEVNQLHGTIPDVIGELKNLQLL 266
           +   L VEV ++    P    + + + +L
Sbjct: 570 DQRQLLVEVERMECATP---SDKQGMPVL 595

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  126 bits (318), Expect = 2e-30
 Identities = 54/274 (19%), Positives = 89/274 (32%), Gaps = 33/274 (12%)

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            C  L    + DN     LP S  NL        +  N +         +   L  L + 
Sbjct: 13  QCMELNFYKIPDN-----LPFSTKNLD-------LSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
             ++          L +L  L L  N +Q         L+ L KL     +L        
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS------ 114

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
             L       L ++  L++     N + +  LP+   NL NL  LD+SSN+   +    L
Sbjct: 115 --LENFPIGHLKTLKELNVA---HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169

Query: 366 STCVSLEYV----DISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK-FLENLSFLE 420
                +  +    D+S N  + I P +   +  +  L +  N  S    K  ++ L+ LE
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 421 FLNLSYNHLEG----EVPTKGVFSNKSKIPLQGN 450
              L           E   K        + ++  
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 77.0 bits (190), Expect = 9e-15
 Identities = 17/112 (15%), Positives = 35/112 (31%), Gaps = 3/112 (2%)

Query: 323 SLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
           ++            +P  +    +   LD+S N    +   +  +   L+ +D+S     
Sbjct: 9   NITYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65

Query: 383 GIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP 434
            I   +   L  +  L ++ N            LS L+ L     +L     
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  211 bits (539), Expect = 1e-62
 Identities = 72/201 (35%), Positives = 107/201 (53%), Gaps = 20/201 (9%)

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECE 581
           S  EL  A+  FS+ N++G+G FG VYKG L  D  +VAVK +  +  +G    F  E E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 582 ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ 641
            +    HRNL+++   C +   +      LV+ YM NGS+   L +  +      L   +
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQ--PPLDWPK 132

Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH--HLD 699
           R  IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +     H+ 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192

Query: 700 TSSKTPSSSIGIKGTVGYVAP 720
           T          ++GT+G++AP
Sbjct: 193 T---------AVRGTIGHIAP 204

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  211 bits (538), Expect = 1e-59
 Identities = 80/471 (16%), Positives = 155/471 (32%), Gaps = 35/471 (7%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           +         S  +L  L L  N L       +    AL+ +      +       L   
Sbjct: 69  IYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG-A 119
           + L  L +  N    +          L+     +N     L  + + +L     L +   
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLN 187

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKV--SIDFSSLKILWRLNLEQNNLGIGAAND 177
            N    I     +++  + L+    Q    +   +  S+++ LW    E  +       D
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD-----ED 242

Query: 178 LGFVTFLTNC-SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNL 236
           +    F   C  S++ ++L  + F     ++    S  +    +    +S  +P G+  L
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG-LQELDLTATHLS-ELPSGLVGL 300

Query: 237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
             L  L +  N+             +L  L +  N  +  + +G L NL  L +LDL  +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 296 SLQGNFIA---------------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQ 340
            ++ +                  S N+ +    +       L   LDL+   L     Q 
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE-LLDLAFTRLKVKDAQS 419

Query: 341 V-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII---PPSLGFLKSIK 396
              NL  L +L++S +              +L+++++  N F         SL  L  ++
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPL 447
            L +S  + S        +L  +  ++LS+N L          S+   I L
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLKGIYL 528

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  209 bits (533), Expect = 7e-59
 Identities = 85/448 (18%), Positives = 134/448 (29%), Gaps = 25/448 (5%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           L          L  L  L L    +     D   +   L  + +  N L     T L   
Sbjct: 45  LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           + L  L   +     +    + N  +LE  YL SN  S S+          LK L    N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNN 163

Query: 121 NFFGLIPDSLSNASNLEL--LDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDL 178
               L  + +S+        L+L+ N   G +        +   LN       +     L
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222

Query: 179 GFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISGTIPLGIRNLV 237
              T      SL + +  D       P     L    +  + +  +              
Sbjct: 223 KNSTI----QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278

Query: 238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSL 297
            L  L +    L   +P  +  L  L+ L L  N  +        N   L  L +     
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI----- 332

Query: 298 QGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS--LPQQVGNLKNLIILDISSN 355
                   N     L    L        LDLS++ +  S     Q+ NL +L  L++S N
Sbjct: 333 ------KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386

Query: 356 QFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS-LGFLKSIKFLDVSCNNFSGQFPKFLE 414
           +   +       C  LE +D++          S    L  +K L++S +       +  +
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 415 NLSFLEFLNLSYNHLEGEVPTK-GVFSN 441
            L  L+ LNL  NH       K      
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQT 474

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  190 bits (485), Expect = 2e-52
 Identities = 88/463 (19%), Positives = 162/463 (34%), Gaps = 35/463 (7%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           +       + +   L++L L  N+++            L+V+  + N++       +  L
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176

Query: 61  RNL--VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV-VNLPNLKELGI 117
           +    + LN+  N   G       + +  +       +    +   +    + +L     
Sbjct: 177 QQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235

Query: 118 GANNFFGLIPDSLSN--ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAA 175
              +   + P         ++E ++L  + F    S  F     L  L+L   +L     
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS---- 291

Query: 176 NDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
                 + L   S+LK L LS N+F      S +N  S   + + G  +        + N
Sbjct: 292 ---ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

Query: 236 LVNLIALAVEVNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLG 293
           L NL  L +  + +         +  L +LQ L L  N              +L  LDL 
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL- 407

Query: 294 SNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDIS 353
                     +  +L     Q       L   L+LS++LL+ S  Q    L  L  L++ 
Sbjct: 408 ----------AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457

Query: 354 SNQFSGMIPV---TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
            N F         +L T   LE + +S      I   +   LK +  +D+S N  +    
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

Query: 411 KFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIP---LQGN 450
           + L +L  + +LNL+ NH+   +P   +    S+     L+ N
Sbjct: 518 EALSHLKGI-YLNLASNHISIILP--SLLPILSQQRTINLRQN 557

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  184 bits (469), Expect = 4e-50
 Identities = 90/444 (20%), Positives = 159/444 (35%), Gaps = 36/444 (8%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVI--HIKGNSLGGKFPTTLG 58
           +      +     KL+ L    N +     + + +L     +  ++ GN + G       
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAF 199

Query: 59  LLRNLVQLNVAENKFYGMFPRSI--CNISSLEYFYLTSNRFSGSLPFDIVVNLP--NLKE 114
                  LN    +   +  + +    I SL             +   +   L   +++ 
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVES 258

Query: 115 LGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA 174
           + +  + FF +  ++    S L+ LDL+      ++      L  L +L L  N      
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF---- 313

Query: 175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGEL-PHSIANLSSTMIVFLIGGNQI--SGTIPL 231
             +L  ++  +N  SL  LS+  N    EL    + NL +   + L   + I  S    L
Sbjct: 314 -ENLCQISA-SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL-SHDDIETSDCCNL 370

Query: 232 GIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKL 290
            +RNL +L +L +  N+      +   E   L+LL L    L+         NL  L  L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 291 DLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG---NLKNL 347
           +L  + L                +QL        +L+L  N       Q+      L  L
Sbjct: 431 NLSHSLLDI------------SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478

Query: 348 IILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG 407
            IL +S    S +     ++   + +VD+S N        +L  LK I +L+++ N+ S 
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI 537

Query: 408 QFPKFLENLSFLEFLNLSYNHLEG 431
             P  L  LS    +NL  N L+ 
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  147 bits (373), Expect = 2e-37
 Identities = 71/327 (21%), Positives = 119/327 (36%), Gaps = 25/327 (7%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
           ++++ L  +Y      +     S LQ + +    L  + P+ L  L  L +L ++ NKF 
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANN--FFGLIPDSLSN 132
            +   S  N  SL +  +  N     L    + NL NL+EL +  ++          L N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            S+L+ L+LS N+     +  F     L  L+L    L           +   N   LKV
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL-----KVKDAQSPFQNLHLLKV 429

Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPL---GIRNLVNLIALAVEVNQL 249
           L+LS +            L + +    + GN            ++ L  L  L +    L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPA-LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLI 309
                     LK +  + L  N L  S    L +L  +  L+L SN +            
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI---------- 537

Query: 310 GALPQQLLSITTLSLYLDLSNNLLNGS 336
             +   LL I +    ++L  N L+ +
Sbjct: 538 --ILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  140 bits (354), Expect = 5e-35
 Identities = 63/306 (20%), Positives = 118/306 (38%), Gaps = 15/306 (4%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
                         LQ L L   +L+ +LP  +  LS L+ + +  N        +    
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324

Query: 61  RNLVQLNVAENKFYGM-FPRSICNISSLEYFYLTSNRFSGS-LPFDIVVNLPNLKELGIG 118
            +L  L++  N          + N+ +L    L+ +    S      + NL +L+ L + 
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384

Query: 119 ANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAAND 177
            N    L  ++      LELLDL+  + K K +   F +L +L  LNL  + L I +   
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ- 443

Query: 178 LGFVTFLTNCSSLKVLSLSDNQFGG---ELPHSIANLSSTMIVFLIGGNQISGTIPLGIR 234
                      +L+ L+L  N F     +  +S+  L   + + ++    +S        
Sbjct: 444 -----LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR-LEILVLSFCDLSSIDQHAFT 497

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
           +L  +  + +  N+L  +  + +  LK + L  L  N +   +PS L  L++   ++L  
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGIYLN-LASNHISIILPSLLPILSQQRTINLRQ 556

Query: 295 NSLQGN 300
           N L   
Sbjct: 557 NPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  104 bits (262), Expect = 1e-23
 Identities = 39/261 (14%), Positives = 80/261 (30%), Gaps = 21/261 (8%)

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH 250
           K  +  +     E+P     L ++        N +          L+NL  L +   Q++
Sbjct: 15  KTYNCENLGLN-EIP---GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIG 310
               D       L  L L  N L     + L     L  L      +           + 
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS----IDFIPLH 126

Query: 311 ALPQQLLSITTLSL-YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCV 369
                       +L  L L +N ++     +    + L +LD  +N    +    +S+  
Sbjct: 127 NQK---------TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177

Query: 370 SLE--YVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
                 ++++ N   G I P        + L+           K L+N +       ++ 
Sbjct: 178 QATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFE 236

Query: 428 HLEGEVPTKGVFSNKSKIPLQ 448
            ++ E  +  VF    ++ ++
Sbjct: 237 DMDDEDISPAVFEGLCEMSVE 257

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 96.6 bits (241), Expect = 6e-21
 Identities = 42/223 (18%), Positives = 67/223 (30%), Gaps = 17/223 (7%)

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQN 306
             L+  IP  +    + + L    N L     +    L  L  LDL    +         
Sbjct: 22  LGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW----IHE 74

Query: 307 KLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLS 366
               +  +       L   L L+ N L       +   K L  L       S +  + L 
Sbjct: 75  DTFQSQHR-------LD-TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126

Query: 367 TCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLE--FLNL 424
              +LE + + SN    I  P     + +K LD   N       + + +L       LNL
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186

Query: 425 SYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPS 467
           + N + G  P     +    +   G   L      L   +  S
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  210 bits (535), Expect = 1e-57
 Identities = 80/458 (17%), Positives = 143/458 (31%), Gaps = 65/458 (14%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
           I K I  L KLQ +  A +  T             +  +            +   L++L 
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLT 494

Query: 65  QLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPF--------DIVVNLPNLKELG 116
            + +         P  + ++  L+   +  NR   +           D     P ++   
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554

Query: 117 IGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNL-GIG 173
           +G NN        SL     L LLD  +N+ +    ++ F +   L  L L+ N +  I 
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR---HLEAFGTNVKLTDLKLDYNQIEEIP 611

Query: 174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISG----- 227
                    F      ++ L  S N+    +P+     S  ++  +    N+I       
Sbjct: 612 E-------DFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663

Query: 228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQ-------GSIPSG 280
           +  +     +N   + +  N++     ++      +  + L  N +              
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723

Query: 281 LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQ 339
             N   L  +DL  N L              L     + T   L  +D+S N  + S P 
Sbjct: 724 YKNTYLLTTIDLRFNKLTS------------LSDDFRATTLPYLSNMDVSYNCFS-SFPT 770

Query: 340 QVGNLKNLIILDI------SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK 393
           Q  N   L    I        N+     P  ++TC SL  + I SN    +    L    
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKV-DEKL--TP 827

Query: 394 SIKFLDVSCN-NFSGQFPKFLENLSFLEFLNLSYNHLE 430
            +  LD++ N N S         +       L Y+  +
Sbjct: 828 QLYILDIADNPNISIDVTSVCPYIE-AGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  201 bits (513), Expect = 8e-55
 Identities = 66/459 (14%), Positives = 137/459 (29%), Gaps = 59/459 (12%)

Query: 3   GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSL-GGKFPTTLGLLR 61
            Q   ++ +  ++  L+LAG    G++PD IG L+ L+V+    +S            L 
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372

Query: 62  NLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFS-----GSLPFDIVVNLPNLKELG 116
             +                +     L    L  +  +       +  D  ++L + +   
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGN 432

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN 176
           +   N    I  ++   + L+++  +N+ F        +        N +          
Sbjct: 433 L--TNRITFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEEL 485

Query: 177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISG--------- 227
                    N   L  + L +     +LP  + +L   +    I  N+            
Sbjct: 486 SWS------NLKDLTDVELYNCPNMTQLPDFLYDLPE-LQSLNIACNRGISAAQLKADWT 538

Query: 228 TIPLGIRNLVNLIALAVEVNQLHG-TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
            +         +    +  N L        + ++  L LL    N ++  + +  G   K
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVK 596

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQ--QVGNL 344
           L  L L  N ++             +P+   + T     L  S+N L   +P      ++
Sbjct: 597 LTDLKLDYNQIEE------------IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV 643

Query: 345 KNLIILDISSNQFSGMIPVTLS-----TCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLD 399
             +  +D S N+                 ++   V +S N               I  + 
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703

Query: 400 VSCNNFS-------GQFPKFLENLSFLEFLNLSYNHLEG 431
           +S N  +              +N   L  ++L +N L  
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  195 bits (496), Expect = 2e-52
 Identities = 65/459 (14%), Positives = 118/459 (25%), Gaps = 85/459 (18%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
                     +L  L  + L       +LPDF+ +L  LQ ++I  N             
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           R                         ++ FY+  N          +  +  L  L    N
Sbjct: 539 R---------------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
                  ++      L  L L  NQ +       +    +  L    N L       +  
Sbjct: 584 KV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-----KYIPN 636

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
           +    +   +  +  S N+                    IG    + +  +     +N  
Sbjct: 637 IFNAKSVYVMGSVDFSYNK--------------------IGSEGRNISCSMDDYKGINAS 676

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQ-------GSIPSGLGNLTKLAKLDLG 293
            + +  N++     ++      +  + L  N +                N   L  +DL 
Sbjct: 677 TVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736

Query: 294 SNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQQVGNLKNLIILDI 352
            N L              L     + T   L  +D+S N  + S P Q  N   L    I
Sbjct: 737 FNKLTS------------LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGI 783

Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKF 412
              +                  D   N      P  +    S+  L +  N+      K 
Sbjct: 784 RHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKL 825

Query: 413 LENLSFLEFLNLSYNHL-EGEVPTKGVFSNKSKIPLQGN 450
                 L  L+++ N     +V +   +       L  +
Sbjct: 826 TPQ---LYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  181 bits (461), Expect = 5e-48
 Identities = 57/416 (13%), Positives = 123/416 (29%), Gaps = 46/416 (11%)

Query: 47  NSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV 106
           +  G +    L     +  L++A     G  P +I  ++ L+     ++  + S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 107 VNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE 166
             L                    L     L L DL  +      + +   +K   R++L+
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLK 426

Query: 167 QNNLGIGAANDLGFV-TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQI 225
              +G    N + F+   +   + L+++  +++ F  +        +           + 
Sbjct: 427 DTQIG-NLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA------NSDYAKQ 479

Query: 226 SGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG---------S 276
                L   NL +L  + +        +PD + +L  LQ L +  N              
Sbjct: 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

Query: 277 IPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQ---------QLLSITTLS---- 323
           +        K+    +G N+L+       +  +  + +         ++  +        
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEE---FPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVK 596

Query: 324 -LYLDLSNNLLNGSLPQQVG-NLKNLIILDISSNQFSGMIP--VTLSTCVSLEYVDISSN 379
              L L  N +   +P+        +  L  S N+    IP      +   +  VD S N
Sbjct: 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYN 654

Query: 380 CFHGIIP-----PSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
                              +   + +S N       +     S +  + LS N + 
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  166 bits (422), Expect = 4e-43
 Identities = 58/426 (13%), Positives = 122/426 (28%), Gaps = 24/426 (5%)

Query: 25  LTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNI 84
               + D+    +  + +  K                N    N   + +       + N 
Sbjct: 264 TAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNN 322

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
             +    L      G +P  I   L  LK L  G ++               ++ +   +
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAI-GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381

Query: 145 QFKGKVSIDF-SSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCS-SLKVLSLSDNQFGG 202
           + +      F    + L   +L Q+ +      ++  +   +  S     +    N+   
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITF 439

Query: 203 ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKN 262
            +  +I  L+  + +     +  +           N      +  + +         LK+
Sbjct: 440 -ISKAIQRLTK-LQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNLKD 492

Query: 263 LQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTL 322
           L  + LY       +P  L +L +L  L++  N       A        L     +   +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS--AAQLKADWTRLADDEDTGPKI 550

Query: 323 SLYLDLSNNLLNGSLPQQV--GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNC 380
                +  N L    P       +  L +LD   N+    +     T V L  + +  N 
Sbjct: 551 Q-IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQ 606

Query: 381 FHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK--FLENLSFLEFLNLSYNHLEGEVPTKGV 438
              I      F   ++ L  S N      P     +++  +  ++ SYN +  E      
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665

Query: 439 FSNKSK 444
             +  K
Sbjct: 666 SMDDYK 671

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 12/118 (10%), Positives = 34/118 (28%), Gaps = 1/118 (0%)

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           LD  + ++           ++    +   + +       L     +  L ++     G+ 
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 410 PKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPS 467
           P  +  L+ L+ L+   +         G       +  +   R+     ++ L     
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  194 bits (495), Expect = 2e-56
 Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 23/201 (11%)

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
              +L +AT+ F    +IG G FG VYKG+L  D   VA+K    +       F  E E 
Sbjct: 30  PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           L   RH +L+ +I  C        +   L+++YM NG+L+  L+ S+       +S  QR
Sbjct: 89  LSFCRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPTM--SMSWEQR 141

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH---HLD 699
           L I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K  +     HL 
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 700 TSSKTPSSSIGIKGTVGYVAP 720
           T          +KGT+GY+ P
Sbjct: 199 T---------VVKGTLGYIDP 210

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  184 bits (470), Expect = 3e-50
 Identities = 98/470 (20%), Positives = 149/470 (31%), Gaps = 55/470 (11%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
                 +  +LQ L L+   +          L  L  + + GN +    P +   L +L 
Sbjct: 48  KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE 107

Query: 65  QLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
            L   E K   +    I  + +L+   +  N            NL NL  + +  N    
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167

Query: 125 LIPDSLSNASNLEL----LDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF 180
           +  + L            LD+S N         F  +K L  L L  N       +    
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFN-----SSNIM 221

Query: 181 VTFLTNCSSLKVLSLSDNQFGGEL------PHSIANLSS-TMIVFLIGGNQISGTIPLGI 233
            T L N + L V  L   +F  E       P  +  L   T+  F +          +  
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281

Query: 234 RNLVNLIALAVEVNQLHGTIPDVIGE--------------------LKNLQLLGLYKNFL 273
             L N+ A+++    +   + DV                       L  L+ L L  N  
Sbjct: 282 HCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMN-- 338

Query: 274 QGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLL 333
           +GSI      L  L+ LDL  N+L            G      L   +L  +LDLS N  
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSF---------SGCCSYSDLGTNSL-RHLDLSFNGA 388

Query: 334 NGSLPQQVGNLKNLIILDISSNQFSGMIPV-TLSTCVSLEYVDISSNCFHGIIPPSLGFL 392
              +      L+ L  LD   +    +       +   L Y+DIS              L
Sbjct: 389 I-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447

Query: 393 KSIKFLDVSCNNFSGQFPK-FLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
            S+  L ++ N+F          N + L FL+LS   LE      GVF  
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW--GVFDT 495

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  184 bits (468), Expect = 5e-50
 Identities = 91/465 (19%), Positives = 157/465 (33%), Gaps = 45/465 (9%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           ++P +I S    + + L+ N L         N S LQ + +    +          L +L
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             L +  N      P S   ++SLE       + + SL    +  L  LK+L +  N   
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIH 141

Query: 124 GL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLK----ILWRLNLEQNNLGIGAANDL 178
              +P   SN +NL  +DLS N  +     D   L+    +   L++  N +        
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201

Query: 179 GFVTFLTNCSSLKVLSLSDNQFGGELP-HSIANLSSTMIVFLIGG-----NQISGTIPLG 232
                      L  L+L  N     +    + NL+   +  LI G       +    P  
Sbjct: 202 -------QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 233 IRNLVNL--IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKL 290
           +  L ++      +               L N+  + L    +       +    K   L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSL 312

Query: 291 DLGSNSLQGNFIA----------SQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQ 339
            +    L+               + NK   +  +  L     SL YLDLS N L+ S   
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP----SLSYLDLSRNALSFSGCC 368

Query: 340 QVGNLK--NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS-LGFLKSIK 396
              +L   +L  LD+S N     +         L+++D   +    +   S    L+ + 
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
           +LD+S  N    F      L+ L  L ++ N  +    +  VF+N
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS-NVFAN 471

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  182 bits (463), Expect = 3e-49
 Identities = 90/461 (19%), Positives = 151/461 (32%), Gaps = 51/461 (11%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTG-KLPDFIGNLSALQVIHIKGNSLGGKFPTTLGL 59
           L       IG L  L+ L +A N++   KLP +  NL+ L  + +  N +       L  
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175

Query: 60  LRNL----VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL 115
           LR      + L+++ N               L    L  N  S ++    + NL  L   
Sbjct: 176 LRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234

Query: 116 GIGANNFFGLIPDSLSNASNLE--------LLDLSNNQFKGKVSIDFSSLKILWRLNLEQ 167
            +    F       +   S +E           L+         + F  L  +  ++L  
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294

Query: 168 NNLGIGAANDLGFVTFLT---------------NCSSLKVLSLSDNQFGGELPHSIANLS 212
            +  I    D+                      +   LK L+L+ N+  G +      L 
Sbjct: 295 VS--IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNK--GSISFKKVALP 350

Query: 213 STMIVFLIGGNQISGTIP--LGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYK 270
           S   + L   N +S +           +L  L +  N     +      L+ LQ L    
Sbjct: 351 SLSYLDL-SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408

Query: 271 NFLQGSIP-SGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLS 329
           + L+     S   +L KL  LD+   + + +F               L +T+L+  L ++
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDF-----------DGIFLGLTSLN-TLKMA 456

Query: 330 NNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS 388
            N    +    V  N  NL  LD+S  Q   +      T   L+ +++S N    +    
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516

Query: 389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHL 429
              L S+  LD S N               L F NL+ N +
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  103 bits (260), Expect = 3e-23
 Identities = 47/247 (19%), Positives = 82/247 (33%), Gaps = 23/247 (9%)

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH 250
                 D +   ++P    ++ S+     +  N +         N   L  L +   ++ 
Sbjct: 14  ITYQCMDQKLS-KVP---DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE 69

Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIG 310
                    L +L  L L  N +Q   P     LT L  L      L          L  
Sbjct: 70  TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS--------LES 121

Query: 311 ALPQQLLSITTLSLYLDLSNNLLNG-SLPQQVGNLKNLIILDISSNQFSGMIPVTLS--- 366
               QL+++      L++++N ++   LP    NL NL+ +D+S N    +    L    
Sbjct: 122 FPIGQLITLK----KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 367 -TCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK-FLENLSFLEFLNL 424
                   +D+S N    I   +   +  +  L +  N  S    K  L+NL+ L    L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 425 SYNHLEG 431
                + 
Sbjct: 237 ILGEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 88.2 bits (219), Expect = 3e-18
 Identities = 31/167 (18%), Positives = 53/167 (31%), Gaps = 17/167 (10%)

Query: 275 GSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN 334
           GS+   +  +  +         L              +P  + S T     +DLS N L 
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLS------------KVPDDIPSSTK---NIDLSFNPLK 45

Query: 335 GSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKS 394
                   N   L  LD+S  +   +          L  + ++ N      P S   L S
Sbjct: 46  ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105

Query: 395 IKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
           ++ L       +      +  L  L+ LN+++N +         FSN
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 19/98 (19%), Positives = 36/98 (36%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
            +  +     +   L  L L+   L          L  LQ++++  N+L     +    L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFS 98
            +L  L+ + N+             SL +F LT+N  +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  176 bits (449), Expect = 8e-50
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 20/206 (9%)

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE- 581
           + +E S          +IG+G +G+VYKG L E    VAVKV +   +   ++F+ E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNI 58

Query: 582 -ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
             +  + H N+ + I         G     LV EY  NGSL  +L              +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWV 111

Query: 641 QRLNIAIDVASAIEYLH------HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
               +A  V   + YLH       H +P + H DL   NVL+ +D    + DFGL+  L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 695 SHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + L    +  +++I   GT+ Y+AP
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAP 197

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  175 bits (445), Expect = 2e-49
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 29/208 (13%)

Query: 523 SYAELSKATSEFSS------SNMIGQGSFGSVYKGILGEDEMIVAVK----VINLKQKGA 572
           S+ EL   T+ F         N +G+G FG VYKG +  +   VAVK    ++++  +  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73

Query: 573 FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV 632
            + F  E + +   +H NL++++   S  D        LV+ YM NGSL D L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVYVYMPNGSLLDRLSCLDGTP 128

Query: 633 EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF 692
               LS   R  IA   A+ I +LH +     +H D+K +N+LLD    A + DFGLA+ 
Sbjct: 129 ---PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
                 +  ++T  +S  I GT  Y+AP
Sbjct: 183 -----SEKFAQTVMTS-RIVGTTAYMAP 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  171 bits (435), Expect = 5e-48
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 24/205 (11%)

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA 582
               L   +       +  +G FG V+K  L  +   VAVK+  ++ K +++    E  +
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 583 LRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR 642
           L  ++H N+++ I          VD   L+  +   GSL D+L  +        +S  + 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKAN-------VVSWNEL 123

Query: 643 LNIAIDVASAIEYLHHH-------CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            +IA  +A  + YLH          +P + H D+K  NVLL +++ A + DFGLA     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE- 182

Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAP 720
                + K+   + G  GT  Y+AP
Sbjct: 183 -----AGKSAGDTHGQVGTRRYMAP 202

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  167 bits (424), Expect = 4e-45
 Identities = 105/425 (24%), Positives = 169/425 (39%), Gaps = 55/425 (12%)

Query: 9   IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNV 68
             +L +     L    +T  +     +L  +  +      +  K    +  L NL Q+N 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75

Query: 69  AENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD 128
           + N+   + P  + N++ L    + +N+ +   P     NL NL  L +  N    + P 
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDIDP- 129

Query: 129 SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCS 188
            L N +NL  L+LS+N      ++  S L  L +L+       +           L N +
Sbjct: 130 -LKNLTNLNRLELSSNTISDISAL--SGLTSLQQLSFGNQVTDLKP---------LANLT 177

Query: 189 SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ 248
           +L+ L +S N+        +A L++   +     NQIS   PLG   L NL  L++  NQ
Sbjct: 178 TLERLDISSNKVSD--ISVLAKLTNLESLIA-TNNQISDITPLG--ILTNLDELSLNGNQ 232

Query: 249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG-NFIASQNK 307
           L       +  L NL  L L  N +    P  L  LTKL +L LG+N +   + +A    
Sbjct: 233 L--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 288

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLST 367
           L                 L+L+ N L    P  + NLKNL  L +  N  S + P  +S+
Sbjct: 289 LT---------------NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329

Query: 368 CVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
              L+ +   +N    +   SL  L +I +L    N  S   P  L NL+ +  L L+  
Sbjct: 330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 385

Query: 428 HLEGE 432
                
Sbjct: 386 AWTNA 390

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  158 bits (401), Expect = 6e-42
 Identities = 97/429 (22%), Positives = 167/429 (38%), Gaps = 55/429 (12%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           +    +  L  L  +  + N LT   P  + NL+ L  I +  N +     T L  L NL
Sbjct: 59  KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNL 114

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             L +  N+   + P  + N+++L    L+SN  S          L +L++L  G N   
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS---GLTSLQQLSFG-NQVT 168

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
            L P  L+N + LE LD+S+N+      +  + L  L  L    N +          +T 
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISD--------ITP 216

Query: 184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA 243
           L   ++L  LSL+ NQ       ++A+L++ +    +  NQIS   PL    L  L  L 
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTN-LTDLDLANNQISNLAPLS--GLTKLTELK 271

Query: 244 VEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG-NFI 302
           +  NQ+    P  +  L  L  L L +N L+   P  + NL  L  L L  N++   + +
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPV 327

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
           +S  KL                 L   NN ++      + NL N+  L    NQ S + P
Sbjct: 328 SSLTKLQ---------------RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQ-FPKFLENLSFLEF 421
             L+    +  + ++   +         +  ++   +   N       P  + +      
Sbjct: 371 --LANLTRITQLGLNDQAWTNAPV---NYKANVSIPNTVKNVTGALIAPATISDGGSYTE 425

Query: 422 LNLSYNHLE 430
            ++++N   
Sbjct: 426 PDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  152 bits (385), Expect = 8e-40
 Identities = 94/427 (22%), Positives = 161/427 (37%), Gaps = 50/427 (11%)

Query: 8   EIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLN 67
            + +L KL  + +  N +       + NL+ L  + +  N +       L  L NL +L 
Sbjct: 85  PLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLE 140

Query: 68  VAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP 127
           ++ N        ++  ++SL+      N+ +   P     NL  L+ L I +N    +  
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLA---NLTTLERLDISSNKVSDI-- 192

Query: 128 DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNC 187
             L+  +NLE L  +NNQ           L  L  L+L  N L          +  L + 
Sbjct: 193 SVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--------IGTLASL 242

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
           ++L  L L++NQ     P  ++ L+  +    +G NQIS   PL    L  L  L +  N
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTK-LTELKLGANQISNISPLA--GLTALTNLELNEN 297

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK 307
           QL    P  I  LKNL  L LY N +    P  + +LTKL +L   +N +          
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-------- 345

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLST 367
                   L ++T ++ +L   +N ++   P  + NL  +  L ++   ++       + 
Sbjct: 346 -----VSSLANLTNIN-WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397

Query: 368 CVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
                 V   +     I P ++    S    D++ N  S    +     S    +     
Sbjct: 398 VSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTT 454

Query: 428 HLEGEVP 434
              G V 
Sbjct: 455 TFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  119 bits (301), Expect = 8e-29
 Identities = 79/330 (23%), Positives = 130/330 (39%), Gaps = 41/330 (12%)

Query: 112 LKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG 171
           L    I  +     I  + +  +      L         ++  + L  +  L  ++  + 
Sbjct: 3   LGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK 59

Query: 172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPL 231
                    +  +   ++L  ++ S+NQ     P  + NL+  ++  L+  NQI+   PL
Sbjct: 60  S--------IDGVEYLNNLTQINFSNNQLTDITP--LKNLTK-LVDILMNNNQIADITPL 108

Query: 232 GIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLD 291
              NL NL  L +  NQ+    P  +  L NL  L L  N +  S  S L  LT L +L 
Sbjct: 109 A--NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLS 162

Query: 292 LGSNSLQGNFIA----------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV 341
            G+       +A          S NK+       L  +T L   L  +NN ++   P  +
Sbjct: 163 FGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE-SLIATNNQISDITP--L 217

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVS 401
           G L NL  L ++ NQ       TL++  +L  +D+++N    + P  L  L  +  L + 
Sbjct: 218 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273

Query: 402 CNNFSGQFPKFLENLSFLEFLNLSYNHLEG 431
            N  S   P  L  L+ L  L L+ N LE 
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLED 301

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 29/153 (18%), Positives = 62/153 (40%), Gaps = 11/153 (7%)

Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
             I +L  L  L L  N ++   P  + +L+ LQ +    N +     ++L  L N+  L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWL 358

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           +   N+   + P  + N++ +    L    ++ + P +   N+     +         + 
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL--IA 413

Query: 127 PDSLSNASNLELLDLSNNQ--FKGKVSIDFSSL 157
           P ++S+  +    D++ N   +  +VS  FS  
Sbjct: 414 PATISDGGSYTEPDITWNLPSYTNEVSYTFSQP 446

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  159 bits (404), Expect = 7e-44
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 23/223 (10%)

Query: 501 RRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGIL-GEDEMI 559
                +     T+        +   ++     + +    IG GSFG+V++    G D   
Sbjct: 6   HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--- 62

Query: 560 VAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMG 617
           VAVK++  +         F+ E   ++ +RH N++  +   +          ++V EY+ 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-----SIVTEYLS 117

Query: 618 NGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 677
            GSL   LH+S  +    +L   +RL++A DVA  + YLH+   PP+VH +LK  N+L+D
Sbjct: 118 RGSLYRLLHKSGARE---QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD 173

Query: 678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
                 V DFGL++  +S        T  SS    GT  ++AP
Sbjct: 174 KKYTVKVCDFGLSRLKAS--------TFLSSKSAAGTPEWMAP 208

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  155 bits (394), Expect = 1e-42
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 24/190 (12%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKII 595
             +G+G +G V++G    +   VAVK+ + + +   +S+  E E      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
               ++         L+  Y   GSL D+L  +        L  +  L I + +AS + +
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAH 120

Query: 656 LH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
           LH        +P + H DLK  N+L+  +    + D GLA   S     ++++    +  
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----STNQLDVGNNP 176

Query: 711 IKGTVGYVAP 720
             GT  Y+AP
Sbjct: 177 RVGTKRYMAP 186

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  155 bits (393), Expect = 2e-42
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
            E     ++G+G+FG V K     +D   VA+K   ++ +   ++F+ E   L  + H N
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD---VAIKQ--IESESERKAFIVELRQLSRVNHPN 62

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++K+   C +          LV EY   GSL + LH +     +   +    ++  +  +
Sbjct: 63  IVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCS 112

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
             + YLH      ++H DLKP N+LL     V  + DFG A  + +H             
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----------MT 161

Query: 710 GIKGTVGYVAP 720
             KG+  ++AP
Sbjct: 162 NNKGSAAWMAP 172

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  153 bits (388), Expect = 5e-42
 Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 27/192 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRH 588
            + +    + +   G ++KG   G D   + VKV+ ++       R F  EC  LR   H
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++ ++  C S          L+  +M  GSL + LH+  +      +   Q +  A+D
Sbjct: 67  PNVLPVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALD 119

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +A  + +LH   +P +    L   +V++D DM A +    +     S             
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------ 166

Query: 709 IGIKGTVGYVAP 720
            G      +VAP
Sbjct: 167 -GRMYAPAWVAP 177

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  154 bits (390), Expect = 1e-41
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 24/190 (12%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKII 595
             IG+G FG V++G    +E  VAVK+ + +++   RS+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
              +  +        LV +Y  +GSL D+L++         +++   + +A+  AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAH 154

Query: 656 LH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
           LH        +P + H DLK  N+L+  +    + D GLA    S     +     +   
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS----ATDTIDIAPNH 210

Query: 711 IKGTVGYVAP 720
             GT  Y+AP
Sbjct: 211 RVGTKRYMAP 220

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  152 bits (385), Expect = 1e-41
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 42/222 (18%)

Query: 513 SPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI------- 565
           +    +FP      L+   +E      IG+G FG V+KG L +D+ +VA+K +       
Sbjct: 2   AMGGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59

Query: 566 NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA--LVFEYMGNGSLED 623
             +    F+ F  E   + N+ H N++K           G+      +V E++  G L  
Sbjct: 60  ETEMIEKFQEFQREVFIMSNLNHPNIVK---------LYGLMHNPPRMVMEFVPCGDLYH 110

Query: 624 WLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-----H 678
            L           +    +L + +D+A  IEY+  +  PP+VH DL+  N+ L       
Sbjct: 111 RLLDKAH-----PIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENA 164

Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + A V DFGL++            +  S  G+ G   ++AP
Sbjct: 165 PVCAKVADFGLSQQ-----------SVHSVSGLLGNFQWMAP 195

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  153 bits (388), Expect = 2e-41
 Identities = 48/190 (25%), Positives = 76/190 (40%), Gaps = 24/190 (12%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLIKII 595
             IG+G +G V+ G    ++  VAVKV    ++    S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
                          L+ +Y  NGSL D+L  +        L     L +A    S + +
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCH 149

Query: 656 LH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
           LH        +P + H DLK  N+L+  +    + D GLA    S     +++       
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS----DTNEVDIPPNT 205

Query: 711 IKGTVGYVAP 720
             GT  Y+ P
Sbjct: 206 RVGTKRYMPP 215

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  160 bits (406), Expect = 4e-41
 Identities = 93/474 (19%), Positives = 171/474 (36%), Gaps = 42/474 (8%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKF--PTTLGLLRNLVQLNV 68
           +L  L+ L L  + +    PD    L  L  + +    L            L+ L +L++
Sbjct: 71  NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130

Query: 69  AENKFYGMFPR-SICNISSLEYFYLTSNRFSGSLPFDIVVNL--PNLKELGIGANNFFGL 125
           ++N+   ++   S   ++SL+    +SN+    +    +  L    L    + AN+ +  
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSR 189

Query: 126 IPDSLSNASN------LELLDLSNNQFKGKVSIDFSS------------LKILWRLNLEQ 167
           +        N      LE+LD+S N +   ++ +FS+               +       
Sbjct: 190 VSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249

Query: 168 NNLGIGAANDLGFVTFLTNC-SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
           +N+      D    TF     SS++ L LS              L    ++ L   N+I+
Sbjct: 250 HNI-----KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNL-AYNKIN 303

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
                    L NL  L +  N L          L  +  + L KN +          L K
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL---YLDLSNNLLNG-SLPQQVG 342
           L  LDL  N+L           I     +L+++  ++L    + LS N L    +   + 
Sbjct: 364 LQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLL 423

Query: 343 NLKNLIILDISSNQFSGMIP-VTLSTCVSLEYVDISSN-----CFHGIIPPSLGFLKSIK 396
            + +L IL ++ N+FS      T S   SLE + +  N         +       L  ++
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGN 450
            L ++ N  +   P    +L+ L  L+L+ N L   +    + +N   + +  N
Sbjct: 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  156 bits (396), Expect = 7e-40
 Identities = 74/374 (19%), Positives = 143/374 (38%), Gaps = 24/374 (6%)

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
           L    +L ++ N    +   S   +  L+   L S     ++  +   NLPNL+ L +G+
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID--FSSLKILWRLNLEQNNLGIGAAND 177
           +  + L PD+     +L  L L        V  D  F +LK L RL+L +N +       
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI-----RS 137

Query: 178 LGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISGTIPLGIRNL 236
           L         +SLK +  S NQ      H +  L    + F  +  N +   + +     
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197

Query: 237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS 296
           +N          +   I DV G    + + G + N +  S    L     +     G ++
Sbjct: 198 MNPFRN------MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

Query: 297 LQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQ 356
           ++     +   L         S+  L    DLS+  +     +    LK+L +L+++ N+
Sbjct: 252 IKDPDQNTFAGL------ARSSVRHL----DLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

Query: 357 FSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENL 416
            + +         +L+ +++S N    +   +   L  + ++D+  N+ +    +  + L
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361

Query: 417 SFLEFLNLSYNHLE 430
             L+ L+L  N L 
Sbjct: 362 EKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  151 bits (384), Expect = 3e-38
 Identities = 82/466 (17%), Positives = 148/466 (31%), Gaps = 62/466 (13%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKF-PTTLGLLRN 62
           Q+P+    L   + L L+ NY+          L  LQ++ +                L N
Sbjct: 18  QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFS-GSLPFDIVVNLPNLKELGIGANN 121
           L  L++  +K Y + P +   +  L    L     S   L      NL  L  L +  N 
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134

Query: 122 FFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKI--LWRLNLEQNNLGIGAANDL 178
              L +  S    ++L+ +D S+NQ       +   L+   L   +L  N+L    + D 
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 179 GFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVN 238
           G          L++L +S N +  ++  + +N              IS +    +    +
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA-------------ISKSQAFSLILAHH 241

Query: 239 LIALAVEVNQLHGTIPDVIGELK--NLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS 296
           ++      + +     +    L   +++ L L   F+          L  L  L+L  N 
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

Query: 297 LQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQ 356
                       I  +  +          L+LS NLL          L  +  +D+  N 
Sbjct: 302 ------------INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 357 FSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG--------- 407
            + +   T      L+ +D+  N        ++ F+ SI  + +S N             
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTAN 404

Query: 408 ------------QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
                           FL  +  L+ L L+ N            S 
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSE 449

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  134 bits (338), Expect = 1e-32
 Identities = 59/352 (16%), Positives = 113/352 (32%), Gaps = 23/352 (6%)

Query: 108 NLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLE 166
            L   + L +  N    +   S      L+LL+L +      +  + F +L  L  L+L 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL--PHSIANLSSTMIVFLIGGNQ 224
            + +       L    F      L  L L        +       NL +   + L   NQ
Sbjct: 82  SSKI-----YFLHPDAF-QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL-SKNQ 134

Query: 225 ISG-TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGEL--KNLQLLGLYKNFLQGSIPSGL 281
           I    +      L +L ++    NQ+       +  L  K L    L  N L   +    
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 282 GNLTK------LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG 335
           G          L  LD+  N    +   + +  I       L +    +      + +  
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254

Query: 336 SLPQQVGNLK--NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK 393
                   L   ++  LD+S      +      T   L+ ++++ N  + I   +   L 
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314

Query: 394 SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKI 445
           +++ L++S N     +      L  + +++L  NH+   +     F    K+
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI--AIIQDQTFKFLEKL 364

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  128 bits (323), Expect = 8e-31
 Identities = 76/453 (16%), Positives = 146/453 (32%), Gaps = 59/453 (13%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSA--LQVIHIKGNSLGGKFPTTLGLLR 61
            +    G L  L+++  + N +       +  L    L    +  NSL  +     G   
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 62  N------LVQLNVAENKFYGMFPRSICN------------ISSLEYFYLTSNRFSGSLPF 103
           N      L  L+V+ N +      +  N               +       +        
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQ 257

Query: 104 DIVVNLP--NLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW 161
           +    L   +++ L +     F L         +L++L+L+ N+        F  L  L 
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317

Query: 162 RLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIG 221
            LNL  N L      +L    F      +  + L  N        +   L     + L  
Sbjct: 318 VLNLSYNLL-----GELYSSNF-YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL-R 370

Query: 222 GNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
            N ++      I  + ++  + +  N+L  T+P +      + L       L   I   L
Sbjct: 371 DNALTT-----IHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL--DILYFL 422

Query: 282 GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV 341
             +  L  L L  N          +      P +  S+      L L  N+L  +   ++
Sbjct: 423 LRVPHLQILILNQNRFS-------SCSGDQTPSENPSLE----QLFLGENMLQLAWETEL 471

Query: 342 -----GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIK 396
                  L +L +L ++ N  + + P   S   +L  + ++SN    +         +++
Sbjct: 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL--SHNDLPANLE 529

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHL 429
            LD+S N      P    +LS    L++++N  
Sbjct: 530 ILDISRNQLLAPNPDVFVSLS---VLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  111 bits (279), Expect = 2e-25
 Identities = 74/393 (18%), Positives = 138/393 (35%), Gaps = 53/393 (13%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
           ++ L L+  ++          L  L+V+++  N +          L NL  LN++ N   
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNAS 134
            ++  +   +  + Y  L  N  +  +       L  L+ L +  N        ++    
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIP 381

Query: 135 NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLS 194
           ++  + LS N+      I+ ++      ++L +N L      +L  + FL     L++L 
Sbjct: 382 SIPDIFLSGNKLVTLPKINLTAN----LIHLSENRL-----ENLDILYFLLRVPHLQILI 432

Query: 195 LSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP 254
           L+ N+F         + + ++    +G N +       +                     
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC-------------------W 473

Query: 255 DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQ 314
           DV   L +LQ+L L  N+L    P    +LT L  L L SN L    ++        LP 
Sbjct: 474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL--TVLSH-----NDLPA 526

Query: 315 QLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPV-TLSTCVSLEY 373
            L         LD+S N L  +    V    +L +LDI+ N+F     + T    ++   
Sbjct: 527 NL-------EILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELSTFINWLNHTN 576

Query: 374 VDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
           V I+      I          +    +S     
Sbjct: 577 VTIAGP-PADIYCVYPDSFSGVSLFSLSTEGCD 608

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 33/138 (23%), Positives = 50/138 (36%), Gaps = 6/138 (4%)

Query: 9   IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNV 68
              L  LQ L L  NYL    P    +L+AL+ + +  N L     +   L  NL  L++
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILDI 533

Query: 69  AENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD 128
           + N+     P       SL    +T N+F         +N  N   + I A     +   
Sbjct: 534 SRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFINWLNHTNVTI-AGPPADIYCV 589

Query: 129 SLSNASNLELLDLSNNQF 146
              + S + L  LS    
Sbjct: 590 YPDSFSGVSLFSLSTEGC 607

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  156 bits (397), Expect = 9e-41
 Identities = 92/463 (19%), Positives = 160/463 (34%), Gaps = 40/463 (8%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           +IP  +      + L L+ N L         +   LQV+ +    +          L +L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             L +  N    +   +   +SSL+         + SL    + +L  LKEL +  N   
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137

Query: 124 GL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL----WRLNLEQNNLGIGAANDL 178
              +P+  SN +NLE LDLS+N+ +     D   L  +      L+L  N +        
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 179 GFVTFLTNCSSLKVLSLSDNQFGGELPH-SIANLSSTMIVFLIGG-----NQISGTIPLG 232
             +        L  L+L +N     +    I  L+   +  L+ G       +       
Sbjct: 198 KEI-------RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 233 IRNLVNLIALAVEVNQLHG---TIPDVIGELKNLQLLGLYKNFLQGSIP-SGLGNLTKLA 288
           +  L NL      +  L      I D+   L N+    L    ++     S       L 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 289 KLDLGSNSLQGNFIA-------SQNKLIGALPQQLLSITTLSLYLDLSNNLLN--GSLPQ 339
            ++          +        + NK   A     + + +L  +LDLS N L+  G   Q
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLE-FLDLSRNGLSFKGCCSQ 367

Query: 340 QVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS-LGFLKSIKFL 398
                 +L  LD+S N     +         LE++D   +    +   S    L+++ +L
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 399 DVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
           D+S  +    F      LS LE L ++ N  +       +F+ 
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTE 468

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  145 bits (368), Expect = 5e-37
 Identities = 77/446 (17%), Positives = 154/446 (34%), Gaps = 44/446 (9%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLT-GKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGL 59
           L       IG L  L+ L +A N +   KLP++  NL+ L+ + +  N +   + T L +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 60  LRNL----VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL 115
           L  +    + L+++ N               L    L +N  S ++    +  L  L+  
Sbjct: 172 LHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230

Query: 116 GI------GANNFFGLIPDSLSNASNLELLDLSNNQ---FKGKVSIDFSSLKILWRLNLE 166
            +         N       +L    NL + +        +   +   F+ L  +   +L 
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
              +       +   ++      L++++    QF      S+  L+          N+  
Sbjct: 291 SVTI-----ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-------FTSNKGG 338

Query: 227 GTIPLGIRNLVNLIALAVEVNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNL 284
                   +L +L  L +  N L   G          +L+ L L  N +  ++ S    L
Sbjct: 339 NAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395

Query: 285 TKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL 344
            +L  LD              + L       +       +YLD+S+     +       L
Sbjct: 396 EQLEHLDF-----------QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 345 KNLIILDISSNQFSGMI-PVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCN 403
            +L +L ++ N F     P   +   +L ++D+S      + P +   L S++ L+++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 404 NFSGQFPKFLENLSFLEFLNLSYNHL 429
                     + L+ L+ + L  N  
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.9 bits (226), Expect = 3e-19
 Identities = 53/273 (19%), Positives = 86/273 (31%), Gaps = 31/273 (11%)

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            C  L    + DN     LP S  NL        +  N +         +   L  L + 
Sbjct: 13  QCMELNFYKIPDN-----LPFSTKNLD-------LSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
             ++          L +L  L L  N +Q         L+ L KL     +L        
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA------- 113

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
             L       L ++  L++     N + +  LP+   NL NL  LD+SSN+   +    L
Sbjct: 114 -SLENFPIGHLKTLKELNVA---HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169

Query: 366 STCVSLEYVDIS---SNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK-FLENLSFLEF 421
                +  +++S   S      I P       +  L +  N  S    K  ++ L+ LE 
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229

Query: 422 LNLSYNHLEG----EVPTKGVFSNKSKIPLQGN 450
             L           E   K        + ++  
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 2/100 (2%)

Query: 5   IPKEI-GSLFKLQALALAGNYLTGKL-PDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
               I   L  L+ L +AGN       PD    L  L  + +    L    PT    L +
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLP 102
           L  LN+A N+   +       ++SL+  +L +N +  S P
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  149 bits (380), Expect = 3e-40
 Identities = 71/394 (18%), Positives = 155/394 (39%), Gaps = 51/394 (12%)

Query: 39  LQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFS 98
              +      +   FP     L   ++  + +         +   + S+    +   + +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 99  GSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSL 157
                +    L NL+ L +  N    + P  LSN   L  L +  N+      I    +L
Sbjct: 58  SIQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT---DISALQNL 109

Query: 158 KILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIV 217
             L  L L ++N+          ++ L N + +  L+L  N         ++N++    +
Sbjct: 110 TNLRELYLNEDNISD--------ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYL 160

Query: 218 FLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI 277
            +   +++    P+   NL +L +L++  NQ+    P  +  L +L     Y N +    
Sbjct: 161 TV-TESKVKDVTPIA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215

Query: 278 PSGLGNLTKLAKLDLGSNSLQG-NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS 336
           P  + N+T+L  L +G+N +   + +A+ ++L                +L++  N ++  
Sbjct: 216 P--VANMTRLNSLKIGNNKITDLSPLANLSQLT---------------WLEIGTNQISD- 257

Query: 337 LPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIK 396
               V +L  L +L++ SNQ S +    L+    L  + +++N         +G L ++ 
Sbjct: 258 -INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
            L +S N+ +   P  L +LS ++  + +   ++
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  148 bits (377), Expect = 1e-39
 Identities = 74/369 (20%), Positives = 138/369 (37%), Gaps = 45/369 (12%)

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
              L         +FP    +++      L     +  +  +    L ++ +L +     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
             +    +   +NLE L+L+ NQ         S+L  L  L +  N +          ++
Sbjct: 57  ASI--QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--------IS 104

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
            L N ++L+ L L+++         +ANL+  M    +G N     +   + N+  L  L
Sbjct: 105 ALQNLTNLRELYLNEDNISD--ISPLANLTK-MYSLNLGANHNLSDLS-PLSNMTGLNYL 160

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            V  +++    P  I  L +L  L L  N ++   P  L +LT L       N +     
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--- 213

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
                 I  +   +  + +L     + NN +    P  + NL  L  L+I +NQ S +  
Sbjct: 214 ------ITPV-ANMTRLNSL----KIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA 260

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFL 422
             +     L+ +++ SN    I    L  L  +  L ++ N    +  + +  L+ L  L
Sbjct: 261 --VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316

Query: 423 NLSYNHLEG 431
            LS NH+  
Sbjct: 317 FLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  129 bits (327), Expect = 4e-33
 Identities = 71/312 (22%), Positives = 125/312 (40%), Gaps = 45/312 (14%)

Query: 7   KEIGSLFKLQALALAGNYLTG--------------------KLPDFIGNLSALQVIHIKG 46
           + I  L  L+ L L GN +T                          + NL+ L+ +++  
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNE 119

Query: 47  NSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV 106
           +++     + L  L  +  LN+  N         + N++ L Y  +T ++     P    
Sbjct: 120 DNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIA-- 174

Query: 107 VNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE 166
            NL +L  L +  N    + P  L++ ++L       NQ         +++  L  L + 
Sbjct: 175 -NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIG 229

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            N +      DL   + L N S L  L +  NQ      +++ +L+  + +  +G NQIS
Sbjct: 230 NNKI-----TDL---SPLANLSQLTWLEIGTNQISD--INAVKDLTK-LKMLNVGSNQIS 278

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
               L   NL  L +L +  NQL     +VIG L NL  L L +N +    P  L +L+K
Sbjct: 279 DISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 287 LAKLDLGSNSLQ 298
           +   D  +  ++
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 27/175 (15%)

Query: 260 LKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSI 319
              L  L    N +         +L +  +  L   S+          ++    ++L SI
Sbjct: 2   AATLATLPAPINQI-----FPDADLAEGIRAVLQKASV--------TDVVT--QEELESI 46

Query: 320 TTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
           T L     ++   +     Q +  L NL  L+++ NQ + + P  LS  V L  + I +N
Sbjct: 47  TKL----VVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTN 98

Query: 380 CFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP 434
               I   +L  L +++ L ++ +N S      L NL+ +  LNL  NH   ++ 
Sbjct: 99  KITDI--SALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS 149

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  152 bits (387), Expect = 1e-39
 Identities = 92/441 (20%), Positives = 166/441 (37%), Gaps = 35/441 (7%)

Query: 6   PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQ 65
             ++ +   LQ L L  + +     D   +L +L+ + +  N L     +  G L +L  
Sbjct: 43  HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102

Query: 66  LNVAENKFYGMFPRSIC-NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
           LN+  N +  +   S+  N+++L+   + +      +       L +L EL I A +   
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
               SL +  ++  L L  ++    + I    L  +  L L   NL     + L      
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222

Query: 185 TNCS--SLKVLSLSDNQFGGELPHSIANLSSTMIVFL---------IGGNQISGTIPLGI 233
           +     + +   L+D  F   L      L  + + F             ++      LG 
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282

Query: 234 RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLG-NLTKLAKLDL 292
              V +  L +    L   +  V   L+ ++ + +  + +   +P     +L  L  LDL
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341

Query: 293 GSNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLN--GSLPQQVGNLKNLII 349
             N +   ++ +     GA P         SL  L LS N L       + +  LKNL  
Sbjct: 342 SENLMVEEYLKNSA-CKGAWP---------SLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           LDIS N F   +P +      + ++++SS     +        ++++ LDVS NN    F
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLD-SF 446

Query: 410 PKFLENLSFLEFLNLSYNHLE 430
             FL     L+ L +S N L+
Sbjct: 447 SLFLPR---LQELYISRNKLK 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  143 bits (362), Expect = 3e-36
 Identities = 84/454 (18%), Positives = 158/454 (34%), Gaps = 38/454 (8%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
            IP  +     +++L L+ N +T      +   + LQV+ +K + +          L +L
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             L++++N    +       +SSL+Y  L  N +       +  NL NL+ L IG    F
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136

Query: 124 GLIP-DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
             I     +  ++L  L++     +   S    S++ +  L L  +         L  + 
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES-----AFLLEIF 191

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
                SS++ L L D         S   +            + S         L+ L+  
Sbjct: 192 A-DILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            +E++++            +  L GL       S    +  L K+  + +    +     
Sbjct: 250 ILELSEVE---------FDDCTLNGL--GDFNPSESDVVSELGKVETVTIRRLHI----- 293

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG-NLKNLIILDISSNQFSGMI 361
             Q  L   L      +  +   + + N+ +   +P     +LK+L  LD+S N      
Sbjct: 294 -PQFYLFYDLSTVYSLLEKVK-RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 362 PVT---LSTCVSLEYVDISSNCFHGIIPPSLGF--LKSIKFLDVSCNNFSGQFPKFLENL 416
                      SL+ + +S N    +         LK++  LD+S N F    P   +  
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP 409

Query: 417 SFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGN 450
             + FLNLS   +   V T  +      + +  N
Sbjct: 410 EKMRFLNLSSTGIR-VVKT-CIPQTLEVLDVSNN 441

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  137 bits (348), Expect = 1e-34
 Identities = 74/441 (16%), Positives = 143/441 (32%), Gaps = 45/441 (10%)

Query: 9   IGSLFKLQALALAGNYLTG-KLPDFIGNLSALQVIHIKG-NSLGGKFPTTLGLLRNLVQL 66
            G L  L+ L L GN      +     NL+ LQ + I    +           L +L +L
Sbjct: 94  FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
            +          +S+ +I  + +  L  +  +  L       L +++ L +   N     
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQ 212

Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL--------GIGAANDL 178
              L        +     +        F+ L  L R  LE + +        G+G  N  
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272

Query: 179 GFVTFLT----NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI- 233
                         +++ L +       +L    + L     + +   +++   +P    
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV-ENSKVF-LVPCSFS 330

Query: 234 RNLVNLIALAVEVNQLHGTI---PDVIGELKNLQLLGLYKNFLQ--GSIPSGLGNLTKLA 288
           ++L +L  L +  N +           G   +LQ L L +N L+        L  L  L 
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 289 KLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLI 348
            LD+  N+               +P        +  +L+LS+  +   +       + L 
Sbjct: 391 SLDISRNTFH------------PMPDSCQWPEKM-RFLNLSSTGIR-VVKT--CIPQTLE 434

Query: 349 ILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQ 408
           +LD+S+N       + L     L+ + IS N    +  P       +  + +S N     
Sbjct: 435 VLDVSNNNLD-SFSLFLP---RLQELYISRNKLKTL--PDASLFPVLLVMKISRNQLKSV 488

Query: 409 FPKFLENLSFLEFLNLSYNHL 429
                + L+ L+ + L  N  
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  123 bits (310), Expect = 1e-29
 Identities = 62/396 (15%), Positives = 128/396 (32%), Gaps = 69/396 (17%)

Query: 6   PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQ 65
            + + S+  +  L L  +     L  F   LS+++ + ++  +L     + L +      
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224

Query: 66  LNVAENKF-------YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV----------VN 108
           +     +        +    + +  I  L          +G   F+            V 
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284

Query: 109 LPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN 168
              ++ L I     F  +    S    ++ + + N++           LK L  L+L +N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

Query: 169 NLGIGAANDLGFVT--FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            +      +             SL+ L LS N         + ++  T  +         
Sbjct: 345 LM-----VEEYLKNSACKGAWPSLQTLVLSQNH--------LRSMQKTGEIL-------- 383

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
                    L NL +L +  N  H  +PD     + ++ L L    ++  + + +     
Sbjct: 384 -------LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQT 432

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKN 346
           L  LD+ +N+L             +    L  +  L     +S N L  +LP        
Sbjct: 433 LEVLDVSNNNLD------------SFSLFLPRLQEL----YISRNKLK-TLPDAS-LFPV 474

Query: 347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
           L+++ IS NQ   +         SL+ + + +N + 
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 96.7 bits (241), Expect = 5e-21
 Identities = 49/297 (16%), Positives = 99/297 (33%), Gaps = 23/297 (7%)

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
           +C +  V       F   +P   + L++ M    +  N+I+      +R   NL  L ++
Sbjct: 3   SCDASGVCDGRSRSFT-SIP---SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
            ++++    D    L +L+ L L  N L     S  G L+ L  L+L  N  Q       
Sbjct: 59  SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT---LGV 115

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVT 364
             L   L             L + N      + +     L +L  L+I +         +
Sbjct: 116 TSLFPNLTN--------LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL 424
           L +   + ++ +  +    ++      L S+++L++   N +      L        +  
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 425 SYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVL 481
                        V +++S   L   +R    + E+    C   G      +   V+
Sbjct: 228 LAFRG-------SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (368), Expect = 4e-39
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 25/191 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHR 589
            + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N++  +   ++         A+V ++    SL   LH S       K  + + ++IA   
Sbjct: 81  NILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQT 129

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
           A  ++YLH      ++H DLK +N+ L  D    +GDFGLA   S        +      
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL---- 182

Query: 710 GIKGTVGYVAP 720
              G++ ++AP
Sbjct: 183 --SGSILWMAP 191

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (363), Expect = 1e-38
 Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 38/202 (18%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLK----QKGAFRSFVAECEALRNI 586
           +E +   +IG G FG VY+    G++   VAVK               +   E +    +
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +H N+I +  +C            LV E+   G L   L          ++     +N A
Sbjct: 64  KHPNIIALRGVCLKEPNL-----CLVMEFARGGPLNRVLSGK-------RIPPDILVNWA 111

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--------HDMVAHVGDFGLAKFLSSHHL 698
           + +A  + YLH     P++H DLK SN+L+          + +  + DFGLA+       
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------ 165

Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
                  ++ +   G   ++AP
Sbjct: 166 ----WHRTTKMSAAGAYAWMAP 183

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  143 bits (363), Expect = 4e-38
 Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 22/214 (10%)

Query: 509 SADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 568
           SA + P +     +   E      +     +IG+G FG VY G    +   VA+++I+++
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIE 66

Query: 569 Q--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
           +  +   ++F  E  A R  RH N++  +  C S         A++       +L   + 
Sbjct: 67  RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL-----AIITSLCKGRTLYSVVR 121

Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD 686
            +        L + +   IA ++   + YLH      ++H DLK  NV  D+  V  + D
Sbjct: 122 DAKI-----VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITD 172

Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           FGL                       G + ++AP
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQN---GWLCHLAP 203

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  142 bits (359), Expect = 1e-37
 Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 19/195 (9%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           S+     ++G+G FG   K    E   ++ +K +    +   R+F+ E + +R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +K I +      K       + EY+  G+L   +   + Q         QR++ A D+AS
Sbjct: 70  LKFIGVLY----KDKRL-NFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIAS 119

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS------KTP 705
            + YLH      ++H DL   N L+  +    V DFGLA+ +                  
Sbjct: 120 GMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 706 SSSIGIKGTVGYVAP 720
                + G   ++AP
Sbjct: 177 KKRYTVVGNPYWMAP 191

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  143 bits (364), Expect = 4e-37
 Identities = 85/446 (19%), Positives = 154/446 (34%), Gaps = 80/446 (17%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           ++P E  ++        A +      P   G    + V  ++             L R  
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC-----------LDRQA 73

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
            +L +         P    +   LE    + N  +  LP ++  +L +L           
Sbjct: 74  HELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELP-ELPQSLKSLLVDNNNLKALS 127

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSI-DFSSLKILWRLNLEQNNL-----GIG---- 173
            L P        LE L +SNNQ +    + +  +   L  ++++ N+L            
Sbjct: 128 DLPP-------LLEYLGVSNNQLE---KLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 177

Query: 174 ---AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIP 230
                N L  +  L N   L  +   +N    +LP    +L S     + G N +     
Sbjct: 178 IAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLSLES----IVAGNNIL--EEL 230

Query: 231 LGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKL 290
             ++NL  L  +  + N L  T+PD+   L+ L +   Y       +P    +LT L   
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT----DLPELPQSLTFLDVS 285

Query: 291 DLGSNSLQ------GNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL 344
           +   + L           AS N+ I +L     S+  L    ++SNN L   LP     L
Sbjct: 286 ENIFSGLSELPPNLYYLNASSNE-IRSLCDLPPSLEEL----NVSNNKLI-ELPALPPRL 339

Query: 345 KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN 404
           + L     S N  +  +P       +L+ + +  N      P     ++ ++      N+
Sbjct: 340 ERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR-----MNS 386

Query: 405 FSGQFPKFLENLSFLEFLNLSYNHLE 430
              + P+  +NL   + L++  N L 
Sbjct: 387 HLAEVPELPQNL---KQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  137 bits (346), Expect = 8e-35
 Identities = 76/439 (17%), Positives = 146/439 (33%), Gaps = 84/439 (19%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
            +P+    L   ++L  + N LT +LP+   +L +L V +    +L         L   L
Sbjct: 85  SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-------LPPLL 133

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
             L V+ N+     P  + N S L+   + +N     LP       P+L+ +  G NN  
Sbjct: 134 EYLGVSNNQL-EKLP-ELQNSSFLKIIDVDNNSLK-KLP----DLPPSLEFIAAG-NNQL 185

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
             +P+ L N   L  +   NN  K    +       L  +    N L          +  
Sbjct: 186 EELPE-LQNLPFLTAIYADNNSLK---KL-PDLPLSLESIVAGNNILEE--------LPE 232

Query: 184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA 243
           L N   L  +   +N     LP    +L +      +  N ++  +P   ++L  L    
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLPDLPPSLEA----LNVRDNYLT-DLPELPQSLTFLDVSE 286

Query: 244 VEVNQLHGTIP-------------DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKL 290
              + L    P              +     +L+ L +  N L   +P+    L +L   
Sbjct: 287 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL--- 342

Query: 291 DLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIIL 350
               N L              +P+   ++      L +  N L    P    ++++L + 
Sbjct: 343 IASFNHLA------------EVPELPQNLK----QLHVEYNPLR-EFPDIPESVEDLRM- 384

Query: 351 DISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
              ++  +  +P       +L+ + + +N      P     ++    L ++       + 
Sbjct: 385 ---NSHLA-EVPELPQ---NLKQLHVETNPLR-EFPDIPESVED---LRMNSERVVDPYE 433

Query: 411 KFLENLSFLEFLNLSYNHL 429
              E    LE     ++H 
Sbjct: 434 FAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  114 bits (288), Expect = 3e-27
 Identities = 70/358 (19%), Positives = 118/358 (32%), Gaps = 59/358 (16%)

Query: 8   EIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLN 67
           E+ +   L+ + +  N L  KLPD   +L  +       N L  +    L  L  L  + 
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQL--EELPELQNLPFLTAIY 201

Query: 68  VAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP 127
              N    +         SLE     +N     LP   + NLP L  +    NN    +P
Sbjct: 202 ADNNSLKKLPD----LPLSLESIVAGNNILE-ELPE--LQNLPFLTTIYAD-NNLLKTLP 253

Query: 128 DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN-------DLGF 180
           D   +   LE L++ +N     +     SL  L       + L     N           
Sbjct: 254 DLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI 309

Query: 181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI 240
            +      SL+ L++S+N+   ELP     L       +   N ++  +P   +NL  L 
Sbjct: 310 RSLCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPELPQNLKQLH 363

Query: 241 ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
              VE N L    PD+   +++L++     N     +P    NL +L    + +N L+  
Sbjct: 364 ---VEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQL---HVETNPLR-- 409

Query: 301 FIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
                       P    S+      L +++  +             L       +   
Sbjct: 410 ----------EFPDIPESVE----DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  113 bits (286), Expect = 5e-27
 Identities = 56/326 (17%), Positives = 105/326 (32%), Gaps = 58/326 (17%)

Query: 107 VNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE 166
           V+   L+E    ++N    +P    N  +      + ++++          + +    L 
Sbjct: 8   VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
                                     L L++      LP    +L S     +   N ++
Sbjct: 67  DC-----------------LDRQAHELELNNLGL-SSLPELPPHLES----LVASCNSLT 104

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
             +P   ++L +L+     +  L    P        L+ LG+  N L+  +P  L N + 
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSF 154

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKN 346
           L  +D+ +NSL+             LP    S+     ++   NN L   LP ++ NL  
Sbjct: 155 LKIIDVDNNSLK------------KLPDLPPSLE----FIAAGNNQLE-ELP-ELQNLPF 196

Query: 347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
           L  +   +N    +        +SLE +   +N       P L  L  +  +    N   
Sbjct: 197 LTAIYADNNSLKKLPD----LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK 250

Query: 407 GQFPKFLENLSFLEFLNLSYNHLEGE 432
              P    +L  L   +     L   
Sbjct: 251 -TLPDLPPSLEALNVRDNYLTDLPEL 275

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  110 bits (278), Expect = 6e-26
 Identities = 75/362 (20%), Positives = 134/362 (37%), Gaps = 65/362 (17%)

Query: 78  PRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLE 137
           PR++ N + L+     S+  +  +P +   N+ +  E     + +    P        + 
Sbjct: 5   PRNVSN-TFLQEPLRHSSNLT-EMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 138 LLDLSNNQFKGKVSIDFSSLKI---------LWRLNLEQNNLGIGAANDLGFVTFLTNCS 188
           +  L +   +    ++ ++L +         L  L    N+L               +  
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTE-------LPELPQSLK 114

Query: 189 SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ 248
           SL V + +      +LP  +  L        +  NQ+   +P  ++N   L  + V+ N 
Sbjct: 115 SLLVDNNNLKALS-DLPPLLEYLG-------VSNNQLE-KLP-ELQNSSFLKIIDVDNNS 164

Query: 249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKL 308
           L   +PD      +L+ +    N L+  +P  L NL  L  +   +NSL+          
Sbjct: 165 LK-KLPD---LPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK---------- 208

Query: 309 IGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTC 368
              LP   LS+ ++       NN+L   LP+ + NL  L  +   +N     +P      
Sbjct: 209 --KLPDLPLSLESI----VAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPP-- 257

Query: 369 VSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNH 428
            SLE +++  N    + P     L     LDVS N FS    +   N   L +LN S N 
Sbjct: 258 -SLEALNVRDNYLTDL-PELPQSLTF---LDVSENIFS-GLSELPPN---LYYLNASSNE 308

Query: 429 LE 430
           + 
Sbjct: 309 IR 310

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 46/224 (20%), Positives = 82/224 (36%), Gaps = 23/224 (10%)

Query: 229 IPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLA 288
           I     +   L       + L   +P     +K+        +  + + P G G   ++A
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 289 KLDLGSNSLQG--NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKN 346
              L     +       +   L  +LP+    + +    L  S N L   LP+   +LK+
Sbjct: 62  VSRLRDCLDRQAHELELNNLGL-SSLPELPPHLES----LVASCNSLT-ELPELPQSLKS 115

Query: 347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS 406
           L++ + +    S + P        LEY+ +S+N    +  P L     +K +DV  N+  
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK 166

Query: 407 GQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGN 450
            + P    +   LEF+    N LE E+P        + I    N
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNN 205

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  140 bits (354), Expect = 7e-37
 Identities = 50/309 (16%), Positives = 106/309 (34%), Gaps = 20/309 (6%)

Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
                ++S  E L    +          S  +  +  +  + +                N
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----------AWRQAN 54

Query: 187 CSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISGTIPLGIRNLVNLIALAVE 245
            ++ ++ + +           + + +    V L +    +    P     L +L  + ++
Sbjct: 55  SNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
              L   +PD + +   L+ L L +N L+ ++P+ + +L +L +L + +           
Sbjct: 113 AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
                    +   +  L   L L    +  SLP  + NL+NL  L I ++  S  +   +
Sbjct: 171 AST--DASGEHQGLVNLQ-SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI 225

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
                LE +D+         PP  G    +K L +   +     P  +  L+ LE L+L 
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285

Query: 426 YNHLEGEVP 434
                  +P
Sbjct: 286 GCVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  135 bits (342), Expect = 3e-35
 Identities = 56/350 (16%), Positives = 109/350 (31%), Gaps = 47/350 (13%)

Query: 27  GKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISS 86
           G       + S  + ++ +G++    +   L   +     +               N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 87  LEYFYLTSNRFSGSLPFDI-VVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ 145
            +    T      +    +     P    L +  +      PD     S+L+ + +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELR-SVPLPQFPDQAFRLSHLQHMTIDAAG 115

Query: 146 FKGKVSIDFSSLKILWRLNLEQNNL-----GIGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
              ++         L  L L +N L      I             + + L+ LS+     
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRALPASIA------------SLNRLRELSIRACPE 162

Query: 201 GGELPHSIANLSSTMIV--------FLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT 252
             ELP  +A+  ++             +    I  ++P  I NL NL +L +  + L   
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220

Query: 253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGAL 312
           +   I  L  L+ L L       + P   G    L +L L             + L+  L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC----------SNLL-TL 269

Query: 313 PQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
           P  +  +T L   LDL   +    LP  +  L    I+ +  +  + +  
Sbjct: 270 PLDIHRLTQLE-KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  134 bits (339), Expect = 7e-35
 Identities = 50/332 (15%), Positives = 96/332 (28%), Gaps = 36/332 (10%)

Query: 108 NLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ 167
           +    + L    +       D LS        D +      +     ++           
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTG 65

Query: 168 NNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISG 227
             L    A+ L   T          L L       + P     LS  +    I    +  
Sbjct: 66  RALKA-TADLLEDATQP----GRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM- 117

Query: 228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN---- 283
            +P  ++    L  L +  N L   +P  I  L  L+ L +        +P  L +    
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 284 -----LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLP 338
                L  L  L L    ++            +LP  + ++  L   L + N+ L+ +L 
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR------------SLPASIANLQNLK-SLKIRNSPLS-ALG 222

Query: 339 QQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL 398
             + +L  L  LD+         P        L+ + +        +P  +  L  ++ L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282

Query: 399 DVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
           D+       + P  +  L     + +  +   
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  127 bits (321), Expect = 2e-32
 Identities = 51/310 (16%), Positives = 93/310 (30%), Gaps = 41/310 (13%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLR--N 62
               +    +         +   +      N +  Q+    G +L       L       
Sbjct: 28  YHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK-ATADLLEDATQPG 82

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
            V L +        FP     +S L++  + +      LP  +      L+ L +  N  
Sbjct: 83  RVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ-QFAGLETLTLARNPL 139

Query: 123 FGLIPDSLSNASNLELLDLS-NNQFK--------GKVSIDFSSLKILWRLNLEQNNL--- 170
             L P S+++ + L  L +    +             S +   L  L  L LE   +   
Sbjct: 140 RAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL 198

Query: 171 --GIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGT 228
              I             N  +LK L + ++     L  +I +L     + L G   +   
Sbjct: 199 PASIA------------NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR-N 244

Query: 229 IPLGIRNLVNLIALAV-EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKL 287
            P        L  L + + + L  T+P  I  L  L+ L L        +PS +  L   
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 288 AKLDLGSNSL 297
             + +  +  
Sbjct: 304 CIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  116 bits (294), Expect = 8e-29
 Identities = 46/270 (17%), Positives = 85/270 (31%), Gaps = 51/270 (18%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           Q P +   L  LQ + +    L  +LPD +   + L+ + +  N L    P ++  L  L
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRL 152

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
            +L++         P  + +  +                      L NL+ L +      
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQ----------------GLVNLQSLRLEWTGIR 196

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
            L P S++N  NL+ L + N+                    L      I           
Sbjct: 197 SL-PASIANLQNLKSLKIRNSP-------------------LSALGPAIH---------- 226

Query: 184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA 243
             +   L+ L L         P      +    + L   + +  T+PL I  L  L  L 
Sbjct: 227 --HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLD 283

Query: 244 VEVNQLHGTIPDVIGELKNLQLLGLYKNFL 273
           +        +P +I +L    ++ +  +  
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (355), Expect = 8e-36
 Identities = 61/436 (13%), Positives = 133/436 (30%), Gaps = 34/436 (7%)

Query: 29  LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE 88
           + +   N +  ++  +  +SL     +      N+ +L+++ N    +    +   + LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 89  YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG 148
              L+SN    +L  +   +L  L+ L +  N         L    ++E L  +NN    
Sbjct: 62  LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 149 KVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI 208
              +  S  +    + L  N +       L  +      S ++ L L  N+        +
Sbjct: 113 --RVSCSRGQGKKNIYLANNKI-----TMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
           A  S T+    +  N I   +   +     L  L +  N+L   +         +  + L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDL 328
             N L   I   L     L   DL  N           +   +  Q++ ++   ++    
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG----TLRDFFSKNQRVQTVAKQTVKKLT 276

Query: 329 SNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS 388
             N    ++P    +       D+ +     +I +          +    +     +   
Sbjct: 277 GQNEEECTVPTLG-HYGAYCCEDLPAPFADRLIALKRK---EHALLSGQGSETER-LECE 331

Query: 389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQ 448
                  + +D     +     +          L      L+ +V        ++   L 
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN----GRRAHAELD 387

Query: 449 GNVRLCGGIDELHLPS 464
           G ++   G  EL   +
Sbjct: 388 GTLQQAVGQIELQHAT 403

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  130 bits (329), Expect = 2e-32
 Identities = 64/429 (14%), Positives = 126/429 (29%), Gaps = 34/429 (7%)

Query: 4   QIPKEIGS-LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
           Q    +    + ++ L L+GN L+      +   + L+++++  N L       L  L  
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L  L++  N       + +    S+E  +  +N  S  +           K + +  N  
Sbjct: 82  LRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR---GQGKKNIYLANNKI 132

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKG-KVSIDFSSLKILWRLNLEQNNLGIGAANDLGFV 181
             L        S ++ LDL  N+      +   +S   L  LNL+ N +      D+   
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-----YDVKGQ 187

Query: 182 TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA 241
                   LK L LS N+    +     + +  +    +  N++   I   +R   NL  
Sbjct: 188 VVFAK---LKTLDLSSNKL-AFMGPEFQSAAG-VTWISLRNNKLV-LIEKALRFSQNLEH 241

Query: 242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF 301
             +  N  H          KN ++  + K  ++          T       G+       
Sbjct: 242 FDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC---- 296

Query: 302 IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMI 361
                 L      +L+++      L          L  +  N      +D    Q+  +I
Sbjct: 297 ----EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352

Query: 362 PVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEF 421
                   +   ++         +         +            +     E  S L+ 
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQL 411

Query: 422 LNLSYNHLE 430
           L       E
Sbjct: 412 LRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 97.2 bits (242), Expect = 2e-21
 Identities = 42/367 (11%), Positives = 101/367 (27%), Gaps = 33/367 (8%)

Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           +E+     ++ L  A N ++ ++          + I++  N +        G    +  L
Sbjct: 93  QELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 67  NVAENKFYGM-FPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGL 125
           ++  N+   + F     +  +LE+  L  N     +   +      LK L +  +N    
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLS-SNKLAF 205

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +     +A+ +  + L NN+    +       + L   +L  N    G   D        
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF------- 257

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
              + +V +++          +    +   +    G              L+ L      
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY-GAYCCEDLPAPFADRLIALKRKEHA 316

Query: 246 VNQLHGTIPDVIGE----LKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF 301
           +    G+  + +          + +   K   +  I            L+    +L    
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376

Query: 302 IASQNKLI------------GALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLII 349
              +                  L       + L L   +        + QQ      +  
Sbjct: 377 SNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRD 436

Query: 350 LDISSNQ 356
            D+  ++
Sbjct: 437 WDMYQHK 443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  133 bits (337), Expect = 4e-34
 Identities = 60/348 (17%), Positives = 120/348 (34%), Gaps = 38/348 (10%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           +L   + +    + +       + +   ++++++    +             + +L +  
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N    + P    N+  L    L  N  S SLP  I  N P L  L +  NN   +  D+ 
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
              ++L+ L LS+N+      +D S +  L+  N+  N L           + L    ++
Sbjct: 162 QATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLL-----------STLAIPIAV 207

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH 250
           + L  S N            L+       +  N ++      + N   L+ + +  N+L 
Sbjct: 208 EELDASHNSINVVRGPVNVELTI----LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE 261

Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIG 310
             +     +++ L+ L +  N L  ++      +  L  LDL  N L             
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL------------ 308

Query: 311 ALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
            + +       L   L L +N +  +L         L  L +S N + 
Sbjct: 309 HVERNQPQFDRLE-NLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  126 bits (318), Expect = 2e-31
 Identities = 69/381 (18%), Positives = 122/381 (32%), Gaps = 44/381 (11%)

Query: 29  LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE 88
           +   +        +HI   +    F      L N   +    +    +    + +   +E
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 89  YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG 148
              L   +    +          +++L +G N    L P    N   L +L L  N    
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 149 KVSID---FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELP 205
             S+    F +   L  L++  NNL       +   TF    +SL+ L LS N+      
Sbjct: 131 --SLPRGIFHNTPKLTTLSMSNNNL-----ERIEDDTF-QATTSLQNLQLSSNRLTHVDL 182

Query: 206 HSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQL 265
             I +L        +  N +S      +   + +  L    N ++  +         L +
Sbjct: 183 SLIPSLFH----ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTI 230

Query: 266 LGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLY 325
           L L  N L       L N   L ++DL  N L+             +             
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE------------KIMYHPFVKMQRLER 276

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           L +SNN L  +L      +  L +LD+S N     +         LE + +  N    + 
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL- 333

Query: 386 PPSLGFLKSIKFLDVSCNNFS 406
              L    ++K L +S N++ 
Sbjct: 334 --KLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  120 bits (303), Expect = 1e-29
 Identities = 62/373 (16%), Positives = 134/373 (35%), Gaps = 41/373 (10%)

Query: 83  NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS 142
            +++ +     ++     LP  ++ +   ++ L +       +   + + A  ++ L + 
Sbjct: 43  TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101

Query: 143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG 202
            N  +      F ++ +L  L LE+N+L     + L    F  N   L  LS+S+N    
Sbjct: 102 FNAIRYLPPHVFQNVPLLTVLVLERNDL-----SSLPRGIF-HNTPKLTTLSMSNNNLER 155

Query: 203 ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKN 262
               +    +S   + L   N+++  + L    + +L    V  N L       +     
Sbjct: 156 IEDDTFQATTSLQNLQL-SSNRLT-HVDLS--LIPSLFHANVSYNLLS-----TLAIPIA 206

Query: 263 LQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTL 322
           ++ L    N +   +   +    +L  L L  N+L              L      +   
Sbjct: 207 VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD---------TAWL-LNYPGLVE- 252

Query: 323 SLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCF 381
              +DLS N L   +       ++ L  L IS+N+    + +      +L+ +D+S N  
Sbjct: 253 ---VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307

Query: 382 HGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
              +  +      ++ L +  N+        L     L+ L LS+N  +     + +F N
Sbjct: 308 L-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRN 362

Query: 442 KSKIPLQGNVRLC 454
            ++  +    + C
Sbjct: 363 VARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  113 bits (284), Expect = 4e-27
 Identities = 57/299 (19%), Positives = 103/299 (34%), Gaps = 29/299 (9%)

Query: 4   QIPKEI-GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
           +I          +Q L +  N +    P    N+  L V+ ++ N L             
Sbjct: 83  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L  L+++ N    +   +    +SL+   L+SNR +  +       +P+L    +  N  
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL 198

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL-GIGAANDLGFV 181
                 +L+    +E LD S+N       +       L  L L+ NNL            
Sbjct: 199 -----STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTDTAW------- 243

Query: 182 TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA 241
             L N   L  + LS N+    + H    +     +++   N++   + L  + +  L  
Sbjct: 244 --LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI-SNNRLV-ALNLYGQPIPTLKV 299

Query: 242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
           L +  N L   +     +   L+ L L  N +  ++   L     L  L L  N    N
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 46/237 (19%), Positives = 87/237 (36%), Gaps = 26/237 (10%)

Query: 228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTK 286
            I   ++       + +++             L N +++    + ++  +P+  L +  +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 287 LAKLDLGSN---SLQGNFIASQNKL---------IGALPQQLLSITTLSLYLDLSNNLLN 334
           +  L+L       +     A  + +         I  LP  +     L   L L  N L+
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 335 GSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK 393
            SLP+ +  N   L  L +S+N    +   T     SL+ + +SSN    +    L  + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 186

Query: 394 SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGN 450
           S+   +VS N  S      L     +E L+ S+N +   V    V    + + LQ N
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 236

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (321), Expect = 2e-32
 Identities = 56/325 (17%), Positives = 106/325 (32%), Gaps = 35/325 (10%)

Query: 104 DIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL 163
           +I  N    K   +  ++    +     +A N++ LDLS N      + D +    L  L
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGN 223
           NL  N L      +   +  L+    L+ L L++N         +    S +       N
Sbjct: 64  NLSSNVL-----YETLDLESLST---LRTLDLNNNYV-----QELLVGPS-IETLHAANN 109

Query: 224 QISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG-SIPSGLG 282
            IS  +            + +  N++        G    +Q L L  N +   +      
Sbjct: 110 NIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166

Query: 283 NLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG 342
           +   L  L+L  N +              +    +    L   LDLS+N L   +  +  
Sbjct: 167 SSDTLEHLNLQYNFIY------------DVK-GQVVFAKLK-TLDLSSNKLA-FMGPEFQ 211

Query: 343 NLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC 402
           +   +  + + +N+   +I   L    +LE+ D+  N FH        F K+ +   V+ 
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAK 269

Query: 403 NNFSGQFPKFLENLSFLEFLNLSYN 427
                   +  E  +     +    
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAY 294

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  126 bits (318), Expect = 3e-32
 Identities = 51/341 (14%), Positives = 105/341 (30%), Gaps = 37/341 (10%)

Query: 29  LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE 88
           + +   N +  ++  +  +SL     +      N+ +L+++ N    +    +   + LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 89  YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG 148
              L+SN    +L  +   +L  L+ L +  N         L    ++E L  +NN    
Sbjct: 62  LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 149 KVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG-ELPHS 207
              +  S  +    + L  N +       L  +      S ++ L L  N+         
Sbjct: 113 --RVSCSRGQGKKNIYLANNKI-----TMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 208 IANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLG 267
            A+  + +    +  N I   +   +     L  L +  N+L   +         +  + 
Sbjct: 165 AASSDT-LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220

Query: 268 LYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ----GNFIASQNKLIGALPQQLLSITTL- 322
           L  N L   I   L     L   DL  N        +F +   ++     Q +  +T   
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279

Query: 323 -----SLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
                   L          LP          ++ +  +   
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  103 bits (259), Expect = 2e-24
 Identities = 46/337 (13%), Positives = 99/337 (29%), Gaps = 58/337 (17%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           I +   N +  ++  ++++  K  ++    S   +  L+L  N L     + +       
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-----SQISAADL-A 55

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
             + L++L+LS N         +                        + +L  L  L + 
Sbjct: 56  PFTKLELLNLSSNV--------LYETLD-------------------LESLSTLRTLDLN 88

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
            N +       +    +++ L    N +   +            + L +N +        
Sbjct: 89  NNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKIT------- 133

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
             L          +  L L     N +   +  +   +   L  L++  N     +    
Sbjct: 134 -MLRDLDEGCRSRVQYLDLK---LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQ 187

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
                L+ +D+SSN     + P       + ++ +  N       K L     LE  +L 
Sbjct: 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245

Query: 426 YNHLEGEVPTKGVFSNK--SKIPLQGNVRLCGGIDEL 460
            N             N+    +  Q   +L G  +E 
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 48/292 (16%), Positives = 90/292 (30%), Gaps = 51/292 (17%)

Query: 6   PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQ 65
             ++    KL+ L L+ N L  +  D   +LS L+ + +  N +       L +  ++  
Sbjct: 51  AADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIET 103

Query: 66  LNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGL 125
           L+ A N                             +           K + +  N    L
Sbjct: 104 LHAANNNI-------------------------SRVSCSR---GQGKKNIYLANNKITML 135

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSID--FSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
                   S ++ LDL  N+    V+     +S   L  LNL+ N +          V  
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIYD--------VKG 186

Query: 184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA 243
               + LK L LS N+    +     + +  +    +  N++   I   +R   NL    
Sbjct: 187 QVVFAKLKTLDLSSNKL-AFMGPEFQSAAG-VTWISLRNNKLV-LIEKALRFSQNLEHFD 243

Query: 244 VEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
           +  N  H          KN ++  + K  ++  +         +  L     
Sbjct: 244 LRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 34/176 (19%), Positives = 62/176 (35%), Gaps = 14/176 (7%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG-KFPTTLGLLRN 62
           ++    G     + + LA N +T       G  S +Q + +K N +    F         
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L  LN+  N  Y      +   + L+   L+SN+ +  +  +   +   +  + +  NN 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEF-QSAAGVTWISL-RNNK 225

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDL 178
             LI  +L  + NLE  DL  N           +L+  +  N     +       L
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNG------FHCGTLRDFFSKNQRVQTVAKQTVKKL 275

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  127 bits (321), Expect = 2e-32
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 14/162 (8%)

Query: 538 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 590
            ++G+G FGSV +G L       + VAVK   +K   +       F++E   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           +I+++ +C     +G+    ++  +M  G L  +L  S  +     + L   L   +D+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 651 SAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             +EYL + +     +H DL   N +L  DM   V DFGL+K
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  131 bits (331), Expect = 3e-32
 Identities = 60/348 (17%), Positives = 120/348 (34%), Gaps = 38/348 (10%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           +L   + +    + +       + +   ++++++    +             + +L +  
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N    + P    N+  L    L  N  S SLP  I  N P L  L +  NN   +  D+ 
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
              ++L+ L LS+N+      +D S +  L+  N+  N L           + L    ++
Sbjct: 168 QATTSLQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLL-----------STLAIPIAV 213

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH 250
           + L  S N            L+       +  N ++      + N   L+ + +  N+L 
Sbjct: 214 EELDASHNSINVVRGPVNVELTI----LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE 267

Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIG 310
             +     +++ L+ L +  N L  ++      +  L  LDL  N L             
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL------------ 314

Query: 311 ALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
            + +       L   L L +N +  +L         L  L +S N + 
Sbjct: 315 HVERNQPQFDRLE-NLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  125 bits (315), Expect = 3e-30
 Identities = 73/423 (17%), Positives = 132/423 (31%), Gaps = 45/423 (10%)

Query: 29  LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE 88
           +   +        +HI   +    F      L N   +    +    +    + +   +E
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 89  YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG 148
              L   +    +          +++L +G N    L P    N   L +L L  N    
Sbjct: 79  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 149 KVSID---FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELP 205
             S+    F +   L  L++  NNL       +   TF    +SL+ L LS N+      
Sbjct: 137 --SLPRGIFHNTPKLTTLSMSNNNL-----ERIEDDTF-QATTSLQNLQLSSNRLTHVDL 188

Query: 206 HSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQL 265
             I +L        +  N +S      +   + +  L    N ++  +         L +
Sbjct: 189 SLIPSLFH----ANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTI 236

Query: 266 LGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLY 325
           L L  N L       L N   L ++DL  N L+             +             
Sbjct: 237 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE------------KIMYHPFVKMQRLER 282

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           L +SNN L  +L      +  L +LD+S N     +         LE + +  N    + 
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL- 339

Query: 386 PPSLGFLKSIKFLDVSCNNFSG-QFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSK 444
              L    ++K L +S N++          N++     +   +         G+   +S 
Sbjct: 340 --KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESD 397

Query: 445 IPL 447
            P 
Sbjct: 398 KPY 400

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  118 bits (296), Expect = 8e-28
 Identities = 67/407 (16%), Positives = 144/407 (35%), Gaps = 41/407 (10%)

Query: 83  NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS 142
            +++ +     ++     LP  ++ +   ++ L +       +   + + A  ++ L + 
Sbjct: 49  TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107

Query: 143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG 202
            N  +      F ++ +L  L LE+N+L     + L    F  N   L  LS+S+N    
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDL-----SSLPRGIF-HNTPKLTTLSMSNNNLER 161

Query: 203 ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKN 262
               +    +S   + L   N+++  + L    + +L    V  N L       +     
Sbjct: 162 IEDDTFQATTSLQNLQL-SSNRLT-HVDLS--LIPSLFHANVSYNLLS-----TLAIPIA 212

Query: 263 LQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTL 322
           ++ L    N +   +   +    +L  L L  N+L              L      +   
Sbjct: 213 VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD---------TAWL-LNYPGLVE- 258

Query: 323 SLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCF 381
              +DLS N L   +       ++ L  L IS+N+    + +      +L+ +D+S N  
Sbjct: 259 ---VDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313

Query: 382 HGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
              +  +      ++ L +  N+        L     L+ L LS+N  +     + +F N
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRN 368

Query: 442 KSKIPLQGNVRLCGGIDELHLPSCPSRGSRKLKITLLKVLIPVAVSC 488
            ++  +    + C    +L    C     +     LL+ +   +V  
Sbjct: 369 VARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVE 415

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  118 bits (296), Expect = 8e-28
 Identities = 71/432 (16%), Positives = 146/432 (33%), Gaps = 41/432 (9%)

Query: 4   QIPKEI-GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
           +I          +Q L +  N +    P    N+  L V+ ++ N L             
Sbjct: 89  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L  L+++ N    +   +    +SL+   L+SNR +  +       +P+L    +  N  
Sbjct: 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL 204

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
                 +L+    +E LD S+N       +       L  L L+ NNL      D     
Sbjct: 205 -----STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNL-----TDTA--- 248

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
           +L N   L  + LS N+    + H    +     +++   N++   + L  + +  L  L
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI-SNNRLV-ALNLYGQPIPTLKVL 306

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            +  N L   +     +   L+ L L  N +  ++   L     L  L L  N    N +
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSL 362

Query: 303 ASQNKLIGALPQQL--LSITTLSLYLDLSNNLLNGSL-PQQVGNLKNLIILDISSNQFSG 359
                   AL + +   ++     +  +   L +G    +      + ++  I+      
Sbjct: 363 R-------ALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVE 415

Query: 360 MIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCN----NFSGQFPKFLEN 415
            +      C + + ++   +  H I       L+  + L+   N           + ++ 
Sbjct: 416 KVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQ 475

Query: 416 LSFLEFLNLSYN 427
              L+ L+   +
Sbjct: 476 EQLLQGLHAEID 487

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 68.8 bits (168), Expect = 3e-12
 Identities = 36/241 (14%), Positives = 78/241 (32%), Gaps = 34/241 (14%)

Query: 228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTK 286
            I   ++       + +++             L N +++    + ++  +P+  L +  +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLK 345
           +  L+L    ++             +     +       L +  N +   LP  V  N+ 
Sbjct: 77  VELLNLNDLQIE------------EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 123

Query: 346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
            L +L +  N  S +          L  + +S+N    I   +     S++ L +S N  
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183

Query: 406 S----GQFP------------KFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQG 449
           +       P              L     +E L+ S+N +   V    V    + + LQ 
Sbjct: 184 THVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQH 241

Query: 450 N 450
           N
Sbjct: 242 N 242

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 23/148 (15%), Positives = 50/148 (33%), Gaps = 4/148 (2%)

Query: 294 SNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDIS 353
               + N    Q +    +   L         + +     +     +   L N  I+   
Sbjct: 2   GGQQRYNVKPRQPEY-KCIDSNLQYDCVFYD-VHIDMQTQDVYFGFEDITLNNQKIVTFK 59

Query: 354 SNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFL 413
           ++    +    L +   +E ++++      I   +  +  +I+ L +  N      P   
Sbjct: 60  NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 119

Query: 414 ENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
           +N+  L  L L  N L   +P +G+F N
Sbjct: 120 QNVPLLTVLVLERNDLS-SLP-RGIFHN 145

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (308), Expect = 6e-31
 Identities = 47/207 (22%), Positives = 79/207 (38%), Gaps = 23/207 (11%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
            +  S+F    ++GQG+FG V K     D    A+K I    +    + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60

Query: 588 HRNLIKIITICSSTDFKGVDFKA--------LVFEYMGNGSLEDWLHQSNDQVEVCKLSL 639
           H+ +++                A        +  EY  NG+L D +H  N          
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQR 115

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
            +   +   +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK +      
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 700 TSSKTPSSSIGIK------GTVGYVAP 720
               + +            GT  YVA 
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVAT 199

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (321), Expect = 7e-31
 Identities = 74/347 (21%), Positives = 120/347 (34%), Gaps = 64/347 (18%)

Query: 81  ICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLD 140
            C  +      +  +  + +LP  +     ++  L I  +N    +P        L  L+
Sbjct: 36  ACLNNGNAVLNVGESGLT-TLPDCL---PAHITTLVI-PDNNLTSLPALPPE---LRTLE 87

Query: 141 LSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
           +S NQ    + +    L  L   +    +L                 S L  L +  NQ 
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------------ALPSGLCKLWIFGNQL 133

Query: 201 GGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGEL 260
              LP     L        +  NQ++ ++P     L  L A     NQL  ++P +    
Sbjct: 134 T-SLPVLPPGLQE----LSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPS-- 181

Query: 261 KNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSIT 320
             LQ L +  N L  S+P+    L KL   +    SL             ALP  L    
Sbjct: 182 -GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLP------------ALPSGLKE-- 225

Query: 321 TLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNC 380
                L +S N L  SLP     LK L    +S N+ +  +P+  S  +SL    +  N 
Sbjct: 226 -----LIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSGLLSL---SVYRNQ 272

Query: 381 FHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
              + P SL  L S   +++  N  S +  + L  ++     +    
Sbjct: 273 LTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  121 bits (305), Expect = 6e-29
 Identities = 72/363 (19%), Positives = 131/363 (36%), Gaps = 62/363 (17%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
            +P  + +   +  L +  N LT  LP     L   + + + GN L    P     L  L
Sbjct: 54  TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLEL 106

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
              +          P     +  L   ++  N+ + SLP    V  P L+EL + ++N  
Sbjct: 107 SIFSNPLTHL----PALPSGLCKL---WIFGNQLT-SLP----VLPPGLQELSV-SDNQL 153

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
             +P   S    L  L   NNQ    + +  S L+    L++  N L             
Sbjct: 154 ASLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDNQL-----------AS 195

Query: 184 LTNC-SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
           L    S L  L   +N+    LP   + L       ++ GN+++ ++P+    L  L+  
Sbjct: 196 LPTLPSELYKLWAYNNRLT-SLPALPSGLKE----LIVSGNRLT-SLPVLPSELKELM-- 247

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            V  N+L  ++P +      L  L +Y+N L   +P  L +L+    ++L  N L     
Sbjct: 248 -VSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS---- 297

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
               +      +++ S    S  + +  ++   S P++   L       +   +     P
Sbjct: 298 ----ERTLQALREITSAPGYSGPI-IRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

Query: 363 VTL 365
              
Sbjct: 353 ADR 355

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  118 bits (297), Expect = 7e-28
 Identities = 77/344 (22%), Positives = 118/344 (34%), Gaps = 67/344 (19%)

Query: 14  KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKF 73
               L +  + LT  LPD +     +  + I  N+L    P        L  L V+ N+ 
Sbjct: 41  GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQL 93

Query: 74  YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNA 133
               P     +  L  F                     L +L I  N    L P      
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQLTSL-PVLPPG- 142

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL 193
             L+ L +S+NQ    +    S L  LW  N   N L           +     S L+ L
Sbjct: 143 --LQELSVSDNQLA-SLPALPSELCKLWAYN---NQL----------TSLPMLPSGLQEL 186

Query: 194 SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI 253
           S+SDNQ    LP   + L           N+++ ++P     L  LI   V  N+L  ++
Sbjct: 187 SVSDNQLA-SLPTLPSELYK----LWAYNNRLT-SLPALPSGLKELI---VSGNRL-TSL 236

Query: 254 PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALP 313
           P +  ELK L + G   N L  S+P     L  L    +  N L              LP
Sbjct: 237 PVLPSELKELMVSG---NRLT-SLPMLPSGLLSL---SVYRNQLT------------RLP 277

Query: 314 QQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
           + L+ +++ +  ++L  N L+     Q   L+ +      S   
Sbjct: 278 ESLIHLSSET-TVNLEGNPLS-ERTLQ--ALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  110 bits (276), Expect = 3e-25
 Identities = 60/297 (20%), Positives = 99/297 (33%), Gaps = 62/297 (20%)

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL 193
           +   +L++  +      ++       +  L +  NNL           +       L+ L
Sbjct: 40  NGNAVLNVGESGLT---TLPDCLPAHITTLVIPDNNL----------TSLPALPPELRTL 86

Query: 194 SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI 253
            +S NQ    LP     L   + +F      +             L  L +  NQL  ++
Sbjct: 87  EVSGNQLT-SLPVLPPGLLE-LSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SL 136

Query: 254 PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALP 313
           P +   L+ L +     N L  S+P+    L KL      +N L             +LP
Sbjct: 137 PVLPPGLQELSVSD---NQLA-SLPALPSELCKL---WAYNNQLT------------SLP 177

Query: 314 QQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEY 373
                +  L     +S+N L  SLP     L  L   +   N+ +  +P   S    L+ 
Sbjct: 178 MLPSGLQEL----SVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPS---GLKE 225

Query: 374 VDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
           + +S N    + P     LK    L VS N  +   P     L     L++  N L 
Sbjct: 226 LIVSGNRLTSL-PVLPSELKE---LMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT 274

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  105 bits (263), Expect = 9e-24
 Identities = 69/355 (19%), Positives = 118/355 (33%), Gaps = 55/355 (15%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL------ 57
            +P       +L+ L ++GN LT  LP     L  L +       L    P+ L      
Sbjct: 75  SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIF 129

Query: 58  --------GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNL 109
                    L   L +L+V++N+     P     +  L   +  +N+ + SLP    +  
Sbjct: 130 GNQLTSLPVLPPGLQELSVSDNQL-ASLPALPSELCKL---WAYNNQLT-SLP----MLP 180

Query: 110 PNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN 169
             L+EL +  +N    +P   S    L  L   NN+    +    S LK    L +  N 
Sbjct: 181 SGLQELSVS-DNQLASLPTLPSE---LYKLWAYNNRLT-SLPALPSGLK---ELIVSGNR 232

Query: 170 LGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTI 229
           L           +     S LK L +S N+    LP   + L S      +  NQ++  +
Sbjct: 233 LT----------SLPVLPSELKELMVSGNRLT-SLPMLPSGLLS----LSVYRNQLT-RL 276

Query: 230 PLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLG---LYKNFLQGSIPSGLGNLTK 286
           P  + +L +   + +E N L       + E+ +        +  +    S P     L  
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL 336

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV 341
            A   L          A +  + G           L    +  N + +     Q+
Sbjct: 337 AAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQI 391

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  100 bits (251), Expect = 3e-22
 Identities = 51/245 (20%), Positives = 88/245 (35%), Gaps = 50/245 (20%)

Query: 187 CSSLKVLSLSDNQFGGELPHSI-ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
            +   VL++ ++     LP  + A++++     +I  N ++ ++P     L  L    V 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPAHITT----LVIPDNNLT-SLPALPPELRTLE---VS 89

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
            NQL  ++P +   L  L +           +P+    L KL    +  N L        
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQLT------- 134

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
                +LP     +      L +S+N L  SLP     L  L      +NQ +  +P+  
Sbjct: 135 -----SLPVLPPGLQ----ELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLP 180

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
           S    L+ + +S N     +P     L     L    N  +   P     L   + L +S
Sbjct: 181 S---GLQELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SLPALPSGL---KELIVS 229

Query: 426 YNHLE 430
            N L 
Sbjct: 230 GNRLT 234

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  121 bits (305), Expect = 2e-30
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 11/161 (6%)

Query: 538 NMIGQGSFGSVYKGIL---GEDEMIVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLI 592
            M+G+G FGSV +  L       + VAVK++  ++        F+ E   ++   H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 593 KIITICSSTDFKGVDFKAL-VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           K++ +   +  KG     + +  +M +G L  +L  S        L L   +   +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 652 AIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            +EYL   +     +H DL   N +L  DM   V DFGL++
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (304), Expect = 3e-30
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIK 593
           +G+G+FGSV              +VAVK   L+  G    R F  E + L+ +    ++K
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
              +      + +    LV EY+ +G L D+L Q +      +L   + L  +  +   +
Sbjct: 89  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFL-QRHRA----RLDASRLLLYSSQICKGM 140

Query: 654 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           EYL    C    VH DL   N+L++ +    + DFGLAK L    
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  119 bits (300), Expect = 6e-30
 Identities = 48/171 (28%), Positives = 71/171 (41%), Gaps = 20/171 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVIN---LKQKGAFRSFVAECEALRN 585
            +      +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + HRNLI++  +  +   K      +V E    GSL D L +           L      
Sbjct: 78  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 126

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           A+ VA  + YL        +H DL   N+LL    +  +GDFGL + L  +
Sbjct: 127 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  121 bits (305), Expect = 6e-30
 Identities = 48/235 (20%), Positives = 91/235 (38%), Gaps = 32/235 (13%)

Query: 497 IVYARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGED 556
           I +    +          + +  P   +  L+    +      IG+G+FG V+ G L  D
Sbjct: 82  IDHLLSTQQPLTKKSGVVLHRAVPKDKW-VLNH--EDLVLGEQIGRGNFGEVFSGRLRAD 138

Query: 557 EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTD--FKGVDFKALVF 613
             +VAVK             F+ E   L+   H N++++I +C+     +       +V 
Sbjct: 139 NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-------IVM 191

Query: 614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 673
           E +  G    +L ++       +L +   L +  D A+ +EYL        +H DL   N
Sbjct: 192 ELVQGGDFLTFL-RTEGA----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARN 243

Query: 674 VLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP-----GKF 723
            L+    V  + DFG+++  +      ++      + +K T    AP     G++
Sbjct: 244 CLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWT----APEALNYGRY 292

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  120 bits (302), Expect = 7e-30
 Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 23/171 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLK---QKGAFRSFVAECEALR 584
           +EF    ++G G+FG+VYKG+      + ++ VA+K   L+      A +  + E   + 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72

Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           ++ + ++ +++ IC ++  +      L+ + M  G L D++ +  D      +     LN
Sbjct: 73  SVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             + +A  + YL       +VH DL   NVL+       + DFGLAK L +
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 1e-29
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV              +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L +  ++     +  I+ L     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEY 160

Query: 656 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           L         +H DL   N+L++++    +GDFGL K L
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL 195

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (298), Expect = 1e-29
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 17/159 (10%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           +G+G+FGSV              +VAVK +    +   R F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +C S   + +    L+ EY+  GSL D+L Q + +    ++  I+ L     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 129

Query: 656 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           L         +H DL   N+L++++    +GDFGL K L
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL 164

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  118 bits (298), Expect = 1e-29
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 22/166 (13%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLI 592
           +G+G FG V               VAVK   LK             E E LRN+ H N++
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           K   IC+     G+    L+ E++ +GSL+++L   N      K++L Q+L  A+ +   
Sbjct: 87  KYKGICTEDGGNGI---KLIMEFLPSGSLKEYL-PKNKN----KINLKQQLKYAVQICKG 138

Query: 653 IEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           ++YL         VH DL   NVL++ +    +GDFGL K + +  
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  121 bits (305), Expect = 2e-29
 Identities = 66/322 (20%), Positives = 118/322 (36%), Gaps = 24/322 (7%)

Query: 39  LQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFS 98
            +++ +  N +            +L +L + EN    + P +  N+ +L    L SNR  
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93

Query: 99  GSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLK 158
             +P  +   L NL +L I  N    L+     +  NL+ L++ +N         FS L 
Sbjct: 94  -LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152

Query: 159 ILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVF 218
            L +L LE+ NL       +      ++   L VL L          +S   L    ++ 
Sbjct: 153 SLEQLTLEKCNL-----TSIPTEAL-SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 219 LIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP 278
           +     +  T+       +NL +L++    L       +  L  L+ L L  N +  +I 
Sbjct: 207 ISHWPYLD-TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIE 264

Query: 279 SG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSL 337
              L  L +L ++ L    L              +             L++S N L  +L
Sbjct: 265 GSMLHELLRLQEIQLVGGQLA------------VVEPYAFRGLNYLRVLNVSGNQLT-TL 311

Query: 338 PQQV-GNLKNLIILDISSNQFS 358
            + V  ++ NL  L + SN  +
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  120 bits (302), Expect = 5e-29
 Identities = 67/328 (20%), Positives = 122/328 (37%), Gaps = 26/328 (7%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
           G+      L++ +N+   +      +   LE   L  N  S ++      NL NL+ LG+
Sbjct: 29  GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGL 87

Query: 118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAND 177
            +N    +     +  SNL  LD+S N+    +   F  L  L  L +  N+L       
Sbjct: 88  RSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-----VY 142

Query: 178 LGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNL 236
           +    F +  +SL+ L+L           ++++L   +++ L     I+  I     + L
Sbjct: 143 ISHRAF-SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL-RHLNIN-AIRDYSFKRL 199

Query: 237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
             L  L +       T+        NL  L +    L  ++P   + +L  L  L+L  N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258

Query: 296 SLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISS 354
            +    I         L  +LL +      + L    L   +       L  L +L++S 
Sbjct: 259 PIS--TIEG-----SML-HELLRLQE----IQLVGGQLA-VVEPYAFRGLNYLRVLNVSG 305

Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFH 382
           NQ + +      +  +LE + + SN   
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  118 bits (298), Expect = 2e-28
 Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 27/308 (8%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +P+ +   +   LLDL  N+ K     +F+S   L  L L +N +               
Sbjct: 26  VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AFN 77

Query: 186 NCSSLKVLSLSDNQFGGELPHSI-ANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALA 243
           N  +L+ L L  N+    +P  +   LS+   + +   N+I   +   + ++L NL +L 
Sbjct: 78  NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI-SENKIV-ILLDYMFQDLYNLKSLE 134

Query: 244 VEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFI 302
           V  N L          L +L+ L L K  L  SIP+  L +L  L  L L   ++     
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN---- 189

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
                   A+             L++S+     ++        NL  L I+    + +  
Sbjct: 190 --------AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFL 422
           + +   V L ++++S N    I    L  L  ++ + +     +   P     L++L  L
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL 301

Query: 423 NLSYNHLE 430
           N+S N L 
Sbjct: 302 NVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  115 bits (289), Expect = 3e-27
 Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 12/290 (4%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           S   L+ L L  N ++   P    NL  L+ + ++ N L          L NL +L+++E
Sbjct: 54  SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           NK   +      ++ +L+   +  N     +       L +L++L +   N   +  ++L
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEAL 172

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
           S+   L +L L +          F  L  L  L +           +           +L
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN------CLYGLNL 226

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQL 249
             LS++          ++ +L     + L   N IS TI   +   L+ L  + +   QL
Sbjct: 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNL-SYNPIS-TIEGSMLHELLRLQEIQLVGGQL 284

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQ 298
               P     L  L++L +  N L  ++   +  ++  L  L L SN L 
Sbjct: 285 AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (288), Expect = 3e-27
 Identities = 60/324 (18%), Positives = 121/324 (37%), Gaps = 24/324 (7%)

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
           +      L  NR   +L  D   + P+L+EL +  N    + P + +N  NL  L L +N
Sbjct: 32  TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90

Query: 145 QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL 204
           + K      F+ L  L +L++ +N +       L    F  +  +LK L + DN      
Sbjct: 91  RLKLIPLGVFTGLSNLTKLDISENKI-----VILLDYMF-QDLYNLKSLEVGDNDLVYIS 144

Query: 205 PHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNL 263
             + + L+S   + L     ++ +IP     +L  LI L +    ++         L  L
Sbjct: 145 HRAFSGLNSLEQLTL-EKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202

Query: 264 QLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLS 323
           ++L +       ++         L  L +   +L             A+P   +      
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT------------AVPYLAVRHLVYL 250

Query: 324 LYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
            +L+LS N ++ ++   +   L  L  + +   Q + + P        L  +++S N   
Sbjct: 251 RFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309

Query: 383 GIIPPSLGFLKSIKFLDVSCNNFS 406
            +       + +++ L +  N  +
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 92.9 bits (231), Expect = 4e-20
 Identities = 45/249 (18%), Positives = 90/249 (36%), Gaps = 11/249 (4%)

Query: 4   QIPKEI-GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
            IP  +   L  L  L ++ N +   L     +L  L+ + +  N L          L +
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
           L QL + +     +   ++ ++  L    L     + ++       L  LK L I    +
Sbjct: 154 LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPY 212

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
              +  +     NL  L +++        +    L  L  LNL  N +     + +    
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-----STIEGSM 267

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIA 241
                  L+ + L   Q     P++   L+   ++ +  GNQ++ T+   +  ++ NL  
Sbjct: 268 L-HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV-SGNQLT-TLEESVFHSVGNLET 324

Query: 242 LAVEVNQLH 250
           L ++ N L 
Sbjct: 325 LILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 29/137 (21%), Positives = 53/137 (38%), Gaps = 5/137 (3%)

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT 364
             K   A+P+ + + T     LDL  N +      +  +  +L  L+++ N  S + P  
Sbjct: 19  HRKRFVAVPEGIPTETR---LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL 424
            +   +L  + + SN    I       L ++  LD+S N          ++L  L+ L +
Sbjct: 76  FNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135

Query: 425 SYNHLEGEVPTKGVFSN 441
             N L   +     FS 
Sbjct: 136 GDNDLV-YISH-RAFSG 150

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  117 bits (294), Expect = 3e-29
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 18/201 (8%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRN 590
           ++F     +G+G FG V++     D+   A+K I L  +   R   + E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 591 LIK----IITICSSTDFKGVDFKALVF---EYMGNGSLEDWLHQSNDQVEVCKLSLIQRL 643
           +++     +   ++   +    K  ++   +     +L+DW++      E         L
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE---RERSVCL 121

Query: 644 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS----HHLD 699
           +I + +A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +        + 
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 700 TSSKTPSSSIGIKGTVGYVAP 720
           T     +   G  GT  Y++P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (293), Expect = 3e-29
 Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 31/204 (15%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR 587
            +   +F    +IG G FG V+K     D     +K +    + A R    E +AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 588 HRNLIK-----------IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK 636
           H N++              T   ++         +  E+   G+LE W+ +   +    K
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118

Query: 637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           L  +  L +   +   ++Y+H      +++ DLKPSN+ L       +GDFGL   L + 
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
              T           KGT+ Y++P
Sbjct: 176 GKRTR---------SKGTLRYMSP 190

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  116 bits (292), Expect = 9e-29
 Identities = 52/166 (31%), Positives = 72/166 (43%), Gaps = 24/166 (14%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLI 592
           +G+G FG V              +VAVK   LK          +  E + LR + H ++I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           K    C       +    LV EY+  GSL D+L +         + L Q L  A  +   
Sbjct: 97  KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEG 146

Query: 653 IEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           + YLH  H     +H DL   NVLLD+D +  +GDFGLAK +   H
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  116 bits (292), Expect = 1e-28
 Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 23/171 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLK---QKGAFRSFVAECEALR 584
           +EF    ++G G+FG+VYKG+      + ++ VA+K   L+      A +  + E   + 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72

Query: 585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
           ++ + ++ +++ IC ++  +      L+ + M  G L D++ +  D      +     LN
Sbjct: 73  SVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             + +A  + YL       +VH DL   NVL+       + DFGLAK L +
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  118 bits (297), Expect = 2e-28
 Identities = 72/399 (18%), Positives = 135/399 (33%), Gaps = 34/399 (8%)

Query: 62  NLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANN 121
           ++  ++++ N    +   S   +  L++  +        +  +    L +L  L +  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 122 FFGLIPDSLSNASNLELLDLSNNQFKGKVSID--FSSLKILWRLNLEQNNLGIGAANDLG 179
           F  L   + +  +NLE+L L+     G V     F  L  L  L L  NN+       + 
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-----KKIQ 145

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
             +F  N     VL L+ N+        + N        L                L ++
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL---------------RLSSI 190

Query: 240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG---LGNLTKLAKLDLGSNS 296
               +    L         +  ++  L L  N  + S+          TK+  L L ++ 
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250

Query: 297 LQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLPQQV-GNLKNLIILDISS 354
             G+                  +    +   DLS + +  +L + V  +  +L  L ++ 
Sbjct: 251 NMGSSF-GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308

Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLE 414
           N+ + +          L  +++S N    I       L  ++ LD+S N+      +   
Sbjct: 309 NEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368

Query: 415 NLSFLEFLNLSYNHLEGEVPTKGVFSNKSK---IPLQGN 450
            L  L+ L L  N L+  VP  G+F   +    I L  N
Sbjct: 369 GLPNLKELALDTNQLK-SVP-DGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  116 bits (293), Expect = 5e-28
 Identities = 81/391 (20%), Positives = 140/391 (35%), Gaps = 37/391 (9%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPT-TLGLLRNLVQLNVAENKF 73
           +  + L+ N +          L  LQ + ++  + G      T   L +L+ L +  N+F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 74  YGMFPRSICNISSLEYFYLTSNRF-SGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL-S 131
             +   +   +++LE   LT        L  +    L +L+ L +  NN   + P S   
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 132 NASNLELLDLSNNQFKGKVSIDFSSL--KILWRLNLEQNNLGIGAANDLGFVTF--LTNC 187
           N     +LDL+ N+ K     D  +   K    L L    L       LG+         
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211

Query: 188 SSLKVLSLSDNQFGGELPHSIAN-LSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEV 246
           +S+  L LS N F   +     + ++ T I  LI  N  +     G  N  +      + 
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

Query: 247 -------------NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDL 292
                        +++   +  V     +L+ L L +N +   I       LT L KL+L
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNL 330

Query: 293 GSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILD 351
             N L          +   + + L  +      LDLS N +  +L  Q    L NL  L 
Sbjct: 331 SQNFLG--------SIDSRMFENLDKLE----VLDLSYNHI-RALGDQSFLGLPNLKELA 377

Query: 352 ISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
           + +NQ   +         SL+ + + +N + 
Sbjct: 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 67/329 (20%), Positives = 114/329 (34%), Gaps = 34/329 (10%)

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL 193
           +++  +DLS N         FS L+ L  L +EQ   G+   N+          SSL +L
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT-----FRGLSSLIIL 84

Query: 194 SLSDNQFGGELPHSI-ANLSSTMIVFLIGGNQI-SGTIPLGI-RNLVNLIALAVEVNQLH 250
            L  NQF  +L       L++  ++ L     +    +     + L +L  L +  N + 
Sbjct: 85  KLDYNQF-LQLETGAFNGLANLEVLTL-TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142

Query: 251 GTIPD-VIGELKNLQLLGLYKNFLQGSIPSGLGNLTK--LAKLDLGSNSLQGNFIASQNK 307
              P      ++   +L L  N ++      L N        L L S +LQ         
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIIL-------------DISS 354
                P +  SITT    LDLS N    S+ ++  +      +                 
Sbjct: 203 EKCGNPFKNTSITT----LDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258

Query: 355 NQFSGMIPVTLS--TCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKF 412
             F      T        ++  D+S +    ++         ++ L ++ N  +      
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318

Query: 413 LENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
              L+ L  LNLS N L G + +  +F N
Sbjct: 319 FWGLTHLLKLNLSQNFL-GSIDS-RMFEN 345

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 89.4 bits (222), Expect = 5e-19
 Identities = 68/354 (19%), Positives = 125/354 (35%), Gaps = 54/354 (15%)

Query: 11  SLFKLQALALAGNYLTG-KLPDFI-GNLSALQVIHIKGNSLGGKFPTTL-GLLRNLVQLN 67
            L  L+ L L    L G  L       L++L+++ ++ N++    P +    +R    L+
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160

Query: 68  VAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP 127
           +  NK      +SIC     E       +    L       L ++    +          
Sbjct: 161 LTFNKV-----KSICE----EDLLNFQGKHFTLL------RLSSITLQDMNEYWLGWEKC 205

Query: 128 DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNC 187
            +    +++  LDLS N FK  ++  F     +    ++   L               + 
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDA--IAGTKIQSLIL---------------SN 248

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQISGTIPLGI-RNLVNLIALAVE 245
           S     S     F      +   L ++ +    +  ++I   +   +  +  +L  L + 
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLA 307

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIAS 304
            N+++    +    L +L  L L +NFL  SI S +  NL KL  LDL  N ++      
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR------ 360

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQF 357
                 AL  Q          L L  N L  S+P  +   L +L  + + +N +
Sbjct: 361 ------ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 47/286 (16%), Positives = 89/286 (31%), Gaps = 38/286 (13%)

Query: 206 HSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP-DVIGELKNLQ 264
           H +  L + +    +  N I+         L +L  L VE       I  +    L +L 
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 265 LLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLS 323
           +L L  N     + +G    L  L  L L   +L G  ++          + L S+    
Sbjct: 83  ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSG-----NFF-KPLTSLE--- 132

Query: 324 LYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
             L L +N +    P     N++   +LD++ N+                   I      
Sbjct: 133 -MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK----------------SICEEDLL 175

Query: 383 GIIPPSLGFLK--SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFS 440
                    L+  SI   D++      +        + +  L+LS N  + E   K  F 
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFD 234

Query: 441 NKSKIPLQ-----GNVRLCGGIDELHLPSCPSRGSRKLKITLLKVL 481
             +   +Q      +  +       +     +   + L+ + +K  
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC 280

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 52/290 (17%), Positives = 102/290 (35%), Gaps = 35/290 (12%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           ++ +   L L  N +     + + N        ++              L ++   ++ E
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITLQDMNE 197

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
                    +    +S+    L+ N F  S+       +   K   +  +N + +     
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
                    D  N  FKG   ++ S +K      L ++ +       L    F ++ + L
Sbjct: 258 HTN----FKDPDNFTFKG---LEASGVKTCD---LSKSKI-----FALLKSVF-SHFTDL 301

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQL 249
           + L+L+ N+      ++   L+  + + L   N +  +I   +  NL  L  L +  N +
Sbjct: 302 EQLTLAQNEINKIDDNAFWGLTHLLKLNL-SQNFLG-SIDSRMFENLDKLEVLDLSYNHI 359

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQ 298
                     L NL+ L L  N L+ S+P G    LT L K+ L +N   
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  114 bits (288), Expect = 3e-28
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 22/163 (13%)

Query: 538 NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 591
            +IG+G FG VY G L      ++  AVK   L +    G    F+ E   +++  H N+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           + ++ IC  ++   +    +V  YM +G L +++            ++   +   + VA 
Sbjct: 89  LSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 139

Query: 652 AIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            ++YL         VH DL   N +LD      V DFGLA+ +
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM 178

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  114 bits (288), Expect = 3e-28
 Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 31/216 (14%)

Query: 520 PMVSYAELSKATSEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAFRS- 575
             V    +        S  +IG+G FG VY G      ++ +  A+K   L +    +  
Sbjct: 9   AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQV 66

Query: 576 --FVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE 633
             F+ E   +R + H N++ +I I      +G+    ++  YM +G L  ++        
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIM--LPPEGLPH--VLLPYMCHGDLLQFIRSPQRN-- 120

Query: 634 VCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF 692
               ++   ++  + VA  +EYL         VH DL   N +LD      V DFGLA+ 
Sbjct: 121 ---PTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARD 173

Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAP-----GKF 723
           +      +  +   + + +K T    A       +F
Sbjct: 174 ILDREYYSVQQHRHARLPVKWT----ALESLQTYRF 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  114 bits (287), Expect = 3e-28
 Identities = 47/186 (25%), Positives = 94/186 (50%), Gaps = 26/186 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 589
           ++ +  + +G G +G VY+G+  +  + VAVK +    +       F+ E   ++ I+H 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           NL++++ +C+     +       ++ E+M  G+L D+L + N Q    ++S +  L +A 
Sbjct: 70  NLVQLLGVCTREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMAT 118

Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
            ++SA+EYL   +     +H DL   N L+  + +  V DFGL++ ++    DT +    
Sbjct: 119 QISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAG 171

Query: 707 SSIGIK 712
           +   IK
Sbjct: 172 AKFPIK 177

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  114 bits (288), Expect = 4e-28
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 19/167 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLK-QKGAFRSFVAECEALRNI 586
           +E     ++G G FG+V+KG+        ++ V +KVI  K  + +F++      A+ ++
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            H ++++++ +C  +  +      LV +Y+  GSL D + Q         L     LN  
Sbjct: 73  DHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWG 121

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           + +A  + YL  H    MVH +L   NVLL       V DFG+A  L
Sbjct: 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  114 bits (288), Expect = 8e-28
 Identities = 48/243 (19%), Positives = 91/243 (37%), Gaps = 34/243 (13%)

Query: 470 SRKLKITLLKVLIPVAVSCWILFSCLTIVY--ARRRRSAHNSADTSPMEKQFPMVSYA-E 526
            R+       +L+P           +  +     ++  + N            + +   E
Sbjct: 15  GRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPE 74

Query: 527 LSKATSEF---------SSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KG 571
           L +A               + +IG+G FG VY G L      ++  AVK   L +    G
Sbjct: 75  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIG 132

Query: 572 AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ 631
               F+ E   +++  H N++ ++ IC  ++   +    +V  YM +G L +++      
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHN 188

Query: 632 VEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
                 ++   +   + VA  +++L         VH DL   N +LD      V DFGLA
Sbjct: 189 -----PTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 691 KFL 693
           + +
Sbjct: 240 RDM 242

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  116 bits (292), Expect = 9e-28
 Identities = 67/419 (15%), Positives = 125/419 (29%), Gaps = 51/419 (12%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
             +   A   +          L+ L  +    +S+     T +  L  L +L    N   
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT 77

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNAS 134
            +    +   ++L Y    SN+ + +L       L  L  L    N    L    +S   
Sbjct: 78  TL---DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNK---LTKLDVSQNP 127

Query: 135 NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLS 194
            L  L+ + N       ID S    L  L+   N               +T  + L  L 
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT--------KLDVTPQTQLTTLD 176

Query: 195 LSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP 254
            S N+        ++     +       N I+  + L     + L  L    N+L   I 
Sbjct: 177 CSFNKITEL---DVSQNKL-LNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLT-EID 228

Query: 255 DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQ 314
             +  L  L       N L   +   +  L+KL  L      L    +    +LI    +
Sbjct: 229 --VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAE 283

Query: 315 QLLSITTLSL-------YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLST 367
               I  L +        LD     +   L   +     L+ L +++ + +  +   +S 
Sbjct: 284 GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSH 337

Query: 368 CVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSY 426
              L+ +   +         S+G + ++     +         + L N S    ++   
Sbjct: 338 NTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  103 bits (258), Expect = 2e-23
 Identities = 66/377 (17%), Positives = 107/377 (28%), Gaps = 61/377 (16%)

Query: 8   EIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLN 67
           ++     L  LA   N LT  L   +  L+ L  ++   N L       +     L  LN
Sbjct: 80  DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLN 133

Query: 68  VAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP 127
            A N    +    + + + L       N+    L          L  L    N    L  
Sbjct: 134 CARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKITEL-- 185

Query: 128 DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNC 187
             +S    L  L+   N       +D +    L  L+   N L      ++      T  
Sbjct: 186 -DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKL-----TEIDV----TPL 232

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
           + L     S N        +++ L++           +   I L   +   LI    E  
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTT----LHCIQTDLL-EIDLT--HNTQLIYFQAEGC 285

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK 307
           +    +   +     L LL      +   +   L    KL  L L +  L    ++   K
Sbjct: 286 RKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTELDVSHNTK 340

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT--- 364
           L                 L   N  +       VG +  L     +  Q   M   T   
Sbjct: 341 LK---------------SLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTN 383

Query: 365 --LSTCVSLEYVDISSN 379
             L+  VS + +D   N
Sbjct: 384 NSLTIAVSPDLLDQFGN 400

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 93.6 bits (233), Expect = 2e-20
 Identities = 61/329 (18%), Positives = 101/329 (30%), Gaps = 44/329 (13%)

Query: 110 PNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQN 168
            N       A         S    + L  LD  N+       +     L  L +L    N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT---DMTGIEKLTGLTKLICTSN 74

Query: 169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGT 228
           N+       L      +  ++L  L+   N+    L   +  L+  +       N+++  
Sbjct: 75  NI-----TTLDL----SQNTNLTYLACDSNKL-TNLD--VTPLTK-LTYLNCDTNKLT-- 119

Query: 229 IPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLA 288
             L +     L  L    N L   I   +     L  L  + N     +   +   T+L 
Sbjct: 120 -KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173

Query: 289 KLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-------YLDLSNNLLNGSLPQQV 341
            LD   N +      SQNKL+  L     +IT L L       +LD S+N L   +   V
Sbjct: 174 TLDCSFNKIT-ELDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EID--V 229

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVS 401
             L  L   D S N  +    + +ST   L  +         I    L     + +    
Sbjct: 230 TPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAE 283

Query: 402 CNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
                 +    + + + L  L+     + 
Sbjct: 284 GCRKIKELD--VTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 86.7 bits (215), Expect = 5e-18
 Identities = 46/330 (13%), Positives = 100/330 (30%), Gaps = 42/330 (12%)

Query: 9   IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNV 68
           +     L  L  A N LT ++   + + + L  +    N         +     L  L+ 
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDC 177

Query: 69  AENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD 128
           + NK   +    +     L      +N  +  L  +       L  L   +N    +   
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKLTEI--- 227

Query: 129 SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN--------------LGIGA 174
            ++  + L   D S N       +D S+L  L  L+  Q +                   
Sbjct: 228 DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEG 284

Query: 175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIR 234
              +  +  +T+ + L +L         EL   ++     ++   +   +++  + +   
Sbjct: 285 CRKIKELD-VTHNTQLYLLDCQAAGIT-ELD--LSQNPK-LVYLYLNNTELT-ELDVS-- 336

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
           +   L +L+     +       +G++  L      +          L N +    +    
Sbjct: 337 HNTKLKSLSCVNAHI--QDFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394

Query: 295 NSLQGNFIASQNKLIGALPQQLLSITTLSL 324
               GN +  +    G   Q   +IT  +L
Sbjct: 395 LDQFGNPMNIEPGDGGVYDQATNTITWENL 424

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  113 bits (285), Expect = 9e-28
 Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 9/183 (4%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G+G F  V       D    A+K I   ++        E +  R   H N+++++    
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94

Query: 600 STDFKGVDFKA-LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
               +G   +A L+  +   G+L + + +  D+     L+  Q L + + +   +E +H 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH- 151

Query: 659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS-SKTPSSSIGIKGTVGY 717
                  H DLKP+N+LL  +    + D G       H   +  + T       + T+ Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 718 VAP 720
            AP
Sbjct: 210 RAP 212

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (292), Expect = 1e-27
 Identities = 42/166 (25%), Positives = 86/166 (51%), Gaps = 21/166 (12%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 589
           ++ +  + +G G +G VY+G+  +  + VAVK +    +       F+ E   ++ I+H 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           NL++++ +C+     +       ++ E+M  G+L D+L + N Q    ++S +  L +A 
Sbjct: 277 NLVQLLGVCTREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMAT 325

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            ++SA+EYL        +H +L   N L+  + +  V DFGL++ +
Sbjct: 326 QISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  116 bits (293), Expect = 1e-27
 Identities = 77/364 (21%), Positives = 127/364 (34%), Gaps = 19/364 (5%)

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
                  ++ N  S  L    +++L  L+ L I  N    L          LE LDLS+N
Sbjct: 21  QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79

Query: 145 QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL 204
           +      I       L  L+L  N       + L       N S LK L LS        
Sbjct: 80  KLV---KISCHPTVNLKHLDLSFNAF-----DALPICKEFGNMSQLKFLGLSTTHLEKSS 131

Query: 205 PHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV--NLIALAVEVNQLHGTIPDVIGELKN 262
              IA+L+ + ++ ++G        P G+++    +L  +     + H  +   +  + N
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191

Query: 263 LQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTL 322
           L+L  +            L  L KL      SN    N   + N  I  L  QL+  TT+
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTV 249

Query: 323 SLYLDLSNNLLNGSLPQQVG-----NLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDIS 377
             Y  +SN  L G L  +       +LK L I  + S+ F            ++   + +
Sbjct: 250 -WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 378 SNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKG 437
            +    +       +     LD S N  +    +   +L+ LE L L  N L+       
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368

Query: 438 VFSN 441
           + + 
Sbjct: 369 MTTQ 372

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  115 bits (289), Expect = 3e-27
 Identities = 88/463 (19%), Positives = 158/463 (34%), Gaps = 40/463 (8%)

Query: 6   PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQ 65
             +I SL KL+ L ++ N +             L+ + +  N L  K         NL  
Sbjct: 38  TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKH 94

Query: 66  LNVAENKFYGM-FPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKE-LGIGANNFF 123
           L+++ N F  +   +   N+S L++  L++           + +L   K  L +G     
Sbjct: 95  LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLLVLGETYGE 153

Query: 124 GLIPDSLSN--ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFV 181
              P+ L +    +L ++  +N +F   + +   ++  L   N++        +  L  +
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213

Query: 182 TFLTNCSSLKVLSLSDNQFGGE-LPHSIANLSSTMIVFL------IGGNQISGTIPLGIR 234
             L     L  L+L++ +         +  +  T + +       + G            
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
           +L  L    V  +        +     N+ +     +  +         ++    LD  +
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333

Query: 295 NSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG---NLKNLIILD 351
           N L                 +     T    L L  N L   L +       +K+L  LD
Sbjct: 334 NLLT------------DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380

Query: 352 ISSNQFSGMIP-VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFP 410
           IS N  S        S   SL  +++SSN     I   L     IK LD+  N      P
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP 437

Query: 411 KFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSK---IPLQGN 450
           K +  L  L+ LN++ N L+  VP  G+F   +    I L  N
Sbjct: 438 KQVVKLEALQELNVASNQLK-SVP-DGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (265), Expect = 3e-24
 Identities = 68/400 (17%), Positives = 147/400 (36%), Gaps = 47/400 (11%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
           I KE G++ +L+ L L+  +L       I +L+  +V+ + G + G K       L++  
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFN 164

Query: 65  QLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
             ++            I ++S      L  +     L  +      ++            
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224

Query: 125 LIPDSLS-------------NASNLELLDLSNNQFKG-----KVSIDFSSLKILWRLNLE 166
           L  +++                + +    +SN + +G           +SLK L    + 
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            +  G   +            S++ + + + +          + +S  + +     N ++
Sbjct: 285 SDVFGFPQSY------IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF-SNNLLT 337

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIG---ELKNLQLLGLYKNFLQGSIPSGL-G 282
            T+     +L  L  L +++NQL   +  +     ++K+LQ L + +N +      G   
Sbjct: 338 DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396

Query: 283 NLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG 342
               L  L++ SN L        + +   LP ++         LDL +N +  S+P+QV 
Sbjct: 397 WTKSLLSLNMSSNILT-------DTIFRCLPPRIK-------VLDLHSNKIK-SIPKQVV 441

Query: 343 NLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
            L+ L  L+++SNQ   +         SL+ + + +N + 
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 44/242 (18%), Positives = 82/242 (33%), Gaps = 23/242 (9%)

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
            +LS    +  I  N IS      I +L  L  L +  N++      V    + L+ L L
Sbjct: 17  KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ-----GNFIA---------SQNKLIGALPQ 314
             N L   I         L  LDL  N+         F           S   L  +   
Sbjct: 77  SHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 315 QLLSITTLSLYLDLSNNLLNGSLPQQVGNL--KNLIILDISSNQFSGMIPVTLSTCVSLE 372
            +  +    + L L         P+ + +   ++L I+  ++ +F  ++ V++ T  +LE
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193

Query: 373 YVDISSNCFHGIIPPSLGFLKSIK----FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNH 428
             +I            L  L  ++      +++ NN    +  F+  L  +    + Y  
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253

Query: 429 LE 430
           + 
Sbjct: 254 IS 255

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 45/163 (27%), Positives = 65/163 (39%), Gaps = 7/163 (4%)

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT 364
               +  +P+ L   TT    L++S N ++      + +L  L IL IS N+   +    
Sbjct: 8   SKNGLIHVPKDLSQKTT---ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF-SGQFPKFLENLSFLEFLN 423
                 LEY+D+S N    I   S     ++K LD+S N F +    K   N+S L+FL 
Sbjct: 65  FKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 424 LSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSCP 466
           LS  HLE          N SK+ L          D   L    
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (282), Expect = 1e-27
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 23/162 (14%)

Query: 540 IGQGSFGSVYKGIL--GEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKI 594
           +G G+FGSV +G+    + ++ VA+KV  LK   +K      + E + +  + +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           I +C +          LV E  G G L  +L    ++     + +     +   V+  ++
Sbjct: 76  IGVCQAEALM------LVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMK 124

Query: 655 YL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           YL   +     VH DL   NVLL +   A + DFGL+K L +
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  112 bits (282), Expect = 1e-27
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 27/185 (14%)

Query: 522 VSYAELSKATSEFSSSN------MIGQGSFGSVYKGIL--GEDEMIVAVKVI--NLKQKG 571
           ++  E+                  +G G+FG+V KG     +    VAVK++        
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60

Query: 572 AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ 631
                +AE   ++ + +  ++++I IC +  +       LV E    G L  +L Q+   
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYLQQNR-- 112

Query: 632 VEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
                +     + +   V+  ++YL   +     VH DL   NVLL     A + DFGL+
Sbjct: 113 ----HVKDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 691 KFLSS 695
           K L +
Sbjct: 165 KALRA 169

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  112 bits (283), Expect = 2e-27
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 27/163 (16%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLI 592
           IG G  G V  G L   G+ ++ VA+K +      +Q+   R F++E   +    H N+I
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNII 113

Query: 593 KIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++  + +             +V EYM NGSL+ +L   + Q      +++Q + +   V 
Sbjct: 114 RLEGVVTRGRLAM-------IVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVG 161

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           + + YL        VH DL   NVL+D ++V  V DFGL++ L
Sbjct: 162 AGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  115 bits (289), Expect = 2e-27
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 22/186 (11%)

Query: 512 TSPMEKQFPMVSYAELSKATSEFSSS-----NMIGQGSFGSVYKGILGEDEMIVAVKVIN 566
             P   +  + +  E  ++    +         IG+G FG V  G    ++  VAVK   
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC-- 223

Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
           +K     ++F+AE   +  +RH NL++++ +      +      +V EYM  GSL D+L 
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR 279

Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
                     L     L  ++DV  A+EYL  ++     VH DL   NVL+  D VA V 
Sbjct: 280 SRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVS 331

Query: 686 DFGLAK 691
           DFGL K
Sbjct: 332 DFGLTK 337

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  111 bits (280), Expect = 2e-27
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 22/178 (12%)

Query: 520 PMVSYAELSKATSEFSSS-----NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR 574
            + +  E  ++    +         IG+G FG V  G    ++  VAVK   +K     +
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQ 59

Query: 575 SFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV 634
           +F+AE   +  +RH NL++++ +      +      +V EYM  GSL D+L         
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS--- 112

Query: 635 CKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             L     L  ++DV  A+EYL  ++     VH DL   NVL+  D VA V DFGL K
Sbjct: 113 -VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (283), Expect = 2e-27
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 28/164 (17%)

Query: 540 IGQGSFGSVYKGIL----GEDEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNL 591
           IG G FG VYKG+L    G+ E+ VA+K +      KQ+     F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNI 108

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           I++  + S             ++ EYM NG+L+ +L + + +      S++Q + +   +
Sbjct: 109 IRLEGVISKYKPMM-------IITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGI 156

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           A+ ++YL +      VH DL   N+L++ ++V  V DFGL++ L
Sbjct: 157 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  111 bits (279), Expect = 3e-27
 Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 15/171 (8%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+GSF +VYKG+  E  + VA   +  ++  K   + F  E E L+ ++H N+++    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 598 CSSTDFKGVDFKALVF--EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
             ST       K +V   E M +G+L+ +L           + +    +    +   +++
Sbjct: 94  WESTVKGK---KCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQF 144

Query: 656 LHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           LH    PP++H DLK  N+ +        +GD GLA    +        TP
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP 194

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  113 bits (284), Expect = 3e-27
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 35/197 (17%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLI 592
           +G G FG V  G L    + E+ VA+K +      KQ+   R F+ E   +    H N+I
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           ++  +   T  K V    +V EYM NGSL+ +L + + Q      ++IQ + +   +AS 
Sbjct: 110 RLEGVV--TKSKPV---MIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASG 159

Query: 653 IEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           ++YL         VH DL   N+L++ ++V  V DFGL + L     + +  T    I I
Sbjct: 160 MKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTRGGKIPI 214

Query: 712 KGTVGYVAP-----GKF 723
           + T    +P      KF
Sbjct: 215 RWT----SPEAIAYRKF 227

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (278), Expect = 4e-27
 Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 24/161 (14%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 593
           IG+G FG V++GI        + VA+K    K          F+ E   +R   H +++K
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I + +           ++ E    G L  +L Q         L L   +  A  +++A+
Sbjct: 81  LIGVITENPVW------IIMELCTLGELRSFL-QVRKY----SLDLASLILYAYQLSTAL 129

Query: 654 EYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL         VH D+   NVL+  +    +GDFGL++++
Sbjct: 130 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 166

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  110 bits (278), Expect = 4e-27
 Identities = 38/161 (23%), Positives = 77/161 (47%), Gaps = 24/161 (14%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 593
           +G+G FG VY+G+      +++ VAVK    K+         F++E   ++N+ H +++K
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I I             ++ E    G L  +L ++ +      L ++  +  ++ +  A+
Sbjct: 78  LIGIIEEEPTW------IIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAM 126

Query: 654 EYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL   +C    VH D+   N+L+       +GDFGL++++
Sbjct: 127 AYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI 163

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  111 bits (279), Expect = 7e-27
 Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 28/167 (16%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 591
           +GQGSFG VY+G+       E E  VA+K   + +         F+ E   ++     ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL----HQSNDQVEVCKLSLIQRLNI 645
           ++++ + S             ++ E M  G L+ +L        +   +   SL + + +
Sbjct: 91  VRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 646 AIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           A ++A  + YL+ +      VH DL   N ++  D    +GDFG+ +
Sbjct: 144 AGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (274), Expect = 1e-26
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHR 589
            + +    +G G FG V  G     +  VA+K+I    +G+     F+ E + + N+ H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 79

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            L+++  +C+     F       ++ EYM NG L ++L +        +    Q L +  
Sbjct: 80  KLVQLYGVCTKQRPIF-------IITEYMANGCLLNYL-REMRH----RFQTQQLLEMCK 127

Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           DV  A+EYL         +H DL   N L++   V  V DFGL++++
Sbjct: 128 DVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (276), Expect = 2e-26
 Identities = 39/189 (20%), Positives = 77/189 (40%), Gaps = 11/189 (5%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKII-- 595
           ++ +G F  VY+          A+K +   ++   R+ + E   ++ +  H N+++    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
                 +      + L+   +  G L ++L +   +     LS    L I      A+++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQH 151

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS----IGI 711
           +H   +PP++H DLK  N+LL +     + DFG A  +S +   + S    +     I  
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 712 KGTVGYVAP 720
             T  Y  P
Sbjct: 211 NTTPMYRTP 219

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (273), Expect = 2e-26
 Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 17/186 (9%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIIT 596
            IG GS+G   K     D  I+  K ++     +   +  V+E   LR ++H N   I+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
                  +      +V EY   G L   + +   + +      +  L +   +  A++  
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKEC 127

Query: 657 H--HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           H        ++H DLKP+NV LD      +GDFGLA+ L+       +          GT
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--------FVGT 179

Query: 715 VGYVAP 720
             Y++P
Sbjct: 180 PYYMSP 185

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  108 bits (273), Expect = 2e-26
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 29/169 (17%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V+          +D+M+VAVK +      A + F  E E L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 595 ITICSSTD--FKGVDFKALVFEYMGNGSLEDWL----------HQSNDQVEVCKLSLIQR 642
             +C   D          +VFEYM +G L  +L               +    +L L Q 
Sbjct: 83  YGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 643 LNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           L+IA  +AS + YL   H     VH DL   N L+  +++  +GDFG++
Sbjct: 136 LHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMS 180

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  108 bits (272), Expect = 2e-26
 Identities = 40/165 (24%), Positives = 80/165 (48%), Gaps = 21/165 (12%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRNIRHR 589
                   +G G FG V+ G        VAVK +    +G+    +F+AE   ++ ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
            L+++  + +           ++ EYM NGSL D+L   +      KL++ + L++A  +
Sbjct: 69  RLVRLYAVVTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQI 118

Query: 650 ASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           A  + ++   +     +H DL+ +N+L+   +   + DFGLA+ +
Sbjct: 119 AEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI 159

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  109 bits (274), Expect = 3e-26
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 28/168 (16%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G+FG V+          +D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 595 ITICSSTD--FKGVDFKALVFEYMGNGSLEDWL---------HQSNDQVEVCKLSLIQRL 643
             +C+             +VFEYM +G L  +L             + V    L L Q L
Sbjct: 109 FGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 644 NIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            +A  VA+ + YL   H     VH DL   N L+   +V  +GDFG++
Sbjct: 162 AVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMS 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (271), Expect = 3e-26
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHR 589
            E +    +G G FG V  G   + +  VAVK+I    +G+     F  E + +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHP 63

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            L+K   +CS     +       +V EY+ NG L ++L +S+ +     L   Q L +  
Sbjct: 64  KLVKFYGVCSKEYPIY-------IVTEYISNGCLLNYL-RSHGK----GLEPSQLLEMCY 111

Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           DV   + +L  H      +H DL   N L+D D+   V DFG+ +++
Sbjct: 112 DVCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  107 bits (270), Expect = 3e-26
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 25/167 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHR 589
           SE +    IG G FG V+ G    ++  VA+K I    +GA     F+ E E +  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 63

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            L+++  +C              LV E+M +G L D+L ++         +    L + +
Sbjct: 64  KLVQLYGVCLEQAPIC-------LVTEFMEHGCLSDYL-RTQRG----LFAAETLLGMCL 111

Query: 648 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
           DV   + YL         +H DL   N L+  + V  V DFG+ +F+
Sbjct: 112 DVCEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFV 154

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  107 bits (270), Expect = 5e-26
 Identities = 35/172 (20%), Positives = 77/172 (44%), Gaps = 34/172 (19%)

Query: 540 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
           +GQG+F  ++KG+           E  V +KV++   +    SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 593 KIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
               +C   D          LV E++  GSL+ +L ++ +      ++++ +L +A  +A
Sbjct: 76  LNYGVCVCGDENI-------LVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLA 123

Query: 651 SAIEYL-HHHCQPPMVHGDLKPSNVLLDHD--------MVAHVGDFGLAKFL 693
           +A+ +L  +      +HG++   N+LL  +            + D G++  +
Sbjct: 124 AAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  108 bits (272), Expect = 5e-26
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 23/187 (12%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITI 597
           ++GQG+  +V++G   +   + A+KV N           + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
               +      K L+ E+   GSL   L + +       L   + L +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 658 HHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            +    +VH ++KP N++     D   V  + DFG A+ L       S         + G
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---------LYG 177

Query: 714 TVGYVAP 720
           T  Y+ P
Sbjct: 178 TEEYLHP 184

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  111 bits (278), Expect = 5e-26
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 17/174 (9%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHRN 590
                   +GQG FG V+ G        VA+K   LK       +F+ E + ++ +RH  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           L+++  + S           +V EYM  GSL D+L     +     L L Q +++A  +A
Sbjct: 241 LVQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIA 290

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
           S + Y+        VH DL+ +N+L+  ++V  V DFGLA+ +  +        
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  110 bits (277), Expect = 6e-26
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 15/162 (9%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
                   +G G FG V+          VAVK +      +  +F+AE   ++ ++H  L
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKL 245

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +K+  + +           ++ E+M  GSL D+L          K  L + ++ +  +A 
Sbjct: 246 VKLHAVVTKEPI------YIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAE 295

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            + ++        +H DL+ +N+L+   +V  + DFGLA+ +
Sbjct: 296 GMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (279), Expect = 7e-26
 Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 24/199 (12%)

Query: 512 TSPMEKQFPMVSYA-----ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 566
           T+      P          E+ +          +GQG FG V+ G        VA+K   
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT-- 298

Query: 567 LKQKGAFR-SFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL 625
           LK       +F+ E + ++ +RH  L+++  + S           +V EYM  GSL D+L
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIVTEYMSKGSLLDFL 352

Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
                +     L L Q +++A  +AS + Y+        VH DL+ +N+L+  ++V  V 
Sbjct: 353 KGETGK----YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405

Query: 686 DFGLAKFLSSHHLDTSSKT 704
           DFGLA+ +  +        
Sbjct: 406 DFGLARLIEDNEYTARQGA 424

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  112 bits (281), Expect = 7e-26
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 32/187 (17%)

Query: 539 MIGQGSFGSVYKGILGEDEMI----VAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIK 593
            I  G  G +Y   L  D  +    V +K +        ++  +AE + L  + H ++++
Sbjct: 87  CIAHGGLGWIY---LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           I      TD  G     +V EY+G  SL+    Q        KL + + +   +++  A+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPAL 195

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            YLH      +V+ DLKP N++L  + +  + D G    ++                + G
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN----SFGY--------LYG 239

Query: 714 TVGYVAP 720
           T G+ AP
Sbjct: 240 TPGFQAP 246

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  107 bits (270), Expect = 1e-25
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 28/167 (16%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +G G+FG VY+G +         + VAVK   L +  + +    F+ E   +    H+N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQS-NDQVEVCKLSLIQRLNIAID 648
           ++ I +   +   F       ++ E M  G L+ +L ++     +   L+++  L++A D
Sbjct: 96  VRCIGVSLQSLPRF-------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148

Query: 649 VASAIEYL-HHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +H     +H D+   N LL       VA +GDFG+A+
Sbjct: 149 IACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  106 bits (268), Expect = 1e-25
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 30/172 (17%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK---GAFRSFVAECEALRNI-RHRN 590
           +G+G+FG V +              VAVK+  LK+       R+ ++E + L +I  H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWL----------HQSNDQVEVCKLSLI 640
           ++ ++  C+           ++ E+   G+L  +L            + + +    L+L 
Sbjct: 93  VVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 641 QRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             +  +  VA  +E+L    C    +H DL   N+LL    V  + DFGLA+
Sbjct: 149 HLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR 196

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  107 bits (268), Expect = 1e-25
 Identities = 48/218 (22%), Positives = 88/218 (40%), Gaps = 27/218 (12%)

Query: 507 HNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 566
           H+   +S ++     + +  +S     +S    IG G    V++  L E + I A+K +N
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN 61

Query: 567 LKQ--KGAFRSFVAECEALRNIRHRNL--IKIITICSSTDFKGVDFKALVFEYMGNGSLE 622
           L++       S+  E   L  ++  +   I++             +  +V E  GN  L 
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMEC-GNIDLN 115

Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
            WL +         +   +R +   ++  A+  +H H    +VH DLKP+N L+   M+ 
Sbjct: 116 SWLKKKK------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML- 165

Query: 683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            + DFG+A  +          +        GTV Y+ P
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDS------QVGTVNYMPP 197

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  110 bits (277), Expect = 2e-25
 Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 23/162 (14%)

Query: 540 IGQGSFGSVYKGIL--GEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKI 594
           +G G+FGSV +G+    + ++ VA+KV  LK   +K      + E + +  + +  ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           I +C +          LV E  G G L  +L    ++     + +     +   V+  ++
Sbjct: 402 IGVCQAEALM------LVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMK 450

Query: 655 YL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           YL   +     VH +L   NVLL +   A + DFGL+K L +
Sbjct: 451 YLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (266), Expect = 2e-25
 Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 34/172 (19%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 591
           +G+  FG VYKG L     GE    VA+K   LK          F  E      ++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL----------HQSNDQVEVCKLSL 639
           + ++ + +             ++F Y  +G L ++L             +D+     L  
Sbjct: 75  VCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 640 IQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
              +++   +A+ +EYL  HH     VH DL   NVL+   +   + D GL 
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF 175

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  106 bits (268), Expect = 2e-25
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 32/173 (18%)

Query: 538 NMIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNL 591
           ++IG+G+FG V K  +      M  A+K   +K+   K   R F  E E L  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQS----------NDQVEVCKLSL 639
           I ++  C      +       L  EY  +G+L D+L +S                  LS 
Sbjct: 89  INLLGACEHRGYLY-------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 640 IQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
            Q L+ A DVA  ++YL         +H DL   N+L+  + VA + DFGL++
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR 190

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  107 bits (269), Expect = 2e-25
 Identities = 44/208 (21%), Positives = 79/208 (37%), Gaps = 30/208 (14%)

Query: 523 SYAELSKATSEFSSSNM--------IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGA 572
             + +   T      +M        IG+GSFG        ED     +K IN+ +     
Sbjct: 7   HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 573 FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV 632
                 E   L N++H N+++         F+      +V +Y   G L   ++      
Sbjct: 67  REESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQKGV- 120

Query: 633 EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF 692
                   Q L+  + +  A++++H      ++H D+K  N+ L  D    +GDFG+A+ 
Sbjct: 121 ---LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           L+S      +          GT  Y++P
Sbjct: 175 LNSTVELARA--------CIGTPYYLSP 194

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (266), Expect = 3e-25
 Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 44/182 (24%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 590
           +G+G FG V K              VAVK+  LK + A     R  ++E   L+ + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 591 LIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL------------------HQSND 630
           +IK+   CS             L+ EY   GSL  +L                    S D
Sbjct: 88  VIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 631 QVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
             +   L++   ++ A  ++  ++YL         VH DL   N+L+       + DFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGL 196

Query: 690 AK 691
           ++
Sbjct: 197 SR 198

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  106 bits (266), Expect = 4e-25
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 44/214 (20%)

Query: 507 HNSADTSPMEKQFPMVSYAELSKATSEFSSSN-----MIGQGSFGSVYKGIL-------G 554
           H+     PM          E  K   EF          +G+G+FG V             
Sbjct: 7   HHHHSQDPMLAGVSEYELPEDPKW--EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKP 64

Query: 555 EDEMIVAVKVINLKQK---GAFRSFVAECEALRNI-RHRNLIKIITICSSTD--FKGVDF 608
           ++ + VAVK+  LK           V+E E ++ I +H+N+I ++  C+     +     
Sbjct: 65  KEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY----- 117

Query: 609 KALVFEYMGNGSLEDWL----------HQSNDQVEVCKLSLIQRLNIAIDVASAIEYL-H 657
             ++ EY   G+L ++L              ++V   +++    ++    +A  +EYL  
Sbjct: 118 --VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             C    +H DL   NVL+  + V  + DFGLA+
Sbjct: 176 QKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  110 bits (275), Expect = 4e-25
 Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 20/187 (10%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKII-T 596
            +G G FG V + I  +    VA+K    +     R     E + ++ + H N++     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
                     D   L  EY   G L  +L+Q  +    C L       +  D++SA+ YL
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYL 137

Query: 657 HHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           H +    ++H DLKP N++L      ++  + D G AK L    L T            G
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---------VG 185

Query: 714 TVGYVAP 720
           T+ Y+AP
Sbjct: 186 TLQYLAP 192

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  106 bits (266), Expect = 4e-25
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 27/187 (14%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL--IK 593
             IG G    V++  L E + I A+K +NL++       S+  E   L  ++  +   I+
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +             +  +V E  GN  L  WL +         +   +R +   ++  A+
Sbjct: 74  LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 121

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
             +H H    +VH DLKP+N L+   M+  + DFG+A  +          +        G
Sbjct: 122 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 171

Query: 714 TVGYVAP 720
           TV Y+ P
Sbjct: 172 TVNYMPP 178

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  106 bits (266), Expect = 5e-25
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 28/167 (16%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 591
           +G G+FG VY+G +         + VAVK   L +  + +    F+ E   +    H+N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQS-NDQVEVCKLSLIQRLNIAID 648
           ++ I +   +   F       ++ E M  G L+ +L ++     +   L+++  L++A D
Sbjct: 137 VRCIGVSLQSLPRF-------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 649 VASAIEYL-HHHCQPPMVHGDLKPSNVLLD---HDMVAHVGDFGLAK 691
           +A   +YL  +H     +H D+   N LL       VA +GDFG+A+
Sbjct: 190 IACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  109 bits (274), Expect = 5e-25
 Identities = 40/161 (24%), Positives = 68/161 (42%), Gaps = 24/161 (14%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIK 593
           IG+G FG V++GI        M VA+K    K          F+ E   +R   H +++K
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I + +           ++ E    G L  +L           L L   +  A  +++A+
Sbjct: 456 LIGVITENPV------WIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTAL 504

Query: 654 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
            YL         VH D+   NVL+  +    +GDFGL++++
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 541

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (267), Expect = 6e-25
 Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 23/187 (12%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIKIITI 597
           ++GQG+  +V++G   +   + A+KV N +         + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
               +      K L+ E+   GSL   L + +       L   + L +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 658 HHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            +    +VH ++KP N++     D   V  + DFG A+ L       S         + G
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---------LYG 177

Query: 714 TVGYVAP 720
           T  Y+ P
Sbjct: 178 TEEYLHP 184

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 8e-25
 Identities = 50/227 (22%), Positives = 80/227 (35%), Gaps = 35/227 (15%)

Query: 501 RRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIV 560
           + RR +     +  ++      S  E S     F   + +G GS+G V+K    ED  + 
Sbjct: 27  QPRRVSFRGEASETLQSPGYDPSRPE-SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85

Query: 561 AVKVINLKQKGAF--RSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKA----LVF 613
           AVK      +G       +AE  +   + +H   ++          +    +     L  
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR---------LEQAWEEGGILYLQT 136

Query: 614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 673
           E  G  SL+              L   Q      D   A+ +LH      +VH D+KP+N
Sbjct: 137 ELCG-PSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPAN 187

Query: 674 VLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           + L       +GDFGL        L T+          +G   Y+AP
Sbjct: 188 IFLGPRGRCKLGDFGLLV-----ELGTAGAGEV----QEGDPRYMAP 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (265), Expect = 9e-25
 Identities = 43/187 (22%), Positives = 75/187 (40%), Gaps = 27/187 (14%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL--IK 593
             IG G    V++  L E + I A+K +NL++       S+  E   L  ++  +   I+
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +             +  +V E  GN  L  WL +         +   +R +   ++  A+
Sbjct: 121 LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAV 168

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
             +H H    +VH DLKP+N L+   M+  + DFG+A  +          +        G
Sbjct: 169 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 218

Query: 714 TVGYVAP 720
            V Y+ P
Sbjct: 219 AVNYMPP 225

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (263), Expect = 1e-24
 Identities = 27/247 (10%), Positives = 54/247 (21%), Gaps = 40/247 (16%)

Query: 499 YARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEM 558
             +   +   +   +   +       + LS+   +      +  G    V+     E   
Sbjct: 29  ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88

Query: 559 IVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLI---------------------KI 594
             A+KV  +  +              A   +   +                         
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV-CKLSLIQRLNIAIDVASAI 653
             +    D   V    L+        LE      +          ++    +   +    
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
             L       +VHG   P N+ +  D    +GD           + T     S       
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL-----WKVGTRGPASS------V 253

Query: 714 TVGYVAP 720
            V Y   
Sbjct: 254 PVTYAPR 260

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  104 bits (262), Expect = 1e-24
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 35/172 (20%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 589
           +G G+FG V +         +  + VAVK+  LK   A      + ++E + + ++ +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL--------HQSNDQVEVCKLSL 639
           N++ ++  C+             ++ EY   G L ++L              +     S 
Sbjct: 111 NIVNLLGACTHGGPVL-------VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 640 IQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
              L+ +  VA  + +L   +C    +H D+   NVLL +  VA +GDFGLA
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLA 211

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  105 bits (263), Expect = 2e-24
 Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 46/220 (20%)

Query: 502 RRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSN-----MIGQGSFGSVYKGIL--- 553
           R  +  +S   +PM          E  K   EF          +G+G FG V        
Sbjct: 48  RITTRLSSTADTPMLAGVSEYELPEDPKW--EFPRDKLTLGKPLGEGCFGQVVMAEAVGI 105

Query: 554 ----GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHRNLIKIITICSSTD-- 602
                ++ + VAVK+  LK   A        V+E E ++ I +H+N+I ++  C+     
Sbjct: 106 DKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162

Query: 603 FKGVDFKALVFEYMGNGSLEDWL----------HQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +       ++ EY   G+L ++L              ++V   +++    ++    +A  
Sbjct: 163 Y-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215

Query: 653 IEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +EYL    C    +H DL   NVL+  + V  + DFGLA+
Sbjct: 216 MEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  103 bits (259), Expect = 2e-24
 Identities = 40/176 (22%), Positives = 72/176 (40%), Gaps = 39/176 (22%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 589
           +G G+FG V +         +  M VAVK++      A      + ++E + L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL------------HQSNDQVEVC 635
           N++ ++  C+             ++ EY   G L ++L              +  + +  
Sbjct: 88  NIVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 636 KLSLIQRLNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
            L L   L+ +  VA  + +L   +C    +H DL   N+LL H  +  + DFGLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA 192

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  103 bits (258), Expect = 3e-24
 Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 29/224 (12%)

Query: 504 RSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVK 563
           +S        P  +    +         + F     IG+G F  VY+     D + VA+K
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63

Query: 564 VINLKQKGAFR---SFVAECEALRNIRHRNLIKIITICSSTDFKG--VDFKAL--VFEYM 616
            + +      +     + E + L+ + H N+IK         +    ++   L  V E  
Sbjct: 64  KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK---------YYASFIEDNELNIVLELA 114

Query: 617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
             G L   +     Q  +     +      + + SA+E++H      ++H D+KP+NV +
Sbjct: 115 DAGDLSRMIKHFKKQKRLIPERTV--WKYFVQLCSALEHMHSRR---VMHRDIKPANVFI 169

Query: 677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
               V  +GD GL +F SS      S        + GT  Y++P
Sbjct: 170 TATGVVKLGDLGLGRFFSSKTTAAHS--------LVGTPYYMSP 205

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (257), Expect = 6e-24
 Identities = 38/202 (18%), Positives = 77/202 (38%), Gaps = 42/202 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-----------------ECEA 582
           + QG F  +      +D    A+K          R F                   E + 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 583 LRNIRHRNLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLS 638
           + +I++   +    I ++ D  +       +++EYM N S+  +       D+   C + 
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVY-------IIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
           +     I   V ++  Y+H+     + H D+KPSN+L+D +    + DFG ++++    +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
             S          +GT  ++ P
Sbjct: 208 KGS----------RGTYEFMPP 219

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  102 bits (256), Expect = 7e-24
 Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 42/181 (23%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 591
           IG+G+FG V++         E   +VAVK+  LK+         F  E   +    + N+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDNPNI 112

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQS------------------NDQ 631
           +K++ +C+             L+FEYM  G L ++L                        
Sbjct: 113 VKLLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165

Query: 632 VEVCKLSLIQRLNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
                LS  ++L IA  VA+ + YL         VH DL   N L+  +MV  + DFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLS 221

Query: 691 K 691
           +
Sbjct: 222 R 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  102 bits (256), Expect = 9e-24
 Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 44/181 (24%)

Query: 540 IGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 589
           +G G+FG V              + VAVK+  LK + A      + ++E + +  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109

Query: 590 NLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL-----------------HQSND 630
           N++ ++  C+ +   +       L+FEY   G L ++L                  +  +
Sbjct: 110 NIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 631 QVEVCKLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
           + ++  L+    L  A  VA  +E+L    C    VH DL   NVL+ H  V  + DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGL 218

Query: 690 A 690
           A
Sbjct: 219 A 219

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  103 bits (259), Expect = 1e-23
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 31/195 (15%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRN 590
            F   +++G G+ G++    + ++   VAVK I  +    A R    E + LR    H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADR----EVQLLRESDEHPN 79

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           +I+    C+    K   F+ +  E     +L++++ Q +          ++ + +     
Sbjct: 80  VIRYF--CT---EKDRQFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTT 128

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           S + +LH      +VH DLKP N+L+        + A + DFGL K L+       S + 
Sbjct: 129 SGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV---GRHSFSR 182

Query: 706 SSSIGIKGTVGYVAP 720
            S +   GT G++AP
Sbjct: 183 RSGVP--GTEGWIAP 195

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  102 bits (256), Expect = 2e-23
 Identities = 44/177 (24%), Positives = 74/177 (41%), Gaps = 39/177 (22%)

Query: 540 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQKGA----FRSFVAECEALRNI-R 587
           +G+G+FG V                  VAVK++      A        ++E E ++ I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 588 HRNLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWL----------HQSNDQVEVC 635
           H+N+I ++  C+     +       ++ EY   G+L ++L            +       
Sbjct: 134 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 636 KLSLIQRLNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
           +LS    ++ A  VA  +EYL    C    +H DL   NVL+  D V  + DFGLA+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  101 bits (253), Expect = 2e-23
 Identities = 58/346 (16%), Positives = 117/346 (33%), Gaps = 54/346 (15%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
           L+ +  +   L  K+P  +       ++ ++ N +          L+NL  L +  NK  
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNAS 134
            + P +   +  LE  YL+ N+    LP  +      L+EL +  N    +     +  +
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLN 145

Query: 135 NLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLK 191
            + +++L  N  K    I+   F  +K L  + +   N+       +          SL 
Sbjct: 146 QMIVVELGTNPLK-SSGIENGAFQGMKKLSYIRIADTNI-----TTIPQGLP----PSLT 195

Query: 192 VLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLH 250
            L L  N+                             +     + L NL  L +  N + 
Sbjct: 196 ELHLDGNKI--------------------------TKVDAASLKGLNNLAKLGLSFNSIS 229

Query: 251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIG 310
                 +    +L+ L L  N L   +P GL +   +  + L +N++    I S +    
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS--AIGSNDFCPP 286

Query: 311 ALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSN 355
               +  S + +SL+   SN +    +       +     + + + 
Sbjct: 287 GYNTKKASYSGVSLF---SNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 60/317 (18%), Positives = 108/317 (34%), Gaps = 48/317 (15%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +P  L    +  LLDL NN+       DF +LK L  L L  N +     + +    F  
Sbjct: 46  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-----SKISPGAF-A 97

Query: 186 NCSSLKVLSLSDNQ---FGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIA 241
               L+ L LS NQ      ++P ++  L        +  N+I+  +   +   L  +I 
Sbjct: 98  PLVKLERLYLSKNQLKELPEKMPKTLQELR-------VHENEIT-KVRKSVFNGLNQMIV 149

Query: 242 LAVEVNQLHGTI--PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG 299
           + +  N L  +         +K L  + +    +  +IP GL     L +L L  N +  
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 205

Query: 300 NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFS 358
                       +    L        L LS N ++ ++      N  +L  L +++N+  
Sbjct: 206 -----------KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253

Query: 359 GMIPVTLSTCVSLEYVDISSNCFHGI------IPPSLGFLKSIKFLDVSCNNFSGQF--P 410
             +P  L+    ++ V + +N    I       P       S   + +  N        P
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312

Query: 411 KFLENLSFLEFLNLSYN 427
                +     + L   
Sbjct: 313 STFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 59/306 (19%), Positives = 105/306 (34%), Gaps = 39/306 (12%)

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
                  L +N+ +  +      NL NL  L +  N    + P + +    LE L LS N
Sbjct: 52  PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110

Query: 145 QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL 204
           Q K    +     K L  L + +N +     +           + + V+ L  N      
Sbjct: 111 QLK---ELPEKMPKTLQELRVHENEITKVRKSVF------NGLNQMIVVELGTNPLKSSG 161

Query: 205 --PHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKN 262
               +   +     + +     I+ TIP G+    +L  L ++ N++       +  L N
Sbjct: 162 IENGAFQGMKKLSYIRI-ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 217

Query: 263 LQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITT 321
           L  LGL  N +  ++ +G L N   L +L L +N L              +P  L     
Sbjct: 218 LAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV------------KVPGGLADHKY 264

Query: 322 LSLYLDLSNNLLNG------SLPQQVGNLKNLIILDISSN--QFSGMIPVTLSTCVSLEY 373
           +   + L NN ++         P       +   + + SN  Q+  + P T         
Sbjct: 265 IQ-VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323

Query: 374 VDISSN 379
           V + + 
Sbjct: 324 VQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 52/245 (21%), Positives = 106/245 (43%), Gaps = 22/245 (8%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
               +L L +N+          NL +   + L   N+IS  I  G    LV L  L +  
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLIL-INNKIS-KISPGAFAPLVKLERLYLSK 109

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQ 305
           NQL   +P+     K LQ L +++N +   +       L ++  ++LG+N L+ + I + 
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN- 164

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
               GA  Q +  ++    Y+ +++  +  ++PQ  G   +L  L +  N+ + +   +L
Sbjct: 165 ----GAF-QGMKKLS----YIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASL 212

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
               +L  + +S N    +   SL     ++ L ++ N    + P  L +  +++ + L 
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

Query: 426 YNHLE 430
            N++ 
Sbjct: 272 NNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 16/195 (8%)

Query: 12  LFK-LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKF--PTTLGLLRNLVQLNV 68
           + K LQ L +  N +T         L+ + V+ +  N L            ++ L  + +
Sbjct: 119 MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178

Query: 69  AENKF----YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
           A+        G+ P       SL   +L  N+ +  +    +  L NL +LG+  N+   
Sbjct: 179 ADTNITTIPQGLPP-------SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA 230

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
           +   SL+N  +L  L L+NN+   KV    +  K +  + L  NN+    +ND     + 
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289

Query: 185 TNCSSLKVLSLSDNQ 199
           T  +S   +SL  N 
Sbjct: 290 TKKASYSGVSLFSNP 304

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  102 bits (256), Expect = 6e-23
 Identities = 73/431 (16%), Positives = 131/431 (30%), Gaps = 60/431 (13%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL--GLLRN 62
           I   I + F L   +   N ++G   D+       +   + G +   +  + L   L+  
Sbjct: 3   IMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRN-EAVSLLKECLINQ 60

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
             +L +         P ++     +    +T N    SLP        +L+ L    +N 
Sbjct: 61  FSELQLNRLNL-SSLPDNLP--PQITVLEITQNALI-SLP----ELPASLEYLDAC-DNR 111

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVT 182
              +P+  ++   L+ LD+ NNQ    +    + L+    +N + N L            
Sbjct: 112 LSTLPELPAS---LKHLDVDNNQLT-MLPELPALLE---YINADNNQL----------TM 154

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL--- 239
                +SL+VLS+ +NQ    LP    +L        +  N +  ++P       +    
Sbjct: 155 LPELPTSLEVLSVRNNQLT-FLPELPESLE----ALDVSTNLLE-SLPAVPVRNHHSEET 208

Query: 240 -IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ 298
            I      N++   IP+ I  L     + L  N L   I   L   T       G     
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT-AQPDYHGPRIYF 266

Query: 299 GNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS 358
                 QN             T      D        +    V  + +    +  +N FS
Sbjct: 267 SMSDGQQN-------------TLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313

Query: 359 GMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSF 418
             +     T  +              +   L  L +   L       +    +  E+   
Sbjct: 314 AFLDRLSDTVSARNTSGFREQ-----VAAWLEKLSASAELRQQSFAVAADATESCEDRVA 368

Query: 419 LEFLNLSYNHL 429
           L + NL    L
Sbjct: 369 LTWNNLRKTLL 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  102 bits (255), Expect = 8e-23
 Identities = 58/317 (18%), Positives = 103/317 (32%), Gaps = 63/317 (19%)

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
           NN F L  +S  N  +    D  +          +   +        +N           
Sbjct: 8   NNNFSLSQNSFYNTISGTYADYFSA---------WDKWEKQALPGENRNEA--------- 49

Query: 180 FVTFLTNC--SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV 237
            V+ L  C  +    L L+       LP ++      + V  I  N +  ++P    +L 
Sbjct: 50  -VSLLKECLINQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELPASLE 103

Query: 238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSL 297
            L A     N+L  T+P++   LK+L +     N L   +P     L  +   +  +N L
Sbjct: 104 YLDACD---NRLS-TLPELPASLKHLDVDN---NQLT-MLPELPALLEYI---NADNNQL 152

Query: 298 QGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
                         LP+   S+  L     + NN L   LP+   +L+    LD+S+N  
Sbjct: 153 T------------MLPELPTSLEVL----SVRNNQLT-FLPELPESLE---ALDVSTNLL 192

Query: 358 SGMIPVTLSTCVSLE----YVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFL 413
              +P         E    +     N    I P ++  L     + +  N  S +  + L
Sbjct: 193 ES-LPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESL 250

Query: 414 ENLSFLEFLNLSYNHLE 430
              +     +    +  
Sbjct: 251 SQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 37/171 (21%), Positives = 62/171 (36%), Gaps = 22/171 (12%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL-GLLRN 62
            +P+   SL   + L +  N LT  LP+    L   + I+   N L     T L  L  +
Sbjct: 114 TLPELPASL---KHLDVDNNQLT-MLPELPALL---EYINADNNQL-----TMLPELPTS 161

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG---A 119
           L  L+V  N+     P       SLE   +++N    SLP   V    + +E  I     
Sbjct: 162 LEVLSVRNNQL-TFLPELP---ESLEALDVSTNLLE-SLPAVPV-RNHHSEETEIFFRCR 215

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
            N    IP+++ +      + L +N    ++    S        +  +   
Sbjct: 216 ENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  100 bits (250), Expect = 7e-23
 Identities = 37/249 (14%), Positives = 75/249 (30%), Gaps = 41/249 (16%)

Query: 498 VYARRRRSAHNSA-DTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGED 556
             +   +SA +S   TS      P    +EL +         ++GQ    +  +    E 
Sbjct: 38  TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 97

Query: 557 EMIVAVKVINLKQKGA----------------FRSFVAECEALRNIRHRNLIKIITICSS 600
                V V    ++                   R    + +A  ++R      ++     
Sbjct: 98  GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157

Query: 601 -------TDFKGVDFKALVFEYMG-NGSLEDWLHQSNDQVEVCK-LSLIQRLNIAIDVAS 651
                   D + +   +  F Y     +L+ +           K L    RL + + V  
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            +  LHH+    +VH  L+P +++LD      +  F       +  + +           
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS----------- 263

Query: 712 KGTVGYVAP 720
             + G+  P
Sbjct: 264 -VSRGFEPP 271

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 27/250 (10%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
           G+  N   LN+ EN+   +   S  ++  LE   L+ N    ++       L NL  L +
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLEL 119

Query: 118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNN----L 170
             N    +   +    S L+ L L NN  +   SI    F+ +  L RL+L +      +
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGELKRLSYI 176

Query: 171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIP 230
             GA             S+L+ L+L+      E+P+ +  L     + L  GN +S  I 
Sbjct: 177 SEGA---------FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL-SGNHLS-AIR 223

Query: 231 LGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLA 288
            G  + L++L  L +  +Q+     +    L++L  + L  N L   +P      L  L 
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 289 KLDLGSNSLQ 298
           ++ L  N   
Sbjct: 283 RIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.0 bits (213), Expect = 7e-18
 Identities = 46/239 (19%), Positives = 92/239 (38%), Gaps = 15/239 (6%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
            + L L  N +     +   +L  L+++ +  N +          L NL  L + +N+  
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNA 133
            +   +   +S L+  +L +N    S+P      +P+L+ L +G       I   +    
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184

Query: 134 SNLELLDLSNNQFKGKVSI-DFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
           SNL  L+L+    +    I + + L  L  L+L  N+L                   L+ 
Sbjct: 185 SNLRYLNLAMCNLR---EIPNLTPLIKLDELDLSGNHLSAIRPGS------FQGLMHLQK 235

Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLH 250
           L +  +Q      ++  NL S + + L   N ++  +P  +   L +L  + +  N  +
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINL-AHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 18/242 (7%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
           ++ ++L+L +NQ      +S  +L    I+ L   N I  TI +G    L NL  L +  
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQL-SRNHIR-TIEIGAFNGLANLNTLELFD 121

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIASQ 305
           N+L          L  L+ L L  N ++ SIPS     +  L +LDLG            
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL---------- 170

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
            +L          ++ L  YL+L+   L   +P  +  L  L  LD+S N  S + P + 
Sbjct: 171 KRLSYISEGAFEGLSNLR-YLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSF 227

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
              + L+ + +  +    I   +   L+S+  ++++ NN +         L  LE ++L 
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287

Query: 426 YN 427
           +N
Sbjct: 288 HN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 59/282 (20%), Positives = 100/282 (35%), Gaps = 50/282 (17%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +PD +S  +N  LL+L  NQ +      F  L+ L  L L +N++       +    F  
Sbjct: 58  VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-----RTIEIGAF-N 109

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAV 244
             ++L  L L DN+       +   LS    ++L   N I  +IP      + +L  L +
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL-RNNPIE-SIPSYAFNRIPSLRRLDL 167

Query: 245 -EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIA 303
            E+ +L          L NL+ L L    L+  IP+ L  L KL +LDL  N L      
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS----- 220

Query: 304 SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPV 363
                  A+                               L +L  L +  +Q   +   
Sbjct: 221 -------AIRPGSFQ------------------------GLMHLQKLWMIQSQIQVIERN 249

Query: 364 TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
                 SL  ++++ N    +       L  ++ + +  N +
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 82.5 bits (204), Expect = 9e-17
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 17/224 (7%)

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
             +S+   +  +  NQI        ++L +L  L +  N +          L NL  L L
Sbjct: 60  DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119

Query: 269 YKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLD 327
           + N L  +IP+G    L+KL +L L +N ++            ++P    +       LD
Sbjct: 120 FDNRLT-TIPNGAFVYLSKLKELWLRNNPIE------------SIPSYAFNRIPSLRRLD 166

Query: 328 LSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIP 386
           L        + +     L NL  L+++       IP  L+  + L+ +D+S N    I P
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224

Query: 387 PSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
            S   L  ++ L +  +          +NL  L  +NL++N+L 
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 41/191 (21%), Positives = 72/191 (37%), Gaps = 16/191 (8%)

Query: 12  LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE- 70
           L  L  L L  N LT         LS L+ + ++ N +          + +L +L++ E 
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
            +   +   +   +S+L Y  L                L  L EL +  N+   + P S 
Sbjct: 171 KRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLT---PLIKLDELDLSGNHLSAIRPGSF 227

Query: 131 SNASNLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNC 187
               +L+ L +  +Q +    I+   F +L+ L  +NL  NNL +   +        T  
Sbjct: 228 QGLMHLQKLWMIQSQIQ---VIERNAFDNLQSLVEINLAHNNLTLLPHD------LFTPL 278

Query: 188 SSLKVLSLSDN 198
             L+ + L  N
Sbjct: 279 HHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 29/137 (21%)

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT 364
             K +  +P  + + T     L+L  N +         +L++L IL +S N         
Sbjct: 51  VRKNLREVPDGISTNTR---LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR------ 101

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL 424
                      I    F+G        L ++  L++  N  +         LS L+ L L
Sbjct: 102 ----------TIEIGAFNG--------LANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143

Query: 425 SYNHLEGEVPTKGVFSN 441
             N +E  +P+   F+ 
Sbjct: 144 RNNPIE-SIPS-YAFNR 158

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 33/189 (17%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
            +G+G F   ++    + + + A K++    L +         E    R++ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                  F+  DF  +V E     SL +     ++  + E     L Q       +    
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ-------IVLGC 128

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS--SHHLDTSSKTPSSSIGI 711
           +YLH +    ++H DLK  N+ L+ D+   +GDFGLA  +            TP+     
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----- 180

Query: 712 KGTVGYVAP 720
                Y+AP
Sbjct: 181 -----YIAP 184

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 47/305 (15%), Positives = 86/305 (28%), Gaps = 36/305 (11%)

Query: 130 LSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL--TNC 187
                +LE L    +      +       I+  L+L++  +             L     
Sbjct: 39  YGGGRSLEYLLKRVDTE----ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGI 94

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
           S L+ L+L + +  G  P  +   +   +  L   N    T    +  L   +       
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL------- 147

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK 307
                          L++L + +          +     L+ LDL  N   G        
Sbjct: 148 ------------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER----GL 191

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL-S 366
           +    P +  ++  L+L  +      +G           L  LD+S N            
Sbjct: 192 ISALCPLKFPTLQVLAL-RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 367 TCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSY 426
               L  +++S      +     G    +  LD+S N      P   E L  +  L+L  
Sbjct: 251 WPSQLNSLNLSFTGLKQVPK---GLPAKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKG 305

Query: 427 NHLEG 431
           N    
Sbjct: 306 NPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 42/219 (19%), Positives = 70/219 (31%), Gaps = 26/219 (11%)

Query: 8   EIGSLFKLQALALAGNYLTGKLPDFIGNLS--ALQVIHIKGNSLGG--KFPTTLG--LLR 61
            +  +  LQ L L    +TG  P  +   +   L +++++  S      +   L   L  
Sbjct: 90  RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149

Query: 62  NLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVV---NLPNLKELGIG 118
            L  L++A+          +    +L    L+ N   G       +     P L+ L + 
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209

Query: 119 ANNF---FGLIPDSLSNASNLELLDLSNNQFKGKV-SIDFSSLKILWRLNLEQNNL---- 170
                   G+     +    L+ LDLS+N  +    +        L  LNL    L    
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269

Query: 171 -GIGAA--------NDLGFVTFLTNCSSLKVLSLSDNQF 200
            G+ A         N L           +  LSL  N F
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 45/259 (17%), Positives = 78/259 (30%), Gaps = 22/259 (8%)

Query: 32  FIGNLSALQVIHIKGNSLGGKFPTTLGLLR-----NLVQLNVAENKFYGMFPRSICNIS- 85
           F   + +L +  +   +         G LR      L +L +   +  G  P  +   + 
Sbjct: 61  FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120

Query: 86  -SLEYFYLTSNRFSGSLPFDIVVN---LPNLKELGIGANNFFGLIPDSLSNASNLELLDL 141
             L    L +  ++    +   +     P LK L I   +      + +     L  LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180

Query: 142 SNNQFKGKVSIDFS----SLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSD 197
           S+N   G+  +  +        L  L L    +                   L+ L LS 
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGM---ETPSGVCSALAAARVQLQGLDLSH 237

Query: 198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVI 257
           N           +  S +    +    +   +P G+     L  L +  N+L    P   
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPS-P 292

Query: 258 GELKNLQLLGLYKNFLQGS 276
            EL  +  L L  N    S
Sbjct: 293 DELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 36/187 (19%), Positives = 56/187 (29%), Gaps = 18/187 (9%)

Query: 260 LKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSI 319
           +K+L L  L     +       G L  L    L   +L         ++ G  P  LL  
Sbjct: 65  IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL------ENLEVTGTAPPPLLEA 118

Query: 320 TTLSL-YLDLSNNLLNGSLPQ----QVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYV 374
           T   L  L+L N             Q      L +L I+           +    +L  +
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178

Query: 375 DISSNCFHGIIPPS----LGFLKSIKFLDVSCNNF---SGQFPKFLENLSFLEFLNLSYN 427
           D+S N   G              +++ L +        SG           L+ L+LS+N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238

Query: 428 HLEGEVP 434
            L     
Sbjct: 239 SLRDAAG 245

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 10/154 (6%)

Query: 290 LDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQ---VGNLKN 346
           L  G  SL+        +        ++   +L   L +    +   +      V  +  
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLK-RLTVRAARIPSRILFGALRVLGISG 96

Query: 347 LIILDISSNQFSGMIPVTLS--TCVSLEYVDISSNCFHGIIPPSLGF----LKSIKFLDV 400
           L  L + + + +G  P  L   T   L  +++ +  +                 +K L +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 401 SCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP 434
           +  +      + +     L  L+LS N   GE  
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 53/301 (17%), Positives = 109/301 (36%), Gaps = 22/301 (7%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
            +  +   L++  N    +       +  L    L +N+ S  +       L  L++L I
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYI 109

Query: 118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAND 177
            + N    IP +L   S+L  L + +N+ +      FS L+ +  + +  N L       
Sbjct: 110 -SKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166

Query: 178 LGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNL 236
             F     +   L  L +S+ +    +P  +    +   + L   N+I   I L      
Sbjct: 167 GAF-----DGLKLNYLRISEAKLT-GIPKDL--PETLNELHL-DHNKIQ-AIELEDLLRY 216

Query: 237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS 296
             L  L +  NQ+       +  L  L+ L L  N L   +P+GL +L  L  + L +N+
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275

Query: 297 LQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSN 355
           +    +   +        +      +SL+   +N +    +       + + + +   + 
Sbjct: 276 IT--KVGVNDFCPVGFGVKRAYYNGISLF---NNPVPYWEVQPATFRCVTDRLAIQFGNY 330

Query: 356 Q 356
           +
Sbjct: 331 K 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 66/322 (20%), Positives = 109/322 (33%), Gaps = 57/322 (17%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +P  +S   +  LLDL NN        DF  L+ L+ L L  N +     + +    F +
Sbjct: 48  VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-----SKIHEKAF-S 99

Query: 186 NCSSLKVLSLSDNQFG---GELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIA 241
               L+ L +S N        LP S+  L        I  N+I   +P G+   L N+  
Sbjct: 100 PLRKLQKLYISKNHLVEIPPNLPSSLVELR-------IHDNRIR-KVPKGVFSGLRNMNC 151

Query: 242 LAVEVNQL-HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN 300
           + +  N L +        +   L  L + +  L   IP  L     L +L L  N +Q  
Sbjct: 152 IEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-- 206

Query: 301 FIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSG 359
                     A+  + L   +    L L +N +   +       L  L  L + +N+ S 
Sbjct: 207 ----------AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS- 254

Query: 360 MIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFL 419
            +P  L     L+ V + +N                    V  N+F      F    ++ 
Sbjct: 255 RVPAGLPDLKLLQVVYLHTN----------------NITKVGVNDFCP--VGFGVKRAYY 296

Query: 420 EFLNLSYNHLEGEVPTKGVFSN 441
             ++L  N +         F  
Sbjct: 297 NGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 55/305 (18%), Positives = 100/305 (32%), Gaps = 36/305 (11%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
           +PKEI        L L  N ++    D    L  L  + +  N +          LR L 
Sbjct: 48  VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 65  QLNVAENKFY----GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           +L +++N        +         SL    +  NR    +P  +   L N+  + +G N
Sbjct: 106 KLYISKNHLVEIPPNLPS-------SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGN 157

Query: 121 NFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
                       +   L  L +S  +      I     + L  L+L+ N +      D  
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELED-- 212

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
               L   S L  L L  NQ       S++ L +   + L   N++S  +P G+ +L  L
Sbjct: 213 ----LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL-DNNKLS-RVPAGLPDLKLL 266

Query: 240 IALAVEVNQLHGTIPD-------VIGELKNLQLLGLYKNFLQ-GSIPSGL-GNLTKLAKL 290
             + +  N +   +            +      + L+ N +    +       +T    +
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325

Query: 291 DLGSN 295
             G+ 
Sbjct: 326 QFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 25/151 (16%), Positives = 52/151 (34%), Gaps = 14/151 (9%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFI-GNLSALQVIHIKGNSLGGKFPTTLGLLRN 62
            IPK       L  L L  N +   +        S L  + +  N +      +L  L  
Sbjct: 186 GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242

Query: 63  LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFD------IVVNLPNLKELG 116
           L +L++  NK     P  + ++  L+  YL +N  +  +  +        V       + 
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300

Query: 117 IGANN--FFGLIPDSLSNASNLELLDLSNNQ 145
           +  N   ++ + P +    ++   +   N +
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 5/105 (4%)

Query: 346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
           +L ++  S       +P  +S       +D+ +N    +       L+ +  L +  N  
Sbjct: 34  HLRVVQCSDLGLKA-VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 406 SGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGN 450
           S    K    L  L+ L +S NHL  E+P   + S+  ++ +  N
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPP-NLPSSLVELRIHDN 133

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 41/187 (21%), Positives = 76/187 (40%), Gaps = 29/187 (15%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
            +G+G F   ++    + + + A K++    L +         E    R++ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                  F+  DF  +V E     SL +     ++  + E     L Q       +    
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ-------IVLGC 154

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           +YLH +    ++H DLK  N+ L+ D+   +GDFGLA  +   +     K       + G
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LCG 203

Query: 714 TVGYVAP 720
           T  Y+AP
Sbjct: 204 TPNYIAP 210

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 41/187 (21%), Positives = 84/187 (44%), Gaps = 28/187 (14%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           ++G+G++G VY G    +++ +A+K I  +     +    E    ++++H+N+++     
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 599 SSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
               + G   +     +  E +  GSL   L      ++  +   I        +   ++
Sbjct: 84  ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLK 136

Query: 655 YLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           YLH +    +VH D+K  NVL++ +  V  + DFG +K L+  +  T +          G
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--------FTG 185

Query: 714 TVGYVAP 720
           T+ Y+AP
Sbjct: 186 TLQYMAP 192

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 98.6 bits (245), Expect = 5e-22
 Identities = 38/245 (15%), Positives = 70/245 (28%), Gaps = 35/245 (14%)

Query: 501 RRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIV 560
             + +A +   TS      P    +EL +         ++GQ    +  +    E     
Sbjct: 47  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106

Query: 561 AVKVINLKQK---GAFRSFVAECEALRNIRH----------------RNLIKIITICSST 601
            V V    ++    A +    E   LR +R                  +L+K        
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166

Query: 602 DFKGVDFKALVFEY-----MGNGSLEDWLHQSNDQVEVCK-LSLIQRLNIAIDVASAIEY 655
             +  +    V            +L+ +           K L    RL + + V   +  
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
           LHH+    +VH  L+P +++LD      +  F             S+ +P          
Sbjct: 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGASAVSPIGR--GFAPP 276

Query: 716 GYVAP 720
              A 
Sbjct: 277 ETTAE 281

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 98.3 bits (245), Expect = 8e-22
 Identities = 57/250 (22%), Positives = 89/250 (35%), Gaps = 27/250 (10%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
           G+  N   LN+ EN    +   +  ++  LE   L  N     +       L +L  L +
Sbjct: 72  GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130

Query: 118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNN----L 170
             N    +   +    S L  L L NN  +   SI    F+ +  L RL+L +      +
Sbjct: 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGELKKLEYI 187

Query: 171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIP 230
             GA              +LK L+L       ++P+ +  L     + +  GN     I 
Sbjct: 188 SEGA---------FEGLFNLKYLNLGMCNI-KDMPN-LTPLVGLEELEM-SGNHFP-EIR 234

Query: 231 LG-IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLA 288
            G    L +L  L V  +Q+     +    L +L  L L  N L  S+P      L  L 
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293

Query: 289 KLDLGSNSLQ 298
           +L L  N   
Sbjct: 294 ELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 18/242 (7%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
           S+ + L+L +N        +  +L    ++ L G N I   I +G    L +L  L +  
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQL-GRNSIR-QIEVGAFNGLASLNTLELFD 132

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQ 305
           N L          L  L+ L L  N ++ SIPS     +  L +LDLG            
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL---------- 181

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
            K +  + +          YL+L    +   +P  +  L  L  L++S N F  + P + 
Sbjct: 182 KK-LEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSF 238

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
               SL+ + + ++    I   +   L S+  L+++ NN S         L +L  L+L 
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLH 298

Query: 426 YN 427
           +N
Sbjct: 299 HN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 53/283 (18%), Positives = 93/283 (32%), Gaps = 52/283 (18%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +P  +   SN   L+L  N  +   +  F  L  L  L L +N++            F  
Sbjct: 69  VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG-----AF-N 120

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
             +SL  L L DN         +  + S                      L  L  L + 
Sbjct: 121 GLASLNTLELFDNW--------LTVIPSGAF-----------------EYLSKLRELWLR 155

Query: 246 VNQLHGTIPDVI-GELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIA 303
            N +  +IP      + +L  L L +      I  G    L  L  L+LG  +++     
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK----- 209

Query: 304 SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIP 362
                   +P  L  +  L   L++S N     +       L +L  L + ++Q S +  
Sbjct: 210 -------DMPN-LTPLVGLE-ELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIER 259

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
                  SL  ++++ N    +       L+ +  L +  N +
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 21/245 (8%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
           +    +  +      E+P  I   S+T  + L   N I        R+L +L  L +  N
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNL-MENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQN 306
            +          L +L  L L+ N+L   IPSG    L+KL +L L +N ++        
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-------- 160

Query: 307 KLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTL 365
               ++P    +     + LDL        + +     L NL  L++        +P  L
Sbjct: 161 ----SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NL 214

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
           +  V LE +++S N F  I P S   L S+K L V  +  S       + L+ L  LNL+
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274

Query: 426 YNHLE 430
           +N+L 
Sbjct: 275 HNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 45/213 (21%), Positives = 76/213 (35%), Gaps = 9/213 (4%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
            L  L+ L L  N +          L++L  + +  N L          L  L +L +  
Sbjct: 97  HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN 156

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N    +   +   + SL    L   +    +       L NLK L +G  N   +   +L
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNL 214

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
           +    LE L++S N F       F  L  L +L +  + + +   N      F    +SL
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN-----AF-DGLASL 268

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGN 223
             L+L+ N     LPH +      ++   +  N
Sbjct: 269 VELNLAHNNL-SSLPHDLFTPLRYLVELHLHHN 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 96.3 bits (240), Expect = 8e-22
 Identities = 52/225 (23%), Positives = 78/225 (34%), Gaps = 33/225 (14%)

Query: 501 RRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIV 560
           R      ++      EK  P+    E  +     +    +G+GSFG V++    +     
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDY--EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86

Query: 561 AVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA----LVFEYM 616
           AVK + L+        V E  A   +    ++            G   +     +  E +
Sbjct: 87  AVKKVRLEV-----FRVEELVACAGLSSPRIVP---------LYGAVREGPWVNIFMELL 132

Query: 617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 676
             GSL   + Q     E                   +EYLH      ++HGD+K  NVLL
Sbjct: 133 EGGSLGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNVLL 183

Query: 677 DHD-MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
             D   A + DFG A  L    L  S  T      I GT  ++AP
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAP 225

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.9 bits (244), Expect = 8e-22
 Identities = 45/202 (22%), Positives = 76/202 (37%), Gaps = 32/202 (15%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALR-NIRHRNLI 592
             S  ++G GS G+V      +    VAVK +           + E + L  +  H N+I
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRML---IDFCDIALMEIKLLTESDDHPNVI 72

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK-LSLIQRLNIAIDVAS 651
           +     ++  F       +  E     +L+D +   N   E  K       +++   +AS
Sbjct: 73  RYYCSETTDRFL-----YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDH-------------DMVAHVGDFGLAKFLSSHHL 698
            + +LH      ++H DLKP N+L+               ++   + DFGL K L S   
Sbjct: 127 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 699 DTSSKTPSSSIGIKGTVGYVAP 720
              +          GT G+ AP
Sbjct: 184 SFRTNLN----NPSGTSGWRAP 201

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 97.6 bits (243), Expect = 2e-21
 Identities = 78/472 (16%), Positives = 162/472 (34%), Gaps = 81/472 (17%)

Query: 6   PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL--GLLRNL 63
             +I  L +L+ L L+ N +             L+ + +  N L       +    + +L
Sbjct: 69  MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL-----QNISCCPMASL 123

Query: 64  VQLNVAENKFYGMFPRSIC--NISSLEYFYLTSNRFSGSLPFDIVVNLP-NLKELGIGAN 120
             L+++ N F  + P      N++ L +  L++ +F   L    V +L  +   L + + 
Sbjct: 124 RHLDLSFNDFDVL-PVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSY 181

Query: 121 NFFGLIPDSLS--NASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN--------- 169
           +  G   +SL   N + L L+   N+ F  +V++  ++L  L   N++ N+         
Sbjct: 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241

Query: 170 --------------LGIGAANDLGFVTFLTN--CSSLKVLSLSDNQFGGELPHSIANLSS 213
                         L          V          ++ L++ +      +       S 
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301

Query: 214 TMIVFL----IGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLY 269
           T +  L    +       +          +    + ++              +   L   
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361

Query: 270 KNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLS 329
           +N    S+  G   L +L  L L  N L+             +     ++++L       
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKN---------FFKVALMTKNMSSLETLDVSL 412

Query: 330 NNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSL 389
           N+L + +  +     +++++L++SSN                    ++ + F   +PP +
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNM-------------------LTGSVFRC-LPPKV 452

Query: 390 GFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSN 441
                 K LD+  N      PK + +L  L+ LN++ N L+  VP  GVF  
Sbjct: 453 ------KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDR 495

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 97.2 bits (242), Expect = 3e-21
 Identities = 66/351 (18%), Positives = 115/351 (32%), Gaps = 17/351 (4%)

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
              +   L+ N  S  L    +  L  L+ L +  N    L         +LE LD+S+N
Sbjct: 52  PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110

Query: 145 QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL 204
           + +   +I    +  L  L+L  N+      + L       N + L  L LS  +F    
Sbjct: 111 RLQ---NISCCPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKLTFLGLSAAKFRQLD 162

Query: 205 PHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQ 264
              +A+L  + I+  +    I G        + N   L +  +        V   +  L 
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKG-GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221

Query: 265 LLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL 324
            L L    L       L              ++    I +  K    L  Q      +  
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL-FQFFWPRPVE- 279

Query: 325 YLDLSNNLLNGSLPQQVGN-----LKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
           YL++ N  +   + ++        LK+L+I  + +  F        S    +    +S +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339

Query: 380 CFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
               I         S  FL+ + N F+    +    L  L+ L L  N L+
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 92.2 bits (229), Expect = 1e-19
 Identities = 66/393 (16%), Positives = 132/393 (33%), Gaps = 35/393 (8%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQV-IHIKGNSLGGKFPTTLGLLRNL 63
           + KE G+L KL  L L+           + +L    + + +    + G    +L +  N 
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NT 196

Query: 64  VQLNVAENK---FYGMFPRSICNISSLEYFYLTSNRFSG----SLPFDIVVNLPNLKELG 116
             L++  +    F      S+  +  L+   +  N  +     +   ++      L    
Sbjct: 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL 256

Query: 117 IGANNFFGLIPDSLSNA--SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA 174
                 +              +E L++ N     ++  +  +       +L   ++    
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316

Query: 175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIR 234
                   + +  + + +  LS +           + SS   +     N  + ++  G  
Sbjct: 317 FLFSKEALY-SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF-TQNVFTDSVFQGCS 374

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-----GNLTKLAK 289
            L  L  L ++ N L      V    KN+  L      L  S+ S            +  
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILV 432

Query: 290 LDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLII 349
           L+L SN L G+           LP ++         LDL NN +  S+P+ V +L+ L  
Sbjct: 433 LNLSSNMLTGSVFRC-------LPPKV-------KVLDLHNNRIM-SIPKDVTHLQALQE 477

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
           L+++SNQ   +         SL+Y+ +  N + 
Sbjct: 478 LNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 6/113 (5%)

Query: 319 ITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDIS 377
           +   +  L LS N ++  L       L  L +L +S N+   +          LEY+D+S
Sbjct: 50  LPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108

Query: 378 SNCFHGIIPPSLGFLKSIKFLDVSCNNF-SGQFPKFLENLSFLEFLNLSYNHL 429
            N    I   S   + S++ LD+S N+F      K   NL+ L FL LS    
Sbjct: 109 HNRLQNI---SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 48/247 (19%), Positives = 83/247 (33%), Gaps = 16/247 (6%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFS-GSLPFDIVVNLPNLKELG 116
           G+  +  +L +  NK   +       ++ L    L+SN  S             +LK L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAA 175
           +  N     +  +      LE LD  ++  K       F SL+ L  L++   +  +   
Sbjct: 85  LSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143

Query: 176 NDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI-ANLSSTMIVFLIGGNQISGTIPLGI- 233
                       SSL+VL ++ N F       I   L +   + L    Q+   +     
Sbjct: 144 G------IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL-SQCQLE-QLSPTAF 195

Query: 234 RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL--GNLTKLAKLD 291
            +L +L  L +  N            L +LQ+L    N +  +          + LA L+
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLN 254

Query: 292 LGSNSLQ 298
           L  N   
Sbjct: 255 LTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 55/301 (18%), Positives = 91/301 (30%), Gaps = 51/301 (16%)

Query: 86  SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ 145
           S       S   + S+P  I     +   L + +N    L        + L  L LS+N 
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 146 FKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELP 205
                              L        +             +SLK L LS N     + 
Sbjct: 64  -------------------LSFKGCCSQSDFGT---------TSLKYLDLSFNGV-ITMS 94

Query: 206 HSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQ 264
            +   L     +     + +       +  +L NLI L +           +   L +L+
Sbjct: 95  SNFLGLEQLEHLDF-QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 153

Query: 265 LLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLS 323
           +L +  N  Q +        L  L  LDL    L+             L     +  +  
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE------------QLSPTAFNSLSSL 201

Query: 324 LYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCV-SLEYVDISSNCF 381
             L++S+N    SL       L +L +LD S N         L     SL +++++ N F
Sbjct: 202 QVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

Query: 382 H 382
            
Sbjct: 261 A 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 58/272 (21%), Positives = 106/272 (38%), Gaps = 26/272 (9%)

Query: 187 CS-SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
           CS S   +  +       +P  I   SS   + L   N++          L  L  L++ 
Sbjct: 5   CSCSGTEIRCNSKGLT-SVPTGI--PSSATRLEL-ESNKLQSLPHGVFDKLTQLTKLSLS 60

Query: 246 VNQLH--GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIA 303
            N L   G          +L+ L L  N +  ++ S    L +L  LD   ++L+     
Sbjct: 61  SNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK---QM 116

Query: 304 SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMI- 361
           S+  +  +L         L +YLD+S+          +   L +L +L ++ N F     
Sbjct: 117 SEFSVFLSLRN-------L-IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167

Query: 362 PVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEF 421
           P   +   +L ++D+S      + P +   L S++ L++S NNF        + L+ L+ 
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227

Query: 422 LNLSYNHLEGEVPT---KGVFSNKSKIPLQGN 450
           L+ S NH+         +   S+ + + L  N
Sbjct: 228 LDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 44/190 (23%), Positives = 77/190 (40%), Gaps = 7/190 (3%)

Query: 12  LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPT-TLGLLRNLVQLNVAE 70
              L+ L L+ N +   +      L  L+ +  + ++L           LRNL+ L+++ 
Sbjct: 77  TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
                 F      +SSLE   +  N F  +   DI   L NL  L +       L P + 
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
           ++ S+L++L++S+N F    +  +  L  L  L+   N++                 SSL
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-----SKKQELQHFPSSL 250

Query: 191 KVLSLSDNQF 200
             L+L+ N F
Sbjct: 251 AFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 3/138 (2%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKF-PTTLGLLRNLVQLNVA 69
           SL  L  L ++  +           LS+L+V+ + GNS    F P     LRNL  L+++
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183

Query: 70  ENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDS 129
           + +   + P +  ++SSL+   ++ N F  SL       L +L+ L    N+        
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242

Query: 130 LSN-ASNLELLDLSNNQF 146
           L +  S+L  L+L+ N F
Sbjct: 243 LQHFPSSLAFLNLTQNDF 260

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 54/207 (26%), Positives = 81/207 (39%), Gaps = 37/207 (17%)

Query: 528 SKATSEFSS----SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---------KGAFR 574
           S +T  F        ++G+G    V + I        AVK+I++           +    
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 575 SFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE 633
           + + E + LR +  H N+I++     +  F       LVF+ M  G L D+L       E
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFF-----FLVFDLMKKGELFDYL------TE 117

Query: 634 VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
              LS  +   I   +   I  LH      +VH DLKP N+LLD DM   + DFG +  L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 694 SSHHLDTSSKTPSSSIGIKGTVGYVAP 720
                            + GT  Y+AP
Sbjct: 175 DPGEKLR---------EVCGTPSYLAP 192

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 49/300 (16%), Positives = 105/300 (35%), Gaps = 45/300 (15%)

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
            +++   L++NR +  +    +    NL+ L + +N    +  DS S+  +LE LDLS N
Sbjct: 52  EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110

Query: 145 QFKGKVSID---FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG 201
                 ++    F  L  L  LNL  N         LG  +  ++ + L++L + +    
Sbjct: 111 YLS---NLSSSWFKPLSSLTFLNLLGNPY-----KTLGETSLFSHLTKLQILRVGNMD-- 160

Query: 202 GELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGEL 260
                                   +  I       L  L  L ++ + L    P  +  +
Sbjct: 161 ----------------------TFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197

Query: 261 KNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSI 319
           +N+  L L+       +        + +  L+L    L     +  +        +  + 
Sbjct: 198 QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256

Query: 320 TTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
                 + +++  L   + + +  +  L+ L+ S NQ   +         SL+ + + +N
Sbjct: 257 R----NVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 90.9 bits (226), Expect = 6e-20
 Identities = 49/286 (17%), Positives = 100/286 (34%), Gaps = 27/286 (9%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
           +++L L+ N +T      +     LQ + +  N +      +   L +L  L+++ N   
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD-SLSNA 133
            +       +SSL +  L  N +       +  +L  L+ L +G  + F  I     +  
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL 193
           + LE L++  +  +        S++ +  L L            L  +      SS++ L
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-----ILLLEIFV-DVTSSVECL 227

Query: 194 SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI 253
            L D                         +++S      +        + +    L   +
Sbjct: 228 ELRDTDLDT-----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269

Query: 254 PDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQ 298
             ++ ++  L  L   +N L+ S+P G    LT L K+ L +N   
Sbjct: 270 MKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 7e-19
 Identities = 48/264 (18%), Positives = 90/264 (34%), Gaps = 29/264 (10%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
               LQAL L  N +     D   +L +L+ + +  N L     +    L +L  LN+  
Sbjct: 74  RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLG 133

Query: 71  NKFYGMFPRSI-CNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDS 129
           N +  +   S+  +++ L+   + +      +       L  L+EL I A++     P S
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193

Query: 130 LSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF--LTNC 187
           L +  N+  L L   Q    + I       +  L L   +L     ++L       L   
Sbjct: 194 LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
            + + + ++D                               +   +  +  L+ L    N
Sbjct: 254 FTFRNVKITDESL--------------------------FQVMKLLNQISGLLELEFSRN 287

Query: 248 QLHGTIPDVIGELKNLQLLGLYKN 271
           QL      +   L +LQ + L+ N
Sbjct: 288 QLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 87.9 bits (218), Expect = 7e-19
 Identities = 53/292 (18%), Positives = 104/292 (35%), Gaps = 38/292 (13%)

Query: 187 CSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVE 245
           C    +   S       +P   + L+  +    +  N+I+  I     +  VNL AL + 
Sbjct: 30  CDRNGICKGSSGSLN-SIP---SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLT 84

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQ------ 298
            N ++    D    L +L+ L L  N+L  ++ S     L+ L  L+L  N  +      
Sbjct: 85  SNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETS 143

Query: 299 --------GNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLII 349
                                + ++  +  T    L++  + L  S   +   +++N+  
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSH 202

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHG--------IIPPSLGFLKSIKFLDVS 401
           L +   Q   ++ + +    S+E +++                   SL    + + + ++
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262

Query: 402 CNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSK---IPLQGN 450
             +   Q  K L  +S L  L  S N L+  VP  G+F   +    I L  N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKS-VP-DGIFDRLTSLQKIWLHTN 311

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 27/186 (14%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKI 594
             +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   F       L+ EY   G++   L + +      K    +      ++A+A+ 
Sbjct: 75  YGY-----FHDATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALS 123

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           Y H      ++H D+KP N+LL       + DFG +    S                 GT
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----------GT 170

Query: 715 VGYVAP 720
           + Y+ P
Sbjct: 171 LDYLPP 176

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.4 bits (232), Expect = 7e-21
 Identities = 51/247 (20%), Positives = 88/247 (35%), Gaps = 57/247 (23%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNI 586
           S+  ++F     +G+G FG V++     D+   A+K I L  +  A    + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND---------------- 630
            H  +++       T  +    +          +       S                  
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 631 -----------------QVEVC-KLSLIQRL---------------NIAIDVASAIEYLH 657
                            Q+++C K +L   +               +I I +A A+E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK----G 713
                 ++H DLKPSN+    D V  VGDFGL   +     + +  TP  +        G
Sbjct: 182 SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 714 TVGYVAP 720
           T  Y++P
Sbjct: 239 TKLYMSP 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 93.9 bits (233), Expect = 8e-21
 Identities = 37/229 (16%), Positives = 76/229 (33%), Gaps = 32/229 (13%)

Query: 509 SADTSPMEKQFPMVS-YAELSKATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAV 562
             +T   + + P +    E    +      +++G+G+F  VY+   G     +++    +
Sbjct: 41  YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVL 100

Query: 563 KVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLE 622
           KV        F       E L+       +K  +          +   LV E    G+L 
Sbjct: 101 KVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLL 155

Query: 623 DWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
           + ++   +  E   +     ++ A+ +   IE +H      ++HGD+KP N +L +  + 
Sbjct: 156 NAINLYKNTPEKV-MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211

Query: 683 HVG-----------DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
                         D G +  +      T             T G+   
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA------KCETSGFQCV 254

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 44/219 (20%), Positives = 85/219 (38%), Gaps = 52/219 (23%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF--RSFVAECEALRN 585
           S+ T+EF     IG G FGSV+K +   D  I A+K       G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 586 I-RHRNLIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
           + +H ++++         +     +     +  EY   GSL D + ++   +   K + +
Sbjct: 67  LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV---------------- 684
           +  ++ + V   + Y+H      +VH D+KPSN+ +    + +                 
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172

Query: 685 ---GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              GD G    +SS  +             +G   ++A 
Sbjct: 173 FKIGDLGHVTRISSPQV------------EEGDSRFLAN 199

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 37/193 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA---------ECEALRNIRHRN 590
           +G G+ G V      +    VA+++I+ K+K A  S            E E L+ + H  
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           +IKI     + D+       +V E M  G L D +      V   +L           + 
Sbjct: 202 IIKIKNFFDAEDY------YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQML 249

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
            A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L         
Sbjct: 250 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR------- 299

Query: 708 SIGIKGTVGYVAP 720
              + GT  Y+AP
Sbjct: 300 --TLCGTPTYLAP 310

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 16/200 (8%)

Query: 515 MEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-F 573
           M +    + +   S    ++    +IG G+   V        +  VA+K INL++     
Sbjct: 1   MSEDSSALPW---SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57

Query: 574 RSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE 633
              + E +A+    H N++      S       +   LV + +  GS+ D + +      
Sbjct: 58  DELLKEIQAMSQCHHPNIVSY--YTSF--VVKDEL-WLVMKLLSGGSVLD-IIKHIVAKG 111

Query: 634 VCKLSLIQRLNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
             K  ++    IA    +V   +EYLH + Q   +H D+K  N+LL  D    + DFG++
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168

Query: 691 KFLSSHHLDTSSKTPSSSIG 710
            FL++    T +K   + +G
Sbjct: 169 AFLATGGDITRNKVRKTFVG 188

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 37/189 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+F  V+         + A+K I         S   E   L+ I+H N++ +  I  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQS-----NDQVEVCKLSLIQRLNIAIDVASAIE 654
           ST         LV + +  G L D + +       D   V +            V SA++
Sbjct: 77  ST-----THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-----------QVLSAVK 120

Query: 655 YLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           YLH +    +VH DLKP N+L    + +    + DFGL+K   +  + T           
Sbjct: 121 YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----------A 167

Query: 712 KGTVGYVAP 720
            GT GYVAP
Sbjct: 168 CGTPGYVAP 176

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 31/192 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIR-HRNLIKIIT 596
           ++G+G+   V   I        AVK+I  KQ G  RS V  E E L   + HRN++++I 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN-----DQVEVCKLSLIQRLNIAIDVAS 651
                 F+  D   LVFE M  GS+   +H+       +   V +           DVAS
Sbjct: 79  F-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----------DVAS 122

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           A+++LH+     + H DLKP N+L    +      + DF L   +  +   +   TP   
Sbjct: 123 ALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 709 IGIKGTVGYVAP 720
               G+  Y+AP
Sbjct: 180 TPC-GSAEYMAP 190

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 30/187 (16%)

Query: 540 IGQGSFGSVYKG---ILGEDEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLIK 593
           +G G   +VY     IL      VA+K I    ++K      F  E      + H+N++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I +          +  LV EY+   +L +++           LS+   +N    +   I
Sbjct: 76  MIDVDEED---DCYY--LVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGI 124

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           ++ H      +VH D+KP N+L+D +    + DFG+AK LS   L T +        + G
Sbjct: 125 KHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNH------VLG 174

Query: 714 TVGYVAP 720
           TV Y +P
Sbjct: 175 TVQYFSP 181

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 40/188 (21%), Positives = 74/188 (39%), Gaps = 30/188 (15%)

Query: 539 MIGQGSFGSVYKG---ILGEDEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLI 592
           ++G+G  G VY+    +       VA+K++   L     FR+    E      ++  +  
Sbjct: 41  LVGRGGMGDVYEAEDTVRERI---VALKLMSETLSSDPVFRTRMQREARTAGRLQEPH-- 95

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ I    +  G  +  +    +    L   L +         L+  + + I   + SA
Sbjct: 96  -VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSA 146

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           ++  H        H D+KP N+L+  D  A++ DFG+A   +   L T            
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGN------TV 196

Query: 713 GTVGYVAP 720
           GT+ Y+AP
Sbjct: 197 GTLYYMAP 204

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 44/189 (23%), Positives = 80/189 (42%), Gaps = 34/189 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+GSF  VY+       + VA+K+I+   + + G  +    E +    ++H +++++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAI 653
                 F+  ++  LV E   NG +  +L        + E      + ++       + +
Sbjct: 79  Y-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQI------ITGM 125

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS--SHHLDTSSKTPSSSIGI 711
            YLH H    ++H DL  SN+LL  +M   + DFGLA  L        T           
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--------- 173

Query: 712 KGTVGYVAP 720
            GT  Y++P
Sbjct: 174 -GTPNYISP 181

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 49/193 (25%), Positives = 78/193 (40%), Gaps = 37/193 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN--------LKQKGAFRSFVAECEALRNIRHRNL 591
           +G G+ G V      +    VA+K+I+         ++     +   E E L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           IKI     + D+       +V E M  G L D +      V   +L           +  
Sbjct: 78  IKIKNFFDAEDY------YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLL 125

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHH-LDTSSKTPSS 707
           A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L     + T       
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----- 177

Query: 708 SIGIKGTVGYVAP 720
                GT  Y+AP
Sbjct: 178 -----GTPTYLAP 185

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 41/186 (22%), Positives = 78/186 (41%), Gaps = 31/186 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+G FG+VY     +++ I+A+KV+    L+++G       E E   ++RH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 597 ICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
                   +       L+ E+   G L   L +        +    +      ++A A+ 
Sbjct: 82  YFHDRKRIY-------LMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALH 128

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
           Y H      ++H D+KP N+L+ +     + DFG +    S    T            GT
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----------GT 175

Query: 715 VGYVAP 720
           + Y+ P
Sbjct: 176 LDYLPP 181

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 36/234 (15%)

Query: 500 ARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSS----SNMIGQGSFGSVYKGILGE 555
           A++   A      +   +            A  EF       ++IG+G    V + +   
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 556 DEMIVAVKVINLKQKGAFRSFVA--------ECEALRNIR-HRNLIKIITICSSTDFKGV 606
                AVK++ +  +      +         E   LR +  H ++I +I    S+ F   
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM-- 175

Query: 607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVH 666
               LVF+ M  G L D+L       E   LS  +  +I   +  A+ +LH +    +VH
Sbjct: 176 ---FLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223

Query: 667 GDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            DLKP N+LLD +M   + DFG +  L                 + GT GY+AP
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---------ELCGTPGYLAP 268

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 39/188 (20%), Positives = 82/188 (43%), Gaps = 24/188 (12%)

Query: 539 MIGQGSFGSVYKG---ILGEDEMIVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLI 592
           ++G G    V+         D   VAVKV+  +L +  +F   F  E +    + H  ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            +       +        +V EY+   +L D +H          ++  + + +  D   A
Sbjct: 76  AVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQA 128

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           + + H +    ++H D+KP+N+++       V DFG+A+ ++      +S T +++  + 
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAA--VI 180

Query: 713 GTVGYVAP 720
           GT  Y++P
Sbjct: 181 GTAQYLSP 188

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 37/177 (20%), Positives = 71/177 (40%), Gaps = 25/177 (14%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
              +     +G G+FG VYK    E   + A KVI  K +     ++ E E L    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           ++K           G  +      ++ E+   G+++  + + +  +   ++ ++ R    
Sbjct: 78  IVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR---- 124

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
             +  A+ +LH      ++H DLK  NVL+  +    + DFG++         T  K
Sbjct: 125 -QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL----KTLQK 173

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 37/215 (17%)

Query: 503 RRSAHNSADTSPMEKQFPMVSYAELSKA----------TSEFSSSNMIGQGSFGSVYKGI 552
             S+     T  +  Q  +V++ +   A               S   IG+GS G V    
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 553 LGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA-- 610
                  VAVK+++L+++        E   +R+ +H N+++                   
Sbjct: 66  EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEE 116

Query: 611 --LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD 668
             ++ E++  G+L D + Q        +L+  Q   +   V  A+ YLH      ++H D
Sbjct: 117 LWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166

Query: 669 LKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
           +K  ++LL  D    + DFG    +S        K
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQIS----KDVPK 197

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.5 bits (225), Expect = 8e-20
 Identities = 42/193 (21%), Positives = 74/193 (38%), Gaps = 41/193 (21%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLIKIITI 597
           ++G G  G V +          A+K++      A +    E +   +     +++ I+ +
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-------EVCKLSLIQRLNIAIDVA 650
             +          ++ E M  G L   + +  DQ        E+ +           D+ 
Sbjct: 91  YENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAEIMR-----------DIG 138

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
           +AI++LH H    + H D+KP N+L    + D V  + DFG AK  + + L T       
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT------- 188

Query: 708 SIGIKGTVGYVAP 720
                 T  YVAP
Sbjct: 189 ---PCYTPYYVAP 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.4 bits (225), Expect = 9e-20
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 19/185 (10%)

Query: 515 MEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAF 573
           M KQ+  V      +  S++     IGQG+FG V+K    +    VA+K + +  +K  F
Sbjct: 1   MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 574 RSF-VAECEALRNIRHRNLIKIITICSSTDFKGVDFKA---LVFEYMGN--GSLEDWLHQ 627
               + E + L+ ++H N++ +I IC +        K    LVF++  +    L   +  
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 119

Query: 628 SNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF 687
                E+ K  +   L       + + Y+H +    ++H D+K +NVL+  D V  + DF
Sbjct: 120 KFTLSEI-KRVMQMLL-------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168

Query: 688 GLAKF 692
           GLA+ 
Sbjct: 169 GLARA 173

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 39/177 (22%), Positives = 74/177 (41%), Gaps = 27/177 (15%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
             +++    IGQG+ G+VY  +       VA++ +NL+Q+      + E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           ++          +           +V EY+  GSL D + +         +   Q   + 
Sbjct: 79  IVN---------YLDSYLVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVC 122

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
            +   A+E+LH +    ++H D+K  N+LL  D    + DFG    ++       SK
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSK 172

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 45/209 (21%)

Query: 526 ELSKATSEFSS----SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECE 581
           +L + + +F+        IG GS+    + I     M  AVK+I+  ++        E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67

Query: 582 AL-RNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN-----DQVEVC 635
            L R  +H N+I +  +          +  +V E M  G L D + +       +   V 
Sbjct: 68  ILLRYGQHPNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILRQKFFSEREASAVL 122

Query: 636 KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAK 691
                        +   +EYLH      +VH DLKPSN+L      +     + DFG AK
Sbjct: 123 F-----------TITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            L +   +    TP        T  +VAP
Sbjct: 169 QLRAE--NGLLMTPC------YTANFVAP 189

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 31/186 (16%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLIKIITI 597
           IG+G+F  V           VA+K+I+  Q      +    E   ++ + H N++K+  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 598 CSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
             +    +       L+ EY   G + D+L      V   ++   +  +    + SA++Y
Sbjct: 83  IETEKTLY-------LIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQY 129

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLSSHHLDTSSKTPSSSIGIKGT 714
            H      +VH DLK  N+LLD DM   + DFG   +F     LD     P         
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP-------- 178

Query: 715 VGYVAP 720
             Y AP
Sbjct: 179 --YAAP 182

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 49/255 (19%), Positives = 81/255 (31%), Gaps = 54/255 (21%)

Query: 507 HNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN 566
           H+    S   +         L +   ++     IGQGS+G V   I  +   I A+K++N
Sbjct: 2   HHHHHHSSGRENLY-FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 567 LKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSL 621
             +              E   ++ + H N+ ++  +     +       LV E    G L
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC-----LVMELCHGGHL 115

Query: 622 EDWLHQSNDQVEVCKLSLIQRL----------------------------------NIAI 647
            D L+   D         + +                                   NI  
Sbjct: 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTP 705
            + SA+ YLH+     + H D+KP N L   +    +   DFGL+K     +        
Sbjct: 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232

Query: 706 SSSIGIKGTVGYVAP 720
                  GT  +VAP
Sbjct: 233 ----TKAGTPYFVAP 243

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 50/241 (20%), Positives = 90/241 (37%), Gaps = 12/241 (4%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
            L RN ++L     K   +   +      LE   ++ N     +  D+  NLP L E+ I
Sbjct: 27  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 118 -GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN 176
             ANN   + P++  N  NL+ L +SN   K    +          L+++ N       +
Sbjct: 87  EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN----IH 142

Query: 177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RN 235
            +   +F+       +L L+ N    E+ +S  N +    + L   N +   +P  +   
Sbjct: 143 TIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHG 200

Query: 236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
               + L +   ++H      +  LK L+    Y       +P+ L  L  L +  L   
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256

Query: 296 S 296
           S
Sbjct: 257 S 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 47/275 (17%), Positives = 86/275 (31%), Gaps = 28/275 (10%)

Query: 187 CS-SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAV 244
           C  S +V    +++   E+P   ++L    I       ++   I  G      +L  + +
Sbjct: 7   CHCSNRVFLCQESKVT-EIP---SDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEI 61

Query: 245 EVNQLHGTIP-DVIGELKNLQLLGLYK-NFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNF 301
             N +   I  DV   L  L  + + K N L   I      NL  L  L + +  ++   
Sbjct: 62  SQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK--- 117

Query: 302 IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV--GNLKNLIILDISSNQFSG 359
                     LP      +   + LD+ +N+   ++ +    G     +IL ++ N    
Sbjct: 118 ---------HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168

Query: 360 MIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFL 419
           +     +     E     +N    +             LD+S           LENL  L
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 228

Query: 420 EFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLC 454
              +        ++PT        +  L      C
Sbjct: 229 RARSTYNLK---KLPTLEKLVALMEASLTYPSHCC 260

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 39/192 (20%), Positives = 61/192 (31%), Gaps = 16/192 (8%)

Query: 11  SLFKLQALALA-GNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVA 69
           +L KL  + +   N L    P+   NL  LQ + I    +              V L++ 
Sbjct: 77  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 136

Query: 70  ENKFYGMFP-RSICNISS-LEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP 127
           +N         S   +S      +L  N     +      N   L EL +  NN    +P
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNS-AFNGTQLDELNLSDNNNLEELP 194

Query: 128 -DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN 186
            D    AS   +LD+S  +     S    +LK L   +                +  L  
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK----------LPTLEK 244

Query: 187 CSSLKVLSLSDN 198
             +L   SL+  
Sbjct: 245 LVALMEASLTYP 256

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 53/210 (25%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN----LKQKGAFRSFVA----------------- 578
           IG+GS+G V       D    A+KV++    ++Q G  R                     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 579 -----ECEALRNIRHRNLIKIIT-ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV 632
                E   L+ + H N++K++  +    +        +VFE +  G + +         
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY----MVFELVNQGPVME-------VP 129

Query: 633 EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF 692
            +  LS  Q      D+   IEYLH+     ++H D+KPSN+L+  D    + DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 693 LSS--HHLDTSSKTPSSSIGIKGTVGYVAP 720
                  L  +  TP+          ++AP
Sbjct: 187 FKGSDALLSNTVGTPA----------FMAP 206

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 51/247 (20%), Positives = 83/247 (33%), Gaps = 43/247 (17%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI 117
           G+     ++ +  N+   +   S     +L   +L SN  +  +       L  L++L +
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDL 87

Query: 118 GANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNNLGIG 173
             N     +   +      L  L L     +    +    F  L  L  L L+ N L   
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQDNAL--- 141

Query: 174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI 233
               L   TF  +  +L  L L                          GN+IS ++P   
Sbjct: 142 --QALPDDTF-RDLGNLTHLFLH-------------------------GNRIS-SVPERA 172

Query: 234 -RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLD 291
            R L +L  L +  N++    P    +L  L  L L+ N L  ++P+  L  L  L  L 
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLR 231

Query: 292 LGSNSLQ 298
           L  N   
Sbjct: 232 LNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 44/222 (19%), Positives = 84/222 (37%), Gaps = 20/222 (9%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
           ++ + + L  N+       S     +  I++L   N ++  I       L  L  L +  
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWL-HSNVLA-RIDAAAFTGLALLEQLDLSD 89

Query: 247 NQLHGTIP-DVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIAS 304
           N    ++       L  L  L L +  LQ  +  G    L  L  L L  N+LQ      
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ------ 142

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPV 363
                 ALP           +L L  N ++ S+P++    L +L  L +  N+ + + P 
Sbjct: 143 ------ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 364 TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
                  L  + + +N    +   +L  L+++++L ++ N +
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 48/218 (22%), Positives = 75/218 (34%), Gaps = 15/218 (6%)

Query: 37  SALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNR 96
           +A Q I + GN +      +    RNL  L +  N    +   +   ++ LE   L+ N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 97  FSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID--- 153
              S+       L  L  L +       L P      + L+ L L +N  +   ++    
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ---ALPDDT 148

Query: 154 FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSS 213
           F  L  L  L L  N +            F     SL  L L  N+     PH+  +L  
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPER-----AF-RGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 214 TMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLH 250
            M ++L   N +S  +P      L  L  L +  N   
Sbjct: 203 LMTLYL-FANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 43/228 (18%), Positives = 74/228 (32%), Gaps = 22/228 (9%)

Query: 228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTK 286
            +P+GI        + +  N++           +NL +L L+ N L   I +     L  
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLK 345
           L +LDL           S N  + ++             L L    L   L   +   L 
Sbjct: 82  LEQLDL-----------SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129

Query: 346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
            L  L +  N    +   T     +L ++ +  N    +   +   L S+  L +  N  
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 406 SGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIP---LQGN 450
           +   P    +L  L  L L  N+L   +P     +    +    L  N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLS-ALP-TEALAPLRALQYLRLNDN 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 88.0 bits (218), Expect = 8e-19
 Identities = 44/194 (22%), Positives = 86/194 (44%), Gaps = 32/194 (16%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRN 590
            +F   + +G G+ G V+K       +++A K+I+L+ K A R+ +  E + L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 591 LIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           ++          F G  +      +  E+M  GSL+  L ++    E      + +  ++
Sbjct: 93  IVG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGK--VS 137

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
           I V   + YL    +  ++H D+KPSN+L++      + DFG++  L     D+ + +  
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS-- 189

Query: 707 SSIGIKGTVGYVAP 720
                 GT  Y++P
Sbjct: 190 ----FVGTRSYMSP 199

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 86.9 bits (216), Expect = 8e-19
 Identities = 38/169 (22%), Positives = 79/169 (46%), Gaps = 14/169 (8%)

Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRH 588
           ++S+F     +G G++ +VYKG+     + VA+K + L  + G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 589 RNLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            N++++  +  + +          LVFE+M +  L+ ++           L L       
Sbjct: 63  ENIVRLYDVIHTENKLT-------LVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             +   + + H +    ++H DLKP N+L++      +GDFGLA+    
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 88.6 bits (220), Expect = 8e-19
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 30/182 (16%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
              ++ + +IG GSFG VY+  L +   +VA+K +   ++   R    E + +R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 591 LIKII-TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ------SNDQV---EVCKLSLI 640
           ++++     SS + K   +  LV +Y+     E  +++         Q       KL + 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLSSHHLD 699
           Q          ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L     +
Sbjct: 164 QLF-------RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

Query: 700 TS 701
            S
Sbjct: 214 VS 215

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 47/185 (25%), Positives = 76/185 (41%), Gaps = 23/185 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
           +G G+FG V+        +   +K IN  + +       AE E L+++ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
               F+      +V E    G L + +  +  + +   LS      +   + +A+ Y H 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFHS 142

Query: 659 HCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
                +VH DLKP N+L           + DFGLA+   S    T+           GT 
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---------AAGTA 190

Query: 716 GYVAP 720
            Y+AP
Sbjct: 191 LYMAP 195

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.5 bits (215), Expect = 9e-19
 Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 39/194 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVA-ECEALRNIRHRNLIK-- 593
           +G+GS+G V + +  E     AVK++    L++     + V  E + LR +RH+N+I+  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 594 -IITICSSTDFKGVDFKALVFEYMGNGSLE--DWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
            ++               +V EY   G  E  D + +        +  + Q       + 
Sbjct: 73  DVLYNEEKQKM------YMVMEYCVCGMQEMLDSVPEK-------RFPVCQAHGYFCQLI 119

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA----KFLSSHHLDTSSKTPS 706
             +EYLH      +VH D+KP N+LL       +   G+A     F +     TS  +P+
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 707 SSIGIKGTVGYVAP 720
                     +  P
Sbjct: 177 ----------FQPP 180

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 34/181 (18%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHR 589
              F+    IG+GSFG V+KGI    + +VA+K+I+L++ +        E   L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 590 NLIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
            + K         + G   K     ++ EY+G GS  D L          +   +    I
Sbjct: 81  YVTK---------YYGSYLKDTKLWIIMEYLGGGSALDLL----------EPGPLDETQI 121

Query: 646 AI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS 702
           A    ++   ++YLH       +H D+K +NVLL       + DFG+A  L+    DT  
Sbjct: 122 ATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQI 174

Query: 703 K 703
           K
Sbjct: 175 K 175

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 56/336 (16%), Positives = 119/336 (35%), Gaps = 59/336 (17%)

Query: 35  NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS 94
            L+    I    +++      T   L  +  L+        +    +  +++L    L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKD 72

Query: 95  NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDF 154
           N+ +   P     NL  + EL +  N    +    ++   +++ LDL++ Q         
Sbjct: 73  NQITDLAPLK---NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--VTPL 125

Query: 155 SSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSST 214
           + L  L  L L+ N +          ++ L   ++L+ LS+ + Q        +++L+  
Sbjct: 126 AGLSNLQVLYLDLNQITN--------ISPLAGLTNLQYLSIGNAQ--------VSDLT-- 167

Query: 215 MIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQ 274
                             + NL  L  L  + N++   I   +  L NL  + L  N + 
Sbjct: 168 -----------------PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQI- 207

Query: 275 GSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKL-----IGALPQQLLSITTLSLYLDLS 329
            S  S L N + L  + L + ++    +   N L     +       ++  T+S     +
Sbjct: 208 -SDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYA 266

Query: 330 NNLLNGSLPQQVGNL----KNLIILDISSNQFSGMI 361
           +  L  +L   + N+       +    ++  FSG +
Sbjct: 267 SPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTV 302

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 61/294 (20%)

Query: 130 LSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSS 189
               +N   +    +     V+   + L  +  L+     +          +  +   ++
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--------IEGVQYLNN 64

Query: 190 LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQL 249
           L  L L DNQ        I +L+                    ++NL  +  L +  N L
Sbjct: 65  LIGLELKDNQ--------ITDLA-------------------PLKNLTKITELELSGNPL 97

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLI 309
                  I  L++++ L L     Q +  + L  L+ L  L L  N +    I+    L 
Sbjct: 98  --KNVSAIAGLQSIKTLDLTST--QITDVTPLAGLSNLQVLYLDLNQITN--ISPLAGL- 150

Query: 310 GALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCV 369
                     T L  YL + N  ++   P  + NL  L  L    N+ S + P  L++  
Sbjct: 151 ----------TNLQ-YLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLP 195

Query: 370 SLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLN 423
           +L  V + +N    + P  L    ++  + ++    + Q   +  NL     + 
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 30/209 (14%)

Query: 223 NQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLG 282
             I+   P     L N I +A   + +  T+     +L  +  L  +   +  +I  G+ 
Sbjct: 7   TAINVIFPD--PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQ 60

Query: 283 NLTKLAKLDLGSNSLQG-NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV 341
            L  L  L+L  N +     + +  K+                 L+LS N L       +
Sbjct: 61  YLNNLIGLELKDNQITDLAPLKNLTKIT---------------ELELSGNPLKN--VSAI 103

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVS 401
             L+++  LD++S Q + + P  L+   +L+ + +  N    I P  L  L ++++L + 
Sbjct: 104 AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIG 159

Query: 402 CNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
               S      L NLS L  L    N + 
Sbjct: 160 NAQVSD--LTPLANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 11/164 (6%)

Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
             I  L  ++ L L    +T      +  LS LQV+++  N +     + L  L NL  L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYL 156

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           ++   +   + P  + N+S L       N+ S   P     +LPNL E+ +  N    + 
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVS 211

Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
           P  L+N SNL ++ L+N     +     ++L +   +       
Sbjct: 212 P--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 40/194 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA---------ECEALRNIRHRN 590
           +G G+FG V+  +  E    V VK I  K+K     ++          E   L  + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGS-LEDWL--HQSNDQVEVCKLSLIQRLNIAI 647
           +IK++ I     F+   F  LV E  G+G  L  ++  H   D+     +   Q      
Sbjct: 91  IIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI-FRQ------ 138

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLSSHHLDTSSKTPS 706
            + SA+ YL       ++H D+K  N+++  D    + DFG  A         T      
Sbjct: 139 -LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---- 190

Query: 707 SSIGIKGTVGYVAP 720
                 GT+ Y AP
Sbjct: 191 ------GTIEYCAP 198

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 25/169 (14%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNL 591
            +   + +G+G++ +VYKG     + +VA+K I L+ + GA  + + E   L++++H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 592 IKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIA 646
           + +  I  +            LVFEY+ +  L+ +L       +   V KL L Q L   
Sbjct: 63  VTLHDIIHTEKSLT-------LVFEYL-DKDLKQYLDDCGNIINMHNV-KLFLFQLL--- 110

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
                 + Y H      ++H DLKP N+L++      + DFGLA+  S 
Sbjct: 111 ----RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 52/186 (27%), Positives = 76/186 (40%), Gaps = 28/186 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           +G+GSFG V K      +   AVKVIN          + + E E L+ + H N++K+  I
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
                 +      +V E    G L D +      ++  + S      I   V S I Y+H
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITYMH 138

Query: 658 HHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
            H    +VH DLKP N+LL   + D    + DFGL+     +                GT
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---------RIGT 186

Query: 715 VGYVAP 720
             Y+AP
Sbjct: 187 AYYIAP 192

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 16/170 (9%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHR 589
              F    ++G G++G VYKG   +   + A+KV+++           E   L+    HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81

Query: 590 NLIKIITICSSTDFKGVDFKA-LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI- 647
           N+          +  G+D +  LV E+ G GS+        D ++  K + ++   IA  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWIAYI 134

Query: 648 --DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             ++   + +LH H    ++H D+K  NVLL  +    + DFG++  L  
Sbjct: 135 CREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 28/186 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           +G+G+F  V + +     +  A K+IN K+     F+    E    R ++H N++++   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
                     F  LVF+ +  G L + +      V     S     +    +  +I Y H
Sbjct: 74  IQEE-----SFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 122

Query: 658 HHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
            +    +VH +LKP N+LL          + DFGLA  ++               G  GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---------GFAGT 170

Query: 715 VGYVAP 720
            GY++P
Sbjct: 171 PGYLSP 176

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 87.3 bits (216), Expect = 2e-18
 Identities = 36/183 (19%), Positives = 62/183 (33%), Gaps = 30/183 (16%)

Query: 540 IGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
           IG+G     +V           V V+ INL+            E    +   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY- 91

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN---IAI---DV 649
              +   F   +   +V  +M  GS +D          +     +  +N   IA     V
Sbjct: 92  -RAT---FIADNELWVVTSFMAYGSAKD----------LICTHFMDGMNELAIAYILQGV 137

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL--DTSSKTPSS 707
             A++Y+HH      VH  +K S++L+  D   ++        + SH          P  
Sbjct: 138 LKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 708 SIG 710
           S+ 
Sbjct: 195 SVK 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 26/203 (12%)

Query: 511 DTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK 570
             S M       +     K    F    M GQG+FG+V  G      M VA+K +    +
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61

Query: 571 GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD--FKALVFEYMGNGSLEDWLHQ- 627
              R  +   + L  + H N++++ +   +   +     +  +V EY+     +  LH+ 
Sbjct: 62  FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRC 115

Query: 628 -----SNDQ---VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-H 678
                         + K+ L Q +        +I  LH      + H D+KP NVL++  
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLI-------RSIGCLHLPSV-NVCHRDIKPHNVLVNEA 167

Query: 679 DMVAHVGDFGLAKFLSSHHLDTS 701
           D    + DFG AK LS    + +
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVA 190

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 63/189 (33%), Positives = 90/189 (47%), Gaps = 36/189 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLIKII 595
           +G G+FG V  G        VAVK++N +QK      V     E + L+  RH ++IK+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 596 T-ICSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLNIAIDVASA 652
             I + TDF       +V EY+  G L D++  H   +++E  +L   Q++       SA
Sbjct: 78  QVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEMEARRL--FQQI------LSA 123

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLSSHHLDTSSKTPSSSIGI 711
           ++Y H H    +VH DLKP NVLLD  M A + DFGL         L TS  +P+     
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----- 175

Query: 712 KGTVGYVAP 720
                Y AP
Sbjct: 176 -----YAAP 179

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 47/184 (25%), Positives = 67/184 (36%), Gaps = 26/184 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GS+G V   +     +  A K I          F  E E ++++ H N+I++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
              F+      LV E    G L + +      V            I  DV SA+ Y H  
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 660 CQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
               + H DLKP N L      D    + DFGLA       +  +           GT  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---------KVGTPY 173

Query: 717 YVAP 720
           YV+P
Sbjct: 174 YVSP 177

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 26/181 (14%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNI 586
           S ATS +     IG G++G+VYK         VA+K + +    G           +R +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--PISTVREV 62

Query: 587 ---------RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSND---QVEV 634
                     H N+++++ +C+++         LVFE++ +  L  +L ++       E 
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAET 121

Query: 635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            K  + Q L         +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 122 IKDLMRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 695 S 695
            
Sbjct: 172 Y 172

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 39/191 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKIIT-I 597
           +G+G++G V   +    E  VAVK++++K+       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKL--SLIQRLNIAIDVASAI 653
                        L  EY   G L D +       + +  +    L+          + +
Sbjct: 75  REGNIQ------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGV 118

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS----HHLDTSSKTPSSSI 709
            YLH      + H D+KP N+LLD      + DFGLA           L+    T     
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP--- 172

Query: 710 GIKGTVGYVAP 720
                  YVAP
Sbjct: 173 -------YVAP 176

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 33/198 (16%)

Query: 516 EKQFPMVSYAELSKATSE------FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
            +  P     +L + +        F     +G+GS+GSVYK I  E   IVA+K + ++ 
Sbjct: 7   LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES 66

Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA----LVFEYMGNGSLEDWL 625
               +  + E   ++     +++K         + G  FK     +V EY G GS+ D +
Sbjct: 67  D--LQEIIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVMEYCGAGSVSDII 115

Query: 626 HQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG 685
              N  +   +++ I +          +EYLH       +H D+K  N+LL+ +  A + 
Sbjct: 116 RLRNKTLTEDEIATILQ-----STLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLA 167

Query: 686 DFGLAKFLSSHHLDTSSK 703
           DFG+A  L+    DT +K
Sbjct: 168 DFGVAGQLT----DTMAK 181

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 28/164 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLIK 593
           IG+GS+G V+K    +   IVA+K     +      K A R    E   L+ ++H NL+ 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAIDVAS 651
           ++ +      K      LVFEY  + ++   L +    V   + K    Q L        
Sbjct: 67  LLEVFRR---KRRLH--LVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQ------- 113

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
           A+ + H H     +H D+KP N+L+    V  + DFG A+ L+ 
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 37/200 (18%)

Query: 503 RRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAV 562
               H+S+    +  Q  M  Y +L K          +G+G++G VYK    +   IVA+
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGR-IVAL 50

Query: 563 KVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTD--FKGVDFKALVFEYMGN 618
           K I L  +  G   + + E   L+ + H N++ +I +  S            LVFE+M  
Sbjct: 51  KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT-------LVFEFM-E 102

Query: 619 GSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 675
             L+  L ++       ++ K+ L Q L         + + H H    ++H DLKP N+L
Sbjct: 103 KDLKKVLDENKTGLQDSQI-KIYLYQLL-------RGVAHCHQHR---ILHRDLKPQNLL 151

Query: 676 LDHDMVAHVGDFGLAKFLSS 695
           ++ D    + DFGLA+    
Sbjct: 152 INSDGALKLADFGLARAFGI 171

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.4 bits (212), Expect = 6e-18
 Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 28/217 (12%)

Query: 509 SADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK 568
           S        +         +K +  +     +G+G+F  V + +     +  A K+IN K
Sbjct: 6   SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65

Query: 569 Q--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
           +     F+    E    R ++H N++++             F  LVF+ +  G L + + 
Sbjct: 66  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDI- 119

Query: 627 QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAH 683
                V     S     +    +  +I Y H +    +VH +LKP N+LL          
Sbjct: 120 -----VAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVK 171

Query: 684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           + DFGLA  ++               G  GT GY++P
Sbjct: 172 LADFGLAIEVNDSEAWH---------GFAGTPGYLSP 199

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 39/203 (19%)

Query: 501 RRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIV 560
               S+     T  +  Q  M  Y  L            +G+GS+G V K    +   IV
Sbjct: 5   HHHHSSGVDLGTENLYFQ-SMEKYENLGL----------VGEGSYGMVMKCRNKDTGRIV 53

Query: 561 AVKVINLKQ------KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFE 614
           A+K            K A R    E + L+ +RH NL+ ++ +C     K   +  LVFE
Sbjct: 54  AIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENLVNLLEVCKK---KKRWY--LVFE 104

Query: 615 YMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPS 672
           ++ + ++ D L    + +  +V +  L Q +N        I + H H    ++H D+KP 
Sbjct: 105 FV-DHTILDDLELFPNGLDYQVVQKYLFQIIN-------GIGFCHSHN---IIHRDIKPE 153

Query: 673 NVLLDHDMVAHVGDFGLAKFLSS 695
           N+L+    V  + DFG A+ L++
Sbjct: 154 NILVSQSGVVKLCDFGFARTLAA 176

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 39/191 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLIKIIT-I 597
           +G+G++G V   +    E  VAVK++++K+       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKL--SLIQRLNIAIDVASAI 653
                        L  EY   G L D +       + +  +    L+          + +
Sbjct: 75  REGNIQ------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGV 118

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS----HHLDTSSKTPSSSI 709
            YLH      + H D+KP N+LLD      + DFGLA           L+    T     
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP--- 172

Query: 710 GIKGTVGYVAP 720
                  YVAP
Sbjct: 173 -------YVAP 176

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 60/190 (31%), Positives = 87/190 (45%), Gaps = 38/190 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLIKII 595
           +G G+FG V  G        VAVK++N +QK      V     E + L+  RH ++IK+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 596 TICSSTD--FKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLNIAIDVAS 651
            + S+    F       +V EY+  G L D++  +   D+ E  +L   Q++       S
Sbjct: 83  QVISTPSDIF-------MVMEYVSGGELFDYICKNGRLDEKESRRL--FQQI------LS 127

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLSSHHLDTSSKTPSSSIG 710
            ++Y H H    +VH DLKP NVLLD  M A + DFGL         L TS  +P+    
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN---- 180

Query: 711 IKGTVGYVAP 720
                 Y AP
Sbjct: 181 ------YAAP 184

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 43/190 (22%), Positives = 74/190 (38%), Gaps = 24/190 (12%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLI 592
             S + ++G G FG V+K       + +A K+I  +          E   +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           ++        F+  +   LV EY+  G L D +   +       L+ +  +     +   
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIG 710
           I ++H      ++H DLKP N+L  +     +   DFGLA+           K       
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKV------ 247

Query: 711 IKGTVGYVAP 720
             GT  ++AP
Sbjct: 248 NFGTPEFLAP 257

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 26/165 (15%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKII 595
             IG+G++G+V+K    E   IVA+K + L     G   S + E   L+ ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 596 TICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAIDVA 650
            +  S            LVFE+  +  L+ +    N   D   V K  L Q L       
Sbjct: 68  DVLHSDKKLT-------LVFEFC-DQDLKKYFDSCNGDLDPEIV-KSFLFQLL------- 111

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             + + H      ++H DLKP N+L++ +    + +FGLA+    
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 85.0 bits (211), Expect = 1e-17
 Identities = 40/186 (21%), Positives = 70/186 (37%), Gaps = 27/186 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           +G+G+F  V + +        A  +IN K+      +    E    R ++H N++++   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
            S           L+F+ +  G L + +      V     S     +    +  A+ + H
Sbjct: 79  ISEE-----GHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127

Query: 658 HHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
                 +VH +LKP N+LL          + DFGLA  +                G  GT
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--------GFAGT 176

Query: 715 VGYVAP 720
            GY++P
Sbjct: 177 PGYLSP 182

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 39/190 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITIC 598
           +G+GSF    K +  +     AVK+I+ + +   +    E  AL+    H N++K+  + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSN-----DQVEVCKLSLIQRLNIAIDVASAI 653
               F       LV E +  G L + + +       +   + +            + SA+
Sbjct: 75  ----FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----------KLVSAV 119

Query: 654 EYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
            ++H      +VH DLKP N+L    + ++   + DFG A+       +   KTP     
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPC---- 170

Query: 711 IKGTVGYVAP 720
              T+ Y AP
Sbjct: 171 --FTLHYAAP 178

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 41/183 (22%), Positives = 72/183 (39%), Gaps = 24/183 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG V++ +      +   K IN        +   E   +  + H  LI +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
              F+      L+ E++  G L D +   +      K+S  + +N        ++++H H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 168

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
               +VH D+KP N++ +    + V   DFGLA  L+    D   K          T  +
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKV------TTATAEF 216

Query: 718 VAP 720
            AP
Sbjct: 217 AAP 219

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 2e-17
 Identities = 65/343 (18%), Positives = 117/343 (34%), Gaps = 76/343 (22%)

Query: 108 NLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLE 166
                 +  +   +    +    +  ++++ +  +N+  K   S+     L  + +L L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK---SVQGIQYLPNVTKLFLN 73

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS 226
            N L      D+     LTN  +L  L L +N+        I +LS              
Sbjct: 74  GNKL-----TDI---KPLTNLKNLGWLFLDENK--------IKDLS-------------- 103

Query: 227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTK 286
                 +++L  L +L++E N +  +  + +  L  L+ L L  N  + +  + L  LTK
Sbjct: 104 -----SLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNN--KITDITVLSRLTK 154

Query: 287 LAKLDLGSNSLQG-NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLK 345
           L  L L  N +     +A   KL                 L LS N +  S  + +  LK
Sbjct: 155 LDTLSLEDNQISDIVPLAGLTKLQ---------------NLYLSKNHI--SDLRALAGLK 197

Query: 346 NLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNF 405
           NL +L++ S +         S  V    V  +          S          D    N 
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNV 250

Query: 406 SGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQ 448
               P+F   +SF+ +  ++          K  F  +   PL+
Sbjct: 251 KWHLPEFTNEVSFIFYQPVTIG------KAKARFHGRVTQPLK 287

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 2e-17
 Identities = 54/294 (18%), Positives = 102/294 (34%), Gaps = 61/294 (20%)

Query: 136 LELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSL 195
           +      +   K ++  D  +     + NL++ ++                 +S+  +  
Sbjct: 1   MGETITVSTPIK-QIFPD-DAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIA 50

Query: 196 SDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPD 255
           +++         I ++                    GI+ L N+  L +  N+L    P 
Sbjct: 51  NNSD--------IKSVQ-------------------GIQYLPNVTKLFLNGNKLTDIKP- 82

Query: 256 VIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQ 315
            +  LKNL  L L +N ++  + S L +L KL  L L  N +           I  L   
Sbjct: 83  -LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI---------SDINGL-VH 129

Query: 316 LLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVD 375
           L  +      L L NN +  +    +  L  L  L +  NQ S ++P  L+    L+ + 
Sbjct: 130 LPQLE----SLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181

Query: 376 ISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHL 429
           +S N    +    L  LK++  L++       +      NL     +  +   L
Sbjct: 182 LSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.0 bits (207), Expect = 5e-17
 Identities = 59/307 (19%), Positives = 106/307 (34%), Gaps = 57/307 (18%)

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
               ++ N+ +             ++S++     ++             LPN+ +L +  
Sbjct: 20  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLNG 74

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAANDL 178
           N    + P  L+N  NL  L L  N+ K    +     LK L  L+LE N +     +D+
Sbjct: 75  NKLTDIKP--LTNLKNLGWLFLDENKIK---DLSSLKDLKKLKSLSLEHNGI-----SDI 124

Query: 179 GFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVN 238
                L +   L+ L L +N+        I +++                    +  L  
Sbjct: 125 ---NGLVHLPQLESLYLGNNK--------ITDIT-------------------VLSRLTK 154

Query: 239 LIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ 298
           L  L++E NQ+   I   +  L  LQ L L KN +  S    L  L  L  L+L S    
Sbjct: 155 LDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECL 210

Query: 299 GNFIASQNKLIGALPQ------QLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDI 352
              I  Q+ L+            L++   +S   D     +   LP+    +  +    +
Sbjct: 211 NKPINHQSNLV-VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 269

Query: 353 SSNQFSG 359
           +  +   
Sbjct: 270 TIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 75.1 bits (184), Expect = 3e-14
 Identities = 59/300 (19%), Positives = 95/300 (31%), Gaps = 84/300 (28%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGN---SLGGKFPTTLGLLRNLVQLN 67
           +  +     L    +T  +      L+++  I    +   S+ G     +  L N+ +L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-----IQYLPNVTKLF 71

Query: 68  VAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP 127
           +  NK        + +I  L                    NL NL  L +  N     I 
Sbjct: 72  LNGNK--------LTDIKPLT-------------------NLKNLGWLFLDENK----IK 100

Query: 128 D--SLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
           D  SL +   L+ L L +N       I+    L  L  L L  N +          +T L
Sbjct: 101 DLSSLKDLKKLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKITD--------ITVL 149

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
           +  + L  LSL DNQ        I+++                     +  L  L  L +
Sbjct: 150 SRLTKLDTLSLEDNQ--------ISDIV-------------------PLAGLTKLQNLYL 182

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIAS 304
             N +  +    +  LKNL +L L+         +   NL     +     SL    I S
Sbjct: 183 SKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 60.9 bits (147), Expect = 9e-10
 Identities = 36/166 (21%), Positives = 68/166 (40%), Gaps = 15/166 (9%)

Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           K + +L  L  L L  N +   L   + +L  L+ + ++ N +       L  L  L  L
Sbjct: 81  KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESL 136

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
            +  NK   +    +  ++ L+   L  N+ S  +P      L  L+ L +  N+    I
Sbjct: 137 YLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLSKNH----I 187

Query: 127 PD--SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
            D  +L+   NL++L+L + +   K     S+L +   +     +L
Sbjct: 188 SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 47/239 (19%), Positives = 81/239 (33%), Gaps = 48/239 (20%)

Query: 505 SAHNSADTSPMEKQFPMVSYAELSKATSEFSSSN------------MIGQGSFGSVYKGI 552
           S H+   +S +  +   ++      AT                   ++G G FGSVY GI
Sbjct: 4   SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63

Query: 553 LGEDEMIVAVKVINLKQKGAFRSFVA-------ECEALRNIRHR--NLIKIITICSSTDF 603
              D + VA+K +  K + +    +        E   L+ +      +I+++      D 
Sbjct: 64  RVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 121

Query: 604 KGVDFKALVFEY-MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQP 662
               F  L+ E       L D++       E   L      +    V  A+ + H+    
Sbjct: 122 ---SF-VLILERPEPVQDLFDFI------TERGALQEELARSFFWQVLEAVRHCHNCG-- 169

Query: 663 PMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            ++H D+K  N+L+D +     + DFG    L                   GT  Y  P
Sbjct: 170 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----------GTRVYSPP 217

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 35/188 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLIKII 595
           +G+GSFG V      + +  VA+K I+ +Q             E   L+ +RH ++IK+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 596 TICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
            + ++            +V EY G G L D++      VE  +++  +       +  AI
Sbjct: 76  DVITTPTDIV-------MVIEYAG-GELFDYI------VEKKRMTEDEGRRFFQQIICAI 121

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL-AKFLSSHHLDTSSKTPSSSIGIK 712
           EY H H    +VH DLKP N+LLD ++   + DFGL       + L TS  +P+      
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------ 172

Query: 713 GTVGYVAP 720
               Y AP
Sbjct: 173 ----YAAP 176

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 39/207 (18%)

Query: 503 RRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAV 562
                 +    P             + +   +     +G+G++G VYK I       VA+
Sbjct: 8   HMGTLEAQTQGPGSMSVSAAPS---ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 563 KVINLKQKG------AFRSFVAECEALRNIRHRNLIKIITICSSTD--FKGVDFKALVFE 614
           K I L+ +       A R    E   L+ ++HRN+I++ ++               L+FE
Sbjct: 65  KRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLH-------LIFE 113

Query: 615 YMGNGSLEDWLHQSND-QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 673
           Y     L+ ++ ++ D  + V K  L Q +       + + + H       +H DLKP N
Sbjct: 114 YA-ENDLKKYMDKNPDVSMRVIKSFLYQLI-------NGVNFCHSRR---CLHRDLKPQN 162

Query: 674 VLLDHDMVAHVG-----DFGLAKFLSS 695
           +LL     +        DFGLA+    
Sbjct: 163 LLLSVSDASETPVLKIGDFGLARAFGI 189

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 45/187 (24%), Positives = 71/187 (37%), Gaps = 34/187 (18%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC- 598
           IG G+FG          + +VAVK I  +      +   E    R++RH N+++   +  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWL--HQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           + T        A++ EY   G L + +       + E       Q+L       S + Y 
Sbjct: 87  TPTHL------AIIMEYASGGELYERICNAGRFSEDEARFF--FQQL------LSGVSYC 132

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAH--VGDFGLAKFLSSHH-LDTSSKTPSSSIGIKG 713
           H      + H DLK  N LLD        + DFG +K    H    ++  TP+       
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------- 182

Query: 714 TVGYVAP 720
              Y+AP
Sbjct: 183 ---YIAP 186

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 25/165 (15%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKII 595
             IG+G++G VYK        +VA+K I L  +  G   + + E   L+ + H N++K++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 596 TICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSNDQ---VEVCKLSLIQRLNIAIDVA 650
            +  + +  +       LVFE++ +  L+ ++  S      + + K  L Q L       
Sbjct: 69  DVIHTENKLY-------LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL------- 113

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             + + H H    ++H DLKP N+L++ +    + DFGLA+    
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 42/187 (22%), Positives = 78/187 (41%), Gaps = 29/187 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FRSFVAECE-ALRNIRHRNLIKIITI 597
           +G+G++G V K        I+AVK I         +  + + + ++R +     +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70

Query: 598 CSSTDFKGVDFK----ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                F G  F+     +  E M   SL+ +  Q  D+ +     ++ +  IA+ +  A+
Sbjct: 71  -----FYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           E+LH      ++H D+KPSNVL++      + DFG++ +L                   G
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDA---G 171

Query: 714 TVGYVAP 720
              Y+AP
Sbjct: 172 CKPYMAP 178

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 84.7 bits (210), Expect = 2e-17
 Identities = 53/187 (28%), Positives = 77/187 (41%), Gaps = 29/187 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G+GSFG V            AVKVI+   +KQK    S + E + L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
                      +  LV E    G L D +       EV    +I++      V S I Y+
Sbjct: 94  FFEDK-----GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYM 142

Query: 657 HHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           H +    +VH DLKP N+LL     D    + DFGL+    +                 G
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---------DKIG 190

Query: 714 TVGYVAP 720
           T  Y+AP
Sbjct: 191 TAYYIAP 197

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 37/187 (19%), Positives = 71/187 (37%), Gaps = 32/187 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FRSFVAECEAL-RNIRHRNLIKIITI 597
           +G G+ G V+K    +   ++AVK +         +  + + + + ++     +++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 598 CSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
                  G         +  E MG    E    +    +    L       + + +  A+
Sbjct: 89  -----CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            YL       ++H D+KPSN+LLD      + DFG++  L     D  +K  S+     G
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSA-----G 186

Query: 714 TVGYVAP 720
              Y+AP
Sbjct: 187 CAAYMAP 193

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 37/184 (20%)

Query: 526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG---------AFRSF 576
           ++      +   + +G+G F +VYK        IVA+K I L  +          A R  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-- 61

Query: 577 VAECEALRNIRHRNLIKIITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSN---DQ 631
             E + L+ + H N+I ++                 LVF++M    LE  +  ++     
Sbjct: 62  --EIKLLQELSHPNIIGLLDAFGHKSNIS-------LVFDFM-ETDLEVIIKDNSLVLTP 111

Query: 632 VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK 691
             + K  ++  L         +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK
Sbjct: 112 SHI-KAYMLMTL-------QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

Query: 692 FLSS 695
              S
Sbjct: 161 SFGS 164

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 42/196 (21%), Positives = 74/196 (37%), Gaps = 40/196 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           IG+G F  V + I  E     AVK+++   K      ++      E      ++H ++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRL------NIAI 647
           ++   SS          +VFE+M    L   +        V +             +   
Sbjct: 91  LLETYSSD-----GMLYMVFEFMDGADLCFEI--------VKRADAGFVYSEAVASHYMR 137

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
            +  A+ Y H +    ++H D+KP  VLL   ++     +G FG+A  L    L      
Sbjct: 138 QILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG--- 191

Query: 705 PSSSIGIKGTVGYVAP 720
                G  GT  ++AP
Sbjct: 192 -----GRVGTPHFMAP 202

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 31/196 (15%)

Query: 508 NSADTSPMEKQFPMVSYAELSKATSE------FSSSNMIGQGSFGSVYKGILGEDEMIVA 561
            + D  P   +   +   ++++   +      FS    IG GSFG+VY      +  +VA
Sbjct: 24  GAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVA 83

Query: 562 VKVINLKQKGA---FRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA----LVFE 614
           +K ++   K +   ++  + E   L+ +RH N I+         ++G   +     LV E
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLREHTAWLVME 134

Query: 615 YMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV 674
           Y   GS  D L      ++  +++ +            + YLH H    M+H D+K  N+
Sbjct: 135 YCL-GSASDLLEVHKKPLQEVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGNI 185

Query: 675 LLDHDMVAHVGDFGLA 690
           LL    +  +GDFG A
Sbjct: 186 LLSEPGLVKLGDFGSA 201

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 45/191 (23%), Positives = 83/191 (43%), Gaps = 17/191 (8%)

Query: 514 PMEKQFPMVSYAELSKATSEFSSSNM-IGQGSFGSVYKGI--LGEDEMIVAVKVINLKQK 570
            M+  F +   +E  +    F      +G+G++G VYK     G+D+   A+K I  +  
Sbjct: 2   KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGT 59

Query: 571 GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGN--GSLEDWLHQS 628
           G   S   E   LR ++H N+I +  +  S   + V    L+F+Y  +    +  +   S
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKV---WLLFDYAEHDLWHIIKFHRAS 116

Query: 629 NDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH----V 684
               +  +L      ++   +   I YLH +    ++H DLKP+N+L+  +        +
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173

Query: 685 GDFGLAKFLSS 695
            D G A+  +S
Sbjct: 174 ADMGFARLFNS 184

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 25/167 (14%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--------FRSFVAECEALRNIRHRNL 591
           IG G FG +Y           A  V+ ++ +          F   VA+ + ++    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 592 IKIITI-----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
           +  + I        T+FKG  ++ +V E +G   L+    Q+              L + 
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNG------TFKKSTVLQLG 157

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVGDFGLAK 691
           I +   +EY+H +     VHGD+K +N+LL   +    ++ D+GL+ 
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 6e-17
 Identities = 46/192 (23%), Positives = 74/192 (38%), Gaps = 40/192 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 598
           +G G  G V +      +   A+K++      A R    E E      +  ++++I+ + 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-------EVCKLSLIQRLNIAIDVAS 651
               + G     +V E +  G L   +    DQ        E+ K            +  
Sbjct: 125 -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----------SIGE 172

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           AI+YLH      + H D+KP N+L      + +  + DFG AK  +SH+   S  TP   
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPC-- 224

Query: 709 IGIKGTVGYVAP 720
                T  YVAP
Sbjct: 225 ----YTPYYVAP 232

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 40/193 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA-FRSFVAECE-ALRNIRHRNLIKIITI 597
           IG+G++GSV K +      I+AVK I         +  + + +  +R+     +++    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85

Query: 598 CSSTDFKGVDFKA----LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN------IAI 647
                F G  F+     +  E M   S + +              L   +       I +
Sbjct: 86  -----FYGALFREGDCWICMELMS-TSFDKFYKY-------VYSVLDDVIPEEILGKITL 132

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
               A+ +L  + +  ++H D+KPSN+LLD      + DFG++  L     D+ +KT  +
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV----DSIAKTRDA 186

Query: 708 SIGIKGTVGYVAP 720
                G   Y+AP
Sbjct: 187 -----GCRPYMAP 194

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.8 bits (205), Expect = 8e-17
 Identities = 54/188 (28%), Positives = 77/188 (40%), Gaps = 28/188 (14%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
            M+G+GSFG V K      +   AVKVIN          + + E E L+ + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            I    D        +V E    G L D +      ++  + S      I   V S I Y
Sbjct: 88  EILE--DSSSF---YIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITY 136

Query: 656 LHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +H H    +VH DLKP N+LL   + D    + DFGL+     +                
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---------RI 184

Query: 713 GTVGYVAP 720
           GT  Y+AP
Sbjct: 185 GTAYYIAP 192

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 82.7 bits (205), Expect = 9e-17
 Identities = 67/437 (15%), Positives = 136/437 (31%), Gaps = 75/437 (17%)

Query: 39  LQVIHIKGNSLGGK-FPTTLGLLRNLVQLNVAENKFYGMFPRSICNI----SSLEYFYLT 93
           +Q + I+   L    +   L LL+    + + +        + I +      +L    L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 94  SNRFSGS----LPFDIVVNLPNLKELGIGANNF----FGLIPDSLSNASNLELLDLSNNQ 145
           SN         +   +      +++L +          G++  +L     L+ L LS+N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 146 FKGKVSIDFSSLKI-----LWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
                        +     L +L LE  +L   +   L  V  L      K L++S+N  
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNNDI 182

Query: 201 GGE----LPHSIANLSSTMIVFLIGGNQIS----GTIPLGIRNLVNLIALAVEVNQLHGT 252
                  L   + +    +    +    ++      +   + +  +L  LA+  N+L   
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 253 -----IPDVIGELKNLQLLGLYKNFLQ----GSIPSGLGNLTKLAKLDLGSNSLQGNFIA 303
                 P ++     L+ L +++  +     G +   L     L +L L  N L      
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD---E 299

Query: 304 SQNKLIGALPQQLLSITTLSLYLDLSNNLLNG----SLPQQVGNLKNLIILDISSNQF-- 357
               L   L +    + +L     + +              +   + L+ L IS+N+   
Sbjct: 300 GARLLCETLLEPGCQLESL----WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355

Query: 358 SGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQ----FPKFL 413
           +G+  +    C  L                       ++ L ++  + S          L
Sbjct: 356 AGVREL----CQGLG----QPGS-------------VLRVLWLADCDVSDSSCSSLAATL 394

Query: 414 ENLSFLEFLNLSYNHLE 430
                L  L+LS N L 
Sbjct: 395 LANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 74.6 bits (184), Expect = 4e-14
 Identities = 54/327 (16%), Positives = 102/327 (31%), Gaps = 58/327 (17%)

Query: 134 SNLELLDLSNNQFKGK-VSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            +++ LD+   +      +     L+    + L+   L      D+     L    +L  
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60

Query: 193 LSLSDNQFGGE----LPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ 248
           L+L  N+ G      +   +   S  +    +    ++G    G   L    +  +    
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---GCGVL----SSTLRTL- 112

Query: 249 LHGTIPDVIGELKNLQLLGLYKNFLQGS-----IPSGLGNLTKLAKLDLGSNSLQGNFIA 303
                         LQ L L  N L  +         L    +L KL L   SL      
Sbjct: 113 ------------PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL-SAASC 159

Query: 304 SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG-----NLKNLIILDISSNQFS 358
                   L   L +       L +SNN +N +  + +      +   L  L + S   +
Sbjct: 160 E------PLASVLRAKPDFK-ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212

Query: 359 ----GMIPVTLSTCVSLEYVDISSNCFH--GIIPPSLGFLK---SIKFLDVSCNNFSGQ- 408
                 +   +++  SL  + + SN     G+     G L     ++ L +     + + 
Sbjct: 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG 272

Query: 409 ---FPKFLENLSFLEFLNLSYNHLEGE 432
                + L     L+ L+L+ N L  E
Sbjct: 273 CGDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 74/415 (17%), Positives = 137/415 (33%), Gaps = 80/415 (19%)

Query: 14  KLQALALAGNYLTGK----LPDFIGNLSALQVIHIKGNSLGGKFPTTL--GLLRN---LV 64
           + Q + L    LT      +   +    AL  ++++ N LG      +  GL      + 
Sbjct: 29  QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 88

Query: 65  QLNVAENKF----YGMFPRSICNISSLEYFYLTSNRFSGS----LPFDIVVNLPNLKELG 116
           +L++          G+   ++  + +L+  +L+ N    +    L   ++     L++L 
Sbjct: 89  KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ 148

Query: 117 IGANNF----FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFS-SLKI----LWRLNLEQ 167
           +   +        +   L    + + L +SNN             LK     L  L LE 
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES 208

Query: 168 NNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE----LPHSIANLSSTMIVFLIGGN 223
             +      DL  +  + + +SL+ L+L  N+ G      L   + + SS +    I   
Sbjct: 209 CGVTSDNCRDLCGI--VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266

Query: 224 QISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN 283
            I+     G  +L       +                ++L+ L L  N L       L  
Sbjct: 267 GIT---AKGCGDL----CRVLRAK-------------ESLKELSLAGNELGDEGARLLCE 306

Query: 284 L-----TKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNN------- 331
                  +L  L + S S      +       ++  Q   +      L +SNN       
Sbjct: 307 TLLEPGCQLESLWVKSCSFTAACCSH----FSSVLAQNRFLLE----LQISNNRLEDAGV 358

Query: 332 -LLNGSLPQQVGNLKNLIILDISSNQFS----GMIPVTLSTCVSLEYVDISSNCF 381
             L   L Q       L +L ++    S      +  TL    SL  +D+S+NC 
Sbjct: 359 RELCQGLGQ---PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 82.8 bits (205), Expect = 1e-16
 Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 28/195 (14%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRH 588
           +  +     +G G++G V         +  A+K+I        +    + E   L+ + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++K+       D +      LV E    G L D +       EV    +I+       
Sbjct: 96  PNIMKLYDFFE--DKRNY---YLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------Q 144

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           V S + YLH H    +VH DLKP N+LL   + D +  + DFGL+    +          
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK----- 196

Query: 706 SSSIGIKGTVGYVAP 720
                  GT  Y+AP
Sbjct: 197 ----ERLGTAYYIAP 207

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 49/234 (20%), Positives = 80/234 (34%), Gaps = 49/234 (20%)

Query: 509 SADTSPMEKQ--FPMVSYAELSKATSEFSSSN-----MIGQGSFGSVYKGILGEDEMIVA 561
           S  T P++     P            E   +      ++G+G FG+V+ G    D + VA
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60

Query: 562 VKVINLKQKGAFRSFVA-------ECEALRNIR----HRNLIKIITICSSTD--FKGVDF 608
           +KVI  + +    S ++       E   L  +     H  +I+++    + +        
Sbjct: 61  IKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM----- 114

Query: 609 KALVFEYMGNGS-LEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHG 667
             LV E       L D++       E   L           V +AI++ H      +VH 
Sbjct: 115 --LVLERPLPAQDLFDYI------TEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHR 163

Query: 668 DLKPSNVLLDHDM-VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           D+K  N+L+D     A + DFG    L                   GT  Y  P
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----------GTRVYSPP 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 83.0 bits (205), Expect = 1e-16
 Identities = 36/183 (19%), Positives = 66/183 (36%), Gaps = 24/183 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG V++          A K +    +    +   E + +  +RH  L+ +     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                  +   +++E+M  G L + +       E  K+S  + +     V   + ++H +
Sbjct: 225 DD-----NEMVMIYEFMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
                VH DLKP N++        +   DFGL   L                   GT  +
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---------TTGTAEF 322

Query: 718 VAP 720
            AP
Sbjct: 323 AAP 325

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 1e-16
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 31/167 (18%)

Query: 538 NMIGQGSFGSVYKGI--LGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIK 593
             IG+G++G VYK     GE     A+K I L+++  G   + + E   L+ ++H N++K
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 594 IITICSSTD--FKGVDFKALVFEYMGNGSLEDWLHQSN---DQVEVCKLSLIQRLNIAID 648
           +  +  +            LVFE++ +  L+  L       + V   K  L+Q L     
Sbjct: 65  LYDVIHTKKRLV-------LVFEHL-DQDLKKLLDVCEGGLESVTA-KSFLLQLL----- 110

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
             + I Y H      ++H DLKP N+L++ +    + DFGLA+    
Sbjct: 111 --NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 31/182 (17%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
              +++  +IG GSFG V++  L E +  VA+K +   ++   R    E + +R ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPN 93

Query: 591 LIKII-TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ---------VEVCKLSLI 640
           ++ +     S+ D K   F  LV EY+     E  +++++           + + KL + 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLAKFLSSHHLD 699
           Q L        ++ Y+H      + H D+KP N+LLD    V  + DFG AK L +   +
Sbjct: 149 QLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 700 TS 701
            S
Sbjct: 199 VS 200

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 45/168 (26%), Positives = 68/168 (40%), Gaps = 16/168 (9%)

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG-IGAANDLGFVTFLTNCSSLKV 192
            +  +L LS N               L +LNL++  L  +     L           L  
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL---------PVLGT 81

Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHG 251
           L LS NQ    LP     L +  ++ +   N+++ ++PLG  R L  L  L ++ N+L  
Sbjct: 82  LDLSHNQL-QSLPLLGQTLPALTVLDV-SFNRLT-SLPLGALRGLGELQELYLKGNELKT 138

Query: 252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQ 298
             P ++     L+ L L  N L   +P+GL   L  L  L L  NSL 
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 48/216 (22%), Positives = 81/216 (37%), Gaps = 21/216 (9%)

Query: 83  NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS 142
            ++S           + +LP D+     +   L +  N  +     +L   + L  L+L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 143 NNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG 201
             +      +    +L +L  L+L  N L    +  L          +L VL +S N+  
Sbjct: 64  RAELT---KLQVDGTLPVLGTLDLSHNQL---QSLPLLG----QTLPALTVLDVSFNRL- 112

Query: 202 GELPHSI-ANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGE 259
             LP      L     ++L  GN++  T+P G+      L  L++  N L      ++  
Sbjct: 113 TSLPLGALRGLGELQELYL-KGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 260 LKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
           L+NL  L L +N L  +IP G      L    L  N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 38/156 (24%), Positives = 59/156 (37%), Gaps = 12/156 (7%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
              +L  L L    LT KL    G L  L  + +  N L    P     L  L  L+V+ 
Sbjct: 53  PYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N+   +   ++  +  L+  YL  N    +LP  ++   P L++L +  NN   L    L
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168

Query: 131 SNASNLELLDLSNNQFKGKVSI-----DFSSLKILW 161
           +   NL+ L L  N      +I         L   +
Sbjct: 169 NGLENLDTLLLQENSLY---TIPKGFFGSHLLPFAF 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 50/193 (25%), Positives = 76/193 (39%), Gaps = 23/193 (11%)

Query: 262 NLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALP--QQLLSI 319
           +  +L L +N L     + L   T+L +L+L    L              L     L  +
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT------------KLQVDGTLPVL 79

Query: 320 TTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
            T    LDLS+N L  SLP     L  L +LD+S N+ + +    L     L+ + +  N
Sbjct: 80  GT----LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134

Query: 380 CFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVF 439
               + P  L     ++ L ++ NN +      L  L  L+ L L  N L   +P KG F
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IP-KGFF 192

Query: 440 SNKS--KIPLQGN 450
            +       L GN
Sbjct: 193 GSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 38/144 (26%), Positives = 52/144 (36%), Gaps = 34/144 (23%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPD--FIGNLSALQVIHIKGNSLGGKFPTTL--GLL 60
           +P    +L  L  L ++ N LT  LP     G L  LQ +++KGN L      TL  GLL
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLT-SLPLGALRG-LGELQELYLKGNEL-----KTLPPGLL 144

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
               +                     LE   L +N  +  LP  ++  L NL  L +   
Sbjct: 145 TPTPK---------------------LEKLSLANNNLT-ELPAGLLNGLENLDTLLL-QE 181

Query: 121 NFFGLIPDSLSNASNLELLDLSNN 144
           N    IP     +  L    L  N
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGN 205

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 65/264 (24%), Positives = 94/264 (35%), Gaps = 61/264 (23%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGI---GAANDLGFVT 182
           IPD+L    + + LDLS N  +   S  F S   L  L+L +  +     GA   L    
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL---- 75

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIA 241
                S L  L L+ N            + S               + LG    L +L  
Sbjct: 76  -----SHLSTLILTGNP-----------IQS---------------LALGAFSGLSSLQK 104

Query: 242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG--LGNLTKLAKLDLGSNSLQG 299
           L      L       IG LK L+ L +  N +Q S        NLT L  LDL SN +Q 
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ- 162

Query: 300 NFIASQNKLIGALP----QQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSN 355
                      ++     + L  +  L+L LDLS N +N  +         L  L + +N
Sbjct: 163 -----------SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210

Query: 356 QFSGMIPVTLSTCVSLEYVDISSN 379
           Q   +         SL+ + + +N
Sbjct: 211 QLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 60/259 (23%), Positives = 92/259 (35%), Gaps = 60/259 (23%)

Query: 108 NLP-NLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRL 163
           NLP + K L +  N    L   S  +   L++LDLS  + +   +I+   + SL  L  L
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ---TIEDGAYQSLSHLSTL 81

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGN 223
            L  N +   A        F +  SSL+ L   +          +A+L +          
Sbjct: 82  ILTGNPIQSLALG-----AF-SGLSSLQKLVAVETN--------LASLENFP-------- 119

Query: 224 QISGTIPLGIRNLVNLIALAVEVNQLHG-TIPDVIGELKNLQLLGLYKNFLQGSIPSG-- 280
                    I +L  L  L V  N +    +P+    L NL+ L L  N +Q SI     
Sbjct: 120 ---------IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169

Query: 281 --LGNLTKLA-KLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSL 337
             L  +  L   LDL  N +              +         L   L L  N L  S+
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMN------------FIQPGAFKEIRLK-ELALDTNQLK-SV 215

Query: 338 PQQV-GNLKNLIILDISSN 355
           P  +   L +L  + + +N
Sbjct: 216 PDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 53/247 (21%), Positives = 93/247 (37%), Gaps = 47/247 (19%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
            S K L LS N       +S  +     ++ L    +I  TI  G  ++L +L  L +  
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL-SRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIASQ 305
           N +          L +LQ L   +  L  S+ +   G+L  L +L++  N +Q       
Sbjct: 86  NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ------- 137

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLII----LDISSNQFSGM 360
                 LP+   ++T L  +LDLS+N +  S+       L  + +    LD+S N  +  
Sbjct: 138 -SFK--LPEYFSNLTNLE-HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191

Query: 361 IPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLE 420
           I       + L+ + + +N            LKS+                  + L+ L+
Sbjct: 192 IQPGAFKEIRLKELALDTN-----------QLKSVP-------------DGIFDRLTSLQ 227

Query: 421 FLNLSYN 427
            + L  N
Sbjct: 228 KIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 46/261 (17%), Positives = 84/261 (32%), Gaps = 60/261 (22%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL--GLLRNLVQLNVAENK 72
            + L L+ N L         +   LQV+ +    +      T+  G  ++L  L      
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-----QTIEDGAYQSLSHL------ 78

Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
                              LT N    SL       L +L++L     N   L    + +
Sbjct: 79  ---------------STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 133 ASNLELLDLSNNQFKGKVSID--FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
              L+ L++++N  +    +   FS+L  L  L+L  N +                    
Sbjct: 123 LKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ------------------- 162

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH 250
              S+            +  +    +   +  N ++  I  G    + L  LA++ NQL 
Sbjct: 163 ---SIYCTDL-----RVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213

Query: 251 GTIPDVIGELKNLQLLGLYKN 271
                +   L +LQ + L+ N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 38/193 (19%), Positives = 68/193 (35%), Gaps = 35/193 (18%)

Query: 262 NLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALP----QQL 316
           + + L L  N L+  + S    +  +L  LDL    +Q             +     Q L
Sbjct: 29  STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ------------TIEDGAYQSL 75

Query: 317 LSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVD 375
             ++T    L L+ N +  SL       L +L  L       + +    +    +L+ ++
Sbjct: 76  SHLST----LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 376 ISSNCFHGIIPPSLGF--LKSIKFLDVSCNNFS----GQFPKFLENLSFLEF-LNLSYNH 428
           ++ N       P   F  L +++ LD+S N             L  +  L   L+LS N 
Sbjct: 131 VAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSLDLSLNP 188

Query: 429 LEGEVPTKGVFSN 441
           +   +   G F  
Sbjct: 189 MN-FIQP-GAFKE 199

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 43/166 (25%), Positives = 64/166 (38%), Gaps = 13/166 (7%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           SL  L  L L GN +          LS+LQ +     +L       +G L+ L +LNVA 
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 71  NK-----FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG---ANNF 122
           N          F     N+++LE+  L+SN+   S+    +  L  +  L +    + N 
Sbjct: 134 NLIQSFKLPEYFS----NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 123 FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN 168
              I         L+ L L  NQ K      F  L  L ++ L  N
Sbjct: 189 MNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 36/181 (19%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAFRSFVAECE----- 581
            +A  ++     IG+G++G V+K   L      VA+K + ++            E     
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLS 57

Query: 582 ALRNI---------RHRNLIKIITICSSTDFKGVDFKALVFEYMGN--GSLEDWLHQSND 630
            +R +          H N++++  +C+ +         LVFE++     +  D + +   
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117

Query: 631 QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
             E  K  + Q L         +++LH H    +VH DLKP N+L+       + DFGLA
Sbjct: 118 PTETIKDMMFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167

Query: 691 K 691
           +
Sbjct: 168 R 168

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 40/169 (23%), Positives = 76/169 (44%), Gaps = 26/169 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMI-----VAVKVIN-----LKQKGAFRSFVAECEALRNIRHR 589
           IGQG FG +Y   +   E +       VKV       L  +  F    A+ E ++     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 590 NLIKIITICS-----STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN 644
             +K + +         D  G  ++ ++ +  G+  L+  ++++N +    + S    L 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAK----RFSRKTVLQ 156

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVGDFGLAK 691
           +++ +   +EY+H H     VHGD+K SN+LL+  +    ++ D+GLA 
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 51/234 (21%), Positives = 83/234 (35%), Gaps = 43/234 (18%)

Query: 507 HNSADTSPMEKQFPMVSYAELSKATSEFSS----SNMIGQGSFGSVYKGILGEDEMIVAV 562
           H+S   +   +   +     + K   +          +G G++G V            A+
Sbjct: 7   HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66

Query: 563 KVINLKQ-------------KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK 609
           KVI   Q             +        E   L+++ H N+IK+  +          + 
Sbjct: 67  KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK-----KYF 121

Query: 610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL 669
            LV E+   G L + +      +   K       NI   + S I YLH H    +VH D+
Sbjct: 122 YLVTEFYEGGELFEQI------INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDI 172

Query: 670 KPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           KP N+LL   +  +   + DFGL+ F S  +               GT  Y+AP
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---------DRLGTAYYIAP 217

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 21/160 (13%), Positives = 46/160 (28%), Gaps = 31/160 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMI---VAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLIK 593
            G       ++     D  +   VA+  +              ++    L  I    + +
Sbjct: 39  HGGVPPLQFWQA---LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 594 IITICSSTDF---KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           ++      D    +      +V E++  GSL++    S         S +  +     +A
Sbjct: 96  VL------DVVHTRAGGL--VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLA 139

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           +A +  H      +      PS V +  D    +      
Sbjct: 140 AAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 38/189 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G+G+   VY+      +   A+KV+        +    E   L  + H N+IK+  I  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN-----DQVEVCKLSLIQRLNIAIDVASAIE 654
           +         +LV E +  G L D + +       D  +  K            +  A+ 
Sbjct: 119 TP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVK-----------QILEAVA 162

Query: 655 YLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           YLH +    +VH DLKP N+L      D    + DFGL+K +    L            +
Sbjct: 163 YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---------TV 210

Query: 712 KGTVGYVAP 720
            GT GY AP
Sbjct: 211 CGTPGYCAP 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 47/191 (24%), Positives = 71/191 (37%), Gaps = 33/191 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V+      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +     ++      L+ E +  G L D+L       +   LS  +  +    +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128

Query: 654 EYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
            YLH      + H DLKP N++L           + DFGLA  +                
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--------- 176

Query: 710 GIKGTVGYVAP 720
            I GT  +VAP
Sbjct: 177 NIFGTPEFVAP 187

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.0 bits (193), Expect = 8e-16
 Identities = 33/189 (17%), Positives = 69/189 (36%), Gaps = 37/189 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G+G FG V++ +    +     K +   +         E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSN------DQVEVCKLSLIQRLNIAIDVASAI 653
           S      +   ++FE++    + + ++ S       + V                V  A+
Sbjct: 72  SM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----------QVCEAL 115

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           ++LH H    + H D++P N++      + +   +FG A+ L       + +       +
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRL------L 163

Query: 712 KGTVGYVAP 720
                Y AP
Sbjct: 164 FTAPEYYAP 172

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 47/191 (24%), Positives = 70/191 (36%), Gaps = 33/191 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  +Q  A R  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +     ++      L+ E +  G L D+L       +   LS  +  +    +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128

Query: 654 EYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
            YLH      + H DLKP N++L           + DFGLA  +                
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--------- 176

Query: 710 GIKGTVGYVAP 720
            I GT  +VAP
Sbjct: 177 NIFGTPEFVAP 187

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 32/212 (15%), Positives = 72/212 (33%), Gaps = 28/212 (13%)

Query: 223 NQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDV-IGELKNLQLLGLYKNFLQGSIPSGL 281
           +Q +  IP         +   +  +       ++   ++ +L  + L    +   + +G+
Sbjct: 11  SQDNVNIPD--STFKAYLNGLLGQSS----TANITEAQMNSLTYITLANINVT-DL-TGI 62

Query: 282 GNLTKLAKLDLGSNSLQG-NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQ 340
                +  L + +      N I+  + L                 L +    +       
Sbjct: 63  EYAHNIKDLTINNIHATNYNPISGLSNLE---------------RLRIMGKDVTSDKIPN 107

Query: 341 VGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDV 400
           +  L +L +LDIS +     I   ++T   +  +D+S N     I P L  L  +K L++
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNI 166

Query: 401 SCNNFSGQFPKFLENLSFLEFLNLSYNHLEGE 432
             +       + +E+   L  L      + G+
Sbjct: 167 QFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 38/234 (16%), Positives = 72/234 (30%), Gaps = 55/234 (23%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           IPDS           L  +      +I  + +  L  + L   N+      DL   T + 
Sbjct: 17  IPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----TDL---TGIE 63

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
              ++K L++++            N +                    I  L NL  L + 
Sbjct: 64  YAHNIKDLTINNIH--------ATNYN-------------------PISGLSNLERLRIM 96

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
              +       +  L +L LL +  +    SI + +  L K+  +DL  N    +     
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD----- 151

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSG 359
                     L ++  L   L++  + ++      + +   L  L   S    G
Sbjct: 152 -------IMPLKTLPELK-SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 29/196 (14%), Positives = 63/196 (32%), Gaps = 24/196 (12%)

Query: 35  NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNIS---SLEYFY 91
              A     +  +S       T   + +L  + +A           +  I    +++   
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLT 72

Query: 92  LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVS 151
           + +   +   P      L NL+ L I   +       +LS  ++L LLD+S++     + 
Sbjct: 73  INNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 152 IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL 211
              ++L  +  ++L  N         +  +  L     LK L++  +         I + 
Sbjct: 130 TKINTLPKVNSIDLSYNGA-------ITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDF 180

Query: 212 SSTMIVFLIGGNQISG 227
              +         I G
Sbjct: 181 PK-LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 35/187 (18%), Positives = 67/187 (35%), Gaps = 22/187 (11%)

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            ++ +Q +  IPD     K      L ++       + + +LT +        +L    +
Sbjct: 7   GLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQMNSLTYI--------TLANINV 56

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
                 +  + +   +I      L ++N       P  +  L NL  L I     +    
Sbjct: 57  TD----LTGI-EYAHNIK----DLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKI 105

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFL 422
             LS   SL  +DIS +     I   +  L  +  +D+S N         L+ L  L+ L
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTLPELKSL 164

Query: 423 NLSYNHL 429
           N+ ++ +
Sbjct: 165 NIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 28/171 (16%), Positives = 59/171 (34%), Gaps = 14/171 (8%)

Query: 33  IGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL 92
              +++L  I +   ++     T +    N+  L +         P  I  +S+LE   +
Sbjct: 40  EAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95

Query: 93  TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSI 152
                +     ++   L +L  L I  +     I   ++    +  +DLS N     +  
Sbjct: 96  MGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM- 153

Query: 153 DFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE 203
              +L  L  LN++ + +     +D      + +   L  L       GG+
Sbjct: 154 PLKTLPELKSLNIQFDGV-----HDY---RGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 23/139 (16%), Positives = 46/139 (33%), Gaps = 28/139 (20%)

Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
             I  L  L+ L + G  +T      +  L++L ++ I  ++      T +  L  +  +
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
           +++ N        +I +I  L+                    LP LK L I  +      
Sbjct: 142 DLSYNG-------AITDIMPLK-------------------TLPELKSLNIQFDGVHDYR 175

Query: 127 PDSLSNASNLELLDLSNNQ 145
              + +   L  L   +  
Sbjct: 176 G--IEDFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 12/95 (12%), Positives = 41/95 (43%), Gaps = 4/95 (4%)

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVS 401
             + +L  + +++   + +    +    +++ + I++       P  +  L +++ L + 
Sbjct: 41  AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96

Query: 402 CNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK 436
             + +      L  L+ L  L++S++  +  + TK
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 3/99 (3%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           +       +  L  L  L ++ +     +   I  L  +  I +  N         L  L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTL 158

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSG 99
             L  LN+  +  +    R I +   L   Y  S    G
Sbjct: 159 PELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 50/191 (26%), Positives = 74/191 (38%), Gaps = 33/191 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K          A K I  ++  + R  V+      E   LR IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  I     F+      L+ E +  G L D+L       E   L+  +       +   +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGV 121

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAH----VGDFGLAKFLSSHHLDTSSKTPSSSI 709
            YLH      + H DLKP N++L    V +    + DFG+A  + +       K      
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKN----- 170

Query: 710 GIKGTVGYVAP 720
            I GT  +VAP
Sbjct: 171 -IFGTPEFVAP 180

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 76.7 bits (189), Expect = 5e-15
 Identities = 33/175 (18%), Positives = 71/175 (40%), Gaps = 24/175 (13%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR--------HRN 590
            +G G F +V+      +   VA+K++   +     +   E + L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 591 LIKIITICSSTDFKGVDFK--ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
              I+ +    + KG +     +VFE +G  +L   + +   +     L  +++  I+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQ--ISKQ 139

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH------VGDFGLAKFLSSHH 697
           +   ++Y+H  C   ++H D+KP NVL++            + D G A +   H+
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 47/191 (24%), Positives = 74/191 (38%), Gaps = 33/191 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  ++  + R  V+      E   L+ I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +     ++      L+ E +  G L D+L       E   L+  +       + + +
Sbjct: 79  LHEV-----YENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGV 127

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAH----VGDFGLAKFLSSHHLDTSSKTPSSSI 709
            YLH      + H DLKP N++L    V      + DFGLA  +         K      
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKN----- 176

Query: 710 GIKGTVGYVAP 720
            I GT  +VAP
Sbjct: 177 -IFGTPEFVAP 186

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 26/169 (15%)

Query: 540 IGQGSFGSVYKGI--------LGEDEMIVAVKV----INLKQKGAFRSFVAECEALRNIR 587
             + + G +Y+           G  +   ++K+      L  +  F    A+   +   +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 588 HRNLIKIITICSSTDF--KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
                 ++ I +   F      ++ LV   +G  SL+  L  S        LS    L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKH----VLSERSVLQV 164

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAK 691
           A  +  A+E+LH +     VHG++   N+ +   D   V  +  +G A 
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 44/222 (19%), Positives = 80/222 (36%), Gaps = 34/222 (15%)

Query: 500 ARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMI 559
           +  ++           +    M       +    +   ++IG GS+G V +     ++ +
Sbjct: 21  SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80

Query: 560 VAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA--L 611
           VA+K I          K   R    E   L  + H +++K++ I    D +   F    +
Sbjct: 81  VAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVE--KFDELYV 134

Query: 612 VFEYMGNGSLEDWLHQ---SNDQVEV--CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVH 666
           V E   +    D   +   +   +     K  L   L         ++Y+H      ++H
Sbjct: 135 VLEIADS----D-FKKLFRTPVYLTELHIKTLLYNLLV-------GVKYVHSA---GILH 179

Query: 667 GDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
            DLKP+N L++ D    V DFGLA+ +       S    S  
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 38/214 (17%), Positives = 74/214 (34%), Gaps = 62/214 (28%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN 590
           + ++S    +G GSFG V +    E     A+K +    +   R    E + ++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 591 LIKIITICSSTDFKGVDFKA---------------------------------LVFEYMG 617
           +IK++    +T  +                                       ++ EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 618 NGSLEDWLHQ-------SNDQV--EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD 668
               +  LH+       S   +   +  + + Q          A+ ++H      + H D
Sbjct: 122 ----DT-LHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSL---GICHRD 166

Query: 669 LKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTS 701
           +KP N+L++  D    + DFG AK L       +
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA 200

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 24/157 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINL-KQKGAFRSFVAECEALRNIR-HRNLIKII-T 596
           +G+G +  V++ I   +   V VK++   K+K   R    E + L N+R   N+I +   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +             LVFE++ N   +       D     +  + + L        A++Y 
Sbjct: 100 VKDPVSRTPA----LVFEHVNNTDFKQLYQTLTD--YDIRFYMYEILK-------ALDYC 146

Query: 657 HHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKF 692
           H      ++H D+KP NV++DH+     + D+GLA+F
Sbjct: 147 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 47/204 (23%), Positives = 77/204 (37%), Gaps = 47/204 (23%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKV------INLKQKGAFRSFVAECEALRN 585
            +F    ++G+GSF +V            A+K+      I   +         E + +  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSR 86

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H   +K+    +   F+  +       Y  NG L               L  I+++  
Sbjct: 87  LDHPFFVKLY--FT---FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGS 126

Query: 646 ---------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
                      ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS  
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
                + +        GT  YV+P
Sbjct: 184 SKQARANS------FVGTAQYVSP 201

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 54/195 (27%), Positives = 82/195 (42%), Gaps = 44/195 (22%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN-----LKQKGAFRSFVAECEALRNIRHRNLIKI 594
           +G+G++G V          IVA+K I      L      R    E + L++ +H N+I I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 595 ITIC---SSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSLIQRLN 644
             I    S  +F  V    ++ E M      D LH+       S+D     +  + Q L 
Sbjct: 75  FNIQRPDSFENFNEV---YIIQELMQ----TD-LHRVISTQMLSDDH---IQYFIYQTLR 123

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKT 704
                  A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D S  T
Sbjct: 124 -------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 705 PSSSIGIKGTVGYVA 719
              S      V +VA
Sbjct: 174 GQQSG----MVEFVA 184

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 51/255 (20%), Positives = 93/255 (36%), Gaps = 31/255 (12%)

Query: 176 NDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
             +  +      +     +L        +      L+S   +     + I  ++  GI+ 
Sbjct: 12  TPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIA-NNSDIK-SVQ-GIQY 66

Query: 236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
           L N+  L +  N+L    P  +  LKNL  L L +N ++  + S L +L KL  L L  N
Sbjct: 67  LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHN 122

Query: 296 SLQG-NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISS 354
            +   N +    +L                 L L NN +  +    +  L  L  L +  
Sbjct: 123 GISDINGLVHLPQLE---------------SLYLGNNKI--TDITVLSRLTKLDTLSLED 165

Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLE 414
           NQ S ++P  L+    L+ + +S N    +   +L  LK++  L++       +      
Sbjct: 166 NQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 221

Query: 415 NLSFLEFLNLSYNHL 429
           NL     +  +   L
Sbjct: 222 NLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 48/253 (18%), Positives = 94/253 (37%), Gaps = 41/253 (16%)

Query: 130 LSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSS 189
               +     +L        V+   + L  + ++    +++       +  + +L N   
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN--- 69

Query: 190 LKVLSLSDNQFGGELPHSIANLSS-TMIVFL-IGGNQISGTIPLGIRNLVNLIALAVEVN 247
           +  L L+ N+        I  L++   + +L +  N++     L  ++L  L +L++E N
Sbjct: 70  VTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVKDLSSL--KDLKKLKSLSLEHN 122

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG-NFIASQN 306
            +  +  + +  L  L+ L L  N +  +  + L  LTKL  L L  N +     +A   
Sbjct: 123 GI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGLT 178

Query: 307 KLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLS 366
           KL                 L LS N +  S  + +  LKNL +L++ S +         S
Sbjct: 179 KLQ---------------NLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQS 221

Query: 367 TCVSLEYVDISSN 379
             V    V  +  
Sbjct: 222 NLVVPNTVKNTDG 234

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 57/334 (17%), Positives = 105/334 (31%), Gaps = 77/334 (23%)

Query: 35  NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS 94
             +     ++K  S+      T   L ++ Q+    +    +    I  + ++   +L  
Sbjct: 22  AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 95  NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD--SLSNASNLELLDLSNNQFKGKVSI 152
           N+ +   P     NL NL  L +  N     + D  SL +   L+ L L +N       I
Sbjct: 78  NKLTDIKPLA---NLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGIS---DI 127

Query: 153 D-FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL 211
           +    L  L  L L  N +          +T L+  + L  LSL DNQ        I+++
Sbjct: 128 NGLVHLPQLESLYLGNNKITD--------ITVLSRLTKLDTLSLEDNQ--------ISDI 171

Query: 212 SSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKN 271
                                +  L  L  L +  N +  +    +  LKNL +L L+  
Sbjct: 172 V-------------------PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQ 210

Query: 272 FLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNN 331
                  +   NL     +                         L++   +S   D    
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDG-------------------SLVTPEIISDDGDYEKP 251

Query: 332 LLNGSLPQQVGNL----KNLIILDISSNQFSGMI 361
            +   LP+    +       + +  +  +F G +
Sbjct: 252 NVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 34/170 (20%), Positives = 56/170 (32%), Gaps = 36/170 (21%)

Query: 279 SGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLY------------- 325
                  +  K +L   S+      +QN+L         SI  +                
Sbjct: 18  FSDDAFAETIKDNLKKKSVTD--AVTQNELN--------SIDQIIANNSDIKSVQGIQYL 67

Query: 326 -----LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNC 380
                L L+ N L    P  + NLKNL  L +  N+   +    L     L+ + +  N 
Sbjct: 68  PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNG 123

Query: 381 FHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
              I    L  L  ++ L +  N  +      L  L+ L+ L+L  N + 
Sbjct: 124 ISDING--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 35/164 (21%), Positives = 67/164 (40%), Gaps = 11/164 (6%)

Query: 7   KEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQL 66
           K + +L  L  L L  N +   L   + +L  L+ + ++ N +       L  L  L  L
Sbjct: 84  KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESL 139

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
            +  NK   +    +  ++ L+   L  N+ S  +P      L  L+ L +  N+   L 
Sbjct: 140 YLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLSKNHISDL- 193

Query: 127 PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
             +L+   NL++L+L + +   K     S+L +   +     +L
Sbjct: 194 -RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 29/200 (14%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
           +  K L L  N+       +   L+   +++L   N++  T+P GI + L NL  L V  
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYL-NDNKLQ-TLPAGIFKELKNLETLWVTD 94

Query: 247 NQLHGTIP-DVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIAS 304
           N+L   +P  V  +L NL  L L +N L+ S+P  +  +LTKL  L LG N LQ      
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ------ 146

Query: 305 QNKLIGALPQ----QLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSG 359
                 +LP+    +L S+  L LY   +N L    +P+     L  L  L + +NQ   
Sbjct: 147 ------SLPKGVFDKLTSLKELRLY---NNQL--KRVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 360 MIPVTLSTCVSLEYVDISSN 379
           +      +   L+ + +  N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 20/195 (10%)

Query: 108 NLP-NLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRL 163
           N+P + K+L + +N    L   +    + L LL L++N+ +   ++    F  LK L  L
Sbjct: 34  NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ---TLPAGIFKELKNLETL 90

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI-ANLSSTMIVFLIGG 222
            +  N L    A  +G    L N   L  L L  NQ    LP  +  +L+    + L G 
Sbjct: 91  WVTDNKL---QALPIGVFDQLVN---LAELRLDRNQLK-SLPPRVFDSLTKLTYLSL-GY 142

Query: 223 NQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
           N++  ++P G+   L +L  L +  NQL         +L  L+ L L  N L+  +P G 
Sbjct: 143 NELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

Query: 282 -GNLTKLAKLDLGSN 295
             +L KL  L L  N
Sbjct: 201 FDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 46/184 (25%), Positives = 70/184 (38%), Gaps = 7/184 (3%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
            + L L  N L+         L+ L+++++  N L          L+NL  L V +NK  
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNAS 134
            +       + +L    L  N+   SLP  +  +L  L  L +G N    L        +
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157

Query: 135 NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLS 194
           +L+ L L NNQ K      F  L  L  L L+ N L               +   LK+L 
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG------AFDSLEKLKMLQ 211

Query: 195 LSDN 198
           L +N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 45/158 (28%), Positives = 66/158 (41%), Gaps = 1/158 (0%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
            L KL+ L L  N L          L  L+ + +  N L          L NL +L +  
Sbjct: 59  RLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR 118

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N+   + PR   +++ L Y  L  N    SLP  +   L +LKEL +  N    +   + 
Sbjct: 119 NQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAF 177

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN 168
              + L+ L L NNQ K      F SL+ L  L L++N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 57/200 (28%), Positives = 83/200 (41%), Gaps = 33/200 (16%)

Query: 262 NLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQNKLIGALP----QQL 316
           + + L L  N L  S+PS     LTKL  L L  N LQ             LP    ++L
Sbjct: 38  DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ------------TLPAGIFKEL 84

Query: 317 LSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVD 375
            ++ T    L +++N L  +LP  V   L NL  L +  NQ   + P    +   L Y+ 
Sbjct: 85  KNLET----LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139

Query: 376 ISSNCFHGIIPPSLGF--LKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEV 433
           +  N    +  P   F  L S+K L +  N          + L+ L+ L L  N L+  V
Sbjct: 140 LGYNELQSL--PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RV 196

Query: 434 PTKGVFSNKSK---IPLQGN 450
           P +G F +  K   + LQ N
Sbjct: 197 P-EGAFDSLEKLKMLQLQEN 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
            IG+GSFG V      + + + A+K +N     ++   R+   E + ++ + H  L+ + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNIAIDVAS 651
              S   F+  +   +V + +  G L   L Q      + V         +L I  ++  
Sbjct: 82  --YS---FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV---------KLFIC-ELVM 126

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A++YL +     ++H D+KP N+LLD     H+ DF +A       L   ++  + +   
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA-----MLPRETQITTMA--- 175

Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 176 -GTKPYMAP 183

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 42/202 (20%), Positives = 71/202 (35%), Gaps = 44/202 (21%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 593
           IG+GS+G VY       E  VA+K +N      +  K   R    E   L  ++   +I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 594 IITIC---SSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEV--CKLSLIQRLNI 645
           +  +        F  +    +V E       +  L +   +   +     K  L   L  
Sbjct: 90  LYDLIIPDDLLKFDEL---YIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLL- 140

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
                    ++H   +  ++H DLKP+N LL+ D    V DFGLA+ ++S          
Sbjct: 141 ------GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 706 SSSIGIKGTV--------GYVA 719
             +                +V 
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVV 213

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 49/201 (24%), Positives = 80/201 (39%), Gaps = 45/201 (22%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRN 585
              +++ + IG+G++G V       +++ VA+K I+  +     +   R    E + L  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81

Query: 586 IRHRNLIK---IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEV-CKLS 638
            RH N+I    II   +    K V    +V + M      D L++   +           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDV---YIVQDLME----TD-LYKLLKTQHLSNDHICYF 133

Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHL 698
           L Q L         ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H 
Sbjct: 134 LYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 699 DTSSKTPSSSIGIKGTVGYVA 719
            T   T            YVA
Sbjct: 184 HTGFLT-----------EYVA 193

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 40/198 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLI 592
           +G+G++G V+K I      +VAVK    K   AF++        R I        H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK----KIFDAFQNSTDAQRTFREIMILTELSGHENIV 72

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEV-CKLSLIQRLNIAID 648
            ++ +  + + + V    LVF+YM      D LH    +N    V  +  + Q +     
Sbjct: 73  NLLNVLRADNDRDV---YLVFDYME----TD-LHAVIRANILEPVHKQYVVYQLIK---- 120

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
               I+YLH      ++H D+KPSN+LL+ +    V DFGL++   +    T++   S +
Sbjct: 121 ---VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 709 IGIKGTV-------GYVA 719
              +           YVA
Sbjct: 175 ENTENFDDDQPILTDYVA 192

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 26/214 (12%)

Query: 513 SPMEKQFPMVSYAELSKATSE-FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LK 568
           S    +F    + E      + F    ++G+G FG V+   +     + A K +N   LK
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224

Query: 569 QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS 628
           ++  ++  + E + L  +  R ++ +    +   F+      LV   M  G +   ++  
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLA--YA---FETKTDLCLVMTIMNGGDIRYHIYNV 279

Query: 629 NDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GD 686
           ++     +         A  + S +E+LH      +++ DLKP NVLLD D   +V   D
Sbjct: 280 DEDNPGFQEPRA-IFYTA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISD 332

Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            GLA           +KT   +    GT G++AP
Sbjct: 333 LGLAV----ELKAGQTKTKGYA----GTPGFMAP 358

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 16/164 (9%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR---NLIKII 595
           +IG+GSFG V K    +    VA+K++  +++   R    E   L ++R +   N + +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +  F+      + FE +   +L + + ++  Q      SL      A  +   ++ 
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDA 215

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAH--VGDFGLAKFLSSHH 697
           LH +    ++H DLKP N+LL     +   V DFG + +     
Sbjct: 216 LHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 39/193 (20%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGA--FRSFVAECEALRNIRHR-NLIKIIT 596
           +G+G F  V + I        A K +  +++G       + E   L   +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--EVCKLSLIQRLNIAIDVASAIE 654
           +     ++      L+ EY   G +         ++  E   + LI+       +   + 
Sbjct: 97  V-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK------QILEGVY 145

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHD------MVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           YLH +    +VH DLKP N+LL          +    DFG+++ +            +  
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIG----------HACE 189

Query: 709 I-GIKGTVGYVAP 720
           +  I GT  Y+AP
Sbjct: 190 LREIMGTPEYLAP 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 18/155 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG GSFG +Y G        VA+K+  +K K        E +  + ++    I  I  C 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
           +      D+  +V E +G  SLED L     +    K SL   L +A  + S IEY+H  
Sbjct: 75  AEG----DYNVMVMELLGP-SLED-LFNFCSR----KFSLKTVLLLADQMISRIEYIHSK 124

Query: 660 CQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAK 691
                +H D+KP N L+       + ++ DFGLAK
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 44/157 (28%), Positives = 65/157 (41%), Gaps = 20/157 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG G+FG +  G        VA+K+     K        E    + +   + I  +    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                   + A+V E +G  SLED L    D+      SL   L IAI + S +EY+H  
Sbjct: 75  PCG----KYNAMVLELLGP-SLED-LFDLCDR----TFSLKTVLMIAIQLISRMEYVHSK 124

Query: 660 CQPPMVHGDLKPSNVLLDHDM-----VAHVGDFGLAK 691
               +++ D+KP N L+         V H+ DF LAK
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 29/214 (13%)

Query: 513 SPMEKQFPMVSYAELSKATSE-FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LK 568
           S    +F    + E    T   F    ++G+G FG V    +     + A K +    +K
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 569 QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQS 628
           ++      + E + L  +  R    ++++  +  ++  D   LV   M  G L+  ++  
Sbjct: 224 KRKGEAMALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMNGGDLKFHIYHM 278

Query: 629 NDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GD 686
                       + +  A ++   +E LH      +V+ DLKP N+LLD     H+   D
Sbjct: 279 GQAG----FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISD 329

Query: 687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            GLA      H+              GTVGY+AP
Sbjct: 330 LGLAV-----HVPEGQTIKGRV----GTVGYMAP 354

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.1 bits (172), Expect = 6e-13
 Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 47/204 (23%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRH 588
            +F    +IG+G+F  V    + +   + A+K++N   + ++G    F  E + L N   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
           R + ++    +   F+  ++  LV EY   G L               L+L+ +    I 
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDL---------------LTLLSKFGERIP 160

Query: 649 ----------VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSH 696
                     +  AI+ +H       VH D+KP N+LLD     H+   DFG    L + 
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRAD 215

Query: 697 HLDTSSKTPSSSIGIKGTVGYVAP 720
                S          GT  Y++P
Sbjct: 216 GTVR-SLVAV------GTPDYLSP 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 31/163 (19%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITIC 598
           +G G  G V +      +   A+K++      A R    E E      +  ++++I+ + 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV-------EVCKLSLIQRLNIAIDVAS 651
               + G     +V E +  G L   +    DQ        E+ K            +  
Sbjct: 81  -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----------SIGE 128

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDFGLAK 691
           AI+YLH      + H D+KP N+L      + +  + DFG AK
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 29/180 (16%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALR 584
              + +   IG G+ G V        E  VA+K ++         K A+R    E   ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79

Query: 585 NIRHRNLIKIITI----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
            + H+N+I ++ +     S  +F+ V    +V E M   +L   +    D  E     L 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDV---YIVMELMDA-NLCQVIQMELDH-ERMSYLLY 134

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
           Q L         I++LH      ++H DLKPSN+++  D    + DFGLA+   +  + T
Sbjct: 135 QMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 35/179 (19%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALR 584
              + S   +G G++GSV   I       VA+K ++      +  K A+R    E   L+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 585 NIRHRNLIKIITI----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEVCKL 637
           +++H N+I ++ +     S  +F       LV  +M      D L +        E  + 
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDF---YLVMPFMQ----TD-LQKIMGLKFSEEKIQY 130

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
            + Q L         ++Y+H      +VH DLKP N+ ++ D    + DFGLA+   + 
Sbjct: 131 LVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 20/157 (12%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GSFG +++G    +   VA+K    +          E    + +     I  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      LV + +G  SLED L     +    K S+      A  + + ++ +H  
Sbjct: 76  QEG----LHNVLVIDLLGP-SLED-LLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK 125

Query: 660 CQPPMVHGDLKPSNVLL-----DHDMVAHVGDFGLAK 691
               +V+ D+KP N L+      +  + +V DFG+ K
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 41/203 (20%), Positives = 79/203 (38%), Gaps = 47/203 (23%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS----FVAECEALRNIR 587
            ++    +IG+G+FG V          + A+K+++ K +   RS    F  E + +    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFAN 127

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
              ++++    +   F+   +  +V EYM  G L               ++L+   ++  
Sbjct: 128 SPWVVQLF--YA---FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDVPE 167

Query: 648 DVA--------SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHH 697
             A         A++ +H       +H D+KP N+LLD     H+   DFG    ++   
Sbjct: 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEG 222

Query: 698 LDTSSKTPSSSIGIKGTVGYVAP 720
           +     T        GT  Y++P
Sbjct: 223 MVR-CDTAV------GTPDYISP 238

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 42/183 (22%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVA------ECEALR 584
              + + + +G G++GSV      +  + VAVK    K    F+S +       E   L+
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLK 83

Query: 585 NIRHRNLIKIITI----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVE 633
           +++H N+I ++ +     S  +F  V    LV   MG     D L+        ++D   
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMG----AD-LNNIVKCQKLTDDH-- 133

Query: 634 VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
             +  + Q L         ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+  
Sbjct: 134 -VQFLIYQILR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182

Query: 694 SSH 696
           +  
Sbjct: 183 ADE 185

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 68.6 bits (167), Expect = 3e-12
 Identities = 48/278 (17%), Positives = 86/278 (30%), Gaps = 27/278 (9%)

Query: 154 FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSS 213
            +    +W  +L   +L          V +  + S  + + L D           A    
Sbjct: 293 RNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE--CWCRDSATDEQ 350

Query: 214 TMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFL 273
                L    + S  +   + +   L  L  E      TI   I  ++ L  L   K   
Sbjct: 351 LFRCEL--SVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKE-- 403

Query: 274 QGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLL 333
                  L   + L  +D     ++  ++             L         L L++  L
Sbjct: 404 ------TLQYFSTLKAVD----PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453

Query: 334 NGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK 393
             ++   +  L  +  LD+S N+    +P  L+    LE +  S N    +    +  L 
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLP 508

Query: 394 SIKFLDVSCNNFSGQFP--KFLENLSFLEFLNLSYNHL 429
            ++ L +  N    Q    + L +   L  LNL  N L
Sbjct: 509 RLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 33/197 (16%), Positives = 65/197 (32%), Gaps = 16/197 (8%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
           +  E+ S  +LQ L     +    +   +  L  L     +           +  +R   
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-EKETLQYFSTL-KAVDPMRAAY 421

Query: 65  QLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
             ++                + +   +L     +  L    +  L  +  L +  N    
Sbjct: 422 LDDLRSKFLLEN-SVLKMEYADVRVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRA 477

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
            +P +L+    LE+L  S+N  +   ++D  ++L  L  L L  N L          +  
Sbjct: 478 -LPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLCNNRL-----QQSAAIQP 528

Query: 184 LTNCSSLKVLSLSDNQF 200
           L +C  L +L+L  N  
Sbjct: 529 LVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.2 bits (158), Expect = 4e-11
 Identities = 36/199 (18%), Positives = 69/199 (34%), Gaps = 21/199 (10%)

Query: 244 VEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIA 303
           V +              + L    L        + S L +  +L +L+  +       I 
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390

Query: 304 SQNKL--IGALPQQLLSITTL-------SLYLDLSNNLLNGSLPQQVGNLKNLIILDISS 354
               L  +    + L   +TL       + YLD   +              ++ +L ++ 
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAH 450

Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCN---NFSGQFPK 411
              + +    L   + + ++D+S N    + PP+L  L+ ++ L  S N   N  G    
Sbjct: 451 KDLTVLCH--LEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDG---- 503

Query: 412 FLENLSFLEFLNLSYNHLE 430
            + NL  L+ L L  N L+
Sbjct: 504 -VANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 42.1 bits (98), Expect = 7e-04
 Identities = 18/69 (26%), Positives = 28/69 (40%), Gaps = 3/69 (4%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG-KFPTTLGLLRN 62
            +P  + +L  L+ L  + N L   +   + NL  LQ + +  N L        L     
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 63  LVQLNVAEN 71
           LV LN+  N
Sbjct: 535 LVLLNLQGN 543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 46/296 (15%), Positives = 104/296 (35%), Gaps = 54/296 (18%)

Query: 108 NLPNLKELGIGANNF----FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKI---- 159
              ++KE+ +  N         + +++++  +LE+ + S+            +L++    
Sbjct: 30  EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89

Query: 160 ------LWRLNLEQNNLG-IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE--------- 203
                 L  + L  N  G          + FL+  + L+ L L +N  G +         
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQE---PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146

Query: 204 ---LPHSIANLSSTMIVFLIGGNQIS--GTIPLG--IRNLVNLIALAVEVNQLH-----G 251
                +  A  +  +   + G N++            ++   L  + +  N +       
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206

Query: 252 TIPDVIGELKNLQLLGLYKNFL--QG--SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK 307
            + + +   + L++L L  N     G  ++   L +   L +L L    L     A+   
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA--- 263

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNG----SLPQQVG-NLKNLIILDISSNQFS 358
           ++ A     L    L   L L  N +      +L   +   + +L+ L+++ N+FS
Sbjct: 264 VVDAF--SKLENIGL-QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 53/346 (15%), Positives = 108/346 (31%), Gaps = 77/346 (22%)

Query: 130 LSNASNLELLDLSNNQFKGK----VSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           ++  S +E   L  +    +    V         +  + L  N +G  AA  L     + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--IA 57

Query: 186 NCSSLKVLSLSDNQFG---GELPHSIANLSS-----TMIVFL-IGGNQISGTIPLGIRNL 236
           +   L++   SD   G    E+P ++  L         +  + +  N      P     L
Sbjct: 58  SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPL 114

Query: 237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFL-------------QGSIPSGLGN 283
           ++ ++                 +   L+ L L+ N L             + ++     N
Sbjct: 115 IDFLS-----------------KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKN 157

Query: 284 LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN-----GSLP 338
              L  +  G N L+       N  +    +   S   L   + +  N +        L 
Sbjct: 158 APPLRSIICGRNRLE-------NGSMKEWAKTFQSHRLLH-TVKMVQNGIRPEGIEHLLL 209

Query: 339 QQVGNLKNLIILDISSNQFS--GMIPV--TLSTCVSLEYVDISSNCFHG----IIPPSLG 390
           + +   + L +LD+  N F+  G   +   L +  +L  + ++           +  +  
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269

Query: 391 FL--KSIKFLDVSCNNFSGQFPKFL-----ENLSFLEFLNLSYNHL 429
            L    ++ L +  N       + L     E +  L FL L+ N  
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 48/299 (16%), Positives = 84/299 (28%), Gaps = 71/299 (23%)

Query: 160 LWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL 219
           +   +L+ + +       +  V  L    S+K + LS N  G E    ++          
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAV--LLEDDSVKEIVLSGNTIGTEAARWLSE--------- 54

Query: 220 IGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPS 279
                        I +  +L                  G +K+     L        +  
Sbjct: 55  ------------NIASKKDLEIAEFSDIF--------TGRVKDEIPEAL------RLLLQ 88

Query: 280 GLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNN-------- 331
            L    KL  + L  N+               L   L   T L  +L L NN        
Sbjct: 89  ALLKCPKLHTVRLSDNAFGPTAQE-------PLIDFLSKHTPLE-HLYLHNNGLGPQAGA 140

Query: 332 -----LLNGSLPQQVGNLKNLIILDISSNQFS--GMIPV--TLSTCVSLEYVDISSNCFH 382
                L   ++ ++  N   L  +    N+     M     T  +   L  V +  N   
Sbjct: 141 KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200

Query: 383 -----GIIPPSLGFLKSIKFLDVSCNNFSGQ----FPKFLENLSFLEFLNLSYNHLEGE 432
                 ++   L + + +K LD+  N F+          L++   L  L L+   L   
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 57/364 (15%), Positives = 123/364 (33%), Gaps = 73/364 (20%)

Query: 15  LQALALAGNYLTGK----LPDFIGNLSALQVIHIKGNSLGGK----FPTTLGLLRNLVQL 66
           ++  +L  + +T +    +   +    +++ I + GN++G +        +   ++L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 67  NVAENKFYGMFP----------RSICNISSLEYFYLTSNRFS--GSLPF-DIVVNLPNLK 113
             ++     +            +++     L    L+ N F      P  D +     L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 114 ELGIGANNF-------------FGLIPDSLSNASNLELLDLSNNQFKGK----VSIDFSS 156
            L +  N                  +     NA  L  +    N+ +       +  F S
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 157 LKILWRLNLEQNNLG-IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL--SS 213
            ++L  + + QN +   G  + L     L  C  LKVL L DN F      ++A    S 
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLL--EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243

Query: 214 TMIVFL-IGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNF 272
             +  L +    +S     G   +V+  A +   N               LQ L L  N 
Sbjct: 244 PNLRELGLNDCLLSAR---GAAAVVD--AFSKLEN-------------IGLQTLRLQYNE 285

Query: 273 LQG----SIPSGLG-NLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLD 327
           ++     ++ + +   +  L  L+     L GN  + ++ ++  + +++ S        +
Sbjct: 286 IELDAVRTLKTVIDEKMPDLLFLE-----LNGNRFSEEDDVVDEI-REVFSTRGRGELDE 339

Query: 328 LSNN 331
           L + 
Sbjct: 340 LDDM 343

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 18/155 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG GSFG +Y G   +    VA+K+ N+K K      + E +  R ++    I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                  D+  LV + +G  SLED L     +    KLSL   L +A  + + +E++H  
Sbjct: 73  VEG----DYNVLVMDLLGP-SLED-LFNFCSR----KLSLKTVLMLADQMINRVEFVHSK 122

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAH---VGDFGLAK 691
                +H D+KP N L+     A+   + DFGLAK
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 54/201 (26%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKII 595
           +G G  G V+  +  + +  VA+K I L      K A R    E + +R + H N++K+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 596 TICSSTDFKGVDFKA---------LVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSL 639
            I   +  +  D            +V EYM      D L           +     +L +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQGPLLEEH---ARLFM 126

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHL 698
            Q L         ++Y+H      ++H DLKP+N+ ++  D+V  +GDFGLA+ +  H+ 
Sbjct: 127 YQLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 699 DTSSKTPSSSIGIKGTVGYVA 719
                +             + 
Sbjct: 177 HKGHLS-----------EGLV 186

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 35/183 (19%)

Query: 531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALR 584
              + +   IG G+ G V        +  VA+K ++         K A+R    E   ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 585 NIRHRNLIKIITI----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQVEVCKL 637
            + H+N+I ++ +     +  +F+ V    LV E M     +  L Q        E    
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDV---YLVMELM-----DANLCQVIQMELDHERMSY 168

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
            L Q L         I++LH      ++H DLKPSN+++  D    + DFGLA+   +  
Sbjct: 169 LLYQMLC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

Query: 698 LDT 700
           + T
Sbjct: 219 MMT 221

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 67.2 bits (164), Expect = 9e-12
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 38/220 (17%)

Query: 512 TSPMEKQFPMVSYAELSKATSE--FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN--- 566
            S    +F      EL+   +   FS   +IG+G FG VY     +   + A+K ++   
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226

Query: 567 LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH 626
           +K K      + E   L  +   +   I+ +  +  F   D  + + + M  G L   L 
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLS 284

Query: 627 Q----SNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 682
           Q    S   +         R   A ++   +E++H+     +V+ DLKP+N+LLD     
Sbjct: 285 QHGVFSEADM---------RFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEH--G 329

Query: 683 HV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           HV   D GLA        D S K P +S+   GT GY+AP
Sbjct: 330 HVRISDLGLAC-------DFSKKKPHASV---GTHGYMAP 359

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 42/174 (24%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G G++G+V   + G     VA+K +       L  K A+R    E   L+++RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 594 IITI----CSSTDFKGVDFKALVFEYMGNGSLEDWLHQ-------SNDQVEVCKLSLIQR 642
           ++ +     +  DF       LV  +MG     D L +         D+    +  + Q 
Sbjct: 89  LLDVFTPDETLDDFTDF---YLVMPFMG----TD-LGKLMKHEKLGEDR---IQFLVYQM 137

Query: 643 LNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
           L         + Y+H      ++H DLKP N+ ++ D    + DFGLA+   S 
Sbjct: 138 LK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 45/201 (22%), Positives = 75/201 (37%), Gaps = 29/201 (14%)

Query: 220 IGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPS 279
           +G   ++  +      L  +     + + +       +    NL+ L L  N  Q S  S
Sbjct: 26  LGKQSVTDLVSQK--ELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHN--QISDLS 79

Query: 280 GLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-YLDLSNNLLNGSLP 338
            L +LTKL +L +  N L+                 L  I +  L  L L NN L     
Sbjct: 80  PLKDLTKLEELSVNRNRLK----------------NLNGIPSACLSRLFLDNNEL--RDT 121

Query: 339 QQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL 398
             + +LKNL IL I +N+   ++   L     LE +D+  N         L  LK + ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI 177

Query: 399 DVSCNNFSGQFPKFLENLSFL 419
           D++      +  K+   L   
Sbjct: 178 DLTGQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 39/213 (18%), Positives = 71/213 (33%), Gaps = 39/213 (18%)

Query: 222 GNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
              I+   P     L N +   +    +   +     EL  +Q      + +Q S+ +G+
Sbjct: 6   PTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGM 59

Query: 282 GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL-----YLDLSNNLLNGS 336
              T L +L L  N                   Q+  ++ L        L ++ N L   
Sbjct: 60  QFFTNLKELHLSHN-------------------QISDLSPLKDLTKLEELSVNRNRLKNL 100

Query: 337 LPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIK 396
                     L  L + +N+        L    +LE + I +N    I    LGFL  ++
Sbjct: 101 NG---IPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLKSI--VMLGFLSKLE 153

Query: 397 FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHL 429
            LD+  N  +      L  L  + +++L+    
Sbjct: 154 VLDLHGNEITN--TGGLTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 54/314 (17%), Positives = 103/314 (32%), Gaps = 80/314 (25%)

Query: 57  LGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG 116
              L N V+ N+ +     +       +S ++ F   ++               NLKEL 
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQ---FFTNLKELH 69

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN 176
           +  N    L P  L + + LE L ++ N+ K   +++      L RL L+ N L      
Sbjct: 70  LSHNQISDLSP--LKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNELRD---- 120

Query: 177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNL 236
                  L +  +L++LS+ +N+                                 ++++
Sbjct: 121 ----TDSLIHLKNLEILSIRNNK---------------------------------LKSI 143

Query: 237 VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS 296
           V L                  G L  L++L L+ N +  +   GL  L K+  +DL    
Sbjct: 144 VML------------------GFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQK 183

Query: 297 LQGNFIASQNKL-----IGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL----KNL 347
                +  Q +L     +     + +S   +S      +  +   LP     +       
Sbjct: 184 CVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEY 243

Query: 348 IILDISSNQFSGMI 361
           I +  +   F G +
Sbjct: 244 INVGETEAIFDGTV 257

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 15/88 (17%), Positives = 38/88 (43%), Gaps = 6/88 (6%)

Query: 343 NLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC 402
            L N +  ++     + ++         ++  +  ++    +    + F  ++K L +S 
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSH 72

Query: 403 NNFSGQFPKFLENLSFLEFLNLSYNHLE 430
           N  S      L++L+ LE L+++ N L+
Sbjct: 73  NQISD--LSPLKDLTKLEELSVNRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 24/163 (14%), Positives = 53/163 (32%), Gaps = 37/163 (22%)

Query: 9   IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNV 68
           +  L KL+ L++  N L       +  + +                        L +L +
Sbjct: 81  LKDLTKLEELSVNRNRLKN-----LNGIPSA----------------------CLSRLFL 113

Query: 69  AENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD 128
             N+       S+ ++ +LE   + +N+    +       L  L+ L +  N        
Sbjct: 114 DNNELRDT--DSLIHLKNLEILSIRNNKLKSIVMLG---FLSKLEVLDLHGNEITNT--G 166

Query: 129 SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG 171
            L+    +  +DL+  +    V+        L+  N  ++  G
Sbjct: 167 GLTRLKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDG 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 45/230 (19%), Positives = 74/230 (32%), Gaps = 77/230 (33%)

Query: 533 EFSSSN-----MIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK---GAFRSFVAE 579
           EF          +G+G+FG V +              VAVK+  LK+       R+ ++E
Sbjct: 18  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSE 75

Query: 580 CEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLH------------ 626
            + L +I  H N++ ++  C  T   G     ++ E+   G+L  +L             
Sbjct: 76  LKILIHIGHHLNVVNLLGAC--TKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKTK 131

Query: 627 -----QSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPM----------------- 664
                Q  D V    + L +RL+      S+        +                    
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191

Query: 665 -----------------------VHGDLKPSNVLLDHDMVAHVGDFGLAK 691
                                  +H DL   N+LL    V  + DFGLA+
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 49/240 (20%), Positives = 92/240 (38%), Gaps = 58/240 (24%)

Query: 507 HNSADTSPMEKQFPMVSYAELSKATSE-----------FSSSNMIGQGSFGSVYKGILGE 555
           ++  + SP+ ++  ++ Y E +K  +            F    +IG+G+FG V    L  
Sbjct: 38  YDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN 97

Query: 556 DEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV 612
            + + A+K++N   + ++     F  E + L N   + +  +    +   F+  +   LV
Sbjct: 98  ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH--YA---FQDDNNLYLV 152

Query: 613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID----------VASAIEYLHHHCQP 662
            +Y   G L               L+L+ +    +           +  AI+ +H     
Sbjct: 153 MDYYVGGDL---------------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH-- 195

Query: 663 PMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
             VH D+KP N+L+D +   H+   DFG    L        S          GT  Y++P
Sbjct: 196 -YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG-TVQSSVAV------GTPDYISP 245

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 39/181 (21%), Positives = 62/181 (34%), Gaps = 39/181 (21%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFRSFVAECEALRNIR---------H 588
           I  GS+G+V  G+  E    VA+K +   +                R +R         H
Sbjct: 30  ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 589 RNLIKIITI---CSSTDFKGVDFKALVFEYMGNGSLEDWLHQ---SNDQV---EVCKLSL 639
            N++ +  I           +    LV E M      D L Q       V   +  +  +
Sbjct: 89  PNILGLRDIFVHFEEPAMHKL---YLVTELMRT----D-LAQVIHDQRIVISPQHIQYFM 140

Query: 640 IQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
              L         +  LH   +  +VH DL P N+LL  +    + DF LA+  ++    
Sbjct: 141 YHILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190

Query: 700 T 700
           T
Sbjct: 191 T 191

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 21/180 (11%)

Query: 539 MIGQGSFGSVYKGILGEDEMI---VAVKVINLKQKGAFRSFVAECEALRNIR-----HRN 590
            +G G F +V+   L  D      VA+KV+   +     + + E   L+++R       N
Sbjct: 44  KLGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPN 99

Query: 591 LIKIITICSSTDFKGVDFK--ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
              ++ +       GV+     +VFE +G+  L  W+ +SN Q     L  +++  I   
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG--LPLPCVKK--IIQQ 154

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           V   ++YLH  C+  ++H D+KP N+LL  +          A           S +  S+
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 55/163 (33%), Positives = 73/163 (44%), Gaps = 15/163 (9%)

Query: 137 ELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLS 196
           E LDL +          F  L  L  LNL+ N L        G    LT    L  L L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL---QTLSAGVFDDLTE---LGTLGLA 91

Query: 197 DNQFGGELPHSI-ANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIP 254
           +NQ    LP  +  +L+    ++L GGNQ+  ++P G+   L  L  L +  NQL  +IP
Sbjct: 92  NNQL-ASLPLGVFDHLTQLDKLYL-GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIP 147

Query: 255 D-VIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
                +L NLQ L L  N LQ S+P G    L KL  + L  N
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 46/161 (28%), Positives = 67/161 (41%), Gaps = 18/161 (11%)

Query: 222 GNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
              ++       R L  L  L ++ NQL      V  +L  L  LGL  N L  S+P G+
Sbjct: 44  STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGV 102

Query: 282 -GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL-SITTLSLYLDLSNNLLNGSLPQ 339
             +LT+L KL LG N L+            +LP  +   +T L   L L+ N L  S+P 
Sbjct: 103 FDHLTQLDKLYLGGNQLK------------SLPSGVFDRLTKLK-ELRLNTNQLQ-SIPA 148

Query: 340 QV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
                L NL  L +S+NQ   +          L+ + +  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 43/160 (26%), Positives = 61/160 (38%), Gaps = 15/160 (9%)

Query: 16  QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYG 75
           + L L    L          L+ L  +++  N L          L  L  L +A N+   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 76  MFPRSICNISSLEYFYLTSNRFSGSLP---FDIVVNLPNLKELGIGANNFFGLIP----D 128
           +      +++ L+  YL  N+   SLP   FD    L  LKEL +   N    IP    D
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFD---RLTKLKELRLN-TNQLQSIPAGAFD 152

Query: 129 SLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN 168
            L+N   L+ L LS NQ +      F  L  L  + L  N
Sbjct: 153 KLTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 46/283 (16%), Positives = 90/283 (31%), Gaps = 64/283 (22%)

Query: 80  SICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELL 139
             C     E F +T       +P       P+ + L +   +   +   + SN  N+  +
Sbjct: 6   PPCECHQEEDFRVTCKDIQ-RIP----SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRI 60

Query: 140 DLSNNQFKGKVSID-FSSLKILWRLNLEQNN----LGIGAANDLGFVTFLTNCSSLKVLS 194
            +S +    ++    F +L  +  + +        +   A         L     LK L 
Sbjct: 61  YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA---------LKELPLLKFLG 111

Query: 195 LSDNQFGGELPH--SIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHG 251
           + +       P    + +     I+ +     ++ +IP+   + L N             
Sbjct: 112 IFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNE------------ 157

Query: 252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGA 311
                         L LY N    S+     N TKL  + L           ++NK +  
Sbjct: 158 -----------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYL-----------NKNKYLTV 194

Query: 312 LPQQLLS--ITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILD 351
           + +       +  S  LD+S   +  +LP +   +LK LI  +
Sbjct: 195 IDKDAFGGVYSGPS-LLDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 38/234 (16%)

Query: 15  LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY 74
            Q L L   +L         NL  +  I++  +            L+ L       + FY
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSID----------VTLQQL-----ESHSFY 77

Query: 75  GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD--SLSN 132
            +        S + +  + + R    +  D +  LP LK LGI  N    + PD   + +
Sbjct: 78  NL--------SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF-NTGLKMFPDLTKVYS 128

Query: 133 ASNLELLDLSNNQFKGKVSID-FSSL-KILWRLNLEQNNLGIGAANDLGFVTFLTNCSSL 190
                +L++++N +   + ++ F  L      L L  N         +    F  N + L
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-----TSVQGYAF--NGTKL 181

Query: 191 KVLSLSDNQFGGELP-HSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIAL 242
             + L+ N++   +   +   + S   +  +    ++  +P     +L  LIA 
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 37/259 (14%), Positives = 82/259 (31%), Gaps = 67/259 (25%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEV 246
            S + L L +        H+ +NL +   +++     +   +      NL  +  + +  
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRN 89

Query: 247 NQLHGTIP-DVIGELKNLQLLGLYKNFLQGSIP--SGLGNLTKLAKLDLGSNSLQGNFIA 303
            +    I  D + EL  L+ LG++   L+   P  + + +      L++           
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI----------- 137

Query: 304 SQNKLIGALPQQLLS-ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
           + N  + ++P      +   +L L L NN    S+     N   L  + ++ N++     
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY----- 191

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFL 422
             L+         I  + F G+                                S    L
Sbjct: 192 --LTV--------IDKDAFGGV-------------------------------YSGPSLL 210

Query: 423 NLSYNHLEGEVPTKGVFSN 441
           ++S   +   +P+     +
Sbjct: 211 DVSQTSVT-ALPS-KGLEH 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 32/189 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           ++G+G+FG V            A+K++    +  K      + E   L+N RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNIAIDVAS 651
              S   F+  D    V EY   G L   L +    S D+          R   A ++ S
Sbjct: 215 --YS---FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---------RFYGA-EIVS 259

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A++YLH      +V+ DLK  N++LD D    + DFGL K      +   +   +     
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFC--- 310

Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 311 -GTPEYLAP 318

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 9/166 (5%)

Query: 39  LQVIHIKGNSLGGKFP-TTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRF 97
             ++ +  N+L       T   L NL  L ++ N    +   +   + +L Y  L+SN  
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100

Query: 98  SGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK---GKVSIDF 154
             +L   +  +L  L+ L +  N+   +  ++  + + L+ L LS NQ      ++  D 
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDG 159

Query: 155 SSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
           + L  L  L+L  N L      DL  +           L L +N  
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV----KNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 12/173 (6%)

Query: 58  GLLRNLVQLNVAENKFYGMFPRSI-CNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG 116
            L      L+++ N    +        +++L    L+ N  +  +  +  V +PNL+ L 
Sbjct: 36  SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94

Query: 117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNNLGIG 173
           + +N+   L     S+   LE+L L NN       +D   F  +  L +L L QN +   
Sbjct: 95  LSSNHLHTLDEFLFSDLQALEVLLLYNNHIV---VVDRNAFEDMAQLQKLYLSQNQISRF 151

Query: 174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL-IGGNQI 225
               +     L     L +L LS N+        +  L + +   L +  N +
Sbjct: 152 PVELIKDGNKLP---KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 37/176 (21%), Positives = 63/176 (35%), Gaps = 19/176 (10%)

Query: 188 SSLKVLSLSDNQFGGELPHSIA--NLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAV 244
           S   +L LS N     L        L++   + L   N ++  I       + NL  L +
Sbjct: 39  SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLL-SHNHLN-FISSEAFVPVPNLRYLDL 95

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIA 303
             N LH     +  +L+ L++L LY N +   +      ++ +L KL L  N +      
Sbjct: 96  SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS--RFP 152

Query: 304 SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL--IILDISSNQF 357
                   + +    +  L   LDLS+N L       +  L       L + +N  
Sbjct: 153 V-----ELI-KDGNKLPKLM-LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 44/185 (23%), Positives = 74/185 (40%), Gaps = 27/185 (14%)

Query: 276 SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG 335
           ++P  L + T    LDL  N+L    + +        P +L ++      L LS+N LN 
Sbjct: 32  NVPQSLPSYTA--LLDLSHNNLSR--LRA-----EWTPTRLTNLH----SLLLSHNHLN- 77

Query: 336 SLPQQV-GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKS 394
            +  +    + NL  LD+SSN    +     S   +LE + + +N    +   +   +  
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQ 137

Query: 395 IKFLDVSCNNFSGQFP----KFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIP---- 446
           ++ L +S N  S +FP    K    L  L  L+LS N L+ ++P                
Sbjct: 138 LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLPAWVKNGL 194

Query: 447 -LQGN 450
            L  N
Sbjct: 195 YLHNN 199

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 54/338 (15%), Positives = 111/338 (32%), Gaps = 62/338 (18%)

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSL-----KILWRLNLEQNNLGIGAANDLG 179
            + +  S    +  LDLS N      +++           +  LNL  N+LG   +++L 
Sbjct: 13  PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGE----LPHSIANLSSTMIVFLIGGNQISGTIPLGIRN 235
            +      +++  L+LS N    +    L  ++A +  T+ V  +G N  S         
Sbjct: 73  QI-LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSE 128

Query: 236 LVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG----SIPSGLGNL-TKLAKL 290
                +                    ++  L L  N L       +   L  +   +  L
Sbjct: 129 FKQAFS----------------NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172

Query: 291 DLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG-----NLK 345
           +L  N+L     A   K + ++P  + S       LDLS NLL      ++         
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTS-------LDLSANLLGLKSYAELAYIFSSIPN 225

Query: 346 NLIILDISSNQFSG----MIPVTLSTCVSLEYVDISSNCFHGI-------IPPSLGFLKS 394
           +++ L++  N   G     + +   +   L+ V +  +    +       +  +   ++ 
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 395 IKFLDVSCNNFSG----QFPKFLENLSF-LEFLNLSYN 427
           I  +D +               +  LS   +  +L   
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 43/290 (14%), Positives = 91/290 (31%), Gaps = 47/290 (16%)

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIA----NLSSTMIVFLIGGNQIS--GTIPLG---I 233
           F +    +  L LS N         +     N  +++    + GN +    +  L     
Sbjct: 17  FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76

Query: 234 RNLVNLIALAVEVNQLHGTIPDVIGEL-----KNLQLLGLYKNFLQGS----IPSGLGNL 284
               N+ +L +  N L     D + +        + +L L  N               NL
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136

Query: 285 -TKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGN 343
              +  L+L  N L      S ++LI  L     ++ +    L+L  N L      ++  
Sbjct: 137 PASITSLNLRGNDLGI---KSSDELIQILAAIPANVNS----LNLRGNNLASKNCAELAK 189

Query: 344 L-----KNLIILDISSNQF--SGMIPVT---LSTCVSLEYVDISSNCFHG----IIPPSL 389
                  ++  LD+S+N         +     S    +  +++  NC HG     +    
Sbjct: 190 FLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLK 249

Query: 390 GFLKSIKFLDVSCNNFSGQFPK-------FLENLSFLEFLNLSYNHLEGE 432
             LK ++ + +  +       +          N+  +  ++ +   +   
Sbjct: 250 DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 37/206 (17%), Positives = 62/206 (30%), Gaps = 36/206 (17%)

Query: 111 NLKELGIGANNF----FGLIPDSL-SNASNLELLDLSNNQFKGKVSIDFSSL-----KIL 160
           N+  L +  NN        +   L S  +++  LDLS N    K   + + +       +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227

Query: 161 WRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSS------T 214
             LNL  N L   +  +L  +    +   L+ + L  +            L +       
Sbjct: 228 VSLNLCLNCLHGPSLENLKLL--KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 215 MIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQ 274
           +I+    G +I    P     + NLI       +L G             LL     F Q
Sbjct: 286 IILVDKNGKEIH---PSHSIPISNLI------RELSGK-------ADVPSLLNQCLIFAQ 329

Query: 275 GSI--PSGLGNLTKLAKLDLGSNSLQ 298
                   L    +L +       L 
Sbjct: 330 KHQTNIEDLNIPDELRESIQTCKPLL 355

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 1e-10
 Identities = 35/204 (17%), Positives = 60/204 (29%), Gaps = 53/204 (25%)

Query: 530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVI--------NLKQKGAFRSFVAECE 581
            T +      IG+G FG V++ I   D   VA+K+I        N   +  F   + E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 582 ALRNI---------RHRNLIKIITIC-------------------------SSTDFKGVD 607
             + +         R    I + ++                             DF   D
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHG 667
              +V E+   G   + +            SL    +I   + +++       +    H 
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQLTASLAVAEASLR--FEHR 186

Query: 668 DLKPSNVLLDHDMVAHVGDFGLAK 691
           DL   NVLL    +  +      K
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 51/199 (25%), Positives = 77/199 (38%), Gaps = 42/199 (21%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFV----AECEALRNIR 587
            +F     +G GSFG V      E     A+K+++ KQK      +     E   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLN--- 644
              L+K+    S   FK      +V EY+  G +  + H          L  I R +   
Sbjct: 100 FPFLVKLE--FS---FKDNSNLYMVMEYVAGGEM--FSH----------LRRIGRFSEPH 142

Query: 645 ---IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
               A  +    EYLH      +++ DLKP N+L+D      V DFG AK      +   
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194

Query: 702 SKTPSSSIGIKGTVGYVAP 720
           + T      + GT   +AP
Sbjct: 195 TWT------LCGTPEALAP 207

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR---NLIK 593
           ++IG+GSFG V K     ++  VA+K+I  K K AF      E   L  +          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           I+ +     F+      LVFE +   +L D L  +N +     L+L ++   A  + +A+
Sbjct: 118 IVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFR--GVSLNLTRK--FAQQMCTAL 170

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAH--VGDFGLAKFLSSHH 697
            +L    +  ++H DLKP N+LL +   +   + DFG +  L    
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 3e-10
 Identities = 74/488 (15%), Positives = 136/488 (27%), Gaps = 163/488 (33%)

Query: 295 NSLQGN--FIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG---------SLPQQVGN 343
             L+ N  F+ S    I    +Q   +T +  Y++  + L N          S  Q    
Sbjct: 85  EVLRINYKFLMSP---IKTEQRQPSMMTRM--YIEQRDRLYNDNQVFAKYNVSRLQPYLK 139

Query: 344 LKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCN 403
           L+  + L++   +      V +                 G+    LG  K+   LDV C 
Sbjct: 140 LRQAL-LELRPAKN-----VLI----------------DGV----LGSGKTWVALDV-CL 172

Query: 404 NFSGQFPKFLENLSFLEF-LNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGID---- 458
           ++     K    + F  F LNL   +    V             LQ   +L   ID    
Sbjct: 173 SY-----KVQCKMDFKIFWLNLKNCNSPETVL----------EMLQ---KLLYQIDPNWT 214

Query: 459 --ELHLPSCPSR------------GSRKLKITLLKVLIPVAVSCWIL----FSCLTIVYA 500
               H  +   R             S+  +  LL VL+ V  +         SC  ++  
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL-VLLNVQ-NAKAWNAFNLSCKILLTT 272

Query: 501 RRRRSAHNSAD--TSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEM 558
           R +       D  ++       +      S   +     +++ +      Y     +D  
Sbjct: 273 RFK----QVTDFLSAATTTHISLD---HHSMTLTPDEVKSLLLK------YLDCRPQDLP 319

Query: 559 IVAVKVINLKQK--GAF-RSFVAECEALRNIRHRNLIKIITIC----SSTDFKGVDFKAL 611
              +     +        R  +A  +  +++    L  II          +++ + F  L
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-FDRL 378

Query: 612 -VFEYMGNGSLED-----------WLHQSNDQVEV-----CKLSLIQRLNIAIDVASAIE 654
            VF                     W       V V      K SL+++         +  
Sbjct: 379 SVFP-------PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK-----QPKESTI 426

Query: 655 YLHHHCQPPMVHGDLKPS--------NVLLDH----------DMVAHVGDFGLAKFLSSH 696
            +        ++ +LK            ++DH          D++    D      +  H
Sbjct: 427 SIPS------IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI-GH 479

Query: 697 HLDTSSKT 704
           HL      
Sbjct: 480 HLKNIEHP 487

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.2 bits (150), Expect = 5e-10
 Identities = 80/621 (12%), Positives = 178/621 (28%), Gaps = 200/621 (32%)

Query: 104 DIV-VNLPNLKELGIGANNF-FGLIPDSLSNASNLELLDLSNNQFK---GKVSIDFSSLK 158
           DI+ V      +      NF    + D   +        LS  +             +L+
Sbjct: 20  DILSVFEDAFVD------NFDCKDVQDMPKSI-------LSKEEIDHIIMSKDAVSGTLR 66

Query: 159 ILWRLNLEQNN-----LGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSS 213
           + W L  +Q       +      +  F+      S +K       Q     P  +  +  
Sbjct: 67  LFWTLLSKQEEMVQKFVEEVLRINYKFLM-----SPIKT---EQRQ-----PSMMTRMYI 113

Query: 214 TMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFL 273
                L   NQ+                  V   Q +  +   + EL+  + + +     
Sbjct: 114 EQRDRLYNDNQV-------------FAKYNVSRLQPYLKLRQALLELRPAKNVLID---- 156

Query: 274 QGSIPSGLGNLTK--LAKLDLGSNSLQGNF--------IASQNKLIGALPQQLLSITTLS 323
                 G+    K  +A     S  +Q           + + N      P+ +L +    
Sbjct: 157 ------GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS-----PETVLEML-QK 204

Query: 324 LYLDLSNNLLNG-----SLPQQVGNLKN--------------LIILD-ISSNQ----FSG 359
           L   +  N  +      ++  ++ +++               L++L  + + +    F+ 
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264

Query: 360 ---------------MIPVTLSTCVSLE-----------------YVDISSNCF----HG 383
                           +    +T +SL+                 Y+D            
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324

Query: 384 IIPPSLGFL-KSIK--------FLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP 434
             P  L  + +SI+        +  V+C+  +      L  L   E+  + ++ L     
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-FDRL----- 378

Query: 435 TKGVFSNKSKIPLQGNVRLCGG---------IDELHLPSCPSRGSRKLKITLLKVLIPVA 485
              VF   + IP      +            +++LH  S   +  ++  I++  + + + 
Sbjct: 379 --SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436

Query: 486 VSCWILFSCL--TIVYARRRRSAHNSADTSPMEKQ---FPMVSY----AELSKATSEF-- 534
           V     ++ L  +IV         +S D  P       +  + +     E  +  + F  
Sbjct: 437 VKLENEYA-LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM 495

Query: 535 --------------SSSNMIGQGSFGSV------YKGILGEDEMIVAVKVINLKQKGAFR 574
                          S+     GS  +       YK  + +++      V  +       
Sbjct: 496 VFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD----- 550

Query: 575 SFVAECEA-LRNIRHRNLIKI 594
            F+ + E  L   ++ +L++I
Sbjct: 551 -FLPKIEENLICSKYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 3e-09
 Identities = 67/416 (16%), Positives = 129/416 (31%), Gaps = 106/416 (25%)

Query: 60  LRN-LVQLNVAENKF-YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV-VNLPNLKE-- 114
           LR  L++L  A+N    G+        + +      S +    + F I  +NL N     
Sbjct: 140 LRQALLELRPAKNVLIDGVLG---SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196

Query: 115 --LGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFS------SLKIL---WRL 163
             L +     + + P+  S + +   + L  +  + ++            L +L      
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGN 223
                     A        F  +C   K+L  +  +        + +  S      I  +
Sbjct: 257 KA------WNA--------FNLSC---KILLTTRFK-------QVTDFLSAATTTHISLD 292

Query: 224 QISGTIPLGIRNLVNLIALAVEVN------QLHGTIP---DVIGELKNLQLLGLYKNFLQ 274
             S T  L    + +L+   ++        ++  T P    +I E      L  + N+  
Sbjct: 293 HHSMT--LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-DGLATWDNWKH 349

Query: 275 GSIPSGLGNLTKLAKL---DLGSNSLQGNF----IASQNKLIGALPQQLLSITTLSLYLD 327
                    LT + +     L     +  F    +   +  I   P  LLS+    ++ D
Sbjct: 350 ----VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI---PTILLSL----IWFD 398

Query: 328 LSNNLLNGSLPQQVGN-LKNLIILDISSNQFSGMIP-VTLSTCVSLE------------Y 373
           +  +         V N L    +++    + +  IP + L   V LE            Y
Sbjct: 399 VIKSD-----VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY 453

Query: 374 VDISSNCFHGIIPPS--------LGF-LKSIKFLDVSCNNFSGQFPKFLENLSFLE 420
               +     +IPP         +G  LK+I+  +      +  F     +  FLE
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE----RMT-LFRMVFLDFRFLE 504

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 42/184 (22%), Positives = 78/184 (42%), Gaps = 38/184 (20%)

Query: 539 MIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHR---NLI 592
            +G+G+FG V + +     +  VA+K+I  +  G +R  + + E   L+ I+ +   N  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARL-EINVLKKIKEKDKENKF 82

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
             + +    +F G     + FE +G  +  ++L ++N Q     L  ++   +A  +  A
Sbjct: 83  LCVLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRH--MAYQLCHA 135

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG-------------------DFGLAKFL 693
           + +LH +    + H DLKP N+L  +     +                    DFG A F 
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 694 SSHH 697
             HH
Sbjct: 193 HEHH 196

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 39/225 (17%)

Query: 139 LDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN 198
            +L        V+   + L  + ++    +++             L N   ++ L+L  N
Sbjct: 24  ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY-----LPN---VRYLALGGN 73

Query: 199 QFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVI 257
           +   ++  ++  L++   + L  GNQ+  ++P G+   L NL  L +  NQL      V 
Sbjct: 74  KLH-DIS-ALKELTNLTYLIL-TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129

Query: 258 GELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQ-- 314
            +L NL  L L  N LQ S+P G+   LT L +LDL  N LQ            +LP+  
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ------------SLPEGV 176

Query: 315 --QLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQ 356
             +L  +  L LY     N L  S+P  V   L +L  + +  N 
Sbjct: 177 FDKLTQLKDLRLY----QNQLK-SVPDGVFDRLTSLQYIWLHDNP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 53/214 (24%), Positives = 76/214 (35%), Gaps = 66/214 (30%)

Query: 86  SLEYFYLTSNRFSGSLP-FDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
           ++ Y  L  N+    +        L NL  L +  N    L        +NL+ L L  N
Sbjct: 64  NVRYLALGGNKLH-DISALK---ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119

Query: 145 QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL 204
           Q +                +L             G    LTN   L  L+L+ NQ     
Sbjct: 120 QLQ----------------SLPD-----------GVFDKLTN---LTYLNLAHNQ----- 144

Query: 205 PHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPD-VIGELKN 262
                 L S               +P G+   L NL  L +  NQL  ++P+ V  +L  
Sbjct: 145 ------LQS---------------LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ 182

Query: 263 LQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
           L+ L LY+N L+ S+P G    LT L  + L  N
Sbjct: 183 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 38/136 (27%), Positives = 55/136 (40%), Gaps = 17/136 (12%)

Query: 223 NQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL- 281
           NQI+   P    +L+NL  L +  NQL      V   L  L +L L  N L   +PS + 
Sbjct: 50  NQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVF 108

Query: 282 GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV 341
             L  L +L +  N L              LP+ +  +T L+ +L L  N L  S+P   
Sbjct: 109 DRLVHLKELFMCCNKLT------------ELPRGIERLTHLT-HLALDQNQLK-SIPHGA 154

Query: 342 -GNLKNLIILDISSNQ 356
              L +L    +  N 
Sbjct: 155 FDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 47/164 (28%), Positives = 63/164 (38%), Gaps = 36/164 (21%)

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL 193
           +N ++L L +NQ        F SL  L  L L  N L    A  +G    LT    L VL
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL---GALPVGVFDSLTQ---LTVL 93

Query: 194 SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGT 252
            L  NQ           L+                +P  +   LV+L  L +  N+L   
Sbjct: 94  DLGTNQ-----------LTV---------------LPSAVFDRLVHLKELFMCCNKLT-E 126

Query: 253 IPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
           +P  I  L +L  L L +N L+ SIP G    L+ L    L  N
Sbjct: 127 LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 35/136 (25%), Positives = 55/136 (40%), Gaps = 16/136 (11%)

Query: 40  QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKF----YGMFPRSICNISSLEYFYLTSN 95
           Q++++  N +    P     L NL +L +  N+      G+F      ++ L    L +N
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS----LTQLTVLDLGTN 98

Query: 96  RFSGSLP---FDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSI 152
           + +  LP   FD    L +LKEL +   N    +P  +   ++L  L L  NQ K     
Sbjct: 99  QLT-VLPSAVFD---RLVHLKELFMC-CNKLTELPRGIERLTHLTHLALDQNQLKSIPHG 153

Query: 153 DFSSLKILWRLNLEQN 168
            F  L  L    L  N
Sbjct: 154 AFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 28/113 (24%), Positives = 40/113 (35%), Gaps = 29/113 (25%)

Query: 264 QLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLS 323
           Q+L L+ N +    P    +L  L +L LGSN L          L   +   L  +T L 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG--------ALPVGVFDSLTQLTVLD 94

Query: 324 L--------------------YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQ 356
           L                     L +  N L   LP+ +  L +L  L +  NQ
Sbjct: 95  LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 38/167 (22%), Positives = 57/167 (34%), Gaps = 41/167 (24%)

Query: 134 SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG---IGAANDLGFVTFLTNCSSL 190
             +  + L  N  K      FS  K L R++L  N +      A   L          SL
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL---------RSL 82

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQL 249
             L L  N+           ++                +P  +   L +L  L +  N++
Sbjct: 83  NSLVLYGNK-----------ITE---------------LPKSLFEGLFSLQLLLLNANKI 116

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
           +    D   +L NL LL LY N LQ +I  G    L  +  + L  N
Sbjct: 117 NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 31/129 (24%), Positives = 60/129 (46%), Gaps = 1/129 (0%)

Query: 40  QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSG 99
             I ++ N++    P      + L +++++ N+   + P +   + SL    L  N+ + 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 100 SLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKI 159
            LP  +   L +L+ L + AN    L  D+  +  NL LL L +N+ +      FS L+ 
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 160 LWRLNLEQN 168
           +  ++L QN
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 29/133 (21%), Positives = 53/133 (39%), Gaps = 18/133 (13%)

Query: 262 NLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQ----GNFIA---------SQNK 307
            +  + L +N ++  IP G      KL ++DL +N +       F             NK
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIPVTLS 366
           +   LP+ L         L L+ N +N  L      +L NL +L +  N+   +   T S
Sbjct: 92  I-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149

Query: 367 TCVSLEYVDISSN 379
              +++ + ++ N
Sbjct: 150 PLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 29/138 (21%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTL--GLLRNLVQLNV 68
              KL+ + L+ N ++   PD    L +L  + + GN +     T L   L   L     
Sbjct: 54  PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-----TELPKSLFEGLFS--- 105

Query: 69  AENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD 128
                             L+   L +N+ +  L  D   +L NL  L +  N    +   
Sbjct: 106 ------------------LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146

Query: 129 SLSNASNLELLDLSNNQF 146
           + S    ++ + L+ N F
Sbjct: 147 TFSPLRAIQTMHLAQNPF 164

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 15/171 (8%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR-SFVAECEALRNIRHR--NLIKII 595
            +G G+FG V      +++   AVKV+  +    +  S   E + L+ I++   N   I+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
                  +       L+FE +G  SL + +   N+      +  I+     I++  A+ Y
Sbjct: 100 KYHGKFMYYD--HMCLIFEPLGP-SLYEII-TRNNYNGF-HIEDIKL--YCIEILKALNY 152

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
           L       + H DLKP N+LLD                        +K+  
Sbjct: 153 LRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 42/168 (25%)

Query: 134 SNLELLDLSNNQFKG-KVSIDFSSLKILWRLNLEQNNLG---IGAANDLGFVTFLTNCSS 189
                L L+NN+F   + +  F  L  L ++N   N +     GA             S 
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA---------SG 82

Query: 190 LKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQ 248
           +  + L+ N+           L +               +   + + L +L  L +  N+
Sbjct: 83  VNEILLTSNR-----------LEN---------------VQHKMFKGLESLKTLMLRSNR 116

Query: 249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
           +     D    L +++LL LY N +  ++  G    L  L+ L+L +N
Sbjct: 117 ITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 27/143 (18%), Positives = 50/143 (34%), Gaps = 25/143 (17%)

Query: 222 GNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG 280
            N+ +     GI + L  L  +    N++             +  + L  N L+ ++   
Sbjct: 41  NNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHK 99

Query: 281 L-GNLTKLAKLDLGSNSLQGNFIASQNKLIGALP----QQLLSITTLSLYLDLSNNLLNG 335
           +   L  L  L L SN +              +       L S+  LSLY    +N +  
Sbjct: 100 MFKGLESLKTLMLRSNRIT------------CVGNDSFIGLSSVRLLSLY----DNQIT- 142

Query: 336 SLPQQV-GNLKNLIILDISSNQF 357
           ++       L +L  L++ +N F
Sbjct: 143 TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 27/113 (23%), Positives = 46/113 (40%), Gaps = 12/113 (10%)

Query: 91  YLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKV 150
            L +N F+      I   LP L+++    N    +   +   AS +  + L++N+ +   
Sbjct: 38  RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQ 97

Query: 151 SIDFSSLKILWRLNLEQNNLG---IGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
              F  L+ L  L L  N +      +   L         SS+++LSL DNQ 
Sbjct: 98  HKMFKGLESLKTLMLRSNRITCVGNDSFIGL---------SSVRLLSLYDNQI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 28/136 (20%), Positives = 50/136 (36%), Gaps = 10/136 (7%)

Query: 16  QALALAGNYLTGKLPDFI-GNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKF- 73
             L L  N  T      I   L  L+ I+   N +             + ++ +  N+  
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

Query: 74  ---YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
              + MF      + SL+   L SNR +  +  D  + L +++ L +  N    + P + 
Sbjct: 95  NVQHKMFKG----LESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149

Query: 131 SNASNLELLDLSNNQF 146
               +L  L+L  N F
Sbjct: 150 DTLHSLSTLNLLANPF 165

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 58.7 bits (143), Expect = 2e-09
 Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 43/176 (24%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKV------INLKQKGAFRSFV----AECE 581
            +F     +G GSFG V+      +    A+KV      + LKQ       V     E  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-------VEHTNDERL 58

Query: 582 ALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKL 637
            L  + H  +I++    +   F+      ++ +Y+  G L   L +     N        
Sbjct: 59  MLSIVTHPFIIRMW--GT---FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----- 108

Query: 638 SLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAK 691
               +   A +V  A+EYLH      +++ DLKP N+LLD +   H+   DFG AK
Sbjct: 109 ----KFYAA-EVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK 154

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 39/184 (21%), Positives = 73/184 (39%), Gaps = 38/184 (20%)

Query: 539 MIGQGSFGSVYKGI-LGEDEMIVAVKVINLKQKGAFR--SFVAECEALRNIRHR---NLI 592
            +G+G+FG V + I        VAVK++  K    +   +   E + L ++      +  
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARS-EIQVLEHLNTTDPNSTF 77

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           + + +    +  G     +VFE +G  S  D++ + N  +   +L  I++  +A  +  +
Sbjct: 78  RCVQMLEWFEHHG--HICIVFELLGL-STYDFI-KENGFLPF-RLDHIRK--MAYQICKS 130

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG-------------------DFGLAKFL 693
           + +LH +    + H DLKP N+L                             DFG A + 
Sbjct: 131 VNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187

Query: 694 SSHH 697
             HH
Sbjct: 188 DEHH 191

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 33/232 (14%)

Query: 499 YARRRRSAHNSADTSPMEKQFPMVSYAELSKATSEFSSSN-----MIGQGSFGSVYKGIL 553
             +  R+       +P EK    +S  + +        ++     ++G+GSFG V     
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSER 362

Query: 554 GEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA 610
              + + AVK++    + Q       + E   L        +  +  C  T     D   
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----DRLY 418

Query: 611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK 670
            V EY+  G L   + Q        +      +  A ++A  + +L       +++ DLK
Sbjct: 419 FVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLK 469

Query: 671 PSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
             NV+LD +   H+   DFG+ K     ++     T +      GT  Y+AP
Sbjct: 470 LDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT----FCGTPDYIAP 511

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 56.8 bits (138), Expect = 8e-09
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 41/194 (21%)

Query: 539 MIGQGSFGSVY---KGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLI 592
           ++GQGSFG V+   K    +   + A+KV+    LK +   R+   E + L  + H  ++
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNIAID 648
           K+    +   F+      L+ +++  G L   L +    + + V         +  +A +
Sbjct: 90  KLH--YA---FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV---------KFYLA-E 134

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPS 706
           +A A+++LH      +++ DLKP N+LLD +   H+   DFGL+K      +D   K  S
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK----ESIDHEKKAYS 185

Query: 707 SSIGIKGTVGYVAP 720
                 GTV Y+AP
Sbjct: 186 ----FCGTVEYMAP 195

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 56.8 bits (138), Expect = 8e-09
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 31/188 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLIKII 595
           ++G+G+FG V            A+K++    +  K      V E   L+N RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ-RLNIAIDVASAIE 654
              +   F+  D    V EY   G L   L +          +  + R   A ++ SA+E
Sbjct: 72  --YA---FQTHDRLCFVMEYANGGELFFHLSRER------VFTEERARFYGA-EIVSALE 119

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           YLH      +V+ D+K  N++LD D   H+   DFGL K      +   +   +      
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK----EGISDGATMKT----FC 166

Query: 713 GTVGYVAP 720
           GT  Y+AP
Sbjct: 167 GTPEYLAP 174

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 20/93 (21%), Positives = 32/93 (34%), Gaps = 1/93 (1%)

Query: 78  PRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLE 137
              +    +L   Y+ + +    L    +  L  L+ L I  +    + PD+      L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 138 LLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
            L+LS N  +         L  L  L L  N L
Sbjct: 84  RLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 2/101 (1%)

Query: 330 NNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP-VTLSTCVSLEYVDISSNCFHGIIPPS 388
                      +   +NL  L I + Q    +    L     L  + I  +    + P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHL 429
             F   +  L++S N       K ++ LS L+ L LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 24/112 (21%), Positives = 37/112 (33%), Gaps = 14/112 (12%)

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQGNFIASQ 305
                     +   +NL  L +        +    L  L +L  L +  + L+  F+A  
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR--FVA-- 72

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
                  P        LS  L+LS N L  SL  +     +L  L +S N  
Sbjct: 73  -------PDAFHFTPRLS-RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 3/97 (3%)

Query: 203 ELPHSIANLSSTMIVFLIGGNQISGTIPLG-IRNLVNLIALAVEVNQLHGTIPDVIGELK 261
           +  H +    +   +++     +   + L  +R L  L  L +  + L    PD      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80

Query: 262 NLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ 298
            L  L L  N L+ S+         L +L L  N L 
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 21/92 (22%), Positives = 31/92 (33%), Gaps = 7/92 (7%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKV-SIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
               L  A NL  L + N Q    +   D   L  L  L + ++ L   A +      F 
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-----AF- 76

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMI 216
                L  L+LS N        ++  LS   +
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQEL 108

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 38/151 (25%), Positives = 60/151 (39%), Gaps = 16/151 (10%)

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
             + +      +  N +          L +L  L +  N+L      V  +L +L  L L
Sbjct: 24  TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83

Query: 269 YKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLD 327
             N LQ S+P+G+   LT+L +L L +N LQ            +LP  +    T    L 
Sbjct: 84  STNQLQ-SLPNGVFDKLTQLKELALNTNQLQ------------SLPDGVFDKLTQLKDLR 130

Query: 328 LSNNLLNGSLPQQV-GNLKNLIILDISSNQF 357
           L  N L  S+P  V   L +L  + +  N +
Sbjct: 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPW 160

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 50/162 (30%), Positives = 66/162 (40%), Gaps = 37/162 (22%)

Query: 137 ELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLS 196
             LDL  N  K   +  F  L  L +L L  N L    +   G    LT+   L  L+LS
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL---QSLPNGVFNKLTS---LTYLNLS 84

Query: 197 DNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPD 255
            NQ           L S               +P G+   L  L  LA+  NQL  ++PD
Sbjct: 85  TNQ-----------LQS---------------LPNGVFDKLTQLKELALNTNQLQ-SLPD 117

Query: 256 -VIGELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSN 295
            V  +L  L+ L LY+N L+ S+P G    LT L  + L  N
Sbjct: 118 GVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 31/112 (27%), Positives = 45/112 (40%), Gaps = 13/112 (11%)

Query: 65  QLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG 124
            L++  N    +       ++SL   YL  N+   SLP  +   L +L  L +  N    
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 125 LIP---DSLSNASNLELLDLSNNQFKGKVSID---FSSLKILWRLNLEQNNL 170
           L     D L   + L+ L L+ NQ +   S+    F  L  L  L L QN L
Sbjct: 91  LPNGVFDKL---TQLKELALNTNQLQ---SLPDGVFDKLTQLKDLRLYQNQL 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 6/107 (5%)

Query: 191 KVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQL 249
             L L  NQF   +P  ++N     ++ L   N+IS T+      N+  L+ L +  N+L
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDL-SNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSN 295
               P     LK+L+LL L+ N +   +P G   +L+ L+ L +G+N
Sbjct: 91  RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/101 (26%), Positives = 40/101 (39%), Gaps = 18/101 (17%)

Query: 264 QLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL-SITTL 322
             L L  N     +P  L N   L  +DL +N +              L  Q   ++T L
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS------------TLSNQSFSNMTQL 80

Query: 323 SLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQFSGMIP 362
              L LS N L   +P +    LK+L +L +  N  S ++P
Sbjct: 81  L-TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.9 bits (125), Expect = 8e-08
 Identities = 26/78 (33%), Positives = 45/78 (57%), Gaps = 4/78 (5%)

Query: 223 NQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
           N++  ++P G+   L  L  L++  NQ+      V  +L  L +L L++N LQ S+P+G+
Sbjct: 38  NKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGV 95

Query: 282 -GNLTKLAKLDLGSNSLQ 298
              LT+L +L L +N L+
Sbjct: 96  FDKLTQLKELALDTNQLK 113

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 35/117 (29%), Positives = 50/117 (42%), Gaps = 16/117 (13%)

Query: 242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGN 300
           L +E N+L      V  +L  L  L L +N +Q S+P G+   LTKL  L L  N LQ  
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-- 89

Query: 301 FIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQ 356
                     +LP  +    T    L L  N L  S+P  +   L +L  + + +N 
Sbjct: 90  ----------SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 33/96 (34%), Positives = 43/96 (44%), Gaps = 18/96 (18%)

Query: 264 QLLGLYKNFLQGSIPSGL-GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL-SITT 321
             L L  N LQ S+P G+   LT+L KL L  N +Q            +LP  +   +T 
Sbjct: 31  TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ------------SLPDGVFDKLTK 77

Query: 322 LSLYLDLSNNLLNGSLPQQV-GNLKNLIILDISSNQ 356
           L+  L L  N L  SLP  V   L  L  L + +NQ
Sbjct: 78  LT-ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQ 111

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 53.7 bits (130), Expect = 9e-08
 Identities = 46/195 (23%), Positives = 80/195 (41%), Gaps = 41/195 (21%)

Query: 539 MIGQGSFGSVY---KGILGEDEMIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNL 591
           ++G+G +G V+   K        I A+KV+     ++         AE   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLNIAI 647
           + +I   +   F+      L+ EY+  G L   L +      D              +A 
Sbjct: 84  VDLI--YA---FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA---------CFYLA- 128

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTP 705
           +++ A+ +LH      +++ DLKP N++L+H    HV   DFGL K        T +   
Sbjct: 129 EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHT--- 180

Query: 706 SSSIGIKGTVGYVAP 720
                  GT+ Y+AP
Sbjct: 181 -----FCGTIEYMAP 190

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 32/189 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLIKI 594
           +IG+GSFG V       +E+  AVKV+    + +K   +  ++E   L +N++H  L+ +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ-RLNIAIDVASAI 653
               S   F+  D    V +Y+  G L   L +             + R   A ++ASA+
Sbjct: 105 H--FS---FQTADKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAA-EIASAL 152

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            YLH      +V+ DLKP N+LLD     H+   DFGL K     +++ +S T +     
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK----ENIEHNSTTST----F 199

Query: 712 KGTVGYVAP 720
            GT  Y+AP
Sbjct: 200 CGTPEYLAP 208

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 35/224 (15%)

Query: 508 NSADTSPMEKQFPMVSYAELSKATSEFSSSN-----MIGQGSFGSVYKGILGEDEMIVAV 562
             A  S +E++   ++  E  KA+S     +     +IG+GS+  V    L + + I A+
Sbjct: 23  QGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAM 82

Query: 563 KVI---NLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNG 619
           +V+    +           E        +   +  +  C  T+ +       V EY+  G
Sbjct: 83  RVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF----FVIEYVNGG 138

Query: 620 SLEDWLHQSNDQVEVCKLSLIQ-RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
            L   + +        KL     R   A +++ A+ YLH      +++ DLK  NVLLD 
Sbjct: 139 DLMFHMQRQR------KLPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDS 188

Query: 679 DMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           +   H+   D+G+ K      L     T +      GT  Y+AP
Sbjct: 189 E--GHIKLTDYGMCK----EGLRPGDTTST----FCGTPNYIAP 222

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 62/428 (14%), Positives = 125/428 (29%), Gaps = 61/428 (14%)

Query: 79  RSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI-GANNF--FGLIPDSL----- 130
           +S   I       +         P  ++   P ++ + + G  +F  F L+PD       
Sbjct: 35  KSWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVY 94

Query: 131 -------SNASNLELLDLSNNQFK----GKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
                  S+ + LE + L            ++  F + K    L L  +  G       G
Sbjct: 95  PWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFK---VLVL-SSCEGFS---TDG 147

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTM-----IVFLIGGNQISGTIPLGIR 234
                  C +LK L L ++       H +++   T      +      +++S +    + 
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFS---ALE 204

Query: 235 NLV----NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKL 290
            LV    NL +L +        +  ++     L+ LG    +     P     L+     
Sbjct: 205 RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG-GYTAEVRPDVYSGLSVALSG 263

Query: 291 DLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSN-NLLNGSLPQQVGNLKNLII 349
                 L G + A     + A+      +T     L+LS   + +  L + +     L  
Sbjct: 264 CKELRCLSGFWDAV-PAYLPAVYSVCSRLT----TLNLSYATVQSYDLVKLLCQCPKLQR 318

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGF-----------LKSIKFL 398
           L +        + V  STC  L  + +       ++ P++                ++ +
Sbjct: 319 LWVLDYIEDAGLEVLASTCKDLRELRV-FPSEPFVMEPNVALTEQGLVSVSMGCPKLESV 377

Query: 399 DVSCNNFSGQ-FPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGI 457
              C   +         N   +    L     +          +     +   V  C  +
Sbjct: 378 LYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAI---VEHCKDL 434

Query: 458 DELHLPSC 465
             L L   
Sbjct: 435 RRLSLSGL 442

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 43/198 (21%), Positives = 84/198 (42%), Gaps = 45/198 (22%)

Query: 539 MIGQGSFGSVY---KGILGEDEMIVAVKVINLKQKGAFRSFVAEC-EALRNIRHRNLIK- 593
           ++G G++G V+   K    +   + A+KV+  K     ++   E     R +    L   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-KATIVQKAKTTEHTRTERQV----LEHI 115

Query: 594 -----IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----SNDQVEVCKLSLIQRLN 644
                ++T+  +  F+      L+ +Y+  G L   L Q    +  +V         ++ 
Sbjct: 116 RQSPFLVTLHYA--FQTETKLHLILDYINGGELFTHLSQRERFTEHEV---------QIY 164

Query: 645 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSS 702
           +  ++  A+E+LH      +++ D+K  N+LLD +   HV   DFGL+K   +   + + 
Sbjct: 165 VG-EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAY 218

Query: 703 KTPSSSIGIKGTVGYVAP 720
                     GT+ Y+AP
Sbjct: 219 -D------FCGTIEYMAP 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 30/188 (15%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLIKI 594
           M+G+GSFG V+     +     A+K +    +         + E   L     H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
              C+   F+  +    V EY+  G L   +   +      K  L +    A ++   ++
Sbjct: 84  F--CT---FQTKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQ 132

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +LH      +V+ DLK  N+LLD D   H+   DFG+ K     ++   +KT +      
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK----ENMLGDAKTNT----FC 179

Query: 713 GTVGYVAP 720
           GT  Y+AP
Sbjct: 180 GTPDYIAP 187

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 35/149 (23%), Positives = 51/149 (34%), Gaps = 35/149 (23%)

Query: 52  KFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPN 111
           K   TL  L+    L ++ N         I  ISSL                     + N
Sbjct: 39  KMDATLSTLKACKHLALSTNN--------IEKISSLS-------------------GMEN 71

Query: 112 LKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG 171
           L+ L +G N     I +  + A  LE L +S NQ    +S     L  L  L +  N + 
Sbjct: 72  LRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKI- 127

Query: 172 IGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
                + G +  L     L+ L L+ N  
Sbjct: 128 ----TNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 20/117 (17%), Positives = 40/117 (34%), Gaps = 8/117 (6%)

Query: 314 QQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEY 373
                   + L+  +   +    +   +  LK    L +S+N    +    LS   +L  
Sbjct: 20  VVATEAEKVELHGMI-PPIEK--MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRI 74

Query: 374 VDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
           + +  N     I        +++ L +S N  +      +E L  L  L +S N + 
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 36/188 (19%), Positives = 62/188 (32%), Gaps = 44/188 (23%)

Query: 255 DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQ 314
            V  E + ++L G+     +  + + L  L     L L +N                   
Sbjct: 20  VVATEAEKVELHGMIPPIEK--MDATLSTLKACKHLALSTN------------------- 58

Query: 315 QLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYV 374
            +  I++LS                    ++NL IL +  N     I    +   +LE +
Sbjct: 59  NIEKISSLS-------------------GMENLRILSLGRNLIKK-IENLDAVADTLEEL 98

Query: 375 DISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG-QFPKFLENLSFLEFLNLSYNHLEGEV 433
            IS N    +    +  L +++ L +S N  +       L  L  LE L L+ N L  + 
Sbjct: 99  WISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156

Query: 434 PTKGVFSN 441
                 S 
Sbjct: 157 KENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 42/179 (23%), Positives = 63/179 (35%), Gaps = 51/179 (28%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
           +  +LS     + L LS N  +    I   S ++ L  L+L +N   I    +L      
Sbjct: 40  MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNL--IKKIENLD----- 89

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
               +L+ L +S NQ        IA+LS                   GI  LVNL  L +
Sbjct: 90  AVADTLEELWISYNQ--------IASLS-------------------GIEKLVNLRVLYM 122

Query: 245 EVNQLHGTIPDV--IGELKNLQLLGLYKNFLQGSIPSG----------LGNLTKLAKLD 291
             N++     ++  +  L  L+ L L  N L                 +  L  L KLD
Sbjct: 123 SNNKI-TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 22/119 (18%), Positives = 52/119 (43%), Gaps = 11/119 (9%)

Query: 5   IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLV 64
           +   + +L   + LAL+ N +  K+   +  +  L+++ +  N +  K      +   L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 65  QLNVAENKFYGMFPRSICNIS---SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           +L ++ N+       S+  I    +L   Y+++N+ +     D +  L  L++L +  N
Sbjct: 97  ELWISYNQI-----ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 24/116 (20%), Positives = 43/116 (37%), Gaps = 7/116 (6%)

Query: 83  NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS 142
             +++    L + + +      +     NL+ L +       +   +L     L+ L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN 198
            N+  G + +    L  L  LNL  N L      D+  +  L     LK L L + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 27/122 (22%), Positives = 44/122 (36%), Gaps = 17/122 (13%)

Query: 259 ELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLS 318
            ++ L L     N   G I         L  L L +  L           +  LP+ L  
Sbjct: 25  AVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLIS---------VSNLPK-LPK 72

Query: 319 ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT-LSTCVSLEYVDIS 377
           +  L    +LS N + G L      L NL  L++S N+   +  +  L     L+ +D+ 
Sbjct: 73  LKKL----ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128

Query: 378 SN 379
           + 
Sbjct: 129 NC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 25/105 (23%), Positives = 46/105 (43%), Gaps = 4/105 (3%)

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           +D+   +      +    ++ L++ +  SN   G I    +  V+LE++ + +     + 
Sbjct: 8   MDMKRRIHLELRNRTPAAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISV- 64

Query: 386 PPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
             +L  L  +K L++S N   G      E L  L  LNLS N L+
Sbjct: 65  -SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 20/78 (25%), Positives = 38/78 (48%), Gaps = 3/78 (3%)

Query: 223 NQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
           N++      G+   L +L+ L ++ NQL G  P+      ++Q L L +N ++  I + +
Sbjct: 39  NELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKM 97

Query: 282 -GNLTKLAKLDLGSNSLQ 298
              L +L  L+L  N + 
Sbjct: 98  FLGLHQLKTLNLYDNQIS 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.9 bits (117), Expect = 5e-07
 Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 7/116 (6%)

Query: 83  NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS 142
             S ++   L ++R +      +      L+ L         +   +L   + L+ L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN 198
           +N+  G + +       L  LNL  N +      DL  +  L    +LK L L + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 17/122 (13%)

Query: 259 ELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLS 318
           ++K L L     N  +G +        +L  L   +  L           I  LP+ L  
Sbjct: 18  DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTS---------IANLPK-LNK 65

Query: 319 ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT-LSTCVSLEYVDIS 377
           +  L    +LS+N ++G L        NL  L++S N+   +  +  L    +L+ +D+ 
Sbjct: 66  LKKL----ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121

Query: 378 SN 379
           + 
Sbjct: 122 NC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 4/88 (4%)

Query: 343 NLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC 402
           ++K L++ +  SN   G +         LE++   +     I   +L  L  +K L++S 
Sbjct: 18  DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73

Query: 403 NNFSGQFPKFLENLSFLEFLNLSYNHLE 430
           N  SG      E    L  LNLS N ++
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 61/390 (15%), Positives = 125/390 (32%), Gaps = 60/390 (15%)

Query: 79  RSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL---GIGANNFFGLIPDSL----- 130
           R    I S    ++T      + P  +    PNL+ L   G      F LIP++      
Sbjct: 42  RRWFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVT 101

Query: 131 -------SNASNLELLDLSNNQFKGKVSIDFSSLKILWRL---NLEQNNL-GIGAANDLG 179
                  +N   L+ +          + +    L  L +    +LE   L         G
Sbjct: 102 PWVTEISNNLRQLKSVHFRR------MIVSDLDLDRLAKARADDLETLKLDKCSGFTTDG 155

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSS------TMIVFLIGGNQIS-GTIPLG 232
            ++ +T+C  +K L + ++ F  +    +  L+        +  ++    +IS   +   
Sbjct: 156 LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215

Query: 233 IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDL 292
            RN  +L+++ V  +     +        NL+            +P    NL    KL  
Sbjct: 216 ARNCRSLVSVKVG-DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274

Query: 293 GSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSN-NLLNGSLPQQVGNLKNLIILD 351
              S  G    ++  ++     Q+         LDL    L        +    NL +L+
Sbjct: 275 LGLSYMGP---NEMPILFPFAAQIRK-------LDLLYALLETEDHCTLIQKCPNLEVLE 324

Query: 352 ISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFL------------KSIKFLD 399
             +      + V    C  L+ + I        +    G +            + ++++ 
Sbjct: 325 TRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMA 384

Query: 400 VSCNNFSGQ----FPKFLENLSFLEFLNLS 425
           V  ++ + +       +L+NL     + L 
Sbjct: 385 VYVSDITNESLESIGTYLKNLCDFRLVLLD 414

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 41/193 (21%), Positives = 75/193 (38%), Gaps = 40/193 (20%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI-----RHRN 590
           ++G+GSFG V        + + AVK++    + Q       + E    + +     +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRVLALPGKPPF 82

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ-RLNIAIDV 649
           L ++        F+ +D    V EY+  G L   + Q        +          A ++
Sbjct: 83  LTQLH--SC---FQTMDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAA-EI 130

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSS 707
           A  + +L       +++ DLK  NV+LD +   H+   DFG+ K     ++     T + 
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT- 180

Query: 708 SIGIKGTVGYVAP 720
                GT  Y+AP
Sbjct: 181 ---FCGTPDYIAP 190

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 36/191 (18%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK----- 593
           +IG+GS+  V    L + + I A+KV+  K+       +   +  +++      +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHV----FEQASNHP 70

Query: 594 -IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQ-RLNIAIDVAS 651
            ++ + S   F+       V EY+  G L   + +        KL     R   A +++ 
Sbjct: 71  FLVGLHSC--FQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSA-EISL 121

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSI 709
           A+ YLH      +++ DLK  NVLLD +   H+   D+G+ K      L     T +   
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK----EGLRPGDTTST--- 169

Query: 710 GIKGTVGYVAP 720
              GT  Y+AP
Sbjct: 170 -FCGTPNYIAP 179

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 7/95 (7%)

Query: 104 DIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL 163
           ++   L     +    N    L  D       L+ L ++NN+          +L  L  L
Sbjct: 36  NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN 198
            L  N+L      +LG +  L +  SL  L +  N
Sbjct: 94  ILTNNSL-----VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 22/105 (20%), Positives = 38/105 (36%), Gaps = 5/105 (4%)

Query: 326 LDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII 385
           + L+  L+  +   Q  N      LD+   +   +I    +T    + +D S N    + 
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57

Query: 386 PPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
                 L+ +K L V+ N          + L  L  L L+ N L 
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 23/110 (20%), Positives = 38/110 (34%), Gaps = 3/110 (2%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           +  + + L L G  +   + +    L     I    N +  +      LLR L  L V  
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 73

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
           N+   +       +  L    LT+N        D + +L +L  L I  N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 11/93 (11%)

Query: 108 NLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLE 166
           N    +EL +       +I +  +     + +D S+N+ +    +D F  L+ L  L + 
Sbjct: 17  NAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVN 72

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQ 199
            N +                   L  L L++N 
Sbjct: 73  NNRICRIGEG------LDQALPDLTELILTNNS 99

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 48.4 bits (116), Expect = 5e-06
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 38/192 (19%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVI---NLKQKGAFRSFVAECEALRNI-----RHRN 590
           ++G+GSFG V    + E   + AVKV+    + Q       + E    + I      H  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE----KRILSLARNHPF 85

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           L ++   C    F+  D    V E++  G L   + +S       +    +    A ++ 
Sbjct: 86  LTQLF--CC---FQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEII 134

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSS 708
           SA+ +LH      +++ DLK  NVLLDH+   H    DFG+ K      +     T +  
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK----EGICNGVTTAT-- 183

Query: 709 IGIKGTVGYVAP 720
               GT  Y+AP
Sbjct: 184 --FCGTPDYIAP 193

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 6e-06
 Identities = 31/165 (18%), Positives = 59/165 (35%), Gaps = 15/165 (9%)

Query: 59  LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVV-NLPNLKEL-- 115
           +L  +  LN  + K             +L+   + S     S+  DI+  +LPNL++L  
Sbjct: 167 VLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVL 226

Query: 116 -----GIGANNFFGLIPDSLSNAS--NLELLDLSNNQFKGKVSIDFSSLKILWRL---NL 165
                  G +    +     S     NL+ L + + + +  V   F    IL +L   ++
Sbjct: 227 YVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDI 286

Query: 166 EQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIAN 210
               L    A  L  +  +     LK +++  N    E+   +  
Sbjct: 287 SAGVLTDEGARLL--LDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 1e-05
 Identities = 28/192 (14%), Positives = 61/192 (31%), Gaps = 39/192 (20%)

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLI 309
              +  V+  +  L  L +       ++  G      L  L++ S  L  + +     ++
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVED---IL 214

Query: 310 GALPQQLLSITTLSLYLDLSNNLLNGSLPQ-----QVGNLKNLIILDISSNQFSGMIPVT 364
           G+    L     L LY+ + +   +G +             NL  L I   +   ++   
Sbjct: 215 GSDLPNL---EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG----QFPKFLENLSFLE 420
                                      L  ++ +D+S    +          ++ +  L+
Sbjct: 272 FLES---------------------DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310

Query: 421 FLNLSYNHLEGE 432
           F+N+ YN+L  E
Sbjct: 311 FINMKYNYLSDE 322

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 26/71 (36%), Positives = 36/71 (50%), Gaps = 4/71 (5%)

Query: 229 IPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKL 287
           +P GI    +   L +  NQ+    P V   L NLQ L    N L  +IP+G+   LT+L
Sbjct: 27  VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 288 AKLDLGSNSLQ 298
            +LDL  N L+
Sbjct: 84  TQLDLNDNHLK 94

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 23/71 (32%), Positives = 32/71 (45%), Gaps = 4/71 (5%)

Query: 229 IPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL-GNLTKL 287
           +P GI        L +  NQ+    P V   L  L  L L  N L   +P+G+   LT+L
Sbjct: 24  VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 288 AKLDLGSNSLQ 298
            +L L  N L+
Sbjct: 81  TQLSLNDNQLK 91

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 26/75 (34%), Positives = 35/75 (46%), Gaps = 4/75 (5%)

Query: 223 NQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSG- 280
           NQI+  +  G+   L  L  L ++ NQL      V  +L  L  L L  N L+ SIP G 
Sbjct: 40  NQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGA 97

Query: 281 LGNLTKLAKLDLGSN 295
             NL  L  + L +N
Sbjct: 98  FDNLKSLTHIWLLNN 112

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 44/303 (14%), Positives = 79/303 (26%), Gaps = 53/303 (17%)

Query: 85  SSLEYFYLTSNRFSGS----LPFDIVVNLPNLKELGIGANNF--FGLIPDSLSNA-SNLE 137
           SSL    L   R +      +   +      L E+ + +      GL   +L        
Sbjct: 72  SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR--TLLPVFLRAR 129

Query: 138 LLDLSNNQFKGKVSIDFSS-LKI----LWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV 192
            L L  N    +   D    L      +  L L  N L       L     L   +S+  
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEG--LAGNTSVTH 187

Query: 193 LSLSDNQFGGELPHSIANL---SSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQL 249
           LSL     G E    +A     +  +    +  N                +A A   +  
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG---DTAAL----ALARAAREH-- 238

Query: 250 HGTIPDVIGELKNLQLLGLYKNFLQ-------GSIPSGLGNLTKLAKLDLGSNSL---QG 299
                       +L+LL LY N L          +        ++        ++     
Sbjct: 239 -----------PSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWS 287

Query: 300 NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL----KNLIILDISSN 355
             ++   + + +  +  +      L  DL ++      P +   L      +  L     
Sbjct: 288 VILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLG 347

Query: 356 QFS 358
              
Sbjct: 348 SSG 350

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 11/46 (23%), Positives = 18/46 (39%), Gaps = 3/46 (6%)

Query: 648 DVASAIEYLHHH---CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
           D     ++L       +    HGDL  SN+ +    V+   D G +
Sbjct: 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211

>4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 7/30 (23%), Positives = 11/30 (36%)

Query: 661 QPPMVHGDLKPSNVLLDHDMVAHVGDFGLA 690
              + HGD    N++ D   +    D G  
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	725
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.94
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.94
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.94
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.94
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.94
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.94
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.93
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.92
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.92
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
3uqc_A	286	Probable conserved transmembrane protein; structur	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.79
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.73
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.71
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.68
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.67
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.66
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.62
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.59
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.53
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.4
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.39
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.38
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.32
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.07
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.94
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.9
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.89
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.62
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.58
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.53
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.51
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.51
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.36
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.21
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.09
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.99
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.94
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.62
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.6
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.53
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.46
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.43
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.33
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.25
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.19
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.14
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.73
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.71
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.64
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.63
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.16
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.08
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.2
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.01
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.55

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.1e-58  Score=540.61  Aligned_cols=447  Identities=33%  Similarity=0.536  Sum_probs=302.1

Q ss_pred             cccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccC----------------------CCCCCC
Q 048668            2 EGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKF----------------------PTTLGL   59 (725)
Q Consensus         2 ~~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~----------------------~~~~~~   59 (725)
                      ++.+|. +.++++|++|+|++|.+++.+|..|..+++|++|++++|++.+..                      |..+..
T Consensus       213 ~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~  291 (768)
T 3rgz_A          213 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSG  291 (768)
T ss_dssp             CSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCT
T ss_pred             CCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHh
Confidence            345565 777777777777777777777777777777777777777666544                      444433


Q ss_pred             C-CCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccC-ccc
Q 048668           60 L-RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNAS-NLE  137 (725)
Q Consensus        60 l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~  137 (725)
                      . ++|++|+|++|++++..|..|+++++|++|+|++|++++.+|...+.++++|++|+|++|++++..|..+..++ +|+
T Consensus       292 ~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~  371 (768)
T 3rgz_A          292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL  371 (768)
T ss_dssp             TCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCS
T ss_pred             hcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCc
Confidence            2 55555555555555555555555555555555555555555555455555555555555555555555555544 555


Q ss_pred             eecCCCccccccCccCccc--ccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccc
Q 048668          138 LLDLSNNQFKGKVSIDFSS--LKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTM  215 (725)
Q Consensus       138 ~L~Ls~N~i~~~~~~~f~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l  215 (725)
                      +|+|++|++++..+..+..  +++|++|++++|.++...      +..+.++++|++|++++|++++.+|..+..++ +|
T Consensus       372 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L  444 (768)
T 3rgz_A          372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI------PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KL  444 (768)
T ss_dssp             EEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC------CGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TC
T ss_pred             EEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc------CHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CC
Confidence            5555555554433333333  444555555555444222      13455566666666666666666666666655 56


Q ss_pred             eeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCC
Q 048668          216 IVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       216 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  295 (725)
                      +.|++++|.+.+.+|..+..+++|++|++++|++.+.+|.++..+++|++|+|++|++.+.+|.++..+++|++|++++|
T Consensus       445 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  524 (768)
T 3rgz_A          445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN  524 (768)
T ss_dssp             CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             CEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCC
Confidence            66666666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             cCCCccccccccccccccccccccccccceecccCCccCCCcc-------------------------------------
Q 048668          296 SLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLP-------------------------------------  338 (725)
Q Consensus       296 ~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~-------------------------------------  338 (725)
                      +++           +.+|..+..+..+ ++|++++|+++|.+|                                     
T Consensus       525 ~l~-----------~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (768)
T 3rgz_A          525 SFS-----------GNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN  592 (768)
T ss_dssp             CCE-----------EECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred             ccc-----------CcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence            444           4555555554444 555555555554444                                     


Q ss_pred             ---------------------------------hhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCcccccc
Q 048668          339 ---------------------------------QQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII  385 (725)
Q Consensus       339 ---------------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  385 (725)
                                                       ..++.+++|+.|||++|+++|.+|.+++.+++|+.|+|++|+++|.+
T Consensus       593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i  672 (768)
T 3rgz_A          593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI  672 (768)
T ss_dssp             EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred             ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence                                             44555688999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCCCCCCCCCC
Q 048668          386 PPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC  465 (725)
Q Consensus       386 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~c  465 (725)
                      |..|+.+++|+.||||+|+++|.+|..+..+++|++|||++|+++|.+|..+.+..+....+.||+++||.+..    .|
T Consensus       673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~----~C  748 (768)
T 3rgz_A          673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP----RC  748 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC----CC
T ss_pred             ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc----CC
Confidence            99999999999999999999999999999999999999999999999999988999999999999999998742    57


Q ss_pred             CCCCCcc
Q 048668          466 PSRGSRK  472 (725)
Q Consensus       466 ~~~~~~~  472 (725)
                      .......
T Consensus       749 ~~~~~~~  755 (768)
T 3rgz_A          749 DPSNADG  755 (768)
T ss_dssp             CSCC---
T ss_pred             CCCccCC
Confidence            6544443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.7e-54  Score=501.62  Aligned_cols=439  Identities=33%  Similarity=0.534  Sum_probs=336.8

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +..+++|++|+|++|++++.+|. |+.+++|++|++++|++++..|..|+.+++|++|+|++|++++..|..  .+++|+
T Consensus       196 ~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~  272 (768)
T 3rgz_A          196 VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQ  272 (768)
T ss_dssp             CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCC
T ss_pred             cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCC
Confidence            37899999999999999987877 999999999999999999999999999999999999999999877765  889999


Q ss_pred             eeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccc-cCccCcccccccCeeecCC
Q 048668           89 YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG-KVSIDFSSLKILWRLNLEQ  167 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~f~~l~~L~~L~L~~  167 (725)
                      +|+|++|++++.+|..++..+++|++|+|++|++++..|..|+++++|++|+|++|++++ ++...|..+++|++|++++
T Consensus       273 ~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~  352 (768)
T 3rgz_A          273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF  352 (768)
T ss_dssp             EEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCS
T ss_pred             EEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcC
Confidence            999999999888888776666999999999999999999999999999999999999984 4444588899999999999


Q ss_pred             ccCCccCCCCcccccccCCCC-CCCEEECccCcccccCChhhhh--ccccceeEEecCccceeccCcccccccCCceEEe
Q 048668          168 NNLGIGAANDLGFVTFLTNCS-SLKVLSLSDNQFGGELPHSIAN--LSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV  244 (725)
Q Consensus       168 N~l~~~~~~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L  244 (725)
                      |.++...+      ..+.+++ +|++|++++|++++.+|..+..  ++ .++.|++++|.+.+.+|..+.++++|++|++
T Consensus       353 n~l~~~~p------~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  425 (768)
T 3rgz_A          353 NEFSGELP------ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN-TLQELYLQNNGFTGKIPPTLSNCSELVSLHL  425 (768)
T ss_dssp             SEEEECCC------TTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC-CCCEEECCSSEEEEECCGGGGGCTTCCEEEC
T ss_pred             CccCcccc------HHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC-CccEEECCCCccccccCHHHhcCCCCCEEEC
Confidence            98863322      2233333 5555555555555544444443  22 4555555555555555555555555555555


Q ss_pred             cccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccc-------------ccccccccc
Q 048668          245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI-------------ASQNKLIGA  311 (725)
Q Consensus       245 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------------~~~~~~~~~  311 (725)
                      ++|++++.+|..|..+++|++|++++|.+.+.+|..+..+++|++|++++|++++..+             .++|.+.+.
T Consensus       426 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  505 (768)
T 3rgz_A          426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE  505 (768)
T ss_dssp             CSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred             cCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCc
Confidence            5555555555555555555555555555555555555555555555555555443211             123355567


Q ss_pred             ccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCcccc--------------------------
Q 048668          312 LPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL--------------------------  365 (725)
Q Consensus       312 ~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--------------------------  365 (725)
                      +|..+..+..+ ++|++++|++++.+|..++.+++|+.|++++|.++|.+|..+                          
T Consensus       506 ~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (768)
T 3rgz_A          506 IPKWIGRLENL-AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK  584 (768)
T ss_dssp             CCGGGGGCTTC-CEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCC
T ss_pred             CChHHhcCCCC-CEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccc
Confidence            88888887777 899999999999999999999999999999999987777544                          


Q ss_pred             --------------------------------------------ccccCCcEEEccCCccccccCccccCCCCCCEEeCC
Q 048668          366 --------------------------------------------STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVS  401 (725)
Q Consensus       366 --------------------------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  401 (725)
                                                                  +.+++|++|||++|+++|.+|..|+.+++|+.|||+
T Consensus       585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls  664 (768)
T 3rgz_A          585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG  664 (768)
T ss_dssp             TTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECC
T ss_pred             ccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCc
Confidence                                                        235678999999999999999999999999999999


Q ss_pred             CCcccccCcccccCCCCCCeEEcccccCeeecCCC-CccCCCCCcCccCCccccCCCCC
Q 048668          402 CNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNVRLCGGIDE  459 (725)
Q Consensus       402 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~~~  459 (725)
                      +|+++|.+|..|+.+++|+.|||++|+++|.+|.. ..+..++.+++++|. +.|.+|.
T Consensus       665 ~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~-l~g~iP~  722 (768)
T 3rgz_A          665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN-LSGPIPE  722 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE-EEEECCS
T ss_pred             CCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc-ccccCCC
Confidence            99999999999999999999999999999999875 557788899999985 5665543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.2e-52  Score=475.28  Aligned_cols=447  Identities=23%  Similarity=0.240  Sum_probs=324.2

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||+.++.  ++++|+|++|.|++..|.+|+.+++|++|+|++|+++++.|.+|+++++|++|+|++|++++..|..|++
T Consensus        26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  103 (606)
T 3t6q_A           26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG  103 (606)
T ss_dssp             SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS
T ss_pred             cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc
Confidence            46666655  5677777777777666666777777777777777776666777777777777777777776666666777


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccC--
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW--  161 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~--  161 (725)
                      +++|++|++++|+++ .++...|.++++|++|+|++|+++++....+..+++|++|+|++|+++++.+..|..+++|+  
T Consensus       104 l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l  182 (606)
T 3t6q_A          104 PKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL  182 (606)
T ss_dssp             CTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSE
T ss_pred             cccccEeeccccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhccccee
Confidence            777777777777776 55444456666777777777776665444454566667777777666666666666666666  


Q ss_pred             eeecCCccCCccCCCCccc-------------------------------------------------------------
Q 048668          162 RLNLEQNNLGIGAANDLGF-------------------------------------------------------------  180 (725)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~-------------------------------------------------------------  180 (725)
                      .|++++|.++...+..+..                                                             
T Consensus       183 ~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~  262 (606)
T 3t6q_A          183 SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ  262 (606)
T ss_dssp             EEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECT
T ss_pred             EEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEee
Confidence            5666666655443322110                                                             


Q ss_pred             --------ccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC
Q 048668          181 --------VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT  252 (725)
Q Consensus       181 --------~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  252 (725)
                              +..|.++++|++|++++|+++ .+|..+..++ .|+.|++++|.+.+..|..+..+++|++|++++|.+.+.
T Consensus       263 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~  340 (606)
T 3t6q_A          263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE  340 (606)
T ss_dssp             TCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCT-TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCB
T ss_pred             cCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccc-cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccc
Confidence                    123566778888888888887 6777777776 788888888888877777777778888888888777644


Q ss_pred             C-ChhhcCCCCccEEeccCcccccCC--CCCCcCCCCCCEEeCCCCcCCCccc-------------cccccccccccccc
Q 048668          253 I-PDVIGELKNLQLLGLYKNFLQGSI--PSGLGNLTKLAKLDLGSNSLQGNFI-------------ASQNKLIGALPQQL  316 (725)
Q Consensus       253 ~-~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~-------------~~~~~~~~~~p~~~  316 (725)
                      + +..+..+++|++|++++|.+.+..  +..+..+++|++|++++|++++...             .+.|.+.+..|...
T Consensus       341 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  420 (606)
T 3t6q_A          341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP  420 (606)
T ss_dssp             CCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCT
T ss_pred             cchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchh
Confidence            3 345777777777777777777554  6667777777777777777654211             12344444555553


Q ss_pred             cccccccceecccCCccCCCcchhhhcCCCCCeEEccCcccccc---CccccccccCCcEEEccCCccccccCccccCCC
Q 048668          317 LSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGM---IPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK  393 (725)
Q Consensus       317 ~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  393 (725)
                      +.....+++|++++|.+++..|..+..+++|++|++++|.+++.   .+..+..+++|++|+|++|++++..|..|+.++
T Consensus       421 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  500 (606)
T 3t6q_A          421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK  500 (606)
T ss_dssp             TTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhcccc
Confidence            33333448899999999988888899999999999999999863   336788899999999999999998899999999


Q ss_pred             CCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC-CccCCCCCcCccCCccccCC
Q 048668          394 SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNVRLCGG  456 (725)
Q Consensus       394 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~  456 (725)
                      +|+.|+|++|++++..|..+..++.| .|++++|++++.+|.. ..++.++.+++++|++.|..
T Consensus       501 ~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  563 (606)
T 3t6q_A          501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC  563 (606)
T ss_dssp             TCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred             CCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence            99999999999999999999999999 9999999999887764 45678899999999998853

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.3e-50  Score=462.17  Aligned_cols=432  Identities=21%  Similarity=0.202  Sum_probs=326.4

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||+.+.  +++++|+|++|.+++..+..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..|++
T Consensus        25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~  102 (606)
T 3vq2_A           25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG  102 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTT
T ss_pred             cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCC
Confidence            5677666  47888888888888767777888888888888888888777888888888888888888888777888888


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeee-CCCcccccCccceecCCCccccccCccCcccccccC-
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW-  161 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~-  161 (725)
                      +++|++|+|++|+++ .++...+.++++|++|+|++|.+++. .|..|+++++|++|+|++|+++++.+..|..+++|+ 
T Consensus       103 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  181 (606)
T 3vq2_A          103 LTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ  181 (606)
T ss_dssp             CTTCCEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTT
T ss_pred             cccCCEEEccCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhcccc
Confidence            888888888888887 66655567788888888888888753 477788888888888888888877777777666554 


Q ss_pred             ---eeecCCccCCccCCCCccc----------------------------------------------------------
Q 048668          162 ---RLNLEQNNLGIGAANDLGF----------------------------------------------------------  180 (725)
Q Consensus       162 ---~L~L~~N~l~~~~~~~~~~----------------------------------------------------------  180 (725)
                         +|++++|.++.++...+..                                                          
T Consensus       182 ~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l  261 (606)
T 3vq2_A          182 VNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV  261 (606)
T ss_dssp             CCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGS
T ss_pred             ccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhc
Confidence               5666666665443321100                                                          


Q ss_pred             -----------------cc---------------------ccCCCCCCCEEECccCcccccCChhhhhccccceeEEecC
Q 048668          181 -----------------VT---------------------FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGG  222 (725)
Q Consensus       181 -----------------~~---------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~  222 (725)
                                       +.                     .+..+++|++|++++|++ +.+| .+ .++ .++.|++++
T Consensus       262 ~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~-~L~~L~l~~  337 (606)
T 3vq2_A          262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFP-TL-DLP-FLKSLTLTM  337 (606)
T ss_dssp             EEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSCC-CC-CCS-SCCEEEEES
T ss_pred             cHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccC-cccc-cC-CCC-ccceeeccC
Confidence                             00                     123334455555555555 2444 22 333 555555555


Q ss_pred             ccceeccCcccccccCCceEEecccccCCC--CChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCc
Q 048668          223 NQISGTIPLGIRNLVNLIALAVEVNQLHGT--IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGN  300 (725)
Q Consensus       223 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  300 (725)
                      |...+..  .+..+++|++|++++|++++.  .+..+..+++|++|++++|.+.+ +|..+..+++|++|++++|+++  
T Consensus       338 n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~--  412 (606)
T 3vq2_A          338 NKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLK--  412 (606)
T ss_dssp             CSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEE--
T ss_pred             CcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccC--
Confidence            5443333  455677777777777777765  36777788888888888888774 5577778888888888888655  


Q ss_pred             ccccccccccccc-ccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccc-cCccccccccCCcEEEccC
Q 048668          301 FIASQNKLIGALP-QQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSG-MIPVTLSTCVSLEYVDISS  378 (725)
Q Consensus       301 ~~~~~~~~~~~~p-~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~  378 (725)
                               +..| ..+..+..+ ++|++++|.+++..|..+..+++|++|++++|.+++ .+|..|..+++|++|+|++
T Consensus       413 ---------~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~  482 (606)
T 3vq2_A          413 ---------RVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK  482 (606)
T ss_dssp             ---------STTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             ---------CccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence                     2344 234445555 899999999998899999999999999999999997 4788999999999999999


Q ss_pred             CccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccC-CCCCcCccCCccccCCC
Q 048668          379 NCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFS-NKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       379 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~  457 (725)
                      |++++..|..|+.+++|+.|+|++|++++..|..|..+++|++|||++|+++..++....++ .++.+++++|++.|...
T Consensus       483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            99999999999999999999999999999999999999999999999999997766655555 58999999999999653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.9e-50  Score=460.71  Aligned_cols=415  Identities=19%  Similarity=0.175  Sum_probs=317.3

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      -++++.++..++ .+|..+..  ++++|+|++|+++++.|.+|+++++|++|+|++|+++++.|.+|+++++|++|+|++
T Consensus        14 ~~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~   90 (606)
T 3t6q_A           14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA   90 (606)
T ss_dssp             TTEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCC
Confidence            568999999998 78887764  799999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA  174 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~  174 (725)
                      |+++ .++...|.++++|++|+|++|+++++.+..|+++++|++|+|++|+++++....+..+++|++|++++|.++.+.
T Consensus        91 n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  169 (606)
T 3t6q_A           91 NPLI-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS  169 (606)
T ss_dssp             CCCS-EECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred             Cccc-ccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccC
Confidence            9998 666667899999999999999999988889999999999999999999987677777999999999999998665


Q ss_pred             CCCcccccccCCCCCCC--EEECccCcccc--------------------------------------------------
Q 048668          175 ANDLGFVTFLTNCSSLK--VLSLSDNQFGG--------------------------------------------------  202 (725)
Q Consensus       175 ~~~~~~~~~~~~l~~L~--~L~L~~N~l~~--------------------------------------------------  202 (725)
                      +      ..+..+++|+  +|++++|.+++                                                  
T Consensus       170 ~------~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i  243 (606)
T 3t6q_A          170 K------EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI  243 (606)
T ss_dssp             H------HHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred             h------hhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhcccccccc
Confidence            4      2344455555  55555555443                                                  


Q ss_pred             -------------------------cCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhh
Q 048668          203 -------------------------ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVI  257 (725)
Q Consensus       203 -------------------------~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  257 (725)
                                               ..+..|..++ .++.|++++|.++ .+|..+..+++|++|++++|.+.+..|..+
T Consensus       244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~  321 (606)
T 3t6q_A          244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA  321 (606)
T ss_dssp             CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCT-TCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCG
T ss_pred             ChhHhchhhcCceeEEEeecCccCccCHHHhcccc-CCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhh
Confidence                                     3344455555 8999999999999 788899999999999999999999889999


Q ss_pred             cCCCCccEEeccCcccccCCCC-CCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCC
Q 048668          258 GELKNLQLLGLYKNFLQGSIPS-GLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS  336 (725)
Q Consensus       258 ~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~  336 (725)
                      ..+++|++|++++|.+.+.+|. .+..+++|++|++++|.+++..         ..|..+..+..+ ++|++++|.+++.
T Consensus       322 ~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------~~~~~~~~l~~L-~~L~l~~n~l~~~  391 (606)
T 3t6q_A          322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD---------CCNLQLRNLSHL-QSLNLSYNEPLSL  391 (606)
T ss_dssp             GGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEE---------ESTTTTTTCTTC-CEEECCSCSCEEE
T ss_pred             hccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccccc---------CcchhcccCCCC-CEEECCCCcCCcC
Confidence            9999999999999999866655 4899999999999999887321         112333333443 5666666666655


Q ss_pred             cchhhhcCCCCCeEEccCccccccCcc-ccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCccccc---Cccc
Q 048668          337 LPQQVGNLKNLIILDISSNQFSGMIPV-TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQ---FPKF  412 (725)
Q Consensus       337 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~  412 (725)
                      .|..|..+++|+.|++++|.+++..+. .+..+++|++|++++|.+++..|..|+.+++|+.|++++|++++.   .+..
T Consensus       392 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  471 (606)
T 3t6q_A          392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS  471 (606)
T ss_dssp             CTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCG
T ss_pred             CHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchh
Confidence            555666666666666666666554443 255666666666666666655555666666666666666666541   2244


Q ss_pred             ccCCCCCCeEEcccccCeeecCCC-CccCCCCCcCccCCc
Q 048668          413 LENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNV  451 (725)
Q Consensus       413 ~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~  451 (725)
                      +..+++|++|++++|.+++.+|.. ..++.++.+++++|.
T Consensus       472 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  511 (606)
T 3t6q_A          472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR  511 (606)
T ss_dssp             GGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             hccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence            556666666666666666555432 334555555666553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=3.6e-50  Score=464.65  Aligned_cols=449  Identities=21%  Similarity=0.217  Sum_probs=259.7

Q ss_pred             CccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccC
Q 048668            6 PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNIS   85 (725)
Q Consensus         6 p~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   85 (725)
                      |..+.++++|++|+|++|.+++..+.+|+++++|++|+|++|+++++.|..|+++++|++|+|++|.+++..|..|.+++
T Consensus        66 ~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  145 (680)
T 1ziw_A           66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE  145 (680)
T ss_dssp             TTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCT
T ss_pred             HHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccc
Confidence            34444444444444444444432223444444444555544444444444444455555555555554444444444455


Q ss_pred             CCceeeccCCCCCCCCChhhhc--CCCCccEEEccCceeeeeCCC-----------------------------------
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVV--NLPNLKELGIGANNFFGLIPD-----------------------------------  128 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~--~l~~L~~L~L~~N~i~~~~~~-----------------------------------  128 (725)
                      +|++|++++|+++ .++...+.  .+++|++|++++|.++++.|.                                   
T Consensus       146 ~L~~L~L~~n~l~-~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L  224 (680)
T 1ziw_A          146 NLQELLLSNNKIQ-ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI  224 (680)
T ss_dssp             TCCEEECCSSCCC-CBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCC
T ss_pred             cCCEEEccCCccc-ccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccc
Confidence            5555555555444 22222211  233444444444444333332                                   


Q ss_pred             ----------------cccccCc--cceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcc-----------
Q 048668          129 ----------------SLSNASN--LELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG-----------  179 (725)
Q Consensus       129 ----------------~~~~l~~--L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~-----------  179 (725)
                                      .|.+++.  |++|+|++|+++++.+..|..+++|++|++++|.+....+..+.           
T Consensus       225 ~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  304 (680)
T 1ziw_A          225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK  304 (680)
T ss_dssp             CEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECT
T ss_pred             cEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEecc
Confidence                            2333322  55555555555555555555555555555555555443321110           


Q ss_pred             ------------ccc----ccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCcccee--ccCcccccc--cCC
Q 048668          180 ------------FVT----FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISG--TIPLGIRNL--VNL  239 (725)
Q Consensus       180 ------------~~~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~--~~~~~~~~l--~~L  239 (725)
                                  ++.    .+.++++|++|++++|++++..|..|.+++ .|+.|++++|.+..  .....|..+  ++|
T Consensus       305 ~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L  383 (680)
T 1ziw_A          305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPL  383 (680)
T ss_dssp             TCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCC
T ss_pred             chhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcC
Confidence                        000    234455555555555555554444444443 33333333332110  000111111  123


Q ss_pred             ceEEecccccCCCCChhhcCCCCccEEeccCcccccCCC-CCCcCCCCCCEEeCCCCcCCCccc-------------ccc
Q 048668          240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP-SGLGNLTKLAKLDLGSNSLQGNFI-------------ASQ  305 (725)
Q Consensus       240 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~-------------~~~  305 (725)
                      +.|++++|++.++.|.+|..+++|++|++++|.+.+.+| ..|.++++|++|++++|++++...             ...
T Consensus       384 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~  463 (680)
T 1ziw_A          384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR  463 (680)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTT
T ss_pred             ceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcc
Confidence            333334444444555555555555555555555554333 345555555555555555432110             011


Q ss_pred             ccc--cccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCc--------cccccccCCcEEE
Q 048668          306 NKL--IGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP--------VTLSTCVSLEYVD  375 (725)
Q Consensus       306 ~~~--~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~  375 (725)
                      +.+  .+.+|..+..+..+ ++|++++|.+++..+..|.++++|++|+|++|++++..+        ..|..+++|++|+
T Consensus       464 n~l~~~~~~p~~~~~l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~  542 (680)
T 1ziw_A          464 VALKNVDSSPSPFQPLRNL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN  542 (680)
T ss_dssp             SCCBCTTCSSCTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEE
T ss_pred             ccccccccCCcccccCCCC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEE
Confidence            111  24567777777776 899999999998888889999999999999999986532        3478899999999


Q ss_pred             ccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC-C-ccCCCCCcCccCCccc
Q 048668          376 ISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-G-VFSNKSKIPLQGNVRL  453 (725)
Q Consensus       376 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~-~~~~~~~~~~~~n~~~  453 (725)
                      |++|+++.+.+..|.++++|+.|||++|+++++.+..|..+++|+.|+|++|++++.+|.. . .++.++.+++++|+|.
T Consensus       543 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~  622 (680)
T 1ziw_A          543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD  622 (680)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCC
T ss_pred             CCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcc
Confidence            9999999766678999999999999999999888888999999999999999999887753 2 4788999999999999


Q ss_pred             cCCC
Q 048668          454 CGGI  457 (725)
Q Consensus       454 c~~~  457 (725)
                      |...
T Consensus       623 c~c~  626 (680)
T 1ziw_A          623 CTCE  626 (680)
T ss_dssp             BCCC
T ss_pred             cCCc
Confidence            9753

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-50  Score=475.26  Aligned_cols=444  Identities=22%  Similarity=0.219  Sum_probs=327.9

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCc-cCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG-KFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      +||+ +.  +++++|+|++|.|++..|..|.++++|++|+|++|...+ +.|.+|+++++|++|+|++|.|+++.|.+|.
T Consensus        18 ~vP~-lp--~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~   94 (844)
T 3j0a_A           18 QVPQ-VL--NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ   94 (844)
T ss_dssp             CCCS-SC--TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred             CCCC-CC--CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence            5676 43  478888888888887777888888888888888885443 4477888888888888888888877788888


Q ss_pred             ccCCCceeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCC-CcccccCccceecCCCccccccCccCcccc--c
Q 048668           83 NISSLEYFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVSIDFSSL--K  158 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l--~  158 (725)
                      ++++|++|+|++|.+++.+|. ..|.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.++++.+..|..+  +
T Consensus        95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~  174 (844)
T 3j0a_A           95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK  174 (844)
T ss_dssp             SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHC
T ss_pred             CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCC
Confidence            888888888888888754543 356778888888888888877654 467888888888888888877777766665  4


Q ss_pred             ccCeeecCCccCCccCCCCcc----------------------------c------------------------------
Q 048668          159 ILWRLNLEQNNLGIGAANDLG----------------------------F------------------------------  180 (725)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~~~~----------------------------~------------------------------  180 (725)
                      +|+.|+++.|.+....+..+.                            +                              
T Consensus       175 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~  254 (844)
T 3j0a_A          175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD  254 (844)
T ss_dssp             SSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTT
T ss_pred             ccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCC
Confidence            555555555544332111000                            0                              


Q ss_pred             --ccccCC--CCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChh
Q 048668          181 --VTFLTN--CSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDV  256 (725)
Q Consensus       181 --~~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  256 (725)
                        ...+.+  .++|++|++++|.+.+..|..+..++ .|+.|++++|.+.+..|..|.++++|++|+|++|.+.++.+.+
T Consensus       255 ~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  333 (844)
T 3j0a_A          255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN  333 (844)
T ss_dssp             GGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCC-CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCS
T ss_pred             CChhhhhccccCCccEEECCCCcccccChhhhhcCC-CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHH
Confidence              001111  25788888888888877777777777 8888888888888888888888888888888888888888888


Q ss_pred             hcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccc--------cccccccccccccc------------
Q 048668          257 IGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI--------ASQNKLIGALPQQL------------  316 (725)
Q Consensus       257 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~~~~~~p~~~------------  316 (725)
                      |.++++|++|++++|.+.+..+..|..+++|++|++++|.+++...        ...|.+. .+|...            
T Consensus       334 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~  412 (844)
T 3j0a_A          334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENR  412 (844)
T ss_dssp             CSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCC-CCCCCCTTCCEEECCSCC
T ss_pred             hcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcc-cccccccccceeecccCc
Confidence            8888888889988888887777788888888888888888775211        1122222 333221            


Q ss_pred             ----------cccccccceecccCCccCCCcch-hhhcCCCCCeEEccCcccc-----ccCccccccccCCcEEEccCCc
Q 048668          317 ----------LSITTLSLYLDLSNNLLNGSLPQ-QVGNLKNLIILDISSNQFS-----GMIPVTLSTCVSLEYVDISSNC  380 (725)
Q Consensus       317 ----------~~~~~ll~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~  380 (725)
                                ..+..+ ++|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|.
T Consensus       413 l~~l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~  491 (844)
T 3j0a_A          413 LENLDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY  491 (844)
T ss_dssp             CCSSTTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHH
T ss_pred             cccCchhhhhhcCCcc-ceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCc
Confidence                      122333 5666666666543332 2444566777777777765     3344567888999999999999


Q ss_pred             cccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCC
Q 048668          381 FHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       381 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                      +++.+|..|..+++|+.|+|++|+|++..|..+.  ++|+.|||++|++++.+|..  +..++.+++++|++.|...
T Consensus       492 l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          492 LNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             HTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred             ccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence            9988888899999999999999999988777776  78999999999999988865  6788999999999999643

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-49  Score=446.24  Aligned_cols=427  Identities=23%  Similarity=0.245  Sum_probs=331.6

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||..+..  ++++|+|++|++++..+.+|..+++|++|+|++|+++++.|.+|.++++|++|+|++|+++++.|.+|.+
T Consensus        21 ~ip~~l~~--~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (570)
T 2z63_A           21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (570)
T ss_dssp             SCCSSSCS--SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCccc--cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence            68887765  8999999999999888889999999999999999999998999999999999999999999888999999


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeee-CCCcccccCccceecCCCccccccCccCccccccc--
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL--  160 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L--  160 (725)
                      +++|++|++++|+++ .++...+.++++|++|+|++|.++++ .|..|+++++|++|++++|+++++.+..|..+++|  
T Consensus        99 l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  177 (570)
T 2z63_A           99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  177 (570)
T ss_dssp             CTTCCEEECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTT
T ss_pred             ccccccccccccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccch
Confidence            999999999999998 77776688999999999999999875 58899999999999999999999999999999998  


Q ss_pred             --CeeecCCccCCccCCCCcccccccCCCCCCCEEECccC----------------------------------------
Q 048668          161 --WRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN----------------------------------------  198 (725)
Q Consensus       161 --~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N----------------------------------------  198 (725)
                        ..|++++|.++.+.+..      +... +|++|++++|                                        
T Consensus       178 ~~~~L~l~~n~l~~~~~~~------~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~  250 (570)
T 2z63_A          178 LNLSLDLSLNPMNFIQPGA------FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA  250 (570)
T ss_dssp             CCCEEECTTCCCCEECTTT------TTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTT
T ss_pred             hhhhcccCCCCceecCHHH------hccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhh
Confidence              89999999988766532      2222 4444444444                                        


Q ss_pred             ------------------cccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhh---
Q 048668          199 ------------------QFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVI---  257 (725)
Q Consensus       199 ------------------~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---  257 (725)
                                        .+.+..|..+..++ .++.|++++|.+. .+|..+..+ +|++|++++|.+..++...+   
T Consensus       251 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L  327 (570)
T 2z63_A          251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSL  327 (570)
T ss_dssp             TGGGGGSEEEEEEEEETTEEESCSTTTTGGGT-TCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSC
T ss_pred             hccccccchhhhhhhcchhhhhhchhhhcCcC-cccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCccccccc
Confidence                              22233344444444 5555555555555 345555554 55555555555552222100   


Q ss_pred             ----------------cCCCCccEEeccCcccccCC--CCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccccc
Q 048668          258 ----------------GELKNLQLLGLYKNFLQGSI--PSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSI  319 (725)
Q Consensus       258 ----------------~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~  319 (725)
                                      ..+++|++|++++|.+.+..  +..+..+++|++|++++|.++            .+|..+..+
T Consensus       328 ~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~------------~~~~~~~~l  395 (570)
T 2z63_A          328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI------------TMSSNFLGL  395 (570)
T ss_dssp             CEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE------------EEEEEEETC
T ss_pred             CEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc------------ccccccccc
Confidence                            33444555555555444322  333444455555555555433            455555555


Q ss_pred             ccccceecccCCccCCCcc-hhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccc-cccCccccCCCCCCE
Q 048668          320 TTLSLYLDLSNNLLNGSLP-QQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFH-GIIPPSLGFLKSIKF  397 (725)
Q Consensus       320 ~~ll~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~  397 (725)
                      ..+ ++|++++|.+++..| ..+..+++|++|++++|.+.+..|..|..+++|++|+|++|.++ +.+|..|..+++|+.
T Consensus       396 ~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~  474 (570)
T 2z63_A          396 EQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  474 (570)
T ss_dssp             TTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             CCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence            555 889999999987665 57889999999999999999888999999999999999999997 578899999999999


Q ss_pred             EeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC-CccCCCCCcCccCCccccCC
Q 048668          398 LDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNVRLCGG  456 (725)
Q Consensus       398 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~  456 (725)
                      |+|++|++++..|..|..+++|++|++++|++++.+|.. ..++.++.+++++|++.|..
T Consensus       475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  534 (570)
T 2z63_A          475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  534 (570)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence            999999999988999999999999999999999887754 45778889999999988753

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.3e-48  Score=451.51  Aligned_cols=436  Identities=19%  Similarity=0.178  Sum_probs=317.3

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      .+||+.+.  +++++|+|++|++++..+..|..+++|++|+|++|++++..|++|+++++|++|+|++|+++++.+.+|+
T Consensus        17 ~~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~   94 (680)
T 1ziw_A           17 TQVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA   94 (680)
T ss_dssp             SSCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhc
Confidence            36888887  4899999999999977777899999999999999999999999999999999999999999977777899


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcc--ccccc
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFS--SLKIL  160 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~--~l~~L  160 (725)
                      ++++|++|+|++|+++ .++...|.++++|++|+|++|.+++..+..|.++++|++|+|++|+++++.+..|.  .+++|
T Consensus        95 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L  173 (680)
T 1ziw_A           95 FCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL  173 (680)
T ss_dssp             TCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEE
T ss_pred             cCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccc
Confidence            9999999999999998 77777788999999999999999999889999999999999999999988877665  45889


Q ss_pred             CeeecCCccCCccCCCCcccccccC---------------------CCCCCCEEECccCcccccCChhhhhcc-ccceeE
Q 048668          161 WRLNLEQNNLGIGAANDLGFVTFLT---------------------NCSSLKVLSLSDNQFGGELPHSIANLS-STMIVF  218 (725)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~~~~~~---------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~-~~l~~L  218 (725)
                      ++|++++|.++...+..+.....+.                     ..++|++|++++|++++..|..+..+. .+|+.|
T Consensus       174 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L  253 (680)
T 1ziw_A          174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTML  253 (680)
T ss_dssp             SEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEE
T ss_pred             cEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEE
Confidence            9999999998876653221100000                     125677777777777777777777665 247778


Q ss_pred             EecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEecc-----------------------------
Q 048668          219 LIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLY-----------------------------  269 (725)
Q Consensus       219 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-----------------------------  269 (725)
                      ++++|.+.+..|..|..+++|++|++++|++.+..|.+|.++++|++|+++                             
T Consensus       254 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~  333 (680)
T 1ziw_A          254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH  333 (680)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCE
T ss_pred             ECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCE
Confidence            888887777777777777778888888777777666655555555555554                             


Q ss_pred             ----CcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccc--cccceecccCCccCCCcchhhhc
Q 048668          270 ----KNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSIT--TLSLYLDLSNNLLNGSLPQQVGN  343 (725)
Q Consensus       270 ----~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~--~ll~~L~L~~n~l~~~~~~~~~~  343 (725)
                          +|.+.+..+..|..+++|++|++++|.++.          ..++...+...  ..++.|++++|++++..|..|..
T Consensus       334 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~----------~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~  403 (680)
T 1ziw_A          334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL----------RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW  403 (680)
T ss_dssp             EECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC----------CEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred             EECCCCccCCCChhHhccccCCcEEECCCCchhh----------hhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence                444444444445555555555555554321          12222222111  12366777777777666777777


Q ss_pred             CCCCCeEEccCccccccCc-cccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCccc--ccCcccccCCCCCC
Q 048668          344 LKNLIILDISSNQFSGMIP-VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS--GQFPKFLENLSFLE  420 (725)
Q Consensus       344 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~  420 (725)
                      +++|+.|+|++|.+++.+| ..|..+++|++|++++|++++..+..|..+++|+.|++++|.++  +..|..|..+++|+
T Consensus       404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~  483 (680)
T 1ziw_A          404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT  483 (680)
T ss_dssp             CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred             CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence            7777777777777765444 56777777777777777777666666777777777777777665  45666677777777


Q ss_pred             eEEcccccCeeecCCC-CccCCCCCcCccCCc
Q 048668          421 FLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNV  451 (725)
Q Consensus       421 ~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~  451 (725)
                      .|++++|.+++.+|.. ..+..++.+++++|.
T Consensus       484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~  515 (680)
T 1ziw_A          484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNN  515 (680)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCcCChhhhccccccCEEeCCCCC
Confidence            7777777776655542 345566666666664

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.3e-48  Score=438.47  Aligned_cols=415  Identities=21%  Similarity=0.182  Sum_probs=349.9

Q ss_pred             cccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccc
Q 048668            2 EGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSI   81 (725)
Q Consensus         2 ~~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~   81 (725)
                      ++..|..|.++++|++|+|++|++++..|.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|++++..+..|
T Consensus        45 ~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~  124 (606)
T 3vq2_A           45 KILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI  124 (606)
T ss_dssp             CEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCC
T ss_pred             CEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccccccc
Confidence            34456689999999999999999998888999999999999999999998889999999999999999999998888899


Q ss_pred             cccCCCceeeccCCCCCC-CCChhhhcCCCCccEEEccCceeeeeCCCcccccCccc----eecCCCccccccCccCccc
Q 048668           82 CNISSLEYFYLTSNRFSG-SLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLE----LLDLSNNQFKGKVSIDFSS  156 (725)
Q Consensus        82 ~~l~~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~Ls~N~i~~~~~~~f~~  156 (725)
                      +++++|++|++++|++++ .+|. .|.++++|++|+|++|+++++.+..|+.+.+|+    +|++++|+++++++..|..
T Consensus       125 ~~l~~L~~L~L~~n~l~~~~lp~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~  203 (606)
T 3vq2_A          125 GQLITLKKLNVAHNFIHSCKLPA-YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG  203 (606)
T ss_dssp             TTCTTCCEEECCSSCCCCCCCCG-GGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT
T ss_pred             CCCCCCCEEeCCCCcccceechH-hHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccC
Confidence            999999999999999984 3554 468999999999999999999888888777665    6888888887666554433


Q ss_pred             ccccCeeecCCccC------------------------------------------------------------------
Q 048668          157 LKILWRLNLEQNNL------------------------------------------------------------------  170 (725)
Q Consensus       157 l~~L~~L~L~~N~l------------------------------------------------------------------  170 (725)
                      . +|++|++++|.+                                                                  
T Consensus       204 ~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~  282 (606)
T 3vq2_A          204 I-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH  282 (606)
T ss_dssp             C-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCG
T ss_pred             c-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccc
Confidence            2 333333333322                                                                  


Q ss_pred             ---------------CccCC--------------CC-cccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEe
Q 048668          171 ---------------GIGAA--------------ND-LGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLI  220 (725)
Q Consensus       171 ---------------~~~~~--------------~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l  220 (725)
                                     ..++.              .. ..++ .+ .+++|++|++++|+..+..  .+..++ .|+.|++
T Consensus       283 ~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~-~L~~L~l  357 (606)
T 3vq2_A          283 CLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALP-SLSYLDL  357 (606)
T ss_dssp             GGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCT-TCCEEEC
T ss_pred             cCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccc-cC-CCCccceeeccCCcCccch--hhccCC-CCCEEEC
Confidence                           21110              00 0112 23 8899999999999665444  455666 8999999


Q ss_pred             cCccceec--cCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCC-CCCcCCCCCCEEeCCCCcC
Q 048668          221 GGNQISGT--IPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP-SGLGNLTKLAKLDLGSNSL  297 (725)
Q Consensus       221 ~~n~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l  297 (725)
                      ++|.+++.  +|..+..+++|++|++++|.+.+. |..|..+++|++|++++|.+.+..| ..+..+++|++|++++|.+
T Consensus       358 s~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l  436 (606)
T 3vq2_A          358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT  436 (606)
T ss_dssp             CSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCC
T ss_pred             cCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCC
Confidence            99999977  488899999999999999999864 5889999999999999999998877 6899999999999999966


Q ss_pred             CCccccccccccccccccccccccccceecccCCccCC-CcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEc
Q 048668          298 QGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG-SLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDI  376 (725)
Q Consensus       298 ~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  376 (725)
                      +           +..|..+..+..+ ++|++++|.+++ .+|..|+.+++|+.|+|++|++++..|..|..+++|++|+|
T Consensus       437 ~-----------~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  504 (606)
T 3vq2_A          437 K-----------IDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM  504 (606)
T ss_dssp             E-----------ECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             C-----------ccchhhhcCCCCC-CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence            5           3455556666666 999999999997 47889999999999999999999999999999999999999


Q ss_pred             cCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCC-CCCeEEcccccCeeecCCCC
Q 048668          377 SSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLS-FLEFLNLSYNHLEGEVPTKG  437 (725)
Q Consensus       377 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~  437 (725)
                      ++|++++..|..|+.+++|+.|||++|+++ .+|..+..++ +|++|++++|+|.|.++..+
T Consensus       505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             CSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             CCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            999999999999999999999999999999 5677798887 59999999999999888643

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=453.63  Aligned_cols=430  Identities=21%  Similarity=0.183  Sum_probs=340.6

Q ss_pred             cEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCc-ccccCcccccccCCCceeeccC
Q 048668           16 QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENK-FYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        16 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      +..+.++++++ .+|.   -.++|++|||++|+|+++.|..|.++++|++|+|++|. +..+.|.+|.++++|++|+|++
T Consensus         7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            57888999999 6776   45799999999999999999999999999999999995 4445589999999999999999


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCc--ccccCccceecCCCccccccCc-cCcccccccCeeecCCccCC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDS--LSNASNLELLDLSNNQFKGKVS-IDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~--~~~l~~L~~L~Ls~N~i~~~~~-~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |+|+ .++...|.++++|++|+|++|.+++..+..  |.++++|++|||++|.++++.+ ..|..+++|++|+|++|.++
T Consensus        83 N~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             CCCC-EECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             CcCc-ccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            9998 666677899999999999999999865554  9999999999999999998765 57999999999999999998


Q ss_pred             ccCCCCcccc--------------------cccCCCC------CCCEEECccCcccccCChhhhhc--------------
Q 048668          172 IGAANDLGFV--------------------TFLTNCS------SLKVLSLSDNQFGGELPHSIANL--------------  211 (725)
Q Consensus       172 ~~~~~~~~~~--------------------~~~~~l~------~L~~L~L~~N~l~~~~p~~~~~l--------------  211 (725)
                      ...+.++...                    ..+..++      +|++|++++|.+++..|..+...              
T Consensus       162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~  241 (844)
T 3j0a_A          162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH  241 (844)
T ss_dssp             CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred             eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence            7655433211                    1122222      38999999998877666555432              


Q ss_pred             -----------------------cccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEec
Q 048668          212 -----------------------SSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL  268 (725)
Q Consensus       212 -----------------------~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  268 (725)
                                             ...++.|++++|.+.+..+..|..+++|+.|+|++|++.++.+.+|.++++|++|+|
T Consensus       242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L  321 (844)
T 3j0a_A          242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL  321 (844)
T ss_dssp             CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEE
T ss_pred             cccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEEC
Confidence                                   147899999999999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCCCCcCCCCCCEEeCCCCcCCCccc-------------cccccccccccc--c-------------ccccc
Q 048668          269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI-------------ASQNKLIGALPQ--Q-------------LLSIT  320 (725)
Q Consensus       269 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-------------~~~~~~~~~~p~--~-------------~~~~~  320 (725)
                      ++|.+.+..|..|..+++|++|++++|++++...             .++|.+. .++.  .             +....
T Consensus       322 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~L~~L~l~~N~l~~l~~~~  400 (844)
T 3j0a_A          322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKIN  400 (844)
T ss_dssp             ESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSC-CCSSCCSCSEEEEESCCCCCCCCCC
T ss_pred             CCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCC-cccCCCCcchhccCCCCcccccccc
Confidence            9999998889999999999999999998874211             0111111 1111  0             00000


Q ss_pred             cccceecccCCccCCCc-chhhhcCCCCCeEEccCccccccCcc-ccccccCCcEEEccCCccc-----cccCccccCCC
Q 048668          321 TLSLYLDLSNNLLNGSL-PQQVGNLKNLIILDISSNQFSGMIPV-TLSTCVSLEYVDISSNCFH-----GIIPPSLGFLK  393 (725)
Q Consensus       321 ~ll~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~  393 (725)
                      ..++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|..++
T Consensus       401 ~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~  480 (844)
T 3j0a_A          401 LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS  480 (844)
T ss_dssp             TTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBC
T ss_pred             cccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcc
Confidence            01122333333333221 12345788888899998888865543 4556788999999999887     44456788999


Q ss_pred             CCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCcc
Q 048668          394 SIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVR  452 (725)
Q Consensus       394 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~  452 (725)
                      +|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|.... ..++.+++++|..
T Consensus       481 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l  538 (844)
T 3j0a_A          481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQL  538 (844)
T ss_dssp             CEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECC
T ss_pred             cccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcC
Confidence            999999999999999999999999999999999999988776533 7888899998854

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.1e-48  Score=443.61  Aligned_cols=418  Identities=19%  Similarity=0.285  Sum_probs=318.0

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCC----------------------------------
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLG----------------------------------   58 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----------------------------------   58 (725)
                      .+++.|+|++|++.|.+|.+|+.+++|++|+|++|.+. ..+..++                                  
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~  159 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS  159 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHH
Confidence            36999999999999999999999999999999999762 1111111                                  


Q ss_pred             -------------------CCCCCCEEEcc--CCcccccCcccccccCCCceeeccCCCCCCC-----------------
Q 048668           59 -------------------LLRNLVQLNVA--ENKFYGMFPRSICNISSLEYFYLTSNRFSGS-----------------  100 (725)
Q Consensus        59 -------------------~l~~L~~L~Ls--~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------  100 (725)
                                         ....++.+.+.  .|++++ +|..|+++++|++|+|++|++++.                 
T Consensus       160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~  238 (636)
T 4eco_A          160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY  238 (636)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence                               11122223332  578887 788888888888888888888853                 


Q ss_pred             CChhhh-cCCCCccEEEccCceeeeeCCCcccccCccceecCCCcc-ccc-cCccCcccc------cccCeeecCCccCC
Q 048668          101 LPFDIV-VNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ-FKG-KVSIDFSSL------KILWRLNLEQNNLG  171 (725)
Q Consensus       101 ~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~-i~~-~~~~~f~~l------~~L~~L~L~~N~l~  171 (725)
                      +|..+. .++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ ..|..+..+      ++|++|++++|.++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            776541 278888888888888888888888888888888888887 876 556666665      88888888888887


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccC-CceEEecccccC
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVN-LIALAVEVNQLH  250 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l~  250 (725)
                      .++..     ..+.++++|++|++++|+++|.+| .+..++ +|+.|++++|.+. .+|..+..+++ |++|++++|+++
T Consensus       319 ~ip~~-----~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~  390 (636)
T 4eco_A          319 TFPVE-----TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK  390 (636)
T ss_dssp             SCCCH-----HHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS
T ss_pred             ccCch-----hhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc
Confidence            43310     157788888888888888888888 777777 7888888888888 77888888888 888888888888


Q ss_pred             CCCChhhcCCC--CccEEeccCcccccCCCCCCc-------CCCCCCEEeCCCCcCCCcccccccccccccccccccccc
Q 048668          251 GTIPDVIGELK--NLQLLGLYKNFLQGSIPSGLG-------NLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITT  321 (725)
Q Consensus       251 ~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~  321 (725)
                       .+|..+..++  +|++|++++|.+.+..|..|.       .+++|++|++++|+++            .+|..++....
T Consensus       391 -~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~------------~lp~~~~~~l~  457 (636)
T 4eco_A          391 -YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS------------KFPKELFSTGS  457 (636)
T ss_dssp             -SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC------------SCCTHHHHTTC
T ss_pred             -ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC------------cCCHHHHccCC
Confidence             5566666654  788888888888888888777       7778888888888776            67777666434


Q ss_pred             ccceecccCCccCCCcchhhhcCC-------CCCeEEccCccccccCccccc--cccCCcEEEccCCccccccCccccCC
Q 048668          322 LSLYLDLSNNLLNGSLPQQVGNLK-------NLIILDISSNQFSGMIPVTLS--TCVSLEYVDISSNCFHGIIPPSLGFL  392 (725)
Q Consensus       322 ll~~L~L~~n~l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l  392 (725)
                      .+++|+|++|.++...+..+....       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+
T Consensus       458 ~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l  535 (636)
T 4eco_A          458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS  535 (636)
T ss_dssp             CCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred             CCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcC
Confidence            447888888888843333344333       8888888888888 5666665  78888888888888886 77888888


Q ss_pred             CCCCEEeC------CCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCC
Q 048668          393 KSIKFLDV------SCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       393 ~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                      ++|+.|+|      ++|++.+.+|..+..+++|++|+|++|++ +.+|.. ..+.++.+++++|++.|-..
T Consensus       536 ~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             SSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEEC
T ss_pred             CCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccccH
Confidence            88888888      55777888888888888888888888888 455543 24778888888888777543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.4e-47  Score=431.63  Aligned_cols=421  Identities=22%  Similarity=0.272  Sum_probs=319.5

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      .+||+.+.  ++|++|+|++|++++..|..|..+++|++|+|++|++++..|++|.++++|++|+|++|++++..|..|+
T Consensus        18 ~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~   95 (549)
T 2z81_A           18 TSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG   95 (549)
T ss_dssp             SSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHT
T ss_pred             ccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhc
Confidence            36888776  5899999999999988889999999999999999999999999999999999999999999988888899


Q ss_pred             ccCCCceeeccCCCCCCCCC-hhhhcCCCCccEEEccCce-eeeeCCCcccccCccceecCCCccccccCccCccccccc
Q 048668           83 NISSLEYFYLTSNRFSGSLP-FDIVVNLPNLKELGIGANN-FFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL  160 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L  160 (725)
                      ++++|++|+|++|+++ .++ ...+.++++|++|++++|. +..+.+..|.++++|++|++++|++++..+..|..+++|
T Consensus        96 ~l~~L~~L~Ls~n~l~-~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  174 (549)
T 2z81_A           96 PLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI  174 (549)
T ss_dssp             TCTTCCEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred             cCCCCcEEECCCCccc-ccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccC
Confidence            9999999999999998 432 2457899999999999998 566666789999999999999999999888888888888


Q ss_pred             CeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccC--Chhhhhccc-------------------------
Q 048668          161 WRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL--PHSIANLSS-------------------------  213 (725)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~-------------------------  213 (725)
                      ++|+++.|.+..++.      ..+..+++|++|++++|++++..  |..+.....                         
T Consensus       175 ~~L~l~~n~~~~~~~------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~  248 (549)
T 2z81_A          175 HHLTLHLSESAFLLE------IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR  248 (549)
T ss_dssp             EEEEEECSBSTTHHH------HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGG
T ss_pred             ceEecccCcccccch------hhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhh
Confidence            888888777654332      22345677777777777776431  212222222                         


Q ss_pred             ---cceeEEecCccceeccC---------c--------------------------ccccccCCceEEecccccCCCCCh
Q 048668          214 ---TMIVFLIGGNQISGTIP---------L--------------------------GIRNLVNLIALAVEVNQLHGTIPD  255 (725)
Q Consensus       214 ---~l~~L~l~~n~i~~~~~---------~--------------------------~~~~l~~L~~L~L~~N~l~~~~~~  255 (725)
                         .++.+.+.+|.+.+...         .                          .+....+|+.|++++|.+..++..
T Consensus       249 ~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~  328 (549)
T 2z81_A          249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS  328 (549)
T ss_dssp             GCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHH
T ss_pred             hhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHH
Confidence               34444444444433110         0                          011234677777777777644333


Q ss_pred             hhcCCCCccEEeccCcccccCCC---CCCcCCCCCCEEeCCCCcCCCcccccccccccccc---ccccccccccceeccc
Q 048668          256 VIGELKNLQLLGLYKNFLQGSIP---SGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALP---QQLLSITTLSLYLDLS  329 (725)
Q Consensus       256 ~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p---~~~~~~~~ll~~L~L~  329 (725)
                      .+..+++|++|++++|.+.+..|   ..+..+++|++|++++|+++            .++   ..+..+..+ ++|+++
T Consensus       329 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~------------~~~~~~~~~~~l~~L-~~L~Ls  395 (549)
T 2z81_A          329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR------------SMQKTGEILLTLKNL-TSLDIS  395 (549)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCC------------CHHHHHHHGGGCTTC-CEEECT
T ss_pred             HHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccc------------ccccchhhhhcCCCC-CEEECC
Confidence            44678888888888888876553   34677888888888888776            232   123344444 788888


Q ss_pred             CCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccC
Q 048668          330 NNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF  409 (725)
Q Consensus       330 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  409 (725)
                      +|+++ .+|..+..+++|++|++++|++++ +|..+.  ++|++|+|++|++++.+    ..+++|+.|+|++|+++ .+
T Consensus       396 ~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~i  466 (549)
T 2z81_A          396 RNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TL  466 (549)
T ss_dssp             TCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SC
T ss_pred             CCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cC
Confidence            88888 567778888888999999888873 343332  57889999999888643    57889999999999998 55


Q ss_pred             cccccCCCCCCeEEcccccCeeecCCC-CccCCCCCcCccCCccccC
Q 048668          410 PKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNVRLCG  455 (725)
Q Consensus       410 p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~  455 (725)
                      |. ...+++|++|||++|++++.+|.. ..+..++.+++++|++.|.
T Consensus       467 p~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          467 PD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            65 467899999999999999888763 5678888999999998774

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=433.08  Aligned_cols=417  Identities=19%  Similarity=0.207  Sum_probs=341.0

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      +-.|..|.++++|++|+|++|++++..+.+|+++++|++|+|++|++++..|.+|+++++|++|+|++|+++++.+..|+
T Consensus        42 ~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~  121 (570)
T 2z63_A           42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG  121 (570)
T ss_dssp             EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCT
T ss_pred             ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccc
Confidence            33456789999999999999999987888999999999999999999988899999999999999999999987777899


Q ss_pred             ccCCCceeeccCCCCCC-CCChhhhcCCCCccEEEccCceeeeeCCCcccccCcc----ceecCCCccccccCccCcccc
Q 048668           83 NISSLEYFYLTSNRFSG-SLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNL----ELLDLSNNQFKGKVSIDFSSL  157 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L----~~L~Ls~N~i~~~~~~~f~~l  157 (725)
                      ++++|++|++++|.+++ .+|. .|.++++|++|++++|+++++.+..|+.+++|    ++|++++|.++++.+..|...
T Consensus       122 ~l~~L~~L~L~~n~l~~~~lp~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~  200 (570)
T 2z63_A          122 HLKTLKELNVAHNLIQSFKLPE-YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI  200 (570)
T ss_dssp             TCTTCCEEECCSSCCCCCCCCG-GGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC
T ss_pred             ccccccEEecCCCccceecChh-hhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC
Confidence            99999999999999984 2454 46889999999999999999988999999998    899999999998888777655


Q ss_pred             cccCeeecCCccCCc-------------------------------cCCC---------------------CcccccccC
Q 048668          158 KILWRLNLEQNNLGI-------------------------------GAAN---------------------DLGFVTFLT  185 (725)
Q Consensus       158 ~~L~~L~L~~N~l~~-------------------------------~~~~---------------------~~~~~~~~~  185 (725)
                       +|++|++++|....                               +...                     ....+..+.
T Consensus       201 -~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~  279 (570)
T 2z63_A          201 -RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN  279 (570)
T ss_dssp             -EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTG
T ss_pred             -cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhc
Confidence             56677666652110                               0000                     000112344


Q ss_pred             CCCCCCEEECccCcccccCChhhhhc-------------------cccceeEEecCccceeccCcccccccCCceEEecc
Q 048668          186 NCSSLKVLSLSDNQFGGELPHSIANL-------------------SSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEV  246 (725)
Q Consensus       186 ~l~~L~~L~L~~N~l~~~~p~~~~~l-------------------~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~  246 (725)
                      .+++|++|++++|.++ .+|..+..+                   ...++.|++.+|.+.+..+.  ..+++|++|++++
T Consensus       280 ~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~  356 (570)
T 2z63_A          280 CLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSR  356 (570)
T ss_dssp             GGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCS
T ss_pred             CcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccc--ccCCCCCEEeCcC
Confidence            4566666666666665 345444433                   11445555555555444333  5788999999999


Q ss_pred             cccCCCC--ChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccc-cccccccc
Q 048668          247 NQLHGTI--PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQ-LLSITTLS  323 (725)
Q Consensus       247 N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~-~~~~~~ll  323 (725)
                      |++.+..  +..+..+++|++|++++|.+.+..+. +..+++|++|++++|.+++           ..|.. +.....+ 
T Consensus       357 n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~-----------~~~~~~~~~l~~L-  423 (570)
T 2z63_A          357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQ-----------MSEFSVFLSLRNL-  423 (570)
T ss_dssp             SCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEES-----------CTTSCTTTTCTTC-
T ss_pred             CccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCcccc-----------ccchhhhhcCCCC-
Confidence            9998664  78899999999999999999965555 8999999999999997662           33323 3344444 


Q ss_pred             ceecccCCccCCCcchhhhcCCCCCeEEccCcccc-ccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCC
Q 048668          324 LYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFS-GMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC  402 (725)
Q Consensus       324 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  402 (725)
                      ++|++++|.+++..|..|..+++|+.|++++|.++ +.+|..+..+++|++|+|++|++++..|..|+.+++|+.|++++
T Consensus       424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  503 (570)
T 2z63_A          424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS  503 (570)
T ss_dssp             CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence            89999999999889999999999999999999998 57899999999999999999999999899999999999999999


Q ss_pred             CcccccCcccccCCCCCCeEEcccccCeeecCCCC
Q 048668          403 NNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKG  437 (725)
Q Consensus       403 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  437 (725)
                      |++++..|..|..+++|+.|++++|+++|.+|...
T Consensus       504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            99999999999999999999999999999998753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-47  Score=443.90  Aligned_cols=393  Identities=20%  Similarity=0.228  Sum_probs=243.6

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEc-cCCcCCcc---------------------------------------
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHI-KGNSLGGK---------------------------------------   52 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l-~~n~l~~~---------------------------------------   52 (725)
                      .+++.|+|++|++.|.+|++|+++++|++|+| ++|.+.|.                                       
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            46888999999999899999999999999999 77765443                                       


Q ss_pred             -------------------------------------CCCCCCCCCCCCEEEccCCcccc-----------------cCc
Q 048668           53 -------------------------------------FPTTLGLLRNLVQLNVAENKFYG-----------------MFP   78 (725)
Q Consensus        53 -------------------------------------~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~~   78 (725)
                                                           +|..|+++++|++|+|++|+|++                 .+|
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP  482 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN  482 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence                                                 45556666666666666666665                 255


Q ss_pred             cccc--ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCce-eee-eCCCcccccC-------ccceecCCCcccc
Q 048668           79 RSIC--NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANN-FFG-LIPDSLSNAS-------NLELLDLSNNQFK  147 (725)
Q Consensus        79 ~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l~-------~L~~L~Ls~N~i~  147 (725)
                      ..++  ++++|++|+|++|++.+.+|. .+.++++|+.|+|++|+ +++ .+|..+..++       +|++|+|++|+|+
T Consensus       483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~-~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          483 EELSWSNLKDLTDVELYNCPNMTQLPD-FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             SCCCGGGCTTCCEEEEESCTTCCSCCG-GGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             hhhhhccCCCCCEEECcCCCCCccChH-HHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            5544  666666666666666656663 34566666666666665 655 4454444443       6666666666666


Q ss_pred             ccCc-cCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccce
Q 048668          148 GKVS-IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS  226 (725)
Q Consensus       148 ~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~  226 (725)
                      .++. ..|..+++|++|+|++|.++.++        .+.++++|++|+|++|+++ .+|..+..++..|+.|++++|.+.
T Consensus       562 ~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--------~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~  632 (876)
T 4ecn_A          562 EFPASASLQKMVKLGLLDCVHNKVRHLE--------AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK  632 (876)
T ss_dssp             BCCCHHHHTTCTTCCEEECTTSCCCBCC--------CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred             ccCChhhhhcCCCCCEEECCCCCcccch--------hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC
Confidence            4332 25666666666666666665322        2456666666666666666 566666666623666666666666


Q ss_pred             eccCcccccccC--CceEEecccccCCCCChhh---c--CCCCccEEeccCcccccCCCCC-CcCCCCCCEEeCCCCcCC
Q 048668          227 GTIPLGIRNLVN--LIALAVEVNQLHGTIPDVI---G--ELKNLQLLGLYKNFLQGSIPSG-LGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       227 ~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~  298 (725)
                       .+|..+..+..  |+.|+|++|++.+.+|...   .  .+++|++|+|++|.+.. +|.. +..+++|+.|+|++|+|+
T Consensus       633 -~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~  710 (876)
T 4ecn_A          633 -YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT  710 (876)
T ss_dssp             -SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCSCCCS
T ss_pred             -cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCCCcCC
Confidence             55655555443  6666666666665544322   1  22356666666666663 3333 335666666666666555


Q ss_pred             Ccccccccccccccccccccccc-------ccceecccCCccCCCcchhhh--cCCCCCeEEccCccccccCcccccccc
Q 048668          299 GNFIASQNKLIGALPQQLLSITT-------LSLYLDLSNNLLNGSLPQQVG--NLKNLIILDISSNQFSGMIPVTLSTCV  369 (725)
Q Consensus       299 ~~~~~~~~~~~~~~p~~~~~~~~-------ll~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~  369 (725)
                                  .+|..++....       .++.|+|++|+++ .+|..+.  .+++|+.|+|++|.+++ +|..+..++
T Consensus       711 ------------~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~  776 (876)
T 4ecn_A          711 ------------SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS  776 (876)
T ss_dssp             ------------CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCT
T ss_pred             ------------ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCC
Confidence                        45554444331       2366666666666 4555554  66666666666666665 566666666


Q ss_pred             CCcEEEccC------CccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecC
Q 048668          370 SLEYVDISS------NCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       370 ~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  434 (725)
                      +|+.|+|++      |.+.+.+|..|..+++|+.|+|++|++ +.+|..+.  ++|+.|||++|++....+
T Consensus       777 ~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~  844 (876)
T 4ecn_A          777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV  844 (876)
T ss_dssp             TCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred             CCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence            666666654      556666666666666666666666666 45555544  466666666666655443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=7.4e-47  Score=430.83  Aligned_cols=406  Identities=19%  Similarity=0.214  Sum_probs=305.4

Q ss_pred             CcccCCccccCcccCcEEecCCCccC------c---------------------------cCCcccc-------------
Q 048668            1 LEGQIPKEIGSLFKLQALALAGNYLT------G---------------------------KLPDFIG-------------   34 (725)
Q Consensus         1 ~~~~ip~~~~~l~~l~~L~l~~n~l~------~---------------------------~~~~~~~-------------   34 (725)
                      ++|.||++++++++|++|+|++|.+.      +                           .+|..+.             
T Consensus        93 l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~  172 (636)
T 4eco_A           93 ASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ  172 (636)
T ss_dssp             CEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTS
T ss_pred             cCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccc
Confidence            57999999999999999999999662      1                           0111111             


Q ss_pred             ------CCCCCcEEEcc--CCcCCccCCCCCCCCCCCCEEEccCCccccc-----------------Cccccc--ccCCC
Q 048668           35 ------NLSALQVIHIK--GNSLGGKFPTTLGLLRNLVQLNVAENKFYGM-----------------FPRSIC--NISSL   87 (725)
Q Consensus        35 ------~l~~L~~L~l~--~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~~~~~~--~l~~L   87 (725)
                            ....++.+.+.  +|++++ +|..|+++++|++|+|++|.+++.                 +|..+.  ++++|
T Consensus       173 ~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L  251 (636)
T 4eco_A          173 KSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDL  251 (636)
T ss_dssp             CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred             cccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCC
Confidence                  01112222222  467776 677777777777777777777764                 677766  77777


Q ss_pred             ceeeccCCCCCCCCChhhhcCCCCccEEEccCce-eee-eCCCccccc------CccceecCCCccccccCc-cCccccc
Q 048668           88 EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANN-FFG-LIPDSLSNA------SNLELLDLSNNQFKGKVS-IDFSSLK  158 (725)
Q Consensus        88 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~Ls~N~i~~~~~-~~f~~l~  158 (725)
                      ++|+|++|++.+.+|.. +.++++|++|+|++|+ +++ .+|..++.+      ++|++|+|++|+++.++. ..|..++
T Consensus       252 ~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~  330 (636)
T 4eco_A          252 TDVEVYNCPNLTKLPTF-LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK  330 (636)
T ss_dssp             CEEEEECCTTCSSCCTT-TTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCT
T ss_pred             CEEEecCCcCCccChHH-HhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCC
Confidence            77777777777667743 4677777777777777 766 566666655      777777777777774433 2677777


Q ss_pred             ccCeeecCCccCC-ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCccccccc
Q 048668          159 ILWRLNLEQNNLG-IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV  237 (725)
Q Consensus       159 ~L~~L~L~~N~l~-~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~  237 (725)
                      +|++|++++|.++ .++        .+.++++|++|++++|+++ .+|..+..++..|+.|++++|.++ .+|..+..+.
T Consensus       331 ~L~~L~L~~N~l~g~ip--------~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~  400 (636)
T 4eco_A          331 KLGMLECLYNQLEGKLP--------AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS  400 (636)
T ss_dssp             TCCEEECCSCCCEEECC--------CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTC
T ss_pred             CCCEEeCcCCcCccchh--------hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcc
Confidence            7777777777776 332        2456677777777777777 677777777733777888888777 6777766654


Q ss_pred             --CCceEEecccccCCCCChhhc-------CCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccc
Q 048668          238 --NLIALAVEVNQLHGTIPDVIG-------ELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKL  308 (725)
Q Consensus       238 --~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  308 (725)
                        +|+.|++++|.+.+..|..|.       .+++|++|+|++|.+.+..+..+..+++|++|+|++|+++          
T Consensus       401 l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~----------  470 (636)
T 4eco_A          401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT----------  470 (636)
T ss_dssp             SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS----------
T ss_pred             cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC----------
Confidence              888899999998888888887       7778999999999888544444566888999999998776          


Q ss_pred             ccccccccccccc-------ccceecccCCccCCCcchhhh--cCCCCCeEEccCccccccCccccccccCCcEEEc---
Q 048668          309 IGALPQQLLSITT-------LSLYLDLSNNLLNGSLPQQVG--NLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDI---  376 (725)
Q Consensus       309 ~~~~p~~~~~~~~-------ll~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L---  376 (725)
                        .+|...+....       .+++|+|++|.++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|   
T Consensus       471 --~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          471 --EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             --BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred             --CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence              66666665442       3488999999998 6777776  89999999999999997 8888999999999999   


Q ss_pred             ---cCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCC
Q 048668          377 ---SSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT  435 (725)
Q Consensus       377 ---s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  435 (725)
                         ++|++.+.+|..++.+++|+.|+|++|++ +.+|..+.  ++|+.|||++|++.+..+.
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~~~  605 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISIDLS  605 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEECT
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccccHH
Confidence               56888899999999999999999999999 57787766  7999999999999876654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=9.1e-46  Score=424.72  Aligned_cols=436  Identities=21%  Similarity=0.209  Sum_probs=340.2

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      .+||+.++.  ++++|+|++|+|++..+.+|.++++|++|||++|+|+++.|++|.++++|++|+|++|+|+++.+.+|.
T Consensus        44 ~~vP~~lp~--~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~  121 (635)
T 4g8a_A           44 YKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS  121 (635)
T ss_dssp             SSCCSSSCT--TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred             CccCCCCCc--CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence            378988876  899999999999977778999999999999999999999999999999999999999999988889999


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeee-CCCcccccCccceecCCCccccccCccCcccccccC
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW  161 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~  161 (725)
                      ++++|++|+|++|+|+ .+|...|.++++|++|+|++|.++.+ .|..++.+++|++|+|++|+|+++.+..|..+.+++
T Consensus       122 ~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~  200 (635)
T 4g8a_A          122 GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP  200 (635)
T ss_dssp             TCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred             CCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhh
Confidence            9999999999999998 88888889999999999999999875 467889999999999999999999998888876654


Q ss_pred             ----eeecCCccCCccCCCCcccc--------------------------------------------------------
Q 048668          162 ----RLNLEQNNLGIGAANDLGFV--------------------------------------------------------  181 (725)
Q Consensus       162 ----~L~L~~N~l~~~~~~~~~~~--------------------------------------------------------  181 (725)
                          .++++.|.++.+.+......                                                        
T Consensus       201 ~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~  280 (635)
T 4g8a_A          201 LLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN  280 (635)
T ss_dssp             TCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGG
T ss_pred             hhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccc
Confidence                57778877765443211000                                                        


Q ss_pred             -------------------cccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCc-----------
Q 048668          182 -------------------TFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPL-----------  231 (725)
Q Consensus       182 -------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~-----------  231 (725)
                                         ..+....+++.+++.+|.+....  .+... ..++.|.+.+|.+.+..+.           
T Consensus       281 l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~-~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~  357 (635)
T 4g8a_A          281 LTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFT  357 (635)
T ss_dssp             SEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSC-CCCSEEEEESCEESSCCCCBCTTCCEEEEE
T ss_pred             hhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccc-hhhhhhhcccccccCcCcccchhhhhcccc
Confidence                               00111123333333333333111  11111 1455555555555433222           


Q ss_pred             --------ccccccCCceEEecccccCC--CCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcc
Q 048668          232 --------GIRNLVNLIALAVEVNQLHG--TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF  301 (725)
Q Consensus       232 --------~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  301 (725)
                              ....+++|+.|+++.|.+..  ..+..+..+.+|+.+++..|.+.. .+..+..+++|+.+++.+|.+.   
T Consensus       358 ~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~---  433 (635)
T 4g8a_A          358 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK---  433 (635)
T ss_dssp             SCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEE---
T ss_pred             cccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccc---
Confidence                    12345667777777776643  345556666777777777777663 4556677777888888777433   


Q ss_pred             ccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccc-cccCccccccccCCcEEEccCCc
Q 048668          302 IASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF-SGMIPVTLSTCVSLEYVDISSNC  380 (725)
Q Consensus       302 ~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~  380 (725)
                              ...+...+.....+..+++++|.+++..+..+..+++|+.|+|++|.+ .+..|..|..+++|++|+|++|+
T Consensus       434 --------~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~  505 (635)
T 4g8a_A          434 --------QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  505 (635)
T ss_dssp             --------STTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             --------ccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCc
Confidence                    334444444444458899999999988999999999999999999975 45678899999999999999999


Q ss_pred             cccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC-Ccc-CCCCCcCccCCccccCC
Q 048668          381 FHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVF-SNKSKIPLQGNVRLCGG  456 (725)
Q Consensus       381 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~-~~~~~~~~~~n~~~c~~  456 (725)
                      |++++|..|+++++|+.|+|++|+|++..|..|..+++|++|||++|++++.+|.. ..+ ..++.+++++|||.|..
T Consensus       506 L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          506 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             cCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            99999999999999999999999999999999999999999999999999998875 233 57889999999999953

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.3e-46  Score=435.20  Aligned_cols=402  Identities=21%  Similarity=0.239  Sum_probs=347.1

Q ss_pred             CcccCCccccCcccCcEEec-CCCccCcc---------------------------------------------------
Q 048668            1 LEGQIPKEIGSLFKLQALAL-AGNYLTGK---------------------------------------------------   28 (725)
Q Consensus         1 ~~~~ip~~~~~l~~l~~L~l-~~n~l~~~---------------------------------------------------   28 (725)
                      |.|.||+.|++|++|++|+| ++|.+.|.                                                   
T Consensus       335 L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~  414 (876)
T 4ecn_A          335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM  414 (876)
T ss_dssp             CEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTS
T ss_pred             CCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccc
Confidence            57999999999999999999 77755433                                                   


Q ss_pred             -------------------------CCccccCCCCCcEEEccCCcCCc-----------------cCCCCCC--CCCCCC
Q 048668           29 -------------------------LPDFIGNLSALQVIHIKGNSLGG-----------------KFPTTLG--LLRNLV   64 (725)
Q Consensus        29 -------------------------~~~~~~~l~~L~~L~l~~n~l~~-----------------~~~~~~~--~l~~L~   64 (725)
                                               +|..|+++++|++|+|++|++++                 .+|..++  ++++|+
T Consensus       415 ~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~  494 (876)
T 4ecn_A          415 KPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT  494 (876)
T ss_dssp             CCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred             cccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCC
Confidence                                     88899999999999999999998                 3888887  999999


Q ss_pred             EEEccCCcccccCcccccccCCCceeeccCCC-CCC-CCChhh------hcCCCCccEEEccCceeeeeCCC--cccccC
Q 048668           65 QLNVAENKFYGMFPRSICNISSLEYFYLTSNR-FSG-SLPFDI------VVNLPNLKELGIGANNFFGLIPD--SLSNAS  134 (725)
Q Consensus        65 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~------~~~l~~L~~L~L~~N~i~~~~~~--~~~~l~  134 (725)
                      +|+|++|.+.+.+|..|.++++|++|+|++|+ +++ .+|..+      +..+++|+.|+|++|+++ .+|.  .|.+++
T Consensus       495 ~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~  573 (876)
T 4ecn_A          495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMV  573 (876)
T ss_dssp             EEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT
T ss_pred             EEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCC
Confidence            99999999999999999999999999999998 886 677643      345669999999999999 6677  899999


Q ss_pred             ccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCC-CCEEECccCcccccCChhhhhccc
Q 048668          135 NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSS-LKVLSLSDNQFGGELPHSIANLSS  213 (725)
Q Consensus       135 ~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~  213 (725)
                      +|++|+|++|+|+.++  .|..+++|+.|+|++|.++.++       ..+.++++ |++|+|++|+++ .+|..+.....
T Consensus       574 ~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls~N~l~~lp-------~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~  643 (876)
T 4ecn_A          574 KLGLLDCVHNKVRHLE--AFGTNVKLTDLKLDYNQIEEIP-------EDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV  643 (876)
T ss_dssp             TCCEEECTTSCCCBCC--CCCTTSEESEEECCSSCCSCCC-------TTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS
T ss_pred             CCCEEECCCCCcccch--hhcCCCcceEEECcCCccccch-------HHHhhccccCCEEECcCCCCC-cCchhhhcccc
Confidence            9999999999999665  8999999999999999998443       34778888 999999999999 78888777652


Q ss_pred             -cceeEEecCccceeccCccc---c--cccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcC-C--
Q 048668          214 -TMIVFLIGGNQISGTIPLGI---R--NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN-L--  284 (725)
Q Consensus       214 -~l~~L~l~~n~i~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l--  284 (725)
                       .|+.|++++|.+.+.+|...   .  .+.+|+.|+|++|++..+++..+..+++|+.|+|++|.+. .+|..+.. .  
T Consensus       644 ~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~  722 (876)
T 4ecn_A          644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDG  722 (876)
T ss_dssp             SCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTS
T ss_pred             CCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccc
Confidence             49999999999998766432   2  3458999999999999766666779999999999999999 55554333 2  


Q ss_pred             -----CCCCEEeCCCCcCCCcccccccccccccccccc--ccccccceecccCCccCCCcchhhhcCCCCCeEEccC---
Q 048668          285 -----TKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL--SITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISS---  354 (725)
Q Consensus       285 -----~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~--~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~---  354 (725)
                           ++|++|+|++|+|+            .+|..++  .+..+ +.|+|++|++++ +|..+..+++|+.|+|++   
T Consensus       723 ~l~nl~~L~~L~Ls~N~L~------------~lp~~l~~~~l~~L-~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~  788 (876)
T 4ecn_A          723 NYKNTYLLTTIDLRFNKLT------------SLSDDFRATTLPYL-SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD  788 (876)
T ss_dssp             CCTTGGGCCEEECCSSCCC------------CCCGGGSTTTCTTC-CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBC
T ss_pred             cccccCCccEEECCCCCCc------------cchHHhhhccCCCc-CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCC
Confidence                 39999999999877            7888877  66666 899999999997 788899999999999976   


Q ss_pred             ---ccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCee
Q 048668          355 ---NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEG  431 (725)
Q Consensus       355 ---N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  431 (725)
                         |++.+.+|..+..+++|+.|+|++|++ +.+|..+.  ++|+.|||++|++....+..+.....+..+.|.+|++..
T Consensus       789 ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred             cccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence               888999999999999999999999999 57888766  699999999999998887887776677778888887753

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=7.9e-47  Score=425.60  Aligned_cols=408  Identities=19%  Similarity=0.201  Sum_probs=338.2

Q ss_pred             cccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc-Cccc
Q 048668            2 EGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM-FPRS   80 (725)
Q Consensus         2 ~~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~   80 (725)
                      ++..|..|.++++|++|+|++|++++..|.+|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++. .|..
T Consensus        39 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  118 (549)
T 2z81_A           39 TYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL  118 (549)
T ss_dssp             CEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCS
T ss_pred             CccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhh
Confidence            445678899999999999999999988889999999999999999999988888899999999999999999864 5678


Q ss_pred             ccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCccccccc
Q 048668           81 ICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL  160 (725)
Q Consensus        81 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L  160 (725)
                      |+++++|++|++++|++.+.+|...|.++++|++|++++|++++..|..+..+++|++|++++|.+..++...+..+++|
T Consensus       119 ~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L  198 (549)
T 2z81_A          119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV  198 (549)
T ss_dssp             CTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTB
T ss_pred             hhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccc
Confidence            99999999999999995558888888999999999999999999999999999999999999999987766666778999


Q ss_pred             CeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCCh----------------------------------
Q 048668          161 WRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPH----------------------------------  206 (725)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~----------------------------------  206 (725)
                      ++|++++|.++........   ....+++|++|++++|.+++..+.                                  
T Consensus       199 ~~L~L~~n~l~~~~~~~~~---~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~  275 (549)
T 2z81_A          199 RYLELRDTNLARFQFSPLP---VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD  275 (549)
T ss_dssp             SEEEEESCBCTTCCCCCCS---SCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTT
T ss_pred             cEEEccCCccccccccccc---hhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchh
Confidence            9999999999865321111   112233444444444433321110                                  


Q ss_pred             ----------------------------hhhhccccceeEEecCccceeccCccc-ccccCCceEEecccccCCCCCh--
Q 048668          207 ----------------------------SIANLSSTMIVFLIGGNQISGTIPLGI-RNLVNLIALAVEVNQLHGTIPD--  255 (725)
Q Consensus       207 ----------------------------~~~~l~~~l~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~--  255 (725)
                                                  .+......++.+++++|.+. .+|..+ ..+++|++|++++|++.+..|.  
T Consensus       276 ~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  354 (549)
T 2z81_A          276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS  354 (549)
T ss_dssp             CCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHH
T ss_pred             hhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccch
Confidence                                        01122347889999999987 667665 6799999999999999986643  


Q ss_pred             -hhcCCCCccEEeccCcccccCCC--CCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCc
Q 048668          256 -VIGELKNLQLLGLYKNFLQGSIP--SGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNL  332 (725)
Q Consensus       256 -~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~  332 (725)
                       .+..+++|++|++++|++++..+  ..+..+++|++|++++|+++            .+|..+.....+ ++|++++|.
T Consensus       355 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~------------~lp~~~~~~~~L-~~L~Ls~N~  421 (549)
T 2z81_A          355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH------------PMPDSCQWPEKM-RFLNLSSTG  421 (549)
T ss_dssp             TCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC------------CCCSCCCCCTTC-CEEECTTSC
T ss_pred             hhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc------------cCChhhcccccc-cEEECCCCC
Confidence             47889999999999999986543  45889999999999999887            677777666666 999999999


Q ss_pred             cCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCccc
Q 048668          333 LNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKF  412 (725)
Q Consensus       333 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  412 (725)
                      +++ +|..+  .++|+.|+|++|++++.+    ..+++|++|+|++|+++ .+|. .+.+++|+.|||++|++++.+|..
T Consensus       422 l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~  492 (549)
T 2z81_A          422 IRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGI  492 (549)
T ss_dssp             CSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTG
T ss_pred             ccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHH
Confidence            984 34333  268999999999999753    57889999999999999 5555 567999999999999999999999


Q ss_pred             ccCCCCCCeEEcccccCeeecCC
Q 048668          413 LENLSFLEFLNLSYNHLEGEVPT  435 (725)
Q Consensus       413 ~~~l~~L~~L~l~~N~l~~~~p~  435 (725)
                      +..+++|+.|++++|++.|.+|.
T Consensus       493 ~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          493 FDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             GGGCTTCCEEECCSSCBCCCHHH
T ss_pred             HhcCcccCEEEecCCCccCCCcc
Confidence            99999999999999999999984

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=415.45  Aligned_cols=425  Identities=22%  Similarity=0.201  Sum_probs=317.9

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||+.+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|+.|+++++|++|+|++|+|+. +|..  .
T Consensus        14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~   88 (520)
T 2z7x_B           14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--P   88 (520)
T ss_dssp             SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--C
T ss_pred             ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--c
Confidence            5777776  588888888888887666788888888888888888887778888888888888888888874 4443  7


Q ss_pred             cCCCceeeccCCCCCC-CCChhhhcCCCCccEEEccCceeeeeCCCcccccCcc--ceecCCCccc--cccCccCccc--
Q 048668           84 ISSLEYFYLTSNRFSG-SLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNL--ELLDLSNNQF--KGKVSIDFSS--  156 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~Ls~N~i--~~~~~~~f~~--  156 (725)
                      +++|++|+|++|++++ .+| ..|.++++|++|+|++|++++   ..|..+++|  ++|+|++|++  .+..+..|..  
T Consensus        89 l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~  164 (520)
T 2z7x_B           89 TVNLKHLDLSFNAFDALPIC-KEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN  164 (520)
T ss_dssp             CCCCSEEECCSSCCSSCCCC-GGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred             cCCccEEeccCCccccccch-hhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccc
Confidence            8888888888888873 233 446788888888888888875   456777777  8888888888  5555555554  


Q ss_pred             ------------------------ccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhc-
Q 048668          157 ------------------------LKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL-  211 (725)
Q Consensus       157 ------------------------l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-  211 (725)
                                              +++|+.|++++|........-.+....+..+++|+.|++++|.+++..+..+... 
T Consensus       165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~  244 (520)
T 2z7x_B          165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV  244 (520)
T ss_dssp             EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHH
T ss_pred             cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHh
Confidence                                    3444444444443000000000001134556667777777666664433332221 


Q ss_pred             -cccceeEEecCccceeccCccc-----ccccCCceEEecccccCCCCChhhcCC---CCccEEeccCcccccCCCCCCc
Q 048668          212 -SSTMIVFLIGGNQISGTIPLGI-----RNLVNLIALAVEVNQLHGTIPDVIGEL---KNLQLLGLYKNFLQGSIPSGLG  282 (725)
Q Consensus       212 -~~~l~~L~l~~n~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~  282 (725)
                       ...++.|++++|.+.+.+|..+     ..+++|+.++++.|.+ ..++..+..+   .+|++|++++|.+....  .+.
T Consensus       245 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~  321 (520)
T 2z7x_B          245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPS  321 (520)
T ss_dssp             HTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCS
T ss_pred             hhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chh
Confidence             1278889999999988888888     8889999999999988 3443556555   67999999999876432  126


Q ss_pred             CCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCC--CcchhhhcCCCCCeEEccCcccccc
Q 048668          283 NLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG--SLPQQVGNLKNLIILDISSNQFSGM  360 (725)
Q Consensus       283 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~  360 (725)
                      .+++|++|++++|++++           .+|..+..+..+ ++|++++|++++  ..|..+..+++|++|++++|.+++.
T Consensus       322 ~l~~L~~L~Ls~n~l~~-----------~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~  389 (520)
T 2z7x_B          322 KISPFLHLDFSNNLLTD-----------TVFENCGHLTEL-ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD  389 (520)
T ss_dssp             SCCCCCEEECCSSCCCT-----------TTTTTCCCCSSC-CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred             hCCcccEEEeECCccCh-----------hhhhhhccCCCC-CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence            88999999999997763           466666666666 899999999986  4567899999999999999999984


Q ss_pred             Ccc-ccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCC-CCc
Q 048668          361 IPV-TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT-KGV  438 (725)
Q Consensus       361 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~  438 (725)
                      +|. .+..+++|++|+|++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|++|+|++|+++..++. ...
T Consensus       390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~  466 (520)
T 2z7x_B          390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR  466 (520)
T ss_dssp             GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             cccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhcc
Confidence            554 588899999999999999888777664  78999999999999 6777777999999999999999976654 345


Q ss_pred             cCCCCCcCccCCccccC
Q 048668          439 FSNKSKIPLQGNVRLCG  455 (725)
Q Consensus       439 ~~~~~~~~~~~n~~~c~  455 (725)
                      +..++.+++++|++.|.
T Consensus       467 l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          467 LTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             CTTCCEEECCSSCBCCC
T ss_pred             CCcccEEECcCCCCccc
Confidence            77888999999998874

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=405.69  Aligned_cols=404  Identities=19%  Similarity=0.245  Sum_probs=338.4

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc-Ccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM-FPRSI   81 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~   81 (725)
                      +..|..|.++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++ +|..  .+++|++|+|++|+++++ .|..|
T Consensus        35 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~  111 (520)
T 2z7x_B           35 ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEF  111 (520)
T ss_dssp             CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGG
T ss_pred             ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCCccccccchhhh
Confidence            4445789999999999999999998889999999999999999999995 4544  899999999999999874 68999


Q ss_pred             cccCCCceeeccCCCCCCCCChhhhcCCCCc--cEEEccCcee--eeeCCCcccc-------------------------
Q 048668           82 CNISSLEYFYLTSNRFSGSLPFDIVVNLPNL--KELGIGANNF--FGLIPDSLSN-------------------------  132 (725)
Q Consensus        82 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~-------------------------  132 (725)
                      +++++|++|++++|+|++    ..+..+++|  +.|+|++|.+  .+..|..|..                         
T Consensus       112 ~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~  187 (520)
T 2z7x_B          112 GNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK  187 (520)
T ss_dssp             GGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCT
T ss_pred             ccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhh
Confidence            999999999999999983    345678888  9999999999  6666665554                         


Q ss_pred             -cCccceecCCCcc-------ccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccC
Q 048668          133 -ASNLELLDLSNNQ-------FKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGEL  204 (725)
Q Consensus       133 -l~~L~~L~Ls~N~-------i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  204 (725)
                       +++|+.|++++|.       +.+..+ .|..+++|+.|++++|.++.......  ... ...++|++|++++|++++.+
T Consensus       188 ~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~--~~~-~~~~~L~~L~l~~n~l~~~~  263 (520)
T 2z7x_B          188 TVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRI--LQL-VWHTTVWYFSISNVKLQGQL  263 (520)
T ss_dssp             TCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHH--HHH-HHTSSCSEEEEEEEEEESCC
T ss_pred             cccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHH--HHH-hhhCcccEEEeecccccCcc
Confidence             7788999999987       655544 78899999999999998864322110  011 12469999999999999999


Q ss_pred             Chhh-----hhccccceeEEecCccceeccC-cccccc---cCCceEEecccccCCCCChhhcCCCCccEEeccCccccc
Q 048668          205 PHSI-----ANLSSTMIVFLIGGNQISGTIP-LGIRNL---VNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       205 p~~~-----~~l~~~l~~L~l~~n~i~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      |..+     ..+. .++.+++++|.+  .+| ..+..+   .+|+.|++++|.+.+..  .+..+++|++|++++|.+.+
T Consensus       264 p~~~~~~~~~~l~-~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~  338 (520)
T 2z7x_B          264 DFRDFDYSGTSLK-ALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTD  338 (520)
T ss_dssp             CCCCCCCCSCCCC-EEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCT
T ss_pred             ccchhhcccccCc-eeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccCh
Confidence            9988     6776 899999999999  555 555555   67999999999987543  23688999999999999999


Q ss_pred             CCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcch-hhhcCCCCCeEEccC
Q 048668          276 SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQ-QVGNLKNLIILDISS  354 (725)
Q Consensus       276 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~  354 (725)
                      ..|..+..+++|++|++++|++++         .+.+|..+..+..+ ++|++++|.+++.+|. .+..+++|+.|++++
T Consensus       339 ~~~~~~~~l~~L~~L~L~~N~l~~---------l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~  408 (520)
T 2z7x_B          339 TVFENCGHLTELETLILQMNQLKE---------LSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS  408 (520)
T ss_dssp             TTTTTCCCCSSCCEEECCSSCCCB---------HHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCS
T ss_pred             hhhhhhccCCCCCEEEccCCccCc---------cccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcC
Confidence            899999999999999999998772         11344555666666 8999999999984554 588899999999999


Q ss_pred             ccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecC
Q 048668          355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       355 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  434 (725)
                      |++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++...+..|..+++|++|++++|+++|.++
T Consensus       409 N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          409 NILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             SCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            999988887765  79999999999999 778888899999999999999996555559999999999999999999887


Q ss_pred             C
Q 048668          435 T  435 (725)
Q Consensus       435 ~  435 (725)
                      .
T Consensus       486 ~  486 (520)
T 2z7x_B          486 R  486 (520)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.2e-44  Score=391.25  Aligned_cols=380  Identities=20%  Similarity=0.218  Sum_probs=289.8

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCc-cCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG-KFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      ++|+ +.  ++|++|+|++|.|++..|..|+.+++|++|+|++|++.+ +.+..|.++++|++|+|++|++++..|..|.
T Consensus        24 ~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  100 (455)
T 3v47_A           24 QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFN  100 (455)
T ss_dssp             SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTT
T ss_pred             cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhcc
Confidence            4666 43  478888888888887778888888888888888888863 4467788888888888888888888888888


Q ss_pred             ccCCCceeeccCCCCCCCCC-hhhhcCCCCccEEEccCceeeeeCCCc-ccccCccceecCCCccccccCccCcccc--c
Q 048668           83 NISSLEYFYLTSNRFSGSLP-FDIVVNLPNLKELGIGANNFFGLIPDS-LSNASNLELLDLSNNQFKGKVSIDFSSL--K  158 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~Ls~N~i~~~~~~~f~~l--~  158 (725)
                      ++++|++|+|++|++++.++ ...|..+++|++|+|++|+++++.|.. |.++++|++|+|++|+++++.+..+..+  .
T Consensus       101 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~  180 (455)
T 3v47_A          101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGK  180 (455)
T ss_dssp             TCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTC
T ss_pred             CcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccc
Confidence            88888888888888874333 334678888888888888888877765 7888888888888888888888877776  6


Q ss_pred             ccCeeecCCccCCccCCCCccc--ccccCCCCCCCEEECccCcccccCChhhhhcc--ccceeEEecCccceeccCcccc
Q 048668          159 ILWRLNLEQNNLGIGAANDLGF--VTFLTNCSSLKVLSLSDNQFGGELPHSIANLS--STMIVFLIGGNQISGTIPLGIR  234 (725)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~~l~~L~l~~n~i~~~~~~~~~  234 (725)
                      +|+.|++++|.+.......+..  ...+..+++|++|++++|++++..|..+....  ..++.|.+++|.+.+..     
T Consensus       181 ~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-----  255 (455)
T 3v47_A          181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-----  255 (455)
T ss_dssp             EEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC-----
T ss_pred             cccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc-----
Confidence            7888888888887665432211  01133567888888888888877777766552  25555555555543221     


Q ss_pred             cccCCceEEecccccCCCCChhhcCC--CCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccc
Q 048668          235 NLVNLIALAVEVNQLHGTIPDVIGEL--KNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGAL  312 (725)
Q Consensus       235 ~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  312 (725)
                               +..+.+.+..+..+.++  ++|++|++++|.+.+..|..|..+++|++|++++|+++              
T Consensus       256 ---------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~--------------  312 (455)
T 3v47_A          256 ---------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN--------------  312 (455)
T ss_dssp             ---------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC--------------
T ss_pred             ---------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccc--------------
Confidence                     11122222223333332  46777777777777666777777777766666666443              


Q ss_pred             cccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCC
Q 048668          313 PQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFL  392 (725)
Q Consensus       313 p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  392 (725)
                                            +..|..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+
T Consensus       313 ----------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  370 (455)
T 3v47_A          313 ----------------------KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL  370 (455)
T ss_dssp             ----------------------EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             ----------------------ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccc
Confidence                                  3456678888999999999999998889999999999999999999999889999999


Q ss_pred             CCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC
Q 048668          393 KSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK  436 (725)
Q Consensus       393 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  436 (725)
                      ++|+.|+|++|++++..+..|..+++|++|++++|+++|.+|..
T Consensus       371 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             ccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            99999999999999888888899999999999999999999864

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=9.6e-44  Score=400.86  Aligned_cols=411  Identities=19%  Similarity=0.185  Sum_probs=261.4

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      .+++++++|+++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++
T Consensus        33 ~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           33 ESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence            356666666665 3554443  5666666666666655555666666666666666666655566666666666666666


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeC-CCcccccCccceecCCCccccccCccCccccccc--CeeecCCccC-
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLI-PDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL--WRLNLEQNNL-  170 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L--~~L~L~~N~l-  170 (725)
                      |+|+ .+|..   .+++|++|+|++|+++++. |..|+++++|++|+|++|+|+..   .|..+++|  ++|++++|.+ 
T Consensus       110 N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~  182 (562)
T 3a79_B          110 NRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH  182 (562)
T ss_dssp             SCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred             CcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence            6665 55544   4566666666666665533 35566666666666666665542   33444444  6666666655 


Q ss_pred             -CccCCCCccc--------------------ccccCCCCCCCEEECccCc----------------------------cc
Q 048668          171 -GIGAANDLGF--------------------VTFLTNCSSLKVLSLSDNQ----------------------------FG  201 (725)
Q Consensus       171 -~~~~~~~~~~--------------------~~~~~~l~~L~~L~L~~N~----------------------------l~  201 (725)
                       +...+..+..                    ...+.++++|+.|++++|+                            +.
T Consensus       183 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~  262 (562)
T 3a79_B          183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT  262 (562)
T ss_dssp             CCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEEC
T ss_pred             ccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCc
Confidence             3222211110                    0123345566666666653                            22


Q ss_pred             ccC----ChhhhhccccceeEEecCccceeccCccc-----ccccCCceEEecccccCCCCChhhcCC---CCccEEecc
Q 048668          202 GEL----PHSIANLSSTMIVFLIGGNQISGTIPLGI-----RNLVNLIALAVEVNQLHGTIPDVIGEL---KNLQLLGLY  269 (725)
Q Consensus       202 ~~~----p~~~~~l~~~l~~L~l~~n~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~  269 (725)
                      +..    +..+ .. ..++.|++++|.+.+.+|..+     ..++.|+.++++.|.+ ..+...+..+   .+|++|+++
T Consensus       263 ~~~~~~~~~~~-~~-~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~  339 (562)
T 3a79_B          263 WKCSVKLFQFF-WP-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSIS  339 (562)
T ss_dssp             HHHHHHHHHHH-TT-SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEE
T ss_pred             HHHHHHHHHhh-hc-ccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhhccCcceEEEcc
Confidence            110    1111 11 167788888888887777766     5666666666666666 2222333322   568888888


Q ss_pred             CcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCC--cchhhhcCCCC
Q 048668          270 KNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS--LPQQVGNLKNL  347 (725)
Q Consensus       270 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~--~~~~~~~l~~L  347 (725)
                      +|.+....  ....+++|++|++++|++++           .+|..+..+..+ ++|++++|++++.  .|..|..+++|
T Consensus       340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~-----------~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~l~~L  405 (562)
T 3a79_B          340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTD-----------SVFQGCSTLKRL-QTLILQRNGLKNFFKVALMTKNMSSL  405 (562)
T ss_dssp             SSCCCCCC--CCSSCCCCCEEECCSSCCCT-----------TTTTTCCSCSSC-CEEECCSSCCCBTTHHHHTTTTCTTC
T ss_pred             CCCccccc--CccCCCCceEEECCCCcccc-----------chhhhhcccCCC-CEEECCCCCcCCcccchhhhcCCCCC
Confidence            88775322  12577888888888886662           455566566665 8888888888863  34668888888


Q ss_pred             CeEEccCccccccCc-cccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEccc
Q 048668          348 IILDISSNQFSGMIP-VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSY  426 (725)
Q Consensus       348 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  426 (725)
                      +.|++++|.+++.+| ..+..+++|++|+|++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|++|+|++
T Consensus       406 ~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~  482 (562)
T 3a79_B          406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS  482 (562)
T ss_dssp             CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCS
T ss_pred             CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCC
Confidence            999999888887344 4578888888999999888876666554  68888899998888 5666666888888999999


Q ss_pred             ccCeeecCC-CCccCCCCCcCccCCccccC
Q 048668          427 NHLEGEVPT-KGVFSNKSKIPLQGNVRLCG  455 (725)
Q Consensus       427 N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~  455 (725)
                      |++++.++. ...++.++.+++++|+|.|.
T Consensus       483 N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          483 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             SCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             CCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence            988866554 45567788888888888774

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.7e-43  Score=398.87  Aligned_cols=405  Identities=20%  Similarity=0.262  Sum_probs=324.7

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||..+.  ++|++|+|++|.|++..|.+|..+++|++|+|++|+++++.|++|.++++|++|+|++|+|+. +|..  .
T Consensus        45 ~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~  119 (562)
T 3a79_B           45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--P  119 (562)
T ss_dssp             SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--C
T ss_pred             cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--c
Confidence            5888776  599999999999998777899999999999999999999999999999999999999999995 4444  8


Q ss_pred             cCCCceeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCCCcccccCcc--ceecCCCccc--cccCccCccc--
Q 048668           84 ISSLEYFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIPDSLSNASNL--ELLDLSNNQF--KGKVSIDFSS--  156 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~Ls~N~i--~~~~~~~f~~--  156 (725)
                      +++|++|+|++|+++ .+|. ..|.++++|++|+|++|+++.   ..|..+++|  ++|+|++|++  ++..+..|..  
T Consensus       120 l~~L~~L~Ls~N~l~-~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~  195 (562)
T 3a79_B          120 MASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN  195 (562)
T ss_dssp             CTTCSEEECCSSCCS-BCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred             cccCCEEECCCCCcc-ccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccC
Confidence            999999999999998 6653 567899999999999999975   356666666  9999999999  7666666654  


Q ss_pred             ------------------------ccccCeeecCCccCCcc------------C------CCC--------cccccccCC
Q 048668          157 ------------------------LKILWRLNLEQNNLGIG------------A------AND--------LGFVTFLTN  186 (725)
Q Consensus       157 ------------------------l~~L~~L~L~~N~l~~~------------~------~~~--------~~~~~~~~~  186 (725)
                                              +++|+.|++++|.....            .      ...        ...+. ...
T Consensus       196 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~-~~~  274 (562)
T 3a79_B          196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ-FFW  274 (562)
T ss_dssp             EEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHH-HHT
T ss_pred             cceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHH-hhh
Confidence                                    45677777777641100            0      000        00000 112


Q ss_pred             CCCCCEEECccCcccccCChhh-----hhccccceeEEecCccceeccC-cccccc---cCCceEEecccccCCCCChhh
Q 048668          187 CSSLKVLSLSDNQFGGELPHSI-----ANLSSTMIVFLIGGNQISGTIP-LGIRNL---VNLIALAVEVNQLHGTIPDVI  257 (725)
Q Consensus       187 l~~L~~L~L~~N~l~~~~p~~~-----~~l~~~l~~L~l~~n~i~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~  257 (725)
                      .++|++|++++|++++.+|..+     ..+. .+..+++..|.+  .+| ..+..+   .+|+.|++++|.+....  .+
T Consensus       275 ~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~-~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~  349 (562)
T 3a79_B          275 PRPVEYLNIYNLTITERIDREEFTYSETALK-SLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CP  349 (562)
T ss_dssp             TSSEEEEEEEEEEECSCCCCCCCCCCSCSCC-EEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CC
T ss_pred             cccccEEEEeccEeeccccchhhhcccccch-heehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--Cc
Confidence            3489999999999999999887     4444 566666766666  344 333322   57999999999986432  12


Q ss_pred             cCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCC-C
Q 048668          258 GELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG-S  336 (725)
Q Consensus       258 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~-~  336 (725)
                      ..+++|++|++++|.+.+..|..+..+++|++|++++|++++         ...+|..+..+..+ ++|++++|.+++ .
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------~~~~~~~~~~l~~L-~~L~l~~N~l~~~~  419 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN---------FFKVALMTKNMSSL-ETLDVSLNSLNSHA  419 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB---------TTHHHHTTTTCTTC-CEEECTTSCCBSCC
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC---------cccchhhhcCCCCC-CEEECCCCcCCCcc
Confidence            678999999999999999899999999999999999998872         11233445555666 899999999998 4


Q ss_pred             cchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCC
Q 048668          337 LPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENL  416 (725)
Q Consensus       337 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  416 (725)
                      .+..+..+++|+.|++++|++++..|..+.  ++|++|+|++|+++ .+|..+..+++|+.|+|++|+++++.+..+..+
T Consensus       420 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l  496 (562)
T 3a79_B          420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRL  496 (562)
T ss_dssp             SSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTC
T ss_pred             ChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcC
Confidence            445688999999999999999987777665  69999999999999 567777799999999999999996555559999


Q ss_pred             CCCCeEEcccccCeeecCCC
Q 048668          417 SFLEFLNLSYNHLEGEVPTK  436 (725)
Q Consensus       417 ~~L~~L~l~~N~l~~~~p~~  436 (725)
                      ++|+.|++++|+|+|.++..
T Consensus       497 ~~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          497 TSLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             TTCCCEECCSCCBCCCHHHH
T ss_pred             CCCCEEEecCCCcCCCcchH
Confidence            99999999999999988753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.3e-42  Score=398.42  Aligned_cols=416  Identities=21%  Similarity=0.208  Sum_probs=332.2

Q ss_pred             CccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccC
Q 048668            6 PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNIS   85 (725)
Q Consensus         6 p~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   85 (725)
                      |..|.++++|++|+|++|+|++..+.+|.++++|++|+|++|+|++..+++|.++++|++|+|++|+|+++.+.+|++++
T Consensus        69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~  148 (635)
T 4g8a_A           69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK  148 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred             HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCc
Confidence            45799999999999999999987788999999999999999999988889999999999999999999988888999999


Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccc----eecCCCccccccCccCcccccccC
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLE----LLDLSNNQFKGKVSIDFSSLKILW  161 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~Ls~N~i~~~~~~~f~~l~~L~  161 (725)
                      +|++|+|++|++++......+..+++|++|+|++|+|+++.+..|..+.+++    .++++.|+++.+.+..+..+ .+.
T Consensus       149 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~-~~~  227 (635)
T 4g8a_A          149 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH  227 (635)
T ss_dssp             TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEE
T ss_pred             ccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccch-hhh
Confidence            9999999999998322345668899999999999999999998887776654    67888888877665444322 112


Q ss_pred             eeecCCccCC-------------------------------------------------------ccC---CC-------
Q 048668          162 RLNLEQNNLG-------------------------------------------------------IGA---AN-------  176 (725)
Q Consensus       162 ~L~L~~N~l~-------------------------------------------------------~~~---~~-------  176 (725)
                      .+++++|...                                                       ...   ..       
T Consensus       228 ~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~  307 (635)
T 4g8a_A          228 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN  307 (635)
T ss_dssp             EEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred             hhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence            2222222100                                                       000   00       


Q ss_pred             ---------CcccccccCCCCCCCEEECccCcccccCChh-------------------hhhccccceeEEecCccce--
Q 048668          177 ---------DLGFVTFLTNCSSLKVLSLSDNQFGGELPHS-------------------IANLSSTMIVFLIGGNQIS--  226 (725)
Q Consensus       177 ---------~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-------------------~~~l~~~l~~L~l~~n~i~--  226 (725)
                               ...-...+.....++.|++++|.+....+..                   ...++ .++.+++++|.+.  
T Consensus       308 l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~-~L~~L~ls~n~l~~~  386 (635)
T 4g8a_A          308 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP-SLEFLDLSRNGLSFK  386 (635)
T ss_dssp             CSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT-TCCEEECCSSCCBEE
T ss_pred             cccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc-ccccchhhccccccc
Confidence                     0000012334456667777666655332222                   22334 7889999999885  


Q ss_pred             eccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCC-CCCcCCCCCCEEeCCCCcCCCcccccc
Q 048668          227 GTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP-SGLGNLTKLAKLDLGSNSLQGNFIASQ  305 (725)
Q Consensus       227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~  305 (725)
                      +..+..+..+.+|+.+++..|.+... +..+..+++|+.+++..|......+ ..|..+++++.++++.|.++       
T Consensus       387 ~~~~~~~~~~~~L~~L~~~~~~~~~~-~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~-------  458 (635)
T 4g8a_A          387 GCCSQSDFGTISLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-------  458 (635)
T ss_dssp             EECCHHHHSCSCCCEEECCSCSEEEE-CSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCE-------
T ss_pred             cccccchhhhhhhhhhhccccccccc-cccccccccccchhhhhccccccccccccccccccccccccccccc-------
Confidence            34566777889999999999998754 5568889999999999988775544 46889999999999999776       


Q ss_pred             ccccccccccccccccccceecccCCcc-CCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccc
Q 048668          306 NKLIGALPQQLLSITTLSLYLDLSNNLL-NGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGI  384 (725)
Q Consensus       306 ~~~~~~~p~~~~~~~~ll~~L~L~~n~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  384 (725)
                           .++...+.....++.|++++|.+ .+..|..|..+++|++|+|++|+|++..|.+|.++++|++|+|++|+|++.
T Consensus       459 -----~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l  533 (635)
T 4g8a_A          459 -----VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL  533 (635)
T ss_dssp             -----ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBC
T ss_pred             -----cccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCC
Confidence                 44444555455558999999975 456788899999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCCCCEEeCCCCcccccCcccccCC-CCCCeEEcccccCeeecCCC
Q 048668          385 IPPSLGFLKSIKFLDVSCNNFSGQFPKFLENL-SFLEFLNLSYNHLEGEVPTK  436 (725)
Q Consensus       385 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~  436 (725)
                      .|..|+.+++|+.|||++|+|++..|..|..+ ++|++|+|++|+|+|.+...
T Consensus       534 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~  586 (635)
T 4g8a_A          534 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ  586 (635)
T ss_dssp             CCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred             ChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence            99999999999999999999999999999998 68999999999999998753

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2e-42  Score=380.13  Aligned_cols=390  Identities=19%  Similarity=0.164  Sum_probs=288.1

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccc-ccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY-GMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~   93 (725)
                      -+.++.+++.++ .+|. +.  ++|++|+|++|++++..|..|.++++|++|+|++|.+. .+.+..|.++++|++|+|+
T Consensus        12 ~~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            456777888877 5666 33  67888888888888777888888888888888888776 3446678888888888888


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCC--CcccccCccceecCCCccccccCccC-cccccccCeeecCCccC
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP--DSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNL  170 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~~~~-f~~l~~L~~L~L~~N~l  170 (725)
                      +|+++ .++...|.++++|++|+|++|++++..+  ..|..+++|++|+|++|+|+++.+.. |..+++|++|++++|.+
T Consensus        88 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l  166 (455)
T 3v47_A           88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV  166 (455)
T ss_dssp             TCTTC-EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred             CCccC-ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence            88887 5555556778888888888888876333  33777788888888888887776554 67777777777777777


Q ss_pred             CccCCCCcccccccCCC--CCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccc
Q 048668          171 GIGAANDLGFVTFLTNC--SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ  248 (725)
Q Consensus       171 ~~~~~~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~  248 (725)
                      +...+..      +.++  .+|+.|++++|.+.+..+..+..                 .....+..+++|++|++++|+
T Consensus       167 ~~~~~~~------l~~l~~~~L~~L~l~~n~l~~~~~~~~~~-----------------~~~~~~~~~~~L~~L~Ls~n~  223 (455)
T 3v47_A          167 KSICEED------LLNFQGKHFTLLRLSSITLQDMNEYWLGW-----------------EKCGNPFKNTSITTLDLSGNG  223 (455)
T ss_dssp             SCCCTTT------SGGGTTCEEEEEECTTCBCTTCSTTCTTH-----------------HHHCCTTTTCEEEEEECTTSC
T ss_pred             cccChhh------hhccccccccccccccCcccccchhhccc-----------------cccccccccceeeeEecCCCc
Confidence            6554422      2222  46666666666666332221111                 011223456778888888888


Q ss_pred             cCCCCChhhcCC---CCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccccc-ccccc
Q 048668          249 LHGTIPDVIGEL---KNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSI-TTLSL  324 (725)
Q Consensus       249 l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~-~~ll~  324 (725)
                      +.+..|..+...   ++|+.|++++|.+.+...              ..+.+.           +..+..+... ...++
T Consensus       224 l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~-----------~~~~~~~~~~~~~~L~  278 (455)
T 3v47_A          224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFK-----------DPDNFTFKGLEASGVK  278 (455)
T ss_dssp             CCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSC-----------CCCTTTTGGGTTSCCC
T ss_pred             ccccchhhhhccccccceeeEeecccccccccc--------------chhhhc-----------cCcccccccccccCce
Confidence            887777766554   678888888877653211              111111           0001111111 12238


Q ss_pred             eecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCc
Q 048668          325 YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN  404 (725)
Q Consensus       325 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  404 (725)
                      +|++++|.+++..|..|+.+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|+.+++|+.|+|++|+
T Consensus       279 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  358 (455)
T 3v47_A          279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH  358 (455)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSC
T ss_pred             EEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCc
Confidence            89999999998889999999999999999999999999999999999999999999999889999999999999999999


Q ss_pred             ccccCcccccCCCCCCeEEcccccCeeecCCC-CccCCCCCcCccCCccccCCC
Q 048668          405 FSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK-GVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       405 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  457 (725)
                      +++..|.+|..+++|++|+|++|++++.++.. ..++.++.+++++|++.|..+
T Consensus       359 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          359 IRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            99999999999999999999999999877754 567889999999999988643

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=370.33  Aligned_cols=349  Identities=20%  Similarity=0.218  Sum_probs=263.8

Q ss_pred             eeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCc
Q 048668           89 YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN  168 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N  168 (725)
                      .++++++.++ .+|..+   .++++.|+|++|+|+++.+..|.++++|++|+|++|.|+++.+..|..+++|++|+|++|
T Consensus        15 ~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            4444555554 444432   234555555555555555555555555555555555555555555555555555555555


Q ss_pred             cCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccc
Q 048668          169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ  248 (725)
Q Consensus       169 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~  248 (725)
                      .++.++.      ..|.++++|++|+|++|++++..|..|..++ +|+.|++++|.+.+..+..|.++++|++|+|++|+
T Consensus        91 ~l~~~~~------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  163 (477)
T 2id5_A           91 RLKLIPL------GVFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN  163 (477)
T ss_dssp             CCCSCCT------TSSTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred             cCCccCc------ccccCCCCCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence            5544333      2344555566666666666555555555555 56666666666666677788889999999999999


Q ss_pred             cCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecc
Q 048668          249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDL  328 (725)
Q Consensus       249 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L  328 (725)
                      ++++.+..|..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+           .+.+|...+....+ ++|++
T Consensus       164 l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~-----------~~~~~~~~~~~~~L-~~L~l  231 (477)
T 2id5_A          164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY-----------LDTMTPNCLYGLNL-TSLSI  231 (477)
T ss_dssp             CSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT-----------CCEECTTTTTTCCC-SEEEE
T ss_pred             CcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc-----------ccccCcccccCccc-cEEEC
Confidence            9988888899999999999999999988888999999999999999843           34677777766655 89999


Q ss_pred             cCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCccccc
Q 048668          329 SNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQ  408 (725)
Q Consensus       329 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  408 (725)
                      ++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++.
T Consensus       232 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  311 (477)
T 2id5_A          232 THCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL  311 (477)
T ss_dssp             ESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCC
T ss_pred             cCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCcee
Confidence            99999977768899999999999999999988889999999999999999999999999999999999999999999998


Q ss_pred             CcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCCCCC
Q 048668          409 FPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDEL  460 (725)
Q Consensus       409 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~  460 (725)
                      .+..|..+++|++|+|++|+|.|.++..+.+.......+.++...|..+...
T Consensus       312 ~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~~  363 (477)
T 2id5_A          312 EESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFV  363 (477)
T ss_dssp             CGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGGG
T ss_pred             CHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchHH
Confidence            8889999999999999999999998765444555556677888889876543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=8.9e-41  Score=364.13  Aligned_cols=358  Identities=24%  Similarity=0.302  Sum_probs=232.7

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCC-------------cEEEccCCcCCccCCCCCCCCCCCCEEEcc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSAL-------------QVIHIKGNSLGGKFPTTLGLLRNLVQLNVA   69 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L-------------~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls   69 (725)
                      |+||++|+++++|++|++++|.+++.+|..++.+++|             ++|++++|++++. |..   .++|++|+|+
T Consensus        24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~~---~~~L~~L~l~   99 (454)
T 1jl5_A           24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PEL---PPHLESLVAS   99 (454)
T ss_dssp             ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CSC---CTTCSEEECC
T ss_pred             hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CCC---cCCCCEEEcc
Confidence            6777778888888888888887777777777777764             7788888887743 332   3677888888


Q ss_pred             CCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccccc
Q 048668           70 ENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGK  149 (725)
Q Consensus        70 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~  149 (725)
                      +|.+++ +|..   +++|++|++++|+++ .+|..    .++|++|++++|+++++ | .|+++++|++|++++|+++++
T Consensus       100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~l  168 (454)
T 1jl5_A          100 CNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKL  168 (454)
T ss_dssp             SSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCCC-c-ccCCCCCCCEEECCCCcCccc
Confidence            888775 4433   367888888888877 45431    26788888888888763 4 477888888888888888765


Q ss_pred             CccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceecc
Q 048668          150 VSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTI  229 (725)
Q Consensus       150 ~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~  229 (725)
                      +..    .++|++|++++|.++.++        .+.++++|++|++++|++++ +|..    +..++.|++++|.+. .+
T Consensus       169 p~~----~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~l  230 (454)
T 1jl5_A          169 PDL----PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-EL  230 (454)
T ss_dssp             CCC----CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SC
T ss_pred             CCC----cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-cc
Confidence            432    247788888888776542        25677888888888888774 4432    236778888888877 55


Q ss_pred             CcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccc
Q 048668          230 PLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLI  309 (725)
Q Consensus       230 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  309 (725)
                      | .+..+++|++|++++|+++++. ..   +++|++|++++|++.+ +|..   .++|++|++++|++++          
T Consensus       231 p-~~~~l~~L~~L~l~~N~l~~l~-~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~----------  291 (454)
T 1jl5_A          231 P-ELQNLPFLTTIYADNNLLKTLP-DL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG----------  291 (454)
T ss_dssp             C-CCTTCTTCCEEECCSSCCSSCC-SC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE----------
T ss_pred             c-ccCCCCCCCEEECCCCcCCccc-cc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc----------
Confidence            6 3777888888888888887643 22   3678888888888775 4443   3678888888887662          


Q ss_pred             ccccccccccccccceecccCCccCCCcchhhhcC-CCCCeEEccCccccccCccccccccCCcEEEccCCccccccCcc
Q 048668          310 GALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL-KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS  388 (725)
Q Consensus       310 ~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  388 (725)
                        +|.    ....+++|++++|.+++. +    .+ ++|+.|++++|++++ +|..   +++|++|++++|++++ +|. 
T Consensus       292 --l~~----~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~-  354 (454)
T 1jl5_A          292 --LSE----LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE-  354 (454)
T ss_dssp             --ESC----CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC-
T ss_pred             --ccC----cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc-
Confidence              221    112337788888888742 2    23 478888888888885 4443   4678888888888884 444 


Q ss_pred             ccCCCCCCEEeCCCCcccc--cCcccccCC-------------CCCCeEEcccccCee
Q 048668          389 LGFLKSIKFLDVSCNNFSG--QFPKFLENL-------------SFLEFLNLSYNHLEG  431 (725)
Q Consensus       389 ~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~l~~N~l~~  431 (725)
                        .+++|+.|++++|++++  .+|..+..+             ++|+.||+++|++++
T Consensus       355 --~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          355 --LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE  410 (454)
T ss_dssp             --CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred             --hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence              46788888888888887  677777766             678888888888876

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=6.4e-40  Score=360.62  Aligned_cols=348  Identities=28%  Similarity=0.384  Sum_probs=246.6

Q ss_pred             cccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           12 LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      ++++++|++++|.++ .+|. +..+++|++|+|++|++++..+  |.++++|++|+|++|.+++..+  +.++++|++|+
T Consensus        45 l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           45 LDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  118 (466)
T ss_dssp             HHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence            556777777777776 3443 6677777777777777775544  7777777777777777775444  77777777777


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      +++|.++ .++.  +..+++|++|++++|.++++.  .+..+++|++|+++ |.+.++.+  +..+++|++|++++|.++
T Consensus       119 L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          119 LFNNQIT-DIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS  190 (466)
T ss_dssp             CCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCC-CChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence            7777776 4543  567777777777777776542  46777777777775 45544432  666777777777777765


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCC
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  251 (725)
                      .++        .+..+++|++|++++|.+++..|                           ++.+++|++|++++|++.+
T Consensus       191 ~~~--------~l~~l~~L~~L~l~~n~l~~~~~---------------------------~~~l~~L~~L~l~~n~l~~  235 (466)
T 1o6v_A          191 DIS--------VLAKLTNLESLIATNNQISDITP---------------------------LGILTNLDELSLNGNQLKD  235 (466)
T ss_dssp             CCG--------GGGGCTTCSEEECCSSCCCCCGG---------------------------GGGCTTCCEEECCSSCCCC
T ss_pred             CCh--------hhccCCCCCEEEecCCccccccc---------------------------ccccCCCCEEECCCCCccc
Confidence            432        24566667777777766663322                           3445666677777776665


Q ss_pred             CCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCC
Q 048668          252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNN  331 (725)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n  331 (725)
                      .  +.+..+++|++|++++|.+.+..+  +..+++|++|++++|+++            .++. +..+..+ +.|++++|
T Consensus       236 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~------------~~~~-~~~l~~L-~~L~L~~n  297 (466)
T 1o6v_A          236 I--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS------------NISP-LAGLTAL-TNLELNEN  297 (466)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC------------CCGG-GTTCTTC-SEEECCSS
T ss_pred             c--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccC------------cccc-ccCCCcc-CeEEcCCC
Confidence            3  346667777777777777765443  666777777777777665            2222 3333333 67777777


Q ss_pred             ccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcc
Q 048668          332 LLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK  411 (725)
Q Consensus       332 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  411 (725)
                      ++++..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..++.+++|+.|++++|++++..| 
T Consensus       298 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-  370 (466)
T 1o6v_A          298 QLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-  370 (466)
T ss_dssp             CCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-
T ss_pred             cccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-
Confidence            7775544  7888999999999999987766  77889999999999999875  578899999999999999998877 


Q ss_pred             cccCCCCCCeEEcccccCeeecC
Q 048668          412 FLENLSFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       412 ~~~~l~~L~~L~l~~N~l~~~~p  434 (725)
                       +..+++|+.|++++|++++.+.
T Consensus       371 -~~~l~~L~~L~l~~n~~~~~p~  392 (466)
T 1o6v_A          371 -LANLTRITQLGLNDQAWTNAPV  392 (466)
T ss_dssp             -GTTCTTCCEEECCCEEEECCCB
T ss_pred             -hhcCCCCCEEeccCCcccCCch
Confidence             8899999999999999987543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.2e-39  Score=355.44  Aligned_cols=345  Identities=19%  Similarity=0.194  Sum_probs=212.4

Q ss_pred             CCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccccc
Q 048668            5 IPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNI   84 (725)
Q Consensus         5 ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l   84 (725)
                      .|..++++++|++|++++|.+++ +| .|+.+++|++|++++|+++++ |  |+.+++|++|+|++|+++++ +  ++++
T Consensus        34 ~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l  105 (457)
T 3bz5_A           34 DTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPL  105 (457)
T ss_dssp             SEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred             cccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence            34456667777777777777774 34 577777777777777777754 3  66777777777777777654 2  6777


Q ss_pred             CCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeee
Q 048668           85 SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN  164 (725)
Q Consensus        85 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~  164 (725)
                      ++|++|++++|+++ .+|   +..+++|++|++++|+++++   .++.+++|++|++++|+..+..  .+..+++|++|+
T Consensus       106 ~~L~~L~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~  176 (457)
T 3bz5_A          106 TKLTYLNCDTNKLT-KLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD  176 (457)
T ss_dssp             TTCCEEECCSSCCS-CCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred             CcCCEEECCCCcCC-eec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence            77777777777776 454   45677777777777777764   2666777777777777432221  466677777777


Q ss_pred             cCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEe
Q 048668          165 LEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV  244 (725)
Q Consensus       165 L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L  244 (725)
                      +++|+++.++         +..+++|++|++++|++++.   .+..++ .|+.|++++|++++ +|  +..+++|+.|++
T Consensus       177 ls~n~l~~l~---------l~~l~~L~~L~l~~N~l~~~---~l~~l~-~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l  240 (457)
T 3bz5_A          177 CSFNKITELD---------VSQNKLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLTE-ID--VTPLTQLTYFDC  240 (457)
T ss_dssp             CCSSCCCCCC---------CTTCTTCCEEECCSSCCSCC---CCTTCT-TCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred             CCCCccceec---------cccCCCCCEEECcCCcCCee---ccccCC-CCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence            7777776532         34566777777777777643   244444 55566666666654 33  455555666666


Q ss_pred             cccccCCCCChhhcCCC-------CccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccc
Q 048668          245 EVNQLHGTIPDVIGELK-------NLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL  317 (725)
Q Consensus       245 ~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~  317 (725)
                      ++|++++.++..+..++       +|++|++++|.+.+.+|  +..+++|+                             
T Consensus       241 ~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~-----------------------------  289 (457)
T 3bz5_A          241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIK-----------------------------  289 (457)
T ss_dssp             CSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCC-----------------------------
T ss_pred             eCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCC-----------------------------
Confidence            66666554433333322       22333333333332222  23334444                             


Q ss_pred             ccccccceecccCCccCCCcch--------hhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccc
Q 048668          318 SITTLSLYLDLSNNLLNGSLPQ--------QVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSL  389 (725)
Q Consensus       318 ~~~~ll~~L~L~~n~l~~~~~~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  389 (725)
                             .|++++|...+.+|.        .+..+++|+.|++++|++++. +  ++.+++|+.|++++|++++      
T Consensus       290 -------~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~------  353 (457)
T 3bz5_A          290 -------ELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD------  353 (457)
T ss_dssp             -------CCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB------
T ss_pred             -------EEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC------
Confidence                   455555544333332        133346777777777777764 2  6777777777777777775      


Q ss_pred             cCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC
Q 048668          390 GFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK  436 (725)
Q Consensus       390 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  436 (725)
                        ++.|..|++++|.++|.     ..+..|..+++++|+++|.+|..
T Consensus       354 --l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          354 --FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             --CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             --ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence              24556667777777765     23455777788888888887754

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.4e-39  Score=354.76  Aligned_cols=374  Identities=24%  Similarity=0.292  Sum_probs=272.0

Q ss_pred             CccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCC-------------CEEEccCCc
Q 048668            6 PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL-------------VQLNVAENK   72 (725)
Q Consensus         6 p~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-------------~~L~Ls~N~   72 (725)
                      |+.+ +.+.|++|++++|.+ +.+|++|+++++|++|++++|++.+..|..++.+++|             ++|++++|.
T Consensus         5 p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A            5 PRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             cccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence            3444 458899999999999 6999999999999999999999999999999998875             999999999


Q ss_pred             ccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCcc
Q 048668           73 FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSI  152 (725)
Q Consensus        73 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~  152 (725)
                      ++++ |..   .++|++|++++|.++ .+|.    .+++|++|++++|+++++. ..   .++|++|++++|++++++  
T Consensus        83 l~~l-p~~---~~~L~~L~l~~n~l~-~lp~----~~~~L~~L~l~~n~l~~l~-~~---~~~L~~L~L~~n~l~~lp--  147 (454)
T 1jl5_A           83 LSSL-PEL---PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKALS-DL---PPLLEYLGVSNNQLEKLP--  147 (454)
T ss_dssp             CSCC-CSC---CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCCC-SC---CTTCCEEECCSSCCSSCC--
T ss_pred             cccC-CCC---cCCCCEEEccCCcCC-cccc----ccCCCcEEECCCCccCccc-CC---CCCCCEEECcCCCCCCCc--
Confidence            9864 432   368999999999999 5874    3589999999999998653 22   278999999999999876  


Q ss_pred             CcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcc
Q 048668          153 DFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG  232 (725)
Q Consensus       153 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~  232 (725)
                      .|..+++|++|++++|.++.++.          ..++|++|++++|++++ +| .+..++ .|+.|++++|.+++ +|..
T Consensus       148 ~~~~l~~L~~L~l~~N~l~~lp~----------~~~~L~~L~L~~n~l~~-l~-~~~~l~-~L~~L~l~~N~l~~-l~~~  213 (454)
T 1jl5_A          148 ELQNSSFLKIIDVDNNSLKKLPD----------LPPSLEFIAAGNNQLEE-LP-ELQNLP-FLTAIYADNNSLKK-LPDL  213 (454)
T ss_dssp             CCTTCTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSS-CC-CCTTCT-TCCEEECCSSCCSS-CCCC
T ss_pred             ccCCCCCCCEEECCCCcCcccCC----------CcccccEEECcCCcCCc-Cc-cccCCC-CCCEEECCCCcCCc-CCCC
Confidence            59999999999999999986543          23599999999999996 66 588887 89999999999986 4543


Q ss_pred             cccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccc
Q 048668          233 IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGAL  312 (725)
Q Consensus       233 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  312 (725)
                      .   .+|++|++++|++.. +| .+..+++|++|++++|++++ +|..   +++|++|++++|+++            .+
T Consensus       214 ~---~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~------------~l  272 (454)
T 1jl5_A          214 P---LSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLT------------DL  272 (454)
T ss_dssp             C---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCS------------CC
T ss_pred             c---CcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCccc------------cc
Confidence            2   589999999999994 45 48999999999999999985 4543   489999999999887            34


Q ss_pred             cccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccc-cCCcEEEccCCccccccCccccC
Q 048668          313 PQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTC-VSLEYVDISSNCFHGIIPPSLGF  391 (725)
Q Consensus       313 p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~  391 (725)
                      |...    ..+++|++++|.+++. |.   ..++|+.|++++|++++. +    .+ ++|++|++++|++++ +|..   
T Consensus       273 ~~~~----~~L~~L~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---  335 (454)
T 1jl5_A          273 PELP----QSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---  335 (454)
T ss_dssp             CCCC----TTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---
T ss_pred             Cccc----CcCCEEECcCCccCcc-cC---cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---
Confidence            4432    3348899999999863 21   126899999999999853 2    23 589999999999996 5543   


Q ss_pred             CCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCee--ecCCC-Ccc-------------CCCCCcCccCCcc
Q 048668          392 LKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEG--EVPTK-GVF-------------SNKSKIPLQGNVR  452 (725)
Q Consensus       392 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~-~~~-------------~~~~~~~~~~n~~  452 (725)
                      +++|+.|++++|++++ +|.   .+++|++|++++|++++  .+|.. ..+             ..++.+++++|..
T Consensus       336 ~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l  408 (454)
T 1jl5_A          336 PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL  408 (454)
T ss_dssp             CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC----------------------
T ss_pred             CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcC
Confidence            5899999999999995 555   47899999999999998  44543 222             4556666666643

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-39  Score=354.54  Aligned_cols=349  Identities=19%  Similarity=0.181  Sum_probs=252.8

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      -+.++.++++++ .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|.|+++.|.+|.++++|++|+|++
T Consensus        13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            468999999998 7787665  6899999999999988899999999999999999999998899999999999999999


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA  174 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~  174 (725)
                      |+++ .+|..+|.++++|++|+|++|+++++.+..|..+++|++|+|++|+++++.+..|..+++|++|++++|.++.++
T Consensus        90 n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  168 (477)
T 2id5_A           90 NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP  168 (477)
T ss_dssp             SCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred             CcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence            9998 889888899999999999999999999999999999999999999999998888888888888888888887654


Q ss_pred             CCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCC
Q 048668          175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP  254 (725)
Q Consensus       175 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  254 (725)
                      .      ..+.++++|+.|+|++|.+.+..+.                         .|..+++|+.|++++|.+.+.++
T Consensus       169 ~------~~l~~l~~L~~L~l~~n~i~~~~~~-------------------------~~~~l~~L~~L~l~~~~~~~~~~  217 (477)
T 2id5_A          169 T------EALSHLHGLIVLRLRHLNINAIRDY-------------------------SFKRLYRLKVLEISHWPYLDTMT  217 (477)
T ss_dssp             H------HHHTTCTTCCEEEEESCCCCEECTT-------------------------CSCSCTTCCEEEEECCTTCCEEC
T ss_pred             h------hHhcccCCCcEEeCCCCcCcEeChh-------------------------hcccCcccceeeCCCCccccccC
Confidence            3      4466778888888888877754333                         44555566666666655554444


Q ss_pred             hhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccC
Q 048668          255 DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN  334 (725)
Q Consensus       255 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~  334 (725)
                      .......+|++|++++|.+++..+..|..+++|++|+|++|+++            .                       
T Consensus       218 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~------------~-----------------------  262 (477)
T 2id5_A          218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS------------T-----------------------  262 (477)
T ss_dssp             TTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCC------------E-----------------------
T ss_pred             cccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCC------------c-----------------------
Confidence            44444446666666666666433345556666666666665433            1                       


Q ss_pred             CCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCccccc
Q 048668          335 GSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLE  414 (725)
Q Consensus       335 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  414 (725)
                       ..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+....+.. .
T Consensus       263 -~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~-~  340 (477)
T 2id5_A          263 -IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL-W  340 (477)
T ss_dssp             -ECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGH-H
T ss_pred             -cChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchH-h
Confidence             12233444556666666666666666666666666666666666666555555666666666666666665432211 1


Q ss_pred             CCCCCCeEEcccccCeeecCC
Q 048668          415 NLSFLEFLNLSYNHLEGEVPT  435 (725)
Q Consensus       415 ~l~~L~~L~l~~N~l~~~~p~  435 (725)
                      -...+..+++.++...|..|.
T Consensus       341 ~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          341 VFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             HHTTTTSSCCTTCCCBEEESG
T ss_pred             HHhhhhccccCccCceeCCch
Confidence            112233455566666666664

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.4e-38  Score=348.08  Aligned_cols=347  Identities=26%  Similarity=0.367  Sum_probs=293.8

Q ss_pred             cCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           34 GNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        34 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      ..+++|+.|++++|.++. +|+ +..+++|++|+|++|.+++..+  +.++++|++|++++|.++ .++.  +.++++|+
T Consensus        43 ~~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~  115 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP--LANLTNLT  115 (466)
T ss_dssp             HHHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCC
T ss_pred             hHhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-cChh--hcCCCCCC
Confidence            346789999999999984 454 8889999999999999986655  999999999999999998 5554  78999999


Q ss_pred             EEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEE
Q 048668          114 ELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL  193 (725)
Q Consensus       114 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L  193 (725)
                      +|+|++|.++++.+  +..+++|++|++++|+++++.  .+..+++|++|+++ |.+...        ..+.++++|++|
T Consensus       116 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~--------~~~~~l~~L~~L  182 (466)
T 1o6v_A          116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL--------KPLANLTTLERL  182 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC--------GGGTTCTTCCEE
T ss_pred             EEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCc--------hhhccCCCCCEE
Confidence            99999999997754  899999999999999999764  48889999999996 444332        226788899999


Q ss_pred             ECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCccc
Q 048668          194 SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFL  273 (725)
Q Consensus       194 ~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  273 (725)
                      ++++|.+++.                           ..+..+++|++|++++|.+.+..+  +..+++|++|++++|.+
T Consensus       183 ~l~~n~l~~~---------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l  233 (466)
T 1o6v_A          183 DISSNKVSDI---------------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL  233 (466)
T ss_dssp             ECCSSCCCCC---------------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             ECcCCcCCCC---------------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCc
Confidence            9999887721                           135678899999999999998765  78899999999999999


Q ss_pred             ccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEcc
Q 048668          274 QGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDIS  353 (725)
Q Consensus       274 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  353 (725)
                      .+.  ..+..+++|++|++++|.+++            ++. +..+..+ ++|++++|.+++..+  +..+++|+.|+++
T Consensus       234 ~~~--~~l~~l~~L~~L~l~~n~l~~------------~~~-~~~l~~L-~~L~l~~n~l~~~~~--~~~l~~L~~L~L~  295 (466)
T 1o6v_A          234 KDI--GTLASLTNLTDLDLANNQISN------------LAP-LSGLTKL-TELKLGANQISNISP--LAGLTALTNLELN  295 (466)
T ss_dssp             CCC--GGGGGCTTCSEEECCSSCCCC------------CGG-GTTCTTC-SEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred             ccc--hhhhcCCCCCEEECCCCcccc------------chh-hhcCCCC-CEEECCCCccCcccc--ccCCCccCeEEcC
Confidence            853  468899999999999998873            232 4444555 899999999997654  8999999999999


Q ss_pred             CccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeec
Q 048668          354 SNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEV  433 (725)
Q Consensus       354 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  433 (725)
                      +|++++..+  +..+++|+.|+|++|++++..|  ++.+++|+.|++++|++++.  ..+..+++|+.|++++|++++.+
T Consensus       296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~  369 (466)
T 1o6v_A          296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLT  369 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCG
T ss_pred             CCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccc
Confidence            999997655  8899999999999999998765  78999999999999999975  47899999999999999999998


Q ss_pred             CCCCccCCCCCcCccCCcccc
Q 048668          434 PTKGVFSNKSKIPLQGNVRLC  454 (725)
Q Consensus       434 p~~~~~~~~~~~~~~~n~~~c  454 (725)
                      | ...++.++.+.+++|++..
T Consensus       370 ~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          370 P-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             G-GTTCTTCCEEECCCEEEEC
T ss_pred             h-hhcCCCCCEEeccCCcccC
Confidence            8 5568889999999997755

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-39  Score=330.62  Aligned_cols=172  Identities=25%  Similarity=0.420  Sum_probs=151.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||+||+|+++.+++.||||++...   +....+.+.+|++++++++|||||++++++...+     .
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            5799999999999999999999999999999999754   2345678999999999999999999999976544     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||+||+|.+++++..      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            999999999999999998654      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.+......      ....+.+||+.|||||++
T Consensus       178 la~~~~~~~~~------~~~~~~~GTp~YmAPEvl  206 (311)
T 4aw0_A          178 TAKVLSPESKQ------ARANSFVGTAQYVSPELL  206 (311)
T ss_dssp             TCEECCTTTTC------CCBCCCCSCGGGCCHHHH
T ss_pred             CceecCCCCCc------ccccCcccCcccCCHHHH
Confidence            99987543211      122347899999999986

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.5e-38  Score=346.79  Aligned_cols=364  Identities=19%  Similarity=0.179  Sum_probs=301.9

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +++......+.+.+..+..++.+++|++|++++|++++. | .|..+++|++|+|++|+++++ |  ++.+++|++|+++
T Consensus        19 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls   93 (457)
T 3bz5_A           19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACD   93 (457)
T ss_dssp             HHHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred             HHHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECc
Confidence            355555555666666777899999999999999999965 5 699999999999999999975 4  8999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc-CCc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN-LGI  172 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~-l~~  172 (725)
                      +|+|+ .++   +.++++|++|+|++|+++++ +  ++.+++|++|++++|+|+++   .+..+++|++|++++|. +..
T Consensus        94 ~N~l~-~~~---~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~  163 (457)
T 3bz5_A           94 SNKLT-NLD---VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITK  163 (457)
T ss_dssp             SSCCS-CCC---CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCC
T ss_pred             CCCCc-eee---cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccc
Confidence            99998 565   67899999999999999986 3  89999999999999999987   38889999999999995 432


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT  252 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  252 (725)
                      +         .+..+++|++|++++|++++ +|  +..++ .++.|++++|.+++.   .+..+++|++|++++|+++++
T Consensus       164 ~---------~~~~l~~L~~L~ls~n~l~~-l~--l~~l~-~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i  227 (457)
T 3bz5_A          164 L---------DVTPQTQLTTLDCSFNKITE-LD--VSQNK-LLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI  227 (457)
T ss_dssp             C---------CCTTCTTCCEEECCSSCCCC-CC--CTTCT-TCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC
T ss_pred             c---------ccccCCcCCEEECCCCccce-ec--cccCC-CCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc
Confidence            2         25688999999999999996 45  66666 899999999999975   388899999999999999984


Q ss_pred             CChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCc
Q 048668          253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNL  332 (725)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~  332 (725)
                       |  +..+++|++|++++|.+++..   +..+++|+.|++++|+++                          .|++++|.
T Consensus       228 -p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L~--------------------------~L~l~~n~  275 (457)
T 3bz5_A          228 -D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDLL--------------------------EIDLTHNT  275 (457)
T ss_dssp             -C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCCS--------------------------CCCCTTCT
T ss_pred             -C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCCC--------------------------EEECCCCc
Confidence             4  788999999999999999754   456788999999988554                          58899999


Q ss_pred             cCCCcchhhhcCCCCCeEEccCccccccCcc--------ccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCc
Q 048668          333 LNGSLPQQVGNLKNLIILDISSNQFSGMIPV--------TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN  404 (725)
Q Consensus       333 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  404 (725)
                      +.+.+|  ++.+++|+.|++++|...+.+|.        .+..+++|++|+|++|++++. +  ++.+++|+.||+++|+
T Consensus       276 ~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~  350 (457)
T 3bz5_A          276 QLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAH  350 (457)
T ss_dssp             TCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred             cCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCC
Confidence            887776  57889999999999987776664        245667899999999999974 3  8889999999999999


Q ss_pred             ccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCCC
Q 048668          405 FSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGID  458 (725)
Q Consensus       405 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  458 (725)
                      +++        ++.|..|++++|.++|..    .+..+..+.++.|. +.|.+|
T Consensus       351 l~~--------l~~L~~L~l~~n~l~g~~----~~~~l~~l~l~~N~-l~g~ip  391 (457)
T 3bz5_A          351 IQD--------FSSVGKIPALNNNFEAEG----QTITMPKETLTNNS-LTIAVS  391 (457)
T ss_dssp             CCB--------CTTGGGSSGGGTSEEEEE----EEEECCCBCCBTTB-EEEECC
T ss_pred             CCC--------ccccccccccCCcEEecc----eeeecCccccccCc-EEEEcC
Confidence            986        356777889999998872    24456667777773 455543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-39  Score=333.77  Aligned_cols=170  Identities=25%  Similarity=0.383  Sum_probs=151.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++...+     ..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            46888899999999999999999999999999998766556677899999999999999999999977654     8999


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||||+||+|.+++...       .+++.++..|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       149 vmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            99999999999999753       489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+....        ....+.+||+.|||||++.
T Consensus       219 ~~~~~~--------~~~~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          219 QVSKEV--------PRRKSLVGTPYWMAPELIS  243 (346)
T ss_dssp             ECCSSS--------CCBCCCCSCGGGCCHHHHT
T ss_pred             ecCCCC--------CcccccccCcCcCCHHHHC
Confidence            764331        1123478999999999864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=6.2e-38  Score=336.87  Aligned_cols=335  Identities=19%  Similarity=0.195  Sum_probs=191.0

Q ss_pred             cccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           12 LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      ++++++|++++|.++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++++.|..|.++++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            45666666666666643334466666666666666666666666666666666666666666666666666666666666


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |++|+++ .+|..+|.++++|++|+|++|+++++.+..|..+++|++|+|++|+++++.   +..+++|+.|++++|.++
T Consensus       124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccc
Confidence            6666666 666666666666666666666666666666666666666666666666542   344455555555555554


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCC
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  251 (725)
                      .+           ...++|++|++++|.++.                         . |..  ..++|+.|++++|.+++
T Consensus       200 ~~-----------~~~~~L~~L~l~~n~l~~-------------------------~-~~~--~~~~L~~L~l~~n~l~~  240 (390)
T 3o6n_A          200 TL-----------AIPIAVEELDASHNSINV-------------------------V-RGP--VNVELTILKLQHNNLTD  240 (390)
T ss_dssp             EE-----------ECCSSCSEEECCSSCCCE-------------------------E-ECC--CCSSCCEEECCSSCCCC
T ss_pred             cc-----------CCCCcceEEECCCCeeee-------------------------c-ccc--ccccccEEECCCCCCcc
Confidence            22           122344555555554441                         1 110  11344444444444443


Q ss_pred             CCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCC
Q 048668          252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNN  331 (725)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n  331 (725)
                      .  .++..+++|++|++++|.+.+..|                                                     
T Consensus       241 ~--~~l~~l~~L~~L~Ls~n~l~~~~~-----------------------------------------------------  265 (390)
T 3o6n_A          241 T--AWLLNYPGLVEVDLSYNELEKIMY-----------------------------------------------------  265 (390)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCEEES-----------------------------------------------------
T ss_pred             c--HHHcCCCCccEEECCCCcCCCcCh-----------------------------------------------------
Confidence            2  234444444444444444443333                                                     


Q ss_pred             ccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcc
Q 048668          332 LLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPK  411 (725)
Q Consensus       332 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  411 (725)
                             ..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++.. | 
T Consensus       266 -------~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~-  334 (390)
T 3o6n_A          266 -------HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K-  334 (390)
T ss_dssp             -------GGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C-
T ss_pred             -------hHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C-
Confidence                   344445555555555555552 3334445556666666666665 3444555666666666666666643 2 


Q ss_pred             cccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCC
Q 048668          412 FLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       412 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                       +..+++|+.|++++|+|++..... .+..+....+.+++..|..+
T Consensus       335 -~~~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          335 -LSTHHTLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             -CCTTCCCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCTT
T ss_pred             -chhhccCCEEEcCCCCccchhHHH-HHHHHHhhcccccCceeccc
Confidence             556677777777777777655432 24445555566777777654

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.5e-38  Score=339.91  Aligned_cols=313  Identities=20%  Similarity=0.219  Sum_probs=202.9

Q ss_pred             CCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEE
Q 048668           36 LSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL  115 (725)
Q Consensus        36 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  115 (725)
                      +++|++|++++|.++.+.+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|+++ .++...|.++++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEE
Confidence            345555555555555444444455555555555555555555555555555555555555555 4444444555555555


Q ss_pred             EccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEEC
Q 048668          116 GIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSL  195 (725)
Q Consensus       116 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L  195 (725)
                      +|++|+++.+++..|.++++|++|+|++|+++++.+..|..                              +++|++|++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~------------------------------l~~L~~L~l  172 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA------------------------------TTSLQNLQL  172 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSS------------------------------CTTCCEEEC
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccC------------------------------CCCCCEEEC
Confidence            55555555444444455555555555555555544444444                              455555555


Q ss_pred             ccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCccccc
Q 048668          196 SDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       196 ~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      ++|++++.                            .+..+++|+.|++++|.+.+.     ...++|++|++++|.+..
T Consensus       173 ~~n~l~~~----------------------------~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~  219 (390)
T 3o6n_A          173 SSNRLTHV----------------------------DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINV  219 (390)
T ss_dssp             CSSCCSBC----------------------------CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCE
T ss_pred             CCCcCCcc----------------------------ccccccccceeeccccccccc-----CCCCcceEEECCCCeeee
Confidence            55554421                            012234455555555544422     223467777777777764


Q ss_pred             CCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCc
Q 048668          276 SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSN  355 (725)
Q Consensus       276 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  355 (725)
                      . |..  ..++|+.|++++|.++                                    +.  ..+..+++|++|+|++|
T Consensus       220 ~-~~~--~~~~L~~L~l~~n~l~------------------------------------~~--~~l~~l~~L~~L~Ls~n  258 (390)
T 3o6n_A          220 V-RGP--VNVELTILKLQHNNLT------------------------------------DT--AWLLNYPGLVEVDLSYN  258 (390)
T ss_dssp             E-ECC--CCSSCCEEECCSSCCC------------------------------------CC--GGGGGCTTCSEEECCSS
T ss_pred             c-ccc--ccccccEEECCCCCCc------------------------------------cc--HHHcCCCCccEEECCCC
Confidence            3 222  1356666666666443                                    21  35777899999999999


Q ss_pred             cccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCC
Q 048668          356 QFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT  435 (725)
Q Consensus       356 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  435 (725)
                      .+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++.... 
T Consensus       259 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~-  335 (390)
T 3o6n_A          259 ELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL-  335 (390)
T ss_dssp             CCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC-
T ss_pred             cCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCc-
Confidence            9999989999999999999999999996 5667788999999999999998 567778889999999999999987643 


Q ss_pred             CCccCCCCCcCccCCccccCCC
Q 048668          436 KGVFSNKSKIPLQGNVRLCGGI  457 (725)
Q Consensus       436 ~~~~~~~~~~~~~~n~~~c~~~  457 (725)
                       ..++.++.+++++|++.|...
T Consensus       336 -~~~~~L~~L~l~~N~~~~~~~  356 (390)
T 3o6n_A          336 -STHHTLKNLTLSHNDWDCNSL  356 (390)
T ss_dssp             -CTTCCCSEEECCSSCEEHHHH
T ss_pred             -hhhccCCEEEcCCCCccchhH
Confidence             457899999999999988643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-39  Score=333.81  Aligned_cols=174  Identities=24%  Similarity=0.351  Sum_probs=145.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||+||+|+++.+|+.||||++....  ....+++.+|++++++++|||||++++++...+     .
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----S   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----E
Confidence            358999999999999999999999999999999997653  334578999999999999999999999976554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||+||+|.+++.....    ..+++.+++.|+.||+.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence            9999999999999999976542    1578999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+...        .....+.+||+.|||||++.
T Consensus       171 la~~~~~~--------~~~~~~~~GT~~YmAPE~l~  198 (350)
T 4b9d_A          171 IARVLNST--------VELARACIGTPYYLSPEICE  198 (350)
T ss_dssp             EESCCCHH--------HHHHHHHHSCCTTCCHHHHT
T ss_pred             cceeecCC--------cccccccCCCccccCHHHHC
Confidence            99876432        11223468999999999864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.9e-38  Score=354.44  Aligned_cols=336  Identities=20%  Similarity=0.198  Sum_probs=175.2

Q ss_pred             CCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEE
Q 048668           37 SALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG  116 (725)
Q Consensus        37 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  116 (725)
                      ++++.|++++|.++.+++..|..+++|++|+|++|.|+++.|..|.++++|++|+|++|.|+ .+|...|.++++|++|+
T Consensus        51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-CCCHHHHcCCCCCCEEE
Confidence            34444444444444333334444444444444444444444444444444444444444444 33334444444444444


Q ss_pred             ccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECc
Q 048668          117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLS  196 (725)
Q Consensus       117 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~  196 (725)
                      |++|.|+++++..|.++++|++|+|++|.|+++++..|..+++|++|++++|.++.++         +..+++|+.|+++
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------~~~l~~L~~L~l~  200 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LSLIPSLFHANVS  200 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------GGGCTTCSEEECC
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------hhhhhhhhhhhcc
Confidence            4444444444444444444444444444444444444444444444444444444321         1233455555555


Q ss_pred             cCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccC
Q 048668          197 DNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGS  276 (725)
Q Consensus       197 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  276 (725)
                      +|.+++.                              ....+|+.|++++|.+....+..   .++|++|+|++|.+++ 
T Consensus       201 ~n~l~~l------------------------------~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~-  246 (597)
T 3oja_B          201 YNLLSTL------------------------------AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD-  246 (597)
T ss_dssp             SSCCSEE------------------------------ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC-
T ss_pred             cCccccc------------------------------cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC-
Confidence            5544421                              01123344444444443222211   1345555555555553 


Q ss_pred             CCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCcc
Q 048668          277 IPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQ  356 (725)
Q Consensus       277 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~  356 (725)
                       +..+..+++|+.|+|++|.++                                    +..|..|+.+++|+.|+|++|.
T Consensus       247 -~~~l~~l~~L~~L~Ls~N~l~------------------------------------~~~~~~~~~l~~L~~L~Ls~N~  289 (597)
T 3oja_B          247 -TAWLLNYPGLVEVDLSYNELE------------------------------------KIMYHPFVKMQRLERLYISNNR  289 (597)
T ss_dssp             -CGGGGGCTTCSEEECCSSCCC------------------------------------EEESGGGTTCSSCCEEECTTSC
T ss_pred             -ChhhccCCCCCEEECCCCccC------------------------------------CCCHHHhcCccCCCEEECCCCC
Confidence             244555555555555555332                                    2234455556666666666666


Q ss_pred             ccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC
Q 048668          357 FSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK  436 (725)
Q Consensus       357 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  436 (725)
                      +++ +|..+..+++|+.|+|++|.++ .+|..++.+++|+.|+|++|.+++..   +..+++|+.|++++|+|+|.+...
T Consensus       290 l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~  364 (597)
T 3oja_B          290 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRA  364 (597)
T ss_dssp             CCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHH
T ss_pred             CCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHH
Confidence            663 3445555667777777777776 45556667777777777777776542   556778888888888888776432


Q ss_pred             CccCCCCCcCccCCccccCCCCC
Q 048668          437 GVFSNKSKIPLQGNVRLCGGIDE  459 (725)
Q Consensus       437 ~~~~~~~~~~~~~n~~~c~~~~~  459 (725)
                       .+.......+.++...|+....
T Consensus       365 -~~~~~~~~~~~~~~~~C~~~~~  386 (597)
T 3oja_B          365 -LFRNVARPAVDDADQHCKIDYQ  386 (597)
T ss_dssp             -HTTTCCTTTBCCCCCCCCTTCE
T ss_pred             -HHHHHhhhccccccccCCcchh
Confidence             2445555566778888886543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=336.02  Aligned_cols=170  Identities=25%  Similarity=0.383  Sum_probs=151.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +.|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++...+     ..|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence            46889999999999999999999999999999998766656677899999999999999999999977654     8999


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||||+||+|.++++..       .+++.++..|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       226 VmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence            99999999999999753       489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+....        ....+.+||+.|||||++.
T Consensus       296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          296 QVSKEV--------PRRKSLVGTPYWMAPELIS  320 (423)
T ss_dssp             ECCSSC--------CCBCCCEECTTTCCHHHHT
T ss_pred             ECCCCC--------ccccccccCcCcCCHHHHC
Confidence            764331        1123478999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-38  Score=318.44  Aligned_cols=171  Identities=28%  Similarity=0.467  Sum_probs=144.2

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +..+.||+|+||+||+|+++.++..||+|++....  ....++|.+|++++++++|||||+++++|.... ...+..|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence            55678999999999999999999999999997543  334578999999999999999999999875431 223468999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFGLAK  691 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Dfgla~  691 (725)
                      ||||+||+|.+++++..      .+++..+..|+.||+.||+|||++ .++||||||||+|||++. ++.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999998654      589999999999999999999998 223999999999999984 7899999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....          ...+.+||+.|||||++
T Consensus       181 ~~~~~----------~~~~~~GTp~YmAPE~~  202 (290)
T 3fpq_A          181 LKRAS----------FAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             GCCTT----------SBEESCSSCCCCCGGGG
T ss_pred             eCCCC----------ccCCcccCccccCHHHc
Confidence            53221          12346899999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.8e-38  Score=315.83  Aligned_cols=170  Identities=31%  Similarity=0.465  Sum_probs=136.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...   ....+++.+|++++++++|||||++++++...+     
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-----   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----
Confidence            468999999999999999999999999999999997542   334567999999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||| +|+|.+++.+..      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence            899999999 679999998764      689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+...+..         ...+.+||+.|||||++.
T Consensus       157 Gla~~~~~~~---------~~~~~~GT~~Y~APE~~~  184 (275)
T 3hyh_A          157 GLSNIMTDGN---------FLKTSCGSPNYAAPEVIS  184 (275)
T ss_dssp             SCC------------------------CTTSCHHHHS
T ss_pred             CCCeecCCCC---------ccCCeeECcccCChhhhc
Confidence            9998754321         112368999999999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-38  Score=323.41  Aligned_cols=178  Identities=27%  Similarity=0.470  Sum_probs=146.9

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|...+.||+|+||+||+|++.     .++..||||+++.......++|.+|++++++++|||||+++|+|...+    
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence            46778899999999999999875     357899999998665556788999999999999999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCC-------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSND-------QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                       ..|+|||||++|+|.++++....       ......++|.+++.|+.||++||+|||++   +||||||||+|||++.+
T Consensus        89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence             78999999999999999986431       11123689999999999999999999999   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+||+|||+|+........      ......+||++|||||++
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~------~~~~~~~gt~~ymAPE~~  202 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESI  202 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCE------EETTTEEECGGGCCHHHH
T ss_pred             CcEEECCcccceecCCCCce------eecCceecChhhcCHHHH
Confidence            99999999999876433211      111235699999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5e-38  Score=323.22  Aligned_cols=172  Identities=26%  Similarity=0.318  Sum_probs=143.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ...|+..+.||+|+||+||+|+++.+|+.||||+++.+..     +.+|++++++++|||||++++++....     ..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-----WVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            3457778899999999999999999999999999975432     247999999999999999999976654     899


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Dfgl  689 (725)
                      +|||||+||+|.+++++..      .+++.++..|+.||+.||+|||++   +||||||||+|||++.+| .+||+|||+
T Consensus       127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            9999999999999998654      589999999999999999999999   999999999999999987 699999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.+.......   ........+||+.|||||++.
T Consensus       198 a~~~~~~~~~~---~~~~~~~~~GT~~YmAPE~~~  229 (336)
T 4g3f_A          198 ALCLQPDGLGK---SLLTGDYIPGTETHMAPEVVM  229 (336)
T ss_dssp             CEEC---------------CCCCCCGGGCCHHHHT
T ss_pred             CeEccCCCccc---ceecCCccccCccccCHHHHC
Confidence            99875432111   111223468999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=324.04  Aligned_cols=179  Identities=27%  Similarity=0.461  Sum_probs=142.3

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|...+.||+|+||+||+|+++     .+++.||||+++.......++|.+|++++++++|||||+++|+|....    
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR----  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence            45677789999999999999875     367899999998666666788999999999999999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCcc---------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQV---------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                       ..|+|||||++|+|.++++......         ....++|.++++|+.||+.||+|||++   +||||||||+|||++
T Consensus       117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence             7899999999999999998654211         123589999999999999999999998   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++.+||+|||+|+........      ......+||+.|||||++.
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~------~~~~~~~gt~~ymAPE~~~  233 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESIL  233 (329)
T ss_dssp             TTTEEEECCCC----------------------CCCCGGGCCHHHHT
T ss_pred             CCCcEEEcccccceeccCCCcc------eecCcccccccccChhhhc
Confidence            9999999999999876433211      1122357999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8e-38  Score=319.55  Aligned_cols=188  Identities=24%  Similarity=0.422  Sum_probs=141.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCC------
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDF------  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  603 (725)
                      .++|+..+.||+|+||+||+|+++.+++.||||+++.... ...+++.+|++++++++|||||++++++...+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3568999999999999999999999999999999976543 345679999999999999999999999865431      


Q ss_pred             -CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          604 -KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       604 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                       ....+.|+|||||+||+|.+++......   ...++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence             1223579999999999999999865432   1356677889999999999999999   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCC----CCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSS----KTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.+.........    .......+.+||+.|||||++.
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  203 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH  203 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence            99999999987543222111    1112234568999999999863

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=318.85  Aligned_cols=171  Identities=32%  Similarity=0.512  Sum_probs=140.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++++..+.||+|+||+||+|+++.   .||||+++...  ....++|.+|++++++++|||||+++|+|...      
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------  104 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------  104 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------
Confidence            34577788999999999999998753   49999997543  33457899999999999999999999987532      


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|||||+||+|.++++....     .+++.++..|+.||+.||+|||++   +||||||||+|||++.++.+||+||
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeec
Confidence            57999999999999999976542     589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+........      ......+||+.|||||++
T Consensus       177 Gla~~~~~~~~~------~~~~~~~GT~~ymAPE~l  206 (307)
T 3omv_A          177 GLATVKSRWSGS------QQVEQPTGSVLWMAPEVI  206 (307)
T ss_dssp             SSCBC------------------CCCCTTSCCHHHH
T ss_pred             cCceecccCCcc------eeecccccCCCccCHHHh
Confidence            999876432111      112346799999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-37  Score=316.83  Aligned_cols=178  Identities=23%  Similarity=0.357  Sum_probs=145.8

Q ss_pred             cCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++++..+.||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|....   
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~---  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ---  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC---
Confidence            34566789999999999999874     357899999997543 334578999999999999999999999987654   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  675 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil  675 (725)
                        ..++|||||++|+|.+++......          .....+++.++++|+.|||+||+|||++   +||||||||+|||
T Consensus       103 --~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          103 --PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             --SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             --EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence              789999999999999999754321          1123589999999999999999999999   9999999999999


Q ss_pred             ecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          676 LDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       676 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.++.+||+|||+|+.........      .....+||++|||||++
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~------~~~~~~gt~~ymAPE~l  219 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYK------LLGNSLLPIRWMAPEAI  219 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBC------SSSSSCBCGGGCCHHHH
T ss_pred             ECCCCCEEECCcccceeccCCCcee------EecccccCCcccCHHHH
Confidence            9999999999999998765432211      12235799999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.4e-38  Score=320.60  Aligned_cols=171  Identities=26%  Similarity=0.343  Sum_probs=140.4

Q ss_pred             cCCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|++.+.||+|+||+||+|++.   .+++.||||+++...  .....++.+|++++++++|||||++++++...+    
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----   99 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG----   99 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence            57999999999999999999873   468899999997542  223346889999999999999999999976654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+|||||+||+|.+++.+..      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       100 -~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A          100 -KLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             -EEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred             -EEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence             8999999999999999998654      589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+......        ....+.+||+.|||||++.
T Consensus       170 FGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~  199 (304)
T 3ubd_A          170 FGLSKESIDHE--------KKAYSFCGTVEYMAPEVVN  199 (304)
T ss_dssp             SEEEEC-------------CCCCSCCCCGGGCCHHHHH
T ss_pred             cccceeccCCC--------ccccccccCcccCCHHHhc
Confidence            99998654321        1122468999999999863

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.2e-35  Score=314.01  Aligned_cols=308  Identities=24%  Similarity=0.362  Sum_probs=196.7

Q ss_pred             cccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCC
Q 048668           32 FIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPN  111 (725)
Q Consensus        32 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~  111 (725)
                      .+..+++|++|++++|+++. .+ .|..+++|++|+|++|+++++.+  |.++++|++|++++|+++ .++  .+.++++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~--~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS--ALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG--GGTTCTT
T ss_pred             cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch--HHcCCCc
Confidence            34566777777777777763 33 37777777777777777775443  777777777777777776 554  3567777


Q ss_pred             ccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCC
Q 048668          112 LKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLK  191 (725)
Q Consensus       112 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~  191 (725)
                      |++|+|++|.++.+.+  +..+++|++|++++|......+ .+..+++|++|++++|.+.....        +..+++|+
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--------~~~l~~L~  180 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--------IANLTDLY  180 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--------GGGCTTCS
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--------hccCCCCC
Confidence            7777777777776543  7777778888888875443322 37777778888888877765432        55677888


Q ss_pred             EEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCc
Q 048668          192 VLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKN  271 (725)
Q Consensus       192 ~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  271 (725)
                      +|++++|.+++. +                         . +..+++|+.|++++|.+.+..+  +..+++|++|++++|
T Consensus       181 ~L~l~~n~l~~~-~-------------------------~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n  231 (347)
T 4fmz_A          181 SLSLNYNQIEDI-S-------------------------P-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN  231 (347)
T ss_dssp             EEECTTSCCCCC-G-------------------------G-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             EEEccCCccccc-c-------------------------c-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence            888888877621 1                         1 3455667777777777765443  666777777777777


Q ss_pred             ccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEE
Q 048668          272 FLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILD  351 (725)
Q Consensus       272 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~  351 (725)
                      .+.+..+  +..+++|++|++++|.+++            +                          +.+..+++|+.|+
T Consensus       232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~------------~--------------------------~~~~~l~~L~~L~  271 (347)
T 4fmz_A          232 KITDLSP--LANLSQLTWLEIGTNQISD------------I--------------------------NAVKDLTKLKMLN  271 (347)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCC------------C--------------------------GGGTTCTTCCEEE
T ss_pred             ccCCCcc--hhcCCCCCEEECCCCccCC------------C--------------------------hhHhcCCCcCEEE
Confidence            7764433  6677777777777775441            1                          1234445555666


Q ss_pred             ccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCe
Q 048668          352 ISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE  430 (725)
Q Consensus       352 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  430 (725)
                      +++|.+++.  +.+..+++|+.|++++|.+++..+..|+.+++|+.|++++|++++..|  +..+++|++|++++|+++
T Consensus       272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            666655533  235555566666666666655555556666666666666666655444  555666666666666554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=9.7e-36  Score=314.59  Aligned_cols=307  Identities=24%  Similarity=0.344  Sum_probs=252.6

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +..+++|++|++++|.++ .++ .+..+++|++|++++|++++..+  |..+++|++|+|++|.++.+  ..|.++++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred             chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence            446788999999999998 444 48889999999999999986544  88999999999999999853  3699999999


Q ss_pred             eeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCc
Q 048668           89 YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN  168 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N  168 (725)
                      +|++++|+++ .++.  +..+++|++|++++|...... ..+..+++|++|++++|.+.++.+  +..+++|++|++++|
T Consensus       114 ~L~l~~n~i~-~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n  187 (347)
T 4fmz_A          114 ELYLNEDNIS-DISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN  187 (347)
T ss_dssp             EEECTTSCCC-CCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred             EEECcCCccc-Cchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence            9999999998 6665  678999999999999655443 348899999999999999987765  888999999999999


Q ss_pred             cCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccc
Q 048668          169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ  248 (725)
Q Consensus       169 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~  248 (725)
                      .+..+..        +..+++|++|++++|.+++.                          +. +..+++|++|++++|.
T Consensus       188 ~l~~~~~--------~~~l~~L~~L~l~~n~l~~~--------------------------~~-~~~~~~L~~L~l~~n~  232 (347)
T 4fmz_A          188 QIEDISP--------LASLTSLHYFTAYVNQITDI--------------------------TP-VANMTRLNSLKIGNNK  232 (347)
T ss_dssp             CCCCCGG--------GGGCTTCCEEECCSSCCCCC--------------------------GG-GGGCTTCCEEECCSSC
T ss_pred             ccccccc--------ccCCCccceeecccCCCCCC--------------------------ch-hhcCCcCCEEEccCCc
Confidence            9875432        66788999999999888732                          11 5567889999999999


Q ss_pred             cCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecc
Q 048668          249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDL  328 (725)
Q Consensus       249 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L  328 (725)
                      +++..+  +..+++|++|++++|.+.+.  ..+..+++|++|++++|+++                              
T Consensus       233 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~------------------------------  278 (347)
T 4fmz_A          233 ITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQIS------------------------------  278 (347)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC------------------------------
T ss_pred             cCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccC------------------------------
Confidence            987654  88899999999999998853  45778888888888888554                              


Q ss_pred             cCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCccc
Q 048668          329 SNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFS  406 (725)
Q Consensus       329 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  406 (725)
                            +.  +.+..+++|+.|++++|.+++..+..+..+++|++|+|++|.+++..|  +..+++|+.|++++|.|+
T Consensus       279 ------~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          279 ------DI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             ------CC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ------CC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence                  11  246678899999999999998888999999999999999999997666  888999999999999886

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=4.2e-35  Score=307.41  Aligned_cols=126  Identities=17%  Similarity=0.309  Sum_probs=62.3

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +++.+++++|.++ .+|..+.  ++|++|++++|++++..|..|.++++|++|+|++|+++++.|..|.++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            3555555555554 3444332  355555555555554445555555555555555555554445555555555555555


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQF  146 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i  146 (725)
                      +|+++ .+|..++   ++|++|++++|+++.+.+..|.++++|++|++++|++
T Consensus       111 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l  159 (332)
T 2ft3_A          111 KNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL  159 (332)
T ss_dssp             SSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCC
T ss_pred             CCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcc
Confidence            55554 4444332   4444444444444444444444444444444444444

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.6e-35  Score=333.71  Aligned_cols=312  Identities=19%  Similarity=0.170  Sum_probs=204.5

Q ss_pred             CCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCcccee
Q 048668           60 LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELL  139 (725)
Q Consensus        60 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  139 (725)
                      +.+++.|++++|.+..+++..|.++++|++|+|++|.|+ .++...|..+++|++|+|++|.|+++.|..|+++++|++|
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC-CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            345555555555555444444555555555555555554 4444444455555555555555555544445555555555


Q ss_pred             cCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEE
Q 048668          140 DLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL  219 (725)
Q Consensus       140 ~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~  219 (725)
                      +|++|.|+++++..|..                              +++|++|+|++|.+++.                
T Consensus       129 ~L~~n~l~~l~~~~~~~------------------------------l~~L~~L~Ls~N~l~~~----------------  162 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHN------------------------------TPKLTTLSMSNNNLERI----------------  162 (597)
T ss_dssp             ECCSSCCCCCCTTTTTT------------------------------CTTCCEEECCSSCCCBC----------------
T ss_pred             EeeCCCCCCCCHHHhcc------------------------------CCCCCEEEeeCCcCCCC----------------
Confidence            55555555444444444                              44444444444444422                


Q ss_pred             ecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCC
Q 048668          220 IGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG  299 (725)
Q Consensus       220 l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  299 (725)
                               .|..|..+++|++|+|++|.+.+..   +..+++|+.|++++|.+.+.     ...++|+.|++++|.++ 
T Consensus       163 ---------~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~-  224 (597)
T 3oja_B          163 ---------EDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSIN-  224 (597)
T ss_dssp             ---------CTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCC-
T ss_pred             ---------ChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccc-
Confidence                     2223344445555555555554432   33345566666666655532     23346677777777665 


Q ss_pred             ccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCC
Q 048668          300 NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN  379 (725)
Q Consensus       300 ~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  379 (725)
                                 .+|....   ..++.|+|++|.+++  +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|
T Consensus       225 -----------~~~~~~~---~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  288 (597)
T 3oja_B          225 -----------VVRGPVN---VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN  288 (597)
T ss_dssp             -----------EEECSCC---SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTS
T ss_pred             -----------ccccccC---CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCC
Confidence                       2222221   123678888888875  367899999999999999999999999999999999999999


Q ss_pred             ccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCC
Q 048668          380 CFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGG  456 (725)
Q Consensus       380 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~  456 (725)
                      .+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++.++  ..++.++.+++++|++.|..
T Consensus       289 ~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~L~~L~l~~N~~~~~~  361 (597)
T 3oja_B          289 RLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL--STHHTLKNLTLSHNDWDCNS  361 (597)
T ss_dssp             CCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC--CTTCCCSEEECCSSCEEHHH
T ss_pred             CCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh--hhcCCCCEEEeeCCCCCChh
Confidence            9996 5677788999999999999999 577888999999999999999987753  34789999999999998864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-36  Score=311.07  Aligned_cols=177  Identities=27%  Similarity=0.355  Sum_probs=139.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+|...+.||+|+||+||+|++  +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.... ......|+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence            3567778999999999999998  5889999999654321 123345666667889999999999987653 22236799


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      |||||++|+|.++++..       .+++..+.+++.|++.||+|||++     +.++||||||||+|||++.++++||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            99999999999999754       488999999999999999999976     246899999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.........    .....+.+||+.|||||++
T Consensus       152 FGla~~~~~~~~~~----~~~~~~~~GT~~ymAPE~l  184 (303)
T 3hmm_A          152 LGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             CTTCEEEETTTTEE----SCC-----CCGGGCCHHHH
T ss_pred             CCCCccccCCCCce----eeecccccccccccCHHHh
Confidence            99998765432111    1112246799999999986

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.2e-34  Score=301.79  Aligned_cols=150  Identities=20%  Similarity=0.315  Sum_probs=85.1

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+++++.|..|.++++|++|+|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            4666666666665 4554443  456666666666665555566666666666666666665556666666666666666


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccc--cCccCcccccccCeeecCCccC
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG--KVSIDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~--~~~~~f~~l~~L~~L~L~~N~l  170 (725)
                      +|+++ .+|..++   ++|++|++++|+++++.+..|.++++|++|++++|+++.  +.+..|..+++|++|++++|.+
T Consensus       109 ~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l  183 (330)
T 1xku_A          109 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  183 (330)
T ss_dssp             SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             CCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence            66665 5555432   455555555555555555555555555555555555542  3333344444444444444433

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=315.72  Aligned_cols=179  Identities=25%  Similarity=0.371  Sum_probs=149.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecC-CCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSST-DFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~~  608 (725)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+++.+|+++|++++|||||++++++... .+...+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47999999999999999999999999999999996543  23456788999999999999999999987643 2444567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||+ |+|.+++....      .+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999996 68999998654      689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+......    ......+.+||+.|||||+++
T Consensus       204 la~~~~~~~~~----~~~~~~~~~GT~~Y~APEv~~  235 (398)
T 4b99_A          204 MARGLCTSPAE----HQYFMTEYVATRWYRAPELML  235 (398)
T ss_dssp             TCBCC-----------CCCCCSSCCCCTTCCHHHHT
T ss_pred             eeeecccCccc----cccccccceeChHhcCHHHhc
Confidence            99876433111    112233478999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-36  Score=313.55  Aligned_cols=189  Identities=21%  Similarity=0.324  Sum_probs=153.4

Q ss_pred             cCHHHHHHHhcCCCCCcccccccceEEEEEEECCC-----ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCC-Ccccce
Q 048668          522 VSYAELSKATSEFSSSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRH-RNLIKI  594 (725)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l  594 (725)
                      ++..+++...++|+..+.||+|+||+||+|++..+     ++.||||++.... ....++|.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            34456666678899999999999999999997543     4689999997543 3345789999999999975 899999


Q ss_pred             eeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 048668          595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPM  664 (725)
Q Consensus       595 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  664 (725)
                      +|+|....    +..|+|||||++|+|.++|+.....          .....+++.++..|+.|||+||+|||++   +|
T Consensus       134 ~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~i  206 (353)
T 4ase_A          134 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC  206 (353)
T ss_dssp             EEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ce
Confidence            99986543    3679999999999999999764321          0122589999999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          665 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       665 vHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||||||+|||++.++.+||+|||+|+.+.....      .......+||+.|||||++
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~------~~~~~~~~gt~~ymAPE~l  259 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETI  259 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHH
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCC------ceeeccccccccccCHHHH
Confidence            9999999999999999999999999987643211      1122346799999999986

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.1e-34  Score=301.13  Aligned_cols=258  Identities=29%  Similarity=0.481  Sum_probs=234.6

Q ss_pred             CCCCEEECccCcccc--cCChhhhhccccceeEEecC-ccceeccCcccccccCCceEEecccccCCCCChhhcCCCCcc
Q 048668          188 SSLKVLSLSDNQFGG--ELPHSIANLSSTMIVFLIGG-NQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQ  264 (725)
Q Consensus       188 ~~L~~L~L~~N~l~~--~~p~~~~~l~~~l~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  264 (725)
                      .+++.|+|++|.+++  .+|..+.+++ .|+.|++++ |.+.+.+|..+.++++|++|+|++|++.+.+|..|..+++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            578888888888888  7888888887 888999985 888888999999999999999999999988999999999999


Q ss_pred             EEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcC
Q 048668          265 LLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL  344 (725)
Q Consensus       265 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l  344 (725)
                      +|+|++|.+.+.+|..|..+++|++|++++|+++           +.+|..+......+++|++++|.+++..|..+..+
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----------~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l  197 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS-----------GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL  197 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE-----------EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCccc-----------CcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC
Confidence            9999999999889999999999999999999554           47788888877455899999999998999999999


Q ss_pred             CCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEc
Q 048668          345 KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL  424 (725)
Q Consensus       345 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  424 (725)
                      + |+.|++++|.+++..|..|..+++|+.|+|++|.+++.+|. +..+++|+.|+|++|++++.+|..+..+++|++|+|
T Consensus       198 ~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  275 (313)
T 1ogq_A          198 N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV  275 (313)
T ss_dssp             C-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEEC
T ss_pred             c-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEEC
Confidence            7 99999999999999999999999999999999999977665 888999999999999999999999999999999999


Q ss_pred             ccccCeeecCCCCccCCCCCcCccCCccccCCCCC
Q 048668          425 SYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDE  459 (725)
Q Consensus       425 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~  459 (725)
                      ++|++++.+|....++.++.+.+.+|+++|+.+..
T Consensus       276 s~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             CSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             cCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            99999999999888899999999999999997643

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3e-33  Score=293.36  Aligned_cols=288  Identities=22%  Similarity=0.222  Sum_probs=161.2

Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeec
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNL  165 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L  165 (725)
                      +|+.+++++|.++ .+|..+   .++|+.|+|++|.++++.+..|.++++|++|+|++|+|+++.+..|..+++|++|++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCcc-ccCCCC---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            4555555555554 455433   245555555555555555555555555555555555555555555555555555555


Q ss_pred             CCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccce--eccCcccccccCCceEE
Q 048668          166 EQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS--GTIPLGIRNLVNLIALA  243 (725)
Q Consensus       166 ~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~--~~~~~~~~~l~~L~~L~  243 (725)
                      ++|.++.++..       +.  ++|++|++++|++++..+..+..++ +|+.|++++|.+.  +..+..+..+ +|+.|+
T Consensus       110 ~~n~l~~l~~~-------~~--~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~  178 (332)
T 2ft3_A          110 SKNHLVEIPPN-------LP--SSLVELRIHDNRIRKVPKGVFSGLR-NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR  178 (332)
T ss_dssp             CSSCCCSCCSS-------CC--TTCCEEECCSSCCCCCCSGGGSSCS-SCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB
T ss_pred             CCCcCCccCcc-------cc--ccCCEEECCCCccCccCHhHhCCCc-cCCEEECCCCccccCCCCcccccCC-ccCEEE
Confidence            55555433321       11  4555555555555422222222222 2222222222221  1223333333 455555


Q ss_pred             ecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccccccccc
Q 048668          244 VEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLS  323 (725)
Q Consensus       244 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll  323 (725)
                      +++|++++++.. +.  ++|++|++++|.+.+..+..|..+++|                                    
T Consensus       179 l~~n~l~~l~~~-~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L------------------------------------  219 (332)
T 2ft3_A          179 ISEAKLTGIPKD-LP--ETLNELHLDHNKIQAIELEDLLRYSKL------------------------------------  219 (332)
T ss_dssp             CCSSBCSSCCSS-SC--SSCSCCBCCSSCCCCCCTTSSTTCTTC------------------------------------
T ss_pred             CcCCCCCccCcc-cc--CCCCEEECCCCcCCccCHHHhcCCCCC------------------------------------
Confidence            555555432221 11  344445555554444444444444444                                    


Q ss_pred             ceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCC------CCCCE
Q 048668          324 LYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFL------KSIKF  397 (725)
Q Consensus       324 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~  397 (725)
                      ++|++++|.+++..+..|..+++|+.|+|++|+++ .+|..+..+++|++|++++|++++..+..|..+      .+|+.
T Consensus       220 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~  298 (332)
T 2ft3_A          220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG  298 (332)
T ss_dssp             SCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSE
T ss_pred             CEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccc
Confidence            44555555555556667788888888888888888 677778888888889998888887777777653      66889


Q ss_pred             EeCCCCccc--ccCcccccCCCCCCeEEccccc
Q 048668          398 LDVSCNNFS--GQFPKFLENLSFLEFLNLSYNH  428 (725)
Q Consensus       398 L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~N~  428 (725)
                      |++++|.+.  +..|.+|..++.|+.+++++|+
T Consensus       299 L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             EECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             eEeecCcccccccCcccccccchhhhhhccccc
Confidence            999999887  6778888899999999998874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-34  Score=319.31  Aligned_cols=170  Identities=25%  Similarity=0.336  Sum_probs=145.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHH---HHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSF---VAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|++.++||+|+||+||+|+++.+|+.||||++.+..   ......+   ..++++++.++|||||++++++...+  
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~--  265 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--  265 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence            457999999999999999999999999999999997532   2222333   34466777889999999999966544  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|+|||||+||+|.+++.+..      .+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+||
T Consensus       266 ---~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          266 ---KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             ---EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence               8999999999999999998754      589999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+.+....          ..+.+||+.|||||++.
T Consensus       334 ~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          334 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             CCCTTCEECSSCC----------CCSCCSCGGGCCHHHHS
T ss_pred             cccceeeecCCCC----------CCCccCCcCccCHHHHh
Confidence            9999998764321          12368999999999874

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=3.2e-37  Score=339.34  Aligned_cols=384  Identities=17%  Similarity=0.136  Sum_probs=193.1

Q ss_pred             ccCcEEecCCCccCccCCc-cccCCCCCcEEEccCCcCCc----cCCCCCCCCCCCCEEEccCCcccccCcccc-cccC-
Q 048668           13 FKLQALALAGNYLTGKLPD-FIGNLSALQVIHIKGNSLGG----KFPTTLGLLRNLVQLNVAENKFYGMFPRSI-CNIS-   85 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~-   85 (725)
                      ++|++|+|++|+++..... .+..+++|++|+|++|++++    .++..|..+++|++|+|++|.++...+..+ ..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            3566777777776643322 26666677777777776653    234555566666666666666654433332 2343 


Q ss_pred             ---CCceeeccCCCCCCCCC----hhhhcCCCCccEEEccCceeeeeCCCcc-----cccCccceecCCCccccccCccC
Q 048668           86 ---SLEYFYLTSNRFSGSLP----FDIVVNLPNLKELGIGANNFFGLIPDSL-----SNASNLELLDLSNNQFKGKVSID  153 (725)
Q Consensus        86 ---~L~~L~L~~N~l~~~~~----~~~~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~Ls~N~i~~~~~~~  153 (725)
                         +|++|+|++|+|+ ...    ...+..+++|++|+|++|.++...+..+     ...++|++|+|++|++++.....
T Consensus        83 ~~~~L~~L~L~~n~i~-~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLT-GAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             TTCCCCEEECTTSCCB-GGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             CCCceeEEEccCCCCC-HHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence               4666666666665 211    2234455566666666665543322222     12334555555555555432111


Q ss_pred             cccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhc----cccceeEEecCccceec-
Q 048668          154 FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL----SSTMIVFLIGGNQISGT-  228 (725)
Q Consensus       154 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l----~~~l~~L~l~~n~i~~~-  228 (725)
                      +                          +..+..+++|++|++++|.+++..+..+...    ...++.|++++|.+++. 
T Consensus       162 l--------------------------~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~  215 (461)
T 1z7x_W          162 L--------------------------ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN  215 (461)
T ss_dssp             H--------------------------HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred             H--------------------------HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence            1                          1223334445555555554443322222211    11334444444443321 


Q ss_pred             ---cCcccccccCCceEEecccccCCCC-----ChhhcCCCCccEEeccCcccccC----CCCCCcCCCCCCEEeCCCCc
Q 048668          229 ---IPLGIRNLVNLIALAVEVNQLHGTI-----PDVIGELKNLQLLGLYKNFLQGS----IPSGLGNLTKLAKLDLGSNS  296 (725)
Q Consensus       229 ---~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~  296 (725)
                         ++..+..+++|++|++++|.+.+..     +..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.
T Consensus       216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~  295 (461)
T 1z7x_W          216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE  295 (461)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred             HHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence               3444555566666666666665322     22233456667777777666542    34445556667777776665


Q ss_pred             CCCccccccccccccccccccccccccceecccCCccCCC----cchhhhcCCCCCeEEccCccccccCcccccc-----
Q 048668          297 LQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS----LPQQVGNLKNLIILDISSNQFSGMIPVTLST-----  367 (725)
Q Consensus       297 l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----  367 (725)
                      +++...       ..+...+......+++|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+..     
T Consensus       296 i~~~~~-------~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~  368 (461)
T 1z7x_W          296 LGDEGA-------RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQP  368 (461)
T ss_dssp             CHHHHH-------HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred             CchHHH-------HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCC
Confidence            441100       011111111112235566666665543    3445555666667777666666544444432     


Q ss_pred             ccCCcEEEccCCcccc----ccCccccCCCCCCEEeCCCCcccccCccccc-----CCCCCCeEEcccccCe
Q 048668          368 CVSLEYVDISSNCFHG----IIPPSLGFLKSIKFLDVSCNNFSGQFPKFLE-----NLSFLEFLNLSYNHLE  430 (725)
Q Consensus       368 l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~  430 (725)
                      .++|++|+|++|.+++    .+|..+..+++|+.|||++|++++.....+.     ....|+.|++.++.+.
T Consensus       369 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~  440 (461)
T 1z7x_W          369 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  440 (461)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             CCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence            4566666666666664    4555566666666666666666543111111     1234555555555544

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.3e-32  Score=288.32  Aligned_cols=275  Identities=17%  Similarity=0.215  Sum_probs=209.2

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      .+|..+..  ++++|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++. +|..+. 
T Consensus        45 ~lp~~~~~--~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~-  120 (330)
T 1xku_A           45 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP-  120 (330)
T ss_dssp             SCCCSCCT--TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC-
T ss_pred             ccCccCCC--CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc-
Confidence            57777764  89999999999997777799999999999999999998889999999999999999999985 444443 


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeee--eCCCcccccCccceecCCCccccccCccCcccccccC
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFG--LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW  161 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~  161 (725)
                       ++|++|++++|+++ .++...|.++++|++|++++|.++.  ..+..|.++++|++|++++|+++.++...+   ++|+
T Consensus       121 -~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~---~~L~  195 (330)
T 1xku_A          121 -KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLT  195 (330)
T ss_dssp             -TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC---TTCS
T ss_pred             -ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc---ccCC
Confidence             79999999999998 8888889999999999999999964  778899999999999999999998776544   7788


Q ss_pred             eeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCce
Q 048668          162 RLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA  241 (725)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~  241 (725)
                      +|++++|.++...+      ..+.++++|++|++++|++++..+..+..++ .|+.|++++|.++ .+|..+..+++|++
T Consensus       196 ~L~l~~n~l~~~~~------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~L~~  267 (330)
T 1xku_A          196 ELHLDGNKITKVDA------ASLKGLNNLAKLGLSFNSISAVDNGSLANTP-HLRELHLNNNKLV-KVPGGLADHKYIQV  267 (330)
T ss_dssp             EEECTTSCCCEECT------GGGTTCTTCCEEECCSSCCCEECTTTGGGST-TCCEEECCSSCCS-SCCTTTTTCSSCCE
T ss_pred             EEECCCCcCCccCH------HHhcCCCCCCEEECCCCcCceeChhhccCCC-CCCEEECCCCcCc-cCChhhccCCCcCE
Confidence            88999988876544      4567788888888888888865555555555 5666666666665 45555555666666


Q ss_pred             EEecccccCCCCChhhcCC------CCccEEeccCccccc--CCCCCCcCCCCCCEEeCCCC
Q 048668          242 LAVEVNQLHGTIPDVIGEL------KNLQLLGLYKNFLQG--SIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       242 L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N  295 (725)
                      |++++|+++++.+..|...      +.|+.|++++|.+..  ..|..|..+.+++.+++++|
T Consensus       268 L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             EECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             EECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence            6666666665555555432      345555555555432  33444555555555555554

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.6e-34  Score=298.67  Aligned_cols=176  Identities=24%  Similarity=0.326  Sum_probs=142.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  605 (725)
                      ..+.|++.+.||+|+||+||+|+++   .+++.||||++....  ...++.+|+++++.+ +|||||++++++...+   
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~---   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND---   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT---
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC---
Confidence            4567999999999999999999874   468899999986443  345788999999998 5999999999976554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CceEE
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHV  684 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~~kl  684 (725)
                        +.|+|||||+||+|.+++.         .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||
T Consensus        94 --~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           94 --HVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             --EEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred             --EEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence              8999999999999999984         478999999999999999999999   99999999999999877 79999


Q ss_pred             cccccccccccCCCCCC--------------------CCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTS--------------------SKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+...+......                    ........+.+||++|||||++.
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~  219 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT  219 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence            99999986543211000                    00011223468999999999874

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.9e-33  Score=291.77  Aligned_cols=249  Identities=29%  Similarity=0.439  Sum_probs=168.7

Q ss_pred             ccCcEEecCCCccCc--cCCccccCCCCCcEEEccC-CcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           13 FKLQALALAGNYLTG--KLPDFIGNLSALQVIHIKG-NSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      .++++|+|++|.+++  .+|..|..+++|++|+|++ |++.+..|..|+.+++|++|+|++|++++..|..|.++++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            356777777777776  6677777777777777774 6776666777777777777777777776666777777777777


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccC-ccceecCCCccccccCccCcccccccCeeecCCc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNAS-NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN  168 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N  168 (725)
                      |+|++|++++.+|.. +..+++|++|+|++|++++..|..+..++ +|++|+|++|++++..+..|..++ |++|++++|
T Consensus       130 L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N  207 (313)
T 1ogq_A          130 LDFSYNALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN  207 (313)
T ss_dssp             EECCSSEEESCCCGG-GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred             EeCCCCccCCcCChH-HhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence            777777776555543 45667777777777777666666666666 677777777777666666666555 666666666


Q ss_pred             cCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccc
Q 048668          169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ  248 (725)
Q Consensus       169 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~  248 (725)
                      .++...+      ..+.++++|++|+|++|++++                         .+|. +..+++|++|+|++|+
T Consensus       208 ~l~~~~~------~~~~~l~~L~~L~L~~N~l~~-------------------------~~~~-~~~l~~L~~L~Ls~N~  255 (313)
T 1ogq_A          208 MLEGDAS------VLFGSDKNTQKIHLAKNSLAF-------------------------DLGK-VGLSKNLNGLDLRNNR  255 (313)
T ss_dssp             EEEECCG------GGCCTTSCCSEEECCSSEECC-------------------------BGGG-CCCCTTCCEEECCSSC
T ss_pred             cccCcCC------HHHhcCCCCCEEECCCCceee-------------------------ecCc-ccccCCCCEEECcCCc
Confidence            5543322      334455555555555555542                         3332 4556778888888888


Q ss_pred             cCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCc
Q 048668          249 LHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNS  296 (725)
Q Consensus       249 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  296 (725)
                      +.+.+|.+|..+++|++|+|++|++++.+|.. ..+++|+.+++++|+
T Consensus       256 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             CEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             ccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            87777788888888888888888888777765 677778777787774

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-33  Score=312.11  Aligned_cols=172  Identities=21%  Similarity=0.324  Sum_probs=150.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|++++|||||++++++....     ..|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-----EEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence            467999999999999999999999999999999998765556678899999999999999999999976554     899


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--CceEEcccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--MVAHVGDFG  688 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~--~~~kl~Dfg  688 (725)
                      +|||||+||+|.+++.....     .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||
T Consensus       231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            99999999999999975432     589999999999999999999999   99999999999999854  899999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+...         ......+||+.|||||++.
T Consensus       303 ~a~~~~~~---------~~~~~~~GT~~y~APEv~~  329 (573)
T 3uto_A          303 LTAHLDPK---------QSVKVTTGTAEFAAPEVAE  329 (573)
T ss_dssp             SCEECCTT---------SEEEEECSSGGGCCHHHHT
T ss_pred             ceeEccCC---------CceeeeEECccccCHHHhC
Confidence            99876432         1123468999999999864

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=7.2e-36  Score=328.52  Aligned_cols=374  Identities=18%  Similarity=0.128  Sum_probs=258.7

Q ss_pred             ccCcccCcEEecCCCccCc----cCCccccCCCCCcEEEccCCcCCccCCCCC-CCCC----CCCEEEccCCcccc----
Q 048668            9 IGSLFKLQALALAGNYLTG----KLPDFIGNLSALQVIHIKGNSLGGKFPTTL-GLLR----NLVQLNVAENKFYG----   75 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~----~L~~L~Ls~N~l~~----   75 (725)
                      +..+++|++|+|++|.++.    .++..+..+++|++|+|++|++++..+..+ ..++    +|++|+|++|+|+.    
T Consensus        24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~  103 (461)
T 1z7x_W           24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  103 (461)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence            6678899999999999984    356788899999999999999976444333 3344    79999999999984    


Q ss_pred             cCcccccccCCCceeeccCCCCCCCCChh----hhcCCCCccEEEccCceeeeeC----CCcccccCccceecCCCcccc
Q 048668           76 MFPRSICNISSLEYFYLTSNRFSGSLPFD----IVVNLPNLKELGIGANNFFGLI----PDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus        76 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                      .++..+..+++|++|+|++|.+++..+..    .+...++|++|+|++|+++...    +..+..+++|++|+|++|+++
T Consensus       104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  183 (461)
T 1z7x_W          104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN  183 (461)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence            45889999999999999999997332322    2334678999999999998643    556777899999999999998


Q ss_pred             ccCccCccc-----ccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecC
Q 048668          148 GKVSIDFSS-----LKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGG  222 (725)
Q Consensus       148 ~~~~~~f~~-----l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~  222 (725)
                      +.....+..     .++|++|++++|.++.....  .++..+..+++|++|++++|.+++.....+..            
T Consensus       184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~------------  249 (461)
T 1z7x_W          184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--DLCGIVASKASLRELALGSNKLGDVGMAELCP------------  249 (461)
T ss_dssp             HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH------------
T ss_pred             hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--HHHHHHHhCCCccEEeccCCcCChHHHHHHHH------------
Confidence            765544433     45899999999988753211  12345667788899999988887432222211            


Q ss_pred             ccceeccCcccccccCCceEEecccccCCC----CChhhcCCCCccEEeccCcccccCCCCCCc-----CCCCCCEEeCC
Q 048668          223 NQISGTIPLGIRNLVNLIALAVEVNQLHGT----IPDVIGELKNLQLLGLYKNFLQGSIPSGLG-----NLTKLAKLDLG  293 (725)
Q Consensus       223 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~  293 (725)
                              ..+..+++|++|++++|+++..    ++..+..+++|++|++++|.+.+..+..+.     ..++|++|+++
T Consensus       250 --------~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  321 (461)
T 1z7x_W          250 --------GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK  321 (461)
T ss_dssp             --------HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             --------HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence                    1122355666777777766643    345556667777777777766543332222     22577777777


Q ss_pred             CCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhc-----CCCCCeEEccCccccc----cCccc
Q 048668          294 SNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGN-----LKNLIILDISSNQFSG----MIPVT  364 (725)
Q Consensus       294 ~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~  364 (725)
                      +|.+++..       ...++..+.....+ ++|++++|.+++..+..+..     .++|+.|+|++|.+++    .+|..
T Consensus       322 ~n~l~~~~-------~~~l~~~l~~~~~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~  393 (461)
T 1z7x_W          322 SCSFTAAC-------CSHFSSVLAQNRFL-LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  393 (461)
T ss_dssp             TSCCBGGG-------HHHHHHHHHHCSSC-CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             CCCCchHH-------HHHHHHHHhhCCCc-cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence            77655210       11233333344444 67777777776554544443     6789999999999986    67888


Q ss_pred             cccccCCcEEEccCCccccccCcccc-----CCCCCCEEeCCCCcccccCccc
Q 048668          365 LSTCVSLEYVDISSNCFHGIIPPSLG-----FLKSIKFLDVSCNNFSGQFPKF  412 (725)
Q Consensus       365 ~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~p~~  412 (725)
                      +..+++|++|+|++|.+++.....+.     ....|+.|++.++.+....+..
T Consensus       394 l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~  446 (461)
T 1z7x_W          394 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR  446 (461)
T ss_dssp             HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred             HHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHH
Confidence            88889999999999998864222222     2346788888877776544443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.5e-31  Score=280.11  Aligned_cols=283  Identities=18%  Similarity=0.159  Sum_probs=233.3

Q ss_pred             CccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccC
Q 048668            6 PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNIS   85 (725)
Q Consensus         6 p~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   85 (725)
                      ++.-..++.....++++|.++ .+|..+.  ++|++|++++|+++++.+..|.++++|++|+|++|+++++.|.+|.+++
T Consensus        24 ~~~~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  100 (353)
T 2z80_A           24 NQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG  100 (353)
T ss_dssp             ---CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             CccCCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence            334455667777899999998 6777665  5899999999999988888899999999999999999988888999999


Q ss_pred             CCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC-CcccccCccceecCCCc-cccccCccCcccccccCee
Q 048668           86 SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNN-QFKGKVSIDFSSLKILWRL  163 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N-~i~~~~~~~f~~l~~L~~L  163 (725)
                      +|++|+|++|+|+ .+|...|.++++|++|+|++|+++.+.+ ..|..+++|++|++++| .++.+.+..|..+++|++|
T Consensus       101 ~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L  179 (353)
T 2z80_A          101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL  179 (353)
T ss_dssp             TCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred             CCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence            9999999999998 8888888899999999999999997765 57899999999999999 5888888889999999999


Q ss_pred             ecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccc---cccCCc
Q 048668          164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIR---NLVNLI  240 (725)
Q Consensus       164 ~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~---~l~~L~  240 (725)
                      ++++|.++...+      ..+.++++|++|++++|+++ .+|..+......++.|++++|.+++..+..+.   ....++
T Consensus       180 ~l~~n~l~~~~~------~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~  252 (353)
T 2z80_A          180 EIDASDLQSYEP------KSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK  252 (353)
T ss_dssp             EEEETTCCEECT------TTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCC
T ss_pred             ECCCCCcCccCH------HHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhh
Confidence            999999886644      45778899999999999987 55555554444899999999999876555443   356788


Q ss_pred             eEEecccccCC----CCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCC
Q 048668          241 ALAVEVNQLHG----TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG  299 (725)
Q Consensus       241 ~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  299 (725)
                      .++|+++.+.+    .+|.++..+++|++|++++|+++...+..|..+++|++|++++|++++
T Consensus       253 ~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          253 KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence            88888888875    357788999999999999999995444446899999999999997763

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=9.7e-32  Score=284.37  Aligned_cols=267  Identities=19%  Similarity=0.235  Sum_probs=233.7

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      .+||+.+..  +|++|++++|++++..+..|..+++|++|++++|++++..|.+|.++++|++|+|++|+++++.+..|.
T Consensus        44 ~~iP~~~~~--~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  121 (353)
T 2z80_A           44 NSIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFK  121 (353)
T ss_dssp             SSCCTTCCT--TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHT
T ss_pred             ccccccccc--cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhC
Confidence            368887775  899999999999976667999999999999999999999999999999999999999999977777799


Q ss_pred             ccCCCceeeccCCCCCCCCCh-hhhcCCCCccEEEccCc-eeeeeCCCcccccCccceecCCCccccccCccCccccccc
Q 048668           83 NISSLEYFYLTSNRFSGSLPF-DIVVNLPNLKELGIGAN-NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL  160 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L  160 (725)
                      ++++|++|+|++|+++ .+|. ..|.++++|++|++++| .++.+.+..|.++++|++|++++|+++++.+..|..+++|
T Consensus       122 ~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  200 (353)
T 2z80_A          122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV  200 (353)
T ss_dssp             TCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred             CCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccC
Confidence            9999999999999998 8887 77889999999999999 5888888999999999999999999999999999999999


Q ss_pred             CeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhh--ccccceeEEecCcccee----ccCcccc
Q 048668          161 WRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIAN--LSSTMIVFLIGGNQISG----TIPLGIR  234 (725)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~~l~~L~l~~n~i~~----~~~~~~~  234 (725)
                      ++|++++|.++.++.      ..+..+++|++|++++|++++..+..+..  ....++.+.+.++.+.+    .+|..+.
T Consensus       201 ~~L~l~~n~l~~~~~------~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~  274 (353)
T 2z80_A          201 SHLILHMKQHILLLE------IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN  274 (353)
T ss_dssp             EEEEEECSCSTTHHH------HHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHH
T ss_pred             CeecCCCCccccchh------hhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHh
Confidence            999999999975543      33456899999999999999765554432  23367788888888876    4678889


Q ss_pred             cccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCC
Q 048668          235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP  278 (725)
Q Consensus       235 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  278 (725)
                      .+++|++|++++|+++.+++..|..+++|++|++++|.+.+..|
T Consensus       275 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            99999999999999997766678999999999999999986443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=3.7e-30  Score=281.64  Aligned_cols=248  Identities=22%  Similarity=0.197  Sum_probs=209.9

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +...++.+++.++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            4678899999988 6777665  689999999999998889999999999999999999998888999999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCC-ccccccCccCcccccccCeeecCCccCCc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSN-NQFKGKVSIDFSSLKILWRLNLEQNNLGI  172 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~f~~l~~L~~L~L~~N~l~~  172 (725)
                      +|+|+ .+|...|.++++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+..+++..|..+++|++|+|++|.++.
T Consensus       132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            99998 88888888999999999999999988888899999999999998 67777888888888899999999998876


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT  252 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  252 (725)
                      ++.        +..+++|++|+|++|++++.                         .|..|.++++|+.|+|++|++.++
T Consensus       211 ~~~--------~~~l~~L~~L~Ls~N~l~~~-------------------------~~~~~~~l~~L~~L~L~~n~l~~~  257 (452)
T 3zyi_A          211 MPN--------LTPLVGLEELEMSGNHFPEI-------------------------RPGSFHGLSSLKKLWVMNSQVSLI  257 (452)
T ss_dssp             CCC--------CTTCTTCCEEECTTSCCSEE-------------------------CGGGGTTCTTCCEEECTTSCCCEE
T ss_pred             ccc--------ccccccccEEECcCCcCccc-------------------------CcccccCccCCCEEEeCCCcCceE
Confidence            532        56777888888888877743                         345566677888888888888888


Q ss_pred             CChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCC
Q 048668          253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      .+.+|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            8888888888888888888888777777888888888888888655

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=4.3e-30  Score=280.15  Aligned_cols=248  Identities=22%  Similarity=0.245  Sum_probs=207.0

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      ..+.++.+++.++ .+|..+.  ++++.|+|++|+++++.+..|.++++|++|+|++|+|+.+.+.+|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            3678888888888 6777665  688999999999988888889999999999999999988888889999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCC-ccccccCccCcccccccCeeecCCccCCc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSN-NQFKGKVSIDFSSLKILWRLNLEQNNLGI  172 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~f~~l~~L~~L~L~~N~l~~  172 (725)
                      +|+|+ .+|...|.++++|++|+|++|+|+.+.+..|..+++|++|+|++ |.+..+.+..|..+++|++|+|++|.++.
T Consensus       121 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             SSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             CCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            99998 88888888899999999999999988888889999999999988 56777777788888888888888888875


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT  252 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  252 (725)
                      ++.        +..+++|++|+|++|++++                         ..|..|.++++|+.|+|++|++.++
T Consensus       200 ~~~--------~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~n~l~~~  246 (440)
T 3zyj_A          200 IPN--------LTPLIKLDELDLSGNHLSA-------------------------IRPGSFQGLMHLQKLWMIQSQIQVI  246 (440)
T ss_dssp             CCC--------CTTCSSCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             ccc--------cCCCcccCEEECCCCccCc-------------------------cChhhhccCccCCEEECCCCceeEE
Confidence            532        5667778888877777764                         3455666777888888888888888


Q ss_pred             CChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCC
Q 048668          253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      .+.+|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       247 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            8888888888888888888888777777888888888888888654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=6.5e-31  Score=274.07  Aligned_cols=171  Identities=25%  Similarity=0.410  Sum_probs=149.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|+..+.||+|+||.||+|++..+|+.||||++....  ....+++.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-----   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence            3568999999999999999999999999999999997543  334567889999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             EEEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence            7899999999999999997654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+......         .....+||+.|+|||++
T Consensus       159 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~  185 (328)
T 3fe3_A          159 GFSNEFTVGG---------KLDAFCGAPPYAAPELF  185 (328)
T ss_dssp             TCCGGGSSSC---------GGGTTSSSGGGCCHHHH
T ss_pred             cCceecCCCC---------ccccccCCcceeCcccc
Confidence            9998654321         12236799999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=1.3e-30  Score=268.40  Aligned_cols=170  Identities=25%  Similarity=0.393  Sum_probs=150.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++...+     ..|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence            457999999999999999999999999999999998766666678999999999999999999999987655     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            999999999999999754       478999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......        .....+||+.|+|||++
T Consensus       164 ~~~~~~~~--------~~~~~~gt~~y~aPE~~  188 (297)
T 3fxz_A          164 AQITPEQS--------KRSTMVGTPYWMAPEVV  188 (297)
T ss_dssp             EECCSTTC--------CBCCCCSCGGGCCHHHH
T ss_pred             eecCCccc--------ccCCccCCcCccChhhh
Confidence            87643321        11235799999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=9.7e-31  Score=273.50  Aligned_cols=172  Identities=27%  Similarity=0.355  Sum_probs=149.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||+||+|+++.+++.||+|+++..   .....+.+.+|++++++++||||+++++++....     
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-----
Confidence            46789999999999999999999999999999999754   2345577899999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence            8899999999999999997654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......        ......+||+.|||||++.
T Consensus       150 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~  178 (337)
T 1o6l_A          150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             TTCBCSCCTT--------CCBCCCEECGGGCCGGGGS
T ss_pred             cchhhcccCC--------CcccccccChhhCChhhhc
Confidence            9998643221        1122367999999999863

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=4.8e-30  Score=265.72  Aligned_cols=249  Identities=22%  Similarity=0.223  Sum_probs=196.5

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc--CcccccccCCCceeec
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM--FPRSICNISSLEYFYL   92 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L   92 (725)
                      .+.++++++.++ .+|..+.  ++|++|+|++|+++.+.+..|.++++|++|+|++|+++..  .+..+..+++|++|+|
T Consensus         9 ~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             CCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            468889999888 6776554  6889999999999876677788899999999999988743  3667778888999999


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC-CcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      ++|.++ .+|.. +.++++|++|++++|+++++.+ ..|..+++|++|++++|+++++.+..|..+++|++|++++|.++
T Consensus        86 s~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  163 (306)
T 2z66_A           86 SFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  163 (306)
T ss_dssp             CSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence            999887 67755 5678888888888888887765 57888888888888888888777777777777777777777765


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCC
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  251 (725)
                      ...     .+..+.++++|++|++++|++++                         ..|..+..+++|++|+|++|++.+
T Consensus       164 ~~~-----~~~~~~~l~~L~~L~Ls~n~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~~  213 (306)
T 2z66_A          164 ENF-----LPDIFTELRNLTFLDLSQCQLEQ-------------------------LSPTAFNSLSSLQVLNMSHNNFFS  213 (306)
T ss_dssp             GGE-----ECSCCTTCTTCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEECTTSCCSB
T ss_pred             ccc-----chhHHhhCcCCCEEECCCCCcCC-------------------------cCHHHhcCCCCCCEEECCCCccCc
Confidence            310     11345566677777776666653                         445567777889999999999988


Q ss_pred             CCChhhcCCCCccEEeccCcccccCCCCCCcCCC-CCCEEeCCCCcCC
Q 048668          252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLT-KLAKLDLGSNSLQ  298 (725)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  298 (725)
                      ..+..+..+++|++|++++|.+.+..|..+..++ +|++|++++|+++
T Consensus       214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence            8888888899999999999999988888888885 8999999999765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=5.8e-31  Score=283.97  Aligned_cols=178  Identities=24%  Similarity=0.326  Sum_probs=150.9

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      +....++|+..+.||+|+||+||+|+++.+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.... 
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-  147 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-  147 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS-
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence            3345678999999999999999999999999999999997532   223345889999999999999999999976654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..|+|||||+||+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       148 ----~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          148 ----NLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             ----EEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ----EEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEE
Confidence                88999999999999999986432     589999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+|+.......       ......+||+.|||||++.
T Consensus       216 L~DFGla~~~~~~~~-------~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          216 LADFGSCLKLMEDGT-------VQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             ECCCTTCEECCTTSC-------EECCSCCSCGGGCCHHHHH
T ss_pred             EcchhhhhhcccCCC-------cccccccCCcCeeChHHHh
Confidence            999999986643211       1122357999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=9.1e-31  Score=275.54  Aligned_cols=172  Identities=27%  Similarity=0.386  Sum_probs=144.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|+..+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+++++.+ +||||+++++++....   
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~---   97 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD---   97 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC---
Confidence            457899999999999999999999999999999999754   233456788999999988 6999999999976554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        98 --~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           98 --RLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             --EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence              7899999999999999998654      589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+......        ......+||+.|||||++
T Consensus       167 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~  196 (353)
T 3txo_A          167 DFGMCKEGICNG--------VTTATFCGTPDYIAPEIL  196 (353)
T ss_dssp             CCTTCBCSCC-----------------CCGGGCCHHHH
T ss_pred             cccceeecccCC--------ccccccCCCcCeEChhhc
Confidence            999998543221        122346899999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=6e-31  Score=281.68  Aligned_cols=177  Identities=20%  Similarity=0.320  Sum_probs=150.3

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      ++....++|+..+.||+|+||+||+|+++.+++.||+|++....   ....+.+.+|+++++.++||||+++++++....
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            33445678999999999999999999999999999999997531   223356789999999999999999999976554


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                           ..|+|||||+||+|.++++..       .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus       143 -----~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          143 -----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             -----EEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             -----EEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCE
Confidence                 889999999999999999753       478999999999999999999999   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.......       ....+.+||+.|||||++.
T Consensus       208 kL~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~APE~l~  242 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLK  242 (410)
T ss_dssp             EECCCTTCEECCTTSE-------EECCSCCSCGGGCCHHHHH
T ss_pred             EEeccceeEeeccCCc-------ccccCCcCCccccCHHHhh
Confidence            9999999987643211       1122467999999999863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=274.77  Aligned_cols=171  Identities=25%  Similarity=0.404  Sum_probs=150.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-----   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            357899999999999999999999999999999997532   344578899999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence            7899999999999999998654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.+....         .....+||+.|||||++.
T Consensus       160 G~a~~~~~~~---------~~~~~~gt~~Y~aPE~~~  187 (384)
T 4fr4_A          160 NIAAMLPRET---------QITTMAGTKPYMAPEMFS  187 (384)
T ss_dssp             TTCEECCTTC---------CBCCCCSCGGGCCGGGTC
T ss_pred             ceeeeccCCC---------ceeccCCCccccCCeeec
Confidence            9998764321         122367999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=3e-30  Score=267.85  Aligned_cols=181  Identities=24%  Similarity=0.423  Sum_probs=150.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|...+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....     ..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeE
Confidence            357888999999999999999999999999999986655566788999999999999999999999987654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.++++....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence            99999999999999987432     589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCC------CCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSS------KTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +...........      .........+||+.|+|||++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN  195 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHT
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhc
Confidence            876443221110      0011122467999999999863

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=280.01  Aligned_cols=178  Identities=24%  Similarity=0.347  Sum_probs=151.0

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      .....++|+..+.||+|+||+||+|+++.+++.||||+++...   ....+.+.+|.+++.+++||||+++++++.... 
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-  134 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-  134 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS-
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-
Confidence            3345678999999999999999999999999999999997532   223456789999999999999999999976554 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..|+||||++||+|.+++.....     .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       135 ----~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          135 ----YLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ----EEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEE
Confidence                89999999999999999976432     589999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+|+.......       ......+||+.|||||++.
T Consensus       203 L~DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          203 LADFGSCLKLRADGT-------VRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             ECCCTTCEECCTTSC-------EECSSCCSCGGGCCHHHHH
T ss_pred             EeechhheeccCCCc-------cccceeccccCcCCHHHHh
Confidence            999999987643211       1122357999999999863

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=1.9e-30  Score=276.12  Aligned_cols=172  Identities=23%  Similarity=0.329  Sum_probs=147.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||+||+|+++.+++.||+|+++...   ....+.+.+|..+++++ +||||+++++++....    
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----  126 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----  126 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence            467999999999999999999999999999999997542   22335678999999887 7999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       127 -~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          127 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             -EEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence             8999999999999999998654      589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+......        ......+||+.|||||++.
T Consensus       197 FGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~  226 (396)
T 4dc2_A          197 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILR  226 (396)
T ss_dssp             CTTCBCCCCTT--------CCBCCCCBCGGGCCHHHHT
T ss_pred             cceeeecccCC--------CccccccCCcccCCchhhc
Confidence            99998532211        1223468999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=6.4e-30  Score=266.34  Aligned_cols=182  Identities=24%  Similarity=0.336  Sum_probs=154.6

Q ss_pred             CccCHHHHHHHhcC----------CCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCC
Q 048668          520 PMVSYAELSKATSE----------FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR  589 (725)
Q Consensus       520 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  589 (725)
                      +.++.+++..++..          |+..+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            44566666666543          56667899999999999999989999999999876666678899999999999999


Q ss_pred             cccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCC
Q 048668          590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDL  669 (725)
Q Consensus       590 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdl  669 (725)
                      ||+++++++....     ..|+||||+++|+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||
T Consensus       103 niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  167 (321)
T 2c30_A          103 NVVEMYKSYLVGE-----ELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI  167 (321)
T ss_dssp             TBCCEEEEEEETT-----EEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             CcceEEEEEEECC-----EEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence            9999999987655     789999999999999998743       489999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          670 KPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       670 kp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+||+++.++.+||+|||+++.......        .....+||+.|+|||++.
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  214 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKDVP--------KRKSLVGTPYWMAPEVIS  214 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSSSC--------CBCCCCSCGGGCCHHHHT
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccCcc--------ccccccCCccccCHhhhc
Confidence            99999999999999999999987643211        112357999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=2.8e-30  Score=270.72  Aligned_cols=174  Identities=24%  Similarity=0.384  Sum_probs=148.7

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      ...++|+..+.||+|+||.||+|+++.+++.||||+++...   ....+.+..|.++++.+ +||||+++++++....  
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~--   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC--
Confidence            45678999999999999999999999999999999997542   33456788999999987 8999999999976554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||
T Consensus        92 ---~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           92 ---NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             ---EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             ---EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence               7899999999999999998654      589999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+......        ......+||+.|+|||++.
T Consensus       160 ~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~  191 (345)
T 1xjd_A          160 ADFGMCKENMLGD--------AKTNTFCGTPDYIAPEILL  191 (345)
T ss_dssp             CCCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHT
T ss_pred             eEChhhhhcccCC--------CcccCCCCCcccCChhhhc
Confidence            9999998543221        1122468999999999863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=5.9e-30  Score=270.02  Aligned_cols=171  Identities=26%  Similarity=0.345  Sum_probs=148.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .+.|+..+.||+|+||.||+|++..+|+.||+|++.....      ...+.+.+|++++++++||||+++++++....  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--   88 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT--   88 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence            4578999999999999999999999999999999975432      13578899999999999999999999976554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~----  680 (725)
                         ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++    
T Consensus        89 ---~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           89 ---DVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             ---EEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence               7899999999999999997654      589999999999999999999999   999999999999998877    


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+||+|||+|+......         .....+||+.|+|||++.
T Consensus       157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  191 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVN  191 (361)
T ss_dssp             CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHT
T ss_pred             CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHc
Confidence            79999999998764421         112357999999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=4.4e-30  Score=266.56  Aligned_cols=169  Identities=26%  Similarity=0.374  Sum_probs=148.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||+||+|+++.+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-----
Confidence            467899999999999999999999999999999997542   234567889999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence            7899999999999999998654      588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....           ....+||+.|+|||++.
T Consensus       151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~  176 (318)
T 1fot_A          151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVS  176 (318)
T ss_dssp             SSCEECSSC-----------BCCCCSCTTTCCHHHHT
T ss_pred             CcceecCCc-----------cccccCCccccCHhHhc
Confidence            999865321           12357999999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=4.8e-30  Score=269.50  Aligned_cols=172  Identities=24%  Similarity=0.330  Sum_probs=147.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+++++++ +||||+++++++....    
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----   83 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----   83 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC----
Confidence            357899999999999999999999999999999997543   23456788999999988 8999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        84 -~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           84 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             -EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence             8899999999999999997654      589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+......        ......+||+.|+|||++.
T Consensus       154 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~  183 (345)
T 3a8x_A          154 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILR  183 (345)
T ss_dssp             GGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHT
T ss_pred             ccccccccCCC--------CcccccCCCccccCccccC
Confidence            99998542211        1122367999999999863

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.8e-29  Score=273.64  Aligned_cols=249  Identities=24%  Similarity=0.290  Sum_probs=218.6

Q ss_pred             CCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEE
Q 048668           37 SALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG  116 (725)
Q Consensus        37 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  116 (725)
                      ...+.++.++++++ .+|..+.  +++++|+|++|+|+.+.+..|.++++|++|+|++|+|+ .++...|.++++|++|+
T Consensus        43 ~~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~  118 (440)
T 3zyj_A           43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE  118 (440)
T ss_dssp             TTSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEE
T ss_pred             CCCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEE
Confidence            35678999999998 6666665  68999999999999989999999999999999999998 88888899999999999


Q ss_pred             ccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCC-ccCCccCCCCcccccccCCCCCCCEEEC
Q 048668          117 IGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ-NNLGIGAANDLGFVTFLTNCSSLKVLSL  195 (725)
Q Consensus       117 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~~l~~L~~L~L  195 (725)
                      |++|+|+.+.+..|..+++|++|+|++|+|+.+++..|..+++|++|++++ |.+..++.      ..|.++++|++|+|
T Consensus       119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------~~~~~l~~L~~L~L  192 (440)
T 3zyj_A          119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE------GAFEGLSNLRYLNL  192 (440)
T ss_dssp             CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------TTTTTCSSCCEEEC
T ss_pred             CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc------chhhcccccCeecC
Confidence            999999988888999999999999999999999999999999999999998 45554443      45778899999999


Q ss_pred             ccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCccccc
Q 048668          196 SDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       196 ~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      ++|+++.                          +| .+..+++|++|+|++|+++++.|..|.++++|++|+|++|++.+
T Consensus       193 ~~n~l~~--------------------------~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  245 (440)
T 3zyj_A          193 AMCNLRE--------------------------IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV  245 (440)
T ss_dssp             TTSCCSS--------------------------CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred             CCCcCcc--------------------------cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence            9998872                          22 25678899999999999999999999999999999999999999


Q ss_pred             CCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccC
Q 048668          276 SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN  334 (725)
Q Consensus       276 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~  334 (725)
                      ..+..|..+++|++|+|++|+|+            .+|...+.....++.|+|++|.+.
T Consensus       246 ~~~~~~~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          246 IERNAFDNLQSLVEINLAHNNLT------------LLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             ECTTSSTTCTTCCEEECTTSCCC------------CCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             EChhhhcCCCCCCEEECCCCCCC------------ccChhHhccccCCCEEEcCCCCcc
Confidence            99999999999999999999888            566666554444589999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=4.8e-30  Score=269.87  Aligned_cols=173  Identities=23%  Similarity=0.318  Sum_probs=148.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|+..+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|.++++.+ +||+|+++++++....   
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~---   94 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD---   94 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS---
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC---
Confidence            456899999999999999999999999999999999754   234457788999999988 7999999999876544   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..|+||||++||+|.+++....      .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        95 --~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           95 --RLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             --EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence              8999999999999999998654      589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+......        ......+||+.|||||++.
T Consensus       164 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~  194 (353)
T 2i0e_A          164 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIA  194 (353)
T ss_dssp             CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHT
T ss_pred             eCCcccccccCC--------cccccccCCccccChhhhc
Confidence            999998542211        1122467999999999863

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=8.5e-30  Score=260.97  Aligned_cols=226  Identities=23%  Similarity=0.227  Sum_probs=183.4

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      -++++.+++.++ .+|..+  .++|++|++++|++++..+..|..+++|++|+|++|.++++.|..|.++++|++|++++
T Consensus        13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            478999999998 667655  46899999999999988888999999999999999999988899999999999999999


Q ss_pred             CC-CCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           95 NR-FSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        95 N~-l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      |+ ++ .++...|..+++|++|+|++|.++++.+..|.++++|++|+|++|+++++++..|..+++|++|++++|.++.+
T Consensus        90 n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  168 (285)
T 1ozn_A           90 NAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (285)
T ss_dssp             CTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence            97 76 77777788999999999999999988888899999999999999999988888888888888888888888765


Q ss_pred             CCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCC
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI  253 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  253 (725)
                      +.      ..+.++++|++|++++|.+++..|.                         .+..+++|+.|++++|+++++.
T Consensus       169 ~~------~~~~~l~~L~~L~l~~n~l~~~~~~-------------------------~~~~l~~L~~L~l~~n~l~~~~  217 (285)
T 1ozn_A          169 PE------RAFRGLHSLDRLLLHQNRVAHVHPH-------------------------AFRDLGRLMTLYLFANNLSALP  217 (285)
T ss_dssp             CT------TTTTTCTTCCEEECCSSCCCEECTT-------------------------TTTTCTTCCEEECCSSCCSCCC
T ss_pred             CH------HHhcCccccCEEECCCCcccccCHh-------------------------HccCcccccEeeCCCCcCCcCC
Confidence            54      3466778888888888887754444                         4455556666666666666555


Q ss_pred             ChhhcCCCCccEEeccCccccc
Q 048668          254 PDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       254 ~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      +..+..+++|++|++++|.+..
T Consensus       218 ~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          218 TEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             HHHHTTCTTCCEEECCSSCEEC
T ss_pred             HHHcccCcccCEEeccCCCccC
Confidence            5556666666666666666653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.7e-29  Score=273.74  Aligned_cols=249  Identities=22%  Similarity=0.259  Sum_probs=215.9

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      ....++.++++++ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+ .++...|.++++|++|+|
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEEC
Confidence            4678999999998 5666555  68999999999999988999999999999999999998 777778889999999999


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCC-ccCCccCCCCcccccccCCCCCCCEEECc
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ-NNLGIGAANDLGFVTFLTNCSSLKVLSLS  196 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~~~l~~L~~L~L~  196 (725)
                      ++|+|+.+.+..|..+++|++|+|++|+|+.+++..|..+++|++|++++ |.+..++.      ..+.++++|++|+|+
T Consensus       131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------~~~~~l~~L~~L~L~  204 (452)
T 3zyi_A          131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE------GAFEGLFNLKYLNLG  204 (452)
T ss_dssp             CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------TTTTTCTTCCEEECT
T ss_pred             CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh------hhccCCCCCCEEECC
Confidence            99999988888899999999999999999999988999999999999998 55554443      346788889999998


Q ss_pred             cCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccC
Q 048668          197 DNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGS  276 (725)
Q Consensus       197 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  276 (725)
                      +|++++                          +| .+..+++|++|+|++|++.++.|..|.++++|++|+|++|.+.+.
T Consensus       205 ~n~l~~--------------------------~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  257 (452)
T 3zyi_A          205 MCNIKD--------------------------MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI  257 (452)
T ss_dssp             TSCCSS--------------------------CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred             CCcccc--------------------------cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence            888872                          12 256788999999999999999999999999999999999999999


Q ss_pred             CCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCC
Q 048668          277 IPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG  335 (725)
Q Consensus       277 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~  335 (725)
                      .+..|..+++|++|+|++|+|+            .+|...+.....++.|+|++|.+.-
T Consensus       258 ~~~~~~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          258 ERNAFDGLASLVELNLAHNNLS------------SLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCS------------CCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             CHHHhcCCCCCCEEECCCCcCC------------ccChHHhccccCCCEEEccCCCcCC
Confidence            9999999999999999999887            5666665544445899999999873

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=1.3e-29  Score=265.91  Aligned_cols=188  Identities=26%  Similarity=0.417  Sum_probs=148.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-----
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-----  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  603 (725)
                      ..++|+..+.||+|+||.||+|+++.+++.||||++.... ....+.+.+|++++++++||||++++++|.....     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3467899999999999999999999999999999997543 3456789999999999999999999999865431     


Q ss_pred             -----------------------------------------------CCcceeeEEEeccCCCCHHHHhcccCCcccccc
Q 048668          604 -----------------------------------------------KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK  636 (725)
Q Consensus       604 -----------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  636 (725)
                                                                     ....+.++||||+++|+|.+++......   ..
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~  160 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---ED  160 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GG
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cc
Confidence                                                           1122479999999999999999876532   24


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCC----CCCccccccc
Q 048668          637 LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSS----KTPSSSIGIK  712 (725)
Q Consensus       637 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~----~~~~~~~~~~  712 (725)
                      .++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+...........    .........+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            57778899999999999999999   9999999999999999999999999999876543211110    0011223357


Q ss_pred             CCccccCCCcc
Q 048668          713 GTVGYVAPGKF  723 (725)
Q Consensus       713 gt~~y~aPE~~  723 (725)
                      ||+.|+|||++
T Consensus       238 gt~~y~aPE~~  248 (332)
T 3qd2_B          238 GTKLYMSPEQI  248 (332)
T ss_dssp             -CGGGSCHHHH
T ss_pred             CCcCccChHHh
Confidence            99999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=6.7e-30  Score=268.76  Aligned_cols=169  Identities=25%  Similarity=0.353  Sum_probs=148.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----
Confidence            357899999999999999999999999999999997542   234578899999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence            7899999999999999998654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....           ....+||+.|+|||++.
T Consensus       186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~  211 (350)
T 1rdq_E          186 GFAKRVKGR-----------TWTLCGTPEALAPEIIL  211 (350)
T ss_dssp             TTCEECSSC-----------BCCCEECGGGCCHHHHT
T ss_pred             ccceeccCC-----------cccccCCccccCHHHhc
Confidence            999865322           12357999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.96  E-value=6.5e-30  Score=280.23  Aligned_cols=184  Identities=23%  Similarity=0.361  Sum_probs=140.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||+||+|+++.+++.||||++...  .....+++.+|++++++++||||+++++++....++....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            35799999999999999999999999999999999643  2334578899999999999999999999987766666678


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+ +|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            99999998 569999997654      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCC-------------------CCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSS-------------------KTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+...........                   .........+||++|||||+++
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  256 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL  256 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence            99876432211000                   0001233467999999999763

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=6.7e-30  Score=264.65  Aligned_cols=236  Identities=21%  Similarity=0.218  Sum_probs=190.1

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCcc--CCCCCCCCCCCCEEEccCCcccccCcccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGK--FPTTLGLLRNLVQLNVAENKFYGMFPRSI   81 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~   81 (725)
                      +||..+.  ++|++|+|++|+++...+..|..+++|++|+|++|+++..  .+..+..+++|++|+|++|.++ .+|..+
T Consensus        21 ~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~   97 (306)
T 2z66_A           21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF   97 (306)
T ss_dssp             SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEE
T ss_pred             cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhc
Confidence            5787776  4899999999999955556789999999999999999843  3677778999999999999998 467779


Q ss_pred             cccCCCceeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccc-cCccCcccccc
Q 048668           82 CNISSLEYFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG-KVSIDFSSLKI  159 (725)
Q Consensus        82 ~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~f~~l~~  159 (725)
                      .++++|++|++++|+++ .++. ..+..+++|++|++++|.+++..+..|..+++|++|+|++|++++ ..+..|..+++
T Consensus        98 ~~l~~L~~L~l~~n~l~-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  176 (306)
T 2z66_A           98 LGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN  176 (306)
T ss_dssp             ETCTTCCEEECTTSEEE-SSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             CCCCCCCEEECCCCccc-ccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcC
Confidence            99999999999999998 5654 678899999999999999999999999999999999999999987 67788999999


Q ss_pred             cCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCccccccc-C
Q 048668          160 LWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV-N  238 (725)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~-~  238 (725)
                      |++|++++|.++...+      ..+.++++|++|+|++|++++..+..+..++ .|+.|++++|.+.+..|..+..++ +
T Consensus       177 L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~  249 (306)
T 2z66_A          177 LTFLDLSQCQLEQLSP------TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN-SLQVLDYSLNHIMTSKKQELQHFPSS  249 (306)
T ss_dssp             CCEEECTTSCCCEECT------TTTTTCTTCCEEECTTSCCSBCCSGGGTTCT-TCCEEECTTSCCCBCSSSSCCCCCTT
T ss_pred             CCEEECCCCCcCCcCH------HHhcCCCCCCEEECCCCccCccChhhccCcc-cCCEeECCCCCCcccCHHHHHhhhcc
Confidence            9999999999987655      4577899999999999999865444444444 444555555555444444444442 4


Q ss_pred             CceEEecccccC
Q 048668          239 LIALAVEVNQLH  250 (725)
Q Consensus       239 L~~L~L~~N~l~  250 (725)
                      |++|+|++|.+.
T Consensus       250 L~~L~L~~N~~~  261 (306)
T 2z66_A          250 LAFLNLTQNDFA  261 (306)
T ss_dssp             CCEEECTTCCEE
T ss_pred             CCEEEccCCCee
Confidence            444444444444

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=9.7e-30  Score=265.58  Aligned_cols=170  Identities=27%  Similarity=0.448  Sum_probs=147.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+++++.++||||+++++++....     
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-----   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence            467999999999999999999999999999999997432   233467899999999999999999999977654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+ +|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence            789999999 789999987654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.......         ....+||+.|+|||++.
T Consensus       153 G~s~~~~~~~~---------~~~~~gt~~y~aPE~~~  180 (336)
T 3h4j_B          153 GLSNIMTDGNF---------LKTSCGSPNYAAPEVIN  180 (336)
T ss_dssp             SCTBTTTTSBT---------TCCCTTSTTTSCGGGSC
T ss_pred             ccceeccCCcc---------cccccCCcCcCCHHHHc
Confidence            99986643321         12357999999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=5.6e-30  Score=266.94  Aligned_cols=173  Identities=24%  Similarity=0.387  Sum_probs=146.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++....     ..
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eE
Confidence            4689999999999999999999999999999999975432 23467889999999999999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence            99999999999999997654      589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+.+......      ......+||+.|+|||++
T Consensus       152 a~~~~~~~~~------~~~~~~~gt~~y~aPE~~  179 (323)
T 3tki_A          152 ATVFRYNNRE------RLLNKMCGTLPYVAPELL  179 (323)
T ss_dssp             CEECEETTEE------CCBCSCCSCGGGSCHHHH
T ss_pred             cceeccCCcc------cccCCCccCcCccCcHHh
Confidence            9876432211      111235799999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=7.6e-30  Score=262.46  Aligned_cols=172  Identities=26%  Similarity=0.453  Sum_probs=143.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....   ....+++.+|++++++++||||+++++++....     
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-----   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-----
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-----
Confidence            357899999999999999999999999999999986542   233568899999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.+++....      .+++..++.++.|++.||+|+|+.   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence            7899999999999999998654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+........       .....+||+.|+|||++
T Consensus       156 g~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~  184 (294)
T 4eqm_A          156 GIAKALSETSLT-------QTNHVLGTVQYFSPEQA  184 (294)
T ss_dssp             SSSTTC--------------------CCSSCCHHHH
T ss_pred             CCcccccccccc-------ccCccccCccccCHhHh
Confidence            999876432111       11235699999999975

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.5e-29  Score=259.08  Aligned_cols=215  Identities=20%  Similarity=0.209  Sum_probs=190.5

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCc-ccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENK-FYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~   82 (725)
                      +||..+.  ++|++|+|++|.+++..+..|..+++|++|+|++|+++++.|..|..+++|++|+|++|. ++.+.|..|.
T Consensus        25 ~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~  102 (285)
T 1ozn_A           25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH  102 (285)
T ss_dssp             SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred             cCCcCCC--CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhc
Confidence            5777665  489999999999997777899999999999999999998889999999999999999997 8877899999


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCe
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWR  162 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~  162 (725)
                      ++++|++|++++|+++ .++...|.++++|++|+|++|+++++.+..|..+++|++|+|++|+|+++++..|..+++|++
T Consensus       103 ~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  181 (285)
T 1ozn_A          103 GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR  181 (285)
T ss_dssp             TCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             CCcCCCEEECCCCcCC-EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCE
Confidence            9999999999999998 677777889999999999999999988888999999999999999999999989999999999


Q ss_pred             eecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceec
Q 048668          163 LNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGT  228 (725)
Q Consensus       163 L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~  228 (725)
                      |++++|.++...+      ..+.++++|++|++++|++++..+..+..++ .|+.|++++|.+.+.
T Consensus       182 L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~~~c~  240 (285)
T 1ozn_A          182 LLLHQNRVAHVHP------HAFRDLGRLMTLYLFANNLSALPTEALAPLR-ALQYLRLNDNPWVCD  240 (285)
T ss_dssp             EECCSSCCCEECT------TTTTTCTTCCEEECCSSCCSCCCHHHHTTCT-TCCEEECCSSCEECS
T ss_pred             EECCCCcccccCH------hHccCcccccEeeCCCCcCCcCCHHHcccCc-ccCEEeccCCCccCC
Confidence            9999999987654      4577899999999999999965555566555 566666666666543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=1.6e-29  Score=267.61  Aligned_cols=172  Identities=25%  Similarity=0.428  Sum_probs=147.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|+..+.||+|+||.||+|+++.+++.||+|++....  ....+.+.+|++++++++||||+++++++....     
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence            3467999999999999999999999999999999997653  234567899999999999999999999977654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CceEE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHV  684 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~---~~~kl  684 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.+   +.+||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            7899999999999999997654      589999999999999999999999   99999999999999865   45999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+.......         ....+||+.|+|||++.
T Consensus       173 ~DfG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  203 (362)
T 2bdw_A          173 ADFGLAIEVNDSEA---------WHGFAGTPGYLSPEVLK  203 (362)
T ss_dssp             CCCTTCBCCTTCCS---------CCCSCSCTTTCCHHHHT
T ss_pred             eecCcceEecCCcc---------cccCCCCccccCHHHHc
Confidence            99999986643211         12357999999999863

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.2e-28  Score=274.21  Aligned_cols=68  Identities=22%  Similarity=0.255  Sum_probs=40.6

Q ss_pred             CCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCC
Q 048668          344 LKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENL  416 (725)
Q Consensus       344 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  416 (725)
                      +++|+.|+|++|.|+. +|.   .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++..|..+..+
T Consensus       240 l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          240 PSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             CCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence            3456666666666653 333   3456666666666666 445566666666666666666666666555543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=273.84  Aligned_cols=173  Identities=24%  Similarity=0.349  Sum_probs=147.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....     
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-----   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-----
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-----
Confidence            4567999999999999999999999999999999997653  234567899999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCceEE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHV  684 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~---~~~~~kl  684 (725)
                      ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++   .++.+||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL  154 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL  154 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred             EEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence            8899999999999999998654      589999999999999999999999   999999999999998   4678999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+.......        .....+||++|||||++.
T Consensus       155 ~DFG~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~  186 (444)
T 3soa_A          155 ADFGLAIEVEGEQQ--------AWFGFAGTPGYLSPEVLR  186 (444)
T ss_dssp             CCCSSCBCCCTTCC--------BCCCSCSCGGGCCHHHHT
T ss_pred             ccCceeEEecCCCc--------eeecccCCcccCCHHHhc
Confidence            99999986643211        112357999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=8.6e-30  Score=269.80  Aligned_cols=172  Identities=31%  Similarity=0.432  Sum_probs=139.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHH-HHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEA-LRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||+||+|+++.+++.||||+++...   ....+.+.+|..+ ++.++||||+++++++....    
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~----  112 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----  112 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence            457999999999999999999999999999999997543   2234566777776 56789999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       113 -~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          113 -KLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             -EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence             8999999999999999998654      588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+.......        .....+||+.|||||++.
T Consensus       183 FG~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~  212 (373)
T 2r5t_A          183 FGLCKENIEHNS--------TTSTFCGTPEYLAPEVLH  212 (373)
T ss_dssp             CCBCGGGBCCCC--------CCCSBSCCCCCCCHHHHT
T ss_pred             CccccccccCCC--------ccccccCCccccCHHHhC
Confidence            999986432211        122368999999999863

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.7e-29  Score=262.28  Aligned_cols=169  Identities=25%  Similarity=0.351  Sum_probs=146.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      +.|+..+.||+|+||.||+|++..+++.||+|++.....      ...+.+.+|++++++++||||+++++++....   
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---   87 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT---   87 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence            468899999999999999999999999999999975432      13578999999999999999999999976554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----c
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----V  681 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~----~  681 (725)
                        ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .
T Consensus        88 --~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           88 --DVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             --EEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCC
T ss_pred             --EEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCC
Confidence              7899999999999999997643      589999999999999999999999   999999999999999887    7


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||+|+.......         ....+||+.|+|||++
T Consensus       157 ~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~  189 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGNE---------FKNIFGTPEFVAPEIV  189 (326)
T ss_dssp             EEECCCTTCEECCTTSC---------CCCCCSCTTTCCHHHH
T ss_pred             EEEEECCCCeECCCCCc---------cccccCCcCcCCceee
Confidence            99999999987643211         1125699999999976

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.6e-29  Score=263.03  Aligned_cols=171  Identities=20%  Similarity=0.303  Sum_probs=147.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++.... .....+.+|+++++.++||||+++++++....     ..|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEE
Confidence            457899999999999999999999999999999997543 34467889999999999999999999986654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CCceEEcccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DMVAHVGDFG  688 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~--~~~~kl~Dfg  688 (725)
                      +||||++||+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||
T Consensus        78 lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999976432     589999999999999999999999   9999999999999997  7899999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+....         ......||+.|+|||++.
T Consensus       150 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  176 (321)
T 1tki_A          150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             TCEECCTTC---------EEEEEESCGGGSCHHHHT
T ss_pred             CCeECCCCC---------ccccccCChhhcCcHHhc
Confidence            998764321         122356999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=2.1e-29  Score=262.07  Aligned_cols=177  Identities=24%  Similarity=0.436  Sum_probs=134.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-----KL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-----EE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-----eE
Confidence            467999999999999999999999999999999997553 334477889999999999999999999976544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++ |+|.+++...........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999997 59999987543222223588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.......        .....+||+.|+|||++.
T Consensus       155 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~  181 (317)
T 2pmi_A          155 ARAFGIPVN--------TFSSEVVTLWYRAPDVLM  181 (317)
T ss_dssp             CEETTSCCC--------CCCCCCSCCTTCCHHHHT
T ss_pred             ceecCCCcc--------cCCCCcccccccCchHhh
Confidence            987643211        111246999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=1.8e-29  Score=278.60  Aligned_cols=173  Identities=25%  Similarity=0.383  Sum_probs=149.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|+++.+|+.||||++...   .......+.+|++++++++||||+++++++....     
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----
Confidence            45788899999999999999999999999999999753   2334567889999999999999999999876544     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.+++.....    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence            89999999999999999976542    2489999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......         .....+||+.|||||++.
T Consensus       331 Gla~~~~~~~---------~~~~~~GT~~Y~APEvl~  358 (576)
T 2acx_A          331 GLAVHVPEGQ---------TIKGRVGTVGYMAPEVVK  358 (576)
T ss_dssp             TTCEECCTTC---------CEECCCSCGGGCCHHHHT
T ss_pred             ccceecccCc---------cccccCCCccccCHHHHc
Confidence            9998764321         112357999999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=2e-29  Score=260.04  Aligned_cols=173  Identities=27%  Similarity=0.426  Sum_probs=142.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------------------------chHHHHHHHHHHHH
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------------------------GAFRSFVAECEALR  584 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  584 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.....                          ...+++.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4679999999999999999999999999999999975421                          12356889999999


Q ss_pred             cCCCCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 048668          585 NIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPM  664 (725)
Q Consensus       585 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  664 (725)
                      +++||||+++++++....   .+..|+||||+++++|.+++...       .+++..+..++.|++.||+|||++   +|
T Consensus        92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            999999999999986532   24789999999999998865432       589999999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          665 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       665 vHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||||||+||+++.++.+||+|||+|+.......        ......||+.|+|||++.
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  210 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--------LLSNTVGTPAFMAPESLS  210 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--------EECCCCSCGGGCCGGGCC
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCccccccccc--------cccCCcCCccccChhhhc
Confidence            9999999999999999999999999987643211        112356999999999863

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=4.5e-28  Score=271.74  Aligned_cols=266  Identities=26%  Similarity=0.242  Sum_probs=148.8

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      ++++|++++|.++ .+|..+.  ++|++|+|++|+|+. +|.   .+++|++|+|++|+|++ +|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence            4677777777777 5666554  677777777777763 333   35677777777777764 333   55677777777


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      +|+|+ .+|.    .+++|+.|+|++|+|+.+++ .   +++|++|+|++|+|++++.    .+++|+.|++++|.++.+
T Consensus       110 ~N~l~-~l~~----~l~~L~~L~L~~N~l~~lp~-~---l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l  176 (622)
T 3g06_A          110 SNPLT-HLPA----LPSGLCKLWIFGNQLTSLPV-L---PPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSL  176 (622)
T ss_dssp             SCCCC-CCCC----CCTTCCEEECCSSCCSCCCC-C---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCC
T ss_pred             CCcCC-CCCC----CCCCcCEEECCCCCCCcCCC-C---CCCCCEEECcCCcCCCcCC----ccCCCCEEECCCCCCCCC
Confidence            77776 5554    45667777777777665432 2   3666777777776665542    234555666666665543


Q ss_pred             CCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCC
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI  253 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  253 (725)
                      +          ..+++|++|++++|++++                          +|..   +++|+.|++++|.++.+.
T Consensus       177 ~----------~~~~~L~~L~Ls~N~l~~--------------------------l~~~---~~~L~~L~L~~N~l~~l~  217 (622)
T 3g06_A          177 P----------MLPSGLQELSVSDNQLAS--------------------------LPTL---PSELYKLWAYNNRLTSLP  217 (622)
T ss_dssp             C----------CCCTTCCEEECCSSCCSC--------------------------CCCC---CTTCCEEECCSSCCSSCC
T ss_pred             c----------ccCCCCcEEECCCCCCCC--------------------------CCCc---cchhhEEECcCCcccccC
Confidence            2          123455555555555542                          1111   234555555555555332


Q ss_pred             ChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCcc
Q 048668          254 PDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLL  333 (725)
Q Consensus       254 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l  333 (725)
                       .   .+++|++|+|++|.|++ +|   ..+++|+.|++++|+|+            .+|.                   
T Consensus       218 -~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~------------~lp~-------------------  258 (622)
T 3g06_A          218 -A---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT------------SLPM-------------------  258 (622)
T ss_dssp             -C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS------------CCCC-------------------
T ss_pred             -C---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC------------cCCc-------------------
Confidence             1   12455666666665553 33   23345555555555444            2222                   


Q ss_pred             CCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccC
Q 048668          334 NGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGF  391 (725)
Q Consensus       334 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  391 (725)
                               .+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|.+++..|..+..
T Consensus       259 ---------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~  306 (622)
T 3g06_A          259 ---------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  306 (622)
T ss_dssp             ---------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHH
T ss_pred             ---------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHh
Confidence                     2345555555555555 44455555555555555555555555544443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=1.5e-29  Score=266.89  Aligned_cols=176  Identities=24%  Similarity=0.349  Sum_probs=146.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      .+.|+..+.||+|+||.||+|+++.+++.||||++....     ....+.+.+|++++++++||||+++++++....   
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG---   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence            357899999999999999999999999999999997432     124578999999999999999999999987654   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc---e
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---A  682 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~---~  682 (725)
                        ..|+|||||+||+|.+++.....  ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +
T Consensus       100 --~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A          100 --MLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             --EEEEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred             --EEEEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence              78999999999999988865321  112478999999999999999999999   9999999999999987654   9


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.......        .....+||+.|+|||++.
T Consensus       173 kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~  206 (351)
T 3c0i_A          173 KLGGFGVAIQLGESGL--------VAGGRVGTPHFMAPEVVK  206 (351)
T ss_dssp             EECCCTTCEECCTTSC--------BCCCCCSCGGGCCHHHHT
T ss_pred             EEecCcceeEecCCCe--------eecCCcCCcCccCHHHHc
Confidence            9999999987644321        112357999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=3.7e-29  Score=257.26  Aligned_cols=171  Identities=25%  Similarity=0.438  Sum_probs=145.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....     ..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EE
Confidence            57889999999999999999999999999999997543  334577889999999999999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++ ++.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999975 66666654332     589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.......        .....+||+.|+|||++.
T Consensus       148 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~  174 (292)
T 3o0g_A          148 ARAFGIPVR--------CYSAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             CEECCSCCS--------CCCSCCSCGGGCCHHHHT
T ss_pred             ceecCCccc--------cccCCccccCCcChHHHc
Confidence            987643211        112256999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=1.6e-29  Score=263.66  Aligned_cols=181  Identities=36%  Similarity=0.605  Sum_probs=152.1

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++...+++|+..+.||+|+||.||+|+++ +++.||||++........+++.+|++++++++||||+++++++....   
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---  108 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN---  108 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT---
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC---
Confidence            34446789999999999999999999975 68899999987766666788999999999999999999999976543   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..++||||+++|+|.+++......  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       109 --~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          109 --EMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             --CCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred             --eEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence              789999999999999999765321  22589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+++........      .......||+.|+|||++
T Consensus       182 Dfg~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~  213 (321)
T 2qkw_B          182 DFGISKKGTELDQT------HLSTVVKGTLGYIDPEYF  213 (321)
T ss_dssp             CCTTCEECSSSSCC------CCBCCCEEETTTCCHHHH
T ss_pred             eccccccccccccc------ccccccCCCccccCHHHh
Confidence            99999865432111      111234699999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=3.3e-29  Score=266.03  Aligned_cols=179  Identities=23%  Similarity=0.445  Sum_probs=146.9

Q ss_pred             hcCCCCCcccccccceEEEEEEEC-------CCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSST  601 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  601 (725)
                      .++|+..+.||+|+||.||+|++.       .++..||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999863       356789999997543 33457899999999999 899999999997654


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      .     ..|+||||+++|+|.+++......          .....+++..++.++.||+.||+|||++   +|+||||||
T Consensus       160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          160 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             S-----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             C-----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence            4     789999999999999999865421          0112578999999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+++.++.+||+|||+|+.........      ......||+.|||||++
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~------~~~~~~~t~~y~aPE~~  277 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYK------KTTNGRLPVKWMAPEAL  277 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTC------TTTTTTSCGGGCCHHHH
T ss_pred             hhEEECCCCCEEEccccCCcccCccccee------cccCCCcccceECHhHh
Confidence            99999999999999999998764432111      11224588999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=3.3e-29  Score=266.67  Aligned_cols=172  Identities=22%  Similarity=0.316  Sum_probs=148.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .+.|+..+.||+|+||.||+|++..+++.||+|++..........+.+|++++++++||||+++++++....     ..|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-----EEE
Confidence            457999999999999999999999999999999997665445567899999999999999999999976554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CCceEEcccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DMVAHVGDFG  688 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~--~~~~kl~Dfg  688 (725)
                      +||||+++|+|.+++.....     .+++..+..++.||+.||+|||+.   +|+||||||+||+++.  ++.+||+|||
T Consensus       125 lv~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999999976432     589999999999999999999999   9999999999999974  4689999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+......         .....+||+.|+|||++.
T Consensus       197 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  223 (387)
T 1kob_A          197 LATKLNPDE---------IVKVTTATAEFAAPEIVD  223 (387)
T ss_dssp             TCEECCTTS---------CEEEECSSGGGCCHHHHT
T ss_pred             cceecCCCc---------ceeeeccCCCccCchhcc
Confidence            998764321         112246999999999863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=2.5e-29  Score=262.57  Aligned_cols=172  Identities=23%  Similarity=0.336  Sum_probs=137.7

Q ss_pred             hcCCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||.||+|++.   .+++.||+|+++...    ......+.+|++++++++||||+++++++.... 
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG-   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence            467999999999999999999984   688999999997542    223456789999999999999999999976554 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..|+||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+|
T Consensus        95 ----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           95 ----KLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred             ----EEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence                7899999999999999997654      578999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+|+.......        .....+||+.|+|||++.
T Consensus       162 l~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  194 (327)
T 3a62_A          162 LTDFGLCKESIHDGT--------VTHTFCGTIEYMAPEILM  194 (327)
T ss_dssp             ECCCSCC------------------CTTSSCCTTSCHHHHT
T ss_pred             EEeCCcccccccCCc--------cccccCCCcCccCHhhCc
Confidence            999999975432211        112357999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.96  E-value=3e-29  Score=272.27  Aligned_cols=184  Identities=23%  Similarity=0.326  Sum_probs=149.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++...  .....+++.+|++++++++||||+++++++....+.....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            45899999999999999999999999999999999753  2334578899999999999999999999987766555567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ |+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            899999996 59999997653      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCC--------------CCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSS--------------KTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+...........              .........+||++|+|||+++
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  224 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL  224 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHT
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence            99876443211000              0001224568999999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=2.7e-29  Score=262.70  Aligned_cols=190  Identities=37%  Similarity=0.657  Sum_probs=158.2

Q ss_pred             CCccCHHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeE
Q 048668          519 FPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITI  597 (725)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  597 (725)
                      ...++..++....++|+..+.||+|+||.||+|++. +++.||||++..... ....++.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345678899999999999999999999999999865 688999999975432 223468899999999999999999999


Q ss_pred             eecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       598 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                      +....     ..++||||+++|+|.+++......  ...+++..+..++.|++.||+|||+.+.++|+||||||+||+++
T Consensus        96 ~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           96 CMTPT-----ERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             ECCSS-----CCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred             EecCC-----ceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence            86554     679999999999999999865422  22589999999999999999999998777999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .++.+||+|||+|+.......       .......||+.|+|||++
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~  207 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDT-------HVTTAVRGTIGHIAPEYL  207 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSS-------CEECCCCSCGGGCCHHHH
T ss_pred             CCCCEEeccCccccccCcccc-------cccccccCCcCccCHHHh
Confidence            999999999999987643211       112235699999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=3.1e-29  Score=273.29  Aligned_cols=171  Identities=30%  Similarity=0.470  Sum_probs=149.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|...+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+++++.++||||+++++++....     
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-----   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----
Confidence            457889999999999999999999999999999997542   234567899999999999999999999976654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence            7899999999999999997654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......         .....+||+.|+|||++.
T Consensus       161 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  188 (476)
T 2y94_A          161 GLSNMMSDGE---------FLRTSCGSPNYAAPEVIS  188 (476)
T ss_dssp             SSCEECCTTC---------CBCCCCSCSTTCCHHHHT
T ss_pred             cchhhccccc---------cccccCCCcCeEChhhcc
Confidence            9998764321         112357999999999863

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=3e-29  Score=261.78  Aligned_cols=175  Identities=28%  Similarity=0.483  Sum_probs=143.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc---eEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE---MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|++..++   ..||||++... .....+.|.+|++++++++||||+++++++...     
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence            356888899999999999999997544   45999999754 233457899999999999999999999997544     


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      +..|+||||+++|+|.++++....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  194 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD  194 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence            378999999999999999975532     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+........     ........||+.|+|||++
T Consensus       195 fg~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~  226 (325)
T 3kul_A          195 FGLSRVLEDDPDA-----AYTTTGGKIPIRWTAPEAI  226 (325)
T ss_dssp             CSSCEECC----C-----CEECC---CCGGGSCHHHH
T ss_pred             CCcccccccCccc-----eeeccCCCCcccccCHhHh
Confidence            9999876443211     1112224578899999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=4.3e-29  Score=275.09  Aligned_cols=175  Identities=24%  Similarity=0.398  Sum_probs=149.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|...+.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|++++++++||||+++++++....     .
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~  259 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-----D  259 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----E
Confidence            57888899999999999999999999999999997542   234577899999999999999999999876554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++||+|.+++......  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecc
Confidence            89999999999999999764321  12589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+.....        .....+||+.|||||++.
T Consensus       335 la~~~~~~~~--------~~~~~~GT~~Y~APE~l~  362 (543)
T 3c4z_A          335 LAVELKAGQT--------KTKGYAGTPGFMAPELLL  362 (543)
T ss_dssp             TCEECCTTCC--------CBCCCCSCTTTSCHHHHT
T ss_pred             eeeeccCCCc--------ccccccCCccccChhhhc
Confidence            9987643311        112357999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=1.3e-29  Score=276.57  Aligned_cols=171  Identities=27%  Similarity=0.352  Sum_probs=138.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++...   ......++.+|++++++++||||+++++++....     
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence            46799999999999999999999999999999999753   2334567889999999999999999999987655     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence            7899999999999999997654      58999999999999999999998 7   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+......        ......+||+.|||||++
T Consensus       293 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~  321 (446)
T 4ejn_A          293 FGLCKEGIKDG--------ATMKTFCGTPEYLAPEVL  321 (446)
T ss_dssp             CCCCCTTCC-------------CCSSSCGGGCCHHHH
T ss_pred             CCCceeccCCC--------cccccccCCccccCHhhc
Confidence            99997543221        112236799999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=1.7e-29  Score=260.12  Aligned_cols=177  Identities=27%  Similarity=0.454  Sum_probs=144.4

Q ss_pred             hcCCCCCcccccccceEEEEEE----ECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|+    +..+++.||||++........+++.+|++++++++||||+++++++...+   .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence            3578899999999999999998    45688999999998665556678999999999999999999999875432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence            357899999999999999976532     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.........     .......||..|+|||++
T Consensus       158 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~  189 (295)
T 3ugc_A          158 FGLTKVLPQDKEFF-----KVKEPGESPIFWYAPESL  189 (295)
T ss_dssp             CCSCC------------------CTTCGGGGCCHHHH
T ss_pred             CcccccccCCccee-----eeccCCCCccceeCcHHh
Confidence            99998764432111     111124588899999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=5.1e-30  Score=269.24  Aligned_cols=169  Identities=21%  Similarity=0.268  Sum_probs=137.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--------cchHHHHHHHHHHHHcCC---------CCcccc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIR---------HRNLIK  593 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  593 (725)
                      .++|+..+.||+|+||+||+|++  +++.||||++....        ....+.+.+|++++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            45788999999999999999998  67999999997542        223478899999999886         666666


Q ss_pred             eeeEeecC-------------------------CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHH
Q 048668          594 IITICSST-------------------------DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID  648 (725)
Q Consensus       594 l~~~~~~~-------------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~  648 (725)
                      +.+++...                         ++...+..|+||||+++|++.+.+.+.       .+++..+..++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q  169 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence            66654211                         011245789999999999777666432       4789999999999


Q ss_pred             HHHHHHHHH-hcCCCCcEecCCCCCCeeecCCC--------------------ceEEcccccccccccCCCCCCCCCCcc
Q 048668          649 VASAIEYLH-HHCQPPMVHGDLKPSNVLLDHDM--------------------VAHVGDFGLAKFLSSHHLDTSSKTPSS  707 (725)
Q Consensus       649 i~~~l~~lH-~~~~~~ivHrdlkp~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~  707 (725)
                      |+.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....           
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----------  235 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----------  235 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence            999999999 88   999999999999999887                    8999999999876432           


Q ss_pred             cccccCCccccCCCccc
Q 048668          708 SIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       708 ~~~~~gt~~y~aPE~~~  724 (725)
                        ..+||+.|||||++.
T Consensus       236 --~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          236 --IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             --EEECCCCTTCSGGGC
T ss_pred             --cEEEeecccChhhhc
Confidence              247999999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.96  E-value=3.6e-29  Score=264.87  Aligned_cols=169  Identities=25%  Similarity=0.340  Sum_probs=139.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.++++++||||+++++++....     ..|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-----EEE
Confidence            4579999999999999999999999999999999975432 2367889999999999999999999987654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc--eEEcccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--AHVGDFG  688 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~--~kl~Dfg  688 (725)
                      +||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||
T Consensus        93 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            9999999999999997654      589999999999999999999999   9999999999999987765  9999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+......         .....+||+.|+|||++
T Consensus       164 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~  189 (361)
T 3uc3_A          164 YSKSSVLHS---------QPKSTVGTPAYIAPEVL  189 (361)
T ss_dssp             CC------------------------CTTSCHHHH
T ss_pred             ccccccccC---------CCCCCcCCCCcCChhhh
Confidence            997432221         11225699999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=3.9e-29  Score=265.54  Aligned_cols=166  Identities=25%  Similarity=0.359  Sum_probs=138.7

Q ss_pred             CCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEec
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      ..+.||+|+||.||+|++..+++.||+|+++.......+++.+|++++++++||||+++++++....     ..++||||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~E~  167 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVMEY  167 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEEC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEeC
Confidence            3568999999999999999999999999998765556678999999999999999999999987654     78999999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee--cCCCceEEccccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL--DHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill--~~~~~~kl~Dfgla~~~  693 (725)
                      +++|+|.+++....     ..+++..++.++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||+|+.+
T Consensus       168 ~~~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          168 VDGGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             CTTCEEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            99999999987543     2589999999999999999999999   99999999999999  56789999999999876


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....         ....+||+.|+|||++
T Consensus       240 ~~~~~---------~~~~~gt~~y~aPE~~  260 (373)
T 2x4f_A          240 KPREK---------LKVNFGTPEFLAPEVV  260 (373)
T ss_dssp             CTTCB---------CCCCCSSCTTCCHHHH
T ss_pred             CCccc---------cccccCCCcEeChhhc
Confidence            43311         1124699999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=4.6e-29  Score=258.26  Aligned_cols=175  Identities=31%  Similarity=0.491  Sum_probs=138.8

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ....+|++.+.||+|+||.||+|++  +++.||||++....  ....+++.+|++++++++||||+++++++....    
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----  107 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP----  107 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC----
Confidence            3456788899999999999999987  57889999997543  234567899999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCceEE
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nill~~~~~~kl  684 (725)
                       ..++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||
T Consensus       108 -~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          108 -NLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             -CCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             -ceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence             68999999999999999986542   12489999999999999999999998   7  999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+.......        ......||+.|+|||++.
T Consensus       181 ~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~  212 (309)
T 3p86_A          181 CDFGLSRLKASTFL--------SSKSAAGTPEWMAPEVLR  212 (309)
T ss_dssp             CCCC-------------------------CCTTSCHHHHT
T ss_pred             CCCCCCcccccccc--------ccccCCCCccccChhhhc
Confidence            99999976433211        112356999999999863

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.7e-28  Score=255.85  Aligned_cols=226  Identities=22%  Similarity=0.249  Sum_probs=150.8

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      .++++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..|+.+++|++|+|++|+++ .+|..|.++++|++|+|
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            56777777777777 66777777777777777777777 66777777777777777777777 56777777777777777


Q ss_pred             cCCCCCCCCChhhh--------cCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeee
Q 048668           93 TSNRFSGSLPFDIV--------VNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN  164 (725)
Q Consensus        93 ~~N~l~~~~~~~~~--------~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~  164 (725)
                      ++|.+.+.+|..+.        .++++|++|+|++|+++ .+|..+..+++|++|+|++|+++++++ .|.         
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~-~l~---------  226 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGP-AIH---------  226 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCG-GGG---------
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCch-hhc---------
Confidence            77766666665441        23555555555555555 334445555555555555555554333 244         


Q ss_pred             cCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEe
Q 048668          165 LEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV  244 (725)
Q Consensus       165 L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L  244 (725)
                                           ++++|++|+|++|++.+.+|..+..++ +|+.|++++|.+.+.+|..+.++++|++|+|
T Consensus       227 ---------------------~l~~L~~L~Ls~n~~~~~~p~~~~~l~-~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L  284 (328)
T 4fcg_A          227 ---------------------HLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRLTQLEKLDL  284 (328)
T ss_dssp             ---------------------GCTTCCEEECTTCTTCCBCCCCTTCCC-CCCEEECTTCTTCCBCCTTGGGCTTCCEEEC
T ss_pred             ---------------------cCCCCCEEECcCCcchhhhHHHhcCCC-CCCEEECCCCCchhhcchhhhcCCCCCEEeC
Confidence                                 445555555555555555555555554 5555555555555567777777888888888


Q ss_pred             cccccCCCCChhhcCCCCccEEeccCcccc
Q 048668          245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQ  274 (725)
Q Consensus       245 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  274 (725)
                      ++|++.+.+|..+..+++|+.+++..+.+.
T Consensus       285 ~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            888888888888888888888888877665

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=1.5e-29  Score=262.64  Aligned_cols=178  Identities=20%  Similarity=0.378  Sum_probs=141.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....   ....+++.+|++++++++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            357899999999999999999999999999999997542   233467899999999999999999999876543 1122


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++||+|.++++...      .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence            4599999999999999998654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.+......     .......+||+.|+|||++
T Consensus       161 g~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~  191 (311)
T 3ork_A          161 GIARAIADSGNS-----VTQTAAVIGTAQYLSPEQA  191 (311)
T ss_dssp             SCC-----------------------CCTTCCHHHH
T ss_pred             cCcccccccccc-----cccccccCcCcccCCHHHh
Confidence            999876443211     1112235699999999976

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.96  E-value=9.6e-29  Score=252.08  Aligned_cols=170  Identities=27%  Similarity=0.349  Sum_probs=149.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++..++..||+|++........+++.+|++++++++||||+++++++....     ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----DIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----eEE
Confidence            457899999999999999999999999999999998765566788999999999999999999999986554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEEccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDF  687 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl~Df  687 (725)
                      +||||+++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            9999999999999987654      589999999999999999999999   99999999999999   78889999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.......         .....||+.|+|||++
T Consensus       154 g~~~~~~~~~~---------~~~~~~t~~y~aPE~~  180 (277)
T 3f3z_A          154 GLAARFKPGKM---------MRTKVGTPYYVSPQVL  180 (277)
T ss_dssp             TTCEECCTTSC---------BCCCCSCTTTCCHHHH
T ss_pred             ccceeccCccc---------hhccCCCCCccChHHh
Confidence            99987643211         1124699999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=8e-29  Score=258.16  Aligned_cols=174  Identities=26%  Similarity=0.430  Sum_probs=147.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++....   ....|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence            57889999999999999999999999999999997543 334577889999999999999999999876543   23678


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCceEEcc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVGD  686 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill----~~~~~~kl~D  686 (725)
                      +||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|
T Consensus        86 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEEeCCCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            99999999999999986532   12389999999999999999999999   99999999999999    7788899999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.......         ....+||+.|+|||++
T Consensus       160 fg~a~~~~~~~~---------~~~~~gt~~y~aPE~~  187 (319)
T 4euu_A          160 FGAARELEDDEQ---------FVSLYGTEEYLHPDMY  187 (319)
T ss_dssp             CTTCEECCTTCC---------BCCCCSCGGGCCHHHH
T ss_pred             CCCceecCCCCc---------eeecccCCCccCHHHh
Confidence            999987643311         1125699999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=9.3e-29  Score=265.14  Aligned_cols=182  Identities=18%  Similarity=0.193  Sum_probs=151.4

Q ss_pred             HhcCCCCCcccccc--cceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQG--SFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|++.+.||+|  +||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++....   
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN---   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC---
Confidence            34579999999999  99999999999999999999997653  334567889999999999999999999987654   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..|+|||||++|+|.+++......    .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       100 --~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B          100 --ELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             --EEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             --EEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence              789999999999999999865321    589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||.+............ ........+||+.|+|||++.
T Consensus       171 dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  208 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRV-VHDFPKYSVKVLPWLSPEVLQ  208 (389)
T ss_dssp             CGGGCEECEETTEECSC-BCCCCTTCTTTGGGSCHHHHS
T ss_pred             ccccceeeccccccccc-cccccccccccccccCHHHHh
Confidence            99998765432211111 111122347999999999864

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=8.3e-30  Score=280.34  Aligned_cols=216  Identities=18%  Similarity=0.155  Sum_probs=127.3

Q ss_pred             CCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEe
Q 048668          188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLG  267 (725)
Q Consensus       188 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  267 (725)
                      ++|++|+|++|.+++..|..|..++ .|+.|++++|.+++..|  +..+++|++|+|++|.|+++.+     .++|++|+
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~  105 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH  105 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence            3555566665555544444454444 45555555555544433  5566666666666666654332     25666666


Q ss_pred             ccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhh-cCCC
Q 048668          268 LYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVG-NLKN  346 (725)
Q Consensus       268 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~-~l~~  346 (725)
                      +++|.+.+..+..   +++|+.|++++|.+++           ..|..+..+..+ ++|+|++|.+++..|..+. .+++
T Consensus       106 L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~-----------~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~  170 (487)
T 3oja_A          106 AANNNISRVSCSR---GQGKKNIYLANNKITM-----------LRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDT  170 (487)
T ss_dssp             CCSSCCCCEEECC---CSSCEEEECCSSCCCS-----------GGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTT
T ss_pred             CcCCcCCCCCccc---cCCCCEEECCCCCCCC-----------CCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCc
Confidence            6666666544432   3556666666665542           223333333333 5666666666665565554 5677


Q ss_pred             CCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEccc
Q 048668          347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSY  426 (725)
Q Consensus       347 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  426 (725)
                      |+.|+|++|.|++..+  +..+++|++|+|++|.+++. |+.|..+++|+.|+|++|.|++ +|..+..+++|+.|++++
T Consensus       171 L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~  246 (487)
T 3oja_A          171 LEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRG  246 (487)
T ss_dssp             CCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTT
T ss_pred             ccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCC
Confidence            7777777777765522  23466777777777777753 3346677777777777777764 455566677777777777


Q ss_pred             ccCe
Q 048668          427 NHLE  430 (725)
Q Consensus       427 N~l~  430 (725)
                      |++.
T Consensus       247 N~l~  250 (487)
T 3oja_A          247 NGFH  250 (487)
T ss_dssp             CCBC
T ss_pred             CCCc
Confidence            7776

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=8.9e-29  Score=256.56  Aligned_cols=171  Identities=28%  Similarity=0.432  Sum_probs=142.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++....     .
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-----C   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-----C
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-----E
Confidence            467999999999999999999996 58999999997543  233567889999999999999999999976544     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++ ++.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            8999999975 88888876542     589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.......        .....+||+.|+|||++.
T Consensus       165 ~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~  192 (311)
T 3niz_A          165 LARAFGIPVR--------SYTHEVVTLWYRAPDVLM  192 (311)
T ss_dssp             TCEETTSCCC-----------CCCCCCTTCCHHHHT
T ss_pred             CceecCCCcc--------cccCCcccCCcCCHHHhc
Confidence            9987643211        112246899999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=2.9e-29  Score=267.48  Aligned_cols=175  Identities=25%  Similarity=0.425  Sum_probs=146.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||+++... ....++|.+|++++++++||||+++++++....     .
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----P  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-----S
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-----C
Confidence            3467888999999999999999999899999999987542 223457889999999999999999999986544     6


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.++++....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             cEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            8999999999999999975432     588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+..........      .....+++.|+|||++
T Consensus       259 ~s~~~~~~~~~~~------~~~~~~~~~y~aPE~~  287 (377)
T 3cbl_A          259 MSREEADGVYAAS------GGLRQVPVKWTAPEAL  287 (377)
T ss_dssp             GCEECTTSEEECC------SSCCEEEGGGSCHHHH
T ss_pred             CceecCCCceeec------CCCCCCCcCcCCHhHh
Confidence            9986533211110      0112367889999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=5e-29  Score=259.87  Aligned_cols=178  Identities=28%  Similarity=0.381  Sum_probs=146.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|+..+.||+|+||.||+|++.  ++.||||++..... ....+.+|+.++++++||||+++++++..... .....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceE
Confidence            3468999999999999999999985  78999999965432 33456679999999999999999999876541 12357


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc-------CCCCcEecCCCCCCeeecCCCce
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH-------CQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      |+||||+++|+|.++++..       .+++..++.++.|++.||+|||+.       +.++|+||||||+||+++.++.+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            9999999999999999754       488999999999999999999975       23489999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+........      ......+||+.|+|||++.
T Consensus       171 kL~DFg~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~  206 (322)
T 3soc_A          171 CIADFGLALKFEAGKSA------GDTHGQVGTRRYMAPEVLE  206 (322)
T ss_dssp             EECCCTTCEEECTTSCC------CCCTTCCCCGGGCCHHHHT
T ss_pred             EEccCCcccccccccCc------cccccCccCccccCHhhcc
Confidence            99999999876543221      1122357999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=5.6e-29  Score=264.49  Aligned_cols=175  Identities=28%  Similarity=0.524  Sum_probs=135.5

Q ss_pred             hcCCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|++.   .++..||||+++... ....++|.+|++++++++||||+++++++....    
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK----  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence            357899999999999999999876   467789999997543 334568999999999999999999999976544    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++|+|.++++....     .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       120 -~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          120 -PVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             -SCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             -ceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence             78999999999999999986542     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.........     .......+|+.|+|||++
T Consensus       191 fg~a~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~  222 (373)
T 2qol_A          191 FGLGRVLEDDPEAA-----YTTRGGKIPIRWTSPEAI  222 (373)
T ss_dssp             C---------------------------CTTSCHHHH
T ss_pred             CccccccccCCccc-----eeccCCCcCCCccChhhh
Confidence            99998764332111     111123467899999975

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=5.5e-31  Score=299.18  Aligned_cols=406  Identities=13%  Similarity=0.057  Sum_probs=287.5

Q ss_pred             ccCcccCcEEecCCCccC---ccCCcccc------------CCCCCcEEEccCCcCCccCCCCCCCC--CCCCEEEccCC
Q 048668            9 IGSLFKLQALALAGNYLT---GKLPDFIG------------NLSALQVIHIKGNSLGGKFPTTLGLL--RNLVQLNVAEN   71 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~---~~~~~~~~------------~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~Ls~N   71 (725)
                      +..+++|++|+|+++...   +.+|..++            .+++|++|+|++|.+++..+..+...  .+|++|+|++|
T Consensus        69 ~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~  148 (592)
T 3ogk_B           69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKC  148 (592)
T ss_dssp             HHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESC
T ss_pred             HHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCC
Confidence            456778999999886421   23443333            78899999999999887666666553  45999999998


Q ss_pred             c-ccc-cCcccccccCCCceeeccCCCCCCCCC---hhhhcCCCCccEEEccCceeee----eCCCcccccCccceecCC
Q 048668           72 K-FYG-MFPRSICNISSLEYFYLTSNRFSGSLP---FDIVVNLPNLKELGIGANNFFG----LIPDSLSNASNLELLDLS  142 (725)
Q Consensus        72 ~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~Ls  142 (725)
                      . ++. ..+....++++|++|+|++|.+++.-.   ...+..+++|++|+|++|.+++    ..+..+.++++|++|+|+
T Consensus       149 ~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~  228 (592)
T 3ogk_B          149 SGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG  228 (592)
T ss_dssp             EEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECS
T ss_pred             CCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEecc
Confidence            7 321 123334578999999999999874321   1245678999999999999873    334445678999999999


Q ss_pred             CccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecC
Q 048668          143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGG  222 (725)
Q Consensus       143 ~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~  222 (725)
                      +|.+.+++ ..+..+++|++|+++.+.......   .....+..+++|+.|+++++... .+|..+..++ +|+.|++++
T Consensus       229 ~~~~~~l~-~~~~~~~~L~~L~l~~~~~~~~~~---~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~-~L~~L~Ls~  302 (592)
T 3ogk_B          229 DFEILELV-GFFKAAANLEEFCGGSLNEDIGMP---EKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAA-QIRKLDLLY  302 (592)
T ss_dssp             SCBGGGGH-HHHHHCTTCCEEEECBCCCCTTCT---TSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGG-GCCEEEETT
T ss_pred             CccHHHHH-HHHhhhhHHHhhcccccccccchH---HHHHHhhccccccccCccccchh-HHHHHHhhcC-CCcEEecCC
Confidence            99998754 678889999999998644321111   12245677889999999886544 5677676666 899999999


Q ss_pred             ccceeccC-cccccccCCceEEecccccC-CCCChhhcCCCCccEEecc-----------CcccccC-CCCCCcCCCCCC
Q 048668          223 NQISGTIP-LGIRNLVNLIALAVEVNQLH-GTIPDVIGELKNLQLLGLY-----------KNFLQGS-IPSGLGNLTKLA  288 (725)
Q Consensus       223 n~i~~~~~-~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~-----------~N~l~~~-~~~~~~~l~~L~  288 (725)
                      |.+.+... ..+..+++|++|+++ +.+. +..+..+..+++|++|+++           .|.+++. ++.....+++|+
T Consensus       303 ~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  381 (592)
T 3ogk_B          303 ALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELE  381 (592)
T ss_dssp             CCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCS
T ss_pred             CcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCe
Confidence            98765443 346788999999998 4443 3345555778899999999           3555532 222234578999


Q ss_pred             EEeCCCCcCCCccccccccccccccccccccccccceeccc----CCccCCC-----cchhhhcCCCCCeEEccCc--cc
Q 048668          289 KLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLS----NNLLNGS-----LPQQVGNLKNLIILDISSN--QF  357 (725)
Q Consensus       289 ~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~----~n~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l  357 (725)
                      +|+++.|.+++           ..+..+....+.++.|+++    .|.+++.     ++..+.++++|+.|+++++  .+
T Consensus       382 ~L~l~~~~l~~-----------~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l  450 (592)
T 3ogk_B          382 YMAVYVSDITN-----------ESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL  450 (592)
T ss_dssp             EEEEEESCCCH-----------HHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGC
T ss_pred             EEEeecCCccH-----------HHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCc
Confidence            99998886653           2333333312233788885    6778764     4445777999999999753  46


Q ss_pred             cccCcccccc-ccCCcEEEccCCccccc-cCccccCCCCCCEEeCCCCccccc-CcccccCCCCCCeEEcccccCeee
Q 048668          358 SGMIPVTLST-CVSLEYVDISSNCFHGI-IPPSLGFLKSIKFLDVSCNNFSGQ-FPKFLENLSFLEFLNLSYNHLEGE  432 (725)
Q Consensus       358 ~~~~~~~~~~-l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~  432 (725)
                      ++..+..+.. +++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|+++..
T Consensus       451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            6655555544 78899999999998863 344457889999999999998754 444456788999999999998643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=3.6e-29  Score=265.53  Aligned_cols=189  Identities=21%  Similarity=0.338  Sum_probs=152.8

Q ss_pred             cCHHHHHHHhcCCCCCcccccccceEEEEEE-----ECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccce
Q 048668          522 VSYAELSKATSEFSSSNMIGQGSFGSVYKGI-----LGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKI  594 (725)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  594 (725)
                      ++...+....++|+..+.||+|+||.||+|+     ...+++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3455666677899999999999999999998     55677999999997543 33456799999999999 79999999


Q ss_pred             eeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCcc------------------------------------------
Q 048668          595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV------------------------------------------  632 (725)
Q Consensus       595 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------  632 (725)
                      ++++....    ...++||||+++|+|.++++......                                          
T Consensus        92 ~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           92 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             EEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            99986544    35799999999999999998654210                                          


Q ss_pred             ------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccccc
Q 048668          633 ------------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       633 ------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~  694 (725)
                                        ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                              011288999999999999999999999   99999999999999999999999999998654


Q ss_pred             cCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          695 SHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....      .......||+.|+|||++
T Consensus       245 ~~~~~------~~~~~~~~t~~y~aPE~~  267 (359)
T 3vhe_A          245 KDPDY------VRKGDARLPLKWMAPETI  267 (359)
T ss_dssp             SCTTC------EEC--CEECGGGCCHHHH
T ss_pred             ccccc------hhccccCCCceeEChhhh
Confidence            32111      112235689999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=1.5e-28  Score=256.37  Aligned_cols=162  Identities=25%  Similarity=0.350  Sum_probs=125.9

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeEEEec
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      .+.||+|+||.||+|++..+++.||||++...   ....+.+|+++++++. ||||+++++++....     ..|+||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-----~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-----HTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----EEEEEEEc
Confidence            47899999999999999999999999999643   3456789999999997 999999999986554     78999999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---ceEEcccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---VAHVGDFGLAKF  692 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~---~~kl~Dfgla~~  692 (725)
                      +++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+|+.
T Consensus        88 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           88 LNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             CCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999998654      589999999999999999999999   999999999999998765   899999999986


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......        .....+||+.|+|||++
T Consensus       159 ~~~~~~--------~~~~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          159 KPPDNQ--------PLKTPCFTLHYAAPELL  181 (325)
T ss_dssp             CCC----------------------------
T ss_pred             cCCCCC--------cccccCCCcCccCHHHh
Confidence            543211        11235689999999986

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.3e-29  Score=261.61  Aligned_cols=258  Identities=16%  Similarity=0.167  Sum_probs=138.1

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      ++.++++++.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+  |..+++|++|+|++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            4445555555543333444455555555555555555555555555555555555555554333  55555555555555


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA  174 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~  174 (725)
                      |+|+ .++     ..++|++|++++|+++++.+..   +++|++|+|++|+|+++.+..|..+++|++|++++|.++...
T Consensus        90 n~l~-~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  160 (317)
T 3o53_A           90 NYVQ-ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN  160 (317)
T ss_dssp             SEEE-EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred             Cccc-ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence            5555 333     1255555555555555554333   344555555555555555555555555555555555555433


Q ss_pred             CCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCC
Q 048668          175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP  254 (725)
Q Consensus       175 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  254 (725)
                      +.     .....+++|++|+|++|++++. |.. ..++ .|+.|++++|.+++. |..+..+++|++|+|++|++++ +|
T Consensus       161 ~~-----~~~~~l~~L~~L~L~~N~l~~~-~~~-~~l~-~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l~  230 (317)
T 3o53_A          161 FA-----ELAASSDTLEHLNLQYNFIYDV-KGQ-VVFA-KLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IE  230 (317)
T ss_dssp             GG-----GGGGGTTTCCEEECTTSCCCEE-ECC-CCCT-TCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-EC
T ss_pred             HH-----HHhhccCcCCEEECCCCcCccc-ccc-cccc-cCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcccc-hh
Confidence            21     1122455555555555555533 211 1122 555555555555533 3335566666666666666663 34


Q ss_pred             hhhcCCCCccEEeccCcccc-cCCCCCCcCCCCCCEEeCC
Q 048668          255 DVIGELKNLQLLGLYKNFLQ-GSIPSGLGNLTKLAKLDLG  293 (725)
Q Consensus       255 ~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~  293 (725)
                      ..+..+++|++|++++|.+. +.+|..+..+++|+.++++
T Consensus       231 ~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             TTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             hHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            45566666666666666665 4555555666666666665

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=255.86  Aligned_cols=170  Identities=25%  Similarity=0.272  Sum_probs=141.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|+..+.||+|+||+||+|++..+++.||||++....  .....++..|+..+.++ +||||++++++|....     .
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-----~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-----E
Confidence            57999999999999999999999999999999986542  22334556677666665 8999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+ +++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            89999999 6799999876542     589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.......         .....||++|+|||++.
T Consensus       203 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  229 (311)
T 3p1a_A          203 LLVELGTAGA---------GEVQEGDPRYMAPELLQ  229 (311)
T ss_dssp             TCEECC---------------CCCCCGGGCCGGGGG
T ss_pred             eeeecccCCC---------CcccCCCccccCHhHhc
Confidence            9986643211         11246999999999863

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=9.6e-29  Score=266.98  Aligned_cols=171  Identities=27%  Similarity=0.381  Sum_probs=138.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCcccceeeEeecC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFRSFVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      ..++|...+.||+|+||.||+|+++.+++.||||++.....        .....+.+|++++++++||||+++++++...
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  212 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE  212 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            45689999999999999999999999999999999975421        1123578999999999999999999986432


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--  679 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~--  679 (725)
                            ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.+  
T Consensus       213 ------~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          213 ------DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             ------EEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSS
T ss_pred             ------ceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCC
Confidence                  4789999999999999987654      589999999999999999999999   99999999999999754  


Q ss_pred             -CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 -MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 -~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                       +.+||+|||+|+......         .....+||+.|||||++.
T Consensus       278 ~~~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  314 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLV  314 (419)
T ss_dssp             SCCEEECCSSTTTSCC--------------------CTTCCTTTTC
T ss_pred             cceEEEeecccceecCCCc---------cccccCCCCCccCceeee
Confidence             459999999998764321         112357999999999863

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.7e-28  Score=251.41  Aligned_cols=225  Identities=18%  Similarity=0.238  Sum_probs=179.5

Q ss_pred             CCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEe
Q 048668          188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLG  267 (725)
Q Consensus       188 ~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  267 (725)
                      ++++.|+|++|.++ .+|..++.++ .|+.|++++|.++ .+|..+..+++|++|+|++|++. .+|..+..+++|++|+
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            55666666666666 5566666655 6666666666666 66777777777777777777777 5566777777777777


Q ss_pred             ccCcccccCCCCCCcC---------CCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcc
Q 048668          268 LYKNFLQGSIPSGLGN---------LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLP  338 (725)
Q Consensus       268 L~~N~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~  338 (725)
                      +++|.+.+.+|..+..         +++|++|++++|+++            .+|..+..+..+ ++|++++|.+++ +|
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~------------~lp~~l~~l~~L-~~L~L~~N~l~~-l~  222 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR------------SLPASIANLQNL-KSLKIRNSPLSA-LG  222 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC------------CCCGGGGGCTTC-CEEEEESSCCCC-CC
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC------------cchHhhcCCCCC-CEEEccCCCCCc-Cc
Confidence            7777777777766654         788888888888666            667666666665 788888888885 55


Q ss_pred             hhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCC
Q 048668          339 QQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSF  418 (725)
Q Consensus       339 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  418 (725)
                      ..+..+++|++|+|++|.+.+.+|..+..+++|++|+|++|.+.+.+|..++.+++|+.|+|++|++.+.+|..+..+++
T Consensus       223 ~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~  302 (328)
T 4fcg_A          223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA  302 (328)
T ss_dssp             GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred             hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence            67889999999999999999999999999999999999999998899999999999999999999999999999999999


Q ss_pred             CCeEEcccccCe
Q 048668          419 LEFLNLSYNHLE  430 (725)
Q Consensus       419 L~~L~l~~N~l~  430 (725)
                      |+.+++..|.+.
T Consensus       303 L~~l~l~~~~~~  314 (328)
T 4fcg_A          303 NCIILVPPHLQA  314 (328)
T ss_dssp             TCEEECCGGGSC
T ss_pred             ceEEeCCHHHHH
Confidence            999999988765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=8.9e-29  Score=260.69  Aligned_cols=169  Identities=27%  Similarity=0.387  Sum_probs=131.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .+.|+..+.||+|+||.||+|++..+++.||||++....  ..+.+.+|++++++++||||+++++++....     ..+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  124 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----EIS  124 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-----eEE
Confidence            457899999999999999999999999999999997543  3356789999999999999999999986554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVGDF  687 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~Df  687 (725)
                      +||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+||
T Consensus       125 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence            9999999999999997654      589999999999999999999999   9999999999999975   789999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++......         .....+||+.|+|||++.
T Consensus       196 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  223 (349)
T 2w4o_A          196 GLSKIVEHQV---------LMKTVCGTPGYCAPEILR  223 (349)
T ss_dssp             C-------------------------CGGGSCHHHHT
T ss_pred             ccccccCccc---------ccccccCCCCccCHHHhc
Confidence            9998654321         112356999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=1.9e-28  Score=254.99  Aligned_cols=177  Identities=26%  Similarity=0.374  Sum_probs=142.2

Q ss_pred             cCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.|++. +.||+|+||.||+|++..+++.||||++........+++.+|++++.++ +||||+++++++....     ..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-----~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-----RF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----EE
Confidence            467764 7899999999999999989999999999866555667899999999985 7999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc---eEEcc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---AHVGD  686 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~---~kl~D  686 (725)
                      |+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             EEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence            99999999999999998654      588999999999999999999999   9999999999999998775   99999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++........... ........+||+.|+|||++
T Consensus       158 fg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~  193 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVV  193 (316)
T ss_dssp             TTCCC--------------------CCSGGGCCHHHH
T ss_pred             ccCccccccCCccccc-cccccccccCCcCccChHHh
Confidence            9999865432111110 11112235699999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=5.3e-29  Score=260.84  Aligned_cols=172  Identities=27%  Similarity=0.440  Sum_probs=147.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCcccceeeEeecC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFRSFVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++.....        ...+.+.+|++++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45689999999999999999999999999999999975421        1234577899999999999999999998655


Q ss_pred             CCCCcceeeEEEeccCCC-CHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC
Q 048668          602 DFKGVDFKALVFEYMGNG-SLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM  680 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~  680 (725)
                      .     ..++||||+.+| +|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       102 ~-----~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A          102 G-----FFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             S-----EEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred             C-----EEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence            4     789999999777 9999998654      589999999999999999999999   999999999999999999


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+||+|||+|+......         .....+||+.|+|||++.
T Consensus       168 ~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  202 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLM  202 (335)
T ss_dssp             CEEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHT
T ss_pred             cEEEeecccceECCCCC---------ceeccCCCccccChhhhc
Confidence            99999999998764321         112357999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=1.1e-28  Score=269.46  Aligned_cols=173  Identities=22%  Similarity=0.294  Sum_probs=140.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  607 (725)
                      .++|+..+.||+|+||+||+|++..+++.||||++...  .....+++.+|+++++.++||||+++++++..... +...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999999999999999999754  23345778899999999999999999999865432 3345


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++ ++.+.+..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            68999999976 57776642        378899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......         .....+||++|+|||++.
T Consensus       209 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  236 (464)
T 3ttj_A          209 GLARTAGTSF---------MMTPYVVTRYYRAPEVIL  236 (464)
T ss_dssp             CCC-----CC---------CC----CCCTTCCHHHHT
T ss_pred             EeeeecCCCc---------ccCCCcccccccCHHHHc
Confidence            9998654321         112357999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=6.8e-29  Score=263.80  Aligned_cols=177  Identities=16%  Similarity=0.213  Sum_probs=143.4

Q ss_pred             HhcCCCCCcccccccceEEEEEE-----ECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC---CCcccceeeEeecC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGI-----LGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLIKIITICSST  601 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  601 (725)
                      ..++|...+.||+|+||.||+|+     +..+++.||||++...   ...++.+|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34678889999999999999994     5668899999999644   3456778888888887   99999999998765


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---  678 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---  678 (725)
                      +     ..|+|||||++|+|.+++...... ....+++..++.|+.||+.||+|||++   +|+||||||+|||++.   
T Consensus       140 ~-----~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          140 N-----GSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             S-----CEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred             C-----CcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence            5     789999999999999999753211 112589999999999999999999998   9999999999999998   


Q ss_pred             --------CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          679 --------DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       679 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                              ++.+||+|||+|+.+.....      .......+||++|||||++.
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~  258 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPK------GTIFTAKCETSGFQCVEMLS  258 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCT------TEEECCSSCTTSCCCHHHHT
T ss_pred             CccccccccCCEEEeeCchhhhhhccCC------CceeeeecCCCCCCChHHhc
Confidence                    89999999999976542211      11223467999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.95  E-value=1.4e-28  Score=254.07  Aligned_cols=174  Identities=26%  Similarity=0.411  Sum_probs=141.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHc--CCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++  +++.||||++...   ..+.+.+|.+++..  ++||||+++++++.... .....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence            46899999999999999999998  6889999998644   23455667777666  78999999999876532 33456


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeeecCCC
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--------HHCQPPMVHGDLKPSNVLLDHDM  680 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivHrdlkp~Nill~~~~  680 (725)
                      .|+||||+++|+|.++++..       .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred             eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence            89999999999999999643       4899999999999999999999        66   999999999999999999


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+||+|||+|+.........    .......+||+.|+|||++.
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~  190 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQL----DVGNNPRVGTKRYMAPEVLD  190 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEE----ECCCCCCCCCGGGCCHHHHT
T ss_pred             CEEEeeCCCeeecccccccc----cccccccccccceeChhhhc
Confidence            99999999998764432111    01112347999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=1.2e-28  Score=258.11  Aligned_cols=177  Identities=24%  Similarity=0.351  Sum_probs=146.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.....  .+++.+|+++++++ +||||+++++++....     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-----YN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-----EE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-----cc
Confidence            3578999999999999999999999999999999875432  24678999999999 8999999999977654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc-----eEE
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-----AHV  684 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~-----~kl  684 (725)
                      ++||||+ +++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence            9999999 9999999986532     589999999999999999999999   9999999999999998887     999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+.+......... ........+||+.|+|||++.
T Consensus       152 ~DFg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  190 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHI-PYREHKSLTGTARYMSINTHL  190 (330)
T ss_dssp             CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHT
T ss_pred             EEcccceeeecCCCCccc-cccccCCcCCCccccChHHHc
Confidence            999999876543221110 111123467999999999863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=5.8e-29  Score=264.00  Aligned_cols=179  Identities=24%  Similarity=0.427  Sum_probs=144.5

Q ss_pred             hcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|+..+.||+|+||.||+|++     ..+++.||||++... ......++.+|+.++++++||||+++++++....  
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence            35788899999999999999994     456789999999644 2334567899999999999999999999976544  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCcc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC---
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM---  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~---  680 (725)
                         ..|+||||+++|+|.+++....... ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++   
T Consensus       148 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          148 ---PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence               6799999999999999998654211 123589999999999999999999999   999999999999999555   


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+||+|||+|+.+.......      ......||+.|+|||++
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~------~~~~~~~t~~y~aPE~~  258 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYR------KGGCAMLPVKWMPPEAF  258 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCT------TCCGGGSCGGGCCHHHH
T ss_pred             eEEECCCccccccccccccc------cCCCcCCcccEECHHHh
Confidence            59999999998664332111      11225689999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=1.8e-28  Score=254.13  Aligned_cols=177  Identities=28%  Similarity=0.438  Sum_probs=145.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-----cchHHHHHHHHHHHHcCC---CCcccceeeEeecC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-----KGAFRSFVAECEALRNIR---HRNLIKIITICSST  601 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  601 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++....     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4568999999999999999999999999999999997532     122356677888777765   99999999998776


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~  681 (725)
                      ........++||||++ |+|.+++......    .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            5444446899999996 5999999876421    489999999999999999999999   9999999999999999999


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||+|+......         .....+||+.|+|||++
T Consensus       159 ~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          159 VKLADFGLARIYSYQM---------ALTPVVVTLWYRAPEVL  191 (308)
T ss_dssp             EEECSCSCTTTSTTCC---------CSGGGGCCCSSCCHHHH
T ss_pred             EEEeeCccccccCCCc---------ccCCccccccccCchHH
Confidence            9999999998653221         11235799999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=9.4e-29  Score=253.63  Aligned_cols=170  Identities=25%  Similarity=0.431  Sum_probs=141.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||.||+|++ .+++.||+|++....  ....+.+.+|++++++++||||+++++++....     ..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence            4788899999999999999998 578999999997543  233477889999999999999999999976554     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++ +|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999975 99999876532     588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.......        ......||+.|+|||++.
T Consensus       147 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~  173 (288)
T 1ob3_A          147 ARAFGIPVR--------KYTHEIVTLWYRAPDVLM  173 (288)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHT
T ss_pred             ccccCcccc--------ccccccccccccCchhee
Confidence            986543211        111246899999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=1.6e-28  Score=249.25  Aligned_cols=171  Identities=30%  Similarity=0.510  Sum_probs=145.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++. +++.||+|++..... ..+++.+|++++++++||||+++++++....     ..+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceE
Confidence            457888999999999999999987 577899999975433 3467899999999999999999999976544     689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence            99999999999999976542     589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......||+.|+|||++
T Consensus       154 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~  179 (269)
T 4hcu_A          154 RFVLDDQYT-------SSTGTKFPVKWASPEVF  179 (269)
T ss_dssp             GGBCCHHHH-------STTSTTCCGGGCCHHHH
T ss_pred             ccccccccc-------cccCcccccccCCHHHh
Confidence            866432211       11124578899999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=1.6e-28  Score=279.79  Aligned_cols=173  Identities=23%  Similarity=0.318  Sum_probs=148.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|+..+.||+|+||+||+|+++.+++.||||+++..   .....+.+..|.++++.+ +||+|+++++++...    
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~----  414 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM----  414 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS----
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC----
Confidence            456899999999999999999999999999999999753   234457788999999988 699999999985443    


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                       +..|+||||++||+|.++++...      .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       415 -~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          415 -DRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred             -CEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence             48999999999999999998654      589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+......        ......+||+.|||||++.
T Consensus       485 DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~  515 (674)
T 3pfq_A          485 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIA  515 (674)
T ss_dssp             CCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHT
T ss_pred             ecceeeccccCC--------cccccccCCCcccCHhhhc
Confidence            999998643221        1123468999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=2.4e-28  Score=254.68  Aligned_cols=170  Identities=26%  Similarity=0.349  Sum_probs=147.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .+.|+..+.||+|+||.||+|++..+++.||+|++.....      ...+++.+|++++++++||||+++++++....  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence            3568899999999999999999999999999999975432      13578999999999999999999999976554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~----  680 (725)
                         ..|+||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        89 ---~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           89 ---DVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence               7899999999999999997643      578999999999999999999999   999999999999999887    


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+||+|||+++.......         .....||+.|+|||++
T Consensus       157 ~~kl~Dfg~~~~~~~~~~---------~~~~~gt~~y~aPE~~  190 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGVE---------FKNIFGTPEFVAPEIV  190 (321)
T ss_dssp             CEEECCCTTCEECCTTCC---------CCCCCSCGGGCCHHHH
T ss_pred             CEEEccCccceecCcccc---------ccccCCCCCccCcccc
Confidence            799999999987643211         1124699999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=2.3e-28  Score=261.98  Aligned_cols=182  Identities=24%  Similarity=0.386  Sum_probs=139.5

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKG  605 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  605 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||||++...  .....+++.+|+.+++++. ||||+++++++...+   
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---
Confidence            3457899999999999999999999999999999998643  2334567889999999997 999999999986543   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      ....|+|||||+ |+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCEEEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            236899999997 5999998753       478899999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCC-------------CCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTS-------------SKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.+........             ..........+||++|+|||++.
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            9999987643211100             00111223468999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=2e-28  Score=256.80  Aligned_cols=168  Identities=28%  Similarity=0.389  Sum_probs=141.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..++|+..+.||+|+||.||+|+++.+++.||||++......    +.+|++++.++ +||||+++++++....     .
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK-----Y   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS-----E
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC-----E
Confidence            356799999999999999999999999999999999755332    34688888888 7999999999976554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC----CceEE
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD----MVAHV  684 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~----~~~kl  684 (725)
                      .|+||||++||+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+||++..+    +.+||
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            899999999999999997654      589999999999999999999999   99999999999998543    35999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+|+.......        .....+||+.|+|||++
T Consensus       162 ~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~  192 (342)
T 2qr7_A          162 CDFGFAKQLRAENG--------LLMTPCYTANFVAPEVL  192 (342)
T ss_dssp             CCCTTCEECBCTTC--------CBCCSSCCSSCCCHHHH
T ss_pred             EECCCcccCcCCCC--------ceeccCCCccccCHHHh
Confidence            99999987643311        11235799999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=7.5e-29  Score=259.40  Aligned_cols=175  Identities=26%  Similarity=0.448  Sum_probs=139.2

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .....++|+..+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|++++++++||||+++++++....  
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  106 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--  106 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT--
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--
Confidence            34456789999999999999999999999999999999975432  23456789999999999999999999987654  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-----CC
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-----HD  679 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-----~~  679 (725)
                         ..|+||||+++ +|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++     .+
T Consensus       107 ---~~~lv~e~~~~-~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  173 (329)
T 3gbz_A          107 ---RLHLIFEYAEN-DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASET  173 (329)
T ss_dssp             ---EEEEEEECCSE-EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----C
T ss_pred             ---EEEEEEecCCC-CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCcc
Confidence               78999999975 9999998654      588999999999999999999999   999999999999994     45


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+||+|||+|+.......        .....+||+.|+|||++.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~  210 (329)
T 3gbz_A          174 PVLKIGDFGLARAFGIPIR--------QFTHEIITLWYRPPEILL  210 (329)
T ss_dssp             CEEEECCTTHHHHHC-------------------CCTTCCHHHHT
T ss_pred             ceEEECcCCCccccCCccc--------ccCCCcCCccccCHHHhc
Confidence            5699999999987643211        112246899999999863

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=248.39  Aligned_cols=174  Identities=26%  Similarity=0.459  Sum_probs=135.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++....   ....+++.+|++++++++||||+++++++....    
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   84 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN----   84 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS----
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC----
Confidence            3467999999999999999999998899999999997542   233578899999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        85 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d  155 (278)
T 3cok_A           85 -YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD  155 (278)
T ss_dssp             -EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred             -eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence             78999999999999999986532     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++.......        ......||+.|+|||++.
T Consensus       156 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~  185 (278)
T 3cok_A          156 FGLATQLKMPHE--------KHYTLCGTPNYISPEIAT  185 (278)
T ss_dssp             CTTCEECC------------------------------
T ss_pred             ecceeeccCCCC--------cceeccCCCCcCCcchhc
Confidence            999986543211        111256999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=6.5e-28  Score=249.87  Aligned_cols=186  Identities=34%  Similarity=0.532  Sum_probs=155.0

Q ss_pred             CCccCHHHHHHHhcCCCCC------cccccccceEEEEEEECCCceEEEEEEeeccc----cchHHHHHHHHHHHHcCCC
Q 048668          519 FPMVSYAELSKATSEFSSS------NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRH  588 (725)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h  588 (725)
                      ...++..++..++.+|...      +.||+|+||.||+|++  +++.||||++....    ....+.+.+|++++++++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4557788999999998877      8899999999999987  57889999986432    3345789999999999999


Q ss_pred             CcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 048668          589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD  668 (725)
Q Consensus       589 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd  668 (725)
                      |||+++++++....     ..++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||++   +|+|||
T Consensus        90 ~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  158 (307)
T 2nru_A           90 ENLVELLGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD  158 (307)
T ss_dssp             TTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCeEEEEEEEecCC-----ceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence            99999999976544     78999999999999999975321   12589999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          669 LKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       669 lkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+||+++.++.+||+|||+++........      .......||+.|+|||++
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~  207 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEAL  207 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHH
T ss_pred             CCHHHEEEcCCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHh
Confidence            9999999999999999999999865432111      111235699999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=3e-28  Score=268.84  Aligned_cols=172  Identities=31%  Similarity=0.426  Sum_probs=147.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|++.+.||+|+||.||+|+++.+++.||||++...  .....+.+.+|++++++++||||+++++++....     
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-----
Confidence            345799999999999999999999999999999999753  2334678899999999999999999999977654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCceEE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHV  684 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~---~~~~~kl  684 (725)
                      ..|+|||||++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++   .++.+||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            7899999999999999987654      589999999999999999999999   999999999999995   4567999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+......         .....+||+.|+|||++.
T Consensus       166 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  196 (486)
T 3mwu_A          166 IDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLR  196 (486)
T ss_dssp             CSCSCTTTBCCC-------------CCTTGGGGCCGGGGG
T ss_pred             EECCcCeECCCCC---------ccCCCcCCCCCCCHHHhC
Confidence            9999998664321         112357999999999863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=9e-29  Score=253.98  Aligned_cols=168  Identities=22%  Similarity=0.438  Sum_probs=145.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc-------eEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE-------MIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||.||+|++..++       ..||+|++........+++.+|++++++++||||+++++++.... 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence            357888999999999999999987665       579999997666666788999999999999999999999986654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc--
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--  681 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~--  681 (725)
                          ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.  
T Consensus        86 ----~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           86 ----ENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             ----CCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred             ----CCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence                67999999999999999986532     489999999999999999999999   9999999999999998887  


Q ss_pred             ------eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 ------AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ------~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                            +||+|||+++.....            ....||+.|+|||++
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~y~aPE~~  189 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPK------------DILQERIPWVPPECI  189 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCH------------HHHHHTTTTSCHHHH
T ss_pred             ccccceeeeccCcccccccCc------------cccCCcCcccCHHHh
Confidence                  999999998654221            124589999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=262.61  Aligned_cols=175  Identities=26%  Similarity=0.429  Sum_probs=147.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++....   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            357889999999999999999999999999999997543 334577889999999999999999999876543   2367


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCceEEc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVG  685 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill----~~~~~~kl~  685 (725)
                      |+||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             EEEEecCCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence            999999999999999986532   12389999999999999999999999   99999999999999    777889999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+.......         ....+||+.|+|||++
T Consensus       159 DFG~a~~~~~~~~---------~~~~~gt~~y~aPE~~  187 (396)
T 4eut_A          159 DFGAARELEDDEQ---------FVSLYGTEEYLHPDMY  187 (396)
T ss_dssp             CGGGCEECCCGGG---------SSCSSSCCTTCCHHHH
T ss_pred             cCCCceEccCCCc---------cccccCCccccCHHHh
Confidence            9999987643321         1125699999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=1.9e-28  Score=257.75  Aligned_cols=166  Identities=30%  Similarity=0.447  Sum_probs=143.7

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      +.|+..+.||+|+||.||+|++..+++.||||++.....   ...+++.+|++++++++||||+++++++....     .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----e
Confidence            458888999999999999999988999999999975432   23467899999999999999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ |++.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEecCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence            899999997 688888865432     589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.....            ...+||+.|+|||++
T Consensus       200 ~a~~~~~~------------~~~~gt~~y~aPE~~  222 (348)
T 1u5q_A          200 SASIMAPA------------NSFVGTPYWMAPEVI  222 (348)
T ss_dssp             TCBSSSSB------------CCCCSCGGGCCHHHH
T ss_pred             CceecCCC------------CcccCCcceeCHhhh
Confidence            99765321            124699999999986

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.4e-29  Score=261.51  Aligned_cols=266  Identities=20%  Similarity=0.212  Sum_probs=126.7

Q ss_pred             CcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEcc
Q 048668           39 LQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG  118 (725)
Q Consensus        39 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  118 (725)
                      ++.++++.+.+.......+..+++|++|+|++|+|+++.|..|.++++|++|+|++|+++ .++.  +..+++|++|+|+
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCE-EEEE--ETTCTTCCEEECC
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCC-cchh--hhhcCCCCEEECc
Confidence            344455555554444444444455555555555555544455555555555555555554 2221  3445555555555


Q ss_pred             CceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccC
Q 048668          119 ANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN  198 (725)
Q Consensus       119 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N  198 (725)
                      +|+++++.+     .++|++|++++|+|+++.+..                                 +++|++|++++|
T Consensus        89 ~n~l~~l~~-----~~~L~~L~l~~n~l~~~~~~~---------------------------------~~~L~~L~l~~N  130 (317)
T 3o53_A           89 NNYVQELLV-----GPSIETLHAANNNISRVSCSR---------------------------------GQGKKNIYLANN  130 (317)
T ss_dssp             SSEEEEEEE-----CTTCCEEECCSSCCSEEEECC---------------------------------CSSCEEEECCSS
T ss_pred             CCccccccC-----CCCcCEEECCCCccCCcCccc---------------------------------cCCCCEEECCCC
Confidence            555544321     244555555555554433222                                 234444444444


Q ss_pred             cccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhh-cCCCCccEEeccCcccccCC
Q 048668          199 QFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVI-GELKNLQLLGLYKNFLQGSI  277 (725)
Q Consensus       199 ~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~  277 (725)
                      ++++..+                         ..+..+++|++|+|++|.+.+..+..+ ..+++|++|+|++|.+++..
T Consensus       131 ~l~~~~~-------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  185 (317)
T 3o53_A          131 KITMLRD-------------------------LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK  185 (317)
T ss_dssp             CCCSGGG-------------------------BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE
T ss_pred             CCCCccc-------------------------hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc
Confidence            4443222                         223333344444444444443333333 23444444444444444321


Q ss_pred             CCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccc
Q 048668          278 PSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF  357 (725)
Q Consensus       278 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  357 (725)
                      +  ...+++|++|++++|+++            .+|..+..+..+ ++|++++|.++ .+|..+..+++|+.|++++|.+
T Consensus       186 ~--~~~l~~L~~L~Ls~N~l~------------~l~~~~~~l~~L-~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~  249 (317)
T 3o53_A          186 G--QVVFAKLKTLDLSSNKLA------------FMGPEFQSAAGV-TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF  249 (317)
T ss_dssp             C--CCCCTTCCEEECCSSCCC------------EECGGGGGGTTC-SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCC
T ss_pred             c--ccccccCCEEECCCCcCC------------cchhhhcccCcc-cEEECcCCccc-chhhHhhcCCCCCEEEccCCCc
Confidence            1  112444444444444443            333333333333 44555555554 3445566666777777777777


Q ss_pred             c-ccCccccccccCCcEEEccCC-ccccccC
Q 048668          358 S-GMIPVTLSTCVSLEYVDISSN-CFHGIIP  386 (725)
Q Consensus       358 ~-~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~  386 (725)
                      . +.+|..+..+++|+.|++++| .+++..|
T Consensus       250 ~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             BHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             cCcCHHHHHhccccceEEECCCchhccCCch
Confidence            6 556666666677777777633 3554443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=3.6e-28  Score=246.51  Aligned_cols=171  Identities=30%  Similarity=0.511  Sum_probs=145.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++. ++..||+|++..... ..+++.+|++++++++||||+++++++....     ..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-----PIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----ceE
Confidence            457889999999999999999887 577899999975433 3467899999999999999999999976544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence            99999999999999976532     589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.......       .......||+.|+|||++
T Consensus       152 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~  177 (268)
T 3sxs_A          152 RYVLDDQY-------VSSVGTKFPVKWSAPEVF  177 (268)
T ss_dssp             EECCTTCE-------EECCSCCCCGGGCCHHHH
T ss_pred             eecchhhh-------hcccCCCcCcccCCHHHH
Confidence            87643311       111234578889999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=1.8e-28  Score=258.38  Aligned_cols=180  Identities=26%  Similarity=0.443  Sum_probs=147.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      ..++|+..+.||+|+||.||+|++.     .+++.||||+++... ....+.+.+|++++++++||||+++++++.... 
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC-
Confidence            4568999999999999999999986     456899999997543 334568999999999999999999999976544 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCcc------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQV------------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                          ..|+||||+++|+|.+++.......                  ....+++.+++.++.||+.||+|||++   +|+
T Consensus       124 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          124 ----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence                7899999999999999998643210                  013689999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+||+++.++.+||+|||+++.........      ......||+.|+|||++
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~  248 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESI  248 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHH
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCcccc------ccCCCcccceecChhhh
Confidence            99999999999999999999999998764332111      11224689999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=3.1e-28  Score=249.28  Aligned_cols=173  Identities=28%  Similarity=0.385  Sum_probs=143.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +.|...+.||+|+||.||+|+++.++..||+|++.... ....+.+.+|++++++++||||+++++++....     ..|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-----eEE
Confidence            47889999999999999999999999999999997653 334678999999999999999999999986554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEEccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDF  687 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl~Df  687 (725)
                      +||||+++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+||
T Consensus        97 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999999865321  112589999999999999999999999   99999999999999   45678999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.......         .....||+.|+|||++
T Consensus       172 g~a~~~~~~~~---------~~~~~~t~~y~aPE~~  198 (285)
T 3is5_A          172 GLAELFKSDEH---------STNAAGTALYMAPEVF  198 (285)
T ss_dssp             CCCCC-------------------CTTGGGCCHHHH
T ss_pred             ecceecCCccc---------CcCcccccCcCChHHh
Confidence            99976543211         1225699999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=2.7e-28  Score=256.28  Aligned_cols=182  Identities=31%  Similarity=0.488  Sum_probs=141.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHH--HHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEA--LRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++  +++.||||++....   ...+..|.++  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46889999999999999999987  68899999997543   2344444444  44589999999998766544555567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC------CCCcEecCCCCCCeeecCCCce
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC------QPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------~~~ivHrdlkp~Nill~~~~~~  682 (725)
                      .++||||+++|+|.+++....       .++..++.++.|++.||+|||+.+      .++|+||||||+||+++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            899999999999999997553       588889999999999999999863      3389999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.+..................+||+.|+|||++.
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  201 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE  201 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHT
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhc
Confidence            999999998765432221111122233457999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=5.1e-28  Score=246.57  Aligned_cols=175  Identities=24%  Similarity=0.369  Sum_probs=149.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....     .
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   79 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----I   79 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-----E
Confidence            3467999999999999999999999899999999997553 334578899999999999999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            899999999999999997543      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++.........      ......||+.|+|||++.
T Consensus       151 ~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~  180 (276)
T 2yex_A          151 LATVFRYNNRER------LLNKMCGTLPYVAPELLK  180 (276)
T ss_dssp             TCEECEETTEEC------CBCCCCSCGGGCCGGGGT
T ss_pred             CccccCCCcchh------cccCCccccCccChHHHh
Confidence            998664321111      112356999999999863

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=2.9e-28  Score=261.34  Aligned_cols=172  Identities=23%  Similarity=0.336  Sum_probs=135.8

Q ss_pred             hcCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHc-CCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN-IRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|... +.||+|+||+||+|++..+++.||||+++..     ..+.+|++++.+ .+||||+++++++... +.+...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence            3456665 6899999999999999999999999999632     456788888754 5799999999987542 122357


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~  685 (725)
                      .|+|||||+||+|.+++.....    ..+++..+..|+.||+.||+|||+.   +|+||||||+||+++.   ++.+||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence            8999999999999999986532    2589999999999999999999999   9999999999999997   7899999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+......         .....+||+.|||||++.
T Consensus       207 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  236 (400)
T 1nxk_A          207 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLG  236 (400)
T ss_dssp             CCTTCEECC--------------------CTTCCGGGSC
T ss_pred             ecccccccCCCC---------ccccCCCCCCccCHhhcC
Confidence            999998654321         112357999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=4.2e-28  Score=257.19  Aligned_cols=175  Identities=29%  Similarity=0.456  Sum_probs=149.8

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------chHHHHHHHHHHHHcC-CCCcccceee
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFRSFVAECEALRNI-RHRNLIKIIT  596 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~  596 (725)
                      ......++|+..+.||+|+||.||+|++..+|+.||||+++....        ...+.+.+|+++++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            344556789999999999999999999988999999999975431        1245688999999999 7999999999


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ++....     ..|+||||++|++|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       168 ~~~~~~-----~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          168 SYESSS-----FMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILL  233 (365)
T ss_dssp             EEEBSS-----EEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEeeCC-----EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            976554     7899999999999999997543      589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++.+||+|||++..+.....         ....+||+.|+|||++
T Consensus       234 ~~~~~ikl~DfG~~~~~~~~~~---------~~~~~gt~~y~aPE~~  271 (365)
T 2y7j_A          234 DDNMQIRLSDFGFSCHLEPGEK---------LRELCGTPGYLAPEIL  271 (365)
T ss_dssp             CTTCCEEECCCTTCEECCTTCC---------BCCCCSCGGGCCHHHH
T ss_pred             CCCCCEEEEecCcccccCCCcc---------cccCCCCCCccChhhc
Confidence            9999999999999987643211         1235799999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=4.8e-28  Score=247.91  Aligned_cols=171  Identities=25%  Similarity=0.431  Sum_probs=147.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....     .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-----E
Confidence            468999999999999999999999999999999997553  234567889999999999999999999986554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc---eEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---AHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~---~kl~  685 (725)
                      .++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            899999999999999987654      589999999999999999999999   9999999999999987655   9999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||.+........         .....||+.|+|||++.
T Consensus       151 Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~  180 (284)
T 3kk8_A          151 DFGLAIEVNDSEA---------WHGFAGTPGYLSPEVLK  180 (284)
T ss_dssp             CCTTCEECCSSCB---------CCCSCSCGGGCCHHHHT
T ss_pred             eceeeEEcccCcc---------ccCCCCCcCCcCchhhc
Confidence            9999976543211         11256999999999853

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=4.1e-28  Score=254.44  Aligned_cols=172  Identities=21%  Similarity=0.350  Sum_probs=148.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|...+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....    
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  114 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----  114 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----
Confidence            3467999999999999999999999999999999997542   234567899999999999999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++++|.+++....      .+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       115 -~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          115 -FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             -EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             -eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEee
Confidence             7899999999999999987654      589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.......        ......||+.|+|||++
T Consensus       185 fg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~  213 (335)
T 2owb_A          185 FGLATKVEYDGE--------RKKVLCGTPNYIAPEVL  213 (335)
T ss_dssp             CTTCEECCSTTC--------CBCCCCSCCSSCCHHHH
T ss_pred             ccCceecccCcc--------cccccCCCccccCHHHh
Confidence            999987643211        11225699999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=4.8e-28  Score=249.22  Aligned_cols=172  Identities=21%  Similarity=0.342  Sum_probs=148.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|...+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence            467889999999999999999999999999999997542   234567889999999999999999999986554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence            7899999999999999987654      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.......        ......||+.|+|||++.
T Consensus       160 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~  188 (294)
T 2rku_A          160 GLATKVEYDGE--------RKKVLCGTPNYIAPEVLS  188 (294)
T ss_dssp             TTCEECCSTTC--------CBCCCCSCCSSCCHHHHT
T ss_pred             cCceecccCcc--------ccccccCCCCcCCcchhc
Confidence            99987543211        112256999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.8e-28  Score=253.10  Aligned_cols=170  Identities=24%  Similarity=0.365  Sum_probs=142.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++.....  ...+.+.+|++++++++||||+++++++....     ..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----RL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----eE
Confidence            578899999999999999999999999999999865432  23467889999999999999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||++++++.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            99999999999999887554      589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+........        ....+||+.|+|||++
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~  174 (311)
T 4agu_A          149 ARLLTGPSDY--------YDDEVATRWYRSPELL  174 (311)
T ss_dssp             CEECC--------------------GGGCCHHHH
T ss_pred             chhccCcccc--------cCCCcCCccccChHHH
Confidence            9876432111        1124699999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=2e-28  Score=270.05  Aligned_cols=174  Identities=26%  Similarity=0.542  Sum_probs=148.1

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ...+|+..+.||+|+||.||+|++..++..||||+++... ...++|.+|++++++++||||++++++|....     ..
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cE
Confidence            3457888899999999999999998889999999997543 34578999999999999999999999986554     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.++++....    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence            999999999999999986432    1588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+........       ......+|+.|+|||++
T Consensus       365 a~~~~~~~~~-------~~~~~~~~~~y~aPE~~  391 (495)
T 1opk_A          365 SRLMTGDTYT-------AHAGAKFPIKWTAPESL  391 (495)
T ss_dssp             EECCTTCCEE-------CCTTCCCCGGGCCHHHH
T ss_pred             ceeccCCcee-------ecCCCcCCcceeCHhHH
Confidence            9876432111       11224578899999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=2.2e-28  Score=257.90  Aligned_cols=185  Identities=25%  Similarity=0.349  Sum_probs=146.7

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc-----ccchHHHHHHHHHHHHcCCCCcccceeeEeecC
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      +....++|+..+.||+|+||.||+|++..+++.||+|++...     .....+++.+|++++++++||||+++++++...
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345566899999999999999999999999999999999753     234567899999999999999999999998655


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCcc----------------------------------ccccCCHHHHHHHHH
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQV----------------------------------EVCKLSLIQRLNIAI  647 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------------------------~~~~~~~~~~~~i~~  647 (725)
                      .     ..++||||+++|+|.+++.......                                  ....+++..++.++.
T Consensus       101 ~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A          101 Q-----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             S-----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             C-----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            4     7899999999999999996321100                                  011246777889999


Q ss_pred             HHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC--ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       648 ~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |++.||+|||+.   +|+||||||+||+++.++  .+||+|||+|+.+.......    ........||+.|+|||++
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----YYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHH
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc----cccccccCCCccccCchhh
Confidence            999999999999   999999999999998776  89999999998764322111    1112235699999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=2.7e-28  Score=249.00  Aligned_cols=170  Identities=26%  Similarity=0.438  Sum_probs=145.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      +.++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....    
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   82 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC----
Confidence            3467999999999999999999999999999999996432   233567889999999999999999999986554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 -~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           83 -RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             -EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred             -EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence             7899999999999999997654      588999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||++.......          .....||+.|+|||++
T Consensus       153 fg~~~~~~~~~----------~~~~~~~~~y~aPE~~  179 (279)
T 3fdn_A          153 FGWSVHAPSSR----------RTDLCGTLDYLPPEMI  179 (279)
T ss_dssp             CCEESCC------------------CCCCTTCCHHHH
T ss_pred             ccccccCCccc----------ccccCCCCCccCHhHh
Confidence            99986543221          1124699999999975

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=1.7e-28  Score=256.17  Aligned_cols=185  Identities=25%  Similarity=0.454  Sum_probs=133.1

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCce---EEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      ..++|+..+.||+|+||.||+|++..++.   .||||+++..  .....+++.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34579999999999999999999876664   8999999754  334567899999999999999999999998765422


Q ss_pred             C-cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          605 G-VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       605 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      + ....++||||+++|+|.+++...........+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence            1 112489999999999999997543222223589999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||+|+.........      ......||+.|+|||++
T Consensus       178 l~Dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~  211 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYR------QGCASKLPVKWLALESL  211 (323)
T ss_dssp             ECCCCC-----------------------CCGGGCCHHHH
T ss_pred             Eeecccccccccccccc------ccccccCcccccCchhh
Confidence            99999998764432111      11124578899999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=1.8e-28  Score=260.13  Aligned_cols=178  Identities=29%  Similarity=0.367  Sum_probs=149.5

Q ss_pred             cCHHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-----CCcccceee
Q 048668          522 VSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----HRNLIKIIT  596 (725)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~  596 (725)
                      +++.+.....++|++.+.||+|+||.||+|++..+++.||||++... ....+.+..|+++++++.     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            34444445567899999999999999999999999999999999643 233466788999999986     999999999


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ++...+     ..|+||||+ +++|.+++......    .+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       104 ~~~~~~-----~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  170 (360)
T 3llt_A          104 KFMYYD-----HMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILL  170 (360)
T ss_dssp             EEEETT-----EEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             eeeECC-----eeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEE
Confidence            987654     789999999 89999999865422    588999999999999999999999   99999999999999


Q ss_pred             cC-------------------------CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          677 DH-------------------------DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       677 ~~-------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.                         ++.+||+|||+|+......           ...+||+.|+|||++.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------~~~~gt~~y~aPE~~~  232 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----------GSIINTRQYRAPEVIL  232 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----------CSCCSCGGGCCHHHHT
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----------cCccCcccccCcHHHc
Confidence            75                         7899999999998643221           1256999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=3.4e-28  Score=268.88  Aligned_cols=170  Identities=26%  Similarity=0.401  Sum_probs=142.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .+.|+..+.||+|+||.||+|+++.++..||+|++....  ......+.+|++++++++||||+++++++....     .
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----N  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence            346889999999999999999999999999999997543  334578899999999999999999999986654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CceEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~---~~~kl~  685 (725)
                      .|+|||||++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||+++..   +.+||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence            899999999999999987654      589999999999999999999999   99999999999999764   459999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+.......         ....+||++|+|||++
T Consensus       182 DfG~a~~~~~~~~---------~~~~~gt~~y~aPE~l  210 (494)
T 3lij_A          182 DFGLSAVFENQKK---------MKERLGTAYYIAPEVL  210 (494)
T ss_dssp             CCTTCEECBTTBC---------BCCCCSCTTTCCHHHH
T ss_pred             ECCCCeECCCCcc---------ccccCCCcCeeCHHHH
Confidence            9999987643311         1235799999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=2.6e-28  Score=259.12  Aligned_cols=178  Identities=25%  Similarity=0.340  Sum_probs=150.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ...+|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++..........
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3458999999999999999999999999999999997543 334477899999999999999999999987766555567


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ |+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcccC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence            899999997 5999998753       488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+..........     .....+||+.|+|||++
T Consensus       174 ~a~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~  203 (364)
T 3qyz_A          174 LARVADPDHDHTG-----FLTEYVATRWYRAPEIM  203 (364)
T ss_dssp             TCEECCGGGCBCC-----TTCCCCSCGGGCCHHHH
T ss_pred             ceEecCCCCCccc-----cccccccccCCCCCHHh
Confidence            9987654322111     11235799999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=6.3e-28  Score=247.40  Aligned_cols=167  Identities=29%  Similarity=0.507  Sum_probs=142.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc-------hHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-------AFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++......       ..+++.+|++++++++||||+++++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            35788899999999999999999999999999999654321       126789999999999999999999987543  


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCc
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nill~~~~~  681 (725)
                           .++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.
T Consensus        96 -----~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           96 -----PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             -----TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred             -----CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence                 2699999999999999876542     589999999999999999999998   7  999999999999988776


Q ss_pred             -----eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 -----AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 -----~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                           +||+|||+|+.....           .....||+.|+|||++
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~-----------~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVHS-----------VSGLLGNFQWMAPETI  198 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSSC-----------EECCCCCCTTSCGGGS
T ss_pred             CCceeEEeCCCCcccccccc-----------ccccCCCccccCchhh
Confidence                 999999999743221           1235699999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.5e-28  Score=257.83  Aligned_cols=171  Identities=23%  Similarity=0.373  Sum_probs=139.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  607 (725)
                      .+.|+..+.||+|+||.||+|++..+|+.||||++...  .....+++.+|++++++++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46789999999999999999999999999999999643  2234567899999999999999999999986543 12234


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+ +++|.++++..       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence            569999999 88999998753       488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.....           ....+||+.|+|||++
T Consensus       173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~  197 (367)
T 1cm8_A          173 GLARQADSE-----------MTGYVVTRWYRAPEVI  197 (367)
T ss_dssp             TTCEECCSS-----------CCSSCSCGGGCCTHHH
T ss_pred             ecccccccc-----------cCcCcCCCCcCCHHHH
Confidence            999865321           1125799999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=3.2e-28  Score=254.54  Aligned_cols=176  Identities=24%  Similarity=0.356  Sum_probs=148.5

Q ss_pred             cCCCCCcccccccceEEEEEE----ECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++...+   ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG---RQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---SC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---Cc
Confidence            578899999999999999999    45688999999998766556678999999999999999999999876432   34


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred             eEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence            68999999999999999976432     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++........     ........||+.|+|||++
T Consensus       172 g~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~  202 (327)
T 3lxl_A          172 GLAKLLPLDKDY-----YVVREPGQSPIFWYAPESL  202 (327)
T ss_dssp             GGCEECCTTCSE-----EECSSCCCSCGGGSCHHHH
T ss_pred             ccceecccCCcc-----ceeeccCCccccccCHHHh
Confidence            999876433211     1111224589999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=4.2e-28  Score=252.16  Aligned_cols=180  Identities=23%  Similarity=0.385  Sum_probs=147.3

Q ss_pred             HhcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      ..++|...+.||+|+||.||+|++     +.+++.||||++.... ....+++.+|++++++++||||+++++++.... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-
Confidence            346788899999999999999987     3456899999997543 334578899999999999999999999976544 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCcc------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQV------------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                          ..++||||+++|+|.+++.......                  ....+++..++.++.|++.||+|||++   +|+
T Consensus       100 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv  172 (314)
T 2ivs_A          100 ----PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV  172 (314)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ----ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence                7899999999999999998654210                  112488999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+||+++.++.+||+|||+++........      .......||+.|+|||++
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  224 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY------VKRSQGRIPVKWMAIESL  224 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE------ECSSCCCSCGGGCCHHHH
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccc------eeccCCCCcccccChhhh
Confidence            9999999999999999999999999876433211      111224588999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=4.4e-28  Score=248.04  Aligned_cols=172  Identities=28%  Similarity=0.500  Sum_probs=142.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|+..+.||+|+||.||+|++. ++..||+|++..... ..+++.+|++++++++||||+++++++....     ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-----Ce
Confidence            4568889999999999999999987 677899999975433 3467899999999999999999999976544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             EEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence            999999999999999976432     589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++........       ......||+.|+|||++
T Consensus       167 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~  193 (283)
T 3gen_A          167 SRYVLDDEYT-------SSVGSKFPVRWSPPEVL  193 (283)
T ss_dssp             GGGBCCHHHH-------STTSTTSCGGGCCHHHH
T ss_pred             cccccccccc-------cccCCccCcccCCHHHh
Confidence            9866432111       11224578899999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=6.4e-28  Score=267.36  Aligned_cols=171  Identities=28%  Similarity=0.421  Sum_probs=145.1

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-------------chHHHHHHHHHHHHcCCCCcccceee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-------------GAFRSFVAECEALRNIRHRNLIKIIT  596 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  596 (725)
                      ..+.|+..+.||+|+||.||+|+++.+++.||+|++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45689999999999999999999999999999999975321             23567899999999999999999999


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ++....     ..|+|||||++|+|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       114 ~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          114 VFEDKK-----YFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL  179 (504)
T ss_dssp             EEECSS-----EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEEcCC-----EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence            986554     7899999999999999997654      589999999999999999999999   99999999999999


Q ss_pred             cCCC---ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDM---VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++   .+||+|||+|+.......         ....+||+.|+|||++
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~  220 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDYK---------LRDRLGTAYYIAPEVL  220 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTSC---------BCCCCSCTTTCCHHHH
T ss_pred             ecCCCCccEEEEECCCCEEcCCCCc---------cccccCCcCCCCHHHh
Confidence            9776   699999999987643211         1225699999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=2.2e-28  Score=255.63  Aligned_cols=173  Identities=26%  Similarity=0.462  Sum_probs=137.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceE----EEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMI----VAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      .++|+..+.||+|+||.||+|++..+++.    ||+|.+... .....++|.+|++++++++||||++++++|...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            35788999999999999999998777765    477776533 234457899999999999999999999998754    


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~  159 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEc
Confidence              36799999999999999987543     589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+........      .......||+.|+|||++
T Consensus       160 Dfg~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~  191 (327)
T 3poz_A          160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESI  191 (327)
T ss_dssp             CTTHHHHHTTTCC-------------CCCGGGSCHHHH
T ss_pred             cCcceeEccCCccc------ccccCCCccccccChHHh
Confidence            99999876443211      111224578999999975

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.6e-29  Score=262.28  Aligned_cols=252  Identities=17%  Similarity=0.198  Sum_probs=147.5

Q ss_pred             cccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccc-ccCccccc-------ccCCCceeeccCCCCCCCCCh
Q 048668           32 FIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY-GMFPRSIC-------NISSLEYFYLTSNRFSGSLPF  103 (725)
Q Consensus        32 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~  103 (725)
                      .++..++|++|++++|++  ..|..+...  |++|+|++|.++ ...|..+.       ++++|++|+|++|++++.+|.
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            344555566666666666  344444432  666666666663 23444333       466666666666666655555


Q ss_pred             hhh-cCCCCccEEEccCceeeeeCCCccccc-----CccceecCCCccccccCccCcccccccCeeecCCccCCccCCCC
Q 048668          104 DIV-VNLPNLKELGIGANNFFGLIPDSLSNA-----SNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAND  177 (725)
Q Consensus       104 ~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~  177 (725)
                      .+| ..+++|++|+|++|++++. |..++.+     ++|++|+|++|+|+++++..|..+++|++|++++|.+....   
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---  189 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER---  189 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHH---
T ss_pred             HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcch---
Confidence            543 5566666666666666655 5555555     66666666666666666666666666666666666643210   


Q ss_pred             cccccc--cCCCCCCCEEECccCcccc--cCChhh-hhccccceeEEecCccceeccC-cccccccCCceEEecccccCC
Q 048668          178 LGFVTF--LTNCSSLKVLSLSDNQFGG--ELPHSI-ANLSSTMIVFLIGGNQISGTIP-LGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       178 ~~~~~~--~~~l~~L~~L~L~~N~l~~--~~p~~~-~~l~~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~  251 (725)
                       ..+..  +.++++|++|+|++|++++  .++..+ ..++ +|+.|++++|.+.+..| ..+..+++|++|+|++|+|+ 
T Consensus       190 -~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-  266 (312)
T 1wwl_A          190 -GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV-QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-  266 (312)
T ss_dssp             -HHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC-CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-
T ss_pred             -HHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC-CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-
Confidence             00111  2566677777777777662  112222 2223 55566666666655543 34455677777777777777 


Q ss_pred             CCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCC
Q 048668          252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      .+|..+.  ++|++|+|++|+|++. |. +..+++|++|++++|+++
T Consensus       267 ~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          267 QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            3444444  6777777777777754 44 777777777777777665

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.2e-28  Score=271.22  Aligned_cols=234  Identities=21%  Similarity=0.209  Sum_probs=153.9

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      ++|++|+|++|.|++..|..|+.+++|++|+|++|++++..|  |..+++|++|+|++|.|+++.+     .++|++|++
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            378888888888887666778888888888888888876555  7778888888888888775433     267888888


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcc-cccccCeeecCCccCC
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFS-SLKILWRLNLEQNNLG  171 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~-~l~~L~~L~L~~N~l~  171 (725)
                      ++|.|+ .++..   .+++|+.|+|++|.++++.|..|+.+++|++|+|++|.|+++.+..|. .+++|++|+|++|.++
T Consensus       107 ~~N~l~-~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          107 ANNNIS-RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CSSCCC-CEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             cCCcCC-CCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            888887 44433   357788888888888877777777788888888888888777666665 6777888888888776


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccC-
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH-  250 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-  250 (725)
                      .++.        ...+++|++|+|++|.+++. |..+..++ .|+.|++++|.+++ +|..+..+++|+.|++++|.+. 
T Consensus       183 ~~~~--------~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~-~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c  251 (487)
T 3oja_A          183 DVKG--------QVVFAKLKTLDLSSNKLAFM-GPEFQSAA-GVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC  251 (487)
T ss_dssp             EEEC--------CCCCTTCCEEECCSSCCCEE-CGGGGGGT-TCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred             cccc--------cccCCCCCEEECCCCCCCCC-CHhHcCCC-CccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence            5532        23467777777777777743 32344443 44455555554442 3434444444444444444444 


Q ss_pred             CCCChhhcCCCCccEEec
Q 048668          251 GTIPDVIGELKNLQLLGL  268 (725)
Q Consensus       251 ~~~~~~~~~l~~L~~L~L  268 (725)
                      +.+|.++..++.|+.+++
T Consensus       252 ~~~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          252 GTLRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             HHHHHHHTTCHHHHHHHH
T ss_pred             cchHHHHHhCCCCcEEec
Confidence            333344444444444444

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.8e-28  Score=256.90  Aligned_cols=174  Identities=30%  Similarity=0.468  Sum_probs=140.0

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-----chHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||||++.....     ...+.+.+|++++++++||||+++++++.... 
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-
Confidence            345689999999999999999999998999999999975321     12346889999999999999999999976544 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..++||||+++ +|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        86 ----~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           86 ----NISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             ----CCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             ----ceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEE
Confidence                78999999976 89999876542     578888999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+|+.......        .....+||+.|+|||++.
T Consensus       153 l~Dfg~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~  185 (346)
T 1ua2_A          153 LADFGLAKSFGSPNR--------AYTHQVVTRWYRAPELLF  185 (346)
T ss_dssp             ECCCGGGSTTTSCCC--------CCCCSCCCCTTCCHHHHT
T ss_pred             EEecccceeccCCcc--------cCCcccccccccCchHhh
Confidence            999999987643211        112356999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.9e-28  Score=258.94  Aligned_cols=173  Identities=22%  Similarity=0.321  Sum_probs=146.0

Q ss_pred             hcCCCCCcccccccceEEEEEEEC---CCceEEEEEEeeccc----cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILG---EDEMIVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      .++|+..+.||+|+||.||+|++.   .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            357999999999999999999984   588999999986432    22345677899999999 6999999999876654


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                           ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       133 -----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  198 (355)
T 1vzo_A          133 -----KLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  198 (355)
T ss_dssp             -----EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             -----eEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence                 7899999999999999998654      588999999999999999999999   99999999999999999999


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.+.....       ......+||+.|+|||++.
T Consensus       199 kl~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          199 VLTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             EESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHT
T ss_pred             EEeeCCCCeecccCCC-------CcccCcccCcCccChhhhc
Confidence            9999999986543211       1122357999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=2.1e-28  Score=255.66  Aligned_cols=172  Identities=28%  Similarity=0.460  Sum_probs=140.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceE----EEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMI----VAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|+..+.||+|+||.||+|++..+++.    ||+|.+.... ....+++.+|+.++++++||||+++++++..      
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence            4788899999999999999999877765    7777765332 2334567889999999999999999998743      


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      +..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence            257899999999999999976532     578889999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.+.......      ......||+.|+|||++
T Consensus       159 fg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~  189 (325)
T 3kex_A          159 FGVADLLPPDDKQL------LYSEAKTPIKWMALESI  189 (325)
T ss_dssp             CSGGGGSCCCTTCC------C-----CCTTTSCHHHH
T ss_pred             CCcccccCcccccc------cccCCCCcccccChHHh
Confidence            99998765432111      11235688899999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=8.6e-28  Score=246.51  Aligned_cols=173  Identities=24%  Similarity=0.379  Sum_probs=145.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++....  .....++.+|+..+.++ +||||+++++++....    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----   84 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----   84 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----
Confidence            3467999999999999999999999899999999997542  33456788999999999 8999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-------
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-------  679 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-------  679 (725)
                       ..++||||+++|+|.+++.....  ....+++..++.++.|++.||+|||++   +|+||||||+||+++.+       
T Consensus        85 -~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           85 -HMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred             -eEEEEEEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence             78999999999999999976421  012589999999999999999999999   99999999999999844       


Q ss_pred             ------------CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 ------------MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ------------~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                                  ..+||+|||.++......            ...||+.|+|||++.
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~  203 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQ  203 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHT
T ss_pred             cccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhc
Confidence                        479999999998654321            135999999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=5.5e-28  Score=249.84  Aligned_cols=176  Identities=27%  Similarity=0.431  Sum_probs=144.5

Q ss_pred             cCCCCCcccccccceEEEEEE----ECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGI----LGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..|+..+.||+|+||.||+|+    +..+++.||+|++.... ....+++.+|++++++++||||+++++++....   .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence            458888999999999999999    45688999999997543 344578899999999999999999999987542   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence            367899999999999999965432     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+........     ........||..|+|||++
T Consensus       170 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~  201 (302)
T 4e5w_A          170 FGLTKAIETDKEY-----YTVKDDRDSPVFWYAPECL  201 (302)
T ss_dssp             CTTCEECCTTCCE-----EECCCCTTCCGGGCCHHHH
T ss_pred             ccccccccCCCcc-----eeccCCCCCCccccCCeee
Confidence            9999876443211     0111234689999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=9.6e-28  Score=244.54  Aligned_cols=171  Identities=30%  Similarity=0.481  Sum_probs=141.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-----   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence            357889999999999999999999899999999997542   234568899999999999999999999976654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++++|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence            7899999999999999997654      588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.......         .....||+.|+|||++.
T Consensus       156 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~  183 (276)
T 2h6d_A          156 GLSNMMSDGEF---------LRTSCGSPNYAAPEVIS  183 (276)
T ss_dssp             CGGGCCCC----------------------CCTGGGT
T ss_pred             ccccccCCCcc---------eecccCCccccCHHHHc
Confidence            99986543211         11246999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.95  E-value=7.7e-28  Score=257.08  Aligned_cols=179  Identities=25%  Similarity=0.411  Sum_probs=146.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECC-------CceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSST  601 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  601 (725)
                      .++|...+.||+|+||.||+|++..       .+..||||++.... ....+++.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4578899999999999999999742       34689999997543 33457889999999999 899999999997655


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCcc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQV----------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      .     ..++||||+++|+|.+++.......          ....+++..++.++.|++.||+|||+.   +|+||||||
T Consensus       148 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          148 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             S-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             C-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence            4     7899999999999999998654210          112589999999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+++.++.+||+|||+|+.........      ......||+.|+|||++
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~------~~~~~~~t~~y~aPE~~  265 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEAL  265 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTC------CCTTCCCGGGGSCHHHH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccc------cccCCCCCcceeCHHHh
Confidence            99999999999999999998764332111      11224588999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=9.1e-28  Score=245.68  Aligned_cols=169  Identities=26%  Similarity=0.362  Sum_probs=144.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++.....      ...+.+.+|++++++++||||+++++++....   
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT---   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC---
Confidence            468899999999999999999998999999999975421      13578999999999999999999999987654   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----c
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----V  681 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~----~  681 (725)
                        ..++||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .
T Consensus        82 --~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           82 --DVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred             --eEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence              7899999999999999997643      589999999999999999999999   999999999999999877    8


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||.++.......         .....||+.|+|||++
T Consensus       151 ~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~  183 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGNE---------FKNIFGTPEFVAPEIV  183 (283)
T ss_dssp             EEECCCTTCEECC-----------------CCCGGGCCHHHH
T ss_pred             eEEEecccceeccCCCc---------ccccCCCcCccCccee
Confidence            99999999986643211         1124699999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=8.6e-28  Score=253.93  Aligned_cols=181  Identities=26%  Similarity=0.415  Sum_probs=147.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC---CC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF---KG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  605 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....  ......+.+|++++++++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999999999999986543  2334678899999999999999999999876431   11


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      .+..|+||||+++ ++.+.+.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence            3468999999975 88888765532     589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.+.......    .......+||+.|+|||++.
T Consensus       167 Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~  201 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLL  201 (351)
T ss_dssp             CCTTCEECCCCSSSS----CCCCCSSCSCGGGCCHHHHT
T ss_pred             cchhccccccccccc----ccccCCcccccCccCchhhc
Confidence            999998765332111    11223357999999999763

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=7.3e-30  Score=289.89  Aligned_cols=400  Identities=14%  Similarity=0.121  Sum_probs=291.5

Q ss_pred             CcccCcEEecCCCccCccCCccccCC--CCCcEEEccCCc-CCc-cCCCCCCCCCCCCEEEccCCccccc----Cccccc
Q 048668           11 SLFKLQALALAGNYLTGKLPDFIGNL--SALQVIHIKGNS-LGG-KFPTTLGLLRNLVQLNVAENKFYGM----FPRSIC   82 (725)
Q Consensus        11 ~l~~l~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~   82 (725)
                      .+++|++|+|++|.+++..+..+...  .+|++|+|++|. ++. ..+.....+++|++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            68899999999999987777777663  459999999997 221 1222334789999999999998765    344567


Q ss_pred             ccCCCceeeccCCCCCCCCCh----hhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccc---ccCccCcc
Q 048668           83 NISSLEYFYLTSNRFSGSLPF----DIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK---GKVSIDFS  155 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~---~~~~~~f~  155 (725)
                      ++++|++|++++|.++ .+..    ..+.++++|++|+|++|.+.++ +..+..+++|++|+++++...   ......+.
T Consensus       190 ~~~~L~~L~L~~n~~~-~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l-~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~  267 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFA-KISPKDLETIARNCRSLVSVKVGDFEILEL-VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV  267 (592)
T ss_dssp             HCCCCCEEECTTCCCS-SCCHHHHHHHHHHCTTCCEEECSSCBGGGG-HHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred             cCCCccEEEeeccCCC-ccCHHHHHHHHhhCCCCcEEeccCccHHHH-HHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence            8899999999999997 3332    2346789999999999999874 578899999999999865433   22334567


Q ss_pred             cccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChh-hhhccccceeEEecCccceeccCcccc
Q 048668          156 SLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHS-IANLSSTMIVFLIGGNQISGTIPLGIR  234 (725)
Q Consensus       156 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~~l~~L~l~~n~i~~~~~~~~~  234 (725)
                      .+++|+.|+++++....       ++..+..+++|++|+|++|.+++..... +..++ +|+.|++.++...+.++..+.
T Consensus       268 ~~~~L~~L~l~~~~~~~-------l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~-~L~~L~L~~~~~~~~l~~~~~  339 (592)
T 3ogk_B          268 FPRKLCRLGLSYMGPNE-------MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP-NLEVLETRNVIGDRGLEVLAQ  339 (592)
T ss_dssp             CCTTCCEEEETTCCTTT-------GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCT-TCCEEEEEGGGHHHHHHHHHH
T ss_pred             ccccccccCccccchhH-------HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCc-CCCEEeccCccCHHHHHHHHH
Confidence            78899999998864332       3356778899999999999987554433 45555 899999994433334445557


Q ss_pred             cccCCceEEec-----------ccccCCC-CChhhcCCCCccEEeccCcccccCCCCCCcC-CCCCCEEeCC----CCcC
Q 048668          235 NLVNLIALAVE-----------VNQLHGT-IPDVIGELKNLQLLGLYKNFLQGSIPSGLGN-LTKLAKLDLG----SNSL  297 (725)
Q Consensus       235 ~l~~L~~L~L~-----------~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l  297 (725)
                      .+++|++|+++           .|.+++. .+..+..+++|++|+++.|.+++..+..+.. +++|++|+++    .|++
T Consensus       340 ~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l  419 (592)
T 3ogk_B          340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI  419 (592)
T ss_dssp             HCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred             hCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence            78999999999           4666643 2333566899999999999998766666655 8899999996    6666


Q ss_pred             CCccccccccccccccccccccccccceecccCC--ccCCCcchhhhc-CCCCCeEEccCcccccc-CccccccccCCcE
Q 048668          298 QGNFIASQNKLIGALPQQLLSITTLSLYLDLSNN--LLNGSLPQQVGN-LKNLIILDISSNQFSGM-IPVTLSTCVSLEY  373 (725)
Q Consensus       298 ~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n--~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~  373 (725)
                      ++...      ...++..+.....+ ++|++++|  .+++..+..+.. +++|+.|++++|.+++. ++..+..+++|++
T Consensus       420 ~~~p~------~~~~~~~~~~~~~L-~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~  492 (592)
T 3ogk_B          420 TDLPL------DNGVRSLLIGCKKL-RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK  492 (592)
T ss_dssp             SSCCC------HHHHHHHHHHCTTC-CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCE
T ss_pred             cCchH------HHHHHHHHHhCCCC-CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCe
Confidence            53100      00122223334444 88999754  366555555554 89999999999999863 4555678899999


Q ss_pred             EEccCCcccccc-CccccCCCCCCEEeCCCCcccccCcccc-cCCCCCCeEEcccc
Q 048668          374 VDISSNCFHGII-PPSLGFLKSIKFLDVSCNNFSGQFPKFL-ENLSFLEFLNLSYN  427 (725)
Q Consensus       374 L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N  427 (725)
                      |+|++|.+++.. +..+..+++|+.|+|++|+++..-...+ ..++.+....+..+
T Consensus       493 L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             EEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             eeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            999999987653 3344679999999999999986543333 35666666555554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=3.3e-28  Score=268.59  Aligned_cols=170  Identities=30%  Similarity=0.442  Sum_probs=147.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-----   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence            357889999999999999999999999999999997542   345678999999999999999999999976654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEE
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHV  684 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl  684 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence            8899999999999999997654      589999999999999999999999   99999999999999   46789999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+|+.+....         .....+||++|+|||++
T Consensus       171 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~  200 (484)
T 3nyv_A          171 IDFGLSTHFEASK---------KMKDKIGTAYYIAPEVL  200 (484)
T ss_dssp             CCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHH
T ss_pred             EeeeeeEEccccc---------ccccCCCCccccCceee
Confidence            9999998764321         12235799999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=8.3e-28  Score=248.66  Aligned_cols=170  Identities=28%  Similarity=0.391  Sum_probs=144.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|...+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....     ..|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----HYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----EEE
Confidence            457889999999999999999999899999999998654444567889999999999999999999976554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEEccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDF  687 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl~Df  687 (725)
                      +||||+++++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+||
T Consensus        83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence            9999999999999997654      588999999999999999999999   99999999999999   77889999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.....          .....+||+.|+|||++.
T Consensus       154 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~  180 (304)
T 2jam_A          154 GLSKMEQNG----------IMSTACGTPGYVAPEVLA  180 (304)
T ss_dssp             STTCCCCCB----------TTHHHHSCCCBCCTTTBS
T ss_pred             CcceecCCC----------ccccccCCCCccChHHhc
Confidence            998754221          112246999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=9.9e-28  Score=245.53  Aligned_cols=170  Identities=24%  Similarity=0.424  Sum_probs=147.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++....     
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-----   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----
Confidence            457899999999999999999999999999999996532   233567899999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence            7899999999999999998654      588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |++.......          .....||+.|+|||++.
T Consensus       159 g~~~~~~~~~----------~~~~~~~~~y~aPE~~~  185 (284)
T 2vgo_A          159 GWSVHAPSLR----------RRTMCGTLDYLPPEMIE  185 (284)
T ss_dssp             TTCEECSSSC----------BCCCCSCGGGCCHHHHT
T ss_pred             cccccCcccc----------cccccCCCCcCCHHHhc
Confidence            9987653221          11256999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=1.3e-27  Score=245.49  Aligned_cols=171  Identities=27%  Similarity=0.435  Sum_probs=145.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .|...+.||+|+||.||+|++..++..||+|++....  ....+.+.+|++++++++||||+++++++.... ......+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence            4677788999999999999999999999999997543  334577899999999999999999999876532 2345789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeec-CCCceEEccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLD-HDMVAHVGDF  687 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nill~-~~~~~kl~Df  687 (725)
                      +||||+++|+|.+++....      .+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+||
T Consensus       106 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            9999999999999997653      588999999999999999999998   6  99999999999998 7899999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.....          ......||+.|+|||++
T Consensus       177 g~~~~~~~~----------~~~~~~~t~~y~aPE~~  202 (290)
T 1t4h_A          177 GLATLKRAS----------FAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             TGGGGCCTT----------SBEESCSSCCCCCGGGG
T ss_pred             CCccccccc----------ccccccCCcCcCCHHHH
Confidence            999754322          11235699999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.8e-28  Score=255.95  Aligned_cols=171  Identities=25%  Similarity=0.431  Sum_probs=138.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc-hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++...... ....+.+|++++++++||||+++++++....     ..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence            5788999999999999999999999999999999754321 2224567999999999999999999976554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++ |+|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence            9999997 599999886542     588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        .....+||+.|+|||++.
T Consensus       148 ~~~~~~~~--------~~~~~~~t~~y~aPE~~~  173 (324)
T 3mtl_A          148 RAKSIPTK--------TYDNEVVTLWYRPPDILL  173 (324)
T ss_dssp             ECC--------------------CGGGCCHHHHT
T ss_pred             ccccCCcc--------ccccccCcccccChhhhc
Confidence            76533211        112246899999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=9.8e-28  Score=248.62  Aligned_cols=174  Identities=22%  Similarity=0.308  Sum_probs=142.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++||||+++++++....    
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----  107 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG----  107 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC----
Confidence            45789999999999999999999998999999999975432   23477899999999999999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       108 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D  177 (309)
T 2h34_A          108 -QLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD  177 (309)
T ss_dssp             -EEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             -eEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence             7899999999999999998654      589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++........       ......||+.|+|||++.
T Consensus       178 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~  208 (309)
T 2h34_A          178 FGIASATTDEKLT-------QLGNTVGTLYYMAPERFS  208 (309)
T ss_dssp             CCC-----------------------CCGGGCCGGGTC
T ss_pred             CccCccccccccc-------cccccCCCcCccCHHHHc
Confidence            9999765432111       111256999999999863

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.1e-28  Score=255.81  Aligned_cols=253  Identities=18%  Similarity=0.215  Sum_probs=207.4

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCC-ccCCCCCC-------CCCCCCEEEccCCcccccCccc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLG-GKFPTTLG-------LLRNLVQLNVAENKFYGMFPRS   80 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~   80 (725)
                      ++..++|++|++++|.+  .+|..+...  |++|+|++|+++ ...|..+.       ++++|++|+|++|++++..|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            46677899999999999  678776654  999999999994 34565554       6899999999999999888887


Q ss_pred             c--cccCCCceeeccCCCCCCCCChhhhcCC-----CCccEEEccCceeeeeCCCcccccCccceecCCCcccccc---C
Q 048668           81 I--CNISSLEYFYLTSNRFSGSLPFDIVVNL-----PNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGK---V  150 (725)
Q Consensus        81 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~---~  150 (725)
                      +  ..+++|++|+|++|+++ .+| ..+..+     ++|++|+|++|+++++.+..|+.+++|++|+|++|++.+.   +
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~-~~~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWA-TRD-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI  192 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCS-SSS-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCc-chh-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence            6  89999999999999998 456 344555     8999999999999999889999999999999999997653   1


Q ss_pred             -ccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceecc
Q 048668          151 -SIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTI  229 (725)
Q Consensus       151 -~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~  229 (725)
                       ...|..+++|++|++++|.++.++..   ....+.++++|++|+|++|++++..|.........|+.|++++|.++ .+
T Consensus       193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~i  268 (312)
T 1wwl_A          193 SALCPLKFPTLQVLALRNAGMETPSGV---CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV  268 (312)
T ss_dssp             HHSCTTSCTTCCEEECTTSCCCCHHHH---HHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SC
T ss_pred             HHHHhccCCCCCEEECCCCcCcchHHH---HHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hh
Confidence             22348899999999999999743220   11334678999999999999998775443333348999999999999 77


Q ss_pred             CcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCccccc
Q 048668          230 PLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       230 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      |..+.  ++|++|+|++|+|++. |. +..+++|++|++++|.+++
T Consensus       269 p~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          269 PKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            87776  8999999999999987 55 8999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=1.7e-27  Score=245.29  Aligned_cols=172  Identities=24%  Similarity=0.383  Sum_probs=143.4

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +|.....||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++....     ..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEEEE
Confidence            4455569999999999999999999999999998765556678999999999999999999999987654     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-CCceEEccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVGDFGLAK  691 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-~~~~kl~Dfgla~  691 (725)
                      |||+++++|.+++.....   ....++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||+++
T Consensus        98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            999999999999986532   12467888999999999999999999   9999999999999987 8999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......        ......||+.|+|||++
T Consensus       172 ~~~~~~~--------~~~~~~~~~~y~aPE~~  195 (295)
T 2clq_A          172 RLAGINP--------CTETFTGTLQYMAPEII  195 (295)
T ss_dssp             ESCC-------------CCCCCCGGGCCHHHH
T ss_pred             ccCCCCC--------cccccCCCccccChhhh
Confidence            7643211        11125699999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=1.3e-27  Score=246.54  Aligned_cols=171  Identities=29%  Similarity=0.413  Sum_probs=147.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---------chHHHHHHHHHHHHcCC-CCcccceeeEee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---------GAFRSFVAECEALRNIR-HRNLIKIITICS  599 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  599 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++.....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            45689999999999999999999999999999999975431         22457889999999996 999999999976


Q ss_pred             cCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC
Q 048668          600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD  679 (725)
Q Consensus       600 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~  679 (725)
                      ...     ..++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        95 ~~~-----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           95 TNT-----FFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD  160 (298)
T ss_dssp             CSS-----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             cCC-----eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence            544     7899999999999999998653      589999999999999999999999   99999999999999999


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+||+|||+++.......         .....||+.|+|||++
T Consensus       161 ~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~  195 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGEK---------LREVCGTPSYLAPEII  195 (298)
T ss_dssp             CCEEECCCTTCEECCTTCC---------BCCCCSCGGGCCHHHH
T ss_pred             CcEEEecccchhhcCCCcc---------cccccCCccccCHHHh
Confidence            9999999999987643211         1225699999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=4.3e-28  Score=257.43  Aligned_cols=184  Identities=20%  Similarity=0.314  Sum_probs=144.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCC-----ceEEEEEEeeccccch-----------HHHHHHHHHHHHcCCCCcccc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGED-----EMIVAVKVINLKQKGA-----------FRSFVAECEALRNIRHRNLIK  593 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  593 (725)
                      ..++|+..+.||+|+||.||+|++..+     ++.||||++.......           ...+.+|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999998754     5789999987543211           123456777788889999999


Q ss_pred             eeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCC
Q 048668          594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSN  673 (725)
Q Consensus       594 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~N  673 (725)
                      +++++.... .+..+.|+||||+ |++|.+++.....     .+++..++.|+.||+.||+|||++   +|+||||||+|
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            999987642 2334689999999 9999999986532     589999999999999999999999   99999999999


Q ss_pred             eeec--CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          674 VLLD--HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       674 ill~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++  .++.+||+|||+|+.+......... ........+||+.|||||++.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  234 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHN  234 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHT
T ss_pred             EEEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhC
Confidence            9999  8899999999999877544322111 111223456999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=3.1e-28  Score=253.06  Aligned_cols=188  Identities=26%  Similarity=0.458  Sum_probs=139.5

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECC---CceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecC
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSST  601 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  601 (725)
                      +....++|...+.||+|+||.||+|++..   ++..||+|++....  ....+.+.+|++++++++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33445678889999999999999998754   56789999997543  33456789999999999999999999998776


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~  681 (725)
                      ...+....++||||+++|+|.+++...........+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            5443445699999999999999996443222233689999999999999999999999   9999999999999999999


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||+++.........      ......|++.|+|||++
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~  221 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYR------QGRIAKMPVKWIAIESL  221 (313)
T ss_dssp             EEECSCSCC----------------------CCGGGSCHHHH
T ss_pred             EEEeecCcceecccccccC------cccccCCCccccCchhh
Confidence            9999999998764332111      11124588999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.7e-28  Score=254.10  Aligned_cols=180  Identities=26%  Similarity=0.439  Sum_probs=145.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ..++|+..+.||+|+||.||+|++     ..++..||||++.... ....+.+.+|+++++++ +||||+++++++....
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            456888999999999999999997     3467789999997542 33457899999999999 8999999999976544


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCcc-----------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQV-----------------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                           ..|+||||+++|+|.+++.......                 ....+++..++.++.|++.||+|||++   +|+
T Consensus       123 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          123 -----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             -----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                 7899999999999999998654210                 012478999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+||+++.++.+||+|||+|+........      .......||+.|+|||++
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHH
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccc------eeccCccCccCccCHHHh
Confidence            9999999999999999999999999876443211      112234588999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=7.4e-28  Score=252.21  Aligned_cols=172  Identities=26%  Similarity=0.402  Sum_probs=142.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|++++++++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-----R   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----E
Confidence            4578999999999999999999999999999999865432  23456889999999999999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++++++.++.....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            899999999999988876543      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++.......        ......||+.|+|||++.
T Consensus       170 ~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~  197 (331)
T 4aaa_A          170 FARTLAAPGE--------VYDDEVATRWYRAPELLV  197 (331)
T ss_dssp             TC--------------------CCCCCTTCCHHHHT
T ss_pred             CceeecCCcc--------ccCCCcCCccccCccccc
Confidence            9986543211        111246999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=1.1e-27  Score=261.33  Aligned_cols=168  Identities=35%  Similarity=0.477  Sum_probs=141.9

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|+..+.||+|+||.||+|++.  ++.||||+++...  ..+.|.+|++++++++||||+++++++....    ...
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cce
Confidence            3467888899999999999999985  6799999997543  4578999999999999999999999976543    368


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.++++....    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence            999999999999999986542    1478999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+......           ....+|+.|+|||++
T Consensus       336 a~~~~~~~-----------~~~~~~~~y~aPE~~  358 (450)
T 1k9a_A          336 TKEASSTQ-----------DTGKLPVKWTAPEAL  358 (450)
T ss_dssp             CEECC-----------------CCCTTTSCHHHH
T ss_pred             cccccccc-----------cCCCCCcceeCHHHh
Confidence            98542210           113578899999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=4.9e-28  Score=248.36  Aligned_cols=174  Identities=26%  Similarity=0.550  Sum_probs=148.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|+..+.||+|+||.||+|++..++..||+|++... ....+++.+|++++++++||||+++++++....     ..
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CE
Confidence            456788999999999999999999988999999999754 334578999999999999999999999976544     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++++|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             EEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence            999999999999999986542    2589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+.......       .......||+.|+|||++
T Consensus       158 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~  184 (288)
T 3kfa_A          158 SRLMTGDTY-------TAHAGAKFPIKWTAPESL  184 (288)
T ss_dssp             GGTSCSSSS-------EEETTEEECGGGCCHHHH
T ss_pred             ceeccCCcc-------ccccCCccccCcCChhhh
Confidence            987643211       112234578899999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.95  E-value=1.7e-27  Score=246.25  Aligned_cols=170  Identities=28%  Similarity=0.439  Sum_probs=148.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      +.|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++....     ..|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEE
Confidence            46888999999999999999999899999999997653 345678999999999999999999999987654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        97 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             EEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence            999999999999999643       588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        ......||+.|+|||++.
T Consensus       167 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~  192 (303)
T 3a7i_A          167 GQLTDTQI--------KRNTFVGTPFWMAPEVIK  192 (303)
T ss_dssp             EECBTTBC--------CBCCCCSCGGGCCHHHHT
T ss_pred             eecCcccc--------ccCccCCCcCccCHHHHh
Confidence            87643321        112356999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=3.4e-28  Score=251.38  Aligned_cols=173  Identities=23%  Similarity=0.352  Sum_probs=144.6

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..+.|++.+.||+|+||.||+|++..+++.||+|++........+++.+|++++++++||||+++++++....     ..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----KL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----eE
Confidence            3457899999999999999999999899999999998766666788999999999999999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+++++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  163 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGV  163 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCC
Confidence            999999999999999876432     589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........        ......||+.|+|||++
T Consensus       164 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          164 SAKNLKTLQ--------KRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             HHHHHHHHH--------C-----CCGGGCCHHHH
T ss_pred             Ccccccccc--------ccccccCChhhcCCeee
Confidence            864322110        01124699999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=4.9e-28  Score=247.34  Aligned_cols=172  Identities=24%  Similarity=0.424  Sum_probs=133.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|++..+   +..||+|++.... ....+.+.+|+.++++++||||+++++++..      
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence            45788899999999999999998643   4579999986543 3345678999999999999999999998732      


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      +..|+||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  159 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  159 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence            257899999999999999976532     588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+........       ......+|+.|+|||++
T Consensus       160 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~  189 (281)
T 1mp8_A          160 FGLSRYMEDSTYY-------KASKGKLPIKWMAPESI  189 (281)
T ss_dssp             --------------------------CCGGGCCHHHH
T ss_pred             cccccccCccccc-------ccccCCCcccccChhhc
Confidence            9999876433211       11123578899999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=1.3e-27  Score=252.93  Aligned_cols=182  Identities=26%  Similarity=0.368  Sum_probs=148.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... .....++.+|++++++++||||+++++++....+......
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457899999999999999999999999999999996443 2345678899999999999999999999877666666788


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++ |+|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999997 5999998753       488999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCC--CCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSS--KTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+...........  .........+||+.|+|||++
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  194 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM  194 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeee
Confidence            9876543211110  001112235799999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=6.2e-28  Score=246.99  Aligned_cols=174  Identities=25%  Similarity=0.482  Sum_probs=145.8

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC------
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF------  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  603 (725)
                      ...+|+..+.||+|+||.||+|++..+++.||+|++....    +.+.+|++++++++||||+++++++....+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3457899999999999999999999899999999997543    346689999999999999999998754211      


Q ss_pred             -----CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC
Q 048668          604 -----KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH  678 (725)
Q Consensus       604 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~  678 (725)
                           ......|+||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                 123457999999999999999975431    2588999999999999999999999   9999999999999999


Q ss_pred             CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       679 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+||+|||+++.......         .....||+.|+|||++
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~  193 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---------RTRSKGTLRYMSPEQI  193 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---------CCCCCSCCTTSCHHHH
T ss_pred             CCCEEECcchhheecccccc---------ccccCCcccccChhhh
Confidence            99999999999987643311         1124699999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=5.2e-28  Score=256.57  Aligned_cols=170  Identities=22%  Similarity=0.363  Sum_probs=146.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....     ..|
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  107 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EIS  107 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----EEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----EEE
Confidence            57888999999999999999999999999999997653 334578899999999999999999999987654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++....      .+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++.+||+|||+|
T Consensus       108 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence            9999999999999998654      5889999999999999999999831  7999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +......          .....||+.|+|||++.
T Consensus       180 ~~~~~~~----------~~~~~gt~~y~aPE~~~  203 (360)
T 3eqc_A          180 GQLIDSM----------ANSFVGTRSYMSPERLQ  203 (360)
T ss_dssp             HHHHHHC--------------CCCCTTCCHHHHT
T ss_pred             ccccccc----------ccCCCCCCCeECHHHHc
Confidence            7654321          11246999999999863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.95  E-value=9.9e-28  Score=247.92  Aligned_cols=186  Identities=25%  Similarity=0.368  Sum_probs=144.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-------
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-------  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  602 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++||||+++++++....       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346789999999999999999999989999999999643 234577899999999999999999999876532       


Q ss_pred             -CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc
Q 048668          603 -FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       603 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~  681 (725)
                       .......|+||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence             1234578999999999999999986432     578889999999999999999999   9999999999999999999


Q ss_pred             eEEcccccccccccCCCCCC------CCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTS------SKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+|||+++..........      ...........||+.|+|||++.
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD  203 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHT
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence            99999999986543210000      00011122356999999999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=1.3e-27  Score=250.56  Aligned_cols=180  Identities=23%  Similarity=0.433  Sum_probs=145.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC-------CCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeec
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG-------EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSS  600 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  600 (725)
                      ..++|+..+.||+|+||.||+|++.       .++..||||++.... ....+++.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3468889999999999999999975       356789999997543 33457789999999999 89999999999765


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCcc----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV----------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK  670 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk  670 (725)
                      ..     ..|+||||+++|+|.+++.......          ....+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       113 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  184 (334)
T 2pvf_A          113 DG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA  184 (334)
T ss_dssp             SS-----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             CC-----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence            44     7899999999999999998654210          112488999999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          671 PSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       671 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+||+++.++.+||+|||+++........      .......||+.|+|||++
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  231 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEAL  231 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSE------ECCSCCCCCGGGCCHHHH
T ss_pred             cceEEEcCCCCEEEccccccccccccccc------cccCCCCcccceeChHHh
Confidence            99999999999999999999876433211      111124578999999975

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=1.2e-27  Score=246.75  Aligned_cols=177  Identities=26%  Similarity=0.493  Sum_probs=142.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ...|+..+.||+|+||.||+|++..+   ...||+|.+.... ....+++.+|++++++++||||+++++++...+    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----
Confidence            34678889999999999999997533   3468999886533 344578999999999999999999999875433    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      +..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred             CceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence            467899999999999999976432     578999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.........    ........||+.|+|||++
T Consensus       172 fg~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          172 FGLARDMYDKEYYS----VHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             CGGGCCCSCGGGCB----C-----CCBCGGGSCHHHH
T ss_pred             ccccccccccchhc----cccccCCCCCccccChHHh
Confidence            99998764432111    1112235688999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=7.3e-28  Score=263.06  Aligned_cols=173  Identities=23%  Similarity=0.483  Sum_probs=144.8

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ...++|+..+.||+|+||.||+|++. ++..||||+++... ...++|.+|++++++++||||+++++++..      +.
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~  256 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP  256 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence            34567888999999999999999986 56789999997543 346789999999999999999999998752      25


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.++++...    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             cEEEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence            799999999999999997542    12578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+........       ......+|+.|+|||++
T Consensus       330 ~a~~~~~~~~~-------~~~~~~~~~~y~aPE~~  357 (454)
T 1qcf_A          330 LARVIEDNEYT-------AREGAKFPIKWTAPEAI  357 (454)
T ss_dssp             GGGGBCCHHHH-------TTCSSSSCGGGSCHHHH
T ss_pred             CceEcCCCcee-------ccCCCcccccccCHHHh
Confidence            99876432111       11123478899999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=4.9e-28  Score=253.11  Aligned_cols=183  Identities=25%  Similarity=0.377  Sum_probs=146.9

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  604 (725)
                      .+....++|+..+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+++++++ +||||+++++++......
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            333456789999999999999999999998999999999975432 346788999999999 799999999998764321


Q ss_pred             C-cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          605 G-VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       605 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      + .+..|+||||+++|+|.+++.....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence            1 3478999999999999999986531    2588999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+++.......        ......||+.|+|||++.
T Consensus       170 l~Dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             ECCCTTTC---------------------CCGGGCCHHHHC
T ss_pred             EeeCcCceecCcCcc--------ccccccCCccccChhhhc
Confidence            999999976543211        111246999999999863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=5.6e-28  Score=256.46  Aligned_cols=175  Identities=26%  Similarity=0.515  Sum_probs=133.0

Q ss_pred             CCCCCcccccccceEEEEEEECCC---ceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .|+..+.||+|+||.||+|++..+   +..||+|.++.. .....++|.+|++++++++||||++++++|...+    +.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----SC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----CC
Confidence            456678999999999999987432   356899998643 3345678999999999999999999999875433    46


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++|+|.++++....     .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence            7899999999999999976542     478889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.+.......    ........||+.|+|||++
T Consensus       238 ~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          238 LARDMYDKEFDS----VHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             ------------------------CCGGGSCHHHH
T ss_pred             cccccccccccc----ccccCCCCCcccccChHHh
Confidence            998764332111    1112234588999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=9.1e-28  Score=249.52  Aligned_cols=180  Identities=24%  Similarity=0.416  Sum_probs=147.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ..++|+..+.||+|+||.||+|++     ..+++.||||++..... ...+.+.+|+++++++ +||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346788999999999999999985     45788999999975532 3457889999999999 8999999999976554


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCc------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQ------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK  670 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk  670 (725)
                           ..++||||+++|+|.+++......            .....+++..++.++.|++.||+|||++   +|+|||||
T Consensus       101 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A          101 -----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             -----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             -----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence                 789999999999999999865421            0112489999999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          671 PSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       671 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+||+++.++.+||+|||+++........      .......||+.|+|||++
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  219 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESI  219 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHH
T ss_pred             cceEEEcCCCCEEEccccccccccccccc------eeccCCCCcceeeChHHh
Confidence            99999999999999999999876443211      111224588999999975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=2.3e-27  Score=244.56  Aligned_cols=177  Identities=21%  Similarity=0.307  Sum_probs=146.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....  ..+.+.+|+++++++ +|++++++++++....     ..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-----ee
Confidence            457899999999999999999998899999999986443  224577899999999 6999999999976554     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc-----eEE
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-----AHV  684 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~-----~kl  684 (725)
                      ++||||+ +++|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.     +||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            9999999 9999999986542     589999999999999999999998   9999999999999987775     999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+........... .........||+.|+|||++.
T Consensus       153 ~Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  191 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHL  191 (298)
T ss_dssp             CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHT
T ss_pred             EECccccccccccccccc-cccCccCCCCCcccCCchhhc
Confidence            999999876543221110 111223467999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.2e-27  Score=255.75  Aligned_cols=177  Identities=22%  Similarity=0.293  Sum_probs=140.1

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-----
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-----  603 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  603 (725)
                      ...++|+..+.||+|+||+||+|++..+++.||||++..+...    ..+|+++++.++||||+++++++.....     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3556899999999999999999999999999999998654322    2379999999999999999999855331     


Q ss_pred             ----------------------------CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHH
Q 048668          604 ----------------------------KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY  655 (725)
Q Consensus       604 ----------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  655 (725)
                                                  ....+.++||||++ |+|.+.+.....  ....+++..+..++.|++.||+|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHH
Confidence                                        22345889999997 588877764211  01268999999999999999999


Q ss_pred             HHhcCCCCcEecCCCCCCeeec-CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          656 LHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       656 lH~~~~~~ivHrdlkp~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+.   +|+||||||+||+++ .++.+||+|||+|+.......         .....||+.|+|||++.
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---------~~~~~~t~~y~aPE~~~  214 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---------SVAYICSRFYRAPELML  214 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---------CCCCCCCSSCCCHHHHT
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---------CcCcccCCCccCHHHhc
Confidence            9998   999999999999998 688999999999987643321         11256899999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=1.7e-27  Score=252.94  Aligned_cols=182  Identities=23%  Similarity=0.287  Sum_probs=144.5

Q ss_pred             HHHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc-----------chHHHHHHHHHHHHcCCCCccc
Q 048668          524 YAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-----------GAFRSFVAECEALRNIRHRNLI  592 (725)
Q Consensus       524 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  592 (725)
                      ..++....++|+..+.||+|+||.||+|++. +++.||||++.....           ...+.+.+|++++++++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4566777899999999999999999999986 489999999864321           1237889999999999999999


Q ss_pred             ceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCC
Q 048668          593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPS  672 (725)
Q Consensus       593 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~  672 (725)
                      ++++++...........|+||||++ |++.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            9999986654344457899999997 689888875432     589999999999999999999999   9999999999


Q ss_pred             CeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          673 NVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       673 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+++.++.+||+|||+|+......         ......||+.|+|||++.
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~  206 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADA---------NKTHYVTHRWYRAPELVM  206 (362)
T ss_dssp             GEEECTTCCEEECCTTC------------------------CGGGCCHHHHT
T ss_pred             HEEEcCCCCEEEEecCccccccccc---------ccceecccceecCcHHhc
Confidence            9999999999999999997543321         112256999999999763

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=1.1e-27  Score=256.23  Aligned_cols=169  Identities=25%  Similarity=0.435  Sum_probs=139.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCC--CCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR--HRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..|+..+.||+|+||.||+|.+.. ++.||||++....  ....+.+.+|++++++++  ||||+++++++....     
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-----  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-----  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-----
Confidence            458899999999999999999874 8899999997553  334578899999999997  599999999987654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||| +.+++|.+++....      .+++..+..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            7899999 56889999998654      578889999999999999999999   999999999999995 579999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.+......      ......+||+.|||||++
T Consensus       199 G~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~  228 (390)
T 2zmd_A          199 GIANQMQPDTTS------VVKDSQVGAVNYMPPEAI  228 (390)
T ss_dssp             SSSCCC---------------CCSCCCGGGCCHHHH
T ss_pred             CccccccCCCcc------ccCCCCCcCCCccChHHh
Confidence            999876433211      111235799999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=252.33  Aligned_cols=170  Identities=25%  Similarity=0.437  Sum_probs=139.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCC--CcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRH--RNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~  606 (725)
                      ...|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|++++++++|  |||+++++++....    
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~----   82 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----   82 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC----
Confidence            356889999999999999999985 68899999997543  2345778999999999986  99999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+|||| .+|+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|
T Consensus        83 -~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           83 -YIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             -EEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             -EEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence             78999995 5889999998754      588999999999999999999999   999999999999997 57899999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+........      ......+||+.|+|||++
T Consensus       151 FG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          151 FGIANQMQPDTTS------VVKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             CSSSCCC------------------CCCCSSCCHHHH
T ss_pred             cccccccCccccc------ccCCCCcCCcCcCCHHHH
Confidence            9999876433211      111235799999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.8e-27  Score=248.73  Aligned_cols=177  Identities=27%  Similarity=0.460  Sum_probs=146.8

Q ss_pred             hcCCCCCcccccccceEEEEEEE----CCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..+|+..+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++....   .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence            35688899999999999999984    5688999999998766666678999999999999999999999876432   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...++||||+++|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence            367899999999999999986542     588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.........     .......||..|+|||++
T Consensus       189 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~  220 (326)
T 2w1i_A          189 FGLTKVLPQDKEYY-----KVKEPGESPIFWYAPESL  220 (326)
T ss_dssp             CTTCEECCSSCSEE-----ECSSCCSCCGGGCCHHHH
T ss_pred             Ccchhhcccccccc-----ccccCCCCceeEECchhh
Confidence            99998764332110     011124578899999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=1.7e-27  Score=248.96  Aligned_cols=179  Identities=21%  Similarity=0.287  Sum_probs=146.4

Q ss_pred             HHHHHHhcCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCC-CCcccceeeEeec
Q 048668          525 AELSKATSEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLIKIITICSS  600 (725)
Q Consensus       525 ~~~~~~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  600 (725)
                      +......+.|... +.||+|+||.||+|++..+++.||+|++....  .....++.+|+.+++++. ||||+++++++..
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344455567776 88999999999999999999999999997542  334678899999999995 6999999999765


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--  678 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~--  678 (725)
                      ..     ..|+||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.  
T Consensus       101 ~~-----~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A          101 TS-----EIILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             SS-----EEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBT
T ss_pred             CC-----eEEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCC
Confidence            54     78999999999999999865432    2589999999999999999999999   9999999999999998  


Q ss_pred             -CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          679 -DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       679 -~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                       ++.+||+|||+|+.......         ....+||+.|+|||++.
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  206 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHACE---------LREIMGTPEYLAPEILN  206 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------------CCCGGGCCHHHHT
T ss_pred             CCCcEEEeeCccccccCCccc---------cccccCCcCccCCeeec
Confidence             78999999999987643211         11256999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.94  E-value=7.6e-28  Score=254.98  Aligned_cols=172  Identities=23%  Similarity=0.366  Sum_probs=129.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+|+.||||++....  ....+++.+|++++++++||||+++++++.... +....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999999999999999996532  234567889999999999999999999986542 22334


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+ +++|.+++...       .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence            679999999 78999988652       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....           ....+||+.|+|||++.
T Consensus       177 G~a~~~~~~-----------~~~~~~t~~y~aPE~~~  202 (367)
T 2fst_X          177 GLARHTADE-----------MTGYVATRWYRAPEIML  202 (367)
T ss_dssp             -------------------------CCCTTCCHHHHT
T ss_pred             ccccccccc-----------CCCcCcCcCccChHHHc
Confidence            999865321           11257999999999863

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=3.3e-27  Score=245.45  Aligned_cols=171  Identities=27%  Similarity=0.420  Sum_probs=142.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..+.|+..+.||+|+||.||+|++..+++.||+|++....  ..+++.+|++++++++||||+++++++....     ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EE
Confidence            4567999999999999999999999899999999997543  3467899999999999999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            999999999999999974332     589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.......        ......||+.|+|||++
T Consensus       172 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~  197 (314)
T 3com_A          172 AGQLTDTMA--------KRNTVIGTPFWMAPEVI  197 (314)
T ss_dssp             CEECBTTBS--------CBCCCCSCGGGCCHHHH
T ss_pred             chhhhhhcc--------ccCccCCCCCccChhhc
Confidence            987643211        11235699999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=2e-27  Score=240.84  Aligned_cols=171  Identities=29%  Similarity=0.492  Sum_probs=145.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++. +++.||+|++..... ..+++.+|++++++++||||+++++++....     ..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeE
Confidence            457888999999999999999987 677899999975543 3468899999999999999999999976544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence            99999999999999976532     578999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......||+.|+|||++
T Consensus       152 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~  177 (267)
T 3t9t_A          152 RFVLDDQYT-------SSTGTKFPVKWASPEVF  177 (267)
T ss_dssp             GGBCCHHHH-------STTSTTCCGGGCCHHHH
T ss_pred             ccccccccc-------ccccccccccccChhhh
Confidence            865432111       11124578899999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=3.1e-28  Score=259.70  Aligned_cols=177  Identities=16%  Similarity=0.201  Sum_probs=136.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHH---HHHHcCCCCccccee-------eE
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAEC---EALRNIRHRNLIKII-------TI  597 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  597 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999999889999999999743   334567889999   555566899999998       44


Q ss_pred             eecCCC-------CCcc-----eeeEEEeccCCCCHHHHhcccCCccc-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 048668          598 CSSTDF-------KGVD-----FKALVFEYMGNGSLEDWLHQSNDQVE-VCKLSLIQRLNIAIDVASAIEYLHHHCQPPM  664 (725)
Q Consensus       598 ~~~~~~-------~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  664 (725)
                      +.....       .+.+     ..|+||||+ +|+|.+++.......+ ...+++..++.|+.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            433210       0111     268999999 6799999986431110 11344688889999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          665 VHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       665 vHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||||||+|||++.++.+||+|||+|+....           .....+| +.|+|||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~  274 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELE  274 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhh
Confidence            9999999999999999999999999985322           1123568 999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=4.2e-27  Score=243.51  Aligned_cols=176  Identities=23%  Similarity=0.411  Sum_probs=145.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....    ....+.+.+|++++++++||||+++++++...+   .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---K   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---C
Confidence            468999999999999999999999999999999997542    234578999999999999999999999975332   2


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      ...|+||||++++ +.+++.....    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence            4689999999876 7777765432    2589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++........      .......||+.|+|||++
T Consensus       153 fg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  183 (305)
T 2wtk_C          153 LGVAEALHPFAAD------DTCRTSQGSPAFQPPEIA  183 (305)
T ss_dssp             CTTCEECCTTCSS------CEECCCCSCGGGCCHHHH
T ss_pred             cccccccCccccc------cccccCCCCCCCcChhhc
Confidence            9999876432111      111235699999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=2.2e-27  Score=241.19  Aligned_cols=169  Identities=27%  Similarity=0.457  Sum_probs=132.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc----cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||.||+|++.  +..||||++....    ....+.+.+|++++++++||||+++++++....    
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   79 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP----   79 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----
Confidence            357888999999999999999984  7889999987542    223577899999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--------
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--------  678 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~--------  678 (725)
                       ..++||||+++++|.+++...       .+++..++.++.|++.||+|||++...+|+||||||+||+++.        
T Consensus        80 -~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           80 -NLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             -ceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence             789999999999999998643       5889999999999999999999982222999999999999986        


Q ss_pred             CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       679 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+||+|||+++.......          ....||+.|+|||++
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~  186 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTTK----------MSAAGAYAWMAPEVI  186 (271)
T ss_dssp             SCCEEECCCCC-----------------------CCGGGSCHHHH
T ss_pred             CcceEEccCCcccccccccc----------cCCCCccceeCHHHh
Confidence            67899999999986543211          124699999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=1.4e-27  Score=249.19  Aligned_cols=169  Identities=28%  Similarity=0.389  Sum_probs=140.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--------cchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....        ......+.+|++++++++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            457999999999999999999999999999999996432        11234588999999999999999999987543 


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc-
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-  681 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~-  681 (725)
                           ..|+||||+++|+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++. 
T Consensus        88 -----~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           88 -----DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             -----SEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred             -----ceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence                 3789999999999999997654      589999999999999999999999   9999999999999987654 


Q ss_pred             --eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 --AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 --~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                        +||+|||+++.....         .......||+.|+|||++
T Consensus       154 ~~~kl~Dfg~~~~~~~~---------~~~~~~~gt~~y~aPE~~  188 (322)
T 2ycf_A          154 CLIKITDFGHSKILGET---------SLMRTLCGTPTYLAPEVL  188 (322)
T ss_dssp             CCEEECCCTTCEECCCC---------HHHHHHHSCCTTCCHHHH
T ss_pred             CeEEEccCccceecccc---------cccccccCCcCccCchhh
Confidence              999999999865322         111235699999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=249.28  Aligned_cols=173  Identities=26%  Similarity=0.462  Sum_probs=137.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEE----EEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIV----AVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      .++|+..+.||+|+||.||+|++..+++.|    |+|.+... .....+++.+|++++++++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            357899999999999999999998777655    66666433 334567899999999999999999999998754    


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             --CceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence              36799999999999999987543     588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+........      .......||+.|+|||++
T Consensus       160 DfG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~  191 (327)
T 3lzb_A          160 DFGLAKLLGAEEKE------YHAEGGKVPIKWMALESI  191 (327)
T ss_dssp             CTTC----------------------CCCGGGSCHHHH
T ss_pred             cCcceeEccCcccc------ccccCCCccccccCHHHH
Confidence            99999876433211      111224578899999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.94  E-value=7.9e-28  Score=250.34  Aligned_cols=188  Identities=21%  Similarity=0.345  Sum_probs=151.0

Q ss_pred             CHHHHHHHhcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccccee
Q 048668          523 SYAELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKII  595 (725)
Q Consensus       523 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  595 (725)
                      +...+....++|+..+.||+|+||.||+|++     ..+++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445555567899999999999999999985     4577899999997543 23456789999999999 699999999


Q ss_pred             eEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccc----------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----------VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       596 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                      +++....    ...++||||+++|+|.+++........          ...+++..++.++.|++.||+|||+.   +|+
T Consensus        98 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~  170 (316)
T 2xir_A           98 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  170 (316)
T ss_dssp             EEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            9976543    358999999999999999986542110          11278899999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+||+++.++.+||+|||+++.......      ........||+.|+|||++
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~  222 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETI  222 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHH
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCcc------ceeccCCCcceeecCchhh
Confidence            999999999999999999999999986543211      1112235689999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=5.2e-28  Score=252.44  Aligned_cols=184  Identities=24%  Similarity=0.425  Sum_probs=148.4

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEee
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICS  599 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  599 (725)
                      ++....++|+..+.||+|+||.||+|++.     .+++.||+|++..... ....++.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34445678999999999999999999875     3578899999975432 34457899999999999999999999976


Q ss_pred             cCCCCCcceeeEEEeccCCCCHHHHhcccCCcc----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 048668          600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  675 (725)
Q Consensus       600 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil  675 (725)
                      ...     ..++||||+++|+|.+++.......    ....+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus        99 ~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl  170 (322)
T 1p4o_A           99 QGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM  170 (322)
T ss_dssp             SSS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred             cCC-----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence            544     7899999999999999997532110    012468899999999999999999999   9999999999999


Q ss_pred             ecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          676 LDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       676 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.++.+||+|||+++........      .......||+.|+|||++
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  212 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESL  212 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCE------EGGGSSEECGGGCCHHHH
T ss_pred             EcCCCeEEECcCcccccccccccc------ccccCCCCCCCccChhhh
Confidence            999999999999999866433211      111224578999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=4.8e-27  Score=246.03  Aligned_cols=167  Identities=23%  Similarity=0.360  Sum_probs=143.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++...   ..+.+.+|++++++++ ||||+++++++....   ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCce
Confidence            35788999999999999999999999999999998643   3467889999999997 999999999987532   2367


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Dfg  688 (725)
                      ++||||+++++|.+++.         .+++..+..++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||
T Consensus       109 ~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            99999999999999885         378889999999999999999999   999999999999999777 89999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.......         .....||+.|+|||++.
T Consensus       177 ~a~~~~~~~~---------~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          177 LAEFYHPGQE---------YNVRVASRYFKGPELLV  203 (330)
T ss_dssp             TCEECCTTCC---------CCSCCSCGGGCCHHHHT
T ss_pred             CceEcCCCCc---------cccccccccccChhhhc
Confidence            9987643321         11246999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.8e-27  Score=249.20  Aligned_cols=174  Identities=29%  Similarity=0.526  Sum_probs=136.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCC----ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGED----EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ++|+..+.||+|+||.||+|++..+    +..||||+++... ......+.+|++++++++||||+++++++....    
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  119 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK----  119 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence            4567779999999999999987544    3569999997543 234567899999999999999999999976543    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          120 -PMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             -SEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             -CcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence             78999999999999999976532     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.........     .......||+.|+|||++
T Consensus       191 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~  222 (333)
T 1mqb_A          191 FGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAI  222 (333)
T ss_dssp             CCC----------------------CCCGGGSCHHHH
T ss_pred             CCcchhhccccccc-----cccCCCCccccccCchhc
Confidence            99998764332111     111123478899999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=3.3e-27  Score=245.74  Aligned_cols=188  Identities=21%  Similarity=0.248  Sum_probs=148.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++||||+++++++.... ......|
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            457999999999999999999998899999999997665556678999999999999999999999986321 2234789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++......  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            999999999999999763211  12589999999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCCC-CCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSS-KTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +........... ..........||+.|+|||++.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  216 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS  216 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhc
Confidence            765321100000 0000112245899999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=3e-27  Score=251.47  Aligned_cols=173  Identities=22%  Similarity=0.291  Sum_probs=137.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  607 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....  ....+++.+|+++++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999999999999999997542  234567889999999999999999999986543 22334


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+++ +|.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            68999999975 78888852        478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......         .....+||+.|+|||++.
T Consensus       172 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~  199 (371)
T 2xrw_A          172 GLARTAGTSF---------MMTPYVVTRYYRAPEVIL  199 (371)
T ss_dssp             CC-------------------------CTTCCHHHHT
T ss_pred             eccccccccc---------ccCCceecCCccCHHHhc
Confidence            9998654321         112257999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=1.9e-27  Score=241.48  Aligned_cols=168  Identities=24%  Similarity=0.398  Sum_probs=143.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++.  ++.||||++....  ....+++.+|++++++++||||+++++++....   ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence            457889999999999999999984  7889999997653  234567999999999999999999999986542   236


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCceEEcc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      .++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence            7999999999999999986542    1589999999999999999999998   6  99999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||++......             ...||+.|+|||++
T Consensus       157 ~~~~~~~~~~-------------~~~~t~~y~aPE~~  180 (271)
T 3kmu_A          157 ADVKFSFQSP-------------GRMYAPAWVAPEAL  180 (271)
T ss_dssp             GGSCCTTSCT-------------TCBSCGGGSCHHHH
T ss_pred             ccceeeeccc-------------CccCCccccChhhh
Confidence            9987542211             24689999999986

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.94  E-value=2.5e-27  Score=244.45  Aligned_cols=172  Identities=26%  Similarity=0.430  Sum_probs=143.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++....     .
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   76 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----K   76 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCC-----c
Confidence            357889999999999999999999899999999997543  223467889999999999999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++ |+|.+++.....    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        77 ~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  148 (299)
T 2r3i_A           77 LYLVFEFLH-QDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  148 (299)
T ss_dssp             EEEEEECCS-EEHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTT
T ss_pred             eEEEEEccc-CCHHHHHHhhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcch
Confidence            899999997 599999986542    1578999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++.......        ......||+.|+|||++
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~  175 (299)
T 2r3i_A          149 LARAFGVPVR--------TYTHEVVTLWYRAPEIL  175 (299)
T ss_dssp             HHHHHCCCSB--------CTTSCBCCCTTCCHHHH
T ss_pred             hhhhccCCcc--------ccCcccccccccCcHHh
Confidence            9987643211        11124689999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.4e-27  Score=243.38  Aligned_cols=175  Identities=24%  Similarity=0.428  Sum_probs=142.6

Q ss_pred             CCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .|...+.||+|+||.||+|++..+   +..||+|++.... ....+.+.+|++++++++||||+++++++...+    ..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CC
Confidence            455668999999999999986544   3479999987543 334578899999999999999999999986543    24


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+.+|+|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             cEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence            5899999999999999976432     578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+..........    .......||+.|+|||++
T Consensus       170 ~~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~  200 (298)
T 3pls_A          170 LARDILDREYYSV----QQHRHARLPVKWTALESL  200 (298)
T ss_dssp             SSCTTTTGGGGCS----CCSSCTTCGGGGSCHHHH
T ss_pred             CcccccCCccccc----ccCcCCCCCccccChhhh
Confidence            9986644321111    112235689999999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.94  E-value=1.7e-27  Score=244.38  Aligned_cols=172  Identities=31%  Similarity=0.499  Sum_probs=134.0

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ..++|+..+.||+|+||.||+|++..   .||+|+++...  ....+.+.+|++++++++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC------
Confidence            35679999999999999999998753   49999997543  33457899999999999999999999975332      


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             ccEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence            57899999999999999975532     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++........      .......||+.|+|||++.
T Consensus       165 g~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          165 GLATEKSRWSGS------HQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             C------------------------CCCTTCCHHHHC
T ss_pred             eecccccccccc------ccccccCCCccccCchhhc
Confidence            999765432111      1112356999999999863

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.2e-26  Score=236.35  Aligned_cols=214  Identities=21%  Similarity=0.207  Sum_probs=121.6

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||+.+..  +|++|++++|++++..+..|..+++|++|++++|+++++.+..|.++++|++|+|++|++++..+..|.+
T Consensus        21 ~ip~~l~~--~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSCT--TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCCC--CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            34554442  5666666666665444445666666666666666665555555666666666666666665555555666


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeee-CCCcccccCccceecCCCccccccCccCcccccccC-
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW-  161 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~-  161 (725)
                      +++|++|++++|+++ .++...+..+++|++|+|++|+++++ .|..|.++++|++|+|++|+|+++.+..|..+++|+ 
T Consensus        99 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  177 (276)
T 2z62_A           99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL  177 (276)
T ss_dssp             CTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT
T ss_pred             CccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccc
Confidence            666666666666665 44444445556666666666666543 255555566666666666666555555555555544 


Q ss_pred             ---eeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccC
Q 048668          162 ---RLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVN  238 (725)
Q Consensus       162 ---~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~  238 (725)
                         +|++++|.++.++.                              ..+. .. +++.|++++|.+++..+..+..+++
T Consensus       178 l~l~L~ls~n~l~~~~~------------------------------~~~~-~~-~L~~L~L~~n~l~~~~~~~~~~l~~  225 (276)
T 2z62_A          178 LNLSLDLSLNPMNFIQP------------------------------GAFK-EI-RLKELALDTNQLKSVPDGIFDRLTS  225 (276)
T ss_dssp             CCEEEECCSSCCCEECT------------------------------TSSC-SC-CEEEEECCSSCCSCCCTTTTTTCCS
T ss_pred             cceeeecCCCcccccCc------------------------------cccC-CC-cccEEECCCCceeecCHhHhccccc
Confidence               44555555543332                              2222 11 3455555555555444555677778


Q ss_pred             CceEEecccccCCC
Q 048668          239 LIALAVEVNQLHGT  252 (725)
Q Consensus       239 L~~L~L~~N~l~~~  252 (725)
                      |+.|++++|.+.+.
T Consensus       226 L~~L~l~~N~~~c~  239 (276)
T 2z62_A          226 LQKIWLHTNPWDCS  239 (276)
T ss_dssp             CCEEECCSSCBCCC
T ss_pred             ccEEEccCCccccc
Confidence            88888888888754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.94  E-value=2.6e-27  Score=248.75  Aligned_cols=186  Identities=22%  Similarity=0.249  Sum_probs=136.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCC---CCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDF---KGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~---~~~  606 (725)
                      ..+|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.....   ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357899999999999999999999999999999997665556678899999999996 9999999999853321   334


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC--cEecCCCCCCeeecCCCceEE
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivHrdlkp~Nill~~~~~~kl  684 (725)
                      ...++||||++ |+|.+++.....   ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            46899999995 699999875321   11589999999999999999999998   7  999999999999999999999


Q ss_pred             cccccccccccCCCCCCC----CCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSS----KTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++...........    ..........||+.|+|||++
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             CCCTTCBCCSSCC------------------------------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            999999876543211100    000111235699999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=2.2e-27  Score=242.50  Aligned_cols=173  Identities=22%  Similarity=0.457  Sum_probs=141.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEECC---CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|+..+.||+|+||.||+|++..   ++..||+|++.... ....+++.+|++++++++||||+++++++...    
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE----   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence            34678899999999999999998643   45579999997553 33457899999999999999999999986532    


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..|+||||+++++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        86 --~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (281)
T 3cc6_A           86 --PTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG  155 (281)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred             --CCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence              46899999999999999976532     588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+++........       ......||+.|+|||++
T Consensus       156 Dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~  186 (281)
T 3cc6_A          156 DFGLSRYIEDEDYY-------KASVTRLPIKWMSPESI  186 (281)
T ss_dssp             CCCGGGCC----------------CCCCCGGGCCHHHH
T ss_pred             ccCCCccccccccc-------ccccCCCCcceeCchhh
Confidence            99999876433211       11124578999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.94  E-value=1.9e-27  Score=250.40  Aligned_cols=181  Identities=20%  Similarity=0.314  Sum_probs=141.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECC---CceEEEEEEeeccccc-----------hHHHHHHHHHHHHcCCCCcccceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGE---DEMIVAVKVINLKQKG-----------AFRSFVAECEALRNIRHRNLIKIIT  596 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  596 (725)
                      .++|+..+.||+|+||.||+|++..   ++..||||++......           ..+.+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3579999999999999999999986   7889999999754321           1234678899999999999999999


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ++... +.+....|+||||+ +++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  184 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence            98763 23345889999999 999999998654      589999999999999999999999   99999999999999


Q ss_pred             cCCC--ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDM--VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++  .+||+|||+|+.+......... .........||+.|+|||++
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~  232 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSLDAH  232 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCHHHH
T ss_pred             ccCCCCcEEEEeCCCceecccccccccc-hhccccccCCCccccCHHHh
Confidence            9887  9999999999877543221111 11122345799999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=4.2e-27  Score=244.16  Aligned_cols=176  Identities=25%  Similarity=0.416  Sum_probs=137.4

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++....   ....+++.+|++++++++||||+++++++....    
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----  105 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN----  105 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----
Confidence            3457999999999999999999998899999999997532   334567899999999999999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..++||||+++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       106 -~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          106 -ELNIVLELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             -EEEEEEECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             -cEEEEEecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEe
Confidence             78999999999999999975321  112588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+++.......        ......||+.|+|||++
T Consensus       180 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~  208 (310)
T 2wqm_A          180 LGLGRFFSSKTT--------AAHSLVGTPYYMSPERI  208 (310)
T ss_dssp             C--------------------------CCSSCCHHHH
T ss_pred             ccceeeecCCCc--------cccccCCCeeEeChHHh
Confidence            999986543211        11124699999999975

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.6e-26  Score=235.43  Aligned_cols=226  Identities=20%  Similarity=0.204  Sum_probs=122.3

Q ss_pred             EEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCC
Q 048668           17 ALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNR   96 (725)
Q Consensus        17 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~   96 (725)
                      ..+..+.+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            3455555555 4555443  356666666666665555566666666666666666655555555656666666666665


Q ss_pred             CCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCC
Q 048668           97 FSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN  176 (725)
Q Consensus        97 l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~  176 (725)
                      ++ .++...|.++++|++|++++|+++++.+..+..+++|++|+|++|+++++.                          
T Consensus        88 l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------------  140 (276)
T 2z62_A           88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK--------------------------  140 (276)
T ss_dssp             CC-EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC--------------------------
T ss_pred             cC-ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec--------------------------
Confidence            55 444444445555555555555555444444555555555555555544322                          


Q ss_pred             CcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCc-eEEecccccCCCCCh
Q 048668          177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI-ALAVEVNQLHGTIPD  255 (725)
Q Consensus       177 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~  255 (725)
                         ++..+.++++|++|++++|++++..+..+..+. .+.                     .|. .|++++|.+.++.+.
T Consensus       141 ---l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~---------------------~l~l~L~ls~n~l~~~~~~  195 (276)
T 2z62_A          141 ---LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH-QMP---------------------LLNLSLDLSLNPMNFIQPG  195 (276)
T ss_dssp             ---CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH-TCT---------------------TCCEEEECCSSCCCEECTT
T ss_pred             ---CchhhccCCCCCEEECCCCCCCcCCHHHhhhhh-hcc---------------------ccceeeecCCCcccccCcc
Confidence               113455666777777777777654444444433 222                     111 455555555544444


Q ss_pred             hhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCC
Q 048668          256 VIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       256 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      .+.. .+|++|++++|.+++..+..|..+++|++|++++|+++
T Consensus       196 ~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  237 (276)
T 2z62_A          196 AFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  237 (276)
T ss_dssp             SSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred             ccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence            4433 25666666666666554445566666666666666554

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6.3e-27  Score=245.90  Aligned_cols=179  Identities=27%  Similarity=0.375  Sum_probs=140.8

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC--CCCcccceeeEeecCCCCCc
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~  606 (725)
                      ...++|+..+.||+|+||.||+|+++  ++.||||++....   ...+.+|.+++...  +||||+++++++.... ...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence            34568999999999999999999984  8899999986432   24455666666655  8999999999987653 222


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEecCCCCCCeeecCCCc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC-----QPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivHrdlkp~Nill~~~~~  681 (725)
                      ...|+||||+++|+|.++++..       .+++..++.++.|++.||+|||+.+     .++|+||||||+||+++.++.
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence            4789999999999999999654       4889999999999999999999752     348999999999999999999


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +||+|||+|+.+........    ......+||+.|+|||++.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~  219 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVD----IPPNTRVGTKRYMPPEVLD  219 (337)
T ss_dssp             EEECCCTTCEECC-------------CCSSCSCGGGCCHHHHT
T ss_pred             EEEEeCCCceeecccccccc----CCCCCCccCcceeChhhcc
Confidence            99999999987644321111    1112357999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=4e-27  Score=240.33  Aligned_cols=171  Identities=25%  Similarity=0.508  Sum_probs=143.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++. ++..||+|++.... ...+.+.+|++++++++||||+++++++...      ..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC------CcE
Confidence            457888999999999999999986 56789999997543 3457899999999999999999999987532      478


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++++|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        84 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            9999999999999997532    12588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......||+.|+|||++
T Consensus       157 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~  182 (279)
T 1qpc_A          157 RLIEDNEYT-------AREGAKFPIKWTAPEAI  182 (279)
T ss_dssp             EECSSSCEE-------CCTTCCCCTTTSCHHHH
T ss_pred             ccccCcccc-------cccCCCCccCccChhhh
Confidence            876433211       11124578899999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=1.7e-27  Score=259.81  Aligned_cols=172  Identities=28%  Similarity=0.502  Sum_probs=139.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|+..+.||+|+||.||+|++.. +..||||+++... ...++|.+|++++++++||||+++++++..      +..
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            44678889999999999999999974 5679999997543 235789999999999999999999998754      257


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+++|+|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  326 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL  326 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             EEEehhhcCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence            89999999999999997532    12588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+........       ......+|+.|+|||++
T Consensus       327 a~~~~~~~~~-------~~~~~~~~~~y~aPE~~  353 (452)
T 1fmk_A          327 ARLIEDNEYT-------ARQGAKFPIKWTAPEAA  353 (452)
T ss_dssp             TC---------------------CCGGGSCHHHH
T ss_pred             ceecCCCcee-------cccCCcccccccCHhHH
Confidence            9876432111       11224578899999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=1.1e-27  Score=244.47  Aligned_cols=177  Identities=26%  Similarity=0.396  Sum_probs=146.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....   ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence            468999999999999999999999999999999997543  234567899999999999999999999875322   247


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEecCCCCCCeeecCCCceE
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPP-----MVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----ivHrdlkp~Nill~~~~~~k  683 (725)
                      .|+||||+++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+|
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence            8999999999999999975421  112489999999999999999999998   7     99999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||.++......        .......||+.|+|||++
T Consensus       157 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~  188 (279)
T 2w5a_A          157 LGDFGLARILNHDT--------SFAKTFVGTPYYMSPEQM  188 (279)
T ss_dssp             ECCCCHHHHC---C--------HHHHHHHSCCTTCCHHHH
T ss_pred             EecCchheeecccc--------ccccccCCCccccChHHh
Confidence            99999998653321        111234699999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=5e-27  Score=244.74  Aligned_cols=177  Identities=25%  Similarity=0.405  Sum_probs=140.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCC--------
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTD--------  602 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  602 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++........+++.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357889999999999999999999899999999998766666788999999999999999999999875331        


Q ss_pred             -CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCC
Q 048668          603 -FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDM  680 (725)
Q Consensus       603 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-~~~  680 (725)
                       +......|+||||++ |+|.+++...       .+++..++.++.|++.||+|||++   +|+||||||+||+++ .++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence             123357899999997 5999999643       478999999999999999999999   999999999999997 567


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+||+|||+++.........     .......||+.|+|||++
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~  196 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHK-----GHLSEGLVTKWYRSPRLL  196 (320)
T ss_dssp             EEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHH
T ss_pred             eEEEccCccccccCCCcccc-----cccccccccccccCcHHh
Confidence            99999999998764321111     111224689999999975

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=4.7e-28  Score=269.91  Aligned_cols=159  Identities=15%  Similarity=0.052  Sum_probs=123.5

Q ss_pred             cccccceEEEEEEECCCceEEEEEEeeccc----------cchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcce
Q 048668          540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ----------KGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       540 ig~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .+.|++|.+..++....|+.||||++..+.          +...++|.+|+++|+++ .|+||+++++++.+..     .
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-----~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-----S  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-----E
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-----E
Confidence            456777777666665678889999997542          12346799999999999 5999999999976554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .||||||++|++|.++|.+..      .+++.   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+|||
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence            999999999999999998765      35543   5889999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+......        ....+.+||++|||||++
T Consensus       385 lAr~~~~~~--------~~~~t~vGTp~YmAPE~l  411 (569)
T 4azs_A          385 SIVTTPQDC--------SWPTNLVQSFFVFVNELF  411 (569)
T ss_dssp             TEESCC-----------CCSHHHHHHHHHHHHHHC
T ss_pred             cCeeCCCCC--------ccccCceechhhccHHHh
Confidence            998764321        122346899999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=2e-27  Score=249.29  Aligned_cols=183  Identities=22%  Similarity=0.352  Sum_probs=147.5

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCce-----EEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEee
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEM-----IVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICS  599 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  599 (725)
                      +....++|+..+.||+|+||.||+|++..++.     .||+|++.... ....+.+.+|+++++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            33445688899999999999999999876554     79999997543 23456789999999999 8999999999976


Q ss_pred             cCCCCCcceeeEEEeccCCCCHHHHhcccCCcc--------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV--------EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       600 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      ...     ..|+||||+++|+|.+++.......        ....+++..++.++.|++.||+|||++   +|+||||||
T Consensus       121 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  192 (333)
T 2i1m_A          121 HGG-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA  192 (333)
T ss_dssp             SSS-----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             cCC-----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence            554     7899999999999999997542100        012478999999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+++.++.+||+|||+|+........      .......||+.|+|||++
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~  238 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSNY------IVKGNARLPVKWMAPESI  238 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTTS------EECSSCEECGGGSCHHHH
T ss_pred             ceEEECCCCeEEECccccccccccccce------eecCCCCCCccccCHHHh
Confidence            9999999999999999999866433211      111224578999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=1e-27  Score=247.97  Aligned_cols=185  Identities=25%  Similarity=0.353  Sum_probs=129.4

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ....++|+..+.||+|+||.||+|++..+++.||||++.... ....+++.+|++++++++||||+++++++....    
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   86 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----   86 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS----
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC----
Confidence            344578999999999999999999998889999999986543 334567889999999999999999999987654    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCC--ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSND--QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                       ..++||||+++++|.+++.....  ......+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        87 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           87 -ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             -CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence             78999999999999999874210  00112589999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++..........   ........||+.|+|||++
T Consensus       163 ~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~  198 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITR---NKVRKTFVGTPCWMAPEVM  198 (303)
T ss_dssp             CCCHHHHHCC------------------CCCTTCCHHHH
T ss_pred             EeccchheeccCCCccc---hhhhcccCCCccccCHHHh
Confidence            99999987643211110   1111235699999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=2.7e-27  Score=247.50  Aligned_cols=179  Identities=24%  Similarity=0.423  Sum_probs=140.4

Q ss_pred             hcCCCCCcccccccceEEEEEE-----ECCCceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGI-----LGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|+..+.||+|+||.||+|+     ...+++.||||++... ......++.+|+.++++++||||+++++++....  
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--
Confidence            4689999999999999999998     4457789999999644 2344568899999999999999999999976554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCcc-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---C
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQV-EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---M  680 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~---~  680 (725)
                         ..|+||||+++|+|.+++....... ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   .
T Consensus       107 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          107 ---PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             ---SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence               6799999999999999998654221 123588999999999999999999999   99999999999999944   4


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .+||+|||+++.........      ......||+.|+|||++
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~  217 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYR------KGGCAMLPVKWMPPEAF  217 (327)
T ss_dssp             CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHH
T ss_pred             eEEECccccccccccccccc------cCCCcCCCcceeCHhHh
Confidence            69999999998654332111      11224689999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.94  E-value=4.6e-27  Score=243.22  Aligned_cols=169  Identities=28%  Similarity=0.470  Sum_probs=134.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++.  ++.||||++...  ...+.|.+|++++++++||||+++++++..       ..+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~   75 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC   75 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence            357888999999999999999984  678999998633  345789999999999999999999998642       468


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc-eEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV-AHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~-~kl~Dfgl  689 (725)
                      +||||+++|+|.+++.....   ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            99999999999999986542   124788899999999999999999932238999999999999998886 79999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++......           ....||+.|+|||++.
T Consensus       153 ~~~~~~~~-----------~~~~gt~~y~aPE~~~  176 (307)
T 2eva_A          153 ACDIQTHM-----------TNNKGSAAWMAPEVFE  176 (307)
T ss_dssp             -----------------------CCTTSSCHHHHT
T ss_pred             cccccccc-----------ccCCCCCceEChhhhC
Confidence            97653221           1245999999999763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5.5e-27  Score=240.37  Aligned_cols=173  Identities=25%  Similarity=0.447  Sum_probs=141.9

Q ss_pred             cCCCCCc-ccccccceEEEEEEEC--CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSN-MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|...+ .||+|+||.||+|+++  .++..||||+++... ....+++.+|++++++++||||+++++++..      +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            4555555 8999999999999864  467889999997643 3346789999999999999999999999732      2


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..++||||+++++|.+++.....     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence            57999999999999999975432     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.........     .......||+.|+|||++
T Consensus       155 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~  185 (287)
T 1u59_A          155 GLSKALGADDSYY-----TARSAGKWPLKWYAPECI  185 (287)
T ss_dssp             TTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHH
T ss_pred             cceeeeccCccee-----eccccccccccccCHHHh
Confidence            9998764332111     111124578999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=4.4e-27  Score=241.60  Aligned_cols=173  Identities=26%  Similarity=0.400  Sum_probs=140.9

Q ss_pred             hcCCCCCc-ccccccceEEEEEEE--CCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSN-MIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~-~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      .++|+..+ .||+|+||.||+|.+  ..+++.||||++....  ....+++.+|++++++++||||+++++++..     
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----
Confidence            35677777 999999999999954  5678899999997543  2335789999999999999999999999832     


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                       +..++||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             -CCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence             25789999999999999998654      588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+++........     ........||+.|+|||++
T Consensus       160 Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~  192 (291)
T 1xbb_A          160 DFGLSKALRADENY-----YKAQTHGKWPVKWYAPECI  192 (291)
T ss_dssp             CCTTCEECCTTCSE-----EEC----CCCGGGCCHHHH
T ss_pred             cCCcceeeccCCCc-----ccccccCCCCceeeChHHh
Confidence            99999876433211     0111123478999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=4.1e-27  Score=246.11  Aligned_cols=175  Identities=29%  Similarity=0.478  Sum_probs=141.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEE--EEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIV--AVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||.||+|++..++..+  |+|.+... .....+++.+|+++++++ +||||+++++++....     
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-----
Confidence            47888999999999999999998788755  89988643 233456789999999999 8999999999986654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                      ..|+||||+++|+|.+++......          .....+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence            789999999999999999865310          0112589999999999999999999999   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .++.+||+|||+++......         ......+|+.|+|||++
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~  213 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESL  213 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHH
T ss_pred             CCCeEEEcccCcCccccccc---------cccCCCCCccccChhhh
Confidence            99999999999997432211         11123578899999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.94  E-value=2.8e-27  Score=255.58  Aligned_cols=174  Identities=26%  Similarity=0.400  Sum_probs=138.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  610 (725)
                      ..|+..+.||+|+||.||+|++..+++.||||++.....    .+.+|++++++++||||+++++++..... ....+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468889999999999999999998999999999865432    23479999999999999999998754321 2233577


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-CceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~~kl~Dfgl  689 (725)
                      +||||+++ ++.+.+.....  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            99999976 67666653210  012589999999999999999999998   99999999999999965 5789999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.+.....         ....+||+.|+|||++.
T Consensus       204 a~~~~~~~~---------~~~~~~t~~y~aPE~~~  229 (420)
T 1j1b_A          204 AKQLVRGEP---------NVSYICSRYYRAPELIF  229 (420)
T ss_dssp             CEECCTTCC---------CCSCCSCTTSCCHHHHT
T ss_pred             hhhcccCCC---------ceeeeeCCCcCCHHHHc
Confidence            987643211         12257999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.94  E-value=3.7e-27  Score=266.78  Aligned_cols=166  Identities=27%  Similarity=0.414  Sum_probs=135.5

Q ss_pred             cccccccceEEEEEEE--CCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGIL--GEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||.||+|.+  +.+++.||||+++...  ....+++.+|++++++++|||||++++++...      ..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence            4799999999999955  4577899999997543  33457899999999999999999999998532      478999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      |||++|+|.+++....      .+++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus       449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            9999999999997654      588999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .......     .......||+.|+|||++
T Consensus       520 ~~~~~~~-----~~~~~~~~t~~y~APE~~  544 (635)
T 4fl3_A          520 RADENYY-----KAQTHGKWPVKWYAPECI  544 (635)
T ss_dssp             TC------------------CGGGSCHHHH
T ss_pred             ccCcccc-----ccccCCCCceeeeChhhh
Confidence            5432111     111224578999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=5.8e-27  Score=243.83  Aligned_cols=172  Identities=30%  Similarity=0.437  Sum_probs=142.0

Q ss_pred             CCCCcccccccceEEEEEEE----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          534 FSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      |+..+.||+|+||.||+|.+    ..+++.||||++.... ....+.+.+|++++++++||||+++++++....   ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cce
Confidence            48889999999999988764    3578899999997553 234567899999999999999999999987542   246


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++|+|.+++...       .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence            89999999999999999754       388999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+........     ........||+.|+|||++
T Consensus       180 ~a~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~  209 (318)
T 3lxp_A          180 LAKAVPEGHEY-----YRVREDGDSPVFWYAPECL  209 (318)
T ss_dssp             GCEECCTTCSE-----EEC---CCCCGGGCCHHHH
T ss_pred             ccccccccccc-----cccccCCCCCceeeChHHh
Confidence            99876443211     0111234589999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=5.1e-27  Score=264.99  Aligned_cols=166  Identities=25%  Similarity=0.450  Sum_probs=135.2

Q ss_pred             ccccccceEEEEEEEC--CCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEEec
Q 048668          539 MIGQGSFGSVYKGILG--EDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       539 ~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      .||+|+||.||+|.++  .++..||||+++... ....++|.+|++++++++||||++++++|...      ..|+||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS------SEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC------CeEEEEEe
Confidence            7999999999999875  456789999997643 34568899999999999999999999998642      47999999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccccc
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS  695 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~  695 (725)
                      |++|+|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       417 ~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          417 AGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             CTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999975532     589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCCCCCCCcccccccCCccccCCCcc
Q 048668          696 HHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       696 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....     .......+|+.|||||++
T Consensus       489 ~~~~~-----~~~~~~~~~~~y~APE~~  511 (613)
T 2ozo_A          489 DDSYY-----TARSAGKWPLKWYAPECI  511 (613)
T ss_dssp             ------------------CCTTSCHHHH
T ss_pred             CCcee-----eeccCCCCccceeCHhhh
Confidence            21111     111123467899999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=4.8e-27  Score=247.97  Aligned_cols=170  Identities=22%  Similarity=0.413  Sum_probs=144.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc-----------------hHHHHHHHHHHHHcCCCCcccc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----------------AFRSFVAECEALRNIRHRNLIK  593 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~  593 (725)
                      .++|+..+.||+|+||.||+|++  +++.||||++......                 ..+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  8999999999754211                 1178999999999999999999


Q ss_pred             eeeEeecCCCCCcceeeEEEeccCCCCHHHH------hcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEe
Q 048668          594 IITICSSTDFKGVDFKALVFEYMGNGSLEDW------LHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVH  666 (725)
Q Consensus       594 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH  666 (725)
                      +++++....     ..|+||||+++|+|.++      +....    ...+++..++.++.|++.||+|||+ .   +|+|
T Consensus       108 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          108 CEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             CSEEEESSS-----EEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             EEEEEeeCC-----eEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            999987654     78999999999999999      54421    2268999999999999999999998 8   9999


Q ss_pred             cCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          667 GDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       667 rdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||||+||+++.++.+||+|||.++.....          ......||+.|+|||++.
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~  223 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFS  223 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhc
Confidence            999999999999999999999999875332          112256999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.94  E-value=9e-27  Score=247.11  Aligned_cols=184  Identities=24%  Similarity=0.304  Sum_probs=135.3

Q ss_pred             HHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-
Q 048668          525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-  603 (725)
Q Consensus       525 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  603 (725)
                      .......++|+..+.||+|+||.||+|++..+++.||||++..... ...++.+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            4566778899999999999999999999999999999999865432 23456788889999999999999999865332 


Q ss_pred             -CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEecCCCCCCeeecC-C
Q 048668          604 -KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDH-D  679 (725)
Q Consensus       604 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivHrdlkp~Nill~~-~  679 (725)
                       ....+.++||||+++ ++.+.+.....  ....+++..+..++.|++.|+.|+|  +.   +|+||||||+||+++. +
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence             122347899999976 55554432110  1125789999999999999999999  77   9999999999999997 8


Q ss_pred             CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          680 MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       680 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.+||+|||+|+.......         .....||+.|+|||++.
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  204 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP---------NVAYICSRYYRAPELIF  204 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC---------CCSTTSCGGGCCHHHHT
T ss_pred             CcEEEeeCCCceecCCCCC---------cccccCCcceeCHHHHc
Confidence            9999999999987643321         11256999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=1e-26  Score=238.37  Aligned_cols=172  Identities=30%  Similarity=0.416  Sum_probs=146.9

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++....    
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----   94 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----   94 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC----
Confidence            34568999999999999999999999899999999997542  335678999999999999999999999976554    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC---CceE
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAH  683 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~---~~~k  683 (725)
                       ..|+||||+++++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+|
T Consensus        95 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           95 -SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             -eEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence             7899999999999999987654      588999999999999999999999   99999999999999764   4799


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||+++.......         .....||+.|+|||++
T Consensus       165 L~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~  195 (287)
T 2wei_A          165 IIDFGLSTCFQQNTK---------MKDRIGTAYYIAPEVL  195 (287)
T ss_dssp             ECSTTGGGTBCCCSS---------CSCHHHHHTTCCHHHH
T ss_pred             EeccCcceeecCCCc---------cccccCcccccChHHh
Confidence            999999986543211         1124589999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.94  E-value=9e-27  Score=239.90  Aligned_cols=179  Identities=27%  Similarity=0.406  Sum_probs=142.2

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ..++|+..+.||+|+||.||+|++..+++.||||++......  +++.+|++++++++|++++..++++....    +..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCC----Cce
Confidence            456899999999999999999999989999999987654322  35778999999999998888777764432    478


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEEcc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGD  686 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl~D  686 (725)
                      ++||||+ +++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence            9999999 9999999985432     589999999999999999999999   99999999999999   7889999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+........... .........||+.|+|||++.
T Consensus       152 fg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  188 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHL  188 (296)
T ss_dssp             CTTCEECBCTTTCCBC-CCCCSCCCCSCGGGCCHHHHT
T ss_pred             CccceeccCcccCccC-CCCcccccCCCccccchHHhc
Confidence            9999876543221110 011222357999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.94  E-value=9.1e-27  Score=252.17  Aligned_cols=169  Identities=24%  Similarity=0.336  Sum_probs=142.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC------CCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI------RHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  604 (725)
                      ..+|+..+.||+|+||.||+|++..+++.||||+++... ...+++.+|+++++.+      +|+||+++++++....  
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~--  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN--  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--
Confidence            456899999999999999999999999999999996432 2346677888888877      5779999999977654  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc--e
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV--A  682 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~--~  682 (725)
                         ..++||||++ ++|.+++......    .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.  +
T Consensus       173 ---~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          173 ---HICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             ---EEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred             ---eEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence               7899999995 6999999865422    589999999999999999999999   9999999999999999987  9


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.....           ....+||+.|||||++.
T Consensus       242 kL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~  272 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVIL  272 (429)
T ss_dssp             EECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHH
T ss_pred             EEeecccceecCCc-----------ccccCCCCCccChHHHh
Confidence            99999999754321           11257999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.94  E-value=1.4e-26  Score=238.58  Aligned_cols=178  Identities=28%  Similarity=0.411  Sum_probs=145.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.....  .+++.+|++++++++|++++..++++....    +..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCC----CceE
Confidence            4679999999999999999999988999999999875433  246889999999999998877777664432    4789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEEccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGDF  687 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl~Df  687 (725)
                      +||||+ +++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+||
T Consensus        82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            999999 8999999975432     589999999999999999999999   99999999999999   47889999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+........... .........||+.|+|||++.
T Consensus       153 g~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  188 (296)
T 3uzp_A          153 GLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHL  188 (296)
T ss_dssp             TTCEECBCTTTCCBC-CCCCSCCCCSCTTTCCHHHHT
T ss_pred             CCccccccccccccc-ccccccccccccccCChhhhc
Confidence            999876543221110 011123457999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.94  E-value=3.9e-27  Score=240.26  Aligned_cols=167  Identities=35%  Similarity=0.480  Sum_probs=135.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++  +++.||||+++..  ...+++.+|++++++++||||+++++++....    +..|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceE
Confidence            46789999999999999999988  4789999998644  24578899999999999999999999875432    3679


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++....    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEecCCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence            9999999999999997543    12478899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +......           ....+|+.|+|||++
T Consensus       165 ~~~~~~~-----------~~~~~~~~y~aPE~~  186 (278)
T 1byg_A          165 KEASSTQ-----------DTGKLPVKWTAPEAL  186 (278)
T ss_dssp             ----------------------CCTTTSCHHHH
T ss_pred             ccccccc-----------cCCCccccccCHHHh
Confidence            7543221           113578999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=3.5e-27  Score=262.59  Aligned_cols=173  Identities=28%  Similarity=0.495  Sum_probs=144.0

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ...++|+..+.||+|+||.||+|++.. +..||||+++... ...++|.+|++++++++||||+++++++..      +.
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~  335 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP  335 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence            345678889999999999999999974 5679999997543 235789999999999999999999998754      25


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||+++|+|.++++...    ...+++.+++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             ceEeeehhcCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            799999999999999997532    12588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++........       ......+|..|||||++
T Consensus       409 ~a~~~~~~~~~-------~~~~~~~~~~y~aPE~~  436 (535)
T 2h8h_A          409 LARLIEDNEYT-------ARQGAKFPIKWTAPEAA  436 (535)
T ss_dssp             STTTCCCHHHH-------TTCSTTSCGGGSCHHHH
T ss_pred             cceecCCCcee-------cccCCcCcccccCHHHh
Confidence            99876432111       11124578899999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.94  E-value=2.2e-26  Score=242.29  Aligned_cols=177  Identities=27%  Similarity=0.388  Sum_probs=145.0

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHc--CCCCcccceeeEeecCCCCC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~  605 (725)
                      ....++|+..+.||+|+||.||+|++  +++.||||++...   ..+.+.+|++++..  ++||||+++++++.... ..
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence            44556899999999999999999998  5889999998643   34567889999887  78999999999987653 12


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEecCCCCCCeeec
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--------HHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------~~~~~~ivHrdlkp~Nill~  677 (725)
                      ....|+||||+++|+|.+++...       .+++..++.++.|++.||+|||        +.   +|+||||||+||+++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK  181 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence            23689999999999999999753       4889999999999999999999        66   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++.+||+|||+|+.........    ........||+.|+|||++.
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~  224 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLD  224 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEE----EECCCSCCCCGGGCCHHHHT
T ss_pred             CCCCEEEEECCCceecccccccc----ccccccCCcCcccCCHhhhc
Confidence            99999999999998764432110    00112356999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=8.2e-27  Score=239.44  Aligned_cols=174  Identities=23%  Similarity=0.271  Sum_probs=131.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||+|++.....  ...+.+.++...++.++||||+++++++....     .
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence            4678999999999999999999999999999999975422  22234445555688889999999999987554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++ +|.+++.....  ....+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             EEEEEehhcc-chHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            8999999974 88888764211  0125899999999999999999999852  89999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.......         .....||+.|+|||++
T Consensus       156 ~~~~~~~~~~---------~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          156 ISGYLVDDVA---------KDIDAGCKPYMAPERI  181 (290)
T ss_dssp             -----------------------CCCCCCSCHHHH
T ss_pred             Cccccccccc---------ccccCCCccccChhhc
Confidence            9987643211         1124699999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.94  E-value=1e-26  Score=247.33  Aligned_cols=171  Identities=23%  Similarity=0.336  Sum_probs=140.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC-Ccc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK-GVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~~~  607 (725)
                      .++|...+.||+|+||.||+|++..+++.||||++....  ....+++.+|++++++++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357888999999999999999999999999999997542  23357788999999999999999999998655421 112


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++ ++|.+++..        .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence            3489999997 589888742        478999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....           ....+||+.|+|||++.
T Consensus       189 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~  214 (371)
T 4exu_A          189 GLARHADAE-----------MTGYVVTRWYRAPEVIL  214 (371)
T ss_dssp             TCC-------------------CTTCCCTTSCHHHHS
T ss_pred             CcccccccC-----------cCCcccCccccCHHHhc
Confidence            999765322           11256899999999763

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.94  E-value=9.8e-27  Score=243.20  Aligned_cols=178  Identities=25%  Similarity=0.452  Sum_probs=144.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC-CCceEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG-EDEMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~  603 (725)
                      ..++|+..+.||+|+||.||+|++. .+++.||+|++....  ......+.+|+++++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 678999999997543  22234566788777766   89999999999864333


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      ......++||||++ |+|.+++......    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence            33457899999997 6999999865421    489999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+++......         ......||+.|+|||++.
T Consensus       161 l~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~  192 (326)
T 1blx_A          161 LADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLL  192 (326)
T ss_dssp             ECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHT
T ss_pred             EecCcccccccCCC---------CccccccccceeCHHHHh
Confidence            99999997654321         112356999999999763

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.94  E-value=8e-27  Score=249.93  Aligned_cols=174  Identities=25%  Similarity=0.360  Sum_probs=135.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~  609 (725)
                      ..+|+..+.||+|+||+||+|++..+++ ||+|++......    ..+|+++++.++||||+++++++..... ....+.
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3468999999999999999999986665 888887543321    2369999999999999999999865432 233457


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-~~~~~kl~Dfg  688 (725)
                      ++||||++++ +.+.+.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||
T Consensus       114 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          114 NLVLEYVPET-VYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEECCSEE-HHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEeeccCcc-HHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            8999999774 4443332100  012589999999999999999999999   999999999999999 78999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.......         ....+||+.|+|||++.
T Consensus       188 ~a~~~~~~~~---------~~~~~~t~~y~aPE~~~  214 (394)
T 4e7w_A          188 SAKILIAGEP---------NVSYICSRYYRAPELIF  214 (394)
T ss_dssp             TCEECCTTCC---------CCSSCSCGGGCCHHHHT
T ss_pred             CcccccCCCC---------CcccccCcCccCHHHHc
Confidence            9987643321         12256899999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.94  E-value=5.1e-27  Score=249.82  Aligned_cols=173  Identities=13%  Similarity=0.065  Sum_probs=125.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHH---HHHHcCCCCccccee-------eE
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAEC---EALRNIRHRNLIKII-------TI  597 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  597 (725)
                      ...|+..+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|+   +.++. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            3458889999999999999999999999999999986542   2345677785   45555 799988755       33


Q ss_pred             eecCCCC------------CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHH------HHHHHHHHHHHHHHHhc
Q 048668          598 CSSTDFK------------GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQR------LNIAIDVASAIEYLHHH  659 (725)
Q Consensus       598 ~~~~~~~------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~  659 (725)
                      +......            .....|+||||++ |+|.+++.....     .+++..+      ..++.||+.||+|||++
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence            3222110            0135799999998 899999986421     2344444      67789999999999999


Q ss_pred             CCCCcEecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       660 ~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                         +|+||||||+|||++.++.+||+|||+|+.....           .....||+.|+|||++.
T Consensus       214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~  264 (371)
T 3q60_A          214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----------GPASSVPVTYAPREFLN  264 (371)
T ss_dssp             ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----------EEGGGSCGGGCCHHHHT
T ss_pred             ---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----------ccCccCCcCCcChhhcc
Confidence               9999999999999999999999999999865321           11245779999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.94  E-value=4.4e-27  Score=248.46  Aligned_cols=175  Identities=15%  Similarity=0.220  Sum_probs=140.7

Q ss_pred             cCCCCCcccccccceEEEEEEECC--------CceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccc----------
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE--------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK----------  593 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  593 (725)
                      ++|+..+.||+|+||.||+|++..        .++.||+|++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            579999999999999999999986        3789999998744     35779999999999999998          


Q ss_pred             -----eeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecC
Q 048668          594 -----IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGD  668 (725)
Q Consensus       594 -----l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrd  668 (725)
                           +++++...    ....|+||||+ +++|.+++....    ...+++..++.++.|++.||+|||++   +|+|||
T Consensus       117 ~~i~~~~~~~~~~----~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  184 (352)
T 2jii_A          117 LAIPTCMGFGVHQ----DKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGN  184 (352)
T ss_dssp             CSCCCCCEEEEET----TTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred             cCccchhhccccC----CcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence                 45555432    24789999999 999999998652    12689999999999999999999999   999999


Q ss_pred             CCCCCeeecCCC--ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          669 LKPSNVLLDHDM--VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       669 lkp~Nill~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+||+++.++  .+||+|||+|+.+......... .........||+.|+|||++.
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  241 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHK  241 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHT
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHc
Confidence            999999999998  8999999999876543221111 111122357999999999763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.94  E-value=1e-26  Score=250.49  Aligned_cols=178  Identities=24%  Similarity=0.313  Sum_probs=128.3

Q ss_pred             CCCC-CcccccccceEEEEEEEC--CCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSS-SNMIGQGSFGSVYKGILG--EDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~-~~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .|+. .++||+|+||.||+|+++  .+++.||||++....  ....+.+|++++++++||||+++++++....   ....
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeE
Confidence            4555 568999999999999975  468899999996442  2357889999999999999999999985432   2478


Q ss_pred             eEEEeccCCCCHHHHhcccCC---ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee----cCCCce
Q 048668          610 ALVFEYMGNGSLEDWLHQSND---QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DHDMVA  682 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill----~~~~~~  682 (725)
                      |+||||++ |+|.+++.....   ......+++..++.++.||+.||+|||+.   +|+||||||+||++    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999996 588888863321   11122489999999999999999999999   99999999999999    677899


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.+......     .......+||+.|+|||++.
T Consensus       172 kl~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~  208 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKP-----LADLDPVVVTFWYRAPELLL  208 (405)
T ss_dssp             EECCTTCCC---------------------CCCTTCCHHHHT
T ss_pred             EEEECCCceecCCCCcc-----cccCCCceecCcccCchhhc
Confidence            99999999876432111     11122357999999999864

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.9e-25  Score=226.50  Aligned_cols=203  Identities=23%  Similarity=0.289  Sum_probs=168.4

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +++++++++++++ .+|..+.  ++|++|+|++|++++..+.+|.++++|++|+|++|+|+.+.+..|.++++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            4789999999998 6777665  689999999999998888889999999999999999987777888999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      +|+++ .+|...|.++++|++|+|++|+++.+.+..|..+++|++|+|++|+|+++++..|..+++|++|++++|.++.+
T Consensus        94 ~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             SSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            99998 78888888899999999999999988888899999999999999999988888888889999999999988876


Q ss_pred             CCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCC
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  251 (725)
                      ++      ..|.++++|++|+|++|++++..+                         ..+..+++|+.|+|++|.+..
T Consensus       173 ~~------~~~~~l~~L~~L~L~~N~l~~~~~-------------------------~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          173 PE------GAFDKLTELKTLKLDNNQLKRVPE-------------------------GAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CT------TTTTTCTTCCEEECCSSCCSCCCT-------------------------TTTTTCTTCCEEECCSSCBCC
T ss_pred             Ch------hHhccCCCcCEEECCCCcCCcCCH-------------------------HHhccccCCCEEEecCCCeeC
Confidence            55      346678888888888888874333                         234455566666666666643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=5.5e-27  Score=243.46  Aligned_cols=173  Identities=25%  Similarity=0.344  Sum_probs=138.7

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcC----CCCcccceee
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNI----RHRNLIKIIT  596 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  596 (725)
                      .....++|+..+.||+|+||.||+|++..+++.||||++.....      .....+.+|+++++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34456789999999999999999999998999999999965432      1223456799999998    8999999999


Q ss_pred             EeecCCCCCcceeeEEEec-cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCee
Q 048668          597 ICSSTDFKGVDFKALVFEY-MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  675 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nil  675 (725)
                      ++....     ..++|||| +++++|.+++....      .+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus       106 ~~~~~~-----~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  171 (312)
T 2iwi_A          106 WFETQE-----GFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENIL  171 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEE
T ss_pred             EEecCC-----eEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEE
Confidence            975543     78999999 78999999998654      589999999999999999999999   9999999999999


Q ss_pred             ec-CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          676 LD-HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       676 l~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++ .++.+||+|||+++......          .....||+.|+|||++
T Consensus       172 ~~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~  210 (312)
T 2iwi_A          172 IDLRRGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWI  210 (312)
T ss_dssp             EETTTTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHH
T ss_pred             EeCCCCeEEEEEcchhhhcccCc----------ccccCCcccccCceee
Confidence            99 88999999999998764321          1124699999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.93  E-value=2.9e-26  Score=250.32  Aligned_cols=177  Identities=27%  Similarity=0.402  Sum_probs=141.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCc-ccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|++.+.||+|+||.||+|++..+++.||||++......  .++.+|+++++.++|++ |+.+..++...     +..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEG-----DYN   78 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEET-----TEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----CEE
Confidence            46799999999999999999999989999999998754332  35789999999999755 44444444333     378


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee---cCCCceEEcc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVGD  686 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill---~~~~~~kl~D  686 (725)
                      ++||||+ +++|.+++.....     .+++..++.|+.||+.||+|||++   +|+||||||+|||+   +.++.+||+|
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence            9999999 9999999985432     589999999999999999999999   99999999999999   5889999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+.+......... ........+||+.|+|||++.
T Consensus       150 FGla~~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~  186 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHI-PYRENKNLTGTARYASVNTHL  186 (483)
T ss_dssp             CTTCEECBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHT
T ss_pred             CCcceeccCCcccccc-ccccccccCCCccccCHHHhc
Confidence            9999877543221110 011122467999999999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=1.1e-26  Score=266.55  Aligned_cols=168  Identities=26%  Similarity=0.390  Sum_probs=140.6

Q ss_pred             cCCCCCcccccccceEEEEEEECC-CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE-DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|++.+.||+|+||.||+|++.. +++.||||++.... ....+.+.+|++++++++||||+++++++......+....
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999975 78999999986443 3345678999999999999999999999876653333336


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||++|++|.+++..        .+++.+++.|+.||+.||+|+|++   +|+||||||+||+++.+ .+||+|||+
T Consensus       160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence            999999999999887653        488999999999999999999999   99999999999999986 899999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.....            ...+||++|||||++
T Consensus       228 a~~~~~~------------~~~~gt~~y~aPE~~  249 (681)
T 2pzi_A          228 VSRINSF------------GYLYGTPGFQAPEIV  249 (681)
T ss_dssp             CEETTCC------------SCCCCCTTTSCTTHH
T ss_pred             chhcccC------------CccCCCccccCHHHH
Confidence            9865332            125699999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=1.1e-26  Score=241.86  Aligned_cols=171  Identities=23%  Similarity=0.339  Sum_probs=145.0

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc------hHHHHHHHHHHHHcCC--CCcccceeeEeec
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG------AFRSFVAECEALRNIR--HRNLIKIITICSS  600 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  600 (725)
                      ...++|+..+.||+|+||.||+|++..+++.||||++......      ..+.+.+|++++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3456799999999999999999999999999999999754321      2245678999999996  5999999999876


Q ss_pred             CCCCCcceeeEEEeccCC-CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-C
Q 048668          601 TDFKGVDFKALVFEYMGN-GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-H  678 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-~  678 (725)
                      ..     ..++||||+.+ ++|.+++....      .+++..++.++.|++.||+|||+.   +|+||||||+||+++ .
T Consensus       120 ~~-----~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          120 PD-----SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             SS-----EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             CC-----cEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence            54     78999999976 89999998654      588999999999999999999999   999999999999999 7


Q ss_pred             CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       679 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ++.+||+|||+++......          .....||+.|+|||++
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~  220 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWI  220 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHH
T ss_pred             CCCEEEeeCcccccccccc----------ccCCCCCccCCChHHh
Confidence            8899999999998764321          1124699999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=2.1e-26  Score=243.41  Aligned_cols=171  Identities=24%  Similarity=0.348  Sum_probs=140.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  607 (725)
                      .++|...+.||+|+||.||+|++..+|+.||||++....  ....+++.+|+.++++++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357888999999999999999999999999999996542  2335678999999999999999999999865431 1112


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||++ |+|.+++..        .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred             eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence            4589999997 588887642        478999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+++.....           ....+||+.|+|||++.
T Consensus       171 g~~~~~~~~-----------~~~~~~t~~y~aPE~~~  196 (353)
T 3coi_A          171 GLARHADAE-----------MTGYVVTRWYRAPEVIL  196 (353)
T ss_dssp             TCTTC-------------------CCSBCCSCHHHHS
T ss_pred             ccccCCCCC-----------ccccccCcCcCCHHHHh
Confidence            999764321           11246899999999753

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=2.7e-25  Score=225.38  Aligned_cols=191  Identities=26%  Similarity=0.305  Sum_probs=176.6

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||..+..  ++++|+|++|++++..+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|+++++.+..|.+
T Consensus        30 ~ip~~~~~--~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  107 (270)
T 2o6q_A           30 AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQ  107 (270)
T ss_dssp             SCCSCCCT--TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             ccCCCCCC--CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHccc
Confidence            57887774  8999999999999777779999999999999999999888888999999999999999999888889999


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCee
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL  163 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L  163 (725)
                      +++|++|+|++|+++ .++...|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++++..|..+++|++|
T Consensus       108 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  186 (270)
T 2o6q_A          108 LVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTL  186 (270)
T ss_dssp             CSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             ccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEE
Confidence            999999999999998 7888888999999999999999999988889999999999999999999999999999999999


Q ss_pred             ecCCccCCccCCCCcccccccCCCCCCCEEECccCccccc
Q 048668          164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       164 ~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                      ++++|.++.++.      ..+..+++|++|+|++|.+...
T Consensus       187 ~L~~N~l~~~~~------~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          187 KLDNNQLKRVPE------GAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             ECCSSCCSCCCT------TTTTTCTTCCEEECCSSCBCCS
T ss_pred             ECCCCcCCcCCH------HHhccccCCCEEEecCCCeeCC
Confidence            999999987665      4567899999999999998743

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.93  E-value=1.2e-26  Score=238.29  Aligned_cols=174  Identities=28%  Similarity=0.419  Sum_probs=134.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECC-C--ceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGE-D--EMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|+..+.||+|+||.||+|++.. +  +..||||+++..   .....+++.+|++++++++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3578999999999999999998632 3  346899998754   234467899999999999999999999997643   


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..++||||+++|+|.+++.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        94 ---~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl  162 (291)
T 1u46_A           94 ---PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI  162 (291)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred             ---CceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence               36899999999999999976432     588999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||+++........     ........||+.|+|||++
T Consensus       163 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~  196 (291)
T 1u46_A          163 GDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPESL  196 (291)
T ss_dssp             CCCTTCEECCC-CCE-----EEC-----CCGGGCCHHHH
T ss_pred             ccccccccccccccc-----hhhhccCCCCceeeCchhh
Confidence            999999876433111     0111224588899999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.93  E-value=1.9e-26  Score=256.91  Aligned_cols=179  Identities=26%  Similarity=0.420  Sum_probs=146.0

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++... .....+++.+|++++++++||||+++++++.... +...+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            46899999999999999999999989999999998754 2334567899999999999999999999865422 222457


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc---eEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV---AHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~---~kl~  685 (725)
                      .|+||||++||+|.+++.....   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            8999999999999999986542   12478888999999999999999999   9999999999999997764   9999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||.|+.......         .....||+.|+|||++.
T Consensus       167 DFG~a~~~~~~~~---------~~~~~gt~~Y~APE~l~  196 (676)
T 3qa8_A          167 DLGYAKELDQGEL---------CTEFVGTLQYLAPELLE  196 (676)
T ss_dssp             SCCCCCBTTSCCC---------CCCCCSCCTTCSSCSSC
T ss_pred             ccccccccccccc---------cccccCCcccCChHHhc
Confidence            9999987643321         11257999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=2.8e-26  Score=246.78  Aligned_cols=174  Identities=22%  Similarity=0.362  Sum_probs=141.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC--------CCcccceeeEeecCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR--------HRNLIKIITICSSTD  602 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~  602 (725)
                      .++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|++++++++        ||||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999999999999999999643 234567889999999985        788999999876322


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC--
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM--  680 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~--  680 (725)
                       ......|+||||+ ++++.+++.....    ..+++..++.++.||+.||+|||+++  +|+||||||+|||++.++  
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             -CCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence             1234789999999 6677777765432    15899999999999999999999853  899999999999999775  


Q ss_pred             -----------------------------------------------ceEEcccccccccccCCCCCCCCCCcccccccC
Q 048668          681 -----------------------------------------------VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG  713 (725)
Q Consensus       681 -----------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~g  713 (725)
                                                                     .+||+|||+|+......           ...+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----------~~~~g  255 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----------TEDIQ  255 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----------CSCCS
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----------ccCCC
Confidence                                                           79999999998764321           12469


Q ss_pred             CccccCCCccc
Q 048668          714 TVGYVAPGKFF  724 (725)
Q Consensus       714 t~~y~aPE~~~  724 (725)
                      |+.|||||++.
T Consensus       256 t~~y~aPE~~~  266 (397)
T 1wak_A          256 TRQYRSLEVLI  266 (397)
T ss_dssp             CGGGCCHHHHH
T ss_pred             CCcccCChhhc
Confidence            99999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.93  E-value=5.2e-26  Score=238.35  Aligned_cols=172  Identities=23%  Similarity=0.336  Sum_probs=123.3

Q ss_pred             HhcCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          530 ATSEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       530 ~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ..++|.+. +.||+|+||.||+|+++.+++.||||++....    ....+....++.++||||+++++++.... .+...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence            34578884 46999999999999999999999999996431    11122233456678999999999976532 22346


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~  685 (725)
                      .++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            8999999999999999986542    2589999999999999999999999   9999999999999986   4559999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+......          ....+||+.|+|||++
T Consensus       174 Dfg~~~~~~~~~----------~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          174 DFGFAKETTQNA----------LQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             CCTTCEEC------------------------------
T ss_pred             ccccceeccccc----------cccCCCCcCccChhhh
Confidence            999998654321          1124689999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=3.1e-26  Score=260.18  Aligned_cols=173  Identities=24%  Similarity=0.420  Sum_probs=140.7

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ..++|+..+.||+|+||.||+|++..+   +..||+|++.... ....+.+.+|+.++++++||||+++++++..     
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence            345677888999999999999998643   4679999986543 3345789999999999999999999998743     


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                       +..|+||||+++|+|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence             257899999999999999986532     588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+........       ......||+.|||||++
T Consensus       534 DFG~a~~~~~~~~~-------~~~~~~~t~~y~aPE~~  564 (656)
T 2j0j_A          534 DFGLSRYMEDSTYY-------KASKGKLPIKWMAPESI  564 (656)
T ss_dssp             CCCCCCSCCC-----------------CCGGGCCHHHH
T ss_pred             ecCCCeecCCCcce-------eccCCCCCcceeCHHHh
Confidence            99999876433211       11124578899999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=4.1e-26  Score=239.84  Aligned_cols=169  Identities=22%  Similarity=0.376  Sum_probs=141.5

Q ss_pred             hcCCCCCcccccccceEEEEEEE-CCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCc------ccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGIL-GEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN------LIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||.||+|++ ..+++.||||+++... ...+.+.+|+++++.++|++      |+++++++.... 
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~-   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG-   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-
Confidence            35799999999999999999998 5678999999996432 33467889999999987654      999999876654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-----  678 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-----  678 (725)
                          ..++||||+ +++|.+++.....    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.     
T Consensus        91 ----~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           91 ----HICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred             ----cEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence                889999999 8899999986542    2578999999999999999999999   9999999999999987     


Q ss_pred             --------------CCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          679 --------------DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       679 --------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                                    ++.+||+|||+|+.....           ....+||+.|+|||++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~  207 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVIL  207 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHT
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhh
Confidence                          668999999999864322           11246999999999863

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=2.6e-25  Score=227.40  Aligned_cols=187  Identities=24%  Similarity=0.243  Sum_probs=143.4

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +.++++++++++++|.++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|.|+++.+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            667788888888888887 5666554  6788888888888877788888888888888888888765443  6788888


Q ss_pred             eeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCc
Q 048668           89 YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN  168 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N  168 (725)
                      +|+|++|+|+ .+|.. +.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++++..|..+++|+.|+|++|
T Consensus        81 ~L~Ls~N~l~-~l~~~-~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLL-GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             EEECCSSCCS-SCCCC-TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCC-cCchh-hccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            8888888887 77753 467888888888888888877778888888888888888888888777777888888888888


Q ss_pred             cCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhh
Q 048668          169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIA  209 (725)
Q Consensus       169 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  209 (725)
                      +++.++.      ..+.++++|++|+|++|+++ .+|..+.
T Consensus       159 ~l~~l~~------~~~~~l~~L~~L~L~~N~l~-~ip~~~~  192 (290)
T 1p9a_G          159 NLTELPA------GLLNGLENLDTLLLQENSLY-TIPKGFF  192 (290)
T ss_dssp             CCSCCCT------TTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred             cCCccCH------HHhcCcCCCCEEECCCCcCC-ccChhhc
Confidence            7776554      34556777777777777776 3444333

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=7.7e-26  Score=236.48  Aligned_cols=175  Identities=21%  Similarity=0.283  Sum_probs=126.4

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHH-HHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... .....++..|+. +++.++||||+++++++....     .
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-----~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----D   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----E
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----c
Confidence            357888999999999999999999899999999997543 233455666666 677789999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+++ +|.+++...... ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence            8999999975 888877631100 0125889999999999999999999852  79999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +++.......         .....||+.|+|||++
T Consensus       172 ~~~~~~~~~~---------~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          172 ISGQLVDSIA---------KTRDAGCRPYMAPERI  197 (327)
T ss_dssp             SSCC-------------------------------
T ss_pred             Cceecccccc---------cccCCCCccccCceee
Confidence            9986643211         1123699999999986

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=4e-29  Score=283.99  Aligned_cols=404  Identities=14%  Similarity=0.109  Sum_probs=266.0

Q ss_pred             ccCcccCcEEecCCCccCc---cCCc------------cccCCCCCcEEEccCCcCCccCCCCCC-CCCCCCEEEccCC-
Q 048668            9 IGSLFKLQALALAGNYLTG---KLPD------------FIGNLSALQVIHIKGNSLGGKFPTTLG-LLRNLVQLNVAEN-   71 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~---~~~~------------~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N-   71 (725)
                      +..+++|++|++++|....   ..|.            .+..+++|++|+|++|.+++..+..+. .+++|++|+|++| 
T Consensus        62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~  141 (594)
T 2p1m_B           62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE  141 (594)
T ss_dssp             HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred             HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence            4567789999999985321   2222            235688999999999999877666665 6889999999999 


Q ss_pred             ccccc-CcccccccCCCceeeccCCCCCCCCCh---hhhcCCCCccEEEccCceeeeeCCCc----ccccCccceecCCC
Q 048668           72 KFYGM-FPRSICNISSLEYFYLTSNRFSGSLPF---DIVVNLPNLKELGIGANNFFGLIPDS----LSNASNLELLDLSN  143 (725)
Q Consensus        72 ~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~Ls~  143 (725)
                      .++.. ++..+.++++|++|+|++|.+++..+.   .+...+++|++|+|++|. ..+....    +..+++|++|+|++
T Consensus       142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~  220 (594)
T 2p1m_B          142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNR  220 (594)
T ss_dssp             EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred             CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCC
Confidence            56543 445556899999999999998743322   223467799999999987 2121222    34569999999999


Q ss_pred             c-cccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEE-ECccCcccccCChhhhhccccceeEEec
Q 048668          144 N-QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL-SLSDNQFGGELPHSIANLSSTMIVFLIG  221 (725)
Q Consensus       144 N-~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~~l~~L~l~  221 (725)
                      | .+.+ .+..+..+++|++|+++.+........-...+..+.++++|+.| .+.+... +.++..+..++ +|+.|+++
T Consensus       221 ~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~-~L~~L~L~  297 (594)
T 2p1m_B          221 AVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCS-RLTTLNLS  297 (594)
T ss_dssp             TSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHT-TCCEEECT
T ss_pred             CCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccch-hhHHHHHHhhC-CCCEEEcc
Confidence            8 5554 44567778899999977654210000000112346677888888 4443332 24444444555 78888888


Q ss_pred             CccceeccC-cccccccCCceEEecccccCCC-CChhhcCCCCccEEeccC---------cccccCCCCCCc-CCCCCCE
Q 048668          222 GNQISGTIP-LGIRNLVNLIALAVEVNQLHGT-IPDVIGELKNLQLLGLYK---------NFLQGSIPSGLG-NLTKLAK  289 (725)
Q Consensus       222 ~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~  289 (725)
                      +|.+.+... ..+..+++|++|++++| +... .+.....+++|++|++++         +.+++.....+. .+++|++
T Consensus       298 ~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~  376 (594)
T 2p1m_B          298 YATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES  376 (594)
T ss_dssp             TCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHH
Confidence            888664432 23457788888888887 4322 223334578888888833         444432222222 3788888


Q ss_pred             EeCCCCcCCCccccccccccccccccccc-cccccceeccc--C----CccCCC-----cchhhhcCCCCCeEEccCccc
Q 048668          290 LDLGSNSLQGNFIASQNKLIGALPQQLLS-ITTLSLYLDLS--N----NLLNGS-----LPQQVGNLKNLIILDISSNQF  357 (725)
Q Consensus       290 L~L~~N~l~~~~~~~~~~~~~~~p~~~~~-~~~ll~~L~L~--~----n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l  357 (725)
                      |+++.|.+++           ..+..+.. ...+ +.|+++  +    |.+++.     ++..+..+++|+.|+|++ .+
T Consensus       377 L~~~~~~l~~-----------~~~~~l~~~~~~L-~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l  443 (594)
T 2p1m_B          377 VLYFCRQMTN-----------AALITIARNRPNM-TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL  443 (594)
T ss_dssp             EEEEESCCCH-----------HHHHHHHHHCTTC-CEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred             HHHhcCCcCH-----------HHHHHHHhhCCCc-ceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc
Confidence            8887776652           22222222 2333 778887  3    555532     222367788999999977 67


Q ss_pred             cccCcccccc-ccCCcEEEccCCccccccCccc-cCCCCCCEEeCCCCcccccCcc-cccCCCCCCeEEcccccCe
Q 048668          358 SGMIPVTLST-CVSLEYVDISSNCFHGIIPPSL-GFLKSIKFLDVSCNNFSGQFPK-FLENLSFLEFLNLSYNHLE  430 (725)
Q Consensus       358 ~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~  430 (725)
                      ++..+..+.. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... ....+++|+.|++++|+++
T Consensus       444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             cHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            6655556655 7889999999999876655555 5688999999999998654443 3456888999999999884

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.93  E-value=8.1e-27  Score=243.04  Aligned_cols=180  Identities=24%  Similarity=0.381  Sum_probs=140.7

Q ss_pred             HHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC
Q 048668          525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD  602 (725)
Q Consensus       525 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  602 (725)
                      +++....++|+..+.||+|+||.||+|++..   .||+|++....  ....+.+.+|++++++++||||+++++++....
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3334456789999999999999999999864   39999997542  233456778999999999999999999987654


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCce
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVA  682 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~  682 (725)
                           ..++||||+++++|.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++ ++.+
T Consensus       103 -----~~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~  168 (319)
T 2y4i_B          103 -----HLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV  168 (319)
T ss_dssp             -----CEEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred             -----ceEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence                 68999999999999999976542     588899999999999999999999   999999999999998 6799


Q ss_pred             EEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          683 HVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       683 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|||+|+.........   .........||+.|+|||++.
T Consensus       169 ~l~Dfg~~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~  207 (319)
T 2y4i_B          169 VITDFGLFSISGVLQAGR---REDKLRIQNGWLCHLAPEIIR  207 (319)
T ss_dssp             EECCCSCCC-------------CCSCBCCSGGGGTSCHHHHS
T ss_pred             EEeecCCccccccccccc---cccccccCCCcccccChHHhh
Confidence            999999987653221111   111122346999999999863

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=3.2e-28  Score=276.51  Aligned_cols=411  Identities=13%  Similarity=0.101  Sum_probs=289.7

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCc---cCCCC------------CCCCCCCCEEEccCCcccccCcc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG---KFPTT------------LGLLRNLVQLNVAENKFYGMFPR   79 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~------------~~~l~~L~~L~Ls~N~l~~~~~~   79 (725)
                      .+.++++++... .....+..+++|++|++++|....   ..|..            +..+++|++|+|++|.+++..+.
T Consensus        45 ~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~  123 (594)
T 2p1m_B           45 RRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLE  123 (594)
T ss_dssp             CCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHH
T ss_pred             ceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHH
Confidence            346677666543 334578889999999999986321   22222            24578999999999999877777


Q ss_pred             ccc-ccCCCceeeccCC-CCCCCCChhhhcCCCCccEEEccCceeeeeCCCccc----ccCccceecCCCccccccCccC
Q 048668           80 SIC-NISSLEYFYLTSN-RFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLS----NASNLELLDLSNNQFKGKVSID  153 (725)
Q Consensus        80 ~~~-~l~~L~~L~L~~N-~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~----~l~~L~~L~Ls~N~i~~~~~~~  153 (725)
                      .+. .+++|++|+|++| .+++.....++.++++|++|+|++|.++...+..+.    .+++|++|+|++|. ..+....
T Consensus       124 ~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~  202 (594)
T 2p1m_B          124 LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSA  202 (594)
T ss_dssp             HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHH
T ss_pred             HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHH
Confidence            775 7999999999999 565222234456899999999999999876544443    66799999999998 3344344


Q ss_pred             cc----cccccCeeecCCcc-CCccCCCCcccccccCCCCCCCEEECccC-------cccccCChhhhhccccceeEE-e
Q 048668          154 FS----SLKILWRLNLEQNN-LGIGAANDLGFVTFLTNCSSLKVLSLSDN-------QFGGELPHSIANLSSTMIVFL-I  220 (725)
Q Consensus       154 f~----~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~L~~N-------~l~~~~p~~~~~l~~~l~~L~-l  220 (725)
                      +.    .+++|++|++++|. +..       ++..+.++++|++|+++.+       .+.+ ++..+.+++ +|+.+. +
T Consensus       203 l~~l~~~~~~L~~L~L~~~~~~~~-------l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~-~L~~Ls~~  273 (594)
T 2p1m_B          203 LERLVTRCPNLKSLKLNRAVPLEK-------LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK-ELRCLSGF  273 (594)
T ss_dssp             HHHHHHHCTTCCEEECCTTSCHHH-------HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT-TCCEEECC
T ss_pred             HHHHHHhCCCCcEEecCCCCcHHH-------HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC-CcccccCC
Confidence            43    45999999999983 221       3456778899999996544       4443 445666666 777773 3


Q ss_pred             cCccceeccCcccccccCCceEEecccccCCCC-ChhhcCCCCccEEeccCcccccC-CCCCCcCCCCCCEEeCCC----
Q 048668          221 GGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI-PDVIGELKNLQLLGLYKNFLQGS-IPSGLGNLTKLAKLDLGS----  294 (725)
Q Consensus       221 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~----  294 (725)
                      .+... ..++..+..+++|++|+|++|.+++.. ...+..+++|++|++++| +... ++.....+++|++|++.+    
T Consensus       274 ~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~  351 (594)
T 2p1m_B          274 WDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPF  351 (594)
T ss_dssp             BTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTT
T ss_pred             cccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCccc
Confidence            33222 345555667899999999999976432 334668899999999998 4422 222233588999999843    


Q ss_pred             -----CcCCCccccccccccccccccccc-cccccceecccCCccCCCcchhhh-cCCCCCeEEcc--C----ccccccC
Q 048668          295 -----NSLQGNFIASQNKLIGALPQQLLS-ITTLSLYLDLSNNLLNGSLPQQVG-NLKNLIILDIS--S----NQFSGMI  361 (725)
Q Consensus       295 -----N~l~~~~~~~~~~~~~~~p~~~~~-~~~ll~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~~  361 (725)
                           +.+++           .-...+.. ...+ ++|.++.|.+++..+..+. .+++|+.|+++  +    |.+++..
T Consensus       352 g~~~~~~l~~-----------~~l~~l~~~~~~L-~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~  419 (594)
T 2p1m_B          352 VMEPNVALTE-----------QGLVSVSMGCPKL-ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP  419 (594)
T ss_dssp             CSSCSSCCCH-----------HHHHHHHHHCTTC-CEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC
T ss_pred             ccccCCCCCH-----------HHHHHHHHhchhH-HHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc
Confidence                 33331           11111222 3334 7888889999876666665 58999999999  4    6666322


Q ss_pred             -----ccccccccCCcEEEccCCccccccCccccC-CCCCCEEeCCCCcccccCcccc-cCCCCCCeEEcccccCeeecC
Q 048668          362 -----PVTLSTCVSLEYVDISSNCFHGIIPPSLGF-LKSIKFLDVSCNNFSGQFPKFL-ENLSFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       362 -----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p  434 (725)
                           +..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|++++..+
T Consensus       420 ~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~  498 (594)
T 2p1m_B          420 LDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL  498 (594)
T ss_dssp             THHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHH
T ss_pred             hhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHH
Confidence                 22367789999999988 677666666665 8999999999999987655555 678999999999999964433


Q ss_pred             C--CCccCCCCCcCccCCc
Q 048668          435 T--KGVFSNKSKIPLQGNV  451 (725)
Q Consensus       435 ~--~~~~~~~~~~~~~~n~  451 (725)
                      .  ...++.++.+++++|+
T Consensus       499 ~~~~~~l~~L~~L~l~~~~  517 (594)
T 2p1m_B          499 LANASKLETMRSLWMSSCS  517 (594)
T ss_dssp             HHTGGGGGGSSEEEEESSC
T ss_pred             HHHHHhCCCCCEEeeeCCC
Confidence            2  2346788888888874

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=1.6e-25  Score=222.65  Aligned_cols=196  Identities=17%  Similarity=0.208  Sum_probs=115.2

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCc-ccccCcccccccCCCceeeccC-CCCCCCCChhhhcCCCCccEE
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENK-FYGMFPRSICNISSLEYFYLTS-NRFSGSLPFDIVVNLPNLKEL  115 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~~L  115 (725)
                      +|++|++++|+++++.+..|.++++|++|+|++|+ ++.+.+.+|.++++|++|++++ |+|+ .+|...|.++++|++|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFL  110 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTCCEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCCCEE
Confidence            56666666666665555566666666666666664 6555555666666666666665 6665 5555555666666666


Q ss_pred             EccCceeeeeCCCcccccCccc---eecCCCc-cccccCccCcccccccC-eeecCCccCCccCCCCcccccccCCCCCC
Q 048668          116 GIGANNFFGLIPDSLSNASNLE---LLDLSNN-QFKGKVSIDFSSLKILW-RLNLEQNNLGIGAANDLGFVTFLTNCSSL  190 (725)
Q Consensus       116 ~L~~N~i~~~~~~~~~~l~~L~---~L~Ls~N-~i~~~~~~~f~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~~~l~~L  190 (725)
                      +|++|+++++ |. |..+++|+   +|++++| +++++++..|..+++|+ +|++++|.++.++.      ..+.. ++|
T Consensus       111 ~l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~------~~~~~-~~L  181 (239)
T 2xwt_C          111 GIFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG------YAFNG-TKL  181 (239)
T ss_dssp             EEEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECT------TTTTT-CEE
T ss_pred             eCCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCH------hhcCC-CCC
Confidence            6666666553 33 55555555   6666666 66666666666666666 66666666654443      12223 566


Q ss_pred             CEEECccCc-ccccCChhhhhc-cccceeEEecCccceeccCcccccccCCceEEeccc
Q 048668          191 KVLSLSDNQ-FGGELPHSIANL-SSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN  247 (725)
Q Consensus       191 ~~L~L~~N~-l~~~~p~~~~~l-~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N  247 (725)
                      ++|++++|+ +++..+..|..+ + .++.|++++|.+++ +|..  .+++|+.|+++++
T Consensus       182 ~~L~L~~n~~l~~i~~~~~~~l~~-~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          182 DAVYLNKNKYLTVIDKDAFGGVYS-GPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             EEEECTTCTTCCEECTTTTTTCSB-CCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             CEEEcCCCCCcccCCHHHhhcccc-CCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            666666663 664444555555 4 56666666666663 3322  4556667766554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1.6e-25  Score=227.15  Aligned_cols=229  Identities=22%  Similarity=0.268  Sum_probs=157.5

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      ..+..+++..+.+...  ..+..+++|+.|++++|.++. . ..+..+++|++|+|++|.+++.  ..+..+++|++|+|
T Consensus        19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L   92 (272)
T 3rfs_A           19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL   92 (272)
T ss_dssp             HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence            3455566666665532  334566677777777777762 2 3466677777777777777642  35677777777777


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCc
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGI  172 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~  172 (725)
                      ++|+++ .++...|.++++|++|+|++|+++++.+..|..+++|++|+|++|+|+++++..|..+++|++|++++|.++.
T Consensus        93 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             TTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            777776 5666666677777777777777777666667777777777777777777777667777777777777777765


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT  252 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  252 (725)
                      +++      ..+.++++|++|++++|++++..|..+..++ .|+.|++++|.+.+.       +++|+.|++..|.+.|.
T Consensus       172 ~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~  237 (272)
T 3rfs_A          172 LPE------GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT-SLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGV  237 (272)
T ss_dssp             CCT------TTTTTCTTCCEEECCSSCCSCCCTTTTTTCT-TCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGG
T ss_pred             cCH------HHhcCCccCCEEECCCCcCCccCHHHHhCCc-CCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCc
Confidence            543      3355677777777777777766665566666 677777777776643       44678888888888888


Q ss_pred             CChhhcCCCC
Q 048668          253 IPDVIGELKN  262 (725)
Q Consensus       253 ~~~~~~~l~~  262 (725)
                      +|.+++.+..
T Consensus       238 ip~~~~~~~~  247 (272)
T 3rfs_A          238 VRNSAGSVAP  247 (272)
T ss_dssp             BBCTTSCBCG
T ss_pred             ccCcccccCC
Confidence            8888777654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.93  E-value=1e-25  Score=240.67  Aligned_cols=173  Identities=26%  Similarity=0.339  Sum_probs=141.9

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CC-----cccceeeEeecCC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HR-----NLIKIITICSSTD  602 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  602 (725)
                      ...++|+..+.||+|+||+||+|++..+++.||||+++.. ....+++.+|+++++.++ |+     +|+++++++....
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3457899999999999999999999999999999999743 233467788999988885 55     4899999876654


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCC
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDM  680 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~--~~~  680 (725)
                           ..|+||||++ |+|.+++.....    ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++  .++
T Consensus       130 -----~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          130 -----HLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             -----EEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             -----ceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence                 8899999996 599999986542    1589999999999999999999953 23899999999999995  477


Q ss_pred             ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          681 VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       681 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+||+|||+|+.....           ....+||+.|+|||++.
T Consensus       199 ~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~  231 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLL  231 (382)
T ss_dssp             CEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHT
T ss_pred             cEEEEeccCceecccc-----------cccccCCccccChHHHc
Confidence            8999999999876322           11256999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.92  E-value=8.2e-26  Score=234.69  Aligned_cols=173  Identities=25%  Similarity=0.417  Sum_probs=139.5

Q ss_pred             HHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCC--CCcccceeeEeecCCC
Q 048668          528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIR--HRNLIKIITICSSTDF  603 (725)
Q Consensus       528 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  603 (725)
                      ....++|+..+.||+|+||.||+|++. +++.||||++....  ....+.+.+|++++++++  ||||+++++++.... 
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-  101 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-  101 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS-
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC-
Confidence            334567999999999999999999986 58899999997543  334578899999999997  599999999987654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..|+||| +.+++|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||++++ +.+|
T Consensus       102 ----~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A          102 ----YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             ----EEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEE
T ss_pred             ----EEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEE
Confidence                7899999 55889999998654      588999999999999999999999   9999999999999964 8999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|||+++........      ......+||+.|+|||++
T Consensus       167 L~Dfg~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~  200 (313)
T 3cek_A          167 LIDFGIANQMQPDTTS------VVKDSQVGTVNYMPPEAI  200 (313)
T ss_dssp             ECCCSSSCC--------------------CCGGGCCHHHH
T ss_pred             EeeccccccccCcccc------ccccCCCCCCCcCCHHHH
Confidence            9999999876433211      111235699999999986

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.3e-25  Score=227.91  Aligned_cols=228  Identities=20%  Similarity=0.201  Sum_probs=140.1

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      .+..+++.++.+...  ..+..+++|+.|++++|.++.  ...+..+++|++|+|++|+++ .++  .+..+++|++|+|
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~L   92 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-DIS--ALKELTNLTYLIL   92 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCC-CCG--GGTTCTTCCEEEC
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCC-Cch--hhcCCCCCCEEEC
Confidence            444555666655533  234456666666666666652  223666666666666666665 333  3456666666666


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECcc
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      ++|.++++.+..|..+++|++|+|++|+++++++..|..+++|++|++++|.++.+++      ..+.++++|++|++++
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~------~~~~~l~~L~~L~l~~  166 (272)
T 3rfs_A           93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPK------GVFDKLTNLTELDLSY  166 (272)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT------TTTTTCTTCCEEECCS
T ss_pred             CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCH------HHhccCccCCEEECCC
Confidence            6666666666666666666666666666666666666666666666666666665443      3345666666666666


Q ss_pred             CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCC
Q 048668          198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI  277 (725)
Q Consensus       198 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  277 (725)
                      |++++..+..+..++ .|+.|++++|.+++..+..+..+++|+.|++++|.+.+.       +++|+.|+++.|.+.|.+
T Consensus       167 n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~i  238 (272)
T 3rfs_A          167 NQLQSLPEGVFDKLT-QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV  238 (272)
T ss_dssp             SCCCCCCTTTTTTCT-TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGB
T ss_pred             CCcCccCHHHhcCCc-cCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcc
Confidence            666655555555555 666666666666666565666666666666666665532       335666666666666666


Q ss_pred             CCCCcCCCC
Q 048668          278 PSGLGNLTK  286 (725)
Q Consensus       278 ~~~~~~l~~  286 (725)
                      |..++.++.
T Consensus       239 p~~~~~~~~  247 (272)
T 3rfs_A          239 RNSAGSVAP  247 (272)
T ss_dssp             BCTTSCBCG
T ss_pred             cCcccccCC
Confidence            666655543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=9.8e-25  Score=223.11  Aligned_cols=206  Identities=22%  Similarity=0.212  Sum_probs=132.0

Q ss_pred             cCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCc
Q 048668          184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNL  263 (725)
Q Consensus       184 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  263 (725)
                      +.++++++++++++|.++ .+|..+.                           ++++.|+|++|.+++..+..|..+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---------------------------~~l~~L~L~~N~l~~~~~~~~~~l~~L   57 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP---------------------------KDTTILHLSENLLYTFSLATLMPYTRL   57 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC---------------------------TTCCEEECTTSCCSEEEGGGGTTCTTC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC---------------------------CCCCEEEcCCCcCCccCHHHhhcCCCC
Confidence            456778888888888887 3443221                           345555555555555555555555555


Q ss_pred             cEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhc
Q 048668          264 QLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGN  343 (725)
Q Consensus       264 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~  343 (725)
                      ++|+|++|.+++..+.  ..+++|++|++++|+|+            .+|..+..+..+ ++|++++|++++..+..|..
T Consensus        58 ~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~------------~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~  122 (290)
T 1p9a_G           58 TQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ------------SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRG  122 (290)
T ss_dssp             CEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS------------SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTT
T ss_pred             CEEECCCCccCcccCC--CCCCcCCEEECCCCcCC------------cCchhhccCCCC-CEEECCCCcCcccCHHHHcC
Confidence            5555555555533221  45555556666555544            334333333333 45555555555555666777


Q ss_pred             CCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEE
Q 048668          344 LKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLN  423 (725)
Q Consensus       344 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  423 (725)
                      +++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.++
T Consensus       123 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~  201 (290)
T 1p9a_G          123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF  201 (290)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEE
T ss_pred             CCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEE
Confidence            777888888888887776677777777888888888887666666777778888888888877 5666666667777888


Q ss_pred             cccccCeeec
Q 048668          424 LSYNHLEGEV  433 (725)
Q Consensus       424 l~~N~l~~~~  433 (725)
                      |++|+|.|.+
T Consensus       202 L~~Np~~C~c  211 (290)
T 1p9a_G          202 LHGNPWLCNC  211 (290)
T ss_dssp             CCSCCBCCSG
T ss_pred             eCCCCccCcC
Confidence            8777777655

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=233.30  Aligned_cols=170  Identities=20%  Similarity=0.306  Sum_probs=126.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccc--hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++......  ..+.+.++..+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-----D   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----E
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----c
Confidence            45788899999999999999999989999999999755322  2234445556788889999999999987654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      .|+||||+ ++.+..+......     .+++..+..++.|++.||+|||+ +   +|+||||||+||+++.++.+||+||
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecc-CCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence            89999999 5566655543321     58899999999999999999998 5   8999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+++.......         .....||+.|+|||++
T Consensus       170 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          170 GISGRLVDDKA---------KDRSAGCAAYMAPERI  196 (318)
T ss_dssp             TTC-----------------------CCTTCCHHHH
T ss_pred             CCchhccCCcc---------ccccCCCccccChhhc
Confidence            99976543211         1124699999999986

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=1.5e-26  Score=245.10  Aligned_cols=256  Identities=20%  Similarity=0.252  Sum_probs=163.7

Q ss_pred             EEecCCCccCccCCccccCCCCCcEEEccCCcCCccCC----CCCCCCC-CCCEEEccCCcccccCccccccc-----CC
Q 048668           17 ALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFP----TTLGLLR-NLVQLNVAENKFYGMFPRSICNI-----SS   86 (725)
Q Consensus        17 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~   86 (725)
                      .+++++|.+++.+|..+...++|++|+|++|++++..+    .+|..++ +|++|+|++|+|++..+..|..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            36788888888888877777779999999999886666    6777887 89999999998887777777775     88


Q ss_pred             CceeeccCCCCCCCCChhh----hcCC-CCccEEEccCceeeeeCCCccc----c-cCccceecCCCccccccCccCc--
Q 048668           87 LEYFYLTSNRFSGSLPFDI----VVNL-PNLKELGIGANNFFGLIPDSLS----N-ASNLELLDLSNNQFKGKVSIDF--  154 (725)
Q Consensus        87 L~~L~L~~N~l~~~~~~~~----~~~l-~~L~~L~L~~N~i~~~~~~~~~----~-l~~L~~L~Ls~N~i~~~~~~~f--  154 (725)
                      |++|+|++|+++ ..+...    +..+ ++|++|+|++|+|+...+..+.    . .++|++|+|++|+|++.....+  
T Consensus        82 L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  160 (362)
T 3goz_A           82 VTSLNLSGNFLS-YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ  160 (362)
T ss_dssp             CCEEECCSSCGG-GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             ccEEECcCCcCC-hHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence            889999988887 343332    3334 7888888888888766554443    3 2578888888888876544333  


Q ss_pred             --cccc-ccCeeecCCccCCccCCCCcccccccCCC-CCCCEEECccCccccc----CChhhhhccccceeEEecCccce
Q 048668          155 --SSLK-ILWRLNLEQNNLGIGAANDLGFVTFLTNC-SSLKVLSLSDNQFGGE----LPHSIANLSSTMIVFLIGGNQIS  226 (725)
Q Consensus       155 --~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~~l~~L~l~~n~i~  226 (725)
                        ..++ +|++|+|++|.++...+..  +...+... ++|++|+|++|.+++.    ++..+....              
T Consensus       161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~--l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~--------------  224 (362)
T 3goz_A          161 ILAAIPANVNSLNLRGNNLASKNCAE--LAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIP--------------  224 (362)
T ss_dssp             HHHTSCTTCCEEECTTSCGGGSCHHH--HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSC--------------
T ss_pred             HHhcCCccccEeeecCCCCchhhHHH--HHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCC--------------
Confidence              3333 6777777777776544321  11233444 4777777777777642    222333222              


Q ss_pred             eccCcccccccCCceEEecccccCCCCC----hhhcCCCCccEEeccCccccc-------CCCCCCcCCCCCCEEeCCCC
Q 048668          227 GTIPLGIRNLVNLIALAVEVNQLHGTIP----DVIGELKNLQLLGLYKNFLQG-------SIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       227 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~-------~~~~~~~~l~~L~~L~L~~N  295 (725)
                                ++|++|+|++|.+++..+    ..+..+++|++|+|++|.+.+       .++..+..+++|+.||+++|
T Consensus       225 ----------~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N  294 (362)
T 3goz_A          225 ----------NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK  294 (362)
T ss_dssp             ----------TTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSC
T ss_pred             ----------CCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCC
Confidence                      245555555555554333    223444555555555555322       12234555666666666666


Q ss_pred             cCCC
Q 048668          296 SLQG  299 (725)
Q Consensus       296 ~l~~  299 (725)
                      .+.+
T Consensus       295 ~l~~  298 (362)
T 3goz_A          295 EIHP  298 (362)
T ss_dssp             BCCG
T ss_pred             cCCC
Confidence            6654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.92  E-value=2.1e-25  Score=236.09  Aligned_cols=169  Identities=24%  Similarity=0.374  Sum_probs=139.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc-eEEEEEEeeccccchHHHHHHHHHHHHcCCCCc------ccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE-MIVAVKVINLKQKGAFRSFVAECEALRNIRHRN------LIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||.||+|++..++ +.||+|+++.. ....+.+.+|++++++++|++      ++.+++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-
Confidence            358999999999999999999997766 78999999643 233467889999999997766      888888876554 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee-------
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-------  676 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill-------  676 (725)
                          ..++||||+ ++++.+++.....    ..+++..+..++.||+.||+|||++   +|+||||||+||++       
T Consensus        96 ----~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           96 ----HMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             ----EEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred             ----eEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence                789999999 6788888765432    2589999999999999999999999   99999999999999       


Q ss_pred             ------------cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          677 ------------DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       677 ------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                                  +.++.+||+|||+|+......           ...+||+.|+|||++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~  212 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----------TTIVATRHYRPPEVIL  212 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----------CSSCSCGGGCCHHHHT
T ss_pred             cccccccccccccCCCcEEEeecCccccccccc-----------cCCcCCCcccCCeeee
Confidence                        567899999999998643221           1256999999999863

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=4.6e-25  Score=219.36  Aligned_cols=211  Identities=17%  Similarity=0.214  Sum_probs=160.1

Q ss_pred             EccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCC-CCCCCChhhhcCCCCccEEEccC-c
Q 048668           43 HIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNR-FSGSLPFDIVVNLPNLKELGIGA-N  120 (725)
Q Consensus        43 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L~~-N  120 (725)
                      ++..++++ .+|. +.  .+|++|+|++|+|+++.+..|.++++|++|++++|+ ++ .++...|.++++|++|+|++ |
T Consensus        17 ~v~c~~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n   91 (239)
T 2xwt_C           17 RVTCKDIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTR   91 (239)
T ss_dssp             EEEECSCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEET
T ss_pred             eeEccCcc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCC
Confidence            33344465 4555 54  489999999999998888899999999999999997 87 88888889999999999998 9


Q ss_pred             eeeeeCCCcccccCccceecCCCccccccCccCcccccccC---eeecCCc-cCCccCCCCcccccccCCCCCCC-EEEC
Q 048668          121 NFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILW---RLNLEQN-NLGIGAANDLGFVTFLTNCSSLK-VLSL  195 (725)
Q Consensus       121 ~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~---~L~L~~N-~l~~~~~~~~~~~~~~~~l~~L~-~L~L  195 (725)
                      +++++.+..|.++++|++|+|++|++++++.  |..+++|+   +|++++| .++.++.      ..|.++++|+ +|++
T Consensus        92 ~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~------~~~~~l~~L~~~L~l  163 (239)
T 2xwt_C           92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPD--LTKVYSTDIFFILEITDNPYMTSIPV------NAFQGLCNETLTLKL  163 (239)
T ss_dssp             TCCEECTTSEECCTTCCEEEEEEECCCSCCC--CTTCCBCCSEEEEEEESCTTCCEECT------TTTTTTBSSEEEEEC
T ss_pred             CeeEcCHHHhCCCCCCCEEeCCCCCCccccc--cccccccccccEEECCCCcchhhcCc------ccccchhcceeEEEc
Confidence            9999988899999999999999999998764  88888888   9999999 8887665      4577889999 9999


Q ss_pred             ccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccc-cCCCCChhhcCC-CCccEEeccCccc
Q 048668          196 SDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ-LHGTIPDVIGEL-KNLQLLGLYKNFL  273 (725)
Q Consensus       196 ~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l  273 (725)
                      ++|+++ .+|.....                        . ++|+.|++++|+ ++++.+..|.++ ++|++|++++|++
T Consensus       164 ~~n~l~-~i~~~~~~------------------------~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l  217 (239)
T 2xwt_C          164 YNNGFT-SVQGYAFN------------------------G-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV  217 (239)
T ss_dssp             CSCCCC-EECTTTTT------------------------T-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCC
T ss_pred             CCCCCc-ccCHhhcC------------------------C-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcc
Confidence            999988 34332222                        2 455566666663 655555566666 6666666666666


Q ss_pred             ccCCCCCCcCCCCCCEEeCCCC
Q 048668          274 QGSIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       274 ~~~~~~~~~~l~~L~~L~L~~N  295 (725)
                      ++..+.   .+++|+.|+++++
T Consensus       218 ~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          218 TALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCCCCT---TCTTCSEEECTTC
T ss_pred             ccCChh---HhccCceeeccCc
Confidence            633222   4556666666654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.92  E-value=9.3e-26  Score=244.75  Aligned_cols=173  Identities=25%  Similarity=0.303  Sum_probs=125.8

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceeeEE
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      |...+.||+|+||+||.+.. .+|+.||||++...   ..+.+.+|+++++++ +||||+++++++....     ..|+|
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~~~lv   87 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYIA   87 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEEE
T ss_pred             eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----eEEEE
Confidence            44568899999999986544 47899999998653   235678999999986 8999999999876544     78999


Q ss_pred             EeccCCCCHHHHhcccCCccccc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC------------
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVC-KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD------------  679 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~------------  679 (725)
                      ||||+ |+|.+++.......... ..++..++.++.||+.||+|||++   +|+||||||+||+++.+            
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCC
Confidence            99995 69999998654221111 123445678999999999999999   99999999999999754            


Q ss_pred             -CceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          680 -MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       680 -~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                       +.+||+|||+|+.........    .......+||+.|||||++
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~  204 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELL  204 (434)
T ss_dssp             SCEEEECCCTTCEECCC------------------CCTTSCHHHH
T ss_pred             ceEEEEcccccceecCCCCccc----eeeecCCCCCCCccCHHHh
Confidence             489999999998765432111    0112235799999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.92  E-value=1.3e-25  Score=239.36  Aligned_cols=173  Identities=20%  Similarity=0.344  Sum_probs=142.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-----------CCcccceeeEee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----------HRNLIKIITICS  599 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  599 (725)
                      .++|+..+.||+|+||.||+|++..+++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357999999999999999999999999999999996432 23467889999999886           899999999976


Q ss_pred             cCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--
Q 048668          600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--  677 (725)
Q Consensus       600 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~--  677 (725)
                      ... ......++||||+ +++|.+++......    .+++..+..++.||+.||+|||+++  +|+||||||+||+++  
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence            542 1223689999999 88999999865422    5889999999999999999999853  899999999999994  


Q ss_pred             ----CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          678 ----HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       678 ----~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                          ..+.+||+|||+|+......           ...+||+.|+|||++
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~  207 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVL  207 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHH
T ss_pred             CCCcCcceEEEcccccccccCCCC-----------CCCCCCccccCcHHH
Confidence                34589999999998664321           124699999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.92  E-value=2.3e-25  Score=240.86  Aligned_cols=170  Identities=26%  Similarity=0.385  Sum_probs=129.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .+|+..+.||+|+||+||.... .+++.||||++.....   ..+.+|+++++++ +||||+++++++....     ..|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-----~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ-----FQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT-----EEE
T ss_pred             EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC-----EEE
Confidence            4688889999999998654333 4788999999965432   2345899999999 7999999999876554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----CCceEEc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-----DMVAHVG  685 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-----~~~~kl~  685 (725)
                      +|||||+ |+|.+++.....     ..++..++.++.||+.||+|||+.   +|+||||||+||+++.     ...+||+
T Consensus        95 lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~  165 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS  165 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred             EEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence            9999996 599999986542     234445678999999999999999   9999999999999953     2368899


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+........     .......+||++|||||++.
T Consensus       166 DFG~a~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          166 DFGLCKKLAVGRHS-----FSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             CTTEEECC-----------------CCSCTTSCCGGGTS
T ss_pred             cccceeeccCCCcc-----eeeccccCCCcCccChhhhh
Confidence            99999876433111     11122367999999999874

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=7.7e-25  Score=242.67  Aligned_cols=162  Identities=18%  Similarity=0.189  Sum_probs=118.7

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeecccc--------chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      ...+.||+|+||.||+|+.  .++.+|+|+...+..        ...+++.+|++++++++||||+++..++....    
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----  412 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD----  412 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence            3457899999999999955  567889998754321        12356899999999999999995555544333    


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..|+||||++|++|.++++.              +..++.|+++||+|||++   +|+||||||+||+++.  .+||+|
T Consensus       413 -~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          413 -NKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             -TTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred             -ccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence             56999999999999999874              357899999999999999   9999999999999999  999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+.......... .........+||++|||||++
T Consensus       473 FGla~~~~~~~~~~~-~~~~~~~~~~GT~~y~APEv~  508 (540)
T 3en9_A          473 FGLGKISNLDEDKAV-DLIVFKKAVLSTHHEKFDEIW  508 (540)
T ss_dssp             CTTCEECCCHHHHHH-HHHHHHHHHHHHCGGGHHHHH
T ss_pred             CccCEECCCcccccc-chhhhhhhhcCCCCcCCHHHH
Confidence            999987643210000 000011246799999999986

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=7.6e-24  Score=212.12  Aligned_cols=181  Identities=22%  Similarity=0.281  Sum_probs=166.7

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      .+.++++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            46789999999998 7787666  68999999999999999999999999999999999999989999999999999999


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCc
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGI  172 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~  172 (725)
                      ++|+|+ .+|...|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++++..|..+++|++|+|++|.++.
T Consensus        91 ~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  169 (251)
T 3m19_A           91 ANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS  169 (251)
T ss_dssp             TTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence            999998 8888888999999999999999999988889999999999999999999999899999999999999999987


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCccccc
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                      +++      ..+.++++|++|+|++|.+.+.
T Consensus       170 ~~~------~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          170 VPH------GAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCT------TTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCH------HHHhCCCCCCEEEeeCCceeCC
Confidence            665      4577889999999999999854

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=1e-25  Score=238.78  Aligned_cols=273  Identities=18%  Similarity=0.257  Sum_probs=185.1

Q ss_pred             EEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCc----ccccccC-CCceeeccCCCCCCCCChhhhcCC-----C
Q 048668           41 VIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFP----RSICNIS-SLEYFYLTSNRFSGSLPFDIVVNL-----P  110 (725)
Q Consensus        41 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l-----~  110 (725)
                      .+++++|++++.+|..+...++|++|+|++|.|++..+    .+|.+++ +|++|+|++|+|+ ......+..+     +
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-FKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGG-GSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCC-HHHHHHHHHHHhccCC
Confidence            46788888888888877777779999999998887776    7788888 8889999998887 4443334443     7


Q ss_pred             CccEEEccCceeeeeCCCcccc----c-CccceecCCCccccccCccCcccc-----cccCeeecCCccCCccCCCCccc
Q 048668          111 NLKELGIGANNFFGLIPDSLSN----A-SNLELLDLSNNQFKGKVSIDFSSL-----KILWRLNLEQNNLGIGAANDLGF  180 (725)
Q Consensus       111 ~L~~L~L~~N~i~~~~~~~~~~----l-~~L~~L~Ls~N~i~~~~~~~f~~l-----~~L~~L~L~~N~l~~~~~~~~~~  180 (725)
                      +|++|+|++|.++...+..+..    + ++|++|+|++|+|++.....+...     ++|++|+|++|.++......  +
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~--l  158 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDE--L  158 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHH--H
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHH--H
Confidence            8888888888887665554433    3 788888888888887766554432     46777777777665433211  1


Q ss_pred             ccccCCCC-CCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccc-cCCceEEecccccCCC----CC
Q 048668          181 VTFLTNCS-SLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNL-VNLIALAVEVNQLHGT----IP  254 (725)
Q Consensus       181 ~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~----~~  254 (725)
                      ...+..++ +|++|+|++|++++..+..+...                     +..+ ++|++|+|++|.+++.    ++
T Consensus       159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~---------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~  217 (362)
T 3goz_A          159 IQILAAIPANVNSLNLRGNNLASKNCAELAKF---------------------LASIPASVTSLDLSANLLGLKSYAELA  217 (362)
T ss_dssp             HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH---------------------HHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             HHHHhcCCccccEeeecCCCCchhhHHHHHHH---------------------HHhCCCCCCEEECCCCCCChhHHHHHH
Confidence            12233343 66666666666664444333322                     2334 4899999999999864    34


Q ss_pred             hhhcC-CCCccEEeccCcccccCCC----CCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceeccc
Q 048668          255 DVIGE-LKNLQLLGLYKNFLQGSIP----SGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLS  329 (725)
Q Consensus       255 ~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~  329 (725)
                      ..+.. .++|++|+|++|.+.+..+    ..+..+++|++|++++|.+.+...    .....++..+.....+ ++|+++
T Consensus       218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~----~~~~~l~~~~~~l~~L-~~LdL~  292 (362)
T 3goz_A          218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSK----EQCKALGAAFPNIQKI-ILVDKN  292 (362)
T ss_dssp             HHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCH----HHHHHHHTTSTTCCEE-EEECTT
T ss_pred             HHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCH----HHHHHHHHHhccCCce-EEEecC
Confidence            45555 4599999999999986544    446778999999999998552110    1112344455555555 889999


Q ss_pred             CCccCCCcchhhh
Q 048668          330 NNLLNGSLPQQVG  342 (725)
Q Consensus       330 ~n~l~~~~~~~~~  342 (725)
                      +|.+....+..+.
T Consensus       293 ~N~l~~~~~~~~~  305 (362)
T 3goz_A          293 GKEIHPSHSIPIS  305 (362)
T ss_dssp             SCBCCGGGCHHHH
T ss_pred             CCcCCCcchHHHH
Confidence            9999876555443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=3.9e-24  Score=225.37  Aligned_cols=250  Identities=16%  Similarity=0.132  Sum_probs=141.4

Q ss_pred             CccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc-Cccccccc
Q 048668            6 PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM-FPRSICNI   84 (725)
Q Consensus         6 p~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l   84 (725)
                      |+.++.+.. ++++.++++++ .+|..+.  +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. .+.+|.++
T Consensus         3 p~~~C~C~~-~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L   78 (350)
T 4ay9_X            3 HHRICHCSN-RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL   78 (350)
T ss_dssp             CCSSSEEET-TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSC
T ss_pred             CCCccEeeC-CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcc
Confidence            333444432 55666666666 5555442  4566666666666655555666666666666666665432 33455666


Q ss_pred             CCCce-eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCC-ccccccCccCcccccccCe
Q 048668           85 SSLEY-FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSN-NQFKGKVSIDFSSLKILWR  162 (725)
Q Consensus        85 ~~L~~-L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~f~~l~~L~~  162 (725)
                      ++|++ +.+++|+|+ .++.++|.++++|++|++++|+|+.+.+..+....++..|++++ |+|..++...|..+.    
T Consensus        79 ~~l~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~----  153 (350)
T 4ay9_X           79 PKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS----  153 (350)
T ss_dssp             TTCCEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB----
T ss_pred             hhhhhhhcccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc----
Confidence            55443 444455665 55555555566666666666666555555555555555555533 345555544444432    


Q ss_pred             eecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecC-ccceeccCcccccccCCce
Q 048668          163 LNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGG-NQISGTIPLGIRNLVNLIA  241 (725)
Q Consensus       163 L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~-n~i~~~~~~~~~~l~~L~~  241 (725)
                                               ..+++|+|++|+|+ .+|...+... .+..+++.+ |.+....+..|.++++|++
T Consensus       154 -------------------------~~l~~L~L~~N~i~-~i~~~~f~~~-~L~~l~l~~~n~l~~i~~~~f~~l~~L~~  206 (350)
T 4ay9_X          154 -------------------------FESVILWLNKNGIQ-EIHNSAFNGT-QLDELNLSDNNNLEELPNDVFHGASGPVI  206 (350)
T ss_dssp             -------------------------SSCEEEECCSSCCC-EECTTSSTTE-EEEEEECTTCTTCCCCCTTTTTTEECCSE
T ss_pred             -------------------------hhhhhhcccccccc-CCChhhcccc-chhHHhhccCCcccCCCHHHhccCcccch
Confidence                                     23455555555555 2333333333 455555543 4444333456788888888


Q ss_pred             EEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCC
Q 048668          242 LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       242 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  295 (725)
                      |+|++|+|+.+++..|.++++|+.+++  +.++ .+| .+..+++|+.+++.++
T Consensus       207 LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          207 LDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             EECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred             hhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence            888888888776666655554444433  2333 455 3677888888888754

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.91  E-value=3.8e-24  Score=218.46  Aligned_cols=144  Identities=13%  Similarity=0.116  Sum_probs=127.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....   ...+++.+|++++++++||||+++++++...+     .
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-----G  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-----c
Confidence            579999999999999999999998999999999975532   23478999999999999999999999977654     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+||||++|++|.++++..        ....++.+|+.|++.||+|||++   +|+||||||+||+++.++.+||+++|
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence            89999999999999999542        24456788999999999999999   99999999999999999999999887


Q ss_pred             ccc
Q 048668          689 LAK  691 (725)
Q Consensus       689 la~  691 (725)
                      ...
T Consensus       175 ~~~  177 (286)
T 3uqc_A          175 TMP  177 (286)
T ss_dssp             CCT
T ss_pred             ccC
Confidence            643

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=1.8e-23  Score=209.49  Aligned_cols=168  Identities=23%  Similarity=0.298  Sum_probs=158.7

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      .+||..+..  ++++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|+++.+..|.
T Consensus        27 ~~~p~~~~~--~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  104 (251)
T 3m19_A           27 DSVPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFD  104 (251)
T ss_dssp             SSCCSCCCT--TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT
T ss_pred             cccCCCCCC--CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhc
Confidence            367887774  899999999999988888999999999999999999999999999999999999999999988889999


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCe
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWR  162 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~  162 (725)
                      .+++|++|+|++|+|+ .+|...|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++++..|..+++|++
T Consensus       105 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  183 (251)
T 3m19_A          105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT  183 (251)
T ss_dssp             TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             ccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence            9999999999999998 888888899999999999999999998889999999999999999999999999999999999


Q ss_pred             eecCCccCCcc
Q 048668          163 LNLEQNNLGIG  173 (725)
Q Consensus       163 L~L~~N~l~~~  173 (725)
                      |++++|.+...
T Consensus       184 L~l~~N~~~c~  194 (251)
T 3m19_A          184 ITLFGNQFDCS  194 (251)
T ss_dssp             EECCSCCBCTT
T ss_pred             EEeeCCceeCC
Confidence            99999999754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=9.6e-24  Score=217.48  Aligned_cols=151  Identities=22%  Similarity=0.372  Sum_probs=129.0

Q ss_pred             hcCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHH-HcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|... +.||+|+||.||+|++..+++.||+|+++..     ..+.+|++++ +..+||||+++++++... ......
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence            4567766 7899999999999999999999999999632     4567889888 556899999999987642 122347


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~  685 (725)
                      .|+||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            8999999999999999987542    2589999999999999999999999   9999999999999998   7899999


Q ss_pred             ccccccccc
Q 048668          686 DFGLAKFLS  694 (725)
Q Consensus       686 Dfgla~~~~  694 (725)
                      |||+|+...
T Consensus       163 Dfg~a~~~~  171 (299)
T 3m2w_A          163 DFGFAKETT  171 (299)
T ss_dssp             CCTTCEECT
T ss_pred             ccccccccc
Confidence            999997654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=5.5e-24  Score=220.34  Aligned_cols=232  Identities=17%  Similarity=0.170  Sum_probs=172.8

Q ss_pred             CCCcEEEccCCcCCccCCC---CCCCCCCCCEEEccCCcccccCcccc--cccCCCceeeccCCCCCCCCC---hhhhcC
Q 048668           37 SALQVIHIKGNSLGGKFPT---TLGLLRNLVQLNVAENKFYGMFPRSI--CNISSLEYFYLTSNRFSGSLP---FDIVVN  108 (725)
Q Consensus        37 ~~L~~L~l~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~---~~~~~~  108 (725)
                      ..++.|.+.++.++...-.   .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+   ...+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            3578888888887532111   12235679999999999998888888  899999999999999986544   233457


Q ss_pred             CCCccEEEccCceeeeeCCCcccccCccceecCCCccccc---cC-ccCcccccccCeeecCCccCCccCCCCccccccc
Q 048668          109 LPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG---KV-SIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL  184 (725)
Q Consensus       109 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~---~~-~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  184 (725)
                      +++|++|+|++|+++++.+..|+.+++|++|||++|++.+   +. ...+..+++|++|+|++|.++.++..   ....+
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~---~~~l~  220 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGV---CAALA  220 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHH---HHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHH---HHHHH
Confidence            8999999999999999988999999999999999999865   32 23347889999999999999754321   01134


Q ss_pred             CCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCcc
Q 048668          185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQ  264 (725)
Q Consensus       185 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  264 (725)
                      .++++|++|+|++|++++..|..+..+.                      .+++|++|+|++|+|+.+ |..+.  ++|+
T Consensus       221 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----------------------~~~~L~~L~Ls~N~l~~l-p~~~~--~~L~  275 (310)
T 4glp_A          221 AAGVQPHSLDLSHNSLRATVNPSAPRCM----------------------WSSALNSLNLSFAGLEQV-PKGLP--AKLR  275 (310)
T ss_dssp             HHTCCCSSEECTTSCCCCCCCSCCSSCC----------------------CCTTCCCEECCSSCCCSC-CSCCC--SCCS
T ss_pred             hcCCCCCEEECCCCCCCccchhhHHhcc----------------------CcCcCCEEECCCCCCCch-hhhhc--CCCC
Confidence            6789999999999999865555443321                      235777788888888743 44443  6788


Q ss_pred             EEeccCcccccCCCCCCcCCCCCCEEeCCCCcCC
Q 048668          265 LLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       265 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      +|+|++|+|++. |. +..+++|+.|++++|+|+
T Consensus       276 ~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          276 VLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             EEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            888888888754 33 567788888888888776

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=8.1e-24  Score=218.52  Aligned_cols=214  Identities=21%  Similarity=0.335  Sum_probs=153.9

Q ss_pred             cccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           12 LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      +.++..+.+..+.++...  .+..+++|++|++++|+++. .| .+..+++|++|+|++|++++..+  +..+++|++|+
T Consensus        18 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence            334555666777666432  34567788888898888874 34 57888888888888888886554  88888888888


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |++|+++ .++  .+..+++|++|+|++|+++++.  .+..+++|++|+|++|+++++.+  +..+++|++|++++|.++
T Consensus        92 L~~n~l~-~~~--~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  164 (308)
T 1h6u_A           92 LSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS  164 (308)
T ss_dssp             CCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             ccCCcCC-Cch--hhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC
Confidence            8888887 554  3677888888888888888653  37888888888888888887655  777778888888888776


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCC
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  251 (725)
                      .+++        +.++++|++|++++|++++..+                           +..+++|++|+|++|++.+
T Consensus       165 ~~~~--------l~~l~~L~~L~l~~n~l~~~~~---------------------------l~~l~~L~~L~L~~N~l~~  209 (308)
T 1h6u_A          165 DLTP--------LANLSKLTTLKADDNKISDISP---------------------------LASLPNLIEVHLKNNQISD  209 (308)
T ss_dssp             CCGG--------GTTCTTCCEEECCSSCCCCCGG---------------------------GGGCTTCCEEECTTSCCCB
T ss_pred             CChh--------hcCCCCCCEEECCCCccCcChh---------------------------hcCCCCCCEEEccCCccCc
Confidence            5332        5667777777777777763211                           4455667777777777765


Q ss_pred             CCChhhcCCCCccEEeccCccccc
Q 048668          252 TIPDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      ..+  +..+++|++|++++|.+++
T Consensus       210 ~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          210 VSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             ccc--ccCCCCCCEEEccCCeeec
Confidence            542  6667777777777777663

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.90  E-value=2.4e-24  Score=232.05  Aligned_cols=176  Identities=18%  Similarity=0.205  Sum_probs=128.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCC-Cccccee---------eEe
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRH-RNLIKII---------TIC  598 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~---------~~~  598 (725)
                      ..|...+.||+|+||+||+|++..+|+.||||++.....   ...+.+.+|+.+++.++| ++.....         ..+
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            356777899999999999999999999999999874322   235789999999999987 2221111         111


Q ss_pred             e------------cCCCCCcceeeEEEeccCCCCHHHHhcccCC-ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          599 S------------STDFKGVDFKALVFEYMGNGSLEDWLHQSND-QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       599 ~------------~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                      .            ..........+++|+++ +++|.++++.... ......+++..++.++.|++.||+|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            1            00000012356777766 6899999852210 00112577889999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+|||++.++.+||+|||+|+.....           ....+| +.|||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhh
Confidence            9999999999999999999999999865332           123568 999999986

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=2e-23  Score=215.63  Aligned_cols=195  Identities=22%  Similarity=0.305  Sum_probs=167.5

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +..+++|++|++++|.++ .++ .+..+++|++|++++|++++..+  |..+++|++|+|++|++++.  ..+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence            345889999999999998 455 68999999999999999986655  99999999999999999854  3699999999


Q ss_pred             eeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCc
Q 048668           89 YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN  168 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N  168 (725)
                      +|+|++|+++ .++.  +..+++|++|+|++|+++++.+  +..+++|++|+|++|+++++.+  +..+++|+.|++++|
T Consensus       111 ~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          111 TLDLTSTQIT-DVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN  183 (308)
T ss_dssp             EEECTTSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             EEECCCCCCC-Cchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCC
Confidence            9999999998 6664  7899999999999999997755  8999999999999999998766  899999999999999


Q ss_pred             cCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccc
Q 048668          169 NLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQ  248 (725)
Q Consensus       169 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~  248 (725)
                      .++.+++        +..+++|++|+|++|++++..                           .+..+++|+.|++++|.
T Consensus       184 ~l~~~~~--------l~~l~~L~~L~L~~N~l~~~~---------------------------~l~~l~~L~~L~l~~N~  228 (308)
T 1h6u_A          184 KISDISP--------LASLPNLIEVHLKNNQISDVS---------------------------PLANTSNLFIVTLTNQT  228 (308)
T ss_dssp             CCCCCGG--------GGGCTTCCEEECTTSCCCBCG---------------------------GGTTCTTCCEEEEEEEE
T ss_pred             ccCcChh--------hcCCCCCCEEEccCCccCccc---------------------------cccCCCCCCEEEccCCe
Confidence            9986543        678899999999999998422                           14456677777777777


Q ss_pred             cCC
Q 048668          249 LHG  251 (725)
Q Consensus       249 l~~  251 (725)
                      +++
T Consensus       229 i~~  231 (308)
T 1h6u_A          229 ITN  231 (308)
T ss_dssp             EEC
T ss_pred             eec
Confidence            764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=1.4e-23  Score=221.12  Aligned_cols=231  Identities=20%  Similarity=0.195  Sum_probs=181.8

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCc-cCCCCCCCCCCCCE-EEccCCcccccCccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG-KFPTTLGLLRNLVQ-LNVAENKFYGMFPRS   80 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~   80 (725)
                      .+||+.+.  +++++|+|++|+|+...+.+|.++++|++|+|++|++.+ +.+++|.++++|++ +.++.|+|+.+.|.+
T Consensus        22 t~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~   99 (350)
T 4ay9_X           22 TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEA   99 (350)
T ss_dssp             CSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTS
T ss_pred             CccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchh
Confidence            37898885  489999999999996555789999999999999999865 45678999999876 667789999999999


Q ss_pred             ccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccC-ceeeeeCCCcccccC-ccceecCCCccccccCccCccccc
Q 048668           81 ICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA-NNFFGLIPDSLSNAS-NLELLDLSNNQFKGKVSIDFSSLK  158 (725)
Q Consensus        81 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~~~~f~~l~  158 (725)
                      |.++++|++|++++|+|+ .+|...+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+.+++..|.. .
T Consensus       100 f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~-~  177 (350)
T 4ay9_X          100 FQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNG-T  177 (350)
T ss_dssp             BCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTT-E
T ss_pred             hhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccc-c
Confidence            999999999999999998 78877777888899999965 789888888888876 6899999999999998888764 5


Q ss_pred             ccCeeecC-CccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCccccccc
Q 048668          159 ILWRLNLE-QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLV  237 (725)
Q Consensus       159 ~L~~L~L~-~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~  237 (725)
                      +|++|+++ +|.++.++.      ++|.++++|++|||++|+|+. +|.                        ..+   .
T Consensus       178 ~L~~l~l~~~n~l~~i~~------~~f~~l~~L~~LdLs~N~l~~-lp~------------------------~~~---~  223 (350)
T 4ay9_X          178 QLDELNLSDNNNLEELPN------DVFHGASGPVILDISRTRIHS-LPS------------------------YGL---E  223 (350)
T ss_dssp             EEEEEECTTCTTCCCCCT------TTTTTEECCSEEECTTSCCCC-CCS------------------------SSC---T
T ss_pred             chhHHhhccCCcccCCCH------HHhccCcccchhhcCCCCcCc-cCh------------------------hhh---c
Confidence            78899997 477877765      457788999999999999883 222                        122   2


Q ss_pred             CCceEEecccccCCCCChhhcCCCCccEEeccCcc
Q 048668          238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNF  272 (725)
Q Consensus       238 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  272 (725)
                      +|+.|.+.++.--...| .+..+++|+.+++.++.
T Consensus       224 ~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          224 NLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             TCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred             cchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence            33333333322222334 36777788888887654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=3.1e-23  Score=214.73  Aligned_cols=226  Identities=18%  Similarity=0.193  Sum_probs=170.9

Q ss_pred             CCCCEEECccCcccccCChh---hhhccccceeEEecCccceeccCccc--ccccCCceEEecccccCCCCC----hhhc
Q 048668          188 SSLKVLSLSDNQFGGELPHS---IANLSSTMIVFLIGGNQISGTIPLGI--RNLVNLIALAVEVNQLHGTIP----DVIG  258 (725)
Q Consensus       188 ~~L~~L~L~~N~l~~~~p~~---~~~l~~~l~~L~l~~n~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~  258 (725)
                      ..++.+.+.++.++...-..   +...+ .++.|++++|.+.+..|..+  ..+++|++|+|++|.+.+..+    ..+.
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~  142 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYS-RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW  142 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHS-CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccC-ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence            34666666666654221111   11222 57888888888887888877  889999999999999987655    4456


Q ss_pred             CCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccc--cccccccceecccCCccCCC
Q 048668          259 ELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQL--LSITTLSLYLDLSNNLLNGS  336 (725)
Q Consensus       259 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~--~~~~~ll~~L~L~~n~l~~~  336 (725)
                      .+++|++|+|++|.+.+..+..|..+++|++|+|++|++.+..         .++...  ..+..+ ++|++++|+++. 
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---------~~~~~~~~~~l~~L-~~L~Ls~N~l~~-  211 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGER---------GLMAALCPHKFPAI-QNLALRNTGMET-  211 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHH---------HHHTTSCTTSSCCC-CSCBCCSSCCCC-
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccch---------hhhHHHhhhcCCCC-CEEECCCCCCCc-
Confidence            7889999999999999888889999999999999999765210         122121  233444 889999999873 


Q ss_pred             cch----hhhcCCCCCeEEccCccccccCccccccc---cCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccC
Q 048668          337 LPQ----QVGNLKNLIILDISSNQFSGMIPVTLSTC---VSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF  409 (725)
Q Consensus       337 ~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  409 (725)
                      ++.    .+..+++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|+.|||++|+|++. 
T Consensus       212 l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-  287 (310)
T 4glp_A          212 PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-  287 (310)
T ss_dssp             HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-
T ss_pred             hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-
Confidence            333    35788999999999999998878777776   69999999999999 5666664  7899999999999865 


Q ss_pred             cccccCCCCCCeEEcccccCe
Q 048668          410 PKFLENLSFLEFLNLSYNHLE  430 (725)
Q Consensus       410 p~~~~~l~~L~~L~l~~N~l~  430 (725)
                      |. +..+++|+.|+|++|+|+
T Consensus       288 ~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          288 PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CC-TTSCCCCSCEECSSTTTS
T ss_pred             ch-hhhCCCccEEECcCCCCC
Confidence            33 678899999999999986

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.7e-23  Score=212.46  Aligned_cols=140  Identities=19%  Similarity=0.224  Sum_probs=112.3

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------------------chHHHHHHHHHHHHcCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------------------GAFRSFVAECEALRNIR  587 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  587 (725)
                      .+......|+..+.||+|+||.||+|++ .+|+.||+|+++....                  .....+.+|++++++++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3344455667779999999999999999 7899999999964321                  12456899999999999


Q ss_pred             CCcccceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEec
Q 048668          588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHG  667 (725)
Q Consensus       588 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHr  667 (725)
                      |   +++++++..      +..|+||||++||+|.+ +...            ....++.|++.||+|+|+.   +|+||
T Consensus       163 ~---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~------------~~~~i~~qi~~~l~~lH~~---giiHr  217 (282)
T 1zar_A          163 G---LAVPKVYAW------EGNAVLMELIDAKELYR-VRVE------------NPDEVLDMILEEVAKFYHR---GIVHG  217 (282)
T ss_dssp             T---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCCS------------CHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             C---CCcCeEEec------cceEEEEEecCCCcHHH-cchh------------hHHHHHHHHHHHHHHHHHC---CCEeC
Confidence            4   555554422      25699999999999998 4321            1346899999999999999   99999


Q ss_pred             CCCCCCeeecCCCceEEcccccccc
Q 048668          668 DLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       668 dlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      ||||+||+++ ++.+||+|||+|+.
T Consensus       218 Dlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          218 DLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             CCCHHHEEEE-CCcEEEEECCCCeE
Confidence            9999999999 99999999999863

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=2.4e-25  Score=238.38  Aligned_cols=260  Identities=18%  Similarity=0.221  Sum_probs=150.0

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccC----CCCCCCCCCCCEEEccCCc---ccccCcccc------
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKF----PTTLGLLRNLVQLNVAENK---FYGMFPRSI------   81 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~---l~~~~~~~~------   81 (725)
                      |+...++...+. .++..+..+++|++|+|++|+++...    +..|..+++|++|+|++|.   +++.+|..+      
T Consensus        11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~   89 (386)
T 2ca6_A           11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA   89 (386)
T ss_dssp             CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH
T ss_pred             cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHH
Confidence            333334444444 56777888888999999999887653    3447788889999888864   444455444      


Q ss_pred             -cccCCCceeeccCCCCCCC----CChhhhcCCCCccEEEccCceeeeeCCCccc----cc---------CccceecCCC
Q 048668           82 -CNISSLEYFYLTSNRFSGS----LPFDIVVNLPNLKELGIGANNFFGLIPDSLS----NA---------SNLELLDLSN  143 (725)
Q Consensus        82 -~~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~----~l---------~~L~~L~Ls~  143 (725)
                       ..+++|++|+|++|.+++.    +|. .+..+++|++|+|++|.++...+..+.    .+         ++|++|+|++
T Consensus        90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~  168 (386)
T 2ca6_A           90 LLKCPKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR  168 (386)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred             HhhCCcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCC
Confidence             6778888888888888731    332 346677888888888887644333333    33         6777777777


Q ss_pred             ccccccCc----cCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEE
Q 048668          144 NQFKGKVS----IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFL  219 (725)
Q Consensus       144 N~i~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~  219 (725)
                      |+|+....    ..|..+++|++|++++|.++...... -.+..+.++++|++|+|++|.++...   .           
T Consensus       169 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~-l~~~~l~~~~~L~~L~Ls~n~l~~~g---~-----------  233 (386)
T 2ca6_A          169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH-LLLEGLAYCQELKVLDLQDNTFTHLG---S-----------  233 (386)
T ss_dssp             SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHH-HHHTTGGGCTTCCEEECCSSCCHHHH---H-----------
T ss_pred             CCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHH-HHHHHhhcCCCccEEECcCCCCCcHH---H-----------
Confidence            77752211    23445566666666666664211000 00013445566666666666654100   0           


Q ss_pred             ecCccceeccCcccccccCCceEEecccccCCC----CChhhcC--CCCccEEeccCccccc----CCCCCC-cCCCCCC
Q 048668          220 IGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT----IPDVIGE--LKNLQLLGLYKNFLQG----SIPSGL-GNLTKLA  288 (725)
Q Consensus       220 l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~--l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~  288 (725)
                             +.+|..+..+++|++|+|++|.+++.    ++.++..  +++|++|+|++|.+.+    .+|..+ .++++|+
T Consensus       234 -------~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~  306 (386)
T 2ca6_A          234 -------SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL  306 (386)
T ss_dssp             -------HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCC
T ss_pred             -------HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCce
Confidence                   12333444555566666666665543    3344422  5566666666666654    244444 3455666


Q ss_pred             EEeCCCCcCC
Q 048668          289 KLDLGSNSLQ  298 (725)
Q Consensus       289 ~L~L~~N~l~  298 (725)
                      +|++++|+++
T Consensus       307 ~L~l~~N~l~  316 (386)
T 2ca6_A          307 FLELNGNRFS  316 (386)
T ss_dssp             EEECTTSBSC
T ss_pred             EEEccCCcCC
Confidence            6666665544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=8e-23  Score=198.48  Aligned_cols=181  Identities=24%  Similarity=0.289  Sum_probs=159.8

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      -+.++++++.++ .+|..+  .++|++|++++|++++..+..|..+++|++|+|++|+++++.+..|.++++|++|+|++
T Consensus         9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            578899999998 566655  35899999999999988888899999999999999999988888899999999999999


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA  174 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~  174 (725)
                      |+|+ .+|...|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++++..|..+++|++|++++|.+.   
T Consensus        86 n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~---  161 (208)
T 2o6s_A           86 NQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD---  161 (208)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC---
T ss_pred             CcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee---
Confidence            9998 788888889999999999999999888888999999999999999999998888999999999999999764   


Q ss_pred             CCCcccccccCCCCCCCEEECccCcccccCChhhhhcc
Q 048668          175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLS  212 (725)
Q Consensus       175 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  212 (725)
                                ..+++|++|+++.|+++|.+|..++.++
T Consensus       162 ----------~~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          162 ----------CTCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             ----------CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             ----------cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence                      3567888999999999888888777665

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=2.1e-24  Score=230.92  Aligned_cols=250  Identities=17%  Similarity=0.207  Sum_probs=182.3

Q ss_pred             cCCccccCcccCcEEecCCCccCccCC----ccccCCCCCcEEEccCCcC---CccCCCCC-------CCCCCCCEEEcc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLP----DFIGNLSALQVIHIKGNSL---GGKFPTTL-------GLLRNLVQLNVA   69 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l---~~~~~~~~-------~~l~~L~~L~Ls   69 (725)
                      .+++.+..+++|++|+|++|.|+...+    ..|..+++|++|+|++|.+   ++..|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            467778889999999999999997644    4477999999999999754   44455444       788999999999


Q ss_pred             CCcccc----cCcccccccCCCceeeccCCCCCCCCChhhh----cCC---------CCccEEEccCceee-eeCC---C
Q 048668           70 ENKFYG----MFPRSICNISSLEYFYLTSNRFSGSLPFDIV----VNL---------PNLKELGIGANNFF-GLIP---D  128 (725)
Q Consensus        70 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~~l---------~~L~~L~L~~N~i~-~~~~---~  128 (725)
                      +|.++.    .+|..+..+++|++|+|++|.|+ ......+    ..+         ++|++|+|++|+++ ...+   .
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~-~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~  181 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG-PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK  181 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH-HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC-HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHH
Confidence            999987    47778999999999999999997 3322222    233         89999999999997 3333   4


Q ss_pred             cccccCccceecCCCccccc-----cCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCccccc
Q 048668          129 SLSNASNLELLDLSNNQFKG-----KVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       129 ~~~~l~~L~~L~Ls~N~i~~-----~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                      .+..+++|++|+|++|+|+.     +.+..+..+++|++|+|++|.++.....  .++..+..+++|++|+|++|.+++.
T Consensus       182 ~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~--~l~~~l~~~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS--ALAIALKSWPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH--HHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             HHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHH--HHHHHHccCCCcCEEECCCCCCchh
Confidence            67789999999999999983     3344788999999999999998532111  1235577889999999999999854


Q ss_pred             CChhhhhccccceeEEecCccceeccCccc--ccccCCceEEecccccCC----CCChhh-cCCCCccEEeccCcccccC
Q 048668          204 LPHSIANLSSTMIVFLIGGNQISGTIPLGI--RNLVNLIALAVEVNQLHG----TIPDVI-GELKNLQLLGLYKNFLQGS  276 (725)
Q Consensus       204 ~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~  276 (725)
                      ....+                     +..+  +.+++|++|+|++|.+++    .+|..+ ..+++|++|++++|.+.+.
T Consensus       260 ~~~~l---------------------~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~  318 (386)
T 2ca6_A          260 GAAAV---------------------VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  318 (386)
T ss_dssp             HHHHH---------------------HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             hHHHH---------------------HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence            22211                     1222  224556666666666654    244444 4456666666666666543


Q ss_pred             C
Q 048668          277 I  277 (725)
Q Consensus       277 ~  277 (725)
                      .
T Consensus       319 ~  319 (386)
T 2ca6_A          319 D  319 (386)
T ss_dssp             S
T ss_pred             h
Confidence            3

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=7.9e-24  Score=222.13  Aligned_cols=223  Identities=20%  Similarity=0.238  Sum_probs=148.2

Q ss_pred             cCcEEecCCCccCccCCccccCC--CCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc-CcccccccCCCcee
Q 048668           14 KLQALALAGNYLTGKLPDFIGNL--SALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM-FPRSICNISSLEYF   90 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L   90 (725)
                      .+++|++++|.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            4788888888876   4566666  7888888888888866665 45688888888888888755 77778888888888


Q ss_pred             eccCCCCCCCCChhhhcCCCCccEEEccCc-eeeee-CCCcccccCccceecCCCc-ccccc-CccCccccc-ccCeeec
Q 048668           91 YLTSNRFSGSLPFDIVVNLPNLKELGIGAN-NFFGL-IPDSLSNASNLELLDLSNN-QFKGK-VSIDFSSLK-ILWRLNL  165 (725)
Q Consensus        91 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~Ls~N-~i~~~-~~~~f~~l~-~L~~L~L  165 (725)
                      +|++|.+++..+. .+..+++|++|+|++| .++.. .+..+.++++|++|+|++| .+++. .+..+..++ +|++|++
T Consensus       124 ~L~~~~l~~~~~~-~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l  202 (336)
T 2ast_B          124 SLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL  202 (336)
T ss_dssp             ECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred             eCcCcccCHHHHH-HHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence            8888888744443 4566888888888888 56642 4555777888888888888 77753 244566677 7777777


Q ss_pred             CCcc--CCccCCCCcccccccCCCCCCCEEECccCc-ccccCChhhhhccccceeEEecCcc-ceeccCcccccccCCce
Q 048668          166 EQNN--LGIGAANDLGFVTFLTNCSSLKVLSLSDNQ-FGGELPHSIANLSSTMIVFLIGGNQ-ISGTIPLGIRNLVNLIA  241 (725)
Q Consensus       166 ~~N~--l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~~l~~L~l~~n~-i~~~~~~~~~~l~~L~~  241 (725)
                      ++|.  ++..     .++..+.++++|++|++++|. +++..+..+..++ +|+.|++++|. +.......+..+++|+.
T Consensus       203 ~~~~~~~~~~-----~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~-~L~~L~l~~~~~~~~~~~~~l~~~~~L~~  276 (336)
T 2ast_B          203 SGYRKNLQKS-----DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN-YLQHLSLSRCYDIIPETLLELGEIPTLKT  276 (336)
T ss_dssp             CSCGGGSCHH-----HHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT-TCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             CCCcccCCHH-----HHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC-CCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence            7773  3311     122345566777777777777 5555555555543 45555555552 22111123444555555


Q ss_pred             EEeccc
Q 048668          242 LAVEVN  247 (725)
Q Consensus       242 L~L~~N  247 (725)
                      |++++|
T Consensus       277 L~l~~~  282 (336)
T 2ast_B          277 LQVFGI  282 (336)
T ss_dssp             EECTTS
T ss_pred             EeccCc
Confidence            555544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=1.2e-21  Score=190.13  Aligned_cols=153  Identities=23%  Similarity=0.282  Sum_probs=126.6

Q ss_pred             CcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEcc
Q 048668           39 LQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG  118 (725)
Q Consensus        39 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~  118 (725)
                      -+.++.++++++ .+|..+  .++|++|+|++|+++++.+..|.++++|++|++++|+++ .+|...|.++++|++|+|+
T Consensus         9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence            367889999997 445444  358999999999999888888999999999999999998 7888888889999999999


Q ss_pred             CceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccC
Q 048668          119 ANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN  198 (725)
Q Consensus       119 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N  198 (725)
                      +|+++++.+..|..+++|++|+|++|+|+++++..|..+++|++|++++|.++.++.      ..+..+++|++|++++|
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~------~~~~~l~~L~~L~l~~N  158 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD------GVFDRLTSLQYIWLHDN  158 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT------TTTTTCTTCCEEECCSC
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH------HHhccCCCccEEEecCC
Confidence            999998888888999999999999999998888778888888888888888875544      33566777777777777


Q ss_pred             ccc
Q 048668          199 QFG  201 (725)
Q Consensus       199 ~l~  201 (725)
                      .+.
T Consensus       159 ~~~  161 (208)
T 2o6s_A          159 PWD  161 (208)
T ss_dssp             CBC
T ss_pred             Cee
Confidence            665

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=3e-23  Score=217.72  Aligned_cols=225  Identities=20%  Similarity=0.212  Sum_probs=102.9

Q ss_pred             CcEEEccCCcCCccCCCCCCCC--CCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEE
Q 048668           39 LQVIHIKGNSLGGKFPTTLGLL--RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELG  116 (725)
Q Consensus        39 L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~  116 (725)
                      ++.|++++|++.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++......+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            555555555553   2334444  4555555555555544333 334555555555555554220112334455555555


Q ss_pred             ccCceeeeeCCCcccccCccceecCCCc-ccccc-CccCcccccccCeeecCCc-cCCccCCCCcccccccCCCC-CCCE
Q 048668          117 IGANNFFGLIPDSLSNASNLELLDLSNN-QFKGK-VSIDFSSLKILWRLNLEQN-NLGIGAANDLGFVTFLTNCS-SLKV  192 (725)
Q Consensus       117 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N-~i~~~-~~~~f~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~~l~-~L~~  192 (725)
                      |++|.++...+..++.+++|++|+|++| .+++. .+..+..+++|++|++++| .++...     ++..+..++ +|++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~-----~~~~~~~l~~~L~~  199 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH-----VQVAVAHVSETITQ  199 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH-----HHHHHHHSCTTCCE
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHH-----HHHHHHhcccCCCE
Confidence            5555554444444445555555555555 34321 1222334444444444444 433210     112233334 4444


Q ss_pred             EECccCcccccCChhhhhccccceeEEecCccce-eccCcccccccCCceEEecccc-cCCCCChhhcCCCCccEEeccC
Q 048668          193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQIS-GTIPLGIRNLVNLIALAVEVNQ-LHGTIPDVIGELKNLQLLGLYK  270 (725)
Q Consensus       193 L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~  270 (725)
                      |++++|.+                       .++ +.++..+..+++|++|++++|. +++..+..+..+++|++|++++
T Consensus       200 L~l~~~~~-----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~  256 (336)
T 2ast_B          200 LNLSGYRK-----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR  256 (336)
T ss_dssp             EECCSCGG-----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             EEeCCCcc-----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCC
Confidence            44444421                       111 1233334445566666666665 4444455555566666666666


Q ss_pred             cc-cccCCCCCCcCCCCCCEEeCCCC
Q 048668          271 NF-LQGSIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       271 N~-l~~~~~~~~~~l~~L~~L~L~~N  295 (725)
                      |. +.......+..+++|++|++++|
T Consensus       257 ~~~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          257 CYDIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             CTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCCCHHHHHHHhcCCCCCEEeccCc
Confidence            63 21111113455556666666555

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=1.6e-21  Score=190.73  Aligned_cols=153  Identities=23%  Similarity=0.340  Sum_probs=135.3

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      -+.++++++.++ .+|..+.  ++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++.|.+|.++++|++|+|++
T Consensus        13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~   89 (220)
T 2v9t_B           13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG   89 (220)
T ss_dssp             TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred             CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence            478999999998 6777665  6899999999999988888999999999999999999988899999999999999999


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |+|+ .+|..+|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++++..|..+++|++|+|++|.+.
T Consensus        90 N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           90 NKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            9998 889888889999999999999999998889999999999999999999888877777777777777776654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=1.5e-21  Score=206.34  Aligned_cols=156  Identities=21%  Similarity=0.203  Sum_probs=122.2

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCC-CCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLG-LLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      -+++++++|+++ .+|..+.  +.++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+.+|.++++|++|+|+
T Consensus        20 ~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           20 SNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            367888888888 5776554  4588888888888888888887 88888888888888888888888888888888888


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCc---ccccccCeeecCCccC
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDF---SSLKILWRLNLEQNNL  170 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f---~~l~~L~~L~L~~N~l  170 (725)
                      +|+|+ .++...|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|+|++++...|   ..+++|+.|+|++|.|
T Consensus        97 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l  175 (361)
T 2xot_A           97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL  175 (361)
T ss_dssp             SSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred             CCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence            88887 7777778888888888888888888888888888888888888888887777666   3455555555555555


Q ss_pred             CccC
Q 048668          171 GIGA  174 (725)
Q Consensus       171 ~~~~  174 (725)
                      +.++
T Consensus       176 ~~l~  179 (361)
T 2xot_A          176 KKLP  179 (361)
T ss_dssp             CCCC
T ss_pred             CccC
Confidence            5433

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=4e-21  Score=212.70  Aligned_cols=194  Identities=23%  Similarity=0.292  Sum_probs=97.9

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +|+.|+|++|+|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. |.+  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            55666666666653 444332  45666666666665 333   234556666666666654 333 433  56666666


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      +|+|+ .+|.    .+++|+.|+|++|+|+++ |.   .+++|++|+|++|+|++++.  |.  ++|++|+|++|.|+.+
T Consensus       129 ~N~l~-~lp~----~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~~l  195 (571)
T 3cvr_A          129 NNQLT-MLPE----LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLESL  195 (571)
T ss_dssp             SSCCS-CCCC----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCSSC
T ss_pred             CCcCC-CCCC----cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCCch
Confidence            66665 3554    355566666666665543 22   34555566666665555443  33  5555555555555533


Q ss_pred             CCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCC
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI  253 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  253 (725)
                      +.  +.- ......+.|++|+|++|+|+                          .+|..+..+++|+.|+|++|.+++.+
T Consensus       196 p~--~~~-~L~~~~~~L~~L~Ls~N~l~--------------------------~lp~~l~~l~~L~~L~L~~N~l~~~~  246 (571)
T 3cvr_A          196 PA--VPV-RNHHSEETEIFFRCRENRIT--------------------------HIPENILSLDPTCTIILEDNPLSSRI  246 (571)
T ss_dssp             CC--CC---------CCEEEECCSSCCC--------------------------CCCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred             hh--HHH-hhhcccccceEEecCCCcce--------------------------ecCHHHhcCCCCCEEEeeCCcCCCcC
Confidence            22  100 00001111255555555544                          34555555566666666666666555


Q ss_pred             ChhhcCC
Q 048668          254 PDVIGEL  260 (725)
Q Consensus       254 ~~~~~~l  260 (725)
                      |..+..+
T Consensus       247 p~~l~~l  253 (571)
T 3cvr_A          247 RESLSQQ  253 (571)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            5555543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=7.7e-21  Score=185.77  Aligned_cols=153  Identities=24%  Similarity=0.270  Sum_probs=124.1

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCC-CCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFP-TTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      -+++++++|.++ .+|..+.  ..+++|+|++|+|++..| +.|..+++|++|+|++|+|+++.+.+|.++++|++|+|+
T Consensus        13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence            468999999988 5777664  457899999999987754 568888999999999999988888889999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      +|+|+ .++...|.++++|++|+|++|+|+++.|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|.+.
T Consensus        90 ~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           90 SNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             SSCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CCccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            99997 777777888888888888888888888888888888888888888888877777766666666666666553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=5.2e-21  Score=195.61  Aligned_cols=169  Identities=27%  Similarity=0.342  Sum_probs=78.2

Q ss_pred             cccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           12 LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      +++|++|++++|.++. ++ .+..+++|++|++++|++++..+  +..+++|++|+|++|++++.  ..+..+++|++|+
T Consensus        45 l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~  118 (291)
T 1h6t_A           45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLS  118 (291)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEE
T ss_pred             cCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEE
Confidence            4445555555555442 22 24444555555555555543332  44455555555555554431  1244455555555


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |++|+|+ .++  .+..+++|+.|+|++|+++++  ..+..+++|++|+|++|+|+++.+  +..+++|++|++++|.++
T Consensus       119 L~~n~i~-~~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          119 LEHNGIS-DIN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             CTTSCCC-CCG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             CCCCcCC-CCh--hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            5555554 232  233445555555555555443  334444555555555555544433  444445555555555444


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      .++        .+..+++|+.|++++|.++
T Consensus       192 ~l~--------~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          192 DLR--------ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             BCG--------GGTTCTTCSEEEEEEEEEE
T ss_pred             CCh--------hhccCCCCCEEECcCCccc
Confidence            321        1344444555555544444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=4e-21  Score=203.12  Aligned_cols=165  Identities=21%  Similarity=0.253  Sum_probs=147.9

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCcccc-CCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIG-NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      +||..+..  .++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+.+|..+++|++|+|++|+|+.+.+..|.
T Consensus        32 ~iP~~~~~--~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  109 (361)
T 2xot_A           32 NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFS  109 (361)
T ss_dssp             SCCSSCCT--TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             ccCccCCC--CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhC
Confidence            58888776  799999999999987778888 999999999999999999999999999999999999999988889999


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcc---cccCccceecCCCccccccCccCcccccc
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL---SNASNLELLDLSNNQFKGKVSIDFSSLKI  159 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~---~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~  159 (725)
                      ++++|++|+|++|+|+ .++...|.++++|+.|+|++|+|+.+.+..|   ..+++|++|||++|+|+.++...|..++.
T Consensus       110 ~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~  188 (361)
T 2xot_A          110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA  188 (361)
T ss_dssp             TCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCH
T ss_pred             CCcCCCEEECCCCccc-EECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccH
Confidence            9999999999999998 7877888999999999999999998877777   67999999999999999998888888776


Q ss_pred             --cCeeecCCccCC
Q 048668          160 --LWRLNLEQNNLG  171 (725)
Q Consensus       160 --L~~L~L~~N~l~  171 (725)
                        ++.|+|++|.+.
T Consensus       189 ~~l~~l~l~~N~~~  202 (361)
T 2xot_A          189 WVKNGLYLHNNPLE  202 (361)
T ss_dssp             HHHTTEECCSSCEE
T ss_pred             hhcceEEecCCCcc
Confidence              367777777664

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=3.6e-21  Score=196.83  Aligned_cols=169  Identities=24%  Similarity=0.323  Sum_probs=120.3

Q ss_pred             cccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           12 LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      +.++..+.+..+.++...  .+..+++|++|++++|+++.. + .+..+++|++|+|++|++++..+  +.++++|++|+
T Consensus        23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            344556677777776432  345678888889998888744 3 47888888888888888886555  88888888888


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |++|+++ .+|.  +..+++|++|+|++|+++++  ..+..+++|++|+|++|+|+++  ..|..+++|++|++++|.++
T Consensus        97 l~~n~l~-~~~~--l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~  169 (291)
T 1h6t_A           97 LDENKVK-DLSS--LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  169 (291)
T ss_dssp             CCSSCCC-CGGG--GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             CCCCcCC-CChh--hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence            8888887 5553  56788888888888888765  4577788888888888888766  45666666666666666665


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      .+.+        +..+++|++|++++|.++
T Consensus       170 ~~~~--------l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          170 DIVP--------LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             CCGG--------GTTCTTCCEEECCSSCCC
T ss_pred             cchh--------hcCCCccCEEECCCCcCC
Confidence            4321        445566666666666555

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=6.5e-21  Score=186.29  Aligned_cols=158  Identities=18%  Similarity=0.148  Sum_probs=122.4

Q ss_pred             ceEEecccccCCCCChhhcCCCCccEEeccCcccccCCC-CCCcCCCCCCEEeCCCCcCCCccccccccccccccccccc
Q 048668          240 IALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP-SGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLS  318 (725)
Q Consensus       240 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~  318 (725)
                      +.+++++|.++.+ |..+.  ..+++|+|++|.|++..+ ..|..+++|++|+|++|                       
T Consensus        14 ~~l~~s~n~l~~i-P~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N-----------------------   67 (220)
T 2v70_A           14 TTVDCSNQKLNKI-PEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN-----------------------   67 (220)
T ss_dssp             TEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSS-----------------------
T ss_pred             CEeEeCCCCcccC-ccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCC-----------------------
Confidence            3566666666543 33221  234566666666654433 23455555555555555                       


Q ss_pred             cccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEE
Q 048668          319 ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL  398 (725)
Q Consensus       319 ~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  398 (725)
                                   .+++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+.|
T Consensus        68 -------------~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  134 (220)
T 2v70_A           68 -------------KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL  134 (220)
T ss_dssp             -------------CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred             -------------cCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence                         4444556678889999999999999998888889999999999999999999989999999999999


Q ss_pred             eCCCCcccccCcccccCCCCCCeEEcccccCeeecCCC
Q 048668          399 DVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTK  436 (725)
Q Consensus       399 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  436 (725)
                      +|++|+|++..|..|..+++|+.|+|++|+|+|.++..
T Consensus       135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~  172 (220)
T 2v70_A          135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLA  172 (220)
T ss_dssp             ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGGH
T ss_pred             ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCchH
Confidence            99999999988999999999999999999999988753

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=1.8e-20  Score=183.12  Aligned_cols=142  Identities=21%  Similarity=0.288  Sum_probs=133.4

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICN   83 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   83 (725)
                      +||..+.  +++++|+|++|+|++..+..|..+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+.+.+..|.+
T Consensus        25 ~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~  102 (220)
T 2v9t_B           25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEG  102 (220)
T ss_dssp             SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTT
T ss_pred             cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccC
Confidence            6788777  48999999999999777789999999999999999999999999999999999999999999888888999


Q ss_pred             cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccc
Q 048668           84 ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus        84 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      +++|++|+|++|+|+ .++...|.++++|++|+|++|+|+++.+..|..+++|++|+|++|++..
T Consensus       103 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          103 LFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCEEECCCCCCC-EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            999999999999998 7777788999999999999999999999999999999999999999974

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=4e-20  Score=181.95  Aligned_cols=152  Identities=22%  Similarity=0.246  Sum_probs=103.3

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      .+.++++++.++ .+|..+.  ++|++|+|++|+++++.|..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            556777777776 5665444  6777777777777777677777777777777777777666666677777777777777


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |+|+ .++...|..+++|++|+|++|+|+. +|..+..+++|++|+|++|+|+++++..|..+++|+.|++++|.+.
T Consensus        98 N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A           98 NQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCCS-CCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             CcCC-ccChhHhCcchhhCeEeccCCcccc-cCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            7776 6666666677777777777777763 3556667777777777777777666655555555555555555443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=3.1e-20  Score=205.57  Aligned_cols=196  Identities=26%  Similarity=0.309  Sum_probs=132.7

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      +|+.|+|++|+|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|+ .+|.  +.+  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~-~ip~--l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLS-TLPE--LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC--CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCC-Ccch--hhc--CCCEEEC
Confidence            77888888888875 454442  67888888888877 444   44677888888888877 4766  333  7777777


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECcc
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      ++|+|+++ |.   .+++|++|+|++|+|++++.    .+++|++|+|++|.++.++.        +.  ++|++|+|++
T Consensus       128 s~N~l~~l-p~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~lp~--------l~--~~L~~L~Ls~  189 (571)
T 3cvr_A          128 DNNQLTML-PE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPE--------LP--ESLEALDVST  189 (571)
T ss_dssp             CSSCCSCC-CC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC--------CC--TTCCEEECCS
T ss_pred             CCCcCCCC-CC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCCcch--------hh--CCCCEEECcC
Confidence            77777764 33   46777777777777776554    45667777777777665332        22  6677777777


Q ss_pred             CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCC
Q 048668          198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI  277 (725)
Q Consensus       198 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  277 (725)
                      |+|+ .+|. +..   .|                 +.....|+.|+|++|+|+. +|..+..+++|++|+|++|.+++.+
T Consensus       190 N~L~-~lp~-~~~---~L-----------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~  246 (571)
T 3cvr_A          190 NLLE-SLPA-VPV---RN-----------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI  246 (571)
T ss_dssp             SCCS-SCCC-CC----------------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred             CCCC-chhh-HHH---hh-----------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcC
Confidence            7666 3332 111   00                 1112334999999999995 5666777999999999999999988


Q ss_pred             CCCCcCCCC
Q 048668          278 PSGLGNLTK  286 (725)
Q Consensus       278 ~~~~~~l~~  286 (725)
                      |..+..+..
T Consensus       247 p~~l~~l~~  255 (571)
T 3cvr_A          247 RESLSQQTA  255 (571)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHhhc
Confidence            887766543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=1.9e-20  Score=209.66  Aligned_cols=193  Identities=22%  Similarity=0.303  Sum_probs=122.6

Q ss_pred             cccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           12 LFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      +..+..+.+..+.+....+  +..+++|+.|++++|.+... | .|..+++|++|+|++|+|+++.+  +..+++|+.|+
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            3345556666666653322  45666777777777777633 3 46667777777777777765444  66777777777


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCC
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      |++|.|+ .+|  .+..+++|+.|+|++|+|+.+  ..+..+++|+.|+|++|+|+++  ..|..+++|+.|+|++|.+.
T Consensus        94 Ls~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           94 LDENKIK-DLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             CCSSCCC-CCT--TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred             CcCCCCC-CCh--hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence            7777776 444  345677777777777777654  3466777777777777777765  45667777777777777766


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceec
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGT  228 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~  228 (725)
                      .+.+        +..+++|+.|+|++|+|++.  ..+..++ +|+.|++++|.+.+.
T Consensus       167 ~~~~--------l~~l~~L~~L~Ls~N~i~~l--~~l~~l~-~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          167 DIVP--------LAGLTKLQNLYLSKNHISDL--RALAGLK-NLDVLELFSQECLNK  212 (605)
T ss_dssp             CCGG--------GTTCTTCCEEECCSSCCCBC--GGGTTCT-TCSEEECCSEEEECC
T ss_pred             Cchh--------hccCCCCCEEECcCCCCCCC--hHHccCC-CCCEEEccCCcCcCC
Confidence            4332        55667777777777777642  2344544 566666666666543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.82  E-value=5.8e-21  Score=192.08  Aligned_cols=171  Identities=23%  Similarity=0.271  Sum_probs=148.8

Q ss_pred             CcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCcee
Q 048668           11 SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYF   90 (725)
Q Consensus        11 ~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L   90 (725)
                      ++.+++.+++++|.++. ++ .+..+++|++|++++|+++. +| .+..+++|++|+|++|+|+++.+  +.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            56788999999999984 44 68899999999999999984 44 68999999999999999997655  9999999999


Q ss_pred             eccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccC
Q 048668           91 YLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus        91 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l  170 (725)
                      +|++|+++ .+|...  . ++|+.|+|++|+|+++  ..+..+++|++|+|++|+|++++  .+..+++|++|++++|.+
T Consensus        91 ~L~~N~l~-~l~~~~--~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i  162 (263)
T 1xeu_A           91 SVNRNRLK-NLNGIP--S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEI  162 (263)
T ss_dssp             ECCSSCCS-CCTTCC--C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCC
T ss_pred             ECCCCccC-CcCccc--c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcC
Confidence            99999998 677533  3 9999999999999976  35899999999999999999874  688999999999999999


Q ss_pred             CccCCCCcccccccCCCCCCCEEECccCccccc
Q 048668          171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       171 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                      +..        ..+..+++|++|++++|.+++.
T Consensus       163 ~~~--------~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          163 TNT--------GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CBC--------TTSTTCCCCCEEEEEEEEEECC
T ss_pred             cch--------HHhccCCCCCEEeCCCCcccCC
Confidence            865        2367889999999999998844

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1e-19  Score=179.06  Aligned_cols=143  Identities=21%  Similarity=0.288  Sum_probs=133.5

Q ss_pred             ccCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            3 GQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         3 ~~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      ++||..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|.
T Consensus        32 ~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~  109 (229)
T 3e6j_A           32 ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFD  109 (229)
T ss_dssp             SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhC
Confidence            47888777  5999999999999988899999999999999999999988888899999999999999999988888899


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccccc
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGK  149 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~  149 (725)
                      .+++|++|+|++|+|+ .+|..+ ..+++|++|+|++|+|+++.+..|..+++|++|+|++|++...
T Consensus       110 ~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          110 RLVHLKELFMCCNKLT-ELPRGI-ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             TCTTCCEEECCSSCCC-SCCTTG-GGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             cchhhCeEeccCCccc-ccCccc-ccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            9999999999999999 898765 7899999999999999999888999999999999999999854

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=4.5e-20  Score=206.64  Aligned_cols=172  Identities=26%  Similarity=0.338  Sum_probs=122.6

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      ..+++|+.|++++|.|. .++ .|..+++|+.|+|++|+|++..|  |..+++|++|+|++|.|++. | .+..+++|+.
T Consensus        40 ~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~  113 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLKS  113 (605)
T ss_dssp             HHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCCE
T ss_pred             hcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCCE
Confidence            45667777777777776 333 47777777777777777775554  77777777777777777642 2 5777777777


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN  169 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~  169 (725)
                      |+|++|+|+ .++  .+..+++|+.|+|++|+|+++  ..|..+++|+.|+|++|+|+++.+  |..+++|+.|+|++|.
T Consensus       114 L~Ls~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          114 LSLEHNGIS-DIN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             EECTTSCCC-CCG--GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEecCCCCC-CCc--cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence            777777776 443  256777777777777777765  467777777777777777777665  7777777777777777


Q ss_pred             CCccCCCCcccccccCCCCCCCEEECccCcccc
Q 048668          170 LGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG  202 (725)
Q Consensus       170 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  202 (725)
                      ++.++        .+..+++|+.|+|++|.+.+
T Consensus       187 i~~l~--------~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          187 ISDLR--------ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CCBCG--------GGTTCTTCSEEECCSEEEEC
T ss_pred             CCCCh--------HHccCCCCCEEEccCCcCcC
Confidence            76542        25677777777777777764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.81  E-value=1.9e-20  Score=195.36  Aligned_cols=275  Identities=13%  Similarity=0.071  Sum_probs=170.8

Q ss_pred             ccCCccccC--cccCcEEecCCCccCccCCccccC-CCCCcEEEccCCcCC--ccCCCCCCCCCCCCEEEccCCcccccC
Q 048668            3 GQIPKEIGS--LFKLQALALAGNYLTGKLPDFIGN-LSALQVIHIKGNSLG--GKFPTTLGLLRNLVQLNVAENKFYGMF   77 (725)
Q Consensus         3 ~~ip~~~~~--l~~l~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~   77 (725)
                      |+++..+..  +.++++|.++++- ....-..+.. +++|++|||++|++.  ...++.+..   +..+.+..|.   +.
T Consensus        13 g~l~~~l~~~~~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~---~~~~~~~~~~---I~   85 (329)
T 3sb4_A           13 GTLISMMTEEEANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN---GKFYIYMANF---VP   85 (329)
T ss_dssp             TCGGGGSCHHHHHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG---GCCEEECTTE---EC
T ss_pred             CcHHhhccchhhCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCccccccc---cccccccccc---cC
Confidence            445555544  6789999998762 2222334444 889999999999998  444444433   5667777674   45


Q ss_pred             cccccc--------cCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcc----
Q 048668           78 PRSICN--------ISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ----  145 (725)
Q Consensus        78 ~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~----  145 (725)
                      +.+|.+        +++|+.|+|.+ .++ .++..+|.++++|+.|++.+|.++.+.+.+|.++.++..+.++.+.    
T Consensus        86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~  163 (329)
T 3sb4_A           86 AYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRF  163 (329)
T ss_dssp             TTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHT
T ss_pred             HHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhc
Confidence            678888        99999999999 898 8999999999999999999999999999999999889888887743    


Q ss_pred             ccccCccCcccccccC-eeecCCccCCccCC---------CC------------cccccccCCCCCCCEEECccCccccc
Q 048668          146 FKGKVSIDFSSLKILW-RLNLEQNNLGIGAA---------ND------------LGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       146 i~~~~~~~f~~l~~L~-~L~L~~N~l~~~~~---------~~------------~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                      ...+...+|..+..|+ .+.+....-  ++.         ..            ..+......+++|++|+|++|+++..
T Consensus       164 ~~~i~~~~f~~~~~L~~~i~~~~~~~--l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I  241 (329)
T 3sb4_A          164 KNRWEHFAFIEGEPLETTIQVGAMGK--LEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTI  241 (329)
T ss_dssp             STTTTTSCEEESCCCEEEEEECTTCC--HHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEE
T ss_pred             cccccccccccccccceeEEecCCCc--HHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCccee
Confidence            3455666777666666 333332110  000         00            00000001245555666655555543


Q ss_pred             CChhhhhccccceeEEecCccceeccCcccccccCCc-eEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCc
Q 048668          204 LPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLI-ALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLG  282 (725)
Q Consensus       204 ~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  282 (725)
                      .+.+|.++. .|+.+.+.+| +....+.+|.++.+|+ .+++.. .++.+.+.+|.++++|+.|+++.|.++...+.+|.
T Consensus       242 ~~~aF~~~~-~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~  318 (329)
T 3sb4_A          242 PDFTFAQKK-YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG  318 (329)
T ss_dssp             CTTTTTTCT-TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred             cHhhhhCCC-CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence            334444444 5555555554 4444445555555555 555555 45445555555555555555555555544455555


Q ss_pred             CCCCCCEEe
Q 048668          283 NLTKLAKLD  291 (725)
Q Consensus       283 ~l~~L~~L~  291 (725)
                      ++++|+.++
T Consensus       319 ~~~~L~~ly  327 (329)
T 3sb4_A          319 NGVPSKLIY  327 (329)
T ss_dssp             TTCCCCEEE
T ss_pred             CCcchhhhc
Confidence            555555554

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=4e-20  Score=185.41  Aligned_cols=138  Identities=21%  Similarity=0.207  Sum_probs=107.3

Q ss_pred             CCCCCcccccccceEEEEEEECCCceE--EEEEEeeccccc------------------------hHHHHHHHHHHHHcC
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMI--VAVKVINLKQKG------------------------AFRSFVAECEALRNI  586 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  586 (725)
                      -|+..+.||+|+||.||+|++..+|+.  ||||+++.....                        ....+.+|+++++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999998667888  999997543111                        113678999999999


Q ss_pred             CCCcc--cceeeEeecCCCCCcceeeEEEeccCC-C----CHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHH-h
Q 048668          587 RHRNL--IKIITICSSTDFKGVDFKALVFEYMGN-G----SLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH-H  658 (725)
Q Consensus       587 ~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~  658 (725)
                      .|+++  +..+++         +..++||||+++ |    +|.++...         .++..+..++.|++.|++|+| +
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH
Confidence            98864  344432         246899999942 4    67766432         123356789999999999999 8


Q ss_pred             cCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          659 HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       659 ~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      .   +|+||||||+|||++.  .++|+|||+|...
T Consensus       190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             S---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             C---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            8   9999999999999998  9999999999765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.79  E-value=2.6e-19  Score=171.92  Aligned_cols=153  Identities=16%  Similarity=0.175  Sum_probs=81.0

Q ss_pred             cCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           34 GNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        34 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      ..+++|++|++++|+++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..+. .+..+++|+
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~-~l~~l~~L~  115 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIP-NLSGLTSLT  115 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSC-CCTTCTTCC
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccCh-hhcCCCCCC
Confidence            44455555555555555 333 3555555555555555443  222455555555555555555522222 234555555


Q ss_pred             EEEccCceeeeeCCCcccccCccceecCCCcc-ccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCE
Q 048668          114 ELGIGANNFFGLIPDSLSNASNLELLDLSNNQ-FKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKV  192 (725)
Q Consensus       114 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~-i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~  192 (725)
                      +|+|++|++++..+..+..+++|++|+|++|+ ++.++  .+..+++|++|++++|.++.+.        .+..+++|++
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~~--------~l~~l~~L~~  185 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDYR--------GIEDFPKLNQ  185 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCCT--------TGGGCSSCCE
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcChH--------HhccCCCCCE
Confidence            55555555555445555555666666666665 55442  3555566666666666655432        2445566666


Q ss_pred             EECccCccc
Q 048668          193 LSLSDNQFG  201 (725)
Q Consensus       193 L~L~~N~l~  201 (725)
                      |++++|+|.
T Consensus       186 L~l~~N~i~  194 (197)
T 4ezg_A          186 LYAFSQTIG  194 (197)
T ss_dssp             EEECBC---
T ss_pred             EEeeCcccC
Confidence            666666654

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.79  E-value=1.5e-19  Score=172.59  Aligned_cols=137  Identities=23%  Similarity=0.282  Sum_probs=111.6

Q ss_pred             ceecccCCccCCCcch-hhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCC
Q 048668          324 LYLDLSNNLLNGSLPQ-QVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC  402 (725)
Q Consensus       324 ~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  402 (725)
                      ++|++++|.+++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus        32 ~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  111 (192)
T 1w8a_A           32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD  111 (192)
T ss_dssp             SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCS
T ss_pred             CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence            5677777777655553 488899999999999999988899999999999999999999988888899999999999999


Q ss_pred             CcccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCCCCC
Q 048668          403 NNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDEL  460 (725)
Q Consensus       403 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~  460 (725)
                      |+|++..|..|..+++|++|+|++|+|+|.++.......++...+.++...|+.+...
T Consensus       112 N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l  169 (192)
T 1w8a_A          112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV  169 (192)
T ss_dssp             SCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred             CcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHH
Confidence            9999999999999999999999999999888754322223333455666678776544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.78  E-value=6e-20  Score=191.58  Aligned_cols=286  Identities=12%  Similarity=0.094  Sum_probs=180.8

Q ss_pred             CCCCCcEEEccCCcCCccCCCCCCC-CCCCCEEEccCCccc--ccCcccccccCCCceeeccCCCCCCCCChhhhcC---
Q 048668           35 NLSALQVIHIKGNSLGGKFPTTLGL-LRNLVQLNVAENKFY--GMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVN---  108 (725)
Q Consensus        35 ~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~---  108 (725)
                      .+.+++.|.++++- ....-..+.. +++|++|||++|+|.  ...+..+.   .++.+.+..|    .+|..+|.+   
T Consensus        23 ~~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~----~I~~~aF~~~~~   94 (329)
T 3sb4_A           23 EANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMAN----FVPAYAFSNVVN   94 (329)
T ss_dssp             HHHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTT----EECTTTTEEEET
T ss_pred             hhCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCcccccc---cccccccccc----ccCHHHhccccc
Confidence            35688999998752 2121222333 788999999999998  33333333   3566666666    567788888   


Q ss_pred             -----CCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccC----CccCCCCcc
Q 048668          109 -----LPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL----GIGAANDLG  179 (725)
Q Consensus       109 -----l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l----~~~~~~~~~  179 (725)
                           +++|+.|+|.+ .++.+.+.+|.++++|++|++++|.+..+.+.+|.+..++.++.+..+..    ..+..    
T Consensus        95 ~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~----  169 (329)
T 3sb4_A           95 GVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH----  169 (329)
T ss_dssp             TEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT----
T ss_pred             ccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc----
Confidence                 99999999999 89989999999999999999999999999999999988787777766322    11111    


Q ss_pred             cccccCCCCCCC-EEECccCcccccCChhhhhc---cccceeEEecCccceeccCcccccccCCceEEecccccCCCCCh
Q 048668          180 FVTFLTNCSSLK-VLSLSDNQFGGELPHSIANL---SSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPD  255 (725)
Q Consensus       180 ~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  255 (725)
                        ..|.++..|+ .+++....   .++..+...   ...+..+.+.++-...........+++|+.++|++|+++.+.+.
T Consensus       170 --~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~  244 (329)
T 3sb4_A          170 --FAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDF  244 (329)
T ss_dssp             --SCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTT
T ss_pred             --cccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHh
Confidence              2244556666 45444322   222222211   11333333333211111110011245566666666666555555


Q ss_pred             hhcCCCCccEEeccCcccccCCCCCCcCCCCCC-EEeCCCCcCCCccccccccccccccccccccccccceecccCCccC
Q 048668          256 VIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLA-KLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLN  334 (725)
Q Consensus       256 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~  334 (725)
                      +|.++++|+.|+|.+| +....+.+|.++++|+ .+++.+                                     .++
T Consensus       245 aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-------------------------------------~l~  286 (329)
T 3sb4_A          245 TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-------------------------------------SVT  286 (329)
T ss_dssp             TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-------------------------------------TCC
T ss_pred             hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-------------------------------------cce
Confidence            5666666666666555 4444555555555555 555544                                     333


Q ss_pred             CCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEc
Q 048668          335 GSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDI  376 (725)
Q Consensus       335 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  376 (725)
                      ...+.+|.++++|+.++++.|.++...+.+|.++++|+.++.
T Consensus       287 ~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          287 AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            345677888888999998888888777888888888888874

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=1.3e-19  Score=182.25  Aligned_cols=103  Identities=19%  Similarity=0.253  Sum_probs=50.5

Q ss_pred             CCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEE
Q 048668           36 LSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKEL  115 (725)
Q Consensus        36 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  115 (725)
                      +.++..+++++|.+++..  .+..+++|++|++++|.|+. ++ .+..+++|++|+|++|+|+ .++.  +.++++|++|
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~-~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQIS-DLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccC-CChh--hccCCCCCEE
Confidence            344555555555555332  34555555555555555553 22 4555555555555555555 3333  3455555555


Q ss_pred             EccCceeeeeCCCcccccCccceecCCCccccc
Q 048668          116 GIGANNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus       116 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      +|++|+++++.+  +.. ++|++|+|++|+|++
T Consensus        91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~  120 (263)
T 1xeu_A           91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRD  120 (263)
T ss_dssp             ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSB
T ss_pred             ECCCCccCCcCc--ccc-CcccEEEccCCccCC
Confidence            555555544322  111 445555555554443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=7.4e-21  Score=211.82  Aligned_cols=204  Identities=19%  Similarity=0.130  Sum_probs=113.5

Q ss_pred             CCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCcc
Q 048668          185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQ  264 (725)
Q Consensus       185 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  264 (725)
                      ..+++|+.|+|++|+++ .+|..++++. .|+.|++++|......|.           .+..+.+.+.+|..+..+++|+
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~-~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCK-ELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHH-HHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHH-HHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhcc
Confidence            45778888888888887 6788777777 677777655542111110           0011123334455555555555


Q ss_pred             EEe-ccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhc
Q 048668          265 LLG-LYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGN  343 (725)
Q Consensus       265 ~L~-L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~  343 (725)
                      .|+ ++.|.+.           .|..+.+++|.++            .+|..     . ++.|+|++|.+++ +|. |+.
T Consensus       413 ~L~~l~~n~~~-----------~L~~l~l~~n~i~------------~l~~~-----~-L~~L~Ls~n~l~~-lp~-~~~  461 (567)
T 1dce_A          413 AVDPMRAAYLD-----------DLRSKFLLENSVL------------KMEYA-----D-VRVLHLAHKDLTV-LCH-LEQ  461 (567)
T ss_dssp             HHCGGGHHHHH-----------HHHHHHHHHHHHH------------HHHHT-----T-CSEEECTTSCCSS-CCC-GGG
T ss_pred             cCcchhhcccc-----------hhhhhhhhccccc------------ccCcc-----C-ceEEEecCCCCCC-CcC-ccc
Confidence            555 4444332           2333333333322            11111     1 2445555555554 333 666


Q ss_pred             CCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccC-cccccCCCCCCeE
Q 048668          344 LKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF-PKFLENLSFLEFL  422 (725)
Q Consensus       344 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L  422 (725)
                      +++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|
T Consensus       462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L  538 (567)
T 1dce_A          462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL  538 (567)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred             cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence            666666666666666 555566666666666666666664 33 5666666666666666666554 6666666666666


Q ss_pred             EcccccCeeecCC
Q 048668          423 NLSYNHLEGEVPT  435 (725)
Q Consensus       423 ~l~~N~l~~~~p~  435 (725)
                      +|++|++++.+|.
T Consensus       539 ~L~~N~l~~~~~~  551 (567)
T 1dce_A          539 NLQGNSLCQEEGI  551 (567)
T ss_dssp             ECTTSGGGGSSSC
T ss_pred             EecCCcCCCCccH
Confidence            6666666655554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=1.4e-21  Score=217.73  Aligned_cols=204  Identities=18%  Similarity=0.156  Sum_probs=123.7

Q ss_pred             CCCCCCCEEEccCCcccccCcccccccCCCceeeccCCC-------------CCCCCChhhhcCCCCccEEE-ccCceee
Q 048668           58 GLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNR-------------FSGSLPFDIVVNLPNLKELG-IGANNFF  123 (725)
Q Consensus        58 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~~l~~L~~L~-L~~N~i~  123 (725)
                      ..+++|+.|+|++|+++ .+|..++++++|+.|++++|.             +. ..+...+..+++|+.|+ ++.|.+ 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~-~~~~~~l~~l~~L~~L~~l~~n~~-  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL-LYEKETLQYFSTLKAVDPMRAAYL-  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTG-GGHHHHHHHHHHHHHHCGGGHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccc-cCCHHHHHHHHhcccCcchhhccc-
Confidence            45666777777777775 556667777777777776553             22 12223334445555554 333322 


Q ss_pred             eeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCccccc
Q 048668          124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE  203 (725)
Q Consensus       124 ~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  203 (725)
                                .+|+.+.+++|.|+.+++      ..|+.|+|++|.|+.++       . +.++++|++|+|++|+|+ .
T Consensus       423 ----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp-------~-~~~l~~L~~L~Ls~N~l~-~  477 (567)
T 1dce_A          423 ----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLC-------H-LEQLLLVTHLDLSHNRLR-A  477 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCC-------C-GGGGTTCCEEECCSSCCC-C
T ss_pred             ----------chhhhhhhhcccccccCc------cCceEEEecCCCCCCCc-------C-ccccccCcEeecCccccc-c
Confidence                      233344444444443322      13666666666666432       2 456667777777777776 5


Q ss_pred             CChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCC-ChhhcCCCCccEEeccCcccccCCCCC--
Q 048668          204 LPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTI-PDVIGELKNLQLLGLYKNFLQGSIPSG--  280 (725)
Q Consensus       204 ~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~--  280 (725)
                      +|..+..++ .|+.|++++|.|++ +| .++.+++|++|+|++|+|++.. |..|..+++|++|+|++|.+++.+|..  
T Consensus       478 lp~~~~~l~-~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  554 (567)
T 1dce_A          478 LPPALAALR-CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER  554 (567)
T ss_dssp             CCGGGGGCT-TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred             cchhhhcCC-CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence            566666555 56666666666664 44 6777778888888888888776 777888888888888888887654432  


Q ss_pred             -CcCCCCCCEEeC
Q 048668          281 -LGNLTKLAKLDL  292 (725)
Q Consensus       281 -~~~l~~L~~L~L  292 (725)
                       +..+++|+.|++
T Consensus       555 l~~~lp~L~~L~l  567 (567)
T 1dce_A          555 LAEMLPSVSSILT  567 (567)
T ss_dssp             HHHHCTTCSEEEC
T ss_pred             HHHHCcccCccCC
Confidence             223677777754

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.77  E-value=1.3e-17  Score=177.53  Aligned_cols=245  Identities=11%  Similarity=0.120  Sum_probs=156.0

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      ..++++.+.++ ++.+...+|.+. +|+.+++..+ ++.+...+|.+. +|+.+.|.. .++.+.+.+|.++++|+.+++
T Consensus       113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            45666666553 443555677774 6888887766 666777777774 688888874 666677778888888888888


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCc
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGI  172 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~  172 (725)
                      ++|+++ .++..+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ ++|+.+.+ .+.++.
T Consensus       188 ~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~  261 (401)
T 4fdw_A          188 SKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN  261 (401)
T ss_dssp             TTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred             CCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence            888887 77777776 477888888744 77777778888888888888764 66777777777 67777777 445555


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCC
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGT  252 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  252 (725)
                      ++.      .+|.++++|+.+++.+|.+..                    +.+....+.+|.++.+|+.+.|. +.+..+
T Consensus       262 I~~------~aF~~c~~L~~l~l~~~~~~~--------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I  314 (401)
T 4fdw_A          262 IAS------RAFYYCPELAEVTTYGSTFND--------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRIL  314 (401)
T ss_dssp             ECT------TTTTTCTTCCEEEEESSCCCC--------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEE
T ss_pred             ECh------hHhhCCCCCCEEEeCCccccC--------------------CcccEECHHHhhCCccCCeEEeC-CceEEE
Confidence            544      456777788888877776540                    00011233444555555555554 234444


Q ss_pred             CChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcC
Q 048668          253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSL  297 (725)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  297 (725)
                      ...+|.++++|+.++|..| ++.....+|.++ +|+.+++.+|.+
T Consensus       315 ~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~  357 (401)
T 4fdw_A          315 GQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP  357 (401)
T ss_dssp             CTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred             hhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence            4555555555555555333 333444455555 555555555543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=1.7e-19  Score=207.18  Aligned_cols=162  Identities=19%  Similarity=0.211  Sum_probs=104.3

Q ss_pred             ccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccc
Q 048668           68 VAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus        68 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                      ++.|.+. ..+..|..+++|+.|+|++|+|+ .+|..+| .+++|++|+|++|.|+ .+|..|..+++|++|||++|+|+
T Consensus       208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~  283 (727)
T 4b8c_D          208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT  283 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred             cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence            3344444 55667777777777777777777 7776665 6777777777777777 45667777888888888888887


Q ss_pred             ccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCcccee
Q 048668          148 GKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISG  227 (725)
Q Consensus       148 ~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~  227 (725)
                      .+ +..|..+++|++|+|++|.|+.++       ..|.++++|++|+|++|.|++.+|..+.........+++.+|.+++
T Consensus       284 ~l-p~~~~~l~~L~~L~L~~N~l~~lp-------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~  355 (727)
T 4b8c_D          284 SL-PAELGSCFQLKYFYFFDNMVTTLP-------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI  355 (727)
T ss_dssp             SC-CSSGGGGTTCSEEECCSSCCCCCC-------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             cc-ChhhcCCCCCCEEECCCCCCCccC-------hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence            55 556777888888888888776543       3367888999999999999988888887765444456677777777


Q ss_pred             ccCcccccccCCceEEeccc
Q 048668          228 TIPLGIRNLVNLIALAVEVN  247 (725)
Q Consensus       228 ~~~~~~~~l~~L~~L~L~~N  247 (725)
                      .+|..      |..|+++.|
T Consensus       356 ~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          356 PLPHE------RRFIEINTD  369 (727)
T ss_dssp             CCCCC---------------
T ss_pred             cCccc------cceeEeecc
Confidence            66654      334555555

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=5.2e-19  Score=169.78  Aligned_cols=153  Identities=15%  Similarity=0.183  Sum_probs=95.1

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      ..+++|++|++++|.|+ .+| .+..+++|++|++++|.++  .+..|..+++|++|+|++|++++..+..|..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            44556667777777666 444 4666666777777776554  2235666667777777777666656666666667777


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCce-eeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANN-FFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQN  168 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N  168 (725)
                      |+|++|++++..| ..+..+++|++|+|++|. ++.+ + .+..+++|++|++++|+|+++.  .+..+++|++|++++|
T Consensus       117 L~Ls~n~i~~~~~-~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          117 LDISHSAHDDSIL-TKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EECCSSBCBGGGH-HHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC
T ss_pred             EEecCCccCcHhH-HHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCc
Confidence            7777776663223 344566677777777666 5443 2 4666666777777777666544  5666666777777766


Q ss_pred             cCC
Q 048668          169 NLG  171 (725)
Q Consensus       169 ~l~  171 (725)
                      ++.
T Consensus       192 ~i~  194 (197)
T 4ezg_A          192 TIG  194 (197)
T ss_dssp             ---
T ss_pred             ccC
Confidence            654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.76  E-value=1.8e-18  Score=161.39  Aligned_cols=135  Identities=18%  Similarity=0.227  Sum_probs=92.4

Q ss_pred             ccCcEEecCCCccC-ccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           13 FKLQALALAGNYLT-GKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        13 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|++++.  ..|..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            46777777777776 56676677777777777777777654  6677777777777777777766666666777777777


Q ss_pred             ccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCC---CcccccCccceecCCCccccccC
Q 048668           92 LTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIP---DSLSNASNLELLDLSNNQFKGKV  150 (725)
Q Consensus        92 L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~Ls~N~i~~~~  150 (725)
                      |++|+|+ .+|. ..+..+++|++|++++|.+++..+   ..|..+++|++|++++|.+..++
T Consensus       102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A          102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             CBSSSCC-SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             ccCCccC-cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence            7777776 5442 445666666667666666665544   35666666666666666665544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=5.1e-18  Score=161.90  Aligned_cols=130  Identities=23%  Similarity=0.356  Sum_probs=103.8

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCC-CCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPT-TLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      .+++++++|+++ .+|..+..  +|++|++++|++++..+. .|+.+++|++|+|++|+|+++.|..|.++++|++|+|+
T Consensus        10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls   86 (192)
T 1w8a_A           10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence            378888888886 67765543  788888888888866664 47888888888888888887778888888888888888


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      +|+|+ .++...|.++++|++|+|++|+|+++.|..|..+++|++|+|++|++++
T Consensus        87 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           87 ENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             SCCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCcCC-ccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            88887 6666667778888888888888888888888888888888888888774

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=5e-17  Score=173.05  Aligned_cols=247  Identities=11%  Similarity=0.081  Sum_probs=202.6

Q ss_pred             cccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCC
Q 048668            8 EIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSL   87 (725)
Q Consensus         8 ~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   87 (725)
                      .|.++ +|+++.+.++ ++.+...+|.+. +|+.+.+.. .++.+.+.+|.++++|+.++|++|+++.+...+|. .++|
T Consensus       131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L  205 (401)
T 4fdw_A          131 AFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI  205 (401)
T ss_dssp             TTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred             hcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence            44554 7999999887 775667789984 799999996 78888899999999999999999999988888998 5899


Q ss_pred             ceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCC
Q 048668           88 EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ  167 (725)
Q Consensus        88 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~  167 (725)
                      +.+.|..+ ++ .++..+|.++++|+.+++..| ++.+...+|.+ .+|+.++| .|.++.+...+|.++++|+.+++.+
T Consensus       206 ~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~  280 (401)
T 4fdw_A          206 EEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYG  280 (401)
T ss_dssp             SEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEES
T ss_pred             CEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCC
Confidence            99999955 87 899999999999999999975 78888899988 89999999 6778899999999999999999999


Q ss_pred             ccCC-----ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceE
Q 048668          168 NNLG-----IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL  242 (725)
Q Consensus       168 N~l~-----~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L  242 (725)
                      |.+.     .++.      .+|.++++|+.+++.+ .++.                         ....+|.++.+|+.+
T Consensus       281 ~~~~~~~~~~I~~------~aF~~c~~L~~l~l~~-~i~~-------------------------I~~~aF~~c~~L~~l  328 (401)
T 4fdw_A          281 STFNDDPEAMIHP------YCLEGCPKLARFEIPE-SIRI-------------------------LGQGLLGGNRKVTQL  328 (401)
T ss_dssp             SCCCCCTTCEECT------TTTTTCTTCCEECCCT-TCCE-------------------------ECTTTTTTCCSCCEE
T ss_pred             ccccCCcccEECH------HHhhCCccCCeEEeCC-ceEE-------------------------EhhhhhcCCCCccEE
Confidence            8875     2332      5678888899888873 3552                         234566777778888


Q ss_pred             EecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCC-CCCEEeCCCCcCC
Q 048668          243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLT-KLAKLDLGSNSLQ  298 (725)
Q Consensus       243 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  298 (725)
                      .|..| ++.+...+|.++ +|+.+++.+|.+....+..|.+++ .++.|++..+.+.
T Consensus       329 ~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          329 TIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             EECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            88544 666777788888 888888888887766677777774 6788888777543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=3.7e-18  Score=162.85  Aligned_cols=136  Identities=24%  Similarity=0.281  Sum_probs=110.9

Q ss_pred             ceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCC
Q 048668          324 LYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCN  403 (725)
Q Consensus       324 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  403 (725)
                      ++|++++|.++ .+|..|..+++|+.|+|++|.|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus        34 ~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N  112 (193)
T 2wfh_A           34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN  112 (193)
T ss_dssp             CEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCC
Confidence            66777777777 56688999999999999999999888899999999999999999999988889999999999999999


Q ss_pred             cccccCcccccCCCCCCeEEcccccCeeecCCCCccCCCCCcCccCCccccCCCCCC
Q 048668          404 NFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDEL  460 (725)
Q Consensus       404 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~  460 (725)
                      +|++..+..|..+++|+.|+|++|+|.|.+........+.......+...|..|...
T Consensus       113 ~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P~~l  169 (193)
T 2wfh_A          113 DISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPGEM  169 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEESGGG
T ss_pred             CCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCchHH
Confidence            999888888999999999999999999887643211111111222334567766544

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.73  E-value=1.1e-16  Score=171.17  Aligned_cols=333  Identities=12%  Similarity=0.082  Sum_probs=179.5

Q ss_pred             cCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChh
Q 048668           25 LTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFD  104 (725)
Q Consensus        25 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  104 (725)
                      ++.+-..+|.++++|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +. .++..
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecce
Confidence            4444456788888888888864 477677778888888888888754 66577778888888888777655 44 66666


Q ss_pred             hhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCccccccc
Q 048668          105 IVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL  184 (725)
Q Consensus       105 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  184 (725)
                      +|.+...+.......  +..+...+|.++.+|+.+.+.++ +..+...+|.++.+|+.+.+..| ++.+..      .+|
T Consensus       135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~------~~F  204 (394)
T 4fs7_A          135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRD------YCF  204 (394)
T ss_dssp             TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECT------TTT
T ss_pred             eeecccccccccCcc--ccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCc------hhh
Confidence            776665444333322  23355667888888888888655 34577777887777887777665 443333      345


Q ss_pred             CCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCcc
Q 048668          185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQ  264 (725)
Q Consensus       185 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  264 (725)
                      .++..|+.+.+..+...  +...                         .....+|+.+.+..+ +..+...+|.++..|+
T Consensus       205 ~~~~~L~~i~~~~~~~~--i~~~-------------------------~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~  256 (394)
T 4fs7_A          205 AECILLENMEFPNSLYY--LGDF-------------------------ALSKTGVKNIIIPDS-FTELGKSVFYGCTDLE  256 (394)
T ss_dssp             TTCTTCCBCCCCTTCCE--ECTT-------------------------TTTTCCCCEEEECTT-CCEECSSTTTTCSSCC
T ss_pred             ccccccceeecCCCceE--eehh-------------------------hcccCCCceEEECCC-ceecccccccccccce
Confidence            66677776666555432  1111                         112233444444322 2223344555555555


Q ss_pred             EEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcC
Q 048668          265 LLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL  344 (725)
Q Consensus       265 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l  344 (725)
                      .+.+..+... .....|.....++.+....+               .++...+.....++.+.+.++ ++.....+|.++
T Consensus       257 ~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~---------------~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c  319 (394)
T 4fs7_A          257 SISIQNNKLR-IGGSLFYNCSGLKKVIYGSV---------------IVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESC  319 (394)
T ss_dssp             EEEECCTTCE-ECSCTTTTCTTCCEEEECSS---------------EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC
T ss_pred             eEEcCCCcce-eeccccccccccceeccCce---------------eeccccccccccccccccccc-cceechhhhcCC
Confidence            5555554332 33444555555544444333               122222211111122333222 222233445555


Q ss_pred             CCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCC
Q 048668          345 KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLE  420 (725)
Q Consensus       345 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  420 (725)
                      .+|+.++|..+ ++.....+|.++.+|+.+++..| ++.+...+|.++.+|+.+++..+ ++ .+..+|.+.++|+
T Consensus       320 ~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~  391 (394)
T 4fs7_A          320 TSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFK  391 (394)
T ss_dssp             TTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEE
T ss_pred             CCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCc
Confidence            55555555432 44344455555555555555544 44444455555555555555433 22 2234454444444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=1.2e-18  Score=200.09  Aligned_cols=181  Identities=25%  Similarity=0.274  Sum_probs=87.4

Q ss_pred             ccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccc
Q 048668          228 TIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK  307 (725)
Q Consensus       228 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  307 (725)
                      ..+..+..+.+|+.|+|++|.+.. +|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+         
T Consensus       215 ~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~---------  283 (727)
T 4b8c_D          215 MPKDSKYDDQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT---------  283 (727)
T ss_dssp             -------CCCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS---------
T ss_pred             cChhhhccCCCCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC---------
Confidence            334555556666666666666653 3333445666666666666666 55555666666666666666554         


Q ss_pred             ccccccccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccC-CcEEEccCCccccccC
Q 048668          308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVS-LEYVDISSNCFHGIIP  386 (725)
Q Consensus       308 ~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~  386 (725)
                         .+|..+..+..+ ++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus       284 ---~lp~~~~~l~~L-~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          284 ---SLPAELGSCFQL-KYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             ---SCCSSGGGGTTC-SEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             ---ccChhhcCCCCC-CEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence               455555555554 56666666665 45556777777777777777777777776654322 2346777777777666


Q ss_pred             ccccCCCCCCEEeCCCC--------cccccCcccccCCCCCCeEEcccccCe
Q 048668          387 PSLGFLKSIKFLDVSCN--------NFSGQFPKFLENLSFLEFLNLSYNHLE  430 (725)
Q Consensus       387 ~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~l~~N~l~  430 (725)
                      ..      |+.|++++|        .+.+..+..+..+..+....+++|.+.
T Consensus       359 ~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          359 HE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             CC-----------------------------------------------CCC
T ss_pred             cc------cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence            53      445556666        333344444555555666666666664

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=1.9e-17  Score=157.92  Aligned_cols=127  Identities=20%  Similarity=0.302  Sum_probs=82.3

Q ss_pred             cEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCC
Q 048668           16 QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSN   95 (725)
Q Consensus        16 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N   95 (725)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            56667777766 4555443  46666777777665 45566666666666776666666666666666666666666666


Q ss_pred             CCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccc
Q 048668           96 RFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus        96 ~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                      +|+ .++...|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|++.
T Consensus        89 ~l~-~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           89 RLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCC-BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             ccC-EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            666 555555666666666666666666665556666666666666666665

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.72  E-value=9.1e-18  Score=153.19  Aligned_cols=127  Identities=20%  Similarity=0.247  Sum_probs=80.3

Q ss_pred             ccCcEEecCCCccC-ccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceee
Q 048668           13 FKLQALALAGNYLT-GKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFY   91 (725)
Q Consensus        13 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   91 (725)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|++++.  ..|+.+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            46777777777776 56666667777777777777777644  5666677777777777777655666666667777777


Q ss_pred             ccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCC---CcccccCccceecCC
Q 048668           92 LTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIP---DSLSNASNLELLDLS  142 (725)
Q Consensus        92 L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~Ls  142 (725)
                      +++|+++ .+|. ..+..+++|++|++++|.+++..+   ..+..+++|++||++
T Consensus        95 ls~N~i~-~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIK-DLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCC-SHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCC-ChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            7777766 4331 334555566666666666555444   345555555555554

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=1.3e-17  Score=155.50  Aligned_cols=137  Identities=20%  Similarity=0.228  Sum_probs=110.2

Q ss_pred             CCCCCcEEEccCCcCC-ccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           35 NLSALQVIHIKGNSLG-GKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        35 ~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      ..++|++|++++|+++ +.+|..|..+++|++|+|++|.|++.  ..|..+++|++|+|++|++++.+| ..+..+++|+
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~   98 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLD-MLAEKLPNLT   98 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCC-HHHHHCTTCC
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHH-HHHhhCCCCC
Confidence            3478999999999997 67788888999999999999999865  778889999999999999984444 4556788999


Q ss_pred             EEEccCceeeeeCC-CcccccCccceecCCCccccccCc---cCcccccccCeeecCCccCCccC
Q 048668          114 ELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVS---IDFSSLKILWRLNLEQNNLGIGA  174 (725)
Q Consensus       114 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~---~~f~~l~~L~~L~L~~N~l~~~~  174 (725)
                      +|+|++|+|+++.. ..+..+++|++|++++|+++++++   ..|..+++|++|++++|.+...+
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence            99999999887643 678888889999999998887766   46777777777777777766544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.71  E-value=6e-17  Score=152.43  Aligned_cols=131  Identities=21%  Similarity=0.291  Sum_probs=105.4

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      .+.+++++|+++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            678888888887 5565443  6888888888888877777788888888888888888877777788888888888888


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccccc
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGK  149 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~  149 (725)
                      |+|+ .+|...|..+++|++|+|++|+++++.+..|..+++|++|+|++|++.+.
T Consensus        86 N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           86 NKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCcc-ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            8887 77777777888888888888888877777778888888888888887753

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.70  E-value=1.4e-15  Score=162.63  Aligned_cols=328  Identities=11%  Similarity=0.053  Sum_probs=224.0

Q ss_pred             cccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCC
Q 048668            8 EIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSL   87 (725)
Q Consensus         8 ~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   87 (725)
                      +|.++++|+++.|..+ ++.+...+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++..+
T Consensus        66 AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~  142 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK  142 (394)
T ss_dssp             TTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred             HhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence            4678899999999754 77566779999999999999865 77788899999999999988755 555788899988765


Q ss_pred             ceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCC
Q 048668           88 EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQ  167 (725)
Q Consensus        88 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~  167 (725)
                      +.......  . .+...+|.++.+|+.+.+..+. ..+...+|.++.+|+.+++..| ++.+...+|.....|+.+.+..
T Consensus       143 ~~~~~~~~--~-~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~  217 (394)
T 4fs7_A          143 EITIPEGV--T-VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN  217 (394)
T ss_dssp             EEECCTTC--C-EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred             ccccCccc--c-ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence            55544433  3 6677889999999999998664 5588889999999999999887 7788999999999999999887


Q ss_pred             ccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEeccc
Q 048668          168 NNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN  247 (725)
Q Consensus       168 N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N  247 (725)
                      +.....        +......+|+.+.+..+. +......+.... .++.+.+..+... .....|..+..++.+.+..+
T Consensus       218 ~~~~i~--------~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~-~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~  286 (394)
T 4fs7_A          218 SLYYLG--------DFALSKTGVKNIIIPDSF-TELGKSVFYGCT-DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV  286 (394)
T ss_dssp             TCCEEC--------TTTTTTCCCCEEEECTTC-CEECSSTTTTCS-SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred             CceEee--------hhhcccCCCceEEECCCc-eecccccccccc-cceeEEcCCCcce-eeccccccccccceeccCce
Confidence            765432        123345678888876443 222233333333 4444444444332 33444445555555544443


Q ss_pred             ccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceec
Q 048668          248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLD  327 (725)
Q Consensus       248 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~  327 (725)
                      .+   ...+|..+.+|+.+.+..+ ++.....+|.++.+|+.+++                                   
T Consensus       287 ~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~l-----------------------------------  327 (394)
T 4fs7_A          287 IV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDL-----------------------------------  327 (394)
T ss_dssp             EE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECC-----------------------------------
T ss_pred             ee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEe-----------------------------------
Confidence            32   2334445555555555433 33333444445555544444                                   


Q ss_pred             ccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEE
Q 048668          328 LSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFL  398 (725)
Q Consensus       328 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  398 (725)
                       .++ ++.....+|.++.+|+.+++..| ++.....+|.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       328 -p~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          328 -PYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             -CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             -CCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence             322 33344567888888999988776 66667788999999999998765 33 345678888887764

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.69  E-value=3.8e-17  Score=149.06  Aligned_cols=129  Identities=22%  Similarity=0.255  Sum_probs=110.9

Q ss_pred             CCCCCcEEEccCCcCC-ccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           35 NLSALQVIHIKGNSLG-GKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        35 ~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      ..++|++|++++|+++ +..|..|..+++|++|+|++|.+++.  ..+..+++|++|++++|++++.+| ..+..+++|+
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~   91 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLE-VLAEKCPNLT   91 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTH-HHHHHCTTCC
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHH-HHhhhCCCCC
Confidence            4478999999999998 78888999999999999999999866  789999999999999999984455 4566799999


Q ss_pred             EEEccCceeeeeC-CCcccccCccceecCCCccccccCc---cCcccccccCeeecC
Q 048668          114 ELGIGANNFFGLI-PDSLSNASNLELLDLSNNQFKGKVS---IDFSSLKILWRLNLE  166 (725)
Q Consensus       114 ~L~L~~N~i~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~~---~~f~~l~~L~~L~L~  166 (725)
                      +|++++|+++++. +..+..+++|++|++++|+++++++   ..|..+++|++|+++
T Consensus        92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            9999999998753 4778999999999999999998876   567778888887775

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=2e-16  Score=148.91  Aligned_cols=129  Identities=22%  Similarity=0.261  Sum_probs=95.2

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      ..+.+++++|+++ .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|+|+ .+|...|.++++|++|+|
T Consensus         8 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l   83 (177)
T 2o6r_A            8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYL   83 (177)
T ss_dssp             ETTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEEC
Confidence            3567888888887 4444433  67888888888888777777888888888888888887 777777777888888888


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccC
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l  170 (725)
                      ++|+|+++.+..|..+++|++|+|++|+|+++++..|..+++|++|++++|.+
T Consensus        84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  136 (177)
T 2o6r_A           84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  136 (177)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCe
Confidence            88888877777777778888888888887776665555555555555555544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.68  E-value=5.9e-17  Score=152.30  Aligned_cols=135  Identities=20%  Similarity=0.209  Sum_probs=74.0

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +.++.+|++|++++|+++ .+|......++|++|++++|++++.  ..|..+++|++|+|++|+|+++.+..|..+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            444556666666666665 3343222233666666666666544  4556666666666666666655445556666666


Q ss_pred             eeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCCC---cccccCccceecCCCcccc
Q 048668           89 YFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIPD---SLSNASNLELLDLSNNQFK  147 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~---~~~~l~~L~~L~Ls~N~i~  147 (725)
                      +|+|++|+|+ .+|. ..+..+++|+.|++++|.++.+.+.   .+..+++|++||+++|.+.
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            6666666664 4543 2344555555555555555533211   2555555555555555544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.67  E-value=2.5e-17  Score=170.74  Aligned_cols=139  Identities=14%  Similarity=0.165  Sum_probs=99.6

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc--------------chHHH--------HHHHHHHHHcC
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK--------------GAFRS--------FVAECEALRNI  586 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l  586 (725)
                      ....-|++.+.||+|+||.||+|.+. +|+.||||+++....              .....        ..+|...|.++
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            33344888999999999999999985 789999999753210              00111        23456666666


Q ss_pred             CCCccc--ceeeEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 048668          587 RHRNLI--KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPM  664 (725)
Q Consensus       587 ~h~niv--~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  664 (725)
                      .+.++.  ..+++         ...++||||++|+++.++...          +  ....++.|++.++.|+|.+   +|
T Consensus       171 ~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~----------~--~~~~l~~qll~~l~~lH~~---gI  226 (397)
T 4gyi_A          171 YEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV----------P--DPASLYADLIALILRLAKH---GL  226 (397)
T ss_dssp             HHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC----------S--CHHHHHHHHHHHHHHHHHT---TE
T ss_pred             HhcCCCCCeeeec---------cCceEEEEecCCccHhhhccc----------H--HHHHHHHHHHHHHHHHHHC---CC
Confidence            444332  22221         134799999999888765321          1  2346789999999999998   99


Q ss_pred             EecCCCCCCeeecCCC----------ceEEcccccccc
Q 048668          665 VHGDLKPSNVLLDHDM----------VAHVGDFGLAKF  692 (725)
Q Consensus       665 vHrdlkp~Nill~~~~----------~~kl~Dfgla~~  692 (725)
                      |||||||.|||+++++          .+.|+||+-+..
T Consensus       227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999999998876          389999997754

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.66  E-value=9.3e-17  Score=150.94  Aligned_cols=135  Identities=17%  Similarity=0.227  Sum_probs=99.1

Q ss_pred             ccccCCCCCcEEEccCCcCCccCCCCCCCC-CCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCC
Q 048668           31 DFIGNLSALQVIHIKGNSLGGKFPTTLGLL-RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNL  109 (725)
Q Consensus        31 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l  109 (725)
                      ..+.++++|++|++++|+++.+ |. +..+ ++|++|+|++|+|+++  ..|..+++|++|+|++|+|+ .+|..+|..+
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l   87 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQAL   87 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHC
T ss_pred             HhcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcC
Confidence            3467788899999999999844 54 4444 4899999999998865  57888888888888888887 7777777788


Q ss_pred             CCccEEEccCceeeeeCC-CcccccCccceecCCCccccccCcc---CcccccccCeeecCCccC
Q 048668          110 PNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVSI---DFSSLKILWRLNLEQNNL  170 (725)
Q Consensus       110 ~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~---~f~~l~~L~~L~L~~N~l  170 (725)
                      ++|++|+|++|+|+.+.+ ..+..+++|++|++++|+++.++..   .+..+++|++|+++.|.+
T Consensus        88 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           88 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             CCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence            888888888888865432 2677888888888888888765432   344555555555555443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.62  E-value=3.5e-18  Score=164.11  Aligned_cols=137  Identities=21%  Similarity=0.228  Sum_probs=105.3

Q ss_pred             ccCcccCcEEecCCCccCccCCc------cccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPD------FIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      +.....++.++++.+.+.+..|.      .|..+++|++|++++|++++ +| .|..+++|++|+|++|+|+ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            34456778888888888877776      78888888888888888875 55 7888888888888888887 5666777


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC-CcccccCccceecCCCccccccCc
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVS  151 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~  151 (725)
                      .+++|++|+|++|+|+ .+|  .+..+++|++|+|++|+++.+.+ ..+..+++|++|++++|++++..+
T Consensus        91 ~~~~L~~L~L~~N~l~-~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A           91 VADTLEELWISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHHHCSEEEEEEEECC-CHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             cCCcCCEEECcCCcCC-cCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence            7788888888888887 565  35677888888888888876543 467778888888888888876544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.59  E-value=1.1e-13  Score=148.02  Aligned_cols=335  Identities=11%  Similarity=0.107  Sum_probs=197.3

Q ss_pred             cCccCCccccCCC-CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCc---ccccCcccccccCCCceeeccCCCCCCC
Q 048668           25 LTGKLPDFIGNLS-ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENK---FYGMFPRSICNISSLEYFYLTSNRFSGS  100 (725)
Q Consensus        25 l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~L~~N~l~~~  100 (725)
                      ++.+-..+|.+.. .|+.+.+-.+ ++.+...+|.++.+|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++ .
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~  127 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-E  127 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-E
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-e
Confidence            3434445777764 5888888754 777888888888888888888764   66677788888888888888765 55 7


Q ss_pred             CChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCccc
Q 048668          101 LPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGF  180 (725)
Q Consensus       101 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~  180 (725)
                      ++..+|.+..+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ ++.+...+|.. ..|+.+.+..+-.. +..     
T Consensus       128 I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~-----  198 (394)
T 4gt6_A          128 IDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGT-----  198 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECT-----
T ss_pred             ehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-ccc-----
Confidence            78888888888888888644 45577778888888888888655 66677778865 56888877665432 222     


Q ss_pred             ccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCC
Q 048668          181 VTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGEL  260 (725)
Q Consensus       181 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  260 (725)
                       .++.++.+++......+... .....+..........           ...+.....+..+.+. +.+..+...+|.++
T Consensus       199 -~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c  264 (394)
T 4gt6_A          199 -NAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYA-----------LIRYPSQREDPAFKIP-NGVARIETHAFDSC  264 (394)
T ss_dssp             -TTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEE-----------EEECCTTCCCSEEECC-TTEEEECTTTTTTC
T ss_pred             -chhhhccccceecccccccc-cccceeeccccccccc-----------ccccccccccceEEcC-CcceEcccceeeec
Confidence             34667777777776665544 1111111111000000           0001111223333332 22333445666667


Q ss_pred             CCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchh
Q 048668          261 KNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQ  340 (725)
Q Consensus       261 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~  340 (725)
                      .+|+.+.+..+... ....+|.++++|+.+.+..+ ++            .                        .....
T Consensus       265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~~-i~------------~------------------------I~~~a  306 (394)
T 4gt6_A          265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSSR-IT------------E------------------------LPESV  306 (394)
T ss_dssp             SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCTT-CC------------E------------------------ECTTT
T ss_pred             ccccEEecccccce-ecCcccccccccccccCCCc-cc------------c------------------------cCcee
Confidence            77777776655433 44555666666666665422 11            1                        22344


Q ss_pred             hhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCC
Q 048668          341 VGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLE  420 (725)
Q Consensus       341 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  420 (725)
                      |.++.+|+.++|..+ ++.....+|.+|.+|+.+.+..+ ++.+-..+|.++++|+.+++.+|....   .++.....|+
T Consensus       307 F~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~  381 (394)
T 4gt6_A          307 FAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQ  381 (394)
T ss_dssp             TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-
T ss_pred             ecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCC
Confidence            555666666666543 44444566666667777776543 554555666777777777776665431   3455556666


Q ss_pred             eEEccccc
Q 048668          421 FLNLSYNH  428 (725)
Q Consensus       421 ~L~l~~N~  428 (725)
                      .+.+..|.
T Consensus       382 ~i~i~~~~  389 (394)
T 4gt6_A          382 NLPVAPGS  389 (394)
T ss_dssp             --------
T ss_pred             EEEeCCCC
Confidence            66655544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=7.8e-15  Score=136.65  Aligned_cols=105  Identities=21%  Similarity=0.325  Sum_probs=56.0

Q ss_pred             cEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccC
Q 048668           40 QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA  119 (725)
Q Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  119 (725)
                      ++|++++|+|+ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|..+|.++++|++|+|++
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCC
Confidence            44555555554 2333332  44555555555555544555555555555555555555 45555555555555555555


Q ss_pred             ceeeeeCCCcccccCccceecCCCccccc
Q 048668          120 NNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus       120 N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      |+|+++.+..|..+++|++|+|++|+++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            55555555555566666666666666553

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=1e-14  Score=135.77  Aligned_cols=108  Identities=19%  Similarity=0.241  Sum_probs=100.1

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      ..++|++++|.++ .+|..+.  ++|++|+|++|+|+++.|..|..+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            4689999999999 6787664  899999999999999999999999999999999999998888899999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeee
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGL  125 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~  125 (725)
                      +|+|+ .+|...|..+++|++|+|++|.++..
T Consensus        87 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLK-SIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCC-CCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccC-EeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            99998 88888889999999999999999754

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.56  E-value=1.3e-14  Score=135.58  Aligned_cols=105  Identities=18%  Similarity=0.351  Sum_probs=61.3

Q ss_pred             cEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccC
Q 048668           40 QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA  119 (725)
Q Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  119 (725)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|..+|.++++|++|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCC
Confidence            45555555554 3344333  45556666666665555555666666666666666665 55555555566666666666


Q ss_pred             ceeeeeCCCcccccCccceecCCCccccc
Q 048668          120 NNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus       120 N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      |+|+++.+..|..+++|++|+|++|++..
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccc
Confidence            66665555556666666666666666653

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=7e-17  Score=154.95  Aligned_cols=140  Identities=20%  Similarity=0.339  Sum_probs=122.0

Q ss_pred             CcccCCc------cccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccc
Q 048668            1 LEGQIPK------EIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFY   74 (725)
Q Consensus         1 ~~~~ip~------~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~   74 (725)
                      ++|.+|+      .+..+++|++|+|++|++++ +| .+..+++|++|++++|+++ .+|..+..+++|++|+|++|+++
T Consensus        30 l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~  106 (198)
T 1ds9_A           30 LHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA  106 (198)
T ss_dssp             CCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC
T ss_pred             eccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCC
Confidence            3566776      89999999999999999995 67 8999999999999999998 67888888899999999999998


Q ss_pred             ccCcccccccCCCceeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCCCc----------ccccCccceecCCC
Q 048668           75 GMFPRSICNISSLEYFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIPDS----------LSNASNLELLDLSN  143 (725)
Q Consensus        75 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~----------~~~l~~L~~L~Ls~  143 (725)
                      + +| .+..+++|++|++++|+|+ .++. ..+..+++|++|++++|.+++..|..          +..+++|++||  +
T Consensus       107 ~-l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~  181 (198)
T 1ds9_A          107 S-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--G  181 (198)
T ss_dssp             C-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--C
T ss_pred             c-CC-ccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--C
Confidence            6 44 6999999999999999998 6664 56789999999999999998776653          78888888887  7


Q ss_pred             ccccc
Q 048668          144 NQFKG  148 (725)
Q Consensus       144 N~i~~  148 (725)
                      |.++.
T Consensus       182 ~~i~~  186 (198)
T 1ds9_A          182 MPVDV  186 (198)
T ss_dssp             GGGTT
T ss_pred             cccCH
Confidence            77764

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=2e-14  Score=134.34  Aligned_cols=107  Identities=21%  Similarity=0.195  Sum_probs=99.2

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccC
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~   94 (725)
                      -+.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            479999999997 7887665  8999999999999999999999999999999999999988888899999999999999


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeee
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGL  125 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~  125 (725)
                      |+|+ .+|...|..+++|+.|+|++|.+...
T Consensus        91 N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLK-SIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCC-CCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             Cccc-eeCHHHhccccCCCEEEeCCCCcccc
Confidence            9998 88888889999999999999999844

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.53  E-value=1.1e-12  Score=140.15  Aligned_cols=329  Identities=10%  Similarity=0.096  Sum_probs=229.1

Q ss_pred             ccCcc-cCcEEecCCCccCccCCccccCCCCCcEEEccCCc---CCccCCCCCCCCCCCCEEEccCCcccccCccccccc
Q 048668            9 IGSLF-KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNS---LGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNI   84 (725)
Q Consensus         9 ~~~l~-~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l   84 (725)
                      |.+++ .|+++.+-.+ ++.+-..+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++.+...+|.++
T Consensus        59 F~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c  136 (394)
T 4gt6_A           59 FCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHC  136 (394)
T ss_dssp             TTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTC
T ss_pred             ccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhh
Confidence            44554 5999999765 665677899999999999999874   77788899999999999999865 666888999999


Q ss_pred             CCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeee
Q 048668           85 SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN  164 (725)
Q Consensus        85 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~  164 (725)
                      .+|+.+.+..+ ++ .++..+|.+..+|+.+.+..+ ++.+...+|.. ..|+.+.+..+- +.+...+|.....+....
T Consensus       137 ~~L~~i~lp~~-~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~-~~i~~~af~~c~~l~~~~  211 (394)
T 4gt6_A          137 EELDTVTIPEG-VT-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV-TRIGTNAFSECFALSTIT  211 (394)
T ss_dssp             TTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC-CEECTTTTTTCTTCCEEE
T ss_pred             cccccccccce-ee-eecccceecccccccccccce-eeEeccccccc-cceeEEEECCcc-cccccchhhhccccceec
Confidence            99999999865 45 788899999999999999765 66687788865 679999997654 457888999999999888


Q ss_pred             cCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEe
Q 048668          165 LEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV  244 (725)
Q Consensus       165 L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L  244 (725)
                      ...+........      .+........-....       +.    . ..+..+.+. +.+......+|.++.+|+.+.+
T Consensus       212 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~-------~~----~-~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~l  272 (394)
T 4gt6_A          212 SDSESYPAIDNV------LYEKSANGDYALIRY-------PS----Q-REDPAFKIP-NGVARIETHAFDSCAYLASVKM  272 (394)
T ss_dssp             ECCSSSCBSSSC------EEEECTTSCEEEEEC-------CT----T-CCCSEEECC-TTEEEECTTTTTTCSSCCEEEC
T ss_pred             ccccccccccce------eeccccccccccccc-------cc----c-cccceEEcC-CcceEcccceeeecccccEEec
Confidence            777665433221      011111111100000       00    0 011222221 2333355677888999999999


Q ss_pred             cccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccc
Q 048668          245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSL  324 (725)
Q Consensus       245 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~  324 (725)
                      ..+.. .+...+|.++++|+.+.+. +.+......+|.++.+|+.+++..+ ++            .             
T Consensus       273 p~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~------------~-------------  324 (394)
T 4gt6_A          273 PDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT------------Q-------------  324 (394)
T ss_dssp             CTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC------------E-------------
T ss_pred             ccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc------------E-------------
Confidence            76644 3778889999999999997 4566567778999999999988654 11            1             


Q ss_pred             eecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCc
Q 048668          325 YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN  404 (725)
Q Consensus       325 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  404 (725)
                                 ....+|.++.+|+.+.+..+ ++.....+|.+|.+|+.+++.+|....   ..|..+.+|+.+.+..|.
T Consensus       325 -----------I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          325 -----------ILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             -----------ECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred             -----------ehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence                       23356777788888888654 665667788888888888888876542   456777888888887765


Q ss_pred             cc
Q 048668          405 FS  406 (725)
Q Consensus       405 l~  406 (725)
                      +.
T Consensus       390 ~~  391 (394)
T 4gt6_A          390 ID  391 (394)
T ss_dssp             --
T ss_pred             EE
Confidence            53

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.42  E-value=2.4e-13  Score=142.65  Aligned_cols=105  Identities=21%  Similarity=0.220  Sum_probs=86.5

Q ss_pred             cEEecCCC-ccCccCCccccCCCCCcEEEccC-CcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           16 QALALAGN-YLTGKLPDFIGNLSALQVIHIKG-NSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        16 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      ..++++++ +|+ .+|. |..+++|++|+|++ |+|+++.+..|.++++|++|+|++|+|+++.|..|.+|++|++|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            45688887 887 5777 88888888888886 88888888888888888888888888888888888888888888888


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeee
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFG  124 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~  124 (725)
                      +|+|+ .+|...|..++ |+.|+|++|.+..
T Consensus        89 ~N~l~-~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           89 FNALE-SLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SSCCS-CCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CCccc-eeCHHHcccCC-ceEEEeeCCCccC
Confidence            88888 77777776665 8888888887764

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.40  E-value=2.8e-13  Score=142.16  Aligned_cols=131  Identities=20%  Similarity=0.196  Sum_probs=106.0

Q ss_pred             eecccCC-ccCCCcchhhhcCCCCCeEEccC-ccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCC
Q 048668          325 YLDLSNN-LLNGSLPQQVGNLKNLIILDISS-NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC  402 (725)
Q Consensus       325 ~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  402 (725)
                      .++++++ .+++ +|. +..+++|+.|+|++ |.|++..+..|..+++|+.|+|++|+|+++.|..|+.+++|+.|||++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4677887 7884 666 99999999999996 999988889999999999999999999999999999999999999999


Q ss_pred             CcccccCcccccCCCCCCeEEcccccCeeecCCCCc--cCCCCCcCccCCccccCCCC
Q 048668          403 NNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGV--FSNKSKIPLQGNVRLCGGID  458 (725)
Q Consensus       403 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~~~~~n~~~c~~~~  458 (725)
                      |+|+++.+..|..++ |+.|+|++|+|.+.+.....  +.......+..+...|..+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            999988887888776 99999999999988763211  11112233444566776654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.39  E-value=3.8e-15  Score=156.95  Aligned_cols=67  Identities=21%  Similarity=0.174  Sum_probs=30.8

Q ss_pred             cCccceecCCCccccccCccCcc-----cccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          133 ASNLELLDLSNNQFKGKVSIDFS-----SLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       133 l~~L~~L~Ls~N~i~~~~~~~f~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      +++|++|+|++|+|+......+.     ..++|++|+|++|.++......  +...+...++|++|+|++|.|+
T Consensus       125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~--l~~~L~~~~~L~~L~Ls~N~l~  196 (372)
T 3un9_A          125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAV--LMEGLAGNTSVTHLSLLHTGLG  196 (372)
T ss_dssp             HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHH--HHHHHHTCSSCCEEECTTSSCH
T ss_pred             HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHH--HHHHHhcCCCcCEEeCCCCCCC
Confidence            34455555555555433322221     2244555555555554322110  1123345566666666666665

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.38  E-value=4.3e-15  Score=156.56  Aligned_cols=170  Identities=16%  Similarity=0.146  Sum_probs=101.4

Q ss_pred             CCCcEEEccCCcCCccCCCCCCC-----CCCCCEEEccCCcccccCcccc-cccCCCceeeccCCCCCCCCChhhh----
Q 048668           37 SALQVIHIKGNSLGGKFPTTLGL-----LRNLVQLNVAENKFYGMFPRSI-CNISSLEYFYLTSNRFSGSLPFDIV----  106 (725)
Q Consensus        37 ~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~----  106 (725)
                      ++|++|+|++|+++......|..     .++|++|+|++|.|+......+ ..+++|+.|+|++|.|+ ......+    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~-~~~~~~L~~~L  150 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG-PEACKDLRDLL  150 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC-HHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC-HHHHHHHHHHH
Confidence            56777777777776443333322     2577777777777764433333 34567777888888776 3222222    


Q ss_pred             -cCCCCccEEEccCceeeee----CCCcccccCccceecCCCccccccC----ccCcccccccCeeecCCccCCccCCCC
Q 048668          107 -VNLPNLKELGIGANNFFGL----IPDSLSNASNLELLDLSNNQFKGKV----SIDFSSLKILWRLNLEQNNLGIGAAND  177 (725)
Q Consensus       107 -~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~  177 (725)
                       ...++|++|+|++|.|+..    .+..+..+++|++|||++|+|++..    ...+...++|++|+|++|.|+......
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             2456777777777777642    2233456677778888888776543    234455567777777777776433211


Q ss_pred             cccccccCCCCCCCEEECccCcccccCChhhh
Q 048668          178 LGFVTFLTNCSSLKVLSLSDNQFGGELPHSIA  209 (725)
Q Consensus       178 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  209 (725)
                        +...+...++|++|+|++|.|+......+.
T Consensus       231 --l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          231 --LARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             --HHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             --HHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence              113344556777777777777654444443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.32  E-value=7.3e-11  Score=125.29  Aligned_cols=147  Identities=13%  Similarity=0.102  Sum_probs=66.3

Q ss_pred             CChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCc
Q 048668          253 IPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNL  332 (725)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~  332 (725)
                      ...++....+|+.+.+..+ +......+|.+...|+.+.+..+ ++            .+....+.....++.+.+..+ 
T Consensus       209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~------------~I~~~aF~~~~~l~~i~l~~~-  273 (379)
T 4h09_A          209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT------------SIGSFLLQNCTALKTLNFYAK-  273 (379)
T ss_dssp             CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC------------EECTTTTTTCTTCCEEEECCC-
T ss_pred             eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc------------EeCccccceeehhcccccccc-
Confidence            3444555555665555443 22234444555555555555443 11            222222222211122222221 


Q ss_pred             cCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCccc
Q 048668          333 LNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKF  412 (725)
Q Consensus       333 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  412 (725)
                      ++......|.++.+|+.+.+.++.++.....+|.++.+|+.+.|..+ ++.+-..+|.++++|+.+.+..+ ++.+-..+
T Consensus       274 i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~a  351 (379)
T 4h09_A          274 VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGA  351 (379)
T ss_dssp             CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhH
Confidence            22122334555555555555555555444455555555555555433 44344455555555555555433 44344444


Q ss_pred             ccCC
Q 048668          413 LENL  416 (725)
Q Consensus       413 ~~~l  416 (725)
                      |.+.
T Consensus       352 F~~c  355 (379)
T 4h09_A          352 FEGS  355 (379)
T ss_dssp             TTTS
T ss_pred             hhCC
Confidence            4443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.29  E-value=9.3e-12  Score=124.94  Aligned_cols=149  Identities=17%  Similarity=0.149  Sum_probs=113.1

Q ss_pred             HHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCC
Q 048668          526 ELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFK  604 (725)
Q Consensus       526 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  604 (725)
                      .+......|+.....+.|+.+.||++...  +..+++|+...........+.+|+++++.+. +..++++++++....  
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--   83 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG--   83 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC--
Confidence            34455667888888888999999999753  6789999987532222346789999999885 677888998876543  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC------------------------  660 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------  660 (725)
                         ..|+||||++|.++.+.....           .....++.+++++++.||+..                        
T Consensus        84 ---~~~lv~e~i~G~~l~~~~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           84 ---WSNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             ---EEEEEEECCSSEEHHHHCCTT-----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             ---ceEEEEEecCCeehhhccCCc-----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence               789999999999998763211           112467889999999999810                        


Q ss_pred             --------------------------------CCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          661 --------------------------------QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       661 --------------------------------~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                                                      .+.++|+|++|.||+++.+..+.|+||+.|..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                            13589999999999998766678999998754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.28  E-value=1.9e-10  Score=122.13  Aligned_cols=312  Identities=11%  Similarity=0.072  Sum_probs=178.3

Q ss_pred             ccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCc
Q 048668           33 IGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNL  112 (725)
Q Consensus        33 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  112 (725)
                      +....+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++ .++..+|.+ .+|
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~-~~L  115 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQG-TDL  115 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTT-CCC
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-Eeccceecc-CCc
Confidence            44455666666653 355566666666666666666533 555666666665 4666655533 44 556566544 356


Q ss_pred             cEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcc------cccccCC
Q 048668          113 KELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG------FVTFLTN  186 (725)
Q Consensus       113 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~------~~~~~~~  186 (725)
                      +.+.+..+ ++.+...+|.+. +|+.+.+-. .++.+...+|.....++.+.+..+...........      ....+..
T Consensus       116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (379)
T 4h09_A          116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA  192 (379)
T ss_dssp             SEEECCTT-CCEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred             ccccCCCc-cccccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence            66666544 333444455443 455544433 34445556666666666665555443322110000      0011122


Q ss_pred             CCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEE
Q 048668          187 CSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLL  266 (725)
Q Consensus       187 l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  266 (725)
                      ...+..+.+..+.                          .......+....+|+.+.+..+ +..+...+|.++.+|+.+
T Consensus       193 ~~~~~~~~~~~~~--------------------------~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i  245 (379)
T 4h09_A          193 AKTGTEFTIPSTV--------------------------KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEI  245 (379)
T ss_dssp             TCCCSEEECCTTC--------------------------CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEE
T ss_pred             cccccccccccce--------------------------eEEeecccccccccceeeeccc-eeEEccccccCCccceEE
Confidence            2222222222211                          1133344555566666666443 444556667777777777


Q ss_pred             eccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcCCC
Q 048668          267 GLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKN  346 (725)
Q Consensus       267 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~  346 (725)
                      .+..+ ++.....+|.+..+|+.+.+..+ ++            .++...|..-..++.+.+.++.++......|.++.+
T Consensus       246 ~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~------------~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~  311 (379)
T 4h09_A          246 AIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK------------TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK  311 (379)
T ss_dssp             EECTT-CCEECTTTTTTCTTCCEEEECCC-CS------------EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred             EcCCC-ccEeCccccceeehhcccccccc-ce------------eccccccccccccccccccccccceehhhhhcCCCC
Confidence            77665 44455556667777777776543 22            455555554444466777777676566678889999


Q ss_pred             CCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCC
Q 048668          347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIK  396 (725)
Q Consensus       347 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  396 (725)
                      |+.++|..+ ++..-..+|.++.+|+.+.+..+ ++.+-..+|.++..++
T Consensus       312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~~~  359 (379)
T 4h09_A          312 LSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSITK  359 (379)
T ss_dssp             CCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSCCC
T ss_pred             CCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCCCc
Confidence            999999755 66566788999999999999765 6666677888775443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.07  E-value=2.4e-10  Score=114.40  Aligned_cols=138  Identities=14%  Similarity=0.115  Sum_probs=96.7

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCc--ccceeeEeecCCCCCcceee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~  610 (725)
                      .+......+.|..+.||++.. .+|..+++|+....   ....+.+|+++++.+.+.+  +++++++....     +..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCE
Confidence            444433434566799999975 35677999987543   2245678999999886444  55677775543     3579


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC------------------------------  660 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------  660 (725)
                      +||||++|.++.  ...         ..   ...++.++++.++.+|+..                              
T Consensus        92 ~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             EEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             EEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            999999998884  211         11   1246677778888888641                              


Q ss_pred             -------------------------CCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          661 -------------------------QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       661 -------------------------~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                                               .+.++|+|++|.||+++.++.++|+|||.|...
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                     113999999999999988766789999998653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.94  E-value=1.8e-09  Score=113.47  Aligned_cols=144  Identities=15%  Similarity=0.201  Sum_probs=104.7

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEee--ccc-cchHHHHHHHHHHHHcCC--CCcccceeeEeecCCCCCcceeeE
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQ-KGAFRSFVAECEALRNIR--HRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      .+.++.|.++.||++...  +..+++|+..  ... ......+.+|+++++.+.  +..+++++.++.....  .+..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEE
Confidence            467899999999998864  4568888775  322 112346788999999997  4567888888765431  235789


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC-------------------------------  660 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------------------------------  660 (725)
                      ||||++|..+.+...        ..++..++..++.+++++|+.||...                               
T Consensus       119 vme~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EEECCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEEecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            999999977744211        13567788889999999999999731                               


Q ss_pred             ------------------------CCCcEecCCCCCCeeecCCCc--eEEcccccccc
Q 048668          661 ------------------------QPPMVHGDLKPSNVLLDHDMV--AHVGDFGLAKF  692 (725)
Q Consensus       661 ------------------------~~~ivHrdlkp~Nill~~~~~--~kl~Dfgla~~  692 (725)
                                              .+.++|+|++|.||+++.++.  +.|+||+.|..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    246999999999999997753  68999998874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.90  E-value=2.7e-10  Score=118.80  Aligned_cols=185  Identities=15%  Similarity=0.169  Sum_probs=92.0

Q ss_pred             cccCcEEecCCCccCc-c-------CCccccCCCCCcEEEccCCcCCc---------cCCCCCCCCCCCCEEEccCCc-c
Q 048668           12 LFKLQALALAGNYLTG-K-------LPDFIGNLSALQVIHIKGNSLGG---------KFPTTLGLLRNLVQLNVAENK-F   73 (725)
Q Consensus        12 l~~l~~L~l~~n~l~~-~-------~~~~~~~l~~L~~L~l~~n~l~~---------~~~~~~~~l~~L~~L~Ls~N~-l   73 (725)
                      ...++.|.+......+ .       +.++...+++|+.|.+.++....         .+...+..+++|+.|+|++|. +
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence            3456777777655432 1       12234567788888876654311         122334556777777777663 2


Q ss_pred             cccCcccccccCCCceeeccCCCCCCCCChhhh-cCCCCccEEEccC--ceeeee-----CCCcc--cccCccceecCCC
Q 048668           74 YGMFPRSICNISSLEYFYLTSNRFSGSLPFDIV-VNLPNLKELGIGA--NNFFGL-----IPDSL--SNASNLELLDLSN  143 (725)
Q Consensus        74 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~l~~L~~L~L~~--N~i~~~-----~~~~~--~~l~~L~~L~Ls~  143 (725)
                      .  .+. +. +++|+.|+|..+.++......+. ..+|+|+.|+|+.  |...+-     +...+  ..+++|++|+|++
T Consensus       186 ~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~  261 (362)
T 2ra8_A          186 S--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD  261 (362)
T ss_dssp             B--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEES
T ss_pred             e--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCC
Confidence            2  222 32 66777777777666421111111 2567777777642  211100     00111  2356677777766


Q ss_pred             ccccccCccCcc---cccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccc
Q 048668          144 NQFKGKVSIDFS---SLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG  202 (725)
Q Consensus       144 N~i~~~~~~~f~---~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  202 (725)
                      |.+.+.....+.   .+++|++|+|+.|.++......  +...+.++++|+.|+|++|.|+.
T Consensus       262 ~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~--L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL--LLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             CTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHH--HHTTHHHHTTCSEEECCSBBCCH
T ss_pred             CCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHH--HHhhcccCCcceEEECCCCcCCH
Confidence            666532222221   3556666666666655422110  11122345666666666666553

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.89  E-value=3.6e-10  Score=117.81  Aligned_cols=180  Identities=19%  Similarity=0.215  Sum_probs=123.2

Q ss_pred             ccccCcccCcEEecCCCccC---------ccCCccccCCCCCcEEEccCCc-CCccCCCCCCCCCCCCEEEccCCccccc
Q 048668            7 KEIGSLFKLQALALAGNYLT---------GKLPDFIGNLSALQVIHIKGNS-LGGKFPTTLGLLRNLVQLNVAENKFYGM   76 (725)
Q Consensus         7 ~~~~~l~~l~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~   76 (725)
                      +.+..+++|++|.+.++...         +.+...+..+++|+.|+|++|. +.  .+. +. +++|++|+|..|.+...
T Consensus       133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~  208 (362)
T 2ra8_A          133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDS  208 (362)
T ss_dssp             TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHH
T ss_pred             HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChH
Confidence            44566789999999765432         1244567889999999999984 32  333 43 78999999999998754


Q ss_pred             Cccccc--ccCCCceeeccC--CCCCCC-----CChhhh--cCCCCccEEEccCceeeeeCCCcc---cccCccceecCC
Q 048668           77 FPRSIC--NISSLEYFYLTS--NRFSGS-----LPFDIV--VNLPNLKELGIGANNFFGLIPDSL---SNASNLELLDLS  142 (725)
Q Consensus        77 ~~~~~~--~l~~L~~L~L~~--N~l~~~-----~~~~~~--~~l~~L~~L~L~~N~i~~~~~~~~---~~l~~L~~L~Ls  142 (725)
                      ....+.  .+++|+.|+|+.  |...+.     +.. .+  ..+|+|++|+|.+|.+....+..+   ..+++|++|||+
T Consensus       209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~-~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs  287 (362)
T 2ra8_A          209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP-LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS  287 (362)
T ss_dssp             HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG-GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECC
T ss_pred             HHHHHHHccCCCCcEEEEeccccccccchhHHHHHH-HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECC
Confidence            444554  789999999964  221111     111 12  257999999999999874322222   257899999999


Q ss_pred             CccccccCcc----CcccccccCeeecCCccCCccCCCCcccccccCC-CCCCCEEECccCc
Q 048668          143 NNQFKGKVSI----DFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTN-CSSLKVLSLSDNQ  199 (725)
Q Consensus       143 ~N~i~~~~~~----~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~-l~~L~~L~L~~N~  199 (725)
                      .|.|++....    .+..+++|+.|+|++|.++.....      .+.. +  ...+++++++
T Consensus       288 ~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~------~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKK------ELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             SSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHH------HHHHHC--CSEEECCSBC
T ss_pred             CCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHH------HHHHHc--CCEEEecCCc
Confidence            9999874332    335679999999999998754321      1111 1  3457777776

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.62  E-value=5.1e-09  Score=103.32  Aligned_cols=81  Identities=21%  Similarity=0.346  Sum_probs=39.0

Q ss_pred             CCCCCCEEEccCCccccc--CcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC-------Cc
Q 048668           59 LLRNLVQLNVAENKFYGM--FPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-------DS  129 (725)
Q Consensus        59 ~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-------~~  129 (725)
                      ++++|++|+|++|+|+++  +|..+..+++|+.|+|++|+|++.-..+.+.++ +|++|+|++|.+++..|       ..
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~i  246 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAI  246 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHH
Confidence            345555555555555542  234445555555555555555521111222222 55555555555554332       12


Q ss_pred             ccccCccceec
Q 048668          130 LSNASNLELLD  140 (725)
Q Consensus       130 ~~~l~~L~~L~  140 (725)
                      +..+++|+.||
T Consensus       247 l~~~P~L~~LD  257 (267)
T 3rw6_A          247 RERFPKLLRLD  257 (267)
T ss_dssp             HHHCTTCCEES
T ss_pred             HHHCcccCeEC
Confidence            45566666654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.58  E-value=1.3e-07  Score=96.76  Aligned_cols=140  Identities=18%  Similarity=0.222  Sum_probs=97.8

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCc--ccceeeEeecCCCCCcceeeEEE
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRN--LIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      .+.++.|....||++.     ..+++|+....  .....+.+|+++++.+. +..  +++++.++....  .....|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEE
Confidence            3568999999999863     34788886422  23467889999998884 333  345554432221  112458999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH----------------------------------  659 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------------------------------  659 (725)
                      ||++|..+.+....        .++..++..++.++++.++.+|+.                                  
T Consensus        96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            99999887653221        356667777888888888888861                                  


Q ss_pred             ---------------------CCCCcEecCCCCCCeeecC--CCceEEccccccccc
Q 048668          660 ---------------------CQPPMVHGDLKPSNVLLDH--DMVAHVGDFGLAKFL  693 (725)
Q Consensus       660 ---------------------~~~~ivHrdlkp~Nill~~--~~~~kl~Dfgla~~~  693 (725)
                                           ..+.++|+|++|.||+++.  +..+.|+||+.+...
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                                 1235899999999999998  456889999988653

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.53  E-value=3.8e-08  Score=97.05  Aligned_cols=80  Identities=20%  Similarity=0.303  Sum_probs=54.4

Q ss_pred             hcCCCCCeEEccCcccccc--CccccccccCCcEEEccCCccccccCccccCCC--CCCEEeCCCCcccccCc-------
Q 048668          342 GNLKNLIILDISSNQFSGM--IPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLK--SIKFLDVSCNNFSGQFP-------  410 (725)
Q Consensus       342 ~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p-------  410 (725)
                      ..+++|+.|+|++|+|++.  +|..+..+++|+.|+|++|+|++.  ..+..++  +|+.|+|++|.+++..|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            4577888888888888763  345666777888888888887754  2344444  77788888888776554       


Q ss_pred             ccccCCCCCCeEE
Q 048668          411 KFLENLSFLEFLN  423 (725)
Q Consensus       411 ~~~~~l~~L~~L~  423 (725)
                      ..+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            2355677777664

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.51  E-value=1.2e-08  Score=95.75  Aligned_cols=118  Identities=14%  Similarity=0.103  Sum_probs=60.5

Q ss_pred             CccccCCCCCcEEEccCC-cCCcc----CCCCCCCCCCCCEEEccCCccccc----CcccccccCCCceeeccCCCCCCC
Q 048668           30 PDFIGNLSALQVIHIKGN-SLGGK----FPTTLGLLRNLVQLNVAENKFYGM----FPRSICNISSLEYFYLTSNRFSGS  100 (725)
Q Consensus        30 ~~~~~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~  100 (725)
                      ...+...+.|++|+|++| .+...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|.+.
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            345566677777777777 66532    233445556677777777776532    233444556677777777766521


Q ss_pred             CC---hhhhcCCCCccEEEc--cCceeeee----CCCcccccCccceecCCCcccc
Q 048668          101 LP---FDIVVNLPNLKELGI--GANNFFGL----IPDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus       101 ~~---~~~~~~l~~L~~L~L--~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                      --   ...+...++|++|+|  ++|.|...    +...+...++|++|+|++|.|.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            10   111233344555555  44544321    1122333344555555555543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.51  E-value=9.4e-09  Score=96.61  Aligned_cols=117  Identities=14%  Similarity=0.122  Sum_probs=91.3

Q ss_pred             ccccCcccCcEEecCCC-ccCcc----CCccccCCCCCcEEEccCCcCCcc----CCCCCCCCCCCCEEEccCCccccc-
Q 048668            7 KEIGSLFKLQALALAGN-YLTGK----LPDFIGNLSALQVIHIKGNSLGGK----FPTTLGLLRNLVQLNVAENKFYGM-   76 (725)
Q Consensus         7 ~~~~~l~~l~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~-   76 (725)
                      +.+...+.|++|+|++| .|...    +.+.+...++|++|+|++|+|...    +...+...++|++|+|++|.|... 
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            34566789999999999 88742    445677789999999999999742    344456678999999999999854 


Q ss_pred             ---CcccccccCCCceeec--cCCCCCCCCC---hhhhcCCCCccEEEccCceee
Q 048668           77 ---FPRSICNISSLEYFYL--TSNRFSGSLP---FDIVVNLPNLKELGIGANNFF  123 (725)
Q Consensus        77 ---~~~~~~~l~~L~~L~L--~~N~l~~~~~---~~~~~~l~~L~~L~L~~N~i~  123 (725)
                         +..++...++|++|+|  ++|.|.....   ...+...++|++|+|++|.|.
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence               4567788889999999  8899973211   123455689999999999985

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.5e-06  Score=88.78  Aligned_cols=138  Identities=16%  Similarity=0.134  Sum_probs=91.0

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCC---cccceeeEeecCCCCCcceeeEEE
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR---NLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      .+.++.|....||+.     +..+++|+..  .......+.+|+++++.+.+.   .+.+.+.++...    .+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEEEE
Confidence            356788888899987     3457788742  223346788999999999752   356666665421    23568999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH----------------------------------  659 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----------------------------------  659 (725)
                      ||++|..+.+....        .++..+...++.++++.++.||+.                                  
T Consensus        93 e~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           93 RKVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             ECCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             eccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            99999887653211        123333444444444444444432                                  


Q ss_pred             -----------------------CCCCcEecCCCCCCeeecC---CCc-eEEccccccccc
Q 048668          660 -----------------------CQPPMVHGDLKPSNVLLDH---DMV-AHVGDFGLAKFL  693 (725)
Q Consensus       660 -----------------------~~~~ivHrdlkp~Nill~~---~~~-~kl~Dfgla~~~  693 (725)
                                             ..+.++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                   2335799999999999997   455 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.36  E-value=1.7e-06  Score=86.62  Aligned_cols=136  Identities=17%  Similarity=0.098  Sum_probs=95.2

Q ss_pred             ccccccce-EEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceeeEEEecc
Q 048668          539 MIGQGSFG-SVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       539 ~ig~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      .+..|..| .||+......+..+++|+-...   ....+.+|.+.|+.+. +--+.++++++...+     ..|+|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~-----~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD-----DAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-----EEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-----eEEEEEEee
Confidence            34445554 6899887767778889986533   3456788999998875 334677888766543     679999999


Q ss_pred             CCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 048668          617 GNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC------------------------------------  660 (725)
Q Consensus       617 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~------------------------------------  660 (725)
                      +|.++.+......          .....++.+++..++-||...                                    
T Consensus       103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            9988876543221          112345556666666666421                                    


Q ss_pred             -------------------CCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          661 -------------------QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       661 -------------------~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                                         .+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               12379999999999999887778999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.09  E-value=5.3e-06  Score=86.78  Aligned_cols=83  Identities=8%  Similarity=0.020  Sum_probs=54.4

Q ss_pred             ccc-ccccceEEEEEEEC--C----CceEEEEEEeeccc---cchHHHHHHHHHHHHcCC-C--CcccceeeEeecCCCC
Q 048668          538 NMI-GQGSFGSVYKGILG--E----DEMIVAVKVINLKQ---KGAFRSFVAECEALRNIR-H--RNLIKIITICSSTDFK  604 (725)
Q Consensus       538 ~~i-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~  604 (725)
                      +.| +.|....+|+....  .    ++..+++|+.....   ......+.+|+++++.+. +  -.+.+++.++..... 
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~-  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV-  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence            556 78888999988653  0    15678889865432   101245678888888875 3  356778877644321 


Q ss_pred             CcceeeEEEeccCCCCHH
Q 048668          605 GVDFKALVFEYMGNGSLE  622 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~  622 (725)
                       .+..|+||||++|..+.
T Consensus       105 -~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 -LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             -TSSCEEEEECCCCBCCC
T ss_pred             -cCCceEEEEecCCCChh
Confidence             13468999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=1.2e-05  Score=85.52  Aligned_cols=76  Identities=17%  Similarity=0.117  Sum_probs=49.0

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeecccc-------chHHHHHHHHHHHHcCCC--C-cccceeeEeecCCCCCc
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK-------GAFRSFVAECEALRNIRH--R-NLIKIITICSSTDFKGV  606 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~  606 (725)
                      .+.+|.|.++.||++....+++.|+||.......       ....++..|+++++.+..  | .+++++.+.  .     
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~-----  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence            4578999999999997665677899998653211       123456789999887742  3 345666542  1     


Q ss_pred             ceeeEEEeccCCC
Q 048668          607 DFKALVFEYMGNG  619 (725)
Q Consensus       607 ~~~~lv~e~~~~g  619 (725)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            1357999999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.99  E-value=1.3e-06  Score=79.77  Aligned_cols=84  Identities=11%  Similarity=0.028  Sum_probs=55.9

Q ss_pred             CCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCc-ccccCccccccc----CCCceeeccCCC-CCCCCChhhhcCCC
Q 048668           37 SALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENK-FYGMFPRSICNI----SSLEYFYLTSNR-FSGSLPFDIVVNLP  110 (725)
Q Consensus        37 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~~l~  110 (725)
                      .+|+.||+++|.++..--..+.++++|++|+|++|. |+...-..+..+    ++|++|+|++|. || .-.-..+..++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT-D~Gl~~L~~~~  139 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT-DKGIIALHHFR  139 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC-HHHHHHGGGCT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC-HHHHHHHhcCC
Confidence            367888888887765555556777888888888874 665444455553    368888888774 66 32223345678


Q ss_pred             CccEEEccCce
Q 048668          111 NLKELGIGANN  121 (725)
Q Consensus       111 ~L~~L~L~~N~  121 (725)
                      +|+.|+|++|.
T Consensus       140 ~L~~L~L~~c~  150 (176)
T 3e4g_A          140 NLKYLFLSDLP  150 (176)
T ss_dssp             TCCEEEEESCT
T ss_pred             CCCEEECCCCC
Confidence            88888887774

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.94  E-value=3.1e-06  Score=77.20  Aligned_cols=93  Identities=15%  Similarity=0.061  Sum_probs=63.2

Q ss_pred             CCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCC-CCCCCChhhhcCC----CCccEEEccCce-eeeeCC
Q 048668           54 PTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNR-FSGSLPFDIVVNL----PNLKELGIGANN-FFGLIP  127 (725)
Q Consensus        54 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l----~~L~~L~L~~N~-i~~~~~  127 (725)
                      |..+..-.+|++|||+++.|+...-..+.++++|+.|+|++|. |+ .-.-..+..+    ++|++|+|++|. ||..--
T Consensus        54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It-D~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE-DGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC-HHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC-HHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            4433333468888888888877666677888888888888884 65 2222223343    368888888874 764433


Q ss_pred             CcccccCccceecCCCcc-cc
Q 048668          128 DSLSNASNLELLDLSNNQ-FK  147 (725)
Q Consensus       128 ~~~~~l~~L~~L~Ls~N~-i~  147 (725)
                      ..+..+++|++|+|+++. |+
T Consensus       133 ~~L~~~~~L~~L~L~~c~~It  153 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLPGVK  153 (176)
T ss_dssp             HHGGGCTTCCEEEEESCTTCC
T ss_pred             HHHhcCCCCCEEECCCCCCCC
Confidence            456778888888888875 54

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.62  E-value=0.00046  Score=71.34  Aligned_cols=44  Identities=23%  Similarity=0.261  Sum_probs=34.5

Q ss_pred             HHHHHHHHHh----------cCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          649 VASAIEYLHH----------HCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       649 i~~~l~~lH~----------~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      +..++++++.          ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4456666663          1245899999999999998888999999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.60  E-value=0.00027  Score=71.58  Aligned_cols=141  Identities=18%  Similarity=0.164  Sum_probs=88.9

Q ss_pred             CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC---CCcccceeeEeecCCCCCcceeeEEE
Q 048668          537 SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      .+.|+.|....+|+...  ++..+++|+....   ....+..|++.|+.+.   ...+++++.++...     +..|+||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence            45688999999999875  4567888987533   3467889999998884   35678888876543     3689999


Q ss_pred             eccCCCCHH--------H---HhcccCC---ccc-------------cccCCHHHHH---HHHH----------------
Q 048668          614 EYMGNGSLE--------D---WLHQSND---QVE-------------VCKLSLIQRL---NIAI----------------  647 (725)
Q Consensus       614 e~~~~g~L~--------~---~l~~~~~---~~~-------------~~~~~~~~~~---~i~~----------------  647 (725)
                      ||++|..+.        +   .++....   ..-             ...-+|....   ++..                
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            999987541        1   1222211   000             0011343221   1111                


Q ss_pred             HHHHH-HHHHHh-cCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          648 DVASA-IEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       648 ~i~~~-l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++.. ...+.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11111 123321 2256899999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.53  E-value=0.00033  Score=70.53  Aligned_cols=77  Identities=16%  Similarity=0.114  Sum_probs=55.1

Q ss_pred             CCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC---CcccceeeEeecCCCCCcceee
Q 048668          534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH---RNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       534 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ....+.+|.|..+.||+.+.. +|+.|.+|+...........|..|++.|+.+.-   --+++++++.         ..+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence            344567899999999999875 788899998764443334567899999998842   2345555541         247


Q ss_pred             EEEeccCCCC
Q 048668          611 LVFEYMGNGS  620 (725)
Q Consensus       611 lv~e~~~~g~  620 (725)
                      +||||++++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999998764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.46  E-value=0.00015  Score=62.94  Aligned_cols=62  Identities=19%  Similarity=0.233  Sum_probs=48.5

Q ss_pred             cEEEccCCccc-cccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeecCC
Q 048668          372 EYVDISSNCFH-GIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPT  435 (725)
Q Consensus       372 ~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  435 (725)
                      ..++.+++.|+ ..+|..+.  ++|+.|||++|+|+.+.+..|..+++|++|+|++|+|.+.+..
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l   73 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL   73 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence            47888888886 23454332  4688999999999988888889999999999999999877653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.43  E-value=0.00038  Score=74.25  Aligned_cols=32  Identities=25%  Similarity=0.448  Sum_probs=27.8

Q ss_pred             CCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          661 QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       661 ~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      .+.++|+|++|.||+++.++ ++++||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            44899999999999998876 999999988653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.33  E-value=3.2e-05  Score=71.88  Aligned_cols=19  Identities=16%  Similarity=0.057  Sum_probs=11.2

Q ss_pred             cccccCCCceeeccCC-CCC
Q 048668           80 SICNISSLEYFYLTSN-RFS   98 (725)
Q Consensus        80 ~~~~l~~L~~L~L~~N-~l~   98 (725)
                      .+.+-+.|++|+|++| .|.
T Consensus        36 ll~~n~~L~~L~L~~nn~ig   55 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVS   55 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSC
T ss_pred             HHhcCCCccEEECCCCCCCC
Confidence            3444556777777764 554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.25  E-value=0.00016  Score=67.28  Aligned_cols=117  Identities=10%  Similarity=0.081  Sum_probs=71.5

Q ss_pred             ccccCCCCCcEEEccCC-cCCc----cCCCCCCCCCCCCEEEccCCccccc----CcccccccCCCceeeccCCCCCCCC
Q 048668           31 DFIGNLSALQVIHIKGN-SLGG----KFPTTLGLLRNLVQLNVAENKFYGM----FPRSICNISSLEYFYLTSNRFSGSL  101 (725)
Q Consensus        31 ~~~~~l~~L~~L~l~~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~  101 (725)
                      ..+.+-+.|+.|+|++| +|..    .+-+++..-+.|+.|+|++|+|...    +-.++..-+.|+.|+|++|.|.+..
T Consensus        35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G  114 (197)
T 1pgv_A           35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL  114 (197)
T ss_dssp             HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred             HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence            34455667777777775 6642    1234455567788888888877633    2344556677888888888876211


Q ss_pred             Ch---hhhcCCCCccEEEccCce---eee----eCCCcccccCccceecCCCcccc
Q 048668          102 PF---DIVVNLPNLKELGIGANN---FFG----LIPDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus       102 ~~---~~~~~l~~L~~L~L~~N~---i~~----~~~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                      -.   .++..-+.|++|+|++|.   +..    .+...+..-+.|++|+++.|.+.
T Consensus       115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            11   123344568888887553   321    12345667788899999887764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.19  E-value=0.00058  Score=59.25  Aligned_cols=35  Identities=17%  Similarity=0.236  Sum_probs=14.9

Q ss_pred             CCEEEccCCcccccCcccccccCCCceeeccCCCC
Q 048668           63 LVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRF   97 (725)
Q Consensus        63 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l   97 (725)
                      |++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            44444444444433334444444444444444433

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.14  E-value=0.0013  Score=66.50  Aligned_cols=73  Identities=11%  Similarity=0.134  Sum_probs=43.8

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcc-cceeeEeecCCCCCcceeeEEE
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      ...+.++.|....+|++      ..+++|+........ ....+|+++++.+....+ .+++++...       .-++|+
T Consensus        21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~   86 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVT   86 (301)
T ss_dssp             CSCEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEE
T ss_pred             cceeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEE
Confidence            33677888999999998      347888875432111 122467777777642222 566654221       246899


Q ss_pred             ecc-CCCCH
Q 048668          614 EYM-GNGSL  621 (725)
Q Consensus       614 e~~-~~g~L  621 (725)
                      ||+ +|.++
T Consensus        87 e~i~~g~~l   95 (301)
T 3dxq_A           87 RYIAGAQTM   95 (301)
T ss_dssp             ECCTTCEEC
T ss_pred             eecCCCccC
Confidence            999 65433

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.75  E-value=0.0085  Score=61.26  Aligned_cols=166  Identities=16%  Similarity=0.126  Sum_probs=87.3

Q ss_pred             CccCHHHHHHHhcCCCC-----CcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCC--ccc
Q 048668          520 PMVSYAELSKATSEFSS-----SNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHR--NLI  592 (725)
Q Consensus       520 ~~~~~~~~~~~~~~~~~-----~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv  592 (725)
                      ...+.+.+......|..     ...++ |....||+.... +|+.+++|+...... ....+..|.++++.+...  .++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence            33445555544444432     23466 778899987653 456788999864321 235667788888877522  244


Q ss_pred             ceeeEeecCC--CCCcceeeEEEeccCCCCHH-----HH---------hccc---CCccccccCCHHHH----H------
Q 048668          593 KIITICSSTD--FKGVDFKALVFEYMGNGSLE-----DW---------LHQS---NDQVEVCKLSLIQR----L------  643 (725)
Q Consensus       593 ~l~~~~~~~~--~~~~~~~~lv~e~~~~g~L~-----~~---------l~~~---~~~~~~~~~~~~~~----~------  643 (725)
                      +++..  .+.  ....+..++||||++|..+.     ++         ++..   ..........+...    .      
T Consensus        86 ~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  163 (328)
T 1zyl_A           86 APVAF--NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDA  163 (328)
T ss_dssp             CCCCB--TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTC
T ss_pred             ceeec--CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhc
Confidence            44433  111  01123567899999875321     11         1110   00000001111110    0      


Q ss_pred             ---------HHHHHHHHHHHHHHhc----CCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          644 ---------NIAIDVASAIEYLHHH----CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       644 ---------~i~~~i~~~l~~lH~~----~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                               .+...+...++.+...    ..+.++|+|+++.||+++ + .+.++||+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          164 TLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     0111112223333321    234689999999999999 4 899999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.73  E-value=0.01  Score=60.82  Aligned_cols=32  Identities=31%  Similarity=0.316  Sum_probs=27.7

Q ss_pred             CCCcEecCCCCCCeeecCC----CceEEcccccccc
Q 048668          661 QPPMVHGDLKPSNVLLDHD----MVAHVGDFGLAKF  692 (725)
Q Consensus       661 ~~~ivHrdlkp~Nill~~~----~~~kl~Dfgla~~  692 (725)
                      .+.++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999875    6799999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.71  E-value=0.0048  Score=66.01  Aligned_cols=73  Identities=14%  Similarity=0.102  Sum_probs=46.5

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcc-cceeeEeecCCCCCcceeeEEEecc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-IKIITICSSTDFKGVDFKALVFEYM  616 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~~  616 (725)
                      +.|+.|-...+|++....++..|++|+......... ...+|..+++.+...++ +++++++.  +       ..||||+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~-------G~v~e~I  183 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N-------GRIEEFM  183 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T-------EEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C-------eEEEEee
Confidence            567778889999998864457788998743321111 12478888988864444 56776641  1       2599999


Q ss_pred             CCCC
Q 048668          617 GNGS  620 (725)
Q Consensus       617 ~~g~  620 (725)
                      +|..
T Consensus       184 ~G~~  187 (458)
T 2qg7_A          184 DGYA  187 (458)
T ss_dssp             CSEE
T ss_pred             CCcc
Confidence            8744

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.71  E-value=0.0033  Score=66.96  Aligned_cols=72  Identities=21%  Similarity=0.164  Sum_probs=48.0

Q ss_pred             cccccccceEEEEEEECC-------CceEEEEEEeeccccchHHHHHHHHHHHHcCCCCc-ccceeeEeecCCCCCccee
Q 048668          538 NMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~  609 (725)
                      +.|+.|....||++....       ++..|++|+....  .....+.+|..+++.+...+ .+++++++.  +       
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-------  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G-------  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T-------
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C-------
Confidence            467778889999998753       2567889987432  11245668999988885333 366666532  1       


Q ss_pred             eEEEeccCCCC
Q 048668          610 ALVFEYMGNGS  620 (725)
Q Consensus       610 ~lv~e~~~~g~  620 (725)
                      .+||||++|..
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            37999998743

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.64  E-value=0.021  Score=58.11  Aligned_cols=168  Identities=13%  Similarity=0.115  Sum_probs=86.9

Q ss_pred             ccCHHHHHHHhcCCCCC-----cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCc--ccc
Q 048668          521 MVSYAELSKATSEFSSS-----NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LIK  593 (725)
Q Consensus       521 ~~~~~~~~~~~~~~~~~-----~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~  593 (725)
                      .++.+++......|...     +.++.|....+|+.... ++ .+++|+.....  ....+..|+++++.+....  +++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence            34556666665666542     34666888899998764 33 57889886521  1234556777777664222  334


Q ss_pred             eeeEeecCCC-CCcceeeEEEeccCCCCHHH--------------HhcccCCc-ccc--ccC---CHHHHHH--------
Q 048668          594 IITICSSTDF-KGVDFKALVFEYMGNGSLED--------------WLHQSNDQ-VEV--CKL---SLIQRLN--------  644 (725)
Q Consensus       594 l~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~-~~~--~~~---~~~~~~~--------  644 (725)
                      ++.......+ ...+..++||+|++|..+..              .++..... ...  ...   .|.....        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            4321100000 01135689999998864311              01111000 000  000   1111000        


Q ss_pred             ----HHHHHHHHHHHHHhc----CCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          645 ----IAIDVASAIEYLHHH----CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       645 ----i~~~i~~~l~~lH~~----~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                          +...+...+++++..    ....++|+|+.+.||+++.++.+.++||+.+..
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                011244455566532    134799999999999999876668999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.63  E-value=0.0048  Score=64.21  Aligned_cols=145  Identities=12%  Similarity=0.125  Sum_probs=81.3

Q ss_pred             cccccccceEEEEEEECC-------CceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          538 NMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.+..|....+|++....       +++.|++|+.... ......+.+|.++++.+. +.-..++++++.  +       
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~-------  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E-------  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T-------
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C-------
Confidence            456668888999998742       3467889986332 123455668999998875 333466666532  1       


Q ss_pred             eEEEeccCCCCHHH--------------H---hcccCCccccccC-CHHHHHHHHHHHHH-------------------H
Q 048668          610 ALVFEYMGNGSLED--------------W---LHQSNDQVEVCKL-SLIQRLNIAIDVAS-------------------A  652 (725)
Q Consensus       610 ~lv~e~~~~g~L~~--------------~---l~~~~~~~~~~~~-~~~~~~~i~~~i~~-------------------~  652 (725)
                      .+||||++|..+..              .   ++........... -+.++.++..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            28999999854421              1   1111100000011 13344444433321                   2


Q ss_pred             HHHHHh----c-CCCCcEecCCCCCCeeecCC----CceEEcccccccc
Q 048668          653 IEYLHH----H-CQPPMVHGDLKPSNVLLDHD----MVAHVGDFGLAKF  692 (725)
Q Consensus       653 l~~lH~----~-~~~~ivHrdlkp~Nill~~~----~~~kl~Dfgla~~  692 (725)
                      ++++..    . ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            333322    1 23468999999999999876    7899999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.16  E-value=0.013  Score=61.01  Aligned_cols=73  Identities=11%  Similarity=0.163  Sum_probs=42.7

Q ss_pred             cccccccceEEEEEEECCC--------ceEEEEEEeeccccchHHHHHHHHHHHHcCCCCc-ccceeeEeecCCCCCcce
Q 048668          538 NMIGQGSFGSVYKGILGED--------EMIVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LIKIITICSSTDFKGVDF  608 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~  608 (725)
                      +.++.|....+|++.....        +..+++|+....... ......|.++++.+.... ++++++..  .       
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-------  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N-------  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T-------
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C-------
Confidence            4577788889999987531        257888887543221 112357888888775323 45666542  1       


Q ss_pred             eeEEEeccCCCC
Q 048668          609 KALVFEYMGNGS  620 (725)
Q Consensus       609 ~~lv~e~~~~g~  620 (725)
                      -++||||++|..
T Consensus       109 ~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 GGRIEEWLYGDP  120 (369)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CcEEEEEecCCc
Confidence            258999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.79  E-value=0.022  Score=58.53  Aligned_cols=31  Identities=19%  Similarity=0.315  Sum_probs=27.8

Q ss_pred             CCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          662 PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       662 ~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.20  E-value=0.067  Score=56.38  Aligned_cols=73  Identities=10%  Similarity=0.048  Sum_probs=46.1

Q ss_pred             cccccccceEEEEEEECCC-------ceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          538 NMIGQGSFGSVYKGILGED-------EMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.+..|....+|++.....       ++.|++|+........ -...+|.++++.+. +.-.+++++.+         .-
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~---------~~  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF---------PE  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE---------TT
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc---------CC
Confidence            4566688889999987521       5678888864332111 12357888888775 33345666532         12


Q ss_pred             eEEEeccCCCC
Q 048668          610 ALVFEYMGNGS  620 (725)
Q Consensus       610 ~lv~e~~~~g~  620 (725)
                      +.||||++|..
T Consensus       146 ~~I~efI~G~~  156 (424)
T 3mes_A          146 GRIEEFIDGEP  156 (424)
T ss_dssp             EEEEECCCSEE
T ss_pred             CEEEEEeCCcc
Confidence            68999999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.01  E-value=0.45  Score=49.83  Aligned_cols=29  Identities=24%  Similarity=0.440  Sum_probs=24.6

Q ss_pred             cEecCCCCCCeee------cCCCceEEcccccccc
Q 048668          664 MVHGDLKPSNVLL------DHDMVAHVGDFGLAKF  692 (725)
Q Consensus       664 ivHrdlkp~Nill------~~~~~~kl~Dfgla~~  692 (725)
                      ++|+|+.+.||++      +.+..++++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4456799999988864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.55  E-value=0.1  Score=55.91  Aligned_cols=62  Identities=13%  Similarity=0.074  Sum_probs=18.0

Q ss_pred             CCcccccccceEEEEEEECCCceEEEE------EEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeec
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAV------KVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSS  600 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  600 (725)
                      ..+.+|   ||.||+|.+.....+|||      |......  ......|.+|..+++..+|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345566   999999998755567888      6654321  2234578899999999999999999887543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	725
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-40
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-38
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-33
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-27
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (402), Expect = 1e-44
 Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 25/191 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHR 589
            + +    IG GSFG+VYKG    D   VAVK++N+        ++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
           N++  +   ++         A+V ++    SL   LH         K  +I+ ++IA   
Sbjct: 65  NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQT 113

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
           A  ++YLH      ++H DLK +N+ L  D+   +GDFGLA   S        +      
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ----- 165

Query: 710 GIKGTVGYVAP 720
            + G++ ++AP
Sbjct: 166 -LSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (401), Expect = 4e-44
 Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 29/211 (13%)

Query: 523 SYAELSKATSEFSSS---------NMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ- 569
           ++ + ++A  EF+            +IG G FG V  G L   G+ E+ VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +   R F++E   +    H N+I +  + + +         ++ E+M NGSL+ +L Q++
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSLDSFLRQND 122

Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
                 + ++IQ + +   +A+ ++YL        VH DL   N+L++ ++V  V DFGL
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           ++FL     DTS  T +S++G K  + + AP
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAP 202

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 7e-41
 Identities = 41/195 (21%), Positives = 82/195 (42%), Gaps = 24/195 (12%)

Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS-FVAECEALRN 585
           +     +F   + +G G+ G V+K       +++A K+I+L+ K A R+  + E + L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
                ++       S         ++  E+M  GSL+  L ++       ++       +
Sbjct: 61  CNSPYIVGFYGAFYSDGEI-----SICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
           +I V   + YL       ++H D+KPSN+L++      + DFG++  L     ++     
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 162

Query: 706 SSSIGIKGTVGYVAP 720
                  GT  Y++P
Sbjct: 163 -----FVGTRSYMSP 172

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 7e-40
 Identities = 43/189 (22%), Positives = 85/189 (44%), Gaps = 22/189 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
                   +G G FG V+ G        VAVK +  +   +  +F+AE   ++ ++H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +++  + +           ++ EYM NGSL D+L   +      KL++ + L++A  +A 
Sbjct: 71  VRLYAVVTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAE 120

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            + ++        +H DL+ +N+L+   +   + DFGLA+ +  +             G 
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-------GA 170

Query: 712 KGTVGYVAP 720
           K  + + AP
Sbjct: 171 KFPIKWTAP 179

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 7e-40
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 21/184 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+GSF +VYKG+  E  + VA   +  ++  K   + F  E E L+ ++H N+++    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
             ST  KG     LV E M +G+L+ +L +         + +    +    +   +++LH
Sbjct: 77  WESTV-KGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129

Query: 658 HHCQPPMVHGDLKPSNVLL-DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
               PP++H DLK  N+ +        +GD GLA    +               + GT  
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----------VIGTPE 178

Query: 717 YVAP 720
           ++AP
Sbjct: 179 FMAP 182

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 22/184 (11%)

Query: 540 IGQGSFGSVYKGIL--GEDEMIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G G+FGSV +G+    + ++ VA+KV+    +K      + E + +  + +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           +C +          LV E  G G L  +L          ++ +     +   V+  ++YL
Sbjct: 77  VCQAEAL------MLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYL 125

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
                   VH DL   NVLL +   A + DFGL+K L +     ++++       K  + 
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLK 177

Query: 717 YVAP 720
           + AP
Sbjct: 178 WYAP 181

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 20/186 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+G FG V++G        VAVK+ + +++ ++    AE      +RH N++  I   +
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
             +        LV +Y  +GSL D+L++         +++   + +A+  AS + +LH  
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHME 119

Query: 660 C-----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
                 +P + H DLK  N+L+  +    + D GLA    S                 GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH----RVGT 175

Query: 715 VGYVAP 720
             Y+AP
Sbjct: 176 KRYMAP 181

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 515 MEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFR 574
           M+   P  +Y +     ++ +  + +G G +G VY+G+  +  + VAVK +  +      
Sbjct: 2   MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 58

Query: 575 SFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEV 634
            F+ E   ++ I+H NL++++ +C+           ++ E+M  G+L D+L + N Q   
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFY-----IITEFMTYGNLLDYLRECNRQ--- 110

Query: 635 CKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            ++S +  L +A  ++SA+EYL        +H DL   N L+  + +  V DFGL++ ++
Sbjct: 111 -EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166

Query: 695 SHHLDTSSKTPSSSIGIKGTVGYVAP 720
                  +       G K  + + AP
Sbjct: 167 GDTYTAHA-------GAKFPIKWTAP 185

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 4e-38
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 18/197 (9%)

Query: 528 SKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRN 585
           S+A  ++     IG GS+G   K     D  I+  K ++     +   +  V+E   LR 
Sbjct: 1   SRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           ++H N+++            +    +V EY   G L   + +   + +   L     L +
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRV 114

Query: 646 AIDVASAIEYLHHH--CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSK 703
              +  A++  H        ++H DLKP+NV LD      +GDFGLA+ L+       + 
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA- 173

Query: 704 TPSSSIGIKGTVGYVAP 720
                    GT  Y++P
Sbjct: 174 -------FVGTPYYMSP 183

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 5e-38
 Identities = 41/181 (22%), Positives = 77/181 (42%), Gaps = 21/181 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG VYK    E  ++ A KVI+ K +     ++ E + L +  H N++K++    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                  +   ++ E+   G+++  + +         L+  Q   +      A+ YLH +
Sbjct: 80  YE-----NNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN 129

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVA 719
               ++H DLK  N+L   D    + DFG++   +       S          GT  ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--------FIGTPYWMA 178

Query: 720 P 720
           P
Sbjct: 179 P 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 7e-38
 Identities = 45/190 (23%), Positives = 73/190 (38%), Gaps = 29/190 (15%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRN 590
           FS    IG GSFG+VY      +  +VA+K ++   K     ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
            I+                 LV EY    + +              L  ++   +     
Sbjct: 77  TIQYRGCYLREHTA-----WLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIG 710
             + YLH H    M+H D+K  N+LL    +  +GDFG A  ++  +             
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------S 170

Query: 711 IKGTVGYVAP 720
             GT  ++AP
Sbjct: 171 FVGTPYWMAP 180

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-37
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 24/187 (12%)

Query: 538 NMIGQGSFGSVYKGIL--GEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIK 593
             +G G+FG+V KG     +    VAVK++  +          +AE   ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +I IC +  +       LV E    G L  +L Q+        +     + +   V+  +
Sbjct: 73  MIGICEAESW------MLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           +YL        VH DL   NVLL     A + DFGL+K L +      ++T       K 
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKW 172

Query: 714 TVGYVAP 720
            V + AP
Sbjct: 173 PVKWYAP 179

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 22/189 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
                   +GQG FG V+ G        VA+K +      +  +F+ E + ++ +RH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +++  + S           +V EYM  GSL D+L     +         Q +++A  +AS
Sbjct: 75  VQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIAS 124

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            + Y+        VH DL+ +N+L+  ++V  V DFGLA+ +  +             G 
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-------GA 174

Query: 712 KGTVGYVAP 720
           K  + + AP
Sbjct: 175 KFPIKWTAP 183

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 42/189 (22%), Positives = 75/189 (39%), Gaps = 21/189 (11%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 591
           ++     +G+G++G V   +    E  VAVK++++K+      +   E    + + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +K        + +      L  EY   G L D +           +           + +
Sbjct: 66  VKFYGHRREGNIQ-----YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMA 114

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
            + YLH      + H D+KP N+LLD      + DFGLA     ++ +           +
Sbjct: 115 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------M 165

Query: 712 KGTVGYVAP 720
            GT+ YVAP
Sbjct: 166 CGTLPYVAP 174

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 4e-36
 Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 27/192 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRH 588
            +F     +G+G FG+VY     + + I+A+KV+    L++ G       E E   ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
            N++++                L+ EY   G++   L + +      K    +      +
Sbjct: 66  PNILRLYGYFHDATRV-----YLILEYAPLGTVYRELQKLS------KFDEQRTATYITE 114

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +A+A+ Y H      ++H D+KP N+LL       + DFG +    S    T        
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-------- 163

Query: 709 IGIKGTVGYVAP 720
             + GT+ Y+ P
Sbjct: 164 --LCGTLDYLPP 173

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-36
 Identities = 61/189 (32%), Positives = 80/189 (42%), Gaps = 26/189 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            E      IG+G FG V  G        VAVK I  K     ++F+AE   +  +RH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 62

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           ++++ +             +V EYM  GSL D+L      V    L     L  ++DV  
Sbjct: 63  VQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYL  +     VH DL   NVL+  D VA V DFGL K  SS                
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----------- 160

Query: 712 KGTVGYVAP 720
           K  V + AP
Sbjct: 161 KLPVKWTAP 169

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 7e-36
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 23/194 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL----GEDEMIVAVKVINLKQKGAFR-SFVAECEALRNI 586
           S  +   +IG G FG VYKG+L    G+ E+ VA+K +        R  F+ E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            H N+I++  + S           ++ EYM NG+L+ +L + +      + S++Q + + 
Sbjct: 67  SHHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKD-----GEFSVLQLVGML 116

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
             +A+ +    +      VH DL   N+L++ ++V  V DFGL++ L      T + +  
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-- 171

Query: 707 SSIGIKGTVGYVAP 720
              G K  + + AP
Sbjct: 172 ---GGKIPIRWTAP 182

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 22/189 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
            + +    +G G FG V  G     +  VA+K+I  +   +   F+ E + + N+ H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +++  +C+           ++ EYM NG L ++L +        +    Q L +  DV  
Sbjct: 62  VQLYGVCTKQRPI-----FIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCE 111

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
           A+EYL        +H DL   N L++   V  V DFGL++++            +SS+G 
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGS 161

Query: 712 KGTVGYVAP 720
           K  V +  P
Sbjct: 162 KFPVRWSPP 170

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-35
 Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 38/213 (17%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAECEALRN 585
                  ++G G+FG V              + VAVK++  K   + R + ++E + +  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 586 I-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV------------ 632
           +  H N++ ++  C+ +         L+FEY   G L ++L    ++             
Sbjct: 97  LGSHENIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 633 -----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF 687
                ++  L+    L  A  VA  +E+L        VH DL   NVL+ H  V  + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208

Query: 688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           GLA+ + S                +  V ++AP
Sbjct: 209 GLARDIMSDSNYVVRGN------ARLPVKWMAP 235

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 6e-35
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 22/189 (11%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 591
           SE +    IG G FG V+ G    ++  VA+K I  +   +   F+ E E +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +++  +C            LVFE+M +G L D+L       +    +    L + +DV  
Sbjct: 63  VQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCE 112

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGI 711
               + +  +  ++H DL   N L+  + V  V DFG+ +F+            +SS G 
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGT 162

Query: 712 KGTVGYVAP 720
           K  V + +P
Sbjct: 163 KFPVKWASP 171

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 8e-35
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)

Query: 519 FPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRS 575
           +P++ +       ++    ++IG+G+FG V K  + +D + +   +  +K+   K   R 
Sbjct: 4   YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 576 FVAECEALRNI-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN----- 629
           F  E E L  +  H N+I ++  C    +       L  EY  +G+L D+L +S      
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 630 -----DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 684
                       LS  Q L+ A DVA     + +  Q   +H DL   N+L+  + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168

Query: 685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
            DFGL++    +   T           +  V ++A 
Sbjct: 169 ADFGLSRGQEVYVKKTMG---------RLPVRWMAI 195

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 46/188 (24%), Positives = 82/188 (43%), Gaps = 20/188 (10%)

Query: 537 SNMIGQGSFGSVYKGILGED---EMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLI 592
           + +IG+G FG VY G L ++   ++  AVK +N +   G    F+ E   +++  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++ IC  ++        +V  YM +G L +++       E    ++   +   + VA  
Sbjct: 92  SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
              +        VH DL   N +LD      V DFGLA+ +     D    +  +  G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY----DKEFDSVHNKTGAK 195

Query: 713 GTVGYVAP 720
             V ++A 
Sbjct: 196 LPVKWMAL 203

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-34
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 510 ADTSPMEKQFPMVSYAELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ 569
           +D   +EK   +VS  +  K   +++    IGQG+ G+VY  +       VA++ +NL+Q
Sbjct: 1   SDEEILEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57

Query: 570 KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSN 629
           +      + E   +R  ++ N++  +           D   +V EY+  GSL D + +  
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-- 110

Query: 630 DQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL 689
                  +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 111 -----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162

Query: 690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
              ++      S+        + GT  ++AP
Sbjct: 163 CAQITPEQSKRST--------MVGTPYWMAP 185

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 51/187 (27%), Positives = 75/187 (40%), Gaps = 25/187 (13%)

Query: 540 IGQGSFGSVYKGIL---GEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIK 593
           +G GSFG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +   K      +V E    GSL D L +           L      A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGM 124

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
            YL        +H DL   N+LL    +  +GDFGL + L  +      +        K 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----HRKV 176

Query: 714 TVGYVAP 720
              + AP
Sbjct: 177 PFAWCAP 183

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 38/222 (17%)

Query: 523 SYAELSKATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFRS-F 576
               L    +       IG+G+FG V++         E   +VAVK++  +     ++ F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 577 VAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVC- 635
             E   +    + N++K++ +C+           L+FEYM  G L ++L   +       
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 636 -----------------KLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH 678
                             LS  ++L IA  VA+ + YL        VH DL   N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 679 DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           +MV  + DFGL++ + S     +             + ++ P
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGN------DAIPIRWMPP 211

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 45/194 (23%), Positives = 88/194 (45%), Gaps = 25/194 (12%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGED----EMIVAVKVINL-KQKGAFRSFVAECEALRNI 586
           +EF    ++G G+FG+VYKG+   +    ++ VA+K +       A +  + E   + ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +          LN  
Sbjct: 69  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI-----GSQYLLNWC 117

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPS 706
           + +A  + YL       +VH DL   NVL+       + DFGLAK L       + +   
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------AEEKEY 168

Query: 707 SSIGIKGTVGYVAP 720
            + G K  + ++A 
Sbjct: 169 HAEGGKVPIKWMAL 182

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 8e-34
 Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 33/208 (15%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAECEALRN 585
           +  S    +G G+FG V +         +  M VAVK++        R + ++E + L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 586 I-RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV------------ 632
           +  H N++ ++  C+           ++ EY   G L ++L +  D              
Sbjct: 83  LGNHMNIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 633 EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF 692
           +   L L   L+ +  VA  + +L        +H DL   N+LL H  +  + DFGLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 693 LSSHHLDTSSKTPSSSIGIKGTVGYVAP 720
           + +                +  V ++AP
Sbjct: 195 IKNDSNYVVKGN------ARLPVKWMAP 216

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-33
 Identities = 44/195 (22%), Positives = 75/195 (38%), Gaps = 23/195 (11%)

Query: 529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRN 585
           K   +F    ++G+GSF +V            A+K++    + ++        E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNI 645
           + H   +K+       +            Y  NG L  ++ +                  
Sbjct: 65  LDHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIG------SFDETCTRFY 113

Query: 646 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
             ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       + + 
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 169

Query: 706 SSSIGIKGTVGYVAP 720
                  GT  YV+P
Sbjct: 170 -----FVGTAQYVSP 179

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  128 bits (323), Expect = 5e-33
 Identities = 36/183 (19%), Positives = 68/183 (37%), Gaps = 24/183 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG V++          A K +    +    +   E + +  +RH  L+ +     
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                  +   +++E+M  G L + +   ++     K+S  + +     V   + ++H +
Sbjct: 94  DD-----NEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
                VH DLKP N++        +   DFGL   L             S     GT  +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---------SVKVTTGTAEF 191

Query: 718 VAP 720
            AP
Sbjct: 192 AAP 194

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-32
 Identities = 42/185 (22%), Positives = 77/185 (41%), Gaps = 25/185 (13%)

Query: 539 MIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLIKI 594
            IG+G FG V++GI        + VA+K        + R  F+ E   +R   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 595 ITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           I + +       +   ++ E    G L  +L           L L   +  A  +++A  
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTA-- 120

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
            L +      VH D+   NVL+  +    +GDFGL++++       +SK        K  
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLP 172

Query: 715 VGYVA 719
           + ++A
Sbjct: 173 IKWMA 177

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 4e-32
 Identities = 43/199 (21%), Positives = 83/199 (41%), Gaps = 24/199 (12%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQKGAFR-SFVAECEALRN 585
            + + S  +GQGSFG VY+G+       E E  VA+K +N       R  F+ E   ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE----VCKLSLIQ 641
               ++++++ + S           ++ E M  G L+ +L      +     +   SL +
Sbjct: 80  FNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 642 RLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
            + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ + +        
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 702 SKTPSSSIGIKGTVGYVAP 720
                        V +++P
Sbjct: 192 GGK------GLLPVRWMSP 204

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  125 bits (314), Expect = 7e-32
 Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 20/179 (11%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK------QKGAFRSFVAECEALRNI 586
           +FS   +IG+G FG VY     +   + A+K ++ K       +    +       +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 587 RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIA 646
               ++ +     + D       + + + M  G L   L Q     E            A
Sbjct: 65  DCPFIVCMSYAFHTPDKL-----SFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113

Query: 647 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTP 705
            ++   +E++H+     +V+ DLKP+N+LLD      + D GLA   S      S  T 
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  122 bits (308), Expect = 9e-32
 Identities = 36/185 (19%), Positives = 76/185 (41%), Gaps = 18/185 (9%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKII 595
           ++G G    V+          VAVKV+     +    +  F  E +    + H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
               +    G     +V EY+   +L D +H          ++  + + +  D   A+ +
Sbjct: 74  DTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNF 126

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
            H +    ++H D+KP+N+++       V DFG+A+      +  S  + + +  + GT 
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR-----AIADSGNSVTQTAAVIGTA 178

Query: 716 GYVAP 720
            Y++P
Sbjct: 179 QYLSP 183

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 1e-31
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 12/170 (7%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIK 593
           ++ + +IG GSFG VY+  L +   +VA+K +   ++   R    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77

Query: 594 IITIC-SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
           +     SS + K   +  LV +Y+         H S  +     L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLSSHHLDTS 701
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L     + S
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  124 bits (312), Expect = 1e-31
 Identities = 38/183 (20%), Positives = 69/183 (37%), Gaps = 24/183 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G+FG V++ +      +   K IN        +   E   +  + H  LI +     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      L+ E++  G L D +   +      K+S  + +N        ++++H H
Sbjct: 97  DK-----YEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
               +VH D+KP N++ +    + V   DFGLA  L+   +               T  +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---------VKVTTATAEF 194

Query: 718 VAP 720
            AP
Sbjct: 195 AAP 197

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-31
 Identities = 48/184 (26%), Positives = 76/184 (41%), Gaps = 17/184 (9%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           + IG+G++G V       +++ VA+K I+  + +   +  + E + L   RH N+I I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           I  +   + +    LV   MG   L   L           LS          +   ++Y+
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYI 125

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
           H      ++H DLKPSN+LL+      + DFGLA+     H  T   T         T  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----YVATRW 177

Query: 717 YVAP 720
           Y AP
Sbjct: 178 YRAP 181

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (295), Expect = 9e-30
 Identities = 42/184 (22%), Positives = 68/184 (36%), Gaps = 21/184 (11%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIIT 596
           +++G G+F  V        + +VA+K I  K  +G   S   E   L  I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
           I  S          L+ + +  G L D + +          +      +   V  A++YL
Sbjct: 75  IYESGGHL-----YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
           H                  LD D    + DFGL+K      + ++           GT G
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---------ACGTPG 174

Query: 717 YVAP 720
           YVAP
Sbjct: 175 YVAP 178

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  117 bits (293), Expect = 9e-30
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 33/193 (17%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAF---------RSFVAECEALRNIR- 587
            ++G+G    V + I        AVK+I++   G+F          + + E + LR +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
           H N+I++     +  F       LVF+ M  G L D+L +         LS  +   I  
Sbjct: 69  HPNIIQLKDTYETNTFF-----FLVFDLMKKGELFDYLTEKV------TLSEKETRKIMR 117

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSS 707
            +   I  LH      +VH DLKP N+LLD DM   + DFG +  L              
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE------ 168

Query: 708 SIGIKGTVGYVAP 720
              + GT  Y+AP
Sbjct: 169 ---VCGTPSYLAP 178

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 47/185 (25%), Positives = 72/185 (38%), Gaps = 19/185 (10%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITIC 598
            IG GSFG +Y G        VA+K+  +K K        E +  + ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
            +      D+  +V E +G    + +   S       K SL   L +A  + S IEY+H 
Sbjct: 72  GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121

Query: 659 HCQPPMVHGDLKPSNVL---LDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTV 715
                 +H D+KP N L        + ++ DFGLAK               +   + GT 
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTA 177

Query: 716 GYVAP 720
            Y + 
Sbjct: 178 RYASI 182

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 5e-29
 Identities = 32/167 (19%), Positives = 69/167 (41%), Gaps = 16/167 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G+G FG V++ +    +     K + +K          E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFE 71

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
           S      +   ++FE++    + + ++ S       +L+  + ++    V  A+++LH H
Sbjct: 72  SM-----EELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHV--GDFGLAKFLSSHHLDTSSKT 704
               + H D++P N++      + +   +FG A+ L          T
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 7e-29
 Identities = 39/205 (19%), Positives = 74/205 (36%), Gaps = 28/205 (13%)

Query: 532 SEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRN 585
                   +G+G+FG V +              VAVK++         R+ ++E + L +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 586 IRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCK--------- 636
           I H   +  +    +          ++ E+   G+L  +L    ++    K         
Sbjct: 73  IGHHLNVVNLLGACTKPG---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 637 -LSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSS 695
            L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 696 HHLDTSSKTPSSSIGIKGTVGYVAP 720
                           +  + ++AP
Sbjct: 187 DPDYVRKGD------ARLPLKWMAP 205

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 43/186 (23%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITI 597
           IGQG+FG V+K    +    VA+K + ++  ++G   + + E + L+ ++H N++ +I I
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 598 CSSTDFKGVDFKA---LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           C +        K    LVF++  +       +         K +L +   +   + +   
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNG-- 129

Query: 655 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
            L++  +  ++H D+K +NVL+  D V  + DFGLA+  S       ++  +       T
Sbjct: 130 -LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN----RVVT 184

Query: 715 VGYVAP 720
           + Y  P
Sbjct: 185 LWYRPP 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-28
 Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 26/186 (13%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLIKIITI 597
           ++G G  G V +      +   A+K++    K        E E   R  +  ++++I+ +
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
                + G     +V E +  G L   +    DQ      +  +   I   +  AI+YLH
Sbjct: 74  Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128

Query: 658 HHCQPPMVHGDLKPSNVLLDH---DMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
                 + H D+KP N+L      + +  + DFG AK  +SH+         S      T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYT 176

Query: 715 VGYVAP 720
             YVAP
Sbjct: 177 PYYVAP 182

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-28
 Identities = 43/192 (22%), Positives = 72/192 (37%), Gaps = 26/192 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEAL-RNIRH 588
           +F    M+G+GSFG V+     +     A+K +    +         + E   L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             L  +     + +         V EY+  G L   +   +      K  L +    A +
Sbjct: 63  PFLTHMFCTFQTKENL-----FFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAE 111

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
           +   +++LH      +V+ DLK  N+LLD D    + DFG+ K        T++      
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT------ 162

Query: 709 IGIKGTVGYVAP 720
               GT  Y+AP
Sbjct: 163 --FCGTPDYIAP 172

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 42/200 (21%), Positives = 78/200 (39%), Gaps = 33/200 (16%)

Query: 540 IGQGSFGSVYKGIL-------GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRN 590
           +G+G+FG V                  VAVK++     +      ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQ----------SNDQVEVCKLSLI 640
           +I ++  C+           ++ EY   G+L ++L            +       +LS  
Sbjct: 81  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
             ++ A  VA     + +      +H DL   NVL+  D V  + DFGLA+ +       
Sbjct: 136 DLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------ 186

Query: 701 SSKTPSSSIGIKGTVGYVAP 720
                  +   +  V ++AP
Sbjct: 187 HIDYYKKTTNGRLPVKWMAP 206

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 27/188 (14%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLI 592
           + +G+G F +VYK        IVA+K I L      + G  R+ + E + L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
            ++              +LVF++M           S                  +     
Sbjct: 64  GLLDAFGHKSNI-----SLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIK 712
           +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK   S +   + +         
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-------- 161

Query: 713 GTVGYVAP 720
            T  Y AP
Sbjct: 162 VTRWYRAP 169

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 23/200 (11%)

Query: 527 LSKATSEFSSSNMIGQGSFGSVYKGI-LGEDEMIVAVKVINLK--QKGAFRSFVAECEAL 583
           L +A  ++     IG+G++G V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 584 RNI---RHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLI 640
           R++    H N++++  +C+ +         LVFE++                    +   
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTE 116

Query: 641 QRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDT 700
              ++   +   +++LH H    +VH DLKP N+L+       + DFGLA+  S     T
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173

Query: 701 SSKTPSSSIGIKGTVGYVAP 720
           S         +  T+ Y AP
Sbjct: 174 S---------VVVTLWYRAP 184

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-27
 Identities = 39/179 (21%), Positives = 76/179 (42%), Gaps = 18/179 (10%)

Query: 526 ELSKATSEFSSS----NMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFRSFVAE 579
           E++K   E  +       +G G++G+V   + G     VA+K +    + +   +    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 580 CEALRNIRHRNLIKIITICSSTD-FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLS 638
              L+++RH N+I ++ + +  +         LV  +MG    +   H+        KL 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--------KLG 119

Query: 639 LIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
             +   +   +   + Y+H      ++H DLKP N+ ++ D    + DFGLA+   S  
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 4e-27
 Identities = 38/192 (19%), Positives = 67/192 (34%), Gaps = 28/192 (14%)

Query: 532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRH 588
            +F     +G GSFG V+      +    A+KV+    + +         E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 589 RNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAID 648
             +I++                ++ +Y+  G L   L +S              +     
Sbjct: 64  PFIIRMWGTFQDAQQI-----FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113

Query: 649 VASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSS 708
                  L +     +++ DLKP N+LLD +    + DFG AK++               
Sbjct: 114 ----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT--------- 160

Query: 709 IGIKGTVGYVAP 720
             + GT  Y+AP
Sbjct: 161 --LCGTPDYIAP 170

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  106 bits (265), Expect = 5e-26
 Identities = 33/186 (17%), Positives = 61/186 (32%), Gaps = 21/186 (11%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           IG+GSFG +++G    +   VA+K    +          E    + +     I  +    
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 600 STDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH 659
                      LV + +G    +             K S+      A  + + ++ +H  
Sbjct: 71  QEG----LHNVLVIDLLGPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK 120

Query: 660 CQPPMVHGDLKPSNVLLDHDMVAHVG-----DFGLAKFLSSHHLDTSSKTPSSSIGIKGT 714
               +V+ D+KP N L+      +       DFG+ KF                  + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSGT 176

Query: 715 VGYVAP 720
             Y++ 
Sbjct: 177 ARYMSI 182

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-25
 Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 25/191 (13%)

Query: 533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 589
           +F    ++G+G+FG V            A+K++    +  K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 590 NLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDV 649
            L  +     + D         V EY   G L   L +          +  +      ++
Sbjct: 66  FLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRE------RVFTEERARFYGAEI 114

Query: 650 ASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
            SA   L +     +V+ D+K  N++LD D    + DFGL K   S          ++  
Sbjct: 115 VSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMK 163

Query: 710 GIKGTVGYVAP 720
              GT  Y+AP
Sbjct: 164 TFCGTPEYLAP 174

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG+G++G+V+K    E   IVA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 598 CSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH 657
             S          LVFE+      + +   + D       S + +L         ++ L 
Sbjct: 70  LHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115

Query: 658 HHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTS 701
                 ++H DLKP N+L++ +    + +FGLA+         S
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  104 bits (259), Expect = 6e-25
 Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 29/183 (15%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITIC 598
           +G+G +  V++ I   +   V VK++   +K   +    E + L N+R   N+I +  I 
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99

Query: 599 SSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH 658
                +     ALVFE++ N   +              L+         ++  A++Y H 
Sbjct: 100 KDPVSRTP---ALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS 147

Query: 659 HCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGY 717
                ++H D+KP NV++DH+     + D+GLA+F                     +  +
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---------RVASRYF 195

Query: 718 VAP 720
             P
Sbjct: 196 KGP 198

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 7e-25
 Identities = 37/191 (19%), Positives = 62/191 (32%), Gaps = 32/191 (16%)

Query: 539 MIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS------FVAECEALRNIR--HRN 590
           ++G G FGSVY GI   D + VA+K +   +   +           E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 591 LIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVA 650
           +I+++           D   L+ E                      L      +    V 
Sbjct: 71  VIRLLDWFERP-----DSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120

Query: 651 SAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVGDFGLAKFLSSHHLDTSSKTPSSSI 709
            A+ + H+     ++H D+K  N+L+D +     + DFG    L                
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--------- 168

Query: 710 GIKGTVGYVAP 720
              GT  Y  P
Sbjct: 169 -FDGTRVYSPP 178

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (259), Expect = 9e-25
 Identities = 37/161 (22%), Positives = 61/161 (37%), Gaps = 17/161 (10%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLIKIIT 596
           +G GSFG V      E     A+K+++   + +       + E   L+ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
                    +     V EY+  G +   L +        + S       A  +    EYL
Sbjct: 109 SFKDNSNLYM-----VMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYL 157

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
           H      +++ DLKP N+L+D      V DFG AK +    
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-24
 Identities = 41/191 (21%), Positives = 72/191 (37%), Gaps = 33/191 (17%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRS------FVAECEALRNIRHRNLIK 593
           +G G F  V K       +  A K I  ++  + R          E   L+ I+H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 594 IITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAI 653
           +  +  +          L+ E +  G L D+L +     E      ++++         +
Sbjct: 78  LHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123

Query: 654 EYLHHHCQPPMVHGDLKPSNVLLDHDMVA----HVGDFGLAKFLSSHHLDTSSKTPSSSI 709
             +++     + H DLKP N++L    V      + DFGLA  +   +   +        
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-------- 175

Query: 710 GIKGTVGYVAP 720
            I GT  +VAP
Sbjct: 176 -IFGTPEFVAP 185

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 15/166 (9%)

Query: 534 FSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 591
           F     IG+G++G VYK        +VA+K I L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 592 IKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVAS 651
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENKL-----YLVFEFLHQ-----DLKKFMDASALTGIPLPLIKSYLFQLLQ 113

Query: 652 AIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHH 697
            + + H H    ++H DLKP N+L++ +    + DFGLA+      
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  100 bits (250), Expect = 4e-24
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 17/161 (10%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKII 595
             IG+G++G VYK      E   A+K I L++  +G   + + E   L+ ++H N++K+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEY 655
            +  +          LVFE++     +              L  +   +  + + + I Y
Sbjct: 67  DVIHTKKRL-----VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAY 115

Query: 656 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSH 696
            H      ++H DLKP N+L++ +    + DFGLA+     
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 6e-24
 Identities = 37/184 (20%), Positives = 73/184 (39%), Gaps = 24/184 (13%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLIKIITI 597
           IG G+ G V        +  VA+K ++   + +   +    E   ++ + H+N+I ++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 598 CSSTD-FKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYL 656
            +     +      LV E M     +    + + +         +   +   +   I++L
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135

Query: 657 HHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVG 716
           H      ++H DLKPSN+++  D    + DFGLA+   +  + T             T  
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---------YVVTRY 183

Query: 717 YVAP 720
           Y AP
Sbjct: 184 YRAP 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 3e-23
 Identities = 37/184 (20%), Positives = 75/184 (40%), Gaps = 16/184 (8%)

Query: 520 PMVSYAELSKATSEFSSS----NMIGQGSFGSVYKGILGEDEMIVAVKVIN--LKQKGAF 573
           P     EL+K   E        + +G G++GSV      +  + VAVK ++   +     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 574 RSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVE 633
           +    E   L++++H N+I ++ + +            +  ++    L + +        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----- 116

Query: 634 VCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL 693
             KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+  
Sbjct: 117 --KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 694 SSHH 697
               
Sbjct: 172 DDEM 175

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 4e-22
 Identities = 34/167 (20%), Positives = 65/167 (38%), Gaps = 20/167 (11%)

Query: 540 IGQGSFGSVYKGILGEDE---MIVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLI 592
           +G G++G V+            + A+KV+     +++         E + L +IR    +
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 593 KIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASA 652
             +     T+        L+ +Y+  G L   L Q     E           + I V   
Sbjct: 92  VTLHYAFQTE----TKLHLILDYINGGELFTHLSQRERFTEHE---------VQIYVGEI 138

Query: 653 IEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLD 699
           +  L H  +  +++ D+K  N+LLD +    + DFGL+K   +   +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 96.6 bits (239), Expect = 5e-22
 Identities = 77/399 (19%), Positives = 138/399 (34%), Gaps = 41/399 (10%)

Query: 35  NLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS 94
            L+      +   ++      +   L  +  L         +    +  +++L     ++
Sbjct: 20  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 95  NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDF 154
           N+ +   P     NL  L ++ +  N    + P +         L  +       +    
Sbjct: 76  NQLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 155 SSLKI------LWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI 208
           +  ++      +  ++       +   +    VT L   ++L  L   D         S+
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
               + +   +   NQIS   PLGI    NL  L++  NQL       +  L NL  L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDL 328
             N +    P  L  LTKL +L LG+N +                  +  +  L+   +L
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISN----------------ISPLAGLTALTNL 290

Query: 329 SNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS 388
             N         + NLKNL  L +  N  S + P  +S+   L+ +  ++N        S
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSS 346

Query: 389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYN 427
           L  L +I +L    N  S   P  L NL+ +  L L+  
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.2 bits (199), Expect = 5e-17
 Identities = 68/382 (17%), Positives = 128/382 (33%), Gaps = 41/382 (10%)

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
           L   ++  + +        ++  ++  +                D V  L NL ++    
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSN 75

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLG 179
           N    + P  L N + L  + ++NNQ      +   +      L   Q        N   
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 180 FVTFLTNCSSLKVLSLSDNQFGGELPHSIAN------LSSTMIVFLIGGNQISGTIPLGI 233
                 + +++  +S        +             L++   +  +  +    +    +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 234 RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLG 293
             L NL +L    NQ+    P  I    NL  L L  N L+      L +LT L  LDL 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 294 SNSLQG-NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDI 352
           +N +     ++   KL                 L L  N ++   P     L  L  L++
Sbjct: 250 NNQISNLAPLSGLTKLT---------------ELKLGANQISNISPLA--GLTALTNLEL 292

Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKF 412
           + NQ   + P++     +L Y+ +  N    I P  +  L  ++ L  + N  S      
Sbjct: 293 NENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSS 346

Query: 413 LENLSFLEFLNLSYNHLEGEVP 434
           L NL+ + +L+  +N +    P
Sbjct: 347 LANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 76.6 bits (187), Expect = 2e-15
 Identities = 75/386 (19%), Positives = 137/386 (35%), Gaps = 39/386 (10%)

Query: 11  SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAE 70
           +L +     L    +T  +     +L  +  +      +  K    +  L NL Q+N + 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N+   + P  + N++ L    + +N+ +   P   + NL  L        +   L   + 
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRL------NLEQNNLGIGAANDLGFVTFL 184
            N   L    +S+      ++                  NL        ++N +  ++ L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
              ++L+ L  ++NQ     P  I    + +    + GNQ+     L   +L NL  L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKDIGTLA--SLTNLTDLDL 248

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIA- 303
             NQ+    P  +  L  L  L L  N +    P  L  LT L  L+L  N L+      
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS 304

Query: 304 ----------SQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDIS 353
                       N +    P  + S+T L   L  +NN ++      + NL N+  L   
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 354 SNQFSGMIPVTLSTCVSLEYVDISSN 379
            NQ S + P  L+    +  + ++  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 71.2 bits (173), Expect = 1e-13
 Identities = 38/188 (20%), Positives = 63/188 (33%), Gaps = 33/188 (17%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           +    P  I +   L  L+L GN L       + +L+ L  + +  N +    P  L  L
Sbjct: 209 ISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGL 262

Query: 61  RNLVQLNVAENKFYGMFPRSICNISS--------------------LEYFYLTSNRFSGS 100
             L +L +  N+   + P +     +                    L Y  L  N  S  
Sbjct: 263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322

Query: 101 LPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKIL 160
            P     +L  L+ L    N        SL+N +N+  L   +NQ         ++L  +
Sbjct: 323 SPVS---SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRI 375

Query: 161 WRLNLEQN 168
            +L L   
Sbjct: 376 TQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.3 bits (150), Expect = 7e-11
 Identities = 62/380 (16%), Positives = 129/380 (33%), Gaps = 60/380 (15%)

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL 184
           +  D+    +      L        VS   + L  +  L  ++  +       +     +
Sbjct: 15  IFTDT--ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI-----KSI---DGV 62

Query: 185 TNCSSLKVLSLSDNQFGGELP-HSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA 243
              ++L  ++ S+NQ     P  ++  L   ++      +         +  L       
Sbjct: 63  EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 122

Query: 244 VEVNQLHGTIPDVIGELKNLQLLGL-----------YKNFLQGSIPSGLGNLTKLAKLDL 292
            +++ L         EL +  +  +                Q +    L NLT L +LD+
Sbjct: 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182

Query: 293 GSNSLQGNFIASQNKLIGALPQQLLSITTLS--------LYLDLSNNLLNGSLPQQVGNL 344
            SN +    + ++   + +L      I+ ++          L L+ N L       + +L
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASL 240

Query: 345 KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIP------------------ 386
            NL  LD+++NQ S + P  LS    L  + + +N    I P                  
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298

Query: 387 --PSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVPTKGVFSNKSK 444
               +  LK++ +L +  NN S   P  + +L+ L+ L  + N +   V +    +N + 
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINW 355

Query: 445 IPLQGNVRLCGGIDELHLPS 464
           +    N ++       +L  
Sbjct: 356 LSAGHN-QISDLTPLANLTR 374

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 90.9 bits (224), Expect = 3e-20
 Identities = 37/187 (19%), Positives = 72/187 (38%), Gaps = 15/187 (8%)

Query: 540 IGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICS 599
           +G G F +V+      +   VA+K++    K    +   E + L+ +   +  K  ++ +
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 600 STDFKGVDF-----KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIE 654
           +   K +D         V   M    L + L     + E   + LI    I+  +   ++
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 655 YLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKG 713
           Y+H  C   ++H D+KP NVL++  D   ++    +A       L  +            
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIA------DLGNACWYDEHYTNSIQ 191

Query: 714 TVGYVAP 720
           T  Y +P
Sbjct: 192 TREYRSP 198

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.9 bits (204), Expect = 7e-19
 Identities = 25/167 (14%), Positives = 53/167 (31%), Gaps = 29/167 (17%)

Query: 538 NMIGQGSFGSVYKGILGEDEMIVAVKVINL----------KQKGAFRSFVAECEALRNIR 587
            ++G+G   +V+     +      VK   +          K+      F           
Sbjct: 6   KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 588 HRNLIKIITICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAI 647
            R L K+  +     +   +  A++ E +    L     ++ D+             +  
Sbjct: 65  FRALQKLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110

Query: 648 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFLS 694
            +   +   +H     +VHGDL   NVL+  +    + DF  +  + 
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.2 bits (209), Expect = 1e-18
 Identities = 71/283 (25%), Positives = 105/283 (37%), Gaps = 19/283 (6%)

Query: 185 TNCSSLKVLSLSDNQFGG--ELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
           T    +  L LS         +P S+ANL     +++ G N + G IP  I  L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 243 AVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFI 302
            +    + G IPD + ++K L  L    N L G++P  + +L  L  +    N + G   
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 303 ASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIP 362
            S               + L   + +S N L G +P    NL    +    S        
Sbjct: 167 DSYGS-----------FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDA 213

Query: 363 VTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFL 422
             L            +          +G  K++  LD+  N   G  P+ L  L FL  L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 423 NLSYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELHLPSC 465
           N+S+N+L GE+P  G            N  LCG      LP+C
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS----PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 65.9 bits (159), Expect = 3e-12
 Identities = 65/273 (23%), Positives = 102/273 (37%), Gaps = 15/273 (5%)

Query: 10  GSLFKLQALALAGNYLTGK--LPDFIGNLSALQVIHIKGN-SLGGKFPTTLGLLRNLVQL 66
              +++  L L+G  L     +P  + NL  L  ++I G  +L G  P  +  L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 67  NVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLI 126
            +      G  P  +  I +L     + N  SG+LP   + +LPNL  +    N   G I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP-PSISSLPNLVGITFDGNRISGAI 165

Query: 127 PDSLSNASNLEL-LDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           PDS  + S L   + +S N+  GK+   F++L + +         G  +           
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
                        +           LS  +    +  N+I GT+P G+  L  L +L V 
Sbjct: 226 IH---------LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIP 278
            N L G IP   G L+   +     N      P
Sbjct: 277 FNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 58/253 (22%), Positives = 89/253 (35%), Gaps = 56/253 (22%)

Query: 3   GQIPKEIGSLFKLQALALAGNY-LTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLR 61
             IP  + +L  L  L + G   L G +P  I  L+ L  ++I   ++ G  P  L  ++
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 62  NLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANN 121
            LV L+ + N   G  P SI ++ +L       NR SG++P            + I  N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 122 FFGLIPDS----------------------------------------------LSNASN 135
             G IP +                                              +  + N
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKN 245

Query: 136 LELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSL 195
           L  LDL NN+  G +    + LK L  LN+  NNL        G +    N     V + 
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL-------CGEIPQGGNLQRFDVSAY 298

Query: 196 SDNQF--GGELPH 206
           ++N+   G  LP 
Sbjct: 299 ANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 49.0 bits (115), Expect = 1e-06
 Identities = 15/54 (27%), Positives = 24/54 (44%), Gaps = 1/54 (1%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFP 54
           + G +P+ +  L  L +L ++ N L G++P   GNL    V     N      P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.5 bits (192), Expect = 2e-16
 Identities = 41/235 (17%), Positives = 87/235 (37%), Gaps = 17/235 (7%)

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
            +L     +  +  N+I+       +NL NL  L +  N++    P     L  L+ L L
Sbjct: 27  KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIA------------SQNKLIGALPQQL 316
            KN L+         L +L   +     ++ +               +  K  G      
Sbjct: 87  SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 317 LSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDI 376
             +  LS    +++  +  ++PQ  G   +L  L +  N+ + +   +L    +L  + +
Sbjct: 147 QGMKKLSYI-RIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202

Query: 377 SSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEG 431
           S N    +   SL     ++ L ++ N    + P  L +  +++ + L  N++  
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 78.2 bits (191), Expect = 2e-16
 Identities = 56/311 (18%), Positives = 98/311 (31%), Gaps = 56/311 (18%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +P  L    +  LLDL NN+       DF +LK L  L L  N +   +           
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA------ 76

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
               L+ L LS NQ   ELP  +      + V      ++  ++     N + ++ L   
Sbjct: 77  PLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTN 134

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQ 305
             +  G        +K L  + +    +         +LT                    
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT-------------------- 174

Query: 306 NKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTL 365
                               L L  N +       +  L NL  L +S N  S +   +L
Sbjct: 175 -------------------ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 215

Query: 366 STCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSG------QFPKFLENLSFL 419
           +    L  + +++N     +P  L   K I+ + +  NN S         P +    +  
Sbjct: 216 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274

Query: 420 EFLNLSYNHLE 430
             ++L  N ++
Sbjct: 275 SGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.3 bits (181), Expect = 5e-15
 Identities = 50/272 (18%), Positives = 93/272 (34%), Gaps = 28/272 (10%)

Query: 85  SSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNN 144
                  L +N+ +  +      NL NL  L +  N    + P + +    LE L LS N
Sbjct: 31  PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 145 QFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFL-----------------TNC 187
           Q K        +L+ L     E   +     N L  +  +                    
Sbjct: 90  QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
             L  + ++D      +      L  ++    + GN+I+      ++ L NL  L +  N
Sbjct: 150 KKLSYIRIADTN----ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK 307
            +       +    +L+ L L  N L   +P GL +   +  + L +N++    I S + 
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA--IGSNDF 262

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQ 339
                  +  S + +SL+   SN +    +  
Sbjct: 263 CPPGYNTKKASYSGVSLF---SNPVQYWEIQP 291

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 70.5 bits (171), Expect = 1e-13
 Identities = 51/297 (17%), Positives = 100/297 (33%), Gaps = 23/297 (7%)

Query: 4   QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNL 63
           ++PK++        L L  N +T        NL  L  + +  N +    P     L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 64  VQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF 123
            +L +++N+   +  +    +  L        +   S+   +  N   + ELG       
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSS 139

Query: 124 GLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTF 183
           G+   +      L  + +++       +I       L  L+L+ N +    A        
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAAS------ 190

Query: 184 LTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALA 243
           L   ++L  L LS N        S+AN  +  +  L   N     +P G+ +   +  + 
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLAN--TPHLRELHLNNNKLVKVPGGLADHKYIQVVY 248

Query: 244 VEVNQLHG------TIPDVIGELKNLQLLGLYKNFLQGS--IPSGLGNLTKLAKLDL 292
           +  N +          P    +  +   + L+ N +Q     PS    +   A + L
Sbjct: 249 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 63.5 bits (153), Expect = 2e-11
 Identities = 44/222 (19%), Positives = 73/222 (32%), Gaps = 28/222 (12%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
           +    P     L KL+ L L+ N L          L  L+V   +   +       L  +
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGAN 120
             + +L     K  G+   +   +  L Y  +     + ++P  +    P+L EL +  N
Sbjct: 127 IVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGN 181

Query: 121 NFFGLIPDSLSNASNLELLDLSNNQFKG-----------------------KVSIDFSSL 157
               +   SL   +NL  L LS N                           KV    +  
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241

Query: 158 KILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQ 199
           K +  + L  NN+    +ND     + T  +S   +SL  N 
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.3 bits (124), Expect = 7e-08
 Identities = 33/141 (23%), Positives = 55/141 (39%), Gaps = 6/141 (4%)

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT 364
            +  +  +P+ L   T     LDL NN +         NLKNL  L + +N+ S + P  
Sbjct: 18  SDLGLEKVPKDLPPDTA---LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL 424
            +  V LE + +S N    +        K+++ L V  N  +         L+ +  + L
Sbjct: 75  FAPLVKLERLYLSKNQLKELPE---KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131

Query: 425 SYNHLEGEVPTKGVFSNKSKI 445
             N L+      G F    K+
Sbjct: 132 GTNPLKSSGIENGAFQGMKKL 152

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.2 bits (170), Expect = 9e-14
 Identities = 43/257 (16%), Positives = 81/257 (31%), Gaps = 18/257 (7%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
           ++ + + L  N+       S     +  I++L                 +       +  
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG-------- 299
           QL    P     L  L  L L +  LQ   P     L  L  L L  N+LQ         
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 300 -----NFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISS 354
                +     N++     +    + +L     L  N +    P    +L  L+ L + +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLE 414
           N  S +    L+   +L+Y+ ++ N +      +      ++    S +      P+ L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 415 NLSFLEFLNLSYNHLEG 431
                    L+ N L+G
Sbjct: 270 GRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (163), Expect = 7e-13
 Identities = 55/271 (20%), Positives = 85/271 (31%), Gaps = 13/271 (4%)

Query: 29  LPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE 88
           +P  I      Q I + GN +      +    RNL  L +  N    +   +   ++ LE
Sbjct: 26  VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 89  YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKG 148
              L+ N    S+       L  L  L +       L P      + L+ L L +N  + 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 149 KVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSI 208
                F  L  L  L L  N +                  SL  L L  N+     PH+ 
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPER------AFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 209 ANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
            +L   ++   +  N +S      +  L  L  L +  N               LQ    
Sbjct: 198 RDL-GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRG 255

Query: 269 YKNFLQGSIPSGLGNLTKLAKLDLGSNSLQG 299
             + +  S+P  L          L +N LQG
Sbjct: 256 SSSEVPCSLPQRLAGRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (157), Expect = 4e-12
 Identities = 47/302 (15%), Positives = 84/302 (27%), Gaps = 50/302 (16%)

Query: 82  CNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDL 141
           C                 ++P  I       + + +  N    +   S     NL +L L
Sbjct: 8   CYNEPKVTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 142 SNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG 201
            +N      +  F+ L +L +L+L  N                     L  L L      
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQ-----LRSVDPATFHGLGRLHTLHLD-RCGL 117

Query: 202 GELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELK 261
            EL   +    + +    +  N +        R+L NL  L +  N++          L 
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177

Query: 262 NLQLLGLYKNFLQGSIPSGLGNLT------------------------KLAKLDLGSNSL 297
           +L  L L++N +    P    +L                          L  L L  N  
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

Query: 298 QGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
             +              +   +         S++ +  SLPQ    L    +  +++N  
Sbjct: 238 VCDC-------------RARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDL 281

Query: 358 SG 359
            G
Sbjct: 282 QG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (153), Expect = 1e-11
 Identities = 52/277 (18%), Positives = 90/277 (32%), Gaps = 25/277 (9%)

Query: 186 NCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE 245
           +C    + ++        +P +   +        + GN+IS       R   NL  L + 
Sbjct: 17  SCPQQGLQAVPVG-----IPAASQRIF-------LHGNRISHVPAASFRACRNLTILWLH 64

Query: 246 VNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI-PSGLGNLTKLAKLDLGSNSLQGNFIAS 304
            N L          L  L+ L L  N    S+ P+    L +L  L L            
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPG 123

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVT 364
             + + AL               L +N L         +L NL  L +  N+ S +    
Sbjct: 124 LFRGLAALQYL-----------YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172

Query: 365 LSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL 424
                SL+ + +  N    + P +   L  +  L +  NN S    + L  L  L++L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232

Query: 425 SYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGIDELH 461
           + N    +   + +++   K     +   C     L 
Sbjct: 233 NDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (147), Expect = 6e-11
 Identities = 40/219 (18%), Positives = 68/219 (31%), Gaps = 15/219 (6%)

Query: 80  SICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELL 139
            +  ++S           + +LP D+     +   L +  N  +     +L   + L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 140 DLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQ 199
           +L   +           L +L  L+L  N L                  S   L+     
Sbjct: 61  NLDRAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT----- 113

Query: 200 FGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGE 259
               LP         +    + GN++    P  +     L  L++  N L      ++  
Sbjct: 114 ---SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 260 LKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQ 298
           L+NL  L L +N L  +IP G      L    L  N   
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 1e-07
 Identities = 42/203 (20%), Positives = 69/203 (33%), Gaps = 17/203 (8%)

Query: 252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGA 311
            +P  +   K+  +L L +N L     + L   T+L +L+L    L    +         
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---- 77

Query: 312 LPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSL 371
                       L     ++    SLP     L  L +LD+S N+ + +    L     L
Sbjct: 78  -----------VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 372 EYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEG 431
           + + +  N    + P  L     ++ L ++ NN +      L  L  L+ L L  N L  
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT 186

Query: 432 EVPTKGVFSNKSKIPLQGNVRLC 454
                          L GN  LC
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 5e-05
 Identities = 41/233 (17%), Positives = 67/233 (28%), Gaps = 51/233 (21%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLT 185
           +P  L    +  +L LS N               L +LNL++             +T L 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-----------LTKLQ 71

Query: 186 NCSSLKVLSLSDNQFGGELPH-SIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
              +L VL   D           +      + V  +  N+++      +R L  L  L +
Sbjct: 72  VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIAS 304
           + N+L    P ++     L+ L L  N L       L  L  L  L L  NSL       
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY------ 185

Query: 305 QNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
                                          ++P+       L    +  N +
Sbjct: 186 -------------------------------TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 6e-04
 Identities = 42/210 (20%), Positives = 64/210 (30%), Gaps = 20/210 (9%)

Query: 185 TNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAV 244
           +  +S   ++         LP    +L     +  +  N +       +     L  L  
Sbjct: 7   SKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL-- 60

Query: 245 EVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGN------------LTKLAKLDL 292
            +++   T   V G L  L  L L  N LQ     G               LT L    L
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 293 GSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDI 352
                        N+ +  LP  LL+ T     L L+NN L       +  L+NL  L +
Sbjct: 121 RGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFH 382
             N     IP        L +  +  N + 
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 15/65 (23%), Positives = 20/65 (30%), Gaps = 3/65 (4%)

Query: 364 TLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLN 423
            +S   S   V+        + PP L   K    L +S N         L   + L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 424 LSYNH 428
           L    
Sbjct: 62  LDRAE 66

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.6 bits (128), Expect = 3e-09
 Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 6/109 (5%)

Query: 325 YLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGI 384
            L L++  L  ++   +  L  +  LD+S N+   + P  L+    LE +  S N    +
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 385 IPPSLGFLKSIKFLDVSCNNF-SGQFPKFLENLSFLEFLNLSYNHLEGE 432
               +  L  ++ L +  N        + L +   L  LNL  N L  E
Sbjct: 59  --DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 1e-05
 Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 12/106 (11%)

Query: 264 QLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNF--IASQNKLIGALPQQLLSITT 321
           ++L L    L  ++   L  L  +  LDL  N L+     +A+   L             
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 322 LS-------LYLDLSNNLLNG-SLPQQVGNLKNLIILDISSNQFSG 359
                      L L NN L   +  Q + +   L++L++  N    
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 7e-05
 Identities = 26/126 (20%), Positives = 49/126 (38%), Gaps = 7/126 (5%)

Query: 40  QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSG 99
           +V+H+    L       L  L  +  L+++ N+   + P     +++L    +     + 
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54

Query: 100 SLPFDIVVNLPNLKELGIGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLK 158
               D V NLP L+EL +  N          L +   L LL+L  N    +  I     +
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 159 ILWRLN 164
           +L  ++
Sbjct: 115 MLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 9e-05
 Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 5/107 (4%)

Query: 16  QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYG 75
           + L LA   LT      +  L  +  + +  N L    P  L  LR L  L    +    
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQA--SDNAL 55

Query: 76  MFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF 122
                + N+  L+   L +NR   S     +V+ P L  L +  N+ 
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.003
 Identities = 20/112 (17%), Positives = 34/112 (30%), Gaps = 29/112 (25%)

Query: 126 IPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWR----------------------L 163
           +   L     +  LDLS+N+ +       ++L+ L                        L
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQEL 70

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTM 215
            L  N L          +  L +C  L +L+L  N    E       L+  +
Sbjct: 71  LLCNNRL-----QQSAAIQPLVSCPRLVLLNLQGNSLCQE-EGIQERLAEML 116

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 43/296 (14%), Positives = 93/296 (31%), Gaps = 29/296 (9%)

Query: 115 LGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA 174
           L +   N    +   L  +  +       +     ++  FS  + +  ++L  + +    
Sbjct: 5   LDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI---- 58

Query: 175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSS-TMIVFLIGGNQISGTIPLGI 233
                    L+ CS L+ LSL   +    + +++A  S+   +            +   +
Sbjct: 59  -EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 234 RNLVNLIALAVEVNQLHG------TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKL 287
            +   L  L +              +  V   +  L L G  KN  +  + + +     L
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 288 AKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSN-NLLNGSLPQQVGNLKN 346
             LD            S + ++     Q         +L LS    +      ++G +  
Sbjct: 178 VHLD-----------LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 347 LIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSC 402
           L  L +      G + +       L    I+ + F  I  P++G  K+ +   + C
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGNKKNQEIWGIKC 279

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 5e-07
 Identities = 38/251 (15%), Positives = 80/251 (31%), Gaps = 5/251 (1%)

Query: 40  QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSG 99
           Q + + G +L       L L + ++      +               +++  L+++    
Sbjct: 3   QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEV 60

Query: 100 SLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLS--NNQFKGKVSIDFSSL 157
           S    I+     L+ L +        I ++L+  SNL  L+LS  +   +  +    SS 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 158 KILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIV 217
             L  LNL            +         + L +     N    +L   +    + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 218 FLIGGNQISGTIPLGIRNLVNLIALAVE-VNQLHGTIPDVIGELKNLQLLGLYKNFLQGS 276
            L     +          L  L  L++     +       +GE+  L+ L ++     G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 277 IPSGLGNLTKL 287
           +      L  L
Sbjct: 241 LQLLKEALPHL 251

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 8e-07
 Identities = 38/287 (13%), Positives = 87/287 (30%), Gaps = 15/287 (5%)

Query: 139 LDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDN 198
           LDL+       V+    S  ++      ++ +    A          +   ++ + LS++
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHF-------SPFRVQHMDLSNS 56

Query: 199 QFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIG 258
                  H I +  S +    + G ++S  I   +    NL+ L +              
Sbjct: 57  VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116

Query: 259 ELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLS 318
                +L  L  ++        +          +   +L G     +N     L   +  
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR---KNLQKSDLSTLVRR 173

Query: 319 ITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISS-NQFSGMIPVTLSTCVSLEYVDIS 377
              L       + +L     Q+   L  L  L +S          + L    +L+ + + 
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233

Query: 378 SNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL 424
                G +       +++  L ++C++F+      + N    E   +
Sbjct: 234 GIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 1e-05
 Identities = 35/245 (14%), Positives = 81/245 (33%), Gaps = 10/245 (4%)

Query: 193 LSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG- 251
           L L+      ++   +  LS  +I F    + +   +         +  + +  + +   
Sbjct: 5   LDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61

Query: 252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGA 311
           T+  ++ +   LQ L L    L   I + L   + L +L+L       +  +        
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC----SGFSEFALQTLL 117

Query: 312 LPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSL 371
                L    LS   D +   +  ++      +  L +     N     +   +  C +L
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 372 EYVDISSNCFH-GIIPPSLGFLKSIKFLDVS-CNNFSGQFPKFLENLSFLEFLNLSYNHL 429
            ++D+S +             L  ++ L +S C +   +    L  +  L+ L +     
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 430 EGEVP 434
           +G + 
Sbjct: 238 DGTLQ 242

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 1e-08
 Identities = 13/78 (16%), Positives = 28/78 (35%), Gaps = 3/78 (3%)

Query: 135 NLELLDLSNNQFKGK-VSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVL 193
           +++ LD+   +      +     L+    + L+   L      D+   + L    +L  L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS--SALRVNPALAEL 60

Query: 194 SLSDNQFGGELPHSIANL 211
           +L  N+ G    H +   
Sbjct: 61  NLRSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 4e-06
 Identities = 9/89 (10%), Positives = 27/89 (30%), Gaps = 4/89 (4%)

Query: 86  SLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNF----FGLIPDSLSNASNLELLDL 141
            ++   +     S +   +++  L   + + +            I  +L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 142 SNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
            +N+                   +++ +L
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 4e-06
 Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 6/87 (6%)

Query: 154 FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGE----LPHSIA 209
                +L  L L   ++   + + L     L    SL+ L LS+N  G      L  S+ 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLA--ATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 210 NLSSTMIVFLIGGNQISGTIPLGIRNL 236
                +   ++     S  +   ++ L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 8/94 (8%)

Query: 237 VNLIALAVEVNQL-HGTIPDVIGELKNLQLLGLYKNFLQG----SIPSGLGNLTKLAKLD 291
           +++ +L ++  +L      +++  L+  Q++ L    L       I S L     LA+L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 292 LGSNSLQGNFIASQNKLIGALPQQLLSITTLSLY 325
           L SN L    +     ++  L      I  LSL 
Sbjct: 62  LRSNELGDVGVHC---VLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 2e-05
 Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 9/83 (10%)

Query: 343 NLKNLIILDISSNQFSGM----IPVTLSTCVSLEYVDISSNCFHGIIPPSLG-----FLK 393
               L +L ++    S      +  TL    SL  +D+S+NC        L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 394 SIKFLDVSCNNFSGQFPKFLENL 416
            ++ L +    +S +    L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 13/84 (15%), Positives = 25/84 (29%), Gaps = 9/84 (10%)

Query: 360 MIPVTLSTCVSLEYVDISSNCFHGI----IPPSLGFLKSIKFLDVSCNNFSGQFPKFL-- 413
           +          L  + ++           +  +L    S++ LD+S N         L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

Query: 414 ---ENLSFLEFLNLSYNHLEGEVP 434
              +    LE L L   +   E+ 
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 11/115 (9%), Positives = 33/115 (28%), Gaps = 27/115 (23%)

Query: 321 TLSL-YLDLS-NNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISS 378
           +L +  LD+    L +    + +  L+   ++ +     +      +S+           
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS----------- 49

Query: 379 NCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFL-----ENLSFLEFLNLSYNH 428
                    +L    ++  L++  N         +          ++ L+L    
Sbjct: 50  ---------ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 11/69 (15%), Positives = 20/69 (28%), Gaps = 5/69 (7%)

Query: 369 VSLEYVDISSNCF-HGIIPPSLGFLKSIKFLDVSCNNFSGQ----FPKFLENLSFLEFLN 423
           + ++ +DI             L  L+  + + +     +          L     L  LN
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 424 LSYNHLEGE 432
           L  N L   
Sbjct: 62  LRSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 15/78 (19%), Positives = 29/78 (37%), Gaps = 9/78 (11%)

Query: 325 YLDLSNNLLNG----SLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCV-----SLEYVD 375
            L L++  ++     SL   +    +L  LD+S+N       + L   V      LE + 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 376 ISSNCFHGIIPPSLGFLK 393
           +    +   +   L  L+
Sbjct: 433 LYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 6/95 (6%)

Query: 111 NLKELGIGANNFFGL-IPDSLSNASNLELLDLSNNQFKGKVSIDFSS----LKILWRLNL 165
           +++ L I           + L      +++ L +         D SS       L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 166 EQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
             N LG    + +      T    ++ LSL +   
Sbjct: 63  RSNELGDVGVHCVLQG-LQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 18/98 (18%), Positives = 38/98 (38%), Gaps = 15/98 (15%)

Query: 261 KNLQLLGLYKNFLQG----SIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQL 316
             L++L L    +      S+ + L     L +LDL +N L    I     L+ ++ Q  
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ---LVESVRQPG 425

Query: 317 LSITTLSLYLDLSNNLLNGSLPQQVGNLK----NLIIL 350
             +      L L +   +  +  ++  L+    +L ++
Sbjct: 426 CLLEQ----LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 16/108 (14%), Positives = 28/108 (25%), Gaps = 29/108 (26%)

Query: 108 NLPNLKELGIGANNF----FGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRL 163
               L+ L +   +        +  +L    +L  LDLSNN       +           
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE------- 419

Query: 164 NLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL 211
                             +       L+ L L D  +  E+   +  L
Sbjct: 420 ------------------SVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 8/91 (8%)

Query: 76  MFPRSICNISSLEYFYLTSNRFSGSLPFDI---VVNLPNLKELGIGANNFFGLIPDSLSN 132
           +        S L   +L     S S    +   ++   +L+EL +  N         L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

Query: 133 A-----SNLELLDLSNNQFKGKVSIDFSSLK 158
           +       LE L L +  +  ++     +L+
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 10/77 (12%), Positives = 25/77 (32%), Gaps = 8/77 (10%)

Query: 160 LWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANL--SSTMIV 217
           +  L+++   L      D  +   L      +V+ L D          I++    +  + 
Sbjct: 4   IQSLDIQCEELS-----DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 218 FL-IGGNQISGTIPLGI 233
            L +  N++       +
Sbjct: 59  ELNLRSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 12/90 (13%), Positives = 28/90 (31%), Gaps = 5/90 (5%)

Query: 15 LQALALAGNYLTGK-LPDFIGNLSALQVIHIKGNSLGGK----FPTTLGLLRNLVQLNVA 69
          +Q+L +    L+     + +  L   QV+ +    L         + L +   L +LN+ 
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 70 ENKFYGMFPRSICNISSLEYFYLTSNRFSG 99
           N+   +    +          +       
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 14/105 (13%), Positives = 33/105 (31%), Gaps = 20/105 (19%)

Query: 287 LAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNG----SLPQQVG 342
           +  LD+    L     A   +L+  L Q           + L +  L       +   + 
Sbjct: 4   IQSLDIQCEELSDARWA---ELLPLLQQ--------CQVVRLDDCGLTEARCKDISSALR 52

Query: 343 NLKNLIILDISSNQFSGMIPVTL-----STCVSLEYVDISSNCFH 382
               L  L++ SN+   +    +     +    ++ + + + C  
Sbjct: 53  VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 35/217 (16%), Positives = 61/217 (28%), Gaps = 34/217 (15%)

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
            L N I +A   + +  T+     +L  +  L  +   +      G+  L  L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 295 NSLQGNFIASQNKLIGALPQQLLSITTL-------------------SLYLDLSNNLLNG 335
           N +           I  L      +  +                   +    L+      
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 336 SLPQQVGNLKNLIILDI-------SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPS 388
            L   +  + N+  L         S           L+    L  +    N    I P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 389 LGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLS 425
           L  L ++  + +  N  S   P  L N S L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 4e-06
 Identities = 20/71 (28%), Positives = 31/71 (43%), Gaps = 5/71 (7%)

Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
                   + N+S L       N+ S   P     +LPNL E+ +  N    + P  L+N
Sbjct: 161 AQVSDLTPLANLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP--LAN 215

Query: 133 ASNLELLDLSN 143
            SNL ++ L+N
Sbjct: 216 TSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 8e-04
 Identities = 33/220 (15%), Positives = 64/220 (29%), Gaps = 42/220 (19%)

Query: 108 NLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLE 166
            L N  ++  G +N    +  + ++   +  L           +I+    L  L  L L+
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLELK 71

Query: 167 QNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHS------------------- 207
            N +   A             S   + ++S       +                      
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 208 ------------IANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPD 255
                       I+ L+    +  +       +    + NL  L  L  + N++    P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 256 VIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSN 295
            +  L NL  + L  N +    P  L N + L  + L +N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 18/94 (19%), Positives = 31/94 (32%), Gaps = 4/94 (4%)

Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
                  +I  ++ L      S   +       + NL  L  L    N    + P  L++
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193

Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLE 166
             NL  + L NNQ         ++   L+ + L 
Sbjct: 194 LPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 38/237 (16%), Positives = 71/237 (29%), Gaps = 58/237 (24%)

Query: 6   PKEIGSLF------KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGL 59
           P  I  +F          +A   + +T  +     +L  +  +   G  +       +  
Sbjct: 6   PTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQY 61

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTS--------------------NRFSG 99
           L NL+ L + +N+   + P       +                             + + 
Sbjct: 62  LNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121

Query: 100 SLPFDIVVNLPNLKELGIGANNFFGLI-----------------PDSLSNASNLELLDLS 142
             P   + NL  L        N   L                     L+N S L  L   
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181

Query: 143 NNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQ 199
           +N+         +SL  L  ++L+ N         +  V+ L N S+L +++L+ NQ
Sbjct: 182 DNKISD--ISPLASLPNLIEVHLKNNQ--------ISDVSPLANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 34/216 (15%), Positives = 68/216 (31%), Gaps = 16/216 (7%)

Query: 60  LRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA 119
           L N +++   ++       ++  ++  +          +     + V  L NL  L +  
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKD 72

Query: 120 NNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN-------LEQNNLGI 172
           N    L P           L  +  +    ++   S   +            L   +   
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 173 GAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLG 232
               DL  +T ++  + L  L             +     S +       N+IS   PL 
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192

Query: 233 IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGL 268
             +L NLI + ++ NQ+    P  +    NL ++ L
Sbjct: 193 --SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 2e-06
 Identities = 38/206 (18%), Positives = 70/206 (33%), Gaps = 14/206 (6%)

Query: 228 TIPLGI------RNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGL 281
           T+P  I            I   ++   +   +     EL ++  +    + ++     G+
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGI 64

Query: 282 GNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQV 341
             L  + KL L  N L      +  K +G L      +  LS   DL            +
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGII--PPSLGFLKSIKFLD 399
            ++  L+ L    + + G   +T  T +S      + +     I     L  L  ++ L 
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLY 184

Query: 400 VSCNNFSGQFPKFLENLSFLEFLNLS 425
           +S N+ S    + L  L  L+ L L 
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 5e-04
 Identities = 39/216 (18%), Positives = 68/216 (31%), Gaps = 20/216 (9%)

Query: 91  YLTSNRFSGSLPFDIVVNLPNLKEL---GIGANNFFGLIPDSLSNASNLELLDLSNNQFK 147
            L S   +   P   + +     E     +   +    +  + +  ++++ +  +N+  K
Sbjct: 2   PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK 59

Query: 148 GKVSIDFSSLKILWRLNLEQN---------NLGIGAANDLGFVTFLTNCSSLKVLSLSDN 198
               I +  L  + +L L  N         NL       L         S   +  L   
Sbjct: 60  SVQGIQY--LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117

Query: 199 QFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIG 258
                    I  L     +  +       T    +  L  L  L++E NQ+   +P  + 
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LA 175

Query: 259 ELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
            L  LQ L L KN +       L  L  L  L+L S
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 3e-06
 Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 9/96 (9%)

Query: 328 LSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPP 387
              N  +  +        +L  L++S+N+    +P        LE +  S N    +  P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAEV--P 320

Query: 388 SLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLN 423
            L   +++K L V  N    +FP   E++  L   +
Sbjct: 321 EL--PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 10/83 (12%)

Query: 183 FLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL 242
                 SL+ L++S+N+   ELP     L       +   N ++  +P   +NL  L   
Sbjct: 279 LCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPELPQNLKQLH-- 330

Query: 243 AVEVNQLHGTIPDVIGELKNLQL 265
            VE N L    PD+   +++L++
Sbjct: 331 -VEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 5e-06
 Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 21/101 (20%)

Query: 247 NQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQN 306
           N     I  +     +L+ L +  N L   +P+    L    +L    N L         
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-------- 317

Query: 307 KLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNL 347
                +P+   ++      L +  N L    P    ++++L
Sbjct: 318 ----EVPELPQNLK----QLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 11/94 (11%)

Query: 71  NKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSL 130
           N              SLE   +++N+    LP       P L+ L     N    +P+  
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELP----ALPPRLERLIAS-FNHLAEVPELP 323

Query: 131 SNASNLELLDLSNNQFKGKVSIDFSSLKILWRLN 164
            N   L+ L +  N  +    I   S++ L R+N
Sbjct: 324 QN---LKQLHVEYNPLREFPDI-PESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.0 bits (102), Expect = 4e-05
 Identities = 20/77 (25%), Positives = 34/77 (44%), Gaps = 8/77 (10%)

Query: 355 NQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLE 414
           N  S  I        SLE +++S+N    + P     L+    L  S N+ + + P+  +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIEL-PALPPRLER---LIASFNHLA-EVPELPQ 324

Query: 415 NLSFLEFLNLSYNHLEG 431
           NL   + L++ YN L  
Sbjct: 325 NL---KQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 4e-04
 Identities = 17/99 (17%), Positives = 28/99 (28%), Gaps = 16/99 (16%)

Query: 141 LSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQF 200
              N    ++         L  LN+  N L          +        L+ L  S N  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL----------IELPALPPRLERLIASFNHL 316

Query: 201 GGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNL 239
             E+P    NL        +  N +    P    ++ +L
Sbjct: 317 -AEVPELPQNLKQ----LHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 5e-04
 Identities = 23/98 (23%), Positives = 37/98 (37%), Gaps = 8/98 (8%)

Query: 73  FYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSN 132
            +     +I +  S     L     S +    +    P+L+EL +  NN    +P     
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS-NNKLIELPALP-- 303

Query: 133 ASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
              LE L  S N    +V     +LK   +L++E N L
Sbjct: 304 -PRLERLIASFNHLA-EVPELPQNLK---QLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 24/111 (21%), Positives = 36/111 (32%), Gaps = 24/111 (21%)

Query: 268 LYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLD 327
            Y N     I S       L +L++ +N L              LP     +      L 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI------------ELPALPPRLE----RLI 310

Query: 328 LSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISS 378
            S N L   +P+   NLK    L +  N      P       S+E + ++S
Sbjct: 311 ASFNHLA-EVPELPQNLKQ---LHVEYNPLRE-FPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.5 bits (85), Expect = 0.004
 Identities = 21/87 (24%), Positives = 33/87 (37%), Gaps = 9/87 (10%)

Query: 1   LEGQIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLL 60
              +I         L+ L ++ N L  +LP     L   + +    N L  + P    L 
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP---ELP 323

Query: 61  RNLVQLNVAENKFYGMFPRSICNISSL 87
           +NL QL+V  N     FP    ++  L
Sbjct: 324 QNLKQLHVEYNPLRE-FPDIPESVEDL 349

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 3e-05
 Identities = 39/313 (12%), Positives = 95/313 (30%), Gaps = 19/313 (6%)

Query: 135 NLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLS 194
           +L+L  ++    K  V         +  + L  N +G  AA  L     + +   L++  
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLS--ENIASKKDLEIAE 65

Query: 195 LSDNQ---FGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG 251
            SD        E+P ++  L   ++      + +  +           +   +  +    
Sbjct: 66  FSDIFTGRVKDEIPEALRLLLQALL-KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGA 311
            +      L       + +   + ++     N   L  +  G N L+   +    K   +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 312 LPQ-QLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVS 370
                 + +    +  +   +LL   L          +  +  ++  S  + + L +  +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244

Query: 371 LEYVDISSNCFHGIIPPSLGF------LKSIKFLDVSCNNFSGQFPKFL-----ENLSFL 419
           L  + ++          ++           ++ L +  N       + L     E +  L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304

Query: 420 EFLNLSYNHLEGE 432
            FL L+ N    E
Sbjct: 305 LFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 14/92 (15%), Positives = 29/92 (31%), Gaps = 4/92 (4%)

Query: 317 LSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSG----MIPVTLSTCVSLE 372
            SI   SL LD        S+   +    ++  + +S N         +   +++   LE
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 373 YVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN 404
             + S      +       L+ +    + C  
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPK 94

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 5e-05
 Identities = 12/57 (21%), Positives = 15/57 (26%)

Query: 89  YFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQ 145
              L+ N     LP D+         L I       L    L N   L      N +
Sbjct: 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 6e-04
 Identities = 12/76 (15%), Positives = 20/76 (26%)

Query: 350 LDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQF 409
           L ++ N    +     +     E     +N    +             LD+S        
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 410 PKFLENLSFLEFLNLS 425
              LENL  L   +  
Sbjct: 218 SYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.002
 Identities = 13/46 (28%), Positives = 18/46 (39%), Gaps = 2/46 (4%)

Query: 125 LIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL 170
           L  D    AS   +LD+S  +     S    +LK L   +    NL
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 7/38 (18%), Positives = 11/38 (28%)

Query: 342 GNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSN 379
                 +ILDIS  +   +    L     L      + 
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 7e-05
 Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 5/103 (4%)

Query: 328 LSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPP 387
           L+  L+  +   Q  N      LD+   +   +I    +T    + +D S N    +   
Sbjct: 3   LTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--D 57

Query: 388 SLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLE 430
               L+ +K L V+ N          + L  L  L L+ N L 
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.003
 Identities = 14/78 (17%), Positives = 29/78 (37%), Gaps = 6/78 (7%)

Query: 92  LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVS 151
           LT+     +  +    N    +EL +       +I +  +     + +D S+N+   +  
Sbjct: 3   LTAELIEQAAQY---TNAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEI--RKL 56

Query: 152 IDFSSLKILWRLNLEQNN 169
             F  L+ L  L +  N 
Sbjct: 57  DGFPLLRRLKTLLVNNNR 74

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 31/190 (16%), Positives = 63/190 (33%), Gaps = 8/190 (4%)

Query: 235 NLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGS 294
            L   +   +    +  T+     +L  +  L   +  ++ SI  G+  L  L +++  +
Sbjct: 16  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 71

Query: 295 NSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILD--I 352
           N L           +  +      I  ++   +L+N         Q+ ++  L  L    
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 353 SSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKF 412
                S  I    +         ++ +         L  L +++ LD+S N  S      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 413 LENLSFLEFL 422
           L  L+ LE L
Sbjct: 190 LAKLTNLESL 199

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.6 bits (93), Expect = 3e-04
 Identities = 31/170 (18%), Positives = 58/170 (34%), Gaps = 16/170 (9%)

Query: 188 SSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN 247
                L L+DN+ G      +      ++   +  NQ++G  P       ++  L +  N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 248 QLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNK 307
           ++      +   L  L+ L LY N +   +P    +L  L  L+L SN    N       
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC------ 142

Query: 308 LIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQF 357
                   L           L+        P     ++++ I D+  ++F
Sbjct: 143 -------HLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 21/106 (19%), Positives = 41/106 (38%), Gaps = 5/106 (4%)

Query: 42  IHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSL 101
           + +  N +          L  L  LN+ +N+   + P S  +++SL    L SN F+ + 
Sbjct: 83  LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142

Query: 102 PFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK 147
                      K L           P  + +   +++ DL +++FK
Sbjct: 143 HLAWFAEWLRKKSLNG--GAARCGAPSKVRD---VQIKDLPHSEFK 183

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	725
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.98
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.98
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.98
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.91
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.84
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.82
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.79
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.68
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.67
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.63
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.61
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.56
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.53
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.49
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.47
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.47
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.81
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.75
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.4
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.78
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.67
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.04
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.03
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.92
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.44

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-38  Score=315.87  Aligned_cols=174  Identities=24%  Similarity=0.376  Sum_probs=148.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||+||+|+++.+|+.||||+++... ....+++.+|++++++++|||||++++++....     ..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----ee
Confidence            457999999999999999999999999999999997653 233467899999999999999999999987655     88


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|||||+||+|.+++....      .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence            99999999999999997654      689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+........      ......+||+.|||||++.
T Consensus       150 a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~  178 (271)
T d1nvra_         150 ATVFRYNNRE------RLLNKMCGTLPYVAPELLK  178 (271)
T ss_dssp             CEECEETTEE------CCBCCCCSCGGGSCTHHHH
T ss_pred             heeeccCCcc------ccccceeeCcCccCHhHhc
Confidence            9876543211      1122367999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-37  Score=311.88  Aligned_cols=170  Identities=25%  Similarity=0.388  Sum_probs=150.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++...+     ..|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence            46999999999999999999999999999999998766666678999999999999999999999987655     8899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||||+||+|.+++.+.       .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        95 vmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            99999999999988653       489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .+.....        .....+||+.|||||++.
T Consensus       165 ~~~~~~~--------~~~~~~gt~~Y~aPE~~~  189 (293)
T d1yhwa1         165 QITPEQS--------KRSTMVGTPYWMAPEVVT  189 (293)
T ss_dssp             ECCSTTC--------CBCCCCSCGGGCCHHHHS
T ss_pred             eeccccc--------cccccccCCCccChhhhc
Confidence            7643321        122357999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-37  Score=304.72  Aligned_cols=169  Identities=25%  Similarity=0.425  Sum_probs=149.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   +....+++.+|++++++++|||||++++++....     .
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----R   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-----E
Confidence            5789999999999999999999999999999999743   2344578899999999999999999999987654     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||++|+|.+++....      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence            899999999999999998654      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.....          .....+||+.|||||++.
T Consensus       152 ~a~~~~~~----------~~~~~~Gt~~Y~APE~~~  177 (263)
T d2j4za1         152 WSVHAPSS----------RRTTLCGTLDYLPPEMIE  177 (263)
T ss_dssp             SCSCCCCC----------CCEETTEEGGGCCHHHHT
T ss_pred             eeeecCCC----------cccccCCCCcccCHHHHc
Confidence            99765332          112357999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=311.55  Aligned_cols=171  Identities=23%  Similarity=0.388  Sum_probs=150.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      +.|++.+.||+|+||+||+|+++.+++.||||+++.......+++.+|++++++++|||||++++++....     ..|+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence            46888999999999999999999999999999998766666778999999999999999999999987655     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||||++|+|.+++.+...     .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999875432     589999999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......        ....+.+||+.|||||++
T Consensus       159 ~~~~~~--------~~~~~~~Gt~~y~APE~l  182 (288)
T d2jfla1         159 KNTRTI--------QRRDSFIGTPYWMAPEVV  182 (288)
T ss_dssp             ECHHHH--------HHHTCCCSCCTTCCHHHH
T ss_pred             ccCCCc--------ccccccccccccCCHHHH
Confidence            653321        112235799999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=307.48  Aligned_cols=173  Identities=25%  Similarity=0.414  Sum_probs=148.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||+||+|+++.+++.||||++...   +....+.+.+|++++++++||||+++++++....     .
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-----E
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-----E
Confidence            5799999999999999999999999999999999753   2345578999999999999999999999976554     8


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||+||+|.+++....      .+++..+..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            899999999999999988665      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+......      ......+||+.|||||++.
T Consensus       154 ~a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~  183 (288)
T d1uu3a_         154 TAKVLSPESKQ------ARANSFVGTAQYVSPELLT  183 (288)
T ss_dssp             TCEECC----------------CCCCGGGCCHHHHH
T ss_pred             cceecccCCcc------cccccccCCccccCceeec
Confidence            99876433211      1122367999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-37  Score=315.42  Aligned_cols=170  Identities=23%  Similarity=0.376  Sum_probs=149.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .++|+..+.||+|+||+||+|+++.+|+.||+|+++... ....+++.+|++++++++|||||+++++|....     ..
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence            468999999999999999999999999999999997653 344578999999999999999999999987654     79


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      |+|||||+||+|.+++.+..      .+++..+..++.|++.||+|||+ +   +|+||||||+|||++.++.+||+|||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            99999999999999998654      58999999999999999999997 5   89999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+.+..          ..+.+||+.|||||++.
T Consensus       151 la~~~~~~~----------~~~~~GT~~Y~APEvl~  176 (322)
T d1s9ja_         151 VSGQLIDSM----------ANSFVGTRSYMSPERLQ  176 (322)
T ss_dssp             CCHHHHHHT----------C---CCSSCCCCHHHHH
T ss_pred             CccccCCCc----------cccccCCccccCchHHc
Confidence            998764321          12367999999999863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-37  Score=306.65  Aligned_cols=180  Identities=25%  Similarity=0.373  Sum_probs=139.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  +...+.+.+|++++++++|||||++++++....   .+..
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence            57999999999999999999999999999999997653  334567899999999999999999999886432   2367


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEecCCCCCCeeecCCCceEEccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC--QPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      |+|||||++|+|.+++.+...  ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            999999999999999875321  1125899999999999999999999862  124999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.+.....        .....+||+.|||||++.
T Consensus       159 G~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~  187 (269)
T d2java1         159 GLARILNHDTS--------FAKAFVGTPYYMSPEQMN  187 (269)
T ss_dssp             HHHHHC-------------------CCCSCCCHHHHT
T ss_pred             cceeecccCCC--------ccccCCCCcccCCHHHHc
Confidence            99987644311        112367999999999863

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-36  Score=299.04  Aligned_cols=171  Identities=28%  Similarity=0.468  Sum_probs=144.1

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +..+.||+|+||+||+|+++.+++.||+|++....  ....++|.+|++++++++|||||++++++.... .+....|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence            55678999999999999999999999999997553  334567999999999999999999999976432 333568999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec-CCCceEEccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVGDFGLAK  691 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~-~~~~~kl~Dfgla~  691 (725)
                      ||||++|+|.+++.+..      .+++..+..++.||+.||+|||++ .++|+||||||+|||++ .++.+||+|||+|+
T Consensus        91 mE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999998654      589999999999999999999998 22399999999999996 57899999999997


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .....          ...+.+||+.|||||++
T Consensus       164 ~~~~~----------~~~~~~GT~~Y~aPE~~  185 (270)
T d1t4ha_         164 LKRAS----------FAKAVIGTPEFMAPEMY  185 (270)
T ss_dssp             GCCTT----------SBEESCSSCCCCCGGGG
T ss_pred             eccCC----------ccCCcccCccccCHHHh
Confidence            54221          12246799999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.4e-37  Score=308.40  Aligned_cols=175  Identities=26%  Similarity=0.544  Sum_probs=150.4

Q ss_pred             HHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          529 KATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       529 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ...++|+..+.||+|+||+||+|+++.+++.||||+++.+. ...++|.+|++++++++|||||+++++|...+     .
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~   87 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----P   87 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----e
Confidence            34567888999999999999999999899999999997543 34578999999999999999999999986554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||++|+|.+++.....    ..+++..+..|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             eEEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence            8999999999999999976542    2689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.......       ....+..||+.|||||++
T Consensus       161 ~a~~~~~~~~-------~~~~~~~g~~~y~aPE~~  188 (287)
T d1opja_         161 LSRLMTGDTY-------TAHAGAKFPIKWTAPESL  188 (287)
T ss_dssp             CTTTCCSSSS-------EEETTEEECGGGCCHHHH
T ss_pred             ceeecCCCCc-------eeeccccccccccChHHH
Confidence            9987643311       112234589999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-36  Score=304.83  Aligned_cols=171  Identities=31%  Similarity=0.520  Sum_probs=141.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||+||+|+++.   .||||+++..  .....++|.+|++++++++|||||++++++...      .
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------Q   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------S
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------E
Confidence            4678999999999999999998642   5999999754  344567899999999999999999999987533      4


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++|||||++|+|.+++.....     .+++..+..|+.||++||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            7899999999999999976542     589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+........      ......+||+.|||||++.
T Consensus       150 la~~~~~~~~~------~~~~~~~gt~~y~APE~l~  179 (276)
T d1uwha_         150 LATVKSRWSGS------HQFEQLSGSILWMAPEVIR  179 (276)
T ss_dssp             CSCC------------------CCCCGGGCCHHHHT
T ss_pred             ceeeccccCCc------ccccccccCcccCCHHHHh
Confidence            99876432111      1122357999999999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-36  Score=307.34  Aligned_cols=172  Identities=27%  Similarity=0.355  Sum_probs=151.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+++.+|++++++++||||+++++++....     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-----
Confidence            45799999999999999999999999999999999754   2345678899999999999999999999976654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|||||+||+|.+++....      .+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence            8999999999999999998765      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......        ......+||+.|||||++.
T Consensus       150 G~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~  178 (337)
T d1o6la_         150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             TTCBCSCCTT--------CCBCCCEECGGGCCGGGGS
T ss_pred             ccccccccCC--------cccccceeCHHHhhhhhcc
Confidence            9998654321        1122468999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-36  Score=306.24  Aligned_cols=166  Identities=27%  Similarity=0.409  Sum_probs=146.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---chHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .|+..+.||+|+||+||+|++..+++.||||++.....   ...+++.+|++++++++|||||++++++....     ..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----EE
Confidence            48889999999999999999999999999999976532   33467899999999999999999999987654     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+|||||++|++..++....      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             EEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccc
Confidence            99999999999987766543      689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.....            ...+||+.|||||++.
T Consensus       162 a~~~~~~------------~~~~GT~~Y~APE~~~  184 (309)
T d1u5ra_         162 ASIMAPA------------NSFVGTPYWMAPEVIL  184 (309)
T ss_dssp             CBSSSSB------------CCCCSCGGGCCHHHHT
T ss_pred             ccccCCC------------CccccCccccCHHHHh
Confidence            9865321            1257999999999863

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-35  Score=308.01  Aligned_cols=171  Identities=21%  Similarity=0.336  Sum_probs=149.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++....     ..|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            458999999999999999999999999999999997665556678999999999999999999999977654     899


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC--CCceEEcccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH--DMVAHVGDFG  688 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~--~~~~kl~Dfg  688 (725)
                      +|||||+||+|.+++.....     .+++..+..|+.||+.||+|||++   +||||||||+|||++.  ++.+||+|||
T Consensus       100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence            99999999999999965432     589999999999999999999999   9999999999999964  5789999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|+.+....         .....+||+.|||||++
T Consensus       172 ~a~~~~~~~---------~~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         172 LTAHLDPKQ---------SVKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             TCEECCTTS---------CEEEECSCTTTCCHHHH
T ss_pred             hheeccccc---------ccceecCcccccCHHHH
Confidence            998764321         12236799999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-35  Score=302.68  Aligned_cols=169  Identities=26%  Similarity=0.381  Sum_probs=149.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.++++++|||||++++++....     
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----   77 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----   77 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-----
Confidence            35799999999999999999999999999999999753   2344678999999999999999999999976554     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|||||+||++.+++....      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eeeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecC
Confidence            8999999999999999988765      578888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.....           ..+.+||+.|||||++.
T Consensus       149 G~a~~~~~~-----------~~~~~Gt~~Y~APE~l~  174 (316)
T d1fota_         149 GFAKYVPDV-----------TYTLCGTPDYIAPEVVS  174 (316)
T ss_dssp             SSCEECSSC-----------BCCCCSCTTTCCHHHHT
T ss_pred             ccceEeccc-----------cccccCcccccCHHHHc
Confidence            999876432           12367999999999863

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-36  Score=303.45  Aligned_cols=171  Identities=28%  Similarity=0.407  Sum_probs=132.8

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      .+.|+..+.||+|+||+||+|+++.+++.||||++.... ......+.+|++++++++|||||++++++....     ..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-----HL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence            356899999999999999999999999999999997553 233456889999999999999999999976554     88


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec---CCCceEEcc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVGD  686 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~---~~~~~kl~D  686 (725)
                      |+|||||+||+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||++.   .++.+||+|
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence            99999999999999997654      589999999999999999999999   999999999999995   578999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ||+|+......         ...+.+||+.|||||++.
T Consensus       154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~  182 (307)
T d1a06a_         154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLA  182 (307)
T ss_dssp             C---------------------------CTTSCHHHHT
T ss_pred             cceeEEccCCC---------eeeeeeeCccccCcHHHc
Confidence            99998654321         112367999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-35  Score=301.66  Aligned_cols=176  Identities=30%  Similarity=0.519  Sum_probs=133.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce---EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM---IVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||+||+|+++.+++   .||||++... .....++|.+|++++++++|||||+++|+|....     
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-----  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----
Confidence            456667899999999999999876654   6889988654 3344578999999999999999999999986654     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|||||++|+|.+++.....     .+++.++..|+.||++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence            78999999999999999886542     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.+.......   +........||+.|||||++
T Consensus       173 Gla~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~  205 (299)
T d1jpaa_         173 GLSRFLEDDTSDP---TYTSALGGKIPIRWTAPEAI  205 (299)
T ss_dssp             --------------------------CGGGSCHHHH
T ss_pred             ccceEccCCCCcc---eeeecccccCCccccCHHHH
Confidence            9998775432211   11122235689999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-35  Score=296.16  Aligned_cols=171  Identities=30%  Similarity=0.500  Sum_probs=138.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|+..+.||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++|+|...+     ..|+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEE
Confidence            57888999999999999999987 56789999997543 34578999999999999999999999987654     7899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAK  691 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~  691 (725)
                      |||||++|+|.+++.....     .+++..+..|+.||+.||+|+|++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999876542     588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          692 FLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ........       ......||+.|||||++.
T Consensus       150 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~  175 (263)
T d1sm2a_         150 FVLDDQYT-------SSTGTKFPVKWASPEVFS  175 (263)
T ss_dssp             ----------------------CTTSCCHHHHT
T ss_pred             eccCCCce-------eecceecCcccCChHHhc
Confidence            76443211       112356999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-35  Score=305.81  Aligned_cols=172  Identities=22%  Similarity=0.318  Sum_probs=149.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++....     ..|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence            357999999999999999999999999999999998665555678889999999999999999999976554     889


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec--CCCceEEcccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVGDFG  688 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~--~~~~~kl~Dfg  688 (725)
                      +|||||+||+|.+++.....     .+++.+++.|+.||+.||+|||++   +|+||||||+|||++  .++.+||+|||
T Consensus       103 ivmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence            99999999999998875542     589999999999999999999999   999999999999998  56899999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+....         .....+||+.|||||++.
T Consensus       175 la~~~~~~~---------~~~~~~gt~~y~aPE~~~  201 (352)
T d1koba_         175 LATKLNPDE---------IVKVTTATAEFAAPEIVD  201 (352)
T ss_dssp             TCEECCTTS---------CEEEECSSGGGCCHHHHT
T ss_pred             cceecCCCC---------ceeeccCcccccCHHHHc
Confidence            998764431         122357999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=298.71  Aligned_cols=171  Identities=25%  Similarity=0.508  Sum_probs=145.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++|||||+++|++...      ..|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeE
Confidence            457888999999999999999986 67889999997543 3457899999999999999999999987543      468


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|||||++|+|.+++....    ...+++..+++|+.||++||+|||++   +|+||||||+||+++.++.+||+|||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence            9999999999999886543    22589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +........       ......||+.|||||++
T Consensus       157 ~~~~~~~~~-------~~~~~~gt~~y~APE~~  182 (272)
T d1qpca_         157 RLIEDNEYT-------AREGAKFPIKWTAPEAI  182 (272)
T ss_dssp             EECSSSCEE-------CCTTCCCCTTTSCHHHH
T ss_pred             EEccCCccc-------cccccCCcccccChHHH
Confidence            876543211       11235699999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-34  Score=294.07  Aligned_cols=170  Identities=25%  Similarity=0.341  Sum_probs=147.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc------cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      +.|+..+.||+|+||+||+|+++.+|+.||||++....      ....+.+.+|++++++++|||||++++++....   
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---   86 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT---   86 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence            56899999999999999999999999999999997532      123578999999999999999999999976554   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC----c
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM----V  681 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~----~  681 (725)
                        ..|+|||||+||+|.+++....      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .
T Consensus        87 --~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          87 --DVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred             --EEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence              8999999999999999998654      589999999999999999999999   999999999999998776    5


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|++|||+|+.......         ....+||+.|||||++.
T Consensus       156 vkl~DfG~a~~~~~~~~---------~~~~~~t~~y~APE~~~  189 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGNE---------FKNIFGTPEFVAPEIVN  189 (293)
T ss_dssp             EEECCCTTCEECTTSCB---------CSCCCCCGGGCCHHHHT
T ss_pred             eEecchhhhhhcCCCcc---------ccccCCCCcccCHHHHc
Confidence            99999999987643321         12357999999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-35  Score=292.91  Aligned_cols=173  Identities=25%  Similarity=0.444  Sum_probs=142.8

Q ss_pred             cCCCCCcc-cccccceEEEEEEECC--CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNM-IGQGSFGSVYKGILGE--DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~-ig~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|...+. ||+|+||+||+|.++.  ++..||||+++... ....++|.+|++++++++|||||+++|+|...      
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence            34556664 9999999999998753  45689999997543 34467899999999999999999999997543      


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|||||++|+|.+++.....     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence            47899999999999999865442     589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.+.......     ......+||+.|||||++
T Consensus       154 Gla~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~  184 (285)
T d1u59a_         154 GLSKALGADDSYY-----TARSAGKWPLKWYAPECI  184 (285)
T ss_dssp             TTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHH
T ss_pred             hhhhccccccccc-----ccccccccCccccChHHH
Confidence            9998775432111     112235699999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-34  Score=285.36  Aligned_cols=171  Identities=28%  Similarity=0.504  Sum_probs=147.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|++++++++||||++++|+|....     ..+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceE
Confidence            368999999999999999999996 788999999976543 3478999999999999999999999986544     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|++.+++.....     .+++..+++++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+|
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhh
Confidence            99999999999999765532     588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.+.+....       ......||+.|||||++
T Consensus       148 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~  173 (258)
T d1k2pa_         148 RYVLDDEYT-------SSVGSKFPVRWSPPEVL  173 (258)
T ss_dssp             CBCSSSSCC-------CCCCSCCCGGGCCHHHH
T ss_pred             eeccCCCce-------eecccCCCCCcCCcHHh
Confidence            876543221       11235699999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-34  Score=300.70  Aligned_cols=168  Identities=25%  Similarity=0.358  Sum_probs=149.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   +....+.+.+|++++++++|||||++++++....     .
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----N  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-----c
Confidence            4799999999999999999999999999999999743   2344578899999999999999999999976554     7


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||||+.+|++.+++....      .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            899999999999999998654      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+...           ..+.+||+.|||||++.
T Consensus       187 ~a~~~~~~-----------~~~~~Gt~~Y~APE~~~  211 (350)
T d1rdqe_         187 FAKRVKGR-----------TWTLCGTPEALAPEIIL  211 (350)
T ss_dssp             TCEECSSC-----------BCCCEECGGGCCHHHHT
T ss_pred             eeeecccc-----------cccccCccccCCHHHHc
Confidence            99876432           11357999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=292.68  Aligned_cols=175  Identities=29%  Similarity=0.516  Sum_probs=138.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc----eEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE----MIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      .+.|+..++||+|+||+||+|+++.++    ..||||+++... .....+|.+|++++++++|||||+++|++....   
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---   82 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---   82 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC---
Confidence            356888899999999999999986544    579999997543 334467999999999999999999999987654   


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..++|||||++|++.+++.....     .+++.++..++.||+.|++|||++   +|+||||||+|||++.++.+||+
T Consensus        83 --~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          83 --PMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             --SEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             --ceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEc
Confidence              78999999999999998876543     589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+.+.......     .......||+.|||||++
T Consensus       153 DFGla~~~~~~~~~~-----~~~~~~~gt~~Y~APE~l  185 (283)
T d1mqba_         153 DFGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAI  185 (283)
T ss_dssp             CCCC----------------------CCCGGGSCHHHH
T ss_pred             ccchhhcccCCCccc-----eEeccCCCCccccCHHHH
Confidence            999998765432111     112235689999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-34  Score=288.35  Aligned_cols=169  Identities=30%  Similarity=0.427  Sum_probs=148.0

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc---------chHHHHHHHHHHHHcCC-CCcccceeeEeecC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK---------GAFRSFVAECEALRNIR-HRNLIKIITICSST  601 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  601 (725)
                      ++|+..+.||+|+||+||+|++..+++.||||+++....         ...+++.+|++++++++ ||||+++++++...
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            578999999999999999999999999999999975421         12346889999999997 99999999997655


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCc
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMV  681 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~  681 (725)
                      +     ..|+|||||++|+|.++++...      .+++.++..++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus        83 ~-----~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          83 T-----FFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             S-----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             c-----ceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence            4     8999999999999999998654      689999999999999999999999   9999999999999999999


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||+|+.+.+...         ....+||+.|+|||++
T Consensus       149 ~kl~DFG~a~~~~~~~~---------~~~~~gt~~y~~PE~~  181 (277)
T d1phka_         149 IKLTDFGFSCQLDPGEK---------LREVCGTPSYLAPEII  181 (277)
T ss_dssp             EEECCCTTCEECCTTCC---------BCCCCSCGGGCCHHHH
T ss_pred             eEEccchheeEccCCCc---------eeeeeccCCCCCHHHh
Confidence            99999999987654321         1235799999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=290.29  Aligned_cols=166  Identities=27%  Similarity=0.414  Sum_probs=137.2

Q ss_pred             cccccccceEEEEEEEC--CCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEEE
Q 048668          538 NMIGQGSFGSVYKGILG--EDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALVF  613 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  613 (725)
                      +.||+|+||+||+|.++  .+++.||||+++..  +....++|.+|++++++++|||||+++|+|...      ..|+||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            47999999999999864  45678999999643  233457899999999999999999999998543      468999


Q ss_pred             eccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccccccc
Q 048668          614 EYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKFL  693 (725)
Q Consensus       614 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~~  693 (725)
                      |||++|+|.++++...      .+++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus        87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            9999999999998654      589999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          694 SSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       694 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ......     ........||+.|||||++
T Consensus       158 ~~~~~~-----~~~~~~~~gt~~y~APE~l  182 (277)
T d1xbba_         158 RADENY-----YKAQTHGKWPVKWYAPECI  182 (277)
T ss_dssp             CTTCSE-----EEC----CCCGGGCCHHHH
T ss_pred             cccccc-----cccccccCCCceecCchhh
Confidence            433211     1122235699999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-34  Score=298.81  Aligned_cols=170  Identities=25%  Similarity=0.336  Sum_probs=144.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHH---HHHHHHHHcCCCCcccceeeEeecCCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSF---VAECEALRNIRHRNLIKIITICSSTDFK  604 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  604 (725)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++....   ......+   .+|+++++.++|||||++++++...+  
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--   80 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--   80 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--
Confidence            468999999999999999999999999999999996432   1222333   34577788889999999999976554  


Q ss_pred             CcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEE
Q 048668          605 GVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV  684 (725)
Q Consensus       605 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl  684 (725)
                         ..|+|||||+||+|.+++....      .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||
T Consensus        81 ---~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl  148 (364)
T d1omwa3          81 ---KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  148 (364)
T ss_dssp             ---EEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred             ---EEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence               8899999999999999998654      578999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          685 GDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       685 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|||+|+.+....          ....+||+.|||||++.
T Consensus       149 ~DFGla~~~~~~~----------~~~~~GT~~y~APE~~~  178 (364)
T d1omwa3         149 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQ  178 (364)
T ss_dssp             CCCTTCEECSSSC----------CCSCCSCGGGCCHHHHS
T ss_pred             eeeceeeecCCCc----------ccccccccccchhHHhh
Confidence            9999998764321          12357999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-34  Score=292.31  Aligned_cols=171  Identities=25%  Similarity=0.397  Sum_probs=147.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecc---ccchHHHHHHHHHHHH-cCCCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK---QKGAFRSFVAECEALR-NIRHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||+||+|+++.+++.||||+++..   .....+.+..|+.++. .++|||||++++++....     
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-----   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-----   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence            5789999999999999999999999999999999753   2344567778888765 689999999999977655     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+|||||++|+|.++++...      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            8999999999999999998655      589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+.......        .....+||+.|||||++.
T Consensus       148 G~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~  176 (320)
T d1xjda_         148 GMCKENMLGDA--------KTNTFCGTPDYIAPEILL  176 (320)
T ss_dssp             TTCBCCCCTTC--------CBCCCCSCGGGCCHHHHT
T ss_pred             chhhhcccccc--------cccccCCCCCcCCHHHHc
Confidence            99986543211        122357999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-34  Score=296.08  Aligned_cols=179  Identities=26%  Similarity=0.433  Sum_probs=143.9

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc-----eEEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE-----MIVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDF  603 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  603 (725)
                      .++|+..+.||+|+||+||+|++..++     ..||+|.+... .......+.+|+++++++ +|||||++++++.... 
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence            457888999999999999999986443     47999998654 233456889999999998 8999999999976554 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCc-----------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQ-----------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVH  666 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH  666 (725)
                          ..|+|||||++|+|.++++.....                 .....+++..++.++.||++||+|||++   +|||
T Consensus       115 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         115 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             ----eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence                789999999999999999765321                 0112588999999999999999999999   9999


Q ss_pred             cCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          667 GDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       667 rdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||||+||+++.++.+||+|||+|+........      ....+.+||+.|||||++
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~aPE~l  238 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESL  238 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHH
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCce------eeeccccCCCccCChHHH
Confidence            999999999999999999999999876543211      112235689999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.8e-34  Score=286.86  Aligned_cols=178  Identities=19%  Similarity=0.355  Sum_probs=143.5

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc---cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...   ....++|.+|++++++++||||+++++++...+ .....
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence            56999999999999999999999999999999997543   233567999999999999999999999986543 22235


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||+||+|.+++....      .+++.++..++.||+.||+|||++   +|+||||||+||+++.++.++++|||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            799999999999999987665      589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .++.......     ........+||+.|||||++.
T Consensus       157 ~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         157 IARAIADSGN-----SVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             TCEECC---------------------TTCCHHHHT
T ss_pred             hhhhhccccc-----cccccccccCcccccCHHHHc
Confidence            9876543221     111223467999999999863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-34  Score=288.49  Aligned_cols=171  Identities=29%  Similarity=0.505  Sum_probs=139.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|++.+.||+|+||+||+|+++.+ +.||||+++... ...++|.+|++++++++|||||+++|+|...      ..|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeE
Confidence            45799999999999999999999755 579999997543 3457899999999999999999999997532      478


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +|||||++|++.+++.....    ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEEecCCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence            99999999999999875431    2589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +...+....       ......||+.|||||++
T Consensus       161 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~  186 (285)
T d1fmka3         161 RLIEDNEYT-------ARQGAKFPIKWTAPEAA  186 (285)
T ss_dssp             C---------------------CCGGGSCHHHH
T ss_pred             hhccCCCce-------eeccccccccccChHHH
Confidence            876433211       11235699999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=290.10  Aligned_cols=172  Identities=23%  Similarity=0.330  Sum_probs=142.4

Q ss_pred             hcCCCCC-cccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSS-NMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|++. +.||+|+||+||+|++..+++.||||+++..     ..+.+|++++.++ +|||||++++++... +.....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            4578876 4699999999999999999999999998632     4567899987655 799999999987542 122347


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVG  685 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~  685 (725)
                      .|+|||||+||+|.+++.....    ..+++.++..|+.||+.||+|||++   +|+||||||+|||++.   ++.+||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            8999999999999999986532    2589999999999999999999999   9999999999999986   4679999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.......         ....+||+.|||||++.
T Consensus       157 DFG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~  186 (335)
T d2ozaa1         157 DFGFAKETTSHNS---------LTTPCYTPYYVAPEVLG  186 (335)
T ss_dssp             CCTTCEECCCCCC---------CCCCSCCCSSCCCCCCC
T ss_pred             ccceeeeccCCCc---------cccccCCcccCCcHHHc
Confidence            9999987644321         12357999999999863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-34  Score=289.18  Aligned_cols=167  Identities=31%  Similarity=0.425  Sum_probs=138.3

Q ss_pred             CCcccccccceEEEEEEECCCceEEEEEEeeccccc-----hHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          536 SSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKG-----AFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       536 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ..++||+|+||+||+|+++.+|+.||||+++.....     ..+++.+|++++++++|||||++++++...+     ..|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----cee
Confidence            357899999999999999999999999999754321     2356889999999999999999999976654     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||++++++..+.....      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        77 ivmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ehhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence            9999999887776665433      578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......        .....+||+.|||||++.
T Consensus       148 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~  173 (299)
T d1ua2a_         148 KSFGSPNR--------AYTHQVVTRWYRAPELLF  173 (299)
T ss_dssp             STTTSCCC--------CCCCSCCCCTTCCHHHHT
T ss_pred             cccCCCcc--------cccceecChhhccHHHHc
Confidence            86543321        112357999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-33  Score=288.72  Aligned_cols=169  Identities=20%  Similarity=0.317  Sum_probs=146.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++.... ....+.+|++++++++|||||++++++....     ..|+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~l   78 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME-----ELVM   78 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEE
Confidence            578899999999999999999999999999999976532 3456889999999999999999999976554     8999


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC--CceEEccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD--MVAHVGDFGL  689 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~--~~~kl~Dfgl  689 (725)
                      |||||+||+|.+++.....     .+++.++..|+.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+
T Consensus        79 vmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence            9999999999999976542     589999999999999999999999   99999999999999854  4899999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+.....         ......+||+.|||||++
T Consensus       151 ~~~~~~~---------~~~~~~~~t~~y~ape~~  175 (321)
T d1tkia_         151 ARQLKPG---------DNFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             CEECCTT---------CEEEEEESCGGGSCHHHH
T ss_pred             hhccccC---------Ccccccccccccccchhc
Confidence            9875332         112235799999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=288.88  Aligned_cols=172  Identities=26%  Similarity=0.464  Sum_probs=140.2

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce----EEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM----IVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .+|+..+.||+|+||+||+|++..+|+    +||+|.++.. .....++|.+|++++++++|||||+++|+|...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            469999999999999999999987775    5888887643 334567899999999999999999999998754     


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                       ..+++|||+.+|+|.+++.....     .+++..+++++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             -CeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence             36789999999999999876543     689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+........      .......||+.|||||++
T Consensus       155 FGla~~~~~~~~~------~~~~~~~gt~~y~APE~l  185 (317)
T d1xkka_         155 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESI  185 (317)
T ss_dssp             CSHHHHTTTTCC--------------CCTTTSCHHHH
T ss_pred             cccceeccccccc------ccccccccCccccChHHH
Confidence            9999876543211      112234699999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.1e-33  Score=285.00  Aligned_cols=172  Identities=26%  Similarity=0.438  Sum_probs=142.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||+||+|++..+|+.||||+++...  ....+++.+|++++++++|||||++++++....     ..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence            57999999999999999999999999999999996543  233578999999999999999999999987655     89


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      |+||||+.+ ++.+++.....    ..+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||.
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             eEEEeecCC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence            999999965 55555543321    1589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+.......        .....+||+.|+|||++.
T Consensus       149 a~~~~~~~~--------~~~~~~gt~~y~apE~~~  175 (298)
T d1gz8a_         149 ARAFGVPVR--------TYTHEVVTLWYRAPEILL  175 (298)
T ss_dssp             HHHHCCCSB--------CTTCCBCCCTTCCHHHHT
T ss_pred             ceeccCCcc--------cceeecccceeeehhhhc
Confidence            987643321        122357999999999753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.2e-33  Score=285.37  Aligned_cols=188  Identities=21%  Similarity=0.338  Sum_probs=141.7

Q ss_pred             CHHHHHHHhcCCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCccccee
Q 048668          523 SYAELSKATSEFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKII  595 (725)
Q Consensus       523 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~  595 (725)
                      +...++...++|+..+.||+|+||+||+|++..     +++.||||+++... ....+.+.+|++++.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            344444445789999999999999999999743     45789999997543 33456788899988887 588999999


Q ss_pred             eEeecCCCCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          596 TICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       596 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                      +++...+    ...++|||||++|+|.++++.....          .....+++.+++.++.||++||+|||++   +||
T Consensus        84 ~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iv  156 (299)
T d1ywna1          84 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  156 (299)
T ss_dssp             EEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             eeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCc
Confidence            9876543    4689999999999999999754321          0122588999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+|||++.++.+||+|||+|+........      ......+||+.|||||++
T Consensus       157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~APE~l  208 (299)
T d1ywna1         157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETI  208 (299)
T ss_dssp             CSCCCGGGEEECGGGCEEECC------CCSCTTS------CCTTSCCCGGGGCCHHHH
T ss_pred             CCcCCccceeECCCCcEEEccCcchhhccccccc------cccCceeeCccccchhHh
Confidence            9999999999999999999999999876433211      112235799999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=3.6e-33  Score=284.79  Aligned_cols=180  Identities=26%  Similarity=0.441  Sum_probs=147.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEEC-----CCceEEEEEEeecccc-chHHHHHHHHHHHHcCCCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILG-----EDEMIVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  603 (725)
                      ..++|+..+.||+|+||+||+|+++     .+++.||||+++.... ...++|.+|++++++++||||++++++|.... 
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-   89 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-   89 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC-
Confidence            4568999999999999999999975     3568999999975533 34568999999999999999999999987654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCc------------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQ------------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMV  665 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv  665 (725)
                          ..++||||+++|+|.+++......                  .....+++..++.|+.|++.||+|+|++   +||
T Consensus        90 ----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          90 ----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence                789999999999999999753311                  1122478999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          666 HGDLKPSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       666 Hrdlkp~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||||||+|||++.++.+||+|||+|+.+.+.....      ...+.+||+.|||||++
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~------~~~~~~~~~~y~aPE~~  214 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESI  214 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHH
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCcccc------ccCCCCcCcCcCCHHHH
Confidence            99999999999999999999999998764432211      12235699999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.7e-33  Score=277.88  Aligned_cols=172  Identities=24%  Similarity=0.424  Sum_probs=134.2

Q ss_pred             hcCCCCCcccccccceEEEEEEECCC---ceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGED---EMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGV  606 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  606 (725)
                      .++|+..+.||+|+||+||+|++..+   +..||||.++... ....+.|.+|++++++++|||||++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35788899999999999999998644   3568899886443 3345679999999999999999999998743      


Q ss_pred             ceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcc
Q 048668          607 DFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGD  686 (725)
Q Consensus       607 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~D  686 (725)
                      +..|+||||+++|++.+++.....     .+++..++.++.||++||+|+|++   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence            257999999999999998875542     589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          687 FGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       687 fgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ||+|+........       ......||+.|||||++
T Consensus       152 fG~a~~~~~~~~~-------~~~~~~gt~~y~apE~l  181 (273)
T d1mp8a_         152 FGLSRYMEDSTYY-------KASKGKLPIKWMAPESI  181 (273)
T ss_dssp             --------------------------CCGGGCCHHHH
T ss_pred             chhheeccCCcce-------eccceecCcccchhhHh
Confidence            9999876433211       11235689999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.7e-33  Score=281.27  Aligned_cols=176  Identities=27%  Similarity=0.357  Sum_probs=138.5

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      +|...+.||+|+||.||+|++  +|+.||||+++.+... ...++.|+..+.+++||||++++++|.... ......|+|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            566778899999999999997  5789999999654321 122334555556789999999999987654 233468999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ||||++|+|.+++++.       .+++..+++++.|++.||+|+|+.     ..++|+||||||+|||++.++.+||+||
T Consensus        80 ~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            9999999999999754       488999999999999999999973     1349999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+|+.........    .......+||++|||||++
T Consensus       153 Gl~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~  184 (303)
T d1vjya_         153 GLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             TTCEEEETTTTEE----CC----CCSCGGGCCHHHH
T ss_pred             CccccccCCCcce----eccccceecccCcCChhhc
Confidence            9998775432111    1122236799999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.5e-33  Score=278.50  Aligned_cols=168  Identities=24%  Similarity=0.344  Sum_probs=142.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeecccc------chHHHHHHHHHHHHcCC--CCcccceeeEeecCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------GAFRSFVAECEALRNIR--HRNLIKIITICSSTDF  603 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  603 (725)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....      ....++.+|++++++++  |||||++++++...+ 
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~-   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD-   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence            579999999999999999999999999999999975421      11234678999999997  899999999976554 


Q ss_pred             CCcceeeEEEeccCC-CCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCC-Cc
Q 048668          604 KGVDFKALVFEYMGN-GSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHD-MV  681 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~-~~  681 (725)
                          ..|+||||+++ +++.+++....      .+++.++..++.|++.||+|||++   +|+||||||+||+++.+ +.
T Consensus        83 ----~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          83 ----SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             ----EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred             ----eEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence                88999999976 68888887654      689999999999999999999999   99999999999999854 79


Q ss_pred             eEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          682 AHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       682 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +||+|||+|+......          ..+.+||+.|||||++
T Consensus       150 vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~  181 (273)
T d1xwsa_         150 LKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWI  181 (273)
T ss_dssp             EEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHH
T ss_pred             EEECccccceeccccc----------ccccccCCCcCCHHHH
Confidence            9999999998653321          1235799999999986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=9.4e-32  Score=276.95  Aligned_cols=257  Identities=29%  Similarity=0.472  Sum_probs=233.3

Q ss_pred             CCCCEEECccCcccc--cCChhhhhccccceeEEecC-ccceeccCcccccccCCceEEecccccCCCCChhhcCCCCcc
Q 048668          188 SSLKVLSLSDNQFGG--ELPHSIANLSSTMIVFLIGG-NQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQ  264 (725)
Q Consensus       188 ~~L~~L~L~~N~l~~--~~p~~~~~l~~~l~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  264 (725)
                      .+++.|+|++|.+++  .+|..+++++ .|+.|++++ |+++|.+|..++++++|++|+|++|++.+..+..+..+.+|+
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence            367888888888876  4788888888 888888886 888889999999999999999999999999999999999999


Q ss_pred             EEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcC
Q 048668          265 LLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL  344 (725)
Q Consensus       265 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l  344 (725)
                      ++++++|.+.+.+|..+..++.|+.+++++|++           .+.+|..+.....++..+++++|++++..|..+..+
T Consensus       129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l-----------~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l  197 (313)
T d1ogqa_         129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRI-----------SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL  197 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCC-----------EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC
T ss_pred             ccccccccccccCchhhccCcccceeecccccc-----------cccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999954           457888888888887899999999999999988887


Q ss_pred             CCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEc
Q 048668          345 KNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNL  424 (725)
Q Consensus       345 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  424 (725)
                      ..+ .++++.|.+.+.+|..+..+++++.+++++|.+++.+ +.++.+++|+.|+|++|+++|.+|..|.++++|++|||
T Consensus       198 ~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~L  275 (313)
T d1ogqa_         198 NLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV  275 (313)
T ss_dssp             CCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEEC
T ss_pred             ccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEEC
Confidence            554 7999999999999999999999999999999999765 46889999999999999999999999999999999999


Q ss_pred             ccccCeeecCCCCccCCCCCcCccCCccccCCCC
Q 048668          425 SYNHLEGEVPTKGVFSNKSKIPLQGNVRLCGGID  458 (725)
Q Consensus       425 ~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  458 (725)
                      ++|+|+|.+|..+.+..++.+.+.+|+.+||.|.
T Consensus       276 s~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             cCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence            9999999999887888999999999999999864

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=2.8e-30  Score=274.20  Aligned_cols=359  Identities=27%  Similarity=0.375  Sum_probs=242.2

Q ss_pred             EEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCC
Q 048668           17 ALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNR   96 (725)
Q Consensus        17 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~   96 (725)
                      ...+..+.+++.+..  ..+.+|++|++++|+|+..  +.++.+++|++|+|++|+|+++.+  |+++++|++|++++|+
T Consensus        26 ~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          26 KTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHHTTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccCH--HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc
Confidence            345666666654432  3456777788887777643  346677778888888887775433  7777778888888887


Q ss_pred             CCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCC
Q 048668           97 FSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAAN  176 (725)
Q Consensus        97 l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~  176 (725)
                      |+ .++.  +.++++|+.|++++|.+++..+  ......+..+....|.+..+....................+      
T Consensus       100 i~-~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~------  168 (384)
T d2omza2         100 IA-DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL------  168 (384)
T ss_dssp             CC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC------
T ss_pred             cc-cccc--cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh------
Confidence            76 4442  4577777777777777765533  33455666777777776655443333322222222222222      


Q ss_pred             CcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChh
Q 048668          177 DLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDV  256 (725)
Q Consensus       177 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  256 (725)
                           ..+...+.........|...  ....+..++ .+..+.+.+|.+++..|  +..+++|++|++++|+++..  +.
T Consensus       169 -----~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~-~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~  236 (384)
T d2omza2         169 -----KPLANLTTLERLDISSNKVS--DISVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GT  236 (384)
T ss_dssp             -----GGGTTCTTCCEEECCSSCCC--CCGGGGGCT-TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GG
T ss_pred             -----hhhccccccccccccccccc--ccccccccc-ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--ch
Confidence                 12333444555555555443  233344444 56666666666665443  34567888888888888753  45


Q ss_pred             hcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCC
Q 048668          257 IGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS  336 (725)
Q Consensus       257 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~  336 (725)
                      +..+++|+.|++++|.+.+..+  +..+++|++|++++|+++            .+++ +.....+ ..++++.|.+++.
T Consensus       237 l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~------------~~~~-~~~~~~l-~~l~~~~n~l~~~  300 (384)
T d2omza2         237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS------------NISP-LAGLTAL-TNLELNENQLEDI  300 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC------------CCGG-GTTCTTC-SEEECCSSCCSCC
T ss_pred             hhcccccchhccccCccCCCCc--ccccccCCEeeccCcccC------------CCCc-ccccccc-ccccccccccccc
Confidence            7788888888888888875443  677888888888888776            2221 2233333 6788888888753


Q ss_pred             cchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCC
Q 048668          337 LPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENL  416 (725)
Q Consensus       337 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  416 (725)
                        ..+..+++++.|++++|++++..+  +..+++|++|++++|++++.  +.++++++|+.|++++|++++..|  +.++
T Consensus       301 --~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~l--~~l~~l~~L~~L~l~~N~l~~l~~--l~~l  372 (384)
T d2omza2         301 --SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANL  372 (384)
T ss_dssp             --GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCBCGG--GTTC
T ss_pred             --cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCCC--hhHcCCCCCCEEECCCCcCCCChh--hccC
Confidence              457888999999999999986543  78889999999999999853  368899999999999999997665  8899


Q ss_pred             CCCCeEEccccc
Q 048668          417 SFLEFLNLSYNH  428 (725)
Q Consensus       417 ~~L~~L~l~~N~  428 (725)
                      ++|+.|+|++|.
T Consensus       373 ~~L~~L~L~~Na  384 (384)
T d2omza2         373 TRITQLGLNDQA  384 (384)
T ss_dssp             TTCSEEECCCEE
T ss_pred             CCCCEeeCCCCc
Confidence            999999999883

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=273.73  Aligned_cols=167  Identities=35%  Similarity=0.478  Sum_probs=136.1

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      .++|+..+.||+|+||.||+|++  .|..||||+++.+  ...++|.+|++++++++||||++++|+|....    +..|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEE
Confidence            45788889999999999999998  4678999999643  34578999999999999999999999986533    3579


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      +||||+++|+|.+++....    ...+++..+++|+.||+.||+|||+.   +|+||||||+||+++.++.+|++|||++
T Consensus        78 lv~ey~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEeccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence            9999999999999997543    12589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.....           .....+|+.|||||++
T Consensus       151 ~~~~~~-----------~~~~~~~~~y~aPE~l  172 (262)
T d1byga_         151 KEASST-----------QDTGKLPVKWTAPEAL  172 (262)
T ss_dssp             ----------------------CCTTTSCHHHH
T ss_pred             eecCCC-----------CccccccccCCChHHH
Confidence            865322           1124589999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.5e-32  Score=281.60  Aligned_cols=177  Identities=25%  Similarity=0.343  Sum_probs=145.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|+..+.||+|+||+||+|++..+|+.||||+++... ....+++.+|+++|++++||||+++++++....+......|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46899999999999999999999999999999997543 34457889999999999999999999998776655444555


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLA  690 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla  690 (725)
                      ++ +|+.+|+|.+++...       .+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|
T Consensus        88 l~-~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          88 LV-THLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             EE-EECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EE-EeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            55 556689999999754       489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.........     ......+||+.|+|||++.
T Consensus       157 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~  185 (345)
T d1pmea_         157 RVADPDHDHT-----GFLTEYVATRWYRAPEIML  185 (345)
T ss_dssp             EECCGGGCBC-----CTTCCCCSCGGGCCGGGTT
T ss_pred             eeccCCCccc-----eeeccccccceechHHHhh
Confidence            8765442211     1123467999999999863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.5e-32  Score=274.50  Aligned_cols=171  Identities=27%  Similarity=0.540  Sum_probs=141.6

Q ss_pred             CcccccccceEEEEEEECCCc---eEEEEEEeecc-ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeEE
Q 048668          537 SNMIGQGSFGSVYKGILGEDE---MIVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKALV  612 (725)
Q Consensus       537 ~~~ig~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  612 (725)
                      .++||+|+||+||+|++..++   ..||||+++.. .....++|.+|++++++++||||++++|+|...+    ...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence            468999999999999986543   46899999643 3445678999999999999999999999986543    368999


Q ss_pred             EeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          613 FEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       613 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      ||||++|+|.+++.....     ..++..+++++.|++.||.|+|+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  179 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred             EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence            999999999999886543     477888999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          693 LSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      ........    ........||+.|+|||.+
T Consensus       180 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~  206 (311)
T d1r0pa_         180 MYDKEFDS----VHNKTGAKLPVKWMALESL  206 (311)
T ss_dssp             TTTTTCCC----TTCTTCSSCCGGGSCHHHH
T ss_pred             cccccccc----ceecccccccccccChHHH
Confidence            65443221    1122235699999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-32  Score=278.64  Aligned_cols=175  Identities=29%  Similarity=0.473  Sum_probs=141.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCce--EEEEEEeecc-ccchHHHHHHHHHHHHcC-CCCcccceeeEeecCCCCCcc
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEM--IVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  607 (725)
                      ++|+..+.||+|+||+||+|+++.++.  .||||+++.. .....++|.+|+++++++ +|||||+++|+|....     
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence            578888999999999999999987776  4677777533 333456899999999999 6999999999987665     


Q ss_pred             eeeEEEeccCCCCHHHHhcccCC----------ccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeec
Q 048668          608 FKALVFEYMGNGSLEDWLHQSND----------QVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  677 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~  677 (725)
                      ..|+||||+++|+|.++++....          ......+++..+++++.||+.|+.|+|++   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            78999999999999999975421          01123689999999999999999999999   999999999999999


Q ss_pred             CCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          678 HDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       678 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      .++.+||+|||+|+.......         .....||+.|+|||.+
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~---------~~~~~gt~~y~aPE~l  198 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVK---------KTMGRLPVRWMAIESL  198 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECC---------C----CCTTTCCHHHH
T ss_pred             CCCceEEcccccccccccccc---------ccceecCCcccchHHh
Confidence            999999999999986543211         1224699999999976

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-32  Score=273.80  Aligned_cols=173  Identities=28%  Similarity=0.421  Sum_probs=134.5

Q ss_pred             cCCCCCcccccccceEEEEEEECC-C--ceEEEEEEeecc---ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGE-D--EMIVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKG  605 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  605 (725)
                      ++|+..+.||+|+||+||+|++.. +  ...||||++...   .....++|.+|++++++++||||++++|++...    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            578899999999999999998642 2  347899998654   234457899999999999999999999998543    


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                        ..++|||||++|++.+++.....     .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             --chheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence              46899999999999998876532     589999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |||+|+........     ........||+.|||||++
T Consensus       154 DfGl~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~  186 (273)
T d1u46a_         154 DFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPESL  186 (273)
T ss_dssp             CCTTCEECCC-CCE-----EEC-----CCGGGCCHHHH
T ss_pred             cchhhhhcccCCCc-----ceecCccccCcccCCHHHH
Confidence            99999976443211     1112235689999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-32  Score=277.63  Aligned_cols=178  Identities=24%  Similarity=0.410  Sum_probs=143.6

Q ss_pred             HhcCCCCCcccccccceEEEEEEECCC-ceEEEEEEeeccc--cchHHHHHHHHHHHHcC---CCCcccceeeEeecCCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGILGED-EMIVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLIKIITICSSTDF  603 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~  603 (725)
                      +.++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+++++.+   +||||+++++++.....
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            356899999999999999999999655 6789999997542  22234566788777665   79999999999876555


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                      +.....+++|||++++.+.........     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence            555688999999988776655443322     589999999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+++......         .....+||+.|||||++.
T Consensus       157 l~dfg~~~~~~~~~---------~~~~~~gT~~Y~APE~~~  188 (305)
T d1blxa_         157 LADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLL  188 (305)
T ss_dssp             ECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHT
T ss_pred             ecchhhhhhhcccc---------cCCCcccChhhcCcchhc
Confidence            99999997653321         122367999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=7.3e-32  Score=273.49  Aligned_cols=170  Identities=24%  Similarity=0.381  Sum_probs=142.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||+||+|+++ +|+.||||+++...  ....+++.+|+.++++++||||+++++++....     ..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            57889999999999999999996 78999999997543  334578999999999999999999999987665     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++||||+.++.+..+.....      .+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||.
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            99999998877776665443      689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |........        ......|++.|+|||++.
T Consensus       147 a~~~~~~~~--------~~~~~~~~~~y~~pE~~~  173 (286)
T d1ob3a_         147 ARAFGIPVR--------KYTHEIVTLWYRAPDVLM  173 (286)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHT
T ss_pred             ceecccCcc--------ccceecccchhhhHHHHh
Confidence            987643321        112346999999999864

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.8e-29  Score=267.82  Aligned_cols=343  Identities=23%  Similarity=0.298  Sum_probs=266.4

Q ss_pred             CcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCcee
Q 048668           11 SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYF   90 (725)
Q Consensus        11 ~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L   90 (725)
                      .+.+|++|++++|+|+. + +.+..+++|++|+|++|+|++..|  |+++++|++|+|++|+|+++.+  ++++++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc--cccccccccc
Confidence            46789999999999984 3 468899999999999999996543  9999999999999999986543  8999999999


Q ss_pred             eccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccC
Q 048668           91 YLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus        91 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l  170 (725)
                      ++++|.++ .++..  .....+..+....|.+....+..................+     ..+...+.........|..
T Consensus       116 ~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  187 (384)
T d2omza2         116 TLFNNQIT-DIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKV  187 (384)
T ss_dssp             ECCSSCCC-CCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCC
T ss_pred             cccccccc-ccccc--cccccccccccccccccccccccccccccccccccccchh-----hhhcccccccccccccccc
Confidence            99999998 55543  3577889999999998766554443333333333322222     2344445555556666554


Q ss_pred             CccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccC
Q 048668          171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLH  250 (725)
Q Consensus       171 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~  250 (725)
                      ...        ..+..+++++.+++++|.+++..|.  .... .++.+.+.+|.++.  .+.+..+++|+.|++++|.++
T Consensus       188 ~~~--------~~~~~l~~~~~l~l~~n~i~~~~~~--~~~~-~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~  254 (384)
T d2omza2         188 SDI--------SVLAKLTNLESLIATNNQISDITPL--GILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS  254 (384)
T ss_dssp             CCC--------GGGGGCTTCSEEECCSSCCCCCGGG--GGCT-TCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred             ccc--------cccccccccceeeccCCccCCCCcc--cccC-CCCEEECCCCCCCC--cchhhcccccchhccccCccC
Confidence            322        3356778899999999988865443  3333 78889999998874  246788999999999999998


Q ss_pred             CCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccC
Q 048668          251 GTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSN  330 (725)
Q Consensus       251 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~  330 (725)
                      +..+  +..+++|++|++++|.+.+..  .+..++.++.+++.+|++++            ++ .+.....+ +.|++++
T Consensus       255 ~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~------------~~-~~~~~~~l-~~L~ls~  316 (384)
T d2omza2         255 NLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED------------IS-PISNLKNL-TYLTLYF  316 (384)
T ss_dssp             CCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC------------CG-GGGGCTTC-SEEECCS
T ss_pred             CCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc------------cc-ccchhccc-CeEECCC
Confidence            7643  788999999999999998543  37788999999999998772            22 23333444 7899999


Q ss_pred             CccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCc
Q 048668          331 NLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNN  404 (725)
Q Consensus       331 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  404 (725)
                      |++++..  .+..+++|++|++++|+|++ ++ .+..+++|++|++++|++++..|  ++++++|+.|+|++|.
T Consensus       317 n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         317 NNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             SCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            9999764  38899999999999999985 34 68999999999999999997754  8999999999999983

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=274.97  Aligned_cols=180  Identities=24%  Similarity=0.411  Sum_probs=148.5

Q ss_pred             HhcCCCCCcccccccceEEEEEEE-----CCCceEEEEEEeeccc-cchHHHHHHHHHHHHcC-CCCcccceeeEeecCC
Q 048668          530 ATSEFSSSNMIGQGSFGSVYKGIL-----GEDEMIVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLIKIITICSSTD  602 (725)
Q Consensus       530 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  602 (725)
                      ..++|+..+.||+|+||.||+|++     ..+++.||||+++... .....+|.+|+++++++ +|||||+++++|....
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            346888899999999999999986     3567899999997653 33456799999999999 6999999999986654


Q ss_pred             CCCcceeeEEEeccCCCCHHHHhcccCCc------------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCC
Q 048668          603 FKGVDFKALVFEYMGNGSLEDWLHQSNDQ------------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLK  670 (725)
Q Consensus       603 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlk  670 (725)
                           ..|+|||||++|+|.++++.....            .....+++..+..++.||+.|++|||++   +|||||||
T Consensus       101 -----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK  172 (311)
T d1t46a_         101 -----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (311)
T ss_dssp             -----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             -----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccc
Confidence                 789999999999999999765321            1122588999999999999999999999   99999999


Q ss_pred             CCCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          671 PSNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       671 p~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      |+||+++.++.+|++|||.|+........      ......+||+.|||||++
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~  219 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESI  219 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHH
T ss_pred             cccccccccCcccccccchheeccCCCcc------eEeeecccChHHcCHHHh
Confidence            99999999999999999999876543211      122236799999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.1e-32  Score=278.44  Aligned_cols=183  Identities=23%  Similarity=0.410  Sum_probs=148.3

Q ss_pred             HHHHhcCCCCCcccccccceEEEEEEECC-----CceEEEEEEeeccc-cchHHHHHHHHHHHHcCCCCcccceeeEeec
Q 048668          527 LSKATSEFSSSNMIGQGSFGSVYKGILGE-----DEMIVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLIKIITICSS  600 (725)
Q Consensus       527 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  600 (725)
                      ++...++|+..+.||+|+||.||+|++..     ++..||||+++... ......|.+|++++++++||||++++++|..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            33345688889999999999999998742     35789999997543 3345678999999999999999999999865


Q ss_pred             CCCCCcceeeEEEeccCCCCHHHHhcccCCcc----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          601 TDFKGVDFKALVFEYMGNGSLEDWLHQSNDQV----EVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      ..     ..++|||||++|+|.+++.......    ....+++..+.+++.|+++||.|||++   +|+||||||+|||+
T Consensus        95 ~~-----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          95 GQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  166 (308)
T ss_dssp             SS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             CC-----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence            54     7899999999999999987532110    112468899999999999999999999   99999999999999


Q ss_pred             cCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          677 DHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +.++++||+|||+|+.......      ........||+.|||||.+
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~~t~~y~aPe~l  207 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESL  207 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHH
T ss_pred             cCCceEEEeecccceeccCCcc------eeeccceecccccCCHHHH
Confidence            9999999999999987654321      1112234699999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.2e-31  Score=274.38  Aligned_cols=181  Identities=25%  Similarity=0.386  Sum_probs=143.7

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeecc--ccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC---CC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF---KG  605 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  605 (725)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|++++++++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57899999999999999999999999999999998654  23445788999999999999999999999865431   22


Q ss_pred             cceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEc
Q 048668          606 VDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVG  685 (725)
Q Consensus       606 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~  685 (725)
                      .+..|+||||++++.+..+.....      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence            346899999998877665544333      588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.........    .....+.+||+.|+|||++.
T Consensus       160 dfg~~~~~~~~~~~~----~~~~~~~~gT~~Y~aPE~~~  194 (318)
T d3blha1         160 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLL  194 (318)
T ss_dssp             CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHT
T ss_pred             ecceeeecccccccc----cccccceecCHHHhhHHHHc
Confidence            999998765432211    11222357999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=2.6e-31  Score=275.01  Aligned_cols=166  Identities=23%  Similarity=0.362  Sum_probs=141.8

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   ..+++.+|+++++++. ||||+++++++....   ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCcee
Confidence            5799999999999999999999999999999998643   3467889999999996 999999999876432   24689


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEccccc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGL  689 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Dfgl  689 (725)
                      +|||||++++|.++.+         .+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+
T Consensus       109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            9999999999977642         588999999999999999999999   999999999999998765 699999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+...+...         ....+||+.|+|||++.
T Consensus       177 a~~~~~~~~---------~~~~~~t~~y~aPE~~~  202 (328)
T d3bqca1         177 AEFYHPGQE---------YNVRVASRYFKGPELLV  202 (328)
T ss_dssp             CEECCTTCC---------CCSCCSCGGGCCHHHHT
T ss_pred             ceeccCCCc---------ccccccCccccCccccc
Confidence            987654321         12357999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=271.22  Aligned_cols=179  Identities=25%  Similarity=0.413  Sum_probs=142.5

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCc-------eEEEEEEeecccc-chHHHHHHHHHHHHcC-CCCcccceeeEeecC
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDE-------MIVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLIKIITICSST  601 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  601 (725)
                      .++|+..+.||+|+||.||+|++..++       ..||||+++.+.. ....++.+|+..+.++ +|||||+++++|...
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            457888999999999999999875443       5799999976543 3457889999999988 799999999998765


Q ss_pred             CCCCcceeeEEEeccCCCCHHHHhcccCCc----------cccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCC
Q 048668          602 DFKGVDFKALVFEYMGNGSLEDWLHQSNDQ----------VEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKP  671 (725)
Q Consensus       602 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp  671 (725)
                      .     ..++|||||++|+|.+++......          .....+++.++++++.|++.||+|||++   +||||||||
T Consensus        92 ~-----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          92 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             S-----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             C-----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence            4     789999999999999999765421          1123589999999999999999999999   999999999


Q ss_pred             CCeeecCCCceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCcc
Q 048668          672 SNVLLDHDMVAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKF  723 (725)
Q Consensus       672 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  723 (725)
                      +|||++.++.+||+|||+++.........      ......||+.|||||++
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~l  209 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEAL  209 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTC------CCTTSCCGGGGSCHHHH
T ss_pred             cceeecCCCCeEeccchhhcccccccccc------ccccCCCChhhhhhhHh
Confidence            99999999999999999998775432221      12235799999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.5e-31  Score=277.15  Aligned_cols=172  Identities=23%  Similarity=0.369  Sum_probs=140.6

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCC-CCCcc
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTD-FKGVD  607 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  607 (725)
                      .++|+..+.||+|+||+||+|+++.+|+.||||+++...  ....+++.+|+++|++++|||||+++++|...+ +....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            457999999999999999999999999999999997542  234567899999999999999999999987654 22344


Q ss_pred             eeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccc
Q 048668          608 FKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDF  687 (725)
Q Consensus       608 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Df  687 (725)
                      ..|+||||+ ++++.++.+..       .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence            679999999 66888877543       589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          688 GLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       688 gla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|+......           ...+||+.|||||+++
T Consensus       166 g~a~~~~~~~-----------~~~~~t~~y~aPE~~~  191 (346)
T d1cm8a_         166 GLARQADSEM-----------TGYVVTRWYRAPEVIL  191 (346)
T ss_dssp             TTCEECCSSC-----------CSSCSCGGGCCTHHHH
T ss_pred             cceeccCCcc-----------ccccccccccCHHHHc
Confidence            9998754321           1356999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-31  Score=276.53  Aligned_cols=173  Identities=27%  Similarity=0.399  Sum_probs=138.0

Q ss_pred             CCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcceeeE
Q 048668          533 EFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVDFKAL  611 (725)
Q Consensus       533 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~l  611 (725)
                      +|+..++||+|+||+||+|++..+|+.||||++..+...    +.+|++++++++||||+++++++..... .+..+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688889999999999999999999999999999755322    2379999999999999999999865432 23346789


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCC-ceEEcccccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVGDFGLA  690 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~-~~kl~Dfgla  690 (725)
                      |||||+++.+........   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|
T Consensus        97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            999998754333322111   112689999999999999999999998   999999999999999775 8999999999


Q ss_pred             cccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          691 KFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       691 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +.......         ..+.+||+.|+|||+++
T Consensus       171 ~~~~~~~~---------~~~~~gt~~y~aPE~~~  195 (350)
T d1q5ka_         171 KQLVRGEP---------NVSYICSRYYRAPELIF  195 (350)
T ss_dssp             EECCTTSC---------CCSCCSCTTSCCHHHHT
T ss_pred             hhccCCcc---------cccccccccccChHHhh
Confidence            87644321         12357999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=7.3e-31  Score=266.30  Aligned_cols=176  Identities=21%  Similarity=0.318  Sum_probs=144.4

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC-CcccceeeEeecCCCCCcceee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH-RNLIKIITICSSTDFKGVDFKA  610 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~  610 (725)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....  ...+.+|++.++.++| +||+.+++++....     ..+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-----ccE
Confidence            579999999999999999999999999999999865432  2356788999999975 89999999876554     789


Q ss_pred             EEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC-----CCceEEc
Q 048668          611 LVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH-----DMVAHVG  685 (725)
Q Consensus       611 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~-----~~~~kl~  685 (725)
                      +||||+ +++|.+++.....     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.     ++.+||+
T Consensus        78 ~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence            999999 7899999876542     589999999999999999999999   9999999999999974     5689999


Q ss_pred             ccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          686 DFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       686 Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |||+|+.+........ .........+||+.|||||++.
T Consensus       149 DFG~a~~~~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~  186 (293)
T d1csna_         149 DFGMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHL  186 (293)
T ss_dssp             CCTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHT
T ss_pred             ccceeEEcccCccccc-eeecccCceEEchhhcCHHHhc
Confidence            9999998754322211 1112233467999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-30  Score=264.68  Aligned_cols=171  Identities=23%  Similarity=0.384  Sum_probs=148.3

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCccee
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      ++|+..+.||+|+||+||+|++..+++.||||+++...  ....+++.+|+.++++++||||+++++++....     ..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence            57899999999999999999999999999999997543  344678999999999999999999999987665     78


Q ss_pred             eEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEccccc
Q 048668          610 ALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFGL  689 (725)
Q Consensus       610 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfgl  689 (725)
                      ++|||++.++++..++....      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            99999999999988887554      578999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          690 AKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       690 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+........        .....+++.|+|||++.
T Consensus       148 a~~~~~~~~~--------~~~~~~~~~~~~pe~~~  174 (292)
T d1unla_         148 ARAFGIPVRC--------YSAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             CEECCSCCSC--------CCSCCSCGGGCCHHHHT
T ss_pred             hhcccCCCcc--------ceeeccccchhhhhHhc
Confidence            9876443211        11245888999999764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.9e-30  Score=263.45  Aligned_cols=177  Identities=28%  Similarity=0.410  Sum_probs=140.1

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcceeeE
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDFKAL  611 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  611 (725)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....  ..++.+|++++++++|++++..++.+....    +..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~----~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET----TEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC----CEEEE
Confidence            469999999999999999999999999999999875432  245778999999999887766665554332    47899


Q ss_pred             EEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecC---CCceEEcccc
Q 048668          612 VFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVGDFG  688 (725)
Q Consensus       612 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~---~~~~kl~Dfg  688 (725)
                      ||||+ ++++.+.+.....     .+++..+..++.|++.||+|||++   +|+||||||+||+++.   +..+|++|||
T Consensus        81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            99999 5677776654432     589999999999999999999999   9999999999998764   4579999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +|+.+......... ........+||+.|||||++.
T Consensus       152 ~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  186 (299)
T d1ckia_         152 LAKKYRDARTHQHI-PYRENKNLTGTARYASINTHL  186 (299)
T ss_dssp             SCEECBCTTTCCBC-CCCBCCSCCCCSSSCCHHHHT
T ss_pred             cceeccccccccce-eccccCCcCCCccccCHHHHh
Confidence            99987654322111 112233467999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-30  Score=271.29  Aligned_cols=173  Identities=21%  Similarity=0.321  Sum_probs=142.3

Q ss_pred             hcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCCCCcce
Q 048668          531 TSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDFKGVDF  608 (725)
Q Consensus       531 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  608 (725)
                      .++|+..+.||+|+||+||+|++..+|+.||||+++...  ....+++.+|++++++++|||||++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            457999999999999999999999999999999997543  234567889999999999999999999986543222234


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .++||+|+.+|+|.+++...       .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            46677788899999999643       489999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      .|......           ..+..||+.|+|||++.
T Consensus       167 ~a~~~~~~-----------~~~~~g~~~y~apE~~~  191 (348)
T d2gfsa1         167 LARHTDDE-----------MTGYVATRWYRAPEIML  191 (348)
T ss_dssp             ---CCTGG-----------GSSSCHHHHTSCHHHHT
T ss_pred             hhcccCcc-----------cccccccccccCchhhc
Confidence            99765322           12356999999999754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.4e-30  Score=269.10  Aligned_cols=172  Identities=22%  Similarity=0.290  Sum_probs=134.9

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccc--cchHHHHHHHHHHHHcCCCCcccceeeEeecCCC-CCcce
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLIKIITICSSTDF-KGVDF  608 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  608 (725)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....  .....++.+|+.++++++||||+++++++..... +...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999999999999999997543  3344678899999999999999999999865432 34568


Q ss_pred             eeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceEEcccc
Q 048668          609 KALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVGDFG  688 (725)
Q Consensus       609 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~kl~Dfg  688 (725)
                      .|+|||||.++ +.+.+..        .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchH-HHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            89999999765 4444432        478999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          689 LAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       689 la~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      +++......         .....+||+.|+|||++.
T Consensus       165 ~~~~~~~~~---------~~~~~~~t~~y~aPE~l~  191 (355)
T d2b1pa1         165 LARTAGTSF---------MMTPYVVTRYYRAPEVIL  191 (355)
T ss_dssp             C------------------------CCTTCCHHHHT
T ss_pred             hhhcccccc---------ccccccccccccChhhhc
Confidence            988654321         112357999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=267.26  Aligned_cols=172  Identities=23%  Similarity=0.339  Sum_probs=146.0

Q ss_pred             cCCCCCcccccccceEEEEEEE---CCCceEEEEEEeeccc----cchHHHHHHHHHHHHcCCC-CcccceeeEeecCCC
Q 048668          532 SEFSSSNMIGQGSFGSVYKGIL---GEDEMIVAVKVINLKQ----KGAFRSFVAECEALRNIRH-RNLIKIITICSSTDF  603 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  603 (725)
                      ++|++.+.||+|+||+||+|++   +.+|+.||||+++...    ....+++.+|++++++++| |||+++++++.... 
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~-  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence            5799999999999999999987   4478999999986432    2335678899999999976 89999999976654 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeeecCCCceE
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH  683 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill~~~~~~k  683 (725)
                          ..++||||+.+|+|.+++....      .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+|
T Consensus       103 ----~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk  169 (322)
T d1vzoa_         103 ----KLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  169 (322)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             ----ceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence                8899999999999999998765      578889999999999999999999   999999999999999999999


Q ss_pred             EcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          684 VGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       684 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      |+|||+|+.+.....       .......||+.|+|||.+.
T Consensus       170 L~DFG~a~~~~~~~~-------~~~~~~~g~~~~~~pe~~~  203 (322)
T d1vzoa_         170 LTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVR  203 (322)
T ss_dssp             ESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHT
T ss_pred             Eeeccchhhhccccc-------ccccccccccccchhHHhh
Confidence            999999987643321       1122357999999999863

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=2.5e-29  Score=258.64  Aligned_cols=235  Identities=29%  Similarity=0.459  Sum_probs=201.6

Q ss_pred             cccCCCCCCCEEECcc-CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCC
Q 048668          182 TFLTNCSSLKVLSLSD-NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGEL  260 (725)
Q Consensus       182 ~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  260 (725)
                      +.+.++++|++|+|++ |+++|.+|..|++++ +|+.|++++|++.+..+..+..+..|+.++++.|.+.+.+|..+..+
T Consensus        70 ~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~-~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l  148 (313)
T d1ogqa_          70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL  148 (313)
T ss_dssp             GGGGGCTTCSEEEEEEETTEESCCCGGGGGCT-TCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred             hHHhcCcccccccccccccccccccccccccc-ccchhhhccccccccccccccchhhhcccccccccccccCchhhccC
Confidence            4567778888888876 778888888888887 88888888888888888888889999999999999998899999999


Q ss_pred             CCccEEeccCcccccCCCCCCcCCCCC-CEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcch
Q 048668          261 KNLQLLGLYKNFLQGSIPSGLGNLTKL-AKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQ  339 (725)
Q Consensus       261 ~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~  339 (725)
                      ++|+++++++|.+.+.+|..+..+..+ +.+++++|+++           +..|..+... .. .+++++++...+.+|.
T Consensus       149 ~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~-----------~~~~~~~~~l-~~-~~l~l~~~~~~~~~~~  215 (313)
T d1ogqa_         149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT-----------GKIPPTFANL-NL-AFVDLSRNMLEGDASV  215 (313)
T ss_dssp             TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE-----------EECCGGGGGC-CC-SEEECCSSEEEECCGG
T ss_pred             cccceeecccccccccccccccccccccccccccccccc-----------cccccccccc-cc-cccccccccccccccc
Confidence            999999999999998899888888776 88999998655           3445444443 33 4689999999999999


Q ss_pred             hhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCC
Q 048668          340 QVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFL  419 (725)
Q Consensus       340 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  419 (725)
                      .+..+++++.+++++|.+.+.+| .+..+++|++|+|++|+++|.+|..|+.+++|+.|||++|+|+|.+|. +.++++|
T Consensus       216 ~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L  293 (313)
T d1ogqa_         216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF  293 (313)
T ss_dssp             GCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGS
T ss_pred             ccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCC
Confidence            99999999999999999987654 688899999999999999999999999999999999999999999985 6889999


Q ss_pred             CeEEcccccC-eee
Q 048668          420 EFLNLSYNHL-EGE  432 (725)
Q Consensus       420 ~~L~l~~N~l-~~~  432 (725)
                      +.+++++|+. .|.
T Consensus       294 ~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         294 DVSAYANNKCLCGS  307 (313)
T ss_dssp             CGGGTCSSSEEEST
T ss_pred             CHHHhCCCccccCC
Confidence            9999999984 443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.7e-27  Score=243.87  Aligned_cols=267  Identities=21%  Similarity=0.249  Sum_probs=201.8

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      .+++++-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|.+|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4788899999998 6787664  689999999999987777789999999999999999998888999999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCcccc--ccCccCcccccccCeeecCCccCC
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFK--GKVSIDFSSLKILWRLNLEQNNLG  171 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~~~~f~~l~~L~~L~L~~N~l~  171 (725)
                      +|+|+ .+|...   .+.+..|++..|.+.++.+..+.....++.++...|...  ......|..+++|+.+++++|.+.
T Consensus        88 ~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_          88 KNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             SSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence            99998 788654   467888999999998887777888888888888888654  344556788888888888888887


Q ss_pred             ccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCC
Q 048668          172 IGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHG  251 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~  251 (725)
                      .++.         ..+++|++|++++|.+++..+..+..++ .++.|.+++|.+.+..+.++.++++|++|+|++|+|+.
T Consensus       164 ~l~~---------~~~~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~  233 (305)
T d1xkua_         164 TIPQ---------GLPPSLTELHLDGNKITKVDAASLKGLN-NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK  233 (305)
T ss_dssp             SCCS---------SCCTTCSEEECTTSCCCEECTGGGTTCT-TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS
T ss_pred             ccCc---------ccCCccCEEECCCCcCCCCChhHhhccc-cccccccccccccccccccccccccceeeecccccccc
Confidence            6543         1246788888888888776666666665 66667777777776666666677777777777777764


Q ss_pred             CCChhhcCCCCccEEeccCcccccCCCCCC------cCCCCCCEEeCCCCcCC
Q 048668          252 TIPDVIGELKNLQLLGLYKNFLQGSIPSGL------GNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       252 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~  298 (725)
                      + |.+|..+++|++|+|++|+|+......|      ..+++|+.|+|++|+++
T Consensus       234 l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         234 V-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             C-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             c-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            3 5566667777777777777664433332      23456666666666554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.6e-27  Score=244.14  Aligned_cols=245  Identities=20%  Similarity=0.291  Sum_probs=200.0

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      .++.+|-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|+++ .++...|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCCccCEecc
Confidence            6788999999998 6676665  68999999999999777789999999999999999999 888788899999999999


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECcc
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      ++|+|+.+....   ...++.|++++|.+.++....|.....+..++...|........    ...+..+++|+++++++
T Consensus        87 ~~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~----~~~~~~l~~L~~l~l~~  159 (305)
T d1xkua_          87 SKNQLKELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE----NGAFQGMKKLSYIRIAD  159 (305)
T ss_dssp             CSSCCSBCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC----TTGGGGCTTCCEEECCS
T ss_pred             cCCccCcCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCC----ccccccccccCcccccc
Confidence            999999765433   36789999999999999988898899999999999876554332    24567889999999999


Q ss_pred             CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCC
Q 048668          198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI  277 (725)
Q Consensus       198 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  277 (725)
                      |+++ .+|..+   ..+++.|++++|.+.+..+..+..++.++.|++++|.+.++.+.+|.++++|++|+|++|+|+ .+
T Consensus       160 n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~l  234 (305)
T d1xkua_         160 TNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV  234 (305)
T ss_dssp             SCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred             CCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cc
Confidence            9988 455443   236777888888877777777777778888888888887777777777788888888888777 45


Q ss_pred             CCCCcCCCCCCEEeCCCCcCC
Q 048668          278 PSGLGNLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       278 ~~~~~~l~~L~~L~L~~N~l~  298 (725)
                      |.+|..+++|++|+|++|+|+
T Consensus       235 p~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         235 PGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CTTTTTCSSCCEEECCSSCCC
T ss_pred             ccccccccCCCEEECCCCccC
Confidence            667777778888877777666

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.5e-27  Score=237.28  Aligned_cols=267  Identities=20%  Similarity=0.177  Sum_probs=176.7

Q ss_pred             cEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc-C
Q 048668           16 QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT-S   94 (725)
Q Consensus        16 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~-~   94 (725)
                      .+++.++++++ .+|..+.  +.+++|+|++|+|+++.+.+|.++++|++|++++|++..+.+..+.+++.++.++.. .
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            34566666666 5565544  456777777777776666677777777777777777776777777777777776654 4


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGA  174 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~  174 (725)
                      |.++ .++...|.++++|++|++++|.+..+.+..+...++|+.+++++|+|+++++..|..+++|+.|++++|+++.++
T Consensus        91 ~~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          91 AQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             TTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             cccc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            4454 666666677777777777777776666666777777777777777777777777777777777777777776655


Q ss_pred             CCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCC
Q 048668          175 ANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIP  254 (725)
Q Consensus       175 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  254 (725)
                      +      .+|.++++|+++++++|++++..|..|..++ +++.|++++|.+.+..+..|.++.+|+.|+|++|.+....+
T Consensus       170 ~------~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~-~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         170 E------RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG-RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             T------TTTTTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             h------hhhccccccchhhhhhccccccChhHhhhhh-hcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            4      3456677777777777777766677777666 67777777777776666777777778888888887764322


Q ss_pred             hhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcC
Q 048668          255 DVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSL  297 (725)
Q Consensus       255 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  297 (725)
                      - -.-...++.+....+.+....|..+.+   ....+++.+.|
T Consensus       243 ~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l  281 (284)
T d1ozna_         243 A-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDL  281 (284)
T ss_dssp             G-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGS
T ss_pred             c-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHC
Confidence            1 111123455555666666556655543   23344444433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.8e-26  Score=233.44  Aligned_cols=244  Identities=18%  Similarity=0.185  Sum_probs=140.6

Q ss_pred             cCCccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEcc-CCcccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVA-ENKFYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~   82 (725)
                      +||..+..  ++++|+|++|+|+...+.+|.++++|++|++++|+++++.+..+..+..++.++.+ .|.++.+.+..|+
T Consensus        25 ~iP~~ip~--~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  102 (284)
T d1ozna_          25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH  102 (284)
T ss_dssp             SCCTTCCT--TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred             ccCCCCCC--CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence            45555543  55666666666664444556666666666666666666666666666666666543 4445555556666


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCe
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWR  162 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~  162 (725)
                      ++++|++|++++|.+. .++...+...++|+.+++++|+|+++.+..|+.+++|++|+|++|+|+++++..|.++++|++
T Consensus       103 ~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~  181 (284)
T d1ozna_         103 GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR  181 (284)
T ss_dssp             TCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             ccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccch
Confidence            6666666666666665 555555555666666666666666655566666666666666666666666666666666666


Q ss_pred             eecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceE
Q 048668          163 LNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIAL  242 (725)
Q Consensus       163 L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L  242 (725)
                      +++++|+++.+.+      ..|.++++|++|++++|++.+..|..|.++. .|+.+++++|.+.+..+. ..-...++.+
T Consensus       182 l~l~~N~l~~i~~------~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~-~L~~L~l~~N~l~C~C~~-~~l~~~l~~~  253 (284)
T d1ozna_         182 LLLHQNRVAHVHP------HAFRDLGRLMTLYLFANNLSALPTEALAPLR-ALQYLRLNDNPWVCDCRA-RPLWAWLQKF  253 (284)
T ss_dssp             EECCSSCCCEECT------TTTTTCTTCCEEECCSSCCSCCCHHHHTTCT-TCCEEECCSSCEECSGGG-HHHHHHHHHC
T ss_pred             hhhhhccccccCh------hHhhhhhhccccccccccccccccccccccc-ccCEEEecCCCCCCCccc-hHHHHHHHhC
Confidence            6666666655443      3345566666666666666655555555554 566666666666543221 1112234444


Q ss_pred             EecccccCCCCChhhc
Q 048668          243 AVEVNQLHGTIPDVIG  258 (725)
Q Consensus       243 ~L~~N~l~~~~~~~~~  258 (725)
                      ....+++....|..+.
T Consensus       254 ~~~~~~~~C~~p~~l~  269 (284)
T d1ozna_         254 RGSSSEVPCSLPQRLA  269 (284)
T ss_dssp             CSEECCCBEEESGGGT
T ss_pred             cCCCCceEeCCchHHc
Confidence            4445555444444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.6e-24  Score=213.11  Aligned_cols=179  Identities=24%  Similarity=0.237  Sum_probs=122.6

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      .+...+.+.+.++++++ .+|+.+.  ++|++|+|++|+|+++.+++|.++++|++|+|++|+|+.+.  .++.+++|++
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~   81 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGT   81 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccc
Confidence            34455666777777777 5666554  46777777777777666677777777777777777776432  3566777777


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN  169 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~  169 (725)
                      |+|++|+++ ..+. .+.++++|+.|++++|.+..+.+..+..+.++++|++++|.++.+++..|..+++|+.+++++|+
T Consensus        82 L~Ls~N~l~-~~~~-~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          82 LDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EECCSSCCS-SCCC-CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccc-cccc-ccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            777777776 4443 34667777777777777777767777777777777777777777777666666777777777776


Q ss_pred             CCccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          170 LGIGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       170 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      ++.+++      ..|..+++|++|+|++|+|+
T Consensus       160 l~~~~~------~~~~~l~~L~~L~Ls~N~L~  185 (266)
T d1p9ag_         160 LTELPA------GLLNGLENLDTLLLQENSLY  185 (266)
T ss_dssp             CSCCCT------TTTTTCTTCCEEECCSSCCC
T ss_pred             ccccCc------cccccccccceeecccCCCc
Confidence            665544      33455666666666666666

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.5e-24  Score=211.97  Aligned_cols=181  Identities=24%  Similarity=0.199  Sum_probs=122.0

Q ss_pred             CCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCcccccccccccccccccc
Q 048668          238 NLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLL  317 (725)
Q Consensus       238 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~  317 (725)
                      ++++|+|++|+|+++.+.+|.++++|++|+|++|+|+.. + .+..+++|++|+|++|+++            .++..+.
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~------------~~~~~~~   97 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ------------SLPLLGQ   97 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS------------SCCCCTT
T ss_pred             CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccccccccc------------ccccccc
Confidence            455555555555555555555566666666666655532 2 2345555666666665544            2233333


Q ss_pred             ccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCCCCCCE
Q 048668          318 SITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKF  397 (725)
Q Consensus       318 ~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  397 (725)
                      .+..+ ++|++++|.+.+..+..+..+.+++.|++++|.++...+..+..++.|+.|++++|++++..+..|..+++|+.
T Consensus        98 ~l~~L-~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~  176 (266)
T d1p9ag_          98 TLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT  176 (266)
T ss_dssp             TCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred             ccccc-ccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccce
Confidence            33333 55555555555556666777788888888888888777777788888888888888888777777888888888


Q ss_pred             EeCCCCcccccCcccccCCCCCCeEEcccccCeeecC
Q 048668          398 LDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEVP  434 (725)
Q Consensus       398 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  434 (725)
                      |||++|+|+ .+|..+..+++|+.|+|++|+|.|.+.
T Consensus       177 L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             eecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            888888888 677777778888888888888877654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.91  E-value=4.9e-25  Score=231.23  Aligned_cols=171  Identities=18%  Similarity=0.267  Sum_probs=131.6

Q ss_pred             cCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-----------CCcccceeeEeec
Q 048668          532 SEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-----------HRNLIKIITICSS  600 (725)
Q Consensus       532 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  600 (725)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.+. ...+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999999999999999997542 23467788999888875           5789999988754


Q ss_pred             CCCCCcceeeEEEeccCCCCH-HHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEecCCCCCCeeecC
Q 048668          601 TDFKGVDFKALVFEYMGNGSL-EDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDH  678 (725)
Q Consensus       601 ~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivHrdlkp~Nill~~  678 (725)
                      ..   ....+.||+++..+.. ........    ...+++..+..++.||+.|++|||+ .   +|+||||||+|||++.
T Consensus        92 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          92 KG---PNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI  161 (362)
T ss_dssp             EE---TTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred             cc---ccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence            32   2355667776655433 23222222    1268899999999999999999998 5   8999999999999986


Q ss_pred             CC------ceEEcccccccccccCCCCCCCCCCcccccccCCccccCCCccc
Q 048668          679 DM------VAHVGDFGLAKFLSSHHLDTSSKTPSSSIGIKGTVGYVAPGKFF  724 (725)
Q Consensus       679 ~~------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  724 (725)
                      ++      .+|++|||.|+......           ...+||+.|+|||++.
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~  202 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLL  202 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHH
T ss_pred             cCcccccceeeEeeccccccccccc-----------ccccccccccChhhcc
Confidence            64      49999999997653321           1256999999999764

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.88  E-value=6.4e-21  Score=198.60  Aligned_cols=142  Identities=26%  Similarity=0.346  Sum_probs=75.9

Q ss_pred             cccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCCCCCCcCCCCCCEEeCCCCcCCCccccccccccccc
Q 048668          233 IRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSIPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGAL  312 (725)
Q Consensus       233 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  312 (725)
                      +..++.|+.+++++|..... +   ....++..+.+.+|.+.. .+.   ..+.+...++..|.+.+            +
T Consensus       200 ~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~------------l  259 (353)
T d1jl5a_         200 LQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSG------------L  259 (353)
T ss_dssp             CTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSE------------E
T ss_pred             cccccccccccccccccccc-c---cccccccccccccccccc-ccc---ccccccccccccccccc------------c
Confidence            45667777777777766532 2   224456777777776653 222   23455566666554331            1


Q ss_pred             cccccccccccceecccCCccCCCcchhhhcCCCCCeEEccCccccccCccccccccCCcEEEccCCccccccCccccCC
Q 048668          313 PQQLLSITTLSLYLDLSNNLLNGSLPQQVGNLKNLIILDISSNQFSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFL  392 (725)
Q Consensus       313 p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  392 (725)
                          ..........++..+.+.+.    ...+++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +
T Consensus       260 ----~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~  323 (353)
T d1jl5a_         260 ----SELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---P  323 (353)
T ss_dssp             ----SCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---C
T ss_pred             ----ccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---c
Confidence                11111113344555554422    123456777777777766 34432   346667777777766 33432   3


Q ss_pred             CCCCEEeCCCCcccccCcc
Q 048668          393 KSIKFLDVSCNNFSGQFPK  411 (725)
Q Consensus       393 ~~L~~L~Ls~N~l~~~~p~  411 (725)
                      ++|+.|++++|+|+ .+|.
T Consensus       324 ~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         324 QNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             TTCCEEECCSSCCS-SCCC
T ss_pred             CCCCEEECcCCcCC-CCCc
Confidence            45666677777665 3443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=9e-20  Score=189.75  Aligned_cols=301  Identities=25%  Similarity=0.319  Sum_probs=180.4

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEc
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGI  117 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  117 (725)
                      +|++|||++|+|+ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++.    -.+.|++|++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LPPLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CCTTCCEEEC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hccccccccc
Confidence            4566666666665 34432   345666666666665 334332   35666666666665 4442    1235666666


Q ss_pred             cCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECcc
Q 048668          118 GANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       118 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      ++|.++.+ | .++.+++|++|++++|.++....    ....+..+.+..+.....        ..+..++.++.|++++
T Consensus       106 ~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~--------~~l~~l~~l~~L~l~~  171 (353)
T d1jl5a_         106 SNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEEL--------PELQNLPFLTAIYADN  171 (353)
T ss_dssp             CSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC--------CCCTTCTTCCEEECCS
T ss_pred             cccccccc-c-chhhhccceeecccccccccccc----ccccccchhhcccccccc--------ccccccccceeccccc
Confidence            66666644 2 24566667777777766654332    234455555555544322        1244567777777777


Q ss_pred             CcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEecccccCCCCChhhcCCCCccEEeccCcccccCC
Q 048668          198 NQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQGSI  277 (725)
Q Consensus       198 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  277 (725)
                      |.+.. .+..                            ....+.+....+.+. ..+ .+..++.|+.+++++|.... .
T Consensus       172 n~~~~-~~~~----------------------------~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~  219 (353)
T d1jl5a_         172 NSLKK-LPDL----------------------------PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-L  219 (353)
T ss_dssp             SCCSS-CCCC----------------------------CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred             ccccc-cccc----------------------------ccccccccccccccc-ccc-cccccccccccccccccccc-c
Confidence            76652 1110                            112234444444444 223 35678899999999998763 3


Q ss_pred             CCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCCcchhhhcC-CCCCeEEccCcc
Q 048668          278 PSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSLPQQVGNL-KNLIILDISSNQ  356 (725)
Q Consensus       278 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~  356 (725)
                      +.   ...++..+.+.+|++.            ..+....    .+...++..+.+.+.     ..+ ......++..|.
T Consensus       220 ~~---~~~~l~~~~~~~~~~~------------~~~~~~~----~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~  275 (353)
T d1jl5a_         220 PD---LPPSLEALNVRDNYLT------------DLPELPQ----SLTFLDVSENIFSGL-----SELPPNLYYLNASSNE  275 (353)
T ss_dssp             CS---CCTTCCEEECCSSCCS------------CCCCCCT----TCCEEECCSSCCSEE-----SCCCTTCCEEECCSSC
T ss_pred             cc---cccccccccccccccc------------ccccccc----ccccccccccccccc-----ccccchhcccccccCc
Confidence            43   3467888889888765            1221111    113344555444321     112 355677888887


Q ss_pred             ccccCccccccccCCcEEEccCCccccccCccccCCCCCCEEeCCCCcccccCcccccCCCCCCeEEcccccCeeec
Q 048668          357 FSGMIPVTLSTCVSLEYVDISSNCFHGIIPPSLGFLKSIKFLDVSCNNFSGQFPKFLENLSFLEFLNLSYNHLEGEV  433 (725)
Q Consensus       357 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  433 (725)
                      +.+.    ...+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..   +++|++|+|++|+++..+
T Consensus       276 ~~~~----~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp  340 (353)
T d1jl5a_         276 IRSL----CDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFP  340 (353)
T ss_dssp             CSEE----CCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCC
T ss_pred             cccc----cccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCC
Confidence            7643    234578999999999998 4554   3678999999999998 56653   457999999999998543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=4.9e-22  Score=187.41  Aligned_cols=133  Identities=20%  Similarity=0.216  Sum_probs=104.8

Q ss_pred             CCCcccccccceEEEEEEECCCceEEEEEEeecccc------------------chHHHHHHHHHHHHcCCCCcccceee
Q 048668          535 SSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQK------------------GAFRSFVAECEALRNIRHRNLIKIIT  596 (725)
Q Consensus       535 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  596 (725)
                      .+.+.||+|+||+||+|++. +|+.||||+++....                  .....+.+|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45689999999999999985 789999998753210                  01234567899999999999998876


Q ss_pred             EeecCCCCCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecCCCCCCeee
Q 048668          597 ICSSTDFKGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  676 (725)
Q Consensus       597 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivHrdlkp~Nill  676 (725)
                      +.         ..++||||++++...+             +++.....++.|++.|++|||++   +|+||||||+|||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv  136 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  136 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             ec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence            52         2379999998765433             23334567899999999999999   99999999999999


Q ss_pred             cCCCceEEcccccccccc
Q 048668          677 DHDMVAHVGDFGLAKFLS  694 (725)
Q Consensus       677 ~~~~~~kl~Dfgla~~~~  694 (725)
                      +++ .++++|||.|+...
T Consensus       137 ~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             ETT-EEEECCCTTCEETT
T ss_pred             eCC-CEEEEECCCcccCC
Confidence            965 58999999997653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=5.8e-21  Score=187.72  Aligned_cols=218  Identities=22%  Similarity=0.246  Sum_probs=119.9

Q ss_pred             cEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEcc-
Q 048668           40 QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIG-  118 (725)
Q Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~-  118 (725)
                      ++++.++++++ .+|+.+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+.+.++...|.+++++++|.+. 
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 4444432  4566777777777655566677777777777777766645666666667777776654 


Q ss_pred             CceeeeeCCCcccccCccceecCCCccccccCccC-cccccccCeeecCCccCCccCCCCcccccccCCC-CCCCEEECc
Q 048668          119 ANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSID-FSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNC-SSLKVLSLS  196 (725)
Q Consensus       119 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~-f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l-~~L~~L~L~  196 (725)
                      .|++....+..|.++++|++|++++|++....+.. +..++.+..+..+++.+..+...      .+.++ ..++.|+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~------~~~~~~~~l~~L~l~  161 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN------SFVGLSFESVILWLN  161 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTT------SSTTSBSSCEEEECC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccc------ccccccccceeeecc
Confidence            35666666667777777777777777776544322 23344444444455555443331      12222 255666666


Q ss_pred             cCcccccCChhhhhccccceeEEecCccceeccCcccccccCCce-EEecccccCCCCChhhcCCCCccEEeccCccccc
Q 048668          197 DNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIA-LAVEVNQLHGTIPDVIGELKNLQLLGLYKNFLQG  275 (725)
Q Consensus       197 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  275 (725)
                      +|+++. ++......                         .+++. +++++|+++.+.+..|.++++|++|+|++|+|+.
T Consensus       162 ~n~l~~-i~~~~~~~-------------------------~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~  215 (242)
T d1xwdc1         162 KNGIQE-IHNCAFNG-------------------------TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS  215 (242)
T ss_dssp             SSCCCE-ECTTTTTT-------------------------CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC
T ss_pred             cccccc-cccccccc-------------------------hhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc
Confidence            666652 22222222                         22222 2344455554444455555555555555555554


Q ss_pred             CCCCCCcCCCCCCEEeC
Q 048668          276 SIPSGLGNLTKLAKLDL  292 (725)
Q Consensus       276 ~~~~~~~~l~~L~~L~L  292 (725)
                      ..+..|.++++|+.+++
T Consensus       216 l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         216 LPSYGLENLKKLRARST  232 (242)
T ss_dssp             CCSSSCTTCCEEESSSE
T ss_pred             cCHHHHcCCcccccCcC
Confidence            43444444444444443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1.5e-23  Score=227.05  Aligned_cols=240  Identities=17%  Similarity=0.108  Sum_probs=131.8

Q ss_pred             CCCCCCEEECccCccccc----CChhhhhccccceeEEecCccceec----cCcccccccCCceEEecccccCC-----C
Q 048668          186 NCSSLKVLSLSDNQFGGE----LPHSIANLSSTMIVFLIGGNQISGT----IPLGIRNLVNLIALAVEVNQLHG-----T  252 (725)
Q Consensus       186 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~~l~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~-----~  252 (725)
                      ....++.++++++.+...    ....+.........+.+..+.+...    ....+.....++.++++.|.+..     .
T Consensus       167 ~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~  246 (460)
T d1z7xw1         167 AKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL  246 (460)
T ss_dssp             HCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchh
Confidence            345566666666654421    1111122222334455544444311    11223445667777777776532     1


Q ss_pred             CChhhcCCCCccEEeccCcccccC----CCCCCcCCCCCCEEeCCCCcCCCccccccccccccccccccccccccceecc
Q 048668          253 IPDVIGELKNLQLLGLYKNFLQGS----IPSGLGNLTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDL  328 (725)
Q Consensus       253 ~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L  328 (725)
                      ....+.....++.+++++|.+...    ....+...+.++.+++++|.+++..       ...+...+......++.+++
T Consensus       247 ~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~-------~~~l~~~l~~~~~~L~~l~l  319 (460)
T d1z7xw1         247 CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG-------ARLLCETLLEPGCQLESLWV  319 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH-------HHHHHHHHTSTTCCCCEEEC
T ss_pred             hcccccccccccccccccccccccccccccccccccccccccccccccccccc-------cchhhccccccccccccccc
Confidence            233344456778888888776532    2223345677788888887665211       00111112222223367777


Q ss_pred             cCCccCCCcch----hhhcCCCCCeEEccCccccccC----ccccc-cccCCcEEEccCCccccc----cCccccCCCCC
Q 048668          329 SNNLLNGSLPQ----QVGNLKNLIILDISSNQFSGMI----PVTLS-TCVSLEYVDISSNCFHGI----IPPSLGFLKSI  395 (725)
Q Consensus       329 ~~n~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L  395 (725)
                      ++|.++.....    .+...++|++|+|++|+|++..    +..+. ..+.|++|+|++|.|+..    ++..+..+++|
T Consensus       320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L  399 (460)
T d1z7xw1         320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL  399 (460)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred             cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence            77777644333    3345567888888888876432    22232 345688888888888643    33445567888


Q ss_pred             CEEeCCCCcccccCccc----cc-CCCCCCeEEcccccCeee
Q 048668          396 KFLDVSCNNFSGQFPKF----LE-NLSFLEFLNLSYNHLEGE  432 (725)
Q Consensus       396 ~~L~Ls~N~l~~~~p~~----~~-~l~~L~~L~l~~N~l~~~  432 (725)
                      +.|||++|+|+......    +. +-..|+.|++++|.+...
T Consensus       400 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence            88888888886532222    22 334688888888887643

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=1.2e-20  Score=177.95  Aligned_cols=173  Identities=21%  Similarity=0.340  Sum_probs=138.9

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCc-cCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGG-KFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      .++++.++++++ .+|+.+.  +++++|+|++|+|++ ..+..|.++++|++|+|++|++..+.+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            568999999998 7787664  689999999999975 557778999999999999999998889999999999999999


Q ss_pred             CCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCcc
Q 048668           94 SNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGIG  173 (725)
Q Consensus        94 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~~  173 (725)
                      +|+|+ .+|.++|.++++|++|+|++|+|+++.+++|..+++|++|+|++|++.......+ -...++.+.+..|.+...
T Consensus        87 ~N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_          87 ENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             SCCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBC
T ss_pred             ccccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeC
Confidence            99998 8888889999999999999999999999999999999999999999875433221 123456666777766543


Q ss_pred             CCCCcccccccCCCCCCCEEECccCccc
Q 048668          174 AANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       174 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      .+         ..+..++.++|+.|.++
T Consensus       165 ~p---------~~l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         165 AP---------SKVRDVQIKDLPHSEFK  183 (192)
T ss_dssp             SS---------TTTTTSBGGGSCTTTCC
T ss_pred             CC---------hhhcCCEeeecCHhhCc
Confidence            32         23455666677777665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=2.4e-20  Score=181.13  Aligned_cols=210  Identities=21%  Similarity=0.320  Sum_probs=139.4

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      .++.++..++++.+++++..  .+..+.+|+.|++++|+|+.. + .+.++++|++|+|++|+|+++.|  +.++++|++
T Consensus        16 ~~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~   89 (227)
T d1h6ua2          16 PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITE   89 (227)
T ss_dssp             HHHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred             HHHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--ccccccccc
Confidence            34455566778777777433  456677888899999988744 3 48888899999999888875544  888888888


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN  169 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~  169 (725)
                      +++++|.++ .++.  +.++++|+.+++++|.....  ..+...+.++.++++.+.+....  .+..+++|++|++++|.
T Consensus        90 l~~~~n~~~-~i~~--l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~  162 (227)
T d1h6ua2          90 LELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQ  162 (227)
T ss_dssp             EECCSCCCS-CCGG--GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSC
T ss_pred             ccccccccc-cccc--cccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccc
Confidence            888888887 6653  45788888888888877644  33566777788888887776432  35666667777777776


Q ss_pred             CCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEeccccc
Q 048668          170 LGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVNQL  249 (725)
Q Consensus       170 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l  249 (725)
                      +....        .+.++++|++|+|++|++++ ++                          .++++++|++|+|++|++
T Consensus       163 ~~~~~--------~l~~l~~L~~L~Ls~n~l~~-l~--------------------------~l~~l~~L~~L~Ls~N~l  207 (227)
T d1h6ua2         163 VSDLT--------PLANLSKLTTLKADDNKISD-IS--------------------------PLASLPNLIEVHLKNNQI  207 (227)
T ss_dssp             CCCCG--------GGTTCTTCCEEECCSSCCCC-CG--------------------------GGGGCTTCCEEECTTSCC
T ss_pred             cccch--------hhcccccceecccCCCccCC-Ch--------------------------hhcCCCCCCEEECcCCcC
Confidence            65322        24556666666666666652 11                          134445555555555555


Q ss_pred             CCCCChhhcCCCCccEEecc
Q 048668          250 HGTIPDVIGELKNLQLLGLY  269 (725)
Q Consensus       250 ~~~~~~~~~~l~~L~~L~L~  269 (725)
                      +++.|  +.++++|++|+++
T Consensus       208 t~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         208 SDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             CBCGG--GTTCTTCCEEEEE
T ss_pred             CCCcc--cccCCCCCEEEee
Confidence            54322  5555555555554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=4.2e-20  Score=181.47  Aligned_cols=218  Identities=16%  Similarity=0.119  Sum_probs=123.9

Q ss_pred             cEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccc-cCcccccccCCCceeeccC
Q 048668           16 QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYG-MFPRSICNISSLEYFYLTS   94 (725)
Q Consensus        16 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~   94 (725)
                      ++++.++.+++ .+|+.+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.. +.+.+|.++++++++++..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 4554432  356666666666665555566666666666666666543 3344566666666666543


Q ss_pred             -CCCCCCCChhhhcCCCCccEEEccCceeeeeCCC-cccccCccceecCCCccccccCccCccccc-ccCeeecCCccCC
Q 048668           95 -NRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD-SLSNASNLELLDLSNNQFKGKVSIDFSSLK-ILWRLNLEQNNLG  171 (725)
Q Consensus        95 -N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~-~L~~L~L~~N~l~  171 (725)
                       |.+. .++...|.++++|++|++++|++....+. .+..+..++.+..+++.+..+....|.+++ .++.|++++|+++
T Consensus        88 ~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          88 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence             4554 55555566666666666666666543322 233445555555566666666666666554 4666666666665


Q ss_pred             ccCCCCcccccccCCCCCCCEE-ECccCcccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEec
Q 048668          172 IGAANDLGFVTFLTNCSSLKVL-SLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVE  245 (725)
Q Consensus       172 ~~~~~~~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~  245 (725)
                      .+...      .+ +.++++.+ ++++|+++...+..|.+++ +|+.|++++|.|+...+..|.++++|+.+++.
T Consensus       167 ~i~~~------~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~-~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         167 EIHNC------AF-NGTQLDELNLSDNNNLEELPNDVFHGAS-GPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             EECTT------TT-TTCCEEEEECTTCTTCCCCCTTTTTTSC-CCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ccccc------cc-cchhhhccccccccccccccHHHhcCCC-CCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            54431      12 22333333 4555666633333445555 66666666666664445567777777776664

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3.4e-22  Score=216.29  Aligned_cols=399  Identities=18%  Similarity=0.146  Sum_probs=248.0

Q ss_pred             ccCcEEecCCCccCcc-CCccccCCCCCcEEEccCCcCCc----cCCCCCCCCCCCCEEEccCCcccccC----ccccc-
Q 048668           13 FKLQALALAGNYLTGK-LPDFIGNLSALQVIHIKGNSLGG----KFPTTLGLLRNLVQLNVAENKFYGMF----PRSIC-   82 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~-   82 (725)
                      .+|++||++.|+++.. +.+.+..++++++|+|++|+++.    .+..++..+++|++|||++|+|+...    ...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            3689999999999853 24557788999999999999873    23455778899999999999986322    22232 


Q ss_pred             ccCCCceeeccCCCCCCCCC----hhhhcCCCCccEEEccCceeeeeCCCcc-----cccCccceecCCCccccccCc--
Q 048668           83 NISSLEYFYLTSNRFSGSLP----FDIVVNLPNLKELGIGANNFFGLIPDSL-----SNASNLELLDLSNNQFKGKVS--  151 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~----~~~~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~Ls~N~i~~~~~--  151 (725)
                      ...+|+.|+|++|.|+ ...    ...+..+++|++|+|++|.|.......+     ........+......+.....  
T Consensus        82 ~~~~L~~L~L~~n~it-~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~  160 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLT-GAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  160 (460)
T ss_dssp             TTCCCCEEECTTSCCB-GGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             CCCCCCEEECCCCCcc-ccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc
Confidence            2357999999999987 332    1345678899999999999864322211     111122333333333321111  


Q ss_pred             --cCcccccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCC----hhhhhccccceeEEecCccc
Q 048668          152 --IDFSSLKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELP----HSIANLSSTMIVFLIGGNQI  225 (725)
Q Consensus       152 --~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~~l~~L~l~~n~i  225 (725)
                        ..+.....++.++++.+........... ............+++..+.+.....    ..+... ..++.+.+..|.+
T Consensus       161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~-~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~-~~~~~l~~~~n~~  238 (460)
T d1z7xw1         161 LASVLRAKPDFKELTVSNNDINEAGVRVLC-QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK-ASLRELALGSNKL  238 (460)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHH-HHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHC-TTCCEEECCSSBC
T ss_pred             cccccccccccccccccccccccccccccc-cccccccccccccccccccccchhhhccccccccc-ccccccchhhccc
Confidence              1123345677788877765432110000 0001223456678888776652211    112222 3677788888776


Q ss_pred             ee-----ccCcccccccCCceEEecccccCCC----CChhhcCCCCccEEeccCcccccCCCCC-----CcCCCCCCEEe
Q 048668          226 SG-----TIPLGIRNLVNLIALAVEVNQLHGT----IPDVIGELKNLQLLGLYKNFLQGSIPSG-----LGNLTKLAKLD  291 (725)
Q Consensus       226 ~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~~l~~L~~L~  291 (725)
                      ..     ...........++.+++++|.+...    ....+...+.++.+++++|.+.......     ......|+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~  318 (460)
T d1z7xw1         239 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW  318 (460)
T ss_dssp             HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             cccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccc
Confidence            43     2233344567899999999988643    2334566788999999999886322211     12346899999


Q ss_pred             CCCCcCCCccccccccccccccccccccccccceecccCCccCCCc----chhhh-cCCCCCeEEccCcccccc----Cc
Q 048668          292 LGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGSL----PQQVG-NLKNLIILDISSNQFSGM----IP  362 (725)
Q Consensus       292 L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~~----~~  362 (725)
                      +++|.++....       ..+......... +++|+|++|.++...    +..+. ..+.|++|+|++|.|+..    +.
T Consensus       319 l~~~~l~~~~~-------~~l~~~~~~~~~-L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~  390 (460)
T d1z7xw1         319 VKSCSFTAACC-------SHFSSVLAQNRF-LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA  390 (460)
T ss_dssp             CTTSCCBGGGH-------HHHHHHHHHCSS-CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             ccccchhhhhh-------hhcccccccccc-hhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence            99997763110       011111122223 488999999987432    23333 456799999999999753    34


Q ss_pred             cccccccCCcEEEccCCccccccCccc----c-CCCCCCEEeCCCCcccccCcccc----cCCCCCCeE
Q 048668          363 VTLSTCVSLEYVDISSNCFHGIIPPSL----G-FLKSIKFLDVSCNNFSGQFPKFL----ENLSFLEFL  422 (725)
Q Consensus       363 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~-~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L  422 (725)
                      ..+..+++|++|+|++|+++......+    . +...|+.|++++|.+.......+    ...|+|+.|
T Consensus       391 ~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~  459 (460)
T d1z7xw1         391 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI  459 (460)
T ss_dssp             HHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred             HHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence            556677999999999999985433333    2 34579999999999986544443    334555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=1.1e-19  Score=171.21  Aligned_cols=164  Identities=20%  Similarity=0.205  Sum_probs=140.0

Q ss_pred             cCCccccCcccCcEEecCCCccCccC-CccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCccccc
Q 048668            4 QIPKEIGSLFKLQALALAGNYLTGKL-PDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSIC   82 (725)
Q Consensus         4 ~ip~~~~~l~~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~   82 (725)
                      +||+.+..  ++++|+|++|+|++.+ +..|..+++|+.|+|++|++.+..++.|..+++|++|+|++|+|+++.+.+|.
T Consensus        22 ~iP~~lp~--~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~   99 (192)
T d1w8aa_          22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL   99 (192)
T ss_dssp             SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSST
T ss_pred             ccCCCCCC--CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHh
Confidence            78998874  8999999999998644 56899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCe
Q 048668           83 NISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWR  162 (725)
Q Consensus        83 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~  162 (725)
                      ++++|++|+|++|+|+ .+|.++|.++++|++|+|++|.+...... ..-...++.+.+..|.++...|.   .+..++.
T Consensus       100 ~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~---~l~~~~l  174 (192)
T d1w8aa_         100 GLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS---KVRDVQI  174 (192)
T ss_dssp             TCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST---TTTTSBG
T ss_pred             CCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCCh---hhcCCEe
Confidence            9999999999999998 89999999999999999999999754322 11123477888889988865554   4555677


Q ss_pred             eecCCccCCccC
Q 048668          163 LNLEQNNLGIGA  174 (725)
Q Consensus       163 L~L~~N~l~~~~  174 (725)
                      ++|+.|.+....
T Consensus       175 ~~L~~n~l~C~~  186 (192)
T d1w8aa_         175 KDLPHSEFKCSS  186 (192)
T ss_dssp             GGSCTTTCCCCC
T ss_pred             eecCHhhCcCCC
Confidence            888888886433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=1.7e-19  Score=172.52  Aligned_cols=168  Identities=23%  Similarity=0.310  Sum_probs=125.1

Q ss_pred             ccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           13 FKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        13 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      .++....+..+.+++.++.  ..+.+|+.|++++|+++.. + .+..+++|++|+|++|+|+++.  .++.+++|++|++
T Consensus        24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l   97 (210)
T d1h6ta2          24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFL   97 (210)
T ss_dssp             HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccc
Confidence            3445556777777755543  3456788889999888743 3 3778888899999988888544  3678888888899


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccCCc
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNLGI  172 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l~~  172 (725)
                      ++|+|+ .+|.  +.++++|+.|++++|.+..+  ..+..+++++.+++++|.+++..  .+..+++|+.+++++|+++.
T Consensus        98 ~~n~i~-~l~~--l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~--~~~~l~~L~~l~l~~n~l~~  170 (210)
T d1h6ta2          98 DENKVK-DLSS--LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISD  170 (210)
T ss_dssp             CSSCCC-CGGG--GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCC
T ss_pred             cccccc-cccc--cccccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccc
Confidence            888887 6663  56788888888888888644  45778888888888888887543  46677888888888888765


Q ss_pred             cCCCCcccccccCCCCCCCEEECccCccc
Q 048668          173 GAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       173 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      +.        .+.++++|++|+|++|+|+
T Consensus       171 i~--------~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         171 IV--------PLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             CG--------GGTTCTTCCEEECCSSCCC
T ss_pred             cc--------cccCCCCCCEEECCCCCCC
Confidence            43        2567788888888888776

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=3.1e-19  Score=169.10  Aligned_cols=170  Identities=24%  Similarity=0.336  Sum_probs=135.2

Q ss_pred             CcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCcee
Q 048668           11 SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYF   90 (725)
Q Consensus        11 ~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L   90 (725)
                      ++.++..+.++.+.+++..+  ...++++++|++++|+++..  +.+..+++|++|+|++|+|++..+  ++++++|++|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            34455667788888875443  34567889999999999843  347888999999999999986544  8899999999


Q ss_pred             eccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccC
Q 048668           91 YLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus        91 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l  170 (725)
                      ++++|.+. .++.  +.++++|+.|++++|.+...  ..+..+++|+.|++++|++..++  .+..+++|++|++++|++
T Consensus        90 ~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~~~~L~~L~l~~n~l  162 (199)
T d2omxa2          90 LMNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLNFSSNQV  162 (199)
T ss_dssp             ECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred             cccccccc-cccc--cccccccccccccccccccc--cccchhhhhHHhhhhhhhhcccc--cccccccccccccccccc
Confidence            99999987 6663  67899999999999988754  35788899999999999987653  478888899999999988


Q ss_pred             CccCCCCcccccccCCCCCCCEEECccCccc
Q 048668          171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQFG  201 (725)
Q Consensus       171 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  201 (725)
                      +.++        .+.++++|++|++++|+++
T Consensus       163 ~~l~--------~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         163 TDLK--------PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CCCG--------GGTTCTTCCEEECCSSCCC
T ss_pred             cCCc--------cccCCCCCCEEECCCCCCC
Confidence            7653        2678888999999988887

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=8.1e-19  Score=167.65  Aligned_cols=166  Identities=27%  Similarity=0.341  Sum_probs=143.6

Q ss_pred             CcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCcee
Q 048668           11 SLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYF   90 (725)
Q Consensus        11 ~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L   90 (725)
                      .+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..  .++.+++|++|++++|+|+++ | .+.++++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccccc-c-ccccccccccc
Confidence            47789999999999984 33 4889999999999999998654  378899999999999999853 4 58999999999


Q ss_pred             eccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCccC
Q 048668           91 YLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus        91 ~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~l  170 (725)
                      ++++|.+. .++  .+..+++++.+++++|.++..  ..+..+++|+++++++|+++++.+  |..+++|++|+|++|.+
T Consensus       118 ~l~~~~~~-~~~--~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i  190 (210)
T d1h6ta2         118 SLEHNGIS-DIN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (210)
T ss_dssp             ECTTSCCC-CCG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             cccccccc-ccc--ccccccccccccccccccccc--cccccccccccccccccccccccc--ccCCCCCCEEECCCCCC
Confidence            99999997 665  357899999999999999754  467889999999999999998754  88999999999999999


Q ss_pred             CccCCCCcccccccCCCCCCCEEECcc
Q 048668          171 GIGAANDLGFVTFLTNCSSLKVLSLSD  197 (725)
Q Consensus       171 ~~~~~~~~~~~~~~~~l~~L~~L~L~~  197 (725)
                      +.++        .+.++++|++|+|++
T Consensus       191 ~~l~--------~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         191 SDLR--------ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CBCG--------GGTTCTTCSEEEEEE
T ss_pred             CCCh--------hhcCCCCCCEEEccC
Confidence            8653        378899999999975

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1.7e-18  Score=167.80  Aligned_cols=172  Identities=22%  Similarity=0.314  Sum_probs=147.2

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      ..+++|++|++++|+|+ .+ +.+..+++|++|++++|++++..|  |..+++|++|++++|.++.+  ..+.++++|++
T Consensus        38 ~~l~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~  111 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (227)
T ss_dssp             HHHHTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHcCCcCEEECCCCCCC-cc-hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccc
Confidence            45788999999999998 45 468999999999999999986554  89999999999999999843  35889999999


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN  169 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~  169 (725)
                      ++++++... .++.  +...+.++.+.++.+.+...  ..+.++++|++|++++|.++...  .|..+++|+.|+|++|+
T Consensus       112 l~l~~~~~~-~~~~--~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~  184 (227)
T d1h6ua2         112 LDLTSTQIT-DVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNK  184 (227)
T ss_dssp             EECTTSCCC-CCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             ccccccccc-ccch--hccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCc
Confidence            999999987 4432  45789999999999998754  35788999999999999998654  48899999999999999


Q ss_pred             CCccCCCCcccccccCCCCCCCEEECccCcccc
Q 048668          170 LGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGG  202 (725)
Q Consensus       170 l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  202 (725)
                      ++.++        .+.++++|++|+|++|++++
T Consensus       185 l~~l~--------~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         185 ISDIS--------PLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             CCCCG--------GGGGCTTCCEEECTTSCCCB
T ss_pred             cCCCh--------hhcCCCCCCEEECcCCcCCC
Confidence            98653        26788999999999999983

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=1.5e-18  Score=164.26  Aligned_cols=163  Identities=24%  Similarity=0.334  Sum_probs=139.6

Q ss_pred             cCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCce
Q 048668           10 GSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEY   89 (725)
Q Consensus        10 ~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   89 (725)
                      ..+.++++|++++|.|+. + +.+..+++|++|++++|++++..|  |.++++|++|++++|.+..+.  .++++++|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred             HHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccc
Confidence            347789999999999984 4 358899999999999999986554  899999999999999997433  4899999999


Q ss_pred             eeccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCCcccccCccceecCCCccccccCccCcccccccCeeecCCcc
Q 048668           90 FYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPDSLSNASNLELLDLSNNQFKGKVSIDFSSLKILWRLNLEQNN  169 (725)
Q Consensus        90 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~f~~l~~L~~L~L~~N~  169 (725)
                      |++++|.+. .++  .+..+++|+.|++++|++..+  ..+..+++|++|++++|+++++.  .|.++++|++|++++|+
T Consensus       111 L~l~~~~~~-~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         111 LTLFNNQIT-DID--PLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNK  183 (199)
T ss_dssp             EECCSSCCC-CCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             ccccccccc-ccc--ccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCC
Confidence            999999987 444  357899999999999999854  46889999999999999999875  48899999999999999


Q ss_pred             CCccCCCCcccccccCCCCCCCEE
Q 048668          170 LGIGAANDLGFVTFLTNCSSLKVL  193 (725)
Q Consensus       170 l~~~~~~~~~~~~~~~~l~~L~~L  193 (725)
                      ++.++        .+.++++|++|
T Consensus       184 i~~i~--------~l~~L~~L~~L  199 (199)
T d2omxa2         184 VSDIS--------VLAKLTNLESL  199 (199)
T ss_dssp             CCCCG--------GGGGCTTCSEE
T ss_pred             CCCCc--------cccCCCCCCcC
Confidence            98653        26678888876

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=3.1e-17  Score=148.82  Aligned_cols=127  Identities=17%  Similarity=0.210  Sum_probs=59.2

Q ss_pred             cCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCcc
Q 048668           34 GNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLK  113 (725)
Q Consensus        34 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  113 (725)
                      .+...|++|||++|+|+. ++..+..+++|++|+|++|+|+.+  ..|..+++|++|++++|+|+ .++..++..+++|+
T Consensus        15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~   90 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT   90 (162)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred             cCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCccccccccccc
Confidence            344444444444444442 233334444444444444444432  12444444555555555544 44444444445555


Q ss_pred             EEEccCceeeeeCC-CcccccCccceecCCCccccccCc---cCcccccccCeee
Q 048668          114 ELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKVS---IDFSSLKILWRLN  164 (725)
Q Consensus       114 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~---~~f~~l~~L~~L~  164 (725)
                      .|+|++|+|+.+.. ..+..+++|++|++++|+++..+.   ..+..+++|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            55555555443321 234555555555555555554432   2344555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=3.4e-17  Score=148.50  Aligned_cols=128  Identities=20%  Similarity=0.201  Sum_probs=87.3

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCc
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLE   88 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   88 (725)
                      +.++.++++|+|++|+|+ .++..+..+++|++|+|++|+|+.+  +.|..+++|++|+|++|+|+.+.+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            456666777777777777 4566666677777777777777643  3467777777777777777766666667777777


Q ss_pred             eeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCC---CcccccCccceec
Q 048668           89 YFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIP---DSLSNASNLELLD  140 (725)
Q Consensus        89 ~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~  140 (725)
                      .|++++|+|+ .++. ..+..+++|++|++++|.++....   ..++.+++|++||
T Consensus        91 ~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceecccccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            7777777776 5543 445677777777777777764421   2456677777766

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.63  E-value=3.7e-16  Score=134.52  Aligned_cols=104  Identities=24%  Similarity=0.370  Sum_probs=57.9

Q ss_pred             cEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccEEEccC
Q 048668           40 QVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKELGIGA  119 (725)
Q Consensus        40 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~  119 (725)
                      |+|||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|+.|++++|.|+ .+|.  +..+++|++|++++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCC
Confidence            35566666665 222 2555566666666666665 33445555666666666666665 4442  34555566666666


Q ss_pred             ceeeeeCC-CcccccCccceecCCCcccccc
Q 048668          120 NNFFGLIP-DSLSNASNLELLDLSNNQFKGK  149 (725)
Q Consensus       120 N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~  149 (725)
                      |+|+.+.. ..+..+++|++|++++|+|+.+
T Consensus        75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             CccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            65554432 3456666666666666666543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.61  E-value=6.2e-16  Score=133.07  Aligned_cols=118  Identities=22%  Similarity=0.288  Sum_probs=99.5

Q ss_pred             cEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCC
Q 048668           16 QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSN   95 (725)
Q Consensus        16 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N   95 (725)
                      |.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|+.|+.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence            68999999998 555 4899999999999999998 5677899999999999999999854 4 5999999999999999


Q ss_pred             CCCCCCCh-hhhcCCCCccEEEccCceeeeeC---CCcccccCcccee
Q 048668           96 RFSGSLPF-DIVVNLPNLKELGIGANNFFGLI---PDSLSNASNLELL  139 (725)
Q Consensus        96 ~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~l~~L~~L  139 (725)
                      +|+ .++. ..+..+++|++|++++|.++...   ...+..+|+|+.|
T Consensus        76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccC-CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            998 6664 56788999999999999997543   2234556777665

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=3e-16  Score=157.00  Aligned_cols=224  Identities=18%  Similarity=0.182  Sum_probs=107.8

Q ss_pred             cEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCccccc-CcccccccCCCceeeccC
Q 048668           16 QALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGM-FPRSICNISSLEYFYLTS   94 (725)
Q Consensus        16 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~   94 (725)
                      ++|||+++.+.......+.. ..+..+.+++..+..... ......+|++|||++|.++.. +...+..+++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            56777777665222221111 134556666655542222 233345677777777766533 234456667777777777


Q ss_pred             CCCCCCCChhhhcCCCCccEEEccCc-eeeeeC-CCcccccCccceecCCCc-cccccCc-cCcccccccCeeecCCccC
Q 048668           95 NRFSGSLPFDIVVNLPNLKELGIGAN-NFFGLI-PDSLSNASNLELLDLSNN-QFKGKVS-IDFSSLKILWRLNLEQNNL  170 (725)
Q Consensus        95 N~l~~~~~~~~~~~l~~L~~L~L~~N-~i~~~~-~~~~~~l~~L~~L~Ls~N-~i~~~~~-~~f~~l~~L~~L~L~~N~l  170 (725)
                      +.+++..+ ..+..+++|++|+|++| .++... ...+.++++|++|+++++ .+++... ..+                
T Consensus        81 ~~l~~~~~-~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~----------------  143 (284)
T d2astb2          81 LRLSDPIV-NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV----------------  143 (284)
T ss_dssp             CBCCHHHH-HHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH----------------
T ss_pred             cCCCcHHH-HHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhh----------------
Confidence            76653222 22345556666666553 333110 111234455555555543 2221000 000                


Q ss_pred             CccCCCCcccccccCCCCCCCEEECccCc--ccccCChhhhhccccceeEEecCccceeccCcccccccCCceEEeccc-
Q 048668          171 GIGAANDLGFVTFLTNCSSLKVLSLSDNQ--FGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNLVNLIALAVEVN-  247 (725)
Q Consensus       171 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N-  247 (725)
                                   -...++|+.|+++++.  ++..   .                     +...+.++++|++|++++| 
T Consensus       144 -------------~~~~~~L~~L~l~~~~~~i~~~---~---------------------l~~l~~~~~~L~~L~L~~~~  186 (284)
T d2astb2         144 -------------AHVSETITQLNLSGYRKNLQKS---D---------------------LSTLVRRCPNLVHLDLSDSV  186 (284)
T ss_dssp             -------------HHSCTTCCEEECCSCGGGSCHH---H---------------------HHHHHHHCTTCSEEECTTCT
T ss_pred             -------------cccccccchhhhcccccccccc---c---------------------cccccccccccccccccccc
Confidence                         0122455555555431  2210   0                     0111233455666666554 


Q ss_pred             ccCCCCChhhcCCCCccEEeccCc-ccccCCCCCCcCCCCCCEEeCCCC
Q 048668          248 QLHGTIPDVIGELKNLQLLGLYKN-FLQGSIPSGLGNLTKLAKLDLGSN  295 (725)
Q Consensus       248 ~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N  295 (725)
                      .+++.....+..+++|++|+++++ .+++.....+..+++|+.|+++++
T Consensus       187 ~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            344444555566666666666663 455444445556666666666655

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.56  E-value=1.2e-16  Score=165.16  Aligned_cols=246  Identities=19%  Similarity=0.233  Sum_probs=128.6

Q ss_pred             ccccCCCCCcEEEccCCcCCcc----CCCCCCCCCCCCEEEccCCccccc----------CcccccccCCCceeeccCCC
Q 048668           31 DFIGNLSALQVIHIKGNSLGGK----FPTTLGLLRNLVQLNVAENKFYGM----------FPRSICNISSLEYFYLTSNR   96 (725)
Q Consensus        31 ~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----------~~~~~~~l~~L~~L~L~~N~   96 (725)
                      ..+.....|+.|+|++|.+...    +...+...++|+.|+++++.+...          +...+..+++|+.|+|++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            3445555566666666655321    223344555666666655543211          11223445566666666666


Q ss_pred             CCCCCCh---hhhcCCCCccEEEccCceeeeeCCC-------------cccccCccceecCCCccccccCccC----ccc
Q 048668           97 FSGSLPF---DIVVNLPNLKELGIGANNFFGLIPD-------------SLSNASNLELLDLSNNQFKGKVSID----FSS  156 (725)
Q Consensus        97 l~~~~~~---~~~~~l~~L~~L~L~~N~i~~~~~~-------------~~~~l~~L~~L~Ls~N~i~~~~~~~----f~~  156 (725)
                      ++..-..   ..+...++|++|++++|.+......             .....+.|+.|++++|+++......    +..
T Consensus       105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~  184 (344)
T d2ca6a1         105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS  184 (344)
T ss_dssp             CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred             cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence            6521111   1223456666666666655311000             0123456777777777766432222    334


Q ss_pred             ccccCeeecCCccCCccCCCCcccccccCCCCCCCEEECccCcccccCChhhhhccccceeEEecCccceeccCcccccc
Q 048668          157 LKILWRLNLEQNNLGIGAANDLGFVTFLTNCSSLKVLSLSDNQFGGELPHSIANLSSTMIVFLIGGNQISGTIPLGIRNL  236 (725)
Q Consensus       157 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l  236 (725)
                      .+.|++|+|++|.++...... .....+...++|++|+|++|.++......+                     ...+...
T Consensus       185 ~~~L~~L~L~~n~i~~~g~~~-~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L---------------------~~~l~~~  242 (344)
T d2ca6a1         185 HRLLHTVKMVQNGIRPEGIEH-LLLEGLAYCQELKVLDLQDNTFTHLGSSAL---------------------AIALKSW  242 (344)
T ss_dssp             CTTCCEEECCSSCCCHHHHHH-HHHTTGGGCTTCCEEECCSSCCHHHHHHHH---------------------HHHGGGC
T ss_pred             hhhhccccccccccccccccc-chhhhhcchhhhcccccccccccccccccc---------------------ccccccc
Confidence            566777777777765321100 011335567788888888888763211111                     1223445


Q ss_pred             cCCceEEecccccCCCCC----hhhcC--CCCccEEeccCcccccC----CCCCCc-CCCCCCEEeCCCCcCC
Q 048668          237 VNLIALAVEVNQLHGTIP----DVIGE--LKNLQLLGLYKNFLQGS----IPSGLG-NLTKLAKLDLGSNSLQ  298 (725)
Q Consensus       237 ~~L~~L~L~~N~l~~~~~----~~~~~--l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~  298 (725)
                      ++|++|+|++|.|++...    .++..  .+.|++|++++|.|...    +...+. +.++|++|++++|++.
T Consensus       243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            666777777776654322    22222  24577888888776532    122222 4567888888888765

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=7.1e-15  Score=132.03  Aligned_cols=112  Identities=18%  Similarity=0.144  Sum_probs=83.3

Q ss_pred             ccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCC-cCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCC
Q 048668            9 IGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGN-SLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSL   87 (725)
Q Consensus         9 ~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   87 (725)
                      .+.+...++++++++++. ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|.++++|
T Consensus         4 ~C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L   82 (156)
T d2ifga3           4 ACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL   82 (156)
T ss_dssp             SSCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred             CCCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence            344556677888888777 56777777888888888665 4777777778888888888888888887777788888888


Q ss_pred             ceeeccCCCCCCCCChhhhcCCCCccEEEccCceee
Q 048668           88 EYFYLTSNRFSGSLPFDIVVNLPNLKELGIGANNFF  123 (725)
Q Consensus        88 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~  123 (725)
                      ++|+|++|+|+ .+|.++|..+ +|+.|+|++|.+.
T Consensus        83 ~~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          83 SRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CEEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             cceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence            88888888887 7777776544 5777777777664

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.53  E-value=4.3e-16  Score=160.99  Aligned_cols=139  Identities=16%  Similarity=0.237  Sum_probs=84.0

Q ss_pred             CCCCCEEeCCCCcCCCccccccccccccccccccccccccceecccCCccCCC-----cchhhhcCCCCCeEEccCcccc
Q 048668          284 LTKLAKLDLGSNSLQGNFIASQNKLIGALPQQLLSITTLSLYLDLSNNLLNGS-----LPQQVGNLKNLIILDISSNQFS  358 (725)
Q Consensus       284 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~p~~~~~~~~ll~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~  358 (725)
                      .+.|+.+++++|+++...       ...+...+.....+ +.|++++|.++..     +...+...++|+.|+|++|.++
T Consensus       157 ~~~L~~l~l~~n~i~~~~-------~~~l~~~l~~~~~L-~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         157 APPLRSIICGRNRLENGS-------MKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             CCCCCEEECCSSCCTGGG-------HHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             Ccccceeecccccccccc-------cccccchhhhhhhh-cccccccccccccccccchhhhhcchhhhccccccccccc
Confidence            456666777666554211       01111122222233 6667777766521     2234566788888888888875


Q ss_pred             cc----CccccccccCCcEEEccCCccccccCccc----c--CCCCCCEEeCCCCccccc----Cccccc-CCCCCCeEE
Q 048668          359 GM----IPVTLSTCVSLEYVDISSNCFHGIIPPSL----G--FLKSIKFLDVSCNNFSGQ----FPKFLE-NLSFLEFLN  423 (725)
Q Consensus       359 ~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~  423 (725)
                      ..    +...+..+++|++|+|++|.|++.....+    .  ..+.|+.||+++|+|+..    +...+. ++++|++|+
T Consensus       229 ~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~  308 (344)
T d2ca6a1         229 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE  308 (344)
T ss_dssp             HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred             ccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEE
Confidence            32    33456677888888888888875422222    2  235688888888888642    333342 467788888


Q ss_pred             cccccCe
Q 048668          424 LSYNHLE  430 (725)
Q Consensus       424 l~~N~l~  430 (725)
                      |++|++.
T Consensus       309 l~~N~~~  315 (344)
T d2ca6a1         309 LNGNRFS  315 (344)
T ss_dssp             CTTSBSC
T ss_pred             CCCCcCC
Confidence            8888885

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.4e-15  Score=150.35  Aligned_cols=177  Identities=15%  Similarity=0.108  Sum_probs=117.5

Q ss_pred             CcEEecCCCccCccCCccccCCCCCcEEEccCCcCCcc-CCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeecc
Q 048668           15 LQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGK-FPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLT   93 (725)
Q Consensus        15 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   93 (725)
                      +..+.++...+.. .........+|++||+++|.+++. .+..+.++++|++|+|++|.++...+..+..+++|++|+++
T Consensus        25 ~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls  103 (284)
T d2astb2          25 VIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  103 (284)
T ss_dssp             CSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence            5667777766653 233344567999999999998744 45567889999999999999988888889999999999999


Q ss_pred             CC-CCCCCCChhhhcCCCCccEEEccCc-eeeee-CCCcccc-cCccceecCCCcc--ccccCcc-CcccccccCeeecC
Q 048668           94 SN-RFSGSLPFDIVVNLPNLKELGIGAN-NFFGL-IPDSLSN-ASNLELLDLSNNQ--FKGKVSI-DFSSLKILWRLNLE  166 (725)
Q Consensus        94 ~N-~l~~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~-l~~L~~L~Ls~N~--i~~~~~~-~f~~l~~L~~L~L~  166 (725)
                      ++ .+++..-..++.++++|++|++++| .++.. ....+.. .++|+.|+++++.  ++..... .+..+++|++|+++
T Consensus       104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~  183 (284)
T d2astb2         104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS  183 (284)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred             ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence            95 5652111234567999999999986 44421 1122333 4689999998753  4322111 12345667777776


Q ss_pred             Ccc-CCccCCCCcccccccCCCCCCCEEECccC
Q 048668          167 QNN-LGIGAANDLGFVTFLTNCSSLKVLSLSDN  198 (725)
Q Consensus       167 ~N~-l~~~~~~~~~~~~~~~~l~~L~~L~L~~N  198 (725)
                      +|. ++....      ..+.++++|++|++++|
T Consensus       184 ~~~~itd~~~------~~l~~~~~L~~L~L~~C  210 (284)
T d2astb2         184 DSVMLKNDCF------QEFFQLNYLQHLSLSRC  210 (284)
T ss_dssp             TCTTCCGGGG------GGGGGCTTCCEEECTTC
T ss_pred             cccCCCchhh------hhhcccCcCCEEECCCC
Confidence            653 332211      33445666666666663

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.49  E-value=2.3e-16  Score=148.28  Aligned_cols=129  Identities=22%  Similarity=0.248  Sum_probs=84.6

Q ss_pred             CcEEecCCC--ccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeec
Q 048668           15 LQALALAGN--YLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYL   92 (725)
Q Consensus        15 l~~L~l~~n--~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   92 (725)
                      ++.++++++  .++ .++..+..+++|++|+|++|+|+.+ + .|..+++|++|+|++|+|+ .+|..+..+++|++|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            455555544  233 4556677777777777777777743 3 4777777777777777776 34555555667777777


Q ss_pred             cCCCCCCCCChhhhcCCCCccEEEccCceeeeeCC-CcccccCccceecCCCccccccC
Q 048668           93 TSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIP-DSLSNASNLELLDLSNNQFKGKV  150 (725)
Q Consensus        93 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~  150 (725)
                      ++|+|+ .++.  +..+++|+.|+|++|+|+.+.. ..|..+++|++|+|++|++....
T Consensus       101 ~~N~i~-~l~~--~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_         101 SYNQIA-SLSG--IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             SEEECC-CHHH--HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             cccccc-cccc--ccccccccccccccchhccccccccccCCCccceeecCCCccccCc
Confidence            777776 5532  4566777777777777765432 35667777777777777766443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=9.2e-14  Score=124.60  Aligned_cols=109  Identities=16%  Similarity=0.138  Sum_probs=91.8

Q ss_pred             CCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCC-cccccCcccccccCCCceeeccCCCCCCCCChhhhcCCCCccE
Q 048668           36 LSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAEN-KFYGMFPRSICNISSLEYFYLTSNRFSGSLPFDIVVNLPNLKE  114 (725)
Q Consensus        36 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~  114 (725)
                      ......++.+++++. ..|..+..+++|++|+|++| .|+.+.+.+|.++++|+.|+|++|+|+ .++.++|.++++|++
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCE
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-Ccccccccccccccc
Confidence            344567888998887 56777888999999999766 588888888999999999999999998 888888899999999


Q ss_pred             EEccCceeeeeCCCcccccCccceecCCCcccc
Q 048668          115 LGIGANNFFGLIPDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus       115 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                      |+|++|+|+.+.++.|..+ +|++|+|++|++.
T Consensus        85 L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             eeccCCCCcccChhhhccc-cccccccCCCccc
Confidence            9999999998777777655 6899999999885

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.47  E-value=3.8e-16  Score=146.74  Aligned_cols=134  Identities=19%  Similarity=0.319  Sum_probs=110.8

Q ss_pred             CccccCcccCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccC
Q 048668            6 PKEIGSLFKLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNIS   85 (725)
Q Consensus         6 p~~~~~l~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   85 (725)
                      |..+..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.+  ..+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence            356888999999999999998 454 5999999999999999998 5566666677899999999999854  3588999


Q ss_pred             CCceeeccCCCCCCCCCh-hhhcCCCCccEEEccCceeeeeCCCc----------ccccCccceecCCCcccc
Q 048668           86 SLEYFYLTSNRFSGSLPF-DIVVNLPNLKELGIGANNFFGLIPDS----------LSNASNLELLDLSNNQFK  147 (725)
Q Consensus        86 ~L~~L~L~~N~l~~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~----------~~~l~~L~~L~Ls~N~i~  147 (725)
                      +|+.|++++|+|+ .++. ..+..+++|+.|+|++|.++...+..          +..+++|+.||  +..|+
T Consensus       116 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         116 NLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            9999999999998 6654 56789999999999999998665543          45677777766  44554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.81  E-value=2.3e-10  Score=102.85  Aligned_cols=105  Identities=26%  Similarity=0.175  Sum_probs=60.5

Q ss_pred             CCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccCcccccccCCCceeeccCCCCCCCCCh--hhhcCCCCccEE
Q 048668           38 ALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMFPRSICNISSLEYFYLTSNRFSGSLPF--DIVVNLPNLKEL  115 (725)
Q Consensus        38 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~l~~L~~L  115 (725)
                      +.+.||+++++..    ..+..+..+..+++.+|.+. .++..+..+++|++|+|++|+|+ .++.  ..+..+++|+.|
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L   96 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKIL   96 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCccccc
Confidence            4556676665432    23444555556666655543 44556677888888888888887 5542  334455666666


Q ss_pred             EccCceeeeeCCCcccccCccceecCCCccccc
Q 048668          116 GIGANNFFGLIPDSLSNASNLELLDLSNNQFKG  148 (725)
Q Consensus       116 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~i~~  148 (725)
                      +|++|+|+.+.+-.+.+..+|+.|+|++|+++.
T Consensus        97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             ccccCccccchhhhhhhccccceeecCCCCcCc
Confidence            666666654433233333455666666666654

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.75  E-value=2.1e-10  Score=103.05  Aligned_cols=121  Identities=20%  Similarity=0.178  Sum_probs=88.5

Q ss_pred             cCcEEecCCCccCccCCccccCCCCCcEEEccCCcCCccCCCCCCCCCCCCEEEccCCcccccC--cccccccCCCceee
Q 048668           14 KLQALALAGNYLTGKLPDFIGNLSALQVIHIKGNSLGGKFPTTLGLLRNLVQLNVAENKFYGMF--PRSICNISSLEYFY   91 (725)
Q Consensus        14 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~   91 (725)
                      ..+.|+++++...   + .+..+..+..|...++... .++..+..+++|++|+|++|+|+.+.  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            4566777766532   2 3455556666666666554 55666677899999999999998654  45688899999999


Q ss_pred             ccCCCCCCCCChhhhcCCCCccEEEccCceeeeeCCC-------cccccCccceec
Q 048668           92 LTSNRFSGSLPFDIVVNLPNLKELGIGANNFFGLIPD-------SLSNASNLELLD  140 (725)
Q Consensus        92 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-------~~~~l~~L~~L~  140 (725)
                      |++|+|+ .++.-.+....+|+.|++++|.++.....       .+..+|+|+.||
T Consensus        98 Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          98 LSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            9999998 77765555667899999999999765443       256678888876

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.40  E-value=7.6e-07  Score=86.37  Aligned_cols=150  Identities=17%  Similarity=0.162  Sum_probs=98.7

Q ss_pred             HHHHHHhcCCCCCcccccccceEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCC
Q 048668          525 AELSKATSEFSSSNMIGQGSFGSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDF  603 (725)
Q Consensus       525 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  603 (725)
                      .++......|+..+..+.++.+.||+...  ++..+++|+...........+.+|...++.+. +--+.+++.++...+ 
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~-   83 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-   83 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence            45555566776655544455578998864  45567788886544333445678888887764 434567776654443 


Q ss_pred             CCcceeeEEEeccCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------
Q 048668          604 KGVDFKALVFEYMGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLHHHC-----------------------  660 (725)
Q Consensus       604 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-----------------------  660 (725)
                          ..|+||++++|..+.+......           ....++.++++.++.+|+..                       
T Consensus        84 ----~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          84 ----WSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             ----EEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             ----ceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence                6799999999988765443211           11234455555666666421                       


Q ss_pred             ---------------------------------CCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          661 ---------------------------------QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       661 ---------------------------------~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                                                       .+.++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                             01378999999999999877778999998864

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.78  E-value=1.7e-06  Score=77.20  Aligned_cols=18  Identities=6%  Similarity=0.176  Sum_probs=8.7

Q ss_pred             ccCCCCCcEEEccCCcCC
Q 048668           33 IGNLSALQVIHIKGNSLG   50 (725)
Q Consensus        33 ~~~l~~L~~L~l~~n~l~   50 (725)
                      +...++|++|+|++|.++
T Consensus        40 L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             HTTCSCCCEEECTTSCCB
T ss_pred             HhhCCccceeeccccccc
Confidence            444444555555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.76  E-value=5.9e-06  Score=73.59  Aligned_cols=114  Identities=11%  Similarity=0.094  Sum_probs=82.1

Q ss_pred             cCCCCCcEEEccCC-cCCcc----CCCCCCCCCCCCEEEccCCccccc----CcccccccCCCceeeccCCCCCCCCChh
Q 048668           34 GNLSALQVIHIKGN-SLGGK----FPTTLGLLRNLVQLNVAENKFYGM----FPRSICNISSLEYFYLTSNRFSGSLPFD  104 (725)
Q Consensus        34 ~~l~~L~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~  104 (725)
                      .+.++|++|+|+++ .++..    +-.++...++|++|+|++|.+...    +...+...+.|+.|+|++|.|++..-..
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999874 46422    233566778999999999999743    2345667789999999999997322222


Q ss_pred             ---hhcCCCCccEEEccCceeeee-------CCCcccccCccceecCCCcccc
Q 048668          105 ---IVVNLPNLKELGIGANNFFGL-------IPDSLSNASNLELLDLSNNQFK  147 (725)
Q Consensus       105 ---~~~~l~~L~~L~L~~N~i~~~-------~~~~~~~l~~L~~L~Ls~N~i~  147 (725)
                         ++..-+.|++|+|++|.+..+       +...+...++|+.|+++.+...
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~  144 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  144 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence               245567899999999976533       2345567789999999887643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.73  E-value=3.7e-05  Score=78.65  Aligned_cols=76  Identities=16%  Similarity=0.113  Sum_probs=48.4

Q ss_pred             cccccccceEEEEEEECCCceEEEEEEeecc----c---cchHHHHHHHHHHHHcCC-C--CcccceeeEeecCCCCCcc
Q 048668          538 NMIGQGSFGSVYKGILGEDEMIVAVKVINLK----Q---KGAFRSFVAECEALRNIR-H--RNLIKIITICSSTDFKGVD  607 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~~  607 (725)
                      +.||.|....||++....+++.|+||.....    .   .....+...|.+.++.+. +  ..+++++.+...       
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~-------  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE-------  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT-------
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC-------
Confidence            4689999999999998777888999976421    1   112334556888887663 2  456677665322       


Q ss_pred             eeeEEEeccCCCC
Q 048668          608 FKALVFEYMGNGS  620 (725)
Q Consensus       608 ~~~lv~e~~~~g~  620 (725)
                      ..++||||+++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            3478999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.67  E-value=4e-05  Score=73.28  Aligned_cols=131  Identities=15%  Similarity=0.106  Sum_probs=79.9

Q ss_pred             ccccccc-eEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCC--CcccceeeEeecCCCCCcceeeEEEec
Q 048668          539 MIGQGSF-GSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLIKIITICSSTDFKGVDFKALVFEY  615 (725)
Q Consensus       539 ~ig~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~  615 (725)
                      .+..|.. +.||+.... ++..+++|.......   ..+..|++.++.+..  -.+.++++++....     ..++||||
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~-----~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAG-----RDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----CEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccccc-----ceEEEEEe
Confidence            3444543 678998764 566678887654432   345677777776642  33566777655433     67899999


Q ss_pred             cCCCCHHHHhcccCCccccccCCHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 048668          616 MGNGSLEDWLHQSNDQVEVCKLSLIQRLNIAIDVASAIEYLH--------------------------------------  657 (725)
Q Consensus       616 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--------------------------------------  657 (725)
                      ++|.++.+.-           ...   ...+.++++.++-||                                      
T Consensus        88 i~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          88 VPGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             CSSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             eecccccccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            9886543210           000   011122222333333                                      


Q ss_pred             -------------hcC----CCCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          658 -------------HHC----QPPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       658 -------------~~~----~~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                                   ...    .+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                         211    12379999999999999877778999998764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.04  E-value=2.2e-05  Score=69.65  Aligned_cols=40  Identities=10%  Similarity=0.069  Sum_probs=16.8

Q ss_pred             CCCCCCEEEccCCccccc----CcccccccCCCceeeccCCCCC
Q 048668           59 LLRNLVQLNVAENKFYGM----FPRSICNISSLEYFYLTSNRFS   98 (725)
Q Consensus        59 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~   98 (725)
                      ..++|++|+|++|.+...    +-..+...++++.+++++|.+.
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            344444444444444321    1122333444555555544443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.03  E-value=2e-05  Score=69.91  Aligned_cols=40  Identities=10%  Similarity=0.066  Sum_probs=20.2

Q ss_pred             CCCCCCEEEccC-Cccccc----CcccccccCCCceeeccCCCCC
Q 048668           59 LLRNLVQLNVAE-NKFYGM----FPRSICNISSLEYFYLTSNRFS   98 (725)
Q Consensus        59 ~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~   98 (725)
                      +.++|++|+|++ +.|+..    +-.++...++|+.|+|++|.++
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence            345666666665 334321    2233445555666666666554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.92  E-value=0.00037  Score=68.99  Aligned_cols=72  Identities=15%  Similarity=0.118  Sum_probs=44.8

Q ss_pred             eEEEEEEECCCceEEEEEEeeccccchHHHHHHHHHHHHcCCCCcc--cceeeEeecCCCCCcceeeEEEeccCCC
Q 048668          546 GSVYKGILGEDEMIVAVKVINLKQKGAFRSFVAECEALRNIRHRNL--IKIITICSSTDFKGVDFKALVFEYMGNG  619 (725)
Q Consensus       546 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~g  619 (725)
                      -.||+++.. +|..|++|+.+.... ..+++..|.+.+..+....+  +..+.......+...+..+.|++|++|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            589999874 778899999875432 34667788888888753222  2222211111122334678899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.50  E-value=0.016  Score=58.43  Aligned_cols=72  Identities=19%  Similarity=0.147  Sum_probs=47.5

Q ss_pred             cccccccceEEEEEEECC-------CceEEEEEEeeccccchHHHHHHHHHHHHcCC-CCcccceeeEeecCCCCCccee
Q 048668          538 NMIGQGSFGSVYKGILGE-------DEMIVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLIKIITICSSTDFKGVDFK  609 (725)
Q Consensus       538 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  609 (725)
                      +.|+.|-.-.+|++....       ..+.|.+++.. .... .....+|.++++.+. +.-.+++++++.  +       
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--~-------  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFS--G-------  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET--T-------
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C-------
Confidence            457778888999998642       23567777764 2222 234568889888885 444457777642  1       


Q ss_pred             eEEEeccCCCC
Q 048668          610 ALVFEYMGNGS  620 (725)
Q Consensus       610 ~lv~e~~~~g~  620 (725)
                      ..||||++|..
T Consensus       117 g~I~efi~g~~  127 (395)
T d1nw1a_         117 GRLEEYIPSRP  127 (395)
T ss_dssp             EEEECCCCEEE
T ss_pred             ceEEEEecccc
Confidence            47999998753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.44  E-value=0.026  Score=54.73  Aligned_cols=31  Identities=29%  Similarity=0.314  Sum_probs=27.6

Q ss_pred             CCcEecCCCCCCeeecCCCceEEcccccccc
Q 048668          662 PPMVHGDLKPSNVLLDHDMVAHVGDFGLAKF  692 (725)
Q Consensus       662 ~~ivHrdlkp~Nill~~~~~~kl~Dfgla~~  692 (725)
                      .++||+|+.+.||+++.+...-|.||+.|..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4799999999999999987778999998763